PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Pesek, J; Buchler, R; Albrecht, R; Boland, W; Zeth, K				Pesek, Jelena; Buechler, Rita; Albrecht, Reinhard; Boland, Wilhelm; Zeth, Kornelius			Structure and Mechanism of Iron Translocation by a Dps Protein from Microbacterium arborescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE DETOXIFICATION; LISTERIA-INNOCUA DPS; DNA-BINDING PROTEIN; MYCOBACTERIUM-SMEGMATIS; STRESS RESISTANCE; ESCHERICHIA-COLI; STARVED CELLS; GROWTH-PHASE; FERRITIN; GENE	Dps (DNA protection during starvation) enzymes are a major class of dodecameric proteins that bacteria use to detoxify their cytosol through the uptake of reactive iron species. In the stationary growth phase of bacteria, Dps enzymes are primarily used to protect DNA by biocrystallization. To characterize the wild type Dps protein from Microbacterium arborescens that displays additional catalytic functions (amide hydrolysis and synthesis), we determined the crystal structure to a resolution of 2.05 angstrom at low iron content. The structure shows a single iron at the ferroxidase center coordinated by an oxo atom, one water molecule, and three ligating residues. An iron-enriched protein structure was obtained at 2 angstrom and shows the stepwise uptake of two hexahydrated iron atoms moving along channels at the 3-fold axis before a restriction site inside the channels requires removal of the hydration sphere. Supporting biochemical data provide insight into the regulation of this acylamino acid hydrolase. Moreover, the peroxidase activity of the protein was determined. The influence of iron and siderophores on the expression of acylamino acid hydrolase was monitored during several stages of cell growth. Altogether our data provide an interesting view of an unusual Dps-like enzyme evolutionarily located apart from the large Dps sequence clusters.	[Pesek, Jelena; Buechler, Rita; Boland, Wilhelm] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, D-07745 Jena, Germany; [Albrecht, Reinhard; Zeth, Kornelius] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany	Max Planck Society; Max Planck Society	Boland, W (corresponding author), Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Hans Knoll Str 8, D-07745 Jena, Germany.	Boland@ice-mpg.de; Kornelius.Zeth@tuebingen.mpg.de	Boland, Wilhelm/K-7762-2012	Boland, Wilhelm/0000-0001-6784-2534	MaxPlanck Society; German Science Foundation Deutsche Forschungsgemeinschaft [ZE522/3-2]; Human Frontier Science Program Foundation; Jena School of Microbial Communication	MaxPlanck Society(Max Planck Society); German Science Foundation Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program Foundation; Jena School of Microbial Communication	This work was supported by institutional funds from the MaxPlanck Society, German Science Foundation Deutsche Forschungsgemeinschaft Grant ZE522/3-2, a grant from the Human Frontier Science Program Foundation (to K. Z.), and the Jena School of Microbial Communication.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alborn HT, 1997, SCIENCE, V276, P945, DOI 10.1126/science.276.5314.945; Ali Azam T., 1999, J BACTERIOL, V181, P6361; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; [Anonymous], PYMOL MOL GRAPH SYST; Antelmann H, 1997, J BACTERIOL, V179, P7251, DOI 10.1128/jb.179.23.7251-7256.1997; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balaji V, 2011, PHYTOPATHOLOGY, V101, P349, DOI 10.1094/PHYTO-05-10-0132; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; Bellapadrona G, 2009, J BIOL CHEM, V284, P19101, DOI 10.1074/jbc.M109.014670; Castruita M, 2006, APPL ENVIRON MICROB, V72, P2918, DOI 10.1128/AEM.72.4.2918-2924.2006; Ceci P, 2003, J BIOL CHEM, V278, P20319, DOI 10.1074/jbc.M302114200; Chiancone E., 2003, IRON PROTEINS IRON S; Chiancone E, 2010, FRONT BIOSCI, V15, P122, DOI 10.2741/3610; Chiancone E, 2008, REND LINCEI-SCI FIS, V19, P261, DOI 10.1007/s12210-008-0018-4; Chowdhury RP, 2008, BIOCHEMISTRY-US, V47, P11110, DOI 10.1021/bi801158e; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Facey PD, 2009, MOL MICROBIOL, V73, P1186, DOI 10.1111/j.1365-2958.2009.06848.x; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Grant RA, 1998, NAT STRUCT BIOL, V5, P294, DOI 10.1038/nsb0498-294; Gupta S, 2002, PROTEIN ENG, V15, P503, DOI 10.1093/protein/15.6.503; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Haikarainen T, 2010, J BIOL INORG CHEM, V15, P183, DOI 10.1007/s00775-009-0582-9; Halsey TA, 2004, INFECT IMMUN, V72, P1155, DOI 10.1128/IAI.72.2.1155-1158.2004; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hong Y, 2006, FREE RADICAL RES, V40, P597, DOI 10.1080/10715760600618882; Ilari A, 2005, BIOCHEMISTRY-US, V44, P5579, DOI 10.1021/bi050005e; Ishikawa T, 2003, J BACTERIOL, V185, P1010, DOI 10.1128/JB.185.3.1010-1017.2003; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Michan C, 1999, J BACTERIOL, V181, P2759; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; Nicodeme M, 2004, CURR MICROBIOL, V48, P51, DOI 10.1007/s00284-003-4116-3; Olsen KN, 2005, MICROBIOL-SGM, V151, P925, DOI 10.1099/mic.0.27552-0; Papinutto E, 2002, J BIOL CHEM, V277, P15093, DOI 10.1074/jbc.M112378200; Ping LY, 2007, ENVIRON MICROBIOL, V9, P1572, DOI 10.1111/j.1462-2920.2007.01279.x; Polidoro M, 2002, GENE, V296, P121, DOI 10.1016/S0378-1119(02)00839-9; Reindel S, 2006, BIOMETALS, V19, P19, DOI 10.1007/s10534-005-3682-1; Sen A, 2000, ARCH MICROBIOL, V173, P352, DOI 10.1007/s002030000153; Strand KR, 2010, ARCH MICROBIOL, V192, P447, DOI 10.1007/s00203-010-0570-z; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; van Poecke RMP, 2004, PLANT BIOLOGY, V6, P387, DOI 10.1055/s-2004-820887; Wang SW, 2009, J BACTERIOL, V191, P4522, DOI 10.1128/JB.00272-09; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; Wiedenheft B, 2005, P NATL ACAD SCI USA, V102, P10551, DOI 10.1073/pnas.0501497102; Zeth K, 2004, P NATL ACAD SCI USA, V101, P13780, DOI 10.1073/pnas.0401821101; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200	54	31	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34872	34882		10.1074/jbc.M111.246108	http://dx.doi.org/10.1074/jbc.M111.246108			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21768097	hybrid, Green Published			2022-12-25	WOS:000295406300041
J	Chritton, JJ; Wickens, M				Chritton, Jacqueline J.; Wickens, Marvin			A Role for the Poly(A)-binding Protein Pab1p in PUF Protein-mediated Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; MSL-2 MESSENGER-RNA; TRANSLATION INITIATION; FUNCTIONAL INTERACTION; XENOPUS PUMILIO; IN-VITRO; YEAST; DROSOPHILA; INTERACTS; GERMLINE	PUF proteins regulate translation and mRNA stability throughout eukaryotes. Using a cell-free translation assay, we examined the mechanisms of translational repression of PUF proteins in the budding yeast Saccharomyces cerevisiae. We demonstrate that the poly(A)-binding protein Pab1p is required for PUF-mediated translational repression for two distantly related PUF proteins: S. cerevisiae Puf5p and Caenorhabditis elegans FBF-2. Pab1p interacts with oligo(A) tracts in the HO 3'-UTR, a target of Puf5p, to dramatically enhance the efficiency of Puf5p repression. Both the Pab1p ability to activate translation and interact with eukaryotic initiation factor 4G (eIF4G) were required to observe maximal repression by Puf5p. Repression was also more efficient when Pab1p was bound in close proximity to Puf5p. Puf5p may disrupt translation initiation by interfering with the interaction between Pab1p and eIF4G. Finally, we demonstrate two separable mechanisms of translational repression employed by Puf5p:a Pab1p-dependent mechanism and a Pab1p-independent mechanism.	[Chritton, Jacqueline J.] Univ Wisconsin Madison, Dept Genet, Madison, WI 53706 USA; [Wickens, Marvin] Univ Wisconsin Madison, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wickens, M (corresponding author), 433 Babcock Dr,315B Biochem Addit, Madison, WI 53706 USA.	wickens@biochem.wisc.edu			National Institutes of Health [GM31892, GM50942]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031892, R01GM050942, R37GM031892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grants GM31892 and GM50942 from the National Institutes of Health (to M. W. and J. J. C.).	ANDERSON JT, 1993, MOL CELL BIOL, V13, P2730, DOI 10.1128/MCB.13.5.2730; Beckmann K, 2005, CELL, V122, P529, DOI 10.1016/j.cell.2005.06.011; Bernstein D, 2005, RNA, V11, P447, DOI 10.1261/rna.7255805; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Burgess HM, 2010, BIOCHEM SOC T, V38, P1517, DOI 10.1042/BST0381517; Cao QP, 2010, RNA, V16, P221, DOI 10.1261/rna.1884610; Chagnovich D, 2001, P NATL ACAD SCI USA, V98, P11359, DOI 10.1073/pnas.201284398; Chang TC, 2004, GENE DEV, V18, P2010, DOI 10.1101/gad.1219104; Christiansen J, 2009, J MOL ENDOCRINOL, V43, P187, DOI 10.1677/JME-09-0016; Chritton JJ, 2010, RNA, V16, P1217, DOI 10.1261/rna.2070110; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Deng YF, 2008, GENE DEV, V22, P1037, DOI 10.1101/gad.1611308; Dresios J, 2000, BIOCHEMISTRY-US, V39, P7236, DOI 10.1021/bi9925266; Duncan KE, 2009, MOL CELL, V36, P571, DOI 10.1016/j.molcel.2009.09.042; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Gallie DR, 1998, GENE, V216, P1, DOI 10.1016/S0378-1119(98)00318-7; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Hook BA, 2007, J BIOL CHEM, V282, P15430, DOI 10.1074/jbc.M611253200; Jinek M, 2010, NAT STRUCT MOL BIOL, V17, P238, DOI 10.1038/nsmb.1768; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kaye JA, 2009, NEURON, V61, P57, DOI 10.1016/j.neuron.2008.11.012; Kessler SH, 1998, MOL CELL BIOL, V18, P51, DOI 10.1128/MCB.18.1.51; Koh YY, 2009, RNA, V15, P1090, DOI 10.1261/rna.1545309; Kozlov G, 2010, J BIOL CHEM, V285, P13599, DOI 10.1074/jbc.M109.089540; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Kuhn U, 1996, J MOL BIOL, V256, P20, DOI 10.1006/jmbi.1996.0065; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; MATHEWS MB, 2007, TRANSLATIONAL CONTRO; Melo EO, 2003, J BIOL CHEM, V278, P46357, DOI 10.1074/jbc.M307624200; Minshall N, 2007, J BIOL CHEM, V282, P37389, DOI 10.1074/jbc.M704629200; Nakahata S, 2003, MECH DEVELOP, V120, P865, DOI 10.1016/S0925-4773(03)00160-6; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; NETO OPD, 1995, NUCLEIC ACIDS RES, V23, P2198, DOI 10.1093/nar/23.12.2198; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Otero LJ, 1999, EMBO J, V18, P3153, DOI 10.1093/emboj/18.11.3153; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Patel GP, 2005, NUCLEIC ACIDS RES, V33, P7074, DOI 10.1093/nar/gki1014; Petrone PM, 2008, P NATL ACAD SCI USA, V105, P16549, DOI 10.1073/pnas.0801795105; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0; Sladic RT, 2004, EUR J BIOCHEM, V271, P450, DOI 10.1046/j.1432-1033.2003.03945.x; Sonenberg N, 2000, TRANSLATIONAL CONTRO; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Spassov DS, 2003, IUBMB LIFE, V55, P359, DOI 10.1080/15216540310001603093; Suh N, 2009, GENETICS, V181, P1249, DOI 10.1534/genetics.108.099440; Verrotti AC, 2000, DEVELOPMENT, V127, P5225; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Winstall E, 2000, J BIOL CHEM, V275, P21817, DOI 10.1074/jbc.M002412200; Wu J, 1998, J BIOL CHEM, V273, P34535, DOI 10.1074/jbc.273.51.34535; Zappavigna V, 2004, P NATL ACAD SCI USA, V101, P14800, DOI 10.1073/pnas.0406451101; Zekri L, 2009, MOL CELL BIOL, V29, P6220, DOI 10.1128/MCB.01081-09; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297	57	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33268	33278		10.1074/jbc.M111.264572	http://dx.doi.org/10.1074/jbc.M111.264572			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21768112	hybrid, Green Published			2022-12-25	WOS:000294968800046
J	Delint-Ramirez, I; Willoughby, D; Hammond, GVR; Ayling, LJ; Cooper, DMF				Delint-Ramirez, Ilse; Willoughby, Debbie; Hammond, Gerald V. R.; Ayling, Laura J.; Cooper, Dermot M. F.			Palmitoylation Targets AKAP79 Protein to Lipid Rafts and Promotes Its Regulation of Calcium-sensitive Adenylyl Cyclase Type 8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-ANCHORING PROTEIN; CAPACITATIVE CA2+ ENTRY; ADULT CARDIAC MYOCYTES; CHOLESTEROL DEPLETION; SIGNALING COMPONENTS; CAMP SYNTHESIS; LIVING CELLS; RICH DOMAINS; LOCALIZATION; MEMBRANE	PKA anchoring proteins (AKAPs) optimize the efficiency of cAMP signaling by clustering interacting partners. Recently, AKAP79 has been reported to directly bind to adenylyl cyclase type 8 (AC8) and to regulate its responsiveness to store-operated Ca2+ entry (SOCE). Although AKAP79 is well targeted to the plasma membrane via phospholipid associations with three N-terminal polybasic regions, recent studies suggest that AKAP79 also has the potential to be palmitoylated, which may specifically allow it to target the lipid rafts where AC8 resides and is regulated by SOCE. In this study, we have addressed the role of palmitoylation of AKAP79 using a combination of pharmacological, mutagenesis, and cell biological approaches. We reveal that AKAP79 is palmitoylated via two cysteines in its N-terminal region. This palmitoylation plays a key role in targeting the AKAP to lipid rafts in HEK-293 cells. Mutation of the two critical cysteines results in exclusion of AKAP79 from lipid rafts and alterations in its membrane diffusion behavior. This is accompanied by a loss of the ability of AKAP79 to regulate SOCE-dependent AC8 activity in intact cells and decreased PKA-dependent phosphorylation of raft proteins, including AC8. We conclude that palmitoylation plays a key role in the targeting and action of AKAP79. This novel property of AKAP79 adds an unexpected regulatory and targeting option for AKAPs, which may be exploited in the cellular context.	[Delint-Ramirez, Ilse; Willoughby, Debbie; Hammond, Gerald V. R.; Ayling, Laura J.; Cooper, Dermot M. F.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Cooper, DMF (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	dmfc2@cam.ac.uk	Hammond, Gerald R/A-5759-2016	Hammond, Gerald R/0000-0002-6660-3272	Wellcome Trust [RG31760]; European Commission [037189]	Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Wellcome Trust Program Grant RG31760 and European Commission Grant 037189 (led by Prof. Enno Klussmann).	Agarwal SR, 2011, J MOL CELL CARDIOL, V50, P500, DOI 10.1016/j.yjmcc.2010.11.015; Anania VG, 2011, J VIROL, V85, P2288, DOI 10.1128/JVI.01961-10; Bal M, 2010, J NEUROSCI, V30, P2311, DOI 10.1523/JNEUROSCI.5175-09.2010; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Calaghan S, 2008, J MOL CELL CARDIOL, V45, P88, DOI 10.1016/j.yjmcc.2008.04.004; Cooper DMF, 2006, TRENDS PHARMACOL SCI, V27, P426, DOI 10.1016/j.tips.2006.06.002; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Dart C, 2001, J BIOL CHEM, V276, P20499, DOI 10.1074/jbc.M101425200; Delint-Ramirez I, 2010, J NEUROSCI, V30, P8162, DOI 10.1523/JNEUROSCI.1792-10.2010; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Fagan KA, 2000, J BIOL CHEM, V275, P26530, DOI 10.1074/jbc.M001369200; Faruque OM, 2009, AM J PHYSIOL-CELL PH, V296, pC306, DOI 10.1152/ajpcell.00216.2008; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gao C, 2008, J NEUROCHEM, V106, P2489, DOI 10.1111/j.1471-4159.2008.05597.x; Gao XJ, 2008, GENOMICS, V92, P457, DOI 10.1016/j.ygeno.2008.08.013; GLANTZ SB, 1992, MOL BIOL CELL, V3, P1215, DOI 10.1091/mbc.3.11.1215; Gomez LL, 2002, J NEUROSCI, V22, P7027; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Huang GC, 2007, GENE DEV, V21, P3283, DOI 10.1101/gad.1610207; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; JACKSON CS, 1995, BIOCHEM SOC T, V23, P568, DOI 10.1042/bst0230568; Kenworthy Anne K., 2007, V398, P179, DOI 10.1007/978-1-59745-513-8_13; Kim C, 2006, EUR J CELL BIOL, V85, P651, DOI 10.1016/j.ejcb.2006.02.004; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Mumby SM, 1997, CURR OPIN CELL BIOL, V9, P148, DOI 10.1016/S0955-0674(97)80056-7; Neuberger G, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-1; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Ohvo H, 1996, BIOCHEMISTRY-US, V35, P8018, DOI 10.1021/bi9528816; Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983; Owen DM, 2009, TRAFFIC, V10, P962, DOI 10.1111/j.1600-0854.2009.00908.x; Pagano M, 2009, AM J PHYSIOL-CELL PH, V296, pC607, DOI 10.1152/ajpcell.00488.2008; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Saxton MJ, 2008, BIOPHYS J, V94, P760, DOI 10.1529/biophysj.107.114074; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; Shvartsman DE, 2006, TRAFFIC, V7, P917, DOI 10.1111/j.1600-0854.2006.00437.x; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; SIMSON R, 1995, BIOPHYS J, V69, P989, DOI 10.1016/S0006-3495(95)79972-6; Simson R, 1998, BIOPHYS J, V74, P297, DOI 10.1016/S0006-3495(98)77787-2; Smith KE, 2002, J BIOL CHEM, V277, P6025, DOI 10.1074/jbc.M109615200; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Suzuki T, 2001, MOL BRAIN RES, V89, P20, DOI 10.1016/S0169-328X(01)00051-1; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Varnai P, 2008, METHODS, V46, P167, DOI 10.1016/j.ymeth.2008.09.019; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Willoughby D, 2010, J BIOL CHEM, V285, P20328, DOI 10.1074/jbc.M110.120725	61	68	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32962	32975		10.1074/jbc.M111.243899	http://dx.doi.org/10.1074/jbc.M111.243899			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21771783	hybrid, Green Published			2022-12-25	WOS:000294968800014
J	Fraser, J; Boo, I; Poumbourios, P; Drummer, HE				Fraser, Johanna; Boo, Irene; Poumbourios, Pantelis; Drummer, Heidi E.			Hepatitis C Virus (HCV) Envelope Glycoproteins E1 and E2 Contain Reduced Cysteine Residues Essential for Virus Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; B TYPE-I; MEMBRANE-FUSION; CD81 BINDING; NEUTRALIZING ANTIBODIES; HEPARAN-SULFATE; CELL-CULTURE; VIRAL ENTRY; INFECTION; PARTICLES	The HCV envelope glycoproteins E1 and E2 contain eight and 18 highly conserved cysteine residues, respectively. Here, we examined the oxidation state of E1E2 heterodimers incorporated into retroviral pseudotyped particles (HCVpp) and investigated the significance of free sulfhydryl groups in cell culture-derived HCV (HCVcc) and HCVpp entry. Alkylation of free sulfhydryl groups on HCVcc/pp with a membrane-impermeable sulfhydryl-alkylating reagent 4-(N-maleimido)benzyl-alpha-trimethylammonium iodide (M135) prior to virus attachment to cells abolished infectivity in a dose-dependent manner. Labeling of HCVpp envelope proteins with EZ-Link maleimide-PEG2-biotin (maleimide-biotin) detected free thiol groups in both E1 and E2. Unlike retroviruses that employ disulfide reduction to facilitate virus entry, the infectivity of alkylated HCVcc could not be rescued by addition of exogenous reducing agents. Furthermore, the infectivity of HCVcc bound to target cells was not affected by addition of M135 indicative of a change in glycoprotein oxidation state from reduced to oxidized following virus attachment to cells. By contrast, HCVpp entry was reduced by 61% when treated with M135 immediately following attachment to cells, suggesting that the two model systems might demonstrate variations in oxidation kinetics. Glycoprotein oxidation was not altered following binding of HCVpp incorporated E1E2 to soluble heparin or recombinant CD81. These results suggest that HCV entry is dependent on the presence of free thiol groups in E1 and E2 prior to cellular attachment and reveals a new essential component of the HCV entry process.	[Fraser, Johanna; Boo, Irene; Poumbourios, Pantelis; Drummer, Heidi E.] Burnet Inst, Melbourne, Vic 3004, Australia; [Fraser, Johanna; Poumbourios, Pantelis; Drummer, Heidi E.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Drummer, Heidi E.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia	Burnet Institute; Monash University; University of Melbourne	Drummer, HE (corresponding author), Burnet Inst, 85 Commercial Rd, Melbourne, Vic 3004, Australia.	hdrummer@burnet.edu.au	Fraser, Johanna/I-2938-2014	Fraser, Johanna/0000-0002-8020-2985; Drummer, Heidi/0000-0002-0042-6277	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Bonnafous P, 2010, J GEN VIROL, V91, P1919, DOI 10.1099/vir.0.021071-0; Catanese MT, 2010, J VIROL, V84, P34, DOI 10.1128/JVI.02199-08; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Deleersnyder V, 1997, J VIROL, V71, P697, DOI 10.1128/JVI.71.1.697-704.1997; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Drummer HE, 2005, BIOCHEM BIOPH RES CO, V328, P251, DOI 10.1016/j.bbrc.2004.12.160; Drummer HE, 2004, J BIOL CHEM, V279, P30066, DOI 10.1074/jbc.M405098200; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; Drummer HE, 2002, J VIROL, V76, P11143, DOI 10.1128/JVI.76.21.11143-11147.2002; Drummer HE, 2007, J GEN VIROL, V88, P1144, DOI 10.1099/vir.0.82567-0; Drummer HE, 2006, J VIROL, V80, P7844, DOI 10.1128/JVI.00029-06; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fenouillet E, 2008, J BIOL CHEM, V283, P26340, DOI 10.1074/jbc.M805221200; Flint M, 2004, J VIROL, V78, P6875, DOI 10.1128/JVI.78.13.6875-6882.2004; Grove J, 2008, J VIROL, V82, P12020, DOI 10.1128/JVI.01569-08; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lavillette D, 2006, J BIOL CHEM, V281, P3909, DOI 10.1074/jbc.M509747200; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Li KJ, 2008, J VIROL, V82, P7135, DOI 10.1128/JVI.00448-08; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; McCaffrey K, 2007, J VIROL, V81, P9584, DOI 10.1128/JVI.02782-06; Meertens L, 2008, J VIROL, V82, P3555, DOI 10.1128/JVI.01977-07; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; Morikawa K, 2007, J MED VIROL, V79, P714, DOI 10.1002/jmv.20842; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Perez-Berna AJ, 2006, BIOCHEMISTRY-US, V45, P3755, DOI 10.1021/bi0523963; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roccasecca R, 2003, J VIROL, V77, P1856, DOI 10.1128/JVI.77.3.1856-1867.2003; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Roingeard P, 2004, BIOL CELL, V96, P103, DOI 10.1016/j.biolcel.2003.11.006; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Wallin M, 2004, EMBO J, V23, P54, DOI 10.1038/sj.emboj.7600012; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; Yagnik AT, 2000, PROTEINS, V40, P355, DOI 10.1002/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K; Yu XK, 2007, VIROLOGY, V367, P126, DOI 10.1016/j.virol.2007.05.038; Zahn A, 2005, J GEN VIROL, V86, P677, DOI 10.1099/vir.0.80614-0; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014; Zeisel MB, 2009, FUTURE MICROBIOL, V4, P511, DOI 10.2217/FMB.09.34; Zheng AH, 2007, J VIROL, V81, P12465, DOI 10.1128/JVI.01457-07; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100	68	37	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					31984	31992		10.1074/jbc.M111.269605	http://dx.doi.org/10.1074/jbc.M111.269605			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21768113	Green Published, hybrid			2022-12-25	WOS:000294726800007
J	Kouno, T; Kizuka, Y; Nakagawa, N; Yoshihara, T; Asano, M; Oka, S				Kouno, Tetsuya; Kizuka, Yasuhiko; Nakagawa, Naoki; Yoshihara, Toru; Asano, Masahide; Oka, Shogo			Specific Enzyme Complex of beta-1,4-Galactosyltransferase-II and Glucuronyltransferase-P Facilitates Biosynthesis of N-linked Human Natural Killer-1 (HNK-1) Carbohydrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; POLYSIALIC ACID; NERVOUS-SYSTEM; GOLGI ENZYMES; EPITOPE HNK-1; MOUSE-BRAIN; GLCAT-P; EXPRESSION; CLONING; FAMILY	Human natural killer-1 (HNK-1) carbohydrate is highly expressed in the nervous system and is involved in synaptic plasticity and dendritic spine maturation. This unique carbohydrate, consisting of a sulfated trisaccharide (HSO3-3GlcA beta 1-3Gal beta 1-4GlcNAc-), is biosynthesized by the successive actions of beta-1,4-galactosyltransferase (beta 4GalT), glucuronyltransferase (GlcAT-P and GlcAT-S), and sulfotransferase (HNK-1ST). A previous study showed that mice lacking beta 4GalT-II, one of seven beta 4GalTs, exhibited a dramatic loss of HNK-1 expression in the brain, although beta 4GalT-I-deficient mice did not. Here, we investigated the underlying molecular mechanism of the regulation of HNK-1 expression. First, focusing on a major HNK-1 carrier, neural cell adhesion molecule, we found that reduced expression of an N-linked HNK-1 carbohydrate caused by a deficiency of beta 4GalT-II is not likely due to a general loss of the beta 1,4-galactose residue as an acceptor for GlcAT-P. Instead, we demonstrated by co-immunoprecipitation and endoplasmic reticulum-retention analyses using Neuro2a (N2a) cells that beta 4GalT-II physically and specifically associates with GlcAT-P. In addition, we revealed by pull-down assay that Golgi luminal domains of beta 4GalT-II and GlcAT-P are sufficient for the complex to form. With an in vitro assay system, we produced the evidence that the kinetic efficiency k(cat)/K-m of GlcAT-P in the presence of beta 4GalT-II was increased about 2.5-fold compared with that in the absence of beta 4GalT-II. Finally, we showed that co-expression of beta 4GalT-II and GlcAT-P increased HNK-1 expression on various glycoproteins in N2a cells, including neural cell adhesion molecule. These results indicate that the specific enzyme complex of beta 4GalT-II with GlcAT-P plays an important role in the biosynthesis of HNK-1 carbohydrate.	[Kouno, Tetsuya; Nakagawa, Naoki; Oka, Shogo] Kyoto Univ, Grad Sch Med, Dept Biol Chem, Kyoto 6068507, Japan; [Kizuka, Yasuhiko] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068507, Japan; [Yoshihara, Toru; Asano, Masahide] Kanazawa Univ, Adv Sci Res Ctr, Div Transgen Anim Sci, Kanazawa, Ishikawa 9208640, Japan; [Yoshihara, Toru] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa 9208640, Japan	Kyoto University; Kyoto University; Kanazawa University; Kanazawa University	Oka, S (corresponding author), Kawahara Cho 53,Sakyo Ku, Kyoto 6068507, Japan.	shogo@hs.med.kyoto-u.ac.jp		Kizuka, Yasuhiko/0000-0002-3181-9743	Ministry of Education, Culture, Sports, Science and Technology [21370053]; Ministry of Health, Labor, and Welfare of Japan Health and Labour Sciences [H21-012]; Grants-in-Aid for Scientific Research [23500493] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan Health and Labour Sciences(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research (B) 21370053 (to S.O.) from the Ministry of Education, Culture, Sports, Science and Technology and in part by the Ministry of Health, Labor, and Welfare of Japan Health and Labour Sciences Research Grant on Comprehensive Research on Disability Health and Welfare, H21-012.	Almeida R, 1997, J BIOL CHEM, V272, P31979, DOI 10.1074/jbc.272.51.31979; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Guo S, 2001, GLYCOBIOLOGY, V11, P813, DOI 10.1093/glycob/11.10.813; Hennet T, 2002, CELL MOL LIFE SCI, V59, P1081, DOI 10.1007/s00018-002-8489-4; Huang HH, 2010, J CELL BIOL, V190, P893, DOI 10.1083/jcb.201004102; Inoue M, 2007, BRAIN RES, V1179, P1, DOI 10.1016/j.brainres.2007.05.012; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Kakuda S, 2005, GLYCOBIOLOGY, V15, P203, DOI 10.1093/glycob/cwi001; Kakuda S, 2004, PROTEIN EXPRES PURIF, V35, P111, DOI 10.1016/j.pep.2003.12.021; Kido M, 1998, BIOCHEM BIOPH RES CO, V245, P860, DOI 10.1006/bbrc.1998.8537; Kizuka Y, 2006, J BIOL CHEM, V281, P13644, DOI 10.1074/jbc.M601453200; Kizuka Y, 2009, J BIOL CHEM, V284, P9247, DOI 10.1074/jbc.M807517200; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; Kudo M, 1996, J BIOL CHEM, V271, P32667, DOI 10.1074/jbc.271.51.32667; Lee PL, 2009, GLYCOBIOLOGY, V19, P655, DOI 10.1093/glycob/cwp035; Lo NW, 1998, GLYCOBIOLOGY, V8, P517, DOI 10.1093/glycob/8.5.517; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Marzban H, 2004, J NEUROCYTOL, V33, P117, DOI 10.1023/B:NEUR.0000029652.96456.0d; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; Morita I, 2009, NEUROSCIENCE, V164, P1685, DOI 10.1016/j.neuroscience.2009.09.065; Morita I, 2009, J BIOL CHEM, V284, P30209, DOI 10.1074/jbc.M109.024208; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Nakamura N, 2001, J NEUROCHEM, V76, P29, DOI 10.1046/j.1471-4159.2001.00004.x; Nakayama J, 1996, J BIOL CHEM, V271, P1829, DOI 10.1074/jbc.271.4.1829; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; OKA S, 1992, J BIOL CHEM, V267, P22711; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SCHWARTING GA, 1987, DEV BIOL, V120, P65, DOI 10.1016/0012-1606(87)90104-7; Seiki T, 1999, BIOCHEM BIOPH RES CO, V255, P182, DOI 10.1006/bbrc.1999.0151; Seko A, 2006, TRENDS GLYCOSCI GLYC, V18, P209, DOI 10.4052/tigg.18.209; Seko A, 2008, J BIOL CHEM, V283, P33094, DOI 10.1074/jbc.M806933200; Sugimoto I, 2007, J BIOL CHEM, V282, P34896, DOI 10.1074/jbc.M704766200; Tagawa H, 2005, J BIOL CHEM, V280, P23876, DOI 10.1074/jbc.M501728200; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; Voshol H, 1996, J BIOL CHEM, V271, P22957, DOI 10.1074/jbc.271.38.22957; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yoshihara T, 2009, J BIOL CHEM, V284, P12550, DOI 10.1074/jbc.M809188200; YOSHIHARA Y, 1991, J CELL BIOL, V115, P731, DOI 10.1083/jcb.115.3.731	46	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31337	31346		10.1074/jbc.M111.233353	http://dx.doi.org/10.1074/jbc.M111.233353			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21771787	Green Published, hybrid			2022-12-25	WOS:000294487500029
J	Brouwers, L; Iskar, M; Zeller, G; van Noort, V; Bork, P				Brouwers, Lucas; Iskar, Murat; Zeller, Georg; van Noort, Vera; Bork, Peer			Network Neighbors of Drug Targets Contribute to Drug Side-Effect Similarity	PLOS ONE			English	Article							DISULFIRAM; INHIBITION; PREDICTION; PHARMACOLOGY	In pharmacology, it is essential to identify the molecular mechanisms of drug action in order to understand adverse side effects. These adverse side effects have been used to infer whether two drugs share a target protein. However, side-effect similarity of drugs could also be caused by their target proteins being close in a molecular network, which as such could cause similar downstream effects. In this study, we investigated the proportion of side-effect similarities that is due to targets that are close in the network compared to shared drug targets. We found that only a minor fraction of side-effect similarities (5.8%) are caused by drugs targeting proteins close in the network, compared to side-effect similarities caused by overlapping drug targets (64%). Moreover, these targets that cause similar side effects are more often in a linear part of the network, having two or less interactions, than drug targets in general. Based on the examples, we gained novel insight into the molecular mechanisms of side effects associated with several drug targets. Looking forward, such analyses will be extremely useful in the process of drug development to better understand adverse side effects.	[Brouwers, Lucas; Iskar, Murat; Zeller, Georg; van Noort, Vera; Bork, Peer] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany; [Bork, Peer] Max Delbruck Ctr Mol Med, Berlin, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Brouwers, L (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.	bork@embl.de	Bork, Peer/F-1813-2013; Zeller, Georg/M-6484-2013; van Noort, Vera/E-1053-2011; van Noort, Vera/GWZ-9038-2022	Bork, Peer/0000-0002-2627-833X; Zeller, Georg/0000-0003-1429-7485; van Noort, Vera/0000-0002-8436-6602; Iskar, Murat/0000-0001-8603-4313; Iskar, Murat/0000-0001-6448-8779	Bundesministerium fuer Bildung und Forschung (Nationales Genomforschungsnetz Foerderkennzeichen) [01GS08169]; European Commission	Bundesministerium fuer Bildung und Forschung (Nationales Genomforschungsnetz Foerderkennzeichen); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported in part by the Bundesministerium fuer Bildung und Forschung (Nationales Genomforschungsnetz Foerderkennzeichen 01GS08169) and by the European Commission (Erasmus fellowship to LB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Appel S, 1997, J CLIN PHARMACOL, V37, P229, DOI 10.1002/j.1552-4604.1997.tb04785.x; Bender A, 2007, CHEMMEDCHEM, V2, P861, DOI 10.1002/cmdc.200700026; Berthouze M, 2005, FEBS LETT, V579, P2973, DOI 10.1016/j.febslet.2005.04.040; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Chiang AP, 2009, CLIN PHARMACOL THER, V85, P259, DOI 10.1038/clpt.2008.274; Deane KH., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004554.PUB2; Desta Z, 2001, ANTIMICROB AGENTS CH, V45, P382, DOI 10.1128/AAC.45.2.382-392.2001; Fliri AF, 2010, TRENDS PHARMACOL SCI, V31, P547, DOI 10.1016/j.tips.2010.07.005; Fliri AF, 2009, J MED CHEM, V52, P8038, DOI 10.1021/jm901001p; Foti RS, 2010, COMB CHEM HIGH T SCR, V13, P145, DOI 10.2174/138620710790596718; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Hase T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000550; Hatton RC, 2007, ANN PHARMACOTHER, V41, P381, DOI 10.1345/aph.1H679; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Iskar M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000925; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; KHARASCH ED, 1993, CLIN PHARMACOL THER, V53, P643, DOI 10.1038/clpt.1993.85; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kuhn M, 2008, FEBS LETT, V582, P1283, DOI 10.1016/j.febslet.2008.02.024; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; LEMBERGER L, 1980, CLIN PHARMACOL THER, V27, P642, DOI 10.1038/clpt.1980.91; Liebler DC, 2005, NAT REV DRUG DISCOV, V4, P410, DOI 10.1038/nrd1720; Lin SF, 2010, ARTIF INTELL MED, V48, P161, DOI 10.1016/j.artmed.2009.11.002; Loughlin J, 2010, J CARDIOVASC PHARM T, V15, P151, DOI 10.1177/1074248409360357; Martin YC, 2002, J MED CHEM, V45, P4350, DOI 10.1021/jm020155c; Nacher Jose C., 2008, BMC Pharmacology, V8, P5, DOI 10.1186/1471-2210-8-5; Pache RA, 2008, FEBS LETT, V582, P1259, DOI 10.1016/j.febslet.2008.02.014; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; PETTERSSON H, 1982, J NEUROCHEM, V39, P628, DOI 10.1111/j.1471-4159.1982.tb07939.x; Reeves RR, 2004, PSYCHOSOMATICS, V45, P537, DOI 10.1176/appi.psy.45.6.537; Sanger GJ, 2009, NEUROGASTROENT MOTIL, V21, P1235, DOI 10.1111/j.1365-2982.2009.01425.x; Suthram S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000662; von Mering C, 2003, P NATL ACAD SCI USA, V100, P15428, DOI 10.1073/pnas.2136809100; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; WHITTING.HG, 1969, AM J PSYCHIAT, V125, P1725, DOI 10.1176/ajp.125.12.1725; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Zanzoni A, 2009, FEBS LETT, V583, P1759, DOI 10.1016/j.febslet.2009.03.001; Zhang L, 2009, AAPS J, V11, P300, DOI 10.1208/s12248-009-9106-3; Zhao SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011764; ZURCHER G, 1990, J NEUR TR S, P375	44	71	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22187	10.1371/journal.pone.0022187	http://dx.doi.org/10.1371/journal.pone.0022187			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765950	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000292781500039
J	Burns, JS; Kristiansen, M; Kristensen, LP; Larsen, KH; Nielsen, MO; Christiansen, H; Nehlin, J; Andersen, JS; Kassem, M				Burns, Jorge S.; Kristiansen, Malthe; Kristensen, Lars P.; Larsen, Kenneth H.; Nielsen, Maria O.; Christiansen, Helle; Nehlin, Jan; Andersen, Jens S.; Kassem, Moustapha			Decellularized Matrix from Tumorigenic Human Mesenchymal Stem Cells Promotes Neovascularization with Galectin-1 Dependent Endothelial Interaction	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; EXTRACELLULAR-MATRIX; TUMOR-GROWTH; DOWN-REGULATION; IN-VITRO; IMPAIRED ANGIOGENESIS; EWING SARCOMA; EXPRESSION; ADHESION; INTEGRIN	Background: Acquisition of a blood supply is fundamental for extensive tumor growth. We recently described vascular heterogeneity in tumours derived from cell clones of a human mesenchymal stem cell (hMSC) strain (hMSC-TERT20) immortalized by retroviral vector mediated human telomerase (hTERT) gene expression. Histological analysis showed that cells of the most vascularized tumorigenic clone, -BD11 had a pericyte-like alpha smooth muscle actin (ASMA+) and CD146+ positive phenotype. Upon serum withdrawal in culture, -BD11 cells formed cord-like structures mimicking capillary morphogenesis. In contrast, cells of the poorly tumorigenic clone, -BC8 did not stain for ASMA, tumours were less vascularized and serum withdrawal in culture led to cell death. By exploring the heterogeneity in hMSC-TERT20 clones we aimed to understand molecular mechanisms by which mesenchymal stem cells may promote neovascularization. Methodology/Principal Findings: Quantitative qRT-PCR analysis revealed similar mRNA levels for genes encoding the angiogenic cytokines VEGF and Angiopoietin-1 in both clones. However, clone-BD11 produced a denser extracellular matrix that supported stable ex vivo capillary morphogenesis of human endothelial cells and promoted in vivo neovascularization. Proteomic characterization of the -BD11 decellularized matrix identified 50 extracellular angiogenic proteins, including galectin-1. siRNA knock down of galectin-1 expression abrogated the ex vivo interaction between decellularized -BD11 matrix and endothelial cells. More stable shRNA knock down of galectin-1 expression did not prevent -BD11 tumorigenesis, but greatly reduced endothelial migration into -BD11 cell xenografts. Conclusions: Decellularized hMSC matrix had significant angiogenic potential with at least 50 angiogenic cell surface and extracellular proteins, implicated in attracting endothelial cells, their adhesion and activation to form tubular structures. hMSC -BD11 surface galectin-1 expression was required to bring about matrix-endothelial interactions and for xenografted hMSC -BD11 cells to optimally recruit host vasculature.	[Burns, Jorge S.; Kristiansen, Malthe; Larsen, Kenneth H.; Kassem, Moustapha] Univ So Denmark, Odense Univ Hosp, Dept Endocrinol & Metab, Mol Endocrinol Lab KMEB, Odense, Denmark; [Burns, Jorge S.] Univ Hosp Modena & Reggio Emilia, Dept Oncol Hematol & Resp Dis, Lab Cell Biol & Adv Canc Therapies, Modena, Italy; [Kristensen, Lars P.; Nielsen, Maria O.; Christiansen, Helle; Andersen, Jens S.] Univ So Denmark, Ctr Expt BioInformat, Dept Biochem & Mol Biol, Odense, Denmark; [Nehlin, Jan] Inst Clin Res, Dept Clin Immunol, Odense, Denmark; [Kassem, Moustapha] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia	University of Southern Denmark; Odense University Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; University of Southern Denmark; University of Southern Denmark; King Saud University	Burns, JS (corresponding author), Univ So Denmark, Odense Univ Hosp, Dept Endocrinol & Metab, Mol Endocrinol Lab KMEB, Odense, Denmark.	jorge.burns@unimore.it	Kassem, Moustapha/O-3819-2019; Larsen, Kenneth/HDO-5510-2022; Nehlin, Jan O./AAR-8721-2020; Burns, Jorge S./J-3395-2012; Burns, Jorge/AAF-5291-2019; Kassem, Moustapha/J-7688-2013; Andersen, Jens S/L-2100-2015	Kassem, Moustapha/0000-0003-1557-0869; Nehlin, Jan O./0000-0001-6038-5027; Burns, Jorge S./0000-0002-8602-1536; Kassem, Moustapha/0000-0003-1557-0869; Andersen, Jens S/0000-0002-6091-140X	Danish Medical Research Council; Danish Stem Cell Center (DASC); Novo Nordisk foundation; County of Funen, Denmark	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Stem Cell Center (DASC); Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); County of Funen, Denmark	This work was supported by grants from the Danish Medical Research Council, The Danish Stem Cell Center (DASC), the Novo Nordisk foundation and a grant from the County of Funen, Denmark. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2005, BIOCHEM BIOPH RES CO, V326, P527, DOI 10.1016/j.bbrc.2004.11.059; Abraham S, 2008, CIRC RES, V102, P562, DOI 10.1161/CIRCRESAHA.107.167908; Akhtar Nasim, 2002, Angiogenesis, V5, P75, DOI 10.1023/A:1021507031486; Arnoys EJ, 2007, ACTA HISTOCHEM, V109, P89, DOI 10.1016/j.acthis.2006.10.002; Arroyo AG, 2010, CARDIOVASC RES, V86, P226, DOI 10.1093/cvr/cvq049; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Ballard VLT, 2006, FASEB J, V20, P717, DOI 10.1096/fj.05-5131fje; Bauer AL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000445; BISSELL MJ, 1987, J CELL SCI, P327; Bohman S, 2005, J BIOL CHEM, V280, P42397, DOI 10.1074/jbc.M506724200; Bolontrade MF, 2002, CLIN CANCER RES, V8, P3622; Boraldi F, 2007, BBA-PROTEINS PROTEOM, V1774, P1402, DOI 10.1016/j.bbapap.2007.08.011; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Bougatef F, 2009, BLOOD, V114, P5547, DOI 10.1182/blood-2009-04-217380; Braden AR, 2009, J NANOSCI NANOTECHNO, V9, P2856, DOI 10.1166/jnn.2009.028; Burns JS, 2008, HISTOL HISTOPATHOL, V23, P1229, DOI 10.14670/HH-23.1229; Burns JS, 2005, CANCER RES, V65, P3126, DOI 10.1158/0008-5472.CAN-04-2218; Cai Weibo, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P407, DOI 10.2174/187152006778226530; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Carmona G, 2009, BLOOD, V113, P488, DOI 10.1182/blood-2008-02-138438; Chen CL, 2010, J CELL SCI, V123, P2901, DOI 10.1242/jcs.069765; Chen CS, 1997, IN VITRO CELL DEV-AN, V33, P796; Cheng CW, 2008, BIOCHEM BIOPH RES CO, V365, P285, DOI 10.1016/j.bbrc.2007.10.166; Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001; Clausse N, 1999, Angiogenesis, V3, P317, DOI 10.1023/A:1026584523789; Corselli M, 2010, ARTERIOSCL THROM VAS, V30, P1104, DOI 10.1161/ATVBAHA.109.191643; Daniels KJ, 1996, LAB INVEST, V75, P55; Davis GE, 2008, CURR OPIN HEMATOL, V15, P197, DOI 10.1097/MOH.0b013e3282fcc321; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; DELGADO VMC, 2010, FASEB J; DELUCA A, 2010, J CELL PHYSL; Demidova-Rice TN, 2011, WOUND REPAIR REGEN, V19, P59, DOI 10.1111/j.1524-475X.2010.00642.x; DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039; Destouches D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002518; Dings RPM, 2010, BIOCONJUGATE CHEM, V21, P20, DOI 10.1021/bc900287y; DuBois SG, 2010, CANCER-AM CANCER SOC, V116, P749, DOI 10.1002/cncr.24844; Fierro-Monti I, 2006, J PROTEOME RES, V5, P1367, DOI 10.1021/pr0504539; Francis ME, 2008, TISSUE ENG PART B-RE, V14, P19, DOI 10.1089/teb.2007.0115; Gaultier A, 2006, J BIOL CHEM, V281, P7332, DOI 10.1074/jbc.M511857200; Ghajar CM, 2010, EXP CELL RES, V316, P813, DOI 10.1016/j.yexcr.2010.01.013; Gong ZD, 2008, FASEB J, V22, P1635, DOI 10.1096/fj.07-087924; Graven KK, 1998, J LAB CLIN MED, V132, P456, DOI 10.1016/S0022-2143(98)90122-6; GRIEB G, 2010, SURGERY; Hovanessian AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015787; Hsieh SH, 2008, ONCOGENE, V27, P3746, DOI 10.1038/sj.onc.1211029; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Huang NF, 2008, REGEN MED, V3, P877, DOI 10.2217/17460751.3.6.877; Huang Y, 2006, BLOOD, V107, P3564, DOI 10.1182/blood-2005-07-2961; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Inagaki Y, 2010, BIOSCI TRENDS, V4, P56; INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317; IOZZOA RV, 2010, J CELL MOL MED; Ireson CR, 2006, MOL CANCER THER, V5, P2957, DOI 10.1158/1535-7163.MCT-06-0172; JEAN C, 2011, ONCOGENE; Kadri T, 2005, STEM CELLS DEV, V14, P204, DOI 10.1089/scd.2005.14.204; Keerl S, 2010, ANN PLAS SURG, V64, P487, DOI 10.1097/SAP.0b013e31819f3a3d; KLEIN G, 1995, BLOOD, V86, P1740, DOI 10.1182/blood.V86.5.1740.bloodjournal8651740; Korff T, 1999, J CELL SCI, V112, P3249; Korn R, 2005, BIOINFORMATICS, V21, P2766, DOI 10.1093/bioinformatics/bti416; Kotecki M, 2010, MICROVASC RES, V80, P339, DOI 10.1016/j.mvr.2010.07.012; Kubota Y, 1996, J DERMATOL SCI, V12, P36, DOI 10.1016/0923-1811(95)00462-9; Le Mercier M, 2008, J NEUROPATH EXP NEUR, V67, P456, DOI 10.1097/NEN.0b013e318170f892; Leifheit-Nestler M, 2010, ARTERIOSCL THROM VAS, V30, P1398, DOI 10.1161/ATVBAHA.110.206086; Leis M, 2004, J GEN VIROL, V85, P1995, DOI 10.1099/vir.0.79818-0; Lin JL, 2008, FEBS LETT, V582, P2615, DOI 10.1016/j.febslet.2008.06.033; Liu WF, 2011, INT J BIOCHEM CELL B, V43, P642, DOI 10.1016/j.biocel.2011.01.004; Loi M, 2010, J CONTROL RELEASE, V145, P66, DOI 10.1016/j.jconrel.2010.03.015; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Maeng YS, 2009, BLOOD, V113, P233, DOI 10.1182/blood-2008-06-162891; Magagnin MG, 2008, PROTEOMICS, V8, P1019, DOI 10.1002/pmic.200700551; Manevich E, 2007, J BIOL CHEM, V282, P25338, DOI 10.1074/jbc.M700089200; Meyer RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003848; Mitchell K, 2009, J CELL SCI, V122, P1778, DOI 10.1242/jcs.040956; Myrsky E, 2008, CLIN EXP IMMUNOL, V152, P111, DOI 10.1111/j.1365-2249.2008.03600.x; Nadalutti C, 2011, CELL PROLIFERAT, V44, P49, DOI 10.1111/j.1365-2184.2010.00716.x; NEHLS V, 1992, CELL TISSUE RES, V270, P469, DOI 10.1007/BF00645048; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Palmieri D, 2010, EXP CELL RES, V316, P789, DOI 10.1016/j.yexcr.2009.12.006; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Potier E, 2007, TISSUE ENG, V13, P1325, DOI 10.1089/ten.2006.0325; Primo L, 2010, CANCER RES, V70, P5759, DOI 10.1158/0008-5472.CAN-10-0507; Rangel R, 2007, P NATL ACAD SCI USA, V104, P4588, DOI 10.1073/pnas.0611653104; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; REING JE, 2008, TISSUE ENG A; Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Ruhl M, 1999, J BIOL CHEM, V274, P34361, DOI 10.1074/jbc.274.48.34361; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Schandorff S, 2007, NAT METHODS, V4, P465, DOI 10.1038/nmeth0607-465; Schlueter C, 2005, AM J PATHOL, V166, P1259, DOI 10.1016/S0002-9440(10)62344-9; Semon JA, 2010, CELL TISSUE RES, V341, P147, DOI 10.1007/s00441-010-0994-4; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; Serakinci N, 2004, ONCOGENE, V23, P5095, DOI 10.1038/sj.onc.1207651; SHIGA A, 2011, HUM MOL GENET; Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Sorrell JM, 2008, WOUND REPAIR REGEN, V16, P300, DOI 10.1111/j.1524-475X.2008.00369.x; Soucy PA, 2009, MATRIX BIOL, V28, P273, DOI 10.1016/j.matbio.2009.04.005; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; St Croix B, 2000, SCIENCE, V289, P1197; Tu QS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.152405; Valentine A, 2011, CLIN CANCER RES, V17, P1044, DOI 10.1158/1078-0432.CCR-10-2241; van der Schaft DWJ, 2005, CANCER RES, V65, P11520, DOI 10.1158/0008-5472.CAN-05-2468; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Virgintino D, 2008, J VASC RES, V45, P129, DOI 10.1159/000109965; Wang J, 2006, J NEUROCHEM, V96, P148, DOI 10.1111/j.1471-4159.2005.03521.x; Wang JH, 2007, CANCER RES, V67, P149, DOI 10.1158/0008-5472.CAN-06-2971; Ward C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012543; Young RM, 2008, J BIOL CHEM, V283, P16309, DOI 10.1074/jbc.M710079200; Zanetti M, 2004, MOL CELL BIOL, V24, P638, DOI 10.1128/MCB.24.2.638-650.2004; Zhang H, 2008, ACTA BIOCH BIOPH SIN, V40, P375, DOI 10.1111/j.1745-7270.2008.00420.x; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje; Zhou ZJ, 2004, CANCER RES, V64, P4699, DOI 10.1158/0008-5472.CAN-04-0810	119	47	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21888	10.1371/journal.pone.0021888	http://dx.doi.org/10.1371/journal.pone.0021888			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779348	Green Submitted, Green Published, gold			2022-12-25	WOS:000292680900014
J	Rozenberg, I; Sluka, SHM; Mocharla, P; Hallenberg, A; Rotzius, P; Boren, J; Krankel, N; Landmesser, U; Borsig, L; Luscher, TF; Eriksson, EE; Tanner, FC				Rozenberg, Izabela; Sluka, Susanna H. M.; Mocharla, Pavani; Hallenberg, Anders; Rotzius, Pierre; Boren, Jan; Kraenkel, Nicolle; Landmesser, Ulf; Borsig, Lubor; Luescher, Thomas F.; Eriksson, Einar E.; Tanner, Felix C.			Deletion of L-Selectin Increases Atherosclerosis Development in ApoE(-/-) Mice	PLOS ONE			English	Article							P-SELECTIN; CELL-ADHESION; IN-VIVO; INFLAMMATION; ENDOTHELIUM; LIGAND; RECRUITMENT; MONOCYTE; ALPHA	Atherosclerosis is an inflammatory disease characterized by accumulation of leukocytes in the arterial intima. Members of the selectin family of adhesion molecules are important mediators of leukocyte extravasation. However, it is unclear whether L-selectin (L-sel) is involved in the pathogenesis of atherosclerosis. In the present study, mice deficient in L-selectin (L-sel(-/-)) animals were crossed with mice lacking Apolipoprotein E (ApoE(-/-)). The development of atherosclerosis was analyzed in double-knockout ApoE/L-sel (ApoE(-/-) L-sel(-/-)) mice and the corresponding ApoE(-/-) controls fed either a normal or a high cholesterol diet (HCD). After 6 weeks of HCD, aortic lesions were increased two-fold in ApoE(-/-) L-sel(-/-) mice as compared to ApoE(-/-) controls (2.46%+/- 0.54% vs 1.28%+/- 0.24% of total aortic area; p < 0.05). Formation of atherosclerotic lesions was also enhanced in 6-month-old ApoE(-/-) L-sel(-/-) animals fed a normal diet (10.45%+/- 2.58% vs 1.87%+/- 0.37%; p < 0.05). In contrast, after 12 weeks of HCD, there was no difference in atheroma formation between ApoE(-/-) L-sel(-/-) and ApoE(-/-) mice. Serum cholesterol levels remained unchanged by L-sel deletion. Atherosclerotic plaques did not exhibit any differences in cellular composition assessed by immunohistochemistry for CD68, CD3, CD4, and CD8 in ApoE(-/-) L-sel(-/-) as compared to ApoE(-/-) mice. Leukocyte rolling on lesions in the aorta was similar in ApoE(-/-) L-sel(-/-) and ApoE(-/-) animals. ApoE(-/-) L-sel(-/-) mice exhibited reduced size and cellularity of peripheral lymph nodes, increased size of spleen, and increased number of peripheral lymphocytes as compared to ApoE(-/-) controls. These data indicate that L-sel does not promote atherosclerotic lesion formation and suggest that it rather protects from early atherosclerosis.	[Rozenberg, Izabela; Sluka, Susanna H. M.; Mocharla, Pavani; Kraenkel, Nicolle; Landmesser, Ulf; Borsig, Lubor; Luescher, Thomas F.; Tanner, Felix C.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Rozenberg, Izabela; Sluka, Susanna H. M.; Mocharla, Pavani; Kraenkel, Nicolle; Landmesser, Ulf; Borsig, Lubor; Luescher, Thomas F.; Tanner, Felix C.] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland; [Hallenberg, Anders; Rotzius, Pierre; Eriksson, Einar E.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Boren, Jan] Univ Gothenburg, Sahlgrenska Acad, Wallenberg Lab, Gothenburg, Sweden; [Landmesser, Ulf; Luescher, Thomas F.; Tanner, Felix C.] Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland; [Eriksson, Einar E.] Karolinska Inst, Dept Mol Med & Surg, Ctr Mol Med, Karolinska Hosp, Stockholm, Sweden	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Karolinska Institutet; University of Gothenburg; University of Zurich; University Zurich Hospital; Karolinska Institutet; Karolinska University Hospital	Rozenberg, I (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	felix.tanner@access.uzh.ch		Sluka, Susanna/0000-0001-9051-8492; Kraenkel, Nicolle/0000-0002-9363-1770; Borsig, Lubor/0000-0003-2263-9545	GEBERT RAceF FOUNDATION; Swiss National Science Foundation [3200B0-113328/1, 3100-068118.02/1]; Novo Nordisk Fonden [NNF11OC1014864] Funding Source: researchfish	GEBERT RAceF FOUNDATION; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was made possible by the GEBERT RAceF FOUNDATION (http://www.grstiftung.ch). Further support was obtained from the Swiss National Science Foundation (www.snf.ch) (grant 3200B0-113328/1 to F.C.T. and grant 3100-068118.02/1 to T.F.L.) and the Velux Foundation (http://www.veluxstiftung.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; BRANDLEY BK, 1990, CELL, V63, P861, DOI 10.1016/0092-8674(90)90487-Y; Dong ZM, 1998, J CLIN INVEST, V102, P145, DOI 10.1172/JCI3001; Eriksson EE, 2001, J EXP MED, V194, P205, DOI 10.1084/jem.194.2.205; Eriksson EE, 2001, FASEB J, V15, P1149, DOI 10.1096/fj.00-0537com; Eriksson EE, 2000, CIRC RES, V86, P526, DOI 10.1161/01.RES.86.5.526; Eriksson EE, 2008, J LEUKOCYTE BIOL, V84, P93, DOI 10.1189/jlb.1107786; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Giuffre L, 1997, J CELL BIOL, V136, P945, DOI 10.1083/jcb.136.4.945; Hansson GK, 2002, CIRC RES, V91, P281, DOI 10.1161/01.RES.0000029784.15893.10; Jung U, 1999, J IMMUNOL, V162, P6755; Kilian K, 2004, J BIOL CHEM, V279, P34472, DOI 10.1074/jbc.M405916200; Kunkel EJ, 1997, AM J PHYSIOL-HEART C, V272, pH1391, DOI 10.1152/ajpheart.1997.272.3.H1391; LEY K, 1991, BLOOD, V77, P2553; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; Mullenix PS, 2005, ANN VASC SURG, V19, P130, DOI 10.1007/s10016-004-0153-z; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; Ramos CL, 1999, CIRC RES, V84, P1237, DOI 10.1161/01.RES.84.11.1237; Rigby S, 2000, EUR J IMMUNOL, V30, P98, DOI 10.1002/1521-4141(200001)30:1<98::AID-IMMU98>3.3.CO;2-R; Rivera-Nieves J, 2006, J EXP MED, V203, P907, DOI 10.1084/jem.20052530; Rotzius P, 2010, AM J PATHOL, V177, P493, DOI 10.2353/ajpath.2010.090480; Rotzius P, 2009, ATHEROSCLEROSIS, V202, P111, DOI 10.1016/j.atherosclerosis.2008.04.009; Rozenberg I, 2010, ARTERIOSCL THROM VAS, V30, P923, DOI 10.1161/ATVBAHA.109.201079; Sperandio M, 2003, J EXP MED, V197, P1355, DOI 10.1084/jem.20021854; SPERTINI O, 1991, J IMMUNOL, V147, P2565; Steeber DA, 1996, J IMMUNOL, V157, P4899; TEDDER TF, 1995, FASEB J, V9, P866, DOI 10.1096/fasebj.9.10.7542213; TEDDER TF, 1995, J EXP MED, V181, P2259, DOI 10.1084/jem.181.6.2259; Willerson JT, 2002, PROG CARDIOVASC DIS, V44, P469, DOI 10.1053/pcad.2002.123782	30	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21675	10.1371/journal.pone.0021675	http://dx.doi.org/10.1371/journal.pone.0021675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760899	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000292657200017
J	Sun, X; Tong, LP; Wang, YT; Wu, YX; Sheng, HS; Lu, LJ; Wang, W				Sun, Xin; Tong, Li-Ping; Wang, Yu-Tong; Wu, Yong-Xiang; Sheng, Hong-Shen; Lu, Lian-Jun; Wang, Wen			Can Global Variation of Nasopharynx Cancer Be Retrieved from the Combined Analyses of IARC Cancer Information (CIN) Databases?	PLOS ONE			English	Article							HONG-KONG; CARCINOMA; SINGAPORE; CHINESE; TRENDS; RISK; EPIDEMIOLOGY; MORTALITY	Background: The international nasopharynx cancer (NPC) burdens are masked due to the lack of integrated studies that examine epidemiological data based on up-to-date international disease databases such as the Cancer Information (CIN) databases provided by the International Agency for Research on Cancer (IARC). Methods: By analyzing the most recently updated NPC epidemiological data available from IARC, we tried to retrieve the worldwide NPC burden and patterns from combined analysis with GLOBOCAN2008 and the Cancer Incidence in Five Continents (CI5) databases. We provide age-standardized rates (ASR) for NPC mortality in 20 highest cancer registries from GLOBOCAN2008 and the World Health Organization (WHO) mortality databases, respectively. However, NPC incidence data can not be retrieved since it is not individually listed in CI5 database. The trend of NPC mortality was investigated with Joinpoint analysis in the selected countries/regions with high ASR. Results: GLOBOCAN 2008 revealed that the highest NPC incidence rates in 2008 were in registries from South-Eastern Asia, Micronesia and Southern Africa with Malaysia, Indonesia and Singapore ranking the top 3. WHO mortality database analysis revealed that China Hong Kong, Singapore and Malta ranks the top 3 regions with the highest 5-year mortality rates. Conclusions: NPC mortality rate is about 2-3 times higher in male than that in female, and shows decrease tendency in those selected countries/regions during the analyzed periods. However, the integrated analyses of the current IARC CIN databases may not be suitable to retrieve epidemiological data of NPC. Much effort is required to improve the local cancer entry and regional death-reporting systems so as to aid similar studies.	[Sun, Xin] Fourth Mil Med Univ, Dept Paediat, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Tong, Li-Ping] Fourth Mil Med Univ, Dept Teaching & Training, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Wang, Yu-Tong] Fourth Mil Med Univ, Dept Emergency, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Wu, Yong-Xiang; Lu, Lian-Jun] Fourth Mil Med Univ, Dept Otolaryngol & Head Neck Surg, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Sheng, Hong-Shen] Gen Hosp Chengdu Mil Area, Dept Otolaryngol, Tian Hui Town, Sichuan, Peoples R China; [Wang, Wen] Fourth Mil Med Univ, KK Leung Brain Res Ctr, Unit Evidence Based Med, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Sun, X (corresponding author), Fourth Mil Med Univ, Dept Paediat, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China.	lulianj@fmmu.edu.cn; wangwen@fmmu.edu.cn			Natural Science Foundation of China [30572022, 30700345, 81070790]; Science and Technique Foundation from Shaanxi Province [2010k15-09-01]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technique Foundation from Shaanxi Province	The study was supported by grants from the Natural Science Foundation of China (numbers 30572022, 30700345 and 81070790) and the Science and Technique Foundation from Shaanxi Province (number 2010k15-09-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GLOBOCAN 2008 CANC I; [Anonymous], 1997, IARC SCI PUBL, Vi-xxxiv, P1; ARMSTRONG RW, 1979, BRIT J CANCER, V40, P557, DOI 10.1038/bjc.1979.221; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Corry J, 2004, Australas Radiol, V48, P509, DOI 10.1111/j.1440-1673.2004.01356.x; Curado M. P., 2008, IARC SCI PUBL, VIX, P1; DETHE G, 1981, YALE J BIOL MED, V54, P33; Devi BCR, 2004, CANCER EPIDEM BIOMAR, V13, P482; HILDESHEIM A, 1993, EPIDEMIOL REV, V15, P466, DOI 10.1093/oxfordjournals.epirev.a036130; JEANNEL D, 1993, INT J CANCER, V54, P536, DOI 10.1002/ijc.2910540403; Jia WH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-178; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; KIMURA Y, 2011, AURIS NASUS LARYNX; KOPPIKAR SB, 1988, J SURG ONCOL, V39, P179, DOI 10.1002/jso.2930390309; Kumar S, 1996, ANN NATL ACAD MED SC, V32, P199; Lee AWM, 2003, INT J CANCER, V103, P680, DOI 10.1002/ijc.10894; LEE HP, 1994, INT J CANCER, V59, P585, DOI 10.1002/ijc.2910590502; Luo JH, 2007, EUR J EPIDEMIOL, V22, P513, DOI 10.1007/s10654-007-9148-8; MUIR C, 1987, IARC SCI PUBL, V5, P1; Parkin DM, 1997, INT J CANCER, V70, P654, DOI 10.1002/(SICI)1097-0215(19970317)70:6&lt;654::AID-IJC5&gt;3.0.CO;2-U; PARKIN DM, 2002, IARC SCI PUBL, V8, P1; Wang H, 2004, ANN ACAD MED SINGAP, V33, P57; WELLS C, 1964, J Laryngol Otol, V78, P320, DOI 10.1017/S0022215100062137; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858	24	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e22039	10.1371/journal.pone.0022039	http://dx.doi.org/10.1371/journal.pone.0022039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760951	Green Submitted, gold, Green Published			2022-12-25	WOS:000292655400043
J	Wentzensen, N; Black, A; Jacobs, K; Yang, HP; Berg, CD; Caporaso, N; Peters, U; Ragard, L; Buys, SS; Chanock, S; Hartge, P				Wentzensen, Nicolas; Black, Amanda; Jacobs, Kevin; Yang, Hannah P.; Berg, Christine D.; Caporaso, Neil; Peters, Ulrike; Ragard, Lawrence; Buys, Saundra S.; Chanock, Stephen; Hartge, Patricia			Genetic Variation on 9p22 Is Associated with Abnormal Ovarian Ultrasound Results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RISK-FACTORS	Background: A recent ovarian cancer genome-wide association study (GWAS) identified a locus on 9p22 associated with reduced ovarian cancer risk. The single nucleotide polymorphism (SNP) markers localize to the BNC2 gene, which has been associated with ovarian development. Methods: We analyzed the association of 9p22 SNPs with transvaginal ultrasound (TVU) screening results and CA-125 blood levels from participants without ovarian cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO); 1,106 women with adequate ultrasound screening results and available genotyping information were included in the study. Results: We observed a significantly increased risk of abnormal suspicious TVU results for seven SNPs on 9p22, with odds ratios between 1.68 (95% CI: 1.04-2.72) for rs4961501 and 2.10 (95% CI: 1.31-3.38) for rs12379183. Associations were restricted to abnormal suspicious findings at the first TVU screen. We did not observe an association between 9p22 SNPs and CA-125 levels. Conclusions: Our findings suggest that 9p22 SNPs, which were found to be associated with decreased risk of ovarian cancer in a recent GWAS, are associated with sonographically detectable ovarian abnormalities. Our results corroborate the relevance of the 9p22 locus for ovarian biology. Further studies are required to understand the complex relationship between screening abnormalities and ovarian carcinogenesis and to evaluate whether this locus can influence the risk stratification of ovarian cancer screening.	[Wentzensen, Nicolas; Black, Amanda; Yang, Hannah P.; Caporaso, Neil; Chanock, Stephen; Hartge, Patricia] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Jacobs, Kevin; Chanock, Stephen] NCI, Core Genotyping Facil, Rockville, MD USA; [Berg, Christine D.] NCI, Canc Prevent Div, Bethesda, MD 20892 USA; [Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98104 USA; [Ragard, Lawrence] Westat Corp, Rockville, MD USA; [Buys, Saundra S.] Huntsman Canc Inst, Div Oncol, Salt Lake City, UT USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fred Hutchinson Cancer Center; Westat; Huntsman Cancer Institute	Wentzensen, N (corresponding author), NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.	wentzenn@mail.nih.gov	Berg, Christine/K-1047-2014; Wentzensen, Nicolas/AAG-8522-2019		Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, NIH, DHHS; NATIONAL CANCER INSTITUTE [ZIACP010152] Funding Source: NIH RePORTER	Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Division of Cancer Prevention, National Cancer Institute, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and by contracts from the Division of Cancer Prevention, National Cancer Institute, NIH, DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2009, CANC FACTS FIG 2009; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Buys SS, 2005, AM J OBSTET GYNECOL, V193, P1630, DOI 10.1016/j.ajog.2005.05.005; Crum CP, 2007, CURR OPIN OBSTET GYN, V19, P3, DOI 10.1097/GCO.0b013e328011a21f; FATHALLA MF, 1971, LANCET, V2, P163; Greenlee RT, 2010, OBSTET GYNECOL SURV, V65, P373, DOI 10.1097/OGX.0b013e3181e5a0d0; Hartge P, 2000, AM J OBSTET GYNECOL, V183, P1232, DOI 10.1067/mob.2000.107401; Loeb S, 2009, J UROLOGY, V182, P101, DOI 10.1016/j.juro.2009.02.126; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Nyante SJ, 2011, GYNECOL ONCOL, V120, P474, DOI 10.1016/j.ygyno.2010.11.015; Partridge E, 2009, OBSTET GYNECOL, V113, P775, DOI 10.1097/AOG.0b013e31819cda77; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; RIES LAG, 1993, CANCER-AM CANCER SOC, V71, P524; Romano RA, 2004, GENOMICS, V83, P821, DOI 10.1016/j.ygeno.2003.11.009; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Salehi F, 2008, J TOXICOL ENV HEAL B, V11, P301, DOI 10.1080/10937400701876095; Sato S, 2000, CANCER, V89, P582, DOI 10.1002/1097-0142(20000801)89:3<582::AID-CNCR13>3.0.CO;2-#; SONG H, 2009, NATURE GENETICS; VAN NJ, 2000, GYNECOL ONCOL, V77, P350; Vanhoutteghem A, 2006, P NATL ACAD SCI USA, V103, P12423, DOI 10.1073/pnas.0605086103; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727	22	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21731	10.1371/journal.pone.0021731	http://dx.doi.org/10.1371/journal.pone.0021731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750727	Green Submitted, gold, Green Published			2022-12-25	WOS:000292655400014
J	Blaschitz, A; Gauster, M; Fuchs, D; Lang, I; Maschke, P; Ulrich, D; Karpf, E; Takikawa, O; Schimek, MG; Dohr, G; Sedlmayr, P				Blaschitz, Astrid; Gauster, Martin; Fuchs, Dietmar; Lang, Ingrid; Maschke, Petra; Ulrich, Daniela; Karpf, Eva; Takikawa, Osamu; Schimek, Michael G.; Dohr, Gottfried; Sedlmayr, Peter			Vascular Endothelial Expression of Indoleamine 2,3-Dioxygenase 1 Forms a Positive Gradient towards the Feto-Maternal Interface	PLOS ONE			English	Article							TRYPTOPHAN CATABOLISM; HUMAN PLACENTA; INTERFERON-GAMMA; SERUM TRYPTOPHAN; DENDRITIC CELLS; T-CELLS; HLA-G; PREGNANCY; IDO; KYNURENINE	We describe the distribution of indoleamine 2,3-dioxygenase 1 (IDO1) in vascular endothelium of human first-trimester and term placenta. Expression of IDO1 protein on the fetal side of the interface extended from almost exclusively subtrophoblastic capillaries in first-trimester placenta to a nearly general presence on villous vascular endothelia at term, including also most bigger vessels such as villous arteries and veins of stem villi and vessels of the chorionic plate. Umbilical cord vessels were generally negative for IDO1 protein. In the fetal part of the placenta positivity for IDO1 was restricted to vascular endothelium, which did not co-express HLA-DR. This finding paralleled detectability of IDO1 mRNA in first trimester and term tissue and a high increase in the kynurenine to tryptophan ratio in chorionic villous tissue from first trimester to term placenta. Endothelial cells isolated from the chorionic plate of term placenta expressed IDO1 mRNA in contrast to endothelial cells originating from human umbilical vein, iliac vein or aorta. In first trimester decidua we found endothelium of arteries rather than veins expressing IDO1, which was complementory to expression of HLA-DR. An estimation of IDO activity on the basis of the ratio of kynurenine and tryptophan in blood taken from vessels of the chorionic plate of term placenta indicated far higher values than those found in the peripheral blood of adults. Thus, a gradient of vascular endothelial IDO1 expression is present at both sides of the feto-maternal interface.	[Blaschitz, Astrid; Gauster, Martin; Lang, Ingrid; Maschke, Petra; Dohr, Gottfried; Sedlmayr, Peter] Med Univ Graz, Ctr Mol Med, Inst Cell Biol Histol & Embryol, Graz, Austria; [Fuchs, Dietmar] Innsbruck Med Univ, Bioctr, Div Biol Chem, Innsbruck, Austria; [Ulrich, Daniela] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria; [Karpf, Eva] Med Univ Graz, Ctr Appl Biomed, Inst Pathol, Graz, Austria; [Takikawa, Osamu] Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Lab Radiat Safety, Obu City, Japan; [Schimek, Michael G.] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria	Medical University of Graz; Medical University of Innsbruck; Medical University of Graz; Medical University of Graz; National Center for Geriatrics & Gerontology; Medical University of Graz	Blaschitz, A (corresponding author), Med Univ Graz, Ctr Mol Med, Inst Cell Biol Histol & Embryol, Graz, Austria.	peter.sedlmayr@medunigraz.at	Gauster, Martin/K-7221-2019; Dohr, Gottfried/E-8070-2010; Fuchs, Dietmar/AAL-8011-2021; Gauster, Martin/M-9659-2019; Gold, Daniela/ABE-4818-2020	Fuchs, Dietmar/0000-0003-1627-9563; Gauster, Martin/0000-0003-0386-6857; Gold, Daniela/0000-0002-7196-454X; Lang-Olip, Ingrid/0000-0003-0403-4884	European Commission (Network of Excellence "The Control of Embryo Implantation (EMBIC)") [FP6-512040]; Medical University of Graz	European Commission (Network of Excellence "The Control of Embryo Implantation (EMBIC)")(European CommissionEuropean Commission Joint Research Centre); Medical University of Graz	This study was supported in part by the European Commission (Network of Excellence "The Control of Embryo Implantation (EMBIC)", FP6-512040, lead researcher involved: P.S.). Martin Gauster has been financially supported by the START funding program of the Medical University of Graz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adams O, 2004, MICROBES INFECT, V6, P806, DOI 10.1016/j.micinf.2004.04.007; Ariga H, 2001, TRANSFUSION, V41, P1524, DOI 10.1046/j.1537-2995.2001.41121524.x; BALL HJ, 2008, INT J BIOCH CELL BIO; Batista CEA, 2009, MOL IMAGING BIOL, V11, P460, DOI 10.1007/s11307-009-0225-0; Beutelspacher SC, 2006, AM J TRANSPLANT, V6, P1320, DOI 10.1111/j.1600-6143.2006.01324.x; Blaschitz A, 2005, MOL HUM REPROD, V11, P699, DOI 10.1093/molehr/gah185; Blaschitz A, 2000, HUM IMMUNOL, V61, P1074, DOI 10.1016/S0198-8859(00)00207-X; Blaschitz A, 2008, HISTOCHEM CELL BIOL, V130, P595, DOI 10.1007/s00418-008-0458-z; Cupurdija K, 2004, AM J REPROD IMMUNOL, V51, P117, DOI 10.1046/j.8755-8920.2003.00128.x; Daubener W, 2009, THROMB HAEMOSTASIS, V102, P1110, DOI 10.1160/TH09-04-0250; Dong MY, 2008, CELL PHYSIOL BIOCHEM, V21, P463, DOI 10.1159/000129639; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; Hansen AM, 2004, INT J PARASITOL, V34, P1309, DOI 10.1016/j.ijpara.2004.07.008; Holt PG, 2000, ALLERGY, V55, P688, DOI 10.1034/j.1398-9995.2000.00118.x; Honig A, 2004, J REPROD IMMUNOL, V61, P79, DOI 10.1016/j.jri.2003.11.002; Jones BJ, 2007, PLACENTA, V28, P1174, DOI 10.1016/j.placenta.2007.07.001; Knolle Percy A., 2006, V43, P151, DOI 10.1007/018; Koch CA, 2007, CELL IMMUNOL, V248, P12, DOI 10.1016/j.cellimm.2007.05.006; Kositz C, 2008, INT ARCH ALLERGY IMM, V147, P35, DOI 10.1159/000128584; Krabchi K, 2001, CLIN GENET, V60, P145, DOI 10.1034/j.1399-0004.2001.600209.x; Kudo Y, 2004, J REPROD IMMUNOL, V61, P87, DOI 10.1016/j.jri.2003.11.004; Lallemant M, 2000, NEW ENGL J MED, V343, P982, DOI 10.1056/NEJM200010053431401; Lang I, 2008, DIFFERENTIATION, V76, P1031, DOI 10.1111/j.1432-0436.2008.00302.x; Ligam P, 2005, PLACENTA, V26, P498, DOI 10.1016/j.placenta.2004.08.009; Lo YMD, 1998, BRIT J HAEMATOL, V100, P605; Lob S, 2008, BLOOD, V111, P2152, DOI 10.1182/blood-2007-10-116111; Lob S, 2009, CANCER IMMUNOL IMMUN, V58, P153, DOI 10.1007/s00262-008-0513-6; MacKenzie CR, 2007, CURR DRUG METAB, V8, P237, DOI 10.2174/138920007780362518; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Neelson JL, 2008, SCI AM, V298, P72; Nishizawa H, 2008, J OBSTET GYNAECOL RE, V34, P1, DOI 10.1111/j.1447-0756.2007.00679.x; Riesenberg R, 2007, CLIN CANCER RES, V13, P6993, DOI 10.1158/1078-0432.CCR-07-0942; Schrocksnadel H, 1996, OBSTET GYNECOL, V88, P47, DOI 10.1016/0029-7844(96)00084-1; Schrocksnadel K, 2003, LIFE SCI, V72, P785, DOI 10.1016/S0024-3205(02)02304-4; Sedlmayr P, 2002, MOL HUM REPROD, V8, P385, DOI 10.1093/molehr/8.4.385; Suzuki S, 2001, BIOCHEM J, V355, P425, DOI 10.1042/0264-6021:3550425; TAKIKAWA O, 1988, J BIOL CHEM, V263, P2041; Thebault P, 2007, AM J TRANSPLANT, V7, P2472, DOI 10.1111/j.1600-6143.2007.01960.x; Vernochet C, 2007, PLACENTA, V28, P639, DOI 10.1016/j.placenta.2006.10.006; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Widner B, 1997, CLIN CHEM, V43, P2424; Yamashita S, 2007, PROG HISTOCHEM CYTO, V41, P141, DOI 10.1016/j.proghi.2006.09.001; Yuasa HJ, 2007, J MOL EVOL, V65, P705, DOI 10.1007/s00239-007-9049-1	46	52	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21774	10.1371/journal.pone.0021774	http://dx.doi.org/10.1371/journal.pone.0021774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755000	Green Published, Green Submitted, gold			2022-12-25	WOS:000292632000027
J	Jurgensen, HJ; Madsen, DH; Ingvarsen, S; Melander, MC; Gardsvoll, H; Patthy, L; Engelholm, LH; Behrendt, N				Jurgensen, Henrik J.; Madsen, Daniel H.; Ingvarsen, Signe; Melander, Maria C.; Gardsvoll, Henrik; Patthy, Laszlo; Engelholm, Lars H.; Behrendt, Niels			A Novel Functional Role of Collagen Glycosylation INTERACTION WITH THE ENDOCYTIC COLLAGEN RECEPTOR uPARAP/ENDO180	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE MANNOSE RECEPTOR; PLASMINOGEN-ACTIVATOR RECEPTOR; GLUCOSYL-GALACTOSYL-PYRIDINOLINE; LYSYL HYDROXYLASE 3; UROKINASE RECEPTOR; EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANE; TRANSMEMBRANE GLYCOPROTEIN; ENDOCYTIC RECEPTOR; LECTIN RECEPTOR	Collagens make up the most abundant component of interstitial extracellular matrices and basement membranes. Collagen remodeling is a crucial process in many normal physiological events and in several pathological conditions. Some collagen subtypes contain specific carbohydrate side chains, the function of which is poorly known. The endocytic collagen receptor urokinase plasminogen activator receptor-associated protein (uPARAP)/Endo180 plays an important role in matrix remodeling through its ability to internalize collagen for lysosomal degradation. uPARAP/Endo180 is a member of the mannose receptor protein family. These proteins all include a fibronectin type II domain and a series of C-type lectin-like domains, of which only a minor part possess carbohydrate recognition activity. At least two of the family members, uPARAP/Endo180 and the mannose receptor, interact with collagens. The molecular basis for this interaction is known to involve the fibronectin type II domain but nothing is known about the function of the lectin domains in this respect. In this study, we have investigated a possible role of the single active lectin domain of uPARAP/Endo180 in the interaction with collagens. By expressing truncated recombinant uPARAP/Endo180 proteins and analyzing their interaction with collagens with high and low levels of glycosylation we demonstrated that this lectin domain interacts directly with glycosylated collagens. This interaction is functionally important because it was found to modulate the endocytic efficiency of the receptor toward highly glycosylated collagens such as basement membrane collagen IV. Surprisingly, this property was not shared by the mannose receptor, which internalized glycosylated collagens independently of its lectin function. This role of modulating its uptake efficiency by a specific receptor is a previously unrecognized function of collagen glycosylation.	[Behrendt, Niels] Rigshosp, BRIC, Finsen Lab, Copenhagen Bioctr, DK-2200 Copenhagen N, Denmark; [Jurgensen, Henrik J.; Madsen, Daniel H.; Ingvarsen, Signe; Melander, Maria C.; Gardsvoll, Henrik; Engelholm, Lars H.; Behrendt, Niels] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Ingvarsen, Signe] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Patthy, Laszlo] Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1113 Budapest, Hungary	Rigshospitalet; University of Copenhagen; University of Copenhagen; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences	Behrendt, N (corresponding author), Rigshosp, BRIC, Finsen Lab, Copenhagen Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	niels.behrendt@finsenlab.dk	Patthy, Laszlo/A-2353-2013; Patthy, Laszlo/Q-6058-2019; Ingvarsen, Signe Ziir/AAT-3296-2020	Ingvarsen, Signe Ziir/0000-0001-7800-6443; Behrendt, Niels/0000-0003-1833-3922; Engelholm, Lars/0000-0002-6616-1232; Madsen, Daniel Hargboel/0000-0002-3183-6201	Danish Cancer Society; Danish Medical Research Council; Danish Cancer Research Foundation; Lundbeck Foundation; Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer); European Community [201279]; "Grosserer Alfred Nielsen og Hustrus" foundation; Copenhagen University Hospital; University of Copenhagen, Faculty of Science; Lundbeck Foundation [R67-2010-6200] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Research Foundation; Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer)(Danmarks Grundforskningsfond); European Community(European Commission); "Grosserer Alfred Nielsen og Hustrus" foundation; Copenhagen University Hospital; University of Copenhagen, Faculty of Science; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Danish Cancer Society, Danish Medical Research Council, Danish Cancer Research Foundation, Lundbeck Foundation, Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer), European Community's Seventh Framework Programme FP7/2007-2011 under Grant agreement 201279 (to N. B.), grants from the "Grosserer Alfred Nielsen og Hustrus" foundation (to L. H. E.), the Copenhagen University Hospital (to D. H. M. and H. J. J.), and the University of Copenhagen, Faculty of Science (to S. I.).	AGUILAR JH, 1973, J BIOL CHEM, V248, P5106; Avery NC, 2006, PATHOL BIOL, V54, P387, DOI 10.1016/j.patbio.2006.07.005; Behrendt N, 2004, BIOL CHEM, V385, P103, DOI 10.1515/BC.2004.031; Behrendt N, 2000, J BIOL CHEM, V275, P1993, DOI 10.1074/jbc.275.3.1993; Brinckmann J, 1999, J INVEST DERMATOL, V113, P617, DOI 10.1046/j.1523-1747.1999.00735.x; Curino AC, 2005, J CELL BIOL, V169, P977, DOI 10.1083/jcb.200411153; East L, 2002, J BIOL CHEM, V277, P50469, DOI 10.1074/jbc.M208985200; East L, 2003, EMBO REP, V4, P710, DOI 10.1038/sj.embor.embor882; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Edge ASB, 2003, BIOCHEM J, V376, P339, DOI 10.1042/BJ20030673; Engelholm LH, 2009, FRONT BIOSCI-LANDMRK, V14, P2103, DOI 10.2741/3365; Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091; Engelholm LH, 2001, LAB INVEST, V81, P1403, DOI 10.1038/labinvest.3780354; Fasquelle C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000666; Gardsvoll H, 2007, PROTEIN EXPRES PURIF, V52, P384, DOI 10.1016/j.pep.2006.11.013; Garnero P, 2002, ARTHRITIS RHEUM-US, V46, P21, DOI 10.1002/1529-0131(200201)46:1<21::AID-ART10061>3.0.CO;2-Q; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Gineyts E, 2001, RHEUMATOLOGY, V40, P315, DOI 10.1093/rheumatology/40.3.315; Hayden MR, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-9; Holmbeck Kenn, 2006, Birth Defects Research, V78, P11, DOI 10.1002/bdrc.20064; Honardoust HA, 2006, HISTOPATHOLOGY, V49, P634, DOI 10.1111/j.1365-2559.2006.02559.x; HONG BS, 1979, BIOCHEMISTRY-US, V18, P4278, DOI 10.1021/bi00587a003; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Howard MJ, 2002, J BIOL CHEM, V277, P32320, DOI 10.1074/jbc.M203631200; Howard MJ, 2004, OSTEOARTHR CARTILAGE, V12, P74, DOI 10.1016/j.joca.2003.07.001; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; ISACKE CM, 1990, MOL CELL BIOL, V10, P2606, DOI 10.1128/MCB.10.6.2606; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Kjaergaard M, 2007, PROTEIN SCI, V16, P1934, DOI 10.1110/ps.072949607; Kjoller L, 2004, EXP CELL RES, V293, P106, DOI 10.1016/j.yexcr.2003.10.008; Kogianni G, 2009, EUR J CANCER, V45, P685, DOI 10.1016/j.ejca.2008.11.023; KRESINA TF, 1979, BIOCHEMISTRY-US, V18, P3089, DOI 10.1021/bi00581a028; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; Madsen DH, 2007, J BIOL CHEM, V282, P27037, DOI 10.1074/jbc.M701088200; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; Marastoni S, 2008, CONNECT TISSUE RES, V49, P203, DOI 10.1080/03008200802143190; Martinez-Pomares L, 2006, EUR J IMMUNOL, V36, P1074, DOI 10.1002/eji.200535685; Messaritou G, 2009, J CELL SCI, V122, P4042, DOI 10.1242/jcs.044305; Mizuno K, 2001, MICRON, V32, P317, DOI 10.1016/S0968-4328(00)00036-6; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Mousavi SA, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-39; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Nielsen BS, 2002, INT J CANCER, V98, P656, DOI 10.1002/ijc.10227; Notbohm H, 1999, J BIOL CHEM, V274, P8988, DOI 10.1074/jbc.274.13.8988; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Rasch MG, 2008, J IMMUNOL METHODS, V339, P55, DOI 10.1016/j.jim.2008.08.002; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Risteli M, 2009, J BIOL CHEM, V284, P28204, DOI 10.1074/jbc.M109.038190; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; SAGE H, 1979, BIOCHEMISTRY-US, V18, P3815, DOI 10.1021/bi00584a027; SAGE H, 1979, J BIOL CHEM, V254, P9893; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; Sheikh H, 2000, J CELL SCI, V113, P1021; Shi F, 2010, AM J PHYSIOL-CELL PH, V298, pC1265, DOI 10.1152/ajpcell.00341.2009; Sipila L, 2007, J BIOL CHEM, V282, P33381, DOI 10.1074/jbc.M704198200; Smith L, 2008, GENE EXPR PATTERNS, V8, P486, DOI 10.1016/j.gep.2008.06.006; Song FY, 2006, FRONT BIOSCI-LANDMRK, V11, P3100, DOI 10.2741/2036; SPIRO RG, 1967, J BIOL CHEM, V242, P4813; SPIRO RG, 1969, J BIOL CHEM, V244, P602; Sulek J, 2007, J HISTOCHEM CYTOCHEM, V55, P347, DOI 10.1369/jhc.6A7133.2006; Takahashi S, 2011, J NEURO-ONCOL, V103, P267, DOI 10.1007/s11060-010-0398-z; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; Thomas EK, 2005, J BIOL CHEM, V280, P22596, DOI 10.1074/jbc.M501155200; Tsilibary EC, 2003, J PATHOL, V200, P537, DOI 10.1002/path.1439; Wagenaar-Miller RA, 2007, MOL CELL BIOL, V27, P6309, DOI 10.1128/MCB.00291-07; WATTS C, 1992, J CELL SCI, V103, P1; Wienke D, 2003, MOL BIOL CELL, V14, P3592, DOI 10.1091/mbc.E02-12-0814; Wienke D, 2007, CANCER RES, V67, P10230, DOI 10.1158/0008-5472.CAN-06-3496; Wu K, 1996, J BIOL CHEM, V271, P21323, DOI 10.1074/jbc.271.35.21323	71	62	65	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32736	32748		10.1074/jbc.M111.266692	http://dx.doi.org/10.1074/jbc.M111.266692			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21768090	hybrid, Green Published			2022-12-25	WOS:000294726800082
J	Szeto, MD; Boissel, SJS; Baker, D; Thyme, SB				Szeto, Mindy D.; Boissel, Sandrine J. S.; Baker, David; Thyme, Summer B.			Mining Endonuclease Cleavage Determinants in Genomic Sequence Data	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIFUNCTIONAL HOMING ENDONUCLEASE; GROUP-I INTRON; DNA; SPECIFICITY; BINDING; RECOGNITION; EVOLUTION; DESIGN	Homing endonucleases have great potential as tools for targeted gene therapy and gene correction, but identifying variants of these enzymes capable of cleaving specific DNA targets of interest is necessary before the widespread use of such technologies is possible. We identified homologues of the LAGLIDADG homing endonuclease I-AniI and their putative target insertion sites by BLAST searches followed by examination of the sequences of the flanking genomic regions. Amino acid substitutions in these homologues that were located close to the target site DNA, and thus potentially conferring differences in target specificity, were grafted onto the I-AniI scaffold. Many of these grafts exhibited novel and unexpected specificities. These findings show that the information present in genomic data can be exploited for endonuclease specificity redesign.	[Szeto, Mindy D.; Boissel, Sandrine J. S.; Baker, David; Thyme, Summer B.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Thyme, Summer B.] Univ Washington, Dept Biomol Struct & Design, Seattle, WA 98195 USA; [Boissel, Sandrine J. S.] Univ Washington, Dept Mol & Cellular Biol, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Thyme, SB (corresponding author), Box 357350, Seattle, WA 98195 USA.	sthyme@u.washington.edu	Baker, David/K-8941-2012; Szeto, Mindy/GPP-5886-2022	Baker, David/0000-0001-7896-6217; Thyme, Summer/0000-0003-3593-4148; Szeto, Mindy/0000-0003-3642-3753	National Institutes of Health [GM084433, RL1CA133832]; Foundation for the National Institutes of Health through the Gates Foundation Grand Challenges in Global Health Initiative; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [RL1CA133832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084433] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the National Institutes of Health through the Gates Foundation Grand Challenges in Global Health Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM084433 and RL1CA133832, the Foundation for the National Institutes of Health through the Gates Foundation Grand Challenges in Global Health Initiative, and the Howard Hughes Medical Institute.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amitai G, 2007, HFSP J, V1, P67, DOI [10.2976/1.2739115/10.2976/1, 10.2976/1.2739115]; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Ashworth J, 2010, NUCLEIC ACIDS RES, V38, P5601, DOI 10.1093/nar/gkq283; Barzel A., 2011, NUCL ACIDS IN PRESS; Becker NB, 2006, NUCLEIC ACIDS RES, V34, P5638, DOI 10.1093/nar/gkl683; Bloom JD, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-17; Bolduc JM, 2003, GENE DEV, V17, P2875, DOI 10.1101/gad.1109003; Chevalier B, 2005, NUCL ACID M, V16, P33; Chevalier B, 2003, J MOL BIOL, V329, P253, DOI 10.1016/S0022-2836(03)00447-9; Chevalier BS, 2002, MOL CELL, V10, P895, DOI 10.1016/S1097-2765(02)00690-1; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Doyon JB, 2006, J AM CHEM SOC, V128, P2477, DOI 10.1021/ja057519l; Gimble FS, 2001, NUCLEIC ACIDS RES, V29, P4215, DOI 10.1093/nar/29.20.4215; Grishin Alexander, 2010, Journal of Bioinformatics and Computational Biology, V8, P453, DOI 10.1142/S0219720010004665; Ho Y, 1997, P NATL ACAD SCI USA, V94, P8994, DOI 10.1073/pnas.94.17.8994; Jarjour J, 2009, NUCLEIC ACIDS RES, V37, P6871, DOI 10.1093/nar/gkp726; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Longo A, 2005, NAT STRUCT MOL BIOL, V12, P779, DOI 10.1038/nsmb976; Moure CM, 2003, J MOL BIOL, V334, P685, DOI 10.1016/j.jmb.2003.09.068; Murphy PM, 2009, P NATL ACAD SCI USA, V106, P9215, DOI 10.1073/pnas.0811070106; Paques F, 2007, CURR GENE THER, V7, P49, DOI 10.2174/156652307779940216; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Scalley-Kim M, 2007, J MOL BIOL, V372, P1305, DOI 10.1016/j.jmb.2007.07.052; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takeuchi R, 2009, NUCLEIC ACIDS RES, V37, P877, DOI 10.1093/nar/gkn1007; Thyme SB, 2009, NATURE, V461, P1300, DOI 10.1038/nature08508; Ulge UY, 2011, NUCLEIC ACIDS RES, V39, P4330, DOI 10.1093/nar/gkr022	33	15	16	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32617	32627		10.1074/jbc.M111.259572	http://dx.doi.org/10.1074/jbc.M111.259572			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778233	Green Published, hybrid			2022-12-25	WOS:000294726800071
J	Walsh, JG; Logue, SE; Luthi, AU; Martin, SJ				Walsh, John G.; Logue, Susan E.; Luethi, Alexander U.; Martin, Seamus J.			Caspase-1 Promiscuity Is Counterbalanced by Rapid Inactivation of Processed Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; NF-KAPPA-B; INFLAMMATORY CASPASES; ACTIVATION; PROTEIN; APOPTOSIS; SUBSTRATE; FORMS; SPECIFICITIES; PROTEASES	Members of the caspase family of cysteine proteases coordinate the highly disparate processes of apoptosis and inflammation. However, although hundreds of substrates for the apoptosis effector caspases (caspase-3 and caspase-7) have been identified, only two confirmed substrates for the key inflammatory protease (caspase-1) are known. Whether this reflects intrinsic differences in the substrate specificity of inflammatory versus apoptotic caspases or their relative abundance in vivo is unknown. To address this issue, we have compared the specificity of caspases-1, -3, and -7 toward peptide and protein substrates. Contrary to expectation, caspase-1 displayed concentration-dependent promiscuity toward a variety of substrates, suggesting that caspase-1 specificity is maintained by restricting its abundance. Although endogenous concentrations of caspase-1 were found to be similar to caspase-3, processed caspase-1 was found to be much more labile, with a half-life of similar to 9 min. This contrasted sharply with the active forms of caspase-3 and caspase-7, which exhibited half-lives of 8 and 11 h, respectively. We propose that the high degree of substrate specificity displayed by caspase-1 is maintained through rapid spontaneous inactivation of this protease.	[Walsh, John G.; Logue, Susan E.; Luethi, Alexander U.; Martin, Seamus J.] Trinity Coll Dublin, Dept Genet, Smurfit Inst, Mol Cell Biol Lab, Dublin 2, Ireland	Trinity College Dublin	Martin, SJ (corresponding author), Trinity Coll Dublin, Dept Genet, Smurfit Inst, Mol Cell Biol Lab, Dublin 2, Ireland.	martinsj@tcd.ie	Logue, Susan/G-3002-2010; Logue, Susan/K-7748-2019	Logue, Susan/0000-0001-7938-3558; Martin, Seamus/0000-0002-8539-3143	Science Foundation Ireland [07/SRC/B1144, 08/IN.1/B2031]; Wellcome Trust United Kingdom [082749]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Wellcome Trust United Kingdom(Wellcome Trust)	This work was supported by Strategic Research Cluster and Principal Investigator grants from the Science Foundation Ireland (07/SRC/B1144 and 08/IN.1/B2031) and The Wellcome Trust United Kingdom (082749).	Agard NJ, 2010, MOL CELL PROTEOMICS, V9, P880, DOI 10.1074/mcp.M900528-MCP200; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Brodbeck WG, 1996, J IMMUNOL, V156, P2528; Creagh EM, 2003, IMMUNOL REV, V193, P10, DOI 10.1034/j.1600-065X.2003.00048.x; Dang LC, 1996, BIOCHEMISTRY-US, V35, P14910, DOI 10.1021/bi9617771; GU Y, 1995, EMBO J, V14, P1923, DOI 10.1002/j.1460-2075.1995.tb07184.x; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Kahns S, 2003, J BIOL CHEM, V278, P23376, DOI 10.1074/jbc.M300495200; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Li HF, 2009, J IMMUNOL, V183, P1528, DOI 10.4049/jimmunol.0901080; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Pereira NA, 2008, BIOCHEM BIOPH RES CO, V377, P873, DOI 10.1016/j.bbrc.2008.10.101; Rehm M, 2006, EMBO J, V25, P4338, DOI 10.1038/sj.emboj.7601295; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Stennicke HR, 1999, METHODS, V17, P313, DOI 10.1006/meth.1999.0745; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Talanian RV, 1996, J BIOL CHEM, V271, P21853, DOI 10.1074/jbc.271.36.21853; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Weigert A, 2010, BLOOD, V115, P3531, DOI 10.1182/blood-2009-10-243444; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273	34	58	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32513	32524		10.1074/jbc.M111.225862	http://dx.doi.org/10.1074/jbc.M111.225862			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21757759	Green Published, hybrid			2022-12-25	WOS:000294726800061
J	Li, G; Deng, XY; Wu, C; Zhou, Q; Chen, LJ; Shi, Y; Huang, HS; Zhou, NM				Li, Guo; Deng, Xiaoyan; Wu, Chun; Zhou, Qi; Chen, Linjie; Shi, Ying; Huang, Haishan; Zhou, Naiming			Distinct Kinetic and Spatial Patterns of Protein Kinase C (PKC)- and Epidermal Growth Factor Receptor (EGFR)-dependent Activation of Extracellular Signal-regulated Kinases 1 and 2 by Human Nicotinic Acid Receptor GPR109A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; COUPLED RECEPTORS; MOLECULAR-IDENTIFICATION; BETA-ARRESTIN; PATHWAY; NIACIN; ERK1/2; ALPHA; GAMMA; TRANSACTIVATION	Nicotinic acid (niacin) has been widely used as a lipid-lowering drug for several decades, and recently, orphan G protein-coupled receptor GPR109A has been identified as a receptor for niacin. Mechanistic investigations have shown that, upon niacin activation, GPR109A couples to a G(i) protein and inhibits adenylate cyclase activity, leading to inhibition of liberation of free fatty acid. However, the underlying molecular mechanisms for GPR109A signaling remain largely unknown. Using CHO-K1 cells stably expressing GPR109A and A431 cells, which are a human epidermoid cell line with high levels of endogenous expression of functional GPR109A receptors, we found that activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) by niacin was rapid, peaking at 5 min, and was significantly blocked by pertussis toxin. Furthermore, time course experiments with different kinase inhibitors demonstrated that GPR109A induced ERK1/2 activation via the matrix metalloproteinase/epidermal growth factor receptor transactivation pathway at both early and later time points (2-5 min); this pathway was distinct from the PKC pathway-mediated ERK1/2 phosphorylation that occurs at early time points (<= 2 min) in response to niacin. Overexpression of G beta gamma subunit scavengers beta ARK1-CT and the G alpha subunit of transducin led to a significant reduction of ERK1/2 phosphorylation, suggesting a critical role for beta gamma subunits in GPR109A-activated ERK1/2 phosphorylation. Using arrestin-2/3-specific siRNA and an internalization-deficient GPR109A mutant, we found that arrestin-2 and arrestin-3 were not involved in GPR109A-mediated ERK1/2 activation. In conclusion, our findings demonstrate that upon binding to niacin GPR109A receptors initially activate G(i), leading to dissociation of the G beta gamma subunit from activated G(i), and subsequently induce ERK1/2 activation via two distinct pathways, one PKC-dependent pathway occurring at a peak time of <= 2 min and the other matrix metalloproteinase-dependent growth factor receptor trans-activation occurring at both early and later time points (2-5 min).	[Li, Guo; Deng, Xiaoyan; Wu, Chun; Zhou, Qi; Chen, Linjie; Shi, Ying; Huang, Haishan; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Zhou, NM (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Biochem, Zijingang Campus,388 Yuhang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	znm2000@yahoo.com	Zhou, Naiming/AHC-1121-2022	Wu, Chun/0000-0003-2858-8064	Ministry of Science and Technology [2008AA02Z138]; Zhejiang Natural Science Foundation [Z2080207]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by Ministry of Science and Technology Grant 2008AA02Z138 and Zhejiang Natural Science Foundation Grant Z2080207.	Ahn S, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M808463200; Antonelli V, 2000, MOL BIOL CELL, V11, P1129, DOI 10.1091/mbc.11.4.1129; Assefa Z, 1999, BIOCHEM BIOPH RES CO, V261, P641, DOI 10.1006/bbrc.1999.1090; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Benyo Z, 2006, MOL PHARMACOL, V70, P1844, DOI 10.1124/mol.106.030833; Bodor ET, 2008, BRIT J PHARMACOL, V153, pS68, DOI 10.1038/sj.bjp.0707528; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; FAURE M, 1994, J BIOL CHEM, V269, P7851; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Gripentrog JM, 2005, CELL SIGNAL, V17, P1300, DOI 10.1016/j.cellsig.2005.01.006; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Guyton JR, 2007, CURR OPIN LIPIDOL, V18, P415, DOI 10.1097/MOL.0b013e3282364add; Hawes BE, 1996, J BIOL CHEM, V271, P12133, DOI 10.1074/jbc.271.21.12133; Herrlich A, 1998, P NATL ACAD SCI USA, V95, P8985, DOI 10.1073/pnas.95.15.8985; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Huet E, 2007, CELL SIGNAL, V19, P1939, DOI 10.1016/j.cellsig.2007.05.006; HUNNINGHAKE DB, 1985, CLIN PHARMACOL THER, V38, P313, DOI 10.1038/clpt.1985.177; Kamanna VS, 2007, AM J CARDIOL, V100, p53N, DOI 10.1016/j.amjcard.2007.09.080; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Kranenburg O, 1997, EMBO J, V16, P3097, DOI 10.1093/emboj/16.11.3097; Li G, 2010, J BIOL CHEM, V285, P22605, DOI 10.1074/jbc.M109.087213; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Luttrell LM, 2003, J MOL ENDOCRINOL, V30, P117, DOI 10.1677/jme.0.0300117; MACK WJ, 1993, STROKE, V24, P1779, DOI 10.1161/01.STR.24.12.1779; Mahboubi K, 2006, BIOCHEM BIOPH RES CO, V340, P482, DOI 10.1016/j.bbrc.2005.12.022; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; Meyers CD, 2007, ATHEROSCLEROSIS, V192, P253, DOI 10.1016/j.atherosclerosis.2006.07.014; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; NIKKILA EA, 1984, BMJ-BRIT MED J, V289, P220, DOI 10.1136/bmj.289.6439.220; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Pritzker LB, 1998, CRIT REV CL LAB SCI, V35, P603, DOI 10.1080/10408369891234291; Ptasznik Andrzej, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P27; Punn A, 2006, MOL ENDOCRINOL, V20, P3179, DOI 10.1210/me.2006-0255; Quan WY, 2008, BIOCHEM BIOPH RES CO, V377, P705, DOI 10.1016/j.bbrc.2008.10.044; Richman JG, 2007, J BIOL CHEM, V282, P18028, DOI 10.1074/jbc.M701866200; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; Semple G, 2006, J MED CHEM, V49, P1227, DOI 10.1021/jm051099t; Semple G, 2008, J MED CHEM, V51, P5101, DOI 10.1021/jm800258p; Shah BH, 2004, MOL ENDOCRINOL, V18, P2035, DOI 10.1210/me.2003-0476; Shah BH, 2003, J BIOL CHEM, V278, P19118, DOI 10.1074/jbc.M212932200; Shi W, 2000, J CELL BIOL, V148, P591, DOI 10.1083/jcb.148.3.591; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Tang H, 2008, BIOCHEM BIOPH RES CO, V375, P562, DOI 10.1016/j.bbrc.2008.08.041; Tang YT, 2006, BIOCHEM BIOPH RES CO, V345, P29, DOI 10.1016/j.bbrc.2006.04.051; Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D; Tunaru S, 2005, MOL PHARMACOL, V68, P1271, DOI 10.1124/mol.105.015750; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; van Herk T, 2003, J MED CHEM, V46, P3945, DOI 10.1021/jm030888c; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Zhang YY, 2005, BIOCHEM BIOPH RES CO, V334, P729, DOI 10.1016/j.bbrc.2005.06.141; Zhou LB, 2007, MOL CELL BIOCHEM, V294, P243, DOI 10.1007/s11010-006-9150-6	59	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31199	31212		10.1074/jbc.M111.241372	http://dx.doi.org/10.1074/jbc.M111.241372			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768093	Green Published, hybrid			2022-12-25	WOS:000294487500015
J	Zhu, QB; Sun, WY; Okano, K; Chen, Y; Zhang, N; Maeda, T; Palczewski, K				Zhu, Qubo; Sun, Wenyu; Okano, Kiichiro; Chen, Yu; Zhang, Ning; Maeda, Tadao; Palczewski, Krzysztof			Sponge Transgenic Mouse Model Reveals Important Roles for the MicroRNA-183 (miR-183)/96/182 Cluster in Postmitotic Photoreceptors of the Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN RETINA; KNOCKOUT MOUSE; LIGHT DAMAGE; CELL-DEATH; SMALL RNAS; IN-VIVO; DEGENERATION; IDENTIFICATION; APOPTOSIS; CASPASE-3	MicroRNA-183 (miR-183), miR-96, and miR-182 comprising the miR-183/96/182 cluster are highly expressed in photoreceptor cells. Although in vitro data have indicated an important role for this cluster in the retina, details of its in vivo biological activity are still unknown. To observe the impact of the miR-183/96/182 cluster on retinal maintenance and light adaptation, we generated a sponge transgenic mouse model that disrupted the activities of the three-component microRNAs simultaneously and selectively in the retina. Although our morphological and functional studies showed no differences between transgenic and wild type mice under normal laboratory lighting conditions, sponge transgenic mice displayed severe retinal degeneration after 30 min of exposure to 10,000 lux light. Histological studies showed that the outer nuclear layer thickness was dramatically reduced in the superior retina of transgenic mice. Real time PCR experiments in both the sponge transgenic mouse model and different microRNA stable cell lines identified Arrdc3, Neurod4, and caspase-2 (Casp2) as probable downstream targets of this cluster, a result also supported by luciferase assay and immuno-blotting analyses. Further studies indicated that expression of both the cluster and Casp2 increased in response to light exposure. Importantly, Casp2 expression was enhanced in transgenic mice, and inhibition of Casp2 partially rescued their light-induced retinal degeneration. By connecting the microRNA and apoptotic pathways, these findings imply an important role for the miR-183/96/182 cluster in acute light-induced retinal degeneration of mice. This study demonstrates a clear involvement of miRs in the physiology of postmitotic cells in vivo.	[Zhu, Qubo; Okano, Kiichiro; Chen, Yu; Zhang, Ning; Maeda, Tadao; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Sun, Wenyu] Polgenix Inc, Cleveland, OH 44106 USA; [Maeda, Tadao] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu	Zhu, Qubo/ACT-7180-2022	Zhu, Qubo/0000-0001-5202-7887	National Institutes of Health [EY008061, K08EY019880]; NATIONAL EYE INSTITUTE [R01EY008061, K08EY019880, R29EY008061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY008061 and K08EY019880.	Arora A, 2007, INVEST OPHTH VIS SCI, V48, P3962, DOI 10.1167/iovs.06-1221; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bode C, 2003, MOL VIS, V9, P144; Chahory S, 2010, NEUROCHEM INT, V57, P278, DOI 10.1016/j.neuint.2010.06.006; Chen J, 1999, INVEST OPHTH VIS SCI, V40, P2978; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Donovan M, 2001, J BIOL CHEM, V276, P23000, DOI 10.1074/jbc.M005359200; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Georgi SA, 2010, J NEUROSCI, V30, P4048, DOI 10.1523/JNEUROSCI.4982-09.2010; Hahn P, 2004, CELL DEATH DIFFER, V11, P1192, DOI 10.1038/sj.cdd.4401486; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; Jaissle GB, 2001, INVEST OPHTH VIS SCI, V42, P506; Jin ZB, 2009, MOL VIS, V15, P523; Jomary C, 2006, INVEST OPHTH VIS SCI, V47, P1620, DOI 10.1167/iovs.05-1176; Jomary C, 2001, MOL CELL NEUROSCI, V18, P335, DOI 10.1006/mcne.2001.1036; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Katai N, 1999, INVEST OPHTH VIS SCI, V40, P1802; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Liu CD, 1999, J NEUROSCI, V19, P4778; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; Luo Y, 2009, GENE, V428, P41, DOI 10.1016/j.gene.2008.09.022; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maroney PA, 2008, NAT PROTOC, V3, P279, DOI 10.1038/nprot.2007.530; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; MUSTAFI D, 2011, FASEB J IN PRESS; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; Perche O, 2007, INVEST OPHTH VIS SCI, V48, P2753, DOI 10.1167/iovs.06-1258; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Robbins MJ, 2000, GENOMICS, V67, P8, DOI 10.1006/geno.2000.6226; Rodieck RW, 1998, 1 STEPS SEEING, P38; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; Tanito M, 2008, EXP EYE RES, V87, P292, DOI 10.1016/j.exer.2008.06.002; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Tomita H, 2005, INVEST OPHTH VIS SCI, V46, P427, DOI 10.1167/iovs.04-0946; Tosini G, 2008, BIOESSAYS, V30, P624, DOI 10.1002/bies.20777; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yoshizawa K, 2002, GRAEF ARCH CLIN EXP, V240, P214, DOI 10.1007/s00417-002-0427-5; Zhang C, 2004, INVEST OPHTH VIS SCI, V45, P2753, DOI 10.1167/iovs.03-1344; Zhu YA, 2010, MOL VIS, V16, P740	47	98	108	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31749	31760		10.1074/jbc.M111.259028	http://dx.doi.org/10.1074/jbc.M111.259028			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768104	Green Published, hybrid			2022-12-25	WOS:000294487500068
J	Hirschler-Laszkiewicz, I; Tong, Q; Waybill, K; Conrad, K; Keefer, K; Zhang, WY; Chen, SJ; Cheung, JY; Miller, BA				Hirschler-Laszkiewicz, Iwona; Tong, Qin; Waybill, Kathleen; Conrad, Kathleen; Keefer, Kerry; Zhang, Wenyi; Chen, Shu-jen; Cheung, Joseph Y.; Miller, Barbara A.			The Transient Receptor Potential (TRP) Channel TRPC3 TRP Domain and AMP-activated Protein Kinase Binding Site Are Required for TRPC3 Activation by Erythropoietin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE ERYTHROLEUKEMIA-CELLS; FREE CALCIUM-CONCENTRATION; NUCLEOTIDE-GATED CHANNELS; CARDIAC-HYPERTROPHY; HUMAN ERYTHROBLASTS; SURFACE EXPRESSION; OXIDATIVE-STRESS; PHOSPHOLIPASE-C; ION CHANNELS; CA2+ INFLUX	Modulation of intracellular calcium ([Ca2+](i)) by erythropoietin (Epo) is an important signaling pathway controlling erythroid proliferation and differentiation. Transient receptor potential (TRP) channels TRPC3 and homologous TRPC6 are expressed on normal human erythroid precursors, but Epo stimulates an increase in [Ca2+](i) through TRPC3 but not TRPC6. Here, the role of specific domains in the different responsiveness of TRPC3 and TRPC6 to erythropoietin was explored. TRPC3 and TRPC6 TRP domains differ in seven amino acids. Substitution of five amino acids (DDKPS) in the TRPC3 TRP domain with those of TRPC6 (EERVN) abolished the Epo-stimulated increase in [Ca2+](i). Substitution of EERVN in TRPC6 TRP domain with DDKPS in TRPC3 did not confer Epo responsiveness. However, substitution of TRPC6 TRP with DDKPS from TRPC3 TRP, as well as swapping the TRPC6 distal C terminus (C2) with that of TRPC3, resulted in a chimeric TRPC6 channel with Epo responsiveness similar to TRPC3. Substitution of TRPC6 with TRPC3 TRP and the putative TRPC3 C-terminal AMP-activated protein kinase (AMPK) binding site straddling TRPC3 C1/C2 also resulted in TRPC6 activation. In contrast, substitution of the TRPC3 C-terminal leucine zipper motif or TRPC3 phosphorylation sites Ser-681, Ser-708, or Ser-764 with TRPC6 sequence did not affect TRPC3 Epo responsiveness. TRPC3, but not TRPC6, and TRPC6 chimeras expressing TRPC3 C2 showed significantly increased plasma membrane insertion following Epo stimulation and substantial cytoskeletal association. The TRPC3 TRP domain, distal C terminus (C2), and AMPK binding site are critical elements that confer Epo responsiveness. In particular, the TRPC3 C2 and AMPK site are essential for association of TRPC3 with the cytoskeleton and increased channel translocation to the cell surface in response to Epo stimulation.	[Miller, Barbara A.] Penn State Univ, Milton S Hershey Med Ctr, Dept Pediat, Coll Med, Hershey, PA 17033 USA; [Miller, Barbara A.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Cheung, Joseph Y.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Jefferson University	Miller, BA (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Pediat, Coll Med, POB 850, Hershey, PA 17033 USA.	bmiller3@psu.edu			National Institutes of Health [R01 DK46778, R01 HL58672, R01 HL74854]; Pennsylvania State University College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074854, R01HL058672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania State University College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK46778 (to B. A. M.) and R01 HL58672 and R01 HL74854 (to J. Y. C.). This work was also supported by the Four Diamonds Fund of the Pennsylvania State University College of Medicine.	Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Bomben VC, 2008, CELL PROLIFERAT, V41, P98, DOI 10.1111/j.1365-2184.2007.00504.x; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Cheung JY, 1997, BLOOD, V89, P92, DOI 10.1182/blood.V89.1.92.92_92_100; CHEUNG JY, 1992, J CLIN INVEST, V90, P1850, DOI 10.1172/JCI116061; Chigurupati S, 2010, CANCER RES, V70, P418, DOI 10.1158/0008-5472.CAN-09-2654; Chu X, 2005, CELL CALCIUM, V37, P173, DOI 10.1016/j.ceca.2004.08.005; Chu X, 2004, J BIOL CHEM, V279, P10514, DOI 10.1074/jbc.M308478200; Chu X, 2002, J BIOL CHEM, V277, P34375, DOI 10.1074/jbc.M205541200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clark K, 2008, EUR J CELL BIOL, V87, P631, DOI 10.1016/j.ejcb.2008.01.009; Di A, 2010, CURR OPIN PHARMACOL, V10, P127, DOI 10.1016/j.coph.2009.11.010; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Ge RL, 2009, CANCER LETT, V283, P43, DOI 10.1016/j.canlet.2009.03.023; GILLO B, 1993, BLOOD, V81, P783; Glitsch MD, 2010, FASEB J, V24, P318, DOI 10.1096/fj.09-134973; Goel M, 2006, AM J PHYSIOL-RENAL, V290, pF1241, DOI 10.1152/ajprenal.00376.2005; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Goel M, 2010, AM J PHYSIOL-RENAL, V298, pF988, DOI 10.1152/ajprenal.00586.2009; Goswami C, 2008, FEBS J, V275, P4684, DOI 10.1111/j.1742-4658.2008.06617.x; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Guinamard R, 2007, BBA-MOL BASIS DIS, V1772, P885, DOI 10.1016/j.bbadis.2007.02.007; HENSOLD JO, 1991, BLOOD, V77, P1362; Hirschler-Laszkiewicz I, 2009, J BIOL CHEM, V284, P4567, DOI 10.1074/jbc.M804734200; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Kieran MW, 1996, P NATL ACAD SCI USA, V93, P9126, DOI 10.1073/pnas.93.17.9126; Ko Kyung Dae, 2009, Commun Integr Biol, V2, P133; KUREBAYASHI N, 1993, BIOPHYS J, V64, P1934, DOI 10.1016/S0006-3495(93)81564-9; LEVENSON R, 1980, P NATL ACAD SCI-BIOL, V77, P5948, DOI 10.1073/pnas.77.10.5948; Lin CS, 1996, GENE DEV, V10, P154, DOI 10.1101/gad.10.2.154; Lockwich T, 2001, J BIOL CHEM, V276, P42401, DOI 10.1074/jbc.M106956200; Miller BA, 2006, J MEMBRANE BIOL, V209, P31, DOI 10.1007/s00232-005-0839-3; MILLER BA, 1989, BLOOD, V73, P1188; Miller BA, 1999, J BIOL CHEM, V274, P20465, DOI 10.1074/jbc.274.29.20465; MILLER BA, 1988, J CLIN INVEST, V82, P309, DOI 10.1172/JCI113588; MISITI J, 1979, J CLIN INVEST, V64, P1573, DOI 10.1172/JCI109618; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Nilius B, 2010, PFLUG ARCH EUR J PHY, V460, P437, DOI 10.1007/s00424-010-0788-2; Numaga T, 2010, J CELL SCI, V123, P927, DOI 10.1242/jcs.061051; Odell AF, 2008, J BIOL CHEM, V283, P4395, DOI 10.1074/jbc.M709729200; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Poteser M, 2008, FEBS LETT, V582, P2696, DOI 10.1016/j.febslet.2008.06.049; Ribelayga C, 2010, CURR BIOL, V20, pR278, DOI 10.1016/j.cub.2010.02.012; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Sharif-Naeini R, 2010, J MOL CELL CARDIOL, V48, P83, DOI 10.1016/j.yjmcc.2009.03.020; Sims B, 2010, BRAIN RES, V1321, P88, DOI 10.1016/j.brainres.2010.01.040; Smyth JT, 2006, J BIOL CHEM, V281, P11712, DOI 10.1074/jbc.M510541200; Sun YH, 2010, BIOCHEM BIOPH RES CO, V394, P955, DOI 10.1016/j.bbrc.2010.03.096; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; Tong Q, 2004, AM J PHYSIOL-CELL PH, V287, pC1667, DOI 10.1152/ajpcell.00265.2004; Tong Q, 2008, J BIOL CHEM, V283, P10385, DOI 10.1074/jbc.M710231200; Trebak M, 2010, PFLUG ARCH EUR J PHY, V459, P369, DOI 10.1007/s00424-009-0740-5; Tu P, 2010, J NEUROCHEM, V112, P204, DOI 10.1111/j.1471-4159.2009.06446.x; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang SB, 2010, J BIOL CHEM, V285, P19976, DOI 10.1074/jbc.M110.102467; Wen WY, 2006, J BIOL CHEM, V281, P12060, DOI 10.1074/jbc.M600336200; Wills J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017953; Woodard GE, 2010, J BIOL CHEM, V285, P8045, DOI 10.1074/jbc.M109.033605; Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107; Wu YM, 1997, AM J PHYSIOL-HEART C, V273, pH2161, DOI 10.1152/ajpheart.1997.273.5.H2161; Yang SL, 2009, ONCOGENE, V28, P1320, DOI 10.1038/onc.2008.475; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200	72	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30636	30646		10.1074/jbc.M111.238360	http://dx.doi.org/10.1074/jbc.M111.238360			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757714	Green Published, hybrid			2022-12-25	WOS:000294283600043
J	Papp, KV; Snyder, PJ; Maruff, P; Bartkowiak, J; Pietrzak, RH				Papp, Kathryn V.; Snyder, Peter J.; Maruff, Paul; Bartkowiak, Jennifer; Pietrzak, Robert H.			Detecting Subtle Changes in Visuospatial Executive Function and Learning in the Amnestic Variant of Mild Cognitive Impairment	PLOS ONE			English	Article							CONVERGENT VALIDITY; VERBAL MEMORY; CONVERSION; MCI; AD; PERFORMANCE; DEMENTIA; WORKING; DECLINE; TRIALS	Background and Purpose: Amnestic mild cognitive impairment (aMCI) is a putative prodromal stage of Alzheimer's disease (AD) characterized by deficits in episodic verbal memory. Our goal in the present study was to determine whether executive dysfunction may also be detectable in individuals diagnosed with aMCI. Methods: This study used a hidden maze learning test to characterize component processes of visuospatial executive function and learning in a sample of 62 individuals with aMCI compared with 94 healthy controls. Results: Relative to controls, individuals with aMCI made more exploratory/learning errors (Cohen's d =.41). Comparison of learning curves revealed that the slope between the first two of five learning trials was four times as steep for controls than for individuals with aMCI (Cohen's d =.64). Individuals with aMCI also made a significantly greater number of rule-break/error monitoring errors across learning trials (Cohen's d =.21). Conclusions: These results suggest that performance on a task of complex visuospatial executive function is compromised in individuals with aMCI, and likely explained by reductions in initial strategy formulation during early visual learning and "on-line" maintenance of task rules.	[Papp, Kathryn V.; Snyder, Peter J.; Bartkowiak, Jennifer] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; [Maruff, Paul] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; [Maruff, Paul; Pietrzak, Robert H.] CogState Ltd, Melbourne, Vic, Australia; [Snyder, Peter J.] Brown Univ, Warren Alpert Med Sch, Dept Clin Neurosci, Providence, RI 02912 USA; [Snyder, Peter J.] Lifespan Hosp Syst, Providence, RI USA; [Pietrzak, Robert H.] VA Connecticut Healthcare Syst, Natl Ctr Posttraumat Stress Disorder, West Haven, CT USA; [Pietrzak, Robert H.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA	University of Connecticut; University of Melbourne; CogState Limited; Brown University; Lifespan Health Rhode Island; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Papp, KV (corresponding author), Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA.	robert.pietrzak@yale.edu	Maruff, Paul/ABA-1673-2020; Maruff, Paul/AAD-2454-2021	Maruff, Paul/0000-0002-6947-9537; Snyder, Peter/0000-0003-0555-4654	Pfizer Global Research and Development, Groton, CT, USA; CogState, Ltd.	Pfizer Global Research and Development, Groton, CT, USA(Pfizer); CogState, Ltd.(CogState Limited)	The studies from which data were drawn were funded by Pfizer Global Research and Development, Groton, CT, USA. Preparation of this report was supported in part by CogState, Ltd. The funders had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.; Drs. Maruff and Darby are employed by CogState, Ltd., the company that markets the Groton Maze Learning Test, which was used in this study. Dr. Snyder is a consultant to and Dr. Pietrzak receives partial salary support from CogState, Ltd. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Albert MS, 2001, J INT NEUROPSYCH SOC, V7, P631, DOI 10.1017/S1355617701755105; Bell-McGinty S, 2002, INT J GERIATR PSYCH, V17, P828, DOI 10.1002/gps.646; Brandt J, 2009, NEUROPSYCHOLOGY, V23, P607, DOI 10.1037/a0015851; Brooks BL, 2006, CLIN NEUROPSYCHOL, V20, P230, DOI 10.1080/13854040590947461; Chang YL, 2010, CEREB CORTEX, V20, P1305, DOI 10.1093/cercor/bhp192; Chao LL, 2010, ALZ DIS ASSOC DIS, V24, P19, DOI 10.1097/WAD.0b013e3181b4f736; Chertkow H, 2007, ALZHEIMERS DEMENT, V3, P266, DOI 10.1016/j.jalz.2007.07.013; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Cromer JR, 2010, EXP CLIN PSYCHOPHARM, V18, P329, DOI 10.1037/a0019591; He J, 2009, ARCH NEUROL-CHICAGO, V66, P1393, DOI 10.1001/archneurol.2009.252; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Johnson SC, 2008, AGING NEUROPSYCHOL C, V15, P129, DOI 10.1080/13825580601139444; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Lewis MS, 2007, CLIN NEUROPSYCHOL, V21, P274, DOI 10.1080/13854040500519752; Mathewson KJ, 2008, PSYCHOPHYSIOLOGY, V45, P936, DOI 10.1111/j.1469-8986.2008.00699.x; Moffat SD, 2006, NEUROBIOL AGING, V27, P965, DOI 10.1016/j.neurobiolaging.2005.05.011; Morris JC, 1997, NEUROLOGY, V48, P1508, DOI 10.1212/WNL.48.6.1508; Moulin CJA, 2007, BRAIN RES, V1136, P132, DOI 10.1016/j.brainres.2006.12.021; Okello A, 2009, NEUROLOGY, V73, P754, DOI 10.1212/WNL.0b013e3181b23564; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Pietrzak RH, 2008, ARCH CLIN NEUROPSYCH, V22, P235; Pietrzak RH, 2007, ARCH CLIN NEUROPSYCH, V22, P235, DOI 10.1016/j.acn.2007.01.018; Pietrzak RH, 2009, INT J NEUROSCI, V119, P1137, DOI 10.1080/00207450902841269; Risacher SL, 2009, CURR ALZHEIMER RES, V6, P347, DOI 10.2174/156720509788929273; Royall DR, 2004, J AM GERIATR SOC, V52, P346, DOI 10.1111/j.1532-5415.2004.52104.x; Salthouse TA, 2003, J EXP PSYCHOL GEN, V132, P566, DOI 10.1037/0096-3445.132.4.566; Snyder AM, 2008, CHILD NEUROPSYCHOL, V14, P211, DOI 10.1080/09297040701220005; Snyder Peter J, 2005, Alzheimers Dement, V1, P126, DOI 10.1016/j.jalz.2005.09.004; Snyder PJ, 2005, HUM PSYCHOPHARM CLIN, V20, P263, DOI 10.1002/hup.692; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Thomas E, 2008, NEUROPSYCHOLOGIA, V46, P2476, DOI 10.1016/j.neuropsychologia.2008.04.010; Tippett WJ, 2009, CYBERPSYCHOL BEHAV, V12, P169, DOI 10.1089/cpb.2008.0218; Troyer AK, 2008, NEUROPSYCHOLOGY, V22, P10, DOI 10.1037/0894-4105.22.1.10; Whitwell JL, 2007, ARCH NEUROL-CHICAGO, V64, P1130, DOI 10.1001/archneur.64.8.1130	35	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21688	10.1371/journal.pone.0021688	http://dx.doi.org/10.1371/journal.pone.0021688			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	793HP	21779333	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811300011
J	Carcagno, AL; Marazita, MC; Ogara, MF; Ceruti, JM; Sonzogni, SV; Scassa, ME; Giono, LE; Canepa, ET				Carcagno, Abel L.; Marazita, Mariela C.; Ogara, Maria F.; Ceruti, Julieta M.; Sonzogni, Silvina V.; Scassa, Maria E.; Giono, Luciana E.; Canepa, Eduardo T.			E2F1-Mediated Upregulation of p19INK4d Determines Its Periodic Expression during Cell Cycle and Regulates Cellular Proliferation	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITORS; MAMMALIAN CDK INHIBITORS; SYSTEMS-LEVEL FEEDBACK; INK4 PROTEINS; DNA-REPAIR; 5-AMINOLEVULINATE SYNTHASE; TRANSCRIPTION FACTORS; GENOTOXIC STRESS; GENE-EXPRESSION; S-PHASE	Background: A central aspect of development and disease is the control of cell proliferation through regulation of the mitotic cycle. Cell cycle progression and directionality requires an appropriate balance of positive and negative regulators whose expression must fluctuate in a coordinated manner. p19INK4d, a member of the INK4 family of CDK inhibitors, has a unique feature that distinguishes it from the remaining INK4 and makes it a likely candidate for contributing to the directionality of the cell cycle. p19INK4d mRNA and protein levels accumulate periodically during the cell cycle under normal conditions, a feature reminiscent of cyclins. Methodology/Principal Findings: In this paper, we demonstrate that p19INK4d is transcriptionally regulated by E2F1 through two response elements present in the p19INK4d promoter. Ablation of this regulation reduced p19 levels and restricted its expression during the cell cycle, reflecting the contribution of a transcriptional effect of E2F1 on p19 periodicity. The induction of p19INK4d is delayed during the cell cycle compared to that of cyclin E, temporally separating the induction of these proliferative and antiproliferative target genes. Specific inhibition of the E2F1-p19INK4d pathway using triplex-forming oligonucleotides that block E2F1 binding on p19 promoter, stimulated cell proliferation and increased the fraction of cells in S phase. Conclusions/Significance: The results described here support a model of normal cell cycle progression in which, following phosphorylation of pRb, free E2F induces cyclin E, among other target genes. Once cyclinE/CDK2 takes over as the cell cycle driving kinase activity, the induction of p19 mediated by E2F1 leads to inhibition of the CDK4,6-containing complexes, bringing the G1 phase to an end. This regulatory mechanism constitutes a new negative feedback loop that terminates the G1 phase proliferative signal, contributing to the proper coordination of the cell cycle and provides an additional mechanism to limit E2F activity.	[Carcagno, Abel L.; Marazita, Mariela C.; Ogara, Maria F.; Ceruti, Julieta M.; Sonzogni, Silvina V.; Scassa, Maria E.; Giono, Luciana E.; Canepa, Eduardo T.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Mol Biol Lab, Buenos Aires, DF, Argentina	University of Buenos Aires	Carcagno, AL (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Mol Biol Lab, Buenos Aires, DF, Argentina.	ecanepa@qb.fcen.uba.ar		Sonzogni, Silvina/0000-0002-6237-6594; Canepa, Eduardo T./0000-0002-4322-1650; Giono, Luciana/0000-0001-6958-6044	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 622]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 567]; Universidad de Buenos Aires [X-036]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires)	1. Agencia Nacional de Promocion Cientifica y Tecnologica. Grant Number: PICT 622 URL: http://www.agencia.mincyt.gov.ar. 2. Consejo Nacional de Investigaciones Cientificas y Tecnicas. Grant Number: PIP 567. URL: http://www.conicet.gov.ar. 3. Universidad de Buenos Aires. Grant Number: X-036. URL: http://www.uba.ar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arata Y, 2000, J BIOL CHEM, V275, P6337, DOI 10.1074/jbc.275.9.6337; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Blais A, 2004, CURR OPIN GENET DEV, V14, P527, DOI 10.1016/j.gde.2004.07.003; Blais A, 2002, J BIOL CHEM, V277, P31679, DOI 10.1074/jbc.M204554200; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Carcagno AL, 2009, IUBMB LIFE, V61, P537, DOI 10.1002/iub.197; Ceruti JM, 2005, ONCOGENE, V24, P4065, DOI 10.1038/sj.onc.1208570; Ceruti JM, 2009, INT J BIOCHEM CELL B, V41, P1344, DOI 10.1016/j.biocel.2008.12.005; Cunningham JJ, 2002, MOL CELL NEUROSCI, V19, P359, DOI 10.1006/mcne.2001.1090; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; del Arroyo AG, 2007, CELL CYCLE, V6, P2697; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Du W, 2006, ONCOGENE, V25, P5190, DOI 10.1038/sj.onc.1209651; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Forget A, 2008, CELL CYCLE, V7, P3737, DOI 10.4161/cc.7.23.7187; Gilles L, 2008, BLOOD, V111, P4081, DOI 10.1182/blood-2007-09-113266; Giono LE, 2001, BIOCHEM J, V353, P307, DOI 10.1042/0264-6021:3530307; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Iaquinta PJ, 2005, COLD SH Q B, V70, P309, DOI 10.1101/sqb.2005.70.050; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Kapuy O, 2009, FEBS LETT, V583, P3992, DOI 10.1016/j.febslet.2009.08.023; Katayama K, 2008, ONCOGENE, V27, P1677, DOI 10.1038/sj.onc.1210813; Komori H, 2005, EMBO J, V24, P3724, DOI 10.1038/sj.emboj.7600836; Lammens T, 2009, TRENDS CELL BIOL, V19, P111, DOI 10.1016/j.tcb.2009.01.002; Lopez-Aviles S, 2009, NATURE, V459, P592, DOI 10.1038/nature07984; Matsuzaki Y, 2002, FEBS LETT, V517, P272, DOI 10.1016/S0014-5793(02)02647-9; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Novak B, 2007, NAT CELL BIOL, V9, P724, DOI 10.1038/ncb0707-724; O'Farrell AM, 2000, J IMMUNOL, V164, P4607, DOI 10.4049/jimmunol.164.9.4607; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Ozono E, 2009, GENES CELLS, V14, P89, DOI 10.1111/j.1365-2443.2008.01248.x; Park KK, 2003, BIOCHEM BIOPH RES CO, V308, P689, DOI 10.1016/S0006-291X(03)01455-4; Pei XH, 2005, ONCOGENE, V24, P2787, DOI 10.1038/sj.onc.1208611; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Radhakrishnan SK, 2004, ONCOGENE, V23, P4173, DOI 10.1038/sj.onc.1207571; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Roussel MF, 1999, ONCOGENE, V18, P5311, DOI 10.1038/sj.onc.1202998; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Scassa ME, 2007, DNA REPAIR, V6, P626, DOI 10.1016/j.dnarep.2006.12.003; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Thullberg M, 2000, FEBS LETT, V470, P161, DOI 10.1016/S0014-5793(00)01307-7; Thullberg M, 2000, ONCOGENE, V19, P2870, DOI 10.1038/sj.onc.1203579; Varone CL, 1997, ARCH BIOCHEM BIOPHYS, V341, P259, DOI 10.1006/abbi.1997.9978; Varone CL, 1999, ARCH BIOCHEM BIOPHYS, V372, P261, DOI 10.1006/abbi.1999.1470; Virolle T, 2003, J BIOL CHEM, V278, P11802, DOI 10.1074/jbc.M210279200; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Yokota T, 2004, ONCOGENE, V23, P5340, DOI 10.1038/sj.onc.1207689; Zindy F, 2006, P NATL ACAD SCI USA, V103, P11579, DOI 10.1073/pnas.0604727103	54	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21938	10.1371/journal.pone.0021938	http://dx.doi.org/10.1371/journal.pone.0021938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765927	Green Published, Green Submitted, gold			2022-12-25	WOS:000292781500024
J	Zhuang, K; Finzi, A; Tasca, S; Shakirzyanova, M; Knight, H; Westmoreland, S; Sodroski, J; Cheng-Mayer, C				Zhuang, Ke; Finzi, Andres; Tasca, Silvana; Shakirzyanova, Madina; Knight, Heather; Westmoreland, Susan; Sodroski, Joseph; Cheng-Mayer, Cecilia			Adoption of an "Open" Envelope Conformation Facilitating CD4 Binding and Structural Remodeling Precedes Coreceptor Switch in R5 SHIV-Infected Macaques	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL DEPLETION; INCREASED NEUTRALIZATION SENSITIVITY; SYNCYTIUM-INDUCING PHENOTYPE; SOLUBLE CD4; MACROPHAGE-TROPISM; TYPE-1 INFECTION; HIV-1 INFECTION; IN-VIVO; ENTRY INHIBITORS	A change in coreceptor preference from CCR5 to CXCR4 towards the end stage disease in some HIV-1 infected individuals has been well documented, but the reasons and mechanisms for this tropism switch remain elusive. It has been suggested that envelope structural constraints in accommodating amino acid changes required for CXCR4 usage is an obstacle to tropism switch, limiting the rate and pathways available for HIV-1 coreceptor switching. The present study was initiated in two R5 SHIV(SF162P3N)-infected rapid progressor macaques with coreceptor switch to test the hypothesis that an early step in the evolution of tropism switch is the adoption of a less constrained and more "open" envelope conformation for better CD4 usage, allowing greater structural flexibility to accommodate further mutational changes that confer CXCR4 utilization. We show that, prior to the time of coreceptor switch, R5 viruses in both macaques evolved to become increasingly sCD4-sensitive, suggestive of enhanced exposure of the CD4 binding site and an "open" envelope conformation, and this correlated with better gp120 binding to CD4 and with more efficient infection of CD4(low) cells such as primary macrophages. Moreover, significant changes in neutralization sensitivity to agents and antibodies directed against functional domains of gp120 and gp41 were seen for R5 viruses close to the time of X4 emergence, consistent with global changes in envelope configuration and structural plasticity. These observations in a simian model of R5-to-X4 evolution provide a mechanistic basis for the HIV-1 coreceptor switch.	[Zhuang, Ke; Tasca, Silvana; Shakirzyanova, Madina; Cheng-Mayer, Cecilia] Aaron Diamond AIDS Res Ctr, New York, NY USA; [Finzi, Andres; Sodroski, Joseph] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS,Dept Pathol,Div AIDS, Boston, MA 02115 USA; [Knight, Heather; Westmoreland, Susan] Harvard Univ, Sch Med, New England Primate Res Ctr, Div Comparat Pathol, Southborough, MA 01772 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University	Zhuang, K (corresponding author), Aaron Diamond AIDS Res Ctr, New York, NY USA.	cmayer@adarc.org		Finzi, Andres/0000-0002-4992-5288	NIH [RO1AI46980, R37AI41945]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI041945, R37AI024755, R01AI046980] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by NIH grants RO1AI46980 and R37AI41945. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander M, 2010, J VIROL, V84, P4100, DOI 10.1128/JVI.02068-09; Bannert N, 2000, J VIROL, V74, P10984, DOI 10.1128/JVI.74.23.10984-10993.2000; Berger EA, 1997, AIDS, V11, pS3; Berkowitz RD, 1998, J VIROL, V72, P10108, DOI 10.1128/JVI.72.12.10108-10117.1998; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; BOUHABIB DC, 1994, J VIROL, V68, P6006, DOI 10.1128/JVI.68.9.6006-6013.1994; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brown CR, 2007, J VIROL, V81, P5594, DOI 10.1128/JVI.00202-07; Brumme ZL, 2005, J INFECT DIS, V192, P466, DOI 10.1086/431519; Bunnik EM, 2007, J VIROL, V81, P525, DOI 10.1128/JVI.01983-06; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Casper C, 2002, AIDS RES HUM RETROV, V18, P343, DOI 10.1089/088922202753519124; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CHOWDHURY IH, 1991, MED MICROBIOL IMMUN, V180, P183, DOI 10.1007/BF00215247; Cocchi F, 1996, NAT MED, V2, P1244, DOI 10.1038/nm1196-1244; Coetzer M, 2008, J VIROL, V82, P11758, DOI 10.1128/JVI.01141-08; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Demarest JF, 2001, AIDS RES HUM RETROV, V17, P1333, DOI 10.1089/08892220152596597; Derdeyn CA, 2001, J VIROL, V75, P8605, DOI 10.1128/JVI.75.18.8605-8614.2001; Etemad B, 2009, J VIROL, V83, P9694, DOI 10.1128/JVI.00925-09; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Ganeshan S, 1997, J VIROL, V71, P663, DOI 10.1128/JVI.71.1.663-677.1997; GORNY MK, 1993, J IMMUNOL, V150, P635; Gray L, 2005, VIROLOGY, V337, P384, DOI 10.1016/j.virol.2005.04.034; GROENINK M, 1995, J VIROL, V69, P523, DOI 10.1128/JVI.69.1.523-527.1995; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; HART TK, 1991, P NATL ACAD SCI USA, V88, P2189, DOI 10.1073/pnas.88.6.2189; Ho SH, 2008, J VIROL, V82, P5653, DOI 10.1128/JVI.00145-08; Ho SH, 2007, J VIROL, V81, P8621, DOI 10.1128/JVI.00759-07; Ho SH, 2006, J VIROL, V80, P6487, DOI 10.1128/JVI.02539-05; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; HWANG SS, 1992, SCIENCE, V257, P535, DOI 10.1126/science.1636088; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Isaacman-Beck J, 2009, J VIROL, V83, P8208, DOI 10.1128/JVI.00296-09; Jansson M, 1996, P NATL ACAD SCI USA, V93, P15382, DOI 10.1073/pnas.93.26.15382; Jensen Mark A., 2003, AIDS Reviews, V5, P104; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; KABAT D, 1994, J VIROL, V68, P2570, DOI 10.1128/JVI.68.4.2570-2577.1994; Karlsson I, 2004, J VIROL, V78, P11807, DOI 10.1128/JVI.78.21.11807-11815.2004; Kassaye S, 2009, JAIDS-J ACQ IMM DEF, V50, P9, DOI 10.1097/QAI.0b013e31818ffdff; Kolchinsky P, 2001, J VIROL, V75, P2041, DOI 10.1128/JVI.75.5.2041-2050.2001; Koning FA, 2003, J INFECT DIS, V188, P864, DOI 10.1086/377105; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; Kozak SL, 1997, J VIROL, V71, P873, DOI 10.1128/JVI.71.2.873-882.1997; KUIKEN CL, 1992, J VIROL, V66, P4622, DOI 10.1128/JVI.66.7.4622-4627.1992; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li S, 1999, J VIROL, V73, P9741, DOI 10.1128/JVI.73.12.9741-9755.1999; Liu SL, 1997, J VIROL, V71, P4284, DOI 10.1128/JVI.71.6.4284-4295.1997; Low AJ, 2008, AIDS RES HUM RETROV, V24, P219, DOI 10.1089/aid.2007.0140; Lusso P, 2005, J VIROL, V79, P6957, DOI 10.1128/JVI.79.11.6957-6968.2005; Malim MH, 2001, CELL, V104, P469, DOI 10.1016/S0092-8674(01)00234-3; Markovic I, 2004, CURR HIV RES, V2, P223, DOI 10.2174/1570162043351327; MARTINRICO P, 1995, AIDS, V9, P95; Mattapallil JJ, 1998, J VIROL, V72, P6421, DOI 10.1128/JVI.72.8.6421-6429.1998; Means RE, 2001, J VIROL, V75, P3903, DOI 10.1128/JVI.75.8.3903-3915.2001; Michael NL, 1997, J INFECT DIS, V175, P1352, DOI 10.1086/516467; MIEDEMA F, 1990, IMMUNOL TODAY, V11, P293, DOI 10.1016/0167-5699(90)90116-Q; Miller ED, 2001, J VIROL, V75, P8498, DOI 10.1128/JVI.75.18.8498-8506.2001; Montagnier L, 1997, J INFECT DIS, V175, P955, DOI 10.1086/513999; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; MOORE JP, 1992, J VIROL, V66, P235, DOI 10.1128/JVI.66.1.235-243.1992; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Mori K, 2000, J VIROL, V74, P10852, DOI 10.1128/JVI.74.22.10852-10859.2000; Moyle GJ, 2005, J INFECT DIS, V191, P866, DOI 10.1086/428096; OBRIEN WA, 1992, J VIROL, V66, P3125, DOI 10.1128/JVI.66.5.3125-3130.1992; OKA S, 1994, AIDS RES HUM RETROV, V10, P271, DOI 10.1089/aid.1994.10.271; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; ORLOFF SL, 1993, J VIROL, V67, P1461, DOI 10.1128/JVI.67.3.1461-1471.1993; Overbaugh J, 2001, SCIENCE, V292, P1106, DOI 10.1126/science.1059128; Pacheco B, 2008, J VIROL, V82, P346, DOI 10.1128/JVI.01299-07; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pastore C, 2004, J VIROL, V78, P7565, DOI 10.1128/JVI.78.14.7565-7574.2004; Peters PJ, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-5; Peters PJ, 2004, J VIROL, V78, P6915, DOI 10.1128/JVI.78.13.6915-6926.2004; Platt EJ, 1997, J VIROL, V71, P883, DOI 10.1128/JVI.71.2.883-890.1997; Platt EJ, 2005, J VIROL, V79, P4347, DOI 10.1128/JVI.79.7.4347-4356.2005; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2000, AIDS RES HUM RETROV, V16, P871, DOI 10.1089/08892220050042819; Poignard P, 1996, IMMUNOL TODAY, V17, P239, DOI 10.1016/0167-5699(96)10007-4; Puffer BA, 2002, J VIROL, V76, P2595, DOI 10.1128/JVI.76.6.2595-2605.2002; Pugach P, 2004, VIROLOGY, V321, P8, DOI 10.1016/j.virol.2003.12.012; Reeves JD, 2005, J VIROL, V79, P4991, DOI 10.1128/JVI.79.8.4991-4999.2005; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Ren WZ, 2010, J VIROL, V84, P340, DOI 10.1128/JVI.01865-09; Repits J, 2005, J GEN VIROL, V86, P2859, DOI 10.1099/vir.0.81111-0; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; SCHUITEMAKER H, 1991, J VIROL, V65, P356, DOI 10.1128/JVI.65.1.356-363.1991; Schwartz AJ, 2002, AIDS RES HUM RETROV, V18, P1021, DOI 10.1089/08892220260235380; Scoggins RM, 2000, J VIROL, V74, P3205, DOI 10.1128/JVI.74.7.3205-3216.2000; Shakirzyanova M, 2010, J VIROL, V84, P12862, DOI 10.1128/JVI.01478-10; SHIODA T, 1991, NATURE, V349, P167, DOI 10.1038/349167a0; SULLIVAN N, 1995, J VIROL, V69, P4413, DOI 10.1128/JVI.69.7.4413-4422.1995; TASCA S, 2011, J VIROL, DOI DOI 10.1128/JVI.021510-021510; Tasca S, 2008, J VIROL, V82, P7089, DOI 10.1128/JVI.00570-08; THALI M, 1992, J VIROL, V66, P5516, DOI 10.1128/JVI.66.9.5516-5524.1992; Thomas ER, 2007, VIROLOGY, V360, P105, DOI 10.1016/j.virol.2006.09.036; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Tuttle DL, 2002, AIDS RES HUM RETROV, V18, P353, DOI 10.1089/088922202753519133; Van Rij RP, 2003, AIDS RES HUM RETROV, V19, P389, DOI 10.1089/088922203765551737; van't Wout AB, 1998, J VIROL, V72, P5099; vantWout AB, 1998, J VIROL, V72, P488; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Walter BL, 2005, J VIROL, V79, P4828, DOI 10.1128/JVI.79.8.4828-4837.2005; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yearley JH, 2008, DEV COMP IMMUNOL, V32, P1510, DOI 10.1016/j.dci.2008.06.006	119	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21350	10.1371/journal.pone.0021350	http://dx.doi.org/10.1371/journal.pone.0021350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760891	Green Published, gold, Green Submitted			2022-12-25	WOS:000292657200010
J	Zhang, JL; Zhang, CY; Chu, TG; Perc, M				Zhang, Jianlei; Zhang, Chunyan; Chu, Tianguang; Perc, Matjaz			Resolution of the Stochastic Strategy Spatial Prisoner's Dilemma by Means of Particle Swarm Optimization	PLOS ONE			English	Article							EVOLUTIONARY GAMES; SOCIAL DILEMMAS; COOPERATION; INDIVIDUALS; SELECTION; RULES	We study the evolution of cooperation among selfish individuals in the stochastic strategy spatial prisoner's dilemma game. We equip players with the particle swarm optimization technique, and find that it may lead to highly cooperative states even if the temptations to defect are strong. The concept of particle swarm optimization was originally introduced within a simple model of social dynamics that can describe the formation of a swarm, i.e., analogous to a swarm of bees searching for a food source. Essentially, particle swarm optimization foresees changes in the velocity profile of each player, such that the best locations are targeted and eventually occupied. In our case, each player keeps track of the highest payoff attained within a local topological neighborhood and its individual highest payoff. Thus, players make use of their own memory that keeps score of the most profitable strategy in previous actions, as well as use of the knowledge gained by the swarm as a whole, to find the best available strategy for themselves and the society. Following extensive simulations of this setup, we find a significant increase in the level of cooperation for a wide range of parameters, and also a full resolution of the prisoner's dilemma. We also demonstrate extreme efficiency of the optimization algorithm when dealing with environments that strongly favor the proliferation of defection, which in turn suggests that swarming could be an important phenomenon by means of which cooperation can be sustained even under highly unfavorable conditions. We thus present an alternative way of understanding the evolution of cooperative behavior and its ubiquitous presence in nature, and we hope that this study will be inspirational for future efforts aimed in this direction.	[Zhang, Jianlei; Zhang, Chunyan; Chu, Tianguang] Peking Univ, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China; [Chu, Tianguang] Peking Univ, Key Lab Machine Percept, Minist Educ, Beijing 100871, Peoples R China; [Perc, Matjaz] Univ Maribor, Dept Phys, Fac Nat Sci & Math, SLO-2000 Maribor, Slovenia	Peking University; Peking University; University of Maribor	Zhang, JL (corresponding author), Peking Univ, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China.	chutg@pku.edu.cn	Perc, Matjaz/A-5148-2009; Chu, Tianguang/C-3521-2012	Perc, Matjaz/0000-0002-3087-541X; Zhang, Jianlei/0000-0002-9932-9265	National Nature Science Foundation of China [60974064, 60736022]; Specialized Research Fund for the Doctoral Program of Higher Education [20060001013]; Slovenian Research Agency [Z1-2032]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the National Nature Science Foundation of China (grant numbers 60974064 and 60736022) and the Specialized Research Fund for the Doctoral Program of Higher Education (grant number 20060001013). MP acknowledges support from the Slovenian Research Agency (grant number Z1-2032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Brandt H, 2006, J THEOR BIOL, V239, P183, DOI 10.1016/j.jtbi.2005.08.045; Brandt H, 2005, P NATL ACAD SCI USA, V102, P2666, DOI 10.1073/pnas.0407370102; Cardillo A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103034; Chen X, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051120; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Droz M, 2009, EUR PHYS J B, V71, P579, DOI 10.1140/epjb/e2009-00160-1; Dugatkin LA, 1996, BIOSYSTEMS, V37, P19, DOI 10.1016/0303-2647(95)01542-6; Eberhart R., 1995, P 6 INT S MICR MACH, V43; Eberhart R.C., 1996, COMPUTATIONAL INTELL; Fu F, 2010, J THEOR BIOL, V266, P358, DOI 10.1016/j.jtbi.2010.06.042; Fu F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036101; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Jiang LL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036108; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; Nowak MA, 1998, J THEOR BIOL, V194, P561, DOI 10.1006/jtbi.1998.0775; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pena J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016110; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Pestelacci Enea, 2008, Biological Theory, V3, P139, DOI 10.1162/biot.2008.3.2.139; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; Poncela J, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/38003; Poncela J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083031; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Rong ZH, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026101; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Sigmund K, 2010, PRINC SER THEOR COMP, P1; Szabo G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.047107; Szabo G, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/18007; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szabo G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016106; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Szolnoki A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036110; Szolnoki A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093033; Tomassini M, 2007, INT J MOD PHYS C, V18, P1173, DOI 10.1142/S0129183107011212; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; Vainstein MH, 2007, J THEOR BIOL, V244, P722, DOI 10.1016/j.jtbi.2006.09.012; Vainstein MH, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051905; Van Segbroeck S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058105; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Wu ZX, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026108; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	58	46	46	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21787	10.1371/journal.pone.0021787	http://dx.doi.org/10.1371/journal.pone.0021787			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760906	Green Published, gold, Green Submitted			2022-12-25	WOS:000292655400019
J	Vianna, FSL; Lopez-Camelo, JS; Leite, JCL; Sanseverino, MTV; Dutra, MD; Castilla, EE; Schuler-Faccini, L				Luiz Vianna, Fernanda Sales; Lopez-Camelo, Jorge S.; Louguercio Leite, Julio Cesar; Vieira Sanseverino, Maria Teresa; Dutra, Maria da Graca; Castilla, Eduardo E.; Schueler-Faccini, Lavinia			Epidemiological Surveillance of Birth Defects Compatible with Thalidomide Embryopathy in Brazil	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA	The thalidomide tragedy of the 1960s resulted in thousands of children being born with severe limb reduction defects (LRD), among other malformations. In Brazil, there are still babies born with thalidomide embryopathy (TE) because of leprosy prevalence, availability of thalidomide, and deficiencies in the control of drug dispensation. Our objective was to implement a system of proactive surveillance to identify birth defects compatible with TE. Along one year, newborns with LRD were assessed in the Brazilian hospitals participating in the Latin-American Collaborative Study of Congenital Malformations (ECLAMC). A phenotype of LRD called thalidomide embryopathy phenotype (TEP) was established for surveillance. Children with TEP born between the years 2000-2008 were monitored, and during the 2007-2008 period we clinically investigated in greater detail all cases with TEP (proactive period). The period from 1982 to 1999 was defined as the baseline period for the cumulative sum statistics. The frequency of TEP during the surveillance period, at 3.10/10,000 births (CI 95%: 2.50-3.70), was significantly higher than that observed in the baseline period (1.92/10,000 births; CI 95%: 1.60-2.20), and not uniformly distributed across different Brazilian regions. During the proactive surveillance (2007-2008), two cases of suspected TE were identified, although the two mothers had denied the use of the drug during pregnancy. Our results suggest that TEP has probably increased in recent years, which coincides with the period of greater thalidomide availability. Our proactive surveillance identified two newborns with suspected TE, proving to be a sensitive tool to detect TE. The high frequency of leprosy and the large use of thalidomide reinforce the need for a continuous monitoring of TEP across Brazil.	[Luiz Vianna, Fernanda Sales; Louguercio Leite, Julio Cesar; Vieira Sanseverino, Maria Teresa; Schueler-Faccini, Lavinia] Hosp Clin Porto Alegre, Med Genet Serv, Teratogen Informat Serv, INAGEMP, Porto Alegre, RS, Brazil; [Luiz Vianna, Fernanda Sales; Schueler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Dept Genet, INAGEMP, Porto Alegre, RS, Brazil; [Lopez-Camelo, Jorge S.] IMBICE, ECLAMC, INAGEMP Latin Amer Collaborat Study Congenital Ma, La Plata, Argentina; [Lopez-Camelo, Jorge S.; Castilla, Eduardo E.] CEMIC, ECLAMC, INAGEMP, Buenos Aires, DF, Argentina; [Dutra, Maria da Graca; Castilla, Eduardo E.] Fiocruz MS, Inst Oswaldo Cruz, Lab Epidemiol Malformacoes Congenitas, INAGEMP,ECLAMC, BR-21045900 Rio De Janeiro, Brazil	Universidade Federal do Rio Grande do Sul; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); Fundacao Oswaldo Cruz	Vianna, FSL (corresponding author), Hosp Clin Porto Alegre, Med Genet Serv, Teratogen Informat Serv, INAGEMP, Porto Alegre, RS, Brazil.	lavinia.faccini@ufrgs.br	SANSEVERINO, MARIA TERESA V/G-3884-2017; Inagemp, Inct/J-9451-2013; Vianna, Fernanda Sales Luiz/O-4337-2019; SCHULER-FACCINI, LAVINIA/C-8309-2013; SCHULER-FACCINI, LAVINIA/K-2927-2016	SANSEVERINO, MARIA TERESA V/0000-0002-7404-2911; SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; Lopez-Camelo, Jorge S./0000-0002-3146-5447; Loguercio Leite, Julio Cesar/0000-0002-3551-6811	INCT (National Institute of Science and Technology); National Council of Research (CNPq) [573993/2008-4]	INCT (National Institute of Science and Technology); National Council of Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by INCT (National Institute of Science and Technology), National Council of Research (CNPq), Process nr 573993/2008-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ANVISA ANDVS, 2003, DIARIO OFICIAL UNIAO; Babcock GD, 2005, BIRTH DEFECTS RES A, V73, P669, DOI 10.1002/bdra.20209; Castilla EE, 1996, TERATOLOGY, V54, P273, DOI 10.1002/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO;2-#; Castilla EE, 2003, AM J MED GENET A, V123A, P123, DOI 10.1002/ajmg.a.20230; Castilla EE, 2004, COMMUNITY GENET, V7, P76, DOI 10.1159/000080776; Magalhaes MDC, 2007, EPIDEMIOL SERV SAUDE, V16, P75; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; *JML, 1985, TECHNOMETRICS; LENZ W, 1988, TERATOLOGY, V38, P203, DOI 10.1002/tera.1420380303; Lenz W, 1961, FRAGEN PRAXIS KINDLI, P2555; LENZ W, 1961, TAG RHEIN KIND DUSS; MCBRIDE, 1961, LANCET; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; NEUHAUS G, 1960, Med Klin, V55, P544; NEWMAN CGH, 1986, CLIN PERINATOL, V13, P555, DOI 10.1016/S0095-5108(18)30810-8; Oliveira M A, 1999, Cad Saude Publica, V15, P99, DOI 10.1590/S0102-311X1999000100011; Rosano A, 2000, AM J MED GENET, V93, P110, DOI 10.1002/1096-8628(20000717)93:2<110::AID-AJMG6>3.0.CO;2-9; SAMPAIO EP, 1991, J EXP MED, V173, P699, DOI 10.1084/jem.173.3.699; *SAUD MD, 2008, VIG SAUD SIT EP HANS; Schuler-Faccini L, 2007, BIRTH DEFECTS RES A, V79, P671, DOI 10.1002/bdra.20384; Sheskin J, 1969, Int J Lepr Other Mycobact Dis, V37, P135; SHESKIN J, 1965, CLIN PHARMACOL THER, V6, P303; SMITHELLS RW, 1992, J MED GENET, V29, P716, DOI 10.1136/jmg.29.10.716; Trent S, 2001, DARK REMEDY IMPACT T; Uhl K, 2006, DRUG SAFETY, V29, P321, DOI 10.2165/00002018-200629040-00003; Yang QH, 1997, AM J MED GENET, V73, P251, DOI 10.1002/(SICI)1096-8628(19971219)73:3<251::AID-AJMG4>3.0.CO;2-V; 2011, DIARIO OFICIAL  0322	27	26	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21735	10.1371/journal.pone.0021735	http://dx.doi.org/10.1371/journal.pone.0021735			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754997	Green Published, gold, Green Submitted			2022-12-25	WOS:000292632000023
J	Malcolm, KC; Kret, JE; Young, RL; Poch, KR; Caceres, SM; Douglas, IS; Coldren, CD; Burnham, EL; Moss, M; Nick, JA				Malcolm, Kenneth C.; Kret, Jennifer E.; Young, Robert L.; Poch, Katie R.; Caceres, Silvia M.; Douglas, Ivor S.; Coldren, Chris D.; Burnham, Ellen L.; Moss, Marc; Nick, Jerry A.			Bacteria-Specific Neutrophil Dysfunction Associated with Interferon-Stimulated Gene Expression in the Acute Respiratory Distress Syndrome	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; STAPHYLOCOCCUS-AUREUS; PULMONARY INFLAMMATION; BLOOD NEUTROPHILS; INFLUENZA-VIRUS; PROTEIN-KINASE; I INTERFERONS; LIPOPOLYSACCHARIDE; APOPTOSIS; ACTIVATION	Acute respiratory distress syndrome (ARDS) is a poorly understood condition with greater than 30% mortality. Massive recruitment of neutrophils to the lung occurs in the initial stages of the ARDS. Significant variability in the severity and duration of ARDS-associated pulmonary inflammation could be linked to heterogeneity in the inflammatory capacity of neutrophils. Interferon-stimulated genes (ISGs) are a broad gene family induced by Type I interferons. While ISGs are central to anti-viral immunity, the potential exists for these genes to evoke extensive modification in cellular response in other clinical settings. In this prospective study, we sought to determine if ISG expression in circulating neutrophils from ARDS patients is associated with changes in neutrophil function. Circulating neutrophil RNA was isolated, and hierarchical clustering ranked patients' expression of three ISGs. Neutrophil response to pathogenic bacteria was compared between normal and high ISG-expressing neutrophils. High neutrophil ISG expression was found in 25 of 95 (26%) of ARDS patients and was associated with reduced migration toward interleukin-8, and altered responses to Staphylococcus aureus, but not Pseudomonas aeruginosa, which included decreased p38 MAP kinase phosphorylation, superoxide anion release, interleukin-8 release, and a shift from necrotic to apoptotic cell death. These alterations in response were reflected in a decreased capacity to kill S. aureus, but not P. aeruginosa. Therefore, the ISG expression signature is associated with an altered circulating neutrophil response phenotype in ARDS that may predispose a large subgroup of patients to increased risk of specific bacterial infections.	[Malcolm, Kenneth C.; Kret, Jennifer E.; Young, Robert L.; Poch, Katie R.; Caceres, Silvia M.; Nick, Jerry A.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Malcolm, Kenneth C.; Young, Robert L.; Douglas, Ivor S.; Coldren, Chris D.; Burnham, Ellen L.; Moss, Marc; Nick, Jerry A.] Univ Colorado Denver, Sch Med, Dept Med, Div Pulm Sci & Crit Care Med, Aurora, CO USA; [Douglas, Ivor S.] Denver Hlth Med Ctr, Dept Med, Denver, CO USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center	Malcolm, KC (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO USA.	malcolmk@njhealth.org	Douglas, Ivor S/AAC-6245-2021	Douglas, Ivor S/0000-0002-4541-1431; Malcolm, Kenneth/0000-0002-8097-6059	CF Foundation; Rebecca Runyon Bryan Chair for Cystic Fibrosis; NIH [1R01HL090991]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090991] Funding Source: NIH RePORTER	CF Foundation; Rebecca Runyon Bryan Chair for Cystic Fibrosis; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this study was provided by the CF Foundation, Rebecca Runyon Bryan Chair for Cystic Fibrosis, and NIH 1R01HL090991 to J.A.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; Aggarwal A, 2000, EUR RESPIR J, V15, P895, DOI 10.1034/j.1399-3003.2000.15e14.x; Arnalich F, 2000, INFECT IMMUN, V68, P1942, DOI 10.1128/IAI.68.4.1942-1945.2000; Bogdan C, 2004, IMMUNOL REV, V202, P33, DOI 10.1111/j.0105-2896.2004.00207.x; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Buckley JM, 2006, J LEUKOCYTE BIOL, V80, P731, DOI 10.1189/jlb.0506312; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Ely EW, 2002, ANN INTERN MED, V136, P25, DOI 10.7326/0003-4819-136-1-200201010-00007; Erwig LP, 2007, AM J PATHOL, V171, P2, DOI 10.2353/ajpath.2007.070135; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; Fessler MB, 2002, J BIOL CHEM, V277, P31291, DOI 10.1074/jbc.M200755200; Fialkow L, 2006, CRIT CARE, V10, DOI 10.1186/cc5090; Gong MN, 2007, CRIT CARE MED, V35, P48, DOI 10.1097/01.CCM.0000251132.10689.F3; Gong MN, 2005, CRIT CARE MED, V33, P1191, DOI 10.1097/01.CCM.0000165566.82925.14; Goodman RB, 1996, AM J RESP CRIT CARE, V154, P602, DOI 10.1164/ajrccm.154.3.8810593; Gungor N, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-24; Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891; GUTHRIE LA, 1984, J EXP MED, V160, P1656, DOI 10.1084/jem.160.6.1656; GYLLENHAMMAR H, 1988, J INTERFERON RES, V8, P441, DOI 10.1089/jir.1988.8.441; Halminen M, 1997, PEDIATR RES, V41, P647, DOI 10.1203/00006450-199705000-00008; Hampton MB, 1996, INFECT IMMUN, V64, P3512, DOI 10.1128/IAI.64.9.3512-3517.1996; HASLETT C, 1985, AM J PATHOL, V119, P101; Kelly-Scumpia KM, 2010, J EXP MED, V207, P319, DOI 10.1084/jem.20091959; Kobayashi SD, 2010, J INNATE IMMUN, V2, P560, DOI 10.1159/000317134; Lamb NJ, 1999, CRIT CARE MED, V27, P1738, DOI 10.1097/00003246-199909000-00007; Landolt-Marticorena C, 2009, ANN RHEUM DIS, V68, P1440, DOI 10.1136/ard.2008.093146; Lee KS, 2008, RESP MED, V102, P464, DOI 10.1016/j.rmed.2007.10.001; Lesur O, 2000, CRIT CARE MED, V28, P3814, DOI 10.1097/00003246-200012000-00010; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; LITTLE R, 1994, J INFECT DIS, V170, P802, DOI 10.1093/infdis/170.4.802; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Malcolm KC, 2003, J BIOL CHEM, V278, P15693, DOI 10.1074/jbc.M212033200; Malcolm KC, 2003, AM J PHYSIOL-LUNG C, V284, pL663, DOI 10.1152/ajplung.00094.2002; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; MARTIN TR, 1991, AM REV RESPIR DIS, V144, P254, DOI 10.1164/ajrccm/144.2.254; Martinelli S, 2004, J BIOL CHEM, V279, P44123, DOI 10.1074/jbc.M405883200; Mascellino MT, 2001, J MED MICROBIOL, V50, P49, DOI 10.1099/0022-2615-50-1-49; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Moss M, 2000, CRIT CARE MED, V28, P2187, DOI 10.1097/00003246-200007000-00001; Nick JA, 2004, BLOOD, V104, P3878, DOI 10.1182/blood-2004-06-2140; Nick JA, 2002, J IMMUNOL, V169, P5260, DOI 10.4049/jimmunol.169.9.5260; Nick JA, 1999, J CLIN INVEST, V103, P851, DOI 10.1172/JCI5257; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Owhashi M, 2003, BIOCHEM BIOPH RES CO, V309, P533, DOI 10.1016/j.bbrc.2003.08.038; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; RIVKIND AI, 1991, CIRC SHOCK, V33, P48; ROERS A, 1994, J INFECT DIS, V169, P807, DOI 10.1093/infdis/169.4.807; Rothberg MB, 2008, AM J MED, V121, P258, DOI 10.1016/j.amjmed.2007.10.040; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakamoto E, 2005, J LEUKOCYTE BIOL, V78, P301, DOI 10.1189/jlb.1104690; SELLERS TF, 1961, J EXP MED, V114, P237, DOI 10.1084/jem.114.2.237; Shiloh MU, 1997, INFECT IMMUN, V65, P3193, DOI 10.1128/IAI.65.8.3193-3198.1997; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stockinger S, 2002, J IMMUNOL, V169, P6522, DOI 10.4049/jimmunol.169.11.6522; Tsangaris I, 2009, THROMB RES, V123, P832, DOI 10.1016/j.thromres.2008.07.018; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Wang KQ, 2003, J IMMUNOL, V171, P1035, DOI 10.4049/jimmunol.171.2.1035; Wright HJ, 2008, J IMMUNOL, V181, P5775, DOI 10.4049/jimmunol.181.8.5775; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	61	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21958	10.1371/journal.pone.0021958	http://dx.doi.org/10.1371/journal.pone.0021958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755013	Green Published, gold, Green Submitted			2022-12-25	WOS:000292632000040
J	Markovets, AM; Fursova, AZ; Kolosova, NG				Markovets, Anton M.; Fursova, Anzhella Z.; Kolosova, Natalia G.			Therapeutic Action of the Mitochondria-Targeted Antioxidant SkQ1 on Retinopathy in OXYS Rats Linked with Improvement of VEGF and PEDF Gene Expression	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RETINAL-PIGMENT EPITHELIUM; MACULAR DEGENERATION; SENESCENCE; CATARACT; DYNAMICS; VISION; EYE	The incidence of age-related macular degeneration (AMD), the main cause of blindness in older patients in the developed countries, is increasing with the ageing population. At present there is no effective treatment for the prevailing geographic atrophy, dry AMD, whereas antiangiogenic therapies successful used in managing the wet form of AMD. Recently we showed that mitochondria-targeted antioxidant plastoquinonyl-decyl-triphenylphosphonium (SkQ1) is able to prevent the development and moreover caused regression of pre-existing signs of the retinopathy in OXYS rats, an animal model of AMD. Here we examine the effects of SkQ1 on expression of key regulators of angiogenesis vascular endothelial growth factor A (VEGF) and its antagonist pigment epithelium-derived factor (PEDF) genes in the retina of OXYS rats as evidenced by real-time PCR and an ELISA test for VEGF using Wistar rats as control. Ophthalmoscopic examinations confirmed that SkQ1 supplementation (from 1.5 to 3 months of age, 250 nmol/kg) prevented development while eye drops SkQ1 (250 nM, from 9 to 12 months) caused some reduction of retinopathy signs in OXYS rats and did not reveal any negative effects on the control Wistar rat's retina. Prevention of premature retinopathy by SkQ1 was connected with an increase of VEGF mRNA and protein in OXYS rat's retina up to the levels corresponding to the Wistar rats, and did not involve changes in PEDF expression. In contrast the treatment with SkQ1 drops caused a decrease of VEGF mRNA and protein levels and an increase in the PEDF mRNA level in the middle-aged OXYS rats, but in Wistar rats the changes of gene expression were the opposite. Conclusions: The beneficial effects of SkQ1 on retinopathy connected with normalization of expression of VEGF and PEDF in the retina of OXYS rats and depended on age of the animals and the stage of retinopathy.	[Markovets, Anton M.; Fursova, Anzhella Z.; Kolosova, Natalia G.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, SB RAS, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Markovets, AM (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, SB RAS, Novosibirsk 630090, Russia.	kolosova@bionet.nsc.ru	fursova, anzhella/AAE-1495-2022; Kolosova, Nataliya G/P-3178-2015; Kolosova, Nataliya G/AAR-7409-2020	fursova, anzhella/0000-0001-6311-5452; Kolosova, Nataliya G/0000-0003-2398-8544; Kolosova, Nataliya G/0000-0003-2398-8544	Russian Foundation for Basic Research RFBR [11-04-00666]; presidium of Russian Academy of Science (RAS) [5.11]; FASI [14.740.11.0758]	Russian Foundation for Basic Research RFBR(Russian Foundation for Basic Research (RFBR)); presidium of Russian Academy of Science (RAS)(Russian Academy of Sciences); FASI(Federal Agency for Science & Innovations (FASI))	This work was supported by grants of Russian Foundation for Basic Research RFBR (11-04-00666), presidium of Russian Academy of Science (RAS) (5.11) and FASI state contract 14.740.11.0758. The funders had no role in study design, datacollection and analysis, decision to publish, or preparation of the manuscript.	Bhutto IA, 2006, EXP EYE RES, V82, P99, DOI 10.1016/j.exer.2005.05.007; Chong EWT, 2007, BMJ-BRIT MED J, V335, P755, DOI 10.1136/bmj.39350.500428.47; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Filleur S, 2009, J CELL BIOCHEM, V106, P769, DOI 10.1002/jcb.22072; GALE C, 2007, INVEST OPHTH VIS SCI, V44, P2461; Grisanti S, 2008, PROG RETIN EYE RES, V27, P372, DOI 10.1016/j.preteyeres.2008.05.002; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; KLIFFEN H, 1997, M BR J OPHTHALMOL, V81, P154; Kolosova NG, 2001, B EXP BIOL MED+, V132, P814, DOI 10.1023/A:1013014919721; Kolosova NG, 2003, B EXP BIOL MED+, V136, P415, DOI 10.1023/B:BEBM.0000010967.24302.78; Markovets AM, 2011, AGING-US, V3, P44; Marsili S, 2004, EXP EYE RES, V79, P595, DOI 10.1016/j.exer.2004.06.008; Neroev VV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1317, DOI 10.1134/S0006297908120043; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Obukhova LA, 2009, AGING-US, V1, P389, DOI 10.18632/aging.100043; Patten DA, 2010, MOL BIOL CELL, V21, P3247, DOI 10.1091/mbc.E10-01-0025; Saprunova VB, 2010, BIOCHEMISTRY-MOSCOW+, V75, P130, DOI 10.1134/S0006297910020021; Severin FF, 2010, P NATL ACAD SCI USA, V107, P663, DOI 10.1073/pnas.0910216107; Shabalina I. G., 1995, Biokhimiya, V60, P441; Skulachev VP, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1385, DOI 10.1134/S0006297907120139; Skulachev VP, 2009, BBA-BIOENERGETICS, V1787, P437, DOI 10.1016/j.bbabio.2008.12.008; SOLOVEVA NA, 1975, GENETIKA+, V11, P63; Spilsbury K, 2000, AM J PATHOL, V157, P135, DOI 10.1016/S0002-9440(10)64525-7; Tan JSL, 2007, OPHTHALMOLOGY, V114, P1143, DOI 10.1016/j.ophtha.2006.09.033; Witmer AN, 2002, J HISTOCHEM CYTOCHEM, V50, P767, DOI 10.1177/002215540205000603; Wolf S, 2008, JPN J OPHTHALMOL, V52, P433, DOI 10.1007/s10384-008-0580-4; Zhdankina AA, 2008, B EXP BIOL MED+, V146, P455, DOI 10.1007/s10517-009-0298-4	28	42	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21682	10.1371/journal.pone.0021682	http://dx.doi.org/10.1371/journal.pone.0021682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750722	gold, Green Published, Green Submitted			2022-12-25	WOS:000292512000019
J	Andreo, U; Elkind, J; Blachford, C; Cederbaum, AI; Fisher, EA				Andreo, Ursula; Elkind, Josh; Blachford, Courtney; Cederbaum, Arthur I.; Fisher, Edward A.			Role of superoxide radical anion in the mechanism of apoB100 degradation induced by DHA in hepatic cells	FASEB JOURNAL			English	Article						polyunsaturated fatty acids; lipid peroxides; VLDL	APOLIPOPROTEIN-B; LIPID-PEROXIDATION; DISMUTASE MIMETICS; OMEGA-3-FATTY-ACIDS; SECRETION; PATHWAY; DISEASE; PROTEIN; ACID	VLDL is produced by the liver. Its major protein is apoB100. Docosahexaenoic acid (DHA), a dietary polyunsaturated fatty acid (PUFA), reduces VLDL levels and is used therapeutically for hypertriglyceridemia. In model systems, DHA lowers VLDL secretion by inducing presecretory apoB100 degradation, a process dependent on PUFA-derived lipid peroxides. We hypothesized that superoxide (SO) was a major participant in DHA-induced apoB100 degradation, given its promotion of lipid peroxidation. SO levels in a model of VLDL metabolism, rat hepatoma McArdle cells, were either decreased by a mimetic of superoxide dismutase 1 (SOD1) or by overexpressing SOD1 or increased by SOD1 siRNA. ApoB100 recovery was assessed by immunoprecipitation, SO by 2-hydroxyethidine, and lipid peroxides by thiobarbituric acid reactive substances. The SOD1 mimetic or SOD1 overexpression reduced SO and inhibited apoB100 degradation in DHA-treated cells by up to 100%. Surprisingly, silencing SOD1 did not increase DHA-induced degradation, although levels of SO were higher (+44%); those of lipid peroxides were similar, and their reduction by alpha-tocopherol decreased degradation by 50%. SO is required for lipid peroxidation in DHA-induced apoB100 degradation, but it is the peroxide level that has a tighter relationship to the level of degradation and the regulation of VLDL production.-Andreo, U., Elkind, J., Blachford, C., Cederbaum, A. I., Fisher, E. A. Role of superoxide radical anion in the mechanism of apoB100 degradation induced by DHA in hepatic cells. FASEB J. 25, 3554-3560 (2011). www.fasebj.org	[Andreo, Ursula; Elkind, Josh; Blachford, Courtney; Fisher, Edward A.] NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol,Marc & Ruti Bell Progr, New York, NY 10016 USA; [Andreo, Ursula; Elkind, Josh; Blachford, Courtney; Fisher, Edward A.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Cederbaum, Arthur I.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY USA; [Fisher, Edward A.] Univ Oxford, Dept Cardiovasc Med, Oxford, England	New York University; New York University; Icahn School of Medicine at Mount Sinai; University of Oxford	Fisher, EA (corresponding author), NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol,Marc & Ruti Bell Progr, Smilow 7,522 1st Ave, New York, NY 10016 USA.	edward.fisher@nyumc.org	Fisher, Edward/ABE-7469-2020	Fisher, Edward/0000-0001-9802-143X	U.S. National Institutes of Health (NIH) [HL-58541]; American Heart Association [0825883D]; NIH [AA-017425, AA-018790]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018790, R01AA017425] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by U.S. National Institutes of Health (NIH) grant HL-58541 (to E.A.F.), American Heart Association postdoctoral fellowship 0825883D (to U.A.), and NIH grants AA-017425 and AA-018790 (to A.I.C.). The authors thank Dr Jacek Zielonka for the 2-hydroxyethidium measurements that were performed at the Free Radical Research Center (Medical College of Wisconsin, Milwaukee, WI, USA), Lisa Grauer (New York University) for help in the manuscript preparation, and Dr. Charles (Liang) Guo (New York University) for helpful discussions.	BELOQUI O, 1986, BIOCHEM PHARMACOL, V35, P2663, DOI 10.1016/0006-2952(86)90172-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caro AA, 2001, MOL PHARMACOL, V60, P742; Day BJ, 1999, FREE RADICAL BIO MED, V26, P730, DOI 10.1016/S0891-5849(98)00261-5; Fisher EA, 2001, J BIOL CHEM, V276, P27855, DOI 10.1074/jbc.M008885200; Fisher EA, 2008, AUTOPHAGY, V4, P721, DOI 10.4161/auto.6346; FRUEBIS J, 1992, P NATL ACAD SCI USA, V89, P10588, DOI 10.1073/pnas.89.22.10588; Gauuan PJF, 2002, BIOORGAN MED CHEM, V10, P3013, DOI 10.1016/S0968-0896(02)00153-0; Ginsberg HN, 2009, J LIPID RES, V50, pS162, DOI 10.1194/jlr.R800090-JLR200; Harris WS, 2008, ATHEROSCLEROSIS, V197, P12, DOI 10.1016/j.atherosclerosis.2007.11.008; Harris WS, 2006, CURR OPIN LIPIDOL, V17, P387, DOI 10.1097/01.mol.0000236363.63840.16; Kris-Etherton PM, 2003, ARTERIOSCL THROM VAS, V23, P151, DOI 10.1161/01.ATV.0000057393.97337.AE; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu Y, 2008, FREE RADICAL BIO MED, V44, P723, DOI 10.1016/j.freeradbiomed.2007.11.004; Pan MH, 2008, P NATL ACAD SCI USA, V105, P5862, DOI 10.1073/pnas.0707460104; Pan MH, 2004, J CLIN INVEST, V113, P1277, DOI 10.1172/JCI200419197; Perez MJ, 2003, HEPATOLOGY, V38, P1146, DOI 10.1053/jhep.2003.50479; PUNTARULO S, 1989, BIOCHEM PHARMACOL, V38, P2911, DOI 10.1016/0006-2952(89)90449-8; REUBEN MA, 1988, J LIPID RES, V29, P1337; Smith C., 2005, MARKS BASIC MED BIOC, P439; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Tran K, 2006, BBA-MOL CELL BIOL L, V1761, P463, DOI 10.1016/j.bbalip.2006.03.018; Trova MP, 2003, BIOORGAN MED CHEM, V11, P2695, DOI 10.1016/S0968-0896(03)00272-4; Uchiyama S, 2006, J BIOL CHEM, V281, P31713, DOI 10.1074/jbc.M603422200; WANG HX, 1994, J BIOL CHEM, V269, P18514; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473	26	17	17	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3554	3560		10.1096/fj.11-182725	http://dx.doi.org/10.1096/fj.11-182725			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21757500	Green Published			2022-12-25	WOS:000295356400025
J	James, JR; McColl, J; Oliveira, MI; Dunne, PD; Huang, E; Jansson, A; Nilsson, P; Sleep, DL; Goncalves, CM; Morgan, SH; Felce, JH; Mahen, R; Fernandes, RA; Carmo, AM; Klenerman, D; Davis, SJ				James, John R.; McColl, James; Oliveira, Marta I.; Dunne, Paul D.; Huang, Elizabeth; Jansson, Andreas; Nilsson, Patric; Sleep, David L.; Goncalves, Carine M.; Morgan, Sara H.; Felce, James H.; Mahen, Robert; Fernandes, Ricardo A.; Carmo, Alexandre M.; Klenerman, David; Davis, Simon J.			The T Cell Receptor Triggering Apparatus Is Composed of Monovalent or Monomeric Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE CD45; SIGNAL-TRANSDUCTION; ANTIGEN RECEPTOR; STRUCTURAL BASIS; CYTOPLASMIC DOMAIN; KINASE-ACTIVITY; ACTIVATION; MOLECULE; ASSOCIATION; TCR	Understanding the component stoichiometry of the T cell antigen receptor (TCR) triggering apparatus is essential for building realistic models of signal initiation. Recent studies suggesting that the TCR and other signaling-associated proteins are preclustered on resting T cells relied on measurements of the behavior of membrane proteins at interfaces with functionalized glass surfaces. Using fluorescence recovery after photo-bleaching, we show that, compared with the apical surface, the mobility of TCRs is significantly reduced at Jurkat T cell/glass interfaces, in a signaling-sensitive manner. Using two biophysical approaches that mitigate these effects, bioluminescence resonance energy transfer and two-color coincidence detection microscopy, we show that, within the uncertainty of the methods, the membrane components of the TCR triggering apparatus, i.e. the TCR complex, MHC molecules, CD4/Lck and CD45, are exclusively monovalent or monomeric in human T cell lines, implying that TCR triggering depends only on the kinetics of TCR/pMHC interactions. These analyses also showed that constraining proteins to two dimensions at the cell surface greatly enhances random interactions versus those between the membrane and the cytoplasm. Simulations of TCR-pMHC complex formation based on these findings suggest how unclustered TCR triggering-associated proteins might nevertheless be capable of generating complex signaling outputs via the differential recruitment of cytosolic effectors to the cell membrane.	[McColl, James; Dunne, Paul D.; Klenerman, David] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [James, John R.; Huang, Elizabeth; Sleep, David L.; Morgan, Sara H.; Felce, James H.; Fernandes, Ricardo A.; Davis, Simon J.] Univ Oxford, Weatherall Inst Mol Med, Nuffield Dept Clin Med, Oxford OX3 9DS, England; [James, John R.; Huang, Elizabeth; Sleep, David L.; Morgan, Sara H.; Felce, James H.; Fernandes, Ricardo A.; Davis, Simon J.] Univ Oxford, Weatherall Inst Mol Med, Med Res Council Human Immunol Unit, Oxford OX3 9DS, England; [Oliveira, Marta I.; Goncalves, Carine M.; Carmo, Alexandre M.] Univ Porto, Inst Biol Mol & Celular, Grp Cell Activat & Gene Express, P-4150180 Oporto, Portugal; [Oliveira, Marta I.; Goncalves, Carine M.; Carmo, Alexandre M.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4099003 Oporto, Portugal; [Jansson, Andreas; Nilsson, Patric] Univ Skovde, Sch Life Sci, Syst Biol Res Ctr, Skovde, Sweden; [Mahen, Robert] Hutchison MRC Res Ctr, Med Res Council Canc Cell Unit, Cambridge CB2 0XZ, England	University of Cambridge; University of Oxford; University of Oxford; Universidade do Porto; Universidade do Porto; University of Skovde	Klenerman, D (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	dk10012@cam.ac.uk; simon.davis@ndm.ox.ac.uk	Carmo, Alexandre/B-5191-2011; Oliveira, Marta I A/M-9386-2013; Fernandes, Ricardo/AAB-8165-2019; James, John R/B-5547-2008; James, John/AAP-3607-2021	Carmo, Alexandre/0000-0002-2508-9799; Oliveira, Marta I A/0000-0002-0578-9202; Fernandes, Ricardo/0000-0001-5343-3334; James, John R/0000-0003-1452-7578; James, John/0000-0003-1452-7578; Klenerman, David/0000-0001-7116-6954; Felce, James/0000-0001-5531-9244; Mahen, Robert/0000-0002-4748-3690; McColl, James/0000-0002-6692-3663; Goncalves, Carine/0000-0002-4512-6147	Wellcome Trust; Biotechnology and Biological Sciences and Research Council; United Kingdom Medical Research Council; Fundacao para a Ciencia e a Tecnologia of Portugal; Biotechnology and Biological Sciences Research Council [BB/D000467/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences and Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust, the Biotechnology and Biological Sciences and Research Council, the United Kingdom Medical Research Council, and the Fundacao para a Ciencia e a Tecnologia of Portugal.	Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Cairo CW, 2010, J BIOL CHEM, V285, P11392, DOI 10.1074/jbc.M109.075648; Cambier JC, 2010, IMMUNOL LETT, V128, P6, DOI 10.1016/j.imlet.2009.09.006; Choudhuri K, 2007, SEMIN IMMUNOL, V19, P255, DOI 10.1016/j.smim.2007.04.005; Clarke RW, 2007, ANAL CHEM, V79, P2771, DOI 10.1021/ac062188w; Corry B, 2006, BIOPHYS J, V91, P1032, DOI 10.1529/biophysj.106.080713; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; DAVIS SJ, 1990, J BIOL CHEM, V265, P10410; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Dornan S, 2002, J BIOL CHEM, V277, P1912, DOI 10.1074/jbc.M108386200; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dunne PD, 2009, BIOPHYS J, V97, pL5, DOI 10.1016/j.bpj.2009.05.046; Dushek O, 2008, J BIOCHEM BIOPH METH, V70, P1224, DOI 10.1016/j.jbbm.2007.07.002; Dushek O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003913; GLAICHENHAUS N, 1991, CELL, V64, P511, DOI 10.1016/0092-8674(91)90235-Q; Graef IA, 1997, EMBO J, V16, P5618, DOI 10.1093/emboj/16.18.5618; Gratton S, 1996, J IMMUNOL, V157, P3305; Haugh JM, 1997, BIOPHYS J, V72, P2014, DOI 10.1016/S0006-3495(97)78846-5; Hayball JD, 2005, MOL CELL BIOCHEM, V273, P1, DOI 10.1007/s11010-005-5281-4; Hoffmann KMV, 1997, J BIOL CHEM, V272, P27505, DOI 10.1074/jbc.272.44.27505; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; Irie A, 2003, EUR J IMMUNOL, V33, P1497, DOI 10.1002/eji.200323618; James JR, 2007, P NATL ACAD SCI USA, V104, P17662, DOI 10.1073/pnas.0700411104; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Kim PW, 2003, SCIENCE, V301, P1725, DOI 10.1126/science.1085643; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Moldovan MC, 2002, J IMMUNOL, V169, P6261, DOI 10.4049/jimmunol.169.11.6261; Nam HJ, 2005, J EXP MED, V201, P441, DOI 10.1084/jem.20041890; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; ROTHSTEIN DM, 1992, J BIOL CHEM, V267, P7139; Salzmann M, 1998, MOL IMMUNOL, V35, P271, DOI 10.1016/S0161-5890(98)00035-2; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Sloan-Lancaster J, 1998, J CELL BIOL, V143, P613, DOI 10.1083/jcb.143.3.613; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Tanaka KAK, 2010, NAT METHODS, V7, P865, DOI 10.1038/nmeth.f.314; Tiganos E, 1997, J VIROL, V71, P4452, DOI 10.1128/JVI.71.6.4452-4460.1997; Tran TM, 2007, BIOCHEMISTRY-US, V46, P14438, DOI 10.1021/bi700922h; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Vignali DAA, 1999, J IMMUNOL, V162, P1431; Wray V, 1998, BIOCHEMISTRY-US, V37, P8527, DOI 10.1021/bi9723111; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yousefi S, 2003, CLIN EXP IMMUNOL, V133, P78, DOI 10.1046/j.1365-2249.2003.02187.x; YUNIS JJ, 1989, BLOOD, V73, P931	55	38	38	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					31993	32001		10.1074/jbc.M111.219212	http://dx.doi.org/10.1074/jbc.M111.219212			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21757710	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000294726800008
J	Li, Y; Yang, JD; Li, SQ; Zhang, J; Zheng, J; Hou, WG; Zhao, HD; Guo, YY; Liu, XP; Dou, KF; Situ, Z; Yao, LB				Li, Yan; Yang, Jiandong; Li, Shaoqing; Zhang, Jian; Zheng, Jin; Hou, Wugang; Zhao, Huadong; Guo, Yanyan; Liu, Xinping; Dou, Kefeng; Situ, Zhenqiang; Yao, Libo			N-myc Downstream-regulated Gene 2, a Novel Estrogen-targeted Gene, Is Involved in the Regulation of Na+/K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT; SODIUM-PUMP; K+-ATPASE; PLASMA-MEMBRANE; GAMMA-SUBUNIT; IN-VIVO; NDRG2; EXPRESSION; RECEPTOR; LOCALIZATION	Na+/K+-ATPase, a plasma membrane protein abundantly expressed in epithelial tissues, has been identified and linked to numerous biological events, including ion transport and reabsorption. In Na+/K+-ATPase, the beta-subunit plays a fundamental role in the structural integrity and functional maturation of holoenzyme. Estrogens are important circulating hormones that can regulateNa(+)/K+-ATPase abundance and activity; however, the specific molecules participating in this process are largely unknown. Here, we characterize that N-myc down-stream-regulated gene 2 (NDRG2) is an estrogen up-regulated gene. 17 beta-Estradiol binds with estrogen receptor beta but not estrogen receptor alpha to up-regulate NDRG2 expression via transcriptional activation. We also find that NDRG2 interacts with the beta 1-subunit of Na+/K+-ATPase and stabilizes the beta 1-subunit by inhibiting its ubiquitination and degradation. NDRG2-induced prolongation of the beta 1-subunit protein half-life is accompanied by a similar increase in Na+/K+-ATPase-mediated Na+ transport and Na+ current in epithelial cells. In addition, NDRG2 silencing largely attenuates the accumulation of beta 1-subunit regulated by 17 beta-estradiol. Our results demonstrate that estrogen/NDRG2/Na+/K+-ATPase beta 1 pathway is important in promoting Na+/K+-ATPase activity and suggest this novel pathway might have substantial roles in ion transport, fluid balance, and homeostasis.	[Situ, Zhenqiang] Fourth Mil Med Univ, Dept Oral Biol, Stomatol Sch, Xian 710032, Shaanxi, Peoples R China; [Li, Yan; Zhang, Jian; Liu, Xinping; Yao, Libo] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Yang, Jiandong; Dou, Kefeng] Fourth Mil Med Univ, Dept Hepatobiliary Surg, Xian 710032, Shaanxi, Peoples R China; [Zheng, Jin] Fourth Mil Med Univ, Dept Oncol, Xian 710032, Shaanxi, Peoples R China; [Hou, Wugang] Fourth Mil Med Univ, Dept Anesthesiol, Xian 710032, Shaanxi, Peoples R China; [Zhao, Huadong] Fourth Mil Med Univ, Dept Gen Surg, Xian 710032, Shaanxi, Peoples R China; [Guo, Yanyan] Fourth Mil Med Univ, Dept Pharmacol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Situ, Z (corresponding author), Fourth Mil Med Univ, Dept Oral Biol, Stomatol Sch, 145 Changle Western Rd, Xian 710032, Shaanxi, Peoples R China.	situzhq@fmmu.edu.cn; bioyao@fmmu.edu.cn	Li, Yan/AAA-6908-2021; Li, Yan/A-7115-2018	Li, Yan/0000-0002-7465-7705; Li, Yan/0000-0002-7465-7705; Li, Yan/0000-0003-0096-0813	Chinese National Key Basic Research and Development Program [2010CB529705]; National Natural Science Foundation of China [31070681, 30830054, 30801121, 81100764, 81072973, 81000563]	Chinese National Key Basic Research and Development Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese National Key Basic Research and Development Program Grant 2010CB529705 and National Natural Science Foundation of China Grants 31070681, 30830054, 30801121, 81100764, 81072973, and 81000563.	Beguin P, 2000, MOL BIOL CELL, V11, P1657, DOI 10.1091/mbc.11.5.1657; BERTORELLO AM, 1990, NATURE, V347, P386, DOI 10.1038/347386a0; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Boulkroun S, 2005, PFLUG ARCH EUR J PHY, V451, P388, DOI 10.1007/s00424-005-1410-x; Boulkroun S, 2002, J BIOL CHEM, V277, P31506, DOI 10.1074/jbc.M200272200; Burchfield JG, 2004, J BIOL CHEM, V279, P18623, DOI 10.1074/jbc.M401504200; Butt AJ, 2005, ENDOCR-RELAT CANCER, V12, pS47, DOI 10.1677/erc.1.00993; Chen L, 2004, NUCLEIC ACIDS RES, V32, P1251, DOI 10.1093/nar/gkh297; CHOW DC, 1995, J EXP BIOL, V198, P1; Dempski RE, 2008, BIOCHEMISTRY-US, V47, P257, DOI 10.1021/bi701799b; Dempski RE, 2009, BBA-BIOENERGETICS, V1787, P714, DOI 10.1016/j.bbabio.2009.03.021; Deng YC, 2001, PROG BIOCHEM BIOPHYS, V28, P72; Deng YC, 2003, INT J CANCER, V106, P342, DOI 10.1002/ijc.11228; Dzurba A, 1997, MOL CELL BIOCHEM, V176, P113, DOI 10.1023/A:1006835214312; Efendiev R, 2007, BRIT J PHARMACOL, V151, P1006, DOI 10.1038/sj.bjp.0707304; EWART HS, 1995, AM J PHYSIOL-CELL PH, V269, pC295, DOI 10.1152/ajpcell.1995.269.2.C295; Foletta VC, 2009, J PHYSIOL-LONDON, V587, P1619, DOI 10.1113/jphysiol.2008.167882; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Hall JM, 1999, ENDOCRINOLOGY, V140, P5566, DOI 10.1210/en.140.12.5566; Hasler U, 1998, J BIOL CHEM, V273, P30826, DOI 10.1074/jbc.273.46.30826; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; Hu XL, 2006, CELL TISSUE RES, V325, P67, DOI 10.1007/s00441-005-0137-5; Kaur G, 1997, MOL CELL BIOCHEM, V167, P107, DOI 10.1023/A:1006876718783; Laube M, 2011, PEDIATR RES, V69, P200, DOI 10.1203/PDR.0b013e3182070ec8; Lefranc F, 2008, NEOPLASIA, V10, P198, DOI 10.1593/neo.07928; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Liu CG, 2007, CLIN EXP PHARMACOL P, V34, P998, DOI 10.1111/j.1440-1681.2007.04675.x; Liu N, 2008, NUCLEIC ACIDS RES, V36, P5335, DOI 10.1093/nar/gkn504; MCDONOUGH AA, 1990, FASEB J, V4, P1598, DOI 10.1096/fasebj.4.6.2156741; MELIS M G, 1990, Bollettino Societa Italiana Biologia Sperimentale, V66, P679; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Ogawa S, 1998, BIOCHEM BIOPH RES CO, V243, P122, DOI 10.1006/bbrc.1997.7893; Qu XH, 2002, MOL CELL BIOCHEM, V229, P35, DOI 10.1023/A:1017934810825; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; Rajasekaran SA, 2010, MOL CANCER THER, V9, P1515, DOI 10.1158/1535-7163.MCT-09-0832; Rivard CJ, 2005, FRONT BIOSCI-LANDMRK, V10, P2604, DOI 10.2741/1724; SIMSSAMPSON G, 1984, ANAT RECORD, V210, P53, DOI 10.1002/ar.1092100109; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Tang CH, 2010, J COMP PHYSIOL B, V180, P813, DOI 10.1007/s00360-010-0458-x; Vagin O, 2007, J BIOENERG BIOMEMBR, V39, P367, DOI 10.1007/s10863-007-9103-0; Wakabayashi Y, 2007, HISTOCHEM CELL BIOL, V127, P463, DOI 10.1007/s00418-007-0274-x; Wang LF, 2008, CELL PHYSIOL BIOCHEM, V21, P239, DOI 10.1159/000113765; Wielputz MO, 2007, J BIOL CHEM, V282, P28264, DOI 10.1074/jbc.M702168200; Yang GZ, 2011, CELL MOL BIOL, V57, P1480, DOI 10.1170/170; Yao LB, 2008, ACTA BIOCH BIOPH SIN, V40, P625, DOI 10.1111/j.1745-7270.2008.00434.x; Yoshimura SH, 2008, J CELL SCI, V121, P2159, DOI 10.1242/jcs.022905; Yu SP, 2003, BIOCHEM PHARMACOL, V66, P1601, DOI 10.1016/S0006-2952(03)00531-8; Zhang J, 2006, J BIOL CHEM, V281, P39159, DOI 10.1074/jbc.M605820200; Zhang J, 2007, BIOCHEM BIOPH RES CO, V352, P6, DOI 10.1016/j.bbrc.2006.10.141; Zhao Chunyan, 2008, Nucl Recept Signal, V6, pe003, DOI 10.1621/nrs.06003; Ziegelhoffer A, 1990, Bratisl Lek Listy, V91, P902	52	63	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32289	32299		10.1074/jbc.M111.247825	http://dx.doi.org/10.1074/jbc.M111.247825			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21771789	Green Published, hybrid			2022-12-25	WOS:000294726800039
J	Sarangapani, KK; Qian, J; Chen, W; Zarnitsyna, VI; Mehta, P; Yago, T; McEver, RP; Zhu, C				Sarangapani, Krishna K.; Qian, Jin; Chen, Wei; Zarnitsyna, Veronika I.; Mehta, Padmaja; Yago, Tadayuki; McEver, Rodger P.; Zhu, Cheng			Regulation of Catch Bonds by Rate of Force Application	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIN GLYCOPROTEIN LIGAND-1; P-SELECTIN; CELL-ADHESION; CONFORMATIONAL DYNAMICS; THRESHOLD SHEAR; MOLECULAR-BONDS; LEWIS-X; SINGLE; DISSOCIATION; SPECTROSCOPY	The current paradigm for receptor-ligand dissociation kinetics assumes off-rates as functions of instantaneous force without impact from its prior history. This a priori assumption is the foundation for predicting dissociation from a given initial state using kinetic equations. Here we have invalidated this assumption by demonstrating the impact of force history with single-bond kinetic experiments involving selectins and their ligands that mediate leukocyte tethering and rolling on vascular surfaces during inflammation. Dissociation of bonds between L-selectin and P-selectin glycoprotein ligand-1 (PSGL-1) loaded at a constant ramp rate to a constant hold force behaved as catchslip bonds at low ramp rates that transformed to slip-only bonds at high ramp rates. Strikingly, bonds between L-selectin and 6-sulfo-sialyl Lewis X were impervious to ramp rate changes. This ligand-specific force history effect resembled the effect of a point mutation at the L-selectin surface (L-selectinA108H) predicted to contact the former but not the latter ligand, suggesting that the high ramp rate induced similar structural changes as the mutation. Although the A108H substitution in L-selectin eliminated the ramp rate responsiveness of its dissociation from PSGL-1, the inverse mutation H108A in P-selectin acquired the ramp rate responsiveness. Our data are well explained by the sliding-rebinding model for catch-slip bonds extended to incorporate the additional force history dependence, with Ala-108 playing a pivotal role in this structural mechanism. These results call for a paradigm shift in modeling the mechanical regulation of receptor-ligand bond dissociation, which includes conformational coupling between binding pocket and remote regions of the interacting molecules.	[Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Chen, Wei; Zarnitsyna, Veronika I.; Zhu, Cheng] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Mehta, Padmaja; Yago, Tadayuki; McEver, Rodger P.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhu, C (corresponding author), 315 Ferst Dr,IBB Bldg,Rm 3312, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu	Qian, Jin/C-6115-2008; Chen, Wei/C-4823-2009	Zarnitsyna, Veronika/0000-0003-3096-3695; Chen, Wei/0000-0001-5366-7253	National Institutes of Health [R01AI077343, R01HL090923]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI077343 (to C. Z. and R. P. M.) and R01HL090923 (to R. P. M.). This work was also supported by an American Heart Association predoctoral scholarship (to W. C.).	Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169; ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0; Bayas MV, 2006, BIOPHYS J, V90, P1385, DOI 10.1529/biophysj.105.069583; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Chen W, 2008, BIOPHYS J, V94, P694, DOI 10.1529/biophysj.107.117895; Chen W, 2010, J BIOL CHEM, V285, P35967, DOI 10.1074/jbc.M110.155770; Chen W, 2008, CELL MOL BIOENG, V1, P276, DOI 10.1007/s12195-008-0024-8; Edman L, 2000, P NATL ACAD SCI USA, V97, P8266, DOI 10.1073/pnas.130589397; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; Evans E, 2001, P NATL ACAD SCI USA, V98, P3784, DOI 10.1073/pnas.061324998; Evans EB, 1999, BIOPHYS CHEM, V82, P83, DOI 10.1016/S0301-4622(99)00108-8; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Guo B, 2006, P NATL ACAD SCI USA, V103, P9844, DOI 10.1073/pnas.0601255103; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; Hanley W, 2003, J BIOL CHEM, V278, P10556, DOI 10.1074/jbc.M213233200; Hanley WD, 2004, J CELL SCI, V117, P2503, DOI 10.1242/jcs.01088; Hummer G, 2003, BIOPHYS J, V85, P5, DOI 10.1016/S0006-3495(03)74449-X; Klopocki AG, 2008, J BIOL CHEM, V283, P11493, DOI 10.1074/jbc.M709785200; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Lawrence MB, 1997, J CELL BIOL, V136, P717, DOI 10.1083/jcb.136.3.717; Li FY, 2003, BIOPHYS J, V84, P1252, DOI 10.1016/S0006-3495(03)74940-6; Li LW, 2005, J MOL BIOL, V345, P817, DOI 10.1016/j.jmb.2004.11.021; Lou JZ, 2007, BIOPHYS J, V92, P1471, DOI 10.1529/biophysj.106.097048; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Marshall BT, 2005, BIOPHYS J, V88, P1458, DOI 10.1529/biophysj.104.050567; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; Pincet F, 2005, BIOPHYS J, V89, P4374, DOI 10.1529/biophysj.105.067769; Prezhdo OV, 2009, ACCOUNTS CHEM RES, V42, P693, DOI 10.1021/ar800202z; Rinko LJ, 2004, BIOPHYS J, V86, P544, DOI 10.1016/S0006-3495(04)74133-8; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Springer TA, 2009, P NATL ACAD SCI USA, V106, P91, DOI 10.1073/pnas.0810784105; Walton EB, 2008, BIOPHYS J, V94, P2621, DOI 10.1529/biophysj.107.114454; Wayman AM, 2010, BIOPHYS J, V99, P1166, DOI 10.1016/j.bpj.2010.05.040; Wu T, 2010, BLOOD, V115, P370, DOI 10.1182/blood-2009-03-210369; Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Yago T, 2007, BIOPHYS J, V92, P330, DOI 10.1529/biophysj.106.090969; Yang H, 2003, SCIENCE, V302, P262, DOI 10.1126/science.1086911; Zarnitsyna VI, 2007, P NATL ACAD SCI USA, V104, P18037, DOI 10.1073/pnas.0704811104; Zhang XH, 2004, CHEMPHYSCHEM, V5, P175, DOI 10.1002/cphc.200300813; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905; Zhang Y, 2008, BIOPHYS J, V95, P5439, DOI 10.1529/biophysj.108.137141; Zhu C, 2008, ANN BIOMED ENG, V36, P604, DOI 10.1007/s10439-008-9464-5; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013	50	41	41	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32749	32761		10.1074/jbc.M111.240044	http://dx.doi.org/10.1074/jbc.M111.240044			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775439	hybrid, Green Published			2022-12-25	WOS:000294726800083
J	Ferraro, GB; Morrison, CJ; Overall, CM; Strittmatter, SM; Fournier, AE				Ferraro, Gino B.; Morrison, Charlotte J.; Overall, Christopher M.; Strittmatter, Stephen M.; Fournier, Alyson E.			Membrane-type Matrix Metalloproteinase-3 Regulates Neuronal Responsiveness to Myelin through Nogo-66 Receptor 1 Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; P75 NEUROTROPHIN RECEPTOR; SPINAL-CORD-INJURY; AXONAL REGENERATION; NEURITE OUTGROWTH; CELL-MIGRATION; INHIBITORS; GROWTH; GLYCOPROTEIN; PROTEIN	Nogo-66 receptor 1 (NgR1) is a glycosylphosphatidylinositol-anchored receptor for myelin-associated inhibitors that restricts plasticity and axonal regrowth in the CNS. NgR1 is cleaved from the cell surface of SH-SY5Y neuroblastoma cells in a metalloproteinase-dependent manner; however, the mechanism and physiological consequence of NgR1 shedding have not been explored. We now demonstrate that NgR1 is shed from multiple populations of primary neurons. Through a loss-of-function approach, we found that membrane-type matrix metalloproteinase-3 (MT3-MMP) regulates endogenous NgR1 shedding in primary neurons. Neuronal knockdown of MT3-MMP resulted in the accumulation of NgR1 at the cell surface and reduced the accumulation of the NgR1 cleavage fragment in medium conditioned by cortical neurons. Recombinant MT1-, MT2-, MT3-, and MT5-MMPs promoted NgR1 shedding from the surface of primary neurons, and this treatment rendered neurons resistant to myelin-associated inhibitors. Introduction of a cleavage-resistant form of NgR1 reconstitutes the neuronal response to these inhibitors, demonstrating that specific metalloproteinases attenuate neuronal responses to myelin in an NgR1-dependent manner.	[Ferraro, Gino B.; Fournier, Alyson E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Morrison, Charlotte J.; Overall, Christopher M.] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; [Strittmatter, Stephen M.] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06536 USA	McGill University; University of British Columbia; Yale University	Fournier, AE (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, 3801 Rue Univ,BT-109, Montreal, PQ H3A 2B4, Canada.	alyson.fournier@mcgill.ca	Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092	Canadian Institutes of Health Research (CIHR); Fonds de la Recherche en Sante du Quebec; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033020] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by a grant from the Canadian Institutes of Health Research (CIHR; to A. E. F.) and by a studentship from the Fonds de la Recherche en Sante du Quebec (to G. B. F.).	Ahmad M, 2006, J BIOCHEM, V139, P517, DOI 10.1093/jb/mvj054; Ahmed Z, 2006, FASEB J, V20, P1939, DOI 10.1096/fj.05-5339fje; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Belien ATJ, 1999, J CELL BIOL, V144, P373, DOI 10.1083/jcb.144.2.373; Cafferty WBJ, 2006, J NEUROSCI, V26, P12242, DOI 10.1523/JNEUROSCI.3827-06.2006; Chivatakarn O, 2007, J NEUROSCI, V27, P7117, DOI 10.1523/JNEUROSCI.1541-07.2007; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Egawa N, 2006, J BIOL CHEM, V281, P37576, DOI 10.1074/jbc.M606993200; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Fournier AE, 2002, J NEUROSCI, V22, P8876; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Hayashita-Kinoh H, 2001, CELL GROWTH DIFFER, V12, P573; Hernandez-Barrantes S, 2002, SEMIN CANCER BIOL, V12, P131, DOI 10.1006/scbi.2001.0421; Hsieh SHK, 2006, J NEUROSCI, V26, P1006, DOI 10.1523/JNEUROSCI.2806-05.2006; IGARASHI M, 1993, SCIENCE, V259, P77, DOI 10.1126/science.8418498; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Karlen A, 2009, P NATL ACAD SCI USA, V106, P20476, DOI 10.1073/pnas.0905390106; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Lee HJ, 2008, J NEUROSCI, V28, P2753, DOI 10.1523/JNEUROSCI.5586-07.2008; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; McDonald CL, 2011, CURR MED CHEM, V18, P234; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Monea S, 2006, J NEUROSCI, V26, P2300, DOI 10.1523/JNEUROSCI.3521-05.2006; Morrison CJ, 2006, J BIOL CHEM, V281, P26528, DOI 10.1074/jbc.M603331200; Nash M, 2009, MOL NEUROBIOL, V40, P224, DOI 10.1007/s12035-009-8083-y; Park JH, 2007, CURR ALZHEIMER RES, V4, P568, DOI 10.2174/156720507783018235; Park JH, 2006, J NEUROSCI, V26, P1386, DOI 10.1523/JNEUROSCI.3291-05.2006; Pool M, 2009, EXP NEUROL, V217, P371, DOI 10.1016/j.expneurol.2009.03.014; Raiker SJ, 2010, J NEUROSCI, V30, P12432, DOI 10.1523/JNEUROSCI.0895-10.2010; Reeves TM, 2003, J NEUROSCI, V23, P10182; Shimada T, 1999, EUR J BIOCHEM, V262, P907, DOI 10.1046/j.1432-1327.1999.00459.x; Thomas S, 2009, J BIOL CHEM, V284, P12410, DOI 10.1074/jbc.M809746200; Toft-Hansen H, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-24; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Voineskos AN, 2009, J NEUROSCI, V29, P5045, DOI 10.1523/JNEUROSCI.0477-09.2009; Walmsley AR, 2004, J CELL SCI, V117, P4591, DOI 10.1242/jcs.01324; Wells JEA, 2003, J NEUROSCI, V23, P10107, DOI 10.1523/jneurosci.23-31-10107.2003; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Yoshiyama Y, 1998, ACTA NEUROPATHOL, V96, P347, DOI 10.1007/s004010050904	43	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31418	31424		10.1074/jbc.M111.249169	http://dx.doi.org/10.1074/jbc.M111.249169			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768085	hybrid, Green Published			2022-12-25	WOS:000294487500036
J	Liao, BS; Hu, Y; Brewer, G				Liao, Baisong; Hu, Yan; Brewer, Gary			RNA-binding Protein Insulin-like Growth Factor mRNA-binding Protein 3 (IMP-3) Promotes Cell Survival via Insulin-like Growth Factor II Signaling after Ionizing Radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BECKWITH-WIEDEMANN SYNDROME; K562 LEUKEMIA-CELLS; CODING REGION; CANCER-CELLS; BIOLOGICAL ACTIONS; IGF-II; EXPRESSION; PROLIFERATION; TRANSLATION; MICRORNA	Ionizing radiation (IR) induces proapoptotic gene expression programs that inhibit cell survival. These programs often involve RNA-binding proteins that associate with their mRNA targets to elicit changes in mRNA stability and/or translation. The RNA-binding protein IMP-3 is an oncofetal protein overexpressed in many human malignancies. IMP-3 abundance correlates with tumor aggressiveness and poor prognosis. As such, IMP-3 is proving to be a highly significant biomarker in surgical pathology. Among its many mRNA targets, IMP-3 binds to and promotes translation of insulin-like growth factor II (IGFII) mRNA. Our earlier studies showed that reducing IMP-3 abundance with siRNAs reduced proliferation of human K562 chronic myeloid leukemia cells because of reduced IGF-II biosynthesis. However, the role of IMP-3 in apoptosis is unknown. Here, we have used IR-induced apoptosis of K562 cells as a model to explore a role for IMP-3 in cell survival. Knockdown of IMP-3 with siRNA increased susceptibility of cells to IR-induced apoptosis and led to reduced IGF-II production. Gene reporter assays revealed that IMP-3 acts through the 5' UTR of IGFII mRNA during apoptosis to promote translation. Finally, culture of IR-treated cells with recombinant IGF-II partially reversed the effects of IMP-3 knockdown on IR-induced apoptosis. Together, these results indicate that IMP-3 acts in part through the IGF-II pathway to promote cell survival in response to IR. Thus, IMP-3 might serve as a new drug target to increase sensitivity of CML cells or other cancers to IR therapy.	[Liao, Baisong; Hu, Yan; Brewer, Gary] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Brewer, G (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, 675 Hoes Ln, Piscataway, NJ 08854 USA.	brewerga@umdnj.edu			National Institutes of Health [R01 CA052443]; NATIONAL CANCER INSTITUTE [R01CA052443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA052443 (to G. B.).	Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; Boudoukha S, 2010, MOL CELL BIOL, V30, P5710, DOI 10.1128/MCB.00665-10; Coxon KM, 2011, METHODS MOL BIOL, V731, P293, DOI 10.1007/978-1-61779-080-5_24; Dai N, 2011, GENE DEV, V25, P1159, DOI 10.1101/gad.2042311; Diamond JM, 2011, LEUKEMIA LYMPHOMA, V52, P12, DOI 10.3109/10428194.2010.546920; Durie D, 2011, ONCOGENE, V30, P1460, DOI 10.1038/onc.2010.527; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; ELISHA Z, 1995, EMBO J, V14, P5109, DOI 10.1002/j.1460-2075.1995.tb00193.x; Findeis-Hosey JJ, 2011, HUM PATHOL, V42, P303, DOI 10.1016/j.humpath.2010.06.003; George Ajish D, 2006, RNA Biol, V3, P57; HAMMARBERG B, 1991, J BIOL CHEM, V266, P11058; Havin L, 1998, GENE DEV, V12, P1593, DOI 10.1101/gad.12.11.1593; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Khandwala HM, 2000, ENDOCR REV, V21, P215, DOI 10.1210/er.21.3.215; Kim CG, 2006, MOL CELLS, V21, P343; Lapucci A, 2002, J BIOL CHEM, V277, P16139, DOI 10.1074/jbc.M201377200; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Liao BS, 2005, J BIOL CHEM, V280, P18517, DOI 10.1074/jbc.M500270200; Liao BS, 2004, J BIOL CHEM, V279, P48716, DOI 10.1074/jbc.M405853200; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; MACAULAY VM, 1992, BRIT J CANCER, V65, P311, DOI 10.1038/bjc.1992.65; Masuda K, 2011, EMBO J, V30, P1040, DOI 10.1038/emboj.2011.24; Mueller F, 2003, BRIT J CANCER, V88, P699, DOI 10.1038/sj.bjc.6600790; MuellerPillasch F, 1997, ONCOGENE, V14, P2729, DOI 10.1038/sj.onc.1201110; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Nielsen J, 2004, NUCLEIC ACIDS RES, V32, P4368, DOI 10.1093/nar/gkh754; Niemoeller OM, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-29; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; PEPE MG, 1987, J CELL PHYSIOL, V133, P219, DOI 10.1002/jcp.1041330204; Perrotti D, 2011, LEUKEMIA LYMPHOMA, V52, P30, DOI 10.3109/10428194.2010.546914; PROKIPCAK RD, 1994, J BIOL CHEM, V269, P9261; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; SANDBERG AC, 1988, NEUROSCI LETT, V93, P114, DOI 10.1016/0304-3940(88)90022-5; SINGH P, 1994, AM J PHYSIOL-GASTR L, V267, pG608, DOI 10.1152/ajpgi.1994.267.4.G608; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; TALLY M, 1987, BIOCHEM BIOPH RES CO, V148, P811, DOI 10.1016/0006-291X(87)90948-X; Tao J, 2011, ONCOL REP, V25, P1721, DOI 10.3892/or.2011.1245; van Dijk EL, 2001, NUCLEIC ACIDS RES, V29, P3477, DOI 10.1093/nar/29.17.3477; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; Yi HK, 2001, EUR J CANCER, V37, P2257, DOI 10.1016/S0959-8049(01)00269-6; Yisraeli JK, 2005, BIOL CELL, V97, P87; ZAPF J, 1986, HORM RES, V24, P121, DOI 10.1159/000180551; ZHANG H, 2011, CELL DEATH IN PRESS; Zhang QM, 1997, J BIOL CHEM, V272, P23703, DOI 10.1074/jbc.272.38.23703	52	43	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31145	31152		10.1074/jbc.M111.263913	http://dx.doi.org/10.1074/jbc.M111.263913			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757716	hybrid, Green Published			2022-12-25	WOS:000294487500009
J	Smock, RG; Blackburn, ME; Gierasch, LM				Smock, Robert G.; Blackburn, Mandy E.; Gierasch, Lila M.			Conserved, Disordered C Terminus of DnaK Enhances Cellular Survival upon Stress and DnaK in Vitro Chaperone Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING DOMAIN; ESCHERICHIA-COLI; MOLECULAR CHAPERONE; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; HSP70 CHAPERONES; QUALITY-CONTROL; PROTEIN; ATPASE; MECHANISM	The 70-kDa heat shock proteins (Hsp70s) function as molecular chaperones through the allosteric coupling of their nucleotide- and substrate-binding domains, the structures of which are highly conserved. In contrast, the roles of the poorly structured, variable length C-terminal regions present on Hsp70s remain unclear. In many eukaryotic Hsp70s, the extreme C-terminal EEVD tetrapeptide sequence associates with co-chaperones via binding to tetratricopeptide repeat domains. It is not known whether this is the only function for this region in eukaryotic Hsp70s and what roles this region performs in Hsp70s that do not form complexes with tetratricopeptide repeat domains. We compared C-terminal sequences of 730 Hsp70 family members and identified a novel conservation pattern in a diverse subset of 165 bacterial and organellar Hsp70s. Mutation of conserved C-terminal sequence in DnaK, the predominant Hsp70 in Escherichia coli, results in significant impairment of its protein refolding activity in vitro without affecting interdomain allostery, interaction with co-chaperones DnaJ and GrpE, or the binding of a peptide substrate, defying classical explanations for the chaperoning mechanism of Hsp70. Moreover, mutation of specific conserved sites within the DnaK C terminus reduces the capacity of the cell to withstand stresses on protein folding caused by elevated temperature or the absence of other chaperones. These features of the C-terminal region support a model in which it acts as a disordered tether linked to a conserved, weak substrate-binding motif and that this enhances chaperone function by transiently interacting with folding clients.	[Smock, Robert G.; Blackburn, Mandy E.; Gierasch, Lila M.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Gierasch, Lila M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Gierasch, LM (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 710 N Pleasant St, Amherst, MA 01003 USA.	gierasch@biochem.umass.edu			National Institutes of Health [GM027616]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008515, R01GM027616] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM027616.	ALEXANDRESCU AT, 1994, BIOCHEMISTRY-US, V33, P1063, DOI 10.1021/bi00171a004; Aponte RA, 2010, J MOL BIOL, V399, P154, DOI 10.1016/j.jmb.2010.03.060; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Budil DE, 1996, J MAGN RESON SER A, V120, P155, DOI 10.1006/jmra.1996.0113; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; BUKAU B, 1990, EMBO J, V9, P4027, DOI 10.1002/j.1460-2075.1990.tb07624.x; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Chang L, 2010, J BIOL CHEM, V285, P21282, DOI 10.1074/jbc.M110.124149; Clerico EM, 2010, BIOPOLYMERS, V94, P742, DOI 10.1002/bip.21426; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker AK, 2008, NAT CHEM BIOL, V4, P229, DOI 10.1038/nchembio0408-229; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fraga H, 2005, FEBS J, V272, P5206, DOI 10.1111/j.1742-4658.2005.04895.x; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; Genest O, 2011, P NATL ACAD SCI USA, V108, P8206, DOI 10.1073/pnas.1104703108; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hu SM, 1996, ARCH BIOCHEM BIOPHYS, V332, P163, DOI 10.1006/abbi.1996.0328; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kthiri F, 2008, BIOCHEM BIOPH RES CO, V374, P668, DOI 10.1016/j.bbrc.2008.07.080; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Lin JS, 2011, J BIOL CHEM, V286, P19459, DOI 10.1074/jbc.M111.238741; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Marcelino AMC, 2006, PROTEINS, V63, P373, DOI 10.1002/prot.20860; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Moro F, 2003, FEBS LETT, V533, P119, DOI 10.1016/S0014-5793(02)03752-3; OSIPIUK J, 1993, J BIOL CHEM, V268, P4821; PAEK KH, 1987, J BACTERIOL, V169, P283, DOI 10.1128/jb.169.1.283-290.1987; PALLEROS DR, 1994, J BIOL CHEM, V269, P13107; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Posfai G, 1997, J BACTERIOL, V179, P4426, DOI 10.1128/jb.179.13.4426-4428.1997; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Sakr S, 2010, J BIOL CHEM, V285, P23504, DOI 10.1074/jbc.M110.133058; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Suh WC, 1999, J BIOL CHEM, V274, P30534, DOI 10.1074/jbc.274.43.30534; Swain JF, 2006, J BIOL CHEM, V281, P1605, DOI 10.1074/jbc.M509356200; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; Todd MJ, 1996, P NATL ACAD SCI USA, V93, P4030, DOI 10.1073/pnas.93.9.4030; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; TSAI MY, 1994, J BIOL CHEM, V269, P5958; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; Ullers RS, 2004, P NATL ACAD SCI USA, V101, P7583, DOI 10.1073/pnas.0402398101; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; YOCHEM J, 1978, MOL GEN GENET, V164, P9, DOI 10.1007/BF00267593; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	59	44	45	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31821	31829		10.1074/jbc.M111.265835	http://dx.doi.org/10.1074/jbc.M111.265835			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768118	Green Published, hybrid			2022-12-25	WOS:000294487500075
J	Abe, T; Sugimura, K; Hosono, Y; Takami, Y; Akita, M; Yoshimura, A; Tada, S; Nakayama, T; Murofushi, H; Okumura, K; Takeda, S; Horikoshi, M; Seki, M; Enomoto, T				Abe, Takuya; Sugimura, Kazuto; Hosono, Yoshifumi; Takami, Yasunari; Akita, Motomu; Yoshimura, Akari; Tada, Shusuke; Nakayama, Tatsuo; Murofushi, Hiromu; Okumura, Katsuzumi; Takeda, Shunichi; Horikoshi, Masami; Seki, Masayuki; Enomoto, Takemi			The Histone Chaperone Facilitates Chromatin Transcription (FACT) Protein Maintains Normal Replication Fork Rates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; DNA-REPLICATION; S-PHASE; FUNCTIONAL COOPERATION; DORMANT ORIGINS; EXCESS MCM2-7; HUMAN-CELLS; SPT16; PROGRESSION; ELONGATION	Ordered nucleosome disassembly and reassembly are required for eukaryotic DNA replication. The facilitates chromatin transcription (FACT) complex, a histone chaperone comprising Spt16 and SSRP1, is involved in DNA replication as well as transcription. FACT associates with the MCM helicase, which is involved in DNA replication initiation and elongation. Although the FACT-MCM complex is reported to regulate DNA replication initiation, its functional role in DNA replication elongation remains elusive. To elucidate the functional role of FACT in replication fork progression during DNA elongation in the cells, we generated and analyzed conditional SSRP1 gene knock-out chicken (Gallus gallus) DT40 cells. SSRP1-depleted cells ceased to grow and exhibited a delay in S-phase cell cycle progression, although SSRP1 depletion did not affect the level of chromatin-bound DNA polymerase alpha or nucleosome reassembly on daughter strands. The tracking length of newly synthesized-DNA, but not origin firing, was reduced in SSRP1-depleted cells, suggesting that the S-phase cell cycle delay is mainly due to the inhibition of replication fork progression rather than to defects in the initiation of DNA replication in these cells. We discuss the mechanisms of how FACT promotes replication fork progression in the cells.	[Horikoshi, Masami] Univ Tokyo, Inst Mol & Cellular Biosci, Dev Biol Lab, Tokyo 1110032, Japan; [Abe, Takuya; Hosono, Yoshifumi; Akita, Motomu; Yoshimura, Akari; Tada, Shusuke; Seki, Masayuki; Enomoto, Takemi] Tohoku Univ, Grad Sch Pharmaceut Sci, Mol Cell Biol Lab, Sendai, Miyagi 9808578, Japan; [Sugimura, Kazuto; Okumura, Katsuzumi] Mie Univ, Grad Sch Bioresources, Dept Life Sci, Tsu, Mie 5148507, Japan; [Sugimura, Kazuto] Mie Univ, Grad Sch Med, Dept Biochem & Prote, Tsu, Mie 5148507, Japan; [Takami, Yasunari; Nakayama, Tatsuo] Miyazaki Univ, Sect Biochem & Mol Biol, Miyazaki Med Coll, Dept Med Sci, Miyazaki 8891692, Japan; [Yoshimura, Akari; Enomoto, Takemi] Musashino Univ, Fac Pharm, Pharmaceut Sci Res Inst, Tokyo 2028585, Japan; [Murofushi, Hiromu] Yamaguchi Univ, Grad Sch Med, Dept Appl Mol Biosci, Yamaguchi 7538512, Japan; [Takeda, Shunichi] Kyoto Univ, Fac Med, Dept Radiat Genet, Kyoto 6068501, Japan	University of Tokyo; Tohoku University; Mie University; Mie University; University of Miyazaki; Yamaguchi University; Kyoto University	Horikoshi, M (corresponding author), 1-1-1 Yayoi,Bunkyo Ku, Tokyo 1130032, Japan.	horikosh@am.iu-tokyo.ac.jp; seki@mail.pharm.tohoku.ac.jp; t_eno@musashino-u.ac.jp	ABE, TAKUYA/A-2861-2015; Yoshimura, Akari/ABE-5626-2020	ABE, TAKUYA/0000-0001-5298-082X; Yoshimura, Akari/0000-0003-4883-8497; Takeda, Shunichi/0000-0002-7924-7991	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [22380188, 21370075] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abe T, 2008, CELL SIGNAL, V20, P1978, DOI 10.1016/j.cellsig.2008.07.006; Baker TA, 1998, CELL, V92, P295, DOI 10.1016/S0092-8674(00)80923-X; Belotserkovskaya R, 2004, CURR OPIN GENET DEV, V14, P139, DOI 10.1016/j.gde.2004.02.004; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bermudez VP, 2010, J BIOL CHEM, V285, P9493, DOI 10.1074/jbc.M109.093609; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Cao S, 2003, MOL CELL BIOL, V23, P5301, DOI 10.1128/MCB.23.15.5301-5307.2003; Chen YH, 2004, DNA REPAIR, V3, P1025, DOI 10.1016/j.dnarep.2004.03.003; Corpet A, 2009, TRENDS CELL BIOL, V19, P29, DOI 10.1016/j.tcb.2008.10.002; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gasser R, 1996, J MOL BIOL, V258, P224, DOI 10.1006/jmbi.1996.0245; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; GRUSS C, 1992, BIOESSAYS, V14, P1, DOI 10.1002/bies.950140102; HAND R, 1975, J HISTOCHEM CYTOCHEM, V23, P475, DOI 10.1177/23.7.1095649; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; JACKSON V, 1990, BIOCHEMISTRY-US, V29, P719, DOI 10.1021/bi00455a019; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Kang SW, 2000, GENES CELLS, V5, P251, DOI 10.1046/j.1365-2443.2000.00323.x; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Katsuno Y, 2009, P NATL ACAD SCI USA, V106, P3184, DOI 10.1073/pnas.0809350106; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; McHenry CS, 2003, MOL MICROBIOL, V49, P1157, DOI 10.1046/j.1365-2958.2003.03645.x; Munakata T, 2000, GENES CELLS, V5, P221, DOI 10.1046/j.1365-2443.2000.00319.x; Nabatiyan A, 2004, MOL CELL BIOL, V24, P2853, DOI 10.1128/MCB.24.7.2853-2862.2004; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; O'Donnell AF, 2004, NUCLEIC ACIDS RES, V32, P5894, DOI 10.1093/nar/gkh922; Okada M, 2009, MOL BIOL CELL, V20, P3986, DOI 10.1091/mbc.E09-01-0065; Okuhara K, 1999, CURR BIOL, V9, P341, DOI 10.1016/S0960-9822(99)80160-2; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Petermann E, 2008, MOL BIOL CELL, V19, P2373, DOI 10.1091/mbc.E07-10-1035; Philpott A, 2000, SEMIN CELL DEV BIOL, V11, P7, DOI 10.1006/scdb.1999.0346; Quivy JP, 2008, NAT STRUCT MOL BIOL, V15, P972, DOI 10.1038/nsmb.1470; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Sugimura K, 2008, J CELL BIOL, V183, P1203, DOI 10.1083/jcb.200806068; Takami Y, 2007, MOL BIOL CELL, V18, P129, DOI 10.1091/mbc.E06-05-0426; Tan BCM, 2006, EMBO J, V25, P3975, DOI 10.1038/sj.emboj.7601271; Tan BCM, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-11; Tanaka S, 2010, CHROMOSOMA, V119, P565, DOI 10.1007/s00412-010-0291-8; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Winkler DD, 2011, J BIOL CHEM, V286, P18369, DOI 10.1074/jbc.R110.180778; Wittmeyer J, 1999, BIOCHEMISTRY-US, V38, P8961, DOI 10.1021/bi982851d; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994	65	56	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30504	30512		10.1074/jbc.M111.264721	http://dx.doi.org/10.1074/jbc.M111.264721			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757688	Green Published, hybrid			2022-12-25	WOS:000294283600029
J	Frisdal, E; Lesnik, P; Olivier, M; Robillard, P; Chapman, MJ; Huby, T; Guerin, M; Le Goff, W				Frisdal, Eric; Lesnik, Philippe; Olivier, Maryline; Robillard, Paul; Chapman, M. John; Huby, Thierry; Guerin, Maryse; Le Goff, Wilfried			Interleukin-6 Protects Human Macrophages from Cellular Cholesterol Accumulation and Attenuates the Proinflammatory Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE-DERIVED MACROPHAGES; NECROSIS-FACTOR-ALPHA; APOPTOTIC CELLS; ABCA1-DEFICIENT MACROPHAGES; INFLAMMATORY RESPONSE; PATHWAY INHIBITOR; ATHEROSCLEROSIS; MICE; EXPRESSION; RECEPTOR	Cholesterol-laden monocyte-derived macrophages are phagocytic cells characteristic of early and advanced atherosclerotic lesions. Interleukin-6 (IL-6) is a macrophage secretory product that is abundantly expressed in atherosclerotic plaques but whose precise role in atherogenesis is unclear. The capacity of macrophages to clear apoptotic cells, through the efferocytosis mechanism, as well as to reduce cellular cholesterol accumulation contributes to prevent plaque progression and instability. By virtue of its capacity to promote cellular cholesterol efflux from phagocyte-macrophages, ABCA1 was reported to reduce atherosclerosis. We demonstrated that lipid loading in human macrophages was accompanied by a strong increase of IL-6 secretion. Interestingly, IL-6 markedly induced ABCA1 expression and enhanced ABCA1-mediated cholesterol efflux from human macrophages to apoAI. Stimulation of ABCA1-mediated cholesterol efflux by IL-6 was, however, abolished by selective inhibition of the Jak-2/Stat3 signaling pathway. In addition, we observed that the expression of molecules described to promote efferocytosis, i.e. c-mer proto-oncogene-tyrosine kinase, thrombospondin-1, and transglutaminase 2, was significantly induced in human macrophages upon treatment with IL-6. Consistent with these findings, IL-6 enhanced the capacity of human macrophages to phagocytose apoptotic cells; moreover, we observed that IL-6 stimulates the ABCA1-mediated efflux of cholesterol derived from the ingestion of free cholesterol-loaded apoptotic macrophages. Finally, the treatment of human macrophages with IL-6 led to the establishment of an anti-inflammatory cytokine profile, characterized by an increased secretion of IL-4 and IL-10 together with a decrease of that of IL-1 beta. Taken together, our results indicate that IL-6 favors the elimination of excess cholesterol in human macrophages and phagocytes by stimulation of ABCA1-mediated cellular free cholesterol efflux and attenuates the macrophage proinflammatory phenotype. Thus, high amounts of IL-6 secreted by lipid laden human macrophages may constitute a protective response from macrophages to prevent accumulation of cytotoxic-free cholesterol. Such a cellular recycling of free cholesterol may contribute to reduce both foam cell formation and the accumulation of apoptotic bodies as well as intraplaque inflammation in atherosclerotic lesions.	Univ Paris 06, INSERM, UMR S939, F-75013 Paris, France; ICAN Inst CardioMetab & Nutr, F-75013 Paris, France; Univ Paris 06, UMR S939, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Le Goff, W (corresponding author), Hop Pitie, INSERM, UMR S939, Pavillon Benjamin Delessert,83 Blvd Hop, F-75651 Paris 13, France.	wilfried.le_goff@upmc.fr	Lesnik, Philippe/AAD-7393-2020; Guerin, Maryse/N-5794-2017; 应, 宁宁/G-9472-2011; Le Goff, Wilfried/N-7593-2019; HUBY, Thierry/N-4820-2019; chapman, john/Y-2742-2019; Lesnik, Philippe F/F-7803-2011; Huby, Thierry/E-6768-2017; Le Goff, Wilfried/N-6326-2017	Lesnik, Philippe/0000-0002-6909-7715; Le Goff, Wilfried/0000-0002-7611-9644; HUBY, Thierry/0000-0001-6634-551X; Huby, Thierry/0000-0001-6634-551X; Le Goff, Wilfried/0000-0002-7611-9644; GUERIN, Maryse/0000-0003-0150-1360	INSERM; Fondation de France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation de France(Fondation de France)	This work was supported by INSERM and the Fondation de France.	Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Blaskovich MA, 2003, CANCER RES, V63, P1270; Brocke-Heidrich K, 2006, ONCOGENE, V25, P7297, DOI 10.1038/sj.onc.1209711; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; CHAPMAN MJ, 1981, J LIPID RES, V22, P339; Cui D, 2007, J LEUKOCYTE BIOL, V82, P1040, DOI 10.1189/jlb.0307192; Daugherty A, 2005, J LIPID RES, V46, P1812, DOI 10.1194/jlr.R500009-JLR200; Dentan C, 1996, EUR J BIOCHEM, V236, P48, DOI 10.1111/j.1432-1033.1996.00048.x; Elhage R, 2001, ATHEROSCLEROSIS, V156, P315, DOI 10.1016/S0021-9150(00)00682-1; Fitzgerald ML, 2010, ATHEROSCLEROSIS, V211, P361, DOI 10.1016/j.atherosclerosis.2010.01.011; Francone OL, 2005, ARTERIOSCL THROM VAS, V25, P1198, DOI 10.1161/01.ATV.0000166522.69552.99; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; Ito H, 2004, GASTROENTEROLOGY, V126, P989, DOI 10.1053/j.gastro.2004.01.012; Iwamoto N, 2006, J LIPID RES, V47, P1915, DOI 10.1194/jlr.M600127-JLR200; Jehle AW, 2006, J CELL BIOL, V174, P547, DOI 10.1083/jcb.200601030; Kawashiri SY, 2011, RHEUMATOL INT, V31, P451, DOI 10.1007/s00296-009-1303-y; Kiss RS, 2006, CURR BIOL, V16, P2252, DOI 10.1016/j.cub.2006.09.043; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Le Goff W, 2006, ARTERIOSCL THROM VAS, V26, P527, DOI 10.1161/01.ATV.0000201042.00725.84; Le Goff W, 2006, J LIPID RES, V47, P51, DOI 10.1194/jlr.M500255-JLR200; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li YK, 2006, J BIOL CHEM, V281, P6707, DOI 10.1074/jbc.M510579200; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Luciani MF, 1996, EMBO J, V15, P226, DOI 10.1002/j.1460-2075.1996.tb00353.x; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; Nishimoto N, 2005, BLOOD, V106, P2627, DOI 10.1182/blood-2004-12-4602; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Petit L, 1999, ARTERIOSCL THROM VAS, V19, P309, DOI 10.1161/01.ATV.19.2.309; Rebe C, 2009, CIRC RES, V105, P393, DOI 10.1161/CIRCRESAHA.109.201855; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Rowe AH, 2003, CIRC RES, V93, P717, DOI 10.1161/01.RES.0000097606.43659.F4; Schieffer B, 2004, CIRCULATION, V110, P3493, DOI 10.1161/01.CIR.0000148135.08582.97; Schrijvers DM, 2007, CARDIOVASC RES, V73, P470, DOI 10.1016/j.cardiores.2006.09.005; Song L, 2004, ATHEROSCLEROSIS, V177, P43, DOI 10.1016/j.atherosclerosis.2004.06.018; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Thakore AH, 2007, AM J CARDIOL, V99, P1598, DOI 10.1016/j.amjcard.2007.01.036; Thorp E, 2009, J LEUKOCYTE BIOL, V86, P1089, DOI 10.1189/jlb.0209115; Van Lenten BJ, 2001, J BIOL CHEM, V276, P1923, DOI 10.1074/jbc.M004074200; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Williams LM, 2007, J BIOL CHEM, V282, P6965, DOI 10.1074/jbc.M609101200; Woods A, 2000, EUR HEART J, V21, P1574, DOI 10.1053/euhj.1999.2207; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yin K, 2011, J BIOL CHEM, V286, P13834, DOI 10.1074/jbc.M110.202275; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; ZHONG WW, 1993, ARCH SURG-CHICAGO, V128, P158; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	56	79	84	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30926	30936		10.1074/jbc.M111.264325	http://dx.doi.org/10.1074/jbc.M111.264325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757719	hybrid, Green Published			2022-12-25	WOS:000294283600071
J	Kendall, T; Mukai, L; Jannuzi, AL; Bunch, TA				Kendall, Timmy; Mukai, Leona; Jannuzi, Alison L.; Bunch, Thomas A.			Identification of Integrin beta Subunit Mutations That Alter Affinity for Extracellular Matrix Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; METAL-BINDING SITE; CYTOPLASMIC DOMAIN; GLANZMANN THROMBASTHENIA; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; POINT MUTATION; ALPHA-IIB-BETA-3 INTEGRIN; RECEPTOR FUNCTION; ACTIVATION	We examined over 50 mutations in the Drosophila beta PS integrin subunit that alter integrin function in situ for their ability to bind a soluble monovalent ligand, TWOW-1. Surprisingly, very few of the mutations, which were selected for conditional lethality in the fly, reduce the ligand binding ability of the integrin. The most prevalent class of mutations activates the integrin heterodimer. These findings emphasize the importance of integrin affinity regulation and point out how molecular interactions throughout the integrin molecule are important in keeping the integrin in a low affinity state. Mutations strongly support the controversial deadbolt hypothesis, where the CD loop in the beta tail domain acts to restrain the I domain in the inactive, bent conformation. Site-directed mutations in the cytoplasmic domains of beta PS and alpha PS2C reveal different effects on ligand binding from those observed for alpha IIb beta 3 integrins and identify for the first time a cytoplasmic cysteine residue, conserved in three human integrins, as being important in affinity regulation. In the fly, we find that genetic interactions of the beta PS mutations with reduction in talin function are consistent with the integrin affinity differences measured in cells. Additionally, these genetic interactions report on increased and decreased integrin functions that do not result in affinity changes in the PS2C integrin measured in cultured cells.	[Kendall, Timmy; Mukai, Leona; Jannuzi, Alison L.; Bunch, Thomas A.] Univ Arizona, Arizona Canc Ctr, Dept Mol & Cellular Biol, Tucson, AZ 85724 USA	Arizona Center Cancer Care; University of Arizona	Bunch, TA (corresponding author), Univ Arizona, Arizona Canc Ctr, Dept Mol & Cellular Biol, Rm 3951A,1515 N Campbell Ave, Tucson, AZ 85724 USA.	tbunch@email.arizona.edu			National Institutes of Health [R01GM42474]; Cancer Center, NCI [CA 023074]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM42474 and CA 023074 (Cancer Center support grant from NCI).	Ahrens IG, 2006, EXP CELL RES, V312, P925, DOI 10.1016/j.yexcr.2005.11.036; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; BAJT ML, 1994, J BIOL CHEM, V269, P20913; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Bunch TA, 2006, J BIOL CHEM, V281, P5050, DOI 10.1074/jbc.M508550200; BUNCH TA, 1992, DEVELOPMENT, V116, P239; BUNCH TA, 1992, GENETICS, V132, P519; Bunch TA, 2010, J BIOL CHEM, V285, P1841, DOI 10.1074/jbc.M109.057349; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen J, 2006, P NATL ACAD SCI USA, V103, P13062, DOI 10.1073/pnas.0605666103; CHEN YP, 1994, BLOOD, V84, P1857; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10169, DOI 10.1073/pnas.89.21.10169; Cheng M, 2007, J BIOL CHEM, V282, P18225, DOI 10.1074/jbc.M701386200; Grimaldi CM, 1996, BLOOD, V88, P1666; Helsten TL, 2008, MOL BIOL CELL, V19, P3589, DOI 10.1091/mbc.E08-01-0085; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jannuzi AL, 2004, MOL BIOL CELL, V15, P3829, DOI 10.1091/mbc.E04-02-0085; Jannuzi AL, 2002, MOL BIOL CELL, V13, P1352, DOI 10.1091/mbc.01-08-0429; Kamata T, 2004, BIOCHEM J, V378, P1079, DOI 10.1042/BJ20031701; Kashiwagi H, 1999, BLOOD, V93, P2559, DOI 10.1182/blood.V93.8.2559.408k12_2559_2568; Kieffer N, 1996, CELL ADHES COMMUN, V4, P25, DOI 10.3109/15419069609010761; Krukonis ES, 2000, CELL MICROBIOL, V2, P219, DOI 10.1046/j.1462-5822.2000.00048.x; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Lindsley D. L., 1992, ANNU REV GENOM HUM G, V4, P1133; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; Luo BH, 2009, J BIOL CHEM, V284, P3917, DOI 10.1074/jbc.M806312200; Martin-Bermudo MD, 1998, J CELL BIOL, V141, P1073, DOI 10.1083/jcb.141.4.1073; Matsumoto A, 2008, BIOPHYS J, V95, P2895, DOI 10.1529/biophysj.108.131045; McKay BS, 1996, J BIOL CHEM, V271, P30544, DOI 10.1074/jbc.271.48.30544; Mor-Cohen R, 2007, THROMB HAEMOSTASIS, V98, P1257, DOI 10.1160/TH07-04-0248; Morel-Kopp MC, 2001, THROMB HAEMOSTASIS, V86, P1425; Mould AP, 2003, J BIOL CHEM, V278, P51622, DOI 10.1074/jbc.M306655200; Murcia M, 2008, PROTEINS, V71, P1779, DOI 10.1002/prot.21859; Nair S, 2004, HAEMATOLOGICA, V89, P1529; Nurden AT, 2002, PLATELETS, V13, P101, DOI 10.1080/09537100220122466; Partridge AW, 2005, J BIOL CHEM, V280, P7294, DOI 10.1074/jbc.M412701200; Perrault C, 1998, CELL ADHES COMMUN, V6, P335, DOI 10.3109/15419069809010792; Prout M, 1997, GENETICS, V146, P275; PuzonMcLaughlin W, 1996, J BIOL CHEM, V271, P20438, DOI 10.1074/jbc.271.34.20438; Ruiz C, 2001, BLOOD, V98, P2432, DOI 10.1182/blood.V98.8.2432; Sakai T, 1998, J CELL BIOL, V141, P527, DOI 10.1083/jcb.141.2.527; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shi ML, 2005, J BIOL CHEM, V280, P30586, DOI 10.1074/jbc.M502525200; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Sun QH, 2002, BLOOD, V100, P2094, DOI 10.1182/blood-2002-02-0418; Takagi J, 2001, P NATL ACAD SCI USA, V98, P11175, DOI 10.1073/pnas.201420198; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; Vanhoorelbeke K, 2009, J BIOL CHEM, V284, P14914, DOI 10.1074/jbc.M809167200; Wright T. R., 1968, P 12 INT C GEN, V1, P41; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Zang Q, 2001, J BIOL CHEM, V276, P6922, DOI 10.1074/jbc.M005868200; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, J BIOL CHEM, V282, P11914, DOI 10.1074/jbc.M700249200; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022	65	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30981	30993		10.1074/jbc.M111.254797	http://dx.doi.org/10.1074/jbc.M111.254797			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757698	Green Published, hybrid			2022-12-25	WOS:000294283600076
J	Osanai, T; Oikawa, A; Azuma, M; Tanaka, K; Saito, K; Hirai, MY; Ikeuchi, M				Osanai, Takashi; Oikawa, Akira; Azuma, Miyuki; Tanaka, Kan; Saito, Kazuki; Hirai, Masami Yokota; Ikeuchi, Masahiko			Genetic Engineering of Group 2 sigma Factor SigE Widely Activates Expressions of Sugar Catabolic Genes in Synechocystis Species PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN PCC-6803; ESCHERICHIA-COLI; RNA-POLYMERASE; OPCA; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; CYANOBACTERIA; INACTIVATION; MECHANISMS; PATHWAYS; PRODUCT	Metabolic engineering of photosynthetic organisms is required for utilization of light energy and for reducing carbon emissions. Control of transcriptional regulators is a powerful approach for changing cellular dynamics, because a set of genes is concomitantly regulated. Here, we show that overexpression of a group 2 sigma factor, SigE, enhances the expressions of sugar catabolic genes in the unicellular cyanobacterium, Synechocystis sp. PCC 6803. Transcriptome analysis revealed that genes for the oxidative pentose phosphate pathway and glycogen catabolism are induced by overproduction of SigE. Immunoblotting showed that protein levels of sugar catabolic enzymes, such as glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, glycogen phosphorylase, and isoamylase, are increased. Glycogen levels are reduced in the SigE-overexpressing strain grown under light. Metabolome analysis revealed that metabolite levels of the TCA cycle and acetyl-CoA are significantly altered by SigE overexpression. The SigE-overexpressing strain also exhibited defective growth under mixotrophic or dark conditions. Thus, SigE overexpression changes sugar catabolism at the transcript to phenotype levels, suggesting a sigma factor-based engineering method for modifying carbon metabolism in photosynthetic bacteria.	[Osanai, Takashi; Ikeuchi, Masahiko] Univ Tokyo, Dept Life Sci Biol, Meguro Ku, Tokyo 1538902, Japan; [Osanai, Takashi; Oikawa, Akira; Saito, Kazuki; Hirai, Masami Yokota] RIKEN Plant Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; [Osanai, Takashi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Azuma, Miyuki; Tanaka, Kan] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Tanaka, Kan] Chiba Univ, Grad Sch Hort, Chiba 2718510, Japan; [Saito, Kazuki] Chiba Univ, Grad Sch Pharmaceut Sci, Inage Ku, Chiba 2638522, Japan	University of Tokyo; RIKEN; Japan Science & Technology Agency (JST); University of Tokyo; Chiba University; Chiba University	Osanai, T (corresponding author), 1-7-22 Suehiro Cho,Tsurumi Ku, Kanagawa 2300045, Japan.	tosanai@psc.riken.jp	Oikawa, Akira/D-2715-2017; Hirai, Masami Y/D-5319-2009; Azuma, Miyuki/AAT-8928-2021; Tanaka, Kan/E-3724-2015; Saito, Kazuki/D-2670-2009	Hirai, Masami Y/0000-0003-0802-6208; Azuma, Miyuki/0000-0002-3529-4585; Tanaka, Kan/0000-0001-7560-7884; Saito, Kazuki/0000-0001-6310-5342	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Nara Institute of Science and Technology; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nara Institute of Science and Technology; Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a grant-in-aid for Japanese Society for the Promotion of Science fellows from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T.O.), grant-in-aid for scientific research for plant graduate students from the Nara Institute of Science and Technology (to T.O. and M.A.), the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and grant-in-aid for CREST (project name "Elucidation of Amino Acid Metabolism in Plants Based on Integrated Omics Analyses") from the Japan Science and Technology Agency (to M.Y.H.).	Azuma M, 2011, PLANT CELL PHYSIOL, V52, P404, DOI 10.1093/pcp/pcq204; Causey TB, 2004, P NATL ACAD SCI USA, V101, P2235, DOI 10.1073/pnas.0308171100; Eisenhut M, 2008, PLANT PHYSIOL, V148, P2109, DOI 10.1104/pp.108.129403; Perez-Perez ME, 2009, MOL PLANT, V2, P270, DOI 10.1093/mp/ssn070; Perez-Perez ME, 2006, PROTEOMICS, V6, pS186, DOI 10.1002/pmic.200500215; Fu J, 2006, FEMS MICROBIOL LETT, V260, P201, DOI 10.1111/j.1574-6968.2006.00312.x; Hagen KD, 2001, J BIOL CHEM, V276, P11477, DOI 10.1074/jbc.M010472200; KADNER RJ, 1992, J GEN MICROBIOL, V138, P2007, DOI 10.1099/00221287-138-10-2007; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Koksharova O, 1998, PLANT MOL BIOL, V36, P183, DOI 10.1023/A:1005925732743; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; Laurent S, 2008, MICROBIOL-SGM, V154, P2161, DOI 10.1099/mic.0.2007/016196-0; Los DA, 1997, MOL MICROBIOL, V25, P1167, DOI 10.1046/j.1365-2958.1997.5641912.x; Min HT, 2000, J BACTERIOL, V182, P6214, DOI 10.1128/JB.182.21.6214-6221.2000; Ohkama-Ohtsu N, 2008, PLANT PHYSIOL, V148, P1603, DOI 10.1104/pp.108.125716; Osanai T, 2005, J BIOL CHEM, V280, P30653, DOI 10.1074/jbc.M505043200; Osanai T, 2008, PHYSIOL PLANTARUM, V133, P490, DOI 10.1111/j.1399-3054.2008.01078.x; Osanai T, 2007, PHOTOCH PHOTOBIO SCI, V6, P508, DOI 10.1039/b616219n; Osanai T, 2006, DNA RES, V13, P185, DOI 10.1093/dnares/dsl010; Osanai T, 2009, P NATL ACAD SCI USA, V106, P6860, DOI 10.1073/pnas.0810040106; Pollari M, 2008, PLANT PHYSIOL, V147, P1994, DOI 10.1104/pp.108.122713; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Satoh S, 2001, J BIOL CHEM, V276, P4293, DOI 10.1074/jbc.M008238200; SCHAAFF I, 1989, YEAST, V5, P285, DOI 10.1002/yea.320050408; Singh AK, 2006, ARCH MICROBIOL, V186, P273, DOI 10.1007/s00203-006-0138-0; Singh AK, 2005, J BACTERIOL, V187, P2368, DOI 10.1128/JB.187.7.2368-2376.2005; Summerfield TC, 2007, J BACTERIOL, V189, P7829, DOI 10.1128/JB.01036-07; Sundaram S, 1998, MICROBIOL-SGM, V144, P1549, DOI 10.1099/00221287-144-6-1549; Tabei Y, 2007, BIOCHEM BIOPH RES CO, V355, P1045, DOI 10.1016/j.bbrc.2007.02.065; Takahashi H, 2008, J EXP BOT, V59, P3009, DOI 10.1093/jxb/ern157; TANAKA K, 1993, P NATL ACAD SCI USA, V90, P3511, DOI 10.1073/pnas.90.8.3511; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Yanagisawa S, 2004, P NATL ACAD SCI USA, V101, P7833, DOI 10.1073/pnas.0402267101; Yang C, 2002, APPL MICROBIOL BIOT, V58, P813, DOI 10.1007/s00253-002-0949-0	34	77	81	1	37	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30962	30971		10.1074/jbc.M111.231183	http://dx.doi.org/10.1074/jbc.M111.231183			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757761	Green Published, hybrid			2022-12-25	WOS:000294283600074
J	Tanaka, N; Meineke, B; Shuman, S				Tanaka, Naoko; Meineke, Birthe; Shuman, Stewart			RtcB, a Novel RNA Ligase, Can Catalyze tRNA Splicing and HAC1 mRNA Splicing in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; POLYNUCLEOTIDE KINASE; JUNCTION PHOSPHATE; CRYSTAL-STRUCTURE; CELL EXTRACT; ENZYME; EUKARYOTES; MECHANISM; PRECURSOR; LIGATION	RtcB enzymes are novel RNA ligases that join 2',3' -cyclic phosphate and 5' -OH ends. The phylogenetic distribution of RtcB points to its candidacy as a tRNA splicing/repair enzyme. Here we show that Escherichia coli RtcB is competent and sufficient for tRNA splicing in vivo by virtue of its ability to complement growth of yeast cells that lack the endogenous "healing/sealing-type" tRNA ligase Trl1. RtcB also protects yeast trl1 Delta cells against a fungal ribotoxin that incises the anticodon loop of cellular tRNAs. Moreover, RtcB can replace Trl1 as the catalyst of HAC1 mRNA splicing during the unfolded protein response. Thus, RtcB is a bona fide RNA repair enzyme with broad physiological actions. Biochemical analysis of RtcB highlights the uniqueness of its active site and catalytic mechanism. Our findings draw attention to tRNA ligase as a promising drug target.	[Tanaka, Naoko; Meineke, Birthe; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [GM46330]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046330, R37GM046330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46330 (to S. S.).	AMITSUR M, 1987, EMBO J, V6, P2499, DOI 10.1002/j.1460-2075.1987.tb02532.x; Brooks MA, 2008, PROTEIN SCI, V17, P1336, DOI 10.1110/ps.035493.108; Englert M, 2011, P NATL ACAD SCI USA, V108, P1290, DOI 10.1073/pnas.1018307108; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Harding HP, 2008, RNA, V14, P225, DOI 10.1261/rna.859908; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jain R, 2009, RNA, V15, P923, DOI 10.1261/rna.1492809; Kato-Murayama M, 2005, J MOL BIOL, V348, P295, DOI 10.1016/j.jmb.2005.02.049; Klassen R, 2008, MOL MICROBIOL, V69, P681, DOI 10.1111/j.1365-2958.2008.06319.x; LASKI FA, 1983, J BIOL CHEM, V258, P1974; Nandakumar J, 2008, MOL CELL, V31, P278, DOI 10.1016/j.molcel.2008.05.019; Okada C, 2006, PROTEINS, V63, P1119, DOI 10.1002/prot.20912; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Ramirez A, 2008, RNA, V14, P1737, DOI 10.1261/rna.1142908; Sawaya R, 2003, J BIOL CHEM, V278, P43928, DOI 10.1074/jbc.M307839200; Schwer B, 2004, P NATL ACAD SCI USA, V101, P2788, DOI 10.1073/pnas.0305859101; Schwer B, 2008, RNA, V14, P204, DOI 10.1261/rna.858108; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Spinelli SL, 1998, P NATL ACAD SCI USA, V95, P14136, DOI 10.1073/pnas.95.24.14136; Tanaka N, 2011, J BIOL CHEM, V286, P7727, DOI 10.1074/jbc.C111.219022; Torchia C, 2008, NUCLEIC ACIDS RES, V36, P6218, DOI 10.1093/nar/gkn602; Wang LK, 2005, RNA, V11, P966, DOI 10.1261/rna.2170305; Weitzer S, 2007, NATURE, V447, P222, DOI 10.1038/nature05777; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410; Zofallova L, 2000, RNA, V6, P1019, DOI 10.1017/S1355838200000613	26	69	73	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30253	30257		10.1074/jbc.C111.274597	http://dx.doi.org/10.1074/jbc.C111.274597			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757685	hybrid, Green Published			2022-12-25	WOS:000294283600002
J	Miller, L; Richter, M; Hapke, C; Stern, D; Nitsche, A				Miller, Lilija; Richter, Marco; Hapke, Christoph; Stern, Daniel; Nitsche, Andreas			Genomic Expression Libraries for the Identification of Cross-Reactive Orthopoxvirus Antigens	PLOS ONE			English	Article							COWPOX VIRUS-INFECTION; TO-HUMAN TRANSMISSION; VACCINIA VIRUS; SMALLPOX VACCINATION; PROTEIN; EFFICACY; IMMUNOGENICITY; HETEROGENEITY; PROTECTION; CANDIDATE	Increasing numbers of human cowpox virus infections that are being observed and that particularly affect young non-vaccinated persons have renewed interest in this zoonotic disease. Usually causing a self-limiting local infection, human cowpox can in fact be fatal for immunocompromised individuals. Conventional smallpox vaccination presumably protects an individual from infections with other Orthopoxviruses, including cowpox virus. However, available live vaccines are causing severe adverse reactions especially in individuals with impaired immunity. Because of a decrease in protective immunity against Orthopoxviruses and a coincident increase in the proportion of immunodeficient individuals in today's population, safer vaccines need to be developed. Recombinant subunit vaccines containing cross-reactive antigens are promising candidates, which avoid the application of infectious virus. However, subunit vaccines should contain carefully selected antigens to confer a solid cross-protection against different Orthopoxvirus species. Little is known about the cross-reactivity of antibodies elicited to cowpox virus proteins. Here, we first identified 21 immunogenic proteins of cowpox and vaccinia virus by serological screenings of genomic Orthopoxvirus expression libraries. Screenings were performed using sera from vaccinated humans and animals as well as clinical sera from patients and animals with a naturally acquired cowpox virus infection. We further analyzed the cross-reactivity of the identified immunogenic proteins. Out of 21 identified proteins 16 were found to be cross-reactive between cowpox and vaccinia virus. The presented findings provide important indications for the design of new-generation recombinant subunit vaccines.	[Miller, Lilija; Richter, Marco; Hapke, Christoph; Stern, Daniel; Nitsche, Andreas] Robert Koch Inst, Ctr Biol Secur 1, D-1000 Berlin, Germany	Robert Koch Institute	Miller, L (corresponding author), Robert Koch Inst, Ctr Biol Secur 1, D-1000 Berlin, Germany.	NitscheA@rki.de	Stern, Daniel/AAF-6280-2020	Stern, Daniel/0000-0001-9057-4283; Nitsche, Andreas/0000-0001-8185-3176	BMBF/VDI	BMBF/VDI(Federal Ministry of Education & Research (BMBF))	This work was supported within the BMBF/VDI financed BiGRUDI network of the Robert Koch Institute (Berlin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; BAXBY D, 1972, J HYG-CAMB, V70, P353, DOI 10.1017/S0022172400022403; Becker C, 2009, DTSCH ARZTEBL INT, V106, P329, DOI 10.3238/arztebl.2009.0329; Bonilla-Guerrero R, 2003, J LAB CLIN MED, V142, P252, DOI 10.1016/S0022-2143(03)00143-4; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; Campe H, 2009, EMERG INFECT DIS, V15, P777, DOI 10.3201/eid1505.090159; Chung CS, 2006, J VIROL, V80, P2127, DOI 10.1128/JVI.80.5.2127-2140.2006; CZERNY CP, 1994, VIROLOGY, V200, P764, DOI 10.1006/viro.1994.1240; DAMON IK, 2006, FIELDS VIROLOGY, P2946; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; DAZCARROLL L, 2007, J VIROL, V81, P8131; Duke-Cohan JS, 2009, VACCINE, V27, P1154, DOI 10.1016/j.vaccine.2008.12.035; EISHUBINGER AM, 1990, LANCET, V336, P880, DOI 10.1016/0140-6736(90)92387-W; Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026; Fang M, 2006, VIROLOGY, V345, P231, DOI 10.1016/j.virol.2005.09.056; Fenner F., 1989, MONKEYPOX VIRUS ORTH, P227; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P251, DOI 10.1086/375825; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P241, DOI 10.1086/375824; Glatz M, 2010, LANCET INFECT DIS, V10, P288, DOI 10.1016/S1473-3099(10)70054-2; Golden JW, 2008, VIROLOGY, V377, P19, DOI 10.1016/j.virol.2008.04.003; Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0; Davies DH, 2007, PROTEOMICS, V7, P1678, DOI 10.1002/pmic.200600926; Kennedy RB, 2009, VACCINE, V27, pD73, DOI 10.1016/j.vaccine.2009.07.103; Kennedy RB, 2009, CURR OPIN IMMUNOL, V21, P314, DOI 10.1016/j.coi.2009.04.004; KITAMOTO N, 1984, ARCH VIROL, V82, P129, DOI 10.1007/BF01309377; Kramski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010412; Kurth A, 2008, EMERG INFECT DIS, V14, P670, DOI 10.3201/eid1404.070817; Kurth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006883; MAA JS, 1987, J VIROL, V61, P3910, DOI 10.1128/JVI.61.12.3910-3919.1987; Matz-Rensing K, 2006, VET PATHOL, V43, P212, DOI 10.1354/vp.43-2-212; MCNEILL TA, 1968, J HYG-CAMB, V66, P549, DOI 10.1017/S0022172400028291; Meyer Hermann, 2004, Methods Mol Biol, V269, P119; Moore ZS, 2006, LANCET, V367, P425, DOI 10.1016/S0140-6736(06)68143-9; Moss B, 2006, FIELDS VIROLOGY, P2905; Nitsche A, 1999, CLIN CHEM, V45, P1932; Nitsche A., 2007, EUROSURVEILLANCE, V12, DOI [10.2807/esw.12.16.03178-en, DOI 10.2807/ESW.12.16.03178-EN]; Otero M, 2006, VACCINE, V24, P4461, DOI 10.1016/j.vaccine.2005.08.010; PARAN N, 2009, HUM VACCIN, V5; Pelkonen PM, 2003, EMERG INFECT DIS, V9, P1458, DOI 10.3201/eid0911.020814; RICE AD, 2010, J VIROL; Sahin U, 2006, EUR J IMMUNOL, V36, P1049, DOI 10.1002/eji.200535538; Sakhatskyy P, 2008, VIROLOGY, V371, P98, DOI 10.1016/j.virol.2007.09.029; Schroeder K, 2010, MOL CELL PROBE, V24, P110, DOI 10.1016/j.mcp.2009.10.008; SEED B, 1982, GENE, V19, P201, DOI 10.1016/0378-1119(82)90007-5; Upton C, 2003, J VIROL, V77, P7590, DOI 10.1128/JVI.77.13.7590-7600.2003; Vijaysri S, 2008, VACCINE, V26, P664, DOI 10.1016/j.vaccine.2007.11.045; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Vollmar J, 2006, VACCINE, V24, P2065, DOI 10.1016/j.vaccine.2005.11.022; Vorou RM, 2008, CURR OPIN INFECT DIS, V21, P153, DOI 10.1097/QCO.0b013e3282f44c74; Wienecke R, 2000, J AM ACAD DERMATOL, V42, P892, DOI 10.1016/S0190-9622(00)90265-2; Wolfs TFW, 2002, EMERG INFECT DIS, V8, P1495, DOI 10.3201/eid0812.020089; Xiao YH, 2007, VACCINE, V25, P1214, DOI 10.1016/j.vaccine.2006.10.009	52	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21950	10.1371/journal.pone.0021950	http://dx.doi.org/10.1371/journal.pone.0021950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779357	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811300028
J	Mirandola, L; Yu, YF; Chui, K; Jenkins, MR; Cobos, E; John, CM; Chiriva-Internati, M				Mirandola, Leonardo; Yu, Yuefei; Chui, Kitty; Jenkins, Marjorie R.; Cobos, Everardo; John, Constance M.; Chiriva-Internati, Maurizio			Galectin-3C Inhibits Tumor Growth and Increases the Anticancer Activity of Bortezomib in a Murine Model of Human Multiple Myeloma	PLOS ONE			English	Article							CARBOHYDRATE-BINDING PROTEIN-35; HOMOTYPIC AGGREGATION; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; IN-VITRO; ANGIOGENESIS; LECTIN; MIGRATION; THERAPY; ANTIGEN	Galectin-3 is a human lectin involved in many cellular processes including differentiation, apoptosis, angiogenesis, neoplastic transformation, and metastasis. We evaluated galectin-3C, an N-terminally truncated form of galectin-3 that is thought to act as a dominant negative inhibitor, as a potential treatment for multiple myeloma (MM). Galectin-3 was expressed at varying levels by all 9 human MM cell lines tested. In vitro galectin-3C exhibited modest anti-proliferative effects on MM cells and inhibited chemotaxis and invasion of U266 MM cells induced by stromal cell-derived factor (SDF)-1a. Galectin-3C facilitated the anticancer activity of bortezomib, a proteasome inhibitor approved by the FDA for MM treatment. Galectin-3C and bortezomib also synergistically inhibited MM-induced angiogenesis activity in vitro. Delivery of galectin-3C intravenously via an osmotic pump in a subcutaneous U266 cell NOD/SCID mouse model of MM significantly inhibited tumor growth. The average tumor volume of bortezomib-treated animals was 19.6% and of galectin-3C treated animals was 13.5% of the average volume of the untreated controls at day 35. The maximal effect was obtained with the combination of galectin-3C with bortezomib that afforded a reduction of 94% in the mean tumor volume compared to the untreated controls at day 35. In conclusion, this is the first study to show that inhibition of galectin-3 is efficacious in a murine model of human MM. Our results demonstrated that galectin-3C alone was efficacious in a xenograft mouse model of human MM, and that it enhanced the anti-tumor activity of bortezomib in vitro and in vivo. These data provide the rationale for continued testing of galectin-3C towards initiation of clinical trials for treatment of MM.	[Mirandola, Leonardo; Yu, Yuefei; Jenkins, Marjorie R.; Cobos, Everardo; Chiriva-Internati, Maurizio] Texas Tech Univ, Hlth Sci Ctr, Div Hematol & Oncol, Lubbock, TX 79430 USA; [Mirandola, Leonardo; Yu, Yuefei; Jenkins, Marjorie R.; Cobos, Everardo; Chiriva-Internati, Maurizio] SW Canc Treatment & Res Ctr, Lubbock, TX USA; [Mirandola, Leonardo; Jenkins, Marjorie R.; Cobos, Everardo; Chiriva-Internati, Maurizio] Texas Tech Univ, Hlth Sci Ctr, Laura W Bush Inst Womens Hlth, Amarillo, TX USA; [Mirandola, Leonardo; Jenkins, Marjorie R.; Cobos, Everardo; Chiriva-Internati, Maurizio] Texas Tech Univ, Hlth Sci Ctr, Ctr Womens Hlth & Gender Based Med, Amarillo, TX USA; [Chui, Kitty; John, Constance M.] MandalMed, San Francisco, CA USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Mirandola, L (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Div Hematol & Oncol, Lubbock, TX 79430 USA.	maurizio.chiriva@ttuhsc.edu	Mirandola, Leonardo/B-1575-2013	cobos, everardo/0000-0001-5799-0074	National Institutes of Health [CA135862-01]; NATIONAL CANCER INSTITUTE [R43CA135862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health grant award (CA135862-01 to C.M.J. and M. C.-I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRWAL N, 1993, J BIOL CHEM, V268, P14932; Akahani S, 1997, CANCER RES, V57, P5272; ALBINI A, 1987, CANCER RES, V47, P3239; Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Anargyrou K, 2008, LEUKEMIA LYMPHOMA, V49, P677, DOI 10.1080/10428190701861686; Ansari NA, 2007, ASIAN PAC J CANCER P, V8, P593; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; BELLAMY WT, 1991, CANCER RES, V51, P995; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Broek IV, 2008, CLIN EXP METASTAS, V25, P325, DOI 10.1007/s10585-007-9108-4; Caers J, 2008, BRIT J CANCER, V98, P1966, DOI 10.1038/sj.bjc.6604388; Delgado VMC, 2011, FASEB J, V25, P242, DOI 10.1096/fj.09-144907; Chauhan D, 2005, ANNU REV PHARMACOL, V45, P465, DOI 10.1146/annurev.pharmtox.45.120403.100037; Chauhan D, 2005, CANCER RES, V65, P8350, DOI 10.1158/0008-5472.CAN-05-0163; Chauhan D, 2004, BLOOD, V103, P3158, DOI 10.1182/blood-2003-08-2873; CHERAYIL BJ, 1990, P NATL ACAD SCI USA, V87, P7324, DOI 10.1073/pnas.87.18.7324; CHERAYIL BJ, 1989, J EXP MED, V170, P1959, DOI 10.1084/jem.170.6.1959; Chiriva-Internati M, 2008, BRIT J HAEMATOL, V140, P465, DOI 10.1111/j.1365-2141.2007.06940.x; Chiriva-Internati M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010471; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Desterro JMP, 2000, CELL MOL LIFE SCI, V57, P1207, DOI 10.1007/PL00000760; Eliceiri BP, 2000, CANCER J, V6, pS245; Engelhardt M, 2010, LEUKEMIA LYMPHOMA, V51, P1424, DOI 10.3109/10428194.2010.487959; Fukumori T, 2007, DRUG RESIST UPDATE, V10, P101, DOI 10.1016/j.drup.2007.04.001; Giatromanolaki A, 2010, ANTICANCER RES, V30, P2831; Granovsky M, 2000, NAT MED, V6, P306; Greenstein S, 2003, EXP HEMATOL, V31, P271, DOI 10.1016/S0301-472X(03)00023-7; Haudek KC, 2009, BIOCHIM BIOPHYS ACTA, V1800, P181; HERRMANN J, 1993, J BIOL CHEM, V268, P26704; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Hirabayashi C, 2002, DENT MATER J, V21, P314, DOI 10.4012/dmj.21.314; HO MK, 1982, J IMMUNOL, V128, P1221; Hsu DK, 2009, J INVEST DERMATOL, V129, P573, DOI 10.1038/jid.2008.276; HSU DK, 1992, J BIOL CHEM, V267, P14167; Jeon SB, 2010, J IMMUNOL, V185, P7037, DOI 10.4049/jimmunol.1000154; John CM, 2003, CLIN CANCER RES, V9, P2374; Kaufman Jonathan, 2009, Curr Hematol Malig Rep, V4, P99, DOI 10.1007/s11899-009-0014-5; Kiziltepe T, 2010, J PHARM PHARMACOL, V62, P145, DOI 10.1211/jpp.62.01.0017; Koomen JM, 2008, MOL CELL PROTEOMICS, V7, P1780, DOI 10.1074/mcp.R800002-MCP200; Kotla V, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-36; Kuklinski S, 1998, J NEUROCHEM, V70, P814; Laubach JP, 2009, LEUKEMIA LYMPHOMA, V50, P694, DOI 10.1080/10428190902866732; Li WW, 2008, BRIT J HAEMATOL, V143, P622, DOI 10.1111/j.1365-2141.2008.07372.x; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Medinger M, 2010, J ONCOL, V2010, DOI 10.1155/2010/729725; MEHUL B, 1995, FEBS LETT, V360, P160, DOI 10.1016/0014-5793(95)00100-N; MEHUL B, 1994, J BIOL CHEM, V269, P18250; Mina-Osorio P, 2007, BIOCHEM BIOPH RES CO, V353, P605, DOI 10.1016/j.bbrc.2006.12.081; Moon BK, 2001, AM J PATHOL, V159, P1055, DOI 10.1016/S0002-9440(10)61780-4; Morabito F, 2010, EUR J HAEMATOL, V85, P181, DOI 10.1111/j.1600-0609.2010.01472.x; Moschetta M, 2010, EUR J CANCER, V46, P420, DOI 10.1016/j.ejca.2009.10.019; Nangia-Makker P, 2007, CANCER RES, V67, P11760, DOI 10.1158/0008-5472.CAN-07-3233; Nangia-Makker P, 2010, INT J CANCER, V127, P2530, DOI 10.1002/ijc.25254; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Ochieng J, 1998, BBA-GEN SUBJECTS, V1379, P97, DOI 10.1016/S0304-4165(97)00086-X; OCHIENG J, 1994, BIOCHEMISTRY-US, V33, P14109, DOI 10.1021/bi00251a020; Orlowski RZ, 2002, J CLIN ONCOL, V20, P4420, DOI 10.1200/JCO.2002.01.133; Rabinovich GA, 2005, BRIT J CANCER, V92, P1188, DOI 10.1038/sj.bjc.6602493; Rajkumar SV, 2003, LEUKEMIA, V17, P775, DOI 10.1038/sj.leu.2402866; Rajkumar SV, 2000, CANCER TREAT REV, V26, P351, DOI 10.1053/ctrv.2000.0188; Rana C, 2010, ANN HEMATOL, V89, P789, DOI 10.1007/s00277-010-0919-z; Richardson PG, 2007, BRIT J HAEMATOL, V137, P429, DOI 10.1111/j.1365-2141.2007.06585.x; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Saraswati S, 2011, PROSTATE, V71, P197, DOI 10.1002/pros.21236; Shin WS, 2008, BIOCHEM BIOPH RES CO, V371, P793, DOI 10.1016/j.bbrc.2008.04.168; Streetly MJ, 2010, BLOOD, V115, P3939, DOI 10.1182/blood-2009-10-251660; Sugahara T, 2009, BIOSCI BIOTECH BIOCH, V73, P2043, DOI 10.1271/bbb.90245; Swelam WM, 2010, PATHOL RES PRACT, V206, P753, DOI 10.1016/j.prp.2010.07.006; Tchakarska G, 2009, HAEMATOL-HEMATOL J, V94, P1781, DOI 10.3324/haematol.2009.011460; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; VACCA A, 1995, AM J HEMATOL, V50, P9, DOI 10.1002/ajh.2830500103; Van den Brule FA, 1998, CELL ADHES COMMUN, V5, P425, DOI 10.3109/15419069809005601; WOO HJ, 1991, J BIOL CHEM, V266, P18419; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154; Zick Y, 2002, GLYCOCONJUGATE J, V19, P517, DOI 10.1023/B:GLYC.0000014081.55445.af	76	48	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21811	10.1371/journal.pone.0021811	http://dx.doi.org/10.1371/journal.pone.0021811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765917	Green Published, gold, Green Submitted			2022-12-25	WOS:000292781500018
J	Zhang, JD; Koerner, C; Bechtel, S; Bender, C; Keklikoglou, I; Schmidt, C; Irsigler, A; Ernst, U; Sahin, O; Wiemann, S; Tschulena, U				Zhang, Jitao David; Koerner, Cindy; Bechtel, Stephanie; Bender, Christian; Keklikoglou, Ioanna; Schmidt, Christian; Irsigler, Anja; Ernst, Ute; Sahin, Oezguer; Wiemann, Stefan; Tschulena, Ulrich			Time-Resolved Human Kinome RNAi Screen Identifies a Network Regulating Mitotic-Events as Early Regulators of Cell Proliferation	PLOS ONE			English	Article							COMBINATORIAL RNAI; BREAST-CANCER; GENOME; BIOINFORMATICS; VALIDATION; PATHWAYS; DIVISION; REACTOME; ASSAY	Analysis of biological processes is frequently performed with the help of phenotypic assays where data is mostly acquired in single end-point analysis. Alternative phenotypic profiling techniques are desired where time-series information is essential to the biological question, for instance to differentiate early and late regulators of cell proliferation in loss-of-function studies. So far there is no study addressing this question despite of high unmet interests, mostly due to the limitation of conventional end-point assaying technologies. We present the first human kinome screen with a real-time cell analysis system (RTCA) to capture dynamic RNAi phenotypes, employing time-resolved monitoring of cell proliferation via electrical impedance. RTCA allowed us to investigate the dynamics of phenotypes of cell proliferation instead of using conventional end-point analysis. By introducing data transformation with first-order derivative, i.e. the cell-index growth rate, we demonstrate this system suitable for high-throughput screenings (HTS). The screen validated previously identified inhibitor genes and, additionally, identified activators of cell proliferation. With the information of time kinetics available, we could establish a network of mitotic-event related genes to be among the first displaying inhibiting effects after RNAi knockdown. The time-resolved screen captured kinetics of cell proliferation caused by RNAi targeting human kinome, serving as a resource for researchers. Our work establishes RTCA technology as a novel robust tool with biological and pharmacological relevance amenable for high-throughput screening.	[Zhang, Jitao David; Koerner, Cindy; Bechtel, Stephanie; Bender, Christian; Keklikoglou, Ioanna; Schmidt, Christian; Irsigler, Anja; Ernst, Ute; Sahin, Oezguer; Wiemann, Stefan; Tschulena, Ulrich] German Canc Res Ctr, Div Mol Genome Anal, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Zhang, JD (corresponding author), German Canc Res Ctr, Div Mol Genome Anal, D-6900 Heidelberg, Germany.	s.wiemann@dkfz-heidelberg.de; u.tschulena@dkfz-heidelberg.de	Sahin, Özgür/F-4403-2014; Wiemann, Stefan/E-4424-2013	Sahin, Özgür/0000-0002-8033-7089; Wiemann, Stefan/0000-0003-4683-3174; Koerner, Cindy/0000-0003-1150-9462; Schmidt, Christian/0000-0002-9605-5959; Keklikoglou, Ioanna/0000-0003-1219-6912	National Genome Research Network of the Federal Ministry of Education and Research (BMBF) [01GS0864, 01GS0816]; German Research Foundation [DIP-WI3499/1-1]; DKFZ	National Genome Research Network of the Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); DKFZ(Helmholtz Association)	This work was supported by the National Genome Research Network (Contracts No. 01GS0864 and 01GS0816) of the Federal Ministry of Education and Research (BMBF), and by the German Research Foundation (DIP-WI3499/1-1). JDZ and CH are supported by the DKFZ International PhD Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Bedard J, 1999, ANTIVIR RES, V41, P35, DOI 10.1016/S0166-3542(98)00061-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; *DDCT, DDCT ALG AN QUANT RE; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; Han A, 2007, CLIN CANCER RES, V13, P139, DOI 10.1158/1078-0432.CCR-06-1346; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Juul N, 2010, LANCET ONCOL, V11, P358, DOI 10.1016/S1470-2045(10)70018-8; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; NICOLINI C, 1975, J BIOL CHEM, V250, P3381; Nir O, 2010, GENOME RES, V20, P372, DOI 10.1101/gr.100248.109; Quereda JJ, 2010, TRANSPL P, V42, P3239, DOI 10.1016/j.transproceed.2010.05.059; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; *RPSIXML, R INT PSI MI 2 5 FIL; *RTCA, RTCA OP SOURC TOOLK; Sahin O, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-1; Sahin O, 2007, P NATL ACAD SCI USA, V104, P6579, DOI 10.1073/pnas.0606827104; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Sianina H, 2011, J MICROBIOL METH, V84, P101, DOI 10.1016/j.mimet.2010.11.004; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Smout MJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000885; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Wang YL, 2004, CANCER BIOL THER, V3, P305, DOI 10.4161/cbt.3.3.697; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167	43	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22176	10.1371/journal.pone.0022176	http://dx.doi.org/10.1371/journal.pone.0022176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765947	gold, Green Submitted, Green Published			2022-12-25	WOS:000292781500038
J	Yassin, AS; Agrawal, RK; Banavali, NK				Yassin, Aymen S.; Agrawal, Rajendra K.; Banavali, Nilesh K.			Computational Exploration of Structural Hypotheses for an Additional Sequence in a Mammalian Mitochondrial Protein	PLOS ONE			English	Article							TRANSLATION INITIATION COMPLEX; STRUCTURE PREDICTION SERVER; SMALL RIBOSOMAL-SUBUNIT; ANGSTROM RESOLUTION; MOLECULAR-DYNAMICS; ESCHERICHIA-COLI; FACTOR IF2; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; DOMAIN	Background: Proteins involved in mammalian mitochondrial translation, when compared to analogous bacterial proteins, frequently have additional sequence regions whose structural or functional roles are not always clear. For example, an additional short insert sequence in the bovine mitochondrial initiation factor 2 (IF2(mt)) seems sufficient to fulfill the added role of eubacterial initiation factor IF1. Prior to our recent cryo-EM study that showed IF2(mt) to structurally occupy both the IF1 and IF2 binding sites, the spatial separation of these sites, and the short length of the insert sequence, posed ambiguity in whether it could perform the role of IF1 through occupation of the IF1 binding site on the ribosome. Results: The present study probes how well computational structure prediction methods can a priori address hypothesized roles of such additional sequences by creating quasi-atomic models of IF2(mt) using bacterial IF2 cryo-EM densities (that lack the insert sequences). How such initial IF2(mt) predictions differ from the observed IF2(mt) cryo-EM map and how they can be suitably improved using further sequence analysis and flexible fitting are analyzed. Conclusions: By hypothesizing that the insert sequence occupies the IF1 binding site, continuous IF2(mt) models that occupy both the IF2 and IF1 binding sites can be predicted computationally. These models can be improved by flexible fitting into the IF2(mt) cryo-EM map to get reasonable quasi-atomic IF2(mt) models, but the exact orientation of the insert structure may not be reproduced. Specific eukaryotic insert sequence conservation characteristics can be used to predict alternate IF2(mt) models that have minor secondary structure rearrangements but fewer unusually extended linker regions. Computational structure prediction methods can thus be combined with medium-resolution cryo-EM maps to explore structure-function hypotheses for additional sequence regions and to guide further biochemical experiments, especially in mammalian systems where high-resolution structures are difficult to determine.	[Yassin, Aymen S.; Agrawal, Rajendra K.] New York State Dept Hlth, Wadsworth Ctr, Div Translat Med, Lab Cellular & Mol Basis Dis, Albany, NY USA; [Agrawal, Rajendra K.; Banavali, Nilesh K.] SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY USA; [Banavali, Nilesh K.] New York State Dept Hlth, Wadsworth Ctr, Div Genet, Lab Computat & Struct Biol, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; Wadsworth Center	Yassin, AS (corresponding author), Cairo Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt.	agrawal@wadsworth.org; banavali@wadsworth.org	; Yassin, Aymen/N-8490-2016	Banavali, Nilesh/0000-0003-2206-7049; Yassin, Aymen/0000-0002-4423-164X	National Institutes of Health [R01 GM61576]; Wadsworth Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wadsworth Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM61576 (to RKA) and Wadsworth Center new investigator equipment funds to NKB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal RK, 2011, RIBOSOMES: STRUCTURE, FUNCTION, AND DYNAMICS, P83; Allen GS, 2007, MOL MICROBIOL, V63, P941, DOI 10.1111/j.1365-2958.2006.05574.x; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ATTARDI G, 1985, INT REV CYTOL, V93, P93, DOI 10.1016/S0074-7696(08)61373-X; Brock S, 1998, MOL MICROBIOL, V29, P409, DOI 10.1046/j.1365-2958.1998.00893.x; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gaur R, 2008, MOL CELL, V29, P180, DOI 10.1016/j.molcel.2007.11.021; Grigoriadou C, 2007, J MOL BIOL, V373, P551, DOI 10.1016/j.jmb.2007.07.031; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Koc EC, 2002, J BIOL CHEM, V277, P35541, DOI 10.1074/jbc.M202498200; Koc EC, 2010, ISR J CHEM, V50, P45, DOI 10.1002/ijch.201000002; La Teana A, 2001, RNA, V7, P1173, DOI 10.1017/S1355838201010366; Lee JH, 1999, P NATL ACAD SCI USA, V96, P4342, DOI 10.1073/pnas.96.8.4342; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McCutcheon JP, 1999, P NATL ACAD SCI USA, V96, P4301, DOI 10.1073/pnas.96.8.4301; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meunier S, 2000, EMBO J, V19, P1918, DOI 10.1093/emboj/19.8.1918; MOAZED D, 1995, J MOL BIOL, V248, P207, DOI 10.1016/S0022-2836(95)80042-5; Mosca R, 2008, NUCLEIC ACIDS RES, V36, pW42, DOI 10.1093/nar/gkn197; Mosca R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-352; Myasnikov AG, 2005, NAT STRUCT MOL BIOL, V12, P1145, DOI 10.1038/nsmb1012; O'Brien TW, 2002, GENE, V286, P73, DOI 10.1016/S0378-1119(01)00808-3; OBRIEN TW, 1971, J BIOL CHEM, V246, P3409; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sette M, 1997, EMBO J, V16, P1436, DOI 10.1093/emboj/16.6.1436; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Simonetti A, 2009, CELL MOL LIFE SCI, V66, P423, DOI 10.1007/s00018-008-8416-4; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Soto CS, 2008, PROTEINS, V70, P834, DOI 10.1002/prot.21612; Spencer AC, 2005, BBA-PROTEINS PROTEOM, V1750, P69, DOI 10.1016/j.bbapap.2005.03.009; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Wienk H, 2005, PROTEIN SCI, V14, P2461, DOI 10.1110/ps.051531305; WILBUR WJ, 1983, P NATL ACAD SCI-BIOL, V80, P726, DOI 10.1073/pnas.80.3.726; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Yassin AS, 2011, P NATL ACAD SCI USA, V108, P3918, DOI 10.1073/pnas.1017425108; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	54	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21871	10.1371/journal.pone.0021871	http://dx.doi.org/10.1371/journal.pone.0021871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779343	Green Submitted, gold, Green Published			2022-12-25	WOS:000292680900012
J	Abubucker, S; Martin, J; Taylor, CM; Mitreva, M				Abubucker, Sahar; Martin, John; Taylor, Christina M.; Mitreva, Makedonka			HelmCoP: An Online Resource for Helminth Functional Genomics and Drug and Vaccine Targets Prioritization	PLOS ONE			English	Article							NEMATODE MELOIDOGYNE-INCOGNITA; CAENORHABDITIS-ELEGANS; EUKARYOTIC GENOMES; HIGH-THROUGHPUT; BRUGIA-MALAYI; WEB SERVER; PROTEIN; PREDICTION; RNAI; DATABASE	A vast majority of the burden from neglected tropical diseases result from helminth infections (nematodes and platyhelminthes). Parasitic helminthes infect over 2 billion, exerting a high collective burden that rivals high-mortality conditions such as AIDS or malaria, and cause devastation to crops and livestock. The challenges to improve control of parasitic helminth infections are multi-fold and no single category of approaches will meet them all. New information such as helminth genomics, functional genomics and proteomics coupled with innovative bioinformatic approaches provide fundamental molecular information about these parasites, accelerating both basic research as well as development of effective diagnostics, vaccines and new drugs. To facilitate such studies we have developed an online resource, HelmCoP (Helminth Control and Prevention), built by integrating functional, structural and comparative genomic data from plant, animal and human helminthes, to enable researchers to develop strategies for drug, vaccine and pesticide prioritization, while also providing a useful comparative genomics platform. HelmCoP encompasses genomic data from several hosts, including model organisms, along with a comprehensive suite of structural and functional annotations, to assist in comparative analyses and to study host-parasite interactions. The HelmCoP interface, with a sophisticated query engine as a backbone, allows users to search for multi-factorial combinations of properties and serves readily accessible information that will assist in the identification of various genes of interest. HelmCoP is publicly available at: http://www.nematode.net/helmcop.html.	[Abubucker, Sahar; Martin, John; Taylor, Christina M.; Mitreva, Makedonka] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA; [Mitreva, Makedonka] Washington Univ, Sch Med, Dept Genet, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Abubucker, S (corresponding author), Washington Univ, Sch Med, Genome Inst, St Louis, MO 63130 USA.	mmitreva@genome.wustl.edu		Mitreva, Makedonka/0000-0001-9572-3436	NIH/NIAID [AI081803]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081803] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH/NIAID grant AI081803 to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; AGUERO F, 2008, NAT REV DRUG DISCOV; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bag S, 2010, ACTA TROP, V113, P48, DOI 10.1016/j.actatropica.2009.09.004; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Besier B, 2007, TRENDS PARASITOL, V23, P21, DOI 10.1016/j.pt.2006.11.004; Brindley PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000538; Brooks DR, 2003, J BIOL CHEM, V278, P52340, DOI 10.1074/jbc.M308858200; Chatr-aryamontri A, 2008, METHODS MOL BIOL, V484, P305, DOI 10.1007/978-1-59745-398-1_20; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; Corradin Giarnpietro, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P259, DOI 10.2174/187153007782794371; Craig H, 2007, TRENDS PARASITOL, V23, P248, DOI 10.1016/j.pt.2007.04.003; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Doyle MA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-222; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Fletcher S, 2006, J R SOC INTERFACE, V3, P215, DOI 10.1098/rsif.2006.0115; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gasbarre LC, 2009, VET PARASITOL, V166, P281, DOI 10.1016/j.vetpar.2009.08.018; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; HAN ET, 2010, TROP MED INT HLTH; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Holden-Dye Lindy, 2007, WormBook, P1, DOI 10.1895/wormbook.1.143.1; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hotez PJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000680; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kalinna BH, 2007, TRENDS PARASITOL, V23, P197, DOI 10.1016/j.pt.2007.03.007; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Krautz-Peterson G, 2010, PARASITOLOGY, V137, P485, DOI 10.1017/S0031182009991168; Kumar S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001189; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Martin J, 2009, NUCLEIC ACIDS RES, V37, pD571, DOI 10.1093/nar/gkn744; McCarter JP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r26; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; Mitreva M, 2005, TRENDS GENET, V21, P573, DOI 10.1016/j.tig.2005.08.003; Mitreva M, 2004, GENOME RES, V14, P209, DOI 10.1101/gr.1524804; Nandan D, 2007, PROTEINS, V67, P53, DOI 10.1002/prot.21278; Olugbile S, 2009, INFECT IMMUN, V77, P5701, DOI 10.1128/IAI.00652-09; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimizu K, 2009, J MOL BIOL, V392, P1253, DOI 10.1016/j.jmb.2009.07.088; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Tice CM, 2001, PEST MANAG SCI, V57, P3, DOI 10.1002/1526-4998(200101)57:1<3::AID-PS269>3.0.CO;2-6; Urban JF, 2007, VET PARASITOL, V148, P14, DOI 10.1016/j.vetpar.2007.05.006; Villard V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000645; von Grotthuss M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-53; Wang ZY, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-23; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Williamson SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000517; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	71	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21832	10.1371/journal.pone.0021832	http://dx.doi.org/10.1371/journal.pone.0021832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760913	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000292657200025
J	Handel, IG; Willoughby, K; Land, F; Koterwas, B; Morgan, KL; Tanya, VN; Bronsvoort, BMD				Handel, Ian G.; Willoughby, Kim; Land, Fiona; Koterwas, Bronwyn; Morgan, Kenton L.; Tanya, Vincent N.; Bronsvoort, Barend M. deC.			Seroepidemiology of Bovine Viral Diarrhoea Virus (BVDV) in the Adamawa Region of Cameroon and Use of the SPOT Test to Identify Herds with PI Calves	PLOS ONE			English	Article							DAIRY HERDS; CATTLE; PREVALENCE; INFECTION; PESTIVIRUSES; ANTIBODIES; ANIMALS; DISEASE; EPIDEMIOLOGY; ERADICATION	Bovine viral diarrhoea, caused by the bovine viral diarrhoea virus (BVDV) in the Pestivirus genus of the Flaviviridae, is one of the most important diseases of cattle world wide causing poor reproductive performance in adult cattle and mucosal disease in calves. In addition it causes immunosuppression and increased susceptibility to other infections, the impact of which is uncertain, particularly in sub-Saharan Africa where animals are exposed to a much wider range and higher intensity of infections compared to Europe. There are no previous estimates of the seroprevalence of BVDV in cattle in Cameroon. This paper describes the serological screening for antibodies to BVDV and antigen of BVDV in a cattle population in the Adamawa Region of Cameroon in 2000. The estimates of herd-level and within herd seroprevalences adjusted for test imperfections were 92% and 30% respectively and 16.5% of herds were classed as having a persistently infected calf (PI) in the herd within the last year based on the "spot" test approach. There was evidence of clustering of herds with PI calves across the north and west of the Region which corresponds with the higher cattle density areas and of self-clearance of infection from herds. A multivariable model was developed for the risk of having a PI calf in the herd; proximity to antelope, owning a goat, mixing with > 10 other herds at grazing and the catchment area of the veterinary centre the herd was registered at were all significant risk factors. Very little is known about BVDV in sub-Saharan Africa and these high seroprevalences suggest that there is a large problem which may be having both direct impacts on fertility and neonate mortality and morbidity and also indirect effects through immunosuppression and susceptibility to other infections. Understanding and accounting for BVDV should be an important component of epidemiological studies of other diseases in sub-Saharan Africa.	[Handel, Ian G.; Land, Fiona; Koterwas, Bronwyn; Bronsvoort, Barend M. deC.] Univ Edinburgh, Roslin Inst, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Morgan, Kenton L.] Univ Liverpool, Dept Vet Clin Sci, Leahurst Vet Teaching Hosp, Wirral L64 7TE, Merseyside, England; [Tanya, Vincent N.] Minist Sci Res & Innovat, Yaounde, Cameroon; [Willoughby, Kim] Moredun Res Inst, Penicuik, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Liverpool; Moredun Research Institute	Handel, IG (corresponding author), Univ Edinburgh, Roslin Inst, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland.	mark.bronsvoort@ed.ac.uk		Bronsvoort, Mark/0000-0002-3271-8485	Wellcome Trust [053840]; BBSRC	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The original project was funded by Wellcome Trust Grant No. 053840 and the current BVDV analysis was supported from an Institutional Funding Award from the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 1998, EPIDEMIOL INFECT, V121, P441, DOI 10.1017/S0950268898001289; Branscum AJ, 2004, PREV VET MED, V66, P101, DOI 10.1016/j.prevetmed.2004.09.009; Bronsvoort BMD, 2003, TROP ANIM HEALTH PRO, V35, P491, DOI 10.1023/A:1027302525301; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Chongsuvivatwong V, 2009, EPICALC EPIDEMIOLOGI; Couacy-Hymann E, 2007, RES VET SCI, V83, P282, DOI 10.1016/j.rvsc.2006.12.010; Ferreira GM, 2000, J S AFR VET ASSOC, V71, P10; GHIROTTI M, 1991, VET RES COMMUN, V15, P25, DOI 10.1007/BF00497787; Gunn GJ, 2005, PREV VET MED, V72, P149, DOI 10.1016/j.prevetmed.2005.08.012; HAMBLIN C, 1990, EPIDEMIOL INFECT, V105, P585, DOI 10.1017/S0950268800048226; Houe H, 2003, BIOLOGICALS, V31, P137, DOI 10.1016/S1045-1056(03)00030-7; HOUE H, 1995, VET CLIN N AM-FOOD A, V11, P521, DOI 10.1016/S0749-0720(15)30465-5; HOUE H, 1992, RES VET SCI, V53, P320, DOI 10.1016/0034-5288(92)90133-M; Innocent G, 1997, EPIDEMIOL INFECT, V119, P91, DOI 10.1017/S0950268897007723; Kabongo N, 2004, J S AFR VET ASSOC, V75, P90; Lindberg A, 2006, REV SCI TECH OIE, V25, P961, DOI 10.20506/rst.25.3.1703; Lindberg A, 2005, PREV VET MED, V72, P55, DOI 10.1016/j.prevetmed.2005.07.018; Lindberg ALE, 1999, VET MICROBIOL, V64, P197, DOI 10.1016/S0378-1135(98)00270-3; Liu LH, 2008, J VIROL METHODS, V154, P82, DOI 10.1016/j.jviromet.2008.09.001; Mishra N, 2009, TROP ANIM HEALTH PRO, V41, P1231, DOI 10.1007/s11250-009-9305-z; Plummer M, 2009, RJAGS BAYESIAN GRAPH; Potgieter L. N. D., 2004, Infectious diseases of livestock. Volume Two, P946; Rufenacht J, 2000, VET REC, V147, P413, DOI 10.1136/vr.147.15.413; Schnute J. T, 2008, PBSMAPPING PBS MAPPI; Scott HM, 2006, CAN VET J, V47, P981; SOINE C, 1992, TROP ANIM HEALTH PRO, V24, P125, DOI 10.1007/BF02356958; Stahl K, 2008, PREV VET MED, V83, P285, DOI 10.1016/j.prevetmed.2007.08.005; Talafha AQ, 2009, TROP ANIM HEALTH PRO, V41, P499, DOI 10.1007/s11250-008-9214-6; TRAVEN M, 1991, J VET MED B, V38, P453, DOI 10.1111/j.1439-0450.1991.tb00895.x; Valle PS, 1999, PREV VET MED, V40, P165, DOI 10.1016/S0167-5877(99)00030-6; Valle PS, 2005, PREV VET MED, V72, P189, DOI 10.1016/j.prevetmed.2005.07.017; Vilcek S, 2006, VET MICROBIOL, V116, P1, DOI 10.1016/j.vetmic.2006.06.003; VILCEK S, 1994, ARCH VIROL, V136, P309, DOI 10.1007/BF01321060	33	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21620	10.1371/journal.pone.0021620	http://dx.doi.org/10.1371/journal.pone.0021620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754993	Green Submitted, Green Published, gold			2022-12-25	WOS:000292632000018
J	Mandelblat-Cerf, Y; Novick, I; Vaadia, E				Mandelblat-Cerf, Yael; Novick, Itai; Vaadia, Eilon			Expressions of Multiple Neuronal Dynamics during Sensorimotor Learning in the Motor Cortex of Behaving Monkeys	PLOS ONE			English	Article							VISUOMOTOR TRANSFORMATIONS; ADAPTATION; CONSOLIDATION; MEMORY; ACQUISITION; ARM; INTERFERENCE; ERROR; COORDINATION; VARIABILITY	Previous studies support the notion that sensorimotor learning involves multiple processes. We investigated the neuronal basis of these processes by recording single-unit activity in motor cortex of non-human primates (Macaca fascicularis), during adaptation to force-field perturbations. Perturbed trials (reaching to one direction) were practiced along with unperturbed trials (to other directions). The number of perturbed trials relative to the unperturbed ones was either low or high, in two separate practice schedules. Unsurprisingly, practice under high-rate resulted in faster learning with more pronounced generalization, as compared to the low-rate practice. However, generalization and retention of behavioral and neuronal effects following practice in high-rate were less stable; namely, the faster learning was forgotten faster. We examined two subgroups of cells and showed that, during learning, the changes in firing-rate in one subgroup depended on the number of practiced trials, but not on time. In contrast, changes in the second subgroup depended on time and practice; the changes in firing-rate, following the same number of perturbed trials, were larger under high-rate than low-rate learning. After learning, the neuronal changes gradually decayed. In the first subgroup, the decay pace did not depend on the practice rate, whereas in the second subgroup, the decay pace was greater following high-rate practice. This group shows neuronal representation that mirrors the behavioral performance, evolving faster but also decaying faster at learning under high-rate, as compared to low-rate. The results suggest that the stability of a new learned skill and its neuronal representation are affected by the acquisition schedule.	[Mandelblat-Cerf, Yael; Novick, Itai; Vaadia, Eilon] Hebrew Univ Jerusalem, Dept Med Neurobiol, Inst Med Res Israel Canada, Fac Med,Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel	Hebrew University of Jerusalem	Mandelblat-Cerf, Y (corresponding author), Hebrew Univ Jerusalem, Dept Med Neurobiol, Inst Med Res Israel Canada, Fac Med,Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel.	yaelma@mit.edu	Vaadia, Eilon/E-9347-2011		Binational Science Foundation (BSF); Israel Science Foundation; Rosetrees Trust; Ida Baruch fund	Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Rosetrees Trust(Rosetrees Trust); Ida Baruch fund	This work was supported in part by the Binational Science Foundation (BSF), the Israel Science Foundation, special contributions from the Rosetrees Trust, and the Ida Baruch fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aboukhalil A, 2004, NEUROSCI LETT, V369, P162, DOI 10.1016/j.neulet.2004.07.085; ARCE F, 2005, FACILITATION RATHER; Arce F, 2010, J NEUROSCI, V30, P5415, DOI 10.1523/JNEUROSCI.0076-10.2010; Bays PM, 2005, EXP BRAIN RES, V163, P400, DOI 10.1007/s00221-005-2299-5; Bock O, 2005, EXP BRAIN RES, V163, P258, DOI 10.1007/s00221-005-2231-z; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; BRASHERSKRUG T, 1996, NATURE; Caithness G, 2004, J NEUROSCI, V24, P8662, DOI 10.1523/JNEUROSCI.2214-04.2004; Commins S, 2003, BEHAV BRAIN RES, V139, P215, DOI 10.1016/S0166-4328(02)00270-X; Criscimagna-Hemminger SE, 2003, J NEUROPHYSIOL, V89, P168, DOI 10.1152/jn.00622.2002; CUNNINGHAM HA, 1994, J EXP PSYCHOL HUMAN, V20, P987, DOI 10.1037/0096-1523.20.5.987; Donchin O, 2003, J NEUROSCI, V23, P9032; Donchin O, 2002, J NEUROPHYSIOL, V88, P2114, DOI 10.1152/jn.2002.88.4.2114; Emken JL, 2007, J NEUROPHYSIOL, V97, P3997, DOI 10.1152/jn.01095.2006; Francis JT, 2005, EXP BRAIN RES, V167, P128, DOI 10.1007/s00221-005-0062-6; Fusi S, 2007, NEURON, V54, P319, DOI 10.1016/j.neuron.2007.03.017; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; GHEZ C, 1995, CAN J PHYSIOL PHARM, V73, P273, DOI 10.1139/y95-038; Goedert KM, 2002, LEARN MEMORY, V9, P279, DOI 10.1101/lm.50102; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; Huang VS, 2007, J NEUROPHYSIOL, V97, P3976, DOI 10.1152/jn.01281.2006; Hwang EJ, 2003, PLOS BIOL, V1, P209, DOI 10.1371/journal.pbio.0000025; Imamizu H, 2007, EXP BRAIN RES, V181, P395, DOI 10.1007/s00221-007-0940-1; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Malfait N, 2002, J NEUROSCI, V22, P9656; Mandelblat-Cerf Y, 2011, J NEUROSCI, V31, P300, DOI 10.1523/JNEUROSCI.4055-10.2011; Mattar AAG, 2007, J NEUROPHYSIOL, V98, P3321, DOI 10.1152/jn.00576.2007; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Newell KM, 2009, HUM MOVEMENT SCI, V28, P655, DOI 10.1016/j.humov.2009.07.001; Newell KM, 2001, PSYCHOL REV, V108, P57, DOI 10.1037//0033-295X.108.1.57; Nudo RJ, 1996, J NEUROSCI, V16, P785; Pascual Leone A, 1995, J NEUROPHYSIOL, V74, P1037; Paz R, 2005, EXP BRAIN RES, V161, P209, DOI 10.1007/s00221-004-2061-4; Paz R, 2003, NAT NEUROSCI, V6, P882, DOI 10.1038/nn1097; Poggio T, 2004, NATURE, V431, P768, DOI 10.1038/nature03014; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Sainburg RL, 1999, J NEUROPHYSIOL, V81, P1045, DOI 10.1152/jn.1999.81.3.1045; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Savion-Lemieux T, 2005, EXP BRAIN RES, V161, P423, DOI 10.1007/s00221-004-2085-9; Scheidt RA, 2001, J NEUROPHYSIOL, V86, P971, DOI 10.1152/jn.2001.86.2.971; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; SHEA CH, 1990, RES Q EXERCISE SPORT, V61, P169, DOI 10.1080/02701367.1990.10608671; Simon DA, 2001, J EXP PSYCHOL LEARN, V27, P907, DOI 10.1037/0278-7393.27.4.907; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; TAMASHITA Y, 2008, PLOS COMPUT BIOL, V4; Thoroughman KA, 2005, J NEUROSCI, V25, P8948, DOI 10.1523/JNEUROSCI.1771-05.2005; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Wulf G, 1997, J EXP PSYCHOL LEARN, V23, P987, DOI 10.1037/0278-7393.23.4.987	58	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21626	10.1371/journal.pone.0021626	http://dx.doi.org/10.1371/journal.pone.0021626			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754994	gold, Green Published, Green Submitted			2022-12-25	WOS:000292632000019
J	Marzinelli, EM; Underwood, AJ; Coleman, RA				Marzinelli, Ezequiel M.; Underwood, Antony J.; Coleman, Ross A.			Modified Habitats Influence Kelp Epibiota via Direct and Indirect Effects	PLOS ONE			English	Article							BENTHIC MARINE-INVERTEBRATES; SEA-URCHIN; ARTIFICIAL STRUCTURES; ASSEMBLAGES; HOST; RECRUITMENT; ROADS; AUSTRALIA; ECOLOGY; BIODIVERSITY	Addition of man-made structures alters abiotic and biotic characteristics of natural habitats, which can influence abundances of biota directly and/or indirectly, by altering the ecology of competitors or predators. Marine epibiota in modified habitats were used to test hypotheses to distinguish between direct and indirect processes. In Sydney Harbour, kelps on pier-pilings supported greater covers of bryozoans, particularly of the non-indigenous species Membranipora membranacea, than found on natural reefs. Pilings influenced these patterns and processes directly due to the provision of shade and indirectly by altering abundances of sea-urchins which, in turn, affected covers of bryozoans. Indirect effects were more important than direct effects. This indicates that artificial structures affect organisms living on secondary substrata in complex ways, altering the biodiversity and indirectly affecting abundances of epibiota. Understanding how these components of habitats affect ecological processes is necessary to allow sensible prediction of the effects of modifying habitats on the ecology of organisms.	[Marzinelli, Ezequiel M.; Underwood, Antony J.; Coleman, Ross A.] Univ Sydney, Sch Biol Sci, Ctr Res Ecol Impacts Coastal Cities, Sydney, NSW 2006, Australia	University of Sydney	Marzinelli, EM (corresponding author), Univ Sydney, Sch Biol Sci, Ctr Res Ecol Impacts Coastal Cities, Sydney, NSW 2006, Australia.	e.marzinelli@unsw.edu.au	Marzinelli, Ezequiel/AAH-2906-2019; Coleman, Ross A/B-1314-2008; Marzinelli, Ezequiel/I-7726-2012	Marzinelli, Ezequiel/0000-0002-3762-3389; Coleman, Ross A/0000-0003-4136-5914; 	Endeavour International Postgraduate Research Scholarship; Australian Research Council	Endeavour International Postgraduate Research Scholarship(Australian Government); Australian Research Council(Australian Research Council)	This work was supported by funds from an Endeavour International Postgraduate Research Scholarship to EMM. AJU and RAC were supported by grants from the Australian Research Council's Special Research Centres Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blockley DJ, 2006, MAR ECOL PROG SER, V327, P27, DOI 10.3354/meps327027; Blockley DJ, 2007, MAR ENVIRON RES, V63, P409, DOI 10.1016/j.marenvres.2006.10.007; Bruno JF, 2001, MARINE COMMUNITY ECOLOGY, P201; Bulleri F, 2005, ENVIRON CONSERV, V32, P101, DOI 10.1017/S0376892905002183; Cabanes C, 2001, SCIENCE, V294, P840, DOI 10.1126/science.1063556; CANCINO JM, 1987, J EXP MAR BIOL ECOL, V113, P105, DOI 10.1016/0022-0981(87)90158-4; CHAPMAN MG, 1986, J EXP MAR BIOL ECOL, V103, P181, DOI 10.1016/0022-0981(86)90140-1; Clynick BG, 2008, AUSTRAL ECOL, V33, P140, DOI 10.1111/j.1442-9993.2007.01802.x; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; Connell Sean D., 2007, P556; DANTONIO C, 1985, J EXP MAR BIOL ECOL, V86, P197, DOI 10.1016/0022-0981(85)90103-0; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; de Nys R, 1999, RECENT ADV MARINE BI, V3, P223; Dean WRJ, 2000, J ARID ENVIRON, V45, P305, DOI 10.1006/jare.2000.0652; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Glasby TM, 2007, MAR BIOL, V151, P887, DOI 10.1007/s00227-006-0552-5; Glasby TM, 1999, J EXP MAR BIOL ECOL, V234, P275, DOI 10.1016/S0022-0981(98)00156-7; Hewitt CL, 2004, MAR BIOL, V144, P183, DOI 10.1007/s00227-003-1173-x; Holloway MG, 2002, ECOL APPL, V12, P1803, DOI 10.2307/3099939; Hunt HL, 1997, MAR ECOL PROG SER, V155, P269, DOI 10.3354/meps155269; KEOUGH MJ, 1982, OECOLOGIA, V54, P348, DOI 10.1007/BF00380003; KNIGHT RL, 1995, BIOL CONSERV, V74, P65, DOI 10.1016/0006-3207(94)00003-9; Lidgard S, 2008, MAR ECOL PROG SER, V359, P117, DOI 10.3354/meps07322; Marzinelli EM, 2009, ECOLOGY, V90, P2948, DOI 10.1890/08-1893.1; MARZINELLI EM, 2009, EFFECTS MODIFICATION; MENGE BA, 1995, ECOL MONOGR, V65, P21, DOI 10.2307/2937158; Parendes LA, 2000, CONSERV BIOL, V14, P64, DOI 10.1046/j.1523-1739.2000.99089.x; People J, 2006, AUSTRAL ECOL, V31, P271, DOI 10.1111/j.1442-9993.2006.01585.x; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; RODRIGUEZ SR, 1993, MAR ECOL PROG SER, V97, P193, DOI 10.3354/meps097193; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; STEINBERG PD, 1995, MAR ECOL PROG SER, V127, P169, DOI 10.3354/meps127169; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; *UN DESA POP DIV, 2007, ESAPWP202 UN DESA PO; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; UNDERWOOD AJ, 1989, BIOL J LINN SOC, V37, P51, DOI 10.1111/j.1095-8312.1989.tb02005.x; VANCE RR, 1979, ECOLOGY, V60, P537, DOI 10.2307/1936074; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WAHL M, 1992, MAR ECOL PROG SER, V88, P225, DOI 10.3354/meps088225; WAHL M, 1995, OECOLOGIA, V102, P329, DOI 10.1007/BF00329800; WAHL M, 1989, MAR ECOL PROG SER, V58, P175, DOI 10.3354/meps058175; Wahl M, 2008, BIOFOULING, V24, P427, DOI 10.1080/08927010802339772; Williamson JE, 2004, ECOLOGY, V85, P1355, DOI 10.1890/02-4083; Williamson JE, 2000, BIOL BULL, V198, P332, DOI 10.2307/1542689	48	33	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21936	10.1371/journal.pone.0021936	http://dx.doi.org/10.1371/journal.pone.0021936			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755011	gold, Green Submitted, Green Published			2022-12-25	WOS:000292632000038
J	Wang, W; Gao, XF; Xiao, L; Xiang, ZH; He, C				Wang, Wei; Gao, Xiao-Fei; Xiao, Lin; Xiang, Zheng-Hua; He, Cheng			K(V)7/KCNQ Channels Are Functionally Expressed in Oligodendrocyte Progenitor Cells	PLOS ONE			English	Article							KCNQ POTASSIUM CHANNELS; OUTER HAIR-CELLS; K+ CHANNELS; NEURONAL EXCITABILITY; SENSORY NEURONS; INHIBITION; BRAIN; SUPPRESSION; MODULATION; CURRENTS	Background: K(V)7/KCNQ channels are widely expressed in neurons and they have multiple important functions, including control of excitability, spike afterpotentials, adaptation, and theta resonance. Mutations in KCNQ genes have been demonstrated to associate with human neurological pathologies. However, little is known about whether K(V)7/KCNQ channels are expressed in oligodendrocyte lineage cells (OLCs) and what their functions in OLCs. Methods and Findings: In this study, we characterized K(V)7/KCNQ channels expression in rat primary cultured OLCs by RT-PCR, immunostaining and electrophysiology. KCNQ2-5 mRNAs existed in all three developmental stages of rat primary cultured OLCs. K(V)7/KCNQ proteins were also detected in oligodendrocyte progenitor cells (OPCs, early developmental stages of OLCs) of rat primary cultures and cortex slices. Voltage-clamp recording revealed that the I-M antagonist XE991 significantly reduced K(V)7/KCNQ channel current ((IK(Q))) in OPCs but not in differentiated oligodendrocytes. In addition, inhibition of K(V)7/KCNQ channels promoted OPCs motility in vitro. Conclusions: These findings showed that K(V)7/KCNQ channels were functionally expressed in rat primary cultured OLCs and might play an important role in OPCs functioning in physiological or pathological conditions.	[Wang, Wei] Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Minist Educ,Inst Neurosci, Shanghai, Peoples R China; Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Minist Educ,Key Lab Mol Neurobiol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Wang, W (corresponding author), Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Minist Educ,Inst Neurosci, Shanghai, Peoples R China.	chenghe@smmu.edu.cn	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	National Natural Science Foundation [30800430]; National Key Basic Research Program [2007CB947100, 2011CB504401]; Ministry of Science and Technology of China [2009ZX09311-001]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	National Natural Science Foundation (30800430), National Key Basic Research Program (2007CB947100, 2011CB504401), and the Ministry of Science and Technology of China (2009ZX09311-001). The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P263, DOI 10.1113/jphysiol.1982.sp014412; Agresti C, 2005, BRAIN RES REV, V48, P157, DOI 10.1016/j.brainresrev.2004.12.005; AIKEN SP, 1995, BRIT J PHARMACOL, V115, P1163, DOI 10.1111/j.1476-5381.1995.tb15019.x; ARMSTRONG RC, 1990, J NEUROSCI RES, V27, P400, DOI 10.1002/jnr.490270319; Attali B, 1997, J NEUROSCI, V17, P8234; Bacia A, 2004, GLIA, V48, P156, DOI 10.1002/glia.20067; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; BJORN CS, 2000, J BIOL CHEM, V275, P24089; Blakemore WF, 1999, J NEUROIMMUNOL, V98, P69, DOI 10.1016/S0165-5728(99)00083-1; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Brown D A, 1988, Ion Channels, V1, P55; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Brown DA, 2000, J AUTONOM NERV SYST, V81, P31, DOI 10.1016/S0165-1838(00)00150-8; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Cao L, 2006, GLIA, V54, P536, DOI 10.1002/glia.20403; Chittajallu R, 2002, P NATL ACAD SCI USA, V99, P2350, DOI 10.1073/pnas.042698399; Cooper EC, 2001, J NEUROSCI, V21, P9529, DOI 10.1523/JNEUROSCI.21-24-09529.2001; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; DUBOISDALCQ M, 1987, EMBO J, V6, P2587, DOI 10.1002/j.1460-2075.1987.tb02549.x; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; GARD AL, 1989, DEVELOPMENT, V106, P119; Grosse G, 2000, J NEUROSCI, V20, P1869; Gudz TI, 2006, J NEUROSCI, V26, P2458, DOI 10.1523/JNEUROSCI.4054-05.2006; Hadley JK, 2003, J NEUROSCI, V23, P5012; Hadley JK, 2000, BRIT J PHARMACOL, V129, P413, DOI 10.1038/sj.bjp.0703086; Hansen HH, 2008, J PHYSIOL-LONDON, V586, P1823, DOI 10.1113/jphysiol.2007.149450; Ivanova A, 2003, J NEUROSCI RES, V73, P581, DOI 10.1002/jnr.10717; JEFFREY SS, 2001, J NEUROSCI, V21, P1096; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kananura C, 2000, NEUROREPORT, V11, P2063, DOI 10.1097/00001756-200006260-00050; KARSCHIN A, 1995, NEUROSCI LETT, V183, P135, DOI 10.1016/0304-3940(94)11133-4; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; KIRK WB, 2005, J NEUROSCI, V2540, P9285; Knutson P, 1997, J NEUROSCI, V17, P2669, DOI 10.1523/jneurosci.17-08-02669.1997; Koyama S, 2006, J NEUROPHYSIOL, V96, P535, DOI 10.1152/jn.00574.2005; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lang PM, 2008, NEUROPHARMACOLOGY, V54, P1271, DOI 10.1016/j.neuropharm.2008.04.006; Lastraioli E, 2004, CANCER RES, V64, P606, DOI 10.1158/0008-5472.CAN-03-2360; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Luyt K, 2007, J NEUROCHEM, V100, P822, DOI 10.1111/j.1471-4159.2006.04255.x; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Morokuma J, 2008, CELL PHYSIOL BIOCHEM, V21, P357, DOI 10.1159/000129628; Neusch C, 2001, J NEUROSCI, V21, P5429, DOI 10.1523/JNEUROSCI.21-15-05429.2001; Nisenbaum ES, 1996, J NEUROPHYSIOL, V76, P1180, DOI 10.1152/jn.1996.76.2.1180; Paez PM, 2010, J NEUROSCI, V30, P6422, DOI 10.1523/JNEUROSCI.5086-09.2010; Paez PM, 2009, J NEUROSCI, V29, P6663, DOI 10.1523/JNEUROSCI.5806-08.2009; Pankratov Y, 2006, PFLUG ARCH EUR J PHY, V452, P589, DOI 10.1007/s00424-006-0061-x; Passmore GM, 2003, J NEUROSCI, V23, P7227, DOI 10.1523/JNEUROSCI.23-18-07227.2003; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Rao JN, 2002, AM J PHYSIOL-CELL PH, V282, pC885, DOI 10.1152/ajpcell.00361.2001; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Saganich MJ, 2001, J NEUROSCI, V21, P4609, DOI 10.1523/JNEUROSCI.21-13-04609.2001; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schwarz JR, 2006, J PHYSIOL-LONDON, V573, P17, DOI 10.1113/jphysiol.2006.106815; Schweitzer P, 2000, J NEUROSCI, V20, P51, DOI 10.1523/JNEUROSCI.20-01-00051.2000; Shah MM, 2002, J PHYSIOL-LONDON, V544, P29, DOI 10.1113/jphysiol.2002.028571; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Shen WX, 2004, J NEUROPHYSIOL, V91, P1337, DOI 10.1152/jn.00414.2003; SHRAGER P, 1995, DEV BRAIN RES, V88, P68, DOI 10.1016/0165-3806(95)00081-N; Tinel N, 1998, FEBS LETT, V438, P171, DOI 10.1016/S0014-5793(98)01296-4; Tiwari-Woodruff S, 2006, AM J PHYSIOL-CELL PH, V291, pC687, DOI 10.1152/ajpcell.00510.2005; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; Toral C, 2007, LIFE SCI, V81, P255, DOI 10.1016/j.lfs.2007.05.014; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wladyka CL, 2008, J PHYSIOL-LONDON, V586, P795, DOI 10.1113/jphysiol.2007.145284; Wladyka CL, 2006, J PHYSIOL-LONDON, V575, P175, DOI 10.1113/jphysiol.2006.113308; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004; Yus-Najera E, 2003, NEUROSCIENCE, V120, P353, DOI 10.1016/S0306-4522(03)00321-X; Zaika O, 2006, J PHYSIOL-LONDON, V575, P49, DOI 10.1113/jphysiol.2006.114074; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	79	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21792	10.1371/journal.pone.0021792	http://dx.doi.org/10.1371/journal.pone.0021792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750731	Green Submitted, Green Published, gold			2022-12-25	WOS:000292512000023
J	Liu, Y; Mayo, MW; Nagji, AS; Smith, PW; Ramsey, CS; Li, D; Jones, DR				Liu, Y.; Mayo, M. W.; Nagji, A. S.; Smith, P. W.; Ramsey, C. S.; Li, D.; Jones, D. R.			Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1	ONCOGENE			English	Article						DNMT-1; phosphorylation; RelA/p65; TNF; transcription	NF-KAPPA-B; CELL LUNG-CANCER; BREAST-CANCER; INDUCED APOPTOSIS; METHYLTRANSFERASE RECRUITMENT; DNA METHYLTRANSFERASES; TARGET PROMOTERS; DOWN-REGULATION; EXPRESSION; ACTIVATION	The majority of patients with lung cancer present with metastatic disease. Chronic inflammation and subsequent activation of nuclear factor-kappa B (NF-kappa B) have been associated with the development of cancers. The RelA/p65 subunit of NF-kappa B is typically associated with transcriptional activation. In this report we show that RelA/p65 can function as an active transcriptional repressor through enhanced methylation of the BRMS1 (breast cancer metastasis suppressor 1) metastasis suppressor gene promoter via direct recruitment of DNMT-1 (DNA (cytosine-5)-methyltransferase 1) to chromatin in response to tumor necrosis factor (TNF). TNF-mediated phosphorylation of S276 on RelA/p65 is required for RelA/p65-DNMT-1 interactions, chromatin loading of DNMT-1 and subsequent BRMS1 promoter methylation and transcriptional repression. The ability of RelA/p65 to function as an active transcriptional repressor is promoter specific, as the NF-kappa B-regulated gene cIAP2 (cellular inhibitor of apoptosis 2) is transcriptionally activated whereas BRMS1 is repressed under identical conditions. Small-molecule inhibition of either of the minimal interacting domains between RelA/p65-DNMT-1 and RelA/p65-BRMS1 promoter abrogates BRMS1 methylation and its transcriptional repression. The ability of RelA/p65 to directly recruit DNMT-1 to chromatin, resulting in promoter-specific methylation and transcriptional repression of tumor metastasis suppressor gene BRMS1, highlights a new mechanism through which NF-kappa B can regulate metastatic disease, and offers a potential target for newer-generation epigenetic oncopharmaceuticals. Oncogene (2012) 31, 1143-1154; doi:10.1038/onc.2011.308; published online 18 July 2011	[Liu, Y.; Nagji, A. S.; Smith, P. W.; Jones, D. R.] Univ Virginia, Dept Surg, Charlottesville, VA 22908 USA; [Mayo, M. W.; Ramsey, C. S.; Li, D.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Jones, DR (corresponding author), Univ Virginia, Dept Surg, Box 800679, Charlottesville, VA 22908 USA.	djones@virginia.edu	Smith, Philip/P-7736-2019	Smith, Philip/0000-0003-3441-1062; Jones, David/0000-0002-3318-0146	 [R01 CA136705];  [R01 CA104397];  [R01 CA132580]; NATIONAL CANCER INSTITUTE [R01CA136705, R01CA104397, R01CA132580] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R01 CA136705 (to DRJ), R01 CA104397 (to MWM) and R01 CA132580 (to MWM). In addition, this project was supported in part by a gift provided to the University of Virginia by Philip Morris USA. The review and approval process was overseen by an independent National External Advisory Board without any affiliation with the University, Philip Morris USA or any other tobacco company.	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bobrovnikova-Marjon EV, 2004, CANCER RES, V64, P4858, DOI 10.1158/0008-5472.CAN-04-0682; BOURS V, 1994, BIOCHEM PHARMACOL, V47, P145, DOI 10.1016/0006-2952(94)90448-0; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Ceribelli M, 2008, MOL CELL BIOL, V28, P2047, DOI 10.1128/MCB.01861-07; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chen YQ, 2000, STRUCT FOLD DES, V8, P419, DOI 10.1016/S0969-2126(00)00123-4; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Denlinger Chadrick E, 2004, Semin Thorac Cardiovasc Surg, V16, P28, DOI 10.1053/j.semtcvs.2003.12.004; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Dong J, 2008, GENE DEV, V22, P1159, DOI 10.1101/gad.1657408; Greten FR, 2004, CANCER LETT, V206, P193, DOI 10.1016/j.canlet.2003.08.029; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Hicks DG, 2006, CLIN CANCER RES, V12, P6702, DOI 10.1158/1078-0432.CCR-06-0635; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Hodge DR, 2005, CANCER RES, V65, P6255, DOI 10.1158/0008-5472.CAN-04-4482; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Jones DR, 2000, ANN THORAC SURG, V70, P930, DOI 10.1016/S0003-4975(00)01635-0; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kim S, 2004, J BIOL CHEM, V279, P4285, DOI 10.1074/jbc.M308383200; Kouba DJ, 1999, J IMMUNOL, V162, P4226; Liu Y, 2006, MOL CELL BIOL, V26, P8683, DOI 10.1128/MCB.00940-06; Liu Y, 2006, J BIOL CHEM, V281, P31359, DOI 10.1074/jbc.M604478200; Mayo MW, 2000, BBA-REV CANCER, V1470, pM55, DOI 10.1016/S0304-419X(00)00002-0; Meehan WJ, 2003, CLIN EXP METASTAS, V20, P45, DOI 10.1023/A:1022542519586; Mottet D, 2009, ONCOGENE, V28, P243, DOI 10.1038/onc.2008.371; Nagji AS, 2010, J PATHOL, V221, P229, DOI 10.1002/path.2707; NEUMANN M, 1995, EMBO J, V14, P1991, DOI 10.1002/j.1460-2075.1995.tb07191.x; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Puto LA, 2008, GENE DEV, V22, P998, DOI 10.1101/gad.1632208; Romano A, 2010, MOL CELL ENDOCRINOL, V314, P90, DOI 10.1016/j.mce.2009.08.008; Sankpal NV, 2009, CANCER RES, V69, P753, DOI 10.1158/0008-5472.CAN-08-2708; Schwarze SR, 2000, TRENDS PHARMACOL SCI, V21, P45, DOI 10.1016/S0165-6147(99)01429-7; Shaw J, 2006, CIRC RES, V99, P1347, DOI 10.1161/01.RES.0000251744.06138.50; Smith PW, 2009, CANCER LETT, V276, P196, DOI 10.1016/j.canlet.2008.11.024; Snyder M, 2010, J BIOL CHEM, V285, P23639, DOI 10.1074/jbc.M110.101063; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takada Y, 2005, ONCOGENE, V24, P6957, DOI 10.1038/sj.onc.1208845; Ushijima T, 2005, CANCER SCI, V96, P206, DOI 10.1111/j.1349-7006.2005.00035.x; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wehbe H, 2006, CANCER RES, V66, P10517, DOI 10.1158/0008-5472.CAN-06-2130; Xia DR, 2007, J BIOL CHEM, V282, P3507, DOI 10.1074/jbc.M610141200; Zhang Q, 2005, P NATL ACAD SCI USA, V102, P6948, DOI 10.1073/pnas.0501959102; Zhang ZH, 2006, CLIN CANCER RES, V12, P6410, DOI 10.1158/1078-0432.CCR-06-1347; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	54	57	58	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	9					1143	1154		10.1038/onc.2011.308	http://dx.doi.org/10.1038/onc.2011.308			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	901EW	21765477	Green Accepted			2022-12-25	WOS:000300945900007
J	Arpaia, E; Blaser, H; Quintela-Fandino, M; Duncan, G; Leong, HS; Ablack, A; Nambiar, SC; Lind, EF; Silvester, J; Fleming, CK; Rufini, A; Tusche, MW; Brustle, A; Ohashi, PS; Lewis, JD; Mak, TW				Arpaia, E.; Blaser, H.; Quintela-Fandino, M.; Duncan, G.; Leong, H. S.; Ablack, A.; Nambiar, S. C.; Lind, E. F.; Silvester, J.; Fleming, C. K.; Rufini, A.; Tusche, M. W.; Bruestle, A.; Ohashi, P. S.; Lewis, J. D.; Mak, T. W.			The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk	ONCOGENE			English	Article						Rho-GTPase; caveolin-1; alpha5-integrin; Src; cancer; intravital microscopy	CELL-MIGRATION; IN-VIVO; PROSTATE-CANCER; ACTIN CYTOSKELETON; SIGNALING PATHWAY; TUMOR PROGRESSION; INTEGRIN ALPHA-5; CARCINOMA-CELLS; MELANOMA-CELLS; KINASE	Proteins containing a caveolin-binding domain (CBD), such as the Rho-GTPases, can interact with caveolin-1 (Cav1) through its caveolin scaffold domain. Rho-GTPases are important regulators of p130(Cas), which is crucial for both normal cell migration and Src kinase-mediated metastasis of cancer cells. However, although Rho-GTPases (particularly RhoC) and Cav1 have been linked to cancer progression and metastasis, the underlying molecular mechanisms are largely unknown. To investigate the function of Cav1-Rho-GTPase interaction in metastasis, we disrupted Cav1-Rho-GTPase binding in melanoma and mammary epithelial tumor cells by overexpressing CBD, and examined the loss-of-function of RhoC in metastatic cancer cells. Cancer cells overexpressing CBD or lacking RhoC had reduced p130(Cas) phosphorylation and Rac1 activation, resulting in an inhibition of migration and invasion in vitro. The activity of Src and the activation of its downstream targets FAK, Pyk2, Ras and extracellular signal-regulated kinase (Erk) 1/2 were also impaired. A reduction in alpha 5-integrin expression, which is required for binding to fibronectin and thus cell migration and survival, was observed in CBD-expressing cells and cells lacking RhoC. As a result of these defects, CBD-expressing melanoma cells had a reduced ability to metastasize in recipient mice, and impaired extravasation and survival in secondary sites in chicken embryos. Our data indicate that interaction between Cav1 and Rho-GTPases (most likely RhoC but not RhoA) promotes metastasis by stimulating alpha 5-integrin expression and regulating the Src-dependent activation of p130(Cas)/Rac1, FAK/Pyk2 and Ras/Erk1/2 signaling cascades. Oncogene (2012) 31, 884-896; doi: 10.1038/onc.2011.288; published online 18 July 2011	[Arpaia, E.; Blaser, H.; Quintela-Fandino, M.; Duncan, G.; Lind, E. F.; Silvester, J.; Fleming, C. K.; Rufini, A.; Tusche, M. W.; Bruestle, A.; Ohashi, P. S.; Mak, T. W.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2M9, Canada; [Arpaia, E.; Ohashi, P. S.; Mak, T. W.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Arpaia, E.; Ohashi, P. S.; Mak, T. W.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Quintela-Fandino, M.] Spain Spanish Natl Canc Ctr CNIO, Clin Invest Unit, Breast Canc Grp, Madrid, Spain; [Leong, H. S.; Ablack, A.; Nambiar, S. C.; Lewis, J. D.] London Reg Canc Program, Translat Prostate Canc Res Grp, London, England; [Rufini, A.] Univ Leicester, Lab Apoptosis Canc, MRC, Toxicol Unit, Lancaster, England	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Leicester	Mak, TW (corresponding author), Univ Hlth Network, Campbell Family Inst Breast Canc Res, 620 Univ Ave,Suite 706, Toronto, ON M5G 2M9, Canada.	tmak@uhnresearch.ca		quintela-fandino, miguel/0000-0003-1648-1964; Silvester, Jennifer/0000-0001-6087-4066; Leong, Hon/0000-0001-7801-1402; Ohashi, Pamela S./0000-0003-2915-9317; Lind, Evan/0000-0001-7026-2012	Canadian Institutes of Health Research [179815]; National Cancer Institute of Canada/Terry Fox Foundation [18176]; Canadian Breast Cancer Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada/Terry Fox Foundation; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	We thank Dr Marc Pellegrini for helpful discussions and Dr Mary Saunders for insightful scientific editing. This work was supported by Grant # 179815 from the Canadian Institutes of Health Research to TWM, and Grant # 18176 from the National Cancer Institute of Canada/Terry Fox Foundation to JDL. HSL is funded by a Canadian Breast Cancer Foundation Post-Doctoral fellowship.	Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Campbell L, 2008, BRIT J CANCER, V98, P931, DOI 10.1038/sj.bjc.6604243; Capozza F, 2003, AM J PATHOL, V162, P2029, DOI 10.1016/S0002-9440(10)64335-0; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Cokakli M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-65; Couet J, 2001, ADV DRUG DELIVER REV, V49, P223, DOI 10.1016/S0169-409X(01)00139-9; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Dent P, 1999, MOL BIOL CELL, V10, P2493, DOI 10.1091/mbc.10.8.2493; Fecchi K, 2012, INT J CANCER, V130, P1273, DOI 10.1002/ijc.26092; Felicetti F, 2009, INT J CANCER, V125, P1514, DOI 10.1002/ijc.24451; Fincham VJ, 1996, J CELL BIOL, V135, P1551, DOI 10.1083/jcb.135.6.1551; GARDNER AM, 1993, J BIOL CHEM, V268, P17896; Giehl K, 2005, BIOL CHEM, V386, P193, DOI 10.1515/BC.2005.025; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Haenssen KK, 2010, J CELL SCI, V123, P1373, DOI 10.1242/jcs.050906; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ho CC, 2002, AM J PATHOL, V161, P1647, DOI 10.1016/S0002-9440(10)64442-2; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Jaffe AB, 2002, ADV CANCER RES, V84, P57, DOI 10.1016/S0065-230X(02)84003-9; Keely P, 1998, TRENDS CELL BIOL, V8, P101, DOI 10.1016/S0962-8924(97)01219-1; Kidera Yasuhiro, 2010, J Exp Clin Cancer Res, V29, P127, DOI 10.1186/1756-9966-29-127; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Krueger JS, 2001, ONCOGENE, V20, P4209, DOI 10.1038/sj.onc.1204541; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Li LK, 2001, CANCER RES, V61, P4386; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim ST, 2010, J BIOL CHEM, V285, P1743, DOI 10.1074/jbc.M109.064212; Lin M, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-21; Marti A, 1997, J BIOL CHEM, V272, P2620, DOI 10.1074/jbc.272.5.2620; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Meenderink LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013412; Mierke CT, 2011, J CELL SCI, V124, P369, DOI 10.1242/jcs.071985; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Nam JM, 2010, CANCER RES, V70, P5238, DOI 10.1158/0008-5472.CAN-09-2319; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; NATALI PG, 1995, BRIT J CANCER, V71, P1243, DOI 10.1038/bjc.1995.240; OBrien V, 1996, EXP CELL RES, V224, P208, DOI 10.1006/excr.1996.0130; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Qian F, 2005, BIOCHEM BIOPH RES CO, V333, P1269, DOI 10.1016/j.bbrc.2005.06.039; Quest AFG, 2008, J CELL MOL MED, V12, P1130, DOI 10.1111/j.1582-4934.2008.00331.x; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Sharma A, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-50; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Thompson TC, 1999, APOPTOSIS, V4, P233, DOI 10.1023/A:1009612708099; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Torii S, 2006, CANCER SCI, V97, P697, DOI 10.1111/j.1349-7006.2006.00244.x; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Williams TM, 2005, J BIOL CHEM, V280, P25134, DOI 10.1074/jbc.M501186200; Williams TM, 2003, MOL BIOL CELL, V14, P1027, DOI 10.1091/mbc.E02-08-0503; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Wu L, 2008, ONCOGENE, V27, P1439, DOI 10.1038/sj.onc.1210770; Yamamoto T, 1999, J BIOCHEM-TOKYO, V126, P799, DOI 10.1093/oxfordjournals.jbchem.a022519; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yip SC, 2007, J CELL SCI, V120, P3138, DOI 10.1242/jcs.005298; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X; Zijlstra A, 2002, CANCER RES, V62, P7083; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	68	85	88	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2012	31	7					884	896		10.1038/onc.2011.288	http://dx.doi.org/10.1038/onc.2011.288			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	897BL	21765460	Green Published, hybrid			2022-12-25	WOS:000300615800007
J	Ma, W; Lin, Y; Xuan, W; Iversen, PL; Smith, LJ; Benchimol, S				Ma, W.; Lin, Y.; Xuan, W.; Iversen, P. L.; Smith, L. J.; Benchimol, S.			Inhibition of p53 expression by peptide-conjugated phosphorodiamidate morpholino oligomers sensitizes human cancer cells to chemotherapeutic drugs	ONCOGENE			English	Article						p53 tumor suppressor protein; morpholino antisense oligomers; chemosensitivity	LI-FRAUMENI-SYNDROME; WILD-TYPE P53; MUTANT P53; MONOCLONAL-ANTIBODIES; PENETRATING PEPTIDES; ANTICANCER AGENTS; BREAST-CANCER; APOPTOSIS; ISOFORMS; DOMAIN	The p53 tumor suppressor gene encodes a transcription factor that is commonly mutated in cancer. Tumors arise when premalignant cells are unable to undergo p53-dependent apoptosis, cell cycle arrest or DNA repair. The p53-signaling pathway affects not only tumor development, but also the response of tumors to chemotherapeutic drugs. In this study, we use cell penetrating peptide conjugates of phosphorodiamidate morpholino oligomers (PPMOs) to inhibit p53 expression. We examine the functional properties of endogenous p53 isoforms that are produced upon PPMO-mediated inhibition of p53 translation and splicing, and report that loss of N-terminal or C-terminal sequences interferes with the transcriptional activity of p53. Importantly, we report that PPMO-mediated inhibition of p53 expression sensitizes human cancer cells with wild-type p53 to chemotherapeutic drugs. Oncogene (2012) 31, 1024-1033; doi:10.1038/onc.2011.300; published online 18 July 2011	[Ma, W.; Lin, Y.; Xuan, W.; Benchimol, S.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [Iversen, P. L.] AVI BioPharma Inc, Corvallis, OR USA; [Smith, L. J.] Eleos Inc, Omaha, NE USA	York University - Canada	Benchimol, S (corresponding author), York Univ, Dept Biol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	benchimo@yorku.ca	Iversen, Patrick L/D-8854-2019; Iversen, Patrick L./L-5454-2019	Iversen, Patrick L/0000-0003-0106-9790; Iversen, Patrick L./0000-0003-0106-9790; Benchimol, Samuel/0000-0003-3433-890X	Eleos Inc; Canada Research Chair	Eleos Inc; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by a grant from Eleos Inc to SB. SB is supported by a Canada Research Chair.	Abes R, 2008, J PEPT SCI, V14, P455, DOI 10.1002/psc.979; Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; BANKS L, 1986, EUR J BIOCHEM, V159, P529, DOI 10.1111/j.1432-1033.1986.tb09919.x; Bertheau P, 2008, PATHOBIOLOGY, V75, P132, DOI 10.1159/000123851; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; Fei PW, 2002, CANCER RES, V62, P7316; Flaman JM, 1996, ONCOGENE, V12, P813; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Ghosh A, 2004, MOL CELL BIOL, V24, P7987, DOI 10.1128/MCB.24.18.7987-7997.2004; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; Harms KL, 2006, CELL DEATH DIFFER, V13, P890, DOI 10.1038/sj.cdd.4401904; HORIKAWA I, 1995, HUM MOL GENET, V4, P313, DOI 10.1093/hmg/4.2.313; Iversen PL, 2001, CURR OPIN MOL THER, V3, P235; Kim E, 2009, BIOCHEM PHARMACOL, V77, P11, DOI 10.1016/j.bcp.2008.08.030; Koonin EV, 2005, CELL CYCLE, V4, P686, DOI 10.4161/cc.4.5.1691; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; McGill G, 1999, J CLIN INVEST, V104, P223, DOI 10.1172/JCI7861; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Nelson MH, 2005, BIOCONJUGATE CHEM, V16, P959, DOI 10.1021/bc0501045; OConnor PM, 1997, CANCER RES, V57, P4285; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; ROVINSKI B, 1987, MOL CELL BIOL, V7, P847, DOI 10.1128/MCB.7.2.847; Stambolsky P, 2010, CANCER CELL, V17, P273, DOI 10.1016/j.ccr.2009.11.025; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WANG C, 1989, LEUKEMIA, V3, P699; Wu RP, 2007, NUCLEIC ACIDS RES, V35, P5182, DOI 10.1093/nar/gkm478; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801; Zhu JH, 1998, J BIOL CHEM, V273, P13030, DOI 10.1074/jbc.273.21.13030	41	11	11	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	8					1024	1033		10.1038/onc.2011.300	http://dx.doi.org/10.1038/onc.2011.300			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	898BG	21765469				2022-12-25	WOS:000300709700008
J	Tann, AW; Boldogh, I; Meiss, G; Qian, W; Van Houten, B; Mitra, S; Szczesny, B				Tann, Anne W.; Boldogh, Istvan; Meiss, Gregor; Qian, Wei; Van Houten, Bennett; Mitra, Sankar; Szczesny, Bartosz			Apoptosis Induced by Persistent Single-strand Breaks in Mitochondrial Genome CRITICAL ROLE OF EXOG (5 '-EXO/ENDONUCLEASE) IN THEIR REPAIR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; DNA-POLYMERASE-GAMMA; ENDONUCLEASE-G; HUMAN-CELLS; ENZYMATIC-PROPERTIES; MAMMALIAN-CELLS; DAMAGE RESPONSE; FREE-RADICALS; CANCER CELLS; COPY NUMBER	Reactive oxygen species (ROS), continuously generated as by-products of respiration, inflict more damage on the mitochondrial (mt) than on the nuclear genome because of the nonchromatinized nature and proximity to the ROS source of the mitochondrial genome. Such damage, particularly single-strand breaks (SSBs) with 5'-blocking deoxyribose products generated directly or as repair intermediates for oxidized bases, is repaired via the base excision/SSB repair pathway in both nuclear and mt genomes. Here, we show that EXOG, a 5'-exo/endonuclease and unique to the mitochondria unlike FEN1 or DNA2, which, like EXOG, has been implicated in the removal of the 5'-blocking residue, is required for repairing endogenous SSBs in the mt genome. EXOG depletion induces persistent SSBs in the mtDNA, enhances ROS levels, and causes apoptosis in normal cells but not in mt genome-deficient rho0 cells. Thus, these data show for the first time that persistent SSBs in the mt genome alone could provide the initial trigger for apoptotic signaling in mammalian cells.	[Szczesny, Bartosz] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Meiss, Gregor] Univ Giessen, Fac Biol & Chem, Inst Biochem, D-35392 Giessen, Germany; [Qian, Wei; Van Houten, Bennett] Univ Pittsburgh, Inst Canc, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Justus Liebig University Giessen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Szczesny, B (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	baszczes@utmb.edu	Van Houten, Bennett/K-2284-2019; Qian, Wei/B-8231-2013		National Institutes of Health [P01 AG10514, R01 CA53791, P01 AG021830]; USPHS; Pennsylvania CURE; Dr.-Herbert-Stolzenberg-Stiftung of the Justus-Liebig-University Giessen;  [T32 ES07254];  [5F30 ES017207-02]; NATIONAL CANCER INSTITUTE [R01CA053791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019566, R01ES018948, T32ES007254, F30ES017207, P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG021830, P01AG010514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Pennsylvania CURE; Dr.-Herbert-Stolzenberg-Stiftung of the Justus-Liebig-University Giessen; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AG10514 and R01 CA53791 (to S. M.) and P01 AG021830 (to I. B.) from USPHS and Training Grants T32 ES07254 and 5F30 ES017207-02 (to A. W. T.). This work was also supported by Pennsylvania CURE (to B. V. H.) and the Dr.-Herbert-Stolzenberg-Stiftung of the Justus-Liebig-University Giessen (to G. M.).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Akbari M, 2008, DNA REPAIR, V7, P605, DOI 10.1016/j.dnarep.2008.01.002; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; Arai T, 2006, TOXICOLOGY, V221, P179, DOI 10.1016/j.tox.2006.01.004; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fortini P, 2007, DNA REPAIR, V6, P398, DOI 10.1016/j.dnarep.2006.10.008; Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Huang KJ, 2006, P NATL ACAD SCI USA, V103, P8995, DOI 10.1073/pnas.0603445103; Izumi T, 1998, CARCINOGENESIS, V19, P525, DOI 10.1093/carcin/19.3.525; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jang YC, 2009, EXP GERONTOL, V44, P256, DOI 10.1016/j.exger.2008.12.006; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kieper J, 2010, PROTEIN EXPRES PURIF, V73, P99, DOI 10.1016/j.pep.2010.04.001; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Koczor CA, 2009, J BIOL CHEM, V284, P36191, DOI 10.1074/jbc.M109.036020; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Lizard G, 1997, ANN PATHOL, V17, P61; Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244; Marchetti P, 1996, CANCER RES, V56, P2033; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Meyer JN, 2010, ECOTOXICOLOGY, V19, P804, DOI 10.1007/s10646-009-0457-4; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Panduri V, 2004, AM J PHYSIOL-LUNG C, V286, pL1220, DOI 10.1152/ajplung.00371.2003; Patel VA, 2006, J BIOL CHEM, V281, P4663, DOI 10.1074/jbc.M508342200; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Pinz KG, 1998, MOL CELL BIOL, V18, P1257, DOI 10.1128/MCB.18.3.1257; Puebla-Osorio N, 2006, MOL CELL BIOL, V26, P3935, DOI 10.1128/MCB.26.10.3935-3941.2006; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Staniek K, 2000, BBA-BIOENERGETICS, V1460, P268, DOI 10.1016/S0005-2728(00)00152-3; Stierum RH, 1999, NUCLEIC ACIDS RES, V27, P3712, DOI 10.1093/nar/27.18.3712; Stuart JA, 2004, NUCLEIC ACIDS RES, V32, P2181, DOI 10.1093/nar/gkh533; Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200; Szczesny B, 2010, MECH AGEING DEV, V131, P330, DOI 10.1016/j.mad.2010.03.009; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Takao M, 2002, EMBO J, V21, P3486, DOI 10.1093/emboj/cdf350; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; Wallace SS, 2002, FREE RADICAL BIO MED, V33, P1, DOI 10.1016/S0891-5849(02)00827-4; Yang XH, 2005, INT J ONCOL, V26, P1675; Yang XH, 2001, CANCER RES, V61, P348; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024	73	110	113	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					31975	31983		10.1074/jbc.M110.215715	http://dx.doi.org/10.1074/jbc.M110.215715			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21768646	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000294726800006
J	Villani, G; Hubscher, U; Gironis, N; Parkkinen, S; Pospiech, H; Shevelev, I; di Cicco, G; Markkanen, E; Syvaaja, JE; Le Gac, NT				Villani, Giuseppe; Hubscher, Ulrich; Gironis, Nadege; Parkkinen, Sinikka; Pospiech, Helmut; Shevelev, Igor; di Cicco, Giulia; Markkanen, Enni; Syvaoja, Juhani E.; Le Gac, Nicolas Tanguy			In Vitro Gap-directed Translesion DNA Synthesis of an Abasic Site Involving Human DNA Polymerases epsilon, lambda, and beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; NUCLEOTIDE EXCISION-REPAIR; REPLICATION PROTEIN-A; DAMAGE TOLERANCE; HELA-CELLS; DELTA; MECHANISMS; LESIONS; STRAND; FORK	DNA polymerase (pol) epsilon is thought to be the leading strand replicase in eukaryotes, whereas pols lambda and beta are believed to be mainly involved in re-synthesis steps of DNA repair. DNA elongation by the human pol epsilon is halted by an abasic site (apurinic/apyrimidinic (AP) site). In this study, we present in vitro evidence that human pols lambda, beta, and eta can perform translesion synthesis (TLS) of an AP site in the presence of pol epsilon, likely by initiating the 3'OHs created at the lesion by the arrested pol epsilon. However, in the case of pols lambda and beta, this TLS requires the presence of a DNA gap downstream from the product synthesized by the pol epsilon, and the optimal gap for efficient TLS is different for the two polymerases. The presence of gaps did not affect the TLS capacity of human pol eta. Characterization of the reaction products showed that pol beta inserted dAMP opposite the AP site, whereas gap filling synthesis by pol lambda resulted in single or double deletions opposite the lesion. The synthesis up to the AP site by pol epsilon and the subsequent TLS by pols lambda and beta are not influenced by human processivity factor proliferating cell nuclear antigen and human single-stranded DNA-binding protein replication protein A. The bypass capacity of pol lambda at the AP site is greatly reduced when a truncated form of the enzyme, which has lost the BRCA1 C-terminal and proline-rich domains, is used. Collectively, our in vitro results support the existence of a mechanism of gap-directed TLS at an AP site involving a switch between the replicative pol epsilon and the repair pols lambda and beta.	[Villani, Giuseppe; Gironis, Nadege; di Cicco, Giulia; Le Gac, Nicolas Tanguy] Univ Toulouse 3, CNRS, Inst Pharmacol & Biol Struct, UMR 5089, F-31077 Toulouse, France; [Pospiech, Helmut] Fritz Lipman Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Pospiech, Helmut] Univ Oulu, Dept Biochem, FI-90014 Oulu, Finland; [Hubscher, Ulrich; Markkanen, Enni] Univ Zurich Irchel, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland; [Parkkinen, Sinikka; Syvaoja, Juhani E.] Univ Eastern Finland, Dept Biol, FI-80101 Joensuu, Finland; [Shevelev, Igor] Acad Sci Czech Republic, Inst Mol Genet, CR-14220 Prague, Czech Republic	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Finland National Institute for Health & Welfare; University of Oulu; University of Zurich; University of Eastern Finland; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Le Gac, NT (corresponding author), Univ Toulouse 3, CNRS, Inst Pharmacol & Biol Struct, UMR 5089, 205 Route Narbonne, F-31077 Toulouse, France.	ntlg@ipbs.fr	Markkanen, Enni/V-9784-2017; Pospiech, Helmut/J-8598-2015	Markkanen, Enni/0000-0001-7780-8233; 	Electricite de France; Academy of Finland [106986, 123082]; University of Zurich; Swiss National Science Foundation	Electricite de France; Academy of Finland(Academy of Finland); University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported in part by a grant from Electricite de France (to G. V.) and by Grants 106986 (to H. P.) and 123082 (to J. E. S.) from the Academy of Finland.; Supported by the University of Zurich and the Swiss National Science Foundation.	Araujo SJ, 2000, GENE DEV, V14, P349; Asturias FJ, 2006, NAT STRUCT MOL BIOL, V13, P35, DOI 10.1038/nsmb1040; Bebenek K, 2008, EMBO REP, V9, P459, DOI 10.1038/embor.2008.33; Blanca G, 2004, BIOCHEMISTRY-US, V43, P11605, DOI 10.1021/bi049050x; Blanca G, 2003, BIOCHEMISTRY-US, V42, P7467, DOI 10.1021/bi034198m; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Brown JA, 2011, DNA REPAIR, V10, P24, DOI 10.1016/j.dnarep.2010.09.005; Chilkova O, 2007, NUCLEIC ACIDS RES, V35, P6588, DOI 10.1093/nar/gkm741; Choi JY, 2010, J MOL BIOL, V404, P34, DOI 10.1016/j.jmb.2010.09.015; Daube SS, 2000, BIOCHEMISTRY-US, V39, P348, DOI 10.1021/bi9917784; Dianov GL, 2003, MUTAT RES-FUND MOL M, V531, P157, DOI 10.1016/j.mrfmmm.2003.09.003; Efrati E, 1997, J BIOL CHEM, V272, P2559; Fiala KA, 2006, J BIOL CHEM, V281, P19038, DOI 10.1074/jbc.M601178200; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Garcia-Diaz M, 2005, DNA REPAIR, V4, P1358, DOI 10.1016/j.dnarep.2005.09.001; Garcia-Diaz M, 2002, J BIOL CHEM, V277, P13184, DOI 10.1074/jbc.M111601200; Garcia-Diaz M, 2009, NAT STRUCT MOL BIOL, V16, P967, DOI 10.1038/nsmb.1654; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hubscher U., 2010, DNA POLYM DISCOVERY; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; Kanuri M, 2002, J BIOL CHEM, V277, P18257, DOI 10.1074/jbc.M112419200; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kornberg A., 1992, DNA REPLICATION; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; LEE SH, 1991, J BIOL CHEM, V266, P22707; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Locatelli GA, 2010, BIOCHEM J, V429, P573, DOI 10.1042/BJ20100405; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Maga G, 2002, J BIOL CHEM, V277, P48434, DOI 10.1074/jbc.M206889200; Mozzherin DJ, 1997, P NATL ACAD SCI USA, V94, P6126, DOI 10.1073/pnas.94.12.6126; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Sabouri N, 2009, J BIOL CHEM, V284, P31555, DOI 10.1074/jbc.M109.043927; Sage E, 2011, MUTAT RES-FUND MOL M, V711, P123, DOI 10.1016/j.mrfmmm.2010.12.010; Seki M, 2004, EMBO J, V23, P4484, DOI 10.1038/sj.emboj.7600424; Sherrer SM, 2011, NUCLEIC ACIDS RES, V39, P609, DOI 10.1093/nar/gkq719; Shevelev I, 2003, NUCLEIC ACIDS RES, V31, P6916, DOI 10.1093/nar/gkg896; Shibutani S, 1997, J BIOL CHEM, V272, P13916, DOI 10.1074/jbc.272.21.13916; SHIVJI MKK, 1995, BIOCHEMISTRY-US, V34, P5011, DOI 10.1021/bi00015a012; Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001; SYVAOJA J, 1989, J BIOL CHEM, V264, P2489; SYVAOJA J, 1990, P NATL ACAD SCI USA, V87, P6664, DOI 10.1073/pnas.87.17.6664; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08	44	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32094	32104		10.1074/jbc.M111.246611	http://dx.doi.org/10.1074/jbc.M111.246611			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21757740	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000294726800019
J	Ding, YF; Winters, A; Ding, M; Graham, S; Akopova, I; Muallem, S; Wang, YX; Hong, JH; Gryczynski, Z; Yang, SH; Birnbaumer, L; Ma, R				Ding, Yanfeng; Winters, Ali; Ding, Min; Graham, Sarabeth; Akopova, Irina; Muallem, Shmuel; Wang, Yanxia; Hong, Jeong Hee; Gryczynski, Zygmunt; Yang, Shao-Hua; Birnbaumer, Lutz; Ma, Rong			Reactive Oxygen Species-mediated TRPC6 Protein Activation in Vascular Myocytes, a Mechanism for Vasoconstrictor-regulated Vascular Tone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR MESANGIAL CELLS; SMOOTH-MUSCLE-CELLS; HYDROGEN-PEROXIDE; CATION CHANNEL; NAD(P)H OXIDASE; RECEPTOR; STIMULATION; EXPRESSION; MODULATION; PATHWAYS	Both TRPC6 and reactive oxygen species (ROS) play an important role in regulating vascular function. However, their interplay has not been explored. The present study examined whether activation of TRPC6 in vascular smooth muscle cells (VSMCs) by ROS was a physiological mechanism for regulating vascular tone by vasoconstrictors. In A7r5 cells, arginine vasopressin (AVP) evoked a striking Ca2+ entry response that was significantly attenuated by either knocking down TRPC6 using siRNA or inhibition of NADPH oxidases with apocynin or diphenyleneiodonium. Inhibition of TRPC6 or ROS production also decreased AVP-stimulated membrane currents. In primary cultured aortic VSMCs, catalase and diphenyleneiodonium significantly suppressed AVP- and angiotensin II-induced whole cell currents and Ca2+ entry, respectively. In freshly isolated and endothelium-denuded thoracic aortas, hyperforin (an activator of TRPC6), but not its vehicle, induced dose- and time-dependent constriction in TRPC6 wide type (WT) mice. This response was not observed in TRPC6 knock-out (KO) mice. Consistent with the ex vivo study, hyperforin stimulated a robust Ca2+ entry in the aortic VSMCs from WT mice but not from KO mice. Phenylephrine induced a dose-dependent contraction of WT aortic segments, and this response was inhibited by catalase. Moreover, H2O2 itself evoked Ca2+ influx and inward currents in A7r5 cells, and these responses were significantly attenuated by either inhibition of TRPC6 or blocking vesicle trafficking. H2O2 also induced inward currents in primary VSMCs from WT but not from TRPC6 KO mice. Additionally, H2O2 stimulated a dose-dependent constriction of the aortas from WT mice but not from the vessels of KO mice. Furthermore, TIRFM showed that H2O2 triggered membrane trafficking of TRPC6 in A7r5 cells. These results suggest a new signaling pathway of ROS-TRPC6 in controlling vessel contraction by vasoconstrictors.	[Ding, Yanfeng; Winters, Ali; Ding, Min; Graham, Sarabeth; Wang, Yanxia; Ma, Rong] Univ N Texas, Hlth Sci Ctr, Dept Integrat Physiol, Ft Worth, TX 76107 USA; [Ding, Yanfeng; Winters, Ali; Ding, Min; Graham, Sarabeth; Wang, Yanxia; Ma, Rong] Univ N Texas, Hlth Sci Ctr, Cardiovasc Res Inst, Ft Worth, TX 76107 USA; [Akopova, Irina; Gryczynski, Zygmunt] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA; [Yang, Shao-Hua] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA; [Muallem, Shmuel; Hong, Jeong Hee] NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA; [Birnbaumer, Lutz] NIH, Transmembrane Signaling Grp, Res Triangle Pk, NC 27709 USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA	Ma, R (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Integrat Physiol, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	rong.ma@unthsc.edu	ma, rong/GVU-3096-2022; Yang, Shaohua/D-1738-2013		NIDDK [5 RO1 DK079968-01A2, 5R21CA149897-02]; American Heart Association South Central Affiliate [09GRNT2260926]; NATIONAL CANCER INSTITUTE [R21CA149897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101684] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association South Central Affiliate(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5 RO1 DK079968-01A2 from NIDDK (to R. M.) and 5R21CA149897-02 (to Z. G.). This work was also supported by Grant-in-aid 09GRNT2260926 from American Heart Association South Central Affiliate (to R. M.).	Ardanaz N, 2006, EXP BIOL MED, V231, P237; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Dietrich A, 2007, CELL CALCIUM, V42, P233, DOI 10.1016/j.ceca.2007.02.009; Du J, 2007, J AM SOC NEPHROL, V18, P1437, DOI 10.1681/ASN.2006091067; Dyachenko V, 2009, CELL CALCIUM, V45, P38, DOI 10.1016/j.ceca.2008.06.003; Estacion M, 2004, J BIOL CHEM, V279, P22047, DOI 10.1074/jbc.M402320200; FAVERO TG, 1995, J BIOL CHEM, V270, P25557, DOI 10.1074/jbc.270.43.25557; Graham S, 2007, AM J PHYSIOL-RENAL, V293, pF1381, DOI 10.1152/ajprenal.00185.2007; Graham S, 2010, J BIOL CHEM, V285, P23464, DOI 10.1074/jbc.M109.093500; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; GROVER AK, 1992, AM J PHYSIOL, V263, pH537, DOI 10.1152/ajpheart.1992.263.2.H537; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Horowitz A, 1996, PHYSIOL REV, V76, P967, DOI 10.1152/physrev.1996.76.4.967; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Inoue R, 2009, CIRC RES, V104, P1399, DOI 10.1161/CIRCRESAHA.108.193227; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Lassegue B, 2004, AM J HYPERTENS, V17, P852, DOI 10.1016/j.amjhyper.2004.02.004; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Leuner K, 2007, FASEB J, V21, P4101, DOI 10.1096/fj.07-8110com; Lyle AN, 2006, PHYSIOLOGY, V21, P269, DOI 10.1152/physiol.00004.2006; Mizuno N, 1999, MOL BRAIN RES, V64, P41, DOI 10.1016/S0169-328X(98)00296-4; Muller M, 2008, J BIOL CHEM, V283, P33942, DOI 10.1074/jbc.M801844200; Poburko D, 2007, CIRC RES, V101, P1030, DOI 10.1161/CIRCRESAHA.107.155531; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Saleh SN, 2006, J PHYSIOL-LONDON, V577, P479, DOI 10.1113/jphysiol.2006.119305; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Sours S, 2006, AM J PHYSIOL-RENAL, V290, pF1507, DOI 10.1152/ajprenal.00268.2005; Suzaki Y, 2002, J BIOL CHEM, V277, P9614, DOI 10.1074/jbc.M111790200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Welsh DG, 2002, CIRC RES, V90, P248, DOI 10.1161/hh0302.105662; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821	37	68	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31799	31809		10.1074/jbc.M111.248344	http://dx.doi.org/10.1074/jbc.M111.248344			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768109	Green Published, hybrid			2022-12-25	WOS:000294487500073
J	Soncin, F; Mohamet, L; Ritson, S; Hawkins, K; Bobola, N; Zeef, L; Merry, CLR; Ward, CM				Soncin, Francesca; Mohamet, Lisa; Ritson, Sarah; Hawkins, Kate; Bobola, Nicoletta; Zeef, Leo; Merry, Catherine L. R.; Ward, Christopher M.			E-Cadherin Acts as a Regulator of Transcripts Associated with a Wide Range of Cellular Processes in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							5T4 ONCOFETAL ANTIGEN; BETA-CATENIN; SIGNALING PATHWAYS; SELF-RENEWAL; PLURIPOTENCY; ADHESION; DIFFERENTIATION; ACTIVATION; GENE; WNT	Background: We have recently shown that expression of the cell adhesion molecule E-cadherin is required for LIF-dependent pluripotency of mouse embryonic stem (ES) cells. Methodology: In this study, we have assessed global transcript expression in E-cadherin null (Ecad-/-) ES cells cultured in either the presence or absence of LIF and compared these to the parental cell line wtD3. Results: We show that LIF has little effect on the transcript profile of Ecad-/- ES cells, with statistically significant transcript alterations observed only for Sp8 and Stat3. Comparison of Ecad-/- and wtD3 ES cells cultured in LIF demonstrated significant alterations in the transcript profile, with effects not only confined to cell adhesion and motility but also affecting, for example, primary metabolic processes, catabolism and genes associated with apoptosis. Ecad-/- ES cells share similar, although not identical, gene expression profiles to epiblast-derived pluripotent stem cells, suggesting that E-cadherin expression may inhibit inner cell mass to epiblast transition. We further show that Ecad-/- ES cells maintain a functional beta-catenin pool that is able to induce beta-catenin/TCF-mediated transactivation but, contrary to previous findings, do not display endogenous beta-catenin/TCF-mediated transactivation. We conclude that loss of E-cadherin in mouse ES cells leads to significant transcript alterations independently of beta-catenin/TCF transactivation.	[Soncin, Francesca; Mohamet, Lisa; Ritson, Sarah; Hawkins, Kate; Bobola, Nicoletta; Ward, Christopher M.] Univ Manchester, Fac Med & Human Sci, Core Technol Facil, Manchester, Lancs, England; [Soncin, Francesca; Merry, Catherine L. R.] Univ Manchester, Ctr Mat Sci, Manchester, Lancs, England; [Zeef, Leo] Univ Manchester, Fac Life Sci, Microarray Facil, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Soncin, F (corresponding author), Univ Manchester, Fac Med & Human Sci, Core Technol Facil, Manchester, Lancs, England.	christopher.ward@manchester.ac.uk	Soncin, Francesca/AAB-6143-2021; Mohamet, Lisa/K-3081-2015	Mohamet, Lisa/0000-0001-6336-8775; merry, catherine/0000-0002-3490-2809; Ward, Christopher/0000-0001-7389-4488	Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Royal Society; Association for International Cancer Research; University of Manchester; Biotechnology and Biological Sciences Research Council [BB/E017355/1, BB/E527239/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [TS/G000646/1] Funding Source: researchfish; BBSRC [BB/E017355/1, BB/E527239/1] Funding Source: UKRI; EPSRC [TS/G000646/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); Association for International Cancer Research; University of Manchester; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by grants from the Biotechnology and Biological Sciences Research Council, Engineering and Physical Sciences Research Council, Royal Society and Association for International Cancer Research. FS was funded by a University of Manchester PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Auernhammer CJ, 1999, P NATL ACAD SCI USA, V96, P6964, DOI 10.1073/pnas.96.12.6964; Bell SM, 2003, P NATL ACAD SCI USA, V100, P12195, DOI 10.1073/pnas.2134310100; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kan NG, 2007, DEVELOPMENT, V134, P31, DOI 10.1242/dev.02722; Kikuchi A, 2000, BIOCHEM BIOPH RES CO, V268, P243, DOI 10.1006/bbrc.1999.1860; Larue L, 1996, DEVELOPMENT, V122, P3185; McCrea PD, 2007, BBA-MOL CELL RES, V1773, P17, DOI 10.1016/j.bbamcr.2006.06.009; McLachlan RW, 2007, MOL BIOL CELL, V18, P3214, DOI 10.1091/mbc.E06-12-1154; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Mohamet L, 2011, J ONCOL, V2011, DOI 10.1155/2011/352616; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Orsulic S, 1999, J CELL SCI, V112, P1237; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Spencer HL, 2007, MOL BIOL CELL, V18, P2838, DOI 10.1091/mbc.E06-09-0875; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Treichel D, 2003, GENE DEV, V17, P2630, DOI 10.1101/gad.274103; Trouillas M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-73; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Leeuwen IMM, 2007, J THEOR BIOL, V247, P77, DOI 10.1016/j.jtbi.2007.01.019; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Ward CM, 2003, J CELL SCI, V116, P4533, DOI 10.1242/jcs.00767; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xie ZJ, 2007, J BIOL CHEM, V282, P8695, DOI 10.1074/jbc.M609135200; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	43	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21463	10.1371/journal.pone.0021463	http://dx.doi.org/10.1371/journal.pone.0021463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779327	Green Submitted, Green Published, gold			2022-12-25	WOS:000292811300010
J	Szendroedi, J; Schmid, AI; Chmelik, M; Krssak, M; Nowotny, P; Prikoszovich, T; Kautzky-Willer, A; Wolzt, M; Waldhausl, W; Roden, M				Szendroedi, Julia; Schmid, Albrecht Ingo; Chmelik, Marek; Krssak, Martin; Nowotny, Peter; Prikoszovich, Thomas; Kautzky-Willer, Alexandra; Wolzt, Michael; Waldhaeusl, Werner; Roden, Michael			Skeletal Muscle Phosphodiester Content Relates to Body Mass and Glycemic Control	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; INDUCED INSULIN-RESISTANCE; OXIDATIVE ENZYME-ACTIVITY; MITOCHONDRIAL DYSFUNCTION; LIPID-CONTENT; GLUCOSE; AGE; SPECTROSCOPY; OBESITY; RESPIRATION	Background: Aging and insulin resistance have been related to reduced mitochondrial function and oxidative stress. Muscular phosphodiesters (PDE) are comprised of metabolites of phospholipid breakdown and may reflect membrane damage. We aimed to test the hypothesis that myocellular PDE are increased in patients with type 2 diabetes (T2D) and correlate inversely with mitochondrial ATP turnover. Methods: A Cross-sectional study in the Clinical Research Facility of an University hospital was performed. 10 nonobese middle-aged patients with T2D, 10 healthy humans matched for sex, age and physical activity index (CONm) and 18 young healthy humans (CONy) were included. Myocellular PDE and unidirectional flux through ATP synthase (fATP) were measured with 31 P magnetic resonance spectroscopy (MRS). Intramyocellular (IMCL) and hepatocellular lipid deposition (HCL) were quantified with H-1 MRS. Insulin sensitivity (Rd) was assessed from hyperinsulinemic-euglycemic clamp tests in 10 T2D, 10 CONm and 11 CONy. Results: During fasting, T2D and CONm had 1.5 fold greater PDE than CONy (2.8 +/- 0.2, 2.5 +/- 0.2, 1.7 +/- 0.1 mmol/l, P = 0.004). Stimulation by insulin did not affect PDE in any group. PDE correlated negatively with Rd (r = -0.552, p < 0.005) and fATP (r = -0.396, p < 0.05) and positively with age (r = 0.656, p < 0.001) and body mass (r = -0.597, p < 0.001). PDE also related positively to HbA1c (r = 0.674, p < 0.001) and fasting plasma glucose (r = 0.629, p < 0.001) within T2D and across all participants. Conclusions: Muscular PDE concentrations associate with age, lower resting mitochondrial activity and insulin resistance, which is determined mainly by body mass and glycemia.	[Szendroedi, Julia; Nowotny, Peter; Roden, Michael] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Szendroedi, Julia; Roden, Michael] Univ Dusseldorf, Dept Metab Dis, Dusseldorf, Germany; [Szendroedi, Julia; Schmid, Albrecht Ingo; Chmelik, Marek; Roden, Michael] Med Univ Vienna, Karl Landsteiner Inst Endocrinol & Metab, Vienna, Austria; [Schmid, Albrecht Ingo; Chmelik, Marek] Med Univ Vienna, MR Ctr Excellence, Vienna, Austria; [Krssak, Martin] Med Univ Vienna, Dept Radiol, Vienna, Austria; [Krssak, Martin; Nowotny, Peter; Prikoszovich, Thomas; Kautzky-Willer, Alexandra; Wolzt, Michael; Waldhaeusl, Werner] Med Univ Vienna, Dept Internal Med 3, Vienna, Austria	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Szendroedi, J (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany.	michael.roden@ddz.uni-duesseldorf.de	Chmelik, Marek/AAR-3911-2020; Krssak, Martin/AAU-8183-2020; Roden, Michael/AAD-3843-2019	Krssak, Martin/0000-0001-9717-803X; Wolzt, Michael/0000-0001-6049-1890; Kautzky-Willer, Alexandra/0000-0002-3520-4105; Schmid, Albrecht Ingo/0000-0002-5196-151X; Chmelik, Marek/0000-0002-9727-9014	European Foundation for the Study of Diabetes (EFSD); Schmutzler Stiftung, the Skroder Stiftung; German Diabetes Foundation (DFG) [SFB 575]; German Center for Diabetes Research	European Foundation for the Study of Diabetes (EFSD); Schmutzler Stiftung, the Skroder Stiftung; German Diabetes Foundation (DFG)(German Research Foundation (DFG)); German Center for Diabetes Research	European Foundation for the Study of Diabetes (EFSD; Lilly-supported grant), the Schmutzler Stiftung, the Skroder Stiftung, the German Diabetes Foundation (DFG; SFB 575) and the German Center for Diabetes Research (DZD e. V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON EJ, 2009, J CLIN INVEST; BERNUS G, 1993, MED SCI SPORT EXER, V25, P479; Boschmann M, 2010, J CLIN ENDOCR METAB, V95, P1634, DOI 10.1210/jc.2009-1293; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; BROWN TR, 1977, P NATL ACAD SCI USA, V74, P5551, DOI 10.1073/pnas.74.12.5551; BURT CT, 1982, BIOCHIM BIOPHYS ACTA, V721, P492, DOI 10.1016/0167-4889(82)90107-0; BURT CT, 1976, BIOCHEMISTRY-US, V15, P4850, DOI 10.1021/bi00667a015; COX IJ, 1992, J HEPATOL, V14, P265, DOI 10.1016/0168-8278(92)90169-P; EDWARDS RHT, 1982, LANCET, V1, P725; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; Hebert SL, 2010, MECH AGEING DEV, V131, P451, DOI 10.1016/j.mad.2010.03.007; Hey-Mogensen M, 2010, DIABETOLOGIA, V53, P1976, DOI 10.1007/s00125-010-1813-x; HICKEY MS, 1995, AM J PHYSIOL-ENDOC M, V268, pE453, DOI 10.1152/ajpendo.1995.268.3.E453; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; HOTHERNIELSEN O, 1993, METABOLISM, V42, P86, DOI 10.1016/0026-0495(93)90177-P; Hug F, 2005, MED SCI SPORT EXER, V37, P846, DOI 10.1249/01.MSS.0000162616.20085.B4; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; JUBRIAS SA, 1994, ARTHRITIS RHEUM-US, V37, P801, DOI 10.1002/art.1780370604; KARAKELIDES H, 2009, DIABETES; KELLEY DE, 1994, J CLIN INVEST, V94, P2349, DOI 10.1172/JCI117600; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kemp GJ, 2008, AM J PHYSIOL-ENDOC M, V294, pE640, DOI 10.1152/ajpendo.00797.2007; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Lanza IR, 2010, PFLUG ARCH EUR J PHY, V459, P277, DOI 10.1007/s00424-009-0724-5; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Lefort N, 2010, DIABETES, V59, P2444, DOI 10.2337/db10-0174; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MANDARINO LJ, 1993, AM J PHYSIOL, V265, pE898, DOI 10.1152/ajpendo.1993.265.6.E898; MATTHEWS PM, 1991, NEUROLOGY, V41, P114, DOI 10.1212/WNL.41.1.114; Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556; Oberbach A, 2006, DIABETES CARE, V29, P895, DOI 10.2337/diacare.29.04.06.dc05-1854; Pan DA, 1995, J CLIN INVEST, V96, P2802, DOI 10.1172/JCI118350; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; PHIELIX E, 2010, GERONTOLOGY; Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Prikoszovich T, 2010, DIABETES CARE; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Ritov VB, AM J PHYSL ENDOCRINO, V298, pE49; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; SATRUSTEGUI J, 1988, MECH AGEING DEV, V42, P105, DOI 10.1016/0047-6374(88)90066-8; Schrauwen-Hinderling VB, 2007, DIABETOLOGIA, V50, P113, DOI 10.1007/s00125-006-0475-1; Schunk K, 1999, INVEST RADIOL, V34, P116, DOI 10.1097/00004424-199902000-00004; Simoneau JA, 1999, FASEB J, V13, P2051, DOI 10.1096/fasebj.13.14.2051; Slade JM, 2006, MUSCLE NERVE, V34, P782, DOI 10.1002/mus.20619; Sleigh A, 2011, J CLIN INVEST; Szendroedi J, 2009, DIABETES CARE; Szendroedi J, 2007, PLOS MED, V4, P858, DOI 10.1371/journal.pmed.0040154; Taylor DJ, 1997, MOL CELL BIOCHEM, V174, P321, DOI 10.1023/A:1006802602497; Velho G, 1996, DIABETES, V45, P478, DOI 10.2337/diabetes.45.4.478; Waters DL, 2003, MECH AGEING DEV, V124, P301, DOI 10.1016/S0047-6374(02)00197-5; YOUNKIN DP, 1987, NEUROLOGY, V37, P165, DOI 10.1212/WNL.37.1.165	55	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21846	10.1371/journal.pone.0021846	http://dx.doi.org/10.1371/journal.pone.0021846			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779337	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811300016
J	Tajbakhsh, J; Gertych, A; Fagg, WS; Hatada, S; Fair, JH				Tajbakhsh, Jian; Gertych, Arkadiusz; Fagg, W. Samuel; Hatada, Seigo; Fair, Jeffrey H.			Early In Vitro Differentiation of Mouse Definitive Endoderm Is Not Correlated with Progressive Maturation of Nuclear DNA Methylation Patterns	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; DYNAMIC CHANGES; PLURIPOTENT; CHROMATIN; ORGANIZATION; ARCHITECTURE; REPLICATION; HETEROGENEITY; TRANSCRIPTION	The genome organization in pluripotent cells undergoing the first steps of differentiation is highly relevant to the reprogramming process in differentiation. Considering this fact, chromatin texture patterns that identify cells at the very early stage of lineage commitment could serve as valuable tools in the selection of optimal cell phenotypes for regenerative medicine applications. Here we report on the first-time use of high-resolution three-dimensional fluorescence imaging and comprehensive topological cell-by-cell analyses with a novel image-cytometrical approach towards the identification of in situ global nuclear DNA methylation patterns in early endodermal differentiation of mouse ES cells (up to day 6), and the correlations of these patterns with a set of putative markers for pluripotency and endodermal commitment, and the epithelial and mesenchymal character of cells. Utilizing this in vitro cell system as a model for assessing the relationship between differentiation and nuclear DNA methylation patterns, we found that differentiating cell populations display an increasing number of cells with a gain in DNA methylation load: first within their euchromatin, then extending into heterochromatic areas of the nucleus, which also results in significant changes of methylcytosine/global DNA codistribution patterns. We were also able to co-visualize and quantify the concomitant stochastic marker expression on a per-cell basis, for which we did not measure any correlation to methylcytosine loads or distribution patterns. We observe that the progression of global DNA methylation is not correlated with the standard transcription factors associated with endodermal development. Further studies are needed to determine whether the progression of global methylation could represent a useful signature of cellular differentiation. This concept of tracking epigenetic progression may prove useful in the selection of cell phenotypes for future regenerative medicine applications.	[Tajbakhsh, Jian; Gertych, Arkadiusz] Cedars Sinai Med Ctr, Dept Surg, Translat Cytom Grp, Los Angeles, CA 90048 USA; [Tajbakhsh, Jian] Cedars Sinai Med Ctr, Dept Surg, Chromatin Biol Lab, Los Angeles, CA 90048 USA; [Fagg, W. Samuel; Fair, Jeffrey H.] Cedars Sinai Med Ctr, Dept Surg, Liver Dis & Transplantat Ctr, Los Angeles, CA 90048 USA; [Fagg, W. Samuel; Hatada, Seigo; Fair, Jeffrey H.] Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Tajbakhsh, J (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Translat Cytom Grp, Los Angeles, CA 90048 USA.	tajbakhshj@cshs.org; jeffrey.fair@cshs.org	Gertych, Arkadiusz/AAW-2572-2021	Gertych, Arkadiusz/0000-0002-3107-602X; Fagg, William/0000-0003-2909-1666	Department of Surgery at Cedars-Sinai Medical Center; National Institutes of Health National Heart, Lung, and Blood Institute [R01HL082606]; Winnick Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082606] Funding Source: NIH RePORTER	Department of Surgery at Cedars-Sinai Medical Center; National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Winnick Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by a research grant from the Department of Surgery at Cedars-Sinai Medical Center (to JT), the National Institutes of Health National Heart, Lung, and Blood Institute research grant R01HL082606 (to JHF), and the Winnick Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Arney KL, 2004, J CELL SCI, V117; Arnold SJ, 2008, DEVELOPMENT, V135, P501, DOI 10.1242/dev.014357; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bhattacharya D, 2009, BIOPHYS J, V96, P3832, DOI 10.1016/j.bpj.2008.11.075; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chakalova L, 2005, NAT REV GENET, V6, P669, DOI 10.1038/nrg1673; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Dean W, 1998, DEVELOPMENT, V125, P2273; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Fair JH, 2005, P NATL ACAD SCI USA, V102, P2958, DOI 10.1073/pnas.0409840102; Fair JH, 2003, SURGERY, V134, P189, DOI 10.1067/msy.2003.225; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; GERTYCH A, 2009, CYTOM PART A, V75, P559; Gertych A, 2010, ADV INTEL SOFT COMPU, V69, P309; Gertych A, 2010, EXP CELL RES, V316, P3150, DOI 10.1016/j.yexcr.2010.08.013; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Hough SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007708; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Jorgensen HF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r169; Kim SH, 2004, CYTOGENET GENOME RES, V105, P292, DOI 10.1159/000078201; Kobayakawa S, 2007, GENES CELLS, V12, P447, DOI 10.1111/j.1365-2443.2007.01063.x; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Marshall WF, 2003, MECH DEVELOP, V120, P1217, DOI 10.1016/j.mod.2003.05.001; Mattout A, 2010, CURR OPIN CELL BIOL, V22, P334, DOI 10.1016/j.ceb.2010.02.001; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Ooi SKT, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-17; Panning MM, 2005, J CELL BIOCHEM, V95, P74, DOI 10.1002/jcb.20395; Parada LA, 2004, EXP CELL RES, V296, P64, DOI 10.1016/j.yexcr.2004.03.013; Scheuermann MO, 2004, EXP CELL RES, V301, P266, DOI 10.1016/j.yexcr.2004.08.031; Snijder B, 2011, NAT REV MOL CELL BIO, V12, P119, DOI 10.1038/nrm3044; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; Tajbakhsh J, 2000, EXP CELL RES, V255, P229, DOI 10.1006/excr.1999.4780; Tajbakhsh J., 2010, DRUG DISCOV WORLD, P27; TAJBAKHSH J, 2008, P SOC PHOTO-OPT INS, V6859; Wiblin AE, 2005, J CELL SCI, V118, P3861, DOI 10.1242/jcs.02500	48	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21861	10.1371/journal.pone.0021861	http://dx.doi.org/10.1371/journal.pone.0021861			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779341	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811300020
J	Hong, KW; Weiss, A; Morimura, N; Udono, T; Hayasaka, I; Humle, T; Murayama, Y; Ito, S; Inoue-Murayama, M				Hong, Kyung-Won; Weiss, Alexander; Morimura, Naruki; Udono, Toshifumi; Hayasaka, Ikuo; Humle, Tatyana; Murayama, Yuichi; Ito, Shin'ichi; Inoue-Murayama, Miho			Polymorphism of the Tryptophan Hydroxylase 2 (TPH2) Gene Is Associated with Chimpanzee Neuroticism	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; MAJOR DEPRESSION; PAN-TROGLODYTES; REGULATORY REGION; PROMOTER POLYMORPHISM; PERSONALITY STRUCTURE; HAPLOTYPE ANALYSIS; ZOOLOGICAL PARKS; NO ASSOCIATION; HARM AVOIDANCE	In the brain, serotonin production is controlled by tryptophan hydroxylase 2 (TPH2), a genotype. Previous studies found that mutations on the TPH2 locus in humans were associated with depression and studies of mice and studies of rhesus macaques have shown that the TPH2 locus was involved with aggressive behavior. We previously reported a functional single nucleotide polymorphism (SNP) in the form of an amino acid substitution, Q468R, in the chimpanzee TPH2 gene coding region. In the present study we tested whether this SNP was associated with neuroticism in captive and wild-born chimpanzees living in Japan and Guinea, respectively. Even after correcting for multiple tests (Bonferroni p = 0.05/6 = 0.008), Q468R was significantly related to higher neuroticism (b = 0.372, p = 0.005). This study is the first to identify a genotype linked to a personality trait in chimpanzees. In light of the prior studies on humans, mice, and rhesus macaques, these findings suggest that the relationship between neuroticism and TPH2 has deep phylogenetic roots.	[Hong, Kyung-Won] Gifu Univ, United Grad Sch Agr Sci, Gifu, Japan; [Weiss, Alexander] Univ Edinburgh, Dept Psychol, Sch Philosophy Psychol & Language Sci, Scottish Primate Res Grp, Edinburgh, Midlothian, Scotland; [Morimura, Naruki; Inoue-Murayama, Miho] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Udono, Toshifumi; Hayasaka, Ikuo] Sanwa Kagaku Kenkyusho Co Ltd, Chimpanzee Sanctuary Uto, Kumamoto, Japan; [Humle, Tatyana] Univ Kent, Sch Anthropol & Conservat, Canterbury, Kent, England; [Murayama, Yuichi] Natl Inst Anim Hlth, Tsukuba, Ibaraki 305, Japan; [Ito, Shin'ichi] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan	Gifu University; University of Edinburgh; Kyoto University; Sanwa Kagaku Kenkyusho Co., Ltd.; University of Kent; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Gifu University	Hong, KW (corresponding author), Korea Natl Inst Hlth, Ctr Genome Sci, Chungbuk, South Korea.	mmurayama@wrc.kyoto-u.ac.jp			Ministry of Education, Science, Sports and Culture [18310152, 21310150]; PRI, Kyoto University; University of Edinburgh [2828]; Daiwa Foundation [6515/6818]	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRI, Kyoto University; University of Edinburgh; Daiwa Foundation	This study was financially supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (B) (#18310152 and #21310150 to MIM) and the Cooperation Research Program of PRI, Kyoto University. Alexander Weiss's work on this project was funded by a University of Edinburgh Development Trust Grant (#2828) and a Daiwa Foundation Small Grant (6515/6818). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TU and IH are employed by a commercial company, Sanwa Kagaku Kenkyusho Co., Ltd. and helped perform the experiments.	Alaerts M, 2009, ARCH GEN PSYCHIAT, V66, P828, DOI 10.1001/archgenpsychiatry.2009.82; Ball D, 1997, NEUROREPORT, V8, P1301, DOI 10.1097/00001756-199703240-00048; Chen GL, 2010, HORM BEHAV, V57, P184, DOI 10.1016/j.yhbeh.2009.10.012; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; Di Fiore A, 2003, YEARB PHYS ANTHROPOL, V46, P62, DOI 10.1002/ajpa.10382; Ebstein RP, 1997, MOL PSYCHIATR, V2, P224, DOI 10.1038/sj.mp.4000275; Frodl T, 2008, AM J MED GENET B, V147B, P1003, DOI 10.1002/ajmg.b.30680; Greenberg BD, 2000, AM J MED GENET, V96, P202, DOI 10.1002/(SICI)1096-8628(20000403)96:2<202::AID-AJMG16>3.0.CO;2-J; Herbst JH, 2000, AM J PSYCHIAT, V157, P1285, DOI 10.1176/appi.ajp.157.8.1285; Hong KW, 2007, NEUROSCI LETT, V412, P195, DOI 10.1016/j.neulet.2006.11.010; Inoue-Murayama M, 2001, CONTEMPORARY NEUROPSYCHIATRY, P425; Jorm AF, 1998, MOL PSYCHIATR, V3, P449, DOI 10.1038/sj.mp.4000424; KAUFMAN S, 1993, ANNU REV NUTR, V13, P261, DOI 10.1146/annurev.nu.13.070193.001401; King JE, 2005, J PERS, V73, P389, DOI 10.1111/j.1467-6494.2005.00313.x; King JE, 1997, J RES PERS, V31, P257, DOI 10.1006/jrpe.1997.2179; Kulikov AV, 2005, GENES BRAIN BEHAV, V4, P482, DOI 10.1111/j.1601-183X.2005.00145.x; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lopez VA, 2007, BIOL PSYCHIAT, V61, P181, DOI 10.1016/j.biopsych.2006.03.028; Middeldorp CM, 2007, BEHAV GENET, V37, P294, DOI 10.1007/s10519-006-9139-7; Morimura N, 2011, AM J PRIMATOL, V73, P226, DOI 10.1002/ajp.20887; Munafo MR, 2009, AM J MED GENET B, V150B, P271, DOI 10.1002/ajmg.b.30808; Murakami F, 1999, J HUM GENET, V44, P15, DOI 10.1007/s100380050098; Pederson AK, 2005, J RES PERS, V39, P534, DOI 10.1016/j.jrp.2004.07.002; Ricketts MH, 1998, PSYCHIATR GENET, V8, P41, DOI 10.1097/00041444-199800820-00001; Sen S, 2004, BIOL PSYCHIAT, V55, P244, DOI 10.1016/j.biopsych.2003.08.006; Tadic A, 2009, AM J MED GENET B, V150B, P487, DOI 10.1002/ajmg.b.30843; Walitza S, 2005, MOL PSYCHIATR, V10, P1126, DOI 10.1038/sj.mp.4001734; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Weiss A, 2002, J PERS SOC PSYCHOL, V83, P1141, DOI 10.1037//0022-3514.83.5.1141; Weiss A, 2009, AM J PRIMATOL, V71, P283, DOI 10.1002/ajp.20649; Weiss A, 2007, AM J PRIMATOL, V69, P1264, DOI 10.1002/ajp.20428; Weissglas-Volkov D, 2010, J LIPID RES, V51, P2032, DOI 10.1194/jlr.R004739; Willis-Owen SAG, 2005, BIOL PSYCHIAT, V58, P451, DOI 10.1016/j.biopsych.2005.04.050; Xu X, 2008, AM J MED GENET B, V147B, P1306, DOI 10.1002/ajmg.b.30737; Zaboli G, 2008, AM J MED GENET B, V147B, P301, DOI 10.1002/ajmg.b.30597; Zhang XD, 2005, NEURON, V45, P11, DOI 10.1016/j.neuron.2004.12.014; Zill P, 2004, MOL PSYCHIATR, V9, P1030, DOI 10.1038/sj.mp.4001525	37	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22144	10.1371/journal.pone.0022144	http://dx.doi.org/10.1371/journal.pone.0022144			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765945	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000292781500037
J	Hwang, S; Kwak, SH; Bhak, J; Kang, HS; Lee, YR; Koo, BK; Park, KS; Lee, HK; Cho, YM				Hwang, Seungwoo; Kwak, Soo Heon; Bhak, Jong; Kang, Hae Sun; Lee, You Ri; Koo, Bo Kyung; Park, Kyong Soo; Lee, Hong Kyu; Cho, Young Min			Gene Expression Pattern in Transmitochondrial Cytoplasmic Hybrid Cells Harboring Type 2 Diabetes-Associated Mitochondrial DNA Haplogroups	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; KOREAN POPULATION; MTDNA; MELLITUS; POLYMORPHISMS; RESISTANCE; SELECTION; PROFILES; MUTATION; HUMANS	Decreased mitochondrial function plays a pivotal role in the pathogenesis of type 2 diabetes mellitus (T2DM). Recently, it was reported that mitochondrial DNA (mtDNA) haplogroups confer genetic susceptibility to T2DM in Koreans and Japanese. Particularly, mtDNA haplogroup N9a is associated with a decreased risk of T2DM, whereas haplogroups D5 and F are associated with an increased risk. To examine functional consequences of these haplogroups without being confounded by the heterogeneous nuclear genomic backgrounds of different subjects, we constructed transmitochondrial cytoplasmic hybrid (cybrid) cells harboring each of the three haplogroups (N9a, D5, and F) in a background of a shared nuclear genome. We compared the functional consequences of the three haplogroups using cell-based assays and gene expression microarrays. Cell-based assays did not detect differences in mitochondrial functions among the haplogroups in terms of ATP generation, reactive oxygen species production, mitochondrial membrane potential, and cellular dehydrogenase activity. However, differential expression and clustering analyses of microarray data revealed that the three haplogroups exhibit a distinctive nuclear gene expression pattern that correlates with their susceptibility to T2DM. Pathway analysis of microarray data identified several differentially regulated metabolic pathways. Notably, compared to the T2DM-resistant haplogroup N9a, the T2DM-susceptible haplogroup F showed down-regulation of oxidative phosphorylation and up-regulation of glycolysis. These results suggest that variations in mtDNA can affect the expression of nuclear genes regulating mitochondrial functions or cellular energetics. Given that impaired mitochondrial function caused by T2DM-associated mtDNA haplogroups is compensated by the nuclear genome, we speculate that defective nuclear compensation, under certain circumstances, might lead to the development of T2DM.	[Hwang, Seungwoo] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea; [Kwak, Soo Heon; Kang, Hae Sun; Lee, You Ri; Koo, Bo Kyung; Park, Kyong Soo; Cho, Young Min] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Bhak, Jong] Theragen BiO Inst, Suwon, South Korea; [Lee, Hong Kyu] Eulji Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Eulji University	Hwang, S (corresponding author), Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea.	ymchomd@snu.ac.kr	Koo, Bo Kyung/ABB-7170-2020; Park, Kyong Soo/C-2265-2008; Cho, Young Min/J-5669-2012; Kwak, Soo Heon/H-1463-2011	Park, Kyong Soo/0000-0003-3597-342X; Kwak, Soo Heon/0000-0003-1230-0919	National Research Foundation [M10753020005-07N5302-00500]; Korea Research Institute of Bioscience and Biotechnology (KRIBB); Seoul National University Hospital, South Korea [03-2005-001-0]	National Research Foundation; Korea Research Institute of Bioscience and Biotechnology (KRIBB); Seoul National University Hospital, South Korea	This work was supported by grants from the National Research Foundation (M10753020005-07N5302-00500), the Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program, and Seoul National University Hospital intramural research fund (03-2005-001-0), South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amo T, 2008, GENE, V411, P69, DOI 10.1016/j.gene.2008.01.007; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Chinnery PF, 2005, LANCET, V366, P1650, DOI 10.1016/S0140-6736(05)67492-2; Cho YM, 2005, DIABETOLOGIA, V48, P2033, DOI 10.1007/s00125-005-1855-7; Chomyn A, 1996, Methods Enzymol, V264, P334, DOI 10.1016/S0076-6879(96)64031-2; Delsite Robert, 2002, Mol Cancer, V1, P6, DOI 10.1186/1476-4598-1-6; Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim JH, 2005, DIABETOLOGIA, V48, P1323, DOI 10.1007/s00125-005-1793-4; Kim TM, 2008, BIOINFORMATICS, V24, P1957, DOI 10.1093/bioinformatics/btn357; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Lu HF, 2010, DIABETES, V59, P448, DOI 10.2337/db09-0129; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x; Park KS, 2008, DIABETOLOGIA, V51, P602, DOI 10.1007/s00125-008-0933-z; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Pravenec M, 2007, GENOME RES, V17, P1319, DOI 10.1101/gr.6548207; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Saxena V, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl766; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tafrechi RSJ, 2005, MUTAT RES-FUND MOL M, V578, P43, DOI 10.1016/j.mrfmmm.2005.02.002; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0	30	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22116	10.1371/journal.pone.0022116	http://dx.doi.org/10.1371/journal.pone.0022116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765942	gold, Green Published, Green Submitted			2022-12-25	WOS:000292781500034
J	Dai, K; Liao, SH; Zhang, JH; Zhang, XC; Tu, XM				Dai, Kun; Liao, Shanhui; Zhang, Jiahai; Zhang, Xuecheng; Tu, Xiaoming			Solution Structure of Tensin2 SH2 Domain and Its Phosphotyrosine-Independent Interaction with DLC-1	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; PHOSPHOLIPASE-C-GAMMA; TYROSINE KINASES; CANCER; RECEPTOR; BINDING; ASSOCIATION; SUPPRESSION; MECHANISM; CTEN	Background: Src homology 2 (SH2) domain is a conserved module involved in various biological processes. Tensin family member was reported to be involved in tumor suppression by interacting with DLC-1 (deleted-in-liver-cancer-1) via its SH2 domain. We explore here the important questions that what the structure of tensin2 SH2 domain is, and how it binds to DLC-1, which might reveal a novel binding mode. Principal Findings: Tensin2 SH2 domain adopts a conserved SH2 fold that mainly consists of five beta-strands flanked by two a-helices. Most SH2 domains recognize phosphorylated ligands specifically. However, tensin2 SH2 domain was identified to interact with nonphosphorylated ligand (DLC-1) as well as phosphorylated ligand. Conclusions: We determined the solution structure of tensin2 SH2 domain using NMR spectroscopy, and revealed the interactions between tensin2 SH2 domain and its ligands in a phosphotyrosine-independent manner.	[Dai, Kun; Liao, Shanhui; Zhang, Jiahai; Tu, Xiaoming] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Sch Life Sci, Hefei, Anhui, Peoples R China; [Zhang, Xuecheng] Anhui Univ, Sch Life Sci, Hefei 230039, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui University	Dai, K (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Sch Life Sci, Hefei, Anhui, Peoples R China.	xmtu@ustc.edu.cn	Tu, Xiaoming/G-5090-2018; Liao, Shanhui/N-1628-2018	Liao, Shanhui/0000-0002-5083-667X	Chinese Academy of Science [KSCX2-EW-Q-4]; National High-Tech RD Program [2006AA02A315]; National Basic Research Program of China (973 Program) [2007CB914503, 2009CB918804]	Chinese Academy of Science(Chinese Academy of Sciences); National High-Tech RD Program; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the Knowledge Innovation Program of the Chinese Academy of Science, Grant KSCX2-EW-Q-4, the National High-Tech R&D Program, Grant 2006AA02A315 and the National Basic Research Program of China (973 Program), Grants 2007CB914503 and 2009CB918804. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albasri A, 2009, J PATHOL, V218, P57, DOI 10.1002/path.2508; Beattie J, 1996, CELL SIGNAL, V8, P75, DOI 10.1016/0898-6568(95)02033-0; Chan LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005572; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; Goddard T.D., SPARKY 3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hwang PM, 2002, EMBO J, V21, P314, DOI 10.1093/emboj/21.3.314; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liao SH, 2009, BIOCHEM J, V422, P207, DOI 10.1042/BJ20090738; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Liao YC, 2009, CANCER RES, V69, P4563, DOI 10.1158/0008-5472.CAN-09-0117; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI 10.1016/S1357-2725(03)00171-7; Machida K, 2005, BBA-PROTEINS PROTEOM, V1747, P1, DOI 10.1016/j.bbapap.2004.10.005; Mahajan NP, 2003, J BIOL CHEM, V278, P42596, DOI 10.1074/jbc.M305817200; MARGOLIS B, 1990, MOL CELL BIOL, V10, P435, DOI 10.1128/MCB.10.2.435; Martuszewska D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004350; MORRISON DK, 1990, MOL CELL BIOL, V10, P2359, DOI 10.1128/MCB.10.5.2359; Pero SC, 2002, J BIOL CHEM, V277, P11918, DOI 10.1074/jbc.M111816200; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Qian XL, 2009, CANCER CELL, V16, P246, DOI 10.1016/j.ccr.2009.07.031; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; Sawyer TK, 1998, BIOPOLYMERS, V47, P243, DOI 10.1002/(SICI)1097-0282(1998)47:3<243::AID-BIP4>3.0.CO;2-P; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Waksman Gabriel, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404007331; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	35	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21965	10.1371/journal.pone.0021965	http://dx.doi.org/10.1371/journal.pone.0021965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765928	Green Published, Green Submitted, gold			2022-12-25	WOS:000292699000016
J	Rands, SA				Rands, Sean A.			Approximating Optimal Behavioural Strategies Down to Rules-of-Thumb: Energy Reserve Changes in Pairs of Social Foragers	PLOS ONE			English	Article							DECISION-MAKING; SELFISH HERD; COLLECTIVE BEHAVIOR; FISH SCHOOLS; GROUP-SIZE; EMERGENCE; DOMINANCE; ANIMALS; MODEL; RISK	Functional explanations of behaviour often propose optimal strategies for organisms to follow. These 'best' strategies could be difficult to perform given biological constraints such as neural architecture and physiological constraints. Instead, simple heuristics or 'rules-of-thumb' that approximate these optimal strategies may instead be performed. From a modelling perspective, rules-of-thumb are also useful tools for considering how group behaviour is shaped by the behaviours of individuals. Using simple rules-of-thumb reduces the complexity of these models, but care needs to be taken to use rules that are biologically relevant. Here, we investigate the similarity between the outputs of a two-player dynamic foraging game (which generated optimal but complex solutions) and a computational simulation of the behaviours of the two members of a foraging pair, who instead followed a rule-of-thumb approximation of the game's output. The original game generated complex results, and we demonstrate here that the simulations following the much-simplified rules-of-thumb also generate complex results, suggesting that the rule-of-thumb was sufficient to make some of the model outcomes unpredictable. There was some agreement between both modelling techniques, but some differences arose - particularly when pair members were not identical in how they gained and lost energy. We argue that exploring how rules-of-thumb perform in comparison to their optimal counterparts is an important exercise for biologically validating the output of agent-based models of group behaviour.	Univ Bristol, Sch Vet Sci, Ctr Behav Biol, Bristol BS18 7DU, Avon, England	University of Bristol	Rands, SA (corresponding author), Univ Bristol, Sch Vet Sci, Ctr Behav Biol, Bristol BS18 7DU, Avon, England.	sean.rands@bristol.ac.uk	Rands, Sean A/B-2243-2008	Rands, Sean A/0000-0002-7400-005X				Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; [Anonymous], 2010, R LANG ENV STAT COMP; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Ballerini M, 2008, ANIM BEHAV, V76, P201, DOI 10.1016/j.anbehav.2008.02.004; Beauchamp G, 2008, BEHAV ECOL, V19, P1361, DOI 10.1093/beheco/arn096; Brierley AS, 2010, CURR BIOL, V20, P1758, DOI 10.1016/j.cub.2010.08.041; Buchkremer EM, 2008, BEHAV ECOL, V19, P984, DOI 10.1093/beheco/arn057; Buchkremer EM, 2010, BEHAV ECOL, V21, P576, DOI 10.1093/beheco/arq026; Camazine S., 2001, SELF ORG BIOLOGICAL, DOI DOI 10.1515/9780691212920; Cavagna A, 2010, BEHAV PROCESS, V84, P653, DOI 10.1016/j.beproc.2010.02.026; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Conradt L, 2009, PHILOS T R SOC B, V364, P719, DOI 10.1098/rstb.2008.0276; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; de Vries H, 2009, BEHAVIOUR, V146, P843, DOI 10.1163/156853909X412241; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Gross R, 2008, J R SOC INTERFACE, V5, P1193, DOI 10.1098/rsif.2007.1348; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hemelrijk CK, 1999, P ROY SOC B-BIOL SCI, V266, P361, DOI 10.1098/rspb.1999.0646; Hemelrijk CK, 2000, ANIM BEHAV, V59, P1035, DOI 10.1006/anbe.2000.1400; Houston AI, 2007, PHILOS T R SOC B, V362, P1531, DOI 10.1098/rstb.2007.2051; Hutchinson JMC, 2005, BEHAV PROCESS, V69, P97, DOI 10.1016/j.beproc.2005.02.019; James R, 2004, J THEOR BIOL, V228, P107, DOI 10.1016/j.jtbi.2003.12.005; Krause J, 2002, LIVING GROUPS; Kunz H, 2003, ARTIF LIFE, V9, P237, DOI 10.1162/106454603322392451; Low C, 2008, BEHAV ECOL, V19, P532, DOI 10.1093/beheco/arm157; Marshall JAR, 2009, J R SOC INTERFACE, V6, P1065, DOI 10.1098/rsif.2008.0511; MCNAMARA JM, 1986, AM NAT, V127, P358, DOI 10.1086/284489; MCNAMARA JM, 1992, ANIM BEHAV, V43, P641, DOI 10.1016/0003-3472(92)90086-O; McNamara JM, 2009, TRENDS ECOL EVOL, V24, P670, DOI 10.1016/j.tree.2009.05.011; MOORING MS, 1992, BEHAVIOUR, V123, P173, DOI 10.1163/156853992X00011; Morrell LJ, 2008, BEHAV ECOL, V19, P909, DOI 10.1093/beheco/arn050; Morrell LJ, 2008, BEHAV ECOL, V19, P193, DOI 10.1093/beheco/arm122; Morrell LJ, 2011, P ROY SOC B-BIOL SCI, V278, P605, DOI 10.1098/rspb.2010.1605; PARKER GA, 1990, NATURE, V348, P27, DOI 10.1038/348027a0; Petit O, 2010, BEHAV PROCESS, V84, P635, DOI 10.1016/j.beproc.2010.04.009; Pulliam HR., 1984, BEHAVIOURAL ECOLOGY, P122; Rands SA, 2004, P ROY SOC B-BIOL SCI, V271, P2613, DOI 10.1098/rspb.2004.2906; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Rands SA, 2006, BEHAV ECOL SOCIOBIOL, V60, P572, DOI 10.1007/s00265-006-0202-4; Rands SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011705; Rands SA, 2010, BEHAV PROCESS, V84, P668, DOI 10.1016/j.beproc.2010.03.001; Rands SA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-51; Rands SA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-81; Riipi M, 2001, NATURE, V413, P512, DOI 10.1038/35097061; SMITH JM, 1978, ANNU REV ECOL SYST, V9, P31, DOI 10.1146/annurev.es.09.110178.000335; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Trimmer PC, 2008, P ROY SOC B-BIOL SCI, V275, P2353, DOI 10.1098/rspb.2008.0417; Vabo R, 1997, FISH OCEANOGR, V6, P155, DOI 10.1046/j.1365-2419.1997.00037.x; Waksberg A, 2009, BEHAV ECOL SOCIOBIOL, V63, P461, DOI 10.1007/s00265-008-0681-6; Wood AJ, 2010, J THEOR BIOL, V264, P1102, DOI 10.1016/j.jtbi.2010.03.035; Wood AJ, 2007, P R SOC B, V274, P1637, DOI 10.1098/rspb.2007.0306; [No title captured]	56	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22104	10.1371/journal.pone.0022104	http://dx.doi.org/10.1371/journal.pone.0022104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765938	gold, Green Published, Green Submitted			2022-12-25	WOS:000292699000024
J	Gentschev, I; Muller, M; Adelfinger, M; Weibel, S; Grummt, F; Zimmermann, M; Bitzer, M; Heisig, M; Zhang, Q; Yu, YA; Chen, NG; Stritzker, J; Lauer, UM; Szalay, AA				Gentschev, Ivaylo; Mueller, Meike; Adelfinger, Marion; Weibel, Stephanie; Grummt, Friedrich; Zimmermann, Martina; Bitzer, Michael; Heisig, Martin; Zhang, Qian; Yu, Yong A.; Chen, Nanhai G.; Stritzker, Jochen; Lauer, Ulrich M.; Szalay, Aladar A.			Efficient Colonization and Therapy of Human Hepatocellular Carcinoma (HCC) Using the Oncolytic Vaccinia Virus Strain GLV-1h68	PLOS ONE			English	Article							BREAST-TUMORS; NUDE-MICE; IN-VIVO; CANCER; ANGIOGENESIS; INHIBITOR; TISSUE; AGENT; COX-2	Virotherapy using oncolytic vaccinia virus strains is one of the most promising new strategies for cancer therapy. In this study, we analyzed for the first time the therapeutic efficacy of the oncolytic vaccinia virus GLV-1h68 in two human hepatocellular carcinoma cell lines HuH7 and PLC/PRF/5 (PLC) in cell culture and in tumor xenograft models. By viral proliferation assays and cell survival tests, we demonstrated that GLV-1h68 efficiently colonized, replicated in, and did lyse these cancer cells in culture. Experiments with HuH7 and PLC xenografts have revealed that a single intravenous injection (i.v.) of mice with GLV-1h68 resulted in a significant reduction of primary tumor sizes compared to uninjected controls. In addition, replication of GLV-1h68 in tumor cells led to strong inflammatory and oncolytic effects resulting in intense infiltration of MHC class II-positive cells like neutrophils, macrophages, B cells and dendritic cells and in up-regulation of 13 pro-inflammatory cytokines. Furthermore, GLV-1h68 infection of PLC tumors inhibited the formation of hemorrhagic structures which occur naturally in PLC tumors. Interestingly, we found a strongly reduced vascular density in infected PLC tumors only, but not in the non-hemorrhagic HuH7 tumor model. These data demonstrate that the GLV-1h68 vaccinia virus may have an enormous potential for treatment of human hepatocellular carcinoma in man.	[Gentschev, Ivaylo; Zhang, Qian; Yu, Yong A.; Chen, Nanhai G.; Stritzker, Jochen; Szalay, Aladar A.] Genelux Corp, San Diego Sci Ctr, San Diego, CA USA; [Gentschev, Ivaylo; Mueller, Meike; Adelfinger, Marion; Weibel, Stephanie; Grummt, Friedrich; Stritzker, Jochen; Szalay, Aladar A.] Univ Wurzburg, Dept Biochem, Wurzburg, Germany; [Szalay, Aladar A.] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Wurzburg, Germany; [Szalay, Aladar A.] Univ Wurzburg, Inst Mol Infect Biol, Wurzburg, Germany; [Zimmermann, Martina; Bitzer, Michael; Lauer, Ulrich M.] Med Univ Hosp, Dept Gastroenterol & Hepatol, Tubingen, Germany; [Heisig, Martin] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Zhang, Qian; Yu, Yong A.; Chen, Nanhai G.; Szalay, Aladar A.] Univ Calif San Diego, Dept Radiat Oncol, Rebecca & John Moores Comprehens Canc Ctr, La Jolla, CA 92093 USA	University of Wurzburg; University of Wurzburg; University of Wurzburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Yale University; University of California System; University of California San Diego	Gentschev, I (corresponding author), Genelux Corp, San Diego Sci Ctr, San Diego, CA USA.	aaszalay@genelux.com	Stritzker, Jochen/E-9094-2011; Gentschev, Ivaylo/F-9454-2011; Gentschev, Ivaylo/AAJ-5819-2021	Gentschev, Ivaylo/0000-0003-3743-6329; Muller, Meike/0000-0003-3119-2327	Research and Development Division of Genelux Corporation, San Diego, USA; Genelux Corp., San Diego, USA; Genelux Corporation; German Research Council (DFG) [SFB 773, C3]	Research and Development Division of Genelux Corporation, San Diego, USA; Genelux Corp., San Diego, USA; Genelux Corporation; German Research Council (DFG)(German Research Foundation (DFG))	The research was supported by the Research and Development Division of Genelux Corporation, San Diego, USA, and a Service Grant to the University of Wurzburg, Germany also funded by Genelux Corp., San Diego, USA. IG QZ YAY NGC JS and AAS are employees and shareholders of Genelux. MA and SW were supported by grants of Genelux Corporation. This work also was supported in part by grants from the German Research Council (DFG) SFB 773 (project C3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Brader P, 2009, CLIN CANCER RES, V15, P3791, DOI 10.1158/1078-0432.CCR-08-3236; Chen NH, 2009, MOL MED, V15, P144, DOI 10.2119/molmed.2009.00014; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Gentschev I, 2009, CANCER GENE THER, V16, P320, DOI 10.1038/cgt.2008.87; Gentschev I, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/489759; Gentschev I, 2010, J ONCOL, V2010, DOI 10.1155/2010/736907; Hu KQ, 2003, INT J ONCOL, V22, P757; Hu KQ, 2002, J LAB CLIN MED, V139, P234, DOI 10.1067/mlc.2002.122281; Kelly KJ, 2008, HUM GENE THER, V19, P774, DOI 10.1089/hum.2008.036; Kelly KJ, 2009, INT J CANCER, V124, P911, DOI 10.1002/ijc.24037; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kondo M, 1999, CLIN CANCER RES, V5, P4005; Lee JC, 2002, CANCER RES, V62, P747; Lin SF, 2007, SURGERY, V142, P976, DOI 10.1016/j.surg.2007.09.017; Lin SF, 2008, J CLIN ENDOCR METAB, V93, P4403, DOI 10.1210/jc.2008-0316; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; ten Hagen TLM, 2003, TECHNOL CANCER RES T, V2, P195; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; Weibel S, 2008, CELL MICROBIOL, V10, P1235, DOI 10.1111/j.1462-5822.2008.01122.x; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Yu YA, 2009, MOL CANCER THER, V8, P141, DOI 10.1158/1535-7163.MCT-08-0533; Yu ZJ, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-45; Zhang Q, 2007, CANCER RES, V67, P10038, DOI 10.1158/0008-5472.CAN-07-0146; Zhang Q, 2009, MOL GENET GENOMICS, V282, P417, DOI 10.1007/s00438-009-0475-1	26	34	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e22069	10.1371/journal.pone.0022069	http://dx.doi.org/10.1371/journal.pone.0022069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779374	Green Published, gold, Green Submitted			2022-12-25	WOS:000292680900027
J	Kobayashi, M; Sasabe, T; Shigihara, Y; Tanaka, M; Watanabe, Y				Kobayashi, Masayuki; Sasabe, Tetsuya; Shigihara, Yoshihito; Tanaka, Masaaki; Watanabe, Yasuyoshi			Gustatory Imagery Reveals Functional Connectivity from the Prefrontal to Insular Cortices Traced with Magnetoencephalography	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ORBITOFRONTAL CORTEX; TASTE PERCEPTION; MACAQUE MONKEY; BRAIN; AREAS; REPRESENTATION; STIMULATION; ACTIVATION; NEURONS	Our experience and prejudice concerning food play an important role in modulating gustatory information processing; gustatory memory stored in the central nervous system influences gustatory information arising from the peripheral nervous system. We have elucidated the mechanism of the 'top-down" modulation of taste perception in humans using functional magnetic resonance imaging (fMRI) and demonstrated that gustatory imagery is mediated by the prefrontal (PFC) and insular cortices (IC). However, the temporal order of activation of these brain regions during gustatory imagery is still an open issue. To explore the source of "top-down" signals during gustatory imagery tasks, we analyzed the temporal activation patterns of activated regions in the cerebral cortex using another non-invasive brain imaging technique, magnetoencephalography (MEG). Gustatory imagery tasks were presented by words (Letter G-V) or pictures (Picture G-V) of foods/beverages, and participants were requested to recall their taste. In the Letter G-V session, 7/9 (77.8%) participants showed activation in the IC with a latency of 401.7 +/- 34.7 ms (n = 7) from the onset of word exhibition. In 5/7 (71.4%) participants who exhibited IC activation, the PFC was activated prior to the IC at a latency of 315.2 +/- 56.5 ms (n = 5), which was significantly shorter than the latency to the IC activation. In the Picture G-V session, the IC was activated in 6/9 (66.7%) participants, and only 1/9 (11.1%) participants showed activation in the PFC. There was no significant dominance between the right and left IC or PFC during gustatory imagery. These results support those from our previous fMRI study in that the Letter G-V session rather than the Picture G-V session effectively activates the PFC and IC and strengthen the hypothesis that the PFC mediates "top-down" control of retrieving gustatory information from the storage of long-term memories and in turn activates the IC.	[Kobayashi, Masayuki] Nihon Univ, Sch Dent, Dept Pharmacol, Chiyoda Ku, Tokyo 101, Japan; [Kobayashi, Masayuki] Nihon Univ, Sch Dent, Dent Res Ctr, Div Oral & Craniomaxillofacial Res,Chiyoda Ku, Tokyo 101, Japan; [Kobayashi, Masayuki; Sasabe, Tetsuya; Shigihara, Yoshihito; Tanaka, Masaaki; Watanabe, Yasuyoshi] Osaka City Univ, Grad Sch Med, Dept Physiol, Abeno Ku, Osaka 558, Japan; [Shigihara, Yoshihito; Tanaka, Masaaki; Watanabe, Yasuyoshi] 21st Century COE Program Base Overcome Fatigue, Abeno Ku, Osaka, Japan; [Watanabe, Yasuyoshi] RIKEN, Ctr Mol Imaging Sci, Mol Probe Dynam Lab, Chuo Ku, Kobe, Hyogo, Japan	Nihon University; Nihon University; Osaka Metropolitan University; RIKEN	Kobayashi, M (corresponding author), Nihon Univ, Sch Dent, Dept Pharmacol, Chiyoda Ku, Tokyo 101, Japan.	masayuki@dent.osaka-u.ac.jp	Shigihara, Yoshihito/AFL-8377-2022; Shigihara, Yoshihito/AAG-8442-2022	Shigihara, Yoshihito/0000-0003-0996-110X; Shigihara, Yoshihito/0000-0003-0996-110X	Japanese Ministry of Education, Culture, Sports, Science and Technology; The Promotion and Mutual Aid Corporation for Private School of Japan; Nihon University	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Promotion and Mutual Aid Corporation for Private School of Japan; Nihon University	This work was supported by Grant for the Promotion of Multi-Disciplinary Research Projects entitled "Translational Research Network on Orofacial Neurological Disorders" from the Japanese Ministry of Education, Culture, Sports, Science and Technology to M.K.; The Promotion and Mutual Aid Corporation for Private School of Japan to M.K.; and Nihon University Joint Research Grant to M.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Barry MA, 2001, CHEM SENSES, V26, P471, DOI 10.1093/chemse/26.5.471; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P371, DOI 10.1093/chemse/26.4.371; Cheng K, 2001, NEURON, V32, P359, DOI 10.1016/S0896-6273(01)00477-9; Damasio A. R., 1999, FEELING WHAT HAPPENS; Darvas F, 2004, NEUROIMAGE, V23, pS289, DOI 10.1016/j.neuroimage.2004.07.014; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Faurion A, 1999, NEUROSCI LETT, V277, P189, DOI 10.1016/S0304-3940(99)00881-2; Francis S, 1999, NEUROREPORT, V10, P453, DOI 10.1097/00001756-199902250-00003; Frey S, 1999, EUR J NEUROSCI, V11, P2985, DOI 10.1046/j.1460-9568.1999.00738.x; Frith C, 1997, PHILOS T R SOC B, V352, P1221, DOI 10.1098/rstb.1997.0104; Fuster JM, 2000, BRAIN RES BULL, V52, P331, DOI 10.1016/S0361-9230(99)00258-0; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; Haase L, 2009, NEUROIMAGE, V44, P1008, DOI 10.1016/j.neuroimage.2008.09.044; HAUSSERHAUW C, 1987, BRAIN, V110, P339, DOI 10.1093/brain/110.2.339; Ishai A, 2002, NEUROIMAGE, V17, P1729, DOI 10.1006/nimg.2002.1330; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; Kikuchi S, 2005, NEUROREPORT, V16, P281, DOI 10.1097/00001756-200502280-00016; KINOMURA S, 1994, BRAIN RES, V659, P263, DOI 10.1016/0006-8993(94)90890-7; Kobayashi M, 2004, NEUROIMAGE, V23, P1271, DOI 10.1016/j.neuroimage.2004.08.002; Kobayashi M, 2002, EUR J NEUROSCI, V16, P975, DOI 10.1046/j.1460-9568.2002.02151.x; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Miyashita Y, 2000, CURR OPIN NEUROBIOL, V10, P187, DOI 10.1016/S0959-4388(00)00071-4; MOTTA G, 1959, Bull Sci Med (Bologna), V131, P480; Murakami S, 2006, J PHYSIOL-LONDON, V575, P925, DOI 10.1113/jphysiol.2006.105379; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Okamoto M, 2006, NEUROIMAGE, V31, P796, DOI 10.1016/j.neuroimage.2005.12.021; Okamoto M, 2011, NEUROIMAGE, V54, P1578, DOI 10.1016/j.neuroimage.2010.08.016; Peltz E, 2011, NEUROIMAGE, V54, P1324, DOI 10.1016/j.neuroimage.2010.09.012; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; PENFIELD W, 1955, BRAIN, V78, P445, DOI 10.1093/brain/78.4.445; Pritchard TC, 1999, BEHAV NEUROSCI, V113, P663, DOI 10.1037/0735-7044.113.4.663; PRITCHARD TC, 1986, J COMP NEUROL, V244, P213, DOI 10.1002/cne.902440208; ROLLS ET, 1990, J NEUROPHYSIOL, V64, P1055, DOI 10.1152/jn.1990.64.4.1055; ROLLS ET, 1994, J NEUROSCI, V14, P5437; SCOTT TR, 1991, J NEUROPHYSIOL, V65, P76, DOI 10.1152/jn.1991.65.1.76; SCOTT TR, 1993, J NEUROPHYSIOL, V69, P1810, DOI 10.1152/jn.1993.69.6.1810; Scott TR, 1999, PHYSIOL BEHAV, V67, P489, DOI 10.1016/S0031-9384(99)00115-8; Shigihara Y, 2010, NEUROSCIENCE, V166, P482, DOI 10.1016/j.neuroscience.2009.12.077; Simmons WK, 2005, CEREB CORTEX, V15, P1602, DOI 10.1093/cercor/bhi038; Small DM, 1999, NEUROREPORT, V10, P7, DOI 10.1097/00001756-199901180-00002; Small DM, 1997, NEUROREPORT, V8, P3913, DOI 10.1097/00001756-199712220-00014; Small DM, 1997, J NEUROSCI, V17, P5136; Tobimatsu S, 2006, CLIN NEUROPHYSIOL, V117, P1414, DOI 10.1016/j.clinph.2006.01.004; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; Veldhuizen MG, 2007, CHEM SENSES, V32, P569, DOI 10.1093/chemse/bjm025; Zatorre RJ, 1996, J COGNITIVE NEUROSCI, V8, P29, DOI 10.1162/jocn.1996.8.1.29	49	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21736	10.1371/journal.pone.0021736	http://dx.doi.org/10.1371/journal.pone.0021736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760903	Green Published, Green Submitted, gold			2022-12-25	WOS:000292657200020
J	Crespi, S; Biagi, L; d'Avossa, G; Burr, DC; Tosetti, M; Morrone, MC				Crespi, Sofia; Biagi, Laura; d'Avossa, Giovanni; Burr, David C.; Tosetti, Michela; Morrone, Maria Concetta			Spatiotopic Coding of BOLD Signal in Human Visual Cortex Depends on Spatial Attention	PLOS ONE			English	Article							AREA MT; DIRECTED ATTENTION; RECEPTIVE-FIELDS; CORTICAL AREA; PARIETAL; MOTION; NEURONS; REPRESENTATION; RETINOTOPY; RESPONSES	The neural substrate of the phenomenological experience of a stable visual world remains obscure. One possible mechanism would be to construct spatiotopic neural maps where the response is selective to the position of the stimulus in external space, rather than to retinal eccentricities, but evidence for these maps has been inconsistent. Here we show, with fMRI, that when human subjects perform concomitantly a demanding attentive task on stimuli displayed at the fovea, BOLD responses evoked by moving stimuli irrelevant to the task were mostly tuned in retinotopic coordinates. However, under more unconstrained conditions, where subjects could attend easily to the motion stimuli, BOLD responses were tuned not in retinal but in external coordinates (spatiotopic selectivity) in many visual areas, including MT, MST, LO and V6, agreeing with our previous fMRI study. These results indicate that spatial attention may play an important role in mediating spatiotopic selectivity.	[Crespi, Sofia; Burr, David C.] Univ Florence, Dept Psychol, Florence, Italy; [Crespi, Sofia] Univ Vita Salute San Raffaele, Dept Psychol, Milan, Italy; [Biagi, Laura; Tosetti, Michela] Fdn Stella Maris, Pisa, Italy; [d'Avossa, Giovanni] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Burr, David C.] CNR, Ist Neurosci, I-56100 Pisa, Italy; [Morrone, Maria Concetta] Univ Pisa, Dept Physiol Sci, Pisa, Italy; [Morrone, Maria Concetta] Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Genoa, Italy	University of Florence; Vita-Salute San Raffaele University; IRCCS Fondazione Stella Maris; Bangor University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Pisa; Istituto Italiano di Tecnologia - IIT	Crespi, S (corresponding author), Univ Florence, Dept Psychol, Florence, Italy.	dave@in.cnr.it	Tosetti, Michela/K-5749-2016; Morrone, Maria Concetta/C-6756-2014; Biagi, Laura/K-5692-2016	Tosetti, Michela/0000-0002-2515-7560; Morrone, Maria Concetta/0000-0002-1025-0316; Biagi, Laura/0000-0003-2159-439X; CRESPI, Sofia Allegra/0000-0001-7429-0440; Burr, David/0000-0003-1541-8832	EEC [85154, 91070]; Italian Ministry of Universities and Research-MIUR	EEC; Italian Ministry of Universities and Research-MIUR(Ministry of Education, Universities and Research (MIUR))	This work was supported by the following: EEC framework 6 project MEMORY, http://cordis.europa.eu/fetch?CALLER = FP6_PROJ&ACTION = D&DOC = 3&CAT = PROJ&QUERY = 012dbd64851c:9d6e:69ebe69b&RCN = 85154; EEC framework 7 project ERC: STANIB, http://cordis.europa.eu/fetch?CALLER = FP7_PROJ_EN&ACTION = D&DOC = 1&CAT = PROJ&QUERY = 012dbd65f4f3:0989:37bc586e&RCN= 91070; and the Italian Ministry of Universities and Research-MIUR, http://prin.miur.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ANDERSEN RA, 1983, J NEUROSCI, V3, P532; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Bremmer F, 1998, EUR J NEUROSCI, V10, P153; BREMMER F, 2009, EXP BRAIN RES; BURR DC, 2010, PHIL T ROY IN PRESS; Cavanagh P, 2010, TRENDS COGN SCI, V14, P147, DOI 10.1016/j.tics.2010.01.007; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; d'Avossa G, 2007, NAT NEUROSCI, V10, P249, DOI 10.1038/nn1824; DeSouza JFX, 2002, CEREB CORTEX, V12, P991, DOI 10.1093/cercor/12.9.991; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Durand JB, 2010, NEURON, V66, P126, DOI 10.1016/j.neuron.2010.03.014; Fetsch CR, 2010, J NEUROPHYSIOL, V104, P1506, DOI 10.1152/jn.91247.2008; Fischer J, 2009, CURR BIOL, V19, P1356, DOI 10.1016/j.cub.2009.06.059; Fox MD, 2005, NEUROIMAGE, V28, P956, DOI 10.1016/j.neuroimage.2005.06.025; Froehler MT, 2002, SCIENCE, V295, P2462, DOI 10.1126/science.1067426; GALLETTI C, 1993, EXP BRAIN RES, V96, P221; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Gardner JL, 2008, J NEUROSCI, V28, P3988, DOI 10.1523/JNEUROSCI.5476-07.2008; Golomb JD, 2008, J NEUROSCI, V28, P10654, DOI 10.1523/JNEUROSCI.2525-08.2008; Golomb JD, 2010, J NEUROSCI, V30, P10493, DOI 10.1523/JNEUROSCI.1546-10.2010; Goossens J, 2006, J NEUROSCI, V26, P5616, DOI 10.1523/JNEUROSCI.0730-06.2006; Hansen KA, 2007, J NEUROSCI, V27, P11896, DOI 10.1523/JNEUROSCI.2991-07.2007; Hasnain MK, 1998, HUM BRAIN MAPP, V6, P301, DOI 10.1002/(SICI)1097-0193(1998)6:4<301::AID-HBM8>3.0.CO;2-7; Huk AC, 2002, J NEUROSCI, V22, P7195; Ilg UJ, 2004, NEURON, V43, P145, DOI 10.1016/j.neuron.2004.06.006; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; Lauritzen TZ, 2009, J VISION, V9, DOI 10.1167/9.13.18; MAFFEI L, 1984, DOC OPHTHALMOL, V58, P97, DOI 10.1007/BF00140905; MATHOT S, 2010, PSYCHOL SCI; Mathot S, 2010, EXP BRAIN RES, V200, P117, DOI 10.1007/s00221-009-2055-3; McKyton A, 2007, CEREB CORTEX, V17, P1164, DOI 10.1093/cercor/bhl027; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; Melcher D, 2004, VISION RES, V44, P1367, DOI 10.1016/j.visres.2003.11.023; Melcher D, 2003, NAT NEUROSCI, V6, P877, DOI 10.1038/nn1098; Melcher D, 2008, TRENDS COGN SCI, V12, P466, DOI 10.1016/j.tics.2008.09.003; Merriam EP, 2007, J NEUROPHYSIOL, V97, P1738, DOI 10.1152/jn.00189.2006; Merriam EP, 2003, NEURON, V39, P361, DOI 10.1016/S0896-6273(03)00393-3; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; MORRIS A, 2010, J VIS IN PRESS; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; Mullette-Gillman OA, 2005, J NEUROPHYSIOL, V94, P2331, DOI 10.1152/jn.00021.2005; Ollinger JM, 2001, NEUROIMAGE, V13, P218, DOI 10.1006/nimg.2000.0711; Ong WS, 2009, J NEUROPHYSIOL, V102, P2435, DOI 10.1152/jn.00684.2009; Pertzov Y, 2010, J NEUROSCI, V30, P8882, DOI 10.1523/JNEUROSCI.3986-09.2010; PITZALIS S, 2009, HUMAN, V6; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Sapir A, 2004, J COGNITIVE NEUROSCI, V16, P503, DOI 10.1162/089892904323057245; Saygin AP, 2008, CEREB CORTEX, V18, P2158, DOI 10.1093/cercor/bhm242; Schlack A, 2005, J NEUROSCI, V25, P4616, DOI 10.1523/JNEUROSCI.0455-05.2005; Sereno MI, 2006, NAT NEUROSCI, V9, P1337, DOI 10.1038/nn1777; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Silver MA, 2009, TRENDS COGN SCI, V13, P488, DOI 10.1016/j.tics.2009.08.005; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Trotter Y, 1999, NATURE, V398, P239, DOI 10.1038/18444; Wexler M, 2001, NATURE, V409, P85, DOI 10.1038/35051081; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; Zaksas D, 2005, J NEUROPHYSIOL, V94, P4156, DOI 10.1152/jn.00505.2005; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	69	66	68	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21661	10.1371/journal.pone.0021661	http://dx.doi.org/10.1371/journal.pone.0021661			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750720	Green Published, Green Submitted, gold			2022-12-25	WOS:000292655400009
J	Damulewicz, M; Pyza, E				Damulewicz, Milena; Pyza, Elzbieta			The Clock Input to the First Optic Neuropil of Drosophila melanogaster Expressing Neuronal Circadian Plasticity	PLOS ONE			English	Article							PIGMENT-DISPERSING FACTOR; RHYTHMIC SIZE CHANGES; MUSCA-DOMESTICA L; VISUAL-SYSTEM; PHOTORECEPTOR TERMINALS; PACEMAKER NEURONS; LATERAL NEURONS; GLIAL-CELLS; CRYPTOCHROME; LIGHT	In the first optic neuropil (lamina) of the fly's visual system, two interneurons, L1 and L2 monopolar cells, and epithelial glial cells show circadian rhythms in morphological plasticity. These rhythms depend on clock gene period (per) and cryptochrome (cry) expression. In the present study, we found that rhythms in the lamina of Drosophila melanogaster may be regulated by circadian clock neurons in the brain since the lamina is invaded by one neurite extending from ventral lateral neurons; the so-called pacemaker neurons. These neurons and the projection to the lamina were visualized by green fluorescent protein (GFP). GFP reporter gene expression was driven by the cry promotor in cry-GAL4/UAS-GFP transgenic lines. We observed that the neuron projecting to the lamina forms arborizations of varicose fibers in the distal lamina. These varicose fibers do not form synaptic contacts with the lamina cells and are immunoreactive to the antisera raised against a specific region of Schistocerca gregaria ion transport peptide (ITP). ITP released in a paracrine way in the lamina cortex, may regulate the swelling and shrinking rhythms of the lamina monopolar cells and the glia by controlling the transport of ions and fluids across cell membranes at particular times of the day.	[Damulewicz, Milena; Pyza, Elzbieta] Jagiellonian Univ, Inst Zool, Dept Cell Biol & Imaging, PL-30060 Krakow, Poland	Jagiellonian University	Damulewicz, M (corresponding author), Jagiellonian Univ, Inst Zool, Dept Cell Biol & Imaging, PL-30060 Krakow, Poland.	elzbieta.pyza@uj.edu.pl	Damulewicz, Milena/AAK-2606-2020		Jagiellonian University [K/ZDS/000793]	Jagiellonian University	Jagiellonian University grant K/ZDS/000793. The funder had no role in study design, data collection and analysi, decision to publish, or preparation of the manuscript.	AUDSLEY N, 1992, J EXP BIOL, V173, P261; Awasaki T, 2008, J NEUROSCI, V28, P13742, DOI 10.1523/JNEUROSCI.4844-08.2008; Balys M, 2001, J EXP BIOL, V204, P3303; Benito J, 2008, J BIOL RHYTHM, V23, P296, DOI 10.1177/0748730408318588; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Collins B, 2006, CURR BIOL, V16, P441, DOI 10.1016/j.cub.2006.01.034; Cusumano P, 2009, NAT NEUROSCI, V12, P1431, DOI 10.1038/nn.2429; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Fujii S, 2010, P NATL ACAD SCI USA, V107, P10590, DOI 10.1073/pnas.0912457107; Gorska-Andrzejak J, 2005, PHOTOCH PHOTOBIO SCI, V4, P721, DOI 10.1039/b417023g; Gorska-Andrzejak J, 2009, J INSECT PHYSIOL, V55, P459, DOI 10.1016/j.jinsphys.2009.02.003; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Helfrich-Forster C, 2007, J COMP NEUROL, V500, P47, DOI 10.1002/cne.21146; Helfrich-Forster C, 2009, J BIOL RHYTHM, V24, P259, DOI 10.1177/0748730409339614; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Im SH, 2010, J COMP NEUROL, V518, P1925, DOI 10.1002/cne.22311; Ivanchenko M, 2001, J BIOL RHYTHM, V16, P205, DOI 10.1177/074873001129001917; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; Kula E, 2007, DEV NEUROBIOL, V67, P1433, DOI 10.1002/dneu.20518; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Miskiewicz K, 2004, NEUROSCI LETT, V363, P73, DOI 10.1016/j.neulet.2004.03.051; Miskiewicz K, 2008, J COMP NEUROL, V509, P422, DOI 10.1002/cne.21765; Miyasako Y, 2007, J BIOL RHYTHM, V22, P115, DOI 10.1177/0748730407299344; Myers EM, 2003, CURR BIOL, V13, P526, DOI 10.1016/S0960-9822(03)00167-2; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Phillips JE, 1996, J EXP ZOOL, V275, P292, DOI 10.1002/(SICI)1097-010X(19960701)275:4&lt;292::AID-JEZ7&gt;3.0.CO;2-K; Pyza E, 2004, J INSECT PHYSIOL, V50, P985, DOI 10.1016/j.jinsphys.2004.08.003; Pyza E, 2004, J NEUROBIOL, V59, P205, DOI 10.1002/neu.10307; Pyza E, 2003, MICROSC RES TECHNIQ, V62, P103, DOI 10.1002/jemt.10365; Pyza E, 1996, J COMP PHYSIOL A, V178, P33, DOI 10.1007/BF00189588; Pyza E, 2002, MICROSC RES TECHNIQ, V58, P335, DOI 10.1002/jemt.10141; Pyza E, 1998, J COMP PHYSIOL A, V183, P719, DOI 10.1007/s003590050294; PYZA E, 1993, P ROY SOC B-BIOL SCI, V254, P97, DOI 10.1098/rspb.1993.0133; Pyza E, 2001, J INSECT PHYSIOL, V47, P897, DOI 10.1016/S0022-1910(01)00062-2; Pyza E, 1997, EUR J NEUROSCI, V9, P1784, DOI 10.1111/j.1460-9568.1997.tb01537.x; Pyza E, 1999, J NEUROBIOL, V40, P77, DOI 10.1002/(SICI)1097-4695(199907)40:1<77::AID-NEU7>3.0.CO;2-0; PYZA E, 1995, J NEUROSCI, V15, P407; Pyza E, 1997, J NEUROBIOL, V32, P517, DOI 10.1002/(SICI)1097-4695(199705)32:5<517::AID-NEU6>3.0.CO;2-8; PYZA E, 1999, COLD SPRING HARB M N, P145; PYZA E, 2010, ENCY EYE, V1, P302; Pyza Elzbieta, 2001, P55, DOI 10.1016/B978-044450608-5/50037-4; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Romero-Calderon R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000245; Shafer OT, 2006, J COMP NEUROL, V498, P180, DOI 10.1002/cne.21021; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; Stanewsky R, 1997, J NEUROSCI, V17, P676; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; Weber P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004290; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Yoshii T, 2005, EUR J NEUROSCI, V22, P1176, DOI 10.1111/j.1460-9568.2005.04295.x; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; ZERR DM, 1990, J NEUROSCI, V10, P2749; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8; Zheng H, 2008, J BIOL RHYTHM, V23, P283, DOI 10.1177/0748730408318566	67	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21258	10.1371/journal.pone.0021258	http://dx.doi.org/10.1371/journal.pone.0021258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21760878	Green Published, gold, Green Submitted			2022-12-25	WOS:000292092600024
J	de Lange, J; Ly, LV; Lodder, K; Verlaan-de Vries, M; Teunisse, AFAS; Jager, MJ; Jochemsen, AG				de Lange, J.; Ly, L. V.; Lodder, K.; Verlaan-de Vries, M.; Teunisse, A. F. A. S.; Jager, M. J.; Jochemsen, A. G.			Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma	ONCOGENE			English	Article						uveal melanoma; p53; Nutlin-3; RITA; topotecan; hypoxia	INDUCIBLE FACTOR 1-ALPHA; CHRONIC LYMPHOCYTIC-LEUKEMIA; DOWN-REGULATION; CANCER-CELLS; IN-VIVO; APOPTOSIS; MDM2; HYPOXIA; ATM; RITA	The prognosis of patients with uveal melanoma is poor. Because of the limited efficacy of current treatments, new therapeutic strategies need to be developed. Because p53 mutations are uncommon in uveal melanoma, reactivation of p53 may be used to achieve tumor regression. We investigated the use of combination therapies for intraocular melanoma, based on the p53 activators Nutlin-3 and reactivation of p53 and induction of tumor cell apoptosis (RITA) and the topoisomerase I inhibitor Topotecan. Nutlin-3 treatment induced p53-dependent growth inhibition in human uveal melanoma cell lines. The sensitivity to Nutlin-3 of the investigated cell lines did not correlate with basal Hdm2 or Hdmx levels. Nutlin-3 synergized with RITA and Topotecan to induce apoptosis in uveal melanoma cell lines and short-term cultures. Drug synergy correlated with enhanced induction of p53-Ser46 phosphorylation, which was attenuated by ATM inhibition. Nutlin-3 and Topotecan also significantly delayed tumor growth in vivo in a murine B16F10 model for ocular melanoma. Combination treatment appeared to inhibit tumor growth slightly more efficient than either drug alone. Nutlin-3, RITA and Topotecan lead to comparable p53 activation and growth inhibition under normoxia and hypoxia. Treatment with Nutlin-3 or RITA had no effect on HIF-1 alpha induction by hypoxia, whereas the combination of these two drugs did inhibit hypoxia-induced HIF-1 alpha. Also Topotecan, alone or in combination with Nutlin-3, reduced HIF-1 alpha protein levels, suggesting that a certain level of DNA damage response is required for p53-mediated downregulation of HIF-1 alpha. In conclusion, combination treatments based on small-molecule-induced p53 activation may have clinical potential for uveal melanoma. Oncogene (2012) 31, 1105-1116; doi:10.1038/onc.2011.309; published online 18 July 2011	[de Lange, J.; Lodder, K.; Verlaan-de Vries, M.; Teunisse, A. F. A. S.; Jochemsen, A. G.] Leiden Univ, Dept Mol Cell Biol, Med Ctr, NL-2300 RC Leiden, Netherlands; [Ly, L. V.; Jager, M. J.] Leiden Univ, Dept Ophthalmol, Med Ctr, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Jochemsen, AG (corresponding author), Leiden Univ, Dept Mol Cell Biol, Med Ctr, POB 9600, NL-2300 RC Leiden, Netherlands.	A.G.Jochemsen@lumc.nl	Jager, Martine/AAR-3525-2020	Jager, Martine/0000-0003-2261-3820; de Lange, Job/0000-0002-9002-8829	Netherlands Organization for Scientific Research NWO [017.003.059]; EC [503576]	Netherlands Organization for Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); EC(European CommissionEuropean Commission Joint Research Centre)	We thank Dr PA van der Velden and M Versluis for the primer sets to detect the expression of the HIF target genes and the early cultures of primary uveal melanoma cells, Dr A Vertegaal for the antibodies detecting HIF-1 alpha and HIF-2 alpha proteins, Prof BR Ksander for providing the Mel cell lines, Dr G Selivanova for providing RITA and Dr A Levine for providing anti-Mdm2 antibody. This study was supported by grants from the Netherlands Organization for Scientific Research NWO (Mozaiek Grant 017.003.059) and by EC FP6 funding (contract 503576).	An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Augsburger JJ, 2009, AM J OPHTHALMOL, V148, P119, DOI 10.1016/j.ajo.2009.01.023; Barbieri E, 2006, MOL CANCER THER, V5, P2358, DOI 10.1158/1535-7163.MCT-06-0305; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G; Chou T.-C., 2007, COMPUSYN SOFTWARE DR; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Coll-Mulet L, 2006, BLOOD, V107, P4109, DOI 10.1182/blood-2005-08-3273; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; DEWAARDSIEBINGA I, 1995, INT J CANCER, V62, P155, DOI 10.1002/ijc.2910620208; Enge M, 2009, CANCER CELL, V15, P171, DOI 10.1016/j.ccr.2009.01.019; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Kaluzova M, 2004, MOL CELL BIOL, V24, P5757, DOI 10.1128/MCB.24.13.5757-5766.2004; Kivela Tero, 2006, International Ophthalmology Clinics, V46, P133, DOI 10.1097/01.iio.0000195861.71558.13; Kodama M, 2010, MOL CELL BIOL, V30, P1620, DOI 10.1128/MCB.00810-09; Kojima K, 2006, BLOOD, V108, P993, DOI 10.1182/blood-2005-12-5148; Krajewski M, 2005, NAT MED, V11, P1135, DOI 10.1038/nm1105-1135; Lam S, 2010, ONCOGENE, V29, P2415, DOI 10.1038/onc.2009.522; LaRusch GA, 2007, CANCER RES, V67, P450, DOI 10.1158/0008-5472.CAN-06-2710; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Lee YM, 2009, CARCINOGENESIS, V30, P1768, DOI 10.1093/carcin/bgp196; Li Y, 2010, MOL CANCER THER, V9, P113, DOI 10.1158/1535-7163.MCT-08-1189; Ly LV, 2010, J IMMUNOL, V185, P3481, DOI 10.4049/jimmunol.0903479; Moeller BJ, 2005, CANCER CELL, V8, P99, DOI 10.1016/j.ccr.2005.06.016; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Ravi R, 2000, GENE DEV, V14, P34; Rinaldo C, 2009, CANCER RES, V69, P6241, DOI 10.1158/0008-5472.CAN-09-0337; Saha MN, 2010, MOL CANCER THER, V9, P3041, DOI 10.1158/1535-7163.MCT-10-0471; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Tomicic MT, 2010, J PHARMACOL EXP THER, V332, P316, DOI 10.1124/jpet.109.159962; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Wade M, 2006, J BIOL CHEM, V281, P33036, DOI 10.1074/jbc.M605405200; White JS, 2008, CELL CYCLE, V7, P1277, DOI 10.4161/cc.7.9.5961; Wynford-Thomas D, 1998, CARCINOGENESIS, V19, P29, DOI 10.1093/carcin/19.1.29; Yang J, 2009, MOL CELL BIOL, V29, P2243, DOI 10.1128/MCB.00959-08	37	46	48	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	9					1105	1116		10.1038/onc.2011.309	http://dx.doi.org/10.1038/onc.2011.309			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	901EW	21765463				2022-12-25	WOS:000300945900004
J	Arwert, EN; Mentink, RA; Driskell, RR; Hoste, E; Goldie, SJ; Quist, S; Watt, FM				Arwert, E. N.; Mentink, R. A.; Driskell, R. R.; Hoste, E.; Goldie, S. J.; Quist, S.; Watt, F. M.			Upregulation of CD26 expression in epithelial cells and stromal cells during wound-induced skin tumour formation	ONCOGENE			English	Article						epidermis; MEK1; IL-1 alpha; CD26; dipeptidyl peptidase-4; Sitagliptin	DIPEPTIDYL-PEPTIDASE-IV; ENZYME-ACTIVITY; EPIDERMAL-CELLS; STEM-CELLS; KERATINOCYTES; INHIBITION; DIFFERENTIATION; PROLIFERATION; GLYCOSYLATION; SITAGLIPTIN	We have previously described InvEE transgenic mice in which non-dividing, differentiating epidermal cells express oncogenically activated MAPK kinase 1 (MEK1). Skin wounding triggers tumour formation in InvEE mice via a mechanism that involves epidermal release of IL-1 alpha and attraction of a pro-tumorigenic inflammatory infiltrate. To look for potential effects on the underlying connective tissue, we screened InvEE and wild-type epidermis for differential expression of cytokines and immune modulators. We identified a single protein, CD26 (dipeptidyl peptidase-4). CD26 serum levels were not increased in InvEE mice. In contrast, CD26 was upregulated in keratinocytes expressing mutant MEK1 and in the epithelial compartment of InvEE tumours, where it accumulated at cell-cell borders. CD26 expression was increased in dermal fibroblasts following skin wounding but was downregulated in tumour stroma. CD26 activity was stimulated by calcium-induced intercellular adhesion in keratinocytes, suggesting that the upregulation of CD26 in InvEE epidermis is due to expansion of the differentiated cell layers. IL-1 alpha treatment of dermal fibroblasts stimulated CD26 activity, and therefore epidermal IL-1 alpha release may contribute to the upregulation of CD26 expression in wounded dermis. Pharmacological blockade of CD26, via Sitagliptin, reduced growth of InvEE tumours, while combined inhibition of IL-1 alpha and CD26 delayed tumour onset and reduced tumour incidence. Our results demonstrate that inappropriate activation of MEK1 in the epidermis leads to changes in dermal fibroblasts that, like the skin inflammatory infiltrate, contribute to tumour formation. Oncogene (2012) 31, 992-1000; doi:10.1038/onc.2011.298; published online 18 July 2011	[Arwert, E. N.; Mentink, R. A.; Hoste, E.; Goldie, S. J.; Quist, S.; Watt, F. M.] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge CB2 0RE, Cambs, England; [Driskell, R. R.; Watt, F. M.] Wellcome Trust Ctr Stem Cell Res, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Watt, FM (corresponding author), Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Robinson Way, Cambridge CB2 0RE, Cambs, England.	Fiona.watt@cancer.org.uk	Quist, Sven R/G-2052-2013; Hoste, Esther/M-9926-2014; Hoste, Esther/AAG-2218-2020; Watt, Fiona/AHB-0226-2022; Quist, Sven R/C-9102-2017	Quist, Sven R/0000-0002-9548-7813; Hoste, Esther/0000-0002-3181-431X; Hoste, Esther/0000-0002-3181-431X; Watt, Fiona/0000-0001-9151-5154; Quist, Sven R/0000-0002-9548-7813; Driskell, Ryan/0000-0001-7673-2564; Arwert, Esther/0000-0001-7475-9704; Mentink, Remco/0000-0003-1005-7767	Cancer Research UK; Dutch Cancer Society; Wellcome Trust; MRC; European Union; Hutchison Whampoa; Cambridge University; Medical Research Council [G0701336, G1100073] Funding Source: researchfish; MRC [G0701336, G1100073] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Dutch Cancer Society(KWF Kankerbestrijding); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Hutchison Whampoa; Cambridge University(University of Cambridge); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to Donna Michelle Smith for performing SG chromatography. We acknowledge support from Cancer Research UK, the Dutch Cancer Society (to RM), the Wellcome Trust, the MRC, the European Union, Hutchison Whampoa and Cambridge University.	Aertgeerts K, 2004, PROTEIN SCI, V13, P145, DOI 10.1110/ps.03352504; Ansorge S, 2009, CLIN CHEM LAB MED, V47, P253, DOI 10.1515/CCLM.2009.063; Arwert EN, 2010, P NATL ACAD SCI USA, V107, P19903, DOI 10.1073/pnas.1007404107; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; Deacon CF, 2007, EXPERT OPIN INV DRUG, V16, P533, DOI 10.1517/13543784.16.4.533; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Fan H, 1997, EUR J BIOCHEM, V246, P243, DOI 10.1111/j.1432-1033.1997.00243.x; Hobbs RM, 2004, J INVEST DERMATOL, V123, P503, DOI 10.1111/j.0022-202X.2004.23225.x; Iwata S, 1999, J EXP MED, V190, P301, DOI 10.1084/jem.190.3.301; Jackson EK, 2008, HYPERTENSION, V51, P1637, DOI 10.1161/HYPERTENSIONAHA.108.112532; Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39; Jones SM, 2006, NAT REV CANCER, V6, P175, DOI 10.1038/nrc1817; Karlsson L, 1999, DEVELOPMENT, V126, P2611; Kim D, 2005, J MED CHEM, V48, P141, DOI 10.1021/jm0493156; KOHL A, 1991, AGENTS ACTIONS, V32, P125, DOI 10.1007/BF01983337; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Lindsay JR, 2005, DIABETIC MED, V22, P654, DOI 10.1111/j.1464-5491.2005.01461.x; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Nemoto E, 1999, INFECT IMMUN, V67, P6225; Novelli M, 1996, BRIT J DERMATOL, V134, P1052, DOI 10.1046/j.1365-2133.1996.d01-900.x; Ohnuma K, 2008, TRENDS IMMUNOL, V29, P295, DOI 10.1016/j.it.2008.02.010; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Pereira DA, 2003, BRAZ J MED BIOL RES, V36, P567, DOI 10.1590/S0100-879X2003000500003; Reinhold D, 1998, FEBS LETT, V428, P100, DOI 10.1016/S0014-5793(98)00502-X; Romero MR, 1999, EXP DERMATOL, V8, P53, DOI 10.1111/j.1600-0625.1999.tb00348.x; Ta NN, 2010, ATHEROSCLEROSIS, V213, P429, DOI 10.1016/j.atherosclerosis.2010.08.064; Takasawa W, 2010, BIOCHEM BIOPH RES CO, V401, P7, DOI 10.1016/j.bbrc.2010.08.112; VIVIER I, 1991, J IMMUNOL, V147, P447; WATT FM, 1984, J CELL BIOL, V98, P16, DOI 10.1083/jcb.98.1.16; Willheim M, 1997, J ALLERGY CLIN IMMUN, V100, P348, DOI 10.1016/S0091-6749(97)70248-3	31	32	34	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	8					992	1000		10.1038/onc.2011.298	http://dx.doi.org/10.1038/onc.2011.298			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	898BG	21765471				2022-12-25	WOS:000300709700005
J	Regan, JL; Kendrick, H; Magnay, FA; Vafaizadeh, V; Groner, B; Smalley, MJ				Regan, J. L.; Kendrick, H.; Magnay, F-A; Vafaizadeh, V.; Groner, B.; Smalley, M. J.			c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer	ONCOGENE			English	Article						Brca1; c-Kit; mammary; progenitor	PROTEIN-TYROSINE KINASE; FUNCTIONAL MAMMARY-GLAND; ESTROGEN-RECEPTOR-ALPHA; 2 SPLICE FORMS; STEM-CELLS; SIGNAL-TRANSDUCTION; LINEAGE-COMMITMENT; BRCA1; ACTIVATION; MOUSE	BRCA1 mutation-associated breast cancer originates in oestrogen receptor-alpha-negative (ER-) progenitors in the mammary luminal epithelium. These cells also express high levels of the Kit gene and a recent study demonstrated a correlation between Brca1 loss and Kit over-expression in the mammary epithelium. However, the functional significance of c-Kit expression in the mammary gland is unknown. To address this, c-Kit(-) and c-Kit(+) mammary epithelial subsets were isolated by flow cytometry, characterised for expression of lineage-specific cell markers and functionally analysed by in vitro colony forming and in vivo transplantation assays. The results confirm that the majority of luminal ER- progenitors are c-Kit(+), but also that most stem cells and the differentiated cell populations are c-Kit(-). A subset of c-Kit(+) cells with high proliferative potential was found in the luminal ER+ population, however, suggesting the existence of a distinct luminal ER+ progenitor cell type. Analysis of mouse Brca1 mammary tumours demonstrated that they expressed Kit and its downstream effector Lyn at levels comparable to the most strongly c-Kit(+) luminal ER- progenitors. Consistent with c-Kit being a progenitor cell marker, in vitro threedimensional differentiation of c-Kit(+) cells resulted in a loss of c-Kit expression, whereas c-Kit over-expression prevented normal differentiation in vivo. Furthermore, c-Kit was a functional marker of proliferative potential, as c-Kit inhibition by short hairpin knockdown prevented normal epithelial growth and caused cells to undergo apoptosis. Therefore, c-Kit defines distinct progenitor populations in the mammary epithelium and is critical for mammary progenitor survival and proliferation. Importantly, c-Kit is only the second mammary epithelial stem/progenitor marker to be shown to have a functional role in the mammary epithelium and the first marker to be shown to be required for progenitor cell function. The c-Kit signalling network has potential as a target for therapy and/or prevention in BRCA1-associated breast cancer. Oncogene (2012) 31, 869-883; doi:10.1038/onc.2011.289; published online 18 July 2011	[Regan, J. L.; Kendrick, H.; Magnay, F-A; Smalley, M. J.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Vafaizadeh, V.; Groner, B.] Georg Speyer Haus, Inst Biomed Res, Frankfurt, Germany	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Octapharma	Smalley, MJ (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, 237 Fulham Rd, London SW3 6JB, England.	matthew.smalley@icr.ac.uk	Regan, Joseph/K-4188-2019; Smalley, Matthew J/M-7000-2015	Regan, Joseph/0000-0001-9987-7942; Smalley, Matthew J/0000-0001-9540-1146; Vafaizadeh, Vida/0000-0002-0875-6246	Breakthrough Breast Cancer; NHS	Breakthrough Breast Cancer; NHS	We thank Eric So for the c-Kit cDNA, Fredrik Wallberg for help with flow cytometry analysis and Jorge Reis-Filho and Arno Gauthier for assistance with assessment of Lyn staining on mouse tumours. This work was funded by Breakthrough Breast Cancer. We acknowledge NHS funding to the NIHR Biomedical Research Centre. This work was funded by Breakthrough Breast Cancer. We acknowledge NHS funding to the NIHR Biomedical Research Centre.	Altiok S, 1999, J BIOL CHEM, V274, P32274, DOI 10.1074/jbc.274.45.32274; Arendt LM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2819; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Barton J, 2006, J CLIN ONCOL, V24, P10716; Baxter LL, 2004, PIGM CELL RES, V17, P215, DOI 10.1111/j.1600-0749.2004.00147.x; BRANNAN CI, 1991, P NATL ACAD SCI USA, V88, P4671, DOI 10.1073/pnas.88.11.4671; Britt KL, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2245; Brizzi MF, 1999, J BIOL CHEM, V274, P16965, DOI 10.1074/jbc.274.24.16965; Caruana G, 1999, ONCOGENE, V18, P5573, DOI 10.1038/sj.onc.1202939; Chew HK, 2006, J CLIN ONCOL S18, V24, P10529; Chin H, 1998, BLOOD, V91, P3734; Clarke RB, 1997, CANCER RES, V57, P4987; DeBerry C, 1997, BIOCHEM J, V327, P73, DOI 10.1042/bj3270073; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Driessen RL, 2003, EXP HEMATOL, V31, P1284, DOI 10.1016/j.exphem.2003.08.015; Fernandez-Gonzalez R, 2009, INTEGR BIOL, V1, P80, DOI 10.1039/b816933k; Gao B, 2001, FEBS LETT, V488, P179, DOI 10.1016/S0014-5793(00)02430-3; Gommerman JL, 1997, J BIOL CHEM, V272, P30519, DOI 10.1074/jbc.272.48.30519; Gommerman JL, 2000, BLOOD, V96, P3734, DOI 10.1182/blood.V96.12.3734.h8003734_3734_3742; Gusterson BA, 2005, BREAST CANCER RES, V7, P143, DOI 10.1186/bcr1041; Haley BB, 2007, J CLIN ONCOL, V25; HAYASHI SI, 1991, NUCLEIC ACIDS RES, V19, P1267, DOI 10.1093/nar/19.6.1267; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Kent D, 2008, CLIN CANCER RES, V14, P1926, DOI 10.1158/1078-0432.CCR-07-5134; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Lilla JN, 2010, DEV BIOL, V337, P124, DOI 10.1016/j.ydbio.2009.10.021; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Linnekin D, 1997, J BIOL CHEM, V272, P27450, DOI 10.1074/jbc.272.43.27450; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; MIYAZAWA K, 1995, BLOOD, V85, P641, DOI 10.1182/blood.V85.3.641.bloodjournal853641; Molyneux G, 2007, CELL MOL LIFE SCI, V64, P3248, DOI 10.1007/s00018-007-7391-5; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Ouchi T, 2000, P NATL ACAD SCI USA, V97, P5208, DOI 10.1073/pnas.080469697; Pathan NI, 1996, J BIOL CHEM, V271, P27517, DOI 10.1074/jbc.271.44.27517; REITH AD, 1991, EMBO J, V10, P2451, DOI 10.1002/j.1460-2075.1991.tb07784.x; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V338, P1307, DOI 10.1016/j.bbrc.2005.09.150; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shivakrupa R, 2005, CELL SIGNAL, V17, P103, DOI 10.1016/j.cellsig.2004.06.004; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Smalley MJ, 2010, METHODS MOL BIOL, V633, P139, DOI 10.1007/978-1-59745-019-5_11; Smart CE, 2011, ONCOGENE, V30, P1597, DOI 10.1038/onc.2010.538; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Sun JM, 2008, J BIOL CHEM, V283, P27444, DOI 10.1074/jbc.M709703200; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Vafaizadeh V, 2010, STEM CELLS, V28, P928, DOI 10.1002/stem.407; Vidarsson H, 2002, FEBS LETT, V532, P247, DOI 10.1016/S0014-5793(02)03684-0; Voytyuk O, 2003, J BIOL CHEM, V278, P9159, DOI 10.1074/jbc.M211726200; Wang HC, 1997, ONCOGENE, V15, P143, DOI 10.1038/sj.onc.1201252; WATERHOUSE DM, 2008, J CLIN ONCOL S, V26; Westbury CB, 2009, J PATHOL, V219, P131, DOI 10.1002/path.2581; Young SM, 2007, CELL SIGNAL, V19, P2572, DOI 10.1016/j.cellsig.2007.08.004; Yu M, 2006, J BIOL CHEM, V281, P28615, DOI 10.1074/jbc.M603742200	56	76	77	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	7					869	883		10.1038/onc.2011.289	http://dx.doi.org/10.1038/onc.2011.289			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	897BL	21765473				2022-12-25	WOS:000300615800006
J	Wang, Y; Lazo, JS				Wang, Y.; Lazo, J. S.			Metastasis-associated phosphatase PRL-2 regulates tumor cell migration and invasion	ONCOGENE			English	Article						PRL-2; lung cancer; cell invasion; ERK	PROTEIN-TYROSINE-PHOSPHATASE; PANCREATIC-CANCER CELLS; REGENERATING LIVER-3; COLORECTAL-CANCER; BREAST-CANCER; LUNG-CANCER; EXPRESSION; PROMOTES; MOTILITY; PROGNOSIS	The phosphatase of regenerating liver (PRL) family, comprising PRL-1, PRL-2 and PRL-3, is a group of prenylated phosphatases that are candidate cancer biomarkers and therapeutic targets. Although several studies have documented that altered expression of PRL-1 or PRL-3 can influence cell proliferation, migration and invasion, there is a dearth of knowledge about the biological functions of PRL-2. Thus, in the current study we have evaluated the role of PRL-2 in cell migration and invasion in human cancer cells. We found that four human lung cancer cells, including A549 cells, overexpress PRL-2 when compared with normal lung cells. PRL-2 knockdown by RNA interference markedly inhibited cell migration and invasion, and this inhibition can be restored by overexpressing the short interference RNA (siRNA)resistant vector HA-PRL-2m. PRL-2 suppression by siRNA decreased p130Cas and vinculin expression, and decreased extracellular signal-regulated kinase (ERK) phosphorylation, while increasing the phosphorylation of ezrin on tyrosine 146. We found no significant changes in total p53, Akt and c-Src expression levels or their phosphorylation status, suggesting that PRL-2 knockdown could inhibit tumor cell migration and invasion through a Src-independent p130Cas signaling pathway. Ectopic expression of wild-type PRL-2, a catalytic inactive C101S mutant and a C-terminal CAAX deletion revealed a requirement for both the PRL-2 catalytic functionality and prenylation site. Expression of wild-type but not mutant forms of PRL-2 caused ERK phosphorylation and nuclear translocation. These results support a model in which PRL-2 promotes cell migration and invasion through an ERK-dependent signaling pathway. Oncogene (2012) 31, 818-827; doi: 10.1038/onc.2011.281; published online 18 July 2011	[Wang, Y.; Lazo, J. S.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lazo, JS (corresponding author), Univ Virginia, Dept Pharmacol, POB 800793, Charlottesville, VA 22908 USA.	lazo@virginia.edu			National Institutes of Health National Cancer Institute [CA78039]; Fiske Drug Discovery Fund; NATIONAL CANCER INSTITUTE [P01CA078039] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fiske Drug Discovery Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Institutes of Health National Cancer Institute (CA78039) and the Fiske Drug Discovery Fund.	Achiwa H, 2007, CANCER RES, V67, P643, DOI 10.1158/0008-5472.CAN-06-2436; Basak S, 2008, MOL CELL, V30, P303, DOI 10.1016/j.molcel.2008.04.002; Cates CA, 1996, CANCER LETT, V110, P49, DOI 10.1016/S0304-3835(96)04459-X; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Forte E, 2008, BBA-MOL CELL RES, V1783, P334, DOI 10.1016/j.bbamcr.2007.11.004; Guo K, 2004, CANCER BIOL THER, V3, P945, DOI 10.4161/cbt.3.10.1111; Han HY, 2002, CANCER RES, V62, P2890; Hardy S, 2010, CANCER RES, V70, P8959, DOI 10.1158/0008-5472.CAN-10-2041; Kato H, 2004, CLIN CANCER RES, V10, P7318, DOI 10.1158/1078-0432.CCR-04-0485; Kim W, 2004, J BIOL CHEM, V279, P8333, DOI 10.1074/jbc.M312026200; Li ZR, 2007, SURG TODAY, V37, P646, DOI 10.1007/s00595-006-3437-9; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Luo Y, 2009, BIOCHEMISTRY-US, V48, P1838, DOI 10.1021/bi8020789; Min SH, 2009, ONCOGENE, V28, P545, DOI 10.1038/onc.2008.409; Ming J, 2009, PATHOLOGY, V41, P118, DOI 10.1080/00313020802579268; Miskad UA, 2004, PATHOBIOLOGY, V71, P176, DOI 10.1159/000078671; Peng LR, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-110; Peng LR, 2004, J CANCER RES CLIN, V130, P521, DOI 10.1007/s00432-004-0563-x; Radke I, 2006, BRIT J CANCER, V95, P347, DOI 10.1038/sj.bjc.6603261; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Stephens BJ, 2005, MOL CANCER THER, V4, P1653, DOI 10.1158/1535-7163.MCT-05-0248; Stephens B, 2008, MOL CANCER THER, V7, P202, DOI 10.1158/1535-7163.MCT-07-0542; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang J, 2002, J BIOL CHEM, V277, P46659, DOI 10.1074/jbc.M206407200; Wang L, 2006, ANN ONCOL, V17, P1517, DOI 10.1093/annonc/mdl159; Wang Q, 2002, CANCER LETT, V175, P63, DOI 10.1016/S0304-3835(01)00703-0; Wang Y, 2007, INT J COLORECTAL DIS, V22, P1179, DOI 10.1007/s00384-007-0303-1; Wu XP, 2004, AM J PATHOL, V164, P2039, DOI 10.1016/S0002-9440(10)63763-7; Yagi T, 2003, BLOOD, V102, P1849, DOI 10.1182/blood-2003-02-0578; Zamir E, 2001, J CELL SCI, V114, P3583; Zeng Q, 2000, J BIOL CHEM, V275, P21444, DOI 10.1074/jbc.M000453200; Zeng Q, 2003, CANCER RES, V63, P2716	34	29	31	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2012	31	7					818	827		10.1038/onc.2011.281	http://dx.doi.org/10.1038/onc.2011.281			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	897BL	21765462	Green Accepted			2022-12-25	WOS:000300615800002
J	Parsons, P; Gilbert, SJ; Vaughan-Thomas, A; Sorrell, DA; Notman, R; Bishop, M; Hayes, AJ; Mason, DJ; Duance, VC				Parsons, Philippa; Gilbert, Sophie J.; Vaughan-Thomas, Anne; Sorrell, David A.; Notman, Rebecca; Bishop, Mark; Hayes, Anthony J.; Mason, Deborah J.; Duance, Victor C.			Type IX Collagen Interacts with Fibronectin Providing an Important Molecular Bridge in Articular Cartilage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; MULTIPLE EPIPHYSEAL DYSPLASIA; EXTRACELLULAR-MATRIX; MESSENGER-RNA; OSTEOARTHRITIC CARTILAGE; ESCHERICHIA-COLI; CROSS-LINKING; ED-A; CHONDROCYTES; EXPRESSION	Type IX collagen is covalently bound to the surface of type II collagen fibrils within the cartilage extracellular matrix. The N-terminal, globular noncollagenous domain (NC4) of the alpha 1(IX) chain protrudes away from the surface of the fibrils into the surrounding matrix and is available for molecular interactions. To define these interactions, we used the NC4 domain in a yeast two-hybrid screen of a human chondrocyte cDNA library. 73% of the interacting clones encoded fibronectin. The interaction was confirmed using in vitro immunoprecipitation and was further characterized by surface plasmon resonance. Using whole and pepsin-derived preparations of type IX collagen, the interaction was shown to be specific for the NC4 domain with no interaction with the triple helical collagenous domains. The interaction was shown to be of high affinity with nanomolar K-d values. Analysis of the fibronectin-interacting clones indicates that the constant domain is the likely site of interaction. Type IX collagen and fibronectin were shown to co-localize in cartilage. This novel interaction between the NC4 domain of type IX collagen and fibronectin may represent an in vivo interaction in cartilage that could contribute to the matrix integrity of the tissue.	[Gilbert, Sophie J.; Notman, Rebecca; Bishop, Mark; Hayes, Anthony J.; Mason, Deborah J.; Duance, Victor C.] Cardiff Univ, Sch Biosci, Pathophysiol & Repair Div, Cardiff CF10 3AX, S Glam, Wales; [Parsons, Philippa] Res Ctr, York YO10 5DF, N Yorkshire, England; [Vaughan-Thomas, Anne] Univ Liverpool, Fac Vet Sci, Liverpool L69 7ZJ, Merseyside, England; [Sorrell, David A.] Horizon Discovery Serv, Cambridge CB4 0WE, England	Cardiff University; University of Liverpool	Duance, VC (corresponding author), Cardiff Univ, Sch Biosci, Pathophysiol & Repair Div, Museum Ave, Cardiff CF10 3AX, S Glam, Wales.	Duance@Cardiff.ac.uk	Gilbert, Sophie/AAT-9908-2020; Notman, Rebecca/C-2066-2009; Hayes, Anthony/F-2658-2012; Mason, Deborah J/F-8265-2010	Gilbert, Sophie/0000-0001-9828-132X; Notman, Rebecca/0000-0002-9721-0375; Mason, Deborah J/0000-0003-4926-3365; Hayes, Anthony/0000-0002-2918-3723	Arthritis Research UK [D0596]; Cardiff University; National Institutes of Health, NICHD	Arthritis Research UK(Versus Arthritis); Cardiff University; National Institutes of Health, NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Arthritis Research UK Grant D0596 and in part by a Cardiff University studentship.; We thank Karl E. Kadler (Manchester University) for the NC4 domain primary antibody. The FN monoclonal antibody (clone HFN36.3) was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institutes of Health, NICHD, and maintained by the University of Iowa, Iowa City, IA 52242.	Bank RA, 1998, BIOCHEM J, V330, P345, DOI 10.1042/bj3300345; BENNETT VD, 1991, J BIOL CHEM, V266, P5918; Blumbach K, 2009, ARTHRITIS RHEUM-US, V60, P3676, DOI 10.1002/art.24979; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; Burton-Wurster N, 1998, MATRIX BIOL, V17, P193, DOI 10.1016/S0945-053X(98)90058-0; BURTONWURSTER N, 1988, BIOCHEM BIOPH RES CO, V154, P1088, DOI 10.1016/0006-291X(88)90252-5; BurtonWurster N, 1997, MATRIX BIOL, V15, P441, DOI 10.1016/S0945-053X(97)90018-4; Czarny-Ratajczak M, 2001, AM J HUM GENET, V69, P969, DOI 10.1086/324023; DUANCE V C, 1991, Biochemical Society Transactions, V19, p376S; Duance V. C., 1999, BIOL SYNOVIAL JOINT, P135; DUANCE VC, 1984, BIOCHEM J, V221, P885, DOI 10.1042/bj2210885; DUANCE VC, 1982, BIOSCIENCE REP, V2, P223, DOI 10.1007/BF01136720; DUANCE VC, 1990, ANN NY ACAD SCI, V580, P480; ELENIUS K, 1990, J BIOL CHEM, V265, P17837; Eyre DR, 2004, J BIOL CHEM, V279, P2568, DOI 10.1074/jbc.M311653200; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Fernandes RJ, 2003, EUR J BIOCHEM, V270, P3243, DOI 10.1046/j.1432-1033.2003.03711.x; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gietz R Daniel, 2006, Methods Mol Biol, V313, P345; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Haimes H. B., 1995, INFLAMM RES S2, V44, P127; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; HOMANDBERG GA, 1994, ARCH BIOCHEM BIOPHYS, V311, P213, DOI 10.1006/abbi.1994.1229; HOMANDBERG GA, 1992, J BIOL CHEM, V267, P3597; Homandberg GA, 1997, BIOCHEM J, V321, P751, DOI 10.1042/bj3210751; HOMANDBERG GA, 1993, J RHEUMATOL, V20, P1378; HOMANDBERG GA, 1999, FRONT BIOSCI, V4, P713; HYNES RO, 1990, FIBRONECTINS, P1; Kapyla J, 2004, J BIOL CHEM, V279, P51677, DOI 10.1074/jbc.M409412200; Kornblihtt AR, 1996, FASEB J, V10, P248, DOI 10.1096/fasebj.10.2.8641558; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOESER RF, 1995, EXP CELL RES, V217, P248, DOI 10.1006/excr.1995.1084; MacLeod JN, 1996, J BIOL CHEM, V271, P18954, DOI 10.1074/jbc.271.31.18954; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; Munakata H, 1999, GLYCOBIOLOGY, V9, P1023, DOI 10.1093/glycob/9.10.1023; NAKATA K, 1993, P NATL ACAD SCI USA, V90, P2870, DOI 10.1073/pnas.90.7.2870; NISHIMURA I, 1989, J BIOL CHEM, V264, P20033; Olsen BR, 1997, INT J BIOCHEM CELL B, V29, P555, DOI 10.1016/S1357-2725(96)00100-8; Pfander D, 1999, J RHEUMATOL, V26, P386; Pihlajamaa T, 2004, J BIOL CHEM, V279, P24265, DOI 10.1074/jbc.M402865200; POOLE CA, 1988, HISTOCHEM J, V20, P567, DOI 10.1007/BF01002611; Posey KL, 2008, AM J PATHOL, V172, P1664, DOI 10.2353/ajpath.2008.071094; RENCIC A, 1995, OSTEOARTHR CARTILAGE, V3, P187, DOI 10.1016/S1063-4584(05)80053-6; SALTER DM, 1992, BRIT J RHEUMATOL, V31, P231; Sambrook J., 2002, MOL CLONING LAB MANU; SAUNDERS S, 1988, J CELL BIOL, V106, P423, DOI 10.1083/jcb.106.2.423; Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4; Schwarzbauer JE, 1991, CURR OPIN CELL BIOL, V3, P786, DOI 10.1016/0955-0674(91)90051-Y; SHIMOKOMAKI M, 1980, FEBS LETT, V121, P51, DOI 10.1016/0014-5793(80)81265-8; Tillgren V, 2009, J BIOL CHEM, V284, P28543, DOI 10.1074/jbc.M109.047076; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; Vaughan-Thomas A, 2008, CONNECT TISSUE RES, V49, P374, DOI 10.1080/03008200802325417; WOTTON SF, 1991, HISTOCHEM J, V23, P328, DOI 10.1007/BF01044964; Wright MO, 1997, J ORTHOPAED RES, V15, P742, DOI 10.1002/jor.1100150517; WU JJ, 1992, J BIOL CHEM, V267, P23007; ZHANG DW, 1995, J BIOL CHEM, V270, P1817, DOI 10.1074/jbc.270.4.1817	61	25	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34986	34997		10.1074/jbc.M111.238188	http://dx.doi.org/10.1074/jbc.M111.238188			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21768108	hybrid, Green Published			2022-12-25	WOS:000295406300052
J	Vigetti, D; Rizzi, M; Moretto, P; Deleonibus, S; Dreyfuss, JM; Karousou, E; Viola, M; Clerici, M; Hascall, VC; Ramoni, MF; De Luca, G; Passi, A				Vigetti, Davide; Rizzi, Manuela; Moretto, Paola; Deleonibus, Sara; Dreyfuss, Jonathan M.; Karousou, Evgenia; Viola, Manuela; Clerici, Moira; Hascall, Vincent C.; Ramoni, Marco F.; De Luca, Giancarlo; Passi, Alberto			Glycosaminoglycans and Glucose Prevent Apoptosis in 4-Methylumbelliferone-treated Human Aortic Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT HYALURONAN; INHIBITS APOPTOSIS; XENOPUS-LAEVIS; CD44; INJURY; EXPRESSION; ADHESION; ACID; P53; OLIGOSACCHARIDES	Smooth muscle cells (SMCs) have a pivotal role in cardiovascular diseases and are responsible for hyaluronan (HA) deposition in thickening vessel walls. HA regulates SMC proliferation, migration, and inflammation, which accelerates neointima formation. We used the HA synthesis inhibitor 4-methylumbelliferone (4-MU) to reduce HA production in human aortic SMCs and found a significant increase of apoptotic cells. Interestingly, the exogenous addition of HA together with 4-MU reduced apoptosis. A similar anti-apoptotic effect was observed also by adding other glycosaminoglycans and glucose to 4-MU-treated cells. Furthermore, the anti-apoptotic effect of HA was mediated by Toll-like receptor 4, CD44, and PI3K but not by ERK1/2.	[Vigetti, Davide; Rizzi, Manuela; Moretto, Paola; Deleonibus, Sara; Karousou, Evgenia; Viola, Manuela; Clerici, Moira; De Luca, Giancarlo; Passi, Alberto] Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, I-21100 Varese, Italy; [Dreyfuss, Jonathan M.; Ramoni, Marco F.] Harvard Univ, Harvard Partners Ctr Genet & Gen, Boston, MA 02115 USA; [Hascall, Vincent C.] Cleveland Clin, Biomed Engn ND20, Cleveland, OH 44195 USA	University of Insubria; Harvard University; Cleveland Clinic Foundation	Passi, A (corresponding author), Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, Via JH Dunant 5, I-21100 Varese, Italy.	alberto.passi@uninsubria.it	Rizzi, Manuela/AAE-9202-2021; passi, alberto g/A-1752-2018; Viola, Manuela/B-7120-2011; Vigetti, Davide/C-9861-2010	Rizzi, Manuela/0000-0002-6174-7111; passi, alberto g/0000-0003-3328-3089; Viola, Manuela/0000-0002-0634-6390; Vigetti, Davide/0000-0002-6339-8453; Dreyfuss, Jonathan/0000-0001-7242-3991	"Centro Grandi Attrezzature per la Ricerca Biomedica" Universita degli Studi dell'Insubria; PhD School in Biological and Medical Sciences; University of Insubria (FAR); Centro Interuniversitario di Biotecnologie; Fondazione Comunitaria del Varesotto-ONLUS; Centro Insubre di Biotecnologie per la Salute Umana	"Centro Grandi Attrezzature per la Ricerca Biomedica" Universita degli Studi dell'Insubria; PhD School in Biological and Medical Sciences; University of Insubria (FAR); Centro Interuniversitario di Biotecnologie; Fondazione Comunitaria del Varesotto-ONLUS; Centro Insubre di Biotecnologie per la Salute Umana	This work was supported by the "Centro Grandi Attrezzature per la Ricerca Biomedica" Universita degli Studi dell'Insubria and the PhD School in Biological and Medical Sciences fellowships (to M. R., M. C., and S. D.). This work was also supported by grants from the University of Insubria (FAR) (to D. V., A. P., and G. D. L.), Centro Interuniversitario di Biotecnologie (to A. P.), Fondazione Comunitaria del Varesotto-ONLUS (to D. V.), and a young researcher award from Centro Insubre di Biotecnologie per la Salute Umana (to D.V.).	Chiu Roland K., 1999, Neoplasia (New York), V1, P446, DOI 10.1038/sj.neo.7900045; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Gorman AM, 1997, CYTOMETRY, V29, P97; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jo SK, 2005, KIDNEY INT, V67, P458, DOI 10.1111/j.1523-1755.2005.67102.x; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Kaneko T, 2000, J ASSIST REPROD GEN, V17, P162, DOI 10.1023/A:1009470206468; Karousou EG, 2005, BIOMED CHROMATOGR, V19, P761, DOI 10.1002/bmc.511; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kothapalli D, 2008, J BIOL CHEM, V283, P31823, DOI 10.1074/jbc.M802934200; Kothapalli D, 2007, J CELL BIOL, V176, P535, DOI 10.1083/jcb.200611058; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Lisignoli G, 2001, ARTHRITIS RHEUM-US, V44, P1800, DOI 10.1002/1529-0131(200108)44:8<1800::AID-ART317>3.0.CO;2-1; Lokeshwar VB, 2010, CANCER RES, V70, P2613, DOI 10.1158/0008-5472.CAN-09-3185; Mullarkey M, 2003, J PHARMACOL EXP THER, V304, P1093, DOI 10.1124/jpet.102.044487; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Onoda M, 2009, HEMATOLOGY, V14, P213, DOI 10.1179/102453309X426236; Pauloin T, 2009, MOL VIS, V15, P577; Perfettini JL, 2004, NAT CELL BIOL, V6, P386, DOI 10.1038/ncb0504-386; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764; Sheehan KM, 2004, LIFE SCI, V75, P3087, DOI 10.1016/j.lfs.2004.02.038; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Suwan K, 2009, J BIOL CHEM, V284, P8596, DOI 10.1074/jbc.M806927200; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Tawada A, 2002, GLYCOBIOLOGY, V12, P421, DOI 10.1093/glycob/cwf048; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2003, MATRIX BIOL, V22, P511, DOI 10.1016/S0945-053X(03)00082-9; Vigetti D, 2008, CELL PHYSIOL BIOCHEM, V22, P137, DOI 10.1159/000149791; Vigetti D, 2008, J BIOL CHEM, V283, P4448, DOI 10.1074/jbc.M709051200; Vigetti D, 2006, FASEB J, V20, P1118, DOI 10.1096/fj.05-4504com; Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Vigetti D, 2008, THESCIENTIFICWORLDJO, V8, P1116, DOI 10.1100/tsw.2008.145; Viola M, 2006, J PHARMACEUT BIOMED, V41, P36, DOI 10.1016/j.jpba.2005.10.010; Voelcker V, 2008, EXP DERMATOL, V17, P100, DOI 10.1111/j.1600-0625.2007.00638.x; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xu HP, 2002, J BIOL CHEM, V277, P17308, DOI 10.1074/jbc.M112371200; Yang TB, 2002, CANCER RES, V62, P2583; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100	50	38	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34497	34503		10.1074/jbc.M111.266312	http://dx.doi.org/10.1074/jbc.M111.266312			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21768115	Green Published, hybrid			2022-12-25	WOS:000295406300003
J	Tzatsos, A; Paskaleva, P; Lymperi, S; Contino, G; Stoykova, S; Chen, Z; Wong, KK; Bardeesy, N				Tzatsos, Alexandros; Paskaleva, Polina; Lymperi, Stephania; Contino, Gianmarco; Stoykova, Svetlana; Chen, Zhao; Wong, Kwok-Kin; Bardeesy, Nabeel			Lysine-specific Demethylase 2B (KDM2B)-let-7-Enhancer of Zester Homolog 2 (EZH2) Pathway Regulates Cell Cycle Progression and Senescence in Primary Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCOMB GROUP; TUMOR-SUPPRESSOR; SKELETAL-MUSCLE; NASOPHARYNGEAL CARCINOMA; EMBRYONIC FIBROBLASTS; MICRORNA EXPRESSION; SELF-RENEWAL; P16(INK4A); MIR-26A; PROLIFERATION	Sustained expression of the histone demethylase, KDM2B (Ndy1/FBXL10/JHDM1B), bypasses cellular senescence in primary mouse embryonic fibroblasts (MEFs). Here, we show that KDM2B is a conserved regulator of lifespan in multiple primary cell types and defines a program in which this chromatin-modifying enzyme counteracts the senescence-associated down-regulation of the EZH2 histone methyltransferase. Senescence in MEFs epigenetically silences KDM2B and induces the tumor suppressor miRNAs let-7b and miR-101, which target EZH2. Forced expression of KDM2B promotes immortalization by silencing these miRNAs through locus-specific histone H3 K36me2 demethylation, leading to EZH2 up-regulation. Overexpression of let-7b down-regulates EZH2, induces premature senescence, and counteracts immortalization of MEFs driven by KDM2B. The KDM2B-let-7-EZH2 pathway also contributes to the proliferation of immortal Ink4a/Arf null fibroblasts suggesting that, beyond its anti-senescence role in primary cells, this histone-modifying enzyme functions more broadly in the regulation of cellular proliferation.	[Tzatsos, Alexandros; Paskaleva, Polina; Contino, Gianmarco; Stoykova, Svetlana; Bardeesy, Nabeel] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; [Lymperi, Stephania] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Chen, Zhao; Wong, Kwok-Kin] Dana Farber Canc Inst, Boston, MA 02115 USA; [Chen, Zhao; Wong, Kwok-Kin] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Tzatsos, A (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, CPZN4216,185 Cambridge St, Boston, MA 02114 USA.	atzatsos@partners.org; nelbardeesy@partners.org		Contino, Gianmarco/0000-0001-5874-0405; wong, kwok kin/0000-0001-6323-235X	National Institutes of Health, NCI/Harvard GI SPORE [P50 CA127003, R01 CA133557-01]; Waxman Foundation; Andrew Warshaw Institute; Nestora fund; NATIONAL CANCER INSTITUTE [P01CA117969, R01CA133557, R01CA122794, P50CA127003] Funding Source: NIH RePORTER	National Institutes of Health, NCI/Harvard GI SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Neurological Disorders & Stroke (NINDS)); Waxman Foundation; Andrew Warshaw Institute; Nestora fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health, NCI/Harvard GI SPORE Grant (P50 CA127003 and R01 CA133557-01). This work was also supported by grants from the Waxman Foundation, the Andrew Warshaw Institute (to N. B.), and from the Nestora fund (to A. T.).	Alajez NM, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.64; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Ciarapica R, 2009, CELL CYCLE, V8, P172, DOI 10.4161/cc.8.1.7292; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Drummond MJ, 2011, PHYSIOL GENOMICS, V43, P595, DOI 10.1152/physiolgenomics.00148.2010; Fan ZP, 2009, NAT CELL BIOL, V11, P1002, DOI 10.1038/ncb1913; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Fukuda T, 2011, MOL CELL NEUROSCI, V46, P614, DOI 10.1016/j.mcn.2011.01.001; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; He J, 2011, BLOOD, V117, P3869, DOI 10.1182/blood-2010-10-312736; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Larson BL, 2008, STEM CELLS, V26, P193, DOI 10.1634/stemcells.2007-0524; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Pfau R, 2008, P NATL ACAD SCI USA, V105, P1907, DOI 10.1073/pnas.0711865105; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Tzatsos A, 2008, CELL STEM CELL, V3, P469, DOI 10.1016/j.stem.2008.10.008; Tzatsos A, 2009, J BIOL CHEM, V284, P22525, DOI 10.1074/jbc.M109.027748; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	38	94	96	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33061	33069		10.1074/jbc.M111.257667	http://dx.doi.org/10.1074/jbc.M111.257667			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21757686	hybrid, Green Published			2022-12-25	WOS:000294968800025
J	Geng, F; Tang, L; Li, Y; Yang, L; Choi, KS; Kazim, AL; Zhang, YS				Geng, Feng; Tang, Li; Li, Yun; Yang, Lu; Choi, Kyoung-Soo; Kazim, A. Latif; Zhang, Yuesheng			Allyl Isothiocyanate Arrests Cancer Cells in Mitosis, and Mitotic Arrest in Turn Leads to Apoptosis via Bcl-2 Protein Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLADDER-CANCER; BETA-TUBULIN; DIETARY ISOTHIOCYANATES; CRUCIFEROUS VEGETABLES; BINDING-SITE; GROWTH; IDENTIFICATION; DEATH; CYSTEINE-354; SERINE-70	Allyl isothiocyanate (AITC) occurs in many commonly consumed cruciferous vegetables and exhibits significant anti-cancer activities. Available data suggest that it is particularly promising for bladder cancer prevention and/or treatment. Here, we show that AITC arrests human bladder cancer cells in mitosis and also induces apoptosis. Mitotic arrest by AITC was associated with increased ubiquitination and degradation of alpha- and beta-tubulin. AITC directly binds to multiple cysteine residues of the tubulins. AITC induced mitochondrion-mediated apoptosis, as shown by cytochrome c release from mitochondria to cytoplasm, activation of caspase-9 and caspase-3, and formation of TUNEL-positive cells. Inhibition of caspase-9 blocked AITC-induced apoptosis. Moreover, we found that apoptosis induction by AITC depended entirely on mitotic arrest and was mediated via Bcl-2 phosphorylation at Ser-70. Pre-arresting cells in G(1) phase by hydroxyurea abrogated both AITC-induced mitotic arrest and Bcl-2 phosphorylation. Overexpression of a Bcl-2 mutant prevented AITC from inducing apoptosis. We further showed that AITC-induced Bcl-2 phosphorylation was caused by c-Jun N-terminal kinase (JNK), and AITC activates JNK. Taken together, this study has revealed a novel anticancer mechanism of a phytochemical that is commonly present in human diet.	[Geng, Feng; Tang, Li; Li, Yun; Yang, Lu; Zhang, Yuesheng] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Choi, Kyoung-Soo; Kazim, A. Latif] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Zhang, YS (corresponding author), Elm & Carlton St, Buffalo, NY 14263 USA.	yuesheng.zhang@roswellpark.org	Geng, Feng/R-8287-2016	Yang, Lu/0000-0003-2532-8638; Zhang, Yuesheng/0000-0002-0976-2875	National Institutes of Health [R01CA124627]; NATIONAL CANCER INSTITUTE [R01CA124627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA124627.	Bai RL, 1996, J BIOL CHEM, V271, P12639, DOI 10.1074/jbc.271.21.12639; Bai RL, 2000, J BIOL CHEM, V275, P40443, DOI 10.1074/jbc.M005299200; Basu A, 1998, INT J ONCOL, V13, P659; Bhattacharya A, 2010, CARCINOGENESIS, V31, P2105, DOI 10.1093/carcin/bgq202; Bhattacharya A, 2010, CARCINOGENESIS, V31, P281, DOI 10.1093/carcin/bgp303; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chang BS, 1997, EMBO J, V16, P968, DOI 10.1093/emboj/16.5.968; Deng XM, 2001, J BIOL CHEM, V276, P23681, DOI 10.1074/jbc.M100279200; Fan MY, 2000, J BIOL CHEM, V275, P29980, DOI 10.1074/jbc.M003776200; Gupta ML, 2001, CELL MOTIL CYTOSKEL, V49, P67, DOI 10.1002/cm.1021; Haldar S, 1996, CANCER RES, V56, P1253; Haldar S, 1998, CANCER RES, V58, P1609; HASEGAWA T, 1993, ANTI-CANCER DRUG, V4, P273, DOI 10.1097/00001813-199304000-00021; Jo H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010318; Mi LX, 2008, J BIOL CHEM, V283, P22136, DOI 10.1074/jbc.M802330200; Mi LX, 2009, J BIOL CHEM, V284, P17039, DOI 10.1074/jbc.M901789200; Michaud DS, 1999, JNCI-J NATL CANCER I, V91, P605, DOI 10.1093/jnci/91.7.605; Shan B, 1999, P NATL ACAD SCI USA, V96, P5686, DOI 10.1073/pnas.96.10.5686; Smith TK, 2004, CARCINOGENESIS, V25, P1409, DOI 10.1093/carcin/bgh149; Srivastava RK, 1999, P NATL ACAD SCI USA, V96, P3775, DOI 10.1073/pnas.96.7.3775; Tang L, 2004, J NUTR, V134, P2004, DOI 10.1093/jn/134.8.2004; Tang L, 2008, CANCER EPIDEM BIOMAR, V17, P938, DOI 10.1158/1055-9965.EPI-07-2502; Tang L, 2006, ANTI-CANCER DRUG, V17, P297, DOI 10.1097/00001813-200603000-00008; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; Xu WH, 2009, MOL CANCER THER, V8, P3318, DOI 10.1158/1535-7163.MCT-09-0548; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang XY, 2007, CANCER LETT, V255, P95, DOI 10.1016/j.canlet.2007.03.025; Zhang YS, 2010, MOL NUTR FOOD RES, V54, P127, DOI 10.1002/mnfr.200900323	29	52	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32259	32267		10.1074/jbc.M111.278127	http://dx.doi.org/10.1074/jbc.M111.278127			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778226	hybrid, Green Published			2022-12-25	WOS:000294726800036
J	Hickey, JM; Lovell, S; Battaile, KP; Hu, L; Middaugh, CR; Hefty, PS				Hickey, John M.; Lovell, Scott; Battaile, Kevin P.; Hu, Lei; Middaugh, C. Russell; Hefty, P. Scott			The Atypical Response Regulator Protein ChxR Has Structural Characteristics and Dimer Interface Interactions That Are Unique within the OmpR/PhoB Subfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; RECEIVER DOMAIN; DEVELOPMENTAL CYCLE; PHOP; DIMERIZATION; ACTIVATION; AUTOREGULATION; MECHANISM; ROLES	Typically as a result of phosphorylation, OmpR/PhoB response regulators form homodimers through a receiver domain as an integral step in transcriptional activation. Phosphorylation stabilizes the ionic and hydrophobic interactions between monomers. Recent studies have shown that some response regulators retain functional activity in the absence of phosphorylation and are termed atypical response regulators. The two currently available receiver domain structures of atypical response regulators are very similar to their phospho-accepting homologs, and their propensity to form homodimers is generally retained. An atypical response regulator, ChxR, from Chlamydia trachomatis, was previously reported to form homodimers; however, the residues critical to this interaction have not been elucidated. We hypothesize that the intra-and intermolecular interactions involved in forming a transcriptionally competent ChxR are distinct from the canonical phosphorylation (activation) paradigm in the OmpR/PhoB response regulator subfamily. To test this hypothesis, structural and functional studies were performed on the receiver domain of ChxR. Two crystal structures of the receiver domain were solved with the recently developed method using triiodo compound I3C. These structures revealed many characteristics unique to OmpR/PhoB subfamily members: typical or atypical. Included was the absence of two alpha-helices present in all other OmpR/PhoB response regulators. Functional studies on various dimer interface residues demonstrated that ChxR forms relatively stable homodimers through hydrophobic interactions, and disruption of these can be accomplished with the introduction of a charged residue within the dimer interface. A gel shift study with monomeric ChxR supports that dimerization through the receiver domain is critical for interaction with DNA.	[Hickey, John M.; Hefty, P. Scott] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Hu, Lei; Middaugh, C. Russell] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA; [Lovell, Scott] Univ Kansas, Del Shankel Struct Biol Ctr, Prot Struct Lab, Lawrence, KS 66047 USA; [Battaile, Kevin P.] Argonne Natl Lab, Adv Photon Source, IMCA CAT, Hauptman Woodward Med Res Inst, Argonne, IL 60439 USA	University of Kansas; University of Kansas; University of Kansas; Hauptman Woodward Medical Research Institute; United States Department of Energy (DOE); Argonne National Laboratory	Hefty, PS (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	pshefty@ku.edu	Hu, Lei/M-5340-2013	Battaile, Kevin/0000-0003-0833-3259	National Institutes of Health [P20RR17708, AI079083]; Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Department of Energy Office of Biological and Environmental Research; National Center for Research Resources; Biomedical Technology Program [P41RR001209]; NIGMS; National Institutes of Health, National Center for Research Resources [P20 RR-17708]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708, P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biomedical Technology Program; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P20RR17708 and AI079083 (to J. M. H. and P. S. H.).; Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-06CH11357. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The Stanford Synchrotron Radiation Laboratory Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program (P41RR001209) and the NIGMS. Use of the KU COBRE Protein Structure Laboratory was supported by National Institutes of Health Grant P20 RR-17708 from the National Center for Research Resources. We thank Drs. Liang Tang and Haiyan Zhao for the recombinant YycF. We are extremely appreciative of critical comments and suggestions provided by Dr. Audrey Lamb.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; Bachhawat P, 2007, J BACTERIOL, V189, P5987, DOI 10.1128/JB.00049-07; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beck T, 2008, ACTA CRYSTALLOGR D, V64, P1179, DOI 10.1107/S0907444908030266; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Cai SJ, 2002, J BIOL CHEM, V277, P24155, DOI 10.1074/jbc.M110715200; Chen YH, 2003, J BACTERIOL, V185, P262, DOI 10.1128/JB.185.1.262-273.2003; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Delany I, 2002, MOL MICROBIOL, V46, P1107, DOI 10.1046/j.1365-2958.2002.03227.x; Delany I, 2002, J BACTERIOL, V184, P4800, DOI 10.1128/JB.184.17.4800-4810.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fraser JS, 2007, MOL MICROBIOL, V65, P319, DOI 10.1111/j.1365-2958.2007.05785.x; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Hickey J. M., 2010, CHLAM INF P 12 INT S, P313; Hickey JM, 2011, J BACTERIOL, V193, P389, DOI 10.1128/JB.00833-10; Hickey JM, 2009, ACTA CRYSTALLOGR F, V65, P791, DOI 10.1107/S1744309109025184; Hong E, 2007, J BIOL CHEM, V282, P20667, DOI 10.1074/jbc.M609104200; Jelesarov Ilian, 2009, V490, P227, DOI 10.1007/978-1-59745-367-7_10; Kato H, 2008, BIOSCI BIOTECH BIOCH, V72, P1072, DOI 10.1271/bbb.70816; Koo IC, 2006, P NATL ACAD SCI USA, V103, P750, DOI 10.1073/pnas.0509690103; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lejona S, 2004, J BACTERIOL, V186, P2476, DOI 10.1128/JB.186.8.2476-2480.2004; Mack TR, 2009, J MOL BIOL, V389, P349, DOI 10.1016/j.jmb.2009.04.014; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nicholson TL, 2003, J BACTERIOL, V185, P3179, DOI 10.1128/JB.185.10.3179-3189.2003; O'Connor TJ, 2005, J MOL BIOL, V351, P1030, DOI 10.1016/j.jmb.2005.06.053; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Ruiz D, 2008, MICROBIOL-SGM, V154, P3002, DOI 10.1099/mic.0.2008/020677-0; Sandhu KS, 2007, PROTEINS, V68, P109, DOI 10.1002/prot.21328; Schar J, 2005, J BACTERIOL, V187, P3100, DOI 10.1128/JB.187.9.3100-3109.2005; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sippel KH, 2008, ACTA CRYSTALLOGR D, V64, P1172, DOI 10.1107/S0907444908030175; Sola M, 1999, J MOL BIOL, V285, P675, DOI 10.1006/jmbi.1998.2326; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Toro-Roman A, 2005, PROTEIN SCI, V14, P3077, DOI 10.1110/ps.051722805; Toro-Roman A, 2005, J MOL BIOL, V349, P11, DOI 10.1016/j.jmb.2005.03.059; Wang LQ, 2009, P NATL ACAD SCI USA, V106, P8617, DOI 10.1073/pnas.0900592106; Wang S, 2007, BIOCHEMISTRY-US, V46, P14751, DOI 10.1021/bi700970a; Zhao HY, 2009, ACTA CRYSTALLOGR F, V65, P719, DOI 10.1107/S1744309109022696	51	12	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32606	32616		10.1074/jbc.M111.220574	http://dx.doi.org/10.1074/jbc.M111.220574			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775428	Green Published, hybrid			2022-12-25	WOS:000294726800070
J	Leichner, GS; Avner, R; Harats, D; Roitelman, J				Leichner, Gil S.; Avner, Rachel; Harats, Dror; Roitelman, Joseph			Metabolically Regulated Endoplasmic Reticulum-associated Degradation of 3-Hydroxy-3-methylglutaryl-CoA Reductase EVIDENCE FOR REQUIREMENT OF A GERANYLGERANYLATED PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMG-COA REDUCTASE; INSIG-DEPENDENT UBIQUITINATION; LOW-DENSITY-LIPOPROTEIN; CHOLESTEROL-SYNTHESIS; IN-VIVO; POLYISOPRENYL PHOSPHATES; ACCELERATES DEGRADATION; FEEDBACK-REGULATION; MEVALONATE PATHWAY; ENZYME DEGRADATION	In mammalian cells, the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR), which catalyzes the rate-limiting step in the mevalonate pathway, is ubiquitylated and degraded by the 26 S proteasome when mevalonate-derived metabolites accumulate, representing a case of metabolically regulated endoplasmic reticulum-associated degradation (ERAD). Here, we studied which mevalonate-derived metabolites signal for HMGR degradation and the ERAD step(s) in which these metabolites are required. In HMGR-deficient UT-2 cells that stably express HMGal, a chimeric protein between beta-galactosidase and the membrane region of HMGR, which is necessary and sufficient for the regulated ERAD, we tested inhibitors specific to different steps in the mevalonate pathway. We found that metabolites downstream of farnesyl pyrophosphate but upstream to lanosterol were highly effective in initiating ubiquitylation, dislocation, and degradation of HMGal. Similar results were observed for endogenous HMGR in cells that express this protein. Ubiquitylation, dislocation, and proteasomal degradation of HMGal were severely hampered when production of geranylgeranyl pyrophosphate was inhibited. Importantly, inhibition of protein geranylgeranylation markedly attenuated ubiquitylation and dislocation, implicating for the first time a geranylgeranylated protein(s) in the metabolically regulated ERAD of HMGR.	[Leichner, Gil S.; Avner, Rachel; Harats, Dror; Roitelman, Joseph] Chaim Sheba Med Ctr, Bert W Strassburger Lipid Ctr, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sackler Fac Med, Dept Human Genet & Biochem, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Roitelman, J (corresponding author), Chaim Sheba Med Ctr, Bert W Strassburger Lipid Ctr, IL-52621 Tel Hashomer, Israel.	roitelma@post.tau.ac.il			Israel Ministry of Health	Israel Ministry of Health	This work was supported in part by a grant from the Chief Scientist of the Israel Ministry of Health.	Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Baron RA, 2009, J BIOL CHEM, V284, P6861, DOI 10.1074/jbc.M806952200; Behmer ST, 2003, ADV INSECT PHYSIOL, V31, P1, DOI 10.1016/S0065-2806(03)31001-X; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; BERGSTROM JD, 1993, P NATL ACAD SCI USA, V90, P80, DOI 10.1073/pnas.90.1.80; Berkhout TA, 1996, J BIOL CHEM, V271, P14376, DOI 10.1074/jbc.271.24.14376; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; BRADFUTE DL, 1994, J BIOL CHEM, V269, P6645; BROWN DA, 1984, P NATL ACAD SCI-BIOL, V81, P1674, DOI 10.1073/pnas.81.6.1674; BROWN MS, 1980, J LIPID RES, V21, P505; Cheng HH, 1999, J BIOL CHEM, V274, P17171, DOI 10.1074/jbc.274.24.17171; CLARK AJ, 1959, J BIOL CHEM, V234, P2578; CORRELL CC, 1994, J BIOL CHEM, V269, P17390; Coxon FP, 2005, BONE, V37, P349, DOI 10.1016/j.bone.2005.04.021; Crick DC, 1997, BIOCHEM BIOPH RES CO, V237, P483, DOI 10.1006/bbrc.1997.7145; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Doolman R, 2004, J BIOL CHEM, V279, P38184, DOI 10.1074/jbc.M405935200; Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235; Elkabetz Y, 2003, J BIOL CHEM, V278, P18922, DOI 10.1074/jbc.M208730200; Engfelt WH, 1998, J LIPID RES, V39, P2182; Engfelt WH, 1997, J BIOL CHEM, V272, P24579, DOI 10.1074/jbc.272.39.24579; FAUST J, 1987, J BIOL CHEM, V262, P1996; FAUST JR, 1988, BIOL CHOLESTEROL, P19; GARCIA CK, 1994, CELL, V76, P865, DOI 10.1016/0092-8674(94)90361-1; Gardner RG, 2001, J BIOL CHEM, V276, P8681, DOI 10.1074/jbc.M007888200; Garza RM, 2009, J BIOL CHEM, V284, P35368, DOI 10.1074/jbc.M109.023994; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; GIRON MD, 1994, P NATL ACAD SCI USA, V91, P6398, DOI 10.1073/pnas.91.14.6398; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hampton RY, 1996, P NATL ACAD SCI USA, V93, P828, DOI 10.1073/pnas.93.2.828; Istvan ES, 2000, EMBO J, V19, P819, DOI 10.1093/emboj/19.5.819; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; KIM CM, 1992, J BIOL CHEM, V267, P23113; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Leichner GS, 2009, MOL BIOL CELL, V20, P3330, DOI 10.1091/mbc.E08-09-0953; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Levy BD, 2002, CELL MOL LIFE SCI, V59, P729, DOI 10.1007/s00018-002-8462-2; Levy BD, 1997, NATURE, V389, P985, DOI 10.1038/40180; LISCUM L, 1983, P NATL ACAD SCI-BIOL, V80, P7165, DOI 10.1073/pnas.80.23.7165; LISCUM L, 1985, J BIOL CHEM, V260, P522; MAYER RJ, 1991, J BIOL CHEM, V266, P20070; McGuire TF, 1996, J BIOL CHEM, V271, P27402, DOI 10.1074/jbc.271.44.27402; Meigs TE, 1997, ARCH BIOCHEM BIOPHYS, V345, P1, DOI 10.1006/abbi.1997.0200; Morand OH, 1997, J LIPID RES, V38, P373; MOSLEY ST, 1983, J BIOL CHEM, V258, P3875; NAKANISHI M, 1988, J BIOL CHEM, V263, P8929; Ownby SE, 2003, LIPIDS, V38, P751, DOI 10.1007/s11745-003-1123-8; Ravid T, 1999, J BIOL CHEM, V274, P29341, DOI 10.1074/jbc.274.41.29341; Ravid T, 2000, J BIOL CHEM, V275, P35840, DOI 10.1074/jbc.M004793200; Roitelman J, 2004, J BIOL CHEM, V279, P6465, DOI 10.1074/jbc.M308094200; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; ROITELMAN J, 1992, J BIOL CHEM, V267, P25264; SCHROEPFER GJ, 1981, ANNU REV BIOCHEM, V50, P585, DOI 10.1146/annurev.bi.50.070181.003101; Sebti SM, 2000, METHOD ENZYMOL, V325, P381; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Shen YX, 2007, BIOCHEM BIOPH RES CO, V352, P919, DOI 10.1016/j.bbrc.2006.11.121; Shmueli A, 2009, BIOCHEM BIOPH RES CO, V390, P758, DOI 10.1016/j.bbrc.2009.10.045; SIPERSTEIN MD, 1960, J CLIN INVEST, V39, P642, DOI 10.1172/JCI104079; SKALNIK DG, 1988, J BIOL CHEM, V263, P6836; Song BL, 2006, J BIOL CHEM, V281, P25054, DOI 10.1074/jbc.M605575200; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wiemer AJ, 2007, BIOCHEM BIOPH RES CO, V353, P921, DOI 10.1016/j.bbrc.2006.12.094; Wojcikiewicz RJH, 2009, CELL CALCIUM, V46, P147, DOI 10.1016/j.ceca.2009.05.002	68	14	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32150	32161		10.1074/jbc.M111.278036	http://dx.doi.org/10.1074/jbc.M111.278036			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778231	hybrid, Green Published			2022-12-25	WOS:000294726800025
J	Danesh, SM; Kundu, P; Lu, R; Stefani, E; Toro, L				Danesh, Shahab M.; Kundu, Pallob; Lu, Rong; Stefani, Enrico; Toro, Ligia			Distinct Transcriptional Regulation of Human Large Conductance Voltage- and Calcium-activated K+ Channel Gene (hSlo1) by Activated Estrogen Receptor alpha and c-Src Tyrosine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNELS; SMOOTH-MUSCLE; BETA-SUBUNIT; EXPRESSION; ESTRADIOL; PATHWAY; BINDING; PP60C-SRC; PROMOTERS; TARGETS	Estrogen receptor alpha (ER alpha) regulates gene transcription via "genomic" (binding directly or indirectly, typically via Sp1 or AP-1 sites, to target genes) and/or "nongenomic" (signaling) mechanisms. ER alpha activation by estrogen up-regulates the murine Ca2+-activated K+ channel alpha subunit gene (mSlo1) via genomic mechanisms. Here, we investigated whether ER alpha also drives transcription of the human (hSlo1) gene. Consistent with this view, estrogen increased hSlo1 transcript levels in primary human smooth muscle cells. Promoter studies revealed that estrogen/hER alpha-mediated hSlo1 transcription was nearly 6-fold more efficient than for mSlo1 (EC50, 0.07 versus 0.4 nM). Unlike the genomic transcriptional mechanism employed by mSlo1, hSlo1 exhibits a nongenomic hER alpha-mediated regulatory mechanism. This is supported by the following: 1) efficient hSlo1 transcription after disruption of the DNA-binding domain of hER alpha or knockdown of Sp1, and 2) lack of AP-1 sites in the hSlo1 promoter. Three nongenomic signaling pathways were explored: Src, Rho, and PI3K. Inhibition of Src with 10 mu M PP2, and reported downstream ERK with 25 mu M PD98059 did not prevent estrogen action but caused an increase in hSlo1 basal transcription; conversely, constitutively active c-Src (Y527F) decreased hSlo1 basal transcription even preventing its estrogen/hER alpha-mediated transcriptional activation. Rho inhibition by coexpressed Clostridium botulinum C3 transferase did not alter estrogen action. In contrast, inhibition of PI3K activity with 10 mu M LY294002 decreased estrogen-stimulated hSlo1 transcription by similar to 40%. These results indicate that the nongenomic PI3K signaling pathway plays a role in estrogen/hER alpha-stimulated hSlo1 gene expression; whereas c-Src activity leads to hSlo1 gene tonic repression independently of estrogen, likely through ERK activation.	[Danesh, Shahab M.; Kundu, Pallob; Lu, Rong; Stefani, Enrico; Toro, Ligia] Univ Calif Los Angeles, Dept Anesthesiol, Div Mol Med, Los Angeles, CA 90095 USA; [Stefani, Enrico] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Toro, Ligia] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Stefani, Enrico; Toro, Ligia] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Stefani, Enrico; Toro, Ligia] Univ Calif Los Angeles, Cardiovasc Res Labs, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Toro, L (corresponding author), Univ Calif Los Angeles, Dept Anesthesiol, Div Mol Med, BH 528,CHS Box 957115, Los Angeles, CA 90095 USA.	ltoro@ucla.edu			National Institutes of Health [HL54970, HL088640];  [NS 007101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054970, R01HL088640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL54970 (to L. T.), HL088640 (to E. S.), and Postdoctoral Fellowship NS 007101 (to S. M. D.).	Alioua A, 2002, P NATL ACAD SCI USA, V99, P14560, DOI 10.1073/pnas.222348099; Bjornstrom L, 2002, MOL ENDOCRINOL, V16, P2202, DOI 10.1210/me.2002-0072; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Cheskis BJ, 2004, J CELL BIOCHEM, V93, P20, DOI 10.1002/jcb.20180; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; COURTNEIDGE SA, 1985, EMBO J, V4, P1471, DOI 10.1002/j.1460-2075.1985.tb03805.x; DeNardo DG, 2007, MOL CELL ENDOCRINOL, V277, P13, DOI 10.1016/j.mce.2007.07.006; Dhulipala PDK, 1999, BBA-GENE STRUCT EXPR, V1444, P254, DOI 10.1016/S0167-4781(98)00276-0; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; DWORETZKY SI, 1994, MOL BRAIN RES, V27, P189, DOI 10.1016/0169-328X(94)90203-8; Eichhorn B, 2007, N-S ARCH PHARMACOL, V376, P145, DOI 10.1007/s00210-007-0193-3; Fox EM, 2009, STEROIDS, V74, P622, DOI 10.1016/j.steroids.2008.10.014; Fu XH, 1998, FEBS LETT, V440, P183, DOI 10.1016/S0014-5793(98)01455-0; Fu XD, 2008, IUBMB LIFE, V60, P502, DOI 10.1002/iub.80; Ghatta S, 2006, PHARMACOL THERAPEUT, V110, P103, DOI 10.1016/j.pharmthera.2005.10.007; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Jamali K, 2003, ENDOCRINE, V20, P227, DOI 10.1385/ENDO:20:3:227; Kalaitzidis D, 2005, TRENDS ENDOCRIN MET, V16, P46, DOI 10.1016/j.tem.2005.01.004; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Kundu P, 2007, J BIOL CHEM, V282, P27478, DOI 10.1074/jbc.M704777200; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Marijic J, 2001, CIRC RES, V88, P210; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044; PHILIPS A, 1993, J BIOL CHEM, V268, P14103; Qiao XY, 2008, GENDER MED, V5, pS46, DOI 10.1016/j.genm.2008.03.006; Segars JH, 2002, TRENDS ENDOCRIN MET, V13, P349, DOI 10.1016/S1043-2760(02)00633-1; Shupnik MA, 2004, ONCOGENE, V23, P7979, DOI 10.1038/sj.onc.1208076; Stoica GE, 2003, ONCOGENE, V22, P7998, DOI 10.1038/sj.onc.1206769; Su LF, 2001, J BIOL CHEM, V276, P3231, DOI 10.1074/jbc.M005547200; Tanaka Yoshio, 2004, Journal of Smooth Muscle Research, V40, P125, DOI 10.1540/jsmr.40.125; Wade CNB, 2003, ENDOCRINOLOGY, V144, P832, DOI 10.1210/en.2002-220899; Wallner M, 1995, RECEPTOR CHANNEL, V3, P185; WUPENG XS, 1992, MOL ENDOCRINOL, V6, P231, DOI 10.1210/me.6.2.231; Xing DQ, 2009, ARTERIOSCL THROM VAS, V29, P289, DOI 10.1161/ATVBAHA.108.182279	38	12	12	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31064	31071		10.1074/jbc.M111.235457	http://dx.doi.org/10.1074/jbc.M111.235457			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757754	Green Published, hybrid			2022-12-25	WOS:000294487500001
J	Rajasekaran, K; Chu, HY; Kumar, P; Xiao, YC; Tinguely, M; Samarakoon, A; Kim, TW; Li, XX; Thakar, MS; Zhang, JW; Malarkannan, S				Rajasekaran, Kamalakannan; Chu, Haiyan; Kumar, Pawan; Xiao, Yechen; Tinguely, Mathew; Samarakoon, Asanga; Kim, Tae Whan; Li, Xiaoxia; Thakar, Monica S.; Zhang, Jiwang; Malarkannan, Subramaniam			Transforming Growth Factor-beta-activated Kinase 1 Regulates Natural Killer Cell-mediated Cytotoxicity and Cytokine Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NK CELLS; NKG2D RECEPTOR; IKK ACTIVATION; T-CELLS; GRANULE POLARIZATION; IMMUNE-RESPONSES; CARMA1; TAK1; PROTEIN	Carma1, a caspase recruitment domain-containing membrane-associated guanylate kinase, initiates a unique signaling cascade via Bcl10 and Malt1 in NK cells. Carma1 deficiency results in reduced phosphorylation of JNK1/2 and activation of NF-kappa B that lead to impaired NK cell-mediated cytotoxicity and cytokine production. However, the precise identities of the downstream signaling molecules that link Carma1 to these effector functions were not defined. Here we show that transforming growth factor-beta (TGF-beta)-activated kinase 1 (TAK1) is abundantly present in NK cells, and activation via NKG2D results in its phosphorylation. Lack of Carma1 considerably reduced TAK1 phosphorylation, demonstrating the dependence of TAK1 on Carma1 in NKG2D-mediated NK cell activations. Pharmacological inhibitor to TAK1 significantly reduced NK-mediated cytotoxicity and its potential to generate IFN-gamma, GM-CSF, MIP-1 alpha, MIP-1 beta, and RANTES. Conditional in vivo knockdown of TAK1 in NK cells from Mx1Cre(+) TAK1(fx/fx) mice resulted in impaired NKG2D-mediated cytotoxicity and cytokine/chemokine production. Inhibition or conditional knockdown of TAK1 severely impaired the NKG2D-mediated phosphorylation of ERK1/2 and JNK1/2 and activation of NF-kappa B and AP1. Our results show that TAK1 links Carma1 to NK cell-mediated effector functions.	[Rajasekaran, Kamalakannan; Chu, Haiyan; Kumar, Pawan; Samarakoon, Asanga; Thakar, Monica S.; Malarkannan, Subramaniam] Med Coll Wisconsin, Lab Mol Immunol & Immunotherapy, Blood Res Inst, Milwaukee, WI 53226 USA; [Tinguely, Mathew; Malarkannan, Subramaniam] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Thakar, Monica S.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Kim, Tae Whan; Li, Xiaoxia] Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA; [Xiao, Yechen; Zhang, Jiwang] Loyola Univ, Med Ctr, Cardinal Bernardin Canc Ctr, Maywood, IL 60153 USA	Medical College of Wisconsin; Versiti Blood Center of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Cleveland Clinic Foundation; Loyola University Chicago	Malarkannan, S (corresponding author), Med Coll Wisconsin, Lab Mol Immunol & Immunotherapy, Blood Res Inst, Milwaukee, WI 53226 USA.	subra.malar@bcw.edu	Malarkannan, Subra/AAQ-9617-2020; Zhang, Jiwang/AAG-2706-2021; RAJASEKARAN, KAMALAKANNAN/F-7350-2015; Malarkannan, Subramaniam/AAQ-3934-2020	RAJASEKARAN, KAMALAKANNAN/0000-0001-5634-9007; Malarkannan, Subramaniam/0000-0002-7511-2731	National Institutes of Health [R01 A1064826]; Cancer Center of the Medical College of Wisconsin; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center of the Medical College of Wisconsin; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 A1064826 (to S. M.).; Recipient of a Breast Cancer Show House Postdoctoral Fellowship from the Cancer Center of the Medical College of Wisconsin.	ARAMBURU J, 1995, J EXP MED, V182, P801, DOI 10.1084/jem.182.3.801; Arase N, 1997, J EXP MED, V186, P1957, DOI 10.1084/jem.186.12.1957; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bennett M, 1995, Semin Immunol, V7, P121, DOI 10.1006/smim.1995.0016; Billadeau DD, 2003, NAT IMMUNOL, V4, P557, DOI 10.1038/ni929; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Che TJ, 2004, J BIOL CHEM, V279, P15870, DOI 10.1074/jbc.M310599200; Chen X, 2007, P NATL ACAD SCI USA, V104, P6329, DOI 10.1073/pnas.0611655104; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; DJEU JY, 1979, J IMMUNOL, V122, P182; Dorner BG, 2004, J IMMUNOL, V172, P3119, DOI 10.4049/jimmunol.172.5.3119; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Geuking P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007709; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Gross O, 2008, BLOOD, V112, P2421, DOI 10.1182/blood-2007-11-123513; Guo HL, 2008, J EXP MED, V205, P2419, DOI 10.1084/jem.20072327; Hara H, 2008, J IMMUNOL, V181, P918, DOI 10.4049/jimmunol.181.2.918; Huang H, 2006, CELL DEATH DIFFER, V13, P1879, DOI 10.1038/sj.cdd.4401882; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Li CL, 2008, P NATL ACAD SCI USA, V105, P3017, DOI 10.1073/pnas.0712310105; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; Malarkannan S, 2000, IMMUNITY, V13, P333, DOI 10.1016/S1074-7613(00)00033-9; Malarkannan S, 1998, J IMMUNOL, V161, P3501; Malarkannan S, 2007, J IMMUNOL, V179, P3752, DOI 10.4049/jimmunol.179.6.3752; Mason LH, 1996, J EXP MED, V184, P2119, DOI 10.1084/jem.184.6.2119; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Regunathan J, 2005, BLOOD, V105, P233, DOI 10.1182/blood-2004-03-1075; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Samarakoon A, 2009, MOL IMMUNOL, V46, P1011, DOI 10.1016/j.molimm.2008.09.035; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; SAYO SJ, 2000, INT IMMUNOL, V12, P1749; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Trotta R, 2000, J IMMUNOL, V165, P1782, DOI 10.4049/jimmunol.165.4.1782; Upshaw JL, 2006, SEMIN IMMUNOL, V18, P167, DOI 10.1016/j.smim.2006.03.001; Ventura JJ, 2003, MOL CELL BIOL, V23, P2871, DOI 10.1128/MCB.23.8.2871-2882.2003; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Wei S, 2000, J IMMUNOL, V165, P3811, DOI 10.4049/jimmunol.165.7.3811; Welteke V, 2009, EMBO REP, V10, P642, DOI 10.1038/embor.2009.64; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Zompi S, 2003, NAT IMMUNOL, V4, P565, DOI 10.1038/ni930	60	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31213	31224		10.1074/jbc.M111.261917	http://dx.doi.org/10.1074/jbc.M111.261917			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21771792	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000294487500016
J	Song, XZ; Yu, H; Chen, X; Lasanajak, Y; Tappert, MM; Air, GM; Tiwari, VK; Cao, HZ; Chokhawala, HA; Zheng, HJ; Cummings, RD; Smith, DF				Song, Xuezheng; Yu, Hai; Chen, Xi; Lasanajak, Yi; Tappert, Mary M.; Air, Gillian M.; Tiwari, Vinod K.; Cao, Hongzhi; Chokhawala, Harshal A.; Zheng, Haojie; Cummings, Richard D.; Smith, David F.			A Sialylated Glycan Microarray Reveals Novel Interactions of Modified Sialic Acids with Proteins and Viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ERYTHROCYTE-MEMBRANE; N-GLYCOLYLNEURAMINIC ACID; H3N2 INFLUENZA-VIRUSES; CHEMOENZYMATIC SYNTHESIS; SPECIFICITY; SIALOSIDES; DIVERSITY; OLIGOSACCHARIDES; NEURAMINIDASE; RECEPTORS	Many glycan-binding proteins in animals and pathogens recognize sialic acid or its modified forms, but their molecular recognition is poorly understood. Here we describe studies on sialic acid recognition using a novel sialylated glycan microarray containing modified sialic acids presented on different glycan backbones. Glycans terminating in beta-linked galactose at the non-reducing end and with an alkylamine-containing fluorophore at the reducing end were sialylated by a one-pot three-enzyme system to generate alpha 2-3- and alpha 2-6-linked sialyl glycans with 16 modified sialic acids. The resulting 77 sialyl glycans were purified and quantified, characterized by mass spectrometry, covalently printed on activated slides, and interrogated with a number of key sialic acid-binding proteins and viruses. Sialic acid recognition by the sialic acid-binding lectins Sambucus nigra agglutinin and Maackia amurensis lectin-I, which are routinely used for detecting alpha 2-6- and alpha 2-3-linked sialic acids, are affected by sialic acid modifications, and both lectins bind glycans terminating with 2-keto-3-deoxy-D-glycero-D-galactonononic acid (Kdn) and Kdn derivatives stronger than the derivatives of more common N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc). Three human parainfluenza viruses bind to glycans terminating with Neu5Ac or Neu5Gc and some of their derivatives but not to Kdn and its derivatives. Influenza A virus also does not bind glycans terminating in Kdn or Kdn derivatives. An especially novel aspect of human influenza A virus binding is its ability to equivalently recognize glycans terminated with either alpha 2-6-linked Neu5Ac9Lt or alpha 2-6-linked Neu5Ac. Our results demonstrate the utility of this sialylated glycan microarray to investigate the biological importance of modified sialic acids in protein-glycan interactions.	[Cummings, Richard D.; Smith, David F.] Emory Univ, Sch Med, Dept Biochem, O Wayne Rollins Res Ctr, Atlanta, GA 30322 USA; [Song, Xuezheng; Lasanajak, Yi; Cummings, Richard D.; Smith, David F.] Emory Univ, Sch Med, Glyc Ctr, Atlanta, GA 30322 USA; [Yu, Hai; Chen, Xi; Tiwari, Vinod K.; Cao, Hongzhi; Chokhawala, Harshal A.; Zheng, Haojie] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Tappert, Mary M.; Air, Gillian M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73126 USA	Emory University; Emory University; University of California System; University of California Davis; University of Oklahoma System; University of Oklahoma Health Sciences Center	Cummings, RD (corresponding author), Emory Univ, Sch Med, Dept Biochem, O Wayne Rollins Res Ctr, 1510 Clifton Rd,Suite 4001, Atlanta, GA 30322 USA.	rdcummi@emory.edu; dfsmith@emory.edu	TIWARI, VINOD K/L-9595-2019; Chen, Xi/H-1811-2018	TIWARI, VINOD K/0000-0001-9244-8889; Chen, Xi/0000-0002-3160-614X; Air, Gillian/0000-0001-5724-3108; CAO, HONGZHI/0000-0003-4736-3143	National Institutes of Health (NIH) [RO1GM085448, GM62116, GM076360]; Consortium for Functional Glycomics under NIGMS; Defense Advanced Research Projects Agency [HR0011-10-00]; Oklahoma Center for the Advancement of Science and Technology [HR09-001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076360, U54GM062116, R01GM085448] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Functional Glycomics under NIGMS; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Oklahoma Center for the Advancement of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant RO1GM085448 (to D. F. S.), a bridging grant from the Consortium for Functional Glycomics under NIGMS, NIH Grant GM62116 (to R. D. C.), and NIH Grant GM076360 (to X. C.). This work was also supported by Defense Advanced Research Projects Agency Grant HR0011-10-00 (to R. D. C.) and Oklahoma Center for the Advancement of Science and Technology Grant HR09-001 (to G. M. A.).	Amonsen M, 2007, J VIROL, V81, P8341, DOI 10.1128/JVI.00718-07; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Avci FY, 2010, ANNU REV IMMUNOL, V28, P107, DOI 10.1146/annurev-immunol-030409-101159; Bohnsack RN, 2009, J BIOL CHEM, V284, P35215, DOI 10.1074/jbc.M109.056184; Bratosin D, 2007, BIOCHIMIE, V89, P355, DOI 10.1016/j.biochi.2006.11.004; Bulai T, 2003, FEBS LETT, V534, P185, DOI 10.1016/S0014-5793(02)03838-3; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Cao HZ, 2009, ORG BIOMOL CHEM, V7, P5137, DOI 10.1039/b916305k; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; Chokhawala HA, 2008, ACS CHEM BIOL, V3, P567, DOI 10.1021/cb800127n; CUMMINGS RD, 1994, METHOD ENZYMOL, V230, P66; Diaz SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004241; Gagneux P, 2001, MOL PHYLOGENET EVOL, V18, P2, DOI 10.1006/mpev.2000.0799; Gulati S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-22; Hirakawa J, 2010, J BIOL CHEM, V285, P40864, DOI 10.1074/jbc.M110.167296; Inoue S, 1998, J BIOL CHEM, V273, P27199, DOI 10.1074/jbc.273.42.27199; Inoue S, 2006, GLYCOCONJUGATE J, V23, P277, DOI 10.1007/s10719-006-6484-y; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; Li YH, 2008, APPL MICROBIOL BIOT, V79, P963, DOI 10.1007/s00253-008-1506-2; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Mitoma J, 2009, GLYCOCONJUGATE J, V26, P511, DOI 10.1007/s10719-008-9207-8; Nelli RK, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-4; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Padler-Karavani V, 2011, CANCER RES, V71, P3352, DOI 10.1158/0008-5472.CAN-10-4102; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; SCHULTZE B, 1990, ADV EXP MED BIOL, V276, P115; Seko A, 1997, BBA-GEN SUBJECTS, V1335, P23, DOI 10.1016/S0304-4165(96)00118-3; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Sillanaukee P, 1999, EUR J CLIN INVEST, V29, P413; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; Song XZ, 2008, GLYCOCONJUGATE J, V25, P15, DOI 10.1007/s10719-007-9066-8; Song XZ, 2011, NAT METHODS, V8, P85, DOI 10.1038/NMETH.1540; Song XZ, 2009, J BIOL CHEM, V284, P35201, DOI 10.1074/jbc.M109.056119; Song XZ, 2009, CHEM BIOL, V16, P36, DOI 10.1016/j.chembiol.2008.11.004; Soundararajan V, 2009, NAT BIOTECHNOL, V27, P510, DOI 10.1038/nbt0609-510; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Taylor ME, 2007, CURR OPIN CELL BIOL, V19, P572, DOI 10.1016/j.ceb.2007.09.004; UCHIDA Y, 1979, J BIOCHEM-TOKYO, V86, P1573, DOI 10.1093/oxfordjournals.jbchem.a132675; Varki A, 2009, ESSENTIALS GLYCOBIOL, P199; Varki A, 2009, GLYCOCONJUGATE J, V26, P231, DOI 10.1007/s10719-008-9183-z; WANG WC, 1988, J BIOL CHEM, V263, P4576; Yu H, 2005, J AM CHEM SOC, V127, P17618, DOI 10.1021/ja0561690; Yu H, 2004, BIOORGAN MED CHEM, V12, P6427, DOI 10.1016/j.bmc.2004.09.030; YU H, 2011, BIOORG MED IN PRESS; Yu H, 2006, NAT PROTOC, V1, P2485, DOI 10.1038/nprot.2006.401; Yu H, 2006, ANGEW CHEM INT EDIT, V45, P3938, DOI 10.1002/anie.200600572; Yu H, 2009, J AM CHEM SOC, V131, P18467, DOI 10.1021/ja907750r	49	104	111	1	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31610	31622		10.1074/jbc.M111.274217	http://dx.doi.org/10.1074/jbc.M111.274217			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757734	Green Published, hybrid			2022-12-25	WOS:000294487500055
J	Yokota, S; Hirayama, T; Hirano, K; Kaneko, R; Toyoda, S; Kawamura, Y; Hirabayashi, M; Hirabayashi, T; Yagi, T				Yokota, Shinnichi; Hirayama, Teruyoshi; Hirano, Keizo; Kaneko, Ryosuke; Toyoda, Shunsuke; Kawamura, Yoshimi; Hirabayashi, Masumi; Hirabayashi, Takahiro; Yagi, Takeshi			Identification of the Cluster Control Region for the Protocadherin-beta Genes Located beyond the Protocadherin-gamma Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ODORANT RECEPTOR GENES; LOCUS-CONTROL REGION; GLOBIN GENE; PROTEIN CTCF; ALPHA FAMILY; HUMAN GENOME; EXPRESSION; MOUSE; MICE; NEURONS	The clustered protocadherins (Pcdhs), Pcdh-alpha, -beta, and -gamma, are transmembrane proteins constituting a subgroup of the cadherin superfamily. Each Pcdh cluster is arranged in tandem on the same chromosome. Each of the three Pcdh clusters shows stochastic and combinatorial expression in individual neurons, thus generating a hugely diverse set of possible cell surface molecules. Therefore, the clustered Pcdhs are candidates for determining neuronal molecular diversity. Here, we showed that the targeted deletion of DNase I hypersensitive (HS) site HS5-1, previously identified as a Pcdh-alpha regulatory element in vitro, affects especially the expression of specific Pcdh-alpha isoforms in vivo. We also identified a Pcdh-beta cluster control region (CCR) containing six HS sites (HS16, 17, 17', 18, 19, and 20) downstream of the Pcdh-gamma cluster. This CCR comprehensively activates the expression of the Pcdh-beta gene cluster in cis, and its deletion dramatically decreases their expression levels. Deleting the CCR non-uniformly down-regulates some Pcdh-gamma isoforms and does not affect Pcdh-alpha expression. Thus, the CCR effect extends beyond the 320-kb region containing the Pcdh-gamma cluster to activate the upstream Pcdh-beta genes. Thus, we concluded that the CCR is a highly specific regulatory unit for Pcdh-beta expression on the clustered Pcdh genomic locus. These findings suggest that each Pcdh cluster is controlled by distinct regulatory elements that activate their expression and that the stochastic gene regulation of the clustered Pcdhs is controlled by the complex chromatin architecture of the clustered Pcdh locus.	[Yokota, Shinnichi; Hirayama, Teruyoshi; Hirano, Keizo; Toyoda, Shunsuke; Hirabayashi, Takahiro; Yagi, Takeshi] Osaka Univ, Grad Sch Frontier Biosci, Labs Integrated Biol, KOKORO Biol Grp, Suita, Osaka 5650871, Japan; [Kaneko, Ryosuke] Gunma Univ, Grad Sch Med, Inst Expt Anim Res, Gunma 3718511, Japan; [Kawamura, Yoshimi] Keio Univ, Sch Med, Dept Physiol, Shinjyuku Ku, Tokyo 1608582, Japan; [Hirabayashi, Masumi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Sect Mammalian Transgenesis, Okazaki, Aichi 4448787, Japan	Osaka University; Gunma University; Keio University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Yagi, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Labs Integrated Biol, KOKORO Biol Grp, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	yagi@fbs.osaka-u.ac.jp	Kawamura, Yoshimi/L-1289-2013; Hirabayashi, Masumi/C-8935-2019	Hirabayashi, Masumi/0000-0002-1059-5883; Toyoda, Shunsuke/0000-0002-5291-7422; Kawamura, Yoshimi/0000-0002-9864-7974	Ministry of Education, Science, Sports, and Culture of Japan; National Institute for Physiological Sciences, Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute for Physiological Sciences, Japan	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan (to T. Y.) and by a grant from the Co-operative Study Program of National Institute for Physiological Sciences, Japan (to M. H.).	Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; Frank M, 2005, MOL CELL NEUROSCI, V29, P603, DOI 10.1016/j.mcn.2005.05.001; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Hambsch B, 2005, J BIOL CHEM, V280, P15888, DOI 10.1074/jbc.M414359200; Hasegawa S, 2008, MOL CELL NEUROSCI, V38, P66, DOI 10.1016/j.mcn.2008.01.016; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Hu X, 2006, BLOOD, V107, P821, DOI 10.1182/blood-2005-06-2308; Johnston RJ, 2010, ANNU REV CELL DEV BI, V26, P689, DOI 10.1146/annurev-cellbio-100109-104113; Junghans D, 2008, EUR J NEUROSCI, V27, P559, DOI 10.1111/j.1460-9568.2008.06052.x; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; Katori S, 2009, J NEUROSCI, V29, P9137, DOI 10.1523/JNEUROSCI.5478-08.2009; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Nishizumi H, 2007, P NATL ACAD SCI USA, V104, P20067, DOI 10.1073/pnas.0706544105; Noguchi Y, 2009, J BIOL CHEM, V284, P32002, DOI 10.1074/jbc.M109.046938; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Phillips GR, 2003, J NEUROSCI, V23, P5096; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Takei Y, 2001, GENOMICS, V72, P321, DOI 10.1006/geno.2000.6468; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Yagi T, 2008, DEV GROWTH DIFFER, V50, pS131, DOI 10.1111/j.1440-169X.2008.00991.x; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	37	60	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31885	31895		10.1074/jbc.M111.245605	http://dx.doi.org/10.1074/jbc.M111.245605			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21771796	Green Published, hybrid			2022-12-25	WOS:000294487500081
J	Douglas, AE; Heim, JA; Shen, F; Almada, LL; Riobo, NA; Fernandez-Zapico, ME; Manning, DR				Douglas, Andrew E.; Heim, Jennifer A.; Shen, Feng; Almada, Luciana L.; Riobo, Natalia A.; Fernandez-Zapico, Martin E.; Manning, David R.			The alpha Subunit of the G Protein G(13) Regulates Activity of One or More Gli Transcription Factors Independently of Smoothened	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; KINASE-II INHIBITOR; SONIC HEDGEHOG; SIGNAL-TRANSDUCTION; G(12) FAMILY; STEM-CELLS; IN-VIVO; ACTIVATION; CANCER; PATHWAYS	Smoothened (Smo) is a seven-transmembrane (7-TM) receptor that is essential to most actions of the Hedgehog family of morphogens. We found previously that Smo couples to members of the G(i) family of heterotrimeric G proteins, which in some cases are integral although alone insufficient in the activation of Gli transcription factors through Hedgehog signaling. In response to a report that the G(12/13) family is relevant to Hedgehog signaling as well, we re-evaluated the coupling of Smo to one member of this family, G(13), and investigated the capacity of this and other G proteins to activate one or more of forms of Gli. We found no evidence that Smo couples directly to G(13). We found nonetheless that G alpha(13) and to some extent G alpha(q) and G alpha(12) are able to effect activation of Gli(s). This capacity is realized in some cells, e.g. C3H10T1/2, MC3T3, and pancreatic cancer cells, but not all cells. The mechanism employed is distinct from that achieved through canonical Hedgehog signaling, as the activation does not involve autocrine signaling or in any other way require active Smo and does not necessarily involve enhanced transcription of Gli1. The activation by G alpha(13) can be replicated through a G(q)/G(12/13)-coupled receptor, CCKA, and is attenuated by inhibitors of p38 mitogen-activated protein kinase and Tec tyrosine kinases. We posit that G proteins, and perhaps G(13) in particular, provide access to Gli that is independent of Smo and that they thus establish a basis for control of at least some forms of Gli-mediated transcription apart from Hedgehogs.	[Douglas, Andrew E.; Shen, Feng; Manning, David R.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Heim, Jennifer A.; Almada, Luciana L.; Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Riobo, Natalia A.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Riobo, Natalia A.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	University of Pennsylvania; Pennsylvania Medicine; Mayo Clinic; Jefferson University; Jefferson University	Manning, DR (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	manning@mail.med.upenn.edu	Galdo, Natalia Riobo-Del/AAP-2938-2020	Galdo, Natalia Riobo-Del/0000-0002-8942-7873	NIDDK [GM080396, CA136526, P50 CA102701, P30 DK084567]; NATIONAL CANCER INSTITUTE [P50CA102701, R01CA136526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080396] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM080396, Mayo Clinic Cancer Center Grant CA136526, Mayo Clinic Pancreatic SPORE Grant P50 CA102701, and Mayo Clinic Center for Cell Signaling in Gastroenterology Grant P30 DK084567 from the NIDDK.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Balordi F, 2007, J NEUROSCI, V27, P5936, DOI 10.1523/JNEUROSCI.1040-07.2007; BUTKERAIT P, 1995, J BIOL CHEM, V270, P18691, DOI 10.1074/jbc.270.31.18691; Campbell C, 2008, CURR OPIN HEMATOL, V15, P319, DOI 10.1097/MOH.0b013e328303b9df; Cayuso J, 2006, DEVELOPMENT, V133, P517, DOI 10.1242/dev.02228; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; DeCamp DL, 2000, J BIOL CHEM, V275, P26322, DOI 10.1074/jbc.M004055200; Dellovade T, 2006, ANNU REV NEUROSCI, V29, P539, DOI 10.1146/annurev.neuro.29.051605.112858; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dennler S, 2009, J BIOL CHEM, V284, P31523, DOI 10.1074/jbc.M109.059964; Fernandez-Zapico ME, 2008, PANCREATOLOGY, V8, P227, DOI 10.1159/000134271; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gao L, 2006, BIOCHEM BIOPH RES CO, V345, P1606, DOI 10.1016/j.bbrc.2006.05.066; Hammerschmidt M, 1998, DEV BIOL, V194, P166, DOI 10.1006/dbio.1997.8796; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Itoh H, 2010, N-S ARCH PHARMACOL, V382, P235, DOI 10.1007/s00210-010-0540-7; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kanda S, 2003, J BIOL CHEM, V278, P8244, DOI 10.1074/jbc.M210635200; Kasai K, 2004, GENES CELLS, V9, P49, DOI 10.1111/j.1356-9597.2004.00701.x; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Ledoux J, 1999, J PHARMACOL EXP THER, V290, P1165; Meigs TE, 2002, J BIOL CHEM, V277, P24594, DOI 10.1074/jbc.M201984200; Meigs TE, 2001, P NATL ACAD SCI USA, V98, P519, DOI 10.1073/pnas.021350998; Murthy KS, 2001, AM J PHYSIOL-GASTR L, V280, pG381, DOI 10.1152/ajpgi.2001.280.3.G381; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Polizio AH, 2011, J BIOL CHEM, V286, P19589, DOI 10.1074/jbc.M110.197111; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Rezazadeh S, 2006, J PHARMACOL EXP THER, V317, P292, DOI 10.1124/jpet.105.097618; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Trousse F, 2001, DEVELOPMENT, V128, P3927; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wilson CW, 2010, DEVELOPMENT, V137, P2079, DOI 10.1242/dev.045021; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Zhang L, 2006, MOL PHARMACOL, V69, P1433, DOI 10.1124/mol.105.019703	49	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30714	30722		10.1074/jbc.M111.219279	http://dx.doi.org/10.1074/jbc.M111.219279			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757753	hybrid, Green Published			2022-12-25	WOS:000294283600051
J	Lalo, U; Roberts, JA; Evans, RJ				Lalo, Ulyana; Roberts, Jonathan A.; Evans, Richard J.			Identification of Human P2X1 Receptor-interacting Proteins Reveals a Role of the Cytoskeleton in Receptor Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; P2X(1) RECEPTORS; ION CHANNELS; FUNCTIONAL EVIDENCE; PLATELET-FUNCTIONS; EXTRACELLULAR ATP; LATERAL MOBILITY; SMOOTH-MUSCLE; ACTIN; ACTIVATION	P2X1 receptors are ATP-gated ion channels expressed by smooth muscle and blood cells. Carboxyl-terminally His-FLAG-tagged human P2X1 receptors were stably expressed in HEK293 cells and co-purified with cytoskeletal proteins including actin. Disruption of the actin cytoskeleton with cytochalasin D inhibited P2X1 receptor currents with no effect on the time course of the response or surface expression of the receptor. Stabilization of the cytoskeleton with jasplakinolide had no effect on P2X1 receptor currents but decreased receptor mobility. P2X2 receptor currents were unaffected by cytochalasin, and P2X1/2 receptor chimeras were used to identify the molecular basis of actin sensitivity. These studies showed that the intracellular amino terminus accounts for the inhibitory effects of cytoskeletal disruption similar to that shown for lipid raft/cholesterol sensitivity. Stabilization of the cytoskeleton with jasplakinolide abolished the inhibitory effects of cholesterol depletion on P2X1 receptor currents, suggesting that lipid rafts may regulate the receptor through stabilization of the cytoskeleton. These studies show that the cytoskeleton plays an important role in P2X1 receptor regulation.	[Lalo, Ulyana; Roberts, Jonathan A.; Evans, Richard J.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Evans, RJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Henry Wellcome Bldg, Leicester LE1 9HN, Leics, England.	rje6@le.ac.uk	Roberts, Jon/A-6771-2012		Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Allsopp RC, 2010, J BIOL CHEM, V285, P32770, DOI 10.1074/jbc.M110.148940; Ase AR, 2005, J PHARMACOL EXP THER, V315, P144, DOI 10.1124/jpet.105.089045; Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; Bruses JL, 2001, J NEUROSCI, V21, P504, DOI 10.1523/JNEUROSCI.21-02-00504.2001; Chaumont S, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162329; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Ennion SJ, 2002, BIOCHEM BIOPH RES CO, V291, P611, DOI 10.1006/bbrc.2002.6488; Fernandes CC, 2010, J NEUROSCI, V30, P8841, DOI 10.1523/JNEUROSCI.6236-09.2010; Gachet C, 2006, ANNU REV PHARMACOL, V46, P277, DOI 10.1146/annurev.pharmtox.46.120604.141207; Gendreau S, 2003, J CHROMATOGR B, V786, P311, DOI 10.1016/S1570-0232(02)00743-2; Gu BJ, 2010, BLOOD, V115, P1621, DOI 10.1182/blood-2009-11-251744; Hechler B, 2005, J PHARMACOL EXP THER, V314, P232, DOI 10.1124/jpet.105.084673; Hering H, 2003, J NEUROSCI, V23, P3262; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Kotnis S, 2010, MOL PHARMACOL, V77, P953, DOI 10.1124/mol.110.063636; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lalo U, 2010, J NEUROCHEM, V113, P1177, DOI 10.1111/j.1471-4159.2010.06730.x; Lecut C, 2009, J IMMUNOL, V183, P2801, DOI 10.4049/jimmunol.0804007; Lewis CJ, 2000, BRIT J PHARMACOL, V131, P1659, DOI 10.1038/sj.bjp.0703744; Li Q, 2003, J BIOL CHEM, V278, P47554, DOI 10.1074/jbc.M308306200; Masin M, 2006, J BIOL CHEM, V281, P4100, DOI 10.1074/jbc.M507735200; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Mulryan K, 2000, NATURE, V403, P86, DOI 10.1038/47495; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Parker KE, 1998, J PHYSIOL-LONDON, V510, P19, DOI 10.1111/j.1469-7793.1998.019bz.x; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Sim JA, 2007, BRIT J PHARMACOL, V152, P1283, DOI 10.1038/sj.bjp.0707504; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Vial C, 2000, BRIT J PHARMACOL, V131, P1489, DOI 10.1038/sj.bjp.0703720; Vial C, 2006, BIOCHEM BIOPH RES CO, V343, P415, DOI 10.1016/j.bbrc.2006.02.174; Vial C, 2005, J BIOL CHEM, V280, P30705, DOI 10.1074/jbc.M504256200; Vial C, 2002, MOL PHARMACOL, V62, P1438, DOI 10.1124/mol.62.6.1438; Wareham K, 2009, BRIT J PHARMACOL, V157, P1215, DOI 10.1111/j.1476-5381.2009.00287.x; Wen HR, 2009, J NEUROCHEM, V108, P331, DOI 10.1111/j.1471-4159.2008.05761.x; Werner P, 1996, P NATL ACAD SCI USA, V93, P15485, DOI 10.1073/pnas.93.26.15485; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707	41	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30591	30599		10.1074/jbc.M111.253153	http://dx.doi.org/10.1074/jbc.M111.253153			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757694	Green Published, hybrid			2022-12-25	WOS:000294283600038
J	Sanchez, FA; Rana, R; Gonzalez, FG; Iwahashi, T; Duran, RG; Fulton, DJ; Beuve, AV; Kim, DD; Duran, WN				Sanchez, Fabiola A.; Rana, Roshniben; Gonzalez, Francisco G.; Iwahashi, Toru; Duran, Ricardo G.; Fulton, David J.; Beuve, Annie V.; Kim, David D.; Duran, Walter N.			Functional Significance of Cytosolic Endothelial Nitric-oxide Synthase (eNOS) REGULATION OF HYPERPERMEABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; PHOSPHORYLATION; GOLGI; PERMEABILITY; ECV304; CELLS; INTERNALIZATION; LOCALIZATION; MECHANISM; PATHWAYS	Endothelial NOS (eNOS)-derived NO is a key factor in regulating microvascular permeability. We demonstrated previously that eNOS translocation from the plasma membrane to the cytosol is required for hyperpermeability. Herein, we tested the hypothesis that eNOS activation in the cytosol is necessary for agonist-induced hyperpermeability. To study the fundamental properties of endothelial cell monolayer permeability, we generated ECV-304 cells that stably express cDNA constructs targeting eNOS to the cytosol or plasma membrane. eNOS-transfected ECV-304 cells recapitulate the eNOS translocation and permeability properties of postcapillary venular endothelial cells (Sanchez, F. A., Rana, R., Kim, D. D., Iwahashi, T., Zheng, R., Lal, B. K., Gordon, D. M., Meininger, C. J., and Duran, W. N. (2009) Proc. Natl. Acad. Sci. U.S.A. 106, 6849-6853). We used platelet-activating factor (PAF) as a proinflammatory agonist. PAF activated eNOS by increasing phosphorylation of Ser-1177 and inducing dephosphorylation of Thr-495, increasing NO production, and elevating permeability to FITC-dextran 70 in monolayers of cells expressing wild-type and cytosolic eNOS. PAF failed to increase permeability to FITC-dextran 70 in monolayers of cells transfected with eNOS targeted to the plasma membrane. Interestingly, this occurred despite eNOS Ser-1177 phosphorylation and production of comparable amounts of NO. Our results demonstrate that the presence of eNOS in the cytosol is necessary for PAF-induced hyperpermeability. Our data provide new insights into the dynamics of eNOS and eNOS-derived NO in the process of inflammation.	[Beuve, Annie V.; Kim, David D.; Duran, Walter N.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07101 USA; [Sanchez, Fabiola A.] Univ Austral Chile, Escuela Med, Inst Inmunol, Valdivia 5110566, Chile; [Fulton, David J.] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Med Coll Georgia, Augusta, GA 30912 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Universidad Austral de Chile; University System of Georgia; Augusta University	Duran, WN (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave, Newark, NJ 07101 USA.	duran@umdnj.edu			National Institutes of Health [5R01 HL070634, 5R01 HL088479]; Fondo Nacional de Desarrollo Cientifico Technologico (FONDECYT) [1100569]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070634, R01HL088479] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo Nacional de Desarrollo Cientifico Technologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01 HL070634 and 5R01 HL088479. This work was also supported by Fondo Nacional de Desarrollo Cientifico Technologico (FONDECYT) Grant 1100569.	Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Bohlen HG, 1998, AM J PHYSIOL-HEART C, V275, pH542, DOI 10.1152/ajpheart.1998.275.2.H542; Breslin JW, 2003, AM J PHYSIOL-HEART C, V284, pH92, DOI 10.1152/ajpheart.00330.2002; Brown J, 2000, LAB INVEST, V80, P37, DOI 10.1038/labinvest.3780006; Church JE, 2006, J BIOL CHEM, V281, P1477, DOI 10.1074/jbc.M505968200; DILLON PK, 1988, CIRC RES, V62, P732, DOI 10.1161/01.RES.62.4.732; Drexler HG, 2002, IN VITRO CELL DEV-AN, V38, P185; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Fulton D, 2004, J BIOL CHEM, V279, P30349, DOI 10.1074/jbc.M402155200; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Gil'yano N. Y., 2009, CELL TISSUE BIOL, V3, P274; Hatakeyama T, 2006, J PHYSIOL-LONDON, V574, P275, DOI 10.1113/jphysiol.2006.108175; Iwakiri Y, 2006, P NATL ACAD SCI USA, V103, P19777, DOI 10.1073/pnas.0605907103; Lenasi H, 2003, CARDIOVASC RES, V59, P844, DOI 10.1016/S0008-6363(03)00505-4; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; Liu JW, 1997, J CELL BIOL, V137, P1525, DOI 10.1083/jcb.137.7.1525; RAMIREZ MM, 1995, MICROVASC RES, V50, P223, DOI 10.1006/mvre.1995.1055; Sanchez FA, 2008, AM J PHYSIOL-HEART C, V295, pH1642, DOI 10.1152/ajpheart.00629.2008; Sanchez FA, 2006, AM J PHYSIOL-HEART C, V291, pH1058, DOI 10.1152/ajpheart.00370.2006; Sanchez FA, 2009, P NATL ACAD SCI USA, V106, P6849, DOI 10.1073/pnas.0812694106; SESSA WC, 1995, J BIOL CHEM, V270, P17641, DOI 10.1074/jbc.270.30.17641; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Sowa G, 1999, J BIOL CHEM, V274, P22524, DOI 10.1074/jbc.274.32.22524; Suda K, 2001, IN VITRO CELL DEV-AN, V37, P505; Varma S, 2002, MICROVASC RES, V63, P172, DOI 10.1006/mvre.2001.2381; Zhang Q, 2006, ARTERIOSCL THROM VAS, V26, P1015, DOI 10.1161/01.ATV.0000216044.49494.c4; Zimmermann K, 2002, P NATL ACAD SCI USA, V99, P17167, DOI 10.1073/pnas.252345399	30	26	26	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30409	30414		10.1074/jbc.M111.234294	http://dx.doi.org/10.1074/jbc.M111.234294			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757745	Green Published, hybrid			2022-12-25	WOS:000294283600019
J	Scheider, L; Grassmann, S; Kaminski, J; Tomasello, M				Scheider, Linda; Grassmann, Susanne; Kaminski, Juliane; Tomasello, Michael			Domestic Dogs Use Contextual Information and Tone of Voice when following a Human Pointing Gesture	PLOS ONE			English	Article							CANIS-FAMILIARIS; HIDDEN FOOD; CUES	Domestic dogs are skillful at using the human pointing gesture. In this study we investigated whether dogs take contextual information into account when following pointing gestures, specifically, whether they follow human pointing gestures more readily in the context in which food has been found previously. Also varied was the human's tone of voice as either imperative or informative. Dogs were more sustained in their searching behavior in the 'context' condition as opposed to the 'no context' condition, suggesting that they do not simply follow a pointing gesture blindly but use previously acquired contextual information to inform their interpretation of that pointing gesture. Dogs also showed more sustained searching behavior when there was pointing than when there was not, suggesting that they expect to find a referent when they see a human point. Finally, dogs searched more in high-pitched informative trials as opposed to the low-pitched imperative trials, whereas in the latter dogs seemed more inclined to respond by sitting. These findings suggest that a dog's response to a pointing gesture is flexible and depends on the context as well as the human's tone of voice.	[Scheider, Linda; Kaminski, Juliane; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany; [Grassmann, Susanne] Univ Groningen, Dept Dev Psychol, Groningen, Netherlands	Max Planck Society; University of Groningen	Scheider, L (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany.	scheider@eva.mpg.de		grassmann, susanne/0000-0003-3421-5600; Kaminski, Juliane/0000-0002-3437-3484	Volkswagenstiftung; Max Planck Gesellschaft	Volkswagenstiftung(Volkswagen); Max Planck Gesellschaft(Max Planck Society)	Juliane Kaminski was funded by a grant from the Volkswagenstiftung (http://www.volkswagen-stiftung.de/), and Linda Scheider was funded by a stipend from the Max Planck Gesellschaft (http://www.mpg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnetta B., 2000, ANIMAL COGNITION, V3, P107, DOI [10.1007/s100710000070, DOI 10.1007/S100710000070, DOI 10.1177/0963721416667718]; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Fukuzawa M, 2005, J COMP PSYCHOL, V119, P117, DOI 10.1037/0735-7036.119.1.117; FUKUZAWA M, 2004, P 38 INT C INT SOC A, P237; Hare B, 1999, J COMP PSYCHOL, V113, P173, DOI 10.1037/0735-7036.113.2.173; Hare B., 1998, EVOL COMMUN, V2, P137; Miklosi A, 2005, J COMP PSYCHOL, V119, P179, DOI 10.1037/0735-7036.119.2.179; Miklosi A, 1998, Anim Cogn, V1, P113, DOI 10.1007/s100710050016; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; Soproni K, 2002, J COMP PSYCHOL, V116, P27, DOI 10.1037//0735-7036.116.1.27; Soproni K, 2001, J COMP PSYCHOL, V115, P122, DOI 10.1037//0735-7036.115.2.122; Szetei V, 2003, APPL ANIM BEHAV SCI, V83, P141, DOI 10.1016/S0168-1591(03)00114-X; Udell MAR, 2010, ANIM BEHAV, V79, pE9, DOI 10.1016/j.anbehav.2009.11.033; Wynne CDL, 2008, ANIM BEHAV, V76, pE1, DOI 10.1016/j.anbehav.2008.03.010	14	66	67	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21676	10.1371/journal.pone.0021676	http://dx.doi.org/10.1371/journal.pone.0021676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	792WQ	21765904	Green Published, gold, Green Submitted			2022-12-25	WOS:000292781500009
J	Kim, Y; Hollenbaugh, JA; Kim, DH; Kim, B				Kim, Yuri; Hollenbaugh, Joseph A.; Kim, Dong-Hyun; Kim, Baek			Novel PI3K/Akt Inhibitors Screened by the Cytoprotective Function of Human Immunodeficiency Virus Type 1 Tat	PLOS ONE			English	Article							PROTEIN-KINASE; COMPOUND K; CELLS; AKT; MACROPHAGES; CANCER; ACTIVATION; METABOLISM; EXPRESSION; INFECTION	The PI3K/Akt pathway regulates various stress-related cellular responses such as cell survival, cell proliferation, metabolism and protein synthesis. Many cancer cell types display the activation of this pathway, and compounds inhibiting this cell survival pathway have been extensively evaluated as anti-cancer agents. In addition to cancers, several human viruses, such as HTLV, HPV, HCV and HIV-1, also modulate this pathway, presumably in order to extend the life span of the infected target cells for productive viral replication. The expression of HIV-1 Tat protein exhibited the cytoprotective effect in macrophages and a human microglial cell line by inhibiting the negative regulator of this pathway, PTEN. This cytoprotective effect of HIV-1 appears to contribute to the long-term survival and persistent HIV-1 production in human macrophage reservoirs. In this study we exploited the PI3K/Akt dependent cytoprotective effect of Tat-expressing CHME5 cells. We screened a collection of compounds known to modulate inflammation, and identified three novel compounds: Lancemaside A, Compound K and Arctigenin that abolished the cytoprotective phenotype of Tat-expressing CHME5 cells. All three compounds antagonized the kinase activity of Akt. Further detailed signaling studies revealed that each of these three compounds targeted different steps of the PI3K/Akt pathway. Arctigenin regulates the upstream PI3K enzyme from converting PIP2 to PIP3. Lancemaside A1 inhibited the movement of Akt to the plasma membrane, a critical step for Akt activation. Compound K inhibited Akt phosphorylation. This study supports that Tat-expressing CHME5 cells are an effective model system for screening novel PI3K/Akt inhibitors.	[Kim, Yuri; Kim, Dong-Hyun] Kyung Hee Univ, Dept Pharm, Seoul, South Korea; [Hollenbaugh, Joseph A.; Kim, Baek] Univ Rochester, Dept Microbiol & Immunol, Med Ctr Rochester, Rochester, NY USA	Kyung Hee University; University of Rochester	Kim, Y (corresponding author), Kyung Hee Univ, Dept Pharm, Seoul, South Korea.	baek_kim@urmc.rochester.edu; dhkim@khu.ac.kr			NIH [A1077401, T32 DA07232]; Ministry of Education, Science and Technology [R33-2008-000-10018-0]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by a grant from NIH A1077401 (BK), NIH grant T32 DA07232 (JAH), and World Class University Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R33-2008-000-10018-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awale S, 2006, CANCER RES, V66, P1751, DOI 10.1158/0008-5472.CAN-05-3143; Bae EA, 2001, ARCH PHARM RES, V24, P297, DOI 10.1007/BF02975095; Borgatti P, 1997, EUR J IMMUNOL, V27, P2805, DOI 10.1002/eji.1830271110; Brown A, 2006, J LEUKOCYTE BIOL, V80, P1127, DOI 10.1189/jlb.0206126; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Chang SY, 2009, BIOMOL THER, V17, P430, DOI 10.4062/biomolther.2009.17.4.430; Choo MK, 2003, PLANTA MED, V69, P518, DOI 10.1055/s-2003-40653; Chugh P, 2007, J MOL BIOL, V366, P67, DOI 10.1016/j.jmb.2006.11.011; Chugh P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-11; Cosenza MA, 2004, NEUROPATH APPL NEURO, V30, P478, DOI 10.1111/j.1365-2990.2004.00563.x; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Deregibus MC, 2002, J BIOL CHEM, V277, P25195, DOI 10.1074/jbc.M200921200; Ferte C, 2010, NAT REV CLIN ONCOL, V7, P367, DOI 10.1038/nrclinonc.2010.84; Gras G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-30; Hernandez-Campos A, 2010, CHEM BIOL DRUG DES, V76, P269, DOI 10.1111/j.1747-0285.2010.01002.x; HU C, 2011, J CELL MOL MED; Irish BP, 2009, AM J INFECT DIS, V5, P231, DOI 10.3844/ajidsp.2009.231.258; Jeong A, 2010, BIOL PHARM BULL, V33, P945, DOI 10.1248/bpb.33.945; Joh EH, 2010, J CELL BIOCHEM, V111, P865, DOI 10.1002/jcb.22773; Joh EH, 2010, INT J COLORECTAL DIS, V25, P545, DOI 10.1007/s00384-009-0858-0; Kim DH, 1998, BIOL PHARM BULL, V21, P360; KIM DH, 1994, BIOL PHARM BULL, V17, P443, DOI 10.1248/bpb.17.443; Kim DY, 2009, J AGR FOOD CHEM, V57, P1532, DOI 10.1021/jf802867b; Kim D, 2010, J BIOL CHEM, V285, P8383, DOI 10.1074/jbc.M109.094060; Kim N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001103; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Komoto N, 2010, J NAT MED-TOKYO, V64, P321, DOI 10.1007/s11418-010-0415-8; Liu Y, 2001, ONCOGENE, V20, P2514, DOI 10.1038/sj.onc.1204364; Lucas A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013121; Noh KH, 2009, MOL THER, V17, P439, DOI 10.1038/mt.2008.255; Park SH, 2005, PLANTA MED, V71, P24, DOI 10.1055/s-2005-837746; SCHRIER RD, 1990, J VIROL, V64, P3280, DOI 10.1128/JVI.64.7.3280-3288.1990; Street A, 2004, J BIOL CHEM, V279, P12232, DOI 10.1074/jbc.M312245200; Tsai WJ, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-12; Vinciguerra M, 2008, ANN HEPATOL, V7, P192, DOI 10.1016/S1665-2681(19)31848-4; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; YAMADA N, 2011, PSYCHOPHARMACOLOGY B; YAO X, 2011, J CELL BIOCH; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990; ZHOU H, 2010, CURR PROTEIN PEPT SC	41	30	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21781	10.1371/journal.pone.0021781	http://dx.doi.org/10.1371/journal.pone.0021781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765914	Green Published, Green Submitted, gold			2022-12-25	WOS:000292699000011
J	Morina, N; von Lersner, U; Prigerson, HG				Morina, Nexhmedin; von Lersner, Ulrike; Prigerson, Holly G.			War and Bereavement: Consequences for Mental and Physical Distress	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHIATRIC INTERVIEW MINI; COMPLICATED GRIEF; HEALTH OUTCOMES; TRAUMATIC GRIEF; BOSNIAN REFUGEES; PARENTAL DEATH; DEPRESSION; VALIDITY; SURVIVORS	Background: Little is known about the long-term impact of the killing of a parent in childhood or adolescence during war on distress and disability in young adulthood. This study assessed current prevalence rates of mental disorders and levels of dysfunction among young adults who had lost their father due to war-related violence in childhood or adolescence. Methods: 179 bereaved young adults and 175 non-bereaved young adults were interviewed a decade after experiencing the war in Kosovo. Prevalence rates of Major Depressive Episode (MDE), anxiety, and substance use disorders, and current suicide risk were assessed using the Mini-International Neuropsychiatric Interview. The syndrome of Prolonged Grief Disorder (PGD) was assessed with the Prolonged Grief Disorder Interview (PG-13). Somatic symptoms were measured with the Patient Health Questionnaire. General health distress was assessed with the General Health Questionnaire. Findings: Bereaved participants were significantly more likely to suffer from either MDE or any anxiety disorder than non-bereaved participants (58.7% vs. 40%). Among bereaved participants, 39.7% met criteria for Post-Traumatic Stress Disorder, 34.6% for PGD, and 22.3% for MDE. Bereaved participants with PGD were more likely to suffer from MDE, any anxiety disorder, or current suicide risk than bereaved participants without PGD. Furthermore, these participants reported significantly greater physical distress than bereaved participants without PGD. Conclusion: War-related loss during middle childhood and adolescence presents significant risk for adverse mental health and dysfunction in young adulthood in addition to exposure to other war-related traumatic events. Furthermore, the syndrome of PGD can help to identify those with the greatest degree of distress and dysfunction.	[Morina, Nexhmedin] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [von Lersner, Ulrike] Humboldt Univ, Dept Psychol, Berlin, Germany; [Prigerson, Holly G.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	University of Amsterdam; Humboldt University of Berlin; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Morina, N (corresponding author), Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands.	n.morina@uva.nl	Prigerson, Holly/L-3800-2019; Morina, Nexhmedin/D-4976-2012; Prigerson, Holly/GWV-3283-2022; Morina, Nexhmedin/AAK-7071-2021	Prigerson, Holly/0000-0002-7075-4268; Morina, Nexhmedin/0000-0002-2331-9140; 	Children and War Foundation; German Psychological Society (DGPs), division for Clinical Psychology and Psychotherapy	Children and War Foundation; German Psychological Society (DGPs), division for Clinical Psychology and Psychotherapy	This study was supported by the Children and War Foundation (www.childrenandwar.org). The preparation for the study was also supported by a travel scholarship to the Harvard Medical School in Boston, USA, given to the first author by the German Psychological Society (DGPs), division for Clinical Psychology and Psychotherapy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agovino T, 1999, LANCET, V353, P1701, DOI 10.1016/S0140-6736(99)04433-5; Attanayake Vindya, 2009, Med Confl Surviv, V25, P4, DOI 10.1080/13623690802568913; Bonanno GA, 2007, J ABNORM PSYCHOL, V116, P342, DOI 10.1037/0021-843X.116.2.342; Brent D, 2009, AM J PSYCHIAT, V166, P786, DOI 10.1176/appi.ajp.2009.08081244; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Doi Y, 2003, PSYCHIAT CLIN NEUROS, V57, P379, DOI 10.1046/j.1440-1819.2003.01135.x; Eytan A, 2011, SOC PSYCH PSYCH EPID, V46, P953, DOI 10.1007/s00127-010-0269-0; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Harrison L, 2001, J ADOLESCENCE, V24, P159, DOI 10.1006/jado.2001.0379; Kashdan TB, 2009, J ANXIETY DISORD, V23, P185, DOI 10.1016/j.janxdis.2008.06.006; KRANZLER EM, 1990, J AM ACAD CHILD PSY, V29, P513, DOI 10.1097/00004583-199007000-00002; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Lichtenthal WG, 2004, CLIN PSYCHOL REV, V24, P637, DOI 10.1016/j.cpr.2004.07.002; Lustig SL, 2004, J AM ACAD CHILD PSY, V43, P24, DOI 10.1097/00004583-200401000-00012; Machel G., 2001, IMPACT WAR CHILDREN; Marshall GN, 2005, JAMA-J AM MED ASSOC, V294, P571, DOI 10.1001/jama.294.5.571; Melhem NM, 2008, ARCH PEDIAT ADOL MED, V162, P403, DOI 10.1001/archpedi.162.5.403; Mollica RF, 2007, J NERV MENT DIS, V195, P572, DOI 10.1097/NMD.0b013e318093ed2c; Momartin S, 2004, COMPR PSYCHIAT, V45, P475, DOI 10.1016/j.comppsych.2004.07.013; MORINA N, 2006, COMMUNICATION; Morina N, 2008, INT J SOC PSYCHIATR, V54, P425, DOI 10.1177/0020764008090505; Morina N, 2010, SOC PSYCH PSYCH EPID, V45, P1167, DOI 10.1007/s00127-009-0160-z; Morina N, 2010, INT J SOC PSYCHIATR, V56, P288, DOI 10.1177/0020764008101638; Morina N, 2010, CLIN PSYCHOL PSYCHOT, V17, P79, DOI 10.1002/cpp.673; Priebe S, 2010, ARCH GEN PSYCHIAT, V67, P518, DOI 10.1001/archgenpsychiatry.2010.37; PRIGERSON HG, 1995, AM J PSYCHIAT, V152, P22; Prigerson HG, 1997, AM J PSYCHIAT, V154, P616, DOI 10.1176/ajp.154.5.616; Prigerson HG, 1999, AM J PSYCHIAT, V156, P1994; Prigerson HG, 1999, BRIT J PSYCHIAT, V174, P67, DOI 10.1192/bjp.174.1.67; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Reynolds CF, 1999, AM J PSYCHIAT, V156, P202; Shear K, 2005, JAMA-J AM MED ASSOC, V293, P2601, DOI 10.1001/jama.293.21.2601; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Wexler ID, 2006, JAMA-J AM MED ASSOC, V296, P579, DOI 10.1001/jama.296.5.579; Wilcox HC, 2010, J AM ACAD CHILD PSY, V49, P514, DOI 10.1016/j.jaac.2010.01.020; Wu NS, 2010, ADDICT BEHAV, V35, P68, DOI 10.1016/j.addbeh.2009.09.003	41	49	49	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22140	10.1371/journal.pone.0022140	http://dx.doi.org/10.1371/journal.pone.0022140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791WM	21765944	Green Published, gold, Green Submitted			2022-12-25	WOS:000292699000025
J	Yeboah-Manu, D; Asante-Poku, A; Bodmer, T; Stucki, D; Koram, K; Bonsu, F; Pluschke, G; Gagneux, S				Yeboah-Manu, Dorothy; Asante-Poku, Adwoa; Bodmer, Thomas; Stucki, David; Koram, Kwadwo; Bonsu, Frank; Pluschke, Gerd; Gagneux, Sebastien			Genotypic Diversity and Drug Susceptibility Patterns among M. tuberculosis Complex Isolates from South-Western Ghana	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; GLOBAL EPIDEMIOLOGY; POLYMORPHISMS; DIAGNOSIS; AFRICANUM	Objective: The aim of this study was to use spoligotyping and large sequence polymorphism (LSP) to study the population structure of M. tuberculosis complex (MTBC) isolates. Methods: MTBC isolates were identified using standard biochemical procedures, IS6110 PCR, and large sequence polymorphisms. Isolates were further typed using spoligotyping, and the phenotypic drug susceptibility patterns were determined by the proportion method. Result: One hundred and sixty-two isolates were characterised by LSP typing. Of these, 130 (80.25%) were identified as Mycobacterium tuberculosis sensu stricto (MTBss), with the Cameroon sub-lineage being dominant (N = 59/130, 45.38%). Thirty-two (19.75%) isolates were classified as Mycobacterium africanum type 1, and of these 26 (81.25%) were identified as West-Africa I, and 6 (18.75%) as West-Africa II. Spoligotyping sub-lineages identified among the MTBss included Haarlem (N = 15, 11.53%), Ghana (N = 22, 16.92%), Beijing (4, 3.08%), EAI (4, 3.08%), Uganda I (4, 3.08%), LAM (2, 1.54%), X (N = 1, 0.77%) and S (2, 1.54%). Nine isolates had SIT numbers with no identified sub-lineages while 17 had no SIT numbers. MTBss isolates were more likely to be resistant to streptomycin (p < 0.008) and to any drug resistance (p < 0.03) when compared to M. africanum. Conclusion: This study demonstrated that overall 36.4% of TB in South-Western Ghana is caused by the Cameroon sublineage of MTBC and 20% by M. africanum type 1, including both the West-Africa 1 and West-Africa 2 lineages. The diversity of MTBC in Ghana should be considered when evaluating new TB vaccines.	[Yeboah-Manu, Dorothy; Asante-Poku, Adwoa; Koram, Kwadwo] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [Bodmer, Thomas] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Bonsu, Frank] Ghana Hlth Serv, Accra, Ghana; [Stucki, David; Gagneux, Sebastien] Natl Inst Med Res, MRC, London NW7 1AA, England; [Stucki, David; Pluschke, Gerd; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Gagneux, Sebastien] Univ Basel, Basel, Switzerland	University of Ghana; University of Bern; Ghana Health Service; MRC National Institute for Medical Research; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Yeboah-Manu, D (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana.	dyeboah-manu@noguchi.mimcom.org	Asante-Poku, Adwoa/AAF-5216-2020; Gagneux, Sebastien/ABE-7909-2020; Kummer, Juerg/B-3322-2011; Yeboah-Manu, Dorothy/A-1933-2016	Gagneux, Sebastien/0000-0001-7783-9048; Yeboah-Manu, Dorothy/0000-0002-1663-6287; Stucki, David/0000-0003-0131-9980; Asante-Poku, Adwoa/0000-0001-8929-193X	UNICEF/UNDP/World Bank/WHO; National Tuberculosis Program, Ghana; Leverhulme-Royal Society Africa	UNICEF/UNDP/World Bank/WHO(World Health Organization); National Tuberculosis Program, Ghana; Leverhulme-Royal Society Africa	This investigation received financial support from the UNICEF/UNDP/World Bank/WHO special program for research and training in Tropical Diseases for DY-M and the National Tuberculosis Program, Ghana. We also acknowledge the Leverhulme-Royal Society Africa Award for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo Kk, 2007, Ghana Med J, V41, P52; Ai XQ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-112; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Bleed D, 2000, Curr Opin Pulm Med, V6, P174, DOI 10.1097/00063198-200005000-00002; BORRELL S, 2009, IJTLD, V13; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Castets M, 1968, Rev Tuberc Pneumol (Paris), V32, P179; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Crampin AC, 2006, EMERG INFECT DIS, V12, P729; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; de Jong BC, 2009, J CLIN MICROBIOL, V47, P994, DOI 10.1128/JCM.01216-08; Diop S, 1976, Bull Soc Med Afr Noire Lang Fr, V21, P50; Easterbrook PJ, 2004, J CLIN MICROBIOL, V42, P4536, DOI 10.1128/JCM.42.10.4536-4544.2004; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Goyal M, 1999, J INFECTION, V38, P171, DOI 10.1016/S0163-4453(99)90246-3; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; HOMOLKA S, 2010, INT J MED M IN PRESS; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kent PT, 1985, GUIDE LEVEL 3 LAB; Maher D, 2005, CLIN CHEST MED, V26, P167, DOI 10.1016/j.ccm.2005.02.009; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Mensah-Quainoo E, 2008, TROP MED INT HEALTH, V13, P191, DOI 10.1111/j.1365-3156.2007.01990.x; Mostowy S, 2004, J CLIN MICROBIOL, V42, P3594, DOI 10.1128/jcm.42.8.3594-3599.2004; Narayanan S, 2004, INDIAN J MED RES, V120, P233; Niemann S, 2004, J CLIN MICROBIOL, V42, P3958, DOI 10.1128/JCM.42.9.3958-3962.2004; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; World Health Organization, 2008, GLOB TUB CONTR SURV; Yeboah-Manu D, 2001, J CLIN MICROBIOL, V39, P4166, DOI 10.1128/JCM.39.11.4166-4168.2001	34	49	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21906	10.1371/journal.pone.0021906	http://dx.doi.org/10.1371/journal.pone.0021906			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779354	Green Submitted, gold, Green Published			2022-12-25	WOS:000292680900017
J	Fenhammar, J; Andersson, A; Forestier, J; Weitzberg, E; Sollevi, A; Hjelmqvist, H; Frithiof, R				Fenhammar, Johan; Andersson, Andreas; Forestier, Jakob; Weitzberg, Eddie; Sollevi, Alf; Hjelmqvist, Hans; Frithiof, Robert			Endothelin Receptor A Antagonism Attenuates Renal Medullary Blood Flow Impairment in Endotoxemic Pigs	PLOS ONE			English	Article							PORCINE ENDOTOXEMIA; SEPTIC SHOCK; ETB-RECEPTOR; B RECEPTORS; TEZOSENTAN; RAT; MICROCIRCULATION; DYSFUNCTION; RESPONSES; PIGLETS	Background: Endothelin-1 is a potent endogenous vasoconstrictor that contributes to renal microcirculatory impairment during endotoxemia and sepsis. Here we investigated if the renal circulatory and metabolic effects of endothelin during endotoxemia are mediated through activation of endothelin-A receptors. Methods and Findings: A randomized experimental study was performed with anesthetized and mechanically ventilated pigs subjected to Escherichia coli endotoxin infusion for five hours. After two hours the animals were treated with the selective endothelin receptor type A antagonist TBC 3711 (2 mg.kg(-1), n = 8) or served as endotoxin-treated controls (n = 8). Renal artery blood flow, diuresis and creatinine clearance decreased in response to endotoxemia. Perfusion in the cortex, as measured by laser doppler flowmetry, was reduced in both groups, but TBC 3711 attenuated the decrease in the medulla (p = 0.002). Compared to control, TBC 3711 reduced renal oxygen extraction as well as cortical and medullary lactate/pyruvate ratios (p < 0.05) measured by microdialysis. Furthermore, TBC 3711 attenuated the decline in renal cortical interstitial glucose levels (p = 0.02) and increased medullary pyruvate levels (p = 0.03). Decreased creatinine clearance and oliguria were present in both groups without any significant difference. Conclusions: These results suggest that endothelin released during endotoxemia acts via endothelin A receptors to impair renal medullary blood flow causing ischemia. Reduced renal oxygen extraction and cortical levels of lactate by TBC 3711, without effects on cortical blood flow, further suggest additional metabolic effects of endothelin type A receptor activation in this model of endotoxin induced acute kidney injury.	[Fenhammar, Johan; Andersson, Andreas; Forestier, Jakob; Sollevi, Alf; Hjelmqvist, Hans] Karolinska Univ Hosp Huddinge, Dept Anaesthesiol & Intens Care, Stockholm, Sweden; [Fenhammar, Johan; Andersson, Andreas; Forestier, Jakob; Sollevi, Alf; Hjelmqvist, Hans] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Weitzberg, Eddie] Karolinska Inst, Sect Anaesthesiol & Intens Care, Dept Physiol & Pharmacol, Stockholm, Sweden; [Frithiof, Robert] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Fenhammar, J (corresponding author), Karolinska Univ Hosp Huddinge, Dept Anaesthesiol & Intens Care, Stockholm, Sweden.	johan.fenhammar@karolinska.se	Andersson, Andreas/AAP-6940-2021	Andersson, Andreas/0000-0001-8371-8920	Karolinska Institutet; Karolinska University Hospital; Lars Hierta Memorial Fund; Soderbergska Foundation	Karolinska Institutet(Karolinska Institutet); Karolinska University Hospital(Karolinska Institutet); Lars Hierta Memorial Fund; Soderbergska Foundation	This study has been financially supported by the Karolinska Institutet, Karolinska University Hospital, Lars Hierta Memorial Fund and Soderbergska Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2006, ACTA ANAESTH SCAND, V50, P1198, DOI 10.1111/j.1399-6576.2006.01140.x; Andersson A, 2010, BRIT J ANAESTH, V105, P640, DOI 10.1093/bja/aeq217; Andersson A, 2008, J SURG RES, V149, P138, DOI 10.1016/j.jss.2007.12.751; Bohr C, 1904, SKAND ARCH PHYSIOL, V16, P402, DOI 10.1111/j.1748-1716.1904.tb01382.x; Bugaj V, 2008, AM J PHYSIOL-RENAL, V295, pF1063, DOI 10.1152/ajprenal.90321.2008; Chen J, 2010, AM J PHYSIOL-RENAL, V298, pF1369, DOI 10.1152/ajprenal.00572.2009; Chin A, 2002, J PEDIATR SURG, V37, P482, DOI 10.1053/jpsu.2002.30871; Chvojka J, 2008, CRIT CARE, V12, DOI 10.1186/cc7164; Evans RG, 2001, J HYPERTENS, V19, P1789, DOI 10.1097/00004872-200110000-00013; EVANS RG, 2010, AM J PHYSL IN PRESS; Fenhammar J, 2008, ACTA ANAESTH SCAND, V52, P1385, DOI 10.1111/j.1399-6576.2008.01768.x; Fenhammar J, 2011, ANESTHESIOLOGY, V114, P1130, DOI 10.1097/ALN.0b013e31820b8b44; Frithiof R, 2011, ACTA ANAESTH SCAND, V55, P401, DOI 10.1111/j.1399-6576.2011.02406.x; FUKURODA T, 1994, BIOCHEM BIOPH RES CO, V199, P1461, DOI 10.1006/bbrc.1994.1395; HEMSEN A, 1991, ACTA PHYSIOL SCAND, V142, P1; KELLEY KW, 1973, J ANIM SCI, V36, P927; Kuklin V, 2005, CRIT CARE, V9, pR211, DOI 10.1186/cc3497; Levy B, 2005, LANCET, V365, P871, DOI 10.1016/S0140-6736(05)71045-X; Nakano D, 2008, AM J PHYSIOL-RENAL, V294, pF1205, DOI 10.1152/ajprenal.00578.2007; Nitescu N, 2008, SHOCK, V29, P402, DOI 10.1097/SHK.0b013e3181454118; Oldner A, 1999, BRIT J PHARMACOL, V127, P1793, DOI 10.1038/sj.bjp.0702736; Oldner A, 1998, GUT, V42, P696, DOI 10.1136/gut.42.5.696; Oldner A, 1996, SHOCK, V6, P188, DOI 10.1097/00024382-199609000-00006; Perreault T, 2001, PEDIATR RES, V50, P374, DOI 10.1203/00006450-200109000-00013; PITTET JF, 1991, ANN SURG, V213, P261, DOI 10.1097/00000658-199103000-00014; Sasser JM, 2007, J AM SOC NEPHROL, V18, P143, DOI 10.1681/ASN.2006030208; Schildroth J, 2011, NEPHROL DIAL TRANSPL, V26, P779, DOI 10.1093/ndt/gfq534; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; SILLDORFF EP, 1995, J CLIN INVEST, V95, P2734, DOI 10.1172/JCI117976; Wanecek M, 1999, EUR J PHARMACOL, V386, P235, DOI 10.1016/S0014-2999(99)00774-8; Weitzberg E, 1996, BRIT J PHARMACOL, V118, P617, DOI 10.1111/j.1476-5381.1996.tb15446.x; Wu CD, 2004, J MED CHEM, V47, P1969, DOI 10.1021/jm030528p; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; ZEIDEL ML, 1989, AM J PHYSIOL, V257, pC1101, DOI 10.1152/ajpcell.1989.257.6.C1101	34	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21534	10.1371/journal.pone.0021534	http://dx.doi.org/10.1371/journal.pone.0021534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760895	Green Published, Green Submitted, gold			2022-12-25	WOS:000292657200014
J	Koulnis, M; Liu, Y; Hallstrom, K; Socolovsky, M				Koulnis, Miroslav; Liu, Ying; Hallstrom, Kelly; Socolovsky, Merav			Negative Autoregulation by Fas Stabilizes Adult Erythropoiesis and Accelerates Its Stress Response	PLOS ONE			English	Article							INDUCED CELL-DEATH; GLUCOCORTICOID-RECEPTOR; C-KIT; MICE; LIGAND; DEFICIENT; EXPANSION; FETAL; PROGENITORS; EXPRESSION	Erythropoiesis maintains a stable hematocrit and tissue oxygenation in the basal state, while mounting a stress response that accelerates red cell production in anemia, blood loss or high altitude. Thus, tissue hypoxia increases secretion of the hormone erythropoietin (Epo), stimulating an increase in erythroid progenitors and erythropoietic rate. Several cell divisions must elapse, however, before Epo-responsive progenitors mature into red cells. This inherent delay is expected to reduce the stability of erythropoiesis and to slow its response to stress. Here we identify a mechanism that helps to offset these effects. We recently showed that splenic early erythroblasts, 'EryA', negatively regulate their own survival by co-expressing the death receptor Fas, and its ligand, FasL. Here we studied mice mutant for either Fas or FasL, bred onto an immune-deficient background, in order to avoid an autoimmune syndrome associated with Fas deficiency. Mutant mice had a higher hematocrit, lower serum Epo, and an increased number of splenic erythroid progenitors, suggesting that Fas negatively regulates erythropoiesis at the level of the whole animal. In addition, Fas-mediated autoregulation stabilizes the size of the splenic early erythroblast pool, since mutant mice had a significantly more variable EryA pool than matched control mice. Unexpectedly, in spite of the loss of a negative regulator, the expansion of EryA and ProE progenitors in response to high Epo in vivo, as well as the increase in erythropoietic rate in mice injected with Epo or placed in a hypoxic environment, lagged significantly in the mutant mice. This suggests that Fas-mediated autoregulation accelerates the erythropoietic response to stress. Therefore, Fas-mediated negative autoregulation within splenic erythropoietic tissue optimizes key dynamic features in the operation of the erythropoietic network as a whole, helping to maintain erythroid homeostasis in the basal state, while accelerating the stress response.	[Koulnis, Miroslav] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Koulnis, M (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA.	merav.socolovsky@umassmed.edu		Socolovsky, Merav/0000-0001-6747-7960	NIH/NHLBI [RO1 HL084168]; American Cancer Society [RSG06-051-01]; Diabetes Endocrinology Research Center [DK32520]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Cancer Society(American Cancer Society); Diabetes Endocrinology Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by NIH/NHLBI RO1 HL084168 (M.S.), and by the American Cancer Society grant RSG06-051-01 (M. S). Core resources supported by the Diabetes Endocrinology Research Center grant DK32520 were also used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bader-Meunier B, 2000, BRIT J HAEMATOL, V108, P300; Bauer A, 1999, GENE DEV, V13, P2996, DOI 10.1101/gad.13.22.2996; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Bessman J.D., 1990, CLIN METHODS HIST PH; BORSOOK HENRY, 1962, NATURE, V196, P347, DOI 10.1038/196347a0; Bouscary D, 2003, BLOOD, V101, P3436, DOI 10.1182/blood-2002-07-2332; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Broudy VC, 1996, BLOOD, V88, P75; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Camas FM, 2006, P NATL ACAD SCI USA, V103, P12718, DOI 10.1073/pnas.0602119103; DANDREA AD, 1989, CELL, V57, P277, DOI 10.1016/0092-8674(89)90965-3; De Maria R, 1999, BLOOD, V93, P796, DOI 10.1182/blood.V93.3.796.403k23_796_803; Ebert BL, 1999, BLOOD, V94, P1864; Fawcett DW, 1997, BLOOM FAWCETT CONCIS, P84; GREGORY CJ, 1975, J CELL PHYSIOL, V86, P1, DOI 10.1002/jcp.1040860102; Guihard S, 2010, BLOOD, V115, P3686, DOI 10.1182/blood-2009-09-242487; Haase VH, 2010, AM J PHYSIOL-RENAL, V299, pF1, DOI 10.1152/ajprenal.00174.2010; HARA H, 1976, AM J HEMATOL, V1, P453, DOI 10.1002/ajh.2830010410; Haseyama Y, 1999, BLOOD, V94, P1568, DOI 10.1182/blood.V94.5.1568.417a07_1568_1577; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kline DD, 2002, P NATL ACAD SCI USA, V99, P821, DOI 10.1073/pnas.022634199; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; KOURY MJ, 1990, SCIENCE, V248, P378, DOI 10.1126/science.2326648; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Longmore GD, 2006, J CLIN INVEST, V116, P626, DOI 10.1172/JCI27988; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Nguyen T, 2001, IMMUNOLOGY, V103, P426, DOI 10.1046/j.1365-2567.2001.01264.x; Palis J, 2008, CURR OPIN HEMATOL, V15, P155, DOI 10.1097/MOH.0b013e3282f97ae1; PAPAYANNOPOULOU T, 1972, J CLIN INVEST, V51, P1179, DOI 10.1172/JCI106911; RAMSDELL F, 1994, EUR J IMMUNOL, V24, P928, DOI 10.1002/eji.1830240422; RHODES MM, 2005, BLOOD; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; RUSSELL ELIZABETH S., 1966, P351; Sathyanarayana P, 2008, BLOOD, V111, P5390, DOI 10.1182/blood-2007-10-119743; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; Schmidt W, 2002, HIGH ALT MED BIOL, V3, P167, DOI 10.1089/15270290260131902; Schneider E, 1999, BLOOD, V94, P2613, DOI 10.1182/blood.V94.8.2613.420k33_2613_2621; Semenza GL, 2009, BLOOD, V114, P2015, DOI 10.1182/blood-2009-05-189985; SENO S, 1964, BLOOD, V24, P582, DOI 10.1182/blood.V24.5.582.582; Silva M, 1999, J BIOL CHEM, V274, P22165, DOI 10.1074/jbc.274.32.22165; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Socolovsky M, 2007, PLOS BIOL, V5, P2296, DOI 10.1371/journal.pbio.0050252; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; STAMATOYANNOPOULOS G, 1985, ANN NY ACAD SCI, V445, P188, DOI 10.1111/j.1749-6632.1985.tb17188.x; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; STEPHENSON JR, 1971, P NATL ACAD SCI USA, V68, P1542, DOI 10.1073/pnas.68.7.1542; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; von Lindern M, 2004, CELL CYCLE, V3, P876; von Lindern M, 1999, BLOOD, V94, P550, DOI 10.1182/blood.V94.2.550.414k39_550_559; Wood AD, 2009, BLOOD, V114, P1820, DOI 10.1182/blood-2009-02-206573	57	35	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21192	10.1371/journal.pone.0021192	http://dx.doi.org/10.1371/journal.pone.0021192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760888	Green Published, gold, Green Submitted			2022-12-25	WOS:000292657200007
J	Meyer, HG; Lindemann, JP; Egelhaaf, M				Meyer, Hanno Gerd; Lindemann, Jens Peter; Egelhaaf, Martin			Pattern-Dependent Response Modulations in Motion-Sensitive Visual Interneurons-A Model Study	PLOS ONE			English	Article							DENDRITIC INTEGRATION; OPTOMOTOR SYSTEM; HORIZONTAL CELLS; GAIN-CONTROL; OPTIC FLOW; FLY; ADAPTATION; DETECTORS; EYE	Even if a stimulus pattern moves at a constant velocity across the receptive field of motion-sensitive neurons, such as lobula plate tangential cells (LPTCs) of flies, the response amplitude modulates over time. The amplitude of these response modulations is related to local pattern properties of the moving retinal image. On the one hand, pattern-dependent response modulations have previously been interpreted as 'pattern-noise', because they deteriorate the neuron's ability to provide unambiguous velocity information. On the other hand, these modulations might also provide the system with valuable information about the textural properties of the environment. We analyzed the influence of the size and shape of receptive fields by simulations of four versions of LPTC models consisting of arrays of elementary motion detectors of the correlation type (EMDs). These models have previously been suggested to account for many aspects of LPTC response properties. Pattern-dependent response modulations decrease with an increasing number of EMDs included in the receptive field of the LPTC models, since spatial changes within the visual field are smoothed out by the summation of spatially displaced EMD responses. This effect depends on the shape of the receptive field, being the more pronounced - for a given total size - the more elongated the receptive field is along the direction of motion. Large elongated receptive fields improve the quality of velocity signals. However, if motion signals need to be localized the velocity coding is only poor but the signal provides - potentially useful - local pattern information. These modelling results suggest that motion vision by correlation type movement detectors is subject to uncertainty: you cannot obtain both an unambiguous and a localized velocity signal from the output of a single cell. Hence, the size and shape of receptive fields of motion sensitive neurons should be matched to their potential computational task.	[Meyer, Hanno Gerd; Lindemann, Jens Peter; Egelhaaf, Martin] Univ Bielefeld, Dept Neurobiol, Bielefeld, Germany; [Lindemann, Jens Peter; Egelhaaf, Martin] Univ Bielefeld, CITEC, Bielefeld, Germany	University of Bielefeld; University of Bielefeld	Meyer, HG (corresponding author), Univ Bielefeld, Dept Neurobiol, Bielefeld, Germany.	hanno.meyer@uni-bielefeld.de	Egelhaaf, Martin/A-9824-2010	Egelhaaf, Martin/0000-0002-9336-4270; Lindemann, Jens Peter/0000-0002-5441-7931; Meyer, Hanno Gerd/0000-0003-2454-3897	Deutsche Forschungsgemeinschaft (DFG); Volkswagen Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Volkswagen Stiftung(Volkswagen)	This project was supported by the Deutsche Forschungsgemeinschaft (DFG) and by a grant of the Volkswagen Stiftung to Anne-Kathrin Warzecha. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORST A, 1995, J COMPUT NEUROSCI, V2, P5, DOI 10.1007/BF00962705; Borst A, 2003, VISION RES, V43, P1309, DOI 10.1016/S0042-6989(03)00092-0; BORST A, 2010, ANNU REV NEUROSCI, P49; Brinkworth RSA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000555; BUCHNER E, 1976, BIOL CYBERN, V24, P85, DOI 10.1007/BF00360648; Dror RO, 2001, J OPT SOC AM A, V18, P241, DOI 10.1364/JOSAA.18.000241; EGELHAAF M, 1989, J OPT SOC AM A, V6, P116, DOI 10.1364/JOSAA.6.000116; EGELHAAF M, 1989, J OPT SOC AM A, V6, P1070, DOI 10.1364/JOSAA.6.001070; EGELHAAF M, 1993, J NEUROSCI, V13, P4563; Egelhaaf M, 2006, INVERTEBRATE VISION, P399; Egelhaaf Martin, 1993, Reviews of Oculomotor Research, V5, P53; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; Harris RA, 1999, VISION RES, V39, P2603, DOI 10.1016/S0042-6989(98)00297-1; Harris RA, 2000, NEURON, V28, P595, DOI 10.1016/S0896-6273(00)00136-7; HAUSEN K, 1982, BIOL CYBERN, V46, P67, DOI 10.1007/BF00335352; HAUSEN K, 1982, BIOL CYBERN, V45, P143, DOI 10.1007/BF00335241; Juusola M, 1995, J NEUROPHYSIOL, V74, P2538, DOI 10.1152/jn.1995.74.6.2538; Krapp HG, 2001, J NEUROPHYSIOL, V85, P724, DOI 10.1152/jn.2001.85.2.724; Kurtz R, 2009, P ROY SOC B-BIOL SCI, V276, P3711, DOI 10.1098/rspb.2009.0596; LAPPE M, 1999, NEURONAL PROCESSING, P44; Lindemann JP, 2005, J NEUROSCI, V25, P6435, DOI 10.1523/JNEUROSCI.1132-05.2005; MADDESS T, 1985, PROC R SOC SER B-BIO, V225, P251, DOI 10.1098/rspb.1985.0061; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P536, DOI 10.1113/jphysiol.1966.sp008001; Petrowitz R, 2000, J COMP PHYSIOL A, V186, P737, DOI 10.1007/s003590000127; Rajesh S, 2005, PROC SPIE, V5651, P160, DOI 10.1117/12.582409; Rajesh S, 2007, PROC SPIE, V6414, DOI 10.1117/12.696105; Reichardt W, 1961, SENS COMMUN, P303; Reinhard E., 2005, HIGH DYNAMIC RANGE I; Reisenman C, 2003, VISION RES, V43, P1291, DOI 10.1016/S0042-6989(03)00091-9; Shoemaker PA, 2005, BIOL CYBERN, V93, P275, DOI 10.1007/s00422-005-0007-y; Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848; SRINIVASAN MV, 1990, J COMP PHYSIOL A, V166, P287, DOI 10.1007/BF00204803; Straw AD, 2008, J VISION, V8, DOI 10.1167/8.3.32; van Hateren JH, 2001, VISION RES, V41, P1851, DOI 10.1016/S0042-6989(01)00052-9	35	23	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21488	10.1371/journal.pone.0021488	http://dx.doi.org/10.1371/journal.pone.0021488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760894	gold, Green Submitted, Green Published			2022-12-25	WOS:000292657200013
J	Chai, Y; Xu, HC; Wang, WX; Liu, B; Yang, DH; Fan, H; Song, FJ; Lu, ZX				Chai, Yun; Xu, Hancheng; Wang, Wenxin; Liu, Bing; Yang, Dehua; Fan, Hong; Song, Fujian; Lu, Zuxun			A Survey of Factors Associated with the Utilization of Community Health Centers for Managing Hypertensive Patients in Chengdu, China	PLOS ONE			English	Article							CHRONIC ILLNESS; SYSTEM REFORM; MANAGEMENT; DISEASES; CARE	Background: For decades the development of community health services has been emphasized in China to cope with the growing burden of chronic diseases by providing basic medical services. This survey aims at investigating factors associated with the use of Community Health Centers (CHCs) for the management of hypertensive patients in Chengdu, China. Methods: We used a systematic sampling method to select 2,030 patients with hypertension or diabetes registered in 29 CHCs in Chengdu in 2007. Researchers interviewed patients who consented to participate at their home. This paper reports findings from the survey of 1,716 hypertensive patients with completed questionnaires. Univariate analyses and multiple logistic regression analyses were conducted to explore factors influencing the use of CHCs for the management of hypertensive patients. Results: 81.4% of hypertensive patients regularly used CHCs for hypertension monitoring and treatment in Chengdu. Univariate analyses indicated that use of CHCs was associated with the education level, occupation, types of medical insurance, Body Mass Index(BMI), patients' knowledge on hypertension, awareness of CHCs functions, satisfaction of the service of CHCs. Multiple regression analyses found that use of CHCs was positively associated with the following factors: the Urban Resident Basic Medical Insurance(URBMI), knowledge on blood pressure, awareness of the sites in CHCs to measure blood pressure, awareness of having to take life-long antihypertensive medicine once the treatment started, awareness of the health records registration in CHCs, regular follow up, improved convenience of seeing doctor. Patients with professional job were less likely to use the services of CHCs. Conclusions: The use of CHCs for hypertension management could be increased by improving residents' knowledge on the monitoring and treatment of hypertension, and the awareness of CHCs functions. The CHCs could play an important role in providing medical care to low-income, unemployed and other disadvantaged patients with hypertension.	[Chai, Yun; Xu, Hancheng; Wang, Wenxin; Fan, Hong; Lu, Zuxun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Chai, Yun; Liu, Bing] Hubei Univ Med, Original Yunyang Med Coll, Fac Publ Adm, Shiyan, Hubei, Peoples R China; [Yang, Dehua] Fourth People Hosp Chengdu, Chengdu, Sichuan, Peoples R China; [Song, Fujian] Univ E Anglia, Fac Hlth, Norwich NR4 7TJ, E Anglia, England; [Xu, Hancheng] Wuhan Univ Sci & Technol, Int Exchange & Cooperat Off, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Hubei University of Medicine; University of East Anglia; Wuhan University of Science & Technology	Chai, Y (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	Fujian.song@uea.ac.uk; luac6@163.com	Song, Fujian/B-3516-2013					Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; *CCDCP, 2009, REP CHRON DIS RISK F; *CCGMH, 2005, GUID PREV TREATM HIG; Dib HH, 2010, HEALTH PLACE, V16, P477, DOI 10.1016/j.healthplace.2009.12.005; HE J, 2009, LANCET; Jiang HL, 2009, HEALTH ECON, V18, pS107, DOI 10.1002/hec.1517; Li C, 2007, MODERN PREVENT MED, V34, P1242; Liu YL, 2008, LANCET, V372, P1914, DOI 10.1016/S0140-6736(08)61362-8; MENG Q, 2007, CHIN J HOSP ADM, V23, P14; *MIN HLTH PEOPL RE, 2003, AN REP NAT HLTH SERV, V4; *MOH, 2006, REP CHRON DIS CHIN; *MOH, 2008, 3 NAT SURV CAUS DEAT; Pan XL, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-93; Peng j, 2005, CHIN J HOSP ADM, V21, P464; Schmittdiel JA, 2006, ANN FAM MED, V4, P117, DOI 10.1370/afm.520; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Weingarten SR, 2002, BRIT MED J, V325, P925, DOI 10.1136/bmj.325.7370.925; Xu JL, 2010, RES ASTRON ASTROPHYS, V10, P151, DOI 10.1088/1674-4527/10/2/006; Xu J, 2010, J HUAZHONG U SCI-MED, V30, P141, DOI 10.1007/s11596-010-0201-6; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; YE H, 2005, CHIN GEN PRAC, V8, P1990; Zhou JA, 2005, CHIN GEN PRAC, V8, P356; ZHOU X, 2006, CHIN GEN PRAC, V9, P559	23	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21718	10.1371/journal.pone.0021718	http://dx.doi.org/10.1371/journal.pone.0021718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750725	Green Published, Green Submitted, gold			2022-12-25	WOS:000292655400012
J	Feng, JY; Lu, L; Hua, C; Qin, L; Zhao, PW; Wang, J; Wang, Y; Li, WY; Shi, XD; Jiang, YF				Feng, Junyan; Lu, Lu; Hua, Cong; Qin, Ling; Zhao, Pingwei; Wang, Juan; Wang, Ye; Li, Wanyu; Shi, Xiaodong; Jiang, Yanfang			High Frequency of CD4(+)CXCR5(+) TFH Cells in Patients with Immune-Active Chronic Hepatitis B	PLOS ONE			English	Article							CYTOMETRIC BEAD ARRAY; NATURAL-KILLER-CELLS; REGULATORY T-CELLS; VIRUS-INFECTION; TRANSGENIC MICE; LIVER-INJURY; HISTORY; MARKERS; LYMPHOMA; DISEASE	Background: T follicular helper (TFH) cells are a special subpopulation of T helper cells and can regulate humoral immune responses. This study examined whether the frequency of CD4(+)CXCR5(+) TFH cells could be associated with active immunity in chronic hepatitis B (CHB) patients. Methodology and Findings: The frequencies of peripheral blood CD4(+)CXCR5(+) TFH cells, inducible T cell costimulator (ICOS), and/or programmed death 1 (PD-1) positive CD4(+)CXCR5(+) TFH cells in immune-active (IA), immune-tolerant (IT) CHB, and healthy controls (HC) were characterized by flow cytometry analysis. The effect of adevofir dipivoxil treatment on the frequency of CD4(+)CXCR5(+) TFH cells, the concentrations of serum IL-2, IFN-gamma, TNF-alpha, IL-4, IL-6, IL-10, IL-21, ALT, AST, HBsAg, HBsAb, HBeAg, HBeAb and HBV loads in IA patients were determined. The potential association of the frequency of CD4(+)CXCR5(+) TFH cells with clinical measures was analyzed. In addition, the frequency of splenic and liver CD4(+)CXCR5(+) TFH cells in HBV-transgenic mice was examined. We found that the frequency of CD4(+)CXCR5(+) TFH cells in IA patients was significantly higher than that of IT patients and HC, and the percentages of CD4(+)CXCR5(+) TFH in IA patients were positively correlated with AST. Furthermore, the percentages of ICOS+, PD-1(+), and ICOS+PD-1(+) in CD4(+)CXCR5(+) TFH cells in CHB patients were significantly higher than that of HC. Treatment with adefovir dipivoxil reduced the frequency of CD4(+)CXCR5(+) TFH, PD-1(+)CD4(+)CXCR5(+) TFH cells and the concentrations of HBsAg and HBeAg, but increased the concentrations of HBsAb, HBeAb, IL-2 and IFN-gamma in IA patients. Moreover, the frequency of splenic and liver CD4(+)CXCR5(+) TFH cells in HBV-transgenic mice was higher than that of wild-type controls. Conclusions: These data indicate that CD4(+)CXCR5(+) TFH cells may participate in the HBV-related immune responses and that high frequency of CD4(+)CXCR5(+) TFH cells may be a biomarker for the evaluation of active immune stage of CHB patients.	[Feng, Junyan; Lu, Lu; Hua, Cong; Qin, Ling; Zhao, Pingwei; Wang, Juan; Wang, Ye; Li, Wanyu; Shi, Xiaodong; Jiang, Yanfang] Jilin Univ, Dept Cent Lab, Hosp 1, Changchun 130023, Peoples R China	Jilin University	Feng, JY (corresponding author), Jilin Univ, Dept Cent Lab, Hosp 1, Changchun 130023, Peoples R China.	yanfangjiang@hotmail.com	Wang, Ye/GWQ-7482-2022		National Natural Science Foundation of China [30972610]; Jilin Province Science and Technology Agency [200705128]; Administration of Chinese Medicine of Jilin Province [08sys-086]; Health Department Research Projects in Jilin Province [2009Z054]; Jilin University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Province Science and Technology Agency; Administration of Chinese Medicine of Jilin Province; Health Department Research Projects in Jilin Province; Jilin University(Jilin University)	This work supported by grants from the National Natural Science Foundation of China (No. 30972610), Jilin Province Science and Technology Agency (No. 200705128), the Subject of Chinese Medical Science and Technology Projects in Administration of Chinese Medicine of Jilin Province (08sys-086), the Health Department Research Projects in Jilin Province (2009Z054), the Cutting-edge Science and Interdisciplinary Innovation Projects of Jilin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandi P, 2010, ANTIMICROB AGENTS CH, V54, P749, DOI 10.1128/AAC.01101-09; Baumert TF, 2007, WORLD J GASTROENTERO, V13, P82, DOI 10.3748/wjg.v13.i1.82; Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; Chen YY, 2007, HEPATOLOGY, V46, P706, DOI 10.1002/hep.21872; Franzese O, 2005, J VIROL, V79, P3322, DOI 10.1128/JVI.79.6.3322-3328.2005; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Huang XY, 2009, J NEUROIMMUNOL, V211, P3, DOI 10.1016/j.jneuroim.2009.04.006; Jiang YF, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/143026; Jiang YF, 2011, CELL MOL IMMUNOL, V8, P75, DOI 10.1038/cmi.2010.37; Lai CL, 2007, J VIRAL HEPATITIS, V14, P6, DOI 10.1111/j.1365-2893.2007.00909.x; Laurent C, 2010, HAEMATOL-HEMATOL J, V95, P356, DOI 10.3324/haematol.2009.019133; Li A, 2010, CLIN VACCINE IMMUNOL, V17, P464, DOI 10.1128/CVI.00457-09; Linterman MA, 2010, SEMIN IMMUNOPATHOL, V32, P183, DOI 10.1007/s00281-009-0194-z; Rodriguez-Pinilla SM, 2008, AM J SURG PATHOL, V32, P1787, DOI 10.1097/PAS.0b013e31817f123e; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Pan Calvin Q, 2005, Int J Med Sci, V2, P36; Pelletier N, 2010, NAT IMMUNOL, V11, P1110, DOI 10.1038/ni.1954; Pesu Marko, 2010, Duodecim, V126, P2179; Pol S, 2006, PRESSE MED, V35, P308, DOI 10.1016/S0755-4982(06)74576-6; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Pinilla SMR, 2009, AM J SURG PATHOL, V33, P81, DOI 10.1097/PAS.0b013e31818e52fe; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Tarnok A, 2003, CLIN CHEM, V49, P1000, DOI 10.1373/49.6.1000; Wang FS, 2001, WORLD J GASTROENTERO, V7, P537; Ye P, 2008, WORLD J GASTROENTERO, V14, P4551, DOI 10.3748/wjg.14.4551; Yim HJ, 2006, HEPATOLOGY, V43, pS173, DOI 10.1002/hep.20956; Zhang Z, 2011, HEPATOLOGY, V53, P73, DOI 10.1002/hep.23977; 张春梅, 2009, [细胞与分子免疫学杂志, Chinese Journal of Cellular and Molecular Immunology], V25, P1063	30	56	68	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21698	10.1371/journal.pone.0021698	http://dx.doi.org/10.1371/journal.pone.0021698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750724	Green Submitted, Green Published, gold			2022-12-25	WOS:000292655400011
J	Brankatschk, B; Pons, V; Parton, RG; Gruenberg, J				Brankatschk, Ben; Pons, Veronique; Parton, Robert G.; Gruenberg, Jean			Role of SNX16 in the Dynamics of Tubulo-Cisternal Membrane Domains of Late Endosomes	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-PHOSPHATE 5-KINASE; MULTIVESICULAR ENDOSOMES; SIGNAL-TRANSDUCTION; ENDOCYTIC PATHWAY; PROTEIN RILP; BAR DOMAINS; TRANSPORT; CELLS; CHOLESTEROL; LOCALIZATION	In this paper, we report that the PX domain-containing protein SNX16, a member of the sorting nexin family, is associated with late endosome membranes. We find that SNX16 is selectively enriched on tubulo-cisternal elements of this membrane system, whose highly dynamic properties and formation depend on intact microtubules. By contrast, SNX16 was not found on vacuolar elements that typically contain LBPA, and thus presumably correspond to multivesicular endosomes. We conclude that SNX16, together with its partner phosphoinositide, define a highly dynamic subset of late endosomal membranes, supporting the notion that late endosomes are organized in distinct morphological and functional regions. Our data also indicate that SNX16 is involved in tubule formation and cholesterol transport as well as trafficking of the tetraspanin CD81, suggesting that the protein plays a role in the regulation of late endosome membrane dynamics.	[Brankatschk, Ben; Pons, Veronique; Gruenberg, Jean] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia	University of Geneva; University of Queensland; University of Queensland	Brankatschk, B (corresponding author), Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland.	jean.gruenberg@unige.ch	Parton, Robert G/C-5673-2009	Parton, Robert G/0000-0002-7494-5248; PONS, Veronique/0000-0001-5821-8481	Swiss National Science Foundation [31003A_124776]; EU; Swiss SystemsX initiative in Systems Biology; Swiss National Science Foundation; National Center for Competence in Research (NCCR); Human Frontier Science Program Organization	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); Swiss SystemsX initiative in Systems Biology; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center for Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Human Frontier Science Program Organization(Human Frontier Science Program)	Support was from the Swiss National Science Foundation (grant number: 31003A_124776), PRISM from the EU Sixth Framework Programme, LipidX from the Swiss SystemsX initiative in Systems Biology, evaluated by the Swiss National Science Foundation and the National Center for Competence in Research (NCCR) in Chemical Biology (to J.G.), and the Human Frontier Science Program Organization (R.G.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Cabezas A, 2006, GENE, V371, P34, DOI 10.1016/j.gene.2005.11.009; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Choi JH, 2004, J CELL SCI, V117, P4209, DOI 10.1242/jcs.01233; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Ferguson CJ, 2010, AUTOPHAGY, V6, P170, DOI 10.4161/auto.6.1.10626; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; GRIFFITHS G, 1984, J ULTRA MOL STRUCT R, V89, P65, DOI 10.1016/S0022-5320(84)80024-6; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; Gu F, 1997, J CELL BIOL, V139, P1183, DOI 10.1083/jcb.139.5.1183; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hanson BJ, 2003, J BIOL CHEM, V278, P34617, DOI 10.1074/jbc.M300143200; Hopkins C, 2000, METHOD ENZYMOL, V327, P35, DOI 10.1016/S0076-6879(00)27265-0; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; Ikonen E, 2004, SEMIN CELL DEV BIOL, V15, P445, DOI 10.1016/j.semcdb.2004.03.001; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kobayashi T, 2000, MOL BIOL CELL, V11, P1829, DOI 10.1091/mbc.11.5.1829; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Luyet PP, 2008, TRAFFIC, V9, P2279, DOI 10.1111/j.1600-0854.2008.00820.x; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nicot AS, 2008, TRAFFIC, V9, P1240, DOI 10.1111/j.1600-0854.2008.00754.x; PARTON RG, 1992, J CELL SCI, V103, P335; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pons V, 2008, PLOS BIOL, V6, P1942, DOI 10.1371/journal.pbio.0060214; Rojo M, 1997, J CELL BIOL, V139, P1119, DOI 10.1083/jcb.139.5.1119; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; SOKOL J, 1988, J BIOL CHEM, V263, P3411; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Teasdale RD, 2001, BIOCHEM J, V358, P7, DOI 10.1042/0264-6021:3580007; TOOZE J, 1991, J CELL BIOL, V115, P635, DOI 10.1083/jcb.115.3.635; TOOZE J, 1992, J CELL BIOL, V118, P813, DOI 10.1083/jcb.118.4.813; Turcic P, 2009, MOLECULES, V14, P5017, DOI 10.3390/molecules14125017; VAICKUS L, 1985, J IMMUNOL, V135, P1987; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	57	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21771	10.1371/journal.pone.0021771	http://dx.doi.org/10.1371/journal.pone.0021771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754999	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000292632000026
J	Fomchenko, EI; Dougherty, JD; Helmy, KY; Katz, AM; Pietras, A; Brennan, C; Huse, JT; Milosevic, A; Holland, EC				Fomchenko, Elena I.; Dougherty, Joseph D.; Helmy, Karim Y.; Katz, Amanda M.; Pietras, Alexander; Brennan, Cameron; Huse, Jason T.; Milosevic, Ana; Holland, Eric C.			Recruited Cells Can Become Transformed and Overtake PDGF-Induced Murine Gliomas In Vivo during Tumor Progression	PLOS ONE			English	Article							TRANSLATIONAL PROFILING APPROACH; GROWTH-FACTOR-RECEPTOR; STEM-CELLS; GLIAL PROGENITORS; CLONAL EVOLUTION; GLIOBLASTOMA; GRADE; PROLIFERATION; IDENTIFICATION; AMPLIFICATION	Background: Gliomas are thought to form by clonal expansion from a single cell-of-origin, and progression-associated mutations to occur in its progeny cells. Glioma progression is associated with elevated growth factor signaling and loss of function of tumor suppressors Ink4a, Arf and Pten. Yet, gliomas are cellularly heterogeneous; they recruit and trap normal cells during infiltration. Methodology/Principal Findings: We performed lineage tracing in a retrovirally mediated, molecularly and histologically accurate mouse model of hPDGFb-driven gliomagenesis. We were able to distinguish cells in the tumor that were derived from the cell-of-origin from those that were not. Phenotypic, tumorigenic and expression analyses were performed on both populations of these cells. Here we show that during progression of hPDGFb-induced murine gliomas, tumor suppressor loss can expand the recruited cell population not derived from the cell-of-origin within glioma microenvironment to dominate regions of the tumor, with essentially no contribution from the progeny of glioma cell-of-origin. Moreover, the recruited cells can give rise to gliomas upon transplantation and passaging, acquire polysomal expression profiles and genetic aberrations typically present in glioma cells rather than normal progenitors, aid progeny cells in glioma initiation upon transplantation, and become independent of PDGFR signaling. Conclusions/Significance: These results indicate that non-cell-of-origin derived cells within glioma environment in the mouse can be corrupted to become bona fide tumor, and deviate from the generally established view of gliomagenesis.	[Fomchenko, Elena I.; Helmy, Karim Y.; Katz, Amanda M.; Pietras, Alexander; Huse, Jason T.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Brennan, Cameron; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Surg Neurosurg, New York, NY 10021 USA; [Brennan, Cameron; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; [Dougherty, Joseph D.; Milosevic, Ana] Rockefeller Univ, Dept Mol Biol, New York, NY 10021 USA; [Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Dept Human Oncol, New York, NY 10021 USA; [Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Dept Pathogenesis, New York, NY 10021 USA; [Brennan, Cameron; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Fomchenko, EI (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, 1275 York Ave, New York, NY 10021 USA.	hollande@mskcc.org	Brennan, Cameron/R-7082-2019	Brennan, Cameron/0000-0003-4064-8891; Dougherty, Joseph/0000-0002-6385-3997; Pietras, Alexander/0000-0002-5783-9347	NIH [U54 CA126518, U54 CA143798]; Starr Foundation; Tegger Foundation; Swedish Research Council; NATIONAL CANCER INSTITUTE [U54CA143798, U54CA126518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS067239] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; Tegger Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants U54 CA126518, U54 CA143798 and the Starr Foundation. AP was supported by the Tegger Foundation and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldape KD, 2004, J NEUROPATH EXP NEUR, V63, P700, DOI 10.1093/jnen/63.7.700; [Anonymous], 2009, 2009 CBTRUS STAT REP; Assanah MC, 2009, GLIA, V57, P1835, DOI 10.1002/glia.20895; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Becher OJ, 2008, CANCER RES, V68, P2241, DOI 10.1158/0008-5472.CAN-07-6350; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Charles NA, 2010, CELL STEM CELL, V6, P6, DOI 10.1016/j.stem.2009.12.005; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Di Rocco F, 1998, NEUROSURGERY, V42, P341, DOI 10.1097/00006123-199802000-00080; Dong ZQ, 2002, HUM PATHOL, V33, P528, DOI 10.1053/hupa.2002.124784; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; FLEMING TP, 1992, CANCER RES, V52, P4550; Gagos S, 1996, CANCER GENET CYTOGEN, V90, P157, DOI 10.1016/S0165-4608(96)00049-0; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gomori E, 2002, J NEUROPATH EXP NEUR, V61, P396; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; HERMANSON M, 1992, CANCER RES, V52, P3213; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Hu XY, 2005, NEOPLASIA, V7, P356, DOI 10.1593/neo.04595; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jelsma R K, 1967, Trans Am Neurol Assoc, V92, P90; Kattar MM, 1997, HUM PATHOL, V28, P1166, DOI 10.1016/S0046-8177(97)90255-0; Kleihues P, 1999, Neuro Oncol, V1, P44, DOI 10.1093/neuonc/1.1.44; Kleihues P, 2000, PATHOLOGY GENETICS T; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lokker NA, 2002, CANCER RES, V62, P3729; Louis DN, 2001, AM J PATHOL, V159, P779, DOI 10.1016/S0002-9440(10)61750-6; McLendon R, 2006, RUSSELL RUBINSTEINS, V7th; Mueller W, 2001, BRAIN PATHOL, V11, P39; Nishikawa Ryo, 2004, Brain Tumor Pathol, V21, P53, DOI 10.1007/BF02484510; Park CC, 2000, J NEUROPATH EXP NEUR, V59, P1044, DOI 10.1093/jnen/59.12.1044; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piccirillo SGM, 2009, ONCOGENE, V28, P1807, DOI 10.1038/onc.2009.27; Scherer HJ, 1940, BRAIN, V40, P631; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith JS, 1999, ONCOGENE, V18, P4144, DOI 10.1038/sj.onc.1202759; Smith JS, 2000, J NEUROPATH EXP NEUR, V59, P495, DOI 10.1093/jnen/59.6.495; Tchougounova E, 2007, ONCOGENE, V26, P6289, DOI 10.1038/sj.onc.1210455; Uhrbom L, 2004, NAT MED, V10, P1257, DOI 10.1038/nm1120; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zhu JJ, 1997, AM J PATHOL, V151, P565	46	60	60	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e20605	10.1371/journal.pone.0020605	http://dx.doi.org/10.1371/journal.pone.0020605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754979	gold, Green Published, Green Submitted			2022-12-25	WOS:000292632000003
J	Klouwenberg, PK; Sasi, P; Bashraheil, M; Awuondo, K; Bonten, M; Berkley, J; Marsh, K; Borrmann, S				Klouwenberg, Peter Klein; Sasi, Philip; Bashraheil, Mahfudh; Awuondo, Ken; Bonten, Marc; Berkley, James; Marsh, Kevin; Borrmann, Steffen			Temporal Association of Acute Hepatitis A and Plasmodium falciparum Malaria in Children	PLOS ONE			English	Article							CASE DEFINITIONS; B-VIRUS; INFECTION; TRANSMISSION; VIREMIA	Background: In sub-Saharan Africa, Plasmodium falciparum and hepatitis A (HAV) infections are common, especially in children. Co-infections with these two pathogens may therefore occur, but it is unknown if temporal clustering exists. Materials and Methods: We studied the pattern of co-infection of P. falciparum malaria and acute HAV in Kenyan children under the age of 5 years in a cohort of children presenting with uncomplicated P. falciparum malaria. HAV status was determined during a 3-month follow-up period. Discussion: Among 222 cases of uncomplicated malaria, 10 patients were anti-HAV IgM positive. The incidence of HAV infections during P. falciparum malaria was 1.7 (95% CI 0.81-3.1) infections/person-year while the cumulative incidence of HAV over the 3-month follow-up period was 0.27 (95% CI 0.14-0.50) infections/person-year. Children with or without HAV co-infections had similar mean P. falciparum asexual parasite densities at presentation (31,000/mu L vs. 34,000/mu L, respectively), largely exceeding the pyrogenic threshold of 2,500 parasites/mL in this population and minimizing risk of over-diagnosis of malaria as an explanation. Conclusion: The observed temporal association between acute HAV and P. falciparum malaria suggests that co-infections of these two hepatotrophic human pathogens may result from changes in host susceptibility. Testing this hypothesis will require larger prospective studies.	[Klouwenberg, Peter Klein; Bonten, Marc] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Klouwenberg, Peter Klein; Sasi, Philip; Bashraheil, Mahfudh; Awuondo, Ken; Berkley, James; Marsh, Kevin; Borrmann, Steffen] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Wellcome Trust Res Programme, Kilifi, Kenya; [Sasi, Philip] Muhimbili Univ, Dar Es Salaam, Tanzania; [Borrmann, Steffen] Heidelberg Univ, Sch Med, Dept Infect Dis, Heidelberg, Germany	Utrecht University; Utrecht University Medical Center; Kenya Medical Research Institute; Ruprecht Karls University Heidelberg	Klouwenberg, PK (corresponding author), Univ Med Ctr Utrecht, Utrecht, Netherlands.	sborrmann@kilifi.kemri-wellcome.org	Borrmann, Steffen/G-1838-2013	Borrmann, Steffen/0000-0001-9189-4393; Berkley, James/0000-0002-1236-849X	Deutsche Forschungsgemeinschaft (DFG) [SFB 544, A7]; Kenya Medical Research Institute; Wellcome Trust	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Kenya Medical Research Institute; Wellcome Trust(Wellcome TrustEuropean Commission)	SB is funded by a Deutsche Forschungsgemeinschaft (DFG) Junior Group grant (SFB 544, A7). This study was supported by the Kenya Medical Research Institute and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Anand AC, 2005, J GASTROEN HEPATOL, V20, P1322, DOI 10.1111/j.1440-1746.2005.03884.x; Barcus MJ, 2002, AM J TROP MED HYG, V66, P140, DOI 10.4269/ajtmh.2002.66.140; Bassat Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007871; Bejon P, 2007, PLOS MED, V4, P1333, DOI 10.1371/journal.pmed.0040251; Bower WA, 2000, J INFECT DIS, V182, P12, DOI 10.1086/315701; BRABIN L, 1989, ANN TROP MED PARASIT, V83, P365, DOI 10.1080/00034983.1989.11812359; Chene A, 2007, PLOS PATHOG, V3, P826, DOI 10.1371/journal.ppat.0030080; Ciocca M, 2000, VACCINE, V18, pS71, DOI 10.1016/S0264-410X(99)00470-3; Jacobsen KH, 2004, EPIDEMIOL INFECT, V132, P1005, DOI 10.1017/S0950268804002857; Jiang XJ, 2000, J VIRAL HEPATITIS, V7, P292; Jimmy EO, 1996, T ROY SOC TROP MED H, V90, P37, DOI 10.1016/S0035-9203(96)90472-1; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; Moormann AM, 2005, J INFECT DIS, V191, P1233, DOI 10.1086/428910; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Normann A, 2004, J MED VIROL, V72, P10, DOI 10.1002/jmv.10532; Olotu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015569; Pasquetto V, 2000, J EXP MED, V192, P529, DOI 10.1084/jem.192.4.529; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; STAPLETON JT, 1995, J INFECT DIS, V171, pS9, DOI 10.1093/infdis/171.Supplement_1.S9; THURSZ MR, 1995, NAT MED, V1, P374, DOI 10.1038/nm0495-374	22	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21013	10.1371/journal.pone.0021013	http://dx.doi.org/10.1371/journal.pone.0021013			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754982	Green Published, Green Submitted, gold			2022-12-25	WOS:000292632000006
J	Lachmann, S; Jevons, A; De Rycker, M; Casamassima, A; Radtke, S; Collazos, A; Parker, PJ				Lachmann, Sylvie; Jevons, Amy; De Rycker, Manu; Casamassima, Adele; Radtke, Simone; Collazos, Alejandra; Parker, Peter J.			Regulatory Domain Selectivity in the Cell-Type Specific PKN-Dependence of Cell Migration	PLOS ONE			English	Article							PROTEIN-KINASE-N; RHO EFFECTOR RECOGNITION; C-TERMINUS; POTENTIAL EFFECTOR; SMALL GTPASE; ACTIVATION; PHOSPHORYLATION; EXPRESSION; BINDING; PRK1	The mammalian protein kinase N (PKN) family of Serine/Threonine kinases comprises three isoforms, which are targets for Rho family GTPases. Small GTPases are major regulators of the cellular cytoskeleton, generating interest in the role(s) of specific PKN isoforms in processes such as cell migration and invasion. It has been reported that PKN3 is required for prostate tumour cell invasion but not PKN1 or 2. Here we employ a cell model, the 5637 bladder tumour cell line where PKN2 is relatively highly expressed, to assess the potential redundancy of these isoforms in migratory responses. It is established that PKN2 has a critical role in the migration and invasion of these cells. Furthermore, using a PKN wild-type and chimera rescue strategy, it is shown that PKN isoforms are not simply redundant in supporting migration, but appear to be linked through isoform specific regulatory domain properties to selective upstream signals. It is concluded that intervention in PKNs may need to be directed at multiple isoforms to be effective in different cell types.	[Lachmann, Sylvie; Jevons, Amy; De Rycker, Manu; Casamassima, Adele; Radtke, Simone; Collazos, Alejandra; Parker, Peter J.] London Res Inst, Prot Phosphorylat Lab, London, England; [Parker, Peter J.] Kings Coll London, Div Canc Studies, London WC2R 2LS, England	University of London; King's College London	Lachmann, S (corresponding author), London Res Inst, Prot Phosphorylat Lab, London, England.	peter.parker@cancer.org.uk	Parker, Peter j/D-5192-2013	parker, peter/0000-0002-6218-2933; De Rycker, Manu/0000-0002-3171-3519	Cancer Research United Kingdom	Cancer Research United Kingdom(Cancer Research UK)	The study was funded through Cancer Research United Kingdom's direct support to the London Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Betson M, 2007, GENETICS, V176, P2201, DOI 10.1534/genetics.107.072967; Blumenstein L, 2004, J BIOL CHEM, V279, P53419, DOI 10.1074/jbc.M409551200; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braverman LE, 1999, J BIOL CHEM, V274, P5542, DOI 10.1074/jbc.274.9.5542; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Calautti E, 2002, J CELL BIOL, V156, P137, DOI 10.1083/jcb.200105140; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Dong LQ, 2000, P NATL ACAD SCI USA, V97, P5089, DOI 10.1073/pnas.090491897; Flynn P, 1998, J BIOL CHEM, V273, P2698, DOI 10.1074/jbc.273.5.2698; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Gotoh Y, 2004, BIOCHEM BIOPH RES CO, V314, P688, DOI 10.1016/j.bbrc.2003.12.148; Hamaguchi T, 2000, BIOCHEM BIOPH RES CO, V274, P825, DOI 10.1006/bbrc.2000.3225; Kato T, 2008, GENES CELLS, V13, P509, DOI 10.1111/j.1365-2443.2008.01182.x; Kim JH, 2006, J BIOL CHEM, V281, P15747, DOI 10.1074/jbc.M509844200; KITAGAWA M, 1995, BIOCHEM J, V310, P657, DOI 10.1042/bj3100657; Leenders F, 2004, EMBO J, V23, P3303, DOI 10.1038/sj.emboj.7600345; Lim MA, 2004, ONCOGENE, V23, P9348, DOI 10.1038/sj.onc.1208147; Lim WG, 2008, ARCH BIOCHEM BIOPHYS, V479, P170, DOI 10.1016/j.abb.2008.09.008; Lim WG, 2006, CELL SIGNAL, V18, P1473, DOI 10.1016/j.cellsig.2005.11.009; Lim WG, 2005, CELL SIGNAL, V17, P1084, DOI 10.1016/j.cellsig.2004.12.003; Lu Y, 1999, GENE DEV, V13, P1168, DOI 10.1101/gad.13.9.1168; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Matsuzawa K, 1997, BIOCHEM BIOPH RES CO, V234, P621, DOI 10.1006/bbrc.1997.6669; Mellor H, 1998, J BIOL CHEM, V273, P4811, DOI 10.1074/jbc.273.9.4811; Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Monami G, 2006, CANCER RES, V66, P7103, DOI 10.1158/0008-5472.CAN-06-0633; Mukai H, 1996, J BIOL CHEM, V271, P9816, DOI 10.1074/jbc.271.16.9816; MUKAI H, 1994, BIOCHEM BIOPH RES CO, V204, P348, DOI 10.1006/bbrc.1994.2466; Mukai H, 1997, J BIOL CHEM, V272, P4740, DOI 10.1074/jbc.272.8.4740; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Oishi K, 1999, BIOCHEM BIOPH RES CO, V261, P808, DOI 10.1006/bbrc.1999.1116; Owen D, 2003, J BIOL CHEM, V278, P50578, DOI 10.1074/jbc.M304313200; PALMER RH, 1995, EUR J BIOCHEM, V227, P344, DOI 10.1111/j.1432-1033.1995.tb20395.x; PALMER RH, 1995, J BIOL CHEM, V270, P22412, DOI 10.1074/jbc.270.38.22412; Quilliam LA, 1996, J BIOL CHEM, V271, P28772, DOI 10.1074/jbc.271.46.28772; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Shibata H, 2001, J BIOCHEM, V130, P23, DOI 10.1093/oxfordjournals.jbchem.a002958; Takahashi M, 2003, J BIOCHEM, V133, P181, DOI 10.1093/jb/mvg022; Torbett NE, 2003, J BIOL CHEM, V278, P32344, DOI 10.1074/jbc.M303532200; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vincent S, 1997, MOL CELL BIOL, V17, P2247, DOI 10.1128/MCB.17.4.2247; Wood W, 2002, NAT CELL BIOL, V4, P907, DOI 10.1038/ncb875; Yu WP, 1997, J BIOL CHEM, V272, P10030	49	57	60	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21732	10.1371/journal.pone.0021732	http://dx.doi.org/10.1371/journal.pone.0021732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754995	Green Published, Green Submitted			2022-12-25	WOS:000292632000021
J	Liu, Y; Chen, XQ; Liang, HX; Zhang, FX; Zhang, B; Jin, J; Chen, YL; Cheng, YX; Zhou, GB				Liu, Ying; Chen, Xiao-Qin; Liang, Heng-Xing; Zhang, Feng-Xiang; Zhang, Bo; Jin, Jie; Chen, Yong-Long; Cheng, Yong-Xian; Zhou, Guang-Biao			Small Compound 6-O-Angeloylplenolin Induces Mitotic Arrest and Exhibits Therapeutic Potentials in Multiple Myeloma	PLOS ONE			English	Article							NF-KAPPA-B; CELL-CYCLE CONTROL; OVERCOMES DRUG-RESISTANCE; CENTIPEDA-MINIMA; ANTITUMOR-ACTIVITY; KINASE-ACTIVITY; HUMAN CANCER; IN-VITRO; ACTIVATION; EXPRESSION	Background: Multiple myeloma (MM) is a disease of cell cycle dysregulation while cell cycle modulation can be a target for MM therapy. In this study we investigated the effects and mechanisms of action of a sesquiterpene lactone 6-O-angeloylplenolin (6-OAP) on MM cells. Methodology/Principal Findings: MM cells were exposed to 6-OAP and cell cycle distribution were analyzed. The role for cyclin B1 to play in 6-OAP-caused mitotic arrest was tested by specific siRNA analyses in U266 cells. MM.1S cells coincubated with interleukin-6 (IL-6), insulin-like growth factor-I (IGF-I), or bone marrow stromal cells (BMSCs) were treated with 6-OAP. The effects of 6-OAP plus other drugs on MM.1S cells were evaluated. The in vivo therapeutic efficacy and pharmacokinetic features of 6-OAP were tested in nude mice bearing U266 cells and Sprague-Dawley rats, respectively. We found that 6-OAP suppressed the proliferation of dexamethasone-sensitive and dexamethasone-resistant cell lines and primary CD138+ MM cells. 6-OAP caused mitotic arrest, accompanied by activation of spindle assembly checkpoint and blockage of ubiquitiniation and subsequent proteasomal degradation of cyclin B1. Combined use of 6-OAP and bortezomib induced potentiated cytotoxicity with inactivation of ERK1/2 and activation of JNK1/2 and Casp-8/-3. 6-OAP overcame the protective effects of IL-6 and IGF-I on MM cells through inhibition of Jak2/Stat3 and Akt, respectively. 6-OAP inhibited BMSCs-facilitated MM cell expansion and TNF-alpha-induced NF-kappa B signal. Moreover, 6-OAP exhibited potent anti-MM activity in nude mice and favorable pharmacokinetics in rats. Conclusions/Significance: These results indicate that 6-OAP is a new cell cycle inhibitor which shows therapeutic potentials for MM.	[Liu, Ying; Zhang, Feng-Xiang; Zhang, Bo; Chen, Yong-Long; Zhou, Guang-Biao] Chinese Acad Sci, Inst Zool, Guangzhou Inst Biomed & Hlth, Beijing, Peoples R China; [Liu, Ying; Zhang, Feng-Xiang; Zhang, Bo; Chen, Yong-Long; Zhou, Guang-Biao] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China; [Liu, Ying] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Chen, Xiao-Qin] Sun Yat Sen Univ, Canc Hosp, Dept Hematol, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Heng-Xing; Cheng, Yong-Xian] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W China, Kunming, Peoples R China; [Jin, Jie] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Sun Yat Sen University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Zhejiang University	Liu, Y (corresponding author), Chinese Acad Sci, Inst Zool, Guangzhou Inst Biomed & Hlth, Beijing, Peoples R China.	yxcheng@mail.kib.ac.cn; gbzhou@ioz.ac.cn	Zhou, Guang-Biao/ABG-5795-2021; Zhou, Guangbiao/J-6575-2017; Liu, Ying/I-2050-2016	Zhou, Guangbiao/0000-0002-6327-2316; Zhou, Guang-Biao/0000-0001-6778-7133	National Key Program for Basic Research (973) [2010CB529201]; CAS [KSCX1-YW-R-26, KSCX2-YW-R-235]; National Natural Science Foundation of China [81071930, 30871110]; National Major Scientific and Technological Program for Drug Discovery [2009ZX09103-101]; Natural Science Foundation of Yunnan [2006B0041Q]; Talent Scholarship for the Youth of Yunnan [2007PY01-48]	National Key Program for Basic Research (973)(National Basic Research Program of China); CAS(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Scientific and Technological Program for Drug Discovery; Natural Science Foundation of Yunnan(Natural Science Foundation of Yunnan Province); Talent Scholarship for the Youth of Yunnan	This work is supported in part by the National Key Program for Basic Research (973, 2010CB529201), the Key Project of Knowledge Innovation Program of the CAS (KSCX1-YW-R-26 and KSCX2-YW-R-235), the National Natural Science Foundation of China (81071930, 30871110), the National Major Scientific and Technological Program for Drug Discovery (2009ZX09103-101), the Natural Science Foundation of Yunnan (2006B0041Q), and the Talent Scholarship for the Youth of Yunnan (No. 2007PY01-48). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attal M, 2003, NEW ENGL J MED, V349, P2495, DOI 10.1056/NEJMoa032290; Bergsagel PL, 2003, IMMUNOL REV, V194, P96, DOI 10.1034/j.1600-065X.2003.00052.x; Bjorck E, 2005, BLOOD, V105, P2908, DOI 10.1182/blood-2004-07-2721; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; CHANGLONG L, 2007, BIOMEDICINE PHARMACO, V62, P401; Chauhan D, 1996, BLOOD, V87, P1104, DOI 10.1182/blood.V87.3.1104.bloodjournal8731104; Chen B, 2006, NEUROSCI LETT, V406, P178, DOI 10.1016/j.neulet.2006.06.074; Chen-Kiang S, 2003, IMMUNOL REV, V194, P39, DOI 10.1034/j.1600-065X.2003.00065.x; Chu S, 2004, BLOOD, V103, P3167, DOI 10.1182/blood-2003-04-1271; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Demoe JH, 2009, CANCER RES, V69, P1509, DOI 10.1158/0008-5472.CAN-08-3133; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Ding LF, 2009, J ASIAN NAT PROD RES, V11, P732, DOI 10.1080/10286020903029231; Ely S, 2005, CANCER RES, V65, P11345, DOI 10.1158/0008-5472.CAN-05-2159; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Fang L, 2008, J CANCER RES CLIN, V134, P1337, DOI 10.1007/s00432-008-0416-0; Faretta M, 1998, CYTOMETRY, V31, P53; Francois G, 1996, PLANTA MED, V62, P126, DOI 10.1055/s-2006-957833; GOLDMANLEIKIN RE, 1989, J LAB CLIN MED, V113, P335; GRANA X, 1995, ONCOGENE, V11, P211; Harikumar KB, 2010, MOL CANCER RES, V8, P751, DOI 10.1158/1541-7786.MCR-09-0565; Hashimoto O, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-292; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hideshima T, 2001, ONCOGENE, V20, P5991, DOI 10.1038/sj.onc.1204833; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; LeBlanc R, 2002, CANCER RES, V62, P4996; Lee TJ, 2006, CANCER LETT, V240, P234, DOI 10.1016/j.canlet.2005.09.013; Lin H, 2002, INT J CANCER, V97, P121, DOI 10.1002/ijc.1570; MANFREDI JJ, 1984, PHARMACOL THERAPEUT, V25, P83, DOI 10.1016/0163-7258(84)90025-1; Menu E, 2008, CANCER RES, V68, P5519, DOI 10.1158/0008-5472.CAN-07-6404; Mitsiades CS, 2004, CANCER CELL, V6, P439, DOI 10.1016/j.ccr.2004.10.020; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; NILSSON K, 1970, CLIN EXP IMMUNOL, V7, P477; Oh HM, 2006, ARCH PHARM RES, V29, P64, DOI 10.1007/BF02977470; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Piloto O, 2007, BLOOD, V109, P1643, DOI 10.1182/blood-2006-05-023804; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Schwikkard S, 2002, NAT PROD REP, V19, P675, DOI 10.1039/b008980j; Shaughnessy JD, 2003, IMMUNOL REV, V194, P140, DOI 10.1034/j.1600-065X.2003.00054.x; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Swanton C, 2004, LANCET ONCOL, V5, P27, DOI 10.1016/S1470-2045(03)01321-4; Taylor RSL, 1998, PHYTOCHEMISTRY, V47, P631, DOI 10.1016/S0031-9422(97)00534-7; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Yamada HY, 2006, MOL CANCER THER, V5, P2963, DOI 10.1158/1535-7163.MCT-06-0319; Yasui H, 2005, CANCER RES, V65, P7478, DOI 10.1158/0008-5472.CAN-05-0850; Zhou GB, 2007, BLOOD, V109, P3441, DOI 10.1182/blood-2006-06-032250	61	35	38	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21930	10.1371/journal.pone.0021930	http://dx.doi.org/10.1371/journal.pone.0021930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755010	gold, Green Submitted, Green Published			2022-12-25	WOS:000292632000037
J	Niu, YJ; Wang, J; Shang, ZQ; Huang, SP; Shyr, CR; Yeh, SY; Chang, CS				Niu, Yuanjie; Wang, Juan; Shang, Zhiqun; Huang, Shu-Pin; Shyr, Chih-Rong; Yeh, Shuyuan; Chang, Chawnshang			Increased CK5/CK8-Positive Intermediate Cells with Stromal Smooth Muscle Cell Atrophy in the Mice Lacking Prostate Epithelial Androgen Receptor	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; IMMUNOHISTOCHEMICAL LOCALIZATION; STEM-CELLS; EXPRESSION; CANCER; DIFFERENTIATION; PROLIFERATION; INDUCTION; IDENTIFICATION	Results from tissue recombination experiments documented well that stromal androgen receptor (AR) plays essential roles in prostate development, but epithelial AR has little roles in prostate development. Using cell specific knockout AR strategy, we generated pes-ARKO mouse with knock out of AR only in the prostate epithelial cells and demonstrated that epithelial AR might also play important roles in the development of prostate gland. We found mice lacking the prostate epithelial AR have increased apoptosis in epithelial CK8-positive luminal cells and increased proliferation in epithelial CK5-positive basal cells. The consequences of these two contrasting results could then lead to the expansion of CK5/CK8-positive intermediate cells, accompanied by stromal atrophy and impaired ductal morphogenesis. Molecular mechanism dissection found AR target gene, TGF-beta(1), might play important roles in this epithelial AR-to-stromal morphogenesis modulation. Collectively, these results provided novel information relevant to epithelial AR functions in epithelial-stromal interactions during the development of normal prostate, and suggested AR could also function as suppressor in selective cells within prostate.	[Niu, Yuanjie; Wang, Juan; Shang, Zhiqun; Chang, Chawnshang] Tianjin Med Univ, Tianjin Inst Urol, Chawnshang Chang Sex Hormone Res Ctr, Tianjin, Peoples R China; [Niu, Yuanjie; Shang, Zhiqun; Huang, Shu-Pin; Yeh, Shuyuan; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Niu, Yuanjie; Shang, Zhiqun; Huang, Shu-Pin; Yeh, Shuyuan; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Shyr, Chih-Rong; Chang, Chawnshang] China Med Univ & Hosp, Sex Hormone Res Ctr, Taichung, Taiwan	Tianjin Medical University; University of Rochester; University of Rochester; China Medical University Taiwan; China Medical University Hospital - Taiwan	Niu, YJ (corresponding author), Tianjin Med Univ, Tianjin Inst Urol, Chawnshang Chang Sex Hormone Res Ctr, Tianjin, Peoples R China.	niuyuanjie@gmail.com; chang@urmc.rochester.edu	shang, zhiqun/J-6631-2018	Chang, Chawnshang/0000-0001-8510-3516	NSFC [30872587]; TSTC [09ZCZDSF04300]	NSFC(National Natural Science Foundation of China (NSFC)); TSTC	This work was supported by NSFC grant 30872587 and TSTC grant 09ZCZDSF04300. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013751; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Cardillo MR, 2000, ANAL QUANT CYTOL, V22, P403; CUNHA GR, 1983, RECENT PROG HORM RES, V39, P559; CUNHA GR, 1976, INT REV CYTOL, V47, P137, DOI 10.1016/S0074-7696(08)60088-1; CUNHA GR, 1981, J STEROID BIOCHEM, V14, P1317, DOI 10.1016/0022-4731(81)90338-1; Cunha GR, 2004, J STEROID BIOCHEM, V92, P221, DOI 10.1016/j.jsbmb.2004.10.017; CUNHA GR, 1978, J EXP ZOOL, V205, P343; Danielpour D, 1996, J CELL PHYSIOL, V166, P231, DOI 10.1002/(SICI)1097-4652(199601)166:1<231::AID-JCP24>3.0.CO;2-G; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hayward SW, 1998, DIFFERENTIATION, V63, P131, DOI 10.1046/j.1432-0436.1998.6330131.x; Huang XM, 2003, FRONT BIOSCI-LANDMRK, V8, pS740, DOI 10.2741/1093; Kassen A, 1996, PROSTATE, V28, P89, DOI 10.1002/(SICI)1097-0045(199602)28:2<89::AID-PROS3>3.0.CO;2-I; Kim IY, 1996, MOL ENDOCRINOL, V10, P107, DOI 10.1210/me.10.1.107; Kim IY, 1996, CLIN CANCER RES, V2, P1255; Klingler HC, 1999, PROSTATE, V41, P110; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; MCNEAL JE, 1983, MONOGR UROL, V4, P1; MORI H, 1990, PROSTATE, V16, P71, DOI 10.1002/pros.2990160108; Nemeth JA, 1997, PROSTATE, V33, P64; Niu Y, 2001, BJU INT, V87, P386, DOI 10.1046/j.1464-410x.2001.00103.x; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12188, DOI 10.1073/pnas.0804701105; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Peehl DM, 1997, EXP CELL RES, V232, P208, DOI 10.1006/excr.1997.3525; Perry KT, 1997, PROSTATE, V33, P133, DOI 10.1002/(SICI)1097-0045(19971001)33:2<133::AID-PROS7>3.0.CO;2-L; Raghow S, 1999, J UROLOGY, V162, P509, DOI 10.1016/S0022-5347(05)68617-X; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Robinson EJ, 1998, PROSTATE, V37, P149, DOI 10.1002/(SICI)1097-0045(19981101)37:3<149::AID-PROS4>3.0.CO;2-E; Salm SN, 2000, J CELL PHYSIOL, V184, P70, DOI 10.1002/(SICI)1097-4652(200007)184:1<70::AID-JCP7>3.3.CO;2-L; Story MT, 1996, J CELL PHYSIOL, V169, P97, DOI 10.1002/(SICI)1097-4652(199610)169:1<97::AID-JCP10>3.0.CO;2-L; STORY MT, 1993, PROSTATE, V22, P183, DOI 10.1002/pros.2990220302; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Wang YZ, 2001, DIFFERENTIATION, V68, P270, DOI 10.1046/j.1432-0436.2001.680414.x; Williams RH, 1996, CLIN CANCER RES, V2, P635; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Xue Y, 1998, PROSTATE, V34, P292, DOI 10.1002/(SICI)1097-0045(19980301)34:4<292::AID-PROS7>3.0.CO;2-J; Zhao H, 2002, BIOCHEM BIOPH RES CO, V292, P482, DOI 10.1006/bbrc.2002.6660; Zhu ML, 2008, PROSTATE, V68, P287, DOI 10.1002/pros.20698	38	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e20202	10.1371/journal.pone.0020202	http://dx.doi.org/10.1371/journal.pone.0020202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754978	Green Submitted, Green Published, gold			2022-12-25	WOS:000292632000002
J	von Boehmer, L; Keller, L; Mortezavi, A; Provenzano, M; Sais, G; Hermanns, T; Sulser, T; Jungbluth, AA; Old, LJ; Kristiansen, G; van den Broek, M; Moch, H; Knuth, A; Wild, PJ				von Boehmer, Lotta; Keller, Lukas; Mortezavi, Ashkan; Provenzano, Maurizio; Sais, Giovanni; Hermanns, Thomas; Sulser, Tullio; Jungbluth, Achim A.; Old, Lloyd J.; Kristiansen, Glen; van den Broek, Maries; Moch, Holger; Knuth, Alexander; Wild, Peter J.			MAGE-C2/CT10 Protein Expression Is an Independent Predictor of Recurrence in Prostate Cancer	PLOS ONE			English	Article							CYTOLYTIC T-LYMPHOCYTES; GENE-EXPRESSION; NY-ESO-1 PROTEIN; TESTIS ANTIGENS; HEPATOCELLULAR-CARCINOMA; MELANOMA PATIENTS; IMMUNE-RESPONSES; CELL RESPONSES; TUMOR-ANTIGENS; MAGE FAMILY	The cancer-testis (CT) family of antigens is expressed in a variety of malignant neoplasms. In most cases, no CT antigen is found in normal tissues, except in testis, making them ideal targets for cancer immunotherapy. A comprehensive analysis of CT antigen expression has not yet been reported in prostate cancer. MAGE-C2/CT-10 is a novel CT antigen. The objective of this study was to analyze extent and prognostic significance of MAGE-C2/CT10 protein expression in prostate cancer. 348 prostate carcinomas from consecutive radical prostatectomies, 29 castration-refractory prostate cancer, 46 metastases, and 45 benign hyperplasias were immunohistochemically analyzed for MAGE-C2/CT10 expression using tissue microarrays. Nuclear MAGE-C2/CT10 expression was identified in only 3.3% primary prostate carcinomas. MAGE-C2/CT10 protein expression was significantly more frequent in metastatic (16.3% positivity) and castration-resistant prostate cancer (17% positivity; p < 0.001). Nuclear MAGE-C2/CT10 expression was identified as predictor of biochemical recurrence after radical prostatectomy (p = 0.015), which was independent of preoperative PSA, Gleason score, tumor stage, and surgical margin status in multivariate analysis (p < 0.05). MAGE-C2/CT10 expression in prostate cancer correlates with the degree of malignancy and indicates a higher risk for biochemical recurrence after radical prostatectomy. Further, the results suggest MAGE-C2/CT10 as a potential target for adjuvant and palliative immunotherapy in patients with prostate cancer.	[von Boehmer, Lotta; Keller, Lukas; van den Broek, Maries; Knuth, Alexander] Univ Zurich Hosp, Clin Oncol, CH-8091 Zurich, Switzerland; [Mortezavi, Ashkan; Provenzano, Maurizio; Sais, Giovanni; Hermanns, Thomas; Sulser, Tullio] Univ Zurich Hosp, Urol Clin, CH-8091 Zurich, Switzerland; [Kristiansen, Glen; Moch, Holger; Wild, Peter J.] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Jungbluth, Achim A.; Old, Lloyd J.] Mem Sloan Kettering Canc Ctr, New York Branch, Ludwig Inst Canc Res, New York, NY 10021 USA	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center	von Boehmer, L (corresponding author), Univ Zurich Hosp, Clin Oncol, CH-8091 Zurich, Switzerland.	Lotta.vonBoehmer@usz.ch	knuth, alexander/H-2608-2014; van den Broek, Maries/G-4128-2016	knuth, alexander/0000-0002-9318-2784; Mortezavi, Ashkan/0000-0001-6307-2659; von Boehmer, Lotta/0000-0001-8018-1814; Wild, Peter Johannes/0000-0002-1017-3744; van den Broek, Maries/0000-0002-9489-3692	Atlantic Philanthropies (New York, USA); Cancer Research Institute; Science Foundation for Oncology; Hanne Liebermann Foundation (Zurich); Hartman Muller Foundation (Zurich); Zurich Cancer League (Zurich); Terry Fox Foundation (Winnipeg, Canada)	Atlantic Philanthropies (New York, USA); Cancer Research Institute; Science Foundation for Oncology; Hanne Liebermann Foundation (Zurich); Hartman Muller Foundation (Zurich); Zurich Cancer League (Zurich); Terry Fox Foundation (Winnipeg, Canada)	This work was supported by Atlantic Philanthropies (New York, USA), Cancer Research Institute, the Science Foundation for Oncology, the Hanne Liebermann Foundation (Zurich), the Hartman Muller Foundation (Zurich), the Zurich Cancer League (Zurich), and the Terry Fox Foundation (Winnipeg, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers SN, 2010, FUTURE ONCOL, V6, P717, DOI [10.2217/fon.10.36, 10.2217/FON.10.36]; Andrade Valeria C C, 2008, Cancer Immun, V8, P2; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Atanackovic D, 2008, P NATL ACAD SCI USA, V105, P1650, DOI 10.1073/pnas.0707140104; Atanackovic D, 2009, CLIN CANCER RES, V15, P1343, DOI 10.1158/1078-0432.CCR-08-0989; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Barrow C, 2006, CLIN CANCER RES, V12, P764, DOI 10.1158/1078-0432.CCR-05-1544; Bender Armin, 2007, Cancer Immun, V7, P16; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Bubendorf L, 1996, J PATHOL, V178, P437, DOI 10.1002/(SICI)1096-9896(199604)178:4<437::AID-PATH484>3.0.CO;2-4; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Davis ID, 2004, P NATL ACAD SCI USA, V101, P10697, DOI 10.1073/pnas.0403572101; De Smet C, 1999, MOL CELL BIOL, V19, P7327; Dearnaley DP, 2005, BRIT J CANCER, V92, P488, DOI 10.1038/sj.bjc.6602301; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Epstein JI, 2005, SCAND J UROL NEPHROL, V39, P34, DOI 10.1080/03008880510030932; Fleischmann A, 2008, CLIN CANCER RES, V14, P7838, DOI 10.1158/1078-0432.CCR-08-1432; Fossa A, 2004, PROSTATE, V59, P440, DOI 10.1002/pros.20025; Foster CS, 2004, ONCOGENE, V23, P5871, DOI 10.1038/sj.onc.1207800; Furuta J, 2004, CANCER SCI, V95, P962, DOI 10.1111/j.1349-7006.2004.tb03184.x; Germeau C, 2005, J EXP MED, V201, P241, DOI 10.1084/jem.20041379; Gjerstorff MF, 2006, BRIT J CANCER, V94, P1864, DOI 10.1038/sj.bjc.6603163; Godelaine D, 2007, CANCER IMMUNOL IMMUN, V56, P753, DOI 10.1007/s00262-006-0244-5; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; Gure AO, 2000, INT J CANCER, V85, P726, DOI 10.1002/(SICI)1097-0215(20000301)85:5<726::AID-IJC21>3.0.CO;2-F; Hudolin T, 2006, PROSTATE, V66, P13, DOI 10.1002/pros.20312; Jager E, 2006, P NATL ACAD SCI USA, V103, P14453, DOI 10.1073/pnas.0606512103; Jager Dirk, 2005, Cancer Immun, V5, P11; Karbach J, 2011, CLIN CANCER RES, V17, P861, DOI 10.1158/1078-0432.CCR-10-1811; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kruger T, 2005, CANCER IMMUNOL IMMUN, V54, P826, DOI 10.1007/s00262-004-0650-5; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lethe B, 1998, INT J CANCER, V76, P903, DOI 10.1002/(SICI)1097-0215(19980610)76:6<903::AID-IJC22>3.0.CO;2-1; Li M, 2005, CLIN CANCER RES, V11, P1809, DOI 10.1158/1078-0432.CCR-04-1365; Lucas S, 2000, INT J CANCER, V87, P55, DOI 10.1002/1097-0215(20000701)87:1<55::AID-IJC8>3.3.CO;2-A; Ma WB, 2004, INT J CANCER, V109, P698, DOI 10.1002/ijc.20038; Meklat F, 2007, BRIT J HAEMATOL, V136, P769, DOI 10.1111/j.1365-2141.2006.06484.x; Nakada Tetsuya, 2003, Cancer Immun, V3, P10; Napoletano C, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.019; Odunsi K, 2003, CANCER RES, V63, P6076; Odunsi K, 2007, P NATL ACAD SCI USA, V104, P12837, DOI 10.1073/pnas.0703342104; Peng JR, 2005, CANCER LETT, V219, P223, DOI 10.1016/j.canlet.2004.07.028; Prikler L, 2004, AKTUEL UROL, V35, P326, DOI 10.1055/s-2004-818510; Riener MO, 2009, INT J CANCER, V124, P352, DOI 10.1002/ijc.23966; Scanlan MJ, 2002, CANCER RES, V62, P4041; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Sharma P, 2006, CLIN CANCER RES, V12, P5442, DOI 10.1158/1078-0432.CCR-06-0527; Sharma Padmanee, 2003, Cancer Immun, V3, P19; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Tyagi P, 2009, CLIN LUNG CANCER, V10, P371, DOI 10.3816/CLC.2009.n.052; Valmori D, 2007, P NATL ACAD SCI USA, V104, P8947, DOI 10.1073/pnas.0703395104; van Baren N, 2005, J CLIN ONCOL, V23, P9008, DOI 10.1200/JCO.2005.08.375; Velazquez Elsa F, 2007, Cancer Immun, V7, P11; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Wischnewski F, 2006, MOL CANCER RES, V4, P339, DOI 10.1158/1541-7786.MCR-05-0229; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Yang B, 2007, J INVEST DERMATOL, V127, P2123, DOI 10.1038/sj.jid.5700836; Zellweger T, 2009, INT J CANCER, V124, P2116, DOI 10.1002/ijc.24174; Zhuang Ran, 2006, Cancer Immun, V6, P7	60	38	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21366	10.1371/journal.pone.0021366	http://dx.doi.org/10.1371/journal.pone.0021366			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754986	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000292632000010
J	Gourion, B; Delmotte, N; Bonaldi, K; Nouwen, N; Vorholt, JA; Giraud, E				Gourion, Benjamin; Delmotte, Nathanael; Bonaldi, Katia; Nouwen, Nico; Vorholt, Julia A.; Giraud, Eric			Bacterial RuBisCO Is Required for Efficient Bradyrhizobium/Aeschynomene Symbiosis	PLOS ONE			English	Article							TRANSPOSON MUTAGENESIS; EXPRESSION; NODULE; GENES; PHOTOSYNTHESIS; METABOLISM; MECHANISM; FIXATION; SEQUENCE; INSIGHTS	Rhizobia and legume plants establish symbiotic associations resulting in the formation of organs specialized in nitrogen fixation. In such organs, termed nodules, bacteria differentiate into bacteroids which convert atmospheric nitrogen and supply the plant with organic nitrogen. As a counterpart, bacteroids receive carbon substrates from the plant. This rather simple model of metabolite exchange underlies symbiosis but does not describe the complexity of bacteroids' central metabolism. A previous study using the tropical symbiotic model Aeschynomene indica/photosynthetic Bradyrhizobium sp. ORS278 suggested a role of the bacterial Calvin cycle during the symbiotic process. Herein we investigated the role of two RuBisCO gene clusters of Bradyrhizobium sp. ORS278 during symbiosis. Using gene reporter fusion strains, we showed that cbbL1 but not the paralogous cbbL2 is expressed during symbiosis. Congruently, CbbL1 was detected in bacteroids by proteome analysis. The importance of CbbL1 for symbiotic nitrogen fixation was proven by a reverse genetic approach. Interestingly, despite its symbiotic nitrogen fixation defect, the cbbL1 mutant was not affected in nitrogen fixation activity under free living state. This study demonstrates a critical role for bacterial RuBisCO during a rhizobia/legume symbiotic interaction.	[Gourion, Benjamin; Bonaldi, Katia; Nouwen, Nico; Giraud, Eric] Univ Montpellier 2, Ctr Cooperat Int Rech Agron Dev, Inst Natl Rech Agron,Inst Rech Dev, Lab Symbioses Trop & Mediterraneennes,SupAgro, Montpellier, France; [Delmotte, Nathanael; Vorholt, Julia A.] Eidgenoss Tech Hsch Zurich, Inst Microbiol, Zurich, Switzerland	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Gourion, B (corresponding author), CNRS, Inst Sci Vegetal, Gif Sur Yvette, France.	benjamin.gourion@isv.cnrs-gif.fr	Delmotte, Nathanael/G-7531-2016; Giraud, Eric/GLS-1036-2022; Delmotte, Nathanael/D-1337-2010; Vorholt, Julia/K-3514-2016; Gourion, Benjamin/AAG-9063-2019	Vorholt, Julia/0000-0002-6011-4910; Gourion, Benjamin/0000-0001-5768-6961	French national research agency [ANR-NEWNOD-2006-BLAN-0095, ANR-SESAM-2010-BLAN-170801]; European Molecular Biology Organization	French national research agency(French National Research Agency (ANR)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported by grants from the French national research agency (ANR-NEWNOD-2006-BLAN-0095 and ANR-SESAM-2010-BLAN-170801); BG was supported by a grant from the European Molecular Biology Organization. This work has benefited from the facilities and expertise of the Functional Genomic Center Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAZARD D, 1990, FEMS MICROBIOL LETT, V68, P177, DOI 10.1111/j.1574-6968.1990.tb04145.x; Amadou C, 2008, GENOME RES, V18, P1472, DOI 10.1101/gr.076448.108; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; Badger MR, 2008, J EXP BOT, V59, P1525, DOI 10.1093/jxb/erm297; Berg IA, 2011, APPL ENVIRON MICROB, V77, P1925, DOI 10.1128/AEM.02473-10; Bonaldi K, 2010, MOL PLANT MICROBE IN, V23, P1537, DOI 10.1094/MPMI-06-10-0137; Bonaldi K, 2010, MOL PLANT MICROBE IN, V23, P760, DOI 10.1094/MPMI-23-6-0760; Delmotte N, 2010, PROTEOMICS, V10, P1391, DOI 10.1002/pmic.200900710; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; DREYFUS BL, 1983, APPL ENVIRON MICROB, V45, P711, DOI 10.1128/AEM.45.2.711-713.1983; EHRHARDT DW, 1992, SCIENCE, V256, P998, DOI 10.1126/science.10744524; FALCONE DL, 1991, J BACTERIOL, V173, P2099, DOI 10.1128/jb.173.6.2099-2108.1991; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Giraud E, 2004, PHOTOSYNTH RES, V82, P115, DOI 10.1007/s11120-004-1768-1; Giraud E, 2000, P NATL ACAD SCI USA, V97, P14795, DOI 10.1073/pnas.250484097; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; GUTTERIDGE S, 1995, PLANT CELL, V7, P809, DOI 10.1105/tpc.7.7.809; HALLENBECK PL, 1990, J BACTERIOL, V172, P1736, DOI 10.1128/jb.172.4.1736-1748.1990; HILLMER P, 1977, J BACTERIOL, V129, P724, DOI 10.1128/JB.129.2.724-731.1977; HUNGRIA M, 1993, BIOL FERT SOILS, V15, P208, DOI 10.1007/BF00361613; Joshi HM, 1996, P NATL ACAD SCI USA, V93, P14515, DOI 10.1073/pnas.93.25.14515; Koch M, 2010, MOL PLANT MICROBE IN, V23, P784, DOI 10.1094/MPMI-23-6-0784; KOKOTEK W, 1989, GENE, V84, P467, DOI 10.1016/0378-1119(89)90522-2; Lorquin J, 1997, APPL ENVIRON MICROB, V63, P1151, DOI 10.1128/AEM.63.3.1151-1154.1997; MAIER RJ, 1981, J BACTERIOL, V145, P533, DOI 10.1128/JB.145.1.533-540.1981; McKinlay JB, 2010, P NATL ACAD SCI USA, V107, P11669, DOI 10.1073/pnas.1006175107; MULLER F. M., 1933, ARCHIV MIKRO BIOL, V4, P131, DOI 10.1007/BF00407535; Oke V, 1999, MOL MICROBIOL, V32, P837, DOI 10.1046/j.1365-2958.1999.01402.x; Pickering BS, 2008, J BACTERIOL, V190, P6409, DOI 10.1128/JB.00757-08; Prell J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013933; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; RICHARDSON DJ, 1988, ARCH MICROBIOL, V150, P131, DOI 10.1007/BF00425152; Sarma AD, 2005, PROTEOMICS, V5, P4170, DOI 10.1002/pmic.200401296; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; White J, 2007, PLANT PHYSIOL, V144, P604, DOI 10.1104/pp.107.097741; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913	40	30	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21900	10.1371/journal.pone.0021900	http://dx.doi.org/10.1371/journal.pone.0021900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750740	Green Published, Green Submitted, gold			2022-12-25	WOS:000292512000032
J	Sumoza-Toledo, A; Lange, I; Cortado, H; Bhagat, H; Mori, Y; Fleig, A; Penner, R; Partida-Sanchez, S				Sumoza-Toledo, Adriana; Lange, Ingo; Cortado, Hanna; Bhagat, Harivadan; Mori, Yasuo; Fleig, Andrea; Penner, Reinhold; Partida-Sanchez, Santiago			Dendritic cell maturation and chemotaxis is regulated by TRPM2-mediated lysosomal Ca2+ release	FASEB JOURNAL			English	Article						ADP-ribose; calcium signaling; IP3R; SOCE	CYCLIC ADP-RIBOSE; TRPM2 CHANNELS; NEUTROPHIL GRANULOCYTES; HYDROGEN-PEROXIDE; BETA-CELLS; CALCIUM; MIGRATION; ACTIVATION; MONOCYTES; RECEPTOR	Chemokines induce calcium (Ca2+) signaling and chemotaxis in dendritic cells (DCs), but the molecular players involved in shaping intracellular Ca2+ changes remain to be characterized. Using siRNA and knockout mice, we show that in addition to inositol 1,4,5-trisphosphate (IP3)-mediated Ca2+ release and store-operated Ca2+ entry (SOCE), the transient receptor potential melastatin 2 (TRPM2) channel contributes to Ca2+ release but not Ca2+ influx in mouse DCs. Consistent with these findings, TRPM2 expression in DCs is restricted to endolysosomal vesicles, whereas in neutrophils, the channel localizes to the plasma membrane. TRPM2-deficient DCs show impaired maturation and severely compromised chemokine-activated directional migration as well as bacterial-induced DC trafficking to the draining lymph nodes. Defective DC chemotaxis is due to perturbed chemokine-receptor-initiated Ca2+ signaling mechanisms, which include suppression of TRPM2-mediated Ca2+ release and secondary modification of SOCE. DCs deficient in both TRPM2 and IP3 receptor signaling lose their ability to perform chemotaxis entirely. These results highlight TRPM2 as a key player regulating DC chemotaxis through its function as Ca2+ release channel and confirm ADP-ribose as a novel second messenger for intracellular Ca2+ mobilization.-Sumoza-Toledo, A., Lange, I., Cortado, H., Bhagat, H., Mori, Y., Fleig, A., Penner, R., Partida-Sanchez, S. Dendritic cell maturation and chemotaxis is regulated by TRPM2-mediated lysosomal Ca2+ release. FASEB J. 25, 3529-3542 (2011). www.fasebj.org	[Sumoza-Toledo, Adriana; Cortado, Hanna; Bhagat, Harivadan; Partida-Sanchez, Santiago] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; [Sumoza-Toledo, Adriana; Lange, Ingo; Fleig, Andrea; Penner, Reinhold] Queens Med Ctr, Ctr Biomed Res, Lab Cell & Mol Signaling, Honolulu, HI USA; [Sumoza-Toledo, Adriana; Lange, Ingo; Fleig, Andrea; Penner, Reinhold] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA; [Sumoza-Toledo, Adriana; Cortado, Hanna; Bhagat, Harivadan; Partida-Sanchez, Santiago] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto, Japan	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; The Queen's Medical Center; University of Hawaii System; University System of Ohio; Ohio State University; Kyoto University	Partida-Sanchez, S (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, 700 Childrens Dr, Columbus, OH 43205 USA.	rpenner@hawaii.edu; santiago.partida-sanchez@nationwidechildrens.org	Partida-Sanchez, Santiago/B-7523-2008; Sumoza-Toledo, Adriana/D-5083-2013	Partida-Sanchez, Santiago/0000-0003-2996-9440; Sumoza-Toledo, Adriana/0000-0002-8366-2047; Fleig, Andrea/0000-0001-8396-7249; Penner, Reinhold/0000-0002-5366-1537; Lange, Ingo/0000-0002-6703-0015	Research Institute at Nationwide Children's Hospital; U.S. National Institutes of Health [GM063954, GM078195]; U.S. National Institute of Allergy and Infectious Diseases [R01AI092117]; Queen Emma Research Foundation; Research Centers in Minority Institutions; Centers of Biomedical Research Excellence [G12-RR003061, P20-RR016453]; COBRE [2P20RR018727-06]; Grants-in-Aid for Scientific Research [20249015] Funding Source: KAKEN; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061, P20RR016453, P20RR018727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM078195, R01GM063954] Funding Source: NIH RePORTER	Research Institute at Nationwide Children's Hospital(Ohio State University); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Queen Emma Research Foundation; Research Centers in Minority Institutions(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); COBRE; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank S. Johne for technical support. This work was supported by the Research Institute at Nationwide Children's Hospital (S.P.-S. and A.S.-T.), U.S. National Institutes of Health grants GM063954 (R.P.) and GM078195 (A.F.), U.S. National Institute of Allergy and Infectious Diseases grant R01AI092117 (S.P.-S), and The Queen Emma Research Foundation (A.S.-T.). The John A. Burns School of Medicine (JABSOM) Histology and Imaging Core facility is supported by both Research Centers in Minority Institutions and Centers of Biomedical Research Excellence grants (G12-RR003061 and P20-RR016453). The JABSOM Molecular and Cellular Immunology Core facility is supported by COBRE grant 2P20RR018727-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicting financial interests.	Bai L, 2009, P NATL ACAD SCI USA, V106, P10254, DOI 10.1073/pnas.0901228106; Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; Beck A, 2006, FASEB J, V20, P962, DOI 10.1096/fj.05-5538fje; Bell D, 1999, J EXP MED, V190, P1417, DOI 10.1084/jem.190.10.1417; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cheng H, 2007, CELL CALCIUM, V41, P51, DOI 10.1016/j.ceca.2006.04.032; Choi EY, 2009, FRONT BIOSCI-LANDMRK, V14, P1596, DOI 10.2741/3327; Christensen KA, 2002, J CELL SCI, V115, P599; Colvin RA, 2010, NAT IMMUNOL, V11, P495, DOI 10.1038/ni.1878; Czerniecki BJ, 1997, J IMMUNOL, V159, P3823; Dauer M, 2003, J IMMUNOL, V170, P4069, DOI 10.4049/jimmunol.170.8.4069; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Du JY, 2009, P NATL ACAD SCI USA, V106, P7239, DOI 10.1073/pnas.0811725106; Dunzendorfer S, 2000, IMMUNOL LETT, V71, P5, DOI 10.1016/S0165-2478(99)00161-3; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P159, DOI 10.1080/10799890600637506; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Heiner I, 2003, CELL CALCIUM, V33, P533, DOI 10.1016/S0143-4160(03)00058-7; Heiner I, 2006, BIOCHEM J, V398, P225, DOI 10.1042/BJ20060183; Honing S, 1996, EMBO J, V15, P5230, DOI 10.1002/j.1460-2075.1996.tb00908.x; Hsu SF, 2001, J IMMUNOL, V166, P6126, DOI 10.4049/jimmunol.166.10.6126; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Koski GK, 1999, BLOOD, V94, P1359, DOI 10.1182/blood.V94.4.1359.416k25_1359_1371; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Lange I, 2008, CELL CALCIUM, V44, P604, DOI 10.1016/j.ceca.2008.05.001; Laszlo C, 2009, J GEN PHYSIOL, V133, P189, DOI 10.1085/jgp.200810109; Massullo P, 2006, SEMIN CELL DEV BIOL, V17, P654, DOI 10.1016/j.semcdb.2006.11.006; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; O'Connell PJ, 2002, FEBS LETT, V512, P67, DOI 10.1016/S0014-5793(01)03321-X; Olah ME, 2009, J PHYSIOL-LONDON, V587, P965, DOI 10.1113/jphysiol.2008.162289; Partida-Sanchez S, 2007, J IMMUNOL, V179, P7827, DOI 10.4049/jimmunol.179.11.7827; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Qamar S, 2007, BIOCHEM SOC T, V35, P124, DOI 10.1042/BST0350124; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Roederer M, 2001, CYTOMETRY, V45, P47, DOI 10.1002/1097-0320(20010901)45:1<47::AID-CYTO1143>3.0.CO;2-A; Rottembourg D, 2010, J IMMUNOL, V184, P7100, DOI 10.4049/jimmunol.0803935; Rubartelli A, 1997, EUR J IMMUNOL, V27, P1893, DOI 10.1002/eji.1830270812; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Seale AP, 2004, CELL PHYSIOL BIOCHEM, V14, P155, DOI 10.1159/000078107; Selvatici R, 2006, EUR J PHARMACOL, V534, P1, DOI 10.1016/j.ejphar.2006.01.034; Starkus JG, 2010, J PHYSIOL-LONDON, V588, P1227, DOI 10.1113/jphysiol.2010.187476; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Stolk M, 2006, J LEUKOCYTE BIOL, V80, P651, DOI 10.1189/jlb.1205739; Turner H, 2003, BIOCHEM J, V371, P341, DOI 10.1042/BJ20021381; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yang W, 2010, J BIOL CHEM, V285, P30411, DOI 10.1074/jbc.M110.139774; ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387	50	99	103	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3529	3542		10.1096/fj.10-178483	http://dx.doi.org/10.1096/fj.10-178483			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21753080	Green Published			2022-12-25	WOS:000295356400023
J	Lemmon, CRM; Woo, JH; Tully, E; Wilsbach, K; Gabrielson, E				Lemmon, Colleen R. M.; Woo, Ju-Hyung; Tully, Ellen; Wilsbach, Kathleen; Gabrielson, Edward			Nuclear Factor-kappa B (NF-kappa B) Mediates a Protective Response in Cancer Cells Treated with Inhibitors of Fatty Acid Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PACLITAXEL-INDUCED APOPTOSIS; LUNG-CANCER; MULTIPLE-MYELOMA; TUMOR-CELLS; ACTIVATION; PATHWAY; THERAPY; DEATH; PHOSPHORYLATION	The efficacy of drugs used to treat cancer can be significantly attenuated by adaptive responses of neoplastic cells to drug-induced stress. To determine how cancer cells respond to inhibition of the enzyme fatty acid synthase (FAS), we focused on NF-kappa B-mediated pathways, which can be activated by various cellular stresses. Treating lung cancer cells with C93, a pharmacological inhibitor of FAS, results in changes indicative of a rapid initiation of NF-kappa B signaling, including translocation of RelA/p65 NF-kappa B to the nucleus, activation of a transfected NF-kappa B-luciferase reporter, and increased expression of NF-kappa B dependent transcripts, IL-6, IL-8, and COX-2. Verifying that these responses to C93 are specifically related to inhibition of FAS, we confirmed that levels of these same transcripts increase in response to siRNA targeting FAS. Inhibiting this NF-kappa B response (either by transfecting a mutant I kappa B alpha or treating with bortezomib) resulted in increased cell killing by C93, indicating that the NF-kappa B response is protective in this setting. Because inhibiting FAS leads to accumulation of intermediate metabolites of fatty acid biosynthesis, we then questioned whether protein kinase C (PKC) is involved in this response to metabolic stress. Immunofluorescence microscopy revealed that C93 treatment results in cellular translocation of PKC alpha and PKC beta isoforms and increased PKC alpha-dependent phosphorylation of the I kappa B alpha subunit of NF-kappa B. Furthermore, inhibiting PKC activity with RO-31-8220 or PKC alpha isoform-specific siRNA attenuates C93-induced I kappa B alpha phosphorylation and NF-kappa B activation and also potentiates C93-induced cell killing. These results suggest a link between PKC and NF-kappa B in protecting cancer cells from metabolic stress induced by inhibiting FAS.	Johns Hopkins Univ, Sch Med, Johns Hopkins Canc Ctr, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Gabrielson, E (corresponding author), Johns Hopkins Canc Ctr CRB2,Room 304,1550 E Orlea, Baltimore, MD 21231 USA.	egabriel@jhmi.edu			National Institutes of Health, NCI [P50 CA058184, R01 CA101232]; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE [P50CA058184, R01CA101232] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants P50 CA058184 and R01 CA101232. This work was also supported by the Flight Attendant Medical Research Institute.	Bian X, 2001, J BIOL CHEM, V276, P48921, DOI 10.1074/jbc.M108674200; Cai H, 1997, MOL CELL BIOL, V17, P732, DOI 10.1128/MCB.17.2.732; Chauhan D, 2005, MOL CANCER THER, V4, P686, DOI 10.1158/1535-7163.MCT-04-0338; Csiki I, 2005, CLIN CANCER RES, V11, P6634, DOI 10.1158/1078-0432.CCR-05-0436; Cusack JC, 2001, CANCER RES, V61, P3535; Davies AM, 2007, CLIN CANCER RES, V13, p4647S, DOI 10.1158/1078-0432.CCR-07-0334; Edelman Martin J, 2005, Clin Lung Cancer, V7 Suppl 2, pS64, DOI 10.3816/CLC.2005.s.011; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Holmes-McNary M, 2000, CANCER RES, V60, P3477; Huang Y, 2002, MOL PHARMACOL, V61, P105, DOI 10.1124/mol.61.1.105; Huang Y, 2000, CANCER RES, V60, P4426; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Lee JM, 2008, CRIT REV ONCOL HEMAT, V66, P208, DOI 10.1016/j.critrevonc.2008.01.004; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Ma MH, 2003, CLIN CANCER RES, V9, P1136; Menendez JA, 2004, INT J ONCOL, V24, P591; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; Pommier Y, 2004, ONCOGENE, V23, P2934, DOI 10.1038/sj.onc.1207515; Ponchel F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-18; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; STEFFAN NM, 1995, J IMMUNOL, V155, P4685; Strozyk E, 2006, ONCOGENE, V25, P6239, DOI 10.1038/sj.onc.1209655; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Woo JH, 2007, CANCER BIOL THER, V6, P2005, DOI 10.4161/cbt.6.12.5168; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914	35	12	12	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31457	31465		10.1074/jbc.M111.274308	http://dx.doi.org/10.1074/jbc.M111.274308			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768098	Green Published, hybrid			2022-12-25	WOS:000294487500040
J	Olucha, J; Meneely, KM; Chilton, AS; Lamb, AL				Olucha, Jose; Meneely, Kathleen M.; Chilton, Annemarie S.; Lamb, Audrey L.			Two Structures of an N-Hydroxylating Flavoprotein Monooxygenase ORNITHINE HYDROXYLASE FROM PSEUDOMONAS AERUGINOSA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVIN-CONTAINING MONOOXYGENASE; P-HYDROXYBENZOATE HYDROXYLASE; CONTAINING MONO-OXYGENASE; BIOCHEMICAL-CHARACTERIZATION; CYCLOHEXANONE MONOOXYGENASE; REACTION-MECHANISM; COFACTOR	The ornithine hydroxylase from Pseudomonas aeruginosa (PvdA) catalyzes the FAD-dependent hydroxylation of the side chain amine of ornithine, which is subsequently formylated to generate the iron-chelating hydroxamates of the siderophore pyoverdin. PvdA belongs to the class B flavoprotein monooxygenases, which catalyze the oxidation of substrates using NADPH as the electron donor and molecular oxygen. Class B enzymes include the well studied flavin-containing monooxygenases and Baeyer-Villiger monooxygenases. The first two structures of a class B N-hydroxylating monooxygenase were determined with FAD in oxidized (1.9 angstrom resolution) and reduced (3.03 angstrom resolution) states. PvdA has the two expected Ross-mann-like dinucleotide-binding domains for FAD and NADPH and also a substrate-binding domain, with the active site at the interface between the three domains. The structures have NADP(H) and (hydroxy) ornithine bound in a solvent-exposed active site, providing structural evidence for substrate and co-substrate specificity and the inability of PvdA to bind FAD tightly. Structural and biochemical evidence indicates that NADP(+) remains bound throughout the oxidative half-reaction, which is proposed to shelter the flavin intermediates from solvent and thereby prevent uncoupling of NADPH oxidation from hydroxylated product formation.	[Olucha, Jose; Meneely, Kathleen M.; Chilton, Annemarie S.; Lamb, Audrey L.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Lamb, AL (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	lamb@ku.edu		Lamb, Audrey/0000-0002-2352-2130	Office of Biological and Environmental Research, United States Department of Energy; National Center for Research Resources Biomedical Technology, National Institutes of Health; NIGMS [T32 GM08545]; Stanford Synchrotron Radiation Lightsource; IDeA Networks of Biomedical Research Excellence of the National Center for Research Resources [P20 RR016475]; NIAID [K02 AI093675]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI093675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008545] Funding Source: NIH RePORTER	Office of Biological and Environmental Research, United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources Biomedical Technology, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stanford Synchrotron Radiation Lightsource; IDeA Networks of Biomedical Research Excellence of the National Center for Research Resources; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. G. R. Moran for insightful discussions and critically reading this manuscript. Diffraction data were collected at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the Office of Basic Energy Sciences, United States Department of Energy. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Office of Biological and Environmental Research, United States Department of Energy; by the National Center for Research Resources Biomedical Technology Program, National Institutes of Health; and by NIGMS. We thank the staff at the Stanford Synchrotron Radiation Lightsource for support and assistance.; This work was supported, in whole or in part, by National Institutes of Health Graduate Training Program in Dynamic Aspects of Chemical Biology Grant T32 GM08545 from NIGMS (to J. O. and K. M. M.) and by National Institutes of Health Grant P20 RR016475 from the IDeA Networks of Biomedical Research Excellence Program of the National Center for Research Resources and Grant K02 AI093675 from NIAID (to A. L. L.).	ADAMS PD, 2010, ACTA CRYSTALLOGR D 2, V66, P213, DOI DOI 10.1107/S0907444909052925; Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; BEATY NB, 1980, J BIOL CHEM, V255, P3817; BEATY NB, 1981, J BIOL CHEM, V256, P4619; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Cho HJ, 2011, J STRUCT BIOL, V175, P39, DOI 10.1016/j.jsb.2011.04.007; Chocklett SW, 2010, BIOCHEMISTRY-US, V49, P6777, DOI 10.1021/bi100291n; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; GATTI DL, 1994, SCIENCE, V266, P110, DOI 10.1126/science.7939628; Ge L, 2006, J BACTERIOL, V188, P7205, DOI 10.1128/JB.00949-06; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamerbeek NM, 2004, EUR J BIOCHEM, V271, P2107, DOI 10.1111/j.1432-1033.2004.04126.x; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Malito E, 2004, P NATL ACAD SCI USA, V101, P13157, DOI 10.1073/pnas.0404538101; Mayfield JA, 2010, J BIOL CHEM, V285, P30375, DOI 10.1074/jbc.M110.157578; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meneely KM, 2007, BIOCHEMISTRY-US, V46, P11930, DOI 10.1021/bi700932q; Meneely KM, 2009, BIOCHEMISTRY-US, V48, P4371, DOI 10.1021/bi900442z; Mirza IA, 2009, J AM CHEM SOC, V131, P8848, DOI 10.1021/ja9010578; Moran GR, 1996, BIOCHEMISTRY-US, V35, P9278, DOI 10.1021/bi960360s; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Orru R, 2010, J BIOL CHEM, V285, P35021, DOI 10.1074/jbc.M110.161372; Palfey BA, 1999, BIOCHEMISTRY-US, V38, P1153, DOI 10.1021/bi9826613; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; THARIATH A, 1993, J BACTERIOL, V175, P589, DOI 10.1128/JB.175.3.589-596.1993; THARIATH AM, 1993, BIOCHIM BIOPHYS ACTA, V1203, P27, DOI 10.1016/0167-4838(93)90032-M; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012	36	50	51	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31789	31798		10.1074/jbc.M111.265876	http://dx.doi.org/10.1074/jbc.M111.265876			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757711	Green Published, hybrid			2022-12-25	WOS:000294487500072
J	So, BR; An, S; Kumar, S; Das, M; Turner, DA; Hadad, CM; Musier-Forsyth, K				So, Byung Ran; An, Songon; Kumar, Sandeep; Das, Mom; Turner, Daniel A.; Hadad, Christopher M.; Musier-Forsyth, Karin			Substrate-mediated Fidelity Mechanism Ensures Accurate Decoding of Proline Codons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; TRANSLATIONAL QUALITY-CONTROL; HAEMOPHILUS-INFLUENZAE YBAK; PROTEIN-SYNTHESIS; STRUCTURAL BASIS; EDITING DOMAIN; AMINO-ACIDS; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI	Aminoacyl-tRNA synthetases attach specific amino acids to cognate tRNAs. Prolyl-tRNA synthetases are known to mischarge tRNA(Pro) with the smaller amino acid alanine and with cysteine, which is the same size as proline. Quality control in proline codon translation is partly ensured by an editing domain (INS) present in most bacterial prolyl-tRNA synthetases that hydrolyzes smaller Ala-tRNA(Pro) and excludes Pro-tRNA(Pro). In contrast, Cys-tRNA(Pro) is cleared by a freestanding INS domain homolog, YbaK. Here, we have investigated the molecular mechanism of catalysis and substrate recognition by Hemophilus influenzae YbaK using site-directed mutagenesis, enzymatic assays of isosteric substrates and functional group analogs, and computational modeling. These studies together with mass spectrometric characterization of the YbaK-catalyzed reaction products support a novel substrate-assisted mechanism of Cys-tRNA(Pro) deacylation that prevents nonspecific Pro-tRNA(Pro) hydrolysis. Collectively, we propose that the INS and YbaK domains co-evolved distinct mechanisms involving steric exclusion and thiol-specific chemistry, respectively, to ensure accurate decoding of proline codons.	[So, Byung Ran; Kumar, Sandeep; Das, Mom; Turner, Daniel A.; Hadad, Christopher M.; Musier-Forsyth, Karin] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Musier-Forsyth, Karin] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Das, Mom; Musier-Forsyth, Karin] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [So, Byung Ran; Kumar, Sandeep; Das, Mom; Musier-Forsyth, Karin] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [An, Songon] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities	Musier-Forsyth, K (corresponding author), Ohio State Univ, Dept Chem, 100 W 18th Ave, Columbus, OH 43210 USA.	musier@chemistry.ohio-state.edu		Das, Mom/0000-0002-9436-6809; Hadad, Christopher/0000-0003-1211-4315; An, Songon/0000-0003-2189-7374	National Institutes of Health [GM049928]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM049928, R55GM049928, R01GM049928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM049928.	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; Ahel I, 2002, J BIOL CHEM, V277, P34743, DOI 10.1074/jbc.M206928200; An S, 2005, J BIOL CHEM, V280, P34465, DOI 10.1074/jbc.M507550200; An SG, 2004, J BIOL CHEM, V279, P42359, DOI 10.1074/jbc.C400304200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beebe K, 2008, NATURE, V451, P90, DOI 10.1038/nature06454; Beuning PJ, 2000, P NATL ACAD SCI USA, V97, P8916, DOI 10.1073/pnas.97.16.8916; Beuning PJ, 2001, J BIOL CHEM, V276, P30779, DOI 10.1074/jbc.M104761200; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; CASE DA, 2006, AMBER 9 U CAL SAN FR; Chong YE, 2008, J BIOL CHEM, V283, P30073, DOI 10.1074/jbc.M805943200; CREIGHTON TE, 1996, PROTEINS STRUCTURE M; Crepin T, 2006, STRUCTURE, V14, P1511, DOI 10.1016/j.str.2006.08.007; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; Dulic M, 2010, J BIOL CHEM, V285, P23799, DOI 10.1074/jbc.M110.133553; Fernandez-Fuentes N, 2006, NUCLEIC ACIDS RES, V34, pW173, DOI 10.1093/nar/gkl113; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P2627, DOI 10.1021/bi00579a030; Fersht AR., 1977, ENZYME STRUCTURE MEC; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612; Hagiwara Y, 2009, FEBS LETT, V583, P1901, DOI 10.1016/j.febslet.2009.05.026; Hendrickson TL, 2004, ANNU REV BIOCHEM, V73, P147, DOI 10.1146/annurev.biochem.73.012803.092429; Hendrickson TL, 2002, MOL CELL, V9, P353, DOI 10.1016/S1097-2765(02)00449-5; Hondal RJ, 2001, J AM CHEM SOC, V123, P5140, DOI 10.1021/ja005885t; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; IGLOI GL, 1977, BIOCHEMISTRY-US, V16, P1696, DOI 10.1021/bi00627a027; JAKUBOWSKI H, 1994, NUCLEIC ACIDS RES, V22, P1155, DOI 10.1093/nar/22.7.1155; Jakubowski H, 1999, BIOCHEMISTRY-US, V38, P8088, DOI 10.1021/bi990629i; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; JAKUBOWSKI H, 1990, P NATL ACAD SCI USA, V87, P4504, DOI 10.1073/pnas.87.12.4504; Jensen JH, 2005, J PHYS CHEM A, V109, P6634, DOI 10.1021/jp051922x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamtekar S, 2003, P NATL ACAD SCI USA, V100, P1673, DOI 10.1073/pnas.0437911100; Korencic D, 2004, P NATL ACAD SCI USA, V101, P10260, DOI 10.1073/pnas.0403926101; Kotik-Kogan O, 2005, STRUCTURE, V13, P1799, DOI 10.1016/j.str.2005.08.013; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lim K, 2003, J BIOL CHEM, V278, P13496, DOI 10.1074/jbc.M213150200; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling J, 2007, P NATL ACAD SCI USA, V104, P72, DOI 10.1073/pnas.0606272104; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Mascarenhas A. P., 2008, PROTEIN ENG, P153; Minajigi A, 2010, J BIOL CHEM, V285, P23810, DOI 10.1074/jbc.M110.105320; Murayama K, 2005, ACTA CRYSTALLOGR F, V61, P26, DOI 10.1107/S1744309104032555; Naganuma M, 2009, P NATL ACAD SCI USA, V106, P8489, DOI 10.1073/pnas.0901572106; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Newberry KJ, 2002, EMBO J, V21, P2778, DOI 10.1093/emboj/21.11.2778; Nordin BE, 2002, J BIOL CHEM, V277, P20510, DOI 10.1074/jbc.M202023200; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Ruan BF, 2008, P NATL ACAD SCI USA, V105, P16502, DOI 10.1073/pnas.0809179105; Ruan BF, 2005, J BIOL CHEM, V280, P25887, DOI 10.1074/jbc.M502174200; Shitivelband S, 2005, J MOL BIOL, V348, P513, DOI 10.1016/j.jmb.2005.02.023; Sokabe M, 2005, P NATL ACAD SCI USA, V102, P11669, DOI 10.1073/pnas.0502119102; Sokabe M, 2009, P NATL ACAD SCI USA, V106, P11028, DOI 10.1073/pnas.0904645106; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Wolf YI, 1999, GENOME RES, V9, P689; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Wong FC, 2002, BIOCHEMISTRY-US, V41, P7108, DOI 10.1021/bi012178j; Yadavalli SS, 2008, P NATL ACAD SCI USA, V105, P19031, DOI 10.1073/pnas.0810781106; Zhang H, 2000, PROTEINS, V40, P86, DOI 10.1002/(SICI)1097-0134(20000701)40:1<86::AID-PROT100>3.0.CO;2-Y	65	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31810	31820		10.1074/jbc.M111.232611	http://dx.doi.org/10.1074/jbc.M111.232611			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768119	hybrid, Green Published			2022-12-25	WOS:000294487500074
J	Hurlimann, HC; Laloo, B; Simon-Kayser, B; Saint-Marc, C; Coulpier, F; Lemoine, S; Daignan-Fornier, B; Pinson, B				Huerlimann, Hans C.; Laloo, Benoit; Simon-Kayser, Barbara; Saint-Marc, Christelle; Coulpier, Fanny; Lemoine, Sophie; Daignan-Fornier, Bertrand; Pinson, Benoit			Physiological and Toxic Effects of Purine Intermediate 5-Amino-4-imidazolecarboxamide Ribonucleotide (AICAR) in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOSIDE; GENE-EXPRESSION; IN-VITRO; BIOSYNTHESIS; INHIBITION; MUTANTS; COREGULATION; PHOSPHATE	5-Amino-4-imidazolecarboxamide ribonucleotide 5'-phosphate (AICAR) is a monophosphate metabolic intermediate of the de novo purine synthesis pathway that has highly promising metabolic and antiproliferative properties. Yeast mutants unable to metabolize AICAR are auxotroph for histidine. A screening for suppressors of this phenotype identified recessive and dominant mutants that result in lowering the intracellular AICAR concentration. The recessive mutants affect the adenosine kinase, which is shown here to catalyze the phosphorylation of AICAR riboside in yeast. The dominant mutants strongly enhance the capacity of the alkaline phosphatase Pho13 to dephosphorylate 5-amino-4-imidazole N-succinocarboxamide ribonucleotide 5'-phosphate(SAICAR) into its non-toxic riboside form. By combining these mutants with transcriptomics and metabolomics analyses, we establish that in yeast responses to AICAR and SAICAR are clearly linked to the concentration of the monophosphate forms, whereas the derived nucleoside moieties have no effect even at high intracellular concentration. Finally, we show that AICAR/SAICAR concentrations vary under physiological conditions known to modulate transcription of the purine and phosphate pathway genes.	[Huerlimann, Hans C.; Laloo, Benoit; Simon-Kayser, Barbara; Saint-Marc, Christelle; Daignan-Fornier, Bertrand; Pinson, Benoit] Univ Segalen, Inst Biochim & Genet Cellulaires, UMR 5095, F-33077 Bordeaux, France; [Huerlimann, Hans C.; Laloo, Benoit; Simon-Kayser, Barbara; Saint-Marc, Christelle; Daignan-Fornier, Bertrand; Pinson, Benoit] CNRS, IBGC, UMR 5095, F-33077 Bordeaux, France; [Coulpier, Fanny; Lemoine, Sophie] ENS, IBENS, Inst Biol ENS, F-75005 Paris, France; [Coulpier, Fanny; Lemoine, Sophie] INSERM, U1024, F-75005 Paris, France; [Coulpier, Fanny; Lemoine, Sophie] CNRS, UMR 8197, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Daignan-Fornier, B (corresponding author), Univ Segalen, Inst Biochim & Genet Cellulaires, UMR 5095, 1 Rue C St Saens, F-33077 Bordeaux, France.	b.daignan-fornier@ibgc.cnrs.fr		Pinson, Benoit/0000-0003-2936-9058	Association Francaise contre les Myopathies; Conseil Regional d'Aquitaine; Universite Bordeaux; Ligue Contre le Cancer	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Universite Bordeaux; Ligue Contre le Cancer(Ligue nationale contre le cancer)	This work was supported in part by grants from the Association Francaise contre les Myopathies, Conseil Regional d'Aquitaine, and Universite Bordeaux 2.; Supported by Ligue Contre le Cancer fellowships.	Breton A, 2008, GENETICS, V178, P815, DOI 10.1534/genetics.107.083295; Canelas AB, 2009, ANAL CHEM, V81, P7379, DOI 10.1021/ac900999t; DAIGNANFORNIER B, 1992, P NATL ACAD SCI USA, V89, P6746, DOI 10.1073/pnas.89.15.6746; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gauthier S, 2008, MOL MICROBIOL, V68, P1583, DOI 10.1111/j.1365-2958.2008.06261.x; Guetsova ML, 1997, GENETICS, V147, P383; Hanko Valoran P, 2004, J Biomol Tech, V15, P317; Jacobs RL, 2007, J BIOL CHEM, V282, P4516, DOI 10.1074/jbc.M605702200; KANEKO Y, 1989, MOL GEN GENET, V220, P133, DOI 10.1007/BF00260867; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Laporte D, 2011, J CELL BIOL, V192, P949, DOI 10.1083/jcb.201009028; Lecoq K, 2001, YEAST, V18, P335, DOI 10.1002/1097-0061(20010315)18:4<335::AID-YEA674>3.0.CO;2-X; Lecoq K, 2000, GENETICS, V156, P953; Lemoine S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-467; Lopez JM, 2003, BIOCHEM J, V370, P1027, DOI 10.1042/BJ20021053; Marie S, 2004, AM J HUM GENET, V74, P1276, DOI 10.1086/421475; Mizunuma M, 2004, P NATL ACAD SCI USA, V101, P6086, DOI 10.1073/pnas.0308314101; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Ndubuisil MI, 2002, BIOCHEMISTRY-US, V41, P7841, DOI 10.1021/bi0255064; Pinson B, 1998, NUCLEIC ACIDS RES, V26, P3977, DOI 10.1093/nar/26.17.3977; Pinson B, 2009, GENE DEV, V23, P1399, DOI 10.1101/gad.521809; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Rebora K, 2005, GENETICS, V170, P61, DOI 10.1534/genetics.104.039396; Rebora K, 2001, MOL CELL BIOL, V21, P7901, DOI 10.1128/MCB.21.23.7901-7912.2001; SABINA RL, 1985, J BIOL CHEM, V260, P6107; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; SULLIVAN JE, 1994, BIOCHEM BIOPH RES CO, V200, P1551, DOI 10.1006/bbrc.1994.1627; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Tibbetts AS, 2000, J BIOL CHEM, V275, P20920, DOI 10.1074/jbc.M909851199	30	25	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30994	31002		10.1074/jbc.M111.262659	http://dx.doi.org/10.1074/jbc.M111.262659			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757731	Green Published, hybrid			2022-12-25	WOS:000294283600077
J	O'Hara, SP; Splinter, PL; Trussoni, CE; Gajdos, GB; Lineswala, PN; LaRusso, NF				O'Hara, Steven P.; Splinter, Patrick L.; Trussoni, Christy E.; Gajdos, Gabriella B.; Lineswala, Pooja N.; LaRusso, Nicholas F.			Cholangiocyte N-Ras Protein Mediates Lipopolysaccharide-induced Interleukin 6 Secretion and Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILIARY EPITHELIAL-CELLS; CRYPTOSPORIDIUM-PARVUM; IMMUNE RECOGNITION; INNATE IMMUNITY; NUCLEAR-FACTOR; EXPRESSION; HELICOBACTER; RESPONSES; BETA-DEFENSIN-2; CYTOMEGALOVIRUS	Cholangiocytes, the epithelial cells lining the bile ducts in the liver, are periodically exposed to potentially injurious microbes and/or microbial products. As a result, cholangiocytes actively participate in microbe-associated, hepatic proinflammatory responses. We previously showed that infection of cultured human cholangiocytes with the protozoan parasite, Cryptosporidium parvum, or treatment with Gram-negative bacteria-derived LPS, activates NF kappa B in a myeloid differentiation 88 (MyD88)-dependent manner. Here, we describe a novel signaling pathway initiated by Toll-like receptors (TLRs) involving the small GTPase, Ras, that mediates cholangiocyte proinflammatory cytokine production and induction of cholangiocyte proliferation. Using cultured human cholangiocytes and a Ras activation assay, we found that agonists of plasma membrane TLRs (TLR 1, 2, 4, 5, and 6) rapidly (< 10 min) activated N-Ras, but not other p21 Ras isoforms, resulting in the rapid (< 15 min) phosphorylation of the downstream Ras effector, ERK1/2. RNA interference-induced depletion of TRAF6, a downstream effector of MyD88 and known activator of MAPK signaling, had no effect on N-Ras activation. Following N-Ras activation the proinflammatory cytokine, IL6, is rapidly secreted. Using a luciferase reporter, we demonstrated that LPS treatment induced IL6 promoter-driven luciferase which was suppressed using MEK/ERK pharmacologic inhibitors (PD98059 or U0126) and RNAi-induced depletion of N-Ras. Finally, we showed that LPS increased cholangiocyte proliferation (1.5-fold), which was inhibited by depletion of N-Ras; TLR agonist-induced proliferation was also inhibited following pretreatment with an IL6 receptor-blocking antibody. Together, our results support a novel signaling axis involving microbial activation of N-Ras likely involved in the cholangiocyte pathogen-induced proinflammatory response.	[O'Hara, Steven P.; Splinter, Patrick L.; Trussoni, Christy E.; Gajdos, Gabriella B.; LaRusso, Nicholas F.] Mayo Clin, Div Gastroenterol & Hepatol, Ctr Digest Dis, Rochester, MN 55905 USA; [Lineswala, Pooja N.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA	Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities	O'Hara, SP (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Ctr Digest Dis, 200 1st St SW, Rochester, MN 55905 USA.	ohara.steven@mayo.edu		Trussoni, Christy/0000-0002-4247-076X	National Institutes of Health [AI089713, DK57993]; American Gastroenterological Association; Genetics Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, R01DK057993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Gastroenterological Association; Genetics Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AI089713 (to S. P. O.) and DK57993 (to N. F. L.). This work was also supported by an American Gastroenterological Association summer research fellowship (to P. N. L.) and the Genetics Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology Grant P30DK084567.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alvaro D, 2007, GASTROENTEROLOGY, V132, P415, DOI 10.1053/j.gastro.2006.07.023; Carratelli CR, 2009, FEMS IMMUNOL MED MIC, V57, P116, DOI 10.1111/j.1574-695X.2009.00586.x; Chen XM, 2008, IMMUNOL CELL BIOL, V86, P497, DOI 10.1038/icb.2008.37; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Chen XM, 2005, J IMMUNOL, V175, P7447, DOI 10.4049/jimmunol.175.11.7447; Chen XM, 2002, SEMIN LIVER DIS, V22, P277, DOI 10.1055/s-2002-34505; Chen XM, 2001, GASTROENTEROLOGY, V120, P1774, DOI 10.1053/gast.2001.24850; Cruickshank SM, 1998, J HEPATOL, V29, P550, DOI 10.1016/S0168-8278(98)80149-9; Domiati-Saad R, 2000, PEDIATR DEVEL PATHOL, V3, P367, DOI 10.1007/s100240010045; Fischler B, 2009, ACTA PAEDIATR, V98, P1600, DOI 10.1111/j.1651-2227.2009.01416.x; GRUBMAN SA, 1994, AM J PHYSIOL, V266, pG1060, DOI 10.1152/ajpgi.1994.266.6.G1060; Hamada T, 2009, HELICOBACTER, V14, P545, DOI 10.1111/j.1523-5378.2009.00729.x; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Harada K, 2004, HEPATOLOGY, V40, P925, DOI 10.1002/hep.20379; Harada K, 2009, CLIN EXP IMMUNOL, V157, P261, DOI 10.1111/j.1365-2249.2009.03947.x; Harada K, 2001, J PATHOL, V193, P218, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH776&gt;3.0.CO;2-H; Isomoto H, 2007, GASTROENTEROLOGY, V132, P384, DOI 10.1053/j.gastro.2006.10.037; Jafri M, 2009, J PEDIATR SURG, V44, P500, DOI 10.1016/j.jpedsurg.2008.07.007; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Karrar A, 2007, GASTROENTEROLOGY, V132, P1504, DOI 10.1053/j.gastro.2007.01.039; Kosaka T, 2010, BRIT J SURG, V97, P544, DOI 10.1002/bjs.6907; Lee HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-87; MORITA M, 1994, HEPATOLOGY, V19, P426; O'Hara SP, 2010, J BIOL CHEM, V285, P216, DOI 10.1074/jbc.M109.041640; O'Hara SP, 2009, J INFECT DIS, V199, P1195, DOI 10.1086/597387; Park J, 1999, HEPATOLOGY, V29, P1037, DOI 10.1002/hep.510290423; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; Prior IA, 2001, J CELL SCI, V114, P1603; Rauschenfels S, 2009, EUR J PEDIATR, V168, P469, DOI 10.1007/s00431-008-0774-2; Scholz M, 1997, TISSUE ANTIGENS, V49, P640, DOI 10.1111/j.1399-0039.1997.tb02813.x; Silva CP, 2003, J CLIN MICROBIOL, V41, P5615, DOI 10.1128/JCM.41.12.5615-5618.2003; Sripa B, 2000, INT J PARASITOL, V30, P735, DOI 10.1016/S0020-7519(00)00054-0; Sripa B, 2011, ACTA TROP, V120, pS158, DOI 10.1016/j.actatropica.2010.07.006; Takayama S, 2010, DIGEST DIS SCI, V55, P1905, DOI 10.1007/s10620-009-0946-6; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Triantafilou M, 2002, J CELL SCI, V115, P2603; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; Wu MH, 2009, J IMMUNOL, V183, P8054, DOI 10.4049/jimmunol.0902140; Yokoyama T, 2006, LIVER INT, V26, P467, DOI 10.1111/j.1478-3231.2006.01254.x	41	49	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30352	30360		10.1074/jbc.M111.269464	http://dx.doi.org/10.1074/jbc.M111.269464			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757746	Green Published, hybrid			2022-12-25	WOS:000294283600013
J	Roy, K; Kansal, R; Bartels, SR; Hamilton, DJ; Shaaban, S; Fleckenstein, JM				Roy, Koushik; Kansal, Rita; Bartels, Scott R.; Hamilton, David J.; Shaaban, Salwa; Fleckenstein, James M.			Adhesin Degradation Accelerates Delivery of Heat-labile Toxin by Enterotoxigenic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-CULTURE CELLS; COLONIZATION FACTOR; MOLECULAR CHARACTERIZATION; ENHANCED TOXICITY; EPITHELIAL-CELLS; OUTER-MEMBRANE; PROTEASE; SECRETION; STRAINS; IDENTIFICATION	Many enteric pathogens, including enterotoxigenic Escherichia coli (ETEC), produce one or more serine proteases that are secreted via the autotransporter (or type V) bacterial secretion pathway. These molecules have collectively been referred to as SPATE proteins (serine protease autotransporter of the Enterobacteriaceae). EatA, an autotransporter previously identified in ETEC, possesses a functional serine protease motif within its secreted amino-terminal passenger domain. Although this protein is expressed by many ETEC strains and is highly immunogenic, its precise function is unknown. Here, we demonstrate that EatA degrades a recently characterized adhesin, EtpA, resulting in modulation of bacterial adhesion and accelerated delivery of the heat-labile toxin, a principal ETEC virulence determinant. Antibodies raised against the passenger domain of EatA impair ETEC delivery of labile toxin to epithelial cells suggesting that EatA may be an effective target for vaccine development.	[Roy, Koushik; Bartels, Scott R.; Fleckenstein, James M.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38163 USA; [Hamilton, David J.] Univ Tennessee, Hlth Sci Ctr, Dept Comparat Med, Memphis, TN 38163 USA; [Fleckenstein, James M.] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN 38163 USA; [Shaaban, Salwa] Beni Sueif Univ, Fac Pharm, Beni Sueif 62514, Egypt; [Fleckenstein, James M.] Vet Affairs Med Ctr, Med Serv, Memphis, TN 38104 USA; [Kansal, Rita] Vet Affairs Med Ctr, Res Serv, Memphis, TN 38104 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Egyptian Knowledge Bank (EKB); Beni Suef University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Fleckenstein, JM (corresponding author), 1030 Jefferson Ave, Memphis, TN 38104 USA.	jflecke1@tennessee.edu	Fleckenstein, James M./P-6242-2019	Fleckenstein, James M./0000-0002-1148-697X	National Institutes of Health [R01 AI089894-01]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089894] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI089894-01 (to J. M. F.). This work was also supported by Merit Review Program funding from the Department of Veterans Affairs (to J. M. F.).	Allen KP, 2006, INFECT IMMUN, V74, P869, DOI 10.1128/IAI.74.2.869-875.2006; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; BENJELLOUNTOUIMI Z, 1995, MOL MICROBIOL, V17, P123, DOI 10.1111/j.1365-2958.1995.mmi_17010123.x; Boisen N, 2009, AM J TROP MED HYG, V80, P294, DOI 10.4269/ajtmh.2009.80.294; BOOTH BA, 1984, INFECT IMMUN, V45, P558, DOI 10.1128/IAI.45.3.558-560.1984; CLEMENTS JD, 1990, INFECT IMMUN, V58, P1159, DOI 10.1128/IAI.58.5.1159-1166.1990; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Coster TS, 2007, INFECT IMMUN, V75, P252, DOI 10.1128/IAI.01131-06; Coutte L, 2003, J EXP MED, V197, P735, DOI 10.1084/jem.20021153; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dorsey FC, 2006, CELL MICROBIOL, V8, P1516, DOI 10.1111/j.1462-5822.2006.00736.x; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; ELSINGHORST EA, 1994, INFECT IMMUN, V62, P3463, DOI 10.1128/IAI.62.8.3463-3471.1994; EVANS DG, 1978, INFECT IMMUN, V19, P727, DOI 10.1128/IAI.19.2.727-736.1978; EVANS DG, 1975, INFECT IMMUN, V12, P656, DOI 10.1128/IAI.12.3.656-667.1975; EVANS DJ, 1973, INFECT IMMUN, V8, P322, DOI 10.1128/IAI.8.3.322-328.1973; Fleckenstein JM, 2010, MICROBES INFECT, V12, P89, DOI 10.1016/j.micinf.2009.10.002; Fleckenstein JM, 2009, NAT PROTOC, V4, P1083, DOI 10.1038/nprot.2009.87; Fleckenstein JM, 2006, INFECT IMMUN, V74, P2245, DOI 10.1128/IAI.74.4.2245-2258.2006; Fleckenstein JM, 1996, INFECT IMMUN, V64, P2256, DOI 10.1128/IAI.64.6.2256-2265.1996; Froehlich B, 2005, J BACTERIOL, V187, P6509, DOI 10.1128/JB.187.18.6509-6516.2005; HARLOW E, 1999, USING ANTIBODIES LAB, P77; Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Johnson AM, 2009, J BACTERIOL, V191, P178, DOI 10.1128/JB.00822-08; Lencer WI, 1997, J BIOL CHEM, V272, P15562, DOI 10.1074/jbc.272.24.15562; Maroncle NM, 2006, INFECT IMMUN, V74, P6124, DOI 10.1128/IAI.01086-06; MUNDELL DH, 1976, INFECT IMMUN, V14, P383, DOI 10.1128/IAI.14.2.383-388.1976; Nooh MM, 2006, J BIOL CHEM, V281, P35281, DOI 10.1074/jbc.M605544200; OFEK I, 1990, INFECT IMMUN, V58, P3737, DOI 10.1128/IAI.58.11.3737-3742.1990; Patel SK, 2004, INFECT IMMUN, V72, P1786, DOI 10.1128/IAI.72.3.1786-1794.2004; Pilonieta MC, 2007, J BACTERIOL, V189, P5060, DOI 10.1128/JB.00131-07; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Roy K, 2010, INFECT IMMUN, V78, P3027, DOI 10.1128/IAI.00264-10; Ruiz-Perez F, 2009, J BACTERIOL, V191, P6571, DOI 10.1128/JB.00754-09; Sahl JW, 2011, INFECT IMMUN, V79, P950, DOI 10.1128/IAI.00932-10; SATTERWHITE TK, 1978, LANCET, V2, P181; Shames SR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001057; Sheikh J, 2002, J CLIN INVEST, V110, P1329, DOI 10.1172/JCI200216172; Tauschek M, 2002, P NATL ACAD SCI USA, V99, P7066, DOI 10.1073/pnas.092152899; ZAFRIRI D, 1987, J CLIN INVEST, V79, P1210, DOI 10.1172/JCI112939	44	36	39	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29771	29779		10.1074/jbc.M111.251546	http://dx.doi.org/10.1074/jbc.M111.251546			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21757737	hybrid, Green Published			2022-12-25	WOS:000294046600036
J	Kelber, A; Jonsson, F; Wallen, R; Warrant, E; Kornfeldt, T; Baird, E				Kelber, Almut; Jonsson, Fredrik; Wallen, Rita; Warrant, Eric; Kornfeldt, Torill; Baird, Emily			Hornets Can Fly at Night without Obvious Adaptations of Eyes and Ocelli	PLOS ONE			English	Article							SPECTRAL SENSITIVITY; NOCTURNAL VISION; FACET LENS; SWEAT BEES; LIGHT; PHOTORECEPTORS; HONEYBEES; LIMITS; SIZE	Hornets, the largest social wasps, have a reputation of being facultatively nocturnal. Here we confirm flight activity of hornet workers in dim twilight. We studied the eyes and ocelli of European hornets (Vespa crabro) and common wasps (Vespula vulgaris) with the goal to find the optical and anatomical adaptations that enable them to fly in dim light. Adaptations described for obligately nocturnal hymenoptera such as the bees Xylocopa tranquebarica and Megalopta genalis and the wasp Apoica pallens include large ocelli and compound eyes with wide rhabdoms and large facet lenses. Interestingly, we did not find any such adaptations in hornet eyes or ocelli. On the contrary, their eyes are even less sensitive than those of the obligately diurnal common wasps. Therefore we conclude that hornets, like several facultatively nocturnal bee species such as Apis mellifera adansonii, A. dorsata and X. tenuiscapa are capable of seeing in dim light simply due to the large body and thus eye size. We propose that neural pooling strategies and behavioural adaptations precede anatomical adaptations in the eyes and ocelli when insects with apposition compound eyes turn to dim light activity.	[Kelber, Almut; Jonsson, Fredrik; Wallen, Rita; Warrant, Eric; Kornfeldt, Torill; Baird, Emily] Lund Univ, Lund Vis Grp, Dept Biol, Lund, Sweden	Lund University	Kelber, A (corresponding author), Lund Univ, Lund Vis Grp, Dept Biol, Lund, Sweden.	almut.kelber@biol.lu.se	Baird, Emily/G-8763-2014; Kelber, Almut/H-6216-2014	Baird, Emily/0000-0003-3625-3897; Kelber, Almut/0000-0003-3937-2808; Warrant, Eric/0000-0001-7480-7016	Crafoord Foundation; Swedish Research Council [2003-7165, 2006-4510]	Crafoord Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was funded by the Crafoord Foundation and the Swedish Research Council (2003-7165, 2006-4510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACKITH R. E., 1958, INSECTS SOCIAUX, V5, P263, DOI 10.1007/BF02223936; BRUNO MS, 1977, J COMP PHYSIOL, V120, P123, DOI 10.1007/BF00619310; Frederiksen R, 2008, J EXP BIOL, V211, P844, DOI 10.1242/jeb.012179; Greiner B, 2006, J COMP NEUROL, V495, P255, DOI 10.1002/cne.20882; Greiner B, 2007, CURR BIOL, V17, pR879, DOI 10.1016/j.cub.2007.08.015; Greiner B, 2006, INT REV CYTOL, V250, P1, DOI 10.1016/S0074-7696(06)50001-4; Homann H., 1924, Z VGL PHYSL, V1, P541, DOI 10.1007/BF00337911; Kelber A, 2006, BEHAV ECOL, V17, P63, DOI 10.1093/beheco/arj001; Kelber A, 2010, OPHTHAL PHYSL OPT, V30, P454, DOI 10.1111/j.1475-1313.2010.00721.x; KERFOOT WB, 1967, AM NAT, V101, P65, DOI 10.1086/282470; KIRSCHFELD K, 1974, Z NATURFORSCH C, VC 29, P592; Land M.F., 1981, HDB SENSORY PHYSL, P471, DOI DOI 10.1007/978-3-642-66907-14; LAND MF, 1985, J COMP PHYSIOL A, V156, P525, DOI 10.1007/BF00613976; MIZUNAMI M, 1995, VISION RES, V35, P443, DOI 10.1016/0042-6989(94)00192-O; Somanathan H, 2008, J COMP PHYSIOL A, V194, P97, DOI 10.1007/s00359-007-0291-1; Somanathan H, 2009, J EXP BIOL, V212, P2448, DOI 10.1242/jeb.031484; Somanathan H, 2009, J COMP PHYSIOL A, V195, P571, DOI 10.1007/s00359-009-0432-9; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; Spiewok S, 2006, PHYSIOL BIOCHEM ZOOL, V79, P188, DOI 10.1086/498181; Stange G, 2002, J COMP PHYSIOL A, V188, P455, DOI 10.1007/s00359-002-0317-7; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P189, DOI 10.1007/s00359-003-0390-6; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P1, DOI 10.1007/s00359-002-0370-2; Theobald JC, 2007, J EXP BIOL, V210, P4034, DOI 10.1242/jeb.003756; Theobald JC, 2006, VISION RES, V46, P2298, DOI 10.1016/j.visres.2006.01.002; Warrant E, 1996, P ROY SOC B-BIOL SCI, V263, P1521, DOI 10.1098/rspb.1996.0222; Warrant EJ, 2004, CURR BIOL, V14, P1309, DOI 10.1016/j.cub.2004.07.057; Warrant EJ, 1998, VISION RES, V38, P195, DOI 10.1016/S0042-6989(97)00151-X; Warrant EJ, 2008, J EXP BIOL, V211, P1737, DOI 10.1242/jeb.015396; Warrant EJ, 2006, ARTHROPOD STRUCT DEV, V35, P293, DOI 10.1016/j.asd.2006.08.012	29	16	16	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21892	10.1371/journal.pone.0021892	http://dx.doi.org/10.1371/journal.pone.0021892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765923	Green Published, gold, Green Submitted			2022-12-25	WOS:000292699000015
J	Rivarola, M; Foster, JT; Chan, AP; Williams, AL; Rice, DW; Liu, XY; Melake-Berhan, A; Creasy, HH; Puiu, D; Rosovitz, MJ; Khouri, HM; Beckstrom-Sternberg, SM; Allan, GJ; Keim, P; Ravel, J; Rabinowicz, PD				Rivarola, Maximo; Foster, Jeffrey T.; Chan, Agnes P.; Williams, Amber L.; Rice, Danny W.; Liu, Xinyue; Melake-Berhan, Admasu; Creasy, Heather Huot; Puiu, Daniela; Rosovitz, M. J.; Khouri, Hoda M.; Beckstrom-Sternberg, Stephen M.; Allan, Gerard J.; Keim, Paul; Ravel, Jacques; Rabinowicz, Pablo D.			Castor Bean Organelle Genome Sequencing and Worldwide Genetic Diversity Analysis	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; PLANT MITOCHONDRIAL GENOMES; CHLOROPLAST GENOME; PHYLOGENETIC-RELATIONSHIPS; DNA; EVOLUTION; MAIZE; ORGANIZATION; METHYLATION; MECHANISM	Castor bean is an important oil-producing plant in the Euphorbiaceae family. Its high-quality oil contains up to 90% of the unusual fatty acid ricinoleate, which has many industrial and medical applications. Castor bean seeds also contain ricin, a highly toxic Type 2 ribosome-inactivating protein, which has gained relevance in recent years due to biosafety concerns. In order to gain knowledge on global genetic diversity in castor bean and to ultimately help the development of breeding and forensic tools, we carried out an extensive chloroplast sequence diversity analysis. Taking advantage of the recently published genome sequence of castor bean, we assembled the chloroplast and mitochondrion genomes extracting selected reads from the available whole genome shotgun reads. Using the chloroplast reference genome we used the methylation filtration technique to readily obtain draft genome sequences of 7 geographically and genetically diverse castor bean accessions. These sequence data were used to identify single nucleotide polymorphism markers and phylogenetic analysis resulted in the identification of two major clades that were not apparent in previous population genetic studies using genetic markers derived from nuclear DNA. Two distinct sub-clades could be defined within each major clade and large-scale genotyping of castor bean populations worldwide confirmed previously observed low levels of genetic diversity and showed a broad geographic distribution of each sub-clade.	[Rivarola, Maximo; Liu, Xinyue; Creasy, Heather Huot; Khouri, Hoda M.; Ravel, Jacques; Rabinowicz, Pablo D.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Foster, Jeffrey T.; Beckstrom-Sternberg, Stephen M.; Keim, Paul] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA; [Chan, Agnes P.; Melake-Berhan, Admasu; Puiu, Daniela; Rosovitz, M. J.; Rabinowicz, Pablo D.] J Craig Venter Inst, Rockville, MD USA; [Williams, Amber L.; Allan, Gerard J.] No Arizona Univ, Dept Biol Sci, Environm Genet & Genom Lab, Flagstaff, AZ 86011 USA; [Rice, Danny W.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Beckstrom-Sternberg, Stephen M.] Translat Genom Res Inst, Pathogen Genom Div, Phoenix, AZ USA; [Ravel, Jacques] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Rabinowicz, Pablo D.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Northern Arizona University; J. Craig Venter Institute; Northern Arizona University; Indiana University System; Indiana University Bloomington; Translational Genomics Research Institute; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Rivarola, M (corresponding author), Inst Nacl Tecnol Agr, Inst Biotecnol, Buenos Aires, DF, Argentina.	Paul.Keim@nau.edu; jravel@som.umaryland.edu; prabinowicz@som.umaryland.edu	Rivarola, Maximo L/C-1261-2014; Ravel, Jacques/D-2530-2009; Keim, Paul S/A-2269-2010	Rivarola, Maximo/0000-0003-2818-1037; Ravel, Jacques/0000-0002-0851-2233; Foster, Jeffrey/0000-0001-8235-8564; Chan, Agnes/0000-0003-2373-9580; Rice, Danny/0000-0002-1123-4617	National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health, Department of Health and Human Services, under NIAID [N01-AI-30071]; Federal Bureau of Investigation (FBI) [J-FBI-04-186]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health, Department of Health and Human Services, under NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Federal Bureau of Investigation (FBI)	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID; http://www.niaid.nih.gov), National Institutes of Health, Department of Health and Human Services, under NIAID Contract N01-AI-30071 (R. communis subproject), and by the Federal Bureau of Investigation (FBI; http://www.fbi.gov) grant J-FBI-04-186. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Allan G, 2008, GENET RESOUR CROP EV, V55, P365, DOI 10.1007/s10722-007-9244-3; ANDERSON S, 1981, NUCLEIC ACIDS RES, V9, P3015, DOI 10.1093/nar/9.13.3015; Bausher MG, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-21; Bedell JA, 2005, PLOS BIOL, V3, P103, DOI 10.1371/journal.pbio.0030013; BIRREN B, 1997, GENOME ANAL LAB MANU; Brigham R.D., 1993, NEW CROPS; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Chung HJ, 2006, PLANT CELL REP, V25, P1369, DOI 10.1007/s00299-006-0196-4; Da Silva ND, 2006, APPL BIOCHEM BIOTECH, V130, P405, DOI 10.1385/ABAB:130:1:405; Daniell H, 2008, THEOR APPL GENET, V116, P723, DOI 10.1007/s00122-007-0706-y; Davis CC, 2007, SCIENCE, V315, P1812, DOI 10.1126/science.1135260; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; DeVries J, 2001, SECURING HARVEST BIO; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Fojtova M, 2001, PLANT SCI, V160, P585, DOI 10.1016/S0168-9452(00)00411-8; Foster JT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-13; Goodrum JW, 2005, BIORESOURCE TECHNOL, V96, P851, DOI 10.1016/j.biortech.2004.07.006; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; GUNSTONE FD, 2005, INFORM, V16, P736; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Kubo N, 2010, DNA RES, V17, P1, DOI 10.1093/dnares/dsp024; Lee SB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-61; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Masood MS, 2004, GENE, V340, P133, DOI 10.1016/j.gene.2004.06.008; MCCULLOUGH AJ, 1992, PLANT PHYSIOL, V100, P958, DOI 10.1104/pp.100.2.958; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Mower JP, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-265; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Newton AC, 1999, TRENDS ECOL EVOL, V14, P140, DOI 10.1016/S0169-5347(98)01555-9; PALMER LE, 2003, SCIENCE IN PRESS; PALMER M, 1991, MOL BIOL PLASTIDS, P5; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Rabinowicz PD, 2007, CHEM REV, V107, P3377, DOI 10.1021/cr0682960; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; Roetheli J.C., 1991, CASTOR ASSESSING FEA; SANDBRINK JM, 1989, BIOCHEM SYST ECOL, V17, P45, DOI 10.1016/0305-1978(89)90041-0; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Steane DA, 2005, DNA RES, V12, P215, DOI 10.1093/dnares/dsi006; Sucher NJ, 2008, PLANTA MED, V74, P603, DOI 10.1055/s-2008-1074517; Sugiura M, 1998, ANNU REV GENET, V32, P437, DOI 10.1146/annurev.genet.32.1.437; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; Whitelaw CA, 2003, SCIENCE, V302, P2118, DOI 10.1126/science.1090047; Woloszynska M, 2010, J EXP BOT, V61, P657, DOI 10.1093/jxb/erp361; Wurdack KJ, 2005, AM J BOT, V92, P1397, DOI 10.3732/ajb.92.8.1397; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352	49	70	71	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21743	10.1371/journal.pone.0021743	http://dx.doi.org/10.1371/journal.pone.0021743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750729	Green Submitted, gold, Green Published			2022-12-25	WOS:000292655400016
J	Briffa, M; Greenaway, J				Briffa, Mark; Greenaway, Julie			High In Situ Repeatability of Behaviour Indicates Animal Personality in the Beadlet Anemone Actinia equina (Cnidaria)	PLOS ONE			English	Article							BRACHYRAPHIS-EPISCOPI; HERMIT-CRABS; BODY-SIZE; BOLDNESS; CONSISTENCY; EVOLUTION; AWARENESS; TRAITS	'Animal personality' means that individuals differ from one another in either single behaviours or suites of related behaviours in a way that is consistent over time. It is usually assumed that such consistent individual differences in behaviour are driven by variation in how individuals respond to information about their environment, rather than by differences in external factors such as variation in microhabitat. Since behavioural variation is ubiquitous in nature we might expect 'animal personality' to be present in diverse taxa, including animals with relatively simple nervous systems. We investigated in situ startle responses in a sea anemone, Actinia equina, to determine whether personalities might be present in this example of an animal with a simple nervous system. We found very high levels of repeatability among individuals that were re-identified in the same locations over a three week sampling period. In a subset of the data, where we used tide-pool temperature measurements to control for a key element of variation in microhabitat, these high levels of repeatability remained. Although a range of other consistent differences in micro-habitat features could have contributed to consistent differences between the behaviour of individuals, these data suggest the presence of animal personality in A. equina. Rather than being restricted to certain groups, personality may be a general feature of animals and may be particularly pronounced in species with simple nervous systems.	[Briffa, Mark; Greenaway, Julie] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England	University of Plymouth	Briffa, M (corresponding author), Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England.	mark.briffa@plymouth.ac.uk	Briffa, Mark/M-9041-2013	Briffa, Mark/0000-0003-2520-0538				AYRE DJ, 1982, MAR BIOL, V68, P199, DOI 10.1007/BF00397607; Bell AM, 2007, P ROY SOC B-BIOL SCI, V274, P755, DOI 10.1098/rspb.2006.0199; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Biro PA, 2010, P ROY SOC B-BIOL SCI, V277, P71, DOI 10.1098/rspb.2009.1346; Bolund E, 2007, ANIM BEHAV, V74, P715, DOI 10.1016/j.anbehav.2006.10.032; Briffa M, 2008, P R SOC B, V275, P1305, DOI 10.1098/rspb.2008.0025; Briffa M, 2011, BIOL LETTERS, V7, P330, DOI 10.1098/rsbl.2010.0761; Briffa M, 2010, CURR BIOL, V20, pR912, DOI 10.1016/j.cub.2010.09.019; Briffa M, 2009, CAN J ZOOL, V87, P597, DOI 10.1139/Z09-047; Brown C, 2005, ANIM BEHAV, V70, P1003, DOI 10.1016/j.anbehav.2004.12.022; Brown C, 2004, ANIM BEHAV, V68, P1325, DOI 10.1016/j.anbehav.2004.04.004; Brusca R.C., 1990, INVERTEBRATES SINAUE; Clarac F, 2007, BRAIN RES REV, V54, P113, DOI 10.1016/j.brainresrev.2006.12.007; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Davidson CJ, 2008, ANNU REV GENET, V42, P253, DOI 10.1146/annurev.genet.42.110807.091601; Fish JD, 2011, STUDENTS GUIDE SEASH; Fraser DF, 2001, AM NAT, V158, P124, DOI 10.1086/321307; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; Magnhagen C, 2008, ANIM BEHAV, V75, P509, DOI 10.1016/j.anbehav.2007.06.007; McNamara JM, 2009, P ROY SOC B-BIOL SCI, V276, P605, DOI 10.1098/rspb.2008.1182; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sinn DL, 2005, J COMP PSYCHOL, V119, P99, DOI 10.1037/0735-7036.119.1.99; Sokal RR, 1995, BIOMETRY; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835	30	48	48	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21963	10.1371/journal.pone.0021963	http://dx.doi.org/10.1371/journal.pone.0021963			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755015	gold, Green Submitted, Green Published			2022-12-25	WOS:000292632000042
J	Hernandez-Lemus, E; Correa-Rodriguez, MD				Hernandez-Lemus, Enrique; Correa-Rodriguez, Maria D.			Non-Equilibrium Hyperbolic Transport in Transcriptional Regulation	PLOS ONE			English	Article							GENE-EXPRESSION; METABOLIC-REGULATION; PULSE; PATTERNS; KINETICS; CELL; THERMODYNAMICS; MOLECULE; SYSTEMS; HYDRODYNAMICS	In this work we studied memory and irreversible transport phenomena in a non-equilibrium thermodynamical model for genomic transcriptional regulation. Transcriptional regulation possess an extremely complex phenomenology, and it is, of course, of foremost importance in organismal cell development and in the pathogenesis of complex diseases. A better understanding of the way in which these processes occur is mandatory to optimize the construction of gene regulatory networks, but also to connect these networks with multi-scale phenomena (e.g. metabolism, signalling pathways, etc.) under an integrative Systems Biology-like vision. In this paper we analyzed three simple mechanisms of genetic stimulation: an instant pulse, a periodic biochemical signal and a saturation process with sigmoidal kinetics and from these we derived the system's thermodynamical response, in the form of, for example, anomalous transcriptional bursts.	[Hernandez-Lemus, Enrique; Correa-Rodriguez, Maria D.] Natl Inst Genom Med, Computat Genom Dept, Mexico City, DF, Mexico; [Hernandez-Lemus, Enrique] Univ Nacl Autonoma Mexico, Ctr Complex Sci, Mexico City, DF, Mexico; [Correa-Rodriguez, Maria D.] Univ Nacl Autonoma Mexico, Sch Sci, Dept Phys, Mexico City, DF, Mexico	Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Hernandez-Lemus, E (corresponding author), Natl Inst Genom Med, Computat Genom Dept, Mexico City, DF, Mexico.	ehernandez@inmegen.gob.mx		Hernandez-Lemus, Enrique/0000-0002-1872-1397	National Institute of Genomic Medicine (Mexico)	National Institute of Genomic Medicine (Mexico)	Work funded by the National Institute of Genomic Medicine (Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Berg J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.188101; Blanchard JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001186; Brynildsen MP, 2005, BIOCHEM SOC T, V33, P1423, DOI 10.1042/BST0331423; Chappell PE, 2003, J NEUROSCI, V23, P11202; Chen CF, 1997, MICROBIOL-UK, V143, P2079, DOI 10.1099/00221287-143-6-2079; Chen J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-286; CHEN M, 1993, J MATH PHYS, V34, P3012, DOI 10.1063/1.530060; Djeridane Y, 2010, J PHYSIOL PHARMACOL, V61, P115; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; Fujiwara T, 2009, DNA RES, V16, P59, DOI 10.1093/dnares/dsn032; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Garcia-Colin LS, 1995, INT J MOD PHYS B, V9, P1993; Geschwind Jean-Francois, 2004, Expert Rev Anticancer Ther, V4, P449, DOI 10.1586/14737140.4.3.449; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; GRABERT H, 1977, Z PHYS B CON MAT, V26, P79, DOI 10.1007/BF01313375; Greive SJ, 2005, NAT REV MOL CELL BIO, V6, P221, DOI 10.1038/nrm1588; Harper CV, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000607; Hatton JP, 2003, J BONE MINER RES, V18, P58, DOI 10.1359/jbmr.2003.18.1.58; Lemus EH, 2009, J NON-EQUIL THERMODY, V34, P371, DOI 10.1515/JNETDY.2009.019; Hernandez-Lemus E, 2006, J NON-EQUIL THERMODY, V31, P397, DOI 10.1515/JNETDY.2006.017; Hernandez-Lemus E, 2010, J NON-NEWTON FLUID, V165, P1029, DOI 10.1016/j.jnnfm.2010.02.016; HERNANDEZLEMUS E, 2010, NEW TRENDS STAT PHYS; Hilioti Z, 2008, CURR BIOL, V18, P1; Hill T. L., 2002, THERMODYNAMICS SMALL; Hill TL, 1998, P NATL ACAD SCI USA, V95, P12779, DOI 10.1073/pnas.95.22.12779; Hill TL, 2004, FREE ENERGY TRANSDUC; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; JOU D, 1985, PHYS REV A, V31, P2502, DOI 10.1103/PhysRevA.31.2502; JOU D, 1980, PHYSICA A, V101, P588, DOI 10.1016/0378-4371(80)90197-1; Kanasaki H, 2009, BIOL REPROD, V81, P465, DOI 10.1095/biolreprod.108.074765; KENKRE VM, 2003, P PASI MOD CHALL STA; Kenkre VM, 2007, CONTRIBUTIONS MATH P, P147; Keys DN, 2005, P NATL ACAD SCI USA, V102, P679, DOI 10.1073/pnas.0408952102; Khanin R, 2007, BIOMETRICS, V63, P816, DOI 10.1111/j.1541-0420.2007.00757.x; Kim BR, 2008, GENETICS, V180, P821, DOI 10.1534/genetics.108.093690; Knipper M, 1998, DEVELOPMENT, V125, P3709; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Komorowski M, 2010, BIOPHYS J, V98, P2759, DOI 10.1016/j.bpj.2010.03.032; Lee AW, 2011, MOL IMMUNOL, V48, P1160, DOI 10.1016/j.molimm.2011.02.010; Manne KK, 2000, PHYS REV E, V61, P4177, DOI 10.1103/PhysRevE.61.4177; Morse P.M., 1953, METHODS THEORETICAL; Muller D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000279; Muller I, 1998, SPRINGER TRACTS NATU, V37, P393; Norris AJ, 2003, MOL ENDOCRINOL, V17, P193, DOI 10.1210/me.2002-0201; Pagonabarraga I, 1997, PHYSICA A, V237, P205, DOI 10.1016/S0378-4371(96)00377-9; Perez-Ortin JE, 2007, TRENDS GENET, V23, P250, DOI 10.1016/j.tig.2007.03.006; Piessens R., 1983, QUADPACK SUBROUTINE; Qian H, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.016102; Reguera D, 2005, J PHYS CHEM B, V109, P21502, DOI 10.1021/jp052904i; Resendis-Antonio O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012383; Rietsch A, 2006, MOL MICROBIOL, V59, P807, DOI 10.1111/j.1365-2958.2005.04990.x; Rozhdestvenskii BL, 2001, ENCY MATH; Rubi JM, 2007, J PHYS CHEM B, V111, P9598, DOI 10.1021/jp073413w; Rubi JM, 2007, ENERGY, V32, P297, DOI 10.1016/j.energy.2005.11.013; Rubi JM, 2008, MATEMATICHE NATUR S1, VLXXXVI; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Shlomi T, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100141; Soranzo N, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-18; Swinburne IA, 2008, GENE DEV, V22, P2342, DOI 10.1101/gad.1696108; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tomi M, 2002, INVEST OPHTH VIS SCI, V43, P774; Wang YF, 2009, BIOPHYS J, V96, P609, DOI 10.1016/j.bpj.2008.09.040; WHITE MRH, 1995, J CELL SCI, V108, P441; Yang HT, 2007, J BIOCHEM, V142, P135, DOI 10.1093/jb/mvm151; YASIN M, 1995, ENDOCRINOLOGY, V136, P1559, DOI 10.1210/en.136.4.1559; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zhdanov VP, 2007, JETP LETT+, V86, P492, DOI 10.1134/S0021364007190149	70	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21558	10.1371/journal.pone.0021558	http://dx.doi.org/10.1371/journal.pone.0021558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754990	Green Published, Green Submitted, gold			2022-12-25	WOS:000292632000014
J	Leaver-Fay, A; Jacak, R; Stranges, PB; Kuhlman, B				Leaver-Fay, Andrew; Jacak, Ron; Stranges, P. Benjamin; Kuhlman, Brian			A Generic Program for Multistate Protein Design	PLOS ONE			English	Article							COMPUTING PARTITION-FUNCTIONS; END ELIMINATION CRITERION; COMPUTATIONAL DESIGN; SEARCH ALGORITHM; AIDED-DESIGN; RAL GTPASES; SEQUENCE; SPECIFICITY; OPTIMIZATION; STABILITY	Some protein design tasks cannot be modeled by the traditional single state design strategy of finding a sequence that is optimal for a single fixed backbone. Such cases require multistate design, where a single sequence is threaded onto multiple backbones (states) and evaluated for its strengths and weaknesses on each backbone. For example, to design a protein that can switch between two specific conformations, it is necessary to to find a sequence that is compatible with both backbone conformations. We present in this paper a generic implementation of multistate design that is suited for a wide range of protein design tasks and demonstrate in silico its capabilities at two design tasks: one of redesigning an obligate homodimer into an obligate heterodimer such that the new monomers would not homodimerize, and one of redesigning a promiscuous interface to bind to only a single partner and to no longer bind the rest of its partners. Both tasks contained negative design in that multistate design was asked to find sequences that would produce high energies for several of the states being modeled. Success at negative design was assessed by computationally redocking the undesired protein-pair interactions; we found that multistate design's accuracy improved as the diversity of conformations for the undesired protein-pair interactions increased. The paper concludes with a discussion of the pitfalls of negative design, which has proven considerably more challenging than positive design.	[Leaver-Fay, Andrew; Jacak, Ron; Stranges, P. Benjamin; Kuhlman, Brian] Univ N Carolina, Dept Biochem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Leaver-Fay, A (corresponding author), Univ N Carolina, Dept Biochem, Chapel Hill, NC 27599 USA.	aleaverfay@gmail.com		Stranges, Peter Benjamin/0000-0003-1377-7321; Kuhlman, Brian/0000-0003-4907-9699	NIH [GM073960, GM073151]; University of North Carolina at Chapel Hill; Research Computing group; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073151, R01GM073960] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina at Chapel Hill; Research Computing group; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM073960 and GM073151 (http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the University of North Carolina at Chapel Hill and the Research Computing group for providing computational resources and support that have contributed to these research results.	Allen BD, 2006, J COMPUT CHEM, V27, P1071, DOI 10.1002/jcc.20420; Allen BD, 2010, J COMPUT CHEM, V31, P904, DOI 10.1002/jcc.21375; Ambroggio XI, 2006, J AM CHEM SOC, V128, P1154, DOI 10.1021/ja054718w; Ashworth J, 2010, NUCLEIC ACIDS RES, V38, P5601, DOI 10.1093/nar/gkq283; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; Chica RA, 2010, P NATL ACAD SCI USA, V107, P20257, DOI 10.1073/pnas.1013910107; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; DESMET J, 1992, NATURE, V356, P539, DOI 10.1038/356539a0; Desmet J, 2002, PROTEINS, V48, P31, DOI 10.1002/prot.10131; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Fenwick RB, 2010, STRUCTURE, V18, P985, DOI 10.1016/j.str.2010.05.013; Fleishman SJ, 2011, SCIENCE IN PRESS; Fleishman SJ, 2011, PLOS 1 UNPUB, V1; Fromer M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000627; Fromer M, 2010, PROTEINS, V78, P530, DOI 10.1002/prot.22575; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Georgiev I, 2008, J COMPUT CHEM, V29, P1527, DOI 10.1002/jcc.20909; Georgiev I, 2006, LECT NOTES COMPUT SC, V3909, P530, DOI 10.1007/11732990_44; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Grigoryan G, 2006, PLOS COMPUT BIOL, V2, P551, DOI 10.1371/journal.pcbi.0020063; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Hu XZ, 2006, PROTEINS, V62, P739, DOI 10.1002/prot.20786; Humphris EL, 2007, PLOS COMPUT BIOL, V3, P1591, DOI 10.1371/journal.pcbi.0030164; Inc G, 1999, EXPERT OPINION THERA, V9, P785; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Joachimiak L, 2006, J MOL BIOL; Kamisetty H, 2011, PROTEINS, V79, P444, DOI 10.1002/prot.22894; Karanicolas J, 2009, CURRENT OPINION STRU, V19, P485; Keating AE, 2001, P NATL ACAD SCI USA, V98, P14825, DOI 10.1073/pnas.261563398; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kuhlman B, 2002, J MOL BIOL, V315, P471, DOI 10.1006/jmbi.2001.5229; Leaver-Fay A, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P16; Leaver-Fay A, 2008, LECT N BIOINFORMAT, V4983, P343, DOI 10.1007/978-3-540-79450-9_32; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; LEAVERFAY A, 2004, 6 WORKSH ALG ENG EXP; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lippow SM, 2007, CURR OPIN BIOTECH, V18, P305, DOI 10.1016/j.copbio.2007.04.009; Liu LF, 2010, CHEM COMMUN, V46, P8803, DOI 10.1039/c0cc02961k; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Lum LG, 2006, EXP HEMATOL, V34, P1, DOI 10.1016/j.exphem.2005.07.013; Luo BH, 2009, J BIOL CHEM, V284, P3917, DOI 10.1074/jbc.M806312200; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; Mandell DJ, 2009, NAT CHEM BIOL, V5, P797, DOI 10.1038/nchembio.251; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; NAUTIYAL S, 1995, BIOCHEMISTRY-US, V34, P11645, DOI 10.1021/bi00037a001; Pierce NA, 2002, PROTEIN ENG, V15, P779, DOI 10.1093/protein/15.10.779; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Shah PS, 2007, J MOL BIOL, V372, P1, DOI 10.1016/j.jmb.2007.06.032; Shimaoka M, 2000, NAT STRUCT BIOL, V7, P674, DOI 10.1038/77978; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Wu Z, 2010, NEOPLASIA, V12, P1003, DOI 10.1593/neo.101080	64	65	65	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e20937	10.1371/journal.pone.0020937	http://dx.doi.org/10.1371/journal.pone.0020937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754981	Green Published, gold, Green Submitted			2022-12-25	WOS:000292632000005
J	Haga, Y; Ishii, K; Suzuki, T				Haga, Yoshimi; Ishii, Kumiko; Suzuki, Tadashi			N-Glycosylation Is Critical for the Stability and Intracellular Trafficking of Glucose Transporter GLUT4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; PLASMA-MEMBRANE; LINKED GLYCANS; INSULIN ACTION; PROTEIN; VESICLES; CELLS; TRANSLOCATION; GLUCOSE-TRANSPORTER-4; GLYCOPROTEIN	The facilitative glucose transporter GLUT4 plays a key role in regulating whole body glucose homeostasis. GLUT4 dramatically changes its distribution upon insulin stimulation, and insulin-resistant diabetes is often linked with compromised translocation of GLUT4 under insulin stimulation. To elucidate the functional significance of the sole N-glycan chain on GLUT4, wild-type GLUT4 and a GLUT4 glycosylation mutant conjugated with enhanced GFP were stably expressed in HeLa cells. The N-glycan contributed to the overall stability of newly synthesized GLUT4. Moreover, cell surface expression of wildtype GLUT4 in HeLa cells was elevated upon insulin treatment, whereas the glycosylation mutant lost the ability to respond to insulin. Subcellular distribution of the mutant was distinct from that of wild-type GLUT4, implying that the subcellular localization required for insulin-mediated translocation was impaired in the mutant protein. Interestingly, kifunensine-treated cells also lost sensitivity to insulin, suggesting the functional importance of the N-glycan structure for GLUT4 trafficking. The Km or turnover rates of wild-type and mutant GLUT4, however, were similar, suggesting that the N-glycan had little effect on transporter activity. These findings underscore the critical roles of the N-glycan chain in quality control as well as intracellular trafficking of GLUT4.	[Haga, Yoshimi; Ishii, Kumiko; Suzuki, Tadashi] RIKEN, Adv Sci Inst, Glycometabolome Team, Wako, Saitama 3510198, Japan	RIKEN	Suzuki, T (corresponding author), RIKEN, Adv Sci Inst, Glycometabolome Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tsuzuki_gm@riken.jp	Suzuki, Tadashi/AAX-5707-2021; Suzuki, Tadashi/I-4536-2014	Suzuki, Tadashi/0000-0003-1030-7631; Haga, Yoshimi/0000-0001-7861-617X	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22570148] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. S.) and a grant-in-aid for Japan Society for the Promotion of Science postdoctoral fellow (to Y.H.).	AROETI B, 1994, EMBO J, V13, P2297, DOI 10.1002/j.1460-2075.1994.tb06513.x; ASANO T, 1991, J BIOL CHEM, V266, P24632; ASANO T, 1993, FEBS LETT, V324, P258, DOI 10.1016/0014-5793(93)80129-I; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; BLAKER GJ, 1971, J CELL SCI, V9, P529; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Dawson K, 2001, BIOCHEM BIOPH RES CO, V287, P445, DOI 10.1006/bbrc.2001.5620; de Virgilio M, 1999, MOL BIOL CELL, V10, P4059, DOI 10.1091/mbc.10.12.4059; Dubois F, 2009, MOL CELL PROTEOMICS, V8, P2487, DOI 10.1074/mcp.M800544-MCP200; FEUGEAS JP, 1990, BIOCHIM BIOPHYS ACTA, V1030, P60, DOI 10.1016/0005-2736(90)90238-J; FEUGEAS JP, 1991, BIOCHIM BIOPHYS ACTA, V1066, P59, DOI 10.1016/0005-2736(91)90250-C; FIEDLER K, 1995, CELL, V81, P309, DOI 10.1016/0092-8674(95)90380-1; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Higai K, 2003, CLIN CHIM ACTA, V329, P117, DOI 10.1016/S0009-8981(02)00427-8; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Ing BL, 1996, BIOCHEM BIOPH RES CO, V218, P76, DOI 10.1006/bbrc.1996.0015; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Itoh N, 2007, AM J PHYSIOL-ENDOC M, V293, pE1069, DOI 10.1152/ajpendo.00182.2007; KANDROR KV, 1994, J BIOL CHEM, V269, P30777; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; KITAGAWA T, 1995, J CELL SCI, V108, P3735; Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626; Lampson MA, 2000, J CELL SCI, V113, P4065; Lee CL, 2011, DIABETES, V60, P909, DOI 10.2337/db10-1186; Li J, 2007, ARCH BIOCHEM BIOPHYS, V463, P102, DOI 10.1016/j.abb.2007.03.005; Lin ZX, 2011, J PROTEOME RES, V10, P2602, DOI 10.1021/pr200102h; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Mohan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014217; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; QUON MJ, 1994, P NATL ACAD SCI USA, V91, P5587, DOI 10.1073/pnas.91.12.5587; Rodriguez-Enriquez S, 2009, J CELL PHYSIOL, V221, P552, DOI 10.1002/jcp.21885; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Sun Y, 2010, P NATL ACAD SCI USA, V107, P19909, DOI 10.1073/pnas.1009523107; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; Xiong WY, 2010, MOL BIOL CELL, V21, P1375, DOI 10.1091/mbc.E09-08-0751; Yamada K, 2007, NAT PROTOC, V2, P753, DOI 10.1038/nprot.2007.76; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723; Zierath JR, 1996, DIABETOLOGIA, V39, P1180, DOI 10.1007/BF02658504	46	50	51	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31320	31327		10.1074/jbc.M111.253955	http://dx.doi.org/10.1074/jbc.M111.253955			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757715	Green Published, hybrid			2022-12-25	WOS:000294487500027
J	Stefan, M; Jacobson, EM; Huber, AK; Greenberg, DA; Li, CW; Skrabanek, L; Conception, E; Fadlalla, M; Ho, K; Tomer, Y				Stefan, Mihaela; Jacobson, Eric M.; Huber, Amanda K.; Greenberg, David A.; Li, Cheuk Wun; Skrabanek, Luce; Conception, Erlinda; Fadlalla, Mohammed; Ho, Kenneth; Tomer, Yaron			Novel Variant of Thyroglobulin Promoter Triggers Thyroid Autoimmunity through an Epigenetic Interferon alpha-modulated Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GENOME; HASHIMOTOS-THYROIDITIS; SUSCEPTIBILITY GENE; LINKAGE ANALYSIS; DISEASE; TRANSCRIPTION; ASSOCIATION; GRAVES; IDENTIFICATION; METHYLATIONS	Autoimmune thyroid diseases (AITD) arise from complex interactions between genetic, epigenetic, and environmental factors. Whole genome linkage scans and association studies have established thyroglobulin (TG) as a major AITD susceptibility gene. However, the causative TG variants and the pathogenic mechanisms are unknown. Here, we describe a genetic/epigenetic mechanism by which a newly identified TG promoter single-nucleotide polymorphism (SNP) variant predisposes to AITD. Sequencing analyses followed by case control and family-based association studies identified an SNP (-1623A -> G) that was associated with AITD in the Caucasian population (p = 0.006). We show that the nucleotide substitution introduced by SNP (-1623A/G) modified a binding site for interferon regulatory factor-1 (IRF-1), a major interferon-induced transcription factor. Using chromatin immunoprecipitation, we demonstrated that IRF-1 binds to the 5' TG promoter motif, and the transcription factor binding correlates with active chromatin structure and is marked by enrichment of mono-methylated Lys-4 residue of histone H3, a signature of active transcriptional enhancers. Using reporter mutations and siRNA approaches, we demonstrate that the disease-associated allele (G) conferred increased TG promoter activity through IRF-1 binding. Finally, treatment of thyroid cells with interferon alpha, a known trigger of AITD, increased TG promoter activity only when it interacted with the disease-associated variant through IRF-1 binding. These results reveal a new mechanism of interaction between environmental (IFN alpha) and genetic (TG) factors to trigger AITD.	[Stefan, Mihaela; Huber, Amanda K.; Conception, Erlinda; Ho, Kenneth; Tomer, Yaron] Mt Sinai Med Ctr, Dept Med, Div Endocrinol, New York, NY 10029 USA; [Jacobson, Eric M.; Li, Cheuk Wun; Fadlalla, Mohammed] Univ Cincinnati, Div Endocrinol, Cincinnati, OH 45267 USA; [Greenberg, David A.] Columbia Univ, Div Stat Genet, New York, NY 10032 USA; [Skrabanek, Luce] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Skrabanek, Luce] Cornell Univ, Weill Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Stefan, Mihaela; Tomer, Yaron] James J Peters Vet Affairs Med Ctr, Bronx, NY 10468 USA	Icahn School of Medicine at Mount Sinai; University System of Ohio; University of Cincinnati; Columbia University; Cornell University; Cornell University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Stefan, M (corresponding author), Mt Sinai Med Ctr, Dept Med, Div Endocrinol, New York, NY 10029 USA.	mihaela.stefan@mssm.edu; yaron.tomer@mssm.edu	Tomer, Yaron/GWU-8933-2022	Huber, Amanda/0000-0003-0375-8709	National Institutes of Health [DK61659, DK067555, DK073681, MH48858, NS27941]; Veterans Affairs merit award; American Thyroid Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067555, R01DK073681, T35DK060444, R01DK061659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027941] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit award(US Department of Veterans Affairs); American Thyroid Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants DK61659, DK067555, and DK073681 (to Y. T.) and Grants MH48858 and NS27941 (to D. A. G.). This work was also supported by a Veterans Affairs merit award (to Y. T.).; Supported by a grant from the American Thyroid Association.	Akeno N, 2011, J IMMUNOL, V186, P4693, DOI 10.4049/jimmunol.1002631; Akeno N, 2008, J AUTOIMMUN, V31, P339, DOI 10.1016/j.jaut.2008.08.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ban Y, 2004, CLIN ENDOCRINOL, V61, P263, DOI 10.1111/j.1365-2265.2004.02096.x; Ban Y, 2003, P NATL ACAD SCI USA, V100, P15119, DOI 10.1073/pnas.2434175100; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berg V, 1996, BBA-GENE STRUCT EXPR, V1307, P35, DOI 10.1016/0167-4781(96)00044-9; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Brown RS, 2009, CURR OPIN PEDIATR, V21, P523, DOI 10.1097/MOP.0b013e32832cf824; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Caputo M, 2010, ENDOCRINE, V37, P389, DOI 10.1007/s12020-010-9317-5; Carayanniotis G, 2007, THYROID, V17, P963, DOI 10.1089/thy.2007.0199; Carella C, 2004, J CLIN ENDOCR METAB, V89, P3656, DOI 10.1210/jc.2004-0627; Caturegli P, 2007, CURR OPIN RHEUMATOL, V19, P44, DOI 10.1097/BOR.0b013e3280113d1a; Chen CR, 2010, ENDOCRINOLOGY, V151, P4583, DOI 10.1210/en.2010-0321; Christophe D, 1987, Horm Metab Res Suppl, V17, P70; CHRISTOPHE D, 1985, NUCLEIC ACIDS RES, V13, P5127, DOI 10.1093/nar/13.14.5127; Collins JE, 2003, J CLIN ENDOCR METAB, V88, P5039, DOI 10.1210/jc.2003-030093; DONDA A, 1993, MOL CELL ENDOCRINOL, V90, pR23, DOI 10.1016/0303-7207(93)90162-D; ESCHLER DC, 2011, CLIN REV AL IN PRESS; Espinoza CR, 2001, J MOL ENDOCRINOL, V27, P59, DOI 10.1677/jme.0.0270059; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; Heintzman ND, 2007, CELL MOL LIFE SCI, V64, P386, DOI 10.1007/s00018-006-6295-0; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hsiao JY, 2008, CLIN EXP MED, V8, P17, DOI 10.1007/s10238-008-0151-5; Hsiao JY, 2007, J CLIN ENDOCR METAB, V92, P3197, DOI 10.1210/jc.2007-0675; Jacobson EM, 2007, THYROID, V17, P949, DOI 10.1089/thy.2007.0153; Jacobson EM, 2007, J AUTOIMMUN, V28, P85, DOI 10.1016/j.jaut.2007.02.006; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Menconi F, 2011, J ENDOCRINOL INVEST, V34, P78, DOI [10.1007/BF03346699, 10.3275/7499]; Prummel MF, 2004, EUR J ENDOCRINOL, V150, P605, DOI 10.1530/eje.0.1500605; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Rose NR, 2000, APPL BIOCHEM BIOTECH, V83, P245, DOI 10.1385/ABAB:83:1-3:245; Sakai K, 2001, HUM MOL GENET, V10, P1379, DOI 10.1093/hmg/10.13.1379; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schonberger J, 2000, J MOL MED, V78, P102, DOI 10.1007/s001090000085; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Shulman S, 1971, Adv Immunol, V14, P85, DOI 10.1016/S0065-2776(08)60284-9; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; TOMER Y, 1993, ENDOCR REV, V14, P107, DOI 10.1210/er.14.1.107; Tomer Y, 2003, AM J HUM GENET, V73, P736, DOI 10.1086/378588; Tomer Y, 2002, J CLIN ENDOCR METAB, V87, P404, DOI 10.1210/jc.87.1.404; Tomer Y, 2007, ENDOCRIN METAB CLIN, V36, P1051, DOI 10.1016/j.ecl.2007.07.001; Tomer Y, 2010, THYROID, V20, P715, DOI 10.1089/thy.2010.1644; Tomer Y, 2010, J AUTOIMMUN, V34, pJ322, DOI 10.1016/j.jaut.2009.11.008; Varela V, 2010, ENDOCRINE, V38, P320, DOI 10.1007/s12020-010-9398-1; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	50	51	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31168	31179		10.1074/jbc.M111.247510	http://dx.doi.org/10.1074/jbc.M111.247510			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757724	Green Published, hybrid			2022-12-25	WOS:000294487500012
J	Tang, J; Pecka, JL; Tan, XD; Beisel, KW; He, DZZ				Tang, Jie; Pecka, Jason L.; Tan, Xiaodong; Beisel, Kirk W.; He, David Z. Z.			Engineered Pendrin Protein, an Anion Transporter and Molecular Motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER HAIR-CELLS; GUINEA-PIG COCHLEA; PLASMA-MEMBRANE; NONLINEAR CAPACITANCE; GENE PDS; PRESTIN; ELECTROMOTILITY; MOTILITY; SALICYLATE; LOCALIZATION	Pendrin and prestin both belong to a distinct anion transporter family called solute carrier protein 26A, or SLC26A. Pendrin (SLC26A4) is a chloride-iodide transporter that is found at the luminal membrane of follicular cells in the thyroid gland as well as in the endolymphatic duct and sac of the inner ear, whereas prestin (SLC26A5) is expressed in the plasma membrane of cochlear outer hair cells and functions as a unique voltage-dependent motor. We recently identified a motif that is critical for the motor function of prestin. We questioned whether it was possible to create a chimeric pendrin protein with motor capability by integrating this motility motif from prestin. The chimeric pendrin was constructed by substituting residues 160-179 in human pendrin with residues 156-169 from gerbil prestin. Non-linear capacitance and somatic motility, two hallmarks representing prestin function, were measured from chimeric pendrin-transfected human embryonic kidney 293 cells using the voltage clamp technique and photodiode-based displacement measurement system. We showed that this 14-amino acid substitution from prestin was able to confer pendrin with voltage-dependent motor capability despite the amino acid sequence disparity between pendrin and prestin. The molecular mechanism that facilitates motor function appeared to be the same as prestin because the motor activity depended on the concentration of intracellular chloride and was blocked by salicylate treatment. Radioisotope-labeled formate uptake measurements showed that the chimeric pendrin protein retained the capability to transport formate, suggesting that the gain of motor function was not at the expense of its inherent transport capability. Thus, the engineered pendrin was capable of both transporting anions and generating force.	[Tang, Jie; Pecka, Jason L.; Tan, Xiaodong; Beisel, Kirk W.; He, David Z. Z.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA	Creighton University	He, DZZ (corresponding author), 2500 Calif Plaza, Omaha, NE 68178 USA.	hed@creighton.edu	Tang, Jie/GNW-2318-2022	Tan, Xiaodong/0000-0003-0251-2774; He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634; Tang, Jie/0000-0001-7882-4462	National Institutes of Health NIH [R01 DC008649]; NIDCD [R01 DC004696]; NCRR, National Institutes of Health [RR17417-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004696, R01DC008649] Funding Source: NIH RePORTER	National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCRR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health NIH Grants R01 DC008649 ( to K. B.) and R01 DC004696 (to D. H.) from the NIDCD. The Integrated Biological Imaging Facility, supported by the Creighton University Medical School, was constructed with support from C06 Grant RR17417-01 from the NCRR, National Institutes of Health.	Albert JT, 2007, J PHYSIOL-LONDON, V580, P451, DOI 10.1113/jphysiol.2007.127993; Ashmore J. F., 1989, COCHLEAR MECH, P107; ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; Bai JP, 2009, BIOPHYS J, V96, P3179, DOI 10.1016/j.bpj.2008.12.3948; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Choi BY, 2009, J MED GENET, V46, P856, DOI 10.1136/jmg.2009.067892; Coyle B, 1996, NAT GENET, V12, P421, DOI 10.1038/ng0496-421; Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Dong XX, 2002, BIOPHYS J, V82, P1254, DOI 10.1016/S0006-3495(02)75481-7; Dossena S, 2009, J MOL ENDOCRINOL, V43, P93, DOI 10.1677/JME-08-0175; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; He DZZ, 2006, J MEMBRANE BIOL, V209, P119, DOI 10.1007/s00232-005-0833-9; He DZZ, 2010, CYTOSKELETON, V67, P43, DOI 10.1002/cm.20423; He DZZ, 2003, J NEUROSCI, V23, P9089; He DZZ, 1997, J NEUROSCI, V17, P3634; Homma K, 2011, J BIOL CHEM, V286, P2297, DOI 10.1074/jbc.M110.185694; Jia SP, 2005, NAT NEUROSCI, V8, P1028, DOI 10.1038/nn1509; Kakehata S, 1996, J NEUROSCI, V16, P4881; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Muallem D, 2006, BIOPHYS J, V90, P4035, DOI 10.1529/biophysj.105.073254; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; Okoruwa OE, 2008, EVOL DEV, V10, P300, DOI 10.1111/j.1525-142X.2008.00239.x; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Pendrin V., 1896, LANCET, V148, P532; Rajagopalan L, 2006, J NEUROSCI, V26, P12727, DOI 10.1523/JNEUROSCI.2734-06.2006; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; Rybalchenko V, 2008, BIOPHYS J, V95, P4439, DOI 10.1529/biophysj.108.134197; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2001, HEARING RES, V159, P69, DOI 10.1016/S0378-5955(01)00321-5; Sarojini V, 2010, J PEPT SCI, V16, P430, DOI 10.1002/psc.1259; Schaechinger TJ, 2011, EMBO J, V30, P2793, DOI 10.1038/emboj.2011.202; Seymour M. L., 2011, 34 M ASS RES OT BALT; Sheffield VC, 1996, NAT GENET, V12, P424, DOI 10.1038/ng0496-424; SHEHATA WE, 1991, ACTA OTO-LARYNGOL, V111, P707, DOI 10.3109/00016489109138403; Tan XD, 2011, J NEUROPHYSIOL, V105, P36, DOI 10.1152/jn.00234.2010; TUNSTALL MJ, 1995, J PHYSIOL-LONDON, V485, P739, DOI 10.1113/jphysiol.1995.sp020765; Wang X, 2010, BRAIN RES, V1333, P28, DOI 10.1016/j.brainres.2010.03.070; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2005, J CELL SCI, V118, P2987, DOI 10.1242/jcs.02431; Zheng J, 2001, NEUROREPORT, V12, P1929, DOI 10.1097/00001756-200107030-00032	44	18	20	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					31014	31021		10.1074/jbc.M111.259564	http://dx.doi.org/10.1074/jbc.M111.259564			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757707	Green Published, hybrid			2022-12-25	WOS:000294283600079
J	Vinnakota, KC; Dash, RK; Beard, DA				Vinnakota, Kalyan C.; Dash, Ranjan K.; Beard, Daniel A.			Stimulatory Effects of Calcium on Respiration and NAD(P)H Synthesis in Intact Rat Heart Mitochondria Utilizing Physiological Substrates Cannot Explain Respiratory Control in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CITRIC-ACID CYCLE; OXIDATIVE-PHOSPHORYLATION; METABOLITE CONCENTRATIONS; PHOSPHATE METABOLITE; MAMMALIAN HEART; CA2+; INVIVO	Mitochondrial TCA cycle dehydrogenase enzymes have been shown to be stimulated by Ca2+ under various substrate and ADP incubation conditions in an attempt to determine and understand the role of Ca2+ in maintaining energy homeostasis in working hearts. In this study, we tested the hypothesis that, at physiological temperature and 1 mM extramitochondrial free magnesium, Ca2+ can stimulate the overall mitochondrial NAD(P)H generation flux in rat heart mitochondria utilizing pyruvate and malate as substrates at both subsaturating and saturating concentrations. In both cases, we found that, in the physiological regime of mitochondrial oxygen consumption observed in the intact animal and in the physiological range of cytosolic Ca2+ concentration averaged per beat, Ca2+ had no observable stimulatory effect. A modest apparent stimulatory effect (22-27%) was observable at supraphysiological maximal ADP-stimulated respiration at 2.5 mM initial phosphate. The stimulatory effects observed over the physiological Ca2+ range are not sufficient to make a significant contribution to the control of oxidative phosphorylation in the heart in vivo.	Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Beard, DA (corresponding author), Med Coll Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53222 USA.	dbeard@mcw.edu	Vinnakota, Kalyan/G-4706-2010	Vinnakota, Kalyan/0000-0003-2185-2213	National Institutes of Health [R01 HL094317]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL094317 (to D.A.B.).	BALABAN RS, 1986, SCIENCE, V232, P1121, DOI 10.1126/science.3704638; Baniene R, 2006, IEE P SYST BIOL, V153, P350, DOI 10.1049/ip-syb:20060009; Beard DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000459; BISHOP PD, 1984, ARCH BIOCHEM BIOPHYS, V230, P335, DOI 10.1016/0003-9861(84)90116-4; Bose S, 2003, J BIOL CHEM, V278, P39155, DOI 10.1074/jbc.M306409200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANCE B, 1955, J BIOL CHEM, V217, P409; Dibb KM, 2007, J PHYSIOL-LONDON, V585, P579, DOI 10.1113/jphysiol.2007.141473; HANSFORD RG, 1981, BIOCHEM J, V198, P525, DOI 10.1042/bj1980525; KATZ LA, 1989, AM J PHYSIOL, V256, pH265, DOI 10.1152/ajpheart.1989.256.1.H265; LANDAW EM, 1984, AM J PHYSIOL, V246, pR665, DOI 10.1152/ajpregu.1984.246.5.R665; Mildaziene V, 1996, BIOCHEM J, V320, P329, DOI 10.1042/bj3200329; Mootha VK, 1997, AM J PHYSIOL-HEART C, V272, pH769, DOI 10.1152/ajpheart.1997.272.2.H769; Okere IC, 2006, J APPL PHYSIOL, V100, P76, DOI 10.1152/japplphysiol.00255.2005; Panov AV, 1996, AM J PHYSIOL-HEART C, V270, pH1398, DOI 10.1152/ajpheart.1996.270.4.H1398; SCADUTO RC, 1994, EUR J BIOCHEM, V223, P751, DOI 10.1111/j.1432-1033.1994.tb19049.x; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Tune JD, 2000, AM J PHYSIOL-HEART C, V278, pH74, DOI 10.1152/ajpheart.2000.278.1.H74; Vinnakota KC, 2004, AM J PHYSIOL-HEART C, V286, pH1742, DOI 10.1152/ajpheart.00478.2003; WAN B, 1989, J BIOL CHEM, V264, P13430; Ward ML, 2003, J PHYSIOL-LONDON, V546, P537, DOI 10.1113/jphysiol.2002.029132; Wu F, 2008, J PHYSIOL-LONDON, V586, P4193, DOI 10.1113/jphysiol.2008.154732	23	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30816	30822		10.1074/jbc.M111.242529	http://dx.doi.org/10.1074/jbc.M111.242529			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757763	hybrid, Green Published			2022-12-25	WOS:000294283600061
J	Yu, E; Zhai, DY; Jin, CF; Gerlic, M; Reed, JC; Liddington, R				Yu, Eric; Zhai, Dayong; Jin, Chaofang; Gerlic, Motti; Reed, John C.; Liddington, Robert			Structural Determinants of Caspase-9 Inhibition by the Vaccinia Virus Protein, F1L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C; CRYSTAL-STRUCTURE; CELL-DEATH; APOPTOTIC PROTEIN; BACULOVIRUS P35; WEB SERVER; ACTIVATION; BCL-2; XIAP; APOPTOSOME	In multicellular organisms, apoptosis is a powerful method of host defense against viral infection. Apoptosis is mediated by a cascade of caspase-family proteases that commit infected cells to a form of programmed cell death. Therefore, to replicate within host cells, viruses have developed various strategies to inhibit caspase activation. In the mitochondrial cell-death pathway, release of cytochrome c from mitochondria into the cytosol triggers assembly of the oligomeric apoptosome, resulting in dimerization and activation of the apical caspase-9 (C9), and in turn its downstream effector caspases, leading to apoptosis. We previously showed that the vaccinia virus-encoded Bcl-2-like protein, F1L, which suppresses cytochrome c release by binding Bcl-2 family proteins, is also a C9 inhibitor. Here, we identify a novel motif within the flexible N-terminal region of F1L that is necessary and sufficient for interaction with and inhibition of C9. Based on functional studies and mutagenesis, we developed an atomic model of the complex in which F1L inhibits C9 by engaging the active site in the reverse orientation with respect to substrate peptides, in a manner analogous to that of XIAP-mediated inhibition of caspases-3 and -7. These studies offer new insights into the mechanism of apoptosome inhibition by F1L as well as novel probes to understand the molecular bases of apoptosome regulation and turnover. They also suggest how the two distinct functionalities of F1L (inhibition of C9 and suppression of pro-apoptotic Bcl-2 family proteins) may operate in a cellular setting.	[Yu, Eric; Zhai, Dayong; Jin, Chaofang; Gerlic, Motti; Reed, John C.; Liddington, Robert] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Liddington, R (corresponding author), Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rlidding@sanfordburnham.org	gerlic, Motti/I-5492-2019; Gerlic, Motti/U-3484-2017	gerlic, Motti/0000-0001-9518-1833; Gerlic, Motti/0000-0001-9518-1833; Yu, Eric/0000-0001-7026-7008	National Institutes of Health [AI056324, AI091967]; Department of Defense [W81XWH-10-1-0093]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091967, R01AI056324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI056324 and AI091967. This work was also supported by Department of Defense Grant W81XWH-10-1-0093).	Aoyagi M, 2007, PROTEIN SCI, V16, P118, DOI 10.1110/ps.062454707; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Best SM, 2008, ANNU REV MICROBIOL, V62, P171, DOI 10.1146/annurev.micro.62.081307.163009; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Campbell S, 2010, J BIOL CHEM, V285, P4695, DOI 10.1074/jbc.M109.053769; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chao Y, 2005, PLOS BIOL, V3, P1079, DOI 10.1371/journal.pbio.0030183; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; Creagh EM, 2003, IMMUNOL REV, V193, P10, DOI 10.1034/j.1600-065X.2003.00048.x; Cuconati A, 2002, GENE DEV, V16, P2465, DOI 10.1101/gad.1012702; dela Cruz WP, 2001, J BIOL CHEM, V276, P32933, DOI 10.1074/jbc.M103930200; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Douglas AE, 2007, PROTEIN SCI, V16, P695, DOI 10.1110/ps.062720107; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Faustin B, 2009, P NATL ACAD SCI USA, V106, P3935, DOI 10.1073/pnas.0809414106; Fisher AJ, 1999, EMBO J, V18, P2031, DOI 10.1093/emboj/18.8.2031; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Huang QL, 2003, J MOL BIOL, V332, P1123, DOI 10.1016/j.jmb.2003.08.007; Huang QL, 2002, P NATL ACAD SCI USA, V99, P3428, DOI 10.1073/pnas.062525799; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; KOMIYAMA T, 1994, J BIOL CHEM, V269, P19331; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Kvansakul M, 2007, MOL CELL, V25, P933, DOI 10.1016/j.molcel.2007.02.004; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Postigo A, 2006, CELL DEATH DIFFER, V13, P1651, DOI 10.1038/sj.cdd.4401853; Postigo A, 2009, MICROBES INFECT, V11, P1071, DOI 10.1016/j.micinf.2009.08.012; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Riedl SJ, 2001, BIOCHEMISTRY-US, V40, P13274, DOI 10.1021/bi010574w; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rost B, 1996, METHOD ENZYMOL, V266, P525; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Stewart TL, 2005, J VIROL, V79, P1084, DOI 10.1128/JVI.79.2.1084-1098.2005; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Taylor JM, 2006, J BIOL CHEM, V281, P39728, DOI 10.1074/jbc.M607465200; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wasilenko ST, 2003, P NATL ACAD SCI USA, V100, P14345, DOI 10.1073/pnas.2235583100; Wasilenko ST, 2005, J VIROL, V79, P14031, DOI 10.1128/JVI.79.22.14031-14043.2005; Wiehe K, 2007, PROTEINS, V69, P719, DOI 10.1002/prot.21747; Xu GZ, 2001, NATURE, V410, P494, DOI 10.1038/35068604; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yuan SJ, 2010, STRUCTURE, V18, P571, DOI 10.1016/j.str.2010.04.001; Zhai DY, 2010, J BIOL CHEM, V285, P5569, DOI 10.1074/jbc.M109.078113; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	52	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30748	30758		10.1074/jbc.M111.280149	http://dx.doi.org/10.1074/jbc.M111.280149			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757755	hybrid, Green Published			2022-12-25	WOS:000294283600055
J	Haugsten, EM; Zakrzewska, M; Brech, A; Pust, S; Olsnes, S; Sandvig, K; Wesche, J				Haugsten, Ellen Margrethe; Zakrzewska, Malgorzata; Brech, Andreas; Pust, Sascha; Olsnes, Sjur; Sandvig, Kirsten; Wesche, Jorgen			Clathrin- and Dynamin-Independent Endocytosis of FGFR3-Implications for Signalling	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; MEDIATED ENDOCYTOSIS; RECEPTOR ENDOCYTOSIS; TRANSFERRIN RECEPTOR; RHO GTPASES; IN-VIVO; INTERNALIZATION; CELLS; PATHWAYS; CANCER	Endocytosis of tyrosine kinase receptors can influence both the duration and the specificity of the signal emitted. We have investigated the mechanisms of internalization of fibroblast growth factor receptor 3 (FGFR3) and compared it to that of FGFR1 which is internalized predominantly through clathrin-mediated endocytosis. Interestingly, we observed that FGFR3 was internalized at a slower rate than FGFR1 indicating that it may use a different endocytic mechanism than FGFR1. Indeed, after depletion of cells for clathrin, internalization of FGFR3 was only partly inhibited while endocytosis of FGFR1 was almost completely abolished. Similarly, expression of dominant negative mutants of dynamin resulted in partial inhibition of the endocytosis of FGFR3 whereas internalization of FGFR1 was blocked. Interfering with proposed regulators of clathrin-independent endocytosis such as Arf6, flotillin 1 and 2 and Cdc42 did not affect the endocytosis of FGFR1 or FGFR3. Furthermore, depletion of clathrin decreased the degradation of FGFR1 resulting in sustained signalling. In the case of FGFR3, both the degradation and the signalling were only slightly affected by clathrin depletion. The data indicate that clathrin-mediated endocytosis is required for efficient internalization and downregulation of FGFR1 while FGFR3, however, is internalized by both clathrin-dependent and clathrin-independent mechanisms.	[Haugsten, Ellen Margrethe; Zakrzewska, Malgorzata; Brech, Andreas; Pust, Sascha; Olsnes, Sjur; Sandvig, Kirsten; Wesche, Jorgen] Univ Oslo, Norwegian Radium Hosp, Fac Div, Ctr Canc Biomed, Oslo, Norway; [Haugsten, Ellen Margrethe; Zakrzewska, Malgorzata; Brech, Andreas; Pust, Sascha; Olsnes, Sjur; Sandvig, Kirsten; Wesche, Jorgen] Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, Oslo, Norway; [Zakrzewska, Malgorzata] Univ Wroclaw, Fac Biotechnol, PL-50138 Wroclaw, Poland	University of Oslo; University of Oslo; University of Wroclaw	Haugsten, EM (corresponding author), Univ Oslo, Norwegian Radium Hosp, Fac Div, Ctr Canc Biomed, Oslo, Norway.	Jorgen.Wesche@rr-research.no	Pust, Sascha/M-3201-2013; Wesche, Jorgen/ABH-7524-2020	Pust, Sascha/0000-0002-0178-2206; Zakrzewska, Malgorzata/0000-0001-8214-1533; Haugsten, Ellen Margrethe/0000-0002-3111-5092; Wesche, Jorgen/0000-0002-9200-9162; Brech, Andreas/0000-0002-9803-1774	South-Eastern Norway Regional Health Authority; Norway through the Norwegian Financial Mechanism within the Polish-Norwegian Research Fund [PNRF-87-AI-1/07]	South-Eastern Norway Regional Health Authority; Norway through the Norwegian Financial Mechanism within the Polish-Norwegian Research Fund	M. H. is a postdoctoral fellow of the Norwegian Cancer Society and J.W. has a research fellowship from the South-Eastern Norway Regional Health Authority. M.Z. was a postdoctoral fellow of the Research Council of Norway. This work has been supported by the grant PNRF-87-AI-1/07 from Norway through the Norwegian Financial Mechanism within the Polish-Norwegian Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Belleudi F, 2007, TRAFFIC, V8, P1854, DOI 10.1111/j.1600-0854.2007.00651.x; Cao H, 2000, J CELL SCI, V113, P1993; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Cho JY, 2004, P NATL ACAD SCI USA, V101, P609, DOI 10.1073/pnas.2237184100; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; del Pozo MA, 1999, EUR J IMMUNOL, V29, P3609; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; GORDEN P, 1978, P NATL ACAD SCI USA, V75, P5025, DOI 10.1073/pnas.75.10.5025; Grimmer S, 2005, TRAFFIC, V6, P144, DOI 10.1111/j.1600-0854.2005.00258.x; Hansen CG, 2009, J CELL SCI, V122, P1713, DOI 10.1242/jcs.033951; Haugsten EM, 2008, MOL BIOL CELL, V19, P3390, DOI 10.1091/mbc.E07-12-1219; Haugsten EM, 2010, MOL CANCER RES, V8, P1439, DOI 10.1158/1541-7786.MCR-10-0168; Haugsten EM, 2005, J CELL SCI, V118, P3869, DOI 10.1242/jcs.02509; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; Houndolo T, 2005, J BIOL CHEM, V280, P5598, DOI 10.1074/jbc.M411456200; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Jean S, 2010, DEV CELL, V19, P426, DOI 10.1016/j.devcel.2010.08.007; Kumari S, 2010, CELL RES, V20, P256, DOI 10.1038/cr.2010.19; LUND KA, 1990, J BIOL CHEM, V265, P15713; Marchese C, 1998, J CELL SCI, V111, P3517; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Munoz R, 1997, ONCOGENE, V15, P525, DOI 10.1038/sj.onc.1201226; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Pust S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008844; Raiborg C, 2006, J CELL SCI, V119, P2414, DOI 10.1242/jcs.02978; Sabe H, 2003, J BIOCHEM, V134, P485, DOI 10.1093/jb/mvg181; SANDVIG K, 2011, CURR OPIN CELL BIOL; Schweitzer JK, 2011, SEMIN CELL DEV BIOL, V22, P39, DOI 10.1016/j.semcdb.2010.09.002; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; van Dam EM, 2002, MOL BIOL CELL, V13, P169, DOI 10.1091/mbc.01-07-0380; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x	43	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21708	10.1371/journal.pone.0021708	http://dx.doi.org/10.1371/journal.pone.0021708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779335	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811300013
J	Jelcick, AS; Yuan, Y; Leehy, BD; Cox, LC; Silveira, AC; Qiu, F; Schenk, S; Sachs, AJ; Morrison, MA; Nystuen, AM; DeAngelis, MM; Haider, NB				Jelcick, Austin S.; Yuan, Yang; Leehy, Barrett D.; Cox, Lakeisha C.; Silveira, Alexandra C.; Qiu, Fang; Schenk, Sarah; Sachs, Andrew J.; Morrison, Margaux A.; Nystuen, Arne M.; DeAngelis, Margaret M.; Haider, Neena B.			Genetic Variations Strongly Influence Phenotypic Outcome in the Mouse Retina	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; MACULAR DEGENERATION; SYSTEMS BIOLOGY; DISEASE; STRAINS; PHOTORECEPTOR; MUTATIONS; DYSTROPHY; MICE; ABCR	Variation in genetic background can significantly influence the phenotypic outcome of both disease and non-disease associated traits. Additionally, differences in temporal and strain specific gene expression can also contribute to phenotypes in the mammalian retina. This is the first report of microarray based cross-strain analysis of gene expression in the retina investigating genetic background effects. Microarray analyses were performed on retinas from the following mouse strains: C57BL6/J, AKR/J, CAST/EiJ, and NOD. NON-H2(-nb1) at embryonic day 18.5 (E18.5) and postnatal day 30.5 (P30.5). Over 3000 differentially expressed genes were identified between strains and developmental stages. Differential gene expression was confirmed by qRT-PCR, Western blot, and immunohistochemistry. Three major gene networks were identified that function to regulate retinal or photoreceptor development, visual perception, cellular transport, and signal transduction. Many of the genes in these networks are implicated in retinal diseases such as bradyopsia, night-blindness, and cone-rod dystrophy. Our analysis revealed strain specific variations in cone photoreceptor cell patterning and retinal function. This study highlights the substantial impact of genetic background on both development and function of the retina and the level of gene expression differences tolerated for normal retinal function. These strain specific genetic variations may also be present in other tissues. In addition, this study will provide valuable insight for the development of more accurate models for human retinal diseases.	[Jelcick, Austin S.; Yuan, Yang; Leehy, Barrett D.; Cox, Lakeisha C.; Schenk, Sarah; Sachs, Andrew J.; Nystuen, Arne M.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Silveira, Alexandra C.; Morrison, Margaux A.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol,Ocular Mol Genet Inst, Boston, MA USA; [Qiu, Fang] Univ Nebraska Med Ctr, Div Biostat, Omaha, NE USA; [DeAngelis, Margaret M.] Univ Utah, Moran Eye Ctr, Salt Lake City, UT USA; [Haider, Neena B.] Harvard Univ, Sch Med, Schepens Eye Res Inst, Dept Ophthalmol, Boston, MA USA	University of Nebraska System; University of Nebraska Medical Center; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of Nebraska System; University of Nebraska Medical Center; Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School; Schepens Eye Research Institute	Jelcick, AS (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA.	nhaider@unmc.edu	DeAngelis, e/J-7863-2015		National Center for Research Resources, NIH [NIH 5 P20 RRO18788-02]; Hope for Vision; NATIONAL EYE INSTITUTE [P30EY014800, R01EY017653] Funding Source: NIH RePORTER	National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Hope for Vision; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the Center for Biomedical Excellence Award through the National Center for Research Resources, NIH (NIH 5 P20 RRO18788-02 (NBH)), and Hope for Vision (NBH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikmets R, 2000, AM J HUM GENET, V67, P793, DOI 10.1086/303100; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Benfey PN, 2008, SCIENCE, V320, P495, DOI 10.1126/science.1153716; BOYCOTT KM, 2008, GENEREVIEWS     0116; Bradshaw K, 2004, DOC OPHTHALMOL, V108, P135, DOI 10.1023/B:DOOP.0000036786.22179.44; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Coenen MJH, 2009, HUM MOL GENET, V18, P4195, DOI 10.1093/hmg/ddp365; Corbo JC, 2007, P NATL ACAD SCI USA, V104, P12069, DOI 10.1073/pnas.0705465104; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Danciger M, 2008, INVEST OPHTH VIS SCI, V49, P2863, DOI 10.1167/iovs.08-1715; De La Paz MA, 1999, OPHTHALMOLOGY, V106, P1531, DOI 10.1016/S0161-6420(99)90449-9; Diaz E, 2003, P NATL ACAD SCI USA, V100, P5491, DOI 10.1073/pnas.0831080100; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Errijgers V, 2008, GENET RES, V90, P341, DOI 10.1017/S0016672308009415; Frankel WN, 2001, GENOMICS, V74, P306, DOI 10.1006/geno.2001.6564; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Guymer RH, 2002, CLIN EXP OPHTHALMOL, V30, P419, DOI 10.1046/j.1442-9071.2002.00572.x; Hackler L, 2010, INVEST OPHTH VIS SCI, V51, P1823, DOI 10.1167/iovs.09-4657; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; Haider NB, 2008, MAMM GENOME, V19, P145, DOI 10.1007/s00335-008-9092-2; Haider NB, 2006, VISUAL NEUROSCI, V23, P917, DOI 10.1017/S095252380623027X; Haider NB, 2009, EXP EYE RES, V89, P365, DOI 10.1016/j.exer.2009.04.006; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hameed A, 2003, J MED GENET, V40, P616, DOI 10.1136/jmg.40.8.616; Hartl D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-32; Heon E, 2002, HUM MOL GENET, V11, P1029, DOI 10.1093/hmg/11.9.1029; HOLLANDER A, 2009, INVES OPTHAL VIS SCI, V50, P1864; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Iannaccone A, 2006, VISION RES, V46, P4556, DOI 10.1016/j.visres.2006.08.018; Ikeda A, 2002, EXP EYE RES, V74, P455, DOI 10.1006/exer.2001.1139; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Johnson BA, 2008, GENETICS, V178, P1785, DOI 10.1534/genetics.107.084905; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Kayser M, 2008, AM J HUM GENET, V82, P411, DOI 10.1016/j.ajhg.2007.10.003; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Koratkar R, 2002, CANCER RES, V62, P5413; Kovalenko PL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-26; Kuroiwa S, 1999, BRIT J OPHTHALMOL, V83, P613, DOI 10.1136/bjo.83.5.613; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Lasky JL, 2005, PEDIATR RES, V57, p104R, DOI 10.1203/01.PDR.0000159632.70510.3D; Lopez-Rios J, 2003, DEVELOPMENT, V130, P185, DOI 10.1242/dev.00185; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Mori K, 2007, INVEST OPHTH VIS SCI, V48, P5315, DOI 10.1167/iovs.07-0426; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Niu HR, 2008, MAMM GENOME, V19, P634, DOI 10.1007/s00335-008-9145-6; PANAGIS L, 2009, INVEST OPHTH VIS SCI, V51, P2024; Rhodes JS, 2007, GENES BRAIN BEHAV, V6, P1, DOI 10.1111/j.1601-183X.2006.00210.x; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Roberts A, 2007, MAMM GENOME, V18, P473, DOI 10.1007/s00335-007-9045-1; Sanchez-Sanchez AV, 2010, DEV DYNAM, V239, P297, DOI 10.1002/dvdy.22168; SANTOS J, 2010, ONCOGENE; Scholl HPN, 2001, INVEST OPHTH VIS SCI, V42, P2728; Silva AO, 2003, J NEUROBIOL, V54, P511, DOI 10.1002/neu.10156; Silveira AC, 2010, VISION RES, V50, P698, DOI 10.1016/j.visres.2009.09.016; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Svenson KL, 2007, J APPL PHYSIOL, V102, P2369, DOI 10.1152/japplphysiol.01077.2006; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TRAVIS GH, 1991, NEURON, V6, P61, DOI 10.1016/0896-6273(91)90122-G; Wahlsten D, 2003, HANDBOOK OF DEVELOPMENTAL PSYCHOLOGY, P18; Wahlsten D, 2003, BRAIN RES, V971, P47, DOI 10.1016/S0006-8993(03)02354-0; Weber BHF, 2002, INVEST OPHTH VIS SCI, V43, P2732; WHEELER RC, 2009, PLOS GENET      0909; White K, 2000, HUM MUTAT, V15, P301, DOI 10.1002/(SICI)1098-1004(200004)15:4<301::AID-HUMU1>3.0.CO;2-N; Wong AA, 2006, GENES BRAIN BEHAV, V5, P389, DOI 10.1111/j.1601-183X.2005.00173.x	73	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21858	10.1371/journal.pone.0021858	http://dx.doi.org/10.1371/journal.pone.0021858			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779340	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811300019
J	Rauschecker, AM; Dastjerdi, M; Weiner, KS; Witthoft, N; Chen, J; Selimbeyoglu, A; Parvizi, J				Rauschecker, Andreas M.; Dastjerdi, Mohammad; Weiner, Kevin S.; Witthoft, Nathan; Chen, Janice; Selimbeyoglu, Aslihan; Parvizi, Josef			Illusions of Visual Motion Elicited by Electrical Stimulation of Human MT Complex	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; BRAIN-DAMAGE; AREA MT; MACAQUE MONKEY; DIRECTION DISCRIMINATION; SELECTIVE IMPAIRMENT; CORTICAL STIMULATION; EXTRASTRIATE CORTEX; CEREBRAL-LESIONS; APPARENT MOTION	Human cortical area MT+ (hMT(+)) is known to respond to visual motion stimuli, but its causal role in the conscious experience of motion remains largely unexplored. Studies in non-human primates demonstrate that altering activity in area MT can influence motion perception judgments, but animal studies are inherently limited in assessing subjective conscious experience. In the current study, we use functional magnetic resonance imaging (fMRI), intracranial electrocorticography (ECoG), and electrical brain stimulation (EBS) in three patients implanted with intracranial electrodes to address the role of area hMT(+) in conscious visual motion perception. We show that in conscious human subjects, reproducible illusory motion can be elicited by electrical stimulation of hMT(+). These visual motion percepts only occurred when the site of stimulation overlapped directly with the region of the brain that had increased fMRI and electrophysiological activity during moving compared to static visual stimuli in the same individual subjects. Electrical stimulation in neighboring regions failed to produce illusory motion. Our study provides evidence for the sufficient causal link between the hMT(+) network and the human conscious experience of visual motion. It also suggests a clear spatial relationship between fMRI signal and ECoG activity in the human brain.	[Rauschecker, Andreas M.; Dastjerdi, Mohammad; Selimbeyoglu, Aslihan; Parvizi, Josef] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Rauschecker, Andreas M.] Stanford Univ, Med Scientist Training Program, Stanford, CA 94305 USA; [Rauschecker, Andreas M.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Rauschecker, Andreas M.; Weiner, Kevin S.; Witthoft, Nathan; Chen, Janice] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Rauschecker, AM (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	jparvizi@stanford.edu		Dastjerdi, Mohammad/0000-0001-5972-5936; Rauschecker, Andreas/0000-0003-0633-9876; chen, janice/0000-0003-4511-4725	Stanford Institute for Neuro-Innovation and Translational Neuroscience; Milken Family Foundation; Stanford University	Stanford Institute for Neuro-Innovation and Translational Neuroscience; Milken Family Foundation; Stanford University(Stanford University)	This work was supported by the Stanford Institute for Neuro-Innovation and Translational Neuroscience (http://neuroscience.stanford.edu), the Milken Family Foundation (www.mff.org), and a Stanford University Bio-X Fellowship (http://biox.stanford.edu/grant/fellowships.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano K, 2009, J NEUROPHYSIOL, V102, P2704, DOI 10.1152/jn.00102.2009; BARTON JJS, 1995, ANN NEUROL, V37, P665, DOI 10.1002/ana.410370517; BECKERS G, 1995, BRAIN, V118, P49, DOI 10.1093/brain/118.1.49; BECKERS G, 1992, P ROY SOC B-BIOL SCI, V249, P173, DOI 10.1098/rspb.1992.0100; Blanke O, 2003, EUR J NEUROSCI, V18, P709, DOI 10.1046/j.1460-9568.2003.02771.x; Blanke O, 2002, EUR J NEUROSCI, V15, P2043, DOI 10.1046/j.1460-9568.2002.02038.x; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; Glover GH, 1999, MAGNET RESON MED, V42, P412, DOI 10.1002/(SICI)1522-2594(199908)42:2<412::AID-MRM25>3.0.CO;2-U; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Greenlee MW, 1997, J NEUROSCI, V17, P804; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; HAGLUND MM, 1993, J NEUROSURG, V78, P785, DOI 10.3171/jns.1993.78.5.0785; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; HOTSON J, 1994, VISION RES, V34, P2115, DOI 10.1016/0042-6989(94)90321-2; Huk AC, 2002, J NEUROSCI, V22, P7195; Jacobs J, 2010, TRENDS COGN SCI, V14, P162, DOI 10.1016/j.tics.2010.01.005; Khawaja FA, 2009, J NEUROSCI, V29, P13702, DOI 10.1523/JNEUROSCI.2844-09.2009; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; Lee HW, 2000, NEUROLOGY, V54, P849, DOI 10.1212/WNL.54.4.849; Logothetis NK, 2010, NAT NEUROSCI, V13, P1283, DOI 10.1038/nn.2631; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Marcar VL, 1997, NEUROPSYCHOLOGIA, V35, P1459, DOI 10.1016/S0028-3932(97)00057-2; MATIN L, 1982, SCIENCE, V216, P198, DOI 10.1126/science.7063881; Matsumoto R, 2004, CLIN NEUROPHYSIOL, V115, P2056, DOI 10.1016/j.clinph.2004.03.030; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; Moo LR, 2008, COGN NEUROPSYCHOL, V25, P677, DOI 10.1080/02643290802271599; Moulton ST, 2009, PHILOS T R SOC B, V364, P1273, DOI 10.1098/rstb.2008.0314; Muckli L, 2002, J NEUROSCI, V22; MULLAN S, 1959, ARCH NEURO PSYCHIATR, V81, P269, DOI 10.1001/archneurpsyc.1959.02340150001001; Murakami I, 1998, NATURE, V395, P798, DOI 10.1038/27435; Murphey DK, 2009, P NATL ACAD SCI USA, V106, P5389, DOI 10.1073/pnas.0804998106; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; NEWSOME WT, 1985, J NEUROSCI, V5, P825; OJEMANN GA, 1983, BEHAV BRAIN SCI, V6, P189, DOI 10.1017/S0140525X00015491; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; PLANT GT, 1993, BRAIN, V116, P1303, DOI 10.1093/brain/116.6.1303; Rubehn B, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/3/036003; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Sasaki Y, 2002, NEURON, V35, P1147, DOI 10.1016/S0896-6273(02)00899-1; Schenk T, 1997, NEUROPSYCHOLOGIA, V35, P1289, DOI 10.1016/S0028-3932(97)00004-3; Selimbeyoglu A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00046; Sestieri C, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.001.2007; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; TANAKA K, 1989, J NEUROPHYSIOL, V62, P642, DOI 10.1152/jn.1989.62.3.642; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034; Vaina LM, 2001, BRAIN, V124, P310, DOI 10.1093/brain/124.2.310; VAINA LM, 1989, BIOL CYBERN, V61, P347, DOI 10.1007/BF00200800; Walsh V, 1998, P ROY SOC B-BIOL SCI, V265, P537, DOI 10.1098/rspb.1998.0328; Wibral M, 2009, CEREB CORTEX, V19, P1567, DOI 10.1093/cercor/bhn192; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI S, 1991, BRAIN, V114, P811, DOI 10.1093/brain/114.2.811; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313	61	18	18	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21798	10.1371/journal.pone.0021798	http://dx.doi.org/10.1371/journal.pone.0021798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765915	Green Published, gold, Green Submitted			2022-12-25	WOS:000292781500016
J	van Wijk, M; de Bruijn, PJA; Sabelis, MW				van Wijk, Michiel; de Bruijn, Paulien J. A.; Sabelis, Maurice W.			Complex Odor from Plants under Attack: Herbivore's Enemies React to the Whole, Not Its Parts	PLOS ONE			English	Article							PHYTOSEIULUS-PERSIMILIS ACARI; PREDATORY MITES LEARN; LIMA-BEAN LEAVES; TETRANYCHUS-URTICAE; METHYL SALICYLATE; HOST-PLANT; VOLATILES; PREY; ATTRACTION; IDENTIFICATION	Background: Insect herbivory induces plant odors that attract herbivores' natural enemies. Assuming this attraction emerges from individual compounds, genetic control over odor emission of crops may provide a rationale for manipulating the distribution of predators used for pest control. However, studies on odor perception in vertebrates and invertebrates suggest that olfactory information processing of mixtures results in odor percepts that are a synthetic whole and not a set of components that could function as recognizable individual attractants. Here, we ask if predators respond to herbivore-induced attractants in odor mixtures or to odor mixture as a whole. Methodology/Principal Findings: We studied a system consisting of Lima bean, the herbivorous mite Tetranychus urticae and the predatory mite Phytoseiulus persimilis. We found that four herbivore-induced bean volatiles are not attractive in pure form while a fifth, methyl salicylate (MeSA), is. Several reduced mixtures deficient in one component compared to the full spider-mite induced blend were not attractive despite the presence of MeSA indicating that the predators cannot detect this component in these odor mixtures. A mixture of all five HIPV is most attractive, when offered together with the non-induced odor of Lima bean. Odors that elicit no response in their pure form were essential components of the attractive mixture. Conclusions/Significance: We conclude that the predatory mites perceive odors as a synthetic whole and that the hypothesis that predatory mites recognize attractive HIPV in odor mixtures is unsupported.	[van Wijk, Michiel; de Bruijn, Paulien J. A.; Sabelis, Maurice W.] Univ Amsterdam, IBED, Sect Populat Biol, Amsterdam, Netherlands	University of Amsterdam	van Wijk, M (corresponding author), Univ Amsterdam, IBED, Sect Populat Biol, Amsterdam, Netherlands.	M.vanwijk@.uva.nl			department of Population Biology of The University of Amsterdam	department of Population Biology of The University of Amsterdam	This research was funded by the department of Population Biology of The University of Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura G, 2001, BIOCHEM SYST ECOL, V29, P1049, DOI 10.1016/S0305-1978(01)00049-7; Bolland H.R., 1998, WORLD CATALOGUE SPID; de Boer JG, 2008, J CHEM ECOL, V34, P281, DOI 10.1007/s10886-007-9405-z; De Boer JG, 2005, ANIM BEHAV, V69, P869, DOI 10.1016/j.anbehav.2004.07.010; De Boer JG, 2004, J CHEM ECOL, V30, P2215, DOI 10.1023/B:JOEC.0000048784.79031.5e; De Boer JG, 2004, J CHEM ECOL, V30, P255, DOI 10.1023/B:JOEC.0000017976.60630.8c; de Boer JG, 2004, ENTOMOL EXP APPL, V110, P181, DOI 10.1111/j.0013-8703.2004.00133.x; DICKE M, 1994, J PLANT PHYSIOL, V143, P465, DOI 10.1016/S0176-1617(11)81808-0; DICKE M, 1990, J CHEM ECOL, V16, P381, DOI 10.1007/BF01021772; Drukker B, 2000, EXP APPL ACAROL, V24, P881, DOI 10.1023/A:1010645720829; El-Sayed AM, DATABASE INSECT PHER; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; Horiuchi J, 2003, APPL ENTOMOL ZOOL, V38, P109, DOI 10.1303/aez.2003.109; Kappers IF, 2005, SCIENCE, V309, P2070, DOI 10.1126/science.1116232; Krips OE, 1999, J CHEM ECOL, V25, P2623, DOI 10.1023/A:1020887104771; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Mithofer A, 2005, PLANT PHYSIOL, V137, P1160, DOI 10.1104/pp.104.054460; Niessing J, 2010, NATURE, V465, P47, DOI 10.1038/nature08961; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; SABELIS MW, 1983, ENTOMOL EXP APPL, V33, P303, DOI 10.1111/j.1570-7458.1983.tb03273.x; Sabelis MW., 1984, ACAROLOGY 6; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Shiojiri K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012161; Sokal RR, 1995, BIOMETRY; Van Den Boom CEM, 2004, J CHEM ECOL, V30, P69, DOI 10.1023/B:JOEC.0000013183.72915.99; van den Boom CEM, 2002, B ENTOMOL RES, V92, P539, DOI 10.1079/BER2002193; van Wijk M, 2008, J CHEM ECOL, V34, P791, DOI 10.1007/s10886-008-9492-5; van Wijk M, 2006, EXP APPL ACAROL, V40, P205, DOI 10.1007/s10493-006-9039-9; van Wijk M, 2006, EXP APPL ACAROL, V40, P217, DOI 10.1007/s10493-006-9038-x; van Wijk M, 2010, J CHEM ECOL, V36, P1211, DOI 10.1007/s10886-010-9858-3; Webster B, 2010, ANIM BEHAV, V79, P451, DOI 10.1016/j.anbehav.2009.11.028; Zar J. H., 1996, BIOSTATISTICAL ANAL	33	49	49	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21742	10.1371/journal.pone.0021742	http://dx.doi.org/10.1371/journal.pone.0021742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765908	Green Submitted, Green Published, gold			2022-12-25	WOS:000292781500011
J	Skyberg, JA; Thornburg, T; Rollins, M; Huarte, E; Jutila, MA; Pascual, DW				Skyberg, Jerod A.; Thornburg, Theresa; Rollins, MaryClare; Huarte, Eduardo; Jutila, Mark A.; Pascual, David W.			Murine and Bovine gamma delta T Cells Enhance Innate Immunity against Brucella abortus Infections	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ESCHERICHIA-COLI INFECTION; CLASS I-DEFICIENT; LISTERIA-MONOCYTOGENES; MYCOBACTERIUM-BOVIS; IL-17 PRODUCTION; BALB/C MICE; GM-CSF; MACROPHAGES; VACCINATION	gamma delta T cells have been postulated to act as a first line of defense against infectious agents, particularly intracellular pathogens, representing an important link between the innate and adaptive immune responses. Human gamma delta T cells expand in the blood of brucellosis patients and are active against Brucella in vitro. However, the role of gamma delta T cells in vivo during experimental brucellosis has not been studied. Here we report TCR delta(-/-) mice are more susceptible to B. abortus infection than C57BL/6 mice at one week post-infection as measured by splenic colonization and splenomegaly. An increase in TCR gamma delta cells was observed in the spleens of B. abortus-infected C57BL/6 mice, which peaked at two weeks post-infection and occurred concomitantly with diminished brucellae. gamma delta T cells were the major source of IL-17 following infection and also produced IFN-gamma. Depletion of gamma delta T cells from C57BL/6, IL-17R alpha(-/-), and GMCSF(-/-) mice enhanced susceptibility to B. abortus infection although this susceptibility was unaltered in the mutant mice; however, when gamma delta T cells were depleted from IFN-gamma(-/-) mice, enhanced susceptibility was observed. Neutralization of gamma delta T cells in the absence of TNF-alpha did not further impair immunity. In the absence of TNF-alpha or gamma delta T cells, B. abortus-infected mice showed enhanced IFN-gamma, suggesting that they augmented production to compensate for the loss of gamma delta T cells and/or TNF-alpha. While the protective role of gamma delta T cells was TNF-alpha-dependent, gamma delta T cells were not the major source of TNF-alpha and activation of gamma delta T cells following B. abortus infection was TNF-alpha-independent. Additionally, bovine TCR gamma delta cells were found to respond rapidly to B. abortus infection upon co-culture with autologous macrophages and could impair the intramacrophage replication of B. abortus via IFN-gamma. Collectively, these results demonstrate gamma delta T cells are important for early protection to B. abortus infections.	[Skyberg, Jerod A.; Thornburg, Theresa; Rollins, MaryClare; Huarte, Eduardo; Jutila, Mark A.; Pascual, David W.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Skyberg, JA (corresponding author), Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA.	dpascual@montana.edu	Pascual, David/AAC-2248-2022	Huarte, Eduardo/0000-0001-7498-7547	USDA [2007-01612, 2009-34397-20133]; Montana Agricultural Station; U.S. Department of Agriculture; National Institutes of Health [P20 RR020185, HHSN266200400009N01-AI, P01 AT004986]; M.J. Murdock Charitable Trust; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004986] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER	USDA(United States Department of Agriculture (USDA)); Montana Agricultural Station; U.S. Department of Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M.J. Murdock Charitable Trust; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work is supported by grants from USDA 2007-01612, USDA 2009-34397-20133, Montana Agricultural Station, U.S. Department of Agriculture Formula Funds, National Institutes of Health Grant P20 RR020185, NIH contract HHSN266200400009N01-AI, P01 AT004986, and an equipment grant from the M.J. Murdock Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin CL, 2002, VET MICROBIOL, V90, P365, DOI 10.1016/S0378-1135(02)00221-3; Belles C, 1996, J IMMUNOL, V156, P4280; BERTOTTO A, 1993, EUR J IMMUNOL, V23, P1177, DOI 10.1002/eji.1830230531; CAMPBELL GA, 1992, VET IMMUNOL IMMUNOP, V34, P291, DOI 10.1016/0165-2427(92)90171-L; Cardoso PCG, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-13; COLMENERO JD, 1991, ANN RHEUM DIS, V50, P23, DOI 10.1136/ard.50.1.23; Denis M, 2005, IMMUNOL CELL BIOL, V83, P643, DOI 10.1111/j.1440-1711.2005.01386.x; Dudal S, 2006, J IMMUNOL, V177, P5533, DOI 10.4049/jimmunol.177.8.5533; Edmonds M, 2000, VET MICROBIOL, V76, P81, DOI 10.1016/S0378-1135(00)00225-X; FERNANDES DM, 1995, INFECT IMMUN, V63, P4029, DOI 10.1128/IAI.63.10.4029-4033.1995; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Hedges JF, 2003, J IMMUNOL, V171, P4959, DOI 10.4049/jimmunol.171.10.4959; HEIN WR, 1991, IMMUNOL TODAY, V12, P30, DOI 10.1016/0167-5699(91)90109-7; HIROMATSU K, 1992, J EXP MED, V175, P49, DOI 10.1084/jem.175.1.49; Holderness J, 2007, J IMMUNOL, V179, P6468, DOI 10.4049/jimmunol.179.10.6468; Holtmeier Wolfgang, 2005, V86, P151, DOI 10.1159/000086659; JIANG XS, 1993, INFECT IMMUN, V61, P124, DOI 10.1128/IAI.61.1.124-134.1993; Jutila Mark A., 2008, Animal Health Research Reviews, V9, P47, DOI 10.1017/S1466252307001363; King DP, 1999, J IMMUNOL, V162, P5033; Ko JY, 2003, CLIN MICROBIOL REV, V16, P65, DOI 10.1128/CMR.16.1.65-78.2003; Koenecke C, 2009, EUR J IMMUNOL, V39, P372, DOI 10.1002/eji.200838741; LADEL CH, 1995, EUR J IMMUNOL, V25, P377, DOI 10.1002/eji.1830250211; Lahn M, 1998, J IMMUNOL, V160, P5221; Leite F, 2005, VET IMMUNOL IMMUNOP, V103, P187, DOI 10.1016/j.vetimm.2004.08.015; LeVine AM, 1999, J CLIN INVEST, V103, P563, DOI 10.1172/JCI5212; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Moore TA, 2000, J IMMUNOL, V165, P2643, DOI 10.4049/jimmunol.165.5.2643; Morris CA, 2007, VET J, V174, P481, DOI 10.1016/j.tvjl.2006.09.006; MULLER D, 1995, INFECT IMMUN, V63, P2361, DOI 10.1128/IAI.63.6.2361-2366.1995; Murphy EA, 2001, FEMS IMMUNOL MED MIC, V32, P85, DOI 10.1111/j.1574-695X.2001.tb00536.x; Murphy EA, 2001, IMMUNOLOGY, V103, P511, DOI 10.1046/j.1365-2567.2001.01258.x; Naessens J, 1997, IMMUNOL TODAY, V18, P365, DOI 10.1016/S0167-5699(97)81055-9; NISHIMURA H, 1995, EUR J IMMUNOL, V25, P1465, DOI 10.1002/eji.1830250551; Ochoa-Reparaz J, 2007, INFECT IMMUN, V75, P5845, DOI 10.1128/IAI.00901-07; Ochoa-Reparaz J, 2007, J IMMUNOL, V178, P1791, DOI 10.4049/jimmunol.178.3.1791; Oliaro J, 2005, J LEUKOCYTE BIOL, V77, P652, DOI 10.1189/jlb.0704433; Ottones F, 2000, J IMMUNOL, V165, P7133, DOI 10.4049/jimmunol.165.12.7133; Palmer MV, 1998, AM J VET RES, V59, P153; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pascual DW, 2002, INFECT IMMUN, V70, P4273, DOI 10.1128/IAI.70.8.4273-4281.2002; Pascual DW, 2001, J IMMUNOL, V167, P407, DOI 10.4049/jimmunol.167.1.407; RANGES GE, 1987, J EXP MED, V166, P991, DOI 10.1084/jem.166.4.991; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Smith RA, 1999, J LEUKOCYTE BIOL, V65, P28, DOI 10.1002/jlb.65.1.28; Takano M, 1998, INFECT IMMUN, V66, P3270, DOI 10.1128/IAI.66.7.3270-3278.1998; Tramonti D, 2006, EUR J IMMUNOL, V36, P1729, DOI 10.1002/eji.200635959; Wilson E, 1998, IMMUNOL LETT, V64, P39, DOI 10.1016/S0165-2478(98)00077-7; Yang XH, 2005, INFECT IMMUN, V73, P7297, DOI 10.1128/IAI.73.11.7297-7303.2005; Yang XH, 2007, VACCINE, V25, P2261, DOI 10.1016/j.vaccine.2006.12.004; Yang XH, 2006, INFECT IMMUN, V74, P3874, DOI 10.1128/IAI.01957-05; Zhan YF, 1998, BLOOD, V91, P863, DOI 10.1182/blood.V91.3.863.863_863_869	53	48	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21978	10.1371/journal.pone.0021978	http://dx.doi.org/10.1371/journal.pone.0021978			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765931	Green Submitted, Green Published, gold			2022-12-25	WOS:000292699000019
J	Cheng, PY; Lin, YP; Chen, YL; Lee, YC; Tai, CC; Wang, YT; Chen, YJ; Kao, CF; Yu, J				Cheng, Pei-Yi; Lin, Yu-Ping; Chen, Ya-Ling; Lee, Yi-Ching; Tai, Chia-Chen; Wang, Yi-Ting; Chen, Yu-Ju; Kao, Cheng-Fu; Yu, John			Interplay between SIN3A and STAT3 Mediates Chromatin Conformational Changes and GFAP Expression during Cellular Differentiation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ASTROCYTE DIFFERENTIATION; HISTONE DEACETYLASE; DNA METHYLATION; CARCINOMA-CELLS; GENE-EXPRESSION; ACTIVE GENES; HUMAN GENOME; OLIGODENDROCYTE DIFFERENTIATION; TRANSCRIPTIONAL REPRESSION	Background: Neurons and astrocytes are generated from common neural precursors, yet neurogenesis precedes astrocyte formation during embryogenesis. The mechanisms of neural development underlying suppression and de-suppression of differentiation-related genes for cell fate specifications are not well understood. Methodology/Principal Findings: By using an in vitro system in which NTera-2 cells were induced to differentiate into an astrocyte-like lineage, we revealed a novel role for Sin3A in maintaining the suppression of GFAP in NTera-2 cells. Sin3A coupled with MeCP2 bound to the GFAP promoter and their occupancies were correlated with repression of GFAP transcription. The repression by Sin3A and MeCP2 may be an essential mechanism underlying the inhibition of cell differentiation. Upon commitment toward an astrocyte-like lineage, Sin3A-MeCP2 departed from the promoter and activated STAT3 simultaneously bound to the promoter and exon 1 of GFAP; meanwhile, olig2 was exported from nuclei to the cytoplasm. This suggested that a three-dimensional or higher-order structure was provoked by STAT3 binding between the promoter and proximal coding regions. STAT3 then recruited CBP/p300 to exon 1 and targeted the promoter for histone H3K9 and H3K14 acetylation. The CBP/p300-mediated histone modification further facilitates chromatin remodeling, thereby enhancing H3K4 trimethylation and recruitment of RNA polymerase II to activate GFAP gene transcription. Conclusions/Significance: These results provide evidence that exchange of repressor and activator complexes and epigenetic modifications are critical strategies for cellular differentiation and lineage-specific gene expression.	[Cheng, Pei-Yi] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Cheng, Pei-Yi; Lin, Yu-Ping; Yu, John] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chen, Ya-Ling; Kao, Cheng-Fu; Yu, John] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Lee, Yi-Ching; Tai, Chia-Chen] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Wang, Yi-Ting; Chen, Yu-Ju] Acad Sinica, Inst Chem, Taipei, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Cheng, PY (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	ckao@gate.sinica.edu.tw; johnyu@gate.sinica.edu.tw	Lee, Yi-Ching/AAE-6900-2022; YU, JOHN/G-8954-2012; Kao, Cheng-Fu/AAE-8400-2022; yu, john/AAA-9255-2021; Chen, Yu-Ju/E-9481-2015	Lee, Yi-Ching/0000-0002-7734-5619; Kao, Cheng-Fu/0000-0002-8875-8152; Chen, Yu-Ju/0000-0002-3178-6697; Yu, John/0000-0002-3237-4272	National Science Council, Taiwan [NSC98-3111-B-001-003]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by NSC98-3111-B-001-003 grants from the National Science Council, Taiwan to JY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Baldassarre G, 1996, INT J CANCER, V66, P538, DOI 10.1002/(SICI)1097-0215(19960516)66:4<538::AID-IJC19>3.0.CO;2-3; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Barres BA, 2001, SCIENCE, V294, P1296, DOI 10.1126/science.1066724; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bossolasco P, 2005, EXP NEUROL, V193, P312, DOI 10.1016/j.expneurol.2004.12.013; Brinkman AB, 2007, NUCLEIC ACIDS RES, V35, P801, DOI 10.1093/nar/gkl1014; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Ferrari A, 2000, FEBS LETT, V486, P121, DOI 10.1016/S0014-5793(00)02251-1; Gavrilov A, 2009, METHODS MOL BIOL, V567, P171, DOI 10.1007/978-1-60327-414-2_12; Ge WH, 2002, J NEUROSCI RES, V69, P848, DOI 10.1002/jnr.10364; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Han CL, 2008, MOL CELL PROTEOMICS, V7, P1983, DOI 10.1074/mcp.M800068-MCP200; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; JESSEN KR, 2001, GLIAL CELL DEV BASIC; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Lee HS, 2010, J CELL SCI, V123, P1959, DOI 10.1242/jcs.063784; Leypoldt F, 2001, J NEUROCHEM, V76, P806, DOI 10.1046/j.1471-4159.2001.00079.x; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin FR, 2007, CANCER RES, V67, P11914, DOI 10.1158/0008-5472.CAN-07-1868; Ling TY, 2006, P NATL ACAD SCI USA, V103, P9530, DOI 10.1073/pnas.0510232103; Marchal-Victorion S, 2003, MOL CELL NEUROSCI, V24, P198, DOI 10.1016/S1044-7431(03)00161-1; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; McDonel P, 2009, INT J BIOCHEM CELL B, V41, P108, DOI 10.1016/j.biocel.2008.07.022; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Molne M, 2000, J NEUROSCI RES, V59, P301, DOI 10.1002/(SICI)1097-4547(20000201)59:3<301::AID-JNR3>3.0.CO;2-H; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nakashima K, 1999, FEBS LETT, V457, P43, DOI 10.1016/S0014-5793(99)00997-7; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nishiyama A, 2005, J ANAT, V207, P687, DOI 10.1111/j.1469-7580.2005.00489.x; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; Ray S, 2002, MOL ENDOCRINOL, V16, P824, DOI 10.1210/me.16.4.824; Sandhu JK, 2002, J NEUROSCI RES, V68, P604, DOI 10.1002/jnr.10236; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Satoh J, 2000, J NEUROSCI METH, V94, P155, DOI 10.1016/S0165-0270(99)00143-0; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tsai CF, 2008, J PROTEOME RES, V7, P4058, DOI 10.1021/pr800364d; Tsou CC, 2010, MOL CELL PROTEOMICS, V9, P131, DOI 10.1074/mcp.M900177-MCP200; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Viti J, 2003, J NEUROSCI, V23, P3385; Vu TH, 2004, HUM MOL GENET, V13, P2233, DOI 10.1093/hmg/ddh244; Wang YT, 2010, J PROTEOME RES, V9, P5582, DOI 10.1021/pr100394u; Wolswijk G, 2000, BRAIN, V123, P105, DOI 10.1093/brain/123.1.105; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	86	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e22018	10.1371/journal.pone.0022018	http://dx.doi.org/10.1371/journal.pone.0022018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779366	Green Published, gold			2022-12-25	WOS:000292680900022
J	Le Saux, G; Magenau, A; Boecking, T; Gaus, K; Gooding, JJ				Le Saux, Guillaume; Magenau, Astrid; Boecking, Till; Gaus, Katharina; Gooding, J. Justin			The Relative Importance of Topography and RGD Ligand Density for Endothelial Cell Adhesion	PLOS ONE			English	Article							MICROPATTERNED SURFACES; INTEGRIN LIGANDS; BEHAVIOR; SILICON; DIFFERENTIATION; PROLIFERATION; CYTOSKELETON; ATTACHMENT; MORPHOGENESIS; FIBRONECTIN	The morphology and function of endothelial cells depends on the physical and chemical characteristics of the extracellular environment. Here, we designed silicon surfaces on which topographical features and surface densities of the integrin binding peptide arginine-glycine-aspartic acid (RGD) could be independently controlled. We used these surfaces to investigate the relative importance of the surface chemistry of ligand presentation versus surface topography in endothelial cell adhesion. We compared cell adhesion, spreading and migration on surfaces with nano-to micro-scaled pyramids and average densities of 6x10(2)-6x10(11) RGD/mm(2). We found that fewer cells adhered onto rough than flat surfaces and that the optimal average RGD density for cell adhesion was 6x10(5) RGD/mm(2) on flat surfaces and substrata with nano-scaled roughness. Only on surfaces with micro-scaled pyramids did the topography hinder cell migration and a lower average RGD density was optimal for adhesion. In contrast, cell spreading was greatest on surfaces with 6x10(8) RGD/mm(2) irrespectively of presence of feature and their size. In summary, our data suggest that the size of pyramids predominately control the number of endothelial cells that adhere to the substratum but the average RGD density governs the degree of cell spreading and length of focal adhesion within adherent cells. The data points towards a two-step model of cell adhesion: the initial contact of cells with a substratum may be guided by the topography while the engagement of cell surface receptors is predominately controlled by the surface chemistry.	[Le Saux, Guillaume; Gooding, J. Justin] Univ New S Wales, Sch Chem, Sydney, NSW, Australia; [Le Saux, Guillaume; Magenau, Astrid; Boecking, Till; Gaus, Katharina] Univ New S Wales, Sch Med Sci, Ctr Vasc Res, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Le Saux, G (corresponding author), Univ New S Wales, Sch Chem, Sydney, NSW, Australia.	k.gaus@unsw.edu.au; justin.gooding@unsw.edu.au	Böcking, Till/A-5829-2010; Le Saux, Guillaume/B-4765-2012	Böcking, Till/0000-0003-1165-3122; Gaus, Katharina/0000-0002-8009-9658; Gooding, John Justin/0000-0002-5398-0597	Australian Research Council; National Health and Medical Research Council of Australia; Human Frontier Science Program	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Human Frontier Science Program(Human Frontier Science Program)	The authors acknowledge funding from the Australian Research Council (KG, JJG), National Health and Medical Research Council of Australia (KG, JJG) and the Human Frontier Science Program (TB, KG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Arnold M, 2008, NANO LETT, V8, P2063, DOI 10.1021/nl801483w; Arnold M, 2009, SOFT MATTER, V5, P72, DOI 10.1039/b815634d; Barbucci R, 2002, BIOMOL ENG, V19, P161, DOI 10.1016/S1389-0344(02)00022-9; Biela SA, 2009, ACTA BIOMATER, V5, P2460, DOI 10.1016/j.actbio.2009.04.003; Bigerelle M, 2005, J BIOMED MATER RES A, V72A, P36, DOI 10.1002/jbm.a.30212; Bozec L, 2006, J MATER SCI-MATER M, V17, P1043, DOI 10.1007/s10856-006-0442-x; Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011; Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730; CHEHROUDI B, 1988, J BIOMED MATER RES, V22, P459, DOI 10.1002/jbm.820220603; CLARK P, 1990, DEVELOPMENT, V108, P635; CLARK P, 1991, J CELL SCI, V99, P73; CLARK P, 1987, DEVELOPMENT, V99, P439; CLARK RAF, 1986, J CELL SCI, V82, P263; Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0; Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415; CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343; Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276; Curtis ASG, 2001, BIOPHYS CHEM, V94, P275, DOI 10.1016/S0301-4622(01)00247-2; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5; den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8; Fan YW, 2002, APPL SURF SCI, V187, P313, DOI 10.1016/S0169-4332(01)01046-7; Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gosalvez MA, 2003, NEW J PHYS, V5; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Houseman BT, 2001, BIOMATERIALS, V22, P943, DOI 10.1016/S0142-9612(00)00259-3; Kaiser JP, 2006, BIOMATERIALS, V27, P5230, DOI 10.1016/j.biomaterials.2006.06.002; Kilian KA, 2007, ADV FUNCT MATER, V17, P2884, DOI 10.1002/adfm.200600790; Kilian KA, 2007, BIOMATERIALS, V28, P3055, DOI 10.1016/j.biomaterials.2007.03.014; Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154; Maheshwari G, 2000, J CELL SCI, V113, P1677; MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314; MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089; Meredith DO, 2007, J ORTHOP RES, V25, P1523, DOI 10.1002/jor.20430; Nelson CM, 2003, LANGMUIR, V19, P1493, DOI 10.1021/la026178b; Pierres A, 2008, BIOPHYS J, V94, P4114, DOI 10.1529/biophysj.107.125278; Pompe T, 2005, BIOPHYS J, V88, P527, DOI 10.1529/biophysj.104.049074; RICH A, 1981, J CELL SCI, V50, P1; Roberts C, 1998, J AM CHEM SOC, V120, P6548, DOI 10.1021/ja972467o; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Secchi AG, 2007, J BIOMED MATER RES A, V83A, P577, DOI 10.1002/jbm.a.31007; Sieval AB, 1998, LANGMUIR, V14, P1759, DOI 10.1021/la971139z; Spatz JP, 2007, METHOD CELL BIOL, V83, P89, DOI 10.1016/S0091-679X(07)83005-6; Stupack D.G., 2002, SCI STKE, P7; Stupack DG, 2004, CURR TOP DEV BIOL, V64, P207, DOI 10.1016/S0070-2153(04)64009-9; Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383; Tilakaratne HK, 2007, BIOMATERIALS, V28, P89, DOI 10.1016/j.biomaterials.2006.08.011; *VA SEM INC, 2003, WET CHEM ETCH CLEAN; Vainionpaa N, 2006, AM J PHYSIOL-CELL PH, V290, pC764, DOI 10.1152/ajpcell.00285.2005; Wilkinson CDW, 1998, J VAC SCI TECHNOL B, V16, P3132, DOI 10.1116/1.590451	53	83	84	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21869	10.1371/journal.pone.0021869	http://dx.doi.org/10.1371/journal.pone.0021869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779342	Green Submitted, Green Published, gold			2022-12-25	WOS:000292680900011
J	Marzal, A; Ricklefs, RE; Valkiunas, G; Albayrak, T; Arriero, E; Bonneaud, C; Czirjak, GA; Ewen, J; Hellgren, O; Horakova, D; Iezhova, TA; Jensen, H; Krizanauskiene, A; Lima, MR; de Lope, F; Magnussen, E; Martin, LB; Moller, AP; Palinauskas, V; Pap, PL; Perez-Tris, J; Sehgal, RNM; Soler, M; Eszter, S; Westerdahl, H; Zetindjiev, P; Bensch, S				Marzal, Alfonso; Ricklefs, Robert E.; Valkiunas, Gediminas; Albayrak, Tamer; Arriero, Elena; Bonneaud, Camille; Czirjak, Gabor A.; Ewen, John; Hellgren, Olof; Horakova, Dita; Iezhova, Tatjana A.; Jensen, Henrik; Krizanauskiene, Asta; Lima, Marcos R.; de Lope, Florentino; Magnussen, Eyofinn; Martin, Lynn B.; Moller, Anders P.; Palinauskas, Vaidas; Pap, Peter L.; Perez-Tris, Javier; Sehgal, Ravinder N. M.; Soler, Manuel; Eszter Szollosi; Westerdahl, Helena; Zetindjiev, Pavel; Bensch, Staffan			Diversity, Loss, and Gain of Malaria Parasites in a Globally Invasive Bird	PLOS ONE			English	Article							SPARROW PASSER-DOMESTICUS; BLOOD PARASITES; AVIAN MALARIA; HAEMOSPORIDIAN PARASITES; LATITUDINAL GRADIENTS; PLASMODIUM; PREVALENCE; EVOLUTION; LINEAGES; INFECTIONS	Invasive species can displace natives, and thus identifying the traits that make aliens successful is crucial for predicting and preventing biodiversity loss. Pathogens may play an important role in the invasive process, facilitating colonization of their hosts in new continents and islands. According to the Novel Weapon Hypothesis, colonizers may out-compete local native species by bringing with them novel pathogens to which native species are not adapted. In contrast, the Enemy Release Hypothesis suggests that flourishing colonizers are successful because they have left their pathogens behind. To assess the role of avian malaria and related haemosporidian parasites in the global spread of a common invasive bird, we examined the prevalence and genetic diversity of haemosporidian parasites (order Haemosporida, genera Plasmodium and Haemoproteus) infecting house sparrows (Passer domesticus). We sampled house sparrows (N = 1820) from 58 locations on 6 continents. All the samples were tested using PCR-based methods; blood films from the PCR-positive birds were examined microscopically to identify parasite species. The results show that haemosporidian parasites in the house sparrows' native range are replaced by species from local host-generalist parasite fauna in the alien environments of North and South America. Furthermore, sparrows in colonized regions displayed a lower diversity and prevalence of parasite infections. Because the house sparrow lost its native parasites when colonizing the American continents, the release from these natural enemies may have facilitated its invasion in the last two centuries. Our findings therefore reject the Novel Weapon Hypothesis and are concordant with the Enemy Release Hypothesis.	[Marzal, Alfonso; Hellgren, Olof; Westerdahl, Helena; Bensch, Staffan] Lund Univ, Dept Biol, Lund, Sweden; [Marzal, Alfonso; de Lope, Florentino] Univ Extremadura, Dept Anat Cellular Biol & Zool, Badajoz, Spain; [Ricklefs, Robert E.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Valkiunas, Gediminas; Iezhova, Tatjana A.; Krizanauskiene, Asta; Palinauskas, Vaidas] Nat Res Ctr, Vilnius, Lithuania; [Albayrak, Tamer] Mehmet Akif Ersoy Univ, Biyol Bolumu, Fen Edebiyat Fak, Burdur, Turkey; [Arriero, Elena] UPMC Univ Paris 06, CNRS, Lab Parasitol Evolut, UMR7103, Paris, France; [Bonneaud, Camille] CNRS, Stn Ecol Expt, USR 2973, Moulis, France; [Czirjak, Gabor A.] Univ Agr Sci & Vet Med, Dept Infect Dis, Cluj Napoca, Romania; [Ewen, John] Zool Soc London, Inst Zool, London NW1 4RY, England; [Horakova, Dita] Charles Univ Prague, Dept Zool, Fac Sci, Prague, Czech Republic; [Jensen, Henrik] Norwegian Univ Sci & Technol, Dept Biol, Ctr Conservat Biol, N-7034 Trondheim, Norway; [Lima, Marcos R.] Univ Brasilia, Dept Ecol IB Posgrad Ecol, Brasilia, DF, Brazil; [Magnussen, Eyofinn] Univ Faroes, Fac Sci & Technol, Torshavn, Faroe Islands, Denmark; [Martin, Lynn B.] Univ S Florida, Dept Integrat Biol, Tampa, FL USA; [Moller, Anders P.] Univ Paris Sud, CNRS, Lab Ecol Systemat & Evolut, UMR 8079, Orsay, France; [Pap, Peter L.] Univ Babes Bolyai, Dept Taxon & Ecol, R-3400 Cluj Napoca, Romania; [Perez-Tris, Javier] Univ Complutense, Dept Zool & Phys Anthropol, E-28040 Madrid, Spain; [Sehgal, Ravinder N. M.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Soler, Manuel] Univ Granada, Dept Anim Biol, Granada, Spain; [Eszter Szollosi] Eotvos Lorand Univ, Dept Systemat Zool & Ecol, Budapest, Hungary; [Zetindjiev, Pavel] Bulgarian Acad Sci, Cent Lab Gen Ecol, Sofia, Bulgaria; [Lima, Marcos R.] Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Exeter, Cornwall, England; [Moller, Anders P.] Ctr Adv Study, Oslo, Norway	Lund University; Universidad de Extremadura; University of Missouri System; University of Missouri Saint Louis; Nature Research Center - Lithuania; Mehmet Akif Ersoy University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; Zoological Society of London; Charles University Prague; Norwegian University of Science & Technology (NTNU); Universidade de Brasilia; State University System of Florida; University of South Florida; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Babes Bolyai University from Cluj; Complutense University of Madrid; California State University System; San Francisco State University; University of Granada; Eotvos Lorand University; Bulgarian Academy of Sciences; University of Exeter	Marzal, A (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Staffan.Bensch@zooekol.lu.se	Martin, Lynn/C-2037-2009; Palinauskas, Vaidas/J-1576-2016; SEHGAL, Ravinder/F-9216-2010; Albayrak, Tamer/R-9608-2016; Szöllősi, Eszter/H-3673-2017; Pérez-Tris, Javier/D-4087-2012; Czirják, Gábor Árpád/F-5440-2011; Zehtidiev, Pavel/K-3236-2012; Arriero, Elena/J-8224-2016; Marzal, Alfonso/J-6677-2012; Lima, Marcos Robalinho/R-8966-2019; Perez, Tristan/G-4874-2010; Križanauskienė, Asta/CAF-5095-2022; Moller, Anders/O-6665-2016; Lima, Marcos/A-4931-2013; Jensen, Henrik/B-5085-2011; Hellgren, Olof/C-7420-2014	Martin, Lynn/0000-0002-5887-4937; Palinauskas, Vaidas/0000-0002-4714-0305; Albayrak, Tamer/0000-0003-4115-3946; Szöllősi, Eszter/0000-0003-2913-2894; Pérez-Tris, Javier/0000-0001-5535-3100; Czirják, Gábor Árpád/0000-0001-9488-0069; Zehtidiev, Pavel/0000-0002-9786-3974; Arriero, Elena/0000-0003-4230-6537; Marzal, Alfonso/0000-0001-5872-1060; Lima, Marcos Robalinho/0000-0002-5901-0911; Perez, Tristan/0000-0003-1486-2202; Moller, Anders/0000-0003-3739-4675; Lima, Marcos/0000-0002-5901-0911; Jensen, Henrik/0000-0001-7804-1564; Hellgren, Olof/0000-0002-4062-7276; SEHGAL, Ravinder/0000-0002-5255-4641	Swedish Research Council; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Spanish Ministry of Education and Science [EX-2006-0557, JC2008-00242]; Junta of Extremadura [PRI08A116]; Spanish Ministry of Science and Innovation [CGL2009-08976]; National Science Foundation [DEB-0089226, DEB-0542390]; Norwegian Research Council; British Ecological Society; Romanian Ministry of Education and Science [CEEX ET94]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Spanish Ministry of Education and Science(Spanish Government); Junta of Extremadura; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Science Foundation(National Science Foundation (NSF)); Norwegian Research Council(Research Council of NorwayEuropean Commission); British Ecological Society; Romanian Ministry of Education and Science(Ministry of Education and Research - Romania)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding was provided from the Swedish Research Council (to SB), the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (to SB), Spanish Ministry of Education and Science EX-2006-0557 and JC2008-00242 (to AM) and Junta of Extremadura PRI08A116 and Spanish Ministry of Science and Innovation CGL2009-08976 (to AM and FdL), National Science Foundation grants DEB-0089226 and DEB-0542390 (to RER), Norwegian Research Council (to HJ), British Ecological Society (to MRL) and Romanian Ministry of Education and Science grant CEEX ET94 (to PLP and GAC).	Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Anderson TR., 2006, BIOL UBIQUITOUS HOUS; Beadell JS, 2006, P ROY SOC B-BIOL SCI, V273, P2935, DOI 10.1098/rspb.2006.3671; Bengtson Sven-Axel, 2004, Frodskaparrit, V51, P237; Bensch S, 2000, P ROY SOC B-BIOL SCI, V267, P1583, DOI 10.1098/rspb.2000.1181; Bensch S, 2004, EVOLUTION, V58, P1617, DOI 10.1111/j.0014-3820.2004.tb01742.x; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Bonneaud C, 2006, EVOLUTION, V60, P383, DOI 10.1111/j.0014-3820.2006.tb01114.x; Brooks DR, 2007, TRENDS PARASITOL, V23, P571, DOI 10.1016/j.pt.2007.08.016; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.2307/3868432; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; Elton C., 1958; Ericson PGP, 1997, J ARCHAEOL SCI, V24, P183, DOI 10.1006/jasc.1996.0102; Garamszegi LZ, 2006, ECOL LETT, V9, P933, DOI 10.1111/j.1461-0248.2006.00936.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hellgren O, 2007, J PARASITOL, V93, P889, DOI 10.1645/GE-1051R1.1; Hellgren O, 2009, ECOLOGY, V90, P2840, DOI 10.1890/08-1059.1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ishtiaq F, 2006, P ROY SOC B-BIOL SCI, V273, P587, DOI 10.1098/rspb.2005.3313; Ishtiaq F, 2007, J WILDLIFE DIS, V43, P382, DOI 10.7589/0090-3558-43.3.382; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kimura M, 2010, J PARASITOL, V96, P144, DOI 10.1645/GE-2060.1; Kimura M, 2006, J PARASITOL, V92, P1043, DOI 10.1645/GE-639R.1; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lee KA, 2006, OECOLOGIA, V150, P383, DOI 10.1007/s00442-006-0537-6; Lima MR, 2010, ACTA PARASITOL, V55, P297, DOI 10.2478/s11686-010-0055-x; Loiseau C, 2008, ECOL LETT, V11, P258, DOI 10.1111/j.1461-0248.2007.01141.x; Loiseau C, 2011, P ROY SOC B-BIOL SCI, V278, P1264, DOI 10.1098/rspb.2010.1968; Martinez-de la Puente J, 2010, BIOL LETTERS, V6, P663, DOI 10.1098/rsbl.2010.0046; MARTINS AMF, 1993, B MUSEU MUNICIPAL S, V2, P181; Marzal A, 2008, J EVOLUTION BIOL, V21, P979, DOI 10.1111/j.1420-9101.2008.01545.x; Merino S, 2008, AUSTRAL ECOL, V33, P329, DOI 10.1111/j.1442-9993.2008.01820.x; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Navarro C, 2004, BEHAV ECOL, V15, P629, DOI 10.1093/beheco/arh054; Nunn CL, 2005, DIVERS DISTRIB, V11, P249, DOI 10.1111/j.1366-9516.2005.00160.x; Nylander J. A. A., 2004, MRMODELTEST V2; Palinauskas V, 2008, EXP PARASITOL, V120, P372, DOI 10.1016/j.exppara.2008.09.001; Poulin R., 2006, EVOLUTIONARY ECOLOGY; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; Ridgely R.S, 1989, GUIDE BIRDS PANAMA C; Sambrook J., 1989, MOL CLONING LAB MANU; Schrey AW, 2011, MOL ECOL, V20, P1133, DOI 10.1111/j.1365-294X.2011.05001.x; Sol D, 2000, ECOGRAPHY, V23, P307, DOI 10.1034/j.1600-0587.2000.d01-1639.x; Summers-Smith J.D., 1988, SPARROWS STUDY GENUS; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Valki<umacron>nas G, 2005, AVIAN MALARIA PARASI; Valkiunas G, 2006, J PARASITOL, V92, P418, DOI 10.1645/GE-3547RN.1; Valkiunas G, 2006, J NAT HIST, V40, P1709, DOI 10.1080/00222930601010127; Valkiunas G, 2008, PARASITOL RES, V102, P1185, DOI 10.1007/s00436-008-0892-9; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN; WILKINSON L, 1992, SYSTAT WINDOWS 10 0	56	141	145	1	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21905	10.1371/journal.pone.0021905	http://dx.doi.org/10.1371/journal.pone.0021905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779353	Green Published, gold			2022-12-25	WOS:000292680900016
J	Zhao, YF; Chen, XP; Yang, H; Zhou, LC; Okoro, EU; Guo, ZM				Zhao, Yanfeng; Chen, Xinping; Yang, Hong; Zhou, Lichun; Okoro, Emmanuel U.; Guo, Zhongmao			A Novel Function of Apolipoprotein E: Upregulation of ATP-Binding Cassette Transporter A1 Expression	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; CHOLESTEROL EFFLUX; X-RECEPTOR; PLASMA-CONCENTRATION; LDL RECEPTOR; GENE; MACROPHAGES; CELLS; ATHEROSCLEROSIS; RECOGNITION	Despite the well known importance of apolipoprotein (Apo) E in cholesterol efflux, the effect of ApoE on the expression of ATP-binding cassette transporter A1 (ABCA1) has never been investigated. The objective of this study was to determine the effect of ApoE on ApoB-carrying lipoprotein-induced expression of ABCA1, a protein that mediates cholesterol efflux. Our data demonstrate that ApoB-carrying lipoproteins obtained from both wild-type and ApoE knockout mice induced ApoAI-mediated cholesterol efflux in mouse macrophages, which was associated with an enhanced ABCA1 promoter activity, and an increased ABCA1 mRNA and protein expression. In addition, these lipoproteins increased the level of phosphorylated specificity protein 1 (Sp1) and the amount of Sp1 bound to the ABCA1 promoter. However, all these inductions were significantly diminished in cells treated with ApoE-free lipoproteins, when compared to those treated with wild-type lipoproteins. Enrichment with human ApoE3 reversed the reduced inducibility of ApoE-free lipoproteins. Moreover, we observed that inhibition of Sp1 DNA-binding by mithramycin A diminished ABCA1 expression and ApoAI-mediated cholesterol efflux induced by ApoB-carrying lipoproteins, and that mutation of the Sp1-binding motif in the ABCA1 promoter region diminished ApoB-carrying lipoprotein-induced ABCA1 promoter activity. Collectively, these data suggest that ApoE associated with ApoB-carrying lipoproteins has an upregulatory role on ABCA1 expression, and that induction of Sp1 phosphorylation is a mechanism by which ApoE upregulates ABCA1 expression.	[Zhao, Yanfeng] Wuhan Univ, Sch Basic Med Sci, Dept Physiol, Wuhan 430072, Peoples R China; [Chen, Xinping; Yang, Hong; Zhou, Lichun; Okoro, Emmanuel U.; Guo, Zhongmao] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA	Wuhan University; Meharry Medical College	Zhao, YF (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Physiol, Wuhan 430072, Peoples R China.	zguo@mmc.edu			National Institutes of Health [R01ES014471, R01HL089382, SC1HL101431, U54RR026140]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089382, SC1HL101431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health grants R01ES014471 and R01HL089382 (Zhongmao Guo), and SC1HL101431 and U54RR026140 (Hong Yang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Blacklow SC, 2007, CURR OPIN STRUC BIOL, V17, P419, DOI 10.1016/j.sbi.2007.08.017; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; CLAVEY V, 1995, ARTERIOSCL THROM VAS, V15, P963, DOI 10.1161/01.ATV.15.7.963; Cohn JS, 1996, ARTERIOSCL THROM VAS, V16, P149, DOI 10.1161/01.ATV.16.1.149; Costet P, 2000, J BIOL CHEM, V275, P28240; Dove DE, 2005, AM J PHYSIOL-CELL PH, V288, pC586, DOI 10.1152/ajpcell.00210.2004; Dove DE, 2005, ARTERIOSCL THROM VAS, V25, P128, DOI 10.1161/01.ATV.0000148323.94021.e5; Geeraert B, 2007, J THROMB HAEMOST, V5, P2529, DOI 10.1111/j.1538-7836.2007.02786.x; Haddy N, 2002, EUR J HUM GENET, V10, P841, DOI 10.1038/sj.ejhg.5200864; Hakamata H, 1998, BIOCHEMISTRY-US, V37, P13720, DOI 10.1021/bi980762v; Heeren J, 2006, ARTERIOSCL THROM VAS, V26, P442, DOI 10.1161/01.ATV.0000201282.64751.47; Heeren J, 2004, J BIOL CHEM, V279, P55483, DOI 10.1074/jbc.M409324200; Heeren J, 2003, J BIOL CHEM, V278, P14370, DOI 10.1074/jbc.M209006200; Huang ZH, 2001, ARTERIOSCL THROM VAS, V21, P2019, DOI 10.1161/hq1201.100242; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Jong MC, 1997, BIOCHEM J, V328, P745; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Reamon-Buettner SM, 2008, CANCER RES, V68, P7587, DOI 10.1158/0008-5472.CAN-08-0967; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Tang TA, 2010, FREE RADICAL BIO MED, V49, P487, DOI 10.1016/j.freeradbiomed.2010.05.007; Thymiakou E, 2007, BIOCHEMISTRY-US, V46, P11473, DOI 10.1021/bi700994m; van der Geer P, 2002, TRENDS CARDIOVAS MED, V12, P160, DOI 10.1016/S1050-1738(02)00154-8; Vedhachalam C, 2007, BIOCHEMISTRY-US, V46, P2583, DOI 10.1021/bi602407r; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; Wang ZF, 2009, FREE RADICAL BIO MED, V47, P1221, DOI 10.1016/j.freeradbiomed.2009.08.001; Wu DF, 2007, J LIPID RES, V48, P2571, DOI 10.1194/jlr.M700217-JLR200; Yu JH, 1999, J BIOL CHEM, V274, P34327, DOI 10.1074/jbc.274.48.34327; Zhang GC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000252; Zhang WY, 1996, J BIOL CHEM, V271, P28641, DOI 10.1074/jbc.271.45.28641; Zhao Yanfeng, 2010, J Bioanal Biomed, V2, P113; Zhao ZZ, 2005, ARTERIOSCL THROM VAS, V25, P168, DOI 10.1161/01.ATV.0000149145.00865.d9; Zhu Y, 2005, CARDIOVASC RES, V68, P425, DOI 10.1016/j.cardiores.2005.07.003	39	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21453	10.1371/journal.pone.0021453	http://dx.doi.org/10.1371/journal.pone.0021453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779326	gold, Green Published, Green Submitted			2022-12-25	WOS:000292680900005
J	Kameda, H; Hirabayashi, K; Wada, K; Fukuyama, K				Kameda, Haruka; Hirabayashi, Kei; Wada, Kei; Fukuyama, Keiichi			Mapping of Protein-Protein Interaction Sites in the Plant-Type [2Fe-2S] Ferredoxin	PLOS ONE			English	Article							MAIN CHAIN FOLD; BLUE-GREEN-ALGA; APHANOTHECE-SACRUM; ELECTRON-TRANSFER; ANGSTROM RESOLUTION; 3-DIMENSIONAL STRUCTURE; SPIRULINA-PLATENSIS; EQUISETUM-ARVENSE; 2.5-A RESOLUTION; STRUCTURAL BASIS	Knowing the manner of protein-protein interactions is vital for understanding biological events. The plant-type [2Fe-2S] ferredoxin (Fd), a well-known small iron-sulfur protein with low redox potential, partitions electrons to a variety of Fd-dependent enzymes via specific protein-protein interactions. Here we have refined the crystal structure of a recombinant plant-type Fd I from the blue green alga Aphanothece sacrum (AsFd-I) at 1.46 angstrom resolution on the basis of the synchrotron radiation data. Incorporating the revised amino-acid sequence, our analysis corrects the 3D structure previously reported; we identified the short alpha-helix (67-71) near the active center, which is conserved in other plant-type [ 2Fe-2S] Fds. Although the 3D structures of the four molecules in the asymmetric unit are similar to each other, detailed comparison of the four structures revealed the segments whose conformations are variable. Structural comparison between the Fds from different sources showed that the distribution of the variable segments in AsFd-I is highly conserved in other Fds, suggesting the presence of intrinsically flexible regions in the plant-type [ 2Fe-2S] Fd. A few structures of the complexes with Fd-dependent enzymes clearly demonstrate that the protein-protein interactions are achieved through these variable regions in Fd. The results described here will provide a guide for interpreting the biochemical and mutational studies that aim at the manner of interactions with Fd-dependent enzymes.	[Kameda, Haruka; Hirabayashi, Kei; Wada, Kei; Fukuyama, Keiichi] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka, Japan	Osaka University	Kameda, H (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka, Japan.	fukuyama@bio.sci.osaka-u.ac.jp		Wada, Kei/0000-0001-7631-4151	Japan Foundation for Applied Enzymology [20370037, 23370052, 21770112]; Kurata Memorial Hitachi Science and Technology Foundation	Japan Foundation for Applied Enzymology; Kurata Memorial Hitachi Science and Technology Foundation	This study was supported in part by Grants-in-Aid for Scientific Research 20370037 and 23370052 (to K. F.) and 21770112 (to K. W.), a grant from the Japan Foundation for Applied Enzymology (to K. W and K. F.) and the Kurata Memorial Hitachi Science and Technology Foundation (to K. W). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi T, 1999, J BIOL CHEM, V274, P29399, DOI 10.1074/jbc.274.41.29399; ARNON DI, 1965, SCIENCE, V149, P1460, DOI 10.1126/science.149.3691.1460; Bes MT, 1999, STRUCT FOLD DES, V7, P1201, DOI 10.1016/S0969-2126(00)80054-4; COLMAN PM, 1987, NATURE, V326, P358, DOI 10.1038/326358a0; Dai SD, 2007, NATURE, V448, P92, DOI 10.1038/nature05937; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fish A, 2005, J MOL BIOL, V350, P599, DOI 10.1016/j.jmb.2005.04.071; FOUST GP, 1969, J BIOL CHEM, V244, P964; Fujishiro T, 2004, APPL ENVIRON MICROB, V70, P3338, DOI 10.1128/AEM.70.6.3338-3345.2004; Fukuyama K, 2004, PHOTOSYNTH RES, V81, P289, DOI 10.1023/B:PRES.0000036882.19322.0a; FUKUYAMA K, 1980, NATURE, V286, P522, DOI 10.1038/286522a0; FUKUYAMA K, 1995, J BIOCHEM-TOKYO, V117, P1017, DOI 10.1093/oxfordjournals.jbchem.a124800; Hanke GT, 2004, PHOTOSYNTH RES, V81, P317, DOI 10.1023/B:PRES.0000036885.01534.b8; Hasegawa K, 2009, J APPL CRYSTALLOGR, V42, P1165, DOI 10.1107/S0021889809042277; HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218; HOLDEN HM, 1994, J BIOENERG BIOMEMBR, V26, P67, DOI 10.1007/BF00763220; IKEMIZU S, 1994, ACTA CRYSTALLOGR D, V50, P167, DOI 10.1107/S0907444993009588; JACOBSON BL, 1993, BIOCHEMISTRY-US, V32, P6788, DOI 10.1021/bi00077a033; KLEYWEGT GJ, 1994, ESF CCP4 NEWSLETTER, V31, P9; KNAFF DB, 1991, BIOCHIM BIOPHYS ACTA, V1056, P93, DOI 10.1016/S0005-2728(05)80277-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; KUNITA A, 1978, J BIOCHEM-TOKYO, V84, P989, DOI 10.1093/oxfordjournals.jbchem.a132214; Kurisu G, 2001, NAT STRUCT BIOL, V8, P117, DOI 10.1038/84097; Kurisu G, 2005, J BIOL CHEM, V280, P2275, DOI 10.1074/jbc.M408904200; Lovenberg W., 1973, IRON SULFUR PROTEINS; Morales R, 2000, EMBO REP, V1, P271, DOI 10.1093/embo-reports/kvd057; Nakamura M, 1999, J BIOCHEM, V126, P10, DOI 10.1093/oxfordjournals.jbchem.a022409; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; RYPNIEWSKI WR, 1991, BIOCHEMISTRY-US, V30, P4126, DOI 10.1021/bi00231a003; TAINER JA, 1984, NATURE, V312, P127, DOI 10.1038/312127a0; TSUKIHARA T, 1990, J MOL BIOL, V216, P399, DOI 10.1016/S0022-2836(05)80330-4; TSUKIHARA T, 1981, J BIOCHEM-TOKYO, V90, P1763, DOI 10.1093/oxfordjournals.jbchem.a133654; TSUTSUI T, 1983, J BIOCHEM-TOKYO, V94, P299, DOI 10.1093/oxfordjournals.jbchem.a134343; WADA K, 1974, J BIOCHEM-TOKYO, V76, P1217, DOI 10.1093/oxfordjournals.jbchem.a130674; WESTHOF E, 1984, NATURE, V311, P123, DOI 10.1038/311123a0; ZANETTI G, 2001, HDB METALLOPROTEINS, P532	37	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21947	10.1371/journal.pone.0021947	http://dx.doi.org/10.1371/journal.pone.0021947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760931	gold, Green Published, Green Submitted			2022-12-25	WOS:000292657200035
J	Nedellec, R; Coetzer, M; Lederman, MM; Offord, RE; Hartley, O; Mosier, DE				Nedellec, Rebecca; Coetzer, Mia; Lederman, Michael M.; Offord, Robin E.; Hartley, Oliver; Mosier, Donald E.			Resistance to the CCR5 Inhibitor 5P12-RANTES Requires a Difficult Evolution from CCR5 to CXCR4 Coreceptor Use	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SMALL-MOLECULE INHIBITOR; CHEMOKINE RECEPTOR CCR5; VAGINAL SHIV CHALLENGE; HIGHLY POTENT; HIV-1 ESCAPE; SELECTIVE TRANSMISSION; TYPE-1 VARIANTS; SINGLE-CYCLE; IN-VIVO	Viral resistance to small molecule allosteric inhibitors of CCR5 is well documented, and involves either selection of preexisting CXCR4-using HIV-1 variants or envelope sequence evolution to use inhibitor-bound CCR5 for entry. Resistance to macromolecular CCR5 inhibitors has been more difficult to demonstrate, although selection of CXCR4-using variants might be expected. We have compared the in vitro selection of HIV-1 CC1/85 variants resistant to either the small molecule inhibitor maraviroc (MVC) or the macromolecular inhibitor 5P12-RANTES. High level resistance to MVC was conferred by the same envelope mutations as previously reported after 16-18 weeks of selection by increasing levels of MVC. The MVC-resistant mutants were fully sensitive to inhibition by 5P12-RANTES. By contrast, only transient and low level resistance to 5P12-RANTES was achieved in three sequential selection experiments, and each resulted in a subsequent collapse of virus replication. A fourth round of selection by 5P12-RANTES led, after 36 weeks, to a "resistant" variant that had switched from CCR5 to CXCR4 as a coreceptor. Envelope sequences diverged by 3.8% during selection of the 5P12-RANTES resistant, CXCR4-using variants, with unique and critical substitutions in the V3 region. A subset of viruses recovered from control cultures after 44 weeks of passage in the absence of inhibitors also evolved to use CXCR4, although with fewer and different envelope mutations. Control cultures contained both viruses that evolved to use CXCR4 by deleting four amino acids in V3, and others that maintained entry via CCR5. These results suggest that coreceptor switching may be the only route to resistance for compounds like 5P12-RANTES. This pathway requires more mutations and encounters more fitness obstacles than development of resistance to MVC, confirming the clinical observations that resistance to small molecule CCR5 inhibitors very rarely involves coreceptor switching.	[Nedellec, Rebecca; Coetzer, Mia; Mosier, Donald E.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Lederman, Michael M.] Case Western Reserve Univ, Dept Med, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Offord, Robin E.] Mintaka Fdn Med Res, Geneva, Switzerland; [Hartley, Oliver] Univ Geneva, Dept Struct Biol & Bioinformat, Geneva, Switzerland	Scripps Research Institute; Case Western Reserve University; Case Western Reserve University Hospital; University of Geneva	Nedellec, R (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	dmosier@scripps.edu			National Institute of Allergy and Infectious Diseases (NIAID) [R01 AI052778, U19 AI076981]; Swiss National Science Foundation; CONRAD; World Health Organization; International Partnership for Microbicides; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052778, U19AI076981] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CONRAD(United States Agency for International Development (USAID)); World Health Organization(World Health Organization); International Partnership for Microbicides; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants R01 AI052778 and U19 AI076981 from the National Institute of Allergy and Infectious Diseases (NIAID; http://www.niaid.nih.gov). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or the National Institutes of Health. Additional support was provided by the La Jolla Foundation for Microbicide Research (http://www.clevelandactu.org/lajolla/), The Mintaka Foundation (http://www.mintakafoundation.org/), and the James B. Pendleton Charitable Trust. OH acknowledges support from the Swiss National Science Foundation (http://www.snf.ch/E/funding/Pages/default.aspx). REO acknowledges support from CONRAD (http://www.conrad.org/),the World Health Organization (http://www.who.int/en/), and the International Partnership for Microbicides (http://www.ipmglobal.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram ME, 2010, J VIROL, V84, P9864, DOI 10.1128/JVI.00915-10; Anastassopoulou CG, 2009, P NATL ACAD SCI USA, V106, P5318, DOI 10.1073/pnas.0811713106; Anonymous, 2005, Antiviral Chemistry & Chemotherapy, V16, P339; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Berro R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000548; Chesebro B, 1996, J VIROL, V70, P9055, DOI 10.1128/JVI.70.12.9055-9059.1996; Coetzer M, 2008, J VIROL, V82, P11758, DOI 10.1128/JVI.01141-08; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Dorn CP, 2001, BIOORG MED CHEM LETT, V11, P259, DOI 10.1016/S0960-894X(00)00637-5; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Dudley DM, 2009, J VIROL, V83, P5067, DOI 10.1128/JVI.00055-09; Fatkenheuer G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMoa0803154; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Hartley O, 2004, P NATL ACAD SCI USA, V101, P16460, DOI 10.1073/pnas.0404802101; Karlsson I, 2004, J VIROL, V78, P11807, DOI 10.1128/JVI.78.21.11807-11815.2004; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kiselyeva Y, 2007, J VIROL, V81, P3657, DOI 10.1128/JVI.02310-06; Kondru R, 2008, MOL PHARMACOL, V73, P789, DOI 10.1124/mol.107.042101; Kuhmann SE, 2004, J VIROL, V78, P2790, DOI 10.1128/JVI.78.6.2790-2807.2004; Learn GH, 2002, J VIROL, V76, P11953, DOI 10.1128/JVI.76.23.11953-11959.2002; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Long EM, 2002, AIDS RES HUM RETROV, V18, P567, DOI 10.1089/088922202753747914; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Marozsan AJ, 2005, VIROLOGY, V338, P182, DOI 10.1016/j.virol.2005.04.035; McGovern RA, 2010, AIDS, V24, P2512, DOI 10.1097/QAD.0b013e32833e6cfb; Michael NL, 1997, NAT MED, V3, P1160, DOI 10.1038/nm1097-1160; Moncunill G, 2008, AIDS, V22, P23, DOI 10.1097/QAD.0b013e3282f303e6; Moore JP, 2009, CURR OPIN HIV AIDS, V4, P118, DOI 10.1097/COH.0b013e3283223d46; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Mosier DE, 1999, J VIROL, V73, P3544, DOI 10.1128/JVI.73.5.3544-3550.1999; Nedellec R, 2010, J VIROL, V84, P5842, DOI 10.1128/JVI.01907-09; Nolan KM, 2008, J VIROL, V82, P664, DOI 10.1128/JVI.01793-07; Pastore C, 2006, J VIROL, V80, P750, DOI 10.1128/JVI.80.2.750-758.2006; Pastore C, 2003, ANTIMICROB AGENTS CH, V47, P509, DOI 10.1128/AAC.47.2.509-517.2003; Pastore C, 2007, J VIROL, V81, P8165, DOI 10.1128/JVI.02792-06; Paxton WA, 1998, AIDS RES HUM RETROV, V14, pS89; Peters PJ, 2006, J VIROL, V80, P6324, DOI 10.1128/JVI.02328-05; Pugach P, 2004, VIROLOGY, V321, P8, DOI 10.1016/j.virol.2003.12.012; Pugach P, 2007, VIROLOGY, V361, P212, DOI 10.1016/j.virol.2006.11.004; Roos JW, 2000, VIROLOGY, V273, P307, DOI 10.1006/viro.2000.0431; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; SEIBERT C, 2006, VIROLOGY; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Strizki JM, 2001, P NATL ACAD SCI USA, V98, P12718, DOI 10.1073/pnas.221375398; Strizki JM, 2005, ANTIMICROB AGENTS CH, V49, P4911, DOI 10.1128/AAC.49.12.4911-4919.2005; Tilton JC, 2010, J VIROL, V84, P10863, DOI 10.1128/JVI.01109-10; Trkola A, 2002, P NATL ACAD SCI USA, V99, P395, DOI 10.1073/pnas.012519099; Tsibris AMN, 2008, J VIROL, V82, P8210, DOI 10.1128/JVI.00444-08; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Veazey RS, 2009, J INFECT DIS, V199, P1525, DOI 10.1086/598685; Veazey RS, 2005, NAT MED, V11, P1293, DOI 10.1038/nm1321; Veazey RS, 2003, J EXP MED, V198, P1551, DOI 10.1084/jem.20031266; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Westby M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006; Westby M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06; Wilkinson DA, 1998, J INFECT DIS, V178, P1163, DOI 10.1086/515675; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316	66	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22020	10.1371/journal.pone.0022020	http://dx.doi.org/10.1371/journal.pone.0022020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760945	Green Submitted, gold, Green Published			2022-12-25	WOS:000292657200040
J	Baguet, A; Everaert, I; Hespel, P; Petrovic, M; Achten, E; Derave, W				Baguet, Audrey; Everaert, Inge; Hespel, Peter; Petrovic, Mirko; Achten, Eric; Derave, Wim			A New Method for Non-Invasive Estimation of Human Muscle Fiber Type Composition	PLOS ONE			English	Article							BETA-ALANINE SUPPLEMENTATION; HUMAN VASTUS LATERALIS; HUMAN SKELETAL-MUSCLE; INTENSITY EXERCISE PERFORMANCE; CARNOSINE CONCENTRATIONS; RELAXATION-TIME; CROSS-SECTIONS; IN-VIVO; SPRINTERS; CAPACITY	Background: It has been established that excellence in sports with short and long exercise duration requires a high proportion of fast-twitch (FT) or type-II fibers and slow-twitch (ST) or type-I fibers, respectively. Until today, the muscle biopsy method is still accepted as gold standard to measure muscle fiber type composition. Because of its invasive nature and high sampling variance, it would be useful to develop a non-invasive alternative. Methodology: Eighty-three control subjects, 15 talented young track-and-field athletes, 51 elite athletes and 14 ex-athletes volunteered to participate in the current study. The carnosine content of all 163 subjects was measured in the gastrocnemius muscle by proton magnetic resonance spectroscopy ((1)H-MRS). Muscle biopsies for fiber typing were taken from 12 untrained males. Principal Findings: A significant positive correlation was found between muscle carnosine, measured by (1)H-MRS, and percentage area occupied by type II fibers. Explosive athletes had similar to 30% higher carnosine levels compared to a reference population, whereas it was similar to 20% lower than normal in typical endurance athletes. Similar results were found in young talents and ex-athletes. When active elite runners were ranked according to their best running distance, a negative sigmoidal curve was found between logarithm of running distance and muscle carnosine. Conclusions: Muscle carnosine content shows a good reflection of the disciplines of elite track-and-field athletes and is able to distinguish between individual track running distances. The differences between endurance and sprint muscle types is also observed in young talents and former athletes, suggesting this characteristic is genetically determined and can be applied in early talent identification. This quick method provides a valid alternative for the muscle biopsy method. In addition, this technique may also contribute to the diagnosis and monitoring of many conditions and diseases that are characterized by an altered muscle fiber type composition.	[Baguet, Audrey; Everaert, Inge; Derave, Wim] Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium; [Hespel, Peter] Katholieke Univ Leuven, Res Ctr Exercise & Hlth, Leuven, Belgium; [Petrovic, Mirko] Univ Ghent, Dept Internal Med, B-9000 Ghent, Belgium; [Achten, Eric] Univ Ghent, Dept Radiol, GIFMI, B-9000 Ghent, Belgium	Ghent University; KU Leuven; Ghent University; Ghent University	Baguet, A (corresponding author), Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium.	wim.derave@ugent.be	Derave, Wim/B-2554-2014	Derave, Wim/0000-0002-2225-5587; Hespel, Peter/0000-0003-1283-2229	Research Foundation - Flanders (FWO) [1.5.149.08, G024311N]; Vlaamse Atletiekliga	Research Foundation - Flanders (FWO)(FWO); Vlaamse Atletiekliga	This study was financially supported by a grant from the Research Foundation - Flanders (FWO 1.5.149.08 and G024311N). A. B. is a recipient of a PhD scholarship from the Research Foundation - Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the support from the Vlaamse Atletiekliga and their coaches and athletes. The assistance of Hanne Gyselbrecht, Sara Willemijns, Dajo Aertssen and Mattias Ysebie is acknowledged. Correspondence and requests for materials should be addressed to Wim Derave (wim.derave@ugent.be).	Albracht K, 2008, J BIOMECH, V41, P2211, DOI 10.1016/j.jbiomech.2008.04.020; Baguet A, 2011, EUR J APPL PHYSIOL, V111, P2571, DOI 10.1007/s00421-011-1877-4; Baguet A, 2010, J APPL PHYSIOL, V109, P1096, DOI 10.1152/japplphysiol.00141.2010; Baguet A, 2009, J APPL PHYSIOL, V106, P837, DOI 10.1152/japplphysiol.91357.2008; BERNUS G, 1993, MED SCI SPORT EXER, V25, P479; Bonny JM, 1998, MAGN RESON IMAGING, V16, P167, DOI 10.1016/S0730-725X(97)00249-X; COSTILL DL, 1976, J APPL PHYSIOL, V40, P149, DOI 10.1152/jappl.1976.40.2.149; De Bock K, 2007, J APPL PHYSIOL, V102, P183, DOI 10.1152/japplphysiol.00799.2006; De Bock K, 2007, AM J PHYSIOL-ENDOC M, V293, pE428, DOI 10.1152/ajpendo.00112.2007; Derave W, 2007, J APPL PHYSIOL, V103, P1736, DOI 10.1152/japplphysiol.00397.2007; Diffee GM, 2002, AM J PHYSIOL-CELL PH, V283, pC1376, DOI 10.1152/ajpcell.00154.2002; ELDER GCB, 1982, J APPL PHYSIOL, V53, P1473, DOI 10.1152/jappl.1982.53.6.1473; Everaert I, 2011, AMINO ACIDS, V40, P1221, DOI 10.1007/s00726-010-0749-2; Frontera WR, 2000, J APPL PHYSIOL, V88, P1321; GOLLNICK PD, 1972, J APPL PHYSIOL, V33, P312, DOI 10.1152/jappl.1972.33.3.312; GOLLNICK PD, 1984, AM J SPORT MED, V12, P212, DOI 10.1177/036354658401200309; Gosker HR, 2007, THORAX, V62, P944, DOI 10.1136/thx.2007.078980; Harris RC, 1998, J SPORT SCI, V16, P639; Harris RC, 2006, AMINO ACIDS, V30, P279, DOI 10.1007/s00726-006-0299-9; Hill CA, 2007, AMINO ACIDS, V32, P225, DOI 10.1007/s00726-006-0364-4; HOUMARD JA, 1995, J APPL PHYSIOL, V78, P807, DOI 10.1152/jappl.1995.78.3.807; Ingalls CP, 2004, J APPL PHYSIOL, V97, P1591, DOI 10.1152/classicessays.00010.2004; Kendrick IP, 2008, AMINO ACIDS, V34, P547, DOI 10.1007/s00726-007-0008-3; Kendrick IP, 2009, EUR J APPL PHYSIOL, V106, P131, DOI 10.1007/s00421-009-0998-5; KUNO S, 1988, RADIOLOGY, V169, P567, DOI 10.1148/radiology.169.2.3175009; LEXELL J, 1985, J APPL PHYSIOL, V59, P1228, DOI 10.1152/jappl.1985.59.4.1228; LEXELL J, 1983, ACTA PHYSIOL SCAND, V117, P115, DOI 10.1111/j.1748-1716.1983.tb07185.x; Malisoux L, 2007, J APPL PHYSIOL, V102, P340, DOI 10.1152/japplphysiol.00609.2006; MANNION AF, 1994, EUR J APPL PHYSIOL O, V68, P356, DOI 10.1007/BF00571457; MANNION AF, 1995, EXP PHYSIOL, V80, P89, DOI 10.1113/expphysiol.1995.sp003837; MANNION AF, 1992, EUR J APPL PHYSIOL O, V64, P47, DOI 10.1007/BF00376439; Nyholm B, 1997, DIABETES, V46, P1822, DOI 10.2337/diabetes.46.11.1822; PARKHOUSE WS, 1985, J APPL PHYSIOL, V58, P14, DOI 10.1152/jappl.1985.58.1.14; Suzuki Y, 2002, JPN J PHYSIOL, V52, P199, DOI 10.2170/jjphysiol.52.199; Trappe S, 2009, J APPL PHYSIOL, V106, P1159, DOI 10.1152/japplphysiol.91578.2008; Van Damme R, 2002, NATURE, V415, P755, DOI 10.1038/415755b; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	37	63	66	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21956	10.1371/journal.pone.0021956	http://dx.doi.org/10.1371/journal.pone.0021956			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760934	Green Published, gold, Green Submitted			2022-12-25	WOS:000292655400031
J	Chen, EZ; Chiu, RWK; Sun, H; Akolekar, R; Chan, KCA; Leung, TY; Jiang, PY; Zheng, YWL; Lun, FMF; Chan, LYS; Jin, YJ; Go, ATJI; Lau, ET; To, WWK; Leung, WC; Tang, RYK; Au-Yeung, SKC; Lam, H; Kung, YY; Zhang, XQ; van Vugt, JMG; Minekawa, R; Tang, MHY; Wang, J; Oudejans, CBM; Lau, TK; Nicolaides, KH; Lo, YMD				Chen, Eric Z.; Chiu, Rossa W. K.; Sun, Hao; Akolekar, Ranjit; Chan, K. C. Allen; Leung, Tak Y.; Jiang, Peiyong; Zheng, Yama W. L.; Lun, Fiona M. F.; Chan, Lisa Y. S.; Jin, Yongjie; Go, Attie T. J. I.; Lau, Elizabeth T.; To, William W. K.; Leung, Wing C.; Tang, Rebecca Y. K.; Au-Yeung, Sidney K. C.; Lam, Helena; Kung, Yu Y.; Zhang, Xiuqing; van Vugt, John M. G.; Minekawa, Ryoko; Tang, Mary H. Y.; Wang, Jun; Oudejans, Cees B. M.; Lau, Tze K.; Nicolaides, Kypros H.; Lo, Y. M. Dennis			Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA Sequencing	PLOS ONE			English	Article							1ST-TRIMESTER; ANEUPLOIDY	Massively parallel sequencing of DNA molecules in the plasma of pregnant women has been shown to allow accurate and noninvasive prenatal detection of fetal trisomy 21. However, whether the sequencing approach is as accurate for the noninvasive prenatal diagnosis of trisomy 13 and 18 is unclear due to the lack of data from a large sample set. We studied 392 pregnancies, among which 25 involved a trisomy 13 fetus and 37 involved a trisomy 18 fetus, by massively parallel sequencing. By using our previously reported standard z-score approach, we demonstrated that this approach could identify 36.0% and 73.0% of trisomy 13 and 18 at specificities of 92.4% and 97.2%, respectively. We aimed to improve the detection of trisomy 13 and 18 by using a non-repeat-masked reference human genome instead of a repeat-masked one to increase the number of aligned sequence reads for each sample. We then applied a bioinformatics approach to correct GC content bias in the sequencing data. With these measures, we detected all (25 out of 25) trisomy 13 fetuses at a specificity of 98.9% (261 out of 264 non-trisomy 13 cases), and 91.9% (34 out of 37) of the trisomy 18 fetuses at 98.0% specificity (247 out of 252 non-trisomy 18 cases). These data indicate that with appropriate bioinformatics analysis, noninvasive prenatal diagnosis of trisomy 13 and trisomy 18 by maternal plasma DNA sequencing is achievable.	[Chen, Eric Z.; Chiu, Rossa W. K.; Sun, Hao; Chan, K. C. Allen; Jiang, Peiyong; Zheng, Yama W. L.; Lun, Fiona M. F.; Chan, Lisa Y. S.; Jin, Yongjie; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Hong Kong, Hong Kong, Peoples R China; [Chen, Eric Z.; Chiu, Rossa W. K.; Sun, Hao; Chan, K. C. Allen; Jiang, Peiyong; Zheng, Yama W. L.; Lun, Fiona M. F.; Chan, Lisa Y. S.; Jin, Yongjie; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Leung, Tak Y.; Lau, Tze K.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Akolekar, Ranjit; Minekawa, Ryoko; Nicolaides, Kypros H.] Kings Coll London, Harris Birthright Res Ctr Fetal Med, London WC2R 2LS, England; [Go, Attie T. J. I.; van Vugt, John M. G.; Oudejans, Cees B. M.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Lau, Elizabeth T.; Tang, Mary H. Y.] Univ Hong Kong, Dept Obstet & Gynaecol, Tsan Yuk Hosp, Hong Kong, Hong Kong, Peoples R China; [To, William W. K.] United Christian Hosp, Hong Kong, Hong Kong, Peoples R China; [Leung, Wing C.] Kwong Wah Hosp, Hong Kong, Hong Kong, Peoples R China; [Tang, Rebecca Y. K.] Pamela Youde Nethersole Eastern Hosp, Hong Kong, Hong Kong, Peoples R China; [Au-Yeung, Sidney K. C.] Tuen Mun Hosp, Hong Kong, Hong Kong, Peoples R China; [Lam, Helena] Princess Margaret Hosp, Hosp Author, Hong Kong, Hong Kong, Peoples R China; [Kung, Yu Y.] YY Kung Med Ctr, Hong Kong, Hong Kong, Peoples R China; [Zhang, Xiuqing; Wang, Jun; Lo, Y. M. Dennis] Joint Chinese Univ Hong Kong, Beijing Genom Inst Genome Res Ctr, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Zhang, Xiuqing; Wang, Jun] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of London; King's College London; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Hong Kong; United Christian Hospital; Kwong Wah Hospital; Pamela Youde Nethersole Eastern Hospital; Tuen Mun Hospital; Chinese University of Hong Kong; Beijing Genomics Institute (BGI)	Chen, EZ (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Hong Kong, Hong Kong, Peoples R China.	loym@cuhk.edu.hk	Lo, Yuk Ming Dennis/D-4468-2011; Vugt, J.M.G./L-4737-2015; Tang, Mary Hoi Yin/A-7638-2013; sun, hao/GRS-7732-2022; Wang, Jun/A-7261-2013; Chan, K.C. Allen/M-2930-2013; Sun, Hao/T-5576-2019; JIANG, Peiyong/AAZ-9898-2020; Sun, Hao/J-9964-2013; c, c/I-5855-2016; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Lo, Yuk Ming Dennis/0000-0001-8746-0293; Chan, K.C. Allen/0000-0003-1780-1691; Sun, Hao/0000-0002-5547-9501; Sun, Hao/0000-0002-5547-9501; Oudejans, Cees/0000-0003-0717-4946; Nicolaides, Kypros/0000-0003-1266-0711; Wang, Jun/0000-0002-2113-5874; MINEKAWA, RYOKO/0000-0001-7429-3203; Jiang, Peiyong/0000-0003-4523-3476; Lau, Tze Kin/0000-0002-0242-1410; Wang, Jun/0000-0002-8540-8931	Sequenom and Life Technologies [ITS/054/09]; University Grants Committee of the Government of the Hong Kong Special Administration Region, China [AoE/M-04/06]; Li Ka Shing Foundation; Sequenom	Sequenom and Life Technologies; University Grants Committee of the Government of the Hong Kong Special Administration Region, China; Li Ka Shing Foundation; Sequenom	The study was supported by the Innovation and Technology Fund (ITS/054/09; co-sponsored by Sequenom and Life Technologies), University Grants Committee of the Government of the Hong Kong Special Administration Region, China, under the Areas of Excellence Scheme (AoE/M-04/06) and an additional sponsored research agreement with Sequenom. Y.M.D. Lo was supported by an Endowed Chair from the Li Ka Shing Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Chiu RWK, 2010, CLIN CHEM, V56, P459, DOI 10.1373/clinchem.2009.136507; Chiu RWK, 2009, TRENDS GENET, V25, P324, DOI 10.1016/j.tig.2009.05.004; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Driscoll DA, 2009, NEW ENGL J MED, V360, P2556, DOI 10.1056/NEJMcp0900134; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Finning K, 2008, BRIT MED J, V336, P816, DOI 10.1136/bmj.39518.463206.25; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 2007, NAT REV GENET, V8, P71, DOI 10.1038/nrg1982; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Papageorgiou EA, 2009, AM J PATHOL, V174, P1609, DOI 10.2353/ajpath.2009.081038; Samura O, 2003, CLIN CHEM, V49, P1193, DOI 10.1373/49.7.1193; TABOR A, 1986, LANCET, V1, P1287; Tong YK, 2006, CLIN CHEM, V52, P2194, DOI 10.1373/clinchem.2006.076851; Tong YK, 2010, CLIN CHEM, V56, P90, DOI 10.1373/clinchem.2009.134114; Tsui NBY, 2009, PRENATAL DIAG, V29, P1031, DOI 10.1002/pd.2340; Wapner R, 2003, NEW ENGL J MED, V349, P1405, DOI 10.1056/NEJMoa025273; Wright CF, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2451	30	216	317	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21791	10.1371/journal.pone.0021791	http://dx.doi.org/10.1371/journal.pone.0021791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755002	Green Published, gold			2022-12-25	WOS:000292632000029
J	Moon, S; Gurkan, UA; Blander, J; Fawzi, WW; Aboud, S; Mugusi, F; Kuritzkes, DR; Demirci, U				Moon, SangJun; Gurkan, Umut Atakan; Blander, Jeffrey; Fawzi, Wafaie W.; Aboud, Said; Mugusi, Ferdinand; Kuritzkes, Daniel R.; Demirci, Utkan			Enumeration of CD4(+) T-Cells Using a Portable Microchip Count Platform in Tanzanian HIV-Infected Patients	PLOS ONE			English	Article							DIAGNOSTIC TECHNOLOGIES; LYMPHOCYTE COUNTS; PREVENTION	Background: CD4(+) T-lymphocyte count (CD4 count) is a standard method used to monitor HIV-infected patients during anti-retroviral therapy (ART). The World Health Organization (WHO) has pointed out or recommended that a handheld, point-of-care, reliable, and affordable CD4 count platform is urgently needed in resource-scarce settings. Methods: HIV-infected patient blood samples were tested at the point-of-care using a portable and label-free microchip CD4 count platform that we have developed. A total of 130 HIV-infected patient samples were collected that included 16 de-identified left over blood samples from Brigham and Women's Hospital (BWH), and 114 left over samples from Muhimbili University of Health and Allied Sciences (MUHAS) enrolled in the HIV and AIDS care and treatment centers in the City of Dar es Salaam, Tanzania. The two data groups from BWH and MUHAS were analyzed and compared to the commonly accepted CD4 count reference method (FACSCalibur system). Results: The portable, battery operated and microscope-free microchip platform developed in our laboratory (BWH) showed significant correlation in CD4 counts compared with FACSCalibur system both at BWH (r = 0.94, p < 0.01) and MUHAS (r = 0.49, p < 0.01), which was supported by the Bland-Altman methods comparison analysis. The device rapidly produced CD4 count within 10 minutes using an in-house developed automated cell counting program. Conclusions: We obtained CD4 counts of HIV-infected patients using a portable platform which is an inexpensive (<$1 material cost) and disposable microchip that uses whole blood sample (< 10 mu l) without any pre-processing. The system operates without the need for antibody-based fluorescent labeling and expensive fluorescent illumination and microscope setup. This portable CD4 count platform displays agreement with the FACSCalibur results and has the potential to expand access to HIV and AIDS monitoring using fingerprick volume of whole blood and helping people who suffer from HIV and AIDS in resource-limited settings.	[Moon, SangJun; Gurkan, Umut Atakan; Blander, Jeffrey; Demirci, Utkan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Demirci Bioacoust MEMS Lab,Ctr Biomed Engn, Boston, MA 02115 USA; [Blander, Jeffrey] Harvard Univ, Sch Med, Dept Epidemiol, Boston, MA USA; [Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Dept Epidemiol,Dept Global Hlth & Populat, Boston, MA 02115 USA; [Aboud, Said] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Mugusi, Ferdinand] Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania; [Kuritzkes, Daniel R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Sect Retroviral Therapeut, Boston, MA 02115 USA; [Demirci, Utkan] Harvard MIT Hlth Sci & Technol, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University	Moon, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Demirci Bioacoust MEMS Lab,Ctr Biomed Engn, Boston, MA 02115 USA.	udemirci@rics.bwh.harvard.edu	Gurkan, Umut A./Z-2496-2019	Gurkan, Umut A./0000-0002-0331-9960	Wallace H. Coulter Foundation; National Institutes of Health (NIH) [R01AI081534, R21AI087107, RR016482, AI060354]; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR016482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R21AI087107, R01AI081534] Funding Source: NIH RePORTER	Wallace H. Coulter Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Demirci would like to thank the Wallace H. Coulter Foundation for the Young Investigator in Bioengineering Award for supporting all the testing, travel and associated costs in Tanzania. Investigators were also partially supported by the National Institutes of Health (NIH) (R01AI081534), NIH (R21AI087107). Dr. Kuritzkes would like to acknowledge NIH grants RR016482 and AI060354 (Harvard University Center for AIDS Research). Dr. Blander acknowledges the NIH Fogarty Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlford A, 2010, ANALYST, V135, P2377, DOI 10.1039/c0an00321b; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Chandrasekaran P, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000343760.70078.89; Cheng XH, 2007, JAIDS-J ACQ IMM DEF, V45, P257; Chin CD, 2007, LAB CHIP, V7, P41, DOI 10.1039/b611455e; Gurkan UA, 2011, BIOTECHNOL J, V6, P138, DOI 10.1002/biot.201000427; Hawkins KR, 2010, PROC SPIE, V7593, DOI 10.1117/12.845500; Lee BS, 2011, LAB CHIP, V11, P70, DOI [10.1039/c0lc00205d, 10.1039/c01c00205d]; Lee WG, 2010, ADV DRUG DELIVER REV, V62, P449, DOI 10.1016/j.addr.2009.11.016; Menon S, 2010, J PUBLIC HEALTH POL, V31, P385, DOI 10.1057/jphp.2010.29; Moon S, 2009, BIOSENS BIOELECTRON, V24, P3208, DOI 10.1016/j.bios.2009.03.037; Rodriguez WR, 2005, PLOS MED, V2, P663, DOI 10.1371/journal.pmed.0020182; Sandstrom E, 2003, INT J STD AIDS, V14, P547, DOI 10.1258/095646203767869165; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Spacek LA, 2006, JAIDS-J ACQ IMM DEF, V41, P607, DOI 10.1097/01.qai.0000214807.98465.a2; Wang SQ, 2010, BIOTECHNOL ADV, V28, P770, DOI 10.1016/j.biotechadv.2010.06.004; Wang YN, 2008, LAB CHIP, V8, P309, DOI 10.1039/b713932b; Weigl BH, 2009, EXPERT REV MED DEVIC, V6, P461, DOI [10.1586/erd.09.31, 10.1586/ERD.09.31]; WHO, 2008, CD4 T CELL EN TECHN; [World Health Organization (WHO) UNAIDS UNICEF], 2010, UN ACC SCAL PRIOR HI; Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064	22	58	61	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21409	10.1371/journal.pone.0021409	http://dx.doi.org/10.1371/journal.pone.0021409			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754988	Green Published, gold, Green Submitted			2022-12-25	WOS:000292632000012
J	Lackner, DH; Durocher, D; Karlseder, J				Lackner, Daniel H.; Durocher, Daniel; Karlseder, Jan			A siRNA-Based Screen for Genes Involved in Chromosome End Protection	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; HUMAN TELOMERES; MEDIATED TRANSCRIPTION; MAMMALIAN TELOMERES; INTERACTING PROTEIN; SKIP INTERACTS; CELL-CYCLE; HIV-1 TAT; TRF2; RNA	Telomeres are nucleoprotein complexes which protect the ends of linear chromosomes from detection as DNA damage and provide a sequence buffer against replication-associated shortening. In mammals, telomeres consist of repetitive DNA sequence (TTAGGG) and associated proteins. The telomeric core complex is called shelterin and is comprised of the proteins TRF1, TRF2, POT1, TIN2, TPP1 and RAP1. Excessive telomere shortening or de-protection of telomeres through the loss of shelterin subunits allows the detection of telomeres as DNA damage, which can be visualized as DNA damage protein foci at chromosome ends called TIF (Telomere Dysfunction-Induced Foci). We sought to exploit the TIF phenotype as marker for telomere dysfunction to identify novel genes involved in telomere protection by siRNA-mediatedknock-down of a set of 386 candidates. Here we report the establishment, specificity and feasibility of such a screen and the results of the genes tested. Only one of the candidate genes showed a unique TIF phenotype comparable to the suppression of the main shelterin components TRF2 or TRF1 and that gene was identified as a TRF1-like pseudogene. We also identified a weak TIF phenotype for SKIIP (SNW1), a splicing factor and transcriptional co-activator. However, the knock-down of SKIIP also induced a general, not telomere-specific DNA damage response, which complicates conclusions about a telomeric role. In summary, this report is a technical demonstration of the feasibility of a cell-based screen for telomere deprotection with the potential of scaling it to a high-throughput approach.	[Lackner, Daniel H.; Karlseder, Jan] Salk Inst Biol Studies, Mol & Cellular Biol Dept, La Jolla, CA 92037 USA; [Durocher, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Salk Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Lackner, DH (corresponding author), Salk Inst Biol Studies, Mol & Cellular Biol Dept, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	Karlseder@salk.edu	Durocher, Daniel/A-7733-2010	Durocher, Daniel/0000-0003-3863-8635	NIH [RO1 AG025837, RO1 GM087476]; Salk Institute for Biological Studies; European Molecular Biology Organization; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025837] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Salk Institute for Biological Studies; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by grants from the NIH (RO1 AG025837, RO1 GM087476) and by an innovation grant from the Salk Institute for Biological Studies (http://www.salk.edu/). DHL is the recipient of a European Molecular Biology Organization long-term postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Baudino TA, 1998, J BIOL CHEM, V273, P16434, DOI 10.1074/jbc.273.26.16434; Bres V, 2005, GENE DEV, V19, P1211, DOI 10.1101/gad.1291705; Bres V, 2009, MOL CELL, V36, P75, DOI 10.1016/j.molcel.2009.08.015; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; CELLI GB, 2006, NAT CELL BIOL, V8, P855; Cesare AJ, 2009, NAT STRUCT MOL BIOL, V16, P1244, DOI 10.1038/nsmb.1725; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Denchi EL, 2006, GENE DEV, V20, P2648, DOI 10.1101/gad.1453606; Figueroa JD, 2004, BIOCHEM BIOPH RES CO, V319, P1105, DOI 10.1016/j.bbrc.2004.05.096; Folk P, 2004, CELL MOL LIFE SCI, V61, P629, DOI 10.1007/s00018-003-3215-4; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; MARTINEZ P, 2010, NAT CELL BI IN PRESS; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Nagai K, 2004, BIOCHEM BIOPH RES CO, V316, P512, DOI 10.1016/j.bbrc.2004.02.077; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Prathapam T, 2002, NUCLEIC ACIDS RES, V30, P5261, DOI 10.1093/nar/gkf658; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; TEO H, 2010, NAT CELL BI IN PRESS; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200; Zhou SF, 2000, J VIROL, V74, P1939, DOI 10.1128/JVI.74.4.1939-1947.2000; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	33	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21407	10.1371/journal.pone.0021407	http://dx.doi.org/10.1371/journal.pone.0021407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21760879	gold, Green Submitted, Green Published			2022-12-25	WOS:000292035400033
J	Blum, AP; Gleitsman, KR; Lester, HA; Dougherty, DA				Blum, Angela P.; Gleitsman, Kristin Rule; Lester, Henry A.; Dougherty, Dennis A.			Evidence for an Extended Hydrogen Bond Network in the Binding Site of the Nicotinic Receptor ROLE OF THE VICINAL DISULFIDE OF THE alpha 1 SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID MUTAGENESIS; CYSTEINYL-L-CYSTEINE; N-METHYL PEPTIDES; ACETYLCHOLINE-RECEPTOR; ALPHA-SUBUNIT; CRYSTAL-STRUCTURE; DELTA-SUBUNIT; DEPENDENT CONTRIBUTIONS; TORPEDO-CALIFORNICA; ANGSTROM RESOLUTION	The defining feature of the alpha subunits of the family of nicotinic acetylcholine receptors is a vicinal disulfide between Cys-192 and Cys-193. Although this structure has played a pivotal role in a number of pioneering studies of nicotinic receptors, its functional role in native receptors remains uncertain. Using mutant cycle analysis and unnatural residue mutagenesis, including backbone mutagenesis of the peptide bond of the vicinal disulfide, we have established the presence of a network of hydrogen bonds that extends from that peptide NH, across a beta turn to another backbone hydrogen bond, and then across the subunit interface to the side chain of a functionally important Asp residue in the non-alpha subunit. We propose that the role of the vicinal disulfide is to distort the beta turn and thereby properly position a backbone NH for intersubunit hydrogen bonding to the key Asp.	[Dougherty, Dennis A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Lester, Henry A.] CALTECH, Dept Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Dougherty, DA (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	dadougherty@caltech.edu			National Institutes of Health [NS 34407, NS 11756]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011756, R37NS034407, R01NS034407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS 34407 (to D.A.D.) and NS 11756 (to H.A.L.).	Akk G, 1999, BIOPHYS J, V76, P207, DOI 10.1016/S0006-3495(99)77190-0; AUBRY A, 1981, INT J PEPT PROT RES, V18, P195; Avizonis DZ, 1996, J AM CHEM SOC, V118, P13031, DOI 10.1021/ja962005v; Beene DL, 2003, CURR OPIN NEUROBIOL, V13, P264, DOI 10.1016/S0959-4388(03)00068-0; Beligere GS, 2000, J AM CHEM SOC, V122, P12079, DOI 10.1021/ja001648e; Blankenship JW, 2002, BIOCHEMISTRY-US, V41, P15676, DOI 10.1021/bi026862p; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; CAPASSO S, 1977, ACTA CRYSTALLOGR B, V33, P2080, DOI 10.1107/S0567740877007778; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; CHABALA LD, 1986, J PHYSIOL-LONDON, V379, P83, DOI 10.1113/jphysiol.1986.sp016242; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Creighton CJ, 2001, J AM CHEM SOC, V123, P12664, DOI 10.1021/ja016505m; CZAJKOWSKI C, 1991, J BIOL CHEM, V266, P22603; CZAJKOWSKI C, 1995, J BIOL CHEM, V270, P3160, DOI 10.1074/jbc.270.7.3160; CZAJKOWSKI C, 1993, P NATL ACAD SCI USA, V90, P6285, DOI 10.1073/pnas.90.13.6285; DAMLE VN, 1980, BIOCHEMISTRY-US, V19, P3924, DOI 10.1021/bi00558a006; Deechongkit S, 2004, J AM CHEM SOC, V126, P16762, DOI 10.1021/ja045934s; Deechongkit S, 2004, NATURE, V430, P101, DOI 10.1038/nature02611; Deechongkit S, 2004, ORG LETT, V6, P497, DOI 10.1021/ol036102m; Dugave C, 2003, CHEM REV, V103, P2475, DOI 10.1021/cr0104375; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; Frisch M., 2016, GAUSSIAN 16 REVISION; Gao F, 2006, MOL PHARMACOL, V70, P1230, DOI 10.1124/mol.106.027185; Gleitsman K. R, 2010, THESIS CALTECH PASAD; Gleitsman KR, 2008, J BIOL CHEM, V283, P35638, DOI 10.1074/jbc.M807226200; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Grutter T, 2001, TRENDS BIOCHEM SCI, V26, P459, DOI 10.1016/S0968-0004(01)01921-1; HATA Y, 1977, ACTA CRYSTALLOGR B, V33, P3561, DOI 10.1107/S0567740877011480; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; Hudaky I, 2004, PROTEINS, V55, P152, DOI 10.1002/prot.10581; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; KAO PN, 1984, J BIOL CHEM, V259, P1662; KAO PN, 1986, J BIOL CHEM, V261, P8085; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; KARLIN A, 1966, BIOCHIM BIOPHYS ACTA, V126, P525, DOI 10.1016/0926-6585(66)90010-0; Karlin A., 1969, J GEN PHYSIOL, V54, P245; Koh JT, 1997, BIOCHEMISTRY-US, V36, P11314, DOI 10.1021/bi9707685; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Makhatadze GI, 2003, J MOL BIOL, V327, P1135, DOI 10.1016/S0022-2836(03)00233-X; Martin M, 1996, J BIOL CHEM, V271, P13497, DOI 10.1074/jbc.271.23.13497; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; Nakhle BM, 2000, J AM CHEM SOC, V122, P8105, DOI 10.1021/ja0006090; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Park JD, 2002, J MED CHEM, V45, P911, DOI 10.1021/jm010272s; Puskar NL, 2011, J BIOL CHEM, V286, P14618, DOI 10.1074/jbc.M110.206565; Romanelli MN, 2007, CHEMMEDCHEM, V2, P746, DOI 10.1002/cmdc.200600207; Ruggles EL, 2009, TETRAHEDRON, V65, P1257, DOI 10.1016/j.tet.2008.11.085; SILMAN I, 1969, SCIENCE, V164, P1420, DOI 10.1126/science.164.3886.1420; Silverman S. K, 1998, THESIS CALTECH PASAD; Sine SM, 2002, J GEN PHYSIOL, V120, P483, DOI 10.1085/jgp.20028568; Sohn CH, 2009, J AM CHEM SOC, V131, P5444, DOI 10.1021/ja806534r; SPARTAN, SPARTAN; Torrice M. M, 2009, THESIS CALTECH PASAD; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VITOUX B, 1981, INT J PEPT PROT RES, V17, P469; WALKER JW, 1981, BIOCHEMISTRY-US, V20, P2191, DOI 10.1021/bi00511a018; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	60	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32251	32258		10.1074/jbc.M111.254235	http://dx.doi.org/10.1074/jbc.M111.254235			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21757705	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000294726800035
J	Boysen, KE; Matuschewski, K				Boysen, Katja E.; Matuschewski, Kai			Arrested Oocyst Maturation in Plasmodium Parasites Lacking Type II NADH:Ubiquinone Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FALCIPARUM DIHYDROOROTATE DEHYDROGENASE; MITOCHONDRIAL ELECTRON-TRANSPORT; ALTERNATIVE NADH DEHYDROGENASE; HIGH-AFFINITY INHIBITOR; MALARIA-PARASITE; QUINONE OXIDOREDUCTASE; RESPIRATORY-CHAIN; DRUG TARGETS; LIFE-CYCLE; COMPLEX-I	The Plasmodium mitochondrial electron transport chain has received considerable attention as a potential target for new antimalarial drugs. Atovaquone, a potent inhibitor of Plasmodium cytochrome bc(1), in combination with proguanil is recommended for chemoprophylaxis and treatment of malaria. The type II NADH: ubiquinone oxidoreductase (NDH2) is considered an attractive drug target, as its inhibition is thought to lead to the arrest of the mitochondrial electron transport chain and, as a consequence, pyrimidine biosynthesis, an essential pathway for the parasite. Using the rodent malaria parasite Plasmodium berghei as an in vivo infection model, we studied the role of NDH2 during Plasmodium life cycle progression. NDH2 can be deleted by targeted gene disruption and, thus, is dispensable for the pathogenic asexual blood stages, disproving the candidacy for an anti-malarial drug target. After transmission to the insect vector, NDH2-deficient ookinetes display an intact mitochondrial membrane potential. However, ndh2(-) parasites fail to develop into mature oocysts in the mosquito midgut. We propose that Plasmodium blood stage parasites rely on glycolysis as the main ATP generating process, whereas in the invertebrate vector, a glucose-deprived environment, the malaria parasite is dependent on an intact mitochondrial respiratory chain.	[Boysen, Katja E.; Matuschewski, Kai] Max Planck Inst Infect Biol, Parasitol Unit, D-10117 Berlin, Germany	Max Planck Society	Matuschewski, K (corresponding author), Max Planck Inst Infect Biol, Parasitol Unit, Charitepl 1, D-10117 Berlin, Germany.	matuschewski@mpiib-berlin.mpg.de		Matuschewski, Kai/0000-0001-6147-8591	Max Planck Society; EviMalar network of excellence [34]	Max Planck Society(Max Planck Society); EviMalar network of excellence	This work was supported by the Max Planck Society and partly by grants from the EviMalar network of excellence (#34).	Aikawa M, 1974, P1; Bajohr LL, 2010, ANTIMICROB AGENTS CH, V54, P517, DOI 10.1128/AAC.01001-09; Baker DA, 2010, MOL BIOCHEM PARASIT, V172, P57, DOI 10.1016/j.molbiopara.2010.03.019; Barton V, 2010, CURR OPIN CHEM BIOL, V14, P440, DOI 10.1016/j.cbpa.2010.05.005; Biagini GA, 2006, ANTIMICROB AGENTS CH, V50, P1841, DOI 10.1128/AAC.50.5.1841-1851.2006; Booker ML, 2010, J BIOL CHEM, V285, P33054, DOI 10.1074/jbc.M110.162081; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brown SV, 2006, EUKARYOT CELL, V5, P45, DOI 10.1128/EC.5.1.45-53.2006; CANNING EU, 1973, PARASITOLOGY, V67, P29, DOI 10.1017/S0031182000046266; Carter V, 2008, MOL MICROBIOL, V68, P1560, DOI 10.1111/j.1365-2958.2008.06254.x; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Davies M, 2009, J MED CHEM, V52, P2683, DOI 10.1021/jm800963t; Dong CK, 2009, BIOORG MED CHEM LETT, V19, P972, DOI 10.1016/j.bmcl.2008.11.071; Eschemann A, 2005, J BIOL CHEM, V280, P3138, DOI 10.1074/jbc.M411217200; Fisher N, 2008, TRENDS PARASITOL, V24, P9, DOI 10.1016/j.pt.2007.10.001; Fisher N, 2007, TRENDS PARASITOL, V23, P305, DOI 10.1016/j.pt.2007.04.014; Fisher N, 2009, METHOD ENZYMOL, V456, P303, DOI 10.1016/S0076-6879(08)04417-0; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; Ganesan SM, 2011, MOL BIOCHEM PARASIT, V177, P29, DOI 10.1016/j.molbiopara.2011.01.004; Ganter M, 2009, MOL MICROBIOL, V74, P1356, DOI 10.1111/j.1365-2958.2009.06828.x; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; HATEFI Y, 1962, J BIOL CHEM, V237, P1676; HEYMANN H, 1948, J BIOL CHEM, V176, P1359; Hirai M, 2010, ACTA TROP, V114, P157, DOI 10.1016/j.actatropica.2009.08.005; Hochachka PW, 1984, BIOCH ADAPTATION, P145; HOWELLS RE, 1969, MIL MED, V134, P893; HOWELLS RE, 1970, ANN TROP MED PARASIT, V64, P181, DOI 10.1080/00034983.1970.11686680; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jayabalasingham B, 2010, CELL RES, V20, P1043, DOI 10.1038/cr.2010.88; Kawahara K, 2009, J BIOCHEM, V145, P229, DOI 10.1093/jb/mvn161; Kerscher SJ, 2000, BBA-BIOENERGETICS, V1459, P274, DOI 10.1016/S0005-2728(00)00162-6; Krungkrai J, 2000, PARASITE, V7, P19, DOI 10.1051/parasite/2000071019; Krungkrai J, 2002, EXP PARASITOL, V100, P54, DOI 10.1006/expr.2001.4674; Lang-Unnasch N, 1998, ANNU REV MICROBIOL, V52, P561, DOI 10.1146/annurev.micro.52.1.561; LANGRETH SG, 1978, J PROTOZOOL, V25, P443, DOI 10.1111/j.1550-7408.1978.tb04167.x; Malmquist NA, 2008, BIOCHEMISTRY-US, V47, P2466, DOI 10.1021/bi702218c; Mather MW, 2007, CURR DRUG TARGETS, V8, P49, DOI 10.2174/138945007779315632; Mather MW, 2008, J BIOENERG BIOMEMBR, V40, P425, DOI 10.1007/s10863-008-9176-4; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Mogi T, 2009, FEMS MICROBIOL LETT, V291, P157, DOI 10.1111/j.1574-6968.2008.01451.x; Mogi T, 2009, MITOCHONDRION, V9, P443, DOI 10.1016/j.mito.2009.08.004; Nina PB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000418; Olszewski KL, 2010, NATURE, V466, P774, DOI 10.1038/nature09301; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Painter HJ, 2010, ANTIMICROB AGENTS CH, V54, P5281, DOI 10.1128/AAC.00937-10; Patel V, 2008, J BIOL CHEM, V283, P35078, DOI 10.1074/jbc.M804990200; Petersen I, 2011, FEBS LETT, V585, P1551, DOI 10.1016/j.febslet.2011.04.042; Phillips Margaret A., 2010, Infectious Disorders - Drug Targets, V10, P226; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; Raine JD, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030030; Rodrigues T, 2010, CURR MED CHEM, V17, P929, DOI 10.2174/092986710790820660; Saleh A, 2007, ANTIMICROB AGENTS CH, V51, P1217, DOI 10.1128/AAC.00895-06; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Siden-Kiamos I, 2000, J CELL SCI, V113, P3419; Sinden R. E., 1997, The molecular biology of insect disease vectors: a methods manual., P67; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Suraveratum N, 2000, MOL BIOCHEM PARASIT, V105, P215, DOI 10.1016/S0166-6851(99)00180-2; TERZAKIS JA, 1967, J CELL BIOL, V34, P311, DOI 10.1083/jcb.34.1.311; TERZAKIS JA, 1974, J PROTOZOOL, V21, P251, DOI 10.1111/j.1550-7408.1974.tb03649.x; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; Vaidya Akhil B., 1998, P355; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; Vontas J, 2005, MOL BIOCHEM PARASIT, V139, P1, DOI 10.1016/j.molbiopara.2004.03.003; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2020, REP ANT DRUG EFF RES	66	60	61	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32661	32671		10.1074/jbc.M111.269399	http://dx.doi.org/10.1074/jbc.M111.269399			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21771793	Green Published, hybrid			2022-12-25	WOS:000294726800075
J	Salinas, RK; Bruschweiler-Li, L; Johnson, E; Bruschweiler, R				Salinas, Roberto K.; Bruschweiler-Li, Lei; Johnson, Eric; Brueschweiler, Rafael			Ca2+ Binding Alters the Interdomain Flexibility between the Two Cytoplasmic Calcium-binding Domains in the Na+/Ca2+ Exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUAL DIPOLAR COUPLINGS; NA+-CA2+ EXCHANGER; CA2+-BINDING DOMAIN; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURES; NMR-SPECTROSCOPY; C-2 DOMAINS; RELAXATION; ALIGNMENT; PROTEINS	The Na+/Ca2+ exchanger (NCX) is a membrane protein, which catalyzes the counter transport of Na+ and Ca2+ ions across the plasma membrane, playing a key role in the maintenance of the intracellular Ca2+ homeostasis in various cell types. NCX consists of a transmembrane part and a large intracellular loop. The activation of the NCX transport function requires the binding of Ca2+ to two tandem C2 domains, CBD1 and CBD2, which are an integral part of the exchanger's intracellular loop. Although high-resolution structures of individual CBD1 and CBD2 are available, their interdomain structure and dynamics and the atomic level mechanism of allosteric Ca2+-regulation remains unknown. Here, we use solution NMR spectroscopy to study the interdomain dynamics of CBD12, a 32 kDa construct that contains both the CBD1 and CBD2 domains connected by a short linker. Analysis of NMR residual dipolar couplings shows that CBD12 assumes on average an elongated shape both in the absence and in the presence of Ca2+. NMR N-15 relaxation data of the Apo state indicate that the two domains sample a wide range of relative arrangements on the nanosecond time scale. These arrangements comprise significantly non-linear interdomain orientations. Binding of Ca2+ to CBD1 significantly restricts the interdomain flexibility, stabilizing a more rigid elongated conformation. These findings suggest a molecular mechanism for the role of CBD12 in the function of NCX.	[Salinas, Roberto K.; Bruschweiler-Li, Lei; Johnson, Eric; Brueschweiler, Rafael] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Salinas, Roberto K.; Bruschweiler-Li, Lei; Johnson, Eric; Brueschweiler, Rafael] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Bruschweiler, R (corresponding author), Florida State Univ, Dept Chem & Biochem, 95 Chieftan Way,Rm 118 DLC, Tallahassee, FL 32306 USA.	bruschweiler@magnet.fsu.edu	Bruschweiler, Rafael/F-6624-2015; Complexos, INCT Fluidos/H-9172-2013; Salinas, Roberto Kopke/C-2036-2012	Salinas, Roberto Kopke/0000-0003-1032-7683; Johnson, Eric/0000-0001-8735-8184	National Science Foundation [MCB-0918362]; American Heart Association	National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association)	This work was supported by Grant MCB-0918362 of the National Science Foundation.; Recipient of postdoctoral fellowship from the American Heart Association.	Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Blackledge M, 2005, PROG NUCL MAG RES SP, V46, P23, DOI 10.1016/j.pnmrs.2004.11.002; Boyman L, 2009, J BIOL CHEM, V284, P6185, DOI 10.1074/jbc.M809012200; Breukels V, 2010, PROTEINS, V78, P1813, DOI 10.1002/prot.22695; Brookes E, 2010, MACROMOL BIOSCI, V10, P746, DOI 10.1002/mabi.200900474; Brutscher B, 1997, BIOCHEMISTRY-US, V36, P13043, DOI 10.1021/bi971538t; Chaptal V, 2009, J BIOL CHEM, V284, P14688, DOI 10.1074/jbc.C900037200; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyck C, 1998, J BIOL CHEM, V273, P12981, DOI 10.1074/jbc.273.21.12981; Fushman D, 2004, PROG NUCL MAG RES SP, V44, P189, DOI 10.1016/j.pnmrs.2004.02.001; Giladi M, 2010, J BIOL CHEM, V285, P28117, DOI 10.1074/jbc.M110.127001; Haussinger D, 2002, J MOL BIOL, V324, P823, DOI 10.1016/S0022-2836(02)01137-3; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; HILGEMANN DW, 1990, NATURE, V344, P242, DOI 10.1038/344242a0; Hus JC, 2008, J AM CHEM SOC, V130, P15927, DOI 10.1021/ja804274s; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Johnson E, 2008, J MOL BIOL, V377, P945, DOI 10.1016/j.jmb.2008.01.046; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Massi F, 2004, J AM CHEM SOC, V126, P2247, DOI 10.1021/ja038721w; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Ottolia M, 2010, CHANNELS, V4, P159, DOI 10.4161/chan.4.3.11386; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Reeves JP, 2008, CHANNELS, V2, P322, DOI 10.4161/chan.2.5.6897; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walsh JD, 2010, BIOPHYS J, V99, P2636, DOI 10.1016/j.bpj.2010.08.036; Wu MS, 2010, J BIOL CHEM, V285, P2554, DOI 10.1074/jbc.M109.059162; Wu MS, 2009, J MOL BIOL, V387, P104, DOI 10.1016/j.jmb.2009.01.045	43	28	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32123	32131		10.1074/jbc.M111.249268	http://dx.doi.org/10.1074/jbc.M111.249268			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778234	Green Published, hybrid			2022-12-25	WOS:000294726800022
J	Suzuki, T; Yoshinaga, N; Tanabe, S				Suzuki, Takuya; Yoshinaga, Naho; Tanabe, Soichi			Interleukin-6 (IL-6) Regulates Claudin-2 Expression and Tight Junction Permeability in Intestinal Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARRIER FUNCTION; EXPERIMENTAL COLITIS; SELECTIVE CHANNELS; CROHNS-DISEASE; CELLS; ACTIVATION; OCCLUDIN; KINASE; APOPTOSIS; PKC	In inflammatory bowel diseases (IBD), intestinal barrier function is impaired as a result of deteriorations in epithelial tight junction (TJ) structure. IL-6, a pleiotropic cytokine, is elevated in IBD patients, although the role of IL-6 in barrier function remains unknown. We present evidence that IL-6 increases TJ permeability by stimulating the expression of channel-forming claudin-2, which is required for increased caudal-related homeobox (Cdx) 2 through the MEK/ERK and PI3K pathways in intestinal epithelial cells. IL-6 increases the cation-selective TJ permeability without any changes to uncharged dextran flux or cell viability in Caco-2 cells. IL-6 markedly induces claudin-2 expression, which is associated with increased TJ permeability. The colonic mucosa of mice injected with IL-6 also exhibits an increase in claudin-2 expression. The claudin-2 expression and TJ permeability induced by IL-6 are sensitive to the inhibition of gp130, MEK, and PI3K. Furthermore, expression of WT-MEK1 induces claudin-2 expression in Caco-2 cells. Claudin-2 promoter activity is increased by IL-6 in a MEK/ERK and PI3K-dependent manner, and deletion of Cdx binding sites in the promoter sequence results in a loss of IL-6-induced promoter activity. IL-6 increases Cdx2 protein expression, which is suppressed by the inhibition of MEK and PI3K. These observations may reveal an important mechanism by which IL-6 can undermine the integrity of the intestinal barrier.	[Suzuki, Takuya; Yoshinaga, Naho; Tanabe, Soichi] Hiroshima Univ, Grad Sch Biosphere Sci, Dept Biofunct Sci & Technol, Higashihiroshima 7398528, Japan	Hiroshima University	Suzuki, T (corresponding author), 1-4-4 Kagamiyama, Higashihiroshima 7398528, Japan.	takuya@hiroshima-u.ac.jp	Tanabe, Soichi/R-6229-2019; Suzuki, Takuya/H-3750-2019	Suzuki, Takuya/0000-0003-3709-543X	Japan Society for the Promotion of Science [21780117]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science, Grant-in-Aid for Young Scientists (B) 21780117.	Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Colegio OR, 2002, AM J PHYSIOL-CELL PH, V283, pC142, DOI 10.1152/ajpcell.00038.2002; Dahan S, 2008, GASTROENTEROLOGY, V134, P192, DOI 10.1053/j.gastro.2007.10.022; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Gunzel D, 2009, J CELL SCI, V122, P1507, DOI 10.1242/jcs.040113; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Inai T, 1999, EUR J CELL BIOL, V78, P849, DOI 10.1016/S0171-9335(99)80086-7; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; KUSUGAMI K, 1995, DIGEST DIS SCI, V40, P949, DOI 10.1007/BF02064182; Louis E, 1997, EUR J GASTROEN HEPAT, V9, P939, DOI 10.1097/00042737-199710000-00004; Mankertz J, 2004, BIOCHEM BIOPH RES CO, V314, P1001, DOI 10.1016/j.bbrc.2003.12.185; Mankertz J, 2009, CELL TISSUE RES, V336, P67, DOI 10.1007/s00441-009-0751-8; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Nunbhakdi-Craig V, 2002, J CELL BIOL, V158, P967, DOI 10.1083/jcb.200206114; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Reinisch W, 1999, AM J GASTROENTEROL, V94, P2156; Sakamoto H, 2010, SCAND J GASTROENTERO, V45, P1273, DOI 10.3109/00365521.2010.501522; Sander LE, 2008, J IMMUNOL, V181, P3586, DOI 10.4049/jimmunol.181.5.3586; Sheth P, 2003, J BIOL CHEM, V278, P49239, DOI 10.1074/jbc.M305654200; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Suzuki T, 2008, J BIOL CHEM, V283, P3574, DOI 10.1074/jbc.M709141200; Suzuki T, 2009, P NATL ACAD SCI USA, V106, P61, DOI 10.1073/pnas.0802741106; Tilg H, 1997, IMMUNOL TODAY, V18, P428, DOI 10.1016/S0167-5699(97)01103-1; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Wang LX, 2007, J BIOL CHEM, V282, P8219, DOI 10.1074/jbc.M604068200; Wang LX, 2003, J IMMUNOL, V171, P3194, DOI 10.4049/jimmunol.171.6.3194; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; Yamamoto M, 2000, J IMMUNOL, V164, P4878, DOI 10.4049/jimmunol.164.9.4878; Yang RK, 2003, AM J PHYSIOL-GASTR L, V285, pG621, DOI 10.1152/ajpgi.00177.2003	40	333	348	4	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31263	31271		10.1074/jbc.M111.238147	http://dx.doi.org/10.1074/jbc.M111.238147			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21771795	Green Published, hybrid			2022-12-25	WOS:000294487500021
J	Bowden, KL; Bilbey, NJ; Bilawchuk, LM; Boadu, E; Sidhu, R; Ory, DS; Du, H; Chan, T; Francis, GA				Bowden, Kristin L.; Bilbey, Nicolas J.; Bilawchuk, Leanne M.; Boadu, Emmanuel; Sidhu, Rohini; Ory, Daniel S.; Du, Hong; Chan, Teddy; Francis, Gordon A.			Lysosomal Acid Lipase Deficiency Impairs Regulation of ABCA1 Gene and Formation of High Density Lipoproteins in Cholesteryl Ester Storage Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-X-RECEPTOR; NIEMANN-PICK DISEASE; PLASMA HDL CHOLESTEROL; PARTICLE FORMATION; HUMAN FIBROBLASTS; LIPID EFFLUX; AGONIST; HYPOALPHALIPOPROTEINEMIA; 27-HYDROXYCHOLESTEROL; ESTERIFICATION	ATP-binding cassette transporter A1 (ABCA1) mediates the rate-limiting step in high density lipoprotein (HDL) particle formation, and its expression is regulated primarily by oxysterol-dependent activation of liver X receptors. We previously reported that ABCA1 expression and HDL formation are impaired in the lysosomal cholesterol storage disorder Niemann-Pick disease type C1 and that plasma HDL-C is low in the majority of Niemann-Pick disease type C patients. Here, we show that ABCA1 regulation and activity are also impaired in cholesteryl ester storage disease (CESD), caused by mutations in the LIPA gene that result in less than 5% of normal lysosomal acid lipase (LAL) activity. Fibroblasts from patients with CESD showed impaired up-regulation of ABCA1 in response to low density lipoprotein (LDL) loading, reduced phospholipid and cholesterol efflux to apolipoprotein A-I, and reduced alpha-HDL particle formation. Treatment of normal fibroblasts with chloroquine to inhibit LAL activity reduced ABCA1 expression and activity, similar to that of CESD cells. Liver X receptor agonist treatment of CESD cells corrected ABCA1 expression but failed to correct LDL cholesteryl ester hydrolysis and cholesterol efflux to apoA-I. LDL-induced production of 27-hydroxycholesterol was reduced in CESD compared with normal fibroblasts. Treatment with conditioned medium containing LAL from normal fibroblasts or with recombinant human LAL rescued ABCA1 expression, apoA-I-mediated cholesterol efflux, HDL particle formation, and production of 27-hydroxycholesterol by CESD cells. These results provide further evidence that the rate of release of cholesterol from late endosomes/lysosomes is a critical regulator of ABCA1 expression and activity, and an explanation for the hypoalphalipoproteinemia seen in CESD patients.	[Bowden, Kristin L.; Bilbey, Nicolas J.; Bilawchuk, Leanne M.; Boadu, Emmanuel; Chan, Teddy; Francis, Gordon A.] St Pauls Hosp, Inst Heart & Lung Hlth, Dept Med, Vancouver, BC V6Z 1Y6, Canada; [Sidhu, Rohini; Ory, Daniel S.] Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA; [Du, Hong] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA	St. Paul's Hospital; University of Saskatchewan; Washington University (WUSTL); University System of Ohio; University of Cincinnati	Francis, GA (corresponding author), St Pauls Hosp, Inst Heart & Lung Hlth, Dept Med, Rm 166,Burrard Bldg,1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	gordon.francis@hli.ubc.ca	应, 宁宁/G-9472-2011; Sidhu, Rohini/G-3547-2012	Sidhu, Rohini/0000-0003-1703-2167	Canadian Institutes of Health Research [MOP-79532]; National Institutes of Health [HL067773, HL087001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067773, R01HL087001] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Canadian Institutes of Health Research Grant MOP-79532 (to G. A. F.). This work was also supported by National Institutes of Health Grants HL067773 (to D. S. O.) and HL087001 (to H. D.).	Anderson RA, 1999, MOL GENET METAB, V68, P333, DOI 10.1006/mgme.1999.2904; Aravindhan K, 2006, J LIPID RES, V47, P1250, DOI 10.1194/jlr.M500512-JLR200; Assmann G, 2001, METABOLIC MOL BASES, P3551; AXELSON M, 1995, J BIOL CHEM, V270, P15102, DOI 10.1074/jbc.270.25.15102; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boadu E, 2006, J BIOL CHEM, V281, P37081, DOI 10.1074/jbc.M606890200; BROWN MS, 1974, J BIOL CHEM, V249, P789; BROWN MS, 1976, J BIOL CHEM, V251, P3277; BROWN MS, 1975, P NATL ACAD SCI USA, V72, P2925, DOI 10.1073/pnas.72.8.2925; Brunham LR, 2006, CIRC RES, V99, P672, DOI 10.1161/01.RES.0000244014.19589.8e; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Chen WG, 2005, J BIOL CHEM, V280, P29277, DOI 10.1074/jbc.M505566200; Choi HY, 2003, J BIOL CHEM, V278, P32569, DOI 10.1074/jbc.M304553200; CHUNG BH, 1980, J LIPID RES, V21, P284; Du H, 1998, MOL GENET METAB, V64, P126, DOI 10.1006/mgme.1998.2707; Du H, 2001, J LIPID RES, V42, P489; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis GA, 1996, BIOCHEMISTRY-US, V35, P15188, DOI 10.1021/bi9618169; Francis GA, 2010, BBA-MOL CELL BIOL L, V1801, P1286, DOI 10.1016/j.bbalip.2010.08.009; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Garver WS, 2010, J LIPID RES, V51, P406, DOI 10.1194/jlr.P000331; GINSBERG HN, 1987, J CLIN INVEST, V80, P1692, DOI 10.1172/JCI113259; GOLDSTEIN JL, 1975, J BIOL CHEM, V250, P8487; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; GUARDIOLA F, 1995, J CHROMATOGR A, V705, P289, DOI 10.1016/0021-9673(95)00034-K; Kennedy MA, 2001, J BIOL CHEM, V276, P39438, DOI 10.1074/jbc.M105863200; KRUTH HS, 1986, J BIOL CHEM, V261, P6769; Langmade SJ, 2006, P NATL ACAD SCI USA, V103, P13807, DOI 10.1073/pnas.0606218103; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Menke JG, 2002, ENDOCRINOLOGY, V143, P2548, DOI 10.1210/en.143.7.2548; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; PENTCHEV PG, 1986, J BIOL CHEM, V261, P6775; PENTCHEV PG, 1987, FASEB J, V1, P40, DOI 10.1096/fasebj.1.1.3609608; Sahoo D, 2004, J LIPID RES, V45, P1122, DOI 10.1194/jlr.M300529-JLR200; SANDO GN, 1985, J BIOL CHEM, V260, P5186; SANDO GN, 1982, J LIPID RES, V23, P114; SATTLER W, 1993, BIOCHEM J, V294, P771, DOI 10.1042/bj2940771; SHERIFF S, 1995, J BIOL CHEM, V270, P27766, DOI 10.1074/jbc.270.46.27766; Tang WQ, 2008, ARTERIOSCL THROM VAS, V28, P448, DOI 10.1161/ATVBAHA.107.160465; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Waddington EI, 2005, METHODS, V36, P196, DOI 10.1016/j.ymeth.2004.12.002; Wang MD, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700326200; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Whitney KD, 2001, J BIOL CHEM, V276, P43509, DOI 10.1074/jbc.M106155200; Wong J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-10; Xie CL, 1999, P NATL ACAD SCI USA, V96, P11992, DOI 10.1073/pnas.96.21.11992; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	50	65	71	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30624	30635		10.1074/jbc.M111.274381	http://dx.doi.org/10.1074/jbc.M111.274381			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757691	Green Published, hybrid			2022-12-25	WOS:000294283600042
J	Fernandes, RJ; Farnand, AW; Traeger, GR; Weis, MA; Eyre, DR				Fernandes, Russell J.; Farnand, Alex W.; Traeger, Geoffrey R.; Weis, Mary Ann; Eyre, David R.			A Role for Prolyl 3-Hydroxylase 2 in Post-translational Modification of Fibril-forming Collagens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE OSTEOGENESIS IMPERFECTA; 3-HYDROXYPROLINE RESIDUES; LYSYL HYDROXYLASE; PROCOLLAGEN-II; AMINO-ACID; CELL-LINE; IN-VITRO; FAMILY; MUTATIONS; LEPRECAN	The fibrillar collagen types I, II, and V/XI have recently been shown to have partially 3-hydroxylated proline (3Hyp) residues at sites other than the established primary Pro-986 site in the collagen triple helical domain. These sites showed tissue specificity in degree of hydroxylation and a pattern of D-periodic spacing. This suggested a contributory role in fibril supramolecular assembly. The sites in clade A fibrillar alpha 1(II), alpha 2(V), and alpha 1(I) collagen chains share common features with known prolyl 3-hydroxylase 2 (P3H2) substrate sites in alpha 1(IV) chains implying a role for this enzyme. We pursued this possibility using the Swarm rat chondrosarcoma cell line (RCS-LTC) found to express high levels of P3H2 mRNA. Mass spectrometry determined that all the additional candidate 3Hyp substrate sites in the pN type II collagen made by these cells were highly hydroxylated. In RNA interference experiments, P3H2 protein synthesis was suppressed coordinately with prolyl 3-hydroxylation at Pro-944, Pro-707, and the C-terminal GPP repeat of the pN alpha 1(II) chain, but Pro-986 remained fully hydroxylated. Furthermore, when P3H2 expression was turned off, as seen naturally in cultured SAOS-2 osteosarcoma cells, full 3Hyp occupancy at Pro-986 in alpha 1(I) chains was unaffected, whereas 3-hydroxylation of residue Pro-944 in the alpha 2(V) chain was largely lost, and 3-hydroxylation of Pro-707 in alpha 2(V) and alpha 2(I) chains were sharply reduced. The results imply that P3H2 has preferred substrate sequences among the classes of 3Hyp sites in clade A collagen chains.	[Fernandes, Russell J.; Farnand, Alex W.; Traeger, Geoffrey R.; Weis, Mary Ann; Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Orthopaed Res Labs, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Fernandes, RJ (corresponding author), 1959 NE Pacific St,HSB BB1010,Box 356500, Seattle, WA 98195 USA.	rjf@u.washington.edu			National Institutes of Health, NIAMS [AR057025, AR036794, AR037318]; National Center for Research Resources [TL1 RR025016]; University of Washington; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036794, R01AR037318, R37AR036794, R01AR057025, R37AR037318] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Washington(University of Washington); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health, NIAMS Grants AR057025 (to R. J. F.) and AR036794 and AR037318 (to D. R. E.). This work was also supported by National Center for Research Resources Grant TL1 RR025016 (to A. W. F.) and the Ernest M. Burgess Endowed Chair research program at the University of Washington.	Arnold WV, 1998, J BIOL CHEM, V273, P31822, DOI 10.1074/jbc.273.48.31822; Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; BISHOP PN, 1994, BIOCHEM BIOPH RES CO, V203, P289, DOI 10.1006/bbrc.1994.2180; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Capellini TD, 2008, GENESIS, V46, P683, DOI 10.1002/dvg.20406; Eyre DR, 2011, J BIOL CHEM, V286, P7732, DOI 10.1074/jbc.C110.195768; Fernandes RJ, 2003, EUR J BIOCHEM, V270, P3243, DOI 10.1046/j.1432-1033.2003.03711.x; Fernandes RJ, 1997, EUR J BIOCHEM, V247, P620, DOI 10.1111/j.1432-1033.1997.00620.x; Fernandes RJ, 2001, J BIOL CHEM, V276, P31502, DOI 10.1074/jbc.M103466200; Fernandes RJ, 2007, MATRIX BIOL, V26, P597, DOI 10.1016/j.matbio.2007.06.007; Fernandes RJ, 2007, BONE, V40, P1343, DOI 10.1016/j.bone.2007.01.011; Goto T, 2006, J BONE MINER RES, V21, P661, DOI 10.1359/JBMR.020605; HOLMES DF, 1993, J BIOL CHEM, V268, P15758; Hudson DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019336; Jarnum S, 2004, BIOCHEM BIOPH RES CO, V317, P342, DOI 10.1016/j.bbrc.2004.03.060; Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j; KADLER KE, 1993, INT J EXP PATHOL, V74, P319; KIVIRIKKO KI, 1973, BIOCHEMISTRY-US, V12, P4966, DOI 10.1021/bi00748a023; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Miller AD, 2006, OSTEOARTHR CARTILAGE, V14, P1315, DOI 10.1016/j.joca.2006.08.004; Mizuno K, 2008, FEBS J, V275, P5830, DOI 10.1111/j.1742-4658.2008.06704.x; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; MOULD AP, 1987, J MOL BIOL, V195, P543, DOI 10.1016/0022-2836(87)90182-3; MYLLYLA R, 1981, BIOCHEM J, V196, P683, DOI 10.1042/bj1960683; OGLE JD, 1962, J BIOL CHEM, V237, P3667; OLSEN BR, 1973, EUR J BIOCHEM, V35, P135, DOI 10.1111/j.1432-1033.1973.tb02819.x; RISTELI J, 1974, BIOCHEM J, V144, P115, DOI 10.1042/bj1440115; SCHUPPAN D, 1982, EUR J BIOCHEM, V123, P505; Shah R, 2009, BRIT J CANCER, V100, P1687, DOI 10.1038/sj.bjc.6605042; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; TRYGGVASON K, 1979, BIOCHEM J, V183, P303, DOI 10.1042/bj1830303; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Vranka J, 2009, CELL STRUCT FUNCT, V34, P97, DOI 10.1247/csf.09002; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; Wassnehove-McCarthy DJ, 1999, J BIOL CHEM, V274, P25004, DOI 10.1074/jbc.274.35.25004; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Willaert A, 2009, J MED GENET, V46, P233, DOI 10.1136/jmg.2008.062729	37	27	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30662	30669		10.1074/jbc.M111.267906	http://dx.doi.org/10.1074/jbc.M111.267906			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757687	Green Published, hybrid			2022-12-25	WOS:000294283600046
J	Li, L; Wang, DL; Jiang, YA; Sun, JF; Zhang, SY; Chen, YY; Wang, XQ				Li, Liang; Wang, Dongli; Jiang, Yinan; Sun, Jianfeng; Zhang, Senyan; Chen, Yuanyuan; Wang, Xinquan			Crystal Structure of Human ISG15 Protein in Complex with Influenza B Virus NS1B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIVIRAL MOLECULE; STIMULATED GENE-15; A VIRUS; UBIQUITIN; DOMAIN; INTERFERONS; RESPONSES; SOFTWARE; BINDING	ISG15 (interferon-stimulated gene 15), the first ubiquitin-like protein (UBL) identified, has emerged as an important cellular antiviral factor. It consists of two UBL domains with a short linker between them. The covalent attachment of ISG15 to host and viral proteins to modify their functions, similar to ubiquitylation, is named ISGylation. Influenza B virus NS1B protein antagonizes human but not mouse ISGylation because NS1B exhibits species specificity; it only binds human and non-human primate ISG15. Previous studies have demonstrated that the N-terminal UBL domain and linker of ISG15 are required for the binding by NS1B and that the linker plays a large role in the species specificity, but the structural basis for them has not been elucidated. Here we report the crystal structure of human ISG15 in complex with NS1B at a resolution of 2.0 angstrom. A loop in the ISG15 N-terminal UBL domain inserts into a pocket in the NS1B dimer, forming a high affinity binding site. The nonspecific van der Waals contacts around the ISG15 linker form a low affinity site for NS1B binding. However, sequence alignment reveals that residues in the high affinity site are highly conserved in primate and non-primate ISG15. We propose that the low affinity binding around the ISG15 linker is important for the initial contact with NS1B and that the stable complex formation is largely contributed by the following high affinity interactions between ISG15 N-terminal UBL domain and NS1B. This provides a structural basis for the species-specific binding of ISG15 by the NS1B protein.	[Li, Liang; Wang, Dongli; Jiang, Yinan; Sun, Jianfeng; Wang, Xinquan] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China; [Chen, Yuanyuan] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Wang, XQ (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Key Lab Prot Sci, Med Sci Bldg C226, Beijing 100084, Peoples R China.	xinquanwang@mail.tsinghua.edu.cn	li, li/HII-4157-2022; Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022; li, li/GPX-3938-2022; zhang, sen/GXH-3513-2022; Chen, Yuanyuan/GXG-2130-2022		Ministry of Science and Technology [2011CB910502, 2010CB912402]; Ministry of Education of China [20090002120036, 20100002110001]; Tsinghua University; Fok Ying Tung Education Foundation	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education of China(Ministry of Education, China); Tsinghua University; Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation)	This work was supported by grants from the Ministry of Science and Technology (Grants 2011CB910502 and 2010CB912402), the Ministry of Education of China (Grants 20090002120036 and 20100002110001), the Tsinghua University 985 Phase II fund, and the Fok Ying Tung Education Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akutsu M, 2011, P NATL ACAD SCI USA, V108, P2228, DOI 10.1073/pnas.1015287108; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Chang YG, 2008, J BIOL CHEM, V283, P13370, DOI 10.1074/jbc.M800162200; Cheng A, 2009, CELL RES, V19, P187, DOI 10.1038/cr.2008.288; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245; James TW, 2011, P NATL ACAD SCI USA, V108, P2222, DOI 10.1073/pnas.1013388108; Jeon YJ, 2010, BBA-MOL BASIS DIS, V1802, P485, DOI 10.1016/j.bbadis.2010.02.006; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Narasimhan J, 2005, J BIOL CHEM, V280, P27356, DOI 10.1074/jbc.M502814200; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Skaug B, 2010, CELL, V143, P187, DOI 10.1016/j.cell.2010.09.033; Sridharan H, 2010, J BIOL CHEM, V285, P7852, DOI 10.1074/jbc.C109.095703; Versteeg GA, 2010, J VIROL, V84, P5423, DOI 10.1128/JVI.02395-09; Yin CF, 2007, J BIOL CHEM, V282, P20584, DOI 10.1074/jbc.M611619200; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Yuan WM, 2002, VIROLOGY, V304, P291, DOI 10.1006/viro.2002.1663; Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110	26	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30258	30262		10.1074/jbc.C111.257899	http://dx.doi.org/10.1074/jbc.C111.257899			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757684	Green Published, hybrid			2022-12-25	WOS:000294283600003
J	Mavaro, A; Abts, A; Bakkes, PJ; Moll, GN; Driessen, AJM; Smits, SHJ; Schmitt, L				Mavaro, Antonino; Abts, Andre; Bakkes, Patrick J.; Moll, Gert N.; Driessen, Arnold J. M.; Smits, Sander H. J.; Schmitt, Lutz			Substrate Recognition and Specificity of the NisB Protein, the Lantibiotic Dehydratase Involved in Nisin Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATION; LEADER PEPTIDE; KINETIC-ANALYSIS; LIPID-II; MECHANISM; TRANSPORT; IMMUNITY; EXPRESSION; PRECURSOR; PRENISIN	Nisin is a posttranslationally modified antimicrobial peptide containing the cyclic thioether amino acids lanthionine and methyllanthionine. Although much is known about its antimicrobial activity and mode of action, knowledge about the nisin modification process is still rather limited. The dehydratase NisB is believed to be the initial interaction partner in modification. NisB dehydrates specific serine and threonine residues in prenisin, whereas the cyclase NisC catalyzes the (methyl) lanthionine formation. The fully modified prenisin is exported and the leader peptide is cleaved off by the extracellular protease NisP. Light scattering analysis demonstrated that purified NisB is a dimer in solution. Using size exclusion chromatography and surface plasmon resonance, the interaction of NisB and prenisin, including several of its modified derivatives, was studied. Unmodified prenisin binds to NisB with an affinity of 1.05 +/- 0.25 mu M, whereas the dehydrated and the fully modified derivatives bind with respective affinities of 0.31 +/- 0.07 and 10.5 +/- 1.7 mu M. The much lower affinity for the fully modified prenisin was related to a > 20-fold higher off-rate. For all three peptides the stoichiometry of binding was 1:1. Active nisin, which is the equivalent of fully modified prenisin lacking the leader peptide did not bind to NisB, nor did prenisin in which the highly conserved FNLD box within the leader peptide was mutated to AAAA. Taken together our data indicate that the leader peptide is essential for initial recognition and binding of prenisin to NisB.	[Mavaro, Antonino; Abts, Andre; Bakkes, Patrick J.; Smits, Sander H. J.; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany; [Moll, Gert N.] BiOMaDe Technol Fdn, NL-9747 AG Groningen, Netherlands; [Driessen, Arnold J. M.] Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Driessen, Arnold J. M.] Univ Groningen, Kluyver Ctr Genom Ind Microorganisms, NL-9747 AG Groningen, Netherlands	Heinrich Heine University Dusseldorf; University of Groningen; University of Groningen	Schmitt, L (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, D-40225 Dusseldorf, Germany.	lutz.schmitt@hhu.de	Institute, Zernike/W-7033-2019; Driessen, Arnold J.M./D-1876-2012	Bakkes, Patrick/0000-0003-1876-7384; Driessen, Arnold J.M./0000-0001-9258-9104	Deutsche Forschungsgemeinschaft [SCHM 1279/10-1]; Heinrich Heine University of Duesseldorf	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heinrich Heine University of Duesseldorf	This work was supported by Deutsche Forschungsgemeinschaft SCHM 1279/10-1 and a grant from the Heinrich Heine University of Duesseldorf (to L. S.).	Abts A., 2011, INT J PEPTI IN PRESS; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 2003, J BIOL CHEM, V278, P19898, DOI 10.1074/jbc.M301463200; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Chatterjee C, 2005, J AM CHEM SOC, V127, P15332, DOI 10.1021/ja0543043; HANSEN JN, 1993, ANNU REV MICROBIOL, V47, P535, DOI 10.1146/annurev.micro.47.1.535; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Hesse M., 1987, SPEKTROSKOPISCHE MET, V4; KARLSSON R, 1994, ANAL BIOCHEM, V221, P142, DOI 10.1006/abio.1994.1390; Kiesau P, 1997, J BACTERIOL, V179, P1475, DOI 10.1128/jb.179.5.1475-1481.1997; Kluskens LD, 2005, BIOCHEMISTRY-US, V44, P12827, DOI 10.1021/bi050805p; Koponen O, 2002, MICROBIOL-SGM, V148, P3561, DOI 10.1099/00221287-148-11-3561; Kuipers A, 2004, J BIOL CHEM, V279, P22176, DOI 10.1074/jbc.M312789200; Kuipers A, 2008, APPL ENVIRON MICROB, V74, P6591, DOI 10.1128/AEM.01334-08; Kuipers A, 2006, APPL ENVIRON MICROB, V72, P7626, DOI 10.1128/AEM.01802-06; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; Lubelski J, 2008, CELL MOL LIFE SCI, V65, P455, DOI 10.1007/s00018-007-7171-2; Lubelski J, 2009, J BIOL CHEM, V284, P25962, DOI 10.1074/jbc.M109.026690; Mistrik P, 2004, ANAL BIOCHEM, V327, P271, DOI 10.1016/j.ab.2004.01.022; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Plat A, 2011, APPL ENVIRON MICROB, V77, P604, DOI 10.1128/AEM.01503-10; Projan SJ, 2007, CURR OPIN MICROBIOL, V10, P441, DOI 10.1016/j.mib.2007.08.007; Qiao M, 1996, J APPL BACTERIOL, V80, P626, DOI 10.1111/j.1365-2672.1996.tb03267.x; Qiao MQ, 1996, FEMS MICROBIOL LETT, V144, P89, DOI 10.1111/j.1574-6968.1996.tb08513.x; Ra SR, 1996, MICROBIOL-SGM, V142, P1281, DOI 10.1099/13500872-142-5-1281; Rew Y, 2002, J MED CHEM, V45, P3746, DOI 10.1021/jm020108k; Rink R, 2010, J PHARMACOL TOX MET, V61, P210, DOI 10.1016/j.vascn.2010.02.010; Rink R, 2005, BIOCHEMISTRY-US, V44, P8873, DOI 10.1021/bi050081h; Rink R, 2007, BIOCHEMISTRY-US, V46, P13179, DOI 10.1021/bi700106z; Rink R, 2007, APPL ENVIRON MICROB, V73, P1792, DOI 10.1128/AEM.02350-06; Sen AK, 1999, EUR J BIOCHEM, V261, P524, DOI 10.1046/j.1432-1327.1999.00303.x; Shioya K, 2010, APPL MICROBIOL BIOT, V86, P891, DOI 10.1007/s00253-009-2334-8; Siegers K, 1996, J BIOL CHEM, V271, P12294, DOI 10.1074/jbc.271.21.12294; SIEZEN RJ, 1995, PROTEIN ENG, V8, P117, DOI 10.1093/protein/8.2.117; Stein T, 2003, J BIOL CHEM, V278, P89, DOI 10.1074/jbc.M207237200; Sun ZZ, 2009, ANTIMICROB AGENTS CH, V53, P1964, DOI 10.1128/AAC.01382-08; van Saparoea HBV, 2008, APPL ENVIRON MICROB, V74, P5541, DOI 10.1128/AEM.00342-08; VANDERMEER JR, 1994, J BIOL CHEM, V269, P3555; Xie LL, 2002, BIOCHEM BIOPH RES CO, V295, P952, DOI 10.1016/S0006-291X(02)00783-0	41	44	45	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30552	30560		10.1074/jbc.M111.263210	http://dx.doi.org/10.1074/jbc.M111.263210			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757717	Green Published, hybrid			2022-12-25	WOS:000294283600034
J	Oshikawa, G; Nagao, T; Wu, N; Kurosu, T; Miura, O				Oshikawa, Gaku; Nagao, Toshikage; Wu, Nan; Kurosu, Tetsuya; Miura, Osamu			c-Cbl and Cbl-b Ligases Mediate 17-Allylaminodemethoxygeldanamycin-induced Degradation of Autophosphorylated Flt3 Kinase with Internal Tandem Duplication through the Ubiquitin Proteasome Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOGENOUS LEUKEMIA; ACUTE MYELOID-LEUKEMIA; MOLECULAR CHAPERONE; INHIBITOR PKC412; HSP90 INHIBITORS; TYROSINE KINASES; DOMAIN MUTATIONS; MUTANT FLT-3; AML CELLS; TRANSFORMATION	The class III receptor-tyrosine kinase Flt3 regulates normal hematopoiesis. Aninternal tandem duplication (ITD) in the juxtamembrane domain of Flt3 (Flt3-ITD) contributes to transformation and is associated with poor prognosis in acute myeloid leukemia. Here, we demonstrate that, as compared with wildtype Flt3 (Flt3-WT), Flt3-ITD more rapidly undergoes degradation through the proteasomal and lysosomal pathways in model hematopoietic 32D cells and in human leukemic MV4-11 cells. The Hsp90 inhibitor 17-allylaminodemethoxygeldanamycin (17-AAG) preferentially induced the polyubiquitination and proteasomal degradation of Flt3-ITD autophosphorylated on Tyr-591 in these cells. The E3 ubiquitin ligases c-Cbl and to a lesser extent Cbl-b facilitated at least partly Lys-48-linked polyubiquitination of autophosphorylated Flt3-ITD when coexpressed in 293T cells. Moreover, c-Cbl and Cbl-b facilitated degradation of Flt3-ITD in 293T cells and significantly enhanced the 17-AAG-induced decline in autophosphorylated Flt3-ITD. The enhancement of Flt3-ITD degradation was also observed in 32D cells inducibly overexpressing c-Cbl or Cbl-b. Furthermore, overexpression of loss-of-function mutants of both c-Cbl (c-Cbl-R420Q) and Cbl-b (Cbl-b-C373A) together in 32D cells retarded the degradation of autophosphorylated Flt3-ITD and significantly inhibited the 17-AAG-induced degradation of Flt3-ITD to confer the resistance to cytotoxicity of 17-AAG on these cells. These results suggest that c-Cbl as well as Cbl-b may play important roles in Hsp90 inhibitor-induced degradation of Flt3-ITD through the ubiquitin proteasome system and in regulation of the basal expression level of Flt3-ITD in leukemic cells.	[Oshikawa, Gaku; Nagao, Toshikage; Wu, Nan; Kurosu, Tetsuya; Miura, Osamu] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Bunkyo Ku, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU)	Miura, O (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	miura.hema@tmd.ac.jp		Miura, Osamu/0000-0002-0981-3054	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Al Shaer L, 2008, BRIT J HAEMATOL, V141, P483, DOI 10.1111/j.1365-2141.2008.07053.x; Bali P, 2004, CLIN CANCER RES, V10, P4991, DOI 10.1158/1078-0432.CCR-04-0210; Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132; Buchwald M, 2010, LEUKEMIA, V24, P1412, DOI 10.1038/leu.2010.114; Choudhary C, 2005, BLOOD, V106, P265, DOI 10.1182/blood-2004-07-2942; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Davies GC, 2004, ONCOGENE, V23, P7104, DOI 10.1038/sj.onc.1207952; George P, 2005, BLOOD, V105, P1768, DOI 10.1182/blood-2004-09-3413; George P, 2004, CANCER RES, V64, P3645, DOI 10.1158/0008-5472.CAN-04-0006; Jung T, 2009, MOL ASPECTS MED, V30, P191, DOI 10.1016/j.mam.2009.04.001; Kales SC, 2010, CANCER RES, V70, P4789, DOI 10.1158/0008-5472.CAN-10-0610; Kancha RK, 2007, EXP HEMATOL, V35, P1522, DOI 10.1016/j.exphem.2007.07.008; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lu ZM, 2009, ANNU REV BIOCHEM, V78, P435, DOI 10.1146/annurev.biochem.013008.092711; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Marx C, 2010, CANCER RES, V70, P3709, DOI 10.1158/0008-5472.CAN-09-3768; Masson K, 2009, CELL SIGNAL, V21, P1717, DOI 10.1016/j.cellsig.2009.06.002; Meshinchi S, 2009, CLIN CANCER RES, V15, P4263, DOI 10.1158/1078-0432.CCR-08-1123; Minami Y, 2002, LEUKEMIA, V16, P1535, DOI 10.1038/sj.leu.2402558; MIURA O, 1993, MOL CELL BIOL, V13, P1788, DOI 10.1128/MCB.13.3.1788; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Padron D, 2007, CANCER RES, V67, P7695, DOI 10.1158/0008-5472.CAN-07-0484; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Quentmeier H, 2003, LEUKEMIA, V17, P120, DOI 10.1038/sj.leu.2402740; Rathinam C, 2010, CANCER CELL, V18, P341, DOI 10.1016/j.ccr.2010.09.008; Reindl C, 2009, CLIN CANCER RES, V15, P2238, DOI 10.1158/1078-0432.CCR-08-1325; Robinson LJ, 2005, EXP HEMATOL, V33, P469, DOI 10.1016/j.exphem.2005.01.004; Rocnik JL, 2006, BLOOD, V108, P1339, DOI 10.1182/blood-2005-11-011429; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sargin B, 2007, BLOOD, V110, P1004, DOI 10.1182/blood-2007-01-066076; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Schmidt-Arras D, 2009, BLOOD, V113, P3568, DOI 10.1182/blood-2007-10-121426; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Toffalini F, 2009, HAEMATOL-HEMATOL J, V94, P1085, DOI 10.3324/haematol.2008.001149; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsirigotis M, 2001, J BIOL CHEM, V276, P46073, DOI 10.1074/jbc.M109023200; Tsirigotis M, 2001, BIOTECHNIQUES, V31, P120, DOI 10.2144/01311rr03; Vempati S, 2008, CLIN CANCER RES, V14, P4437, DOI 10.1158/1078-0432.CCR-07-1873; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yao Q, 2005, LEUKEMIA, V19, P1605, DOI 10.1038/sj.leu.2403881; Yao Q, 2003, CLIN CANCER RES, V9, P4483; Yao Q, 2007, CLIN CANCER RES, V13, P1591, DOI 10.1158/1078-0432.CCR-06-1750; Zhang WG, 2008, JNCI-J NATL CANCER I, V100, P184, DOI 10.1093/jnci/djm328	46	30	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30263	30273		10.1074/jbc.M111.232348	http://dx.doi.org/10.1074/jbc.M111.232348			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21768087	Green Published, hybrid			2022-12-25	WOS:000294283600004
J	Gao, K; Miller, J				Gao, Kun; Miller, Jonathan			Algebraic Distribution of Segmental Duplication Lengths in Whole-Genome Sequence Self-Alignments	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; DNA; MODEL; EVOLUTION; EXPANSION; ELEMENTS; RECOMBINATION; INSERTIONS; DELETIONS; PATTERNS	Distributions of duplicated sequences from genome self-alignment are characterized, including forward and backward alignments in bacteria and eukaryotes. A Markovian process without auto-correlation should generate an exponential distribution expected from local effects of point mutation and selection on localised function; however, the observed distributions show substantial deviation from exponential form - they are roughly algebraic instead - suggesting a novel kind of long-distance correlation that must be non-local in origin.	[Gao, Kun; Miller, Jonathan] Okinawa Inst Sci & Technol, Phys & Biol Unit, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University	Gao, K (corresponding author), Okinawa Inst Sci & Technol, Phys & Biol Unit, Okinawa, Japan.	jm@oist.jp	Gao, Kun/G-2881-2015; Miller, Jonathan/M-4389-2014	Miller, Jonathan/0000-0003-2190-6824				APARICIO S, 1995, P NATL ACAD SCI USA, V92, P1684, DOI 10.1073/pnas.92.5.1684; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bodmer W. F., 1962, ADV GENETICS; BULDYREV SV, 1993, BIOPHYS J, V65, P2673, DOI 10.1016/S0006-3495(93)81290-6; Buldyrev SV, 1999, PHYSICA A, V273, P19, DOI 10.1016/S0378-4371(99)00338-6; BULDYREV SV, 1993, PHYS REV E, V47, P4514, DOI 10.1103/PhysRevE.47.4514; Csuros M, 2007, TRENDS GENET, V23, P543, DOI 10.1016/j.tig.2007.07.008; DESCLOIZEAUX J, 1980, J PHYS-PARIS, V41, P223, DOI 10.1051/jphys:01980004103022300; DOVER GA, 1986, TRENDS GENET, V2, P159, DOI 10.1016/0168-9525(86)90211-8; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; GROSBERG A, 1993, EUROPHYS LETT, V23, P373, DOI 10.1209/0295-5075/23/5/012; GU X, 1995, J MOL EVOL, V40, P464, DOI 10.1007/BF00164032; Hedrick P. W., 2011, GENETICS POPULATIONS; Kammandel B, 1999, DEV BIOL, V205, P79, DOI 10.1006/dbio.1998.9128; KARLIN S, 1985, MOL BIOL EVOL, V2, P35; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Knoch TA, 2009, EUR BIOPHYS J BIOPHY, V38, P757, DOI 10.1007/s00249-009-0489-y; Laherrere J, 1998, EUR PHYS J B, V2, P525, DOI 10.1007/s100510050276; LI W, 1992, EUROPHYS LETT, V17, P655, DOI 10.1209/0295-5075/17/7/014; LI WT, 1992, IEEE T INFORM THEORY, V38, P1842, DOI 10.1109/18.165464; Li WT, 1997, COMPUT CHEM, V21, P257, DOI 10.1016/S0097-8485(97)00022-3; LI WT, 1991, PHYS REV A, V43, P5240, DOI 10.1103/PhysRevA.43.5240; Luscombe NM, 2002, GENOME BIOL, V3; Mandelbrot B, 1977, FRACTAL GEOMETRY NAT; Mani A, 2010, NUCLEIC ACIDS RES, V38, P2036, DOI 10.1093/nar/gkp1177; Messer PW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.138103; Miller J, 2009, IEICE TECHNICAL REPO, V109; Ohno S., 1970, EVOLUTION GENE DUPLI; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Sagi D, 2006, NUCLEIC ACIDS RES, V34, P5021, DOI 10.1093/nar/gkl586; Salerno W, 2006, P NATL ACAD SCI USA, V103, P13121, DOI 10.1073/pnas.0605735103; Santoyo G, 2005, FEMS MICROBIOL REV, V29, P169, DOI 10.1016/j.femsre.2004.10.004; Shibata T, 2001, P NATL ACAD SCI USA, V98, P8425, DOI 10.1073/pnas.111005198; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sindi SS, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061912; Stephan W, 2010, PHILOS T R SOC B, V365, P1245, DOI 10.1098/rstb.2009.0278; Stone EA, 2005, ANNU REV GENOM HUM G, V6, P143, DOI 10.1146/annurev.genom.6.080604.162146; Stringer MJ, 2010, J AM SOC INF SCI TEC, V61, P1377, DOI 10.1002/asi.21335; Zhang J, 2010, APPL BIOCHEM BIOTECH, V162, P321, DOI 10.1007/s12010-009-8793-7; Zhang LQ, 2005, MOL BIOL EVOL, V22, P135, DOI 10.1093/molbev/msh262; Zhang ZL, 2003, NUCLEIC ACIDS RES, V31, P5338, DOI 10.1093/nar/gkg745	47	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e18464	10.1371/journal.pone.0018464	http://dx.doi.org/10.1371/journal.pone.0018464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779315	Green Submitted, Green Published, gold			2022-12-25	WOS:000292811300001
J	Sugiura, D; Tateno, M				Sugiura, Daisuke; Tateno, Masaki			Optimal Leaf-to-Root Ratio and Leaf Nitrogen Content Determined by Light and Nitrogen Availabilities	PLOS ONE			English	Article							BIOMASS ALLOCATION; SHADE TOLERANCE; SEEDLING GROWTH; TREE SEEDLINGS; PHOTOSYNTHESIS; SURVIVAL; OPTIMIZATION; ACCLIMATION; MORPHOLOGY; PLANTS	Plants exhibit higher leaf-to-root ratios (L/R) and lower leaf nitrogen content (N-area) in low-light than in high-light environments, but an ecological significance of this trait has not been explained from a whole-plant perspective. This study aimed to theoretically and experimentally demonstrate whether these observed L/R and N-area are explained as optimal biomass allocation that maximize whole-plant relative growth rate (RGR). We developed a model which predicts optimal L/R and N-area in response to nitrogen and light availability. In the model, net assimilation rate (NAR) was determined by light-photosynthesis curve, light availability measured during experiments, and leaf temperature affecting the photosynthesis and leaf dark respiration rate in high and low-light environments. Two pioneer trees, Morus bombycis and Acer buergerianum, were grown in various light and nitrogen availabilities in an experimental garden and used for parameterizing and testing the model predictions. They were grouped into four treatment groups (relative photosynthetic photon flux density, RPPFD 100% or 10% x nitrogen-rich or nitrogen-poor conditions) and grown in an experimental garden for 60 to 100 days. The model predicted that optimal L/R is higher and N-area is lower in low-light than high-light environments when compared in the same soil nitrogen availability. Observed L/R and N-area of the two pioneer trees were close to the predicted optimums. From the model predictions and pot experiments, we conclude that the pioneer trees, M. bombycis and A. buergerianum, regulated L/R and N-area to maximize RGR in response to nitrogen and light availability.	[Sugiura, Daisuke; Tateno, Masaki] Univ Tokyo, Grad Sch Sci, Nikko Bot Garden, Nikko, Tochigi, Japan	University of Tokyo	Sugiura, D (corresponding author), Univ Tokyo, Grad Sch Sci, Nikko Bot Garden, Nikko, Tochigi, Japan.	dsugiura@biol.s.u-tokyo.ac.jp			MEXT, Japan	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN GI, 1987, PLANT CELL ENVIRON, V10, P579, DOI 10.1111/j.1365-3040.1987.tb01838.x; Atkin OK, 2000, PLANT PHYSIOL, V122, P915, DOI 10.1104/pp.122.3.915; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; ELLSWORTH DS, 1992, FUNCT ECOL, V6, P423, DOI 10.2307/2389280; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; FIELD C, 1986, EC PLANT FORM FUNCTI, P28; GARNIER E, 1991, TRENDS ECOL EVOL, V6, P126, DOI 10.1016/0169-5347(91)90091-B; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63, DOI 10.1071/PP9880063; GIVNISH TJ, 1982, AM NAT, V120, P353, DOI 10.1086/283995; GLEESON SK, 1993, ANN BOT-LONDON, V71, P23, DOI 10.1006/anbo.1993.1003; Hikosaka K, 2006, J EXP BOT, V57, P291, DOI 10.1093/jxb/erj049; HIKOSAKA K, 1995, PLANT CELL ENVIRON, V18, P605, DOI 10.1111/j.1365-3040.1995.tb00562.x; Hikosaka K, 1999, OECOLOGIA, V118, P388, DOI 10.1007/s004420050740; HILBERT DW, 1990, ANN BOT-LONDON, V66, P91, DOI 10.1093/oxfordjournals.aob.a088005; HILBERT DW, 1991, ANN BOT-LONDON, V68, P417, DOI 10.1093/oxfordjournals.aob.a088273; HIROSE T, 1987, OECOLOGIA, V72, P520, DOI 10.1007/BF00378977; HIROSE T, 1986, ANN BOT-LONDON, V58, P479, DOI 10.1093/annbot/58.4.479; Ida TY, 2008, ANN BOT-LONDON, V101, P435, DOI 10.1093/aob/mcm296; IWASA Y, 1984, THEOR POPUL BIOL, V25, P78, DOI 10.1016/0040-5809(84)90007-8; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; MURAKAMI T, 1983, Bulletin of the Sericultural Experiment Station (Tokyo), V29, P1; Myers JA, 2007, J ECOL, V95, P383, DOI 10.1111/j.1365-2745.2006.01207.x; Niinemets U, 1997, FUNCT ECOL, V11, P518, DOI 10.1046/j.1365-2435.1997.00109.x; Oguchi R, 2008, OECOLOGIA, V155, P665, DOI 10.1007/s00442-007-0951-4; Osone Y, 2005, FUNCT ECOL, V19, P460, DOI 10.1111/j.1365-2435.2005.00970.x; Osone Y, 2003, FUNCT ECOL, V17, P627, DOI 10.1046/j.1365-2435.2003.00763.x; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P595, DOI 10.1071/PP99173; Poorter L, 1999, FUNCT ECOL, V13, P396, DOI 10.1046/j.1365-2435.1999.00332.x; Reich PB, 1998, FUNCT ECOL, V12, P327, DOI 10.1046/j.1365-2435.1998.00208.x; Reich PB, 1998, FUNCT ECOL, V12, P395, DOI 10.1046/j.1365-2435.1998.00209.x; Sack L, 2002, OECOLOGIA, V131, P175, DOI 10.1007/s00442-002-0873-0; SATOH M, 1976, P CROP SCI SOC JPN, V45, P51; Schreeg LA, 2005, CAN J FOREST RES, V35, P263, DOI [10.1139/x04-168, 10.1139/X04-168]; Seiwa K, 2007, ANN BOT-LONDON, V99, P537, DOI 10.1093/aob/mcl283; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; TATENO M, 1990, PLANT PHYSIOL, V92, P12, DOI 10.1104/pp.92.1.12; Tsutsumi T, 1989, FOREST ECOLOGY; Valladares F, 2000, ECOLOGY, V81, P1925, DOI 10.1890/0012-9658(2000)081[1925:PPRTLO]2.0.CO;2; WALTERS MB, 1993, OECOLOGIA, V96, P219, DOI 10.1007/BF00317735; Walters MB, 2000, ECOLOGY, V81, P1887, DOI 10.1890/0012-9658(2000)081[1887:SSNSAG]2.0.CO;2; WALTERS MB, 1993, OECOLOGIA, V94, P7, DOI 10.1007/BF00317294; Walters MB, 1996, ECOLOGY, V77, P841, DOI 10.2307/2265505	43	37	41	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22236	10.1371/journal.pone.0022236	http://dx.doi.org/10.1371/journal.pone.0022236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765957	Green Published, Green Submitted, gold			2022-12-25	WOS:000292699000033
J	Karnauskas, M; Cherubin, LM; Paris, CB				Karnauskas, Mandy; Cherubin, Laurent M.; Paris, Claire B.			Adaptive Significance of the Formation of Multi-Species Fish Spawning Aggregations near Submerged Capes	PLOS ONE			English	Article							GROUPER EPINEPHELUS-STRIATUS; NASSAU GROUPER; LOCAL RETENTION; BARRIER-REEF; FLOW; VARIABILITY; POPULATIONS; MECHANISMS; DISPERSAL; TRANSPORT	Background: Many fishes are known to spawn at distinct geomorphological features such as submerged capes or "promontories," and the widespread use of these sites for spawning must imply some evolutionary advantage. Spawning at these capes is thought to result in rapid offshore transport of eggs, thereby reducing predation levels and facilitating dispersal to areas of suitable habitat. Methodology/Principal Findings: To test this "off-reef transport" hypothesis, we use a hydrodynamic model and explore the effects of topography on currents at submerged capes where spawning occurs and at similar capes where spawning does not occur, along the Mesoamerican Barrier Reef. All capes modeled in this study produced eddy-shedding regimes, but specific eddy attributes differed between spawning and non-spawning sites. Eddies at spawning sites were significantly stronger than those at non-spawning sites, and upwelling and fronts were the products of the eddy formation process. Frontal zones, present particularly at the edges of eddies near the shelf, may serve to retain larvae and nutrients. Spawning site eddies were also more predictable in terms of diameter and longevity. Passive particles released at spawning and control sites were dispersed from the release site at similar rates, but particles from spawning sites were more highly aggregated in their distributions than those from control sites, and remained closer to shore at all times. Conclusions/Significance: Our findings contradict previous hypotheses that cape spawning leads to high egg dispersion due to offshore transport, and that they are attractive for spawning due to high, variable currents. Rather, we show that current regimes at spawning sites are more predictable, concentrate the eggs, and keep larvae closer to shore. These attributes would confer evolutionary advantages by maintaining relatively similar recruitment patterns year after year.	[Karnauskas, Mandy] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, Miami, FL 33149 USA; [Cherubin, Laurent M.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Meteorol & Phys Oceanog, Miami, FL 33149 USA; [Paris, Claire B.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Appl Marine Phys, Miami, FL 33149 USA	University of Miami; University of Miami; University of Miami	Karnauskas, M (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, Miami, FL 33149 USA.	mkarnauskas@rsmas.miami.edu		Paris-Limouzy, Claire Beatrix/0000-0002-0637-1334; Karnauskas, Mandy/0000-0002-6631-0592	University of Miami; Conservation International Marine Management Area Science Program (MMASP); NSF [OCE0825625, OCE0550732, OCE0928423]	University of Miami; Conservation International Marine Management Area Science Program (MMASP); NSF(National Science Foundation (NSF))	M. Karnauskas was supported by a University of Miami Fellowship while completing this work. The study was in part supported by a Conservation International Marine Management Area Science Program (MMASP) award to C. B. Paris and L. M. Cherubin to model larval dispersal at spawning aggregation sites in Belize. C. B. Paris and L. M. Cherubin are also funded by NSF OCE0825625; C. B. Paris is funded by NSF OCE0550732, OCE0928423. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini VN, 2002, FISH OCEANOGR, V11, P129, DOI 10.1046/j.1365-2419.2002.00201.x; Aguilar-Perera A, 2006, MAR ECOL PROG SER, V327, P289, DOI 10.3354/meps327289; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Bakun A., 1996, OCEAN PROCESSES MARI; BARLOW GW, 1981, ENVIRON BIOL FISH, V6, P65, DOI 10.1007/BF00001801; Bez N, 2000, FISH OCEANOGR, V9, P372, DOI 10.1046/j.1365-2419.2000.00148.x; Bolden SK, 2000, FISH B-NOAA, V98, P642; BOYER DL, 1987, J FLUID MECH, V180, P429, DOI 10.1017/S0022112087001885; Cherubin LM, 2008, CORAL REEFS, V27, P503, DOI 10.1007/s00338-007-0348-1; Cherubin LM, 2006, J PHYS OCEANOGR, V36, P569, DOI 10.1175/JPO2871.1; Claro Rodolfo, 2003, Gulf and Caribbean Research, V14, P91; DAVIES PA, 1990, DYNAM ATMOS OCEANS, V14, P497; De Mitcheson YS, 2008, CONSERV BIOL, V22, P1233, DOI 10.1111/j.1523-1739.2008.01020.x; Doglioli AM, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002422; DOHERTY PJ, 1985, ENVIRON BIOL FISH, V12, P81, DOI 10.1007/BF00002761; Domeier ML, 1997, B MAR SCI, V60, P698; Dong CM, 2007, J PHYS OCEANOGR, V37, P962, DOI 10.1175/JPO3047.1; Ertel H., 1942, METEOROL Z, V59, P271; Ezer T, 2005, OCEAN DYNAM, V55, P458, DOI 10.1007/s10236-005-0033-2; Gladstone W, 2007, MAR ECOL PROG SER, V351, P235, DOI 10.3354/meps07108; Graham RT, 2007, FISH RES, V84, P71, DOI 10.1016/j.fishres.2006.11.026; Graham RT, 2005, FISH B-NOAA, V103, P426; Hansen C, 2010, DEEP-SEA RES PT I, V57, P1079, DOI 10.1016/j.dsr.2010.05.013; HEPPELL SA, 2008, P 61 ANN GULF CAR FI, P325; Heyman W, 2002, STATUS MULTISPECIES; Heyman WD, 2005, J FISH BIOL, V67, P83, DOI 10.1111/j.0022-1112.2005.00714.x; Heyman WD, 2008, B MAR SCI, V83, P531; JOHANNES R E, 1978, Environmental Biology of Fishes, V3, P65, DOI 10.1007/BF00006309; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Kobara S, 2010, MAR ECOL PROG SER, V405, P243, DOI 10.3354/meps08512; Kobara S, 2008, MAR GEOD, V31, P231, DOI 10.1080/01490410802466397; Levy M, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001577; MacCready P, 2001, J PHYS OCEANOGR, V31, P2824, DOI 10.1175/1520-0485(2001)031<2824:SFAACS>2.0.CO;2; Mace AJ, 2006, MAR ECOL PROG SER, V318, P19, DOI 10.3354/meps318019; Magaldi MG, 2008, OCEAN MODEL, V25, P65, DOI 10.1016/j.ocemod.2008.06.006; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; MURDOCH RC, 1989, ESTUAR COAST SHELF S, V29, P361, DOI 10.1016/0272-7714(89)90034-6; OKUBO A, 1971, DEEP-SEA RES, V18, P789, DOI 10.1016/0011-7471(71)90046-5; PAGE MA, 1985, J FLUID MECH, V156, P205, DOI 10.1017/S0022112085002051; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Paris CB, 2007, MAR ECOL PROG SER, V347, P285, DOI 10.3354/meps06985; Pedlosky J, 1987, GEOPHYS FLUID DYN, DOI [10.1007/978-1-4612-4650-3, DOI 10.1007/978-1-4612-4650-3]; RICHARDS WJ, 2005, EARLY STAGES ATLANTI, P1225; Richardson DE, 2009, PROG OCEANOGR, V82, P252, DOI 10.1016/j.pocean.2009.07.003; Sadovy Y, 2005, FISH FISH, V6, P167, DOI 10.1111/j.1467-2979.2005.00186.x; Sadovy Y., 1999, NOAA TECHNICAL REPOR, V146, P1; Sala E, 2001, FISHERIES, V26, P23, DOI 10.1577/1548-8446(2001)026<0023:RDONGS>2.0.CO;2; Salas E, 2010, MAR BIOL, V157, P437, DOI 10.1007/s00227-009-1330-y; Santos AMP, 2007, PROG OCEANOGR, V74, P192, DOI 10.1016/j.pocean.2007.04.008; SCHULTZ ET, 1994, MAR ECOL PROG SER, V109, P15, DOI 10.3354/meps109015; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Starr RM, 2007, MAR ECOL PROG SER, V343, P239, DOI 10.3354/meps06897; Warner RR, 2002, B MAR SCI, V70, P245; Whaylen L, 2004, ENVIRON BIOL FISH, V70, P305, DOI 10.1023/B:EBFI.0000033341.57920.a8; WING SR, 1995, LIMNOL OCEANOGR, V40, P316, DOI 10.4319/lo.1995.40.2.0316	55	44	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22067	10.1371/journal.pone.0022067	http://dx.doi.org/10.1371/journal.pone.0022067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760954	Green Submitted, gold, Green Published			2022-12-25	WOS:000292657200044
J	Li, C; Huang, LM; Xu, CG; Zhao, Y; Zhou, DX				Li, Chen; Huang, Limin; Xu, Caiguo; Zhao, Yu; Zhou, Dao-Xiu			Altered Levels of Histone Deacetylase OsHDT1 Affect Differential Gene Expression Patterns in Hybrid Rice	PLOS ONE			English	Article							CHROMATIN MODIFICATION; NUCLEOLAR DOMINANCE; ALLELIC VARIATION; MOLECULAR-BASIS; ARABIDOPSIS; MAIZE; REGULATOR; HETEROSIS; ACETYLTRANSFERASE; IDENTIFICATION	Hybrids between different inbred varieties display novel patterns of gene expression resulted from parental variation in allelic nucleotide sequences. To study the function of chromatin regulators in hybrid gene expression, the histone deacetylase gene OsHDT1 whose expression displayed a circadian rhythm was over-expressed or inactivated by RNAi in an elite rice parent. Increased OsHDT1 expression did not affect plant growth in the parent but led to early flowering in the hybrid. Nonadditive up-regulation of key flowering time genes was found to be related to flowering time of the hybrid. Over-expression of OsHDT1 repressed the nonadditive expression of the key flowering repressors in the hybrid (i.e. OsGI and Hd1) inducing early flowering. Analysis of histone acetylation suggested that OsHDT1 over-expression might promote deacetylation on OsGI and Hd1 chromatin during the peak expression phase. High throughput differential gene expression analysis revealed that altered OsHDT1 levels affected nonadditive expression of many genes in the hybrid. These data demonstrate that nonadditive gene expression was involved in flowering time control in the hybrid rice and that OsHDT1 level was important for nonadditive or differential expression of many genes including the flowering time genes, suggesting that OsHDT1 may be involved in epigenetic control of parental genome interaction for differential gene expression.	[Li, Chen; Huang, Limin; Xu, Caiguo; Zhao, Yu; Zhou, Dao-Xiu] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Zhou, Dao-Xiu] Univ Paris 11, CNRS, UMR8618, Inst Biol Plantes, F-91405 Orsay, France	Huazhong Agricultural University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Li, C (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	dao-xiu.zhou@u-psud.fr		Zhou, Dao-Xiu/0000-0002-1540-0598	Chinese Ministry of Agriculture Transgenic Programs; National Natural Science Foundation	Chinese Ministry of Agriculture Transgenic Programs; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese Ministry of Agriculture Transgenic Programs and the National Natural Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Chen ZJ, 2007, BBA-GENE STRUCT EXPR, V1769, P295, DOI 10.1016/j.bbaexp.2007.04.007; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Crane YM, 2007, P NATL ACAD SCI USA, V104, P15156, DOI 10.1073/pnas.0706986104; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Guo M, 2003, PLANT J, V36, P30, DOI 10.1046/j.1365-313X.2003.01852.x; Hayama R, 2004, PLANT PHYSIOL, V135, P677, DOI 10.1104/pp.104.042614; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Huang LM, 2007, PLANT PHYSIOL, V144, P1508, DOI 10.1104/pp.107.099473; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Ishikawa R, 2009, MOL PLANT, V2, P589, DOI 10.1093/mp/ssp028; Itoh H, 2010, NAT GENET, V42, P635, DOI 10.1038/ng.606; Izawa T, 2011, PLANT CELL, V23, P1741, DOI 10.1105/tpc.111.083238; Komiya R, 2009, DEVELOPMENT, V136, P3443, DOI 10.1242/dev.040170; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Lin YJ, 2005, PLANT CELL REP, V23, P540, DOI 10.1007/s00299-004-0843-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lusser A, 1997, SCIENCE, V277, P88, DOI 10.1126/science.277.5322.88; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Pandey R, 2002, NUCLEIC ACIDS RES, V30, P5036, DOI 10.1093/nar/gkf660; Pontes O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001157; Qin FJ, 2010, MOL PLANT, V3, P773, DOI 10.1093/mp/ssq030; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rubio V, 2005, PLANT J, V41, P767, DOI 10.1111/j.1365-313X.2004.02328.x; Servet C, 2010, MOL PLANT, V3, P670, DOI 10.1093/mp/ssq018; Song RT, 2003, P NATL ACAD SCI USA, V100, P9055, DOI 10.1073/pnas.1032999100; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; Sun QW, 2008, P NATL ACAD SCI USA, V105, P13679, DOI 10.1073/pnas.0805901105; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Ueno Y, 2007, PLANT CELL, V19, P445, DOI 10.1105/tpc.106.042325; Wei G, 2009, P NATL ACAD SCI USA, V106, P7695, DOI 10.1073/pnas.0902340106; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Zhao Y, 2009, PLANT CELL, V21, P736, DOI 10.1105/tpc.108.061655; Zhou CH, 2004, PLANT J, V38, P715, DOI 10.1111/j.1365-313X.2004.02083.x	43	39	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21789	10.1371/journal.pone.0021789	http://dx.doi.org/10.1371/journal.pone.0021789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760907	Green Published, gold, Green Submitted			2022-12-25	WOS:000292657200021
J	Murphy, K; O'Sullivan, O; Rea, MC; Cotter, PD; Ross, RP; Hill, C				Murphy, Kiera; O'Sullivan, Orla; Rea, Mary C.; Cotter, Paul D.; Ross, R. Paul; Hill, Colin			Genome Mining for Radical SAM Protein Determinants Reveals Multiple Sactibiotic-Like Gene Clusters	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE; BACILLUS-SUBTILIS; NARROW-SPECTRUM; BACTERIOCIN; IDENTIFICATION; BIOSYNTHESIS; SEQUENCE; METHYLTRANSFERASE; VISUALIZATION; LANTIBIOTICS	Thuricin CD is a two-component bacteriocin produced by Bacillus thuringiensis that kills a wide range of clinically significant Clostridium difficile. This bacteriocin has recently been characterized and consists of two distinct peptides, Trn beta and Trn alpha, which both possess 3 intrapeptide sulphur to alpha-carbon bridges and act synergistically. Indeed, thuricin CD and subtilosin A are the only antimicrobials known to possess these unusual structures and are known as the sactibiotics (sulplur to alpha carbon-containing antibiotics). Analysis of the thuricin CD-associated gene cluster revealed the presence of genes encoding two highly unusual SAM proteins (TrnC and TrnD) which are proposed to be responsible for these unusual post-translational modifications. On the basis of the frequently high conservation among enzymes responsible for the post-translational modification of specific antimicrobials, we performed an in silico screen for novel thuricin CD-like gene clusters using the TrnC and TrnD radical SAM proteins as driver sequences to perform an initial homology search against the complete non-redundant database. Fifteen novel thuricin CD-like gene clusters were identified, based on the presence of TrnC and TrnD homologues in the context of neighbouring genes encoding potential bacteriocin structural peptides. Moreover, metagenomic analysis revealed that TrnC or TrnD homologs are present in a variety of metagenomic environments, suggesting a widespread distribution of thuricin-like operons in a variety of environments. In-silico analysis of radical SAM proteins is sufficient to identify novel putative sactibiotic clusters.	[Murphy, Kiera; Hill, Colin] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Murphy, Kiera; O'Sullivan, Orla; Rea, Mary C.; Cotter, Paul D.; Ross, R. Paul] TEAGASC, Food Res Ctr, Fermoy, Cork, Ireland; [Rea, Mary C.; Cotter, Paul D.; Ross, R. Paul; Hill, Colin] Alimentary Pharmabiot Ctr, Cork, Ireland	University College Cork; Teagasc; University College Cork	Murphy, K (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland.		O'Sullivan, Orla/ABE-5980-2020; Ross, Paul/A-7584-2015; Cotter, Paul/AAX-5449-2021; Cotter, Paul/B-7781-2008; Hill, Colin/A-5611-2012; STANTON, CATHERINE/A-9549-2015	O'Sullivan, Orla/0000-0002-4332-1109; Ross, Paul/0000-0003-4876-8839; Cotter, Paul/0000-0002-5465-9068; Cotter, Paul/0000-0002-5465-9068; Hill, Colin/0000-0002-8527-1445; Rea, Mary/0000-0003-3782-0232; STANTON, CATHERINE/0000-0002-6724-7011	Science Foundation of Ireland-funded Centre for Science, Engineering and Technology (SFI-CSET); Alimentary Pharmabiotic Centre (APC)	Science Foundation of Ireland-funded Centre for Science, Engineering and Technology (SFI-CSET)(Science Foundation Ireland); Alimentary Pharmabiotic Centre (APC)(Science Foundation Ireland)	This work was supported by the Science Foundation of Ireland-funded Centre for Science, Engineering and Technology (SFI-CSET): the Alimentary Pharmabiotic Centre (APC), http://www.sfi.ie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Begley M, 2009, APPL ENVIRON MICROB, V75, P5451, DOI 10.1128/AEM.00730-09; Brede DA, 2004, APPL ENVIRON MICROB, V70, P7303, DOI 10.1128/AEM.70.12.7303-7310.2004; Bredholt S, 1999, INT J SYST BACTERIOL, V49, P991, DOI 10.1099/00207713-49-3-991; Cotter PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000144; Dabard J, 2001, APPL ENVIRON MICROB, V67, P4111, DOI 10.1128/AEM.67.9.4111-4118.2001; Diep DB, 2007, P NATL ACAD SCI USA, V104, P2384, DOI 10.1073/pnas.0608775104; Dineen SS, 2000, APPL ENVIRON MICROB, V66, P5480, DOI 10.1128/AEM.66.12.5480-5483.2000; Dischinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006788; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; GIALLO J, 1983, APPL ENVIRON MICROB, V45, P843, DOI 10.1128/AEM.45.3.843-849.1983; Gonzalez DJ, 2010, J BIOL CHEM, V285, P28220, DOI 10.1074/jbc.M110.118554; Granum PE, 1997, FEMS MICROBIOL LETT, V157, P223, DOI 10.1016/S0378-1097(97)00438-2; Guedon E, 1999, J BACTERIOL, V181, P3262, DOI 10.1128/JB.181.10.3262-3269.1999; Haft DH, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-70; Hamahata A, 1996, BIOCHEM J, V317, P141, DOI 10.1042/bj3170141; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Hyink O, 2007, APPL ENVIRON MICROB, V73, P1107, DOI 10.1128/AEM.02265-06; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Kaminska KH, 2010, NUCLEIC ACIDS RES, V38, P1652, DOI 10.1093/nar/gkp1142; Kawulka KE, 2004, BIOCHEMISTRY-US, V43, P3385, DOI 10.1021/bi0359527; LaButti K, 2009, STAND GENOMIC SCI, V1, P159, DOI 10.4056/sigs.24194; Larsen L, 1997, ARCH MICROBIOL, V168, P114, DOI 10.1007/s002030050476; Lawton EM, 2007, MINI-REV MED CHEM, V7, P1236, DOI 10.2174/138955707782795638; Lawton EM, 2007, FEMS MICROBIOL LETT, V267, P64, DOI 10.1111/j.1574-6968.2006.00539.x; Lee SW, 2008, P NATL ACAD SCI USA, V105, P5879, DOI 10.1073/pnas.0801338105; LI AW, 1982, CAN J MICROBIOL, V28, P860, DOI 10.1139/m82-128; Li SY, 2009, CHEMBIOCHEM, V10, P1297, DOI 10.1002/cbic.200900088; Lien T, 1998, INT J SYST BACTERIOL, V48, P1007, DOI 10.1099/00207713-48-3-1007; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; MADDEN RH, 1982, INT J SYST BACTERIOL, V32, P87, DOI 10.1099/00207713-32-1-87; Marsh AJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-679; McClerren AL, 2006, P NATL ACAD SCI USA, V103, P17243, DOI 10.1073/pnas.0606088103; Nes IF, 1996, ANTON LEEUW INT J G, V70, P113, DOI 10.1007/BF00395929; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; NISHIO C, 1983, BIOCHEM BIOPH RES CO, V116, P751, DOI 10.1016/0006-291X(83)90588-0; O'Sullivan L, 2002, BIOCHIMIE, V84, P593, DOI 10.1016/S0300-9084(02)01457-8; Pag U, 2002, CURR PHARM DESIGN, V8, P815, DOI 10.2174/1381612023395439; Rea MC, 2011, P NATL ACAD SCI USA, V108, P4639, DOI 10.1073/pnas.1001224107; Rea MC, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P29, DOI 10.1007/978-1-4419-7692-5_3; Rea MC, 2010, P NATL ACAD SCI USA, V107, P9352, DOI 10.1073/pnas.0913554107; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Scholz R, 2011, J BACTERIOL, V193, P215, DOI 10.1128/JB.00784-10; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Stein T, 2002, J BACTERIOL, V184, P1703, DOI 10.1128/JB.184.6.1703-1711.2002; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; WALK ST, 2008, INTERDISCIPLINARY PE, P12508; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Yutin N, 2007, ENVIRON MICROBIOL, V9, P1464, DOI 10.1111/j.1462-2920.2007.01265.x; Zheng GL, 2000, J BACTERIOL, V182, P3266, DOI 10.1128/JB.182.11.3266-3273.2000	55	63	63	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e20852	10.1371/journal.pone.0020852	http://dx.doi.org/10.1371/journal.pone.0020852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760885	gold, Green Published, Green Submitted			2022-12-25	WOS:000292657200004
J	Nakerakanti, SS; Bujor, AM; Trojanowska, M				Nakerakanti, Sashidhar S.; Bujor, Andreea M.; Trojanowska, Maria			CCN2 Is Required for the TGF-beta Induced Activation of Smad1-Erk1/2 Signaling Network	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; COLLAGEN-SYNTHESIS; FACTOR EXPRESSION; RECEPTOR; SMAD1; PHOSPHORYLATION; FIBROSIS; PATHWAY; GENE; SRC	Connective tissue growth factor (CCN2) is a multifunctional matricellular protein, which is frequently overexpressed during organ fibrosis. CCN2 is a mediator of the pro-fibrotic effects of TGF-beta in cultured cells, but the specific function of CCN2 in the fibrotic process has not been elucidated. In this study we characterized the CCN2-dependent signaling pathways that are required for the TGF-beta induced fibrogenic response. By depleting endogenous CCN2 we show that CCN2 is indispensable for the TGF-beta-induced phosphorylation of Smad1 and Erk1/2, but it is unnecessary for the activation of Smad3. TGF-beta stimulation triggered formation of the CCN2/beta(3) integrin protein complexes and activation of Src signaling. Furthermore, we demonstrated that signaling through the alpha(v)beta(3) integrin receptor and Src was required for the TGF-beta induced Smad1 phosphorylation. Recombinant CCN2 activated Src and Erk1/2 signaling, and induced phosphorylation of Fli1, but was unable to stimulate Smad1 or Smad3 phosphorylation. Additional experiments were performed to investigate the role of CCN2 in collagen production. Consistent with the previous studies, blockade of CCN2 abrogated TGF-beta-induced collagen mRNA and protein levels. Recombinant CCN2 potently stimulated collagen mRNA levels and upregulated activity of the COL1A2 promoter, however CCN2 was a weak inducer of collagen protein levels. CCN2 stimulation of collagen was dose-dependent with the lower doses (<50 ng/ml) having a stimulatory effect and higher doses having an inhibitory effect on collagen gene expression. In conclusion, our study defines a novel CCN2/alpha(v)beta(3) integrin/Src/Smad1 axis that contributes to the pro-fibrotic TGF-beta signaling and suggests that blockade of this pathway may be beneficial for the treatment of fibrosis.	[Nakerakanti, Sashidhar S.; Bujor, Andreea M.; Trojanowska, Maria] Boston Univ, Sch Med, Arthrit Ctr, Boston, MA 02118 USA	Boston University	Nakerakanti, SS (corresponding author), Boston Univ, Sch Med, Arthrit Ctr, Boston, MA 02118 USA.	trojanme@bu.edu	Bujor, Andreea/AAN-8621-2021	Bujor, Andreea/0000-0002-8840-8937; Trojanowska, Maria/0000-0001-9550-7178	National Institutes of Health [AR44883, AR42334]; Scleroderma Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044883, R56AR044883, R01AR042334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the National Institutes of Health grants AR44883 and AR42334 (MT) and by the Scleroderma Foundation New Investigator grant (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2004, J BIOL CHEM, V279, P14201, DOI 10.1074/jbc.M310427200; Abraham D, 2008, RHEUMATOLOGY, V47, pV8, DOI 10.1093/rheumatology/ken278; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; Asano Y, 2009, MOL CELL BIOL, V29, P1882, DOI 10.1128/MCB.01320-08; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Bhattacharyya S, 2008, AM J PATHOL, V173, P1085, DOI 10.2353/ajpath.2008.080382; Bleau AM, 2005, FRONT BIOSCI-LANDMRK, V10, P998, DOI 10.2741/1594; Bujor AM, 2010, EXP DERMATOL, V19, P347, DOI 10.1111/j.1600-0625.2010.01065.x; Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200; Crean JKG, 2002, J BIOL CHEM, V277, P44187, DOI 10.1074/jbc.M203715200; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Fonseca C, 2007, NEW ENGL J MED, V357, P1210, DOI 10.1056/NEJMoa067655; Gautschi O, 2008, CANCER RES, V68, P2250, DOI 10.1158/0008-5472.CAN-07-6403; Gore-Hyer E, 2003, ARTHRITIS RHEUM-US, V48, P798, DOI 10.1002/art.10953; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; KAPANADZE B, 2009, J CELL MOL MED; Kucich U, 2001, ARCH BIOCHEM BIOPHYS, V395, P103, DOI 10.1006/abbi.2001.2571; Lasky JA, 1998, AM J PHYSIOL-LUNG C, V275, pL365, DOI 10.1152/ajplung.1998.275.2.L365; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Leivonen SK, 2005, J INVEST DERMATOL, V124, P1162, DOI 10.1111/j.0022-202X.2005.23750.x; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Luchetti MM, 2003, J BIOL CHEM, V278, P1533, DOI 10.1074/jbc.M204392200; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mima A, 2006, LAB INVEST, V86, P927, DOI 10.1038/labinvest.3700445; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Morris E, 2011, J CELL PHYSL; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Moustakas A, 2008, FEBS LETT, V582, P2051, DOI 10.1016/j.febslet.2008.03.027; Nakerakanti SS, 2006, J BIOL CHEM, V281, P25259, DOI 10.1074/jbc.M600466200; Pannu J, 2008, ARTHRITIS RHEUM-US, V58, P2528, DOI 10.1002/art.23698; Pannu J, 2007, J BIOL CHEM, V282, P10405, DOI 10.1074/jbc.M611742200; Quan TH, 2010, J INVEST DERMATOL, V130, P415, DOI 10.1038/jid.2009.224; Rachfal AW, 2005, VITAM HORM, V70, P69, DOI 10.1016/S0083-6729(05)70003-0; Ricupero DA, 1999, AM J PHYSIOL-LUNG C, V277, pL1165, DOI 10.1152/ajplung.1999.277.6.L1165; Scaffidi AK, 2004, J BIOL CHEM, V279, P37726, DOI 10.1074/jbc.M403010200; Shi-Wen X, 2000, EXP CELL RES, V259, P213, DOI 10.1006/excr.2000.4972; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Skhirtladze C, 2008, ARTHRITIS RHEUM, V58, P1475, DOI 10.1002/art.23436; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; SONNYLAL S, ARTHRITIS RHEUM, V62, P1523; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Wahab NA, 2005, J AM SOC NEPHROL, V16, P340, DOI 10.1681/ASN.2003100905; Wang B, 2010, J MED GENET, V47, P391, DOI 10.1136/jmg.2009.073098; Wenger C, 1999, ONCOGENE, V18, P1073, DOI 10.1038/sj.onc.1202395; Wiercinska E, 2006, HEPATOLOGY, V43, P1032, DOI 10.1002/hep.21135; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Yokoi H, 2001, AM J KIDNEY DIS, V38, pS134, DOI 10.1053/ajkd.2001.27422; Zhang C, 2004, LIFE SCI, V75, P367, DOI 10.1016/j.lfs.2004.02.005; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	54	67	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21911	10.1371/journal.pone.0021911	http://dx.doi.org/10.1371/journal.pone.0021911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760921	gold, Green Published, Green Submitted			2022-12-25	WOS:000292657200028
J	Renoir, T; Zajac, MS; Du, X; Pang, TY; Leang, L; Chevarin, C; Lanfumey, L; Hannan, AJ				Renoir, Thibault; Zajac, Michelle S.; Du, Xin; Pang, Terence Y.; Leang, Leah; Chevarin, Caroline; Lanfumey, Laurence; Hannan, Anthony J.			Sexually Dimorphic Serotonergic Dysfunction in a Mouse Model of Huntington's Disease and Depression	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; SEROTONIN(1A) RECEPTOR-BINDING; POSITRON-EMISSION-TOMOGRAPHY; 5-HT1A RECEPTOR; SEX-DIFFERENCES; MAJOR DEPRESSION; HUMAN BRAIN; MICE; GENDER; GENE	Depression is the most common psychiatric disorder in Huntington's disease (HD) patients. In the general population, women are more prone to develop depression and such susceptibility might be related to serotonergic dysregulation. There is yet to be a study of sexual dimorphism in the development and presentation of depression in HD patients. We investigated whether 8-week-old male and female R6/1 transgenic HD mice display depressive-like endophenotypes associated with serotonergic impairments. We also studied the behavioral effects of acute treatment with sertraline. We found that only female HD mice exhibited a decreased preference for saccharin as well as impaired emotionality-related behaviors when assessed on the novelty-suppressed feeding test (NSFT) and the forced-swimming test (FST). The exaggerated immobility time displayed by female HD in the FST was reduced by acute administration of sertraline. We also report an increased response to the 5-HT1A receptor agonist 8-OH-DPAT in inducing hypothermia and a decreased 5-HT2A receptor function in HD animals. While tissue levels of serotonin were reduced in both male and female HD mice, we found that serotonin concentration and hydroxylase-2 (TPH2) mRNA levels were higher in the hippocampus of males compared to female animals. Finally, the antidepressant-like effects of sertraline in the FST were blunted in male HD animals. This study reveals sex-specific depressive-related behaviors during an early stage of HD prior to any cognitive and motor deficits. Our data suggest a crucial role for disrupted serotonin signaling in mediating the sexually dimorphic depression-like phenotype in HD mice.	[Renoir, Thibault; Zajac, Michelle S.; Du, Xin; Pang, Terence Y.; Leang, Leah; Hannan, Anthony J.] Univ Melbourne, Florey Neurosci Inst, Howard Florey Inst, Parkville, Vic 3052, Australia; [Zajac, Michelle S.; Du, Xin; Hannan, Anthony J.] Univ Melbourne, Dept Anat & Cell Biol, Parkville, Vic 3052, Australia; [Chevarin, Caroline; Lanfumey, Laurence] Univ Paris 06, UMR S894, UPMC, Paris, France; [Chevarin, Caroline; Lanfumey, Laurence] INSERM, UMR S894, Paris, France	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Renoir, T (corresponding author), Univ Melbourne, Florey Neurosci Inst, Howard Florey Inst, Parkville, Vic 3052, Australia.	thibault.renoir@florey.edu.au	Pang, Terence Y/D-2826-2012; Lanfumey, Laurence/P-3037-2017; Du, Xin/L-9412-2019; Chevarin, Caroline/M-1438-2015; Pang, Terence Y/L-6444-2019; Lanfumey, Laurence/F-7695-2013	Du, Xin/0000-0003-3960-5317; Pang, Terence Y/0000-0002-7000-5304; Hannan, Anthony/0000-0001-7532-8922	National Health and Medical Research Council (NHMRC); Pfizer; NHMRC-INSERM; University of Melbourne	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Pfizer(Pfizer); NHMRC-INSERM(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne)	This work was supported by National Health and Medical Research Council (NHMRC) Project Grants (AJH), philanthropic support from a Pfizer Australia Research Fellowship (AJH), NHMRC-INSERM Exchange Fellowship (TR) and University of Melbourne Research Scholarships (MSZ and XD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster D, 2010, BIOL PSYCHOL, V83, P214, DOI 10.1016/j.biopsycho.2009.12.010; Bai F, 2001, PHARMACOL BIOCHEM BE, V70, P187, DOI 10.1016/S0091-3057(01)00599-8; Bauer A, 2005, J NEUROCHEM, V94, P639, DOI 10.1111/j.1471-4159.2005.03169.x; Bert B, 2006, BEHAV BRAIN RES, V167, P328, DOI 10.1016/j.bbr.2005.09.020; Bhagwagar Z, 2004, MOL PSYCHIATR, V9, P386, DOI 10.1038/sj.mp.4001401; BILL DJ, 1991, BRIT J PHARMACOL, V103, P1857, DOI 10.1111/j.1476-5381.1991.tb12342.x; Bjorkqvist M, 2006, HUM MOL GENET, V15, P1713, DOI 10.1093/hmg/ddl094; Bode FJ, 2008, HUM MOL GENET, V17, P2595, DOI 10.1093/hmg/ddn159; Bouali S, 2003, EUR J NEUROSCI, V18, P2203, DOI 10.1046/j.1460-9568.2003.02960.x; Brummett BH, 2008, BEHAV GENET, V38, P34, DOI 10.1007/s10519-007-9172-1; Celada P, 2004, J PSYCHIATR NEUROSCI, V29, P252; Chopra KK, 2009, PSYCHONEUROENDOCRINO, V34, P1235, DOI 10.1016/j.psyneuen.2009.03.014; DALLA C, 2009, BASIC CLIN PHARM TOX; Dawson LA, 2002, J PSYCHOPHARMACOL, V16, P145, DOI 10.1177/026988110201600205; Dorner JL, 2007, BEHAV BRAIN RES, V178, P90, DOI 10.1016/j.bbr.2006.12.004; Drevets WC, 2007, NUCL MED BIOL, V34, P865, DOI 10.1016/j.nucmedbio.2007.06.008; Duff K, 2007, BIOL PSYCHIAT, V62, P1341, DOI 10.1016/j.biopsych.2006.11.034; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; El Yacoubi M, 2003, P NATL ACAD SCI USA, V100, P6227, DOI 10.1073/pnas.1034823100; Fava M, 2000, NEURON, V28, P335, DOI 10.1016/S0896-6273(00)00112-4; Frey BN, 2008, NEUROIMAGE, V42, P850, DOI 10.1016/j.neuroimage.2008.05.009; Frey BN, 2010, PSYCHIAT RES-NEUROIM, V183, P157, DOI 10.1016/j.pscychresns.2010.05.005; Goswami DB, 2010, J NEUROCHEM, V112, P397, DOI 10.1111/j.1471-4159.2009.06462.x; Grabe HJ, 2005, MOL PSYCHIATR, V10, P220, DOI 10.1038/sj.mp.4001555; Harkin A, 2002, J PSYCHOPHARMACOL, V16, P115, DOI 10.1177/026988110201600201; Hedlund PB, 2004, EUR J PHARMACOL, V487, P125, DOI 10.1016/j.ejphar.2004.01.031; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; Jennings KA, 2008, NEUROPHARMACOLOGY, V54, P776, DOI 10.1016/j.neuropharm.2007.12.001; Julien CL, 2007, J NEUROL NEUROSUR PS, V78, P939, DOI 10.1136/jnnp.2006.103309; Kinney GG, 1997, BRAIN RES, V756, P68, DOI 10.1016/S0006-8993(97)00119-4; Kornstein SG, 2000, AM J PSYCHIAT, V157, P1445, DOI 10.1176/appi.ajp.157.9.1445; Li Q, 2000, J NEUROSCI, V20, P7888; Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marcus SM, 2008, COMPR PSYCHIAT, V49, P238, DOI 10.1016/j.comppsych.2007.06.012; Marshall J, 2007, ARCH NEUROL-CHICAGO, V64, P116, DOI 10.1001/archneur.64.1.116; Mato S, 2007, J NEUROCHEM, V103, P2111, DOI 10.1111/j.1471-4159.2007.04961.x; Matuszewich L, 2003, PSYCHOPHARMACOLOGY, V169, P169, DOI 10.1007/s00213-003-1498-7; Messa C, 2003, PSYCHOPHARMACOLOGY, V167, P72, DOI 10.1007/s00213-002-1379-5; Miller JM, 2009, NEUROPSYCHOPHARMACOL, V34, P2275, DOI 10.1038/npp.2009.54; Mizuno T, 2006, J PSYCHOSOM RES, V60, P91, DOI 10.1016/j.jpsychores.2005.06.068; Mnie-Filali O, 2007, DRUG NEWS PERSPECT, V20, P613, DOI 10.1358/dnp.2007.20.10.1181354; NAKANO Y, 1992, EUR J PHARMACOL, V219, P339; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; Nithianantharajah J, 2008, NEUROBIOL DIS, V29, P490, DOI 10.1016/j.nbd.2007.11.006; Olivier JDA, 2008, NEUROSCIENCE, V152, P573, DOI 10.1016/j.neuroscience.2007.12.032; Overstreet DH, 2003, STRESS, V6, P101, DOI 10.1080/1025389031000111311; Overstreet DH, 2002, BEHAV GENET, V32, P335, DOI 10.1023/A:1020262205227; Pang TYC, 2006, NEUROSCIENCE, V141, P569, DOI 10.1016/j.neuroscience.2006.04.013; Pang TYC, 2009, HUM MOL GENET, V18, P753, DOI 10.1093/hmg/ddn385; Paulsen JS, 2005, J NEUROPSYCH CLIN N, V17, P496, DOI 10.1176/appi.neuropsych.17.4.496; Pouladi MA, 2009, BRAIN, V132, P919, DOI 10.1093/brain/awp006; Preece P, 2003, MOL BRAIN RES, V118, P60, DOI 10.1016/S0169-328X(03)00337-1; Renard CE, 2001, PSYCHOPHARMACOLOGY, V159, P42, DOI 10.1007/s002130100836; Renoir T, 2008, INT J NEUROPSYCHOPH, V11, P1149, DOI 10.1017/S1461145708009048; Reynolds GP, 1999, J NEUROCHEM, V72, P1773, DOI 10.1046/j.1471-4159.1999.721773.x; Richardson-Jones JW, 2010, NEURON, V65, P40, DOI 10.1016/j.neuron.2009.12.003; Rogoz Z, 2006, PHARMACOL REP, V58, P493; Rossi DV, 2008, J NEUROCHEM, V105, P1091, DOI 10.1111/j.1471-4159.2007.05201.x; Sargent PA, 2000, ARCH GEN PSYCHIAT, V57, P174, DOI 10.1001/archpsyc.57.2.174; Sarkisyan G, 2010, BEHAV BRAIN RES, V209, P99, DOI 10.1016/j.bbr.2010.01.022; Sjoberg RL, 2006, INT J NEUROPSYCHOPH, V9, P443, DOI 10.1017/S1461145705005936; Stockmeier CA, 1998, J NEUROSCI, V18, P7394; Sun YH, 2009, NEUROPSYCHOPHARMACOL, V34, P1601, DOI 10.1038/npp.2008.217; Szewczyk B, 2009, INT J NEUROPSYCHOPH, V12, P155, DOI 10.1017/S1461145708009012; van Gaalen MM, 2002, GENES BRAIN BEHAV, V1, P174, DOI 10.1034/j.1601-183X.2002.10305.x; Wood NI, 2008, BRAIN RES BULL, V76, P70, DOI 10.1016/j.brainresbull.2007.12.007; Wood NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009077; Yatham LN, 2000, ARCH GEN PSYCHIAT, V57, P850, DOI 10.1001/archpsyc.57.9.850; Yohrling GJ, 2002, J NEUROCHEM, V82, P1416, DOI 10.1046/j.1471-4159.2002.01084.x; ZAJAC MS, 2009, HIPPOCAMPUS	71	74	75	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22133	10.1371/journal.pone.0022133	http://dx.doi.org/10.1371/journal.pone.0022133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760962	Green Published, gold			2022-12-25	WOS:000292657200051
J	Pucci, L; Grazioso, G; Dallanoce, C; Rizzi, L; De Micheli, C; Clementi, F; Bertrand, S; Bertrand, D; Longhi, R; De Amici, M; Gotti, C				Pucci, Luca; Grazioso, Giovanni; Dallanoce, Clelia; Rizzi, Luca; De Micheli, Carlo; Clementi, Francesco; Bertrand, Sonia; Bertrand, Daniel; Longhi, Renato; De Amici, Marco; Gotti, Cecilia			Engineering of alpha-conotoxin MII-derived peptides with increased selectivity for native alpha 6 beta 2*nicotinic acetylcholine receptors	FASEB JOURNAL			English	Article						molecular modeling; striatum; binding assays; neurotransmitter release	NEURONAL NICOTINIC RECEPTORS; RAT STRIATAL SYNAPTOSOMES; VENTRAL TEGMENTAL AREA; 3 BETA 2; PARKINSONS-DISEASE; HIPPOCAMPAL SYNAPTOSOMES; DOPAMINERGIC TERMINALS; MOLECULAR-DYNAMICS; NACHR SUBTYPES; RELEASE	alpha 6 beta 2* Nicotinic acetylcholine receptors are expressed in selected central nervous system areas, where they are involved in striatal dopamine (DA) release and its behavioral consequences, and other still uncharacterized brain activities. alpha 6 beta 2* receptors are selectively blocked by the alpha-conotoxins MII and PIA, which bear a characteristic N-terminal amino acid tail [arginine (R), aspartic acid (D), and proline (P)]. We synthesized a group of PIA-related peptides in which R1 was mutated or the RDP motif gradually removed. Binding and striatal DA release assays of native rat alpha 6 beta 2* receptors showed that the RDP sequence, and particularly residue R1, is essential for the activity of PIA. On the basis of molecular modeling analyses, we synthesized a hybrid peptide (RDP-MII) that had increased potency (7-fold) and affinity (13-fold) for alpha 6 beta 2* receptors but not for the very similar alpha 3 beta 2* subtype. As docking studies also suggested that E11 of MII might be a key residue engendering alpha 6 beta 2* vs. alpha 3 beta 2* selectivity, we prepared MII[E11R] and RDP-MII[E11R] peptides. Their affinity and potency for native alpha 6 beta 2* receptors were similar to those of their parent analogues, whereas, for the oocyte expressed rat alpha 3 beta 2* subtype, they showed a 31- and 14-fold lower affinity and 21- and 3.5-fold lower potency. Thus, MII[E11R] and RDP-MII[E11R] are potent antagonists showing a degree of alpha 6 beta 2* vs. alpha 3 beta 2* selectivity in vivo.-Pucci, L., Grazioso, G., Dallanoce, C., Rizzi, L., De Micheli, C., Clementi, F., Bertrand, S., Bertrand, D., Longhi, R., De Amici, M., Gotti, C. Engineering of alpha-conotoxin MII-derived peptides with increased selectivity for native alpha 6 beta 2* nicotinic acetylcholine receptors. FASEB J. 25, 3775-3789 (2011). www.fasebj.org	[Pucci, Luca; Clementi, Francesco; Gotti, Cecilia] Univ Milan, CNR, Ist Neurosci, Dipartimento Farmacol Chemioterapia & Tossicol Me, I-20133 Milan, Italy; [Pucci, Luca; Clementi, Francesco; Gotti, Cecilia] Univ Milan, CNR, Ist Neurosci Farmacol Cellulare & Mol, I-20133 Milan, Italy; [Grazioso, Giovanni; Dallanoce, Clelia; Rizzi, Luca; De Micheli, Carlo] Univ Milan, Dipartimento Sci Farmaceut Pietro Pratesi, I-20133 Milan, Italy; [Bertrand, Sonia; Bertrand, Daniel] HiQScreen Sarl, Geneva, Switzerland; [Longhi, Renato; De Amici, Marco] CNR, Ist Chim Riconoscimento Mol, I-20133 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Milan; Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Gotti, C (corresponding author), Univ Milan, CNR, Ist Neurosci, Dipartimento Farmacol Chemioterapia & Tossicol Me, Via Vanvitelli 32, I-20133 Milan, Italy.	c.gotti@in.cnr.it	Grazioso, Giovanni/AFU-7952-2022; DE MICHELI, CARLO/A-9656-2011; De Amici, Marco/F-9684-2015	Grazioso, Giovanni/0000-0002-3261-9356; DE MICHELI, CARLO/0000-0003-3549-4365; Dallanoce, Clelia/0000-0002-7383-1484; De Amici, Marco/0000-0002-0236-0662	Italian FIRB [RBNE03H5Y]; PRIN [20072BTSR2]; EC from Regione Lombardia [ID 16983]; Associazione Oasi Maria SS (Troina, Italy)	Italian FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); EC from Regione Lombardia; Associazione Oasi Maria SS (Troina, Italy)	This research was financially supported by the Italian FIRB grant RBNE03H5Y to C.D.M. and PRIN grant 20072BTSR2 to F.C. and M.D.A. An EC Neurocypres grant, TERDISMENTAL grant ID 16983 SAL-50 from Regione Lombardia to C.G., and a grant from the Associazione Oasi Maria SS (Troina, Italy) to F.C. are also gratefully acknowledged.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Azam L, 2008, J BIOL CHEM, V283, P11625, DOI 10.1074/jbc.M710288200; Azam L, 2006, MOL PHARMACOL, V70, P967, DOI 10.1124/mol.106.024513; Azam L, 2010, FASEB J, V24, P5113, DOI 10.1096/fj.10-166272; Barik J, 2006, MOL PHARMACOL, V69, P618, DOI 10.1124/mol.105.018184; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bordia T, 2007, MOL PHARMACOL, V72, P52, DOI 10.1124/mol.107.035998; Brunzell DH, 2010, NEUROPSYCHOPHARMACOL, V35, P665, DOI 10.1038/npp.2009.171; Capelli AM, 2011, BRIT J PHARMACOL, V163, P313, DOI 10.1111/j.1476-5381.2011.01213.x; Case D, 2006, AMBER 9; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; ChavezNoriega LE, 1997, J PHARMACOL EXP THER, V280, P346; Chi SW, 2005, BIOCHEM BIOPH RES CO, V338, P1990, DOI 10.1016/j.bbrc.2005.10.176; Clarke PBS, 1996, BRIT J PHARMACOL, V117, P595, DOI 10.1111/j.1476-5381.1996.tb15232.x; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Cox BC, 2008, J NEUROCHEM, V105, P1924, DOI 10.1111/j.1471-4159.2008.05282.x; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; David R, 2010, EUR J NEUROSCI, V31, P978, DOI 10.1111/j.1460-9568.2010.07133.x; De Biasi M, 2002, J NEUROBIOL, V53, P568, DOI 10.1002/neu.10145; Dowell C, 2003, J NEUROSCI, V23, P8445; Drenan RM, 2008, NEURON, V60, P123, DOI 10.1016/j.neuron.2008.09.009; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; FORNASARI D, 1990, NEUROSCI LETT, V111, P351, DOI 10.1016/0304-3940(90)90287-J; Gotti C, 2006, CURR PHARM DESIGN, V12, P407, DOI 10.2174/138161206775474486; Gotti C, 2005, MOL PHARMACOL, V68, P1162, DOI 10.1124/mol.105.015925; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Gotti C, 2006, NEUROBIOL DIS, V23, P481, DOI 10.1016/j.nbd.2006.04.005; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Grady SR, 2007, BIOCHEM PHARMACOL, V74, P1235, DOI 10.1016/j.bcp.2007.07.032; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; Harvey SC, 1997, MOL PHARMACOL, V51, P336, DOI 10.1124/mol.51.2.336; Harvey SC, 1996, J NEUROSCI, V16, P3798; Hill JM, 1998, BIOCHEMISTRY-US, V37, P15621, DOI 10.1021/bi981535w; Hogg RC, 2008, J NEUROSCI METH, V169, P65, DOI 10.1016/j.jneumeth.2007.11.028; Janes RW, 2005, CURR OPIN PHARMACOL, V5, P280, DOI 10.1016/j.coph.2005.01.013; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KING DS, 1990, INT J PEPT PROT RES, V36, P255; Kulak JM, 1997, J NEUROSCI, V17, P5263; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Lai A, 2005, MOL PHARMACOL, V67, P1639, DOI 10.1124/mol.104.006429; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lomazzo E, 2010, J NEUROCHEM, V115, P625, DOI 10.1111/j.1471-4159.2010.06967.x; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; Moretti M, 2004, MOL PHARMACOL, V66, P85, DOI 10.1124/mol.66.1.85; Moretti M, 2010, MOL PHARMACOL, V78, P287, DOI 10.1124/mol.110.064071; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Nicke A, 2003, J BIOL CHEM, V278, P3137, DOI 10.1074/jbc.M210280200; Papke RL, 2008, NEUROPHARMACOLOGY, V54, P1189, DOI 10.1016/j.neuropharm.2008.03.010; Parker MJ, 1998, MOL PHARMACOL, V54, P1132, DOI 10.1124/mol.54.6.1132; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Quik M, 2006, J PHARMACOL EXP THER, V316, P481, DOI 10.1124/jpet.105.094375; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sidhpura N, 2007, EUR J PHARMACOL, V567, P102, DOI 10.1016/j.ejphar.2007.03.052; Turner JR, 2005, J NEUROSCI, V25, P9258, DOI 10.1523/JNEUROSCI.2112-05.2005; Turner M, 2009, BIOORGAN MED CHEM, V17, P5894, DOI 10.1016/j.bmc.2009.07.005; Wang F, 1998, J BIOL CHEM, V273, P28721, DOI 10.1074/jbc.273.44.28721; Whiteaker P, 2002, J NEUROSCI, V22, P2522, DOI 10.1523/JNEUROSCI.22-07-02522.2002; Xiao YX, 2004, J PHARMACOL EXP THER, V310, P98, DOI 10.1124/jpet.104.066787; Yang KC, 2009, ACTA PHARMACOL SIN, V30, P740, DOI 10.1038/aps.2009.63; Zoli M, 2002, J NEUROSCI, V22, P8785	66	32	34	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2011	25	11					3775	3789		10.1096/fj.10-179853	http://dx.doi.org/10.1096/fj.10-179853			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21778325				2022-12-25	WOS:000296723100004
J	Vincents, B; Guentsch, A; Kostolowska, D; von Pawel-Rammingen, U; Eick, S; Potempa, J; Abrahamson, M				Vincents, Bjarne; Guentsch, Arndt; Kostolowska, Dominika; von Pawel-Rammingen, Ulrich; Eick, Sigrun; Potempa, Jan; Abrahamson, Magnus			Cleavage of IgG(1) and IgG(3) by gingipain K from Porphyromonas gingivalis may compromise host defense in progressive periodontitis	FASEB JOURNAL			English	Article						cysteine proteases; cysteine peptidases; host-pathogen interactions; enzyme kinetics; immunoglobulin G; native substrates	STEADY-STATE KINETICS; CYSTEINE PROTEINASES; BACTERIAL PROTEINASES; CREVICULAR FLUID; IMMUNOGLOBULIN-G; VIRULENCE FACTORS; CYSTATIN C; INACTIVATION; DEGRADATION; RESPONSES	Degradation of immunoglobulins is an effective strategy of bacteria to evade the immune system. We have tested whether human IgG is a substrate for gingipain K of Porphyromonas gingivalis and found that the enzyme can hydrolyze subclass 1 and 3 of human IgG. The heavy chain of IgG(1) was cleaved at a single site within the hinge region, generating Fab and Fc fragments. IgG(3) was also cleaved within the heavy chain, but at several sites around the CH2 region. Investigation of the enzyme kinetics of IgG proteolysis by gingipain K, using FPLC- and isothermal titration calorimetry-based assays followed by Hill plots, revealed non-Michaelis-Menten kinetics involving a mechanism of positive cooperativity. In ex vivo studies, it was shown that gingipain K retained its IgG hydrolyzing activity in human plasma despite the high content of natural protease inhibitors; that IgG(1) cleavage products were detected in gingival crevicular fluid samples from patients with severe periodontitis; and that gingipain K treatment of serum samples from patients with high antibody titers against P. gingivalis significantly hindered opsonin-dependent phagocytosis of clinical isolates of P. gingivalis by neutrophils. Altogether, these findings underline a biological function of gingipain K as an IgG protease of pathophysiological importance.-Vincents, B., Guentsch, A., Kostolowska, D., von Pawel-Rammingen, U., Eick, S., Potempa, J., Abrahamson, M. Cleavage of IgG(1) and IgG(3) by gingipain K from Porphyromonas gingivalis may compromise host defense in progressive periodontitis. FASEB J. 25, 3741-3750 (2011). www.fasebj.org	[Vincents, Bjarne; Abrahamson, Magnus] Lund Univ, Univ Hosp, Dept Lab Med, Div Clin Chem & Pharmacol, SE-22185 Lund, Sweden; [Guentsch, Arndt] Univ Hosp Jena, Dept Conservat Dent, Jena, Germany; [Kostolowska, Dominika; Potempa, Jan] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [von Pawel-Rammingen, Ulrich] Umea Univ, Dept Mol Biol, Umea, Sweden; [Eick, Sigrun] Univ Bern, Dept Periodontol, Lab Oral Microbiol, Bern, Switzerland; [Potempa, Jan] Univ Louisville, Sch Dent, Ctr Oral Hlth & System Dis, Louisville, KY 40202 USA	Lund University; Skane University Hospital; Friedrich Schiller University of Jena; Jagiellonian University; Umea University; University of Bern; University of Louisville	Abrahamson, M (corresponding author), Lund Univ, Univ Hosp, Dept Lab Med, Div Clin Chem & Pharmacol, SE-22185 Lund, Sweden.	jspote01@louisville.edu; magnus.abrahamson@med.lu.se	Abrahamson, Magnus/CAG-9507-2022; Potempa, Jan/AAA-6850-2021; Guentsch, Arndt/N-4427-2015; Guentsch, Arndt/AAE-9389-2020	Guentsch, Arndt/0000-0001-8989-1441; Guentsch, Arndt/0000-0001-8989-1441; Potempa, Jan/0000-0002-3600-7461	Foundation for Polish Science [DPS/424-329/10]; Ministry of Science and Higher Education (Warsaw, Poland) [1642/B/P01/2008/35]; European Commission [FP7-HEALTH-2010-261460]; U.S. National Institutes of Health [DE 09761]; Swedish Research Council [14800, 14767, 09915]; Commission of the European Communities; Crafoord and A. Osterberg foundations; Royal Physiographic Society (Lund, Sweden); Faculty of Medicine at Lund University; European Union [POIG.02.01.00-12-064/08]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE009761] Funding Source: NIH RePORTER	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Ministry of Science and Higher Education (Warsaw, Poland)(Ministry of Science and Higher Education, Poland); European Commission(European CommissionEuropean Commission Joint Research Centre); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Commission of the European Communities(European Commission); Crafoord and A. Osterberg foundations; Royal Physiographic Society (Lund, Sweden); Faculty of Medicine at Lund University; European Union(European Commission); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors are grateful to Dr. Peter Westh (Roskilde University, Roskilde, Denmark) for use of his ITC equipment and helpful comments. J.P. acknowledges support from Foundation for Polish Science (TEAM project DPS/424-329/10). This study was partially supported by funding from the Ministry of Science and Higher Education (Warsaw, Poland; 1642/B/P01/2008/35), the European Commission (FP7-HEALTH-2010-261460; Gums and Joints), and the U.S. National Institutes of Health (DE 09761), and by grants from the Swedish Research Council (14800, 14767, and 09915), the Commission of the European Communities, the Crafoord and A. Osterberg foundations; the Royal Physiographic Society (Lund, Sweden), the Faculty of Medicine at Lund University, and Insamlingsstiftelsen at Umea University. The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of structural funds from the European Union (POIG.02.01.00-12-064/08; Molecular Biotechnology for Health).	Abrahamson M, 1997, J CLIN PATHOL-MOL PA, V50, P291, DOI 10.1136/mp.50.6.291; Ashimoto A, 1996, ORAL MICROBIOL IMMUN, V11, P266, DOI 10.1111/j.1399-302X.1996.tb00180.x; CORNISHBOWDEN A, 1987, BIOCHEM EDUC, V15, P144, DOI 10.1016/0307-4412(87)90048-3; CORNISHBOWDEN A, 1987, J THEOR BIOL, V124, P1, DOI 10.1016/S0022-5193(87)80248-5; Curtis MA, 2002, INFECT IMMUN, V70, P6968, DOI 10.1128/IAI.70.12.6968-6975.2002; Dias IHK, 2008, INFECT IMMUN, V76, P317, DOI 10.1128/IAI.00618-07; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; Eley BM, 2003, PERIODONTOL 2000, V31, P105, DOI 10.1034/j.1600-0757.2003.03107.x; Ermert D, 2009, J INNATE IMMUN, V1, P181, DOI 10.1159/000205281; FRENCH M, 1986, MONOGR ALLERGY, V19, P100; Gibson FC, 2005, J PERIODONTOL, V76, P1629, DOI 10.1902/jop.2005.76.10.1629; Guentsch A, 2009, J PERIODONTAL RES, V44, P368, DOI 10.1111/j.1600-0765.2008.01113.x; Guentsch A, 2011, J PERIODONTOL, V82, P1051, DOI 10.1902/jop.2011.100565; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Imamura T, 2003, CURR PROTEIN PEPT SC, V4, P443, DOI 10.2174/1389203033487027; Inagaki S, 2003, J PERIODONTOL, V74, P1432, DOI 10.1902/jop.2003.74.10.1432; Inomata M, 2009, J PERIODONTOL, V80, P1511, DOI 10.1902/jop.2009.090114; Janeway C., 1994, IMMUNOBIOLOGY IMMUNE; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; Katz J, 2002, INFECT IMMUN, V70, P2512, DOI 10.1128/IAI.70.5.2512-2518.2002; Kilian M, 1996, APMIS, V104, P321, DOI 10.1111/j.1699-0463.1996.tb00724.x; Kinane DF, 1999, CLIN EXP IMMUNOL, V115, P534; Lamster IB, 2007, ANN NY ACAD SCI, V1098, P216, DOI 10.1196/annals.1384.027; Lefranc M. P., 2009, NUCLEIC ACIDS RES, V32, pD160; Mahtout H, 2009, ORAL MICROBIOL IMMUN, V24, P396, DOI 10.1111/j.1399-302X.2009.00532.x; Medina E, 2009, J INNATE IMMUN, V1, P176, DOI 10.1159/000203699; Mezyk-Kopec R, 2005, INFECT IMMUN, V73, P1506, DOI 10.1128/IAI.73.3.1506-1514.2005; Mikolajczyk-Pawlinska J, 1998, FEBS LETT, V440, P282, DOI 10.1016/S0014-5793(98)01461-6; NILSSON T, 1985, INFECT IMMUN, V50, P467, DOI 10.1128/IAI.50.2.467-471.1985; O'Brien-Simpson NM, 2000, INFECT IMMUN, V68, P2704, DOI 10.1128/IAI.68.5.2704-2712.2000; Oleksy A, 2002, MICROB PATHOGENESIS, V32, P173, DOI 10.1006/mpat.2002.0491; PIKE R, 1994, J BIOL CHEM, V269, P406; Potempa J, 1997, BIOL CHEM, V378, P223, DOI 10.1515/bchm.1997.378.3-4.223; Potempa J, 1998, J BIOL CHEM, V273, P21648, DOI 10.1074/jbc.273.34.21648; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Potempa J, 2000, PERIODONTOL 2000, V24, P153, DOI 10.1034/j.1600-0757.2000.2240108.x; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; Puklo M, 2008, ORAL MICROBIOL IMMUN, V23, P328, DOI 10.1111/j.1399-302X.2008.00433.x; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Segel I.H., 1975, ENZYME KINETICS; Sheets SA, 2005, INFECT IMMUN, V73, P1543, DOI 10.1128/IAI.73.3.1543-1552.2005; SUNDQVIST G, 1985, J MED MICROBIOL, V19, P85, DOI 10.1099/00222615-19-1-85; Takeuchi Y, 2006, ORAL MICROBIOL IMMUN, V21, P314, DOI 10.1111/j.1399-302X.2006.00296.x; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; Toh ECY, 2011, ANTIMICROB AGENTS CH, V55, P1155, DOI 10.1128/AAC.00466-10; Travis J, 2000, BBA-PROTEIN STRUCT M, V1477, P35, DOI 10.1016/S0167-4838(99)00278-2; Vincents B, 2004, BIOCHEMISTRY-US, V43, P15540, DOI 10.1021/bi048284d; Vincents B, 2008, CHEM BIOL, V15, P960, DOI 10.1016/j.chembiol.2008.07.021; VLUG A, 1994, ANN BIOL CLIN-PARIS, V52, P561; von Pawel-Rammingen U, 2003, CURR OPIN MICROBIOL, V6, P50, DOI 10.1016/S1369-5274(03)00003-1; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; Willemoes M, 2002, EUR J BIOCHEM, V269, P4772, DOI 10.1046/j.1432-1033.2002.03175.x; WILTON JMA, 1993, ARCH ORAL BIOL, V38, P55, DOI 10.1016/0003-9969(93)90155-F; Yasuhara R, 2009, BIOCHEM J, V419, P159, DOI 10.1042/BJ20081469	55	40	42	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3741	3750		10.1096/fj.11-187799	http://dx.doi.org/10.1096/fj.11-187799			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21768393	Green Published			2022-12-25	WOS:000295356400042
J	Fauquant, C; Redeker, V; Landrieu, I; Wieruszeski, JM; Verdegem, D; Laprevote, O; Lippens, G; Gigant, B; Knossow, M				Fauquant, Caroline; Redeker, Virginie; Landrieu, Isabelle; Wieruszeski, Jean-Michel; Verdegem, Dries; Laprevote, Olivier; Lippens, Guy; Gigant, Benoit; Knossow, Marcel			Systematic Identification of Tubulin-interacting Fragments of the Microtubule-associated Protein Tau Leads to a Highly Efficient Promoter of Microtubule Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATHMIN-LIKE DOMAIN; DYNAMIC INSTABILITY; PROJECTION DOMAIN; BINDING DOMAINS; COMPLEX; PHOSPHORYLATION; TAUOPATHIES; ISOFORMS; DISEASE; REGIONS	Tau is a microtubule-associated protein that stabilizes microtubules and stimulates their assembly. Current descriptions of the tubulin-interacting regions of Tau involve microtubules as the target and result mainly from deletions of Tau domains based on sequence analysis and from NMR spectros-copy experiments. Here, instead of microtubules, we use the complex of two tubulin heterodimers with the stathmin-like domain of the RB3 protein (T2R) to identify interacting Tau fragments generated by limited proteolysis. We show that fragments in the proline-rich region and in the microtubule-binding repeats domain each interact on their own not only with T2R but also with microtubules, albeit with moderate affinity. NMR analysis of the interaction with T2R of constructs in these two regions leads to a fragment, composed of adjacent parts of the microtubule-binding repeat domain and of the proline-rich region, that binds tightly to stabilized microtubules. This demonstrates the synergy of the two Tau regions we identified in the Tau-microtubule interaction. Moreover, we show that this fragment, which binds to two tubulin heterodimers, stimulates efficiently microtubule assembly.	[Fauquant, Caroline; Redeker, Virginie; Gigant, Benoit; Knossow, Marcel] CNRS, Lab Enzymol & Biochim Struct, Ctr Rech Gif, F-91198 Gif Sur Yvette, France; [Landrieu, Isabelle; Wieruszeski, Jean-Michel; Verdegem, Dries; Lippens, Guy] Univ Sci & Technol Lille, Unite Glycobiol Struct & Fonct, UMR CNRS 8576, IFR 147, F-59655 Villeneuve Dascq, France; [Laprevote, Olivier] CNRS, Lab Spectrometrie Masse, Inst Chim Subst Nat, Ctr Rech Gif, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Gigant, B (corresponding author), CNRS, Lab Enzymol & Biochim Struct, Ctr Rech Gif, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	gigant@lebs.cnrs-gif.fr; knossow@lebs.cnrs-gif.fr	Landrieu, Isabelle/AAF-8495-2019; Redeker, Virginie/L-8929-2018	Landrieu, Isabelle/0000-0002-4883-2637; Redeker, Virginie/0000-0003-2694-8388; Gigant, Benoit/0000-0002-5946-6759; Lippens, Guy/0000-0002-8236-0901	CNRS; Agence Nationale pour la Recherche [ANR-05-Blanc-6320-01]; Equipments RMN THC [Fr3050]; Fondation pour la Recherche Medicale [DEQ20081213979]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Equipments RMN THC; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the CNRS, Agence Nationale pour la Recherche Grant ANR-05-Blanc-6320-01, Tres Grands Equipments RMN THC Fr3050, and Fondation pour la Recherche Medicale Grant DEQ20081213979.	Ackmann M, 2000, J BIOL CHEM, V275, P30335, DOI 10.1074/jbc.M002590200; Amniai L, 2009, FASEB J, V23, P1146, DOI 10.1096/fj.08-121590; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Avila J, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00049; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Black MM, 1996, J NEUROSCI, V16, P3601; Brandt R, 2005, BBA-MOL BASIS DIS, V1739, P331, DOI 10.1016/j.bbadis.2004.06.018; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; BRANDT R, 1993, J BIOL CHEM, V268, P3414; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Cao BR, 2009, BIOMACROMOLECULES, V10, P555, DOI 10.1021/bm801224q; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Charbaut E, 2002, FEBS LETT, V529, P341, DOI 10.1016/S0014-5793(02)03421-X; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; Chau MF, 1998, BIOCHEMISTRY-US, V37, P17692, DOI 10.1021/bi9812118; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; CORREIA JJ, 1987, J BIOL CHEM, V262, P17278; Dehmelt L, 2005, GENOME BIOL, V6; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; DETRICH HW, 1978, BIOCHEMISTRY-US, V17, P3900, DOI 10.1021/bi00612a002; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hernandez F, 2007, CELL MOL LIFE SCI, V64, P2219, DOI 10.1007/s00018-007-7220-x; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; HIMMLER A, 1989, MOL CELL BIOL, V9, P1389, DOI 10.1128/MCB.9.4.1389; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; KANAI Y, 1992, EMBO J, V11, P3953, DOI 10.1002/j.1460-2075.1992.tb05489.x; Mukhopadhyay R, 2001, FEBS LETT, V505, P374, DOI 10.1016/S0014-5793(01)02844-7; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Preuss U, 1997, J CELL SCI, V110, P789; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Redeker V, 2000, J BIOL CHEM, V275, P6841, DOI 10.1074/jbc.275.10.6841; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Sillen A, 2007, BIOCHEMISTRY-US, V46, P3055, DOI 10.1021/bi061920i; STEINER B, 1990, EMBO J, V9, P3539, DOI 10.1002/j.1460-2075.1990.tb07563.x; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; van der Vaart B, 2009, BIOCHEM SOC T, V37, P1007, DOI 10.1042/BST0371007; Verdegem D, 2008, J BIOMOL NMR, V42, P11, DOI 10.1007/s10858-008-9262-2; Weissmann C, 2009, TRAFFIC, V10, P1655, DOI 10.1111/j.1600-0854.2009.00977.x	47	43	46	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33358	33368		10.1074/jbc.M111.223545	http://dx.doi.org/10.1074/jbc.M111.223545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21757739	Green Published, hybrid			2022-12-25	WOS:000294968800054
J	Fan, ACY; Kozlov, G; Hoegl, A; Marcellus, RC; Wong, MJH; Gehring, K; Young, JC				Fan, Anna C. Y.; Kozlov, Guennadi; Hoegl, Annabelle; Marcellus, Richard C.; Wong, Michael J. H.; Gehring, Kalle; Young, Jason C.			Interaction between the Human Mitochondrial Import Receptors Tom20 and Tom70 in Vitro Suggests a Chaperone Displacement Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT; OUTER-MEMBRANE; PREPROTEIN TRANSLOCASE; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONES; ADP/ATP CARRIER; COMPLEX; PRESEQUENCE; RECOGNITION; DOMAIN	The mitochondrial import receptor Tom70 contains a tetratricopeptide repeat (TPR) clamp domain, which allows the receptor to interact with the molecular chaperones, Hsc70/Hsp70 and Hsp90. Preprotein recognition by Tom70, a critical step to initiate import, is dependent on these cytosolic chaperones. Preproteins are subsequently released from the receptor for translocation across the outer membrane, yet the mechanism of this step is unknown. Here, we report that Tom20 interacts with the TPR clamp domain of Tom70 via a conserved C-terminal DDVE motif. This interaction was observed by cross-linking endogenous proteins on the outer membrane of mitochondria from HeLa cells and in co-precipitation and NMR titrations with purified proteins. Upon mutation of the TPR clamp domain or deletion of the DDVE motif, the interaction was impaired. In co-precipitation experiments, the Tom20-Tom70 interaction was inhibited by C-terminal peptides from Tom20, as well as from Hsc70 and Hsp90. The Hsp90-Tom70 interaction was measured with surface plasmon resonance, and the same peptides inhibited the interaction. Thus, Tom20 competes with the chaperones for Tom70 binding. Interestingly, antibody blocking of Tom20 did not increase the efficiency of Tom70-dependent preprotein import; instead, it impaired the Tom70 import pathway in addition to the Tom20 pathway. The functional interaction between Tom20 and Tom70 may be required at a later step of the Tom70-mediated import, after chaperone docking. We suggest a novel model in which Tom20 binds Tom70 to facilitate preprotein release from the chaperones by competition.	McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University	Young, JC (corresponding author), 3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	jason.young2@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	Canadian Institutes of Health Research; Canadian Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	The work was supported by the Canadian Institutes of Health Research and the Canadian Foundation for Innovation.	Abdul KM, 2000, BIOCHEM BIOPH RES CO, V276, P1028, DOI 10.1006/bbrc.2000.3589; Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Ahting U, 2005, J BIOL CHEM, V280, P48, DOI 10.1074/jbc.M410905200; Ahting U, 1999, J CELL BIOL, V147, P959, DOI 10.1083/jcb.147.5.959; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bhangoo MK, 2007, MOL BIOL CELL, V18, P3414, DOI 10.1091/mbc.E07-01-0088; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chewawiwat N, 1999, J BIOCHEM, V125, P721, DOI 10.1093/oxfordjournals.jbchem.a022342; Chou CH, 2006, MOL BIOL CELL, V17, P3952, DOI 10.1091/mbc.E06-04-0319; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; Fan ACY, 2006, J BIOL CHEM, V281, P33313, DOI 10.1074/jbc.M605250200; Fan ACY, 2010, BIOCHEM J, V429, P553, DOI 10.1042/BJ20091855; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Haucke V, 1996, EMBO J, V15, P1231, DOI 10.1002/j.1460-2075.1996.tb00464.x; Igura M, 2005, ACTA CRYSTALLOGR F, V61, P514, DOI 10.1107/S1744309105011577; Iwahashi J, 1997, J BIOL CHEM, V272, P18467, DOI 10.1074/jbc.272.29.18467; Joseph AM, 2004, AM J PHYSIOL-CELL PH, V286, pC867, DOI 10.1152/ajpcell.00191.2003; KIEBLER M, 1990, NATURE, V348, P610, DOI 10.1038/348610a0; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Li JX, 2009, J BIOL CHEM, V284, P23852, DOI 10.1074/jbc.M109.023986; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Mills RD, 2009, J MOL BIOL, V388, P1043, DOI 10.1016/j.jmb.2009.03.070; Model K, 2002, J MOL BIOL, V316, P657, DOI 10.1006/jmbi.2001.5365; Model K, 2008, J MOL BIOL, V383, P1049, DOI 10.1016/j.jmb.2008.07.087; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Saitoh T, 2007, EMBO J, V26, P4777, DOI 10.1038/sj.emboj.7601888; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schlegel T, 2007, MOL BIOL EVOL, V24, P2763, DOI 10.1093/molbev/msm211; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; SOLLNER T, 1992, NATURE, V355, P84, DOI 10.1038/355084a0; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Suzuki H, 2002, J CELL SCI, V115, P1895; Suzuki H, 2000, J BIOL CHEM, V275, P37930, DOI 10.1074/jbc.M006558200; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Terada K, 1997, J CELL BIOL, V139, P1089, DOI 10.1083/jcb.139.5.1089; Truscott KN, 2002, MOL CELL BIOL, V22, P7780, DOI 10.1128/MCB.22.22.7780-7789.2002; Tsaytler PA, 2009, CELL STRESS CHAPERON, V14, P629, DOI 10.1007/s12192-009-0115-z; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Wiedemann N, 2001, EMBO J, V20, P951, DOI 10.1093/emboj/20.5.951; Yang CS, 2002, ARCH BIOCHEM BIOPHYS, V400, P105, DOI 10.1006/abbi.2002.2778; Yano M, 2003, J CELL BIOL, V163, P45, DOI 10.1083/jcb.200305051; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; ZARA V, 1992, J BIOL CHEM, V267, P12077	48	34	35	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32208	32219		10.1074/jbc.M111.280446	http://dx.doi.org/10.1074/jbc.M111.280446			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21771790	hybrid, Green Published			2022-12-25	WOS:000294726800031
J	Carrasco-Lopez, C; Rojas-Altuve, A; Zhang, WL; Hesek, D; Lee, M; Barbe, S; Andre, I; Ferrer, P; Silva-Martin, N; Castro, GR; Martinez-Ripoll, M; Mobashery, S; Hermoso, JA				Carrasco-Lopez, Cesar; Rojas-Altuve, Alzoray; Zhang, Weilie; Hesek, Dusan; Lee, Mijoon; Barbe, Sophie; Andre, Isabelle; Ferrer, Pilar; Silva-Martin, Noella; Castro, German R.; Martinez-Ripoll, Martin; Mobashery, Shahriar; Hermoso, Juan A.			Crystal Structures of Bacterial Peptidoglycan Amidase AmpD and an Unprecedented Activation Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CITROBACTER-FREUNDII AMPD; GRAM-NEGATIVE BACTERIA; RECOGNITION PROTEIN-S; L-ALANINE AMIDASE; PATTERN-RECOGNITION; ESCHERICHIA-COLI; DROSOPHILA-MELANOGASTER; MOLECULAR-DYNAMICS; FORCE-FIELD; BINDING	AmpD is a cytoplasmic peptidoglycan (PG) amidase involved in bacterial cell-wall recycling and in induction of beta-lactamase, a key enzyme of beta-lactam antibiotic resistance. AmpD belongs to the amidase_2 family that includes zinc-dependent amidases and the peptidoglycan-recognition proteins (PGRPs), highly conserved pattern-recognition molecules of the immune system. Crystal structures of Citrobacter freundii AmpD were solved in this study for the apoenzyme, for the holoenzyme at two different pH values, and for the complex with the reaction products, providing insights into the PG recognition and the catalytic process. These structures are significantly different compared with the previously reported NMR structure for the same protein. The NMR structure does not possess an accessible active site and shows the protein in what is proposed herein as an inactive "closed" conformation. The transition of the protein from this inactive conformation to the active "open" conformation, as seen in the x-ray structures, was studied by targeted molecular dynamics simulations, which revealed large conformational rearrangements (as much as 17 angstrom) in four specific regions representing one-third of the entire protein. It is proposed that the large conformational change that would take the inactive NMR structure to the active x-ray structure represents an unprecedented mechanism for activation of AmpD. Analysis is presented to argue that this activation mechanism might be representative of a regulatory process for other intracellular members of the bacterial amidase_2 family of enzymes.	[Carrasco-Lopez, Cesar; Rojas-Altuve, Alzoray; Silva-Martin, Noella; Martinez-Ripoll, Martin; Hermoso, Juan A.] CSIC, Inst Quim Fis Rocasolano, Dept Cristalog & Biol Estruct, E-28006 Madrid, Spain; [Zhang, Weilie; Hesek, Dusan; Lee, Mijoon; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Barbe, Sophie; Andre, Isabelle] LISBP, INP, UPS, INSA, F-31077 Toulouse, France; [Barbe, Sophie; Andre, Isabelle] CNRS, UMR5504, F-31400 Toulouse, France; [Barbe, Sophie; Andre, Isabelle] Univ Toulouse, INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Ferrer, Pilar; Castro, German R.] European Synchrotron Radiat Facil, SpLine Spanish CRG Beamline, F-38043 Grenoble, France; [Ferrer, Pilar; Castro, German R.] CSIC, ICMM, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Notre Dame; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); European Synchrotron Radiation Facility (ESRF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM)	Mobashery, S (corresponding author), Serrano 119, Madrid 28006, Spain.	mobashery@nd.edu; xjuan@iqfr.csic.es	Hermoso, Juan/J-3433-2012; Castro, German/AAG-7411-2020; Castro, German R/H-6679-2015; Lee, Mijoon/AFK-1543-2022; Martinez-Ripoll, Martin/A-8313-2012; Ferrer, Pilar/E-7836-2014; Barbe, Sophie/ABD-9530-2020	Hermoso, Juan/0000-0002-1862-8950; Castro, German/0000-0003-4251-3245; Castro, German R/0000-0003-4251-3245; Lee, Mijoon/0000-0001-7432-0427; Martinez-Ripoll, Martin/0000-0002-4019-0529; Ferrer, Pilar/0000-0001-9807-7679; Carrasco-Lopez, Cesar/0000-0002-3853-8776; Barbe, Sophie/0000-0003-2581-5022	National Institutes of Health; Spanish Ministry of Science and Technology [BFU2008-01711]; European Union [EU-CP223111]; COMBACT program [S-BIO-0260/2006]; Spanish Ministerio de Ciencia e Innovacion [PI201060E013]; Consejo Superior de Investigaciones Cientificas	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); COMBACT program; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejo Superior de Investigaciones Cientificas	This work was supported, in whole or in part, by the National Institutes of Health. This work was also supported by grants from the Spanish Ministry of Science and Technology (BFU2008-01711), EU-CP223111 (CARE-PNEUMO, European Union), and the COMBACT program (S-BIO-0260/2006). We acknowledge the Spanish Ministerio de Ciencia e Innovacion (PI201060E013) and Consejo Superior de Investigaciones Cientificas for financial support and for provision of synchrotron radiation facilities.	ADAMS PD, 2010, ACTA CRYSTALLOGR D 2, V66, P213, DOI DOI 10.1107/S0907444909052925; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castro GR, 1998, J SYNCHROTRON RADIAT, V5, P657, DOI 10.1107/S0909049597019079; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Chang CI, 2004, PLOS BIOL, V2, P1293, DOI 10.1371/journal.pbio.0020277; Chang CI, 2005, P NATL ACAD SCI USA, V102, P10279, DOI 10.1073/pnas.0504547102; Cheng QM, 2002, J BACTERIOL, V184, P6434, DOI 10.1128/JB.184.23.6434-6436.2002; Cho S, 2007, P NATL ACAD SCI USA, V104, P8761, DOI 10.1073/pnas.0701453104; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; COWTAN K, 1994, JOINT CCP4 ESF EACBM, P31; de Pedro MA, 2001, J BACTERIOL, V183, P4115, DOI 10.1128/JB.183.14.4115-4126.2001; DELEON JM, 1991, PHYS REV B, V44, P4146, DOI 10.1103/PhysRevB.44.4146; Doyle R.J., 2001, MOL MED MICROBIOLOGY, P137; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS P, 1993, CCP4 DARESBURY STUDY, P114; Genereux C, 2004, BIOCHEM J, V377, P111, DOI 10.1042/BJ20030862; GROCHULSKI P, 1994, PROTEIN SCI, V3, P82; Guan RJ, 2004, P NATL ACAD SCI USA, V101, P17168, DOI 10.1073/pnas.0407856101; Guan RJ, 2007, TRENDS MICROBIOL, V15, P127, DOI 10.1016/j.tim.2007.01.006; Hesek D, 2009, J AM CHEM SOC, V131, P5187, DOI 10.1021/ja808498m; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jaeger T, 2008, CELL MOL LIFE SCI, V65, P928, DOI 10.1007/s00018-007-7399-x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kerff F, 2010, J MOL BIOL, V397, P249, DOI 10.1016/j.jmb.2009.12.038; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Lee MC, 2004, PROTEINS, V55, P620, DOI 10.1002/prot.10470; Lee MJ, 2009, J AM CHEM SOC, V131, P8742, DOI 10.1021/ja9025566; Leone P, 2008, MOL IMMUNOL, V45, P2521, DOI 10.1016/j.molimm.2008.01.015; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB, P26; Liepinsh E, 2003, J MOL BIOL, V327, P833, DOI 10.1016/S0022-2836(03)00185-2; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petrosino JF, 2002, ANTIMICROB AGENTS CH, V46, P1535, DOI 10.1128/AAC.46.5.1535-1539.2002; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Reider A, 2009, EMBO J, V28, P3103, DOI 10.1038/emboj.2009.248; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Tydell CC, 2006, J IMMUNOL, V176, P1154, DOI 10.4049/jimmunol.176.2.1154; Wang MH, 2007, J IMMUNOL, V178, P3116, DOI 10.4049/jimmunol.178.5.3116; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Wiedemann B, 1998, DRUG RESIST UPDATE, V1, P223, DOI 10.1016/S1368-7646(98)80002-2; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771	54	38	40	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31714	31722		10.1074/jbc.M111.264366	http://dx.doi.org/10.1074/jbc.M111.264366			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21775432	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000294487500064
J	Melton, EM; Cerny, RL; Watkins, PA; Dirusso, CC; Black, PN				Melton, Elaina M.; Cerny, Ronald L.; Watkins, Paul A.; Dirusso, Concetta C.; Black, Paul N.			Human Fatty Acid Transport Protein 2a/Very Long Chain Acyl-CoA Synthetase 1 (FATP2a/Acsvl1) Has a Preference in Mediating the Channeling of Exogenous n-3 Fatty Acids into Phosphatidylinositol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; COENZYME-A; VECTORIAL ACYLATION; CELLULAR UPTAKE; HEPG2 CELLS; METABOLISM; SYSTEM; COMPONENTS; MUTATIONS	The trafficking of fatty acids across the membrane and into downstream metabolic pathways requires their activation to CoA thioesters. Members of the fatty acid transport protein/very long chain acyl-CoA synthetase (FATP/Acsvl) family are emerging as key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis. We have expressed two naturally occurring splice variants of human FATP2 (Acsvl1) in yeast and 293T-REx cells and addressed their roles in fatty acid transport, activation, and intracellular trafficking. Although both forms (FATP2a (M-r 70,000) and FATP2b (M-r 65,000 and lacking exon3, which encodes part of the ATP binding site)) were functional in fatty acid import, only FATP2a had acyl-CoA synthetase activity, with an apparent preference toward very long chain fatty acids. To further address the roles of FATP2a or FATP2b in fatty acid uptake and activation, LC-MS/MS was used to separate and quantify different acyl-CoA species (C14-C24) and to monitor the trafficking of different classes of exogenous fatty acids into intracellular acyl-CoA pools in 293T-REx cells expressing either isoform. The use of stable isotopically labeled fatty acids demonstrated FATP2a is involved in the uptake and activation of exogenous fatty acids, with a preference toward n-3 fatty acids (C18:3 and C22:6). Using the same cells expressing FATP2a or FATP2b, electrospray ionization/MS was used to follow the trafficking of stable isotopically labeled n-3 fatty acids into phosphatidylcholine and phosphatidylinositol. The expression of FATP2a resulted in the trafficking of C18:3-CoA and C22:6-CoA into both phosphatidylcholine and phosphatidylinositol but with a distinct preference for phosphatidylinositol. Collectively these data demonstrate FATP2a functions in fatty acid transport and activation and provides specificity toward n-3 fatty acids in which the corresponding n-3 acyl-CoAs are preferentially trafficked into acyl-CoA pools destined for phosphatidylinositol incorporation.	[Black, Paul N.] Univ Nebraska, Dept Biochem, George W Beadle Ctr N200, Lincoln, NE 68588 USA; [Cerny, Ronald L.] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA; [Melton, Elaina M.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Watkins, Paul A.] Kennedy Krieger Res Inst, Baltimore, MD 21205 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Albany Medical College; Kennedy Krieger Institute	Black, PN (corresponding author), Univ Nebraska, Dept Biochem, George W Beadle Ctr N200, Lincoln, NE 68588 USA.	pblack2@unl.edu	DiRusso, Concetta C/M-1884-2014	Black, Paul/0000-0002-6272-6881; DiRusso, Concetta/0000-0001-7388-9152; Watkins, Paul A./0000-0002-3246-1405; Melton, Elaina/0000-0002-4030-7766	National Institutes of Health [RO1-DK07076, RO1-GM56850, 1F31DK085961]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK085961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK07076 and RO1-GM56850 (to P. N. B. and C. C. D.) and 1F31DK085961 (to E. M. M.).	Alderson NL, 2005, J LIPID RES, V46, P1569, DOI 10.1194/jlr.D500013-JLR200; Arias-Barrau E, 2009, METHODS MOL BIOL, V580, P233, DOI 10.1007/978-1-60761-325-1_13; Bartz R, 2007, MOL BIOL CELL, V18, P3015, DOI 10.1091/mbc.E06-09-0869; Black Paul N, 2007, Novartis Found Symp, V286, P127; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Black PN, 2003, MICROBIOL MOL BIOL R, V67, P454, DOI 10.1128/MMBR.67.3.454-472.2003; Black PN, 2000, J NUTR, V130, p305S, DOI 10.1093/jn/130.2.305S; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bu SY, 2010, J LIPID RES, V51, P3270, DOI 10.1194/jlr.M009407; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Coe NR, 1999, J BIOL CHEM, V274, P36300, DOI 10.1074/jbc.274.51.36300; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; DiRusso CC, 2000, EUR J BIOCHEM, V267, P4422, DOI 10.1046/j.1432-1327.2000.01489.x; DiRusso CC, 2004, J BIOL CHEM, V279, P49563, DOI 10.1074/jbc.R400026200; Dirusso CC, 2008, BBA-MOL CELL BIOL L, V1781, P135, DOI 10.1016/j.bbalip.2008.01.002; Ellis JM, 2010, CURR OPIN LIPIDOL, V21, P212, DOI 10.1097/MOL.0b013e32833884bb; Faergeman NJ, 2001, J BIOL CHEM, V276, P37051, DOI 10.1074/jbc.M100884200; Faergeman NJ, 1997, J BIOL CHEM, V272, P8531, DOI 10.1074/jbc.272.13.8531; Gimeno RE, 2003, J BIOL CHEM, V278, P16039, DOI 10.1074/jbc.M211412200; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; Han XL, 2000, BIOCHEM J, V352, P79, DOI 10.1042/0264-6021:3520079; Hatch GM, 2002, J LIPID RES, V43, P1380, DOI 10.1194/jlr.M200130-JLR200; Haynes CA, 2008, J LIPID RES, V49, P1113, DOI 10.1194/jlr.D800001-JLR200; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; Jia ZZ, 2007, J MOL NEUROSCI, V33, P25, DOI 10.1007/s12031-007-0038-z; Kaiser C., 1994, YEAST GENETICS; Kemp S, 2004, CLIN CHEM, V50, P1824, DOI 10.1373/clinchem.2004.038539; Li H, 2007, BBA-MOL CELL BIOL L, V1771, P1246, DOI 10.1016/j.bbalip.2007.05.009; Liebisch G, 1999, J LIPID RES, V40, P1539; Magnes C, 2005, ANAL CHEM, V77, P2889, DOI 10.1021/ac048314i; Marszalek JR, 2005, J BIOL CHEM, V280, P10817, DOI 10.1074/jbc.M411750200; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; OVERATH P, 1969, EUR J BIOCHEM, V7, P559; Parkes HA, 2006, AM J PHYSIOL-ENDOC M, V291, pE737, DOI 10.1152/ajpendo.00112.2006; Richards MR, 2006, J LIPID RES, V47, P665, DOI 10.1194/jlr.M500514-JLR200; Rizzo C, 2003, PEDIATR RES, V53, P1013, DOI 10.1203/01.PDR.0000064902.59052.0F; Schaffer JE, 2002, AM J PHYSIOL-ENDOC M, V282, pE239, DOI 10.1152/ajpendo.00462.2001; Schaiff WT, 2007, ENDOCRINOLOGY, V148, P3625, DOI 10.1210/en.2007-0211; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Steinberg SJ, 1999, MOL GENET METAB, V68, P32, DOI 10.1006/mgme.1999.2883; Steinberg SJ, 2000, J BIOL CHEM, V275, P15605, DOI 10.1074/jbc.C000015200; Steinberg SJ, 1999, BIOCHEM BIOPH RES CO, V257, P615, DOI 10.1006/bbrc.1999.0510; Stremmel W, 2001, LIPIDS, V36, P981, DOI 10.1007/s11745-001-0809-2; Stuhlsatz-Krouper SM, 1999, PROSTAG LEUKOTR ESS, V60, P285, DOI 10.1016/S0952-3278(99)80001-5; Stuhlsatz-Krouper SM, 1998, J BIOL CHEM, V273, P28642, DOI 10.1074/jbc.273.44.28642; Sun D, 2006, ANAL BIOCHEM, V349, P87, DOI 10.1016/j.ab.2005.10.006; Tong FM, 2006, ARCH BIOCHEM BIOPHYS, V447, P46, DOI 10.1016/j.abb.2006.01.005; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Yee JK, 2008, J LIPID RES, V49, P2124, DOI 10.1194/jlr.M700600-JLR200; Zhou ZG, 2011, LIPIDS, V46, P879, DOI 10.1007/s11745-011-3575-8; Zou ZY, 2003, J BIOL CHEM, V278, P16414, DOI 10.1074/jbc.M210557200; Zou ZY, 2002, J BIOL CHEM, V277, P31062, DOI 10.1074/jbc.M205034200	57	42	43	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30670	30679		10.1074/jbc.M111.226316	http://dx.doi.org/10.1074/jbc.M111.226316			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21768100	Green Published, hybrid			2022-12-25	WOS:000294283600047
J	Wu, J; Song, RR; Song, WQ; Li, YJ; Zhang, QM; Chen, Y; Fu, YM; Fang, WJ; Wang, JD; Zhong, ZH; Ling, H; Zhang, LM; Zhang, FM				Wu, Jing; Song, Rongrong; Song, Wuqi; Li, Yujun; Zhang, Qingmeng; Chen, Yang; Fu, Yingmei; Fang, Wenjuan; Wang, Jindong; Zhong, Zhaohua; Ling, Hong; Zhang, Liming; Zhang, Fengmin			Chlorpromazine Protects Against Apoptosis Induced by Exogenous Stimuli in the Developing Rat Brain	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; IN-VIVO; HEPATOCYTE APOPTOSIS; MOUSE-BRAIN; ETHANOL; BCL-2; SCHIZOPHRENIA; EXPRESSION; CASPASE-3; BAX	Background: Chlorpromazine (CPZ), a commonly used antipsychotic drug, was found to play a neuroprotective role in various models of toxicity. However, whether CPZ has the potential to affect brain apoptosis in vivo is still unknown. The purpose of this study was to investigate the potential effect of CPZ on the apoptosis induced by exogenous stimuli. Methodology: The ethanol treated infant rat was utilized as a valid apoptotic model, which is commonly used and could trigger robust apoptosis in brain tissue. Prior to the induction of apoptosis by subcutaneous injection of ethanol, 7-day-old rats were treated with CPZ at several doses (5 mg/kg, 10 mg/kg and 20 mg/kg) by intraperitoneal injection. Apoptotic cells in the brain were measured using TUNEL analysis, and the levels of cleaved caspase-3, cytochrome c, the pro-apoptotic factor Bax and the anti-apoptotic factor Bcl-2 were assessed by immunostaining or western blot. Findings: Compared to the group injected with ethanol only, the brains of the CPZ-pretreated rats had fewer apoptotic cells, lower expression of cleaved caspase-3, cytochrome c and Bax, and higher expression of Bcl-2. These results demonstrate that CPZ could prevent apoptosis in the brain by regulating the mitochondrial pathway. Conclusions: CPZ exerts an inhibitory effect on apoptosis induced by ethanol in the rat brain, intimating that it may offer a means of protecting nerve cells from apoptosis induced by exogenous stimuli.	[Wu, Jing; Song, Wuqi; Li, Yujun; Zhang, Qingmeng; Chen, Yang; Fu, Yingmei; Fang, Wenjuan; Wang, Jindong; Zhong, Zhaohua; Ling, Hong; Zhang, Fengmin] Harbin Med Univ, Dept Microbiol, Heilongjiang Key Lab Immun & Infect, Harbin, Heilongjiang, Peoples R China; [Song, Rongrong; Zhang, Liming] Harbin Med Univ, Affiliated Hosp, Dept Neurol, Harbin, Heilongjiang, Peoples R China; [Song, Wuqi; Li, Yujun; Zhang, Fengmin] Harbin Med Univ, Minist Educ, Key Lab Biopharmaceut, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Wu, J (corresponding author), Harbin Med Univ, Dept Microbiol, Heilongjiang Key Lab Immun & Infect, Harbin, Heilongjiang, Peoples R China.	zfx001@yahoo.com; fengminzhang@yahoo.com.cn	Zhong, Zhaohua/N-1659-2019	Zhong, Zhaohua/0000-0002-0778-5053; ling, hong/0000-0002-1886-1242	National Natural Science Foundation of China (NSFC) [30371242, 30070673, J0730858, J0830834]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (NSFC) (30371242, 30070673, J0730858, J0830834). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CE, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-15; Akbarian S, 1996, ARCH GEN PSYCHIAT, V53, P425; An JJ, 2003, MOL CELL ENDOCRINOL, V206, P49, DOI 10.1016/S0303-7207(03)00236-3; Ashe PC, 2001, PROG NEURO-PSYCHOPH, V25, P691, DOI 10.1016/S0278-5846(01)00159-2; Bastianetto S, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-28; Bozzi Y, 2000, J NEUROSCI, V20, P8643, DOI 10.1523/JNEUROSCI.20-22-08643.2000; Carloni S, 2004, J NEUROCHEM, V89, P197, DOI 10.1111/j.1471-4159.2004.02341.x; Carpenter WT, 2008, NEUROPSYCHOPHARMACOL, V33, P2061, DOI 10.1038/sj.npp.1301639; Catts VS, 2000, SCHIZOPHR RES, V41, P405, DOI 10.1016/S0920-9964(99)00077-8; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; Chong ZZ, 2004, J CEREBR BLOOD F MET, V24, P728, DOI 10.1097/01.WCB.0000122746.72175.0E; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; He P, 1999, ACTA PHARMACOL SIN, V20, P970; Hieronymus T, 2000, ARTHRITIS RHEUM, V43, P1994, DOI 10.1002/1529-0131(200009)43:9<1994::AID-ANR10>3.0.CO;2-7; Honig LS, 2000, AM J MED, V108, P317, DOI 10.1016/S0002-9343(00)00291-6; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Jarskog LF, 2000, BIOL PSYCHIAT, V48, P641, DOI 10.1016/S0006-3223(00)00988-4; Kikuchi T, 2010, CHEM PHARM BULL, V58, P568, DOI 10.1248/cpb.58.568; Konstantinidou AE, 2007, APOPTOSIS, V12, P695, DOI 10.1007/s10495-006-0001-4; Krajewska M, 1997, CANCER RES, V57, P1605; Lee HY, 2008, J MICROBIOL BIOTECHN, V18, P1590; MADUH EU, 1988, TOXICOL APPL PHARM, V96, P60, DOI 10.1016/0041-008X(88)90247-5; MARGOLIS RL, 1994, BIOL PSYCHIAT, V35, P946, DOI 10.1016/0006-3223(94)91241-6; Mooney SM, 2001, BRAIN RES, V911, P71, DOI 10.1016/S0006-8993(01)02718-4; Nair VD, 2003, BIOCHEM J, V373, P25, DOI 10.1042/BJ20030017; Olney JW, 2002, DEV BRAIN RES, V133, P115, DOI 10.1016/S0165-3806(02)00279-1; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Owen MJ, 2011, BRIT J PSYCHIAT, V198, P173, DOI 10.1192/bjp.bp.110.084384; Sader AA, 2002, J CARDIOVASC SURG, V43, P827; Schaubli M, 2008, ANIM REPROD SCI, V103, P215, DOI 10.1016/j.anireprosci.2006.12.015; Shichinohe H, 2004, BRAIN RES, V1001, P51, DOI 10.1016/j.brainres.2003.11.054; Stone J. M., 2007, CNS & Neurological Disorders-Drug Targets, V6, P265; Tsutsui S, 2003, EXP ANIM TOKYO, V52, P43, DOI 10.1538/expanim.52.43; Ueda K, 1997, BRAIN RES, V748, P184, DOI 10.1016/S0006-8993(96)01300-5; Young C, 2003, CELL DEATH DIFFER, V10, P1148, DOI 10.1038/sj.cdd.4401277; Zhelev Z, 2004, CANCER CHEMOTH PHARM, V53, P267, DOI 10.1007/s00280-003-0738-1; Zong Xue-Mei, 2003, Shengli Xuebao, V55, P565	37	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21966	10.1371/journal.pone.0021966	http://dx.doi.org/10.1371/journal.pone.0021966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779358	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811300029
J	Willis, EL; Kersey, DC; Durrant, BS; Kouba, AJ				Willis, Erin L.; Kersey, David C.; Durrant, Barbara S.; Kouba, Andrew J.			The Acute Phase Protein Ceruloplasmin as a Non-Invasive Marker of Pseudopregnancy, Pregnancy, and Pregnancy Loss in the Giant Panda	PLOS ONE			English	Article							AILUROPODA-MELANOLEUCA; OXIDASE ACTIVITY; STEROID METABOLITES; ENZYME-IMMUNOASSAY; PRE-ECLAMPSIA; HUMAN SERUM; COPPER; IMMUNOPOTENTIATION; HETEROGENEITY; HYPERTENSION	After ovulation, non-pregnant female giant pandas experience pseudopregnancy. During pseudopregnancy, non-pregnant females exhibit physiological and behavioral changes similar to pregnancy. Monitoring hormonal patterns that are usually different in pregnant mammals are not effective at determining pregnancy status in many animals that undergo pseudopregnancy, including the giant panda. Therefore, a physiological test to distinguish between pregnancy and pseudopregnancy in pandas has eluded scientists for decades. We examined other potential markers of pregnancy and found that activity of the acute phase protein ceruloplasmin increases in urine of giant pandas in response to pregnancy. Results indicate that in term pregnancies, levels of active urinary ceruloplasmin were elevated the first week of pregnancy and remain elevated until 20-24 days prior to parturition, while no increase was observed during the luteal phase in known pseudopregnancies. Active ceruloplasmin also increased during ultrasound-confirmed lost pregnancies; however, the pattern was different compared to term pregnancies, particularly during the late luteal phase. In four out of the five additional reproductive cycles included in the current study where females were bred but no birth occurred, active ceruloplasmin in urine increased during the luteal phase. Similar to the known lost pregnancies, the temporal pattern of change in urinary ceruloplasmin during the luteal phase deviated from the term pregnancies suggesting that these cycles may have also been lost pregnancies. Among giant pandas in captivity, it has been presumed that there is a high rate of pregnancy loss and our results are the first to provide evidence supporting this notion.	[Willis, Erin L.; Kouba, Andrew J.] Memphis Zool Soc, Dept Conservat & Res, Memphis, TN USA; [Kersey, David C.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Dept Reprod Sci, Ctr Species Survival, Front Royal, VA USA; [Durrant, Barbara S.] San Diego Zoo Global, Inst Conservat Res, Reprod Physiol Div, Escondido, CA USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Willis, EL (corresponding author), Memphis Zool Soc, Dept Conservat & Res, Memphis, TN USA.	ewillis@memphiszoo.org	Durrant, Barbara/AAF-7451-2021		Memphis Zoo Department of Conservation and Research	Memphis Zoo Department of Conservation and Research	Support for this work was provided by the Memphis Zoo Department of Conservation and Research's TM Giant Panda Physiology and Nutrition Research Program. The director of the Memphis Zoo's Department of Conservation and Research partipated in the decision to fund the project, and in the preparation of and decision to publish the manuscript.	Anagnostopoulos AK, 2010, J PROTEOMICS, V73, P943, DOI 10.1016/j.jprot.2009.12.009; Boivin S, 2001, BIOCHEM BIOPH RES CO, V288, P1006, DOI 10.1006/bbrc.2001.5881; BURROWS S, 1971, AM J OBSTET GYNECOL, V109, P907, DOI 10.1016/0002-9378(71)90805-2; CHAUDHURI M, 1988, J REPROD FERTIL, V84, P23; CURZON G, 1960, BIOCHEM J, V74, P279, DOI 10.1042/bj0740279; Czekala N, 2003, ZOO BIOL, V22, P389, DOI 10.1002/zoo.10108; Dehnhard M, 2006, THERIOGENOLOGY, V66, P1755, DOI 10.1016/j.theriogenology.2006.01.012; DENKO CW, 1979, AGENTS ACTIONS, V9, P333, DOI 10.1007/BF01970657; Durrant BS, 2006, THERIOGENOLOGY, V66, P1729, DOI 10.1016/j.theriogenology.2006.02.046; Edmondson RD, 1996, J AM SOC MASS SPECTR, V7, P995, DOI 10.1016/1044-0305(96)00027-X; Ellis S, 2006, GIANT PANDAS: BIOLOGY, VETERINARY MEDICINE AND MANAGEMENT, P1, DOI 10.1017/CBO9780511542244.002; FATTAH MMA, 1976, ACTA OBSTET GYN SCAN, V55, P383, DOI 10.3109/00016347609158520; Goldstein I M, 1979, Trans Assoc Am Physicians, V92, P360; Goritz F, 1997, J REPROD FERTIL, P303; Graham L, 2001, ZOO BIOL, V20, P227, DOI 10.1002/zoo.1022; GRIFFIN JFT, 1983, AUST NZ J OBSTET GYN, V23, P11, DOI 10.1111/j.1479-828X.1983.tb00150.x; HARTLEY HO, 1950, BIOMETRIKA, V37, P308, DOI 10.2307/2332383; Hildebrandt TB, 2006, BIOL GIANT PANDA, P410; HODGES JK, 1984, J ZOOL, V203, P253; HOLMBERG CG, 1948, ACTA CHEM SCAND, V2, P550, DOI 10.3891/acta.chem.scand.02-0550; IUCN/ SSC, 2010, 2010 BREED STRAT REC; Jenkins C, 2000, ANTIOXID REDOX SIGN, V2, P623, DOI 10.1089/15230860050192369; Kersey DC, 2010, REPROD FERT DEVELOP, V22, P901, DOI 10.1071/RD09178; Kersey DC, 2010, REPRODUCTION, V140, P183, DOI 10.1530/REP-10-0003; KINGSTON IB, 1977, P NATL ACAD SCI USA, V74, P5377, DOI 10.1073/pnas.74.12.5377; Komlos L, 2007, INT J IMMUNOGENET, V34, P241, DOI 10.1111/j.1744-313X.2007.00682.x; KOMLOS L, 1977, CLIN IMMUNOL IMMUNOP, V7, P330, DOI 10.1016/0090-1229(77)90066-6; LOWENSTEIN H, 1975, INT J PEPT PROT RES, V7, P1; MARKOWITZ H, 1955, J CLIN INVEST, V34, P1498, DOI 10.1172/JCI103201; McGeehan L, 2002, ZOO BIOL, V21, P449, DOI 10.1002/zoo.10047; MEDDA R, 1987, PREP BIOCHEM, V17, P447, DOI 10.1080/00327488708062507; MONFORT SL, 1989, J REPROD FERTIL, V85, P203; MUNRO CJ, 1991, CLIN CHEM, V37, P838; Neter J, 1985, APPL LINEAR REGRESSI; OSAKI S, 1966, J BIOL CHEM, V241, P2746; Robertson SA, 1997, AM J REPROD IMMUNOL, V37, P438; RYAN TP, 1992, ARCH BIOCHEM BIOPHYS, V293, P1, DOI 10.1016/0003-9861(92)90357-3; Savion S, 2002, REPRODUCTION, V123, P399, DOI 10.1530/reprod/123.3.399; Serdar Z, 2006, CELL BIOCHEM FUNCT, V24, P209, DOI 10.1002/cbf.1235; Steinetz BG, 2005, ANN NY ACAD SCI, V1041, P367, DOI 10.1196/annals.1282.057; Steinman KJ, 2006, GIANT PANDAS: BIOLOGY, VETERINARY MEDICINE AND MANAGEMENT, P198, DOI 10.1017/CBO9780511542244.009; SUNDERMAN FW, 1970, CLIN CHEM, V16, P903; Sutherland-Smith M, 2004, ZOO BIOL, V23, P449, DOI 10.1002/zoo.20022; TANGRI S, 1993, BIOL REPROD, V49, P850, DOI 10.1095/biolreprod49.4.850; TAUSSKY HH, 1954, J BIOL CHEM, V208, P853; Toder V, 1989, J Reprod Fertil Suppl, V37, P79; TSUBOTA T, 1990, INT C BEAR, V8, P125; Ulutas PA, 2009, RES VET SCI, V86, P373, DOI 10.1016/j.rvsc.2008.09.001; Vannucchi CI, 2002, ANIM REPROD SCI, V74, P87, DOI 10.1016/S0378-4320(02)00160-4; WISDOM SJ, 1991, AM J OBSTET GYNECOL, V165, P1701, DOI 10.1016/0002-9378(91)90018-M; Zhang HM, 2009, REPRODUCTION, V138, P979, DOI 10.1530/REP-09-0241; ZIGRIL M, 1991, FERTIL STERIL, V56, P653	52	28	28	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21159	10.1371/journal.pone.0021159	http://dx.doi.org/10.1371/journal.pone.0021159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765892	gold, Green Submitted, Green Published			2022-12-25	WOS:000292781500003
J	Stone, N; Pangilinan, F; Molloy, AM; Shane, B; Scott, JM; Ueland, PM; Mills, JL; Kirke, PN; Sethupathy, P; Brody, LC				Stone, Nicole; Pangilinan, Faith; Molloy, Anne M.; Shane, Barry; Scott, John M.; Ueland, Per Magne; Mills, James L.; Kirke, Peader N.; Sethupathy, Praveen; Brody, Lawrence C.			Bioinformatic and Genetic Association Analysis of MicroRNA Target Sites in One-Carbon Metabolism Genes	PLOS ONE			English	Article							MICROBIOLOGICAL ASSAY; METHIONINE SYNTHASE; FOLATE-DEFICIENCY; CELLULAR UPTAKE; MITOCHONDRIAL; REDUCTASE; RECEPTOR; MUTATION; BIOSYNTHESIS; PURIFICATION	One-carbon metabolism (OCM) is linked to DNA synthesis and methylation, amino acid metabolism and cell proliferation. OCM dysfunction has been associated with increased risk for various diseases, including cancer and neural tube defects. MicroRNAs (miRNAs) are similar to 22 nt RNA regulators that have been implicated in a wide array of basic cellular processes, such as differentiation and metabolism. Accordingly, mis-regulation of miRNA expression and/or activity can underlie complex disease etiology. We examined the possibility of OCM regulation by miRNAs. Using computational miRNA target prediction methods and Monte-Carlo based statistical analyses, we identified two candidate miRNA "master regulators" (miR-22 and miR-125) and one candidate pair of "master co-regulators" (miR-344-5p/484 and miR-488) that may influence the expression of a significant number of genes involved in OCM. Interestingly, miR-22 and miR-125 are significantly up-regulated in cells grown under low-folate conditions. In a complementary analysis, we identified 15 single nucleotide polymorphisms (SNPs) that are located within predicted miRNA target sites in OCM genes. We genotyped these 15 SNPs in a population of healthy individuals (age 18-28, n = 2,506) that was previously phenotyped for various serum metabolites related to OCM. Prior to correction for multiple testing, we detected significant associations between TCblR rs9426 and methylmalonic acid (p = 0.045), total homocysteine levels (tHcy) (p = 0.033), serum B12 (p < 0.0001), holo transcobalamin (p < 0.0001) and total transcobalamin (p < 0.0001); and between MTHFR rs1537514 and red blood cell folate (p < 0.0001). However, upon further genetic analysis, we determined that in each case, a linked missense SNP is the more likely causative variant. Nonetheless, our Monte-Carlo based in silico simulations suggest that miRNAs could play an important role in the regulation of OCM.	[Stone, Nicole; Pangilinan, Faith; Sethupathy, Praveen; Brody, Lawrence C.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Molloy, Anne M.; Scott, John M.] Trinity Coll Dublin, Sch Immunol & Biochem, Dublin, Ireland; [Shane, Barry] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Ueland, Per Magne] Univ Bergen, Pharmacol Sect, Inst Med, Bergen, Norway; [Ueland, Per Magne] Univ Bergen, Haukeland Univ Hosp, Bergen, Norway; [Mills, James L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Epidemiol Stat & Prevent Res, NIH, Bethesda, MD USA; [Kirke, Peader N.] Hlth Res Board Ireland, Child Hlth Epidemiol Unit, Dublin, Ireland	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Trinity College Dublin; University of California System; University of California Berkeley; University of Bergen; University of Bergen; Haukeland University Hospital; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Health Research Board - Ireland	Stone, N (corresponding author), Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA.	sethupathyp@mail.nih.gov; lbrody@mail.nih.gov	Ueland, Per M/C-7340-2013	Mills, James/0000-0003-4496-332X; Molloy, Anne/0000-0002-1688-9049; Ueland, Per Magne/0000-0002-1903-0571	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Human Genome Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002502] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000167] Funding Source: NIH RePORTER	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by the Intramural Research Programs of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Human Genome Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Bolusani S, 2011, J BIOL CHEM, V286, P5166, DOI 10.1074/jbc.M110.196840; Brody LC, 1999, MOL GENET METAB, V67, P324, DOI 10.1006/mgme.1999.2881; Bulock KG, 2002, J BIOL CHEM, V277, P22168, DOI 10.1074/jbc.M111964200; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; Crott JW, 2008, J NUTR BIOCHEM, V19, P328, DOI 10.1016/j.jnutbio.2007.05.003; Czech MP, 2006, NEW ENGL J MED, V354, P1194, DOI 10.1056/NEJMcibr060065; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Field MS, 2006, J BIOL CHEM, V281, P4215, DOI 10.1074/jbc.M510624200; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Galivan J, 2000, PHARMACOL THERAPEUT, V85, P207, DOI 10.1016/S0163-7258(99)00063-7; Garrow TA, 1996, J BIOL CHEM, V271, P22831, DOI 10.1074/jbc.271.37.22831; GARROW TA, 1993, ADV EXP MED BIOL, V338, P659; GARROW TA, 1993, J BIOL CHEM, V268, P11910; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Gu Shuo, 2010, Silence, V1, P11, DOI 10.1186/1758-907X-1-11; Halsted CH, 2000, J BIOL CHEM, V275, P30746; KELLEHER BP, 1991, J CLIN PATHOL, V44, P592, DOI 10.1136/jcp.44.7.592; Kohls D, 1999, ACTA CRYSTALLOGR D, V55, P1206, DOI 10.1107/S0907444999003601; Kozyraki R, 1998, BLOOD, V91, P3593; KREMER JM, 1986, ARTHRITIS RHEUM, V29, P832, DOI 10.1002/art.1780290703; Krupenko NI, 2010, J BIOL CHEM, V285, P23054, DOI 10.1074/jbc.M110.128843; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Lee JE, 2011, AM J CLIN NUTR; Li GR, 2009, MECH AGEING DEV, V130, P731, DOI 10.1016/j.mad.2009.09.002; Luka Z, 2002, HUM GENET, V110, P68, DOI 10.1007/s00439-001-0648-4; MacFarlane AJ, 2009, J BIOL CHEM, V284, P1533, DOI 10.1074/jbc.M808281200; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; McCarty EA, 2004, J BIOL CHEM, V279, P33829, DOI 10.1074/jbc.M403677200; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; Moestrup SK, 1996, P NATL ACAD SCI USA, V93, P8612, DOI 10.1073/pnas.93.16.8612; Molloy AM, 1997, METHOD ENZYMOL, V281, P43; Molloy AM, 2009, BIRTH DEFECTS RES A, V85, P285, DOI 10.1002/bdra.20566; Mudd SH, 2011, AM J MED GENET C, V157C, P3, DOI 10.1002/ajmg.c.30293; NANAO K, 1994, GENOMICS, V19, P27, DOI 10.1006/geno.1994.1007; Neely LA, 2006, NAT METHODS, V3, P41, DOI 10.1038/NMETH825; PANGILINAN F, 2010, J MED GENET; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; PORTER DH, 1985, ARCH BIOCHEM BIOPHYS, V243, P396, DOI 10.1016/0003-9861(85)90516-8; Quadros EV, 2010, HUM MUTAT, V31, P924, DOI 10.1002/humu.21297; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; Ramani K, 2010, HEPATOLOGY, V51, P986, DOI 10.1002/hep.23411; Rosa A, 2009, CELL CYCLE, V8, P3513, DOI 10.4161/cc.8.21.9847; SCHWEITZER BI, 1990, FASEB J, V4, P2441, DOI 10.1096/fasebj.4.8.2185970; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SHEVELL MI, 1993, AM J MED GENET, V45, P619, DOI 10.1002/ajmg.1320450521; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takeuchi N, 1998, J BIOL CHEM, V273, P15085, DOI 10.1074/jbc.273.24.15085; Welin M, 2010, NUCLEIC ACIDS RES, V38, P7308, DOI 10.1093/nar/gkq595; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200; XIONG J, 2010, ONCOGENE; Yamada K, 2005, P NATL ACAD SCI USA, V102, P10454, DOI 10.1073/pnas.0504786102; Yamada K, 2006, P NATL ACAD SCI USA, V103, P9476, DOI 10.1073/pnas.0603694103; ZHAO R, 2010, ANN REV NUTR; Zittoun J, 1993, Rev Prat, V43, P1358	63	35	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21851	10.1371/journal.pone.0021851	http://dx.doi.org/10.1371/journal.pone.0021851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765920	Green Accepted, gold, Green Published			2022-12-25	WOS:000292699000013
J	Tikhmyanova, N; Golemis, EA				Tikhmyanova, Nadezhda; Golemis, Erica A.			NEDD9 and BCAR1 Negatively Regulate E-Cadherin Membrane Localization, and Promote E-Cadherin Degradation	PLOS ONE			English	Article							FOCAL ADHESION KINASE; CELL-CELL-ADHESION; TYROSINE PHOSPHORYLATION; ANTIGEN RECEPTOR; DOCKING PROTEIN; BREAST-CANCER; C-SRC; V-SRC; P130CAS; CAS	The Cas scaffolding proteins (NEDD9/HEF1/CAS-L, BCAR1/p130Cas, EFSSIN, and HEPL/CASS4) regulate cell migration, division and survival, and are often deregulated in cancer. High BCAR1 expression is linked to poor prognosis in breast cancer patients, while upregulation of NEDD9 contributes to the metastatic behavior of melanoma and glioblastoma cells. Our recent work knocking out the single Drosophila Cas protein, Dcas, identified a genetic interaction with E-cadherin. As E-cadherin is often downregulated during epithelial-mesenchymal transition (EMT) prior to metastasis, if such an activity was conserved in mammals it might partially explain how Cas proteins promote aggressive tumor behavior. We here establish that Cas proteins negatively regulate E-cadherin expression in human mammary cells. Cas proteins do not affect E-cadherin transcription, but rather, BCAR1 and NEDD9 signal through SRC to promote E-cadherin removal from the cell membrane and lysosomal degradation. We also find mammary tumors arising in MMTV-polyoma virus T-antigen mice have enhanced junctional E-cadherin in a Nedd9(-/-) background. Cumulatively, these results suggest a new role for Cas proteins in cell-cell adhesion signaling in cancer.	[Tikhmyanova, Nadezhda; Golemis, Erica A.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Tikhmyanova, Nadezhda] Drexel Univ, Sch Med, Dept Biochem, Philadelphia, PA 19104 USA	Fox Chase Cancer Center; Drexel University	Tikhmyanova, N (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	ea_golemis@fccc.edu		Golemis, Erica/0000-0003-3618-3673	NIH [CA63366, CA113342, CA06927]; Pennsylvania Tobacco Settlement Funds; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [P30CA006927, R29CA063366, R01CA113342, R01CA063366] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Tobacco Settlement Funds; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH R01s CA63366 and CA113342, and by Pennsylvania Tobacco Settlement Funds (to EAG); and by an appropriation from the Commonwealth of Pennsylvania, and NIH core grant CA06927 (to Fox Chase Cancer Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Y, 2007, MOL BIOL CELL, V18, P3752, DOI 10.1091/mbc.E07-03-0281; Astier A, 1997, LEUKEMIA LYMPHOMA, V28, P65, DOI 10.3109/10428199709058332; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; BRIKNAROVA K, 2005, J BIOL CHEM; Brinkman A, 2000, JNCI-J NATL CANCER I, V92, P112, DOI 10.1093/jnci/92.2.112; Bui LC, 2009, ONCOGENE, V28, P3642, DOI 10.1038/onc.2009.224; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Cabodi S, 2010, FASEB J, V24, P3796, DOI 10.1096/fj.10-157347; Dadke D, 2006, MOL BIOL CELL, V17, P1204, DOI 10.1091/mbc.E05-03-0237; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Enan E, 1996, BIOCHEM PHARMACOL, V52, P1599, DOI 10.1016/S0006-2952(96)00566-7; Fashena SJ, 2002, J CELL SCI, V115, P99; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Giehl K, 2008, FRONT BIOSCI-LANDMRK, V13, P3975, DOI 10.2741/2985; Guo C, 2008, HEPATOB PANCREAT DIS, V7, P490; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ishino M, 1995, ONCOGENE, V11, P2331; Izumchenko E, 2009, CANCER RES, V69, P7198, DOI 10.1158/0008-5472.CAN-09-0795; JANDA E, 2006, ONCOGENE; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Law SF, 1996, MOL CELL BIOL, V16, P3327; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Manie SN, 1997, J BIOL CHEM, V272, P4230, DOI 10.1074/jbc.272.7.4230; MATSUYOSHI N, 1992, J CELL BIOL, V118, P703, DOI 10.1083/jcb.118.3.703; Minegishi M, 1996, J EXP MED, V184, P1365, DOI 10.1084/jem.184.4.1365; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; O'Neill GM, 2007, CANCER RES, V67, P8975, DOI 10.1158/0008-5472.CAN-07-1328; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Peifer M, 2003, J CELL BIOL, V163, P437, DOI 10.1083/jcb.200310090; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sattler M, 1997, J BIOL CHEM, V272, P14320, DOI 10.1074/jbc.272.22.14320; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Singh MK, 2008, MOL BIOL CELL, V19, P1627, DOI 10.1091/mbc.E07-09-0953; Singh MK, 2007, CELL BIOCHEM BIOPHYS, V48, P54, DOI 10.1007/s12013-007-0036-3; Singh MK, 2010, CANCER RES, V70, P8907, DOI 10.1158/0008-5472.CAN-10-0353; Tikhmyanova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012369; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; TORNILLO G, 2010, EUR J CELL BIOL; van der Flier S, 2000, JNCI-J NATL CANCER I, V92, P120, DOI 10.1093/jnci/92.2.120; van Seventer GA, 2001, EUR J IMMUNOL, V31, P1417, DOI 10.1002/1521-4141(200105)31:5<1417::AID-IMMU1417>3.0.CO;2-C; Xing LZ, 2000, MOL CELL BIOL, V20, P7363, DOI 10.1128/MCB.20.19.7363-7377.2000	45	62	62	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22102	10.1371/journal.pone.0022102	http://dx.doi.org/10.1371/journal.pone.0022102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765937	Green Published, Green Submitted, gold			2022-12-25	WOS:000292699000023
J	Baatz, F; Nijhuis, M; Lemaire, M; Riedijk, M; Wensing, AMJ; Servais, JY; van Ham, PM; Hoepelman, AIM; Koopmans, PP; Sprenger, HG; Devaux, C; Schmit, JC; Bercoff, DP				Baatz, Franky; Nijhuis, Monique; Lemaire, Morgane; Riedijk, Martiene; Wensing, Annemarie M. J.; Servais, Jean-Yves; van Ham, Petra M.; Hoepelman, Andy I. M.; Koopmans, Peter P.; Sprenger, Herman G.; Devaux, Carole; Schmit, Jean-Claude; Bercoff, Danielle Perez			Impact of the HIV-1 env Genetic Context outside HR1-HR2 on Resistance to the Fusion Inhibitor Enfuvirtide and Viral Infectivity in Clinical Isolates	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BASE-LINE SUSCEPTIBILITY; TYPE-1 GP41; PHENOTYPIC RESISTANCE; ENTRY INHIBITORS; ENVELOPE GLYCOPROTEIN; MEMBRANE-FUSION; HEPTAD REPEAT; MAXIMUM-LIKELIHOOD; FUNCTIONAL-ROLE	Resistance mutations to the HIV-1 fusion inhibitor enfuvirtide emerge mainly within the drug's target region, HR1, and compensatory mutations have been described within HR2. The surrounding envelope (env) genetic context might also contribute to resistance, although to what extent and through which determinants remains elusive. To quantify the direct role of the env context in resistance to enfuvirtide and in viral infectivity, we compared enfuvirtide susceptibility and infectivity of recombinant viral pairs harboring the HR1-HR2 region or the full Env ectodomain of longitudinal env clones from 5 heavily treated patients failing enfuvirtide therapy. Prior to enfuvirtide treatment onset, no env carried known resistance mutations and full Env viruses were on average less susceptible than HR1-HR2 recombinants. All escape clones carried at least one of G36D, V38A, N42D and/or N43D/S in HR1, and accordingly, resistance increased 11- to 2800-fold relative to baseline. Resistance of full Env recombinant viruses was similar to resistance of their HR1-HR2 counterpart, indicating that HR1 and HR2 are the main contributors to resistance. Strictly X4 viruses were more resistant than strictly R5 viruses, while dual-tropic Envs featured similar resistance levels irrespective of the coreceptor expressed by the cell line used. Full Env recombinants from all patients gained infectivity under prolonged drug pressure; for HR1-HR2 viruses, infectivity remained steady for 3/5 patients, while for 2/5 patients, gains in infectivity paralleled those of the corresponding full Env recombinants, indicating that the env genetic context accounts mainly for infectivity adjustments. Phylogenetic analyses revealed that quasispecies selection is a step-wise process where selection of enfuvirtide resistance is a dominant factor early during therapy, while increased infectivity is the prominent driver under prolonged therapy.	[Baatz, Franky; Lemaire, Morgane; Servais, Jean-Yves; Devaux, Carole; Schmit, Jean-Claude; Bercoff, Danielle Perez] CRP Sante, Lab Retrovirol, Luxembourg, Luxembourg; [Nijhuis, Monique; Riedijk, Martiene; Wensing, Annemarie M. J.; van Ham, Petra M.] UMC Utrecht, Dept Virol, Utrecht, Netherlands; [Riedijk, Martiene; Hoepelman, Andy I. M.] UMC Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Koopmans, Peter P.] Radboud Univ Nijmegen, Med Ctr, Dept Gen Internal Med, Div Infect Dis, NL-6525 ED Nijmegen, Netherlands; [Sprenger, Herman G.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Infect Dis, NL-9713 AV Groningen, Netherlands	Luxembourg Institute of Health; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; University of Groningen	Baatz, F (corresponding author), CRP Sante, Lab Retrovirol, Luxembourg, Luxembourg.	danielle.perezbercoff@crp-sante.lu	wensing, a.m.j./F-3005-2011	Seguin-Devaux, Carole/0000-0003-0636-5222; Perez Bercoff, Danielle/0000-0003-4415-0150	Fonds National de Recherche, Luxembourg [TR-PHD BFR06-033]; Netherlands Organisation for Scientific Research (NWO) [91796349]; Dutch Ministry of Health	Fonds National de Recherche, Luxembourg; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Ministry of Health	FB was supported by a fellowship from the Fonds National de Recherche, Luxembourg [TR-PHD BFR06-033]. MN and PvH were supported by The Netherlands Organisation for Scientific Research (NWO) VIDI (91796349). The ATHENA database is supported by a grant from the Dutch Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAI X, 2008, BIOCHEMISTRY; Baldwin CE, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-84; Bjorndal A, 1997, J VIROL, V71, P7478; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; CHEN SSL, 1994, J VIROL, V68, P2002, DOI 10.1128/JVI.68.3.2002-2010.1994; Chen SSL, 1998, J VIROL, V72, P4765, DOI 10.1128/JVI.72.6.4765-4774.1998; Derdeyn CA, 2001, J VIROL, V75, P8605, DOI 10.1128/JVI.75.18.8605-8614.2001; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Doms RW, 2000, GENE DEV, V14, P2677, DOI 10.1101/gad.833300; Doms RW, 2000, J CELL BIOL, V151, pF9, DOI 10.1083/jcb.151.2.F9; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Goubard A, 2009, ANTIVIR THER, V14, P597; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; GROENINK M, 1993, SCIENCE, V260, P1513, DOI 10.1126/science.8502996; GU X, 1995, MOL BIOL EVOL, V12, P546; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanna GJ, 2002, CLIN LAB MED, V22, P637, DOI 10.1016/S0272-2712(02)00007-0; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heil ML, 2004, J VIROL, V78, P7582, DOI 10.1128/JVI.78.14.7582-7589.2004; Jenwitheesuk E, 2005, ANTIVIR THER, V10, P893; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; KOITO A, 1994, J VIROL, V68, P2253, DOI 10.1128/JVI.68.4.2253-2259.1994; Labrosse B, 2003, J VIROL, V77, P1610, DOI 10.1128/JVI.77.2.1610-1613.2003; Labrosse B, 2006, J VIROL, V80, P8807, DOI 10.1128/JVI.02706-05; Lohrengel S, 2005, J VIROL, V79, P10237, DOI 10.1128/JVI.79.16.10237-10246.2005; Lu J, 2004, J VIROL, V78, P4628, DOI 10.1128/JVI.78.9.4628-4637.2004; Lu J, 2006, JAIDS-J ACQ IMM DEF, V43, P60, DOI 10.1097/01.qai.0000234083.34161.55; Markosyan RM, 2003, MOL BIOL CELL, V14, P926, DOI 10.1091/mbc.E02-09-0573; Melby T, 2007, AIDS RES HUM RETROV, V23, P1366, DOI 10.1089/aid.2006.0277; Melby T, 2006, AIDS RES HUM RETROV, V22, P375, DOI 10.1089/aid.2006.22.375; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Menzo S, 2004, ANTIMICROB AGENTS CH, V48, P3253, DOI 10.1128/AAC.48.9.3253-3259.2004; Mink M, 2005, J VIROL, V79, P12447, DOI 10.1128/JVI.79.19.12447-12454.2005; Moyle G, 2003, J ANTIMICROB CHEMOTH, V51, P213, DOI 10.1093/jac/dkg066; Nameki D, 2005, J VIROL, V79, P764, DOI 10.1128/JVI.79.2.764-770.2005; PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990; Perez-Alvarez L, 2006, J MED VIROL, V78, P141, DOI 10.1002/jmv.20520; Perez-Bercoff D, 2007, J VIROL, V81, P4540, DOI 10.1128/JVI.01620-06; Platt EJ, 2005, J VIROL, V79, P4347, DOI 10.1128/JVI.79.7.4347-4356.2005; Ray N, 2007, J VIROL, V81, P3240, DOI 10.1128/JVI.02413-06; Ray N, 2009, J VIROL, V83, P2989, DOI 10.1128/JVI.02496-08; Reeves JD, 2004, J VIROL, V78, P5476, DOI 10.1128/JVI.78.10.5476-5485.2004; Reeves JD, 2005, J VIROL, V79, P4991, DOI 10.1128/JVI.79.8.4991-4999.2005; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Roman F, 2006, J VIROL METHODS, V131, P99, DOI 10.1016/j.jviromet.2005.07.005; Sista PR, 2004, AIDS, V18, P1787, DOI 10.1097/00002030-200409030-00007; Su C, 2006, J CLIN VIROL, V36, P249, DOI 10.1016/j.jcv.2006.03.007; SULLIVAN N, 1993, J VIROL, V67, P3674, DOI 10.1128/JVI.67.6.3674-3679.1993; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Xu L, 2005, ANTIMICROB AGENTS CH, V49, P1113, DOI 10.1128/AAC.49.3.1113-1119.2005	54	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21535	10.1371/journal.pone.0021535	http://dx.doi.org/10.1371/journal.pone.0021535			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760896	gold, Green Published, Green Submitted			2022-12-25	WOS:000292657200015
J	Khalafalla, RE				Khalafalla, Reda E.			A Survey Study on Gastrointestinal Parasites of Stray Cats in Northern Region of Nile Delta, Egypt	PLOS ONE			English	Article							INTESTINAL HELMINTHS; DOMESTIC CATS; TOXOCARA-CATI; PREVALENCE; URBAN; DOGS	A survey study on gastrointestinal parasites in 113 faecal samples from stray cats collected randomly from Kafrelsheikh province, northern region of Nile delta of Egypt; was conducted in the period between January and May 2010. The overall prevalence was 91%. The results of this study reported seven helminth species: Toxocara cati (9%), Ancylostoma tubaeforme (4%), Toxascaris leonina (5%), Dipylidium caninum (5%), Capillaria spp. (3%), Taenia taeniformis (22%) and Heterophyes heterophyes (3%), four protozoal species: Toxoplasma gondii (9%), Sarcocyst spp. (1%), Isospora spp. (2%) and Giardia spp. (2%) and two arthropod species; Linguatula serrata (2%) and mites eggs (13%). The overall prevalence of intestinal parasites may continue to rise due to lack of functional veterinary clinics for cat care in Egypt. Therefore, there is a need to plan adequate control programs to diagnose, treat and control gastrointestinal parasites of companion as well as stray cats in the region.	Kafrelsheikh Univ, Fac Vet Med, Dept Parasitol, Kafrelsheikh, Egypt	Egyptian Knowledge Bank (EKB); Kafrelsheikh University	Khalafalla, RE (corresponding author), Kafrelsheikh Univ, Fac Vet Med, Dept Parasitol, Kafrelsheikh, Egypt.	Redabast@hotmail.de	Khalafalla, Reda/Q-7880-2019	khalafalla, Reda/0000-0002-1810-9501	Faculty of Veterinary Medicine and the Department of Parasitology at the University of Kafrelsheikh, Egypt	Faculty of Veterinary Medicine and the Department of Parasitology at the University of Kafrelsheikh, Egypt(Kafrelsheikh University)	The funders are the Faculty of Veterinary Medicine and the Department of Parasitology at the University of Kafrelsheikh, Egypt; these funds are part of a general institutional research fund offered by the faculty council to the Department of Parasitology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Madi MA, 2010, VET PARASITOL, V168, P284, DOI 10.1016/j.vetpar.2009.11.027; Abu-Madi MA, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-39; ABU-ZAKHAM A A, 1989, Journal of the Egyptian Society of Parasitology, V19, P225; BAKER MK, 1989, J S AFR VET ASSOC, V60, P139; Calvete C, 1998, VET PARASITOL, V75, P235, DOI 10.1016/S0304-4017(97)00182-9; Dryden MW, 2005, VET THER, V6, P15; El-Shabrawy M.N., 1978, Journal of the Egyptian Veterinary Medical Association, V38, P19; Faust E. C., 1938, American Journal of Tropical Medicine, V18, P169; HARALAMPIDIS ST, 1977, THESIS ARISTOTLE U T; HENDRIX CM, 1983, VET CLIN N AM-SMALL, V13, P627, DOI 10.1016/S0195-5616(83)50063-6; HOSSAIN A, 1986, TROP GEOGR MED, V38, P244; HUTCHISON WM, 1957, J PARASITOL, V43, P318, DOI 10.2307/3274356; Labarthe N, 2004, VET PARASITOL, V123, P133, DOI 10.1016/j.vetpar.2004.06.002; LENGY J, 1969, J PARASITOL, V55, P1239, DOI 10.2307/3277266; MCCOLM AA, 1980, J HELMINTHOL, V54, P255, DOI 10.1017/S0022149X00006714; McGlade TR, 2003, VET PARASITOL, V117, P251, DOI 10.1016/j.vetpar.2003.08.010; Morsy T.A., 1980, Journal of the Egyptian Society of Parasitology, V10, P5; NIAK A, 1972, VET REC, V91, P534, DOI 10.1136/vr.91.22.534; NICHOL S, 1981, VET PARASITOL, V9, P107, DOI 10.1016/0304-4017(81)90028-5; Serra Cathia Maria Barrientos, 2003, Rev. Soc. Bras. Med. Trop., V36, P331, DOI 10.1590/S0037-86822003000300003; Sharif M., 2010, Comparative Clinical Pathology, V19, P257, DOI 10.1007/s00580-009-0866-z; SOULSBY EJL, 1982, HELMINTHS ARTHROPODA; THIENPONT D, 1981, RECL MED VET, V157, P591; Zibaei M, 2007, TROP BIOMED, V24, P39; LOOKLEX ENCY ORIENT	25	31	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e20283	10.1371/journal.pone.0020283	http://dx.doi.org/10.1371/journal.pone.0020283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760884	Green Published, gold, Green Submitted			2022-12-25	WOS:000292657200003
J	Wesley, CS; Guo, H; Chaudhry, KA; Thali, MJ; Yin, JC; Clason, T; Wesley, UV				Wesley, Cedric S.; Guo, Heng; Chaudhry, Kanita A.; Thali, Markus J.; Yin, Jerry C.; Clason, Todd; Wesley, Umadevi V.			Loss of PTB or Negative Regulation of Notch mRNA Reveals Distinct Zones of Notch and Actin Protein Accumulation in Drosophila Embryo	PLOS ONE			English	Article							TRACT-BINDING-PROTEIN; CELL FATE; LIGAND ENDOCYTOSIS; DORSAL ECTODERM; DOWN-REGULATION; DELTA; ACTIVATION; MASTERMIND; RECEPTOR; ENCODES	Polypyrimidine Tract Binding (PTB) protein is a regulator of mRNA processing and translation. Genetic screens and studies of wing and bristle development during the post-embryonic stages of Drosophila suggest that it is a negative regulator of the Notch pathway. How PTB regulates the Notch pathway is unknown. Our studies of Drosophila embryogenesis indicate that (1) the Notch mRNA is a potential target of PTB, (2) PTB and Notch functions in the dorso-lateral regions of the Drosophila embryo are linked to actin regulation but not their functions in the ventral region, and (3) the actin-related Notch activity in the dorsolateral regions might require a Notch activity at or near the cell surface that is different from the nuclear Notch activity involved in cell fate specification in the ventral region. These data raise the possibility that the Drosophila embryo is divided into zones of different PTB and Notch activities based on whether or not they are linked to actin regulation. They also provide clues to the almost forgotten role of Notch in cell adhesion and reveal a role for the Notch pathway in cell fusions.	[Wesley, Cedric S.; Yin, Jerry C.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Wesley, Cedric S.; Yin, Jerry C.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; [Guo, Heng] Boston Univ, Dept Biochem, Boston, MA 02215 USA; [Chaudhry, Kanita A.] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA; [Thali, Markus J.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Clason, Todd] Univ Vermont, Dept Anat & Neurobiol, Burlington, VT 05405 USA; [Wesley, Umadevi V.] Univ Wisconsin, Dept Neurol Surg, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Boston University; University of Vermont; University of Vermont; University of Vermont; University of Wisconsin System; University of Wisconsin Madison	Wesley, CS (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	cswesley@wisc.edu		Thali, Markus/0000-0001-8621-2095	NIH [1 R21 HD062928-01]; University of Vermont Neuroscience NIH/NCRR COBRE [P20 RR16435]; University of Vermont-College of Medicine;  [R01 NS063245-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063245] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Vermont Neuroscience NIH/NCRR COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Vermont-College of Medicine; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH 1 R21 HD062928-01 (to CSW), University of Vermont Neuroscience NIH/NCRR COBRE (P20 RR16435), University of Vermont-College of Medicine Bridge Fund, and R01 NS063245-01 (to JCY) provided financial support for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Ahimou F, 2004, J CELL BIOL, V167, P1217, DOI 10.1083/jcb.200407100; Albrecht S, 2006, MECH DEVELOP, V123, P372, DOI 10.1016/j.mod.2006.03.005; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ASHBURNER M, 2004, DROSOPHHILA LAB HDB; Baker R, 1996, DEVELOPMENT, V122, P617; Bardot B, 2005, EXP CELL RES, V304, P202, DOI 10.1016/j.yexcr.2004.10.030; Ben-Yaacov S, 2001, J CELL BIOL, V152, P1, DOI 10.1083/jcb.152.1.1; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Berechid BE, 2002, J BIOL CHEM, V277, P8154, DOI 10.1074/jbc.M108238200; Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Bier E, 2004, GENE, V342, P1, DOI 10.1016/j.gene.2004.07.018; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Chartier A, 2002, DEVELOPMENT, V129, P3241; CROSS DP, 1978, J EMBRYOL EXP MORPH, V45, P173; Dansereau DA, 2002, DEVELOPMENT, V129, P5553, DOI 10.1242/dev.00153; Davis MB, 2002, MECH DEVELOP, V111, P143, DOI 10.1016/S0925-4773(01)00595-0; Delon I, 2003, MECH DEVELOP, V120, P747, DOI 10.1016/S0925-4773(03)00081-9; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Harden N, 2002, DIFFERENTIATION, V70, P181, DOI 10.1046/j.1432-0436.2002.700408.x; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; Herranz H, 2006, BIOESSAYS, V28, P113, DOI 10.1002/bies.20366; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Hori K, 2004, DEVELOPMENT, V131, P5527, DOI 10.1242/dev.01448; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Kankel MW, 2007, GENETICS, V177, P2493, DOI 10.1534/genetics.107.080994; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Langdon T, 2006, DEV DYNAM, V235, P998, DOI 10.1002/dvdy.20735; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Le Sommer C, 2005, MOL CELL BIOL, V25, P9595, DOI 10.1128/MCB.25.21.9595-9607.2005; LeComte M, 2006, DEV DYNAM, V235, P411, DOI 10.1002/dvdy.20650; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; LYMAN D, 1993, P NATL ACAD SCI USA, V90, P10395, DOI 10.1073/pnas.90.21.10395; Major RJ, 2005, DEVELOPMENT, V132, P3823, DOI 10.1242/dev.01957; Martin D, 1999, J CELL BIOL, V145, P191, DOI 10.1083/jcb.145.1.191; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; Mok LP, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-6; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Noll E, 2000, DEV BIOL, V227, P450, DOI 10.1006/dbio.2000.9925; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Parks AL, 2000, DEVELOPMENT, V127, P1373; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Pazdera TM, 1998, DEVELOPMENT, V125, P3427; Poulson DF, 1937, P NATL ACAD SCI USA, V23, P133, DOI 10.1073/pnas.23.3.133; RICHARD ML, 1997, DEVELOPMENT, V124, P2129; Robida M, 2010, P NATL ACAD SCI USA, V107, P12570, DOI 10.1073/pnas.1007935107; Robida MD, 2003, EMBO J, V22, P2924, DOI 10.1093/emboj/cdg301; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Sapir A, 2005, DEVELOPMENT, V132, P123, DOI 10.1242/dev.01546; Shepherd A, 2010, DEV DYNAM, V239, P1220, DOI 10.1002/dvdy.22262; Shepherd AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008063; Stronach BE, 2001, DEVELOPMENT, V128, P2905; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Sullivan W., 2000, DROSOPHILA PROTOCOLS; Tao Y, 2007, SEMIN CELL DEV BIOL, V18, P3, DOI 10.1016/j.semcdb.2006.12.001; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Valcarcel J, 1997, CURR BIOL, V7, pR705, DOI 10.1016/S0960-9822(06)00361-7; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wesley CS, 2003, MOL CELL BIOL, V23, P5581, DOI 10.1128/MCB.23.16.5581-5593.2003; Wesley CS, 2000, J BIOL CHEM, V275, P9099, DOI 10.1074/jbc.275.13.9099; Wesley CS, 2000, J CELL BIOL, V149, P683, DOI 10.1083/jcb.149.3.683; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wilkin MB, 2005, MOL MEMBR BIOL, V22, P279, DOI 10.1080/09687860500129778; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Wilusz CJ, 2001, RNA, V7, P1416; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	78	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21876	10.1371/journal.pone.0021876	http://dx.doi.org/10.1371/journal.pone.0021876			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750738	Green Published, gold, Green Submitted			2022-12-25	WOS:000292512000030
J	Mesnard, L; Rafat, C; Vandermeersch, S; Hertig, A; Cathelin, D; Xu-Dubois, YC; Jouanneau, C; Keller, AC; Ribeil, JA; Leite-de-Moraes, MC; Rondeau, E				Mesnard, Laurent; Rafat, Cedric; Vandermeersch, Sophie; Hertig, Alexandre; Cathelin, Dominique; Xu-Dubois, Yi-Chun; Jouanneau, Chantal; Keller, Alexandre Castro; Ribeil, Jean-Antoine; Leite-de-Moraes, Maria C.; Rondeau, Eric			Vitronectin dictates intraglomerular fibrinolysis in immune-mediated glomerulonephritis	FASEB JOURNAL			English	Article						complement system; mouse model; PAI-1; Kidney	PLASMINOGEN-ACTIVATOR INHIBITOR-1; ANTI-GBM GLOMERULONEPHRITIS; DISEASED HUMAN KIDNEYS; S-PROTEIN VITRONECTIN; EXPRESSION IN-VIVO; CRESCENTIC GLOMERULONEPHRITIS; NEPHROTOXIC NEPHRITIS; GLOMERULAR INJURY; BIOLOGICAL ROLE; MESSENGER-RNA	During human glomerulonephritis, the severity of injuries correlates with glomerular fibrin deposits, which are tightly regulated by the intraglomerular fibrinolytic system. Here, we evaluated the role of vitronectin (VTN; also known as complement S protein), the principal cofactor of the plasminogen activator inhibitor-1 (PAI-1), in a mouse model of acute glomerulonephritis. We found that in mice subjected to nephrotoxic serum, the absence of VTN resulted in a lower glomerular PAI-1 activity and a higher glomerular fibrinolytic activity. Challenged VTN-/- mice displayed significantly less fibrin deposits, proteinuria, and renal failure than their wild-type counterparts. Notably, this protective effect afforded by VTN deficiency was still observed after a C3 depletion. Finally, the injection of VTN+/+ serum in VTN-/- mice induced the glomerular deposition of VTN, increased PAI-1 deposition, decreased glomerular fibrinolytic activity, and aggravated glomerular injury. As in mice, abundant glomerular VTN deposits were also observed in patients with severe glomerulonephritis. Here, we show that plasma-exchange therapy, admittedly beneficial in this clinical context, induces a significant depletion in circulating VTN, which might modulate PAI-1 activity locally and accelerate the clearance of fibrin deposits in the glomeruli. Collectively, these results demonstrate that VTN exerts a deleterious role independently from complement, by directing PAI-dependent fibrinolysis in the glomerular compartment.-Mesnard, L., Rafat, C., Vandermeersch, S., Hertig, A., Cathelina, D., Xu-Dubois, Y. -C., Jouanneau, C., Castro Keller, A., Ribeil, J. -A., Leite-de-Moraes, M. C., Rondeau, E. Vitronectin dictates intraglomerular fibrinolysis in immune-mediated glomerulonephritis. FASEB J. 25, 3543-3553 (2011). www.fasebj.org	[Mesnard, Laurent; Rafat, Cedric; Vandermeersch, Sophie; Hertig, Alexandre; Cathelin, Dominique; Xu-Dubois, Yi-Chun; Jouanneau, Chantal; Rondeau, Eric] Univ Paris 06, INSERM, UMR S702, Hop Tenon, F-75020 Paris, France; [Mesnard, Laurent; Rafat, Cedric; Hertig, Alexandre; Rondeau, Eric] Univ Paris 06, Hop Tenon, APHP, F-75020 Paris, France; [Keller, Alexandre Castro; Ribeil, Jean-Antoine; Leite-de-Moraes, Maria C.] Hop Necker Enfants Malad, CNRS, UMR 8147, Paris, France; [Ribeil, Jean-Antoine] Hop Necker Enfants Malad, APHP, Fac Med Rene Descartes, Dept Biotherapie, Paris, France; [Keller, Alexandre Castro] Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, Brazil	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universidade Federal de Sao Paulo (UNIFESP)	Mesnard, L (corresponding author), Univ Paris 06, INSERM, UMR S702, Hop Tenon, 4 Rue Chine, F-75020 Paris, France.	laurent.mesnard@tnn.aphp.fr; eric.rondeau@tnn.aphp.fr	Ribeil, Jean-Antoine/AAK-7979-2020; Keller, Alexandre C/E-4621-2012; de Moraes, Maria Leite/AAV-9159-2020; Ribeil, Jean-Antoine/F-7896-2017	Ribeil, Jean-Antoine/0000-0002-4549-4783; Keller, Alexandre C/0000-0002-7827-0292; de Moraes, Maria Leite/0000-0002-2891-2269; Ribeil, Jean-Antoine/0000-0002-5733-9123; VANDERMEERSCH, sophie/0000-0001-6021-1334	Institut National de la Sante et de la Recherche Medicale (INSERM); Faculte de Medecine Pierre et Marie Curie; Academie de Medecine; European Renal Association-European Dialysis and Transplant Association (ERA-EDTA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/07120-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) in Brazil [501848/2009-6]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Faculte de Medecine Pierre et Marie Curie; Academie de Medecine; European Renal Association-European Dialysis and Transplant Association (ERA-EDTA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) in Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financially supported by the Institut National de la Sante et de la Recherche Medicale (INSERM) and by the Faculte de Medecine Pierre et Marie Curie. L.M. is a research fellow of INSERM. C.R. received grants from the Academie de Medecine. D.C. is recipient of a grant from the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA). A.C.K. is recipient of grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2007/07120-0) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq 501848/2009-6) in Brazil. The authors thank Chantal, Carole, Corinne, Ismael, and Mariam for their technical assistance. The authors thank Caroline Martin and Claude Kitou for providing animal housing. The authors are grateful to Prof. B. P Morgan and Dr. T. Hughes (Cardiff University, Cardiff, UK), who provided antibodies against C9, DAF, and CD59a.	BARIETY J, 1989, CLIN EXP IMMUNOL, V75, P76; De Prada NA, 2002, EUR J BIOCHEM, V269, P184, DOI 10.1046/j.0014-2956.2002.02639.x; Drew AF, 2001, AM J PHYSIOL-RENAL, V281, pF1157, DOI 10.1152/ajprenal.0002.2001; Elberg G, 2006, NEPHRON EXP NEPHROL, V102, pE113, DOI 10.1159/000090070; FALK RJ, 1987, AM J PATHOL, V127, P182; Farrehi PM, 1998, CIRCULATION, V97, P1002; GIROUX L, 1979, LAB INVEST, V40, P415; Grandaliano G, 2000, AM J KIDNEY DIS, V35, P726, DOI 10.1016/S0272-6386(00)70022-9; Henseleit U, 1995, Exp Dermatol, V4, P249; Hertig A, 2004, J AM SOC NEPHROL, V15, P844, DOI 10.1097/01.ASN.0000115400.52705.83; Hertig A, 2003, FASEB J, V17, P1904, DOI 10.1096/fj.03-0084fje; Huang YF, 2003, J CLIN INVEST, V112, P379, DOI 10.1172/JCI200318038; Huang YF, 2009, AM J PHYSIOL-RENAL, V297, pF1045, DOI 10.1152/ajprenal.00024.2009; Kitching AR, 2003, J AM SOC NEPHROL, V14, P1487, DOI 10.1097/01.ASN.0000065550.13931.00; Kitching AR, 1997, J EXP MED, V185, P963, DOI 10.1084/jem.185.5.963; Lin F, 2004, J IMMUNOL, V172, P2636, DOI 10.4049/jimmunol.172.4.2636; Lloyd GM, 1997, J EXP MED, V185, P1371, DOI 10.1084/jem.185.7.1371; LOSKUTOFF DJ, 1993, THROMB HAEMOSTASIS, V70, P135; MALLIAROS J, 1993, KIDNEY INT, V44, P557, DOI 10.1038/ki.1993.281; Mesnard L, 2009, J AM SOC NEPHROL, V20, P1282, DOI 10.1681/ASN.2008040433; MORLEY AR, 1985, J PATHOL, V145, P315, DOI 10.1002/path.1711450405; OGAWA T, 1994, NEPHRON, V68, P87, DOI 10.1159/000188225; OKADA M, 1993, VIRCHOWS ARCH A, V422, P367, DOI 10.1007/BF01605455; Osmers I, 2006, MOL IMMUNOL, V43, P1722, DOI 10.1016/j.molimm.2005.10.004; Podor TJ, 2002, J BIOL CHEM, V277, P7520, DOI 10.1074/jbc.M109677200; PODOR TJ, 1992, ANN NY ACAD SCI, V667, P173, DOI 10.1111/j.1749-6632.1992.tb51609.x; PREISSNER KT, 1991, THROMB HAEMOSTASIS, V66, P123; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; Preissner KT, 1996, SEMIN THROMB HEMOST, V22, P165, DOI 10.1055/s-2007-999005; RONDEAU E, 1990, CLIN NEPHROL, V33, P55; SALANT DJ, 1988, METHOD ENZYMOL, V162, P421; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; SEIFFERT D, 1991, P NATL ACAD SCI USA, V88, P9402, DOI 10.1073/pnas.88.21.9402; SEIFFERT D, 1994, J BIOL CHEM, V269, P19836; Seiffert D, 1997, HISTOL HISTOPATHOL, V12, P787; Stoop AA, 2000, ARTERIOSCL THROM VAS, V20, P1143, DOI 10.1161/01.ATV.20.4.1143; Tomasini B R, 1991, Prog Hemost Thromb, V10, P269; Turnberg D, 2003, J AM SOC NEPHROL, V14, P2271, DOI 10.1097/01.ASN.0000083901.47783.2E; Tuzun E, 2003, J IMMUNOL, V171, P3847, DOI 10.4049/jimmunol.171.7.3847; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANDIJK H, 1980, J IMMUNOL METHODS, V36, P29, DOI 10.1016/0022-1759(80)90091-5; VASSALLI P, 1964, ANN NY ACAD SCI, V116, P1052, DOI 10.1111/j.1749-6632.1964.tb52567.x; WARDLE EN, 1974, CLIN NEPHROL, V2, P85; WETSEL RA, 1990, J BIOL CHEM, V265, P2435; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Xie C, 2004, J IMMUNOL, V172, P5047, DOI 10.4049/jimmunol.172.8.5047; Zheng XX, 1995, P NATL ACAD SCI USA, V92, P12426, DOI 10.1073/pnas.92.26.12426; Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943	48	7	7	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3543	3553		10.1096/fj.11-180752	http://dx.doi.org/10.1096/fj.11-180752			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21764994				2022-12-25	WOS:000295356400024
J	Stewart, AP; Haerteis, S; Diakov, A; Korbmacher, C; Edwardson, JM				Stewart, Andrew P.; Haerteis, Silke; Diakov, Alexei; Korbmacher, Christoph; Edwardson, J. Michael			Atomic Force Microscopy Reveals the Architecture of the Epithelial Sodium Channel (ENaC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; SUBUNIT STOICHIOMETRY; ACTIVATION; RECEPTORS; MUTATION	The epithelial sodium channel (ENaC) is a member of the ENaC/degenerin superfamily. ENaC is a heteromultimer containing three homologous subunits (alpha, beta, and gamma); however, the subunit stoichiometry is still controversial. Here, we addressed this issue using atomic force microscopy imaging of complexes between isolated ENaC and antibodies/Fab fragments directed against specific epitope tags on the alpha-, beta- and gamma-subunits. We show that for alpha-, beta- and gamma-ENaC alone, pairs of antibodies decorate the channel at an angle of 120 degrees, indicating that the individual subunits assemble as homotrimers. A similar approach demonstrates that alpha beta gamma-ENaC assembles as a heterotrimer containing one copy of each subunit. Intriguingly, all four subunit combinations also produce higher-order structures containing two or three individual trimers. The trimer-of-trimers organization would account for earlier reports that ENaC contains eight to nine subunits.	[Stewart, Andrew P.; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Haerteis, Silke; Diakov, Alexei; Korbmacher, Christoph] Univ Erlangen Nurnberg, Inst Zellulare & Mol Physiol, D-91054 Erlangen, Germany	University of Cambridge; University of Erlangen Nuremberg	Edwardson, JM (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	jme1000@cam.ac.uk	Haerteis, Silke/AGS-5314-2022	Haerteis, Silke/0000-0002-9440-3307	Jean Shanks Foundation; James Baird Fund; IZKF (Interdisciplinary Centre of Clinical Research); Friedrich-Alexander-Universitat Erlangen-Nurnberg; Bayerische Forschungsstiftung; Deutsche Forschungsgemeinschaft [SFB 423, A12]; Kidney Research UK; Kidney Research UK [RP11/2009] Funding Source: researchfish	Jean Shanks Foundation; James Baird Fund; IZKF (Interdisciplinary Centre of Clinical Research); Friedrich-Alexander-Universitat Erlangen-Nurnberg; Bayerische Forschungsstiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kidney Research UK(Kidney Research UK (KRUK)); Kidney Research UK(Kidney Research UK (KRUK))	Member of the University of Cambridge MB/PhD Programme and supported by the Jean Shanks Foundation and the James Baird Fund.; Supported by a young investigator grant from the IZKF (Interdisciplinary Centre of Clinical Research) and the Erlanger Leistungsbezogene Anschub-finanzierung und Nachwuchsfoerderung (ELAN) program of the Friedrich-Alexander-Universitat Erlangen-Nurnberg and recipient of a travel grant from the Bayerische Forschungsstiftung.; Supported by the Deutsche Forschungsgemeinschaft (SFB 423, Project A12).; Supported by Kidney Research UK. To whom correspondence should be addressed: Dept. of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, United Kingdom. Tel.: 44-1223-334014; Fax: 44-1223-334100; E-mail: jme1000@cam.ac.uk.	Anantharam A, 2007, J GEN PHYSIOL, V130, P55, DOI 10.1085/jgp.200609716; Barrera NP, 2008, PFLUG ARCH EUR J PHY, V456, P199, DOI 10.1007/s00424-007-0381-5; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Carnally SM, 2008, BIOCHEM BIOPH RES CO, V372, P752, DOI 10.1016/j.bbrc.2008.05.100; Carnally SM, 2010, BIOPHYS J, V98, P1182, DOI 10.1016/j.bpj.2009.12.4293; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Dijkink L, 2002, PFLUG ARCH EUR J PHY, V444, P549, DOI 10.1007/s00424-002-0855-4; Eskandari S, 1999, J BIOL CHEM, V274, P27281, DOI 10.1074/jbc.274.38.27281; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Haerteis S, 2009, J BIOL CHEM, V284, P29024, DOI 10.1074/jbc.M109.018945; Huber R, 2010, CELL PHYSIOL BIOCHEM, V25, P145, DOI 10.1159/000272059; Ismailov II, 1996, J BIOL CHEM, V271, P807, DOI 10.1074/jbc.271.2.807; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kobori T, 2009, J BIOL CHEM, V284, P35507, DOI 10.1074/jbc.M109.060228; KORBMACHER C, 1995, J MEMBRANE BIOL, V146, P29; Krueger B, 2009, CELL PHYSIOL BIOCHEM, V24, P605, DOI 10.1159/000257516; Loffing J, 2009, PFLUG ARCH EUR J PHY, V458, P111, DOI 10.1007/s00424-009-0656-0; Neaves KJ, 2009, NUCLEIC ACIDS RES, V37, P2053, DOI 10.1093/nar/gkp042; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Snyder PM, 1998, J BIOL CHEM, V273, P681, DOI 10.1074/jbc.273.2.681; Staruschenko A, 2004, J BIOL CHEM, V279, P27729, DOI 10.1074/jbc.M404169200; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Zhou Y, 2003, J NEUROSCI, V23, P9004	34	48	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					31944	31952		10.1074/jbc.M111.275289	http://dx.doi.org/10.1074/jbc.M111.275289			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775436	Green Published, hybrid			2022-12-25	WOS:000294726800003
J	Xu, XJ; Pan, C; Zhang, LN; Ashida, H				Xu, Xiaojuan; Pan, Chen; Zhang, Lina; Ashida, Hitoshi			Immunomodulatory beta-Glucan from Lentinus edodes Activates Mitogen-activated Protein Kinases and Nuclear Factor-kappa B in Murine RAW 264.7 Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; TRANSCRIPTION FACTOR; ANTIFUNGAL IMMUNITY; FRUIT BODIES; TUMOR-CELLS; ANTITUMOR; LIPOPOLYSACCHARIDE; PATHWAY; CANCER	Lentinan, a cell wall beta-glucan from the fruiting bodies of Lentinus edodes, is well known to be a biological defense modifier, but the signal transduction pathway(s) induced by Lentinan have not been elucidated. In this study, we extracted Lentinan (LNT-S) by ultrasonication from Lentinus edodes and report that, in murine RAW 264.7 macrophages, LNT-S glucan activated NF-kappa B p65 and triggered its nuclear translocation as determined by Western blotting. Moreover, LNT-S enhanced NF-kappa B-luciferase activity in the Dual-Luciferase gene system assay. Its upstream signaling molecules, MAPKs such as ERK1/2 and JNK1/2, were shown to be activated by assessing the level of phosphorylation in a time- and concentration-dependent manner, but its downstream proinflammatory enzyme, inducible NOS, was not observed. The data evaluated using a TNF-alpha ELISA kit and Griess reagent further demonstrated that no proinflammatory mediators such as TNF-alpha and NO were produced by LNT-S stimulation in RAW 264.7 cells. In contrast, LPS significantly induced inducible NOS expression and increased NO and TNF-alpha production, which are associated with activation of the NF-kappa B p65/p50 heterodimer complex. It is possible that LNT-S did not activate NF-kappa B p65/p50, and the activation of NF-kappa B p65 was not sufficient to stimulate cytokine production. These data demonstrate that LNT-S glucan carries out its immunomodulating activity by activating MAPK signaling pathways without secretion of TNF-alpha and NO.	[Xu, Xiaojuan; Pan, Chen; Zhang, Lina] Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China; [Xu, Xiaojuan; Ashida, Hitoshi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Nada Ku, Kobe, Hyogo 6578501, Japan	Wuhan University; Kobe University	Xu, XJ (corresponding author), Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China.	xuxj626@263.net	Zhang, Li/GWM-7501-2022; Wei, Qin/AAF-3325-2019	Chen, Pan/0000-0003-3794-717X; Xu, Xiaojuan/0000-0002-1404-5088	Japan Society for the Promotion of Science [20.08431]; National Natural Science Foundation [20874078]; Youth Technology Chenguang Project of Wuhan [200950431193]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Youth Technology Chenguang Project of Wuhan	This work was supported by Japan Society for the Promotion of Science Postdoctoral Fellowship 20.08431 (to X. X.), National Natural Science Foundation Grant 20874078, and Youth Technology Chenguang Project of Wuhan 200950431193.	ABEL G, 1989, INT J IMMUNOPHARMACO, V11, P615, DOI 10.1016/0192-0561(89)90146-X; Adams DS, 1997, J LEUKOCYTE BIOL, V62, P865, DOI 10.1002/jlb.62.6.865; AKIYAMA T, 1987, MANIPULATION HOST DE, P227; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Chen JZ, 2007, MYCOL RES, V111, P635, DOI 10.1016/j.mycres.2007.02.011; Cleary JA, 1999, IMMUNOL CELL BIOL, V77, P395, DOI 10.1046/j.1440-1711.1999.00848.x; Fang NB, 2006, J ALTERN COMPLEM MED, V12, P125, DOI 10.1089/acm.2006.12.125; FRUEHAUF JP, 1982, IMMUNOPHARMACOLOGY, V5, P65, DOI 10.1016/0162-3109(82)90037-6; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HERLYN D, 1985, JPN J CANCER RES, V76, P37; Herre J, 2004, CRIT REV IMMUNOL, V24, P193, DOI 10.1615/CritRevImmunol.v24.i3.30; Kerekgyarto C, 1996, INT J IMMUNOPHARMACO, V18, P347, DOI 10.1016/S0192-0561(96)00038-0; Kim JW, 2005, BIOCHEM PHARMACOL, V70, P1352, DOI 10.1016/j.bcp.2005.08.006; Kournikakis Bill, 2003, MedGenMed, V5, P1; Kupfahl C, 2006, INT IMMUNOPHARMACOL, V6, P686, DOI 10.1016/j.intimp.2005.10.008; LADANYI A, 1993, CANCER IMMUNOL IMMUN, V36, P123, DOI 10.1007/BF01754412; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li B, 2007, CLIN IMMUNOL, V124, P170, DOI 10.1016/j.clim.2007.05.002; Li B, 2006, J IMMUNOL, V177, P1661, DOI 10.4049/jimmunol.177.3.1661; Liu F, 1999, LIFE SCI, V64, P1005, DOI 10.1016/S0024-3205(99)00027-2; Lo HC, 2006, LIFE SCI, V78, P1957, DOI 10.1016/j.lfs.2005.08.033; LORSBACH RB, 1993, J BIOL CHEM, V268, P1908; Markova N, 2005, PHARMAZIE, V60, P42; Markova N, 2003, INT IMMUNOPHARMACOL, V3, P1557, DOI 10.1016/S1567-5769(03)00178-4; Masihi KN, 1997, INT J IMMUNOPHARMACO, V19, P463; Mayell M, 2001, Altern Med Rev, V6, P48; NANBA H, 1987, CHEM PHARM BULL, V35, P2453; NANBA H, 1987, CHEM PHARM BULL, V35, P2459; Nicolosi R, 1999, AM J CLIN NUTR, V70, P208; OKAMURA K, 1986, CANCER, V58, P865, DOI 10.1002/1097-0142(19860815)58:4<865::AID-CNCR2820580411>3.0.CO;2-S; PETER G, 1988, IMMUNOPHARM IMMUNOT, V10, P157; Ross GD, 1999, IMMUNOPHARMACOLOGY, V42, P61, DOI 10.1016/S0162-3109(99)00013-2; Ruan Z, 2005, INT IMMUNOPHARMACOL, V5, P811, DOI 10.1016/j.intimp.2004.11.011; Sevag MG, 1934, BIOCHEM Z, V273, P419; Shimojoh M, 2010, BIOMACROMOLECULES, V11, P1212, DOI 10.1021/bm9013793; SUGA T, 1984, CANCER RES, V44, P5132; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Taguchi T., 1986, HOST DEFENSE MECHANI, P221; TEBO JM, 1994, J IMMUNOL, V153, P4713; Vetvicka V, 2004, INT IMMUNOPHARMACOL, V4, P721, DOI 10.1016/j.intimp.2004.02.007; Vetvicka V, 2008, BIOMED PHARMACOTHER, V62, P283, DOI 10.1016/j.biopha.2007.05.011; Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7; XIE QW, 1994, J BIOL CHEM, V269, P4705; Young SH, 2001, J BIOL CHEM, V276, P20781, DOI 10.1074/jbc.M101111200	49	46	52	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31194	31198		10.1074/jbc.M111.246470	http://dx.doi.org/10.1074/jbc.M111.246470			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21775433	Green Published, hybrid			2022-12-25	WOS:000294487500014
J	Koutsoupakis, C; Kolaj-Robin, O; Soulimane, T; Varotsis, C				Koutsoupakis, Constantinos; Kolaj-Robin, Olga; Soulimane, Tewfik; Varotsis, Constantinos			Probing Protonation/Deprotonation of Tyrosine Residues in Cytochrome ba(3) Oxidase from Thermus thermophilus by Time-resolved Step-scan Fourier Transform Infrared Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-COPPER OXIDASES; B-CO COMPLEX; ACTIVE-SITE; PARACOCCUS-DENITRIFICANS; PROTON TRANSLOCATION; ELECTRON-TRANSFER; CARBON-MONOXIDE; CROSS-LINK; HIS-TYR; HISTIDINE	Elucidating the properties of the heme Fe-Cu-B binuclear center and the dynamics of the protein response in cytochrome c oxidase is crucial to understanding not only the dioxygen activation and bond cleavage by the enzyme but also the events related to the release of the produced water molecules. The time-resolved step-scan FTIR difference spectra show the nu 7a(CO) of the protonated form of Tyr residues at 1247 cm(-1) and that of the deprotonated form at 1301 cm(-1). By monitoring the intensity changes of the 1247 and 1301 cm(-1) modes as a function of pH, we measured a pK(a) of 7.8 for the observed tyrosine. The FTIR spectral changes associated with the tyrosine do not belong to Tyr-237 but are attributed to the highly conserved in heme-copper oxidases Tyr-136 and/or Tyr-133 residue (Koutsoupakis, K., Stavrakis, S., Pinakoulaki, E., Soulimane, T., and Varotsis, C. (2002) J. Biol. Chem. 277, 32860-32866). The oxygenation of CO by the mixed-valence form of the enzyme revealed the formation of the similar to 607 nm P (Fe(IV) = O) species in the pH 6-9 range and the return to the oxidized form without the formation of the 580 nm F form. The data indicate that Tyr-237 is not involved in the proton transfer pathway in the oxygenation of CO by the mixed-valence form of the enzyme. The implication of these results with respect to the role of Tyr-136 and Tyr-133 in proton transfer/gating along with heme a(3) ring D propionate-H2O-ring A propionate-Asp-372 site to the exit/output proton channel (H2O pool) is discussed.	[Koutsoupakis, Constantinos; Varotsis, Constantinos] Cyprus Univ Technol, Dept Environm Sci & Technol, CY-3603 Lemesos, Cyprus; [Kolaj-Robin, Olga; Soulimane, Tewfik] Univ Limerick, Chem & Environm Sci Dept, Limerick, Ireland; [Kolaj-Robin, Olga; Soulimane, Tewfik] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland	Cyprus University of Technology; University of Limerick; University of Limerick	Varotsis, C (corresponding author), Cyprus Univ Technol, Dept Environm Sci & Technol, CY-3603 Lemesos, Cyprus.	c.varotsis@cut.ac.cy	Ng, Kwan Hoong/D-2231-2009	Varotsis, Constantinos/0000-0003-2771-8891	Cyprus University of Technology; Science Foundation Ireland [BICF865]	Cyprus University of Technology; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by research funds from the Cyprus University of Technology (to C. V.) and the Science Foundation Ireland Grant BICF865 (to T. S.).	Aki M, 2002, J PHYS CHEM A, V106, P3436, DOI 10.1021/jp012492n; Budiman K, 2004, BIOCHEMISTRY-US, V43, P11709, DOI 10.1021/bi048898i; Buse G, 1999, PROTEIN SCI, V8, P985, DOI 10.1110/ps.8.5.985; Cappuccio JA, 2002, J AM CHEM SOC, V124, P1750, DOI 10.1021/ja011852h; Chang HY, 2009, P NATL ACAD SCI USA, V106, P16169, DOI 10.1073/pnas.0905264106; Daskalakis V, 2007, J PHYS CHEM B, V111, P10502, DOI 10.1021/jp0718597; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Fern W. O., 1932, AM J PHYSIOL, V102, P379; Giuffre A, 1999, P NATL ACAD SCI USA, V96, P14718, DOI 10.1073/pnas.96.26.14718; HAN SH, 1990, J AM CHEM SOC, V112, P9445, DOI 10.1021/ja00182a001; Hellwig P, 2002, BIOCHEMISTRY-US, V41, P9116, DOI 10.1021/bi012056r; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kannt A, 1998, BIOPHYS J, V74, P708, DOI 10.1016/S0006-3495(98)73996-7; Kim Y, 2001, J AM CHEM SOC, V123, P757, DOI 10.1021/ja0027867; Klinman JP, 1996, CHEM REV, V96, P2541, DOI 10.1021/cr950047g; Koutsoupakis C, 2004, BIOPHYS J, V86, P2438, DOI 10.1016/S0006-3495(04)74300-3; Koutsoupakis C, 2003, J AM CHEM SOC, V125, P14728, DOI 10.1021/ja036107e; Koutsoupakis K, 2003, J BIOL CHEM, V278, P14893, DOI 10.1074/jbc.M210293200; Koutsoupakis K, 2002, J BIOL CHEM, V277, P32860, DOI 10.1074/jbc.M204943200; Luna VM, 2008, BIOCHEMISTRY-US, V47, P4657, DOI 10.1021/bi800045y; McCauley KM, 2000, J AM CHEM SOC, V122, P2403, DOI 10.1021/ja993774s; Michel H, 1999, BIOCHEMISTRY-US, V38, P15129, DOI 10.1021/bi9910934; Morgan JE, 2001, BIOCHEMISTRY-US, V40, P6882, DOI 10.1021/bi010246w; Pinakoulaki E, 2003, J BIOL CHEM, V278, P18761, DOI 10.1074/jbc.M211925200; Pinakoulaki E, 2002, J BIOL CHEM, V277, P32867, DOI 10.1074/jbc.M205568200; Pinakoulaki E, 2002, J BIOL CHEM, V277, P13563, DOI 10.1074/jbc.M112200200; Proshlyakov DA, 1998, P NATL ACAD SCI USA, V95, P8020, DOI 10.1073/pnas.95.14.8020; Smirnova IA, 2008, J BIOENERG BIOMEMBR, V40, P281, DOI 10.1007/s10863-008-9157-7; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Stavrakis S, 2002, J AM CHEM SOC, V124, P3814, DOI 10.1021/ja0169825; Szundi I, 2010, P NATL ACAD SCI USA, V107, P21010, DOI 10.1073/pnas.1008603107; Tomson F, 2002, BIOCHEMISTRY-US, V41, P14383, DOI 10.1021/bi026370c; VAROTSIS C, 1990, J BIOL CHEM, V265, P11131; Wiertz FGM, 2004, FEBS LETT, V575, P127, DOI 10.1016/j.febslet.2004.08.048; WOODRUFF WH, 1993, J BIOENERG BIOMEMBR, V25, P177, DOI 10.1007/BF00762859; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; YOUNG LJ, 1986, BIOCHEMISTRY-US, V25, P152, DOI 10.1021/bi00349a022	37	19	19	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30600	30605		10.1074/jbc.M111.252213	http://dx.doi.org/10.1074/jbc.M111.252213			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757723	Green Published, hybrid			2022-12-25	WOS:000294283600039
J	Gu, XR; Feng, CG; Ma, L; Song, C; Wang, YQ; Da, Y; Li, HF; Chen, KW; Ye, SH; Ge, CR; Hu, XX; Li, N				Gu, Xiaorong; Feng, Chungang; Ma, Li; Song, Chi; Wang, Yanqiang; Da, Yang; Li, Huifang; Chen, Kuanwei; Ye, Shaohui; Ge, Changrong; Hu, Xiaoxiang; Li, Ning			Genome-Wide Association Study of Body Weight in Chicken F2 Resource Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PRINCIPAL-COMPONENTS; COMPLEX TRAITS; GENE; DISSECTION; SELECTION; CARCASS; GROWTH; MOUSE; LINES	Chicken body weight is an economically important trait and great genetic progress has been accomplished in genetic selective for body weight. To identify genes and chromosome regions associated with body weight, we performed a genome-wide association study using the chicken 60 k SNP panel in a chicken F2 resource population derived from the cross between Silky Fowl and White Plymouth Rock. A total of 26 SNP effects involving 9 different SNP markers reached 5% Bonferroni genome-wide significance. A chicken chromosome 4 (GGA4) region approximately 8.6 Mb in length (71.6-80.2 Mb) had a large number of significant SNP effects for late growth during weeks 7-12. The LIM domain-binding factor 2 (LDB2) gene in this region had the strongest association with body weight for weeks 7-12 and with average daily gain for weeks 6-12. This GGA4 region was previously reported to contain body weight QTL. GGA1 and GGA18 had three SNP effects on body weight with genome-wide significance. Some of the SNP effects with the significance of "suggestive linkage" overlapped with previously reported results.	[Gu, Xiaorong; Feng, Chungang; Song, Chi; Wang, Yanqiang; Hu, Xiaoxiang; Li, Ning] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Ma, Li; Da, Yang] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA; [Song, Chi; Li, Huifang; Chen, Kuanwei] Chinese Acad Agr Sci, Inst Poultry Sci, Yangzhou, Peoples R China; [Ye, Shaohui; Ge, Changrong; Li, Ning] Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Peoples R China	China Agricultural University; University of Minnesota System; University of Minnesota Twin Cities; Chinese Academy of Agricultural Sciences; Yunnan Agricultural University	Gu, XR (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	huxx@cau.edu.cn; ninglcau@cau.edu.cn	Gu, xiaorong/Q-7152-2016; Ma, Li/B-1844-2010; ma, li/C-1585-2014	Gu, xiaorong/0000-0001-5158-8009; Feng, Chungang/0000-0002-7031-4211	National Advanced Technology Research and Development Program of China [2011AA100301]; National Natural Science Foundation of China [U0831003]; High-end Science & Technology Talents Introducing Plan of Yunnan [2010CI118]	National Advanced Technology Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High-end Science & Technology Talents Introducing Plan of Yunnan	This work was supported by grants from the National Advanced Technology Research and Development Program of China (No. 2011AA100301), the National Natural Science Foundation of China (No. U0831003), and the High-end Science & Technology Talents Introducing Plan of Yunnan (No. 2010CI118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzmon G, 2008, J HERED, V99, P528, DOI 10.1093/jhered/esn030; Boschiero C., 2009, International Journal of Poultry Science, V8, P615; Carlborg O, 2003, GENOME RES, V13, P413, DOI 10.1101/gr.528003; Carlborg R, 2004, GENET RES, V83, P197, DOI 10.1017/S0016672304006779; Duchesnes CE, 2009, PHYSIOL GENOMICS, V37, P164, DOI 10.1152/physiolgenomics.90336.2008; Gaya LG, 2006, POULTRY SCI, V85, P837, DOI 10.1093/ps/85.5.837; Georges M, 2007, ANNU REV GENOM HUM G, V8, P131, DOI 10.1146/annurev.genom.8.080706.092408; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; Jacobsson L, 2005, GENET RES, V86, P115, DOI 10.1017/S0016672305007767; Javerzat S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007856; Johansson AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001188; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Ledur MC, 2010, HEREDITY, V105, P173, DOI 10.1038/hdy.2009.149; Ma L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-315; Nicodemus KK, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S78; Ostendorff HP, 2006, DEV DYNAM, V235, P786, DOI 10.1002/dvdy.20669; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sewalem A, 2002, POULTRY SCI, V81, P1775, DOI 10.1093/ps/81.12.1775; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; Tatsuda K, 2001, BRIT POULTRY SCI, V42, P333, DOI 10.1080/00071660120055296; Tsudzuki M, 2007, CYTOGENET GENOME RES, V117, P288, DOI 10.1159/000103190; Wahlberg P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-248; Wang Dai, 2009, BMC Proc, V3 Suppl 7, pS109; Zhao JH, 2007, J STAT SOFTW, V23; ENTREZ GENE GPC5 GLY	29	111	130	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21872	10.1371/journal.pone.0021872	http://dx.doi.org/10.1371/journal.pone.0021872			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779344	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811300021
J	Holl, D; Kuckenberg, P; Woynecki, T; Egert, A; Becker, A; Huss, S; Stabenow, D; Zimmer, A; Knolle, P; Tolba, R; Fischer, HP; Schorle, H				Holl, Daniel; Kuckenberg, Peter; Woynecki, Tatiana; Egert, Angela; Becker, Astrid; Huss, Sebastian; Stabenow, Dirk; Zimmer, Andreas; Knolle, Percy; Tolba, Rene; Fischer, Hans-Peter; Schorle, Hubert			Transgenic Overexpression of Tcfap2c/AP-2gamma Results in Liver Failure and Intestinal Dysplasia	PLOS ONE			English	Article							TRANSCRIPTION FACTOR AP-2; INVASIVE BREAST-CANCER; GERM-CELL TUMORS; FACTOR AP-2-GAMMA; CARCINOMA-CELLS; ACTIVATOR PROTEIN-2; NONCODING RNA; EXPRESSION; GENE; CLONING	Background: The transcription factor Tcfap2c has been demonstrated to be essential for various processes during mammalian development. It has been found to be upregulated in various undifferentiated tumors and is implicated with poor prognosis. Tcfap2c is reported to impinge on cellular proliferation, differentiation and apoptosis. However, the physiological consequences of Tcfap2c-expression remain largely unknown. Methodology/Principal Findings: Therefore we established a gain of function model to analyze the role of Tcfap2c in development and disease. Induction of the transgene led to robust expression in all tissues (except brain and testis) and lead to rapid mortality within 3-7 days. In the liver cellular proliferation and apoptosis was detected. Accumulation of microvesicular lipid droplets and breakdown of major hepatic metabolism pathways resulted in steatosis. Serum analysis showed a dramatic increase of enzymes indicative for hepatic failure. After induction of Tcfap2c we identified a set of 447 common genes, which are deregulated in both liver and primary hepatocyte culture. Further analysis showed a prominent repression of the cytochrome p450 system, PPARA, Lipin1 and Lipin2. These data indicate that in the liver Tcfap2c represses pathways, which are responsible for fatty acid metabolism. In the intestine, Tcfap2c expression resulted in expansion of Sox9 positive and proliferative active epithelial progenitor cells resulting in dysplastic growth of mucosal crypt cells and loss of differentiated mucosa. Conclusions: The transgenic mice show that ectopic expression of Tcfap2c is not tolerated. Due to the phenotype observed, iTcfap2c-mice represent a model system to study liver failure. In intestine, Tcfap2c induced cellular hyperplasia and suppressed terminal differentiation indicating that Tcfap2c serves as a repressor of differentiation and inducer of proliferation. This might be achieved by the Tcfap2c mediated activation of Sox9 known to be expressed in intestinal and hepatic stem/progenitor cell populations.	[Holl, Daniel; Kuckenberg, Peter; Woynecki, Tatiana; Egert, Angela; Schorle, Hubert] Univ Bonn, Inst Pathol, Sch Med, Dept Dev Pathol, D-5300 Bonn, Germany; [Becker, Astrid; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, D-5300 Bonn, Germany; [Stabenow, Dirk; Knolle, Percy] Univ Bonn, Inst Expt Immunol, D-5300 Bonn, Germany; [Tolba, Rene] Univ Aachen, Inst Lab Anim Sci & Expt Surg, D-5100 Aachen, Germany	University of Bonn; University of Bonn; University of Bonn; RWTH Aachen University	Holl, D (corresponding author), Univ Bonn, Inst Pathol, Sch Med, Dept Dev Pathol, D-5300 Bonn, Germany.	hubert.schorle@ukb.uni-bonn.de	Schorle, Hubert/M-5001-2016; Wohlleber, Dirk/J-2549-2017; Zimmer, Andreas/B-8357-2009; Schorle, Hubert/S-1713-2019	Schorle, Hubert/0000-0001-8272-0076; Wohlleber, Dirk/0000-0003-3861-5150; Knolle, Percy A./0000-0003-2983-0414; Holl, Daniel/0000-0002-2254-7889	Deutsche Forschungsgesellschaft (DFG) [Scho503/10]; Ministry of Innovation, Science, Research and Technology, North Rhine Westfalia (NRW)	Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG)); Ministry of Innovation, Science, Research and Technology, North Rhine Westfalia (NRW)	This study was supported by a grant from the Deutsche Forschungsgesellschaft (DFG) by the funds Scho503/10 to HS. PK was supported by a fellowship of the International Graduate Research School, LIMES-Chemical Biology funded by the Ministry of Innovation, Science, Research and Technology, North Rhine Westfalia (NRW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auman HJ, 2002, DEVELOPMENT, V129, P2733; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; BOSHER JM, 1995, P NATL ACAD SCI USA, V92, P744, DOI 10.1073/pnas.92.3.744; Chazaud C, 1996, MECH DEVELOP, V54, P83, DOI 10.1016/0925-4773(95)00463-7; DORRELL C, GENES DEV, V25, P1193; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Feng WG, 2003, MOL CELL NEUROSCI, V24, P460, DOI 10.1016/S1044-7431(03)00209-4; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; Friedrichs N, 2005, MODERN PATHOL, V18, P431, DOI 10.1038/modpathol.3800292; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gabory A, 2010, BIOESSAYS, V32, P473, DOI 10.1002/bies.200900170; Gee JMW, 2009, J PATHOL, V217, P32, DOI 10.1002/path.2430; Gee JMW, 1999, J PATHOL, V189, P514, DOI 10.1002/(SICI)1096-9896(199912)189:4<514::AID-PATH463>3.0.CO;2-9; Gropler MC, 2009, J BIOL CHEM, V284, P6763, DOI 10.1074/jbc.M807882200; Hao JH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000138; He AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-279; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hoei-Hansen CE, 2004, CLIN CANCER RES, V10, P8521, DOI 10.1158/1078-0432.CCR-04-1285; Jager R, 2010, DEV DYNAM, V239, P1027, DOI 10.1002/dvdy.22239; Jager R, 2003, MOL CANCER RES, V1, P921; Gomez-Lechon MJ, 2009, CURR DRUG METAB, V10, P692, DOI 10.2174/138920009789895543; Kidder BL, 2010, GENOME RES, V20, P458, DOI 10.1101/gr.101469.109; Kuckenberg P, 2010, MOL CELL BIOL, V30, P3310, DOI 10.1128/MCB.01215-09; Li HL, 2006, NEOPLASIA, V8, P568, DOI 10.1593/neo.06367; Lind AB, 2003, PHARMACOL TOXICOL, V92, P295, DOI 10.1034/j.1600-0773.2003.920607.x; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; MOSER M, 1995, DEVELOPMENT, V121, P2779; Nottoli T, 1998, P NATL ACAD SCI USA, V95, P13714, DOI 10.1073/pnas.95.23.13714; OuladAbdelghani M, 1996, EXP CELL RES, V225, P338, DOI 10.1006/excr.1996.0184; Oyama N, 2002, ARCH DERMATOL RES, V294, P273, DOI 10.1007/s00403-002-0327-x; Pauls K, 2005, INT J CANCER, V115, P470, DOI 10.1002/ijc.20913; Pellikainen J, 2002, CLIN CANCER RES, V8, P3487; Pellikainen JM, 2007, INT J CANCER, V120, P2061, DOI 10.1002/ijc.22648; Pinto L, 2009, NAT NEUROSCI, V12, P1229, DOI 10.1038/nn.2399; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Thewes V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-192; Turner BC, 1998, CANCER RES, V58, P5466; Wang Q, 2007, ONCOGENE, V26, P6560, DOI 10.1038/sj.onc.1210472; Weber S, 2010, BIOL REPROD, V82, P214, DOI 10.1095/biolreprod.109.078717; Werling U, 2002, MOL CELL BIOL, V22, P3149, DOI 10.1128/MCB.22.9.3149-3156.2002; Williams CMJ, 2009, EMBO J, V28, P3591, DOI 10.1038/emboj.2009.290; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; Woodfield GW, 2010, GENE CHROMOSOME CANC, V49, P948, DOI 10.1002/gcc.20807; Yu ST, 2003, CURR MOL MED, V3, P561, DOI 10.2174/1566524033479537; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0; Zhao C, 2003, CANCER, V98, P18, DOI 10.1002/cncr.11482; Zhao F, 2001, J BIOL CHEM, V276, P40755, DOI 10.1074/jbc.M106284200	49	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22034	10.1371/journal.pone.0022034	http://dx.doi.org/10.1371/journal.pone.0022034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21779369	Green Submitted, Green Published, gold			2022-12-25	WOS:000292781500026
J	Lee, ST; Chu, K; Jung, KH; Song, YM; Jeon, D; Kim, SU; Kim, M; Lee, SK; Roh, JK				Lee, Soon-Tae; Chu, Kon; Jung, Keun-Hwa; Song, Young-Mi; Jeon, Daejong; Kim, Seung U.; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu			Direct Generation of Neurosphere-Like Cells from Human Dermal Fibroblasts	PLOS ONE			English	Article							NEURAL STEM-CELLS; PROGENITOR CELLS; SOMATIC-CELLS; TRANSPLANTATION; NEURONS; INDUCTION; MOUSE; DIFFERENTIATION; ENGRAFTMENT; MECHANISM	Neural stem cell (NSC) transplantation replaces damaged brain cells and provides disease-modifying effects in many neurological disorders. However, there has been no efficient way to obtain autologous NSCs in patients. Given that ectopic factors can reprogram somatic cells to be pluripotent, we attempted to generate human NSC-like cells by reprograming human fibroblasts. Fibroblasts were transfected with NSC line-derived cellular extracts and grown in neurosphere culture conditions. The cells were then analyzed for NSC characteristics, including neurosphere formation, gene expression patterns, and ability to differentiate. The obtained induced neurosphere-like cells (iNS), which formed daughter neurospheres after serial passaging, expressed neural stem cell markers, and had demethylated SOX2 regulatory regions, all characteristics of human NSCs. The iNS had gene expression patterns that were a combination of the patterns of NSCs and fibroblasts, but they could be differentiated to express neuroglial markers and neuronal sodium channels. These results show for the first time that iNS can be directly generated from human fibroblasts. Further studies on their application in neurological diseases are warranted.	[Lee, Soon-Tae; Chu, Kon; Jung, Keun-Hwa; Song, Young-Mi; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ Hosp, Clin Res Inst, Dept Neurol, Seoul 110744, South Korea; [Lee, Soon-Tae; Chu, Kon; Jung, Keun-Hwa; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ, Program Neurosci, Neurosci Res Inst SNUMRC, Seoul, South Korea; [Jeon, Daejong] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kim, Seung U.] Univ British Columbia, Dept Med, Div Neurol, UBC Hosp, Vancouver, BC V6T 1W5, Canada; [Kim, Seung U.] Chung Ang Univ, Sch Med, Med Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); University of British Columbia; Chung Ang University; Chung Ang University Hospital	Lee, ST (corresponding author), Seoul Natl Univ Hosp, Clin Res Inst, Dept Neurol, Seoul 110744, South Korea.	rohjk@snu.ac.kr	Lee, Sang Kun/J-5578-2012; Jeon, Daejong/C-1814-2011; Kim, Manho/J-2738-2012; Roh, Jae Kyu/J-5459-2012; Lee, Soon-Tae/C-4663-2013	Lee, Soon-Tae/0000-0003-4767-7564; Jeon, Daejong/0000-0002-6998-7603; Chu, Kon/0000-0001-5863-0302	Ministry for Health, Welfare & Family Affairs, Republic of Korea [A100548]; Seoul National University Hospital [0320090200, 0420080160, 0320090160, 0320110160, 0420100200, 0420080620, 0320110360, 0420090280]	Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Seoul National University Hospital	This study was supported by Research Grants from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A100548). JKR was supported by Seoul National University Hospital Research Funds (0320090200, 0420080160). SKL was supported by Seoul National University Hospital Research Funds (0320090160, 0320110160, 0420100200, 0420080620). KC was supported by Seoul National University Hospital Research Funds (0320110360, 0420090280). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnhold S, 2004, INVEST OPHTH VIS SCI, V45, P4251, DOI 10.1167/iovs.03-1108; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Chu K, 2004, BRAIN RES, V1023, P213, DOI 10.1016/j.brainres.2004.07.045; Chu K, 2008, BRAIN RES, V1207, P182, DOI 10.1016/j.brainres.2008.02.043; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Hakelien AM, 2002, NAT BIOTECHNOL, V20, P460, DOI 10.1038/nbt0502-460; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jeon D, 2003, NEURON, V38, P965, DOI 10.1016/S0896-6273(03)00334-9; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim Seung U., 2008, V438, P103, DOI 10.1007/978-1-59745-133-8_10; Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015; Koch P, 2009, LANCET NEUROL, V8, P819, DOI 10.1016/S1474-4422(09)70202-9; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Qin M, 2005, STEM CELLS, V23, P712, DOI 10.1634/stemcells.2004-0195; Rajasingh J, 2008, CIRC RES, V102, pE107, DOI 10.1161/CIRCRESAHA.108.176115; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Seminatore C, 2010, STROKE, V41, P153, DOI 10.1161/STROKEAHA.109.563015; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranger CK, 2005, MOL BIOL CELL, V16, P5719, DOI 10.1091/mbc.e05-06-0572; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wernig M, 2004, J NEUROSCI, V24, P5258, DOI 10.1523/JNEUROSCI.0428-04.200; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	41	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21801	10.1371/journal.pone.0021801	http://dx.doi.org/10.1371/journal.pone.0021801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765916	gold, Green Published, Green Submitted			2022-12-25	WOS:000292781500017
J	Navarro, JA; Llorens, JV; Soriano, S; Botella, JA; Schneuwly, S; Martinez-Sebastian, MJ; Molto, MD				Navarro, Juan A.; Llorens, Jose V.; Soriano, Sirena; Botella, Jose A.; Schneuwly, Stephan; Martinez-Sebastian, Maria J.; Molto, Maria D.			Overexpression of Human and Fly Frataxins in Drosophila Provokes Deleterious Effects at Biochemical, Physiological and Developmental Levels	PLOS ONE			English	Article							FRIEDREICH ATAXIA; OXIDATIVE STRESS; PARKINSONS-DISEASE; IRON CHAPERONE; IN-VIVO; SACCHAROMYCES-CEREVISIAE; ENERGY-METABOLISM; ESCHERICHIA-COLI; SCAFFOLD PROTEIN; UP-REGULATION	Background: Friedreich's ataxia (FA), the most frequent form of inherited ataxias in the Caucasian population, is caused by a reduced expression of frataxin, a highly conserved protein. Model organisms have contributed greatly in the efforts to decipher the function of frataxin; however, the precise function of this protein remains elusive. Overexpression studies are a useful approach to investigate the mechanistic actions of frataxin; however, the existing literature reports contradictory results. To further investigate the effect of frataxin overexpression, we analyzed the consequences of overexpressing human (FXN) and fly (FH) frataxins in Drosophila. Methodology/Principal Findings: We obtained transgenic flies that overexpressed human or fly frataxins in a general pattern and in different tissues using the UAS-GAL4 system. For both frataxins, we observed deleterious effects at the biochemical, histological and behavioral levels. Oxidative stress is a relevant factor in the frataxin overexpression phenotypes. Systemic frataxin overexpression reduces Drosophila viability and impairs the normal embryonic development of muscle and the peripheral nervous system. A reduction in the level of aconitase activity and a decrease in the level of NDUF3 were also observed in the transgenic flies that overexpressed frataxin. Frataxin overexpression in the nervous system reduces life span, impairs locomotor ability and causes brain degeneration. Frataxin aggregation and a misfolding of this protein have been shown not to be the mechanism that is responsible for the phenotypes that have been observed. Nevertheless, the expression of human frataxin rescues the aconitase activity in the fh knockdown mutant. Conclusion/Significance: Our results provide in vivo evidence of a functional equivalence for human and fly frataxins and indicate that the control of frataxin expression is important for treatments that aim to increase frataxin levels.	[Navarro, Juan A.; Botella, Jose A.; Schneuwly, Stephan] Univ Regensburg, Inst Zool, D-8400 Regensburg, Germany; [Llorens, Jose V.; Soriano, Sirena; Martinez-Sebastian, Maria J.; Molto, Maria D.] Univ Valencia, Dept Genet, Valencia, Spain; [Llorens, Jose V.] CSIC, Inst Biomed, Valencia, Spain; [Molto, Maria D.] CIBERSAM Ctr Invest Biomed & Red Salud Mental, Madrid, Spain	University of Regensburg; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Navarro, JA (corresponding author), Univ Regensburg, Inst Zool, Univ Str 31, D-8400 Regensburg, Germany.	jose.vicente.llorens@uv.es	Langa, Juan Antonio Navarro/AAA-8013-2020	Langa, Juan Antonio Navarro/0000-0003-2266-728X; Martinez-Sebastian, Maria-Jose/0000-0001-5549-7921; Molto, Maria Dolores/0000-0001-5219-2022; Soriano, Sirena/0000-0001-9967-7262; Schneuwly, Stephan/0000-0001-7711-8902; Llorens, Jose V./0000-0001-9823-6246	Fondo Investigaciones Sanitarias [ISCIII06- PI0677]; La Fundacio la Marato TV3 of Spain [exp 101932]; European Friedreich's Ataxia Consortium for Translational Studies; Ministerio de Ciencia e Innovacion of Spain; NICHD	Fondo Investigaciones Sanitarias(Instituto de Salud Carlos III); La Fundacio la Marato TV3 of Spain; European Friedreich's Ataxia Consortium for Translational Studies; Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from Fondo Investigaciones Sanitarias (ISCIII06- PI0677) and La Fundacio la Marato TV3 (exp 101932) of Spain. JVL is supported by the European Friedreich's Ataxia Consortium for Translational Studies. SS is a recipient of a fellowship from Ministerio de Ciencia e Innovacion of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Dan Kiehart and Dr. Francesc Palau for the generous gifts of the anti-MHC and anti-Frataxin, respectively. The hybridoma antibodies 22C10 and BP102, which were developed by S. Benzer and C. Goodman, respectively, were obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of the NICHD, and maintained by the University of Iowa, Department of Biological Sciences, IA 52242. We also thank the Bloomington Stock Center for the fly stocks. The authors would like to thank Uschi Roth for their technical assistance, and Dr. Juan Ferre and Dr. Emmanuel Lesuisse for their technical assistance and protocol for the gel filtration experiment. We also thank the Servicio Central de Soporte a la Investigacion Experimental de la Universitat de Valencia for access to the DNA analysis resources and databases.	Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Aloria K, 2004, EMBO REP, V5, P1096, DOI 10.1038/sj.embor.7400272; Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Anderson PR, 2005, HUM MOL GENET, V14, P3397, DOI 10.1093/hmg/ddi367; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Botella JA, 2004, CURR BIOL, V14, P782, DOI 10.1016/j.cub.2004.04.036; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Canizares J, 2000, GENE, V256, P35, DOI 10.1016/S0378-1119(00)00343-7; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209; Delaval E, 2004, EUR J BIOCHEM, V271, P4559, DOI 10.1111/j.1432-1033.2004.04422.x; Emond M, 2000, NEUROLOGY, V55, P1752, DOI 10.1212/WNL.55.11.1752; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Fernandez-Funez P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000507; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Gibson TJ, 1996, TRENDS NEUROSCI, V19, P465, DOI 10.1016/S0166-2236(96)20054-2; Gonzalez-Cabo P, 2005, HUM MOL GENET, V14, P2091, DOI 10.1093/hmg/ddi214; Guillon B, 2009, FEBS J, V276, P1036, DOI 10.1111/j.1742-4658.2008.06847.x; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; HARDING AE, 1993, ADV NEUROL, V61, P1; HARDING AE, 1983, Q J MED, V52, P489; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; Kondapalli KC, 2008, BIOCHEMISTRY-US, V47, P6917, DOI 10.1021/bi800366d; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127; Li KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012286; Llorens JV, 2007, FASEB J, V21, P333, DOI 10.1096/fj.05-5709com; Marsh JL, 2003, HUM MOL GENET, V12, pR187, DOI 10.1093/hmg/ddg271; Miranda CJ, 2004, FEBS LETT, V572, P281, DOI 10.1016/j.febslet.2004.07.022; Moreno-Cermeno A, 2010, J BIOL CHEM, V285, P41653, DOI 10.1074/jbc.M110.149443; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Mutsuddi M, 2004, CURR BIOL, V14, P302, DOI 10.1016/j.cub.2004.01.034; Navarro JA, 2010, HUM MOL GENET, V19, P2828, DOI 10.1093/hmg/ddq183; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Oktay Y, 2007, J BIOL CHEM, V282, P11750, DOI 10.1074/jbc.M611133200; ORR WC, 1992, ARCH BIOCHEM BIOPHYS, V297, P35, DOI 10.1016/0003-9861(92)90637-C; Palau F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-47; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Runkoa AP, 2008, FEBS LETT, V582, P715, DOI 10.1016/j.febslet.2008.01.046; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Schulz JB, 2000, NEUROLOGY, V55, P1719, DOI 10.1212/WNL.55.11.1719; Schulz TJ, 2010, AGING-US, V2, P843, DOI 10.18632/aging.100234; Schulz TJ, 2006, J BIOL CHEM, V281, P977, DOI 10.1074/jbc.M511064200; Seguin A, 2009, MITOCHONDRION, V9, P130, DOI 10.1016/j.mito.2009.01.007; Shidara Y, 2010, J NEUROSCI, V30, P11369, DOI 10.1523/JNEUROSCI.0529-10.2010; Shoichet SA, 2002, HUM MOL GENET, V11, P815, DOI 10.1093/hmg/11.7.815; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Sutak R, 2008, PROTEOMICS, V8, P1731, DOI 10.1002/pmic.200701049; Vazquez-Manrique RP, 2005, FASEB J, V19, P172, DOI 10.1096/fj.05-4212fje; Venderova K, 2009, HUM MOL GENET, V18, P4390, DOI 10.1093/hmg/ddp394; Vivas E, 2006, J BACTERIOL, V188, P1175, DOI 10.1128/JB.188.3.1175-1179.2006; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532	66	26	26	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21017	10.1371/journal.pone.0021017	http://dx.doi.org/10.1371/journal.pone.0021017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779322	Green Submitted, gold, Green Published			2022-12-25	WOS:000292680900003
J	Rozhkov, NV; Zelentsova, ES; Shostak, NG; Evgen'ev, MB				Rozhkov, Nikolay V.; Zelentsova, Elena S.; Shostak, Natalia G.; Evgen'ev, Michael B.			Expression of Drosophila virilis Retroelements and Role of Small RNAs in Their Intrastrain Transposition	PLOS ONE			English	Article							HYBRID DYSGENESIS SYNDROME; TRANSPOSABLE ELEMENTS; MOBILE ELEMENTS; DOT CHROMOSOME; SPECIES GROUP; MELANOGASTER; EVOLUTION; PENELOPE; GYPSY; RETROTRANSPOSON	Transposition of two retroelements (Ulysses and Penelope) mobilized in the course of hybrid dysgenesis in Drosophila virilis has been investigated by in situ hybridization on polytene chromosomes in two D. virilis strains of different cytotypes routinely used to get dysgenic progeny. The analysis has been repeatedly performed over the last two decades, and has revealed transpositions of Penelope in one of the strains, while, in the other strain, the LTR-containing element Ulysses was found to be transpositionally active. The gypsy retroelement, which has been previously shown to be transpositionally inactive in D. virilis strains, was also included in the analysis. Whole mount is situ hybridization with the ovaries revealed different subcellular distribution of the transposable elements transcripts in the strains studied. Ulysses transpositions occur only in the strain where antisense piRNAs homologous to this TE are virtually absent and the ping-pong amplification loop apparently does not take place. On the other hand small RNAs homologous to Penelope found in the other strain, belong predominantly to the siRNA category (21nt), and consist of sense and antisense species observed in approximately equal proportion. The number of Penelope copies in the latter strain has significantly increased during the last decades, probably because Penelope-derived siRNAs are not maternally inherited, while the low level of Penelope-piRNAs, which are faithfully transmitted from mother to the embryo, is not sufficient to silence this element completely. Therefore, we speculate that intrastrain transposition of the three retroelements studied is controlled predominantly at the post-transcriptional level.	[Rozhkov, Nikolay V.; Zelentsova, Elena S.; Shostak, Natalia G.; Evgen'ev, Michael B.] Russian Acad Sci, Inst Mol Biol, Moscow, Russia; [Evgen'ev, Michael B.] Inst Cell Biophys, Pushchino, Russia	Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS	Rozhkov, NV (corresponding author), Russian Acad Sci, Inst Mol Biol, Moscow, Russia.	misha572001@yahoo.com			Russian Foundation for Basic Research [09-04-00643, 09-04-00660]; "Genofond Dynamics'' program; Program of Molecular and Cellular Biology RAN	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); "Genofond Dynamics'' program; Program of Molecular and Cellular Biology RAN	This work was supported by the Russian Foundation for Basic Research, projects # 09-04-00643 and 09-04-00660, project from the "Genofond Dynamics'' program, and a grant from the Program of Molecular and Cellular Biology RAN to M. B. E. The funders had no role in study design, data collection, or preparation of the manuscript.	Alberola TM, 1996, NUCLEIC ACIDS RES, V24, P914, DOI 10.1093/nar/24.5.914; Arkhipova IR, 2003, NAT GENET, V33, P123, DOI 10.1038/ng1074; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Blumenstiel JP, 2005, P NATL ACAD SCI USA, V102, P15965, DOI 10.1073/pnas.0508192102; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; Evgen'ev MB, 2005, CYTOGENET GENOME RES, V110, P510, DOI 10.1159/000084984; Evgen'ev MB, 2000, P NATL ACAD SCI USA, V97, P11337, DOI 10.1073/pnas.210386297; Evgenev MB, 1997, P NATL ACAD SCI USA, V94, P196, DOI 10.1073/pnas.94.1.196; Fontanillas P, 2007, PLOS GENET, V3, P2256, DOI 10.1371/journal.pgen.0030210; Kapitonov VV, 2003, P NATL ACAD SCI USA, V100, P6569, DOI 10.1073/pnas.0732024100; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; KUZIN AB, 1994, NUCLEIC ACIDS RES, V22, P4641, DOI 10.1093/nar/22.22.4641; Leung W, 2010, GENETICS, V185, P1519, DOI 10.1534/genetics.110.116129; LOZOVSKAYA ER, 1990, GENETICS, V126, P619; Lyozin GT, 2001, J MOL EVOL, V52, P445, DOI 10.1007/s002390010174; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Mejlumian L, 2002, GENETICS, V160, P201; Mevel-Ninio M, 2007, GENETICS, V175, P1615, DOI 10.1534/genetics.106.068106; MIZROKHI LJ, 1991, NUCLEIC ACIDS RES, V19, P913, DOI 10.1093/nar/19.4.913; Moschetti R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013142; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; Nogare DED, 2002, MOL BIOL EVOL, V19, P247, DOI 10.1093/oxfordjournals.molbev.a004078; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; PETROV DA, 1995, P NATL ACAD SCI USA, V92, P8050, DOI 10.1073/pnas.92.17.8050; Pyatkov KI, 2002, P NATL ACAD SCI USA, V99, P16150, DOI 10.1073/pnas.252641799; Rozhkov NV, 2010, RNA, V16, P1634, DOI 10.1261/rna.2217810; RUBIN GM, 1982, CELL, V29, P987, DOI 10.1016/0092-8674(82)90462-7; SCHEINKER VS, 1990, P NATL ACAD SCI USA, V87, P9615, DOI 10.1073/pnas.87.24.9615; Schostak N, 2008, NUCLEIC ACIDS RES, V36, P2522, DOI 10.1093/nar/gkm1166; Slawson EE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r15; Sokolova M I, 2010, Ontogenez, V41, P451; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Vieira J, 1998, GENET RES, V71, P109, DOI 10.1017/S001667239800322X; Zakharenko LP, 2007, HEREDITY, V99, P525, DOI 10.1038/sj.hdy.6801029; Zelentsova H, 1999, CHROMOSOMA, V108, P443, DOI 10.1007/s004120050396	38	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21883	10.1371/journal.pone.0021883	http://dx.doi.org/10.1371/journal.pone.0021883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779346	Green Published, gold, Green Submitted			2022-12-25	WOS:000292680900013
J	Eronina, T; Borzova, V; Maloletkina, O; Kleymenov, S; Asryants, R; Markossian, K; Kurganov, B				Eronina, Tatyana; Borzova, Vera; Maloletkina, Olga; Kleymenov, Sergey; Asryants, Regina; Markossian, Kira; Kurganov, Boris			A Protein Aggregation Based Test for Screening of the Agents Affecting Thermostability of Proteins	PLOS ONE			English	Article							GLYCOGEN-PHOSPHORYLASE-B; RABBIT SKELETAL-MUSCLE; THERMAL AGGREGATION; ALPHA-CRYSTALLIN; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; GLOBULAR-PROTEINS; LIGHT-SCATTERING; BETA-LACTOGLOBULIN; MECHANISM; KINETICS	To search for agents affecting thermal stability of proteins, a test based on the registration of protein aggregation in the regime of heating with a constant rate was used. The initial parts of the dependences of the light scattering intensity (I) on temperature (T) were analyzed using the following empiric equation: I = K-agg(T-T-0)(2), where K-agg is the parameter characterizing the initial rate of aggregation and T-0 is a temperature at which the initial increase in the light scattering intensity is registered. The aggregation data are interpreted in the frame of the model assuming the formation of the start aggregates at the initial stages of the aggregation process. Parameter T-0 corresponds to the moment of the origination of the start aggregates. The applicability of the proposed approach was demonstrated on the examples of thermal aggregation of glycogen phosphorylase b from rabbit skeletal muscles and bovine liver glutamate dehydrogenase studied in the presence of agents of different chemical nature. The elaborated approach to the study of protein aggregation may be used for rapid identification of small molecules that interact with protein targets.	[Eronina, Tatyana; Borzova, Vera; Maloletkina, Olga; Markossian, Kira; Kurganov, Boris] Russian Acad Sci, Bach Inst Biochem, Moscow, Russia; [Kleymenov, Sergey] Russian Acad Sci, Koltsov Inst Dev Biol, Moscow, Russia; [Asryants, Regina] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; Lomonosov Moscow State University	Eronina, T (corresponding author), Russian Acad Sci, Bach Inst Biochem, Moscow, Russia.	eronina@inbi.ras.ru; kurganov@inbi.ras.ru	Kurganov, Boris/M-1286-2019; Borzova, Vera/F-4021-2017; Asryants, Regina/E-1348-2013; Kleymenov, Sergey/R-1195-2018	Borzova, Vera/0000-0003-1544-8804; Kurganov, Boris/0000-0002-2930-2286; Kleymenov, Sergey/0000-0001-5085-0327	Russian Foundation for Basic Research [11-04-00932-?, 11-04-01271-a, 11-04-01350-?]; Presidium of the Russian Academy of Sciences; Dmitry Zimin Dynasty Foundation; Federal Target Program "Scientific and Scientific-Pedagogical Personnel of Innovative Russia" [P1356]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Dmitry Zimin Dynasty Foundation; Federal Target Program "Scientific and Scientific-Pedagogical Personnel of Innovative Russia"	This study was funded by the Russian Foundation for Basic Research (grants 11-04-00932-?, 11-04-01271-a and 11-04-01350-?), the Program "Molecular and Cell Biology" of the Presidium of the Russian Academy of Sciences and Dmitry Zimin Dynasty Foundation, the Federal Target Program "Scientific and Scientific-Pedagogical Personnel of Innovative Russia" in 2009-2013 (the state contract No. P1356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aymard P, 1996, J CHIM PHYS PCB, V93, P987, DOI 10.1051/jcp/1996930987; Baussay K, 2004, INT J BIOL MACROMOL, V34, P21, DOI 10.1016/j.ijbiomac.2003.11.003; Bolen D W, 2001, Methods Mol Biol, V168, P17; Bumagina Z, 2010, INT J MOL SCI, V11, P4556, DOI 10.3390/ijms11114556; Bumagina ZM, 2010, BIOPHYS CHEM, V146, P108, DOI 10.1016/j.bpc.2009.11.002; Cellmer T, 2007, BIOPHYS CHEM, V125, P350, DOI 10.1016/j.bpc.2006.09.010; Chaitankar V, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S19; Chebotareva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1239, DOI 10.1007/s10541-005-0070-y; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; CHRUNYK BA, 1993, PROTEIN ENG, V6, P733, DOI 10.1093/protein/6.7.733; CHRUNYK BA, 1993, J BIOL CHEM, V268, P18053; DEYOUNG LR, 1993, ACCOUNTS CHEM RES, V26, P614, DOI 10.1021/ar00036a002; Durand D, 2002, PHYSICA A, V304, P253, DOI 10.1016/S0378-4371(01)00514-3; Duy C, 2005, J BIOL CHEM, V280, P37360, DOI 10.1074/jbc.M507530200; Eronina TB, 2010, BIOPOLYMERS, V93, P986, DOI 10.1002/bip.21508; Eronina TB, 2010, MACROMOL BIOSCI, V10, P768, DOI 10.1002/mabi.200900396; Eronina TB, 2009, BIOPHYS CHEM, V141, P66, DOI 10.1016/j.bpc.2008.12.007; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Golub N, 2007, FEBS LETT, V581, P4223, DOI 10.1016/j.febslet.2007.07.066; Golub NV, 2009, EUR BIOPHYS J BIOPHY, V38, P547, DOI 10.1007/s00249-009-0403-7; Ignatova Z, 2005, BIOCHEMISTRY-US, V44, P7266, DOI 10.1021/bi047404e; KASTENSCHMIDT LL, 1968, BIOCHEMISTRY-US, V7, P3590, DOI 10.1021/bi00850a037; Khanova HA, 2005, BIOCHEMISTRY-US, V44, P15480, DOI 10.1021/bi051175u; Khanova HA, 2007, BIOPHYS CHEM, V125, P521, DOI 10.1016/j.bpc.2006.11.002; KIRSCHENBAUM DM, 1972, INT J PROT RES, V4, P63; Kornilaev BA, 1996, BIOCHEM MOL BIOL INT, V38, P921; Kornilaev BA, 1996, BIOCHEMISTRY-MOSCOW+, V61, P628; Kornilaev BA, 1997, MOL BIOL+, V31, P82; KORNILAEV BA, 1997, DOKLADY BIOCH, V1352, P1; Kurganov BI, 2000, BIOCHEMISTRY-US, V39, P13144, DOI 10.1021/bi000975w; Kurganov BI, 1998, BIOCHEMISTRY-MOSCOW+, V63, P364; Le Bon C, 1999, MACROMOLECULES, V32, P6120, DOI 10.1021/ma9905775; Li Y, 2009, J PHYS CHEM B, V113, P7020, DOI 10.1021/jp8083088; Maloletkina OI, 2010, INT J BIOL MACROMOL, V46, P487, DOI 10.1016/j.ijbiomac.2010.03.008; Maloletkina OI, 2010, BIOPHYS CHEM, V148, P121, DOI 10.1016/j.bpc.2010.03.005; Markossian K. A., 2006, P89; Markossian KA, 2008, BBA-PROTEINS PROTEOM, V1784, P1286, DOI 10.1016/j.bbapap.2008.04.030; Markossian KA, 2006, BIOCHEMISTRY-US, V45, P13375, DOI 10.1021/bi0610707; Markossian KA, 2010, PROTEIN J, V29, P11, DOI 10.1007/s10930-009-9217-9; Markossian KA, 2009, INT J MOL SCI, V10, P1314, DOI 10.3390/ijms10031314; Mauro M, 2007, J MOL BIOL, V366, P258, DOI 10.1016/j.jmb.2006.11.008; Meremyanin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P518, DOI 10.1134/S0006297907050082; Meremyanin AV, 2008, BIOPOLYMERS, V89, P124, DOI 10.1002/bip.20872; *MICR INC, 1995, SCI EXP DAT FITT MIC; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Muranov KO, 2011, EXP EYE RES, V92, P76, DOI 10.1016/j.exer.2010.11.005; NODA L, 1955, METHOD ENZYMOL, V2, P605, DOI 10.1016/S0076-6879(55)02264-7; Panyukov Y, 2007, BIOPHYS CHEM, V127, P9, DOI 10.1016/j.bpc.2006.11.006; Philo JS, 2009, CURR PHARM BIOTECHNO, V10, P348, DOI 10.2174/138920109788488932; Pouzot M, 2004, MACROMOLECULES, V37, P614, DOI 10.1021/ma035117x; Privalov P L, 1986, Methods Enzymol, V131, P4; Putilina T, 2003, J BIOL CHEM, V278, P13747, DOI 10.1074/jbc.M208157200; Raibekas AA, 2008, ANAL BIOCHEM, V380, P331, DOI 10.1016/j.ab.2008.05.023; ROBERTS CJ, 2006, MISBEHAVING PROTEINS, P17; Sabbaghian M, 2009, INT J BIOL MACROMOL, V44, P156, DOI 10.1016/j.ijbiomac.2008.11.011; SCOPES RK, 1982, METHOD ENZYMOL, V90, P479; Senisterra GA, 2010, J BIOMOL SCREEN, V15, P314, DOI 10.1177/1087057109357117; Senisterra GA, 2006, J BIOMOL SCREEN, V11, P940, DOI 10.1177/1087057106294699; Speed MA, 1997, BIOTECHNOL BIOENG, V54, P333; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; SUGUNAKAR YP, 1996, BIOPHYS J, V70, P2888; Tomita S, 2011, BIOPOLYMERS, V95, P695, DOI 10.1002/bip.21637; Wang KY, 2003, BIOPHYS CHEM, V106, P97, DOI 10.1016/S0301-4622(03)00134-0; Weiss WF, 2009, J PHARM SCI-US, V98, P1246, DOI 10.1002/jps.21521	64	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22154	10.1371/journal.pone.0022154	http://dx.doi.org/10.1371/journal.pone.0022154			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760963	Green Published, gold, Green Submitted			2022-12-25	WOS:000292657200052
J	Trottier, J; Bialek, A; Caron, P; Straka, RJ; Milkiewicz, P; Barbier, O				Trottier, Jocelyn; Bialek, Andrzej; Caron, Patrick; Straka, Robert J.; Milkiewicz, Piotr; Barbier, Olivier			Profiling Circulating and Urinary Bile Acids in Patients with Biliary Obstruction before and after Biliary Stenting	PLOS ONE			English	Article							INTRAHEPATIC CHOLESTASIS; LITHOCHOLIC ACID; RAT-LIVER; FENOFIBRATE; EXPRESSION; GOLDN; TRIGLYCERIDE; ASSOCIATION; METABOLISM; PREGNANCY	Bile acids are considered as extremely toxic at the high concentrations reached during bile duct obstruction, but each acid displays variable cytotoxic properties. This study investigates how biliary obstruction and restoration of bile flow interferes with urinary and circulating levels of 17 common bile acids. Bile acids (conjugated and unconjugated) were quantified by liquid chromatography coupled with tandem mass spectrometry in serum and urine samples from 17 patients (8 men and 9 women) with biliary obstruction, before and after biliary stenting. Results were compared with serum concentrations measured in 40 age-and sex-paired control donors (20 men and 20 women). The total circulating bile acid concentration increases from 2.7 mu M in control donors to 156.9 mu M in untreated patients with biliary stenosis. Serum taurocholic and glycocholic acids exhibit 304- and 241-fold accumulations in patients with biliary obstruction compared to controls. The enrichment in chenodeoxycholic acid species reached a maximum of only 39-fold, while all secondary and 6 alpha-hydroxylated species -except taurolithocholic acids - were either unchanged or significantly reduced. Stenting was efficient in restoring an almost normal circulating profile and in reducing urinary bile acids. Conclusion: These results demonstrate that biliary obstruction affects differentially the circulating and/or urinary levels of the various bile acids. The observation that the most drastically affected acids correspond to the less toxic species supports the activation of self-protecting mechanisms aimed at limiting the inherent toxicity of bile acids in face of biliary obstruction.	[Trottier, Jocelyn; Caron, Patrick; Barbier, Olivier] CHUQ, Res Ctr, Mol Pharmacol Lab, Quebec City, PQ, Canada; [Trottier, Jocelyn; Caron, Patrick; Barbier, Olivier] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Bialek, Andrzej] Pomeranian Med Univ, Dept Gastroenterol, Szczecin, Poland; [Straka, Robert J.] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Milkiewicz, Piotr] Pomeranian Med Univ, Liver Unit, Szczecin, Poland; [Milkiewicz, Piotr] Pomeranian Med Univ, Liver Res Labs, Szczecin, Poland	Laval University; Laval University; Pomeranian Medical University; University of Minnesota System; University of Minnesota Twin Cities; Pomeranian Medical University; Pomeranian Medical University	Trottier, J (corresponding author), CHUQ, Res Ctr, Mol Pharmacol Lab, Quebec City, PQ, Canada.	olivier.barbier@crchul.ulaval.ca	Bialek, Andrzej/A-8135-2015	Barbier, Olivier/0000-0002-3067-1134; Straka, Robert/0000-0002-9541-7823; Milkiewicz, Piotr/0000-0002-1817-0724	Canadian Institutes of Health Research (CIHR) [MOP-84338, MSH95330]; Canadian Foundation for Innovation (CFI) [10469]; Fonds pour la Recherche en Sante du Quebec, FRSQ; NIH Heart, Lung and Blood Institute [U 01 HL72524]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072524] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds pour la Recherche en Sante du Quebec, FRSQ(Fonds de la Recherche en Sante du Quebec); NIH Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the Canadian Institutes of Health Research (CIHR; grant #MOP-84338) and the Canadian Foundation for Innovation (CFI, grant #10469). J. Trottier is holder of a CIHR Scholarship. O. Barbier is holder of a salary grant from the CIHR (New investigator award #MSH95330) and the "Fonds pour la Recherche en Sante du Quebec, FRSQ" (Junior 2 Scholarship). The GOLDN study was supported by the NIH Heart, Lung and Blood Institute Grant U 01 HL72524 Genetic and Environmental Determinants of Triglycerides. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araya Z, 1999, BBA-MOL CELL BIOL L, V1438, P47, DOI 10.1016/S1388-1981(99)00031-1; Baiocchi L, 2008, TRANSPL INT, V21, P792, DOI 10.1111/j.1432-2277.2008.00682.x; Bairaktari E, 2001, HEPATOLOGY, V33, P1365, DOI 10.1053/jhep.2001.25089; Basiglio CL, 2010, CHEM-BIOL INTERACT, V188, P386, DOI 10.1016/j.cbi.2010.08.004; Bodin K, 2005, BBA-MOL CELL BIOL L, V1687, P84, DOI 10.1016/j.bbalip.2004.11.003; Chijiiwa K, 2002, WORLD J SURG, V26, P457; Hirano F, 2006, J GASTROEN HEPATOL, V21, P1807, DOI 10.1111/j.1440-1746.2006.04363.x; Hofmann AF, 2004, DRUG METAB REV, V36, P703, DOI 10.1081/DMR-200033475; Hofmann AF, 1999, NEWS PHYSIOL SCI, V14, P24, DOI 10.1152/physiologyonline.1999.14.1.24; Hunt MC, 2000, J BIOL CHEM, V275, P28947, DOI 10.1074/jbc.M002782200; KRAHENBUHL S, 1994, HEPATOLOGY, V20, P1595, DOI 10.1002/hep.1840200632; Lai CQ, 2007, ARTERIOSCL THROM VAS, V27, P1417, DOI 10.1161/ATVBAHA.107.140103; Mann DV, 2002, GUT, V50, P118, DOI 10.1136/gut.50.1.118; Monte MJ, 2009, WORLD J GASTROENTERO, V15, P804, DOI 10.3748/wjg.15.804; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Pusl T, 2008, BIOCHEM BIOPH RES CO, V367, P208, DOI 10.1016/j.bbrc.2007.12.122; Rust C, 2000, J BIOL CHEM, V275, P20210, DOI 10.1074/jbc.M909992199; Schaap FG, 2009, HEPATOLOGY, V49, P1228, DOI 10.1002/hep.22771; Sharma R, 2010, BIOORGAN MED CHEM, V18, P6886, DOI 10.1016/j.bmc.2010.07.030; Shen J, 2008, DIABETES CARE, V31, P910, DOI 10.2337/dc07-1687; Shoda J, 2001, AM J GASTROENTEROL, V96, P3368; Smith JA, 2008, EUR J HUM GENET, V16, P603, DOI 10.1038/sj.ejhg.5202003; Torchia EC, 1997, EUR J CELL BIOL, V74, P190; Torchia EC, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-11; Tribe RM, 2010, AM J GASTROENTEROL, V105, P585, DOI 10.1038/ajg.2009.633; TROTTIER J, CLIN PHARM IN PRESS; Trottier J, 2006, MOL PHARMACEUT, V3, P212, DOI 10.1021/mp060020t; VYVODA OS, 1977, BIOCHIM BIOPHYS ACTA, V465, P68, DOI 10.1016/0005-2736(77)90356-X; Wimmer R, 2008, GUT, V57, P1448, DOI 10.1136/gut.2007.140871; Wojczynski MK, 2010, J LIPID RES, V51, P3316, DOI 10.1194/jlr.P001834; YANAGISAWA J, 1989, Gastroenterologia Japonica, V24, P156; Ye L, 2007, J CHROMATOGR B, V860, P10, DOI 10.1016/j.jchromb.2007.09.031	32	64	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22094	10.1371/journal.pone.0022094	http://dx.doi.org/10.1371/journal.pone.0022094			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760958	Green Published, gold, Green Submitted			2022-12-25	WOS:000292657200047
J	Bralten, LB; Nouwens, S; Kockx, C; Erdem, L; Hoogenraad, CC; Kros, JM; Moorhouse, MJ; Smitt, PAS; van der Spek, P; van Ijcken, W; Stubbs, A; French, PJ				Bralten, Linda B.; Nouwens, Stephan; Kockx, Christel; Erdem, Lale; Hoogenraad, Casper C.; Kros, Johan M.; Moorhouse, Michael J.; Smitt, Peter A. Sillevis; van der Spek, Peter; van Ijcken, Wilfred; Stubbs, Andrew; French, Pim J.			Absence of Common Somatic Alterations in Genes on 1p and 19q in Oligodendrogliomas	PLOS ONE			English	Article							CANDIDATE TUMOR-SUPPRESSOR; CANCER; MUTATIONS; IDH1; IDENTIFICATION; RESTORATION; SURVIVAL; REGION; GLIOMA; 10Q	A common and histologically well defined subtype of glioma are the oligodendroglial brain tumors. Approximately 70% of all oligodendrogliomas have a combined loss of the entire 1p and 19q chromosomal arms. This remarkably high frequency suggests that the remaining arms harbor yet to be identified tumor suppressor genes. Identification of these causal genetic changes in oligodendrogliomas is important because they form direct targets for treatment. In this study we therefore performed targeted resequencing of all exons, microRNAs, splice sites and promoter regions residing on 1p and 19q on 7 oligodendrogliomas and 4 matched controls. Only one missense mutation was identified in a single sample in the ARHGEF16 gene. This mutation lies within-and disrupts the conserved PDZ binding domain. No similar ARHGEF16 mutations or deletions were found in a larger set of oligodendrogliomas. The absence of common somatic changes within genes located on 1p and 19q in three out of four samples indicates that no additional "second hit'' is required to drive oncogenic transformation on either chromosomal arm.	[Bralten, Linda B.; Erdem, Lale; Smitt, Peter A. Sillevis; French, Pim J.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Nouwens, Stephan; Moorhouse, Michael J.; van der Spek, Peter; Stubbs, Andrew] Erasmus MC, Dept Bioinformat, Rotterdam, Netherlands; [Kockx, Christel; van Ijcken, Wilfred] Erasmus MC, Ctr Biom, Rotterdam, Netherlands; [Hoogenraad, Casper C.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Kros, Johan M.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Bralten, LB (corresponding author), Erasmus MC, Dept Neurol, Rotterdam, Netherlands.	p.french@erasmusmc.nl	van ijcken, willem/N-9805-2018	van ijcken, willem/0000-0002-0421-8301; Hoogenraad, Casper/0000-0002-2666-0758; French, Pim/0000-0002-0668-9529; Kockx, Christel/0000-0002-8871-3659	Erasmus MC [2006, 2008]	Erasmus MC	This work was supported by Erasmus MC grants 2006 and 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2005, CANCER RES, V65, P2565, DOI 10.1158/0008-5472.CAN-04-4283; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Barbashina V, 2005, CLIN CANCER RES, V11, P1119; Bralten LBC, 2011, ANN NEUROL, V69, P455, DOI 10.1002/ana.22390; Bralten LBC, 2010, GENE CHROMOSOME CANC, V49, P509, DOI 10.1002/gcc.20760; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; FIGUEROA ME, CANC CELL, V18, P553; French PJ, 2007, CANCER RES, V67, P5635, DOI 10.1158/0008-5472.CAN-06-2869; French PJ, 2005, CANCER RES, V65, P11335, DOI 10.1158/0008-5472.CAN-05-1886; Gravendeel LAM, 2010, HUM MUTAT, V31, pE1186, DOI 10.1002/humu.21201; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hampson L, 2009, BRIT J CANCER, V101, P829, DOI 10.1038/sj.bjc.6605208; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Kloosterhof NK, 2011, LANCET ONCOL, V12, P83, DOI 10.1016/S1470-2045(10)70053-X; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Riemenschneider MJ, 2008, INT J CANCER, V122, P2503, DOI 10.1002/ijc.23409; Taby R, 2010, CA-CANCER J CLIN, V60, P376, DOI 10.3322/caac.20085; Tews B, 2006, INT J CANCER, V119, P792, DOI 10.1002/ijc.21901; Thiessen B, 2003, J NEURO-ONCOL, V64, P271, DOI 10.1023/A:1025689004046; Ueki K, 2002, CLIN CANCER RES, V8, P196; van den Bent MJ, 2003, J CLIN ONCOL, V21, P2525, DOI 10.1200/JCO.2003.12.015; van den Bent MJ, 2003, CANCER-AM CANCER SOC, V97, P1276, DOI 10.1002/cncr.11187; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2008, CANCER RES, V68, P3086; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014	37	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e22000	10.1371/journal.pone.0022000	http://dx.doi.org/10.1371/journal.pone.0022000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760942	Green Published, gold, Green Submitted			2022-12-25	WOS:000292655400037
J	Bardaweel, S; Ghosh, B; Chou, TF; Sadowsky, MJ; Wagner, CR				Bardaweel, Sanaa; Ghosh, Brahma; Chou, Tsui-Fen; Sadowsky, Michael J.; Wagner, Carston R.			E. coli Histidine Triad Nucleotide Binding Protein 1 (ecHinT) Is a Catalytic Regulator of D-Alanine Dehydrogenase (DadA) Activity In Vivo	PLOS ONE			English	Article							AMINO-ACID DEHYDROGENASE; ESCHERICHIA-COLI; PHENOTYPE MICROARRAYS; SUBSTRATE-SPECIFICITY; MYCOPLASMA-HOMINIS; HINT; PHOSPHORAMIDASE; SUPERFAMILY; EXPRESSION; INDUCTION	Histidine triad nucleotide binding proteins (Hints) are highly conserved members of the histidine triad (HIT) protein superfamily. Hints comprise the most ancient branch of this superfamily and can be found in Archaea, Bacteria, and Eukaryota. Prokaryotic genomes, including a wide diversity of both Gram-negative and Gram-positive bacteria, typically have one Hint gene encoded by hinT (ycfF in E. coli). Despite their ubiquity, the foundational reason for the wide-spread conservation of Hints across all kingdoms of life remains a mystery. In this study, we used a combination of phenotypic screening and complementation analyses with wild-type and hinT knock-out Escherichia coli strains to show that catalytically active ecHinT is required in E. coli for growth on D-alanine as a sole carbon source. We demonstrate that the expression of catalytically active ecHinT is essential for the activity of the enzyme D-alanine dehydrogenase (DadA) (equivalent to D-amino acid oxidase in eukaryotes), a necessary component of the D-alanine catabolic pathway. Site-directed mutagenesis studies revealed that catalytically active C-terminal mutants of ecHinT are unable to activate DadA activity. In addition, we have designed and synthesized the first cell-permeable inhibitor of ecHinT and demonstrated that the wild-type E. coli treated with the inhibitor exhibited the same phenotype observed for the hinT knock-out strain. These results reveal that the catalytic activity and structure of ecHinT is essential for DadA function and therefore alanine metabolism in E. coli. Moreover, they provide the first biochemical evidence linking the catalytic activity of this ubiquitous protein to the biological function of Hints in Escherichia coli.	[Bardaweel, Sanaa; Ghosh, Brahma; Chou, Tsui-Fen; Wagner, Carston R.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Sadowsky, Michael J.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; [Sadowsky, Michael J.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bardaweel, S (corresponding author), Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA.	sadowsky@umn.edu; wagne003@umn.edu	Sadowsky, Michael/J-2507-2016; Bardaweel, Sanaa/C-2556-2015	Sadowsky, Michael/0000-0001-8779-2781; Ghosh, Brahma/0000-0003-2288-8293	University of Minnesota	University of Minnesota(University of Minnesota System)	Funding was provided by the University of Minnesota. No external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON JLA, 1983, EUR J BIOCHEM, V134, P77, DOI 10.1111/j.1432-1033.1983.tb07533.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bardaweel S, 2010, J MOL BIOL, V404, P627, DOI 10.1016/j.jmb.2010.09.066; Bieganowski P, 2002, J BIOL CHEM, V277, P10852, DOI 10.1074/jbc.M111480200; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Brenner C, 1999, J CELL PHYSIOL, V181, P179, DOI 10.1002/(SICI)1097-4652(199911)181:2<179::AID-JCP1>3.0.CO;2-8; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Chou TF, 2005, J BIOL CHEM, V280, P15356, DOI 10.1074/jbc.M500434200; Chou TF, 2007, BIOCHEMISTRY-US, V46, P13074, DOI 10.1021/bi701244h; Chou TF, 2007, MOL PHARMACEUT, V4, P208, DOI 10.1021/mp060070y; Chou TF, 2007, J BIOL CHEM, V282, P4719, DOI 10.1074/jbc.M610530200; Deutch CE, 2004, FEMS MICROBIOL LETT, V238, P383, DOI 10.1016/j.femsle.2004.08.001; FRANKLIN FCH, 1976, MOL GEN GENET, V149, P229, DOI 10.1007/BF00332894; Hopfe M, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-46; Hsieh SY, 2009, J PROTEOME RES, V8, P3977, DOI 10.1021/pr900289g; Ito M, 2005, METAB ENG, V7, P318, DOI 10.1016/j.ymben.2005.06.004; Kitzerow A, 2001, MOL MICROBIOL, V41, P279, DOI 10.1046/j.1365-2958.2001.02524.x; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Korsisaari N, 2000, J BIOL CHEM, V275, P34837, DOI 10.1074/jbc.C000505200; Korsisaari N, 2003, MOL CELL BIOL, V23, P3929, DOI 10.1128/MCB.23.11.3929-3935.2003; Li H, 2006, ONCOGENE, V25, P713, DOI 10.1038/sj.onc.1209111; Lima CD, 1996, P NATL ACAD SCI USA, V93, P5357, DOI 10.1073/pnas.93.11.5357; LOBOCKA M, 1994, J BACTERIOL, V176, P1500, DOI 10.1128/jb.176.5.1500-1510.1994; Martin J, 2011, HEPATOLOGY, V53, P243, DOI 10.1002/hep.23978; OLSIEWSKI PJ, 1980, J BIOL CHEM, V255, P4487; Pollegioni L, 2007, CELL MOL LIFE SCI, V64, P1373, DOI 10.1007/s00018-007-6558-4; RAUNIO RP, 1973, J BACTERIOL, V115, P560, DOI 10.1128/JB.115.2.560-566.1973; Sambrook J.E.F., 1989, MOL CLONING LAB MANU, P1659; Su T, 2003, P NATL ACAD SCI USA, V100, P7824, DOI 10.1073/pnas.1332160100; WALSH CT, 1989, J BIOL CHEM, V264, P2393; Weiske J, 2005, J CELL SCI, V118, P3117, DOI 10.1242/jcs.02437; YASUDA Y, 1985, MICROBIOL IMMUNOL, V29, P229, DOI 10.1111/j.1348-0421.1985.tb00822.x; Yuan BZ, 2004, NEOPLASIA, V6, P412, DOI 10.1593/neo.03490	34	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e20897	10.1371/journal.pone.0020897	http://dx.doi.org/10.1371/journal.pone.0020897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754980	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000292632000004
J	Lu, SX; Kappel, LW; Charbonneau-Allard, AM; Atallah, R; Holland, AM; Turbide, C; Hubbard, VM; Rotolo, JA; Smith, M; Suh, D; King, C; Rao, UK; Yim, N; Bautista, JL; Jenq, RR; Penack, O; Na, IK; Liu, C; Murphy, G; Alpdogan, O; Blumberg, RS; Macian, F; Holmes, KV; Beauchemin, N; van den Brink, MRM				Lu, Sydney X.; Kappel, Lucy W.; Charbonneau-Allard, Anne-Marie; Atallah, Renee; Holland, Amanda M.; Turbide, Claire; Hubbard, Vanessa M.; Rotolo, Jimmy A.; Smith, Marsinay; Suh, David; King, Christopher; Rao, Uttam K.; Yim, Nury; Bautista, Johanne L.; Jenq, Robert R.; Penack, Olaf; Na, Il-Kang; Liu, Chen; Murphy, George; Alpdogan, Onder; Blumberg, Richard S.; Macian, Fernando; Holmes, Kathryn V.; Beauchemin, Nicole; van den Brink, Marcel R. M.			Ceacam1 Separates Graft-versus-Host-Disease from Graft-versus-Tumor Activity after Experimental Allogeneic Bone Marrow Transplantation	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; CARCINOEMBRYONIC ANTIGEN FAMILY; ALLOREACTIVE T-CELLS; BILIARY GLYCOPROTEIN; C-CAM; TAP2-DEFICIENT PATIENTS; SUPPRESSOR GENES; HUMAN-MELANOMA; GROWTH-FACTOR; NK CELLS	Background: Allogeneic bone marrow transplantation (allo-BMT) is a potentially curative therapy for a variety of hematologic diseases, but benefits, including graft-versus-tumor (GVT) activity are limited by graft-versus-host-disease (GVHD). Carcinoembryonic antigen related cell adhesion molecule 1 (Ceacam1) is a transmembrane glycoprotein found on epithelium, T cells, and many tumors. It regulates a variety of physiologic and pathological processes such as tumor biology, leukocyte activation, and energy homeostasis. Previous studies suggest that Ceacam1 negatively regulates inflammation in inflammatory bowel disease models. Methods: We studied Ceacam1 as a regulator of GVHD and GVT after allogeneic bone marrow transplantation (allo-BMT) in mouse models. In vivo, Ceacam1(-/-) T cells caused increased GVHD mortality and GVHD of the colon, and greater numbers of donor T cells were positive for activation markers (CD25(hi), CD62L(lo)). Additionally, Ceacam1(-/-) CD8 T cells had greater expression of the gut-trafficking integrin alpha(4)beta(7), though both CD4 and CD8 T cells were found increased numbers in the gut post-transplant. Ceacam1(-/-) recipients also experienced increased GVHD mortality and GVHD of the colon, and alloreactive T cells displayed increased activation. Additionally, Ceacam1(-/-) mice had increased mortality and decreased numbers of regenerating small intestinal crypts upon radiation exposure. Conversely, Ceacam1-overexpressing T cells caused attenuated target-organ and systemic GVHD, which correlated with decreased donor T cell numbers in target tissues, and mortality. Finally, graft-versus-tumor survival in a Ceacam1(+) lymphoma model was improved in animals receiving Ceacam1(-/-) vs. control T cells. Conclusions: We conclude that Ceacam1 regulates T cell activation, GVHD target organ damage, and numbers of donor T cells in lymphoid organs and GVHD target tissues. In recipients of allo-BMT, Ceacam1 may also regulate tissue radiosensitivity. Because of its expression on both the donor graft and host tissues, this suggests that targeting Ceacam1 may represent a potent strategy for the regulation of GVHD and GVT after allogeneic transplantation.	[Lu, Sydney X.; Kappel, Lucy W.; Holland, Amanda M.; Hubbard, Vanessa M.; Smith, Marsinay; Suh, David; King, Christopher; Rao, Uttam K.; Yim, Nury; Bautista, Johanne L.; Jenq, Robert R.; Penack, Olaf; Na, Il-Kang; Alpdogan, Onder; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Immunol & Med, New York, NY 10021 USA; [Kappel, Lucy W.; Holland, Amanda M.] Weill Cornell Grad Sch Med Sci, Dept Immunol, New York, NY USA; [Charbonneau-Allard, Anne-Marie; Atallah, Renee; Turbide, Claire; Beauchemin, Nicole] McGill Canc Ctr, Goodman Canc Ctr, Montreal, PQ, Canada; [Charbonneau-Allard, Anne-Marie; Atallah, Renee; Turbide, Claire; Beauchemin, Nicole] McGill Canc Ctr, Dept Biochem, Montreal, PQ, Canada; [Charbonneau-Allard, Anne-Marie; Atallah, Renee; Turbide, Claire; Beauchemin, Nicole] McGill Canc Ctr, Dept Med, Montreal, PQ, Canada; [Charbonneau-Allard, Anne-Marie; Atallah, Renee; Beauchemin, Nicole] McGill Canc Ctr, Dept Oncol, Montreal, PQ, Canada; [Hubbard, Vanessa M.; Macian, Fernando] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Rotolo, Jimmy A.] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10021 USA; [Penack, Olaf; Na, Il-Kang] Charite CBF Univ Med Berlin, Dept Hematol & Oncol, Berlin, Germany; [Liu, Chen] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL USA; [Murphy, George] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Alpdogan, Onder] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Blumberg, Richard S.] Brigham & Womens Hosp, Dept Gastroenterol, Boston, MA 02115 USA; [Holmes, Kathryn V.] Univ Colorado, Dept Microbiol, Sch Med, Aurora, CO USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; McGill University; McGill University; McGill University; McGill University; Yeshiva University; Albert Einstein College of Medicine; Memorial Sloan Kettering Cancer Center; State University System of Florida; University of Florida; Harvard University; Brigham & Women's Hospital; Yale University; Harvard University; Brigham & Women's Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus	Lu, SX (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Immunol & Med, 1275 York Ave, New York, NY 10021 USA.	vandenbm@mskcc.org	van den Brink, Marcel R. M./HGB-9434-2022; Penack, Olaf/L-1068-2016	Penack, Olaf/0000-0003-4876-802X; Rotolo, Jim/0000-0003-4195-6167; Na, Il-Kang/0000-0001-9902-5424; Macian, Fernando/0000-0003-2666-035X; Lu, Sydney/0000-0002-2217-1674	National Institutes of Health [RO1-HL069929, RO1-CA107096, RO1-AI080455, PO1-CA33049, R01-HL095075, P20-CA103694]; US Department of Defense [W81XWH-09-1-0294]; Radiation Effects Research Foundation (RERF-NIAID); Ryan Gibson Foundation (Dallas, TX); Elsa U. Pardee Foundation (Midland, MI); Byrne Foundation (Etna, NH); Emerald Foundation (New York, NY); Mr. William H. Goodwin and Mrs. Alice Goodwin, Alex's Lemonade Stand; Commonwealth Foundation for Cancer Research (Richmond, VA); Bobby Zucker Memorial Fund (Phoenixville, PA); Lymphoma Foundation (New York, NY); Canadian Institutes of Health Reseach; National Marrow Donor Program (NMDP); Marrow Foundation; Deutsche Krebshilfe, Mildred-Scheel-Stiftung; Deutsche Forschungsgemeinschaft; NATIONAL CANCER INSTITUTE [R01CA107096, P01CA033049, P20CA103694, P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069929, R01HL095075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080455, R01AI059738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Radiation Effects Research Foundation (RERF-NIAID); Ryan Gibson Foundation (Dallas, TX); Elsa U. Pardee Foundation (Midland, MI); Byrne Foundation (Etna, NH); Emerald Foundation (New York, NY); Mr. William H. Goodwin and Mrs. Alice Goodwin, Alex's Lemonade Stand; Commonwealth Foundation for Cancer Research (Richmond, VA); Bobby Zucker Memorial Fund (Phoenixville, PA); Lymphoma Foundation (New York, NY); Canadian Institutes of Health Reseach; National Marrow Donor Program (NMDP); Marrow Foundation; Deutsche Krebshilfe, Mildred-Scheel-Stiftung(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health grants RO1-HL069929 (MvdB), RO1-CA107096 (MvdB), RO1-AI080455 (MvdB), PO1-CA33049 (MvdB) and R01-HL095075 (MvdB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Support was also received from the US Department of Defense: USAMRAA Award W81XWH-09-1-0294 (MvdB), the Radiation Effects Research Foundation (RERF-NIAID) (MvdB). Support was also received from the Ryan Gibson Foundation (Dallas, TX), the Elsa U. Pardee Foundation (Midland, MI), the Byrne Foundation (Etna, NH), the Emerald Foundation (New York, NY), and The Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center funded by Mr. William H. Goodwin and Mrs. Alice Goodwin, Alex's Lemonade Stand, and The Peter Solomon Fund the Commonwealth Foundation for Cancer Research (Richmond, VA), The Bobby Zucker Memorial Fund (Phoenixville, PA) and The Lymphoma Foundation (New York, NY). NB is supported by the Canadian Institutes of Health Reseach. OA is the recipient of an Amy Strelzer Manasevit Scholar Award from The National Marrow Donor Program (NMDP) and The Marrow Foundation and is supported by grant P20-CA103694 from the National Institutes of Health. IKN is supported by the Deutsche Krebshilfe, Mildred-Scheel-Stiftung. OP is supported by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Rjaily GA, 2004, J CLIN INVEST, V114, P944, DOI 10.1172/JCI200421786; Bamberger AM, 2002, VIRCHOWS ARCH, V440, P139, DOI 10.1007/s00428-001-0554-0; Beauchemin N, 1999, EXP CELL RES, V252, P243; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; CANMAN CE, 1995, SEMIN CANCER BIOL, V6, P17, DOI 10.1006/scbi.1995.0003; Carrasco M, 2000, ANN HEMATOL, V79, P299, DOI 10.1007/s002779900146; Donda A, 2000, EUR J IMMUNOL, V30, P2593, DOI 10.1002/1521-4141(200009)30:9<2593::AID-IMMU2593>3.0.CO;2-0; Dutt S, 2005, BLOOD, V106, P4009, DOI 10.1182/blood-2005-06-2339; Ergun S, 2000, MOL CELL, V5, P311, DOI 10.1016/S1097-2765(00)80426-8; Ferrara J L, 1999, Biol Blood Marrow Transplant, V5, P347, DOI 10.1016/S1083-8791(99)70011-X; Ferrara JLM, 2006, SEMIN HEMATOL, V43, P3, DOI 10.1053/j.seminhematol.2005.09.001; GAGNETEN S, 1995, J VIROL, V69, P889, DOI 10.1128/JVI.69.2.889-895.1995; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Gray-Owen SD, 1997, MOL MICROBIOL, V26, P971, DOI 10.1046/j.1365-2958.1997.6342006.x; Hemmila E, 2004, J VIROL, V78, P10156, DOI 10.1128/JVI.78.18.10156-10165.2004; Hill GR, 2000, BLOOD, V95, P2754, DOI 10.1182/blood.V95.9.2754.009k25_2754_2759; HSIEH JT, 1995, CANCER RES, V55, P190; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Hunter I, 1998, FEBS LETT, V425, P141, DOI 10.1016/S0014-5793(98)00223-3; Iijima H, 2004, J EXP MED, V199, P471, DOI 10.1084/jem.20030437; Kammerer R, 2004, J PATHOL, V204, P258, DOI 10.1002/path.1657; KUIJPERS TW, 1992, J CELL BIOL, V118, P457, DOI 10.1083/jcb.118.2.457; Laack E, 2002, J CLIN ONCOL, V20, P4279, DOI 10.1200/JCO.2002.08.067; Leung N, 2008, ONCOGENE, V27, P4943, DOI 10.1038/onc.2008.136; LEUSCH HG, 1991, ZBL BAKT-INT J MED M, V275, P118; Markel G, 2004, BLOOD, V103, P1770, DOI 10.1182/blood-2003-06-2114; Markel G, 2004, EUR J IMMUNOL, V34, P2138, DOI 10.1002/eji.200425021; Markel G, 2004, J IMMUNOL, V173, P3732, DOI 10.4049/jimmunol.173.6.3732; Markel G, 2002, J IMMUNOL, V168, P2803, DOI 10.4049/jimmunol.168.6.2803; Markel G, 2002, J CLIN INVEST, V110, P943, DOI 10.1172/JCI200215643; Morales VM, 1999, J IMMUNOL, V163, P1363; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Nakajima A, 2002, J IMMUNOL, V168, P1028, DOI 10.4049/jimmunol.168.3.1028; Nittka S, 2004, ONCOGENE, V23, P9306, DOI 10.1038/sj.onc.1208259; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; OCKLIND C, 1982, J BIOL CHEM, V257, P6788; Park SY, 2006, AM J PHYSIOL-ENDOC M, V291, pE517, DOI 10.1152/ajpendo.00077.2006; Petrovic A, 2004, BLOOD, V103, P1542, DOI 10.1182/blood-2003-03-0957; Pomp J, 1996, RADIAT RES, V146, P374, DOI 10.2307/3579299; Prall F, 1996, J HISTOCHEM CYTOCHEM, V44, P35, DOI 10.1177/44.1.8543780; Reddy P, 2003, HEMATOL ONCOL, V21, P149, DOI 10.1002/hon.716; Reddy P, 2003, BLOOD REV, V17, P187, DOI 10.1016/S0268-960X(03)00009-2; ROJAS M, 1990, CELL GROWTH DIFFER, V1, P527; Singer BB, 2002, J IMMUNOL, V168, P5139, DOI 10.4049/jimmunol.168.10.5139; Waldman E, 2006, BLOOD, V107, P1703, DOI 10.1182/blood-2005-08-3445	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21611	10.1371/journal.pone.0021611	http://dx.doi.org/10.1371/journal.pone.0021611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21760897	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000292632000017
J	Saini, V; Staren, DM; Ziarek, JJ; Nashaat, ZN; Campbell, EM; Volkman, BF; Marchese, A; Majetschak, M				Saini, Vikas; Staren, Daniel M.; Ziarek, Joshua J.; Nashaat, Zayd N.; Campbell, Edward M.; Volkman, Brian F.; Marchese, Adriano; Majetschak, Matthias			The CXC Chemokine Receptor 4 Ligands Ubiquitin and Stromal Cell-derived Factor-1 alpha Function through Distinct Receptor Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MOLECULAR-PATTERN MOLECULES; EXTRACELLULAR UBIQUITIN; EXOGENOUS UBIQUITIN; FACTOR-I; LYMPHOCYTE CHEMOATTRACTANT; ARRESTIN-2 INTERACTS; T-LYMPHOCYTES; BINDING; INJURY	Recently, we identified extracellular ubiquitin as an endogenous CXC chemokine receptor (CXCR) 4 agonist. However, the receptor selectivity and molecular basis of the CXCR4 agonist activity of ubiquitin are unknown, and functional consequences of CXCR4 activation with ubiquitin are poorly defined. Here, we provide evidence that ubiquitin and the cognate CXCR4 ligand stromal cell-derived factor (SDF)-1 alpha do not share CXCR7 as a receptor. We further demonstrate that ubiquitin does not utilize the typical two-site binding mechanism of chemokine-receptor interactions, in which the receptor N terminus is important for ligand binding. CXCR4 activation with ubiquitin and SDF-1 alpha lead to similar G alpha(1)-iresponses and to a comparable magnitude of phosphorylation of ERK-1/2, p90 ribosomal S6 kinase-l and Akt, although phosphorylations occur more transiently after activation with ubiquitin. Despite the similarity of signal transduction events after activation of CXCR4 with both ligands, ubiquitin possesses weaker chemotactic activity than SDF-l alpha in cell migration assays and does not interfere with productive entry of HIV-1 into P4.R5 multinuclear activation of galactosidase indicator cells. Unlike SDF-1 alpha, ubiquitin lacks interactions with an N-terminal CXCR4 peptide in NMR spectroscopy experiments. Binding and signaling studies in the presence of antibodies against the N terminus and extracellular loops 2/3 of CXCR4 confirm that the ubiquitin CXCR4 interaction is independent of the N-terminal receptor domain, whereas blockade of extracellular loops 2/3 prevents receptor binding and activation. Our findings define ubiquitin as a CXCR4 agonist, which does not interfere with productive cellular entry of HIV-1, and provide new mechanistic insights into interactions between CXCR4 and its natural ligands.	[Saini, Vikas; Staren, Daniel M.; Majetschak, Matthias] Loyola Univ Chicago, Stritch Sch Med, Burn & Shock Trauma Inst, Dept Surg, Maywood, IL 60153 USA; [Nashaat, Zayd N.; Campbell, Edward M.] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA; [Marchese, Adriano; Majetschak, Matthias] Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Ziarek, Joshua J.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Medical College of Wisconsin	Majetschak, M (corresponding author), 2160 S 1st Ave, Maywood, IL 60153 USA.	mmajetschak@lumc.edu	Volkman, Brian F./ABE-7312-2020; Volkman, Brian F./ABE-7306-2020	Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179; Ziarek, Joshua/0000-0002-3740-9999	U.S. Army Medical Research and Materiel Command (USAMRMC); Telemedicine and Advanced Technology Research Center (TATRC), at Fort Detrick, MD [W81XWH1020122]; National Institutes of Health [GM075159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075159] Funding Source: NIH RePORTER	U.S. Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Telemedicine and Advanced Technology Research Center (TATRC), at Fort Detrick, MD; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant that was awarded and administered by the U.S. Army Medical Research and Materiel Command (USAMRMC) and the Telemedicine and Advanced Technology Research Center (TATRC), at Fort Detrick, MD, under Contract Number W81XWH1020122 (to M. M.). This work was also supported in part by National Institutes of Health Grant GM075159 (to A. M.). The therapeutic use of ubiquitin has been patented (US patent # 7,262,162) and M. M. is an inventor. M. M. has not received any income related to the patent.	Ahn HC, 2009, EXP NEUROL, V220, P120, DOI 10.1016/j.expneurol.2009.07.031; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Bosier B, 2010, BIOCHEM PHARMACOL, V80, P1, DOI 10.1016/j.bcp.2010.02.013; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Cai DQ, 2004, ARCH BIOCHEM BIOPHYS, V425, P42, DOI 10.1016/j.abb.2004.02.027; Campbell EM, 2004, J VIROL, V78, P5745, DOI 10.1128/JVI.78.11.5745-5755.2004; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Di Salvo J, 2000, EUR J PHARMACOL, V409, P143, DOI 10.1016/S0014-2999(00)00846-3; Doranz BJ, 1999, J VIROL, V73, P2752, DOI 10.1128/JVI.73.4.2752-2761.1999; Earle SA, 2005, SURGERY, V138, P431, DOI 10.1016/j.surg.2005.06.026; Earle SA, 2006, TRANSPLANTATION, V82, P1544, DOI 10.1097/01.tp.0000236057.56721.d0; Ethier MF, 1996, AM J PHYSIOL-LUNG C, V270, pL199, DOI 10.1152/ajplung.1996.270.2.L199; FAN H, 2011, INFLAMMATION; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Garcia-Covarrubias L, 2008, CRIT CARE MED, V36, P979, DOI 10.1097/CCM.0B013E318164E417; Gifford AN, 1999, J PHARMACOL EXP THER, V288, P478; Gozansky EK, 2005, J MOL BIOL, V345, P651, DOI 10.1016/j.jmb.2004.11.003; Griebenow M, 2007, J NEUROTRAUM, V24, P1529, DOI 10.1089/neu.2007.0306; Gupta SK, 2001, IMMUNOL LETT, V78, P29, DOI 10.1016/S0165-2478(01)00228-0; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hesselgesser J, 1998, J IMMUNOL, V160, P877; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; Hudson BD, 2010, MOL PHARMACOL, V77, P1, DOI 10.1124/mol.109.060251; Karin N, 2010, J LEUKOCYTE BIOL, V88, P463, DOI 10.1189/jlb.0909602; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Kuritzkes DR, 2009, CURR OPIN HIV AIDS, V4, P82, DOI 10.1097/COH.0b013e328322402e; Lee Y, 2002, BLOOD, V99, P4307, DOI 10.1182/blood.V99.12.4307; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Li MC, 2010, CELL REPROGRAM, V12, P405, DOI 10.1089/cell.2009.0088; Loetscher P, 1998, J BIOL CHEM, V273, P22279, DOI 10.1074/jbc.273.35.22279; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Majetschak M, 2006, IMMUNOL CELL BIOL, V84, P59, DOI 10.1111/j.1440-1711.2005.01399.x; Majetschak M, 2004, SURGERY, V135, P536, DOI 10.1016/j.surg.2003.09.006; Majetschak M, 2004, J TRAUMA, V56, P991, DOI 10.1097/01.TA.0000127770.29009.5A; Majetschak M, 2003, BLOOD, V101, P1882, DOI 10.1182/blood-2002-03-0918; Majetschak M, 2008, J TRAUMA, V64, P586, DOI 10.1097/TA.0b013e3181641bc5; Majetschak M, 2011, J LEUKOCYTE BIOL, V89, P205, DOI 10.1189/jlb.0510316; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nishio M, 2005, BLOOD, V106, P1012, DOI 10.1182/blood-2004-03-0889; O'Hayre M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011716; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Saini Vikas, 2010, Commun Integr Biol, V3, P608, DOI 10.4161/cib.3.6.13375; Saini V, 2010, J BIOL CHEM, V285, P15566, DOI 10.1074/jbc.M110.103408; Shyu WC, 2008, J PHARMACOL EXP THER, V324, P834, DOI 10.1124/jpet.107.127746; Soto AG, 2010, J BIOL CHEM, V285, P18781, DOI 10.1074/jbc.M110.111088; Steen A, 2009, MINI-REV MED CHEM, V9, P1605, DOI 10.2174/138955709791012265; Struyf S, 2009, J IMMUNOL, V182, P666, DOI 10.4049/jimmunol.182.1.666; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Veldkamp CT, 2010, J AM CHEM SOC, V132, P7242, DOI 10.1021/ja1002263; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zaruba MM, 2010, EXPERT OPIN BIOL TH, V10, P321, DOI 10.1517/14712590903460286	70	71	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33466	33477		10.1074/jbc.M111.233742	http://dx.doi.org/10.1074/jbc.M111.233742			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21757744	Green Published, hybrid			2022-12-25	WOS:000294968800064
J	Heidler, J; Al-Furoukh, N; Kukat, C; Salwig, I; Ingelmann, ME; Seibel, P; Kruger, M; Holtz, J; Wittig, I; Braun, T; Szibor, M				Heidler, Juliana; Al-Furoukh, Natalie; Kukat, Christian; Salwig, Isabelle; Ingelmann, Marie-Elisabeth; Seibel, Peter; Krueger, Marcus; Holtz, Juergen; Wittig, Ilka; Braun, Thomas; Szibor, Marten			Nitric Oxide-associated Protein 1 (NOA1) Is Necessary for Oxygen-dependent Regulation of Mitochondrial Respiratory Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; CHAIN SUPERCOMPLEXES; ELECTRON-TRANSPORT; HEART-MITOCHONDRIA; APOPTOSIS; HYPOXIA; METABOLISM; SYNTHASE; PHOSPHORYLATION; ORGANIZATION	In eukaryotic cells, maintenance of cellular ATP stores depends mainly on mitochondrial oxidative phosphorylation (OXPHOS), which in turn requires sufficient cellular oxygenation. The crucial role of proper oxygenation for cellular viability is reflected by involvement of several mechanisms, which sense hypoxia and regulate activities of respiratory complexes according to available oxygen concentrations. Here, we focus on mouse nitric oxide-associated protein 1 (mNOA1), which has been identified as an important component of the machinery that adjusts OXPHOS activity to oxygen concentrations. mNOA1 is an evolutionary conserved GTP-binding protein that is involved in the regulation of mitochondrial protein translation and respiration. We found that mNOA1 is located mostly in the mitochondrial matrix from where it interacts with several high molecular mass complexes, most notably with the complex IV of the respiratory chain and the prohibitin complex. Knockdown of mNOA1 impaired enzyme activity I+III, resulting in oxidative stress and eventually cell death. mNOA1 is transcriptionally regulated in an oxygen-sensitive manner. We propose that oxygen-dependent regulation of mNOA1 is instrumental to adjusting OXPHOS activity to oxygen availability, thereby controlling mitochondrial metabolism.	[Heidler, Juliana; Al-Furoukh, Natalie; Salwig, Isabelle; Ingelmann, Marie-Elisabeth; Krueger, Marcus; Braun, Thomas; Szibor, Marten] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, D-61231 Bad Nauheim, Germany; [Heidler, Juliana] Goethe Univ Frankfurt, Sch Med, Dept Mol Hematol, D-60590 Frankfurt, Germany; [Kukat, Christian] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Seibel, Peter] Univ Leipzig, Ctr Biotechnol & Biomed, D-04103 Leipzig, Germany; [Wittig, Ilka] Goethe Univ Frankfurt, Zentrum Biol Chem, D-60590 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt; Max Planck Society; Leipzig University; Goethe University Frankfurt	Braun, T (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Ludwigstr 43, D-61231 Bad Nauheim, Germany.	thomas.braun@mpi-bn.mpg.de; marten.szibor@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008; Kukat, Christian/AAW-1268-2020	Kukat, Christian/0000-0003-1508-0229; Schindler, Natalie/0000-0001-7281-4597; Braun, Thomas/0000-0002-6165-4804	Max-Planck-Society; Deutsche Forschungsgemeinschaft [Br1416]; Excellence Initiative "Cardiopulmonary System"; University of Giessen-Marburg Lung Center; Deutsche Forschungsgemeinschaft, Sonderforschungsbereich [815, Z1]	Max-Planck-Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative "Cardiopulmonary System"; University of Giessen-Marburg Lung Center; Deutsche Forschungsgemeinschaft, Sonderforschungsbereich(German Research Foundation (DFG))	This work was supported by the Max-Planck-Society, the Deutsche Forschungsgemeinschaft Grant Br1416, the Excellence Initiative "Cardiopulmonary System," and the University of Giessen-Marburg Lung Center (to T. B.), and the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 815 (Redox-Proteomics), Project Z1 (to I. W.).	Acin-Perez R, 2011, CELL METAB, V13, P712, DOI 10.1016/j.cmet.2011.03.024; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; Chen Q, 2000, CELL DEATH DIFFER, V7, P227, DOI 10.1038/sj.cdd.4400629; Cunillera N, 1997, J BIOL CHEM, V272, P15381, DOI 10.1074/jbc.272.24.15381; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng127; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Galkin A, 2009, J BIOL CHEM, V284, P36055, DOI 10.1074/jbc.M109.054346; Gas E, 2009, PLANT CELL, V21, P18, DOI 10.1105/tpc.108.065243; Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Jezek P, 2009, INT J BIOCHEM CELL B, V41, P1790, DOI 10.1016/j.biocel.2009.02.014; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Kolanczyk M, 2011, MOL BIOL CELL, V22, P1, DOI 10.1091/mbc.E10-07-0643; Kruger M, 2008, P NATL ACAD SCI USA, V105, P2451, DOI 10.1073/pnas.0711713105; Kukat A, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn124; Lu CF, 2005, BIOCHEM BIOPH RES CO, V331, P1114, DOI 10.1016/j.bbrc.2005.04.027; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Moreau M, 2008, J BIOL CHEM, V283, P32957, DOI 10.1074/jbc.M804838200; Nemoto Y, 1999, EMBO J, V18, P2991, DOI 10.1093/emboj/18.11.2991; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Oswald C, 2009, J MOL BIOL, V389, P470, DOI 10.1016/j.jmb.2009.04.034; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Parihar MS, 2008, BBA-GEN SUBJECTS, V1780, P921, DOI 10.1016/j.bbagen.2008.02.006; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, J BIOL CHEM, V276, P37861; Schild L, 2001, FASEB J, V15, P565; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P577, DOI 10.1073/pnas.97.2.577; Solaini G, 2010, BBA-BIOENERGETICS, V1797, P1171, DOI 10.1016/j.bbabio.2010.02.011; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; Sudhamsu J, 2008, J BIOL CHEM, V283, P32968, DOI 10.1074/jbc.M804837200; Tang TD, 2009, J BIOL CHEM, V284, P5414, DOI 10.1074/jbc.M807797200; Taylor SW, 2002, J PROTEOME RES, V1, P451, DOI 10.1021/pr025533g; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Tyc J, 2010, INT J PARASITOL, V40, P73, DOI 10.1016/j.ijpara.2009.07.008; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200	47	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32086	32093		10.1074/jbc.M111.221986	http://dx.doi.org/10.1074/jbc.M111.221986			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21771794	Green Published, hybrid			2022-12-25	WOS:000294726800018
J	Kim, SY; Lee, JH; Huh, JW; Ro, JY; Oh, YM; Lee, SD; An, S; Lee, YS				Kim, Sun-Yong; Lee, Ji-Hyun; Huh, Jin Won; Ro, Jai Youl; Oh, Yeon-Mock; Lee, Sang-Do; An, Sungkwan; Lee, Yun-Song			Cigarette Smoke Induces Akt Protein Degradation by the Ubiquitin-Proteasome System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LUNG FIBROBLASTS; SIGNAL-REGULATING KINASE-1; OXIDATIVE STRESS; CELLULAR SENESCENCE; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; DOWN-REGULATION; ACTIVATION; EMPHYSEMA; MECHANISMS	Emphysema is one of the characteristic features of chronic obstructive pulmonary disease, which is caused mainly by cigarette smoking. Recent data have suggested that apoptosis and cell cycle arrest may contribute to the development of emphysema. In this study, we addressed the question of whether and how cigarette smoke affected Akt, which plays a critical role in cell survival and proliferation. In normal human lung fibroblasts, cigarette smoke extract (CSE) caused cell death, accompanying degradation of total and phosphorylated Akt (p-Akt), which was inhibited by MG132. CSE exposure resulted in preferential ubiquitination of the active Akt (myristoylated), rather than the inactive (T308A/S473A double mutant) Akt. Consistent with cytotoxicity, CSE induced a progressive decrease of phosphorylated human homolog of mouse double minute homolog 2 (p-HDM2) and phosphorylated apoptosis signal regulating kinase 1 (p-ASK1) with concomitant elevation of p53, p21, and phosphorylated p38 MAPK. Forced expression of the active Akt reduced both CSE-induced cytotoxicity and alteration in HDM2/p53/p21 and ASK1/p38 MAPK, compared with the inactive Akt. Of note, CSE induced expression of the tetratricopeptide repeat domain 3 (TTC3), known as a ubiquitin ligase for active Akt. TTC3 siRNAs suppressed not only CSE-induced Akt degradation but also CSE-induced cytotoxicity. Accordingly, rat lungs exposed to cigarette smoke for 3 months showed elevated TTC3 expression and reduced Akt and p-Akt. Taken together, these data suggest that cigarette smoke induces cytotoxicity, partly through Akt degradation via the ubiquitin-proteasome system, in which TTC3 acts as a ubiquitin ligase for active Akt.	[Kim, Sun-Yong; Ro, Jai Youl; Lee, Yun-Song] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Div Pharmacol, Suwon 440746, South Korea; [Lee, Ji-Hyun] Pochon CHA Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Songnam 463712, South Korea; [Huh, Jin Won; Oh, Yeon-Mock; Lee, Sang-Do] Univ Ulsan, Coll Med, Asthma Ctr, Dept Pulm & Crit Care Med, Seoul 138736, South Korea; [Huh, Jin Won; Oh, Yeon-Mock; Lee, Sang-Do] Univ Ulsan, Coll Med, Asan Med Ctr, Clin Res Ctr Chron Obstruct Airway Dis, Seoul 138736, South Korea; [An, Sungkwan] Konkuk Univ, Funct Genoproteome Res Ctr, Seoul 143701, South Korea	Sungkyunkwan University (SKKU); Pochon Cha University; University of Ulsan; University of Ulsan; Asan Medical Center; Konkuk University	Lee, YS (corresponding author), 300 Chunchun Dong, Suwon 440746, South Korea.	yslee@skku.edu			National Research Foundation of Korea [2010-0007209]; Ministry of Education, Science and Technology; Korea Healthcare Technology R&D Welfare & Family Affairs Project, Republic of Korea [A084753]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Healthcare Technology R&D Welfare & Family Affairs Project, Republic of Korea	This research was supported by Grant 2010-0007209 from the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology and by Grant A084753 from the Korea Healthcare Technology R&D Welfare & Family Affairs Project, Republic of Korea.	Adenuga D, 2009, AM J RESP CELL MOL, V40, P464, DOI 10.1165/rcmb.2008-0255OC; Alphonse RS, 2011, AM J RESP CELL MOL, V44, P146, DOI 10.1165/rcmb.2009-0182OC; Barnes PJ, 2009, ANNU REV PHYSIOL, V71, P451, DOI 10.1146/annurev.physiol.010908.163257; Carnevali S, 2003, AM J PHYSIOL-LUNG C, V284, pL955, DOI 10.1152/ajplung.00466.2001; Carnevali S, 1998, AM J PHYSIOL-LUNG C, V274, pL591, DOI 10.1152/ajplung.1998.274.4.L591; Churg A, 2008, AM J PHYSIOL-LUNG C, V294, pL612, DOI 10.1152/ajplung.00390.2007; COONEY TP, 1982, NEW ENGL J MED, V307, P1170, DOI 10.1056/NEJM198211043071902; Damico R, 2011, AM J RESP CELL MOL, V44, P323, DOI 10.1165/rcmb.2009-0379OC; Di Lorenzo A, 2009, P NATL ACAD SCI USA, V106, P14552, DOI 10.1073/pnas.0904073106; Edirisinghe I, 2008, FASEB J, V22, P2297, DOI 10.1096/fj.07-099481; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Holz O, 2004, EUR RESPIR J, V24, P575, DOI 10.1183/09031936.04.00143703; Hsu MJ, 2007, J NEUROSCI, V27, P5719, DOI 10.1523/JNEUROSCI.1874-06.2007; Huh J. W., 2011, AM J PHYSL IN PRESS; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Kuang PP, 2007, AM J PHYSIOL-LUNG C, V292, pL944, DOI 10.1152/ajplung.00184.2006; Liao Y, 2010, AM J TRANSL RES, V2, P19; Liu W, 2003, CELL DEATH DIFFER, V10, P772, DOI 10.1038/sj.cdd.4401238; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marwick JA, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-11; Medina EA, 2005, ENDOCRINOLOGY, V146, P2726, DOI 10.1210/en.2004-1074; NAKAMURA Y, 1995, AM J RESP CRIT CARE, V151, P1497, DOI 10.1164/ajrccm.151.5.7735606; Nyunoya T, 2006, AM J RESP CELL MOL, V35, P681, DOI 10.1165/rcmb.2006-0169OC; Nyunoya T, 2009, AM J RESP CRIT CARE, V179, P279, DOI 10.1164/rccm.200802-320OC; Osoata GO, 2009, BIOCHEM BIOPH RES CO, V384, P366, DOI 10.1016/j.bbrc.2009.04.128; Pagano M, 1997, FASEB J, V11, P1067, DOI 10.1096/fasebj.11.13.9367342; Park JW, 2008, J IMMUNOL, V180, P4668, DOI 10.4049/jimmunol.180.7.4668; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ricupero DA, 2001, AM J PHYSIOL-CELL PH, V281, pC99, DOI 10.1152/ajpcell.2001.281.1.C99; Riesterer O, 2004, ONCOGENE, V23, P4624, DOI 10.1038/sj.onc.1207596; Somanath PR, 2007, J BIOL CHEM, V282, P22964, DOI 10.1074/jbc.M700241200; Suizu F, 2009, DEV CELL, V17, P800, DOI 10.1016/j.devcel.2009.09.007; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Togo S, 2008, AM J RESP CRIT CARE, V178, P248, DOI 10.1164/rccm.200706-929OC; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Tsukahara F, 1996, J BIOCHEM-TOKYO, V120, P820; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wu YT, 2011, J BIOL CHEM, V286, P14190, DOI 10.1074/jbc.M111.219923; Xiang T, 2008, CANCER RES, V68, P10040, DOI 10.1158/0008-5472.CAN-08-3009; Yan D, 2006, J CELL BIOL, V174, P415, DOI 10.1083/jcb.200511028; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	49	55	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					31932	31943		10.1074/jbc.M111.267633	http://dx.doi.org/10.1074/jbc.M111.267633			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778238	Green Published, hybrid			2022-12-25	WOS:000294726800002
J	Kizuka, Y; Kitazume, S; Yoshida, M; Taniguchi, N				Kizuka, Yasuhiko; Kitazume, Shinobu; Yoshida, Minoru; Taniguchi, Naoyuki			Brain-specific Expression of N-Acetylglucosaminyltransferase IX (GnT-IX) Is Regulated by Epigenetic Histone Modifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BLOCKING ACTIVITY; SYNAPTIC PLASTICITY; MOLECULAR-CLONING; POLYSIALIC ACID; NERVOUS-SYSTEM; MICE DEFICIENT; PROTEIN CTCF; GLYCOSYLATION; PROMOTER; DIFFERENTIATION	It is well known that biosynthesis of glycans takes place in organ-and tissue-specific manners and glycan expression is controlled by various factors including glycosyltransferases. The expression mechanism of glycosyltransferases, however, is poorly understood. Here we investigated the expression mechanism of a brain-specific glycosyltransferase, GnT-IX (N-acetyl-glucosaminyltransferase IX, also designated as GnT-Vb), which synthesizes branched O-mannose glycan. Using an epigenetic approach, we revealed that the genomic region around the transcriptional start site of the GnT-IX gene was highly associated with active chromatin histone marks in a neural cell-specific manner, indicating that brain-specific GnT-IX expression is under control of an epigenetic "histone code." By EMSA and ChIP analyses we identified two regulatory proteins, NeuroD1 and CTCF that bind to and activate the GnT-IX promoter. We also revealed that GnT-IX expression was suppressed in CTCF-and NeuroD1-depleted cells, indicating that a NeuroD1- and CTCF-dependent epigenetic mechanism governs brain-specific GnT-IX expression. Several other neural glycosyltransferase genes are also found to be regulated by epigenetic histone modifications. This is the first report demonstrating a molecular mechanism at the chromatin level underlying tissue-specific glycan expression.	[Kizuka, Yasuhiko; Kitazume, Shinobu; Taniguchi, Naoyuki] RIKEN, Syst Glycobiol Res Grp, Dis Glyc Team, Wako, Saitama 3510198, Japan; [Yoshida, Minoru] RIKEN, Adv Sci Inst, Chem Genom Res Grp, Wako, Saitama 3510198, Japan; [Taniguchi, Naoyuki] Osaka Univ, Inst Sci & Ind Res, RIKEN Osaka Univ Alliance Lab, Osaka 5670047, Japan	RIKEN; RIKEN; Osaka University; RIKEN	Taniguchi, N (corresponding author), 2-1 Hirosawa, Wako, Saitama, Japan.	tani52@wd5.so-net.ne.jp	Taniguchi, Naoyuki/I-4182-2014; Taniguchi, Naoyuki/A-7086-2016; Yoshida, Minoru/C-8049-2014	Taniguchi, Naoyuki/0000-0001-5889-5968; Yoshida, Minoru/0000-0002-4376-5674; Kizuka, Yasuhiko/0000-0002-3181-9743	Systems Glycobiology Research project; RIKEN ASI; Osaka University; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [23770163] Funding Source: KAKEN	Systems Glycobiology Research project; RIKEN ASI; Osaka University; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Systems Glycobiology Research project (to N. T.), a Grant for the Strategic programs for R&D of RIKEN ASI, Global COE Program of Osaka University, and Grants-in-Aid for Scientific Research (A) (to N. T.) and for Young Scientists (B) (to Y. K.) from the Japan Society for the Promotion of Science (JSPS).	Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Chen GY, 2006, P NATL ACAD SCI USA, V103, P16894, DOI 10.1073/pnas.0607926103; Chernukhin I, 2007, MOL CELL BIOL, V27, P1631, DOI 10.1128/MCB.01993-06; Cho JH, 2004, MOL NEUROBIOL, V30, P35, DOI 10.1385/MN:30:1:035; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Granovsky M, 2000, NAT MED, V6, P306; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Inamori K, 2004, J BIOL CHEM, V279, P2337, DOI 10.1074/jbc.C300480200; Inamori K, 2003, J BIOL CHEM, V278, P43102, DOI 10.1074/jbc.M308255200; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Kaneko M, 2003, FEBS LETT, V554, P515, DOI 10.1016/S0014-5793(03)01234-1; Ko JH, 1999, J BIOL CHEM, V274, P22941, DOI 10.1074/jbc.274.33.22941; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee I, 2006, J NEUROCHEM, V97, P947, DOI 10.1111/j.1471-4159.2006.03785.x; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rajput B, 1996, J BIOL CHEM, V271, P5131, DOI 10.1074/jbc.271.9.5131; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Takashima S, 1998, J BIOL CHEM, V273, P7675, DOI 10.1074/jbc.273.13.7675; Taniguchi N., 2002, HDB GLYCOSYLTRANSFER; Taniguchi N, 2006, CURR OPIN STRUC BIOL, V16, P561, DOI 10.1016/j.sbi.2006.08.011; Tu LN, 2010, CELL MOL LIFE SCI, V67, P29, DOI 10.1007/s00018-009-0126-z; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Wuensch SA, 2000, GLYCOBIOLOGY, V10, P67, DOI 10.1093/glycob/10.1.67; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yamamoto S, 2002, J BIOCHEM, V131, P337, DOI 10.1093/oxfordjournals.jbchem.a003108; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	42	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31875	31884		10.1074/jbc.M111.251173	http://dx.doi.org/10.1074/jbc.M111.251173			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21771782	Green Published, hybrid			2022-12-25	WOS:000294487500080
J	Nagano, M; Hoshino, D; Koshiba, S; Shuo, T; Koshikawa, N; Tomizawa, T; Hayashi, F; Tochio, N; Harada, T; Akizawa, T; Watanabe, S; Handa, N; Shirouzu, M; Kigawa, T; Yokoyama, S; Seiki, M				Nagano, Makoto; Hoshino, Daisuke; Koshiba, Seizo; Shuo, Takuya; Koshikawa, Naohiko; Tomizawa, Tadashi; Hayashi, Fumiaki; Tochio, Naoya; Harada, Takushi; Akizawa, Toshifumi; Watanabe, Satoru; Handa, Noriko; Shirouzu, Mikako; Kigawa, Takanori; Yokoyama, Shigeyuki; Seiki, Motoharu			ZF21 Protein, a Regulator of the Disassembly of Focal Adhesions and Cancer Metastasis, Contains a Novel Noncanonical Pleckstrin Homology Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL MOTILITY; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; CYTOPLASMIC TAIL; NMR STRUCTURE; FYVE DOMAIN; BINDING; INTEGRINS; MIGRATION; DYNAMICS; KINASE	Directional migration of adherent cells on an extracellular matrix requires repeated formation and disassembly of focal adhesions (FAs). Directional migration of adherent cells We have identified ZF21 as a regulator of disassembly of FAs and cell migration, and increased expression of the gene has been linked to metastatic colon cancer. ZF21 is a member of a protein family characterized by the presence of the FYVE domain, which is conserved among Fab1p, YOPB, Vps27p, and EEA1 proteins, and has been shown to mediate the binding of such proteins to phosphoinositides in the lipid layers of cell membranes. ZF21 binds multiple factors that promote disassembly of FAs such as FAK, beta-tubulin, m-calpain, and SHP-2. ZF21 does not contain any other known protein motifs other than the FYVE domain, but a region of the protein C-terminal to the FYVE domain is sufficient to mediate binding to beta-tubulin. In this study, we demonstrate that the C-terminal region is important for the ability of ZF21 to induce disassembly of FAs and cell migration, and to promote an early step of experimental metastasis to the lung in mice. In light of the importance of the C-terminal region, we analyzed its ternary structure using NMR spectroscopy. We demonstrate that this region exhibits a structure similar to that of a canonical pleckstrin homology domain, but that it lacks a positively charged interface to bind phosphatidylinositol phosphate. Thus, ZF21 contains a novel noncanonical PH-like domain that is a possible target to develop a therapeutic strategy to treat metastatic cancer.	[Nagano, Makoto; Hoshino, Daisuke; Shuo, Takuya; Koshikawa, Naohiko; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo 1088639, Japan; [Nagano, Makoto; Akizawa, Toshifumi] Setsunan Univ, Fac Pharmaceut Sci, Hirakata Osaka 5730101, Japan; [Koshiba, Seizo; Tomizawa, Tadashi; Hayashi, Fumiaki; Tochio, Naoya; Harada, Takushi; Watanabe, Satoru; Handa, Noriko; Shirouzu, Mikako; Kigawa, Takanori; Yokoyama, Shigeyuki] Yokohama Inst, RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Koshiba, Seizo] Yokohama City Univ, Int Grad Sch Arts & Sci, Dept Supramol Biol, Yokohama, Kanagawa 2300045, Japan; [Kigawa, Takanori] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; RIKEN; Yokohama City University; Tokyo Institute of Technology; University of Tokyo	Seiki, M (corresponding author), 4-6-1 Shirokanedai,Minato Ku, Tokyo 1088639, Japan.	mseiki@ims.u-tokyo.ac.jp	Yokoyama, Shigeyuki/N-6911-2015; Nagano, Makoto/J-7050-2015; watanabe, satoru s/E-9501-2012; Shirouzu, Mikako/A-6521-2016; Tochio, Naoya/E-9495-2012; Koshikawa, Naohiko/S-7306-2017; Seiki, Motoharu/K-9443-2015; Kigawa, Takanori/A-7679-2010	Yokoyama, Shigeyuki/0000-0003-3133-7338; Nagano, Makoto/0000-0002-1948-1591; watanabe, satoru s/0000-0001-5329-9278; Koshikawa, Naohiko/0000-0002-4539-888X; Kigawa, Takanori/0000-0003-0146-9719	Core Research for Evolutional Science and Technology (CREST); RIKEN Structural Genomics/Proteomics Initiative (RSGI); Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22591762] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); RIKEN Structural Genomics/Proteomics Initiative (RSGI); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (S) and Core Research for Evolutional Science and Technology (CREST) (to M. S.), the RIKEN Structural Genomics/Proteomics Initiative (RSGI), and the National Project on Protein Structural and Functional Analyses (to S. Y.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Baron CB, 1999, BIOCHEM J, V341, P805, DOI 10.1042/0264-6021:3410805; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hoshino D, 2009, J BIOL CHEM, V284, P27315, DOI 10.1074/jbc.M109.041400; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; Kutateladze TG, 1999, MOL CELL, V3, P805, DOI 10.1016/S1097-2765(01)80013-7; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Li H, 2008, J BIOL CHEM, V283, P27165, DOI 10.1074/jbc.M803892200; Liu SC, 2000, J CELL SCI, V113, P3563; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Meighan CM, 2008, CURR OPIN CELL BIOL, V20, P520, DOI 10.1016/j.ceb.2008.05.010; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; NAGANO M, 2010, CELL ADH MIGR, V5, P23; Nagano M, 2010, J BIOL CHEM, V285, P21013, DOI 10.1074/jbc.M110.106443; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Niiya D, 2009, J BIOL CHEM, V284, P27360, DOI 10.1074/jbc.M109.029124; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Sakamoto T, 2009, J BIOL CHEM, V284, P30350, DOI 10.1074/jbc.M109.019216; Shen Y, 1999, MOL BIOL CELL, V10, P2507, DOI 10.1091/mbc.10.8.2507; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Takeuchi H, 1998, BIOCHEM J, V334, P211, DOI 10.1042/bj3340211; Tomari T, 2009, CANCER SCI, V100, P1284, DOI 10.1111/j.1349-7006.2009.01173.x; Truong H, 2009, CELL ADHES MIGR, V3, P179, DOI 10.4161/cam.3.2.8036; Uekita T, 2004, J BIOL CHEM, V279, P12734, DOI 10.1074/jbc.M309957200; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yabuki Takashi, 2007, Journal of Structural and Functional Genomics, V8, P173, DOI 10.1007/s10969-007-9038-z; Yagisawa H, 1998, J BIOL CHEM, V273, P417, DOI 10.1074/jbc.273.1.417; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zhang ZY, 2006, J BIOL CHEM, V281, P1746, DOI 10.1074/jbc.M509590200	58	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31598	31609		10.1074/jbc.M110.199430	http://dx.doi.org/10.1074/jbc.M110.199430			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768110	Green Published, hybrid			2022-12-25	WOS:000294487500054
J	Philp, A; Chen, A; Lan, D; Meyer, GA; Murphy, AN; Knapp, AE; Olfert, IM; McCurdy, CE; Marcotte, GR; Hogan, MC; Baar, K; Schenk, S				Philp, Andrew; Chen, Ai; Lan, Debin; Meyer, Gretchen A.; Murphy, Anne N.; Knapp, Amy E.; Olfert, I. Mark; McCurdy, Carrie E.; Marcotte, George R.; Hogan, Michael C.; Baar, Keith; Schenk, Simon			Sirtuin 1 (SIRT1) Deacetylase Activity Is Not Required for Mitochondrial Biogenesis or Peroxisome Proliferator-activated Receptor-gamma Coactivator-1 alpha (PGC-1 alpha) Deacetylation following Endurance Exercise	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SKELETAL-MUSCLE; PROTEIN-KINASE ACTIVATION; ENERGY-METABOLISM; ENZYME-ACTIVITY; ACETYLATION; INCREASES; RAT; EXPRESSION; AMPK; TRANSCRIPTION	The protein deacetylase, sirtuin 1 (SIRT1), is a proposed master regulator of exercise-induced mitochondrial biogenesis in skeletal muscle, primarily via its ability to deacetylate and activate peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha). To investigate regulation of mitochondrial biogenesis by SIRT1 in vivo, we generated mice lacking SIRT1 deacetylase activity in skeletal muscle (mKO). We hypothesized that deacetylation of PGC-1 alpha and mitochondrial biogenesis in sedentary mice and after endurance exercise would be impaired in mKO mice. Skeletal muscle contractile characteristics were determined in extensor digitorum longus muscle ex vivo. Mitochondrial biogenesis was assessed after 20 days of voluntary wheel running by measuring electron transport chain protein content, enzyme activity, and mitochondrial DNA expression. PGC-1 alpha expression, nuclear localization, acetylation, and interacting protein association were determined following an acute bout of treadmill exercise (AEX) using co-immunoprecipitation and immunoblotting. Contrary to our hypothesis, skeletal muscle endurance, electron transport chain activity, and voluntary wheel running-induced mitochondrial biogenesis were not impaired in mKO versus wild-type (WT) mice. Moreover, PGC-1 alpha expression, nuclear translocation, activity, and deacetylation after AEX were similar in mKO versus WT mice. Alternatively, we made the novel observation that deacetylation of PGC-1 alpha after AEX occurs in parallel with reduced nuclear abundance of the acetyltransferase, general control of amino-acid synthesis 5 (GCN5), as well as reduced association between GCN5 and nuclear PGC-1 alpha. These findings demonstrate that SIRT1 deacetylase activity is not required for exercise-induced deacetylation of PGC-1 alpha or mitochondrial biogenesis in skeletal muscle and suggest that changes in GCN5 acetyltransferase activity may be an important regulator of PGC-1 alpha activity after exercise.	[Lan, Debin; Schenk, Simon] Univ Calif San Diego, Dept Orthopaed Surg, La Jolla, CA 92093 USA; [Chen, Ai] Univ Calif San Diego, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Meyer, Gretchen A.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Murphy, Anne N.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Knapp, Amy E.; Hogan, Michael C.] Univ Calif San Diego, Div Physiol, La Jolla, CA 92093 USA; [Philp, Andrew; Marcotte, George R.; Baar, Keith] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Olfert, I. Mark] W Virginia Univ, Sch Med, Div Exercise Physiol, Morgantown, WV 26506 USA; [McCurdy, Carrie E.] Univ Colorado, Dept Pediat, Aurora, CO 80045 USA; [McCurdy, Carrie E.] Univ Colorado, Charles C Gates Regenerat Med & Stem Cell Biol Pr, Aurora, CO 80045 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Davis; West Virginia University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Schenk, S (corresponding author), Univ Calif San Diego, Dept Orthopaed Surg, La Jolla, CA 92093 USA.	sschenk@ucsd.edu	; Murphy, Anne N/H-3217-2016	Baar, Keith/0000-0001-9337-6186; Schenk, Simon/0000-0002-8224-3203; Murphy, Anne N/0000-0002-5222-9902; Marcotte, George/0000-0002-9162-135X; Philp, Andrew/0000-0003-3860-4136; Meyer, Gretchen/0000-0001-9268-3993	National Institutes of Health [P30 AR058878-02, K12 HD057022]; National Skeletal Muscle Research Center [R24 HD050837]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050837, K12HD057022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040155, P30AR058878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Skeletal Muscle Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 AR058878-02 and K12 HD057022. This work was also supported by National Skeletal Muscle Research Center Grant R24 HD050837.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Amat R, 2009, J BIOL CHEM, V284, P21872, DOI 10.1074/jbc.M109.022749; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chabi B, 2009, J APPL PHYSIOL, V107, P1730, DOI 10.1152/japplphysiol.91451.2008; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; CONSTABLE SH, 1987, AM J PHYSIOL, V253, pC316, DOI 10.1152/ajpcell.1987.253.2.C316; Coste A, 2008, P NATL ACAD SCI USA, V105, P17187, DOI 10.1073/pnas.0808207105; Dominy JE, 2010, BBA-PROTEINS PROTEOM, V1804, P1676, DOI 10.1016/j.bbapap.2009.11.023; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; GOLLNICK PD, 1973, J APPL PHYSIOL, V34, P107, DOI 10.1152/jappl.1973.34.1.107; Gurd BJ, 2011, AM J PHYSIOL-REG I, V301, pR67, DOI 10.1152/ajpregu.00417.2010; Gurd BJ, 2010, APPL PHYSIOL NUTR ME, V35, P350, DOI 10.1139/H10-030; Gurd BJ, 2009, J PHYSIOL-LONDON, V587, P1817, DOI 10.1113/jphysiol.2008.168096; Hamilton DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011624; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hawley JA, 2009, NUTR REV, V67, P172, DOI 10.1111/j.1753-4887.2009.00185.x; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li L, 2011, DIABETES, V60, P157, DOI 10.2337/db10-0331; Little JP, 2010, AM J PHYSIOL-REG I, V298, pR912, DOI 10.1152/ajpregu.00409.2009; Little JP, 2010, J PHYSIOL-LONDON, V588, P1011, DOI 10.1113/jphysiol.2009.181743; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Philp A, 2010, AM J PHYSIOL-CELL PH, V299, pC240, DOI 10.1152/ajpcell.00438.2009; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Poux AN, 2002, P NATL ACAD SCI USA, V99, P14065, DOI 10.1073/pnas.222373899; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; SACKS RD, 1982, J MORPHOL, V173, P185, DOI 10.1002/jmor.1051730206; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Spina RJ, 1996, J APPL PHYSIOL, V80, P2250, DOI 10.1152/jappl.1996.80.6.2250; Suwa M, 2008, METABOLISM, V57, P986, DOI 10.1016/j.metabol.2008.02.017; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Yan Z, 2011, J APPL PHYSIOL, V110, P264, DOI 10.1152/japplphysiol.00993.2010; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	45	137	141	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30561	30570		10.1074/jbc.M111.261685	http://dx.doi.org/10.1074/jbc.M111.261685			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757760	Green Published, hybrid			2022-12-25	WOS:000294283600035
J	Wang, LM; Guo, DG; Xing, BW; Zhang, JL; Shu, HB; Guo, L; Huang, XY				Wang, Limin; Guo, Dagang; Xing, Bowen; Zhang, Jillian; Shu, Hong-Bing; Guo, Lin; Huang, Xin-Yun			Resistance to Inhibitors of Cholinesterase-8A (Ric-8A) Is Critical for Growth Factor Receptor-induced Actin Cytoskeletal Reorganization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; ASYMMETRIC CELL-DIVISION; CAENORHABDITIS-ELEGANS EMBRYOS; PROTEIN-COUPLED RECEPTORS; HETEROTRIMERIC G-PROTEINS; G-ALPHA; C-ELEGANS; SIGNAL-TRANSDUCTION; MITOTIC SPINDLE; CORTICAL LOCALIZATION	Heterotrimeric G proteins are critical transducers of cellular signaling. In addition to their classic roles in relaying signals from G protein-coupled receptors (GPCRs), heterotrimeric G proteins also mediate physiological functions from non-GPCRs. Previously, we have shown that G alpha(13), a member of the heterotrimeric G proteins, is essential for growth factor receptor-induced actin cytoskeletal reorganization such as dynamic dorsal ruffle turnover and cell migration. These G alpha(13)-mediated dorsal ruffle turnover and cell migration by growth factors acting on their receptor tyrosine kinases (RTKs) are independent of GPCRs. However, the mechanism by which RTKs signal to G alpha(13) is not known. Here, we show that cholinesterase-8A (Ric-8A), a nonreceptor guanine nucleotide exchange factor for some heterotrimeric G proteins, is critical for coupling RTKs to G alpha(13). Down-regulation of Ric-8A protein levels in cells by RNA interference slowed down platelet-derived growth factor (PDGF)-induced dorsal ruffle turnover and inhibited PDGF-initiated cell migration. PDGF was able to increase the activity of Ric-8A in cells. Furthermore, purified Ric-8A proteins interact directly with purified G alpha(13) protein in a nucleotide-dependent manner. Deficiency of Ric-8A prevented the translocation of G alpha(13) to the cell cortex. Hence, Ric-8A is critical for growth factor receptor-induced actin cytoskeletal reorganization.	[Wang, Limin; Xing, Bowen; Shu, Hong-Bing; Guo, Lin; Huang, Xin-Yun] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Guo, Dagang; Zhang, Jillian] Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10065 USA	Wuhan University; Cornell University	Huang, XY (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	xyhuang@med.cornell.edu	Wang, Limin/AAX-4273-2020	Wang, Limin/0000-0001-5998-2609	National Institutes of Health [HL91525]; 111 Project of China [B06018]; National Science Foundation of China [31028015, 30921001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 111 Project of China(Ministry of Education, China - 111 Project); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL91525. This work was also supported by the 111 Project of China Grant B06018 and the National Science Foundation of China Grants 31028015 and 30921001.	Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Alderton F, 2001, J BIOL CHEM, V276, P28578, DOI 10.1074/jbc.M102771200; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Couwenbergs C, 2004, CURR BIOL, V14, P1871, DOI 10.1016/j.cub.2004.09.059; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; DHANASEKARAN DN, 2006, SCI STKE, pPE31; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Gu JL, 2002, P NATL ACAD SCI USA, V99, P9352, DOI 10.1073/pnas.102291599; Guo DG, 2007, CELL, V128, P341, DOI 10.1016/j.cell.2006.11.048; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; HEDBERG KM, 1993, CELL MOTIL CYTOSKEL, V24, P139, DOI 10.1002/cm.970240207; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; Jiang Y, 1998, NATURE, V395, P808, DOI 10.1038/27454; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Lowry WE, 2002, DEV CELL, V2, P733, DOI 10.1016/S1534-5807(02)00175-2; MANNING DR, 2003, SCI STKE, pPE35; MELLSTROM K, 1988, EXP CELL RES, V177, P347, DOI 10.1016/0014-4827(88)90468-5; MELLSTROM K, 1983, J MUSCLE RES CELL M, V4, P589, DOI 10.1007/BF00712117; Meng JW, 1999, J BIOL CHEM, V274, P36663, DOI 10.1074/jbc.274.51.36663; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Miller KG, 2000, GENETICS, V156, P1649; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; Moxham CM, 1996, NATURE, V379, P840, DOI 10.1038/379840a0; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; SCHLIWA M, 1984, J CELL BIOL, V99, P1045, DOI 10.1083/jcb.99.3.1045; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Sun H, 1997, J BIOL CHEM, V272, P5413, DOI 10.1074/jbc.272.9.5413; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2004, METHOD ENZYMOL, V390, P377; Thomas CJ, 2008, J BIOL CHEM, V283, P23150, DOI 10.1074/jbc.M802422200; Tonissoo T, 2006, BEHAV BRAIN RES, V167, P42, DOI 10.1016/j.bbr.2005.08.025; Von Dannecker LEC, 2005, J NEUROSCI, V25, P3793, DOI 10.1523/JNEUROSCI.4595-04.2005; Wang DW, 2006, J BIOL CHEM, V281, P32660, DOI 10.1074/jbc.M604588200; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; WARN R, 1993, SYM SOC EXP BIOL, V47, P325; Waters C, 2004, SEMIN CELL DEV BIOL, V15, P309, DOI 10.1016/j.semcdb.2003.12.020; Waters C, 2003, J BIOL CHEM, V278, P6282, DOI 10.1074/jbc.M208560200; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	59	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					31055	31061		10.1074/jbc.M111.253427	http://dx.doi.org/10.1074/jbc.M111.253427			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21771786	Green Published, hybrid			2022-12-25	WOS:000294283600083
J	Huang, HJ; Ahmed, AA				Huang, Helen J.; Ahmed, Alaa A.			Tradeoff between Stability and Maneuverability during Whole-Body Movements	PLOS ONE			English	Article							POSTURAL ORIENTATION; YOUNG; COCONTRACTION; VARIABILITY; STIFFNESS; BALANCE	Background: Understanding how stability and/or maneuverability affects motor control strategies can provide insight on moving about safely in an unpredictable world. Stability in human movement has been well-studied while maneuverability has not. Further, a tradeoff between stability and maneuverability during movement seems apparent, yet has not been quantified. We proposed that greater maneuverability, the ability to rapidly and purposefully change movement direction and speed, is beneficial in uncertain environments. We also hypothesized that gaining maneuverability comes at the expense of stability and perhaps also corresponds with decreased muscle coactivation. Materials and Methods: We used a goal-directed forward lean movement task that integrated both stability and maneuverability. Subjects (n = 11) used their center of pressure to control a cursor on a computer monitor to reach a target. We added task uncertainty by shifting the target anterior-posterior position mid-movement. We used a balance board with a narrow beam that reduced the base of support in the medio-lateral direction and defined stability as the probability that subjects could keep the balance board level during the task. Results: During the uncertainty condition, subjects were able to change direction of their anterior-posterior center of pressure more rapidly, indicating that subjects were more maneuverable. Furthermore, medio-lateral center of pressure excursions also approached the edges of the beam and reduced stability margins, implying that subjects were less stable (i.e. less able to keep the board level). On the narrow beam board, subjects increased muscle coactivation of lateral muscle pairs and had greater muscle activity in the left leg. However, there were no statistically significant differences in muscle activity amplitudes or coactivation with uncertainty. Conclusions/Significance: These results demonstrate that there is a tradeoff between stability and maneuverability during a goal-directed whole-body movement. Tasks with added uncertainty could help individuals learn to be more maneuverable yet sufficiently stable.	[Huang, Helen J.; Ahmed, Alaa A.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Huang, HJ (corresponding author), Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA.	helen.huang@colorado.edu	, Alaa/GVR-7153-2022	Huang, Helen J./0000-0003-4731-3242	National Institutes of Health [T32 5AG000279]; NATIONAL INSTITUTE ON AGING [T32AG000279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by a National Institutes of Health (NIH) Training Grant, T32 5AG000279, to HJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjuya N, 2004, J GERONTOL A-BIOL, V59, P166; Bierbaum S, 2010, J BIOMECH, V43, P2362, DOI 10.1016/j.jbiomech.2010.04.025; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Cenciarini M, 2010, IEEE T BIO-MED ENG, V57, P267, DOI 10.1109/TBME.2009.2031874; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; Feldman F, 2005, GAIT POSTURE, V22, P258, DOI 10.1016/j.gaitpost.2004.10.001; Feldman F, 2004, EXP AGING RES, V30, P275, DOI 10.1080/03610730490447903; Franklin DW, 2004, J NEUROPHYSIOL, V92, P3097, DOI 10.1152/jn.00364.2004; Franklin DW, 2003, EXP BRAIN RES, V151, P145, DOI 10.1007/s00221-003-1443-3; Full RJ, 2002, INTEGR COMP BIOL, V42, P149, DOI 10.1093/icb/42.1.149; Gribble PL, 2003, J NEUROPHYSIOL, V89, P2396, DOI 10.1152/jn.01020.2002; Hasan Z, 2005, J MOTOR BEHAV, V37, P484, DOI 10.3200/JMBR.37.6.484-493; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Hortobagyi T, 2000, J ELECTROMYOGR KINES, V10, P117, DOI 10.1016/S1050-6411(99)00026-7; Hortobagyi T, 2009, GAIT POSTURE, V29, P558, DOI 10.1016/j.gaitpost.2008.12.007; Jindrich DL, 2009, CHAOS, V19, DOI 10.1063/1.3143031; Ketcham CJ, 2002, J GERONTOL B-PSYCHOL, V57, pP54, DOI 10.1093/geronb/57.1.P54; Liu D, 2007, J NEUROSCI, V27, P9354, DOI 10.1523/JNEUROSCI.1110-06.2007; Maki BE, 1996, CLIN GERIATR MED, V12, P635; O'Connor SM, 2009, J NEUROPHYSIOL, V102, P1411, DOI 10.1152/jn.00131.2009; OSTROSKY KM, 1994, PHYS THER, V74, P637, DOI 10.1093/ptj/74.7.637; Patton JL, 2000, EXP BRAIN RES, V135, P117, DOI 10.1007/s002210000500; Popovic MR, 2000, J BIOMECH, V33, P1359, DOI 10.1016/S0021-9290(00)00123-8; Seidler-Dobrin R D, 1998, Motor Control, V2, P314; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Ting LH, 2009, CHAOS, V19, DOI 10.1063/1.3142245; van Emmerik REA, 2000, J APPL BIOMECH, V16, P394, DOI 10.1123/jab.16.4.394; van Wegen EEH, 2002, HUM MOVEMENT SCI, V21, P61, DOI 10.1016/S0167-9457(02)00077-5	29	27	27	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21815	10.1371/journal.pone.0021815	http://dx.doi.org/10.1371/journal.pone.0021815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779336	gold, Green Published, Green Submitted			2022-12-25	WOS:000292811300015
J	Montefeltro, FC; Larsson, HCE; Langer, MC				Montefeltro, Felipe C.; Larsson, Hans C. E.; Langer, Max C.			A New Baurusuchid (Crocodyliformes, Mesoeucrocodylia) from the Late Cretaceous of Brazil and the Phylogeny of Baurusuchidae	PLOS ONE			English	Article							BAURU BASIN; ADAMANTINA FORMATION; SP-NOV.; CROCODYLOMORPHA; EVOLUTION; PATAGONIA; ANATOMY; THALATTOSUCHIA; ARCHOSAURIA; NOTOSUCHIA	Background: Baurusuchidae is a group of extinct Crocodyliformes with peculiar, dog-faced skulls, hypertrophied canines, and terrestrial, cursorial limb morphologies. Their importance for crocodyliform evolution and biogeography is widely recognized, and many new taxa have been recently described. In most phylogenetic analyses of Mesoeucrocodylia, the entire clade is represented only by Baurusuchus pachecoi, and no work has attempted to study the internal relationships of the group or diagnose the clade and its members. Methodology/Principal Findings: Based on a nearly complete skull and a referred partial skull and lower jaw, we describe a new baurusuchid from the Vale do Rio do Peixe Formation (Bauru Group), Late Cretaceous of Brazil. The taxon is diagnosed by a suite of characters that include: four maxillary teeth, supratemporal fenestra with equally developed medial and anterior rims, four laterally visible quadrate fenestrae, lateral Eustachian foramina larger than medial Eustachian foramen, deep depression on the dorsal surface of pterygoid wing. The new taxon was compared to all other baurusuchids and their internal relationships were examined based on the maximum parsimony analysis of a discrete morphological data matrix. Conclusion: The monophyly of Baurusuchidae is supported by a large number of unique characters implying an equally large morphological gap between the clade and its immediate outgroups. A complex phylogeny of baurusuchids was recovered. The internal branch pattern suggests two main lineages, one with a relatively broad geographical range between Argentina and Brazil (Pissarrachampsinae), which includes the new taxon, and an endemic clade of the Bauru Group in Brazil (Baurusuchinae).	[Montefeltro, Felipe C.; Langer, Max C.] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Larsson, Hans C. E.] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada	Universidade de Sao Paulo; McGill University	Montefeltro, FC (corresponding author), Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil.	felipecm@pg.ffclrp.usp.br	Larsson, Hans/AAD-4579-2019; Montefeltro, Felipe Chinaglia/AAQ-4003-2020; Langer, Max C/F-7483-2012; Montefeltro, Felipe C/L-5780-2015; Langer, Max/Y-1753-2019	Larsson, Hans/0000-0002-6377-4770; Montefeltro, Felipe Chinaglia/0000-0001-6519-8546; Langer, Max C/0000-0003-1009-4605; 	FAPESP [2008/57642-6]; Programa de Pos-Graduacao em Biologia Comparada; FFCLRP-USP; Programa Doutorando com Estagio no Exterior; CAPES [1275/10-0]; CNPQ; CRC; NSERC	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Programa de Pos-Graduacao em Biologia Comparada; FFCLRP-USP; Programa Doutorando com Estagio no Exterior; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	FAPESP (grant number: 2008/57642-6), Programa de Pos-Graduacao em Biologia Comparada, FFCLRP-USP, and Programa Doutorando com Estagio no Exterior, CAPES (grant number 1275/10-0) to FCM, CNPQ and FAPESP to MCL, CRC and NSERC to HCEL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2008, CLADISTICS, V24, P51, DOI [10.1111/j.1096-0031.2007.00168.x, 10.1111/j.1096-0031.2008.00229.x]; Antunes M.T., 1975, COMUNICACOES SERVICO, V59, P285; BAEZ A M, 1989, Anais da Academia Brasileira de Ciencias, V61, P447; Barcelos JH, 1984, RECONSTRUCAO PALEOGE; BARRY T. H., 1957, PALAEONTOL AFRICANA, V5, P57; Benton M.J., 1988, Systematics Association Special Volume Series, P295; Bonaparte JF., 1991, REV MUSEO ARGENTINO, V4, P17; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; Brochu CA, 2002, J PALEONTOL, V76, P1060, DOI 10.1666/0022-3360(2002)076<1060:ADCBFM>2.0.CO;2; Brochu CA, 1999, J VERTEBR PALEONTOL, V19, P9, DOI 10.1080/02724634.1999.10011201; Buckley GA, 1999, SPEC PAP PALAEONTOL, P149; Buckley GA, 2000, NATURE, V405, P941, DOI 10.1038/35016061; BUFFETAUT E, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V208, P1; BUFFETAUT E, 1980, Annales de Paleontologie Vertebres, V66, P1; BUSBEY AB, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P173; Buscalioni A.D., 1988, Historical Biology, V1, P233; Campos DA, 1988, ANAIS ACAD BRASILEIR, V60, P492; Campos Diogenes de Almeida, 2001, Boletim do Museu Nacional Nova Serie Geologia, V57, P1; Candeiro CRA, 2006, J S AM EARTH SCI, V22, P116, DOI 10.1016/j.jsames.2006.08.001; Candeiro CRA, 2004, J S AM EARTH SCI, V18, P1, DOI 10.1016/j.jsames.2004.08.004; Carvalho I.S., 1999, GEOLOGIA COLOMBIANA, V24, P83, DOI DOI 10.15446/GC; Carvalho ID, 2004, GONDWANA RES, V7, P975, DOI 10.1016/S1342-937X(05)71079-0; Carvalho ID, 2005, GONDWANA RES, V8, P11, DOI 10.1016/S1342-937X(05)70259-8; Carvalho ID, 2010, PALAEOGEOGR PALAEOCL, V297, P252, DOI 10.1016/j.palaeo.2010.08.003; CLARK JM, 1994, IN THE SHADOW OF THE DINOSAURS, P84; Coimbra, 2003, 18 C BRAS PAL BRAS B, P152; COLBERT EH, 1946, B AM MUS NAT HIST, V87, P223; Company J, 2005, J VERTEBR PALEONTOL, V25, P343, DOI 10.1671/0272-4634(2005)025[0343:ANSODC]2.0.CO;2; de Andrade MB, 2008, HIST BIOL, V20, P101, DOI 10.1080/08912960701642949; De Andrade Marco Brandalise, 2008, Arquivos do Museu Nacional Rio de Janeiro, V66, P7; De Andrade Marco Brandalise, 2006, REVISTA BRASILEIRA DE PALEONTOLOGIA, V9, P323; de Gasparini Z.B., 1972, Ameghiniana, V9, P23; DEBUFFRENIL V, 1982, ZOOMORPHOLOGY, V99, P155, DOI 10.1007/BF00310307; Dias-Brito Dimas, 2001, Revue de Paleobiologie, V20, P245; ESTES R, 1973, SCIENCE, V180, P748, DOI 10.1126/science.180.4087.748; FARRIS JS, 1970, SYST ZOOL, V19, P83, DOI 10.2307/2412028; Fernandes L.A., 2000, REV BRASILEIRA GEOCI, V30, P717, DOI DOI 10.25249/0375-7536.2000304717728; Fernandes LA., 1996, ANAIS ACAD BRASILEIR, V68, P105; Fiorelli Lucas, 2008, Arquivos do Museu Nacional Rio de Janeiro, V66, P83; Fiorelli Lucas E., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P417; FRANCA MAG, 2005, GEODIVERSITAS, V27, P391; Gasparini Z, 2006, SCIENCE, V311, P70, DOI 10.1126/science.1120803; Gasparini Z., 1991, Journal of Vertebrate Paleontology, V11, P316; GASPARINI Z, 1981, Ameghiniana, V18, P177; Gasparini Zulma, 1993, Historical Biology, V7, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hill RV, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)395<0001:ANSOPG>2.0.CO;2; Holliday CM, 2007, J MORPHOL, V268, P457, DOI 10.1002/jmor.10524; Holliday CM, 2009, J VERTEBR PALEONTOL, V29, P715, DOI 10.1671/039.029.0330; Horner JR, 2006, P ROY SOC B-BIOL SCI, V273, P2757, DOI 10.1098/rspb.2006.3643; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; IORDANSKY N. N., 1964, ANAT ANZ, V115, P256; Iordansky N.N., 1973, P201; Kuhn, 1968, VORZEITLICHEN KROKOD; Larsson H.C.E., 1998, NEUES JB GEOLOGIE PA, V210, P345; Larsson HCE, 2007, ZOOL J LINN SOC-LOND, V149, P533, DOI 10.1111/j.1096-3642.2007.00271.x; Lauprasert K, 2009, GEOL SOC SPEC PUBL, V315, P175, DOI 10.1144/SP315.13; Laurenti J. N, 1768, SPECIMEN MEDICUM EXH; Lecuona A, 2008, CR PALEVOL, V7, P407, DOI 10.1016/j.crpv.2008.07.001; Marinho TS, 2009, J S AM EARTH SCI, V27, P36, DOI 10.1016/j.jsames.2008.11.005; Martill DM, 2006, PALAEONTOLOGY, V49, P925, DOI 10.1111/j.1475-4983.2006.00575.x; Leardi JM, 2009, CRETACEOUS RES, V30, P1376, DOI 10.1016/j.cretres.2009.08.002; Martinelli AG, 2008, CR PALEVOL, V7, P371, DOI 10.1016/j.crpv.2008.05.002; Mook CC, 1921, B AM MUS NAT HIST, V44, P51; Nascimento Paulo Miranda, 2010, Pap. Avulsos Zool. (São Paulo), V50, P323, DOI 10.1590/S0031-10492010002100001; Nascimento PM, 2008, DESCRICAO MORFOLOGIC; Nascimento PM, 2010, ZOOLOGICAL IN PRESS; O'Connor PM, 2010, NATURE, V466, P748, DOI 10.1038/nature09061; Ortega F, 1996, GEOBIOS-LYON, V29, P353, DOI 10.1016/S0016-6995(96)80037-4; Ortega F, 2000, J VERTEBR PALEONTOL, V20, P57, DOI 10.1671/0272-4634(2000)020[0057:ANSOAC]2.0.CO;2; Piacentini Pinheiro Andre Eduardo, 2008, Revista Brasileira de Paleontologia, V11, P37; Pol D, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)458<0001:ANGCTF>2.0.CO;2; Pol D, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)445<0001:ANCFCM>2.0.CO;2; Pol D, 2004, CRETACEOUS RES, V25, P603, DOI 10.1016/j.cretres.2004.05.002; Pol D, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)490[0001:NARFTE]2.0.CO;2; Pol D, ZOOLOGICAL IN PRESS; Pol D, 1999, ESQUELETO POSTCRANEA; Pol Diego, 2007, P116; Pol D, 2009, B AM MUS NAT HIST, P1; Pol D, 2009, J SYST PALAEONTOL, V7, P163, DOI 10.1017/S1477201908002605; Prasad Guntupalli V.R., 2002, Annales de Paleontologie, V88, P19, DOI 10.1016/S0753-3969(02)01036-4; Price L.I., 1945, NOTAS PRELIMINARES E, V25, P1; PRICE LI, 1959, B DGM RJ, V118, P1; Price LI, 1955, D F, V27, P487; Riff D, ZOOLOGICAL IN PRESS; Riff Douglas, 2001, Boletim do Museu Nacional Nova Serie Geologia, V59, P1; Romer A, 1956, OSTEOLOGY REPTILES; Rossmann Torsten, 2000, Palaeontologische Zeitschrift, V74, P379; Santucci R.M., 2001, BRAZ J GENET, V31, P307; Sereno PC, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.28.325; Sereno PC, 2003, J VERTEBR PALEONTOL, V23, P477, DOI 10.1671/0272-4634(2003)023[0477:ANNFTE]2.0.CO;2; Sereno PC, 2001, SCIENCE, V294, P1516, DOI 10.1126/science.1066521; SHUTE C. C. D., 1955, PROC ZOOL SOC LONDON, V124, P741; Simpson G. G., 1937, American Museum Novitates, P1; Smith JB, 2003, J VERTEBR PALEONTOL, V23, P1, DOI 10.1671/0272-4634(2003)23[1:APFAST]2.0.CO;2; Soares P.C., 1980, REV BRASILEIRA GEOCI, V10, P177, DOI DOI 10.25249/0375-7536.1980177185; Steyer JS, 2000, ZOOL J LINN SOC-LOND, V130, P449, DOI 10.1006/zjls.1999.0220; SWOFFORD DL, 1987, MATH BIOSCI, V87, P199, DOI 10.1016/0025-5564(87)90074-5; TARSITANO SF, 1989, AM ZOOL, V29, P843; Tsuihiji T, 2007, J MORPHOL, V268, P986, DOI 10.1002/jmor.10565; Turner AH, 2004, P ROY SOC B-BIOL SCI, V271, P2003, DOI 10.1098/rspb.2004.2840; Turner AH, 2005, J VERTEBR PALEONTOL, V25, P87, DOI 10.1671/0272-4634(2005)025[0087:ANSCFT]2.0.CO;2; Turner AH, 2008, J VERTEBR PALEONTOL, V28, P382, DOI 10.1671/0272-4634(2008)28[382:MICMCA]2.0.CO;2; Turner AH, 2010, J VERTEBR PALEONTOL, V30, P177, DOI 10.1080/02724634.2010.532348; Tykoski RS, 2002, J VERTEBR PALEONTOL, V22, P593, DOI 10.1671/0272-4634(2002)022[0593:CVANCF]2.0.CO;2; Vasc F. M., 2005, ANU INST GEOCIENC, V28, P49; Vasconcellos FM., 2010, B NEW MEXICO MUSEUM, V51, P227; WALKER AD, 1970, PHILOS T ROY SOC B, V257, P323, DOI 10.1098/rstb.1970.0028; WALKER AD, 1968, GEOL MAG, V105, P1, DOI 10.1017/S0016756800046434; Whetstone K.N., 1983, OCCASIONAL PAPERS MU, V106, P1, DOI DOI 10.1017/CBO9781107415324.004; Wilson Jeffrey A., 2001, Contributions from the Museum of Paleontology University of Michigan, V30, P321; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Woodward A.S., 1896, ANALES MUSEO PLATA P, V4, P1; Wu XC, 1996, J VERTEBR PALEONTOL, V16, P688, DOI 10.1080/02724634.1996.10011358; Young MT, 2009, ZOOL J LINN SOC-LOND, V157, P551, DOI 10.1111/j.1096-3642.2009.00536.x; Zaher H, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3512[1:ROTCMO]2.0.CO;2	116	62	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21916	10.1371/journal.pone.0021916	http://dx.doi.org/10.1371/journal.pone.0021916			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765925	Green Submitted, Green Published, gold			2022-12-25	WOS:000292781500022
J	Gaveau, J; Papaxanthis, C				Gaveau, Jeremie; Papaxanthis, Charalambos			The Temporal Structure of Vertical Arm Movements	PLOS ONE			English	Article							MOTOR CORTICAL REPRESENTATION; DIRECTIONAL ISOMETRIC FORCE; SIGNAL-DEPENDENT NOISE; POINTING MOVEMENTS; SAGITTAL PLANE; CORTEX; INTEGRATION; GRAVITY; SENSORIMOTOR; MODEL	The present study investigates how the CNS deals with the omnipresent force of gravity during arm motor planning. Previous studies have reported direction-dependent kinematic differences in the vertical plane; notably, acceleration duration was greater during a downward than an upward arm movement. Although the analysis of acceleration and deceleration phases has permitted to explore the integration of gravity force, further investigation is necessary to conclude whether feedforward or feedback control processes are at the origin of this incorporation. We considered that a more detailed analysis of the temporal features of vertical arm movements could provide additional information about gravity force integration into the motor planning. Eight subjects performed single joint vertical arm movements (45 degrees rotation around the shoulder joint) in two opposite directions (upwards and downwards) and at three different speeds (slow, natural and fast). We calculated different parameters of hand acceleration profiles: movement duration (MD), duration to peak acceleration (D PA), duration from peak acceleration to peak velocity (D PA-PV), duration from peak velocity to peak deceleration (D PV-PD), duration from peak deceleration to the movement end (D PD-End), acceleration duration (AD), deceleration duration (DD), peak acceleration (PA), peak velocity (PV), and peak deceleration (PD). While movement durations and amplitudes were similar for upward and downward movements, the temporal structure of acceleration profiles differed between the two directions. More specifically, subjects performed upward movements faster than downward movements; these direction-dependent asymmetries appeared early in the movement (i.e., before PA) and lasted until the moment of PD. Additionally, PA and PV were greater for upward than downward movements. Movement speed also changed the temporal structure of acceleration profiles. The effect of speed and direction on the form of acceleration profiles is consistent with the premise that the CNS optimises motor commands with respect to both gravitational and inertial constraints.	[Gaveau, Jeremie; Papaxanthis, Charalambos] INSERM, U Motr Plast 887, Dijon, France; [Gaveau, Jeremie; Papaxanthis, Charalambos] Univ Bourgogne, UFR STAPS, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Gaveau, J (corresponding author), INSERM, U Motr Plast 887, Dijon, France.	charalambos.Papaxanthis@u-bourgogne.fr	Gaveau, Jeremie/AAJ-7822-2020	Gaveau, Jeremie/0000-0001-8827-1486	INSERM; Ministere de l'Education Nationale, de l'Enseignement et de la Recherche	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Education Nationale, de l'Enseignement et de la Recherche	This work was supported by INSERM. Jeremie Gaveau was supported by grants from the 'Ministere de l'Education Nationale, de l'Enseignement et de la Recherche'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashe J, 1997, BEHAV BRAIN RES, V87, P255; ATKESON CG, 1985, J NEUROSCI, V5, P2318; Berret B, 2009, J NEUROSCI, V29, P191, DOI 10.1523/JNEUROSCI.3426-08.2009; Berret B, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000194; Biess A, 2007, J NEUROSCI, V27, P13045, DOI 10.1523/JNEUROSCI.4334-06.2007; CAMINITI R, 1991, J NEUROSCI, V11, P1182; Cheron G, 1997, ELECTROMYOGR MOTOR C, V105, P58, DOI 10.1016/S0924-980X(96)96544-3; Courtine G, 2002, NEUROSCI LETT, V332, P70, DOI 10.1016/S0304-3940(02)00909-6; Crevecoeur F, 2009, NEUROSCIENCE, V161, P589, DOI 10.1016/j.neuroscience.2009.03.025; Crevecoeur F, 2009, J NEUROPHYSIOL, V102, P786, DOI 10.1152/jn.00113.2009; Fautrelle L, 2010, NEUROSCIENCE, V169, P697, DOI 10.1016/j.neuroscience.2010.05.014; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Furuya S, 2009, NEUROSCIENCE, V164, P822, DOI 10.1016/j.neuroscience.2009.08.024; GAVEAU J, 2011, KINEMATIC ELECTROMYO; Gaveau J., 2011, J NEUROPHYSIOL; Gentili R, 2007, NEUROSCIENCE, V145, P20, DOI 10.1016/j.neuroscience.2006.11.035; Gentili RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005176; GEORGOPOULOS A, 1990, ATTENTION PERFORM, P227; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Indovina I, 2005, SCIENCE, V308, P416, DOI 10.1126/science.1107961; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; Kakei S, 2003, NEUROSCI RES, V46, P1, DOI 10.1016/S0168-0102(03)00031-2; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Lackner JR, 2000, EXP BRAIN RES, V130, P2, DOI 10.1007/s002210050002; Le Seac'h AB, 2007, NEUROSCI LETT, V423, P211, DOI 10.1016/j.neulet.2007.07.034; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Nishikawa KC, 1999, J NEUROPHYSIOL, V81, P2582, DOI 10.1152/jn.1999.81.5.2582; Paillard J, 1996, CAN J PHYSIOL PHARM, V74, P401, DOI 10.1139/cjpp-74-4-401; Papaxanthis C, 2005, NEUROSCIENCE, V135, P371, DOI 10.1016/j.neuroscience.2005.06.063; Papaxanthis C, 2003, NEUROSCIENCE, V117, P779, DOI 10.1016/S0306-4522(02)00964-8; Papaxanthis C, 2003, EXP BRAIN RES, V148, P498, DOI 10.1007/s00221-002-1327-y; Papaxanthis C, 1998, NEUROSCI LETT, V253, P103, DOI 10.1016/S0304-3940(98)00604-1; Papaxanthis C, 1998, EXP BRAIN RES, V120, P233, DOI 10.1007/s002210050397; Pozzo T, 1998, BRAIN RES REV, V28, P92, DOI 10.1016/S0165-0173(98)00030-7; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; Saijo N, 2005, J NEUROSCI, V25, P4941, DOI 10.1523/JNEUROSCI.4143-04.2005; Sergio LE, 1998, J NEUROPHYSIOL, V80, P1577, DOI 10.1152/jn.1998.80.3.1577; Sergio LE, 2003, J NEUROPHYSIOL, V89, P212, DOI 10.1152/jn.00016.2002; SOECHTING JF, 1983, J NEUROPHYSIOL, V49, P548, DOI 10.1152/jn.1983.49.2.548; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Torres E, 2006, J NEUROPHYSIOL, V96, P2613, DOI 10.1152/jn.00188.2006; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd	47	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22045	10.1371/journal.pone.0022045	http://dx.doi.org/10.1371/journal.pone.0022045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765935	gold, Green Submitted, Green Published			2022-12-25	WOS:000292699000021
J	Page, SH; Wright, EK; Gama, L; Clements, JE				Page, Stephen H.; Wright, Edward K., Jr.; Gama, Lucio; Clements, Janice E.			Regulation of CCL2 Expression by an Upstream TALE Homeodomain Protein-Binding Site That Synergizes with the Site Created by the A-2578G SNP	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NF-KAPPA-B; MCP-1 GENE-TRANSCRIPTION; CEREBROSPINAL-FLUID; INCREASED SUSCEPTIBILITY; PULMONARY TUBERCULOSIS; ASTROCYTOMA-CELLS; IFN-GAMMA; POLYMORPHISM; PROMOTER	CC Chemokine Ligand 2 (CCL2) is a potent chemoattractant produced by macrophages and activated astrocytes during periods of inflammation within the central nervous system. Increased CCL2 expression is correlated with disease progression and severity, as observed in pulmonary tuberculosis, HCV-related liver disease, and HIV-associated dementia. The CCL2 distal promoter contains an A/G polymorphism at position -2578 and the homozygous -2578 G/G genotype is associated with increased CCL2 production and inflammation. However, the mechanisms that contribute to the phenotypic differences in CCL2 expression are poorly understood. We previously demonstrated that the -2578 G polymorphism creates a TALE homeodomain protein binding site (TALE binding site) for PREP1/PBX2 transcription factors. In this study, we identified the presence of an additional TALE binding site 22 bp upstream of the site created by the -2578 G polymorphism and demonstrated the synergistic effects of the two sites on the activation of the CCL2 promoter. Using chromatin immunoprecipitation (ChIP) assays, we demonstrated increased binding of the TALE proteins PREP1 and PBX2 to the -2578 G allele, and binding of IRF1 to both the A and G alleles. The presence of TALE binding sites that form inverted repeats within the -2578 G allele results in increased transcriptional activation of the CCL2 distal promoter while the presence of only the upstream TALE binding site within the -2578 A allele exerts repression of promoter activity.	[Page, Stephen H.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA; [Page, Stephen H.; Gama, Lucio; Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA; [Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Neurol Pathol & Mol Biol & Genet, Baltimore, MD USA; [Wright, Edward K., Jr.] Henry M Jackson Fdn Adv Mil Med, Washington, DC USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Page, SH (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	jclements@jhmi.edu		Gama, Lucio/0000-0001-9511-012X	NIH [NS050028, NS47984, MH70306]; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH070306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050028, R01NS047984] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by NIH grants to J.E.C. (NS050028, NS47984, and MH70306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2005, J NEUROIMMUNOL, V160, P219, DOI 10.1016/j.jneuroim.2004.11.009; Abraham S, 2003, VIROLOGY, V309, P196, DOI 10.1016/S0042-6822(03)00112-0; Bernasconi S, 1996, J INFECT DIS, V174, P1098, DOI 10.1093/infdis/174.5.1098; Berthelsen J, 1999, GENE DEV, V13, P946, DOI 10.1101/gad.13.8.946; Boekhoudt GH, 2003, J IMMUNOL, V170, P4139, DOI 10.4049/jimmunol.170.8.4139; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Cho ML, 2004, AUTOIMMUNITY, V37, P77, DOI 10.1080/08916930310001609446; Christopherson K, 2001, STEM CELLS, V19, P388, DOI 10.1634/stemcells.19-5-388; Dickson ME, 2008, CIRC RES, V103, P940, DOI 10.1161/CIRCRESAHA.108.180653; Fenoglio C, 2004, NEUROBIOL AGING, V25, P1169, DOI 10.1016/j.neurobiolaging.2003.11.008; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Froberg MK, 2001, CIRC RES, V89, P1224, DOI 10.1161/hh2401.100601; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Goudet G, 1999, J BIOL CHEM, V274, P4067, DOI 10.1074/jbc.274.7.4067; Kim HL, 2002, AM J KIDNEY DIS, V40, P1146, DOI 10.1053/ajkd.2002.36858; Kumar SN, 2000, MOL IMMUNOL, V37, P623, DOI 10.1016/S0161-5890(00)00097-3; Lim SP, 2000, J VIROL, V74, P1632, DOI 10.1128/JVI.74.4.1632-1640.2000; Majumder S, 1996, J NEUROSCI RES, V45, P758, DOI 10.1002/(SICI)1097-4547(19960915)45:6<758::AID-JNR12>3.0.CO;2-S; Mankowski JL, 2004, J NEUROIMMUNOL, V157, P66, DOI 10.1016/j.jneuroim.2004.08.031; Mori Honami, 2005, Clin Exp Nephrol, V9, P297, DOI 10.1007/s10157-005-0375-6; Muhlbauer M, 2003, GASTROENTEROLOGY, V125, P1085, DOI 10.1016/S0016-5085(03)01213-7; Okada Y, 2003, BIOCHEM BIOPH RES CO, V305, P155, DOI 10.1016/S0006-291X(03)00718-6; Ping DS, 1999, J IMMUNOL, V162, P727; Ping DS, 2000, J BIOL CHEM, V275, P1708, DOI 10.1074/jbc.275.3.1708; Ping DS, 1996, IMMUNITY, V4, P455, DOI 10.1016/S1074-7613(00)80412-4; Rose CE, 2003, MICROCIRCULATION, V10, P273, DOI 10.1038/sj.mn.7800193; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Saura M, 1999, J MOL BIOL, V289, P459, DOI 10.1006/jmbi.1999.2752; Shen WF, 1999, MOL CELL BIOL, V19, P3051; Shen WF, 1997, MOL CELL BIOL, V17, P6448, DOI 10.1128/MCB.17.11.6448; SHYY YJ, 1993, BIOCHEM BIOPH RES CO, V192, P693, DOI 10.1006/bbrc.1993.1470; Simeoni E, 2004, DIABETOLOGIA, V47, P1574, DOI 10.1007/s00125-004-1494-4; Sui YJ, 2005, AM J PATHOL, V166, P355, DOI 10.1016/S0002-9440(10)62259-6; Szalai C, 2001, J ALLERGY CLIN IMMUN, V108, P375, DOI 10.1067/mai.2001.117930; Tabara Y, 2003, HYPERTENS RES, V26, P677, DOI 10.1291/hypres.26.677; Tamouza R, 2006, M S-MED SCI, V22, P571, DOI 10.1051/medsci/20062267571; Teferedegne B, 2006, MOL CELL BIOL, V26, P5759, DOI 10.1128/MCB.00271-06; ter Veld F, 2009, J ENDOCRINOL INVEST, V32, P123, DOI 10.1007/BF03345700; Tucci M, 2004, ARTHRITIS RHEUM-US, V50, P1842, DOI 10.1002/art.20266; UEDA A, 1994, J IMMUNOL, V153, P2052; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; Winter C, 2009, J IMMUNOL, V182, P4931, DOI 10.4049/jimmunol.0804096; Wright EK, 2008, GENES IMMUN, V9, P419, DOI 10.1038/gene.2008.33; YADAV A, CLIN CHIM ACTA, V411, P1570; Zhou ZHL, 1998, J IMMUNOL, V160, P3908; Zhou ZHL, 2001, FASEB J, V15, P383, DOI 10.1096/fj.00-0373com; Zink MC, 2001, J INFECT DIS, V184, P1015, DOI 10.1086/323478	48	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22052	10.1371/journal.pone.0022052	http://dx.doi.org/10.1371/journal.pone.0022052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760952	Green Published, gold, Green Submitted			2022-12-25	WOS:000292657200042
J	Facente, SN; Pilcher, CD; Hartogensis, WE; Klausner, JD; Philip, SS; Louie, B; Christopoulos, KA; Dowling, T; Colfax, GN				Facente, Shelley N.; Pilcher, Christopher D.; Hartogensis, Wendy E.; Klausner, Jeffrey D.; Philip, Susan S.; Louie, Brian; Christopoulos, Katerina A.; Dowling, Teri; Colfax, Grant N.			Performance of Risk-Based Criteria for Targeting Acute HIV Screening in San Francisco	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; INFECTION; TRANSMISSION; ADULTS; SURVEILLANCE; ADOLESCENTS	Background: Federal guidelines now recommend supplemental HIV RNA testing for persons at high risk for acute HIV infection. However, many rapid HIV testing sites do not include HIV RNA or p24 antigen testing due to concerns about cost, the need for results follow-up, and the impact of expanded venipuncture on clinic flow. We developed criteria to identify patients in a municipal STD clinic in San Francisco who are asymptomatic but may still be likely to have acute infection. Methods: Data were from patients tested with serial HIV antibody and HIV RNA tests to identify acute HIV infection. BED-CEIA results were used to classify non-acute cases as recent or longstanding. Demographics and self-reported risk behaviors were collected at time of testing. Multivariate models were developed and preliminarily evaluated using predictors associated with recent infection in bivariate analyses as a proxy for acute HIV infection. Multivariate models demonstrating >= 70% sensitivity for recent infection while testing <= 60% of patients in this development dataset were then validated by determining their performance in identifying acute infections. Results: From 2004-2007, 137 of 12,622 testers had recent and 36 had acute infections. A model limiting acute HIV screening to MSM plus any one of a series of other predictors resulted in a sensitivity of 83.3% and only 47.6% of patients requiring testing. A single-factor model testing only patients reporting any receptive anal intercourse resulted in 88.9% sensitivity with only 55.2% of patients requiring testing. Conclusions: In similar high risk HIV testing sites, acute screening using "supplemental" HIV p24 antigen or RNA tests can be rationally targeted to testers who report particular HIV risk behaviors. By improving the efficiency of acute HIV testing, such criteria could facilitate expanded acute case identification.	[Facente, Shelley N.] Facente Consulting, San Francisco, CA USA; [Facente, Shelley N.; Pilcher, Christopher D.; Hartogensis, Wendy E.; Christopoulos, Katerina A.] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA; [Klausner, Jeffrey D.; Philip, Susan S.] San Francisco Dept Publ Hlth STD Prevent & Contro, San Francisco, CA USA; [Louie, Brian] San Francisco Dept Publ Hlth, Microbiol Lab, San Francisco, CA USA; [Dowling, Teri; Colfax, Grant N.] San Francisco Dept Publ Hlth, HIV Prevent Sect, San Francisco, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco Department of Public Health; San Francisco Department of Public Health; San Francisco Department of Public Health	Facente, SN (corresponding author), Facente Consulting, San Francisco, CA USA.	shelley@facenteconsulting.com	Facente, Shelley/M-1147-2019	Facente, Shelley N./0000-0002-7266-352X	NIAID NIH HHS [P30 AI027763] Funding Source: Medline; NIMH NIH HHS [K23 MH092220] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH092220] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott Laboratories, 2009, ARCHITECT HIV AG AB; Abbott Molecular, 2009, ABB REALTIME HIV 1 A; [Association of Public Health Laboratories (APHL) Centers for Disease Control and Prevention], 2009, HIV TEST ALG STAT RE; Bayer Healthcare, 2004, VERS HIV 1 RNA 3 0 A; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Braunstein SL, 2009, AIDS REV, V11, P140; Brooks JT, 2006, AIDS, V20, P923, DOI 10.1097/01.aids.0000218558.82402.59; Centers for Disease Control and Prevention, 1989, MMWR; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; McWalter TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007368; Miller WC, 2009, AIDS, V23, P835, DOI 10.1097/QAD.0b013e328326f55e; Patel P, 2006, JAIDS-J ACQ IMM DEF, V42, P75, DOI 10.1097/01.qai.0000218363.21088.ad; Pilcher CD, 2005, NEW ENGL J MED, V352, P1873, DOI 10.1056/NEJMoa042291; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Plant AJ, 1998, SOC SCI MED, V47, P1147, DOI 10.1016/S0277-9536(98)00186-5; Powers KA, 2007, AIDS, V21, P2237, DOI 10.1097/QAD.0b013e3282f08b4d; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; San Francisco Department of Public Health, 2009, HIV AIDS EP ANN REP; San Francisco Department of Public Health, 2010, SAN FRANC HIV PREV P; Sherlock M, 2007, SEX TRANSM DIS, V34, P314, DOI 10.1097/01.olq.0000263262.00273.9c; Stein CR, 2008, ANN EPIDEMIOL, V18, P560, DOI 10.1016/j.annepidem.2008.03.002; Stekler J, 2005, AIDS, V19, P1323, DOI 10.1097/01.aids.0000180105.73264.81; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Westreich DJ, 2008, J CLIN MICROBIOL, V46, P1785, DOI 10.1128/JCM.00787-07	25	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21813	10.1371/journal.pone.0021813	http://dx.doi.org/10.1371/journal.pone.0021813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755003	gold, Green Published			2022-12-25	WOS:000292632000030
J	Vitvitsky, V; Garg, SK; Banerjee, R				Vitvitsky, Victor; Garg, Sanjay K.; Banerjee, Ruma			Taurine Biosynthesis by Neurons and Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISETHIONIC ACID; ORGANIC OSMOLYTES; RAT-BRAIN; HYPOTAURINE; METABOLISM; CYSTEINE; OXIDATION; CELLS; IDENTIFICATION; DECARBOXYLASE	The physiological roles of taurine, a product of cysteine degradation and one of the most abundant amino acids in the body, remain elusive. Taurine deficiency leads to heart dysfunction, brain development abnormalities, retinal degradation, and other pathologies. The taurine synthetic pathway is proposed to be incomplete in astrocytes and neurons, and metabolic cooperation between these cell types is reportedly needed to complete the pathway. In this study, we analyzed taurine synthesis capability as reported by incorporation of radioactivity from [S-35]cysteine into taurine, in primary murine astrocytes and neurons, and in several transformed cell lines (human (SH-SY5Y) and murine (N1E-115) neuroblastoma, human astrocytoma (U-87MG and 1321 N1), and rat glioma (C6)). Extensive incorporation of radioactivity from [S-35]cysteine into taurine was observed in rat glioma cells as well as in primary mouse astrocytes and neurons, establishing the presence of an intact taurine synthesis pathway in these cells. Interestingly, exposure of cells to cysteine or cysteamine resulted in elevated intracellular hypotaurine without a corresponding increase in taurine levels, suggesting that oxidation of hypotaurine limits taurine synthesis in cells. Consistent with its role as an organic osmolyte, taurine synthesis was stimulated under hypertonic conditions in neurons.	[Vitvitsky, Victor; Garg, Sanjay K.; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, 3320B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Vitvitsky, Victor/ABA-2967-2021	Vitvitsky, Victor/0000-0001-6251-6115	National Institutes of Health [DK64959]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK64959.	Albrecht J, 2005, NEUROCHEM RES, V30, P1615, DOI 10.1007/s11064-005-8986-6; Banerjee R, 2008, TRENDS BIOCHEM SCI, V33, P413, DOI 10.1016/j.tibs.2008.06.006; Beetsch JW, 1998, AM J PHYSIOL-CELL PH, V274, pC866, DOI 10.1152/ajpcell.1998.274.4.C866; Bhardwaj A, 2006, ANN NEUROL, V59, P229, DOI 10.1002/ana.20788; Bothwell JH, 2001, J NEUROCHEM, V77, P1632, DOI 10.1046/j.1471-4159.2001.00403.x; Brand A, 1997, CELL MOL BIOL, V43, P645; Brand A, 1998, J NEUROCHEM, V71, P827; Dominy J, 2004, NEUROCHEM RES, V29, P97, DOI 10.1023/B:NERE.0000010437.81860.d5; Dominy JE, 2007, AM J PHYSIOL-ENDOC M, V293, pE62, DOI 10.1152/ajpendo.00053.2007; Dominy J, 2007, J BIOL CHEM, V282, P25189, DOI 10.1074/jbc.M703089200; Fellman J H, 1987, Adv Exp Med Biol, V217, P39; FIORI A, 1969, Acta Vitaminologica et Enzymologica, V23, P204; Fisher SK, 2008, J NEUROCHEM, V106, P1998, DOI 10.1111/j.1471-4159.2008.05510.x; Foster DJ, 2009, J NEUROCHEM, V108, P437, DOI 10.1111/j.1471-4159.2008.05773.x; Garg SK, 2008, J IMMUNOL, V180, P3866, DOI 10.4049/jimmunol.180.6.3866; Garg SK, 2010, METHODS IN REDOX SIGNALING, P7; Garg SK, 2009, J NEUROCHEM, V108, P1155, DOI 10.1111/j.1471-4159.2009.05872.x; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hussy N, 2000, ADV EXP MED BIOL, V483, P227; HUXTABLE R, 1972, J NUTR, V102, P805, DOI 10.1093/jn/102.7.805; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; HUXTABLE RJ, 1989, PROG NEUROBIOL, V32, P471, DOI 10.1016/0301-0082(89)90019-1; JACKSON PS, 1993, AM J PHYSIOL, V265, pC1489, DOI 10.1152/ajpcell.1993.265.6.C1489; Kimelberg H K, 1987, Cent Nerv Syst Trauma, V4, P3; Lambert IH, 2004, NEUROCHEM RES, V29, P27, DOI 10.1023/B:NERE.0000010433.08577.96; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; LIEN YHH, 1991, J CLIN INVEST, V88, P303, DOI 10.1172/JCI115292; Morales I, 2007, AM J PHYSIOL-CELL PH, V292, pC1934, DOI 10.1152/ajpcell.00593.2006; Nakamura H, 2006, AMINO ACIDS, V31, P27, DOI 10.1007/s00726-005-0277-7; OJA SS, 1981, BIOCHIM BIOPHYS ACTA, V677, P350, DOI 10.1016/0304-4165(81)90246-4; PECK EJ, 1967, BIOCHIM BIOPHYS ACTA, V141, P499, DOI 10.1016/0304-4165(67)90178-X; PERRY TL, 1973, J NEUROCHEM, V21, P1009, DOI 10.1111/j.1471-4159.1973.tb07547.x; READ WO, 1962, J BIOL CHEM, V237, P1521; RICCI G, 1978, PHYSIOL CHEM PHYS M, V10, P435; Schuller-Levis GB, 2003, FEMS MICROBIOL LETT, V226, P195, DOI 10.1016/S0378-1097(03)00611-6; STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119; SUMIZU K, 1962, BIOCHIM BIOPHYS ACTA, V63, P210, DOI 10.1016/0006-3002(62)90357-8; TAPPAZ M, 1994, ADV EXP MED BIOL, V359, P257; Tuz K, 2001, J NEUROCHEM, V79, P143, DOI 10.1046/j.1471-4159.2001.00546.x; Warskulat U, 2007, METHOD ENZYMOL, V428, P439, DOI 10.1016/S0076-6879(07)28025-5; WORDEN JA, 1985, COMP BIOCHEM PHYS B, V82, P233, DOI 10.1016/0305-0491(85)90232-9	41	83	85	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32002	32010		10.1074/jbc.M111.253344	http://dx.doi.org/10.1074/jbc.M111.253344			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778230	Green Published, hybrid			2022-12-25	WOS:000294726800009
J	Yang, R; Fredman, G; Krishnamoorthy, S; Agrawal, N; Irimia, D; Piomelli, D; Serhan, CN				Yang, Rong; Fredman, Gabrielle; Krishnamoorthy, Sriram; Agrawal, Nitin; Irimia, Daniel; Piomelli, Daniele; Serhan, Charles N.			Decoding Functional Metabolomics with Docosahexaenoyl Ethanolamide (DHEA) Identifies Novel Bioactive Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANNABINOID RECEPTOR; WHOLE-BLOOD; FATTY-ACIDS; ANANDAMIDE; ENDOCANNABINOIDS; PLATELETS; INJURY; BINDS; D1; INFLAMMATION	Neuroinflammation and traumatic brain injury involve activation of inflammatory cells and production of local pro-inflammatory mediators that can amplify tissue damage. Using LC-UV-MS-MS-based lipidomics in tandem with functional screening at the single-cell level in microfluidic chambers, we identified a series of novel bioactive oxygenated docosahexaenoyl ethanolamide( DHEA) derived products that regulated leukocyte motility. These included 10,17-dihydroxydocosahexaenoyl ethanolamide (10,17-diHDHEA) and 15-hydroxy-16(17)-epoxy-docosapentaenoyl ethanolamide (15-HEDPEA), each of which was an agonist of recombinant CB2 receptors with EC50 3.9 X 10(-10) and 1.0 X 10(-10)M. In human whole blood, 10,17-diHDHEA and 15-HEDPEA at concentrations as low as 10 pM each prevented formation of platelet-leukocyte aggregates involving either platelet-monocyte or platelet-polymorphonuclear leukocyte. In vivo, 15-HEDPEA was organ-protective in mouse reperfusion second organ injury. Together these results indicate that DHEA oxidative metabolism produces potent novel molecules with anti-inflammatory and organ-protective properties.	[Yang, Rong; Fredman, Gabrielle; Krishnamoorthy, Sriram; Serhan, Charles N.] Brigham & Womens Hosp, Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Yang, Rong; Fredman, Gabrielle; Krishnamoorthy, Sriram; Serhan, Charles N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Agrawal, Nitin; Irimia, Daniel] Shriners Hosp Children, Massachusetts Gen Hosp, Ctr Engn Med & Surg Serv, BioMEMS Resource Ctr, Boston, MA 02129 USA; [Agrawal, Nitin; Irimia, Daniel] Harvard Univ, Sch Med, Boston, MA 02129 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92617 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92617 USA; [Piomelli, Daniele] Italian Inst Technol, I-16163 Genoa, Italy	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California Irvine; University of California System; University of California Irvine; Istituto Italiano di Tecnologia - IIT	Serhan, CN (corresponding author), Brigham & Womens Hosp, Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, 829,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu	Irimia, Daniel/S-5404-2019; Irimia, Daniel/A-4095-2008; Yang, Rong/ABA-7587-2021	Irimia, Daniel/0000-0001-7347-2082; Irimia, Daniel/0000-0001-7347-2082; Yang, Rong/0000-0001-8837-0089	National Institutes of Health [R01NS067686, RC2AT005909, R01DE019938]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [RC2AT005909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS067686 (to C. N. S.), RC2AT005909 (to C. N. S.), and R01DE019938 (to C. N. S. and D. I.).	Arnason BG, 2010, NEUROIMMUNE, V9, P1; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bazan NG, 2010, J LIPID RES, V51, P2018, DOI 10.1194/jlr.R001131; Berger A, 2001, P NATL ACAD SCI USA, V98, P6402, DOI 10.1073/pnas.101119098; Calder PC, 2010, P NUTR SOC, V69, P565, DOI 10.1017/S0029665110000157; De Petrocellis L, 2000, CHEM PHYS LIPIDS, V108, P191, DOI 10.1016/S0009-3084(00)00196-1; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Dona M, 2008, BLOOD, V112, P848, DOI 10.1182/blood-2007-11-122598; FELDER CC, 1993, P NATL ACAD SCI USA, V90, P7656, DOI 10.1073/pnas.90.16.7656; Franklin A, 2003, J NEUROSCI, V23, P7767; Furman MI, 2001, J AM COLL CARDIOL, V38, P1002, DOI 10.1016/S0735-1097(01)01485-1; Hassan IR, 2009, J IMMUNOL, V182, P3223, DOI 10.4049/jimmunol.0802064; Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h; Kasuga K, 2008, J IMMUNOL, V181, P8677, DOI 10.4049/jimmunol.181.12.8677; KILGORE KS, 1999, REPERFUSION INJURY; Kim HY, 2011, BIOCHEM J, V435, P327, DOI 10.1042/BJ20102118; Kozak KR, 2002, PROSTAG LEUKOTR ESS, V66, P211, DOI 10.1054/plef.2001.0359; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Kumar V., 2004, ROBBINS COTRAN PATHO; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Nishiura H, 1996, J BIOL CHEM, V271, P878, DOI 10.1074/jbc.271.2.878; Olson KR, 2007, ASSAY DRUG DEV TECHN, V5, P137, DOI 10.1089/adt.2006.052; Pace-Asciak CR, 1999, ADV EXP MED BIOL, V447, P123; Pavlopoulos S, 2006, CURR PHARM DESIGN, V12, P1751, DOI 10.2174/138161206776873743; PREISSNER WC, 1983, BRIT J DERMATOL, V109, P1, DOI 10.1111/j.1365-2133.1983.tb03984.x; Qiu FH, 2000, P NATL ACAD SCI USA, V97, P4267, DOI 10.1073/pnas.97.8.4267; RINDER HM, 1991, BLOOD, V78, P1730; ROWLEY FA, 1998, EICOSANOIDS; Sarma J, 2002, CIRCULATION, V105, P2166, DOI 10.1161/01.CIR.0000015700.27754.6F; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Sheskin T, 1997, J MED CHEM, V40, P659, DOI 10.1021/jm960752x; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Tjonahen E, 2006, CHEM BIOL, V13, P1193, DOI 10.1016/j.chembiol.2006.09.011; UEDA N, 1995, BBA-LIPID LIPID MET, V1254, P127, DOI 10.1016/0005-2760(94)00170-4; van Gils JM, 2009, J LEUKOCYTE BIOL, V85, P195, DOI 10.1189/jlb.0708400; Weyrich AS, 2004, TRENDS IMMUNOL, V25, P489, DOI 10.1016/j.it.2004.07.003; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; YANG R, 2011, CURR PR S94 IN PRESS; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	42	68	71	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31532	31541		10.1074/jbc.M111.237990	http://dx.doi.org/10.1074/jbc.M111.237990			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757729	Green Published, hybrid			2022-12-25	WOS:000294487500048
J	Razani, B; Zhang, HX; Schulze, PC; Schilling, JD; Verbsky, J; Lodhi, IJ; Topkara, VK; Feng, C; Coleman, T; Kovacs, A; Kelly, DP; Saffitz, JE; Dorn, GW; Nichols, CG; Semenkovich, CF				Razani, Babak; Zhang, Haixia; Schulze, P. Christian; Schilling, Joel D.; Verbsky, John; Lodhi, Irfan J.; Topkara, Veli K.; Feng, Chu; Coleman, Trey; Kovacs, Attila; Kelly, Daniel P.; Saffitz, Jeffrey E.; Dorn, Gerald W., II; Nichols, Colin G.; Semenkovich, Clay F.			Fatty Acid Synthase Modulates Homeostatic Responses to Myocardial Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; ACTIVATES PPAR-ALPHA; SARCOLEMMAL K-ATP; CARDIAC-HYPERTROPHY; HEART-FAILURE; IN-VIVO; PRESSURE-OVERLOAD; DIABETIC CARDIOMYOPATHY; CALMODULIN KINASE; GENE-EXPRESSION	Fatty acid synthase (FAS) promotes energy storage through de novo lipogenesis and participates in signaling by the nuclear receptor PPAR alpha in noncardiac tissues. To determine if de novo lipogenesis is relevant to cardiac physiology, we generated and characterized FAS knockout in the myocardium (FASKard) mice. FASKard mice develop normally, manifest normal resting heart function, and have normal cardiac PPAR alpha signaling as well as fatty acid oxidation. However, they decompensate with stress. Most die within 1 h of transverse aortic constriction, probably due to arrhythmia. Voltage clamp measurements of FASKard cardiomyocytes show hyperactivation of L-type calcium channel current that could not be reversed with palmitate supplementation. Of the classic regulators of this current, Ca2+/calmodulin-dependent protein kinase II (CaMKII) but not protein kinase A signaling is activated in FASKard hearts, and knockdown of FAS in cultured cells activates CaMKII. In addition to being intolerant of the stress of acute pressure, FASKard hearts were also intolerant of the stress of aging, reflected as persistent CaMKII hyperactivation, progression to dilatation, and premature death by similar to 1 year of age. CaMKII signaling appears to be pathogenic in FASKard hearts because inhibition of its signaling in vivo rescues mice from early mortality after transverse aortic constriction. FAS was also increased in two mechanistically distinct mouse models of heart failure and in the hearts of humans with end stage cardiomyopathy. These data implicate a novel relationship between FAS and calcium signaling in the heart and suggest that FAS induction in stressed myocardium represents a compensatory response to protect cardiomyocytes from pathological calcium flux.	[Razani, Babak; Lodhi, Irfan J.; Feng, Chu; Coleman, Trey; Semenkovich, Clay F.] Washington Univ, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Razani, Babak; Schilling, Joel D.; Topkara, Veli K.; Kovacs, Attila] Washington Univ, Div Cardiol, St Louis, MO 63110 USA; [Zhang, Haixia; Verbsky, John; Nichols, Colin G.; Semenkovich, Clay F.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Dorn, Gerald W., II] Washington Univ, Ctr Pharmacogenom, St Louis, MO 63110 USA; [Schulze, P. Christian] Columbia Univ, Div Cardiol, New York, NY 10032 USA; [Kelly, Daniel P.] Sanford Burnham Med Res Inst, Orlando, FL 32827 USA; [Saffitz, Jeffrey E.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Columbia University; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Semenkovich, CF (corresponding author), Washington Univ, Div Endocrinol Metab & Lipid Res, Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	csemenko@wustl.edu	Nichols, Colin/D-6336-2012; Kelly, Daniel/ABG-2056-2021; Schulze, Christian/AGJ-7744-2022	Schulze, Christian/0000-0001-9442-7141; Semenkovich, Clay/0000-0003-1163-1871; Topkara, Veli/0000-0002-2236-2008; Razani, Babak/0000-0002-7172-9240; Lodhi, Irfan/0000-0002-6246-9862	National Institutes of Health [P50 HL083762, DK076729, HL95010, DK088083, DK20579, DK56341, F32 DK083895, K08 HL098559]; Washington University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL098373, R01HL059888, R01HL058493, K08HL098559, R01HL095010, P50HL083762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088083, P60DK020579, R01DK076729, P30DK056341, F32DK083895, P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 HL083762, DK076729, HL95010, DK088083, DK20579, DK56341, F32 DK083895, and K08 HL098559. This work was also supported by the Physician Scientist Training Program and Cardiovascular Training Grant at Washington University.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Anderson ME, 2009, J CLIN INVEST, V119, P1082, DOI 10.1172/JCI39262; Anderson ME, 2004, TRENDS CARDIOVAS MED, V14, P152, DOI 10.1016/j.tcm.2004.02.005; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; BALLARD FB, 1960, J CLIN INVEST, V39, P717, DOI 10.1172/JCI104088; Belke DD, 1999, AM J PHYSIOL-REG I, V277, pR1210, DOI 10.1152/ajpregu.1999.277.4.R1210; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Boland LM, 2008, CELL BIOCHEM BIOPHYS, V52, P59, DOI 10.1007/s12013-008-9027-2; Browne CD, 2006, FASEB J, V20, P2027, DOI 10.1096/fj.05-5404com; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Bugger H, 2009, DIS MODEL MECH, V2, P454, DOI 10.1242/dmm.001941; Burchfield JS, 2010, CIRC-HEART FAIL, V3, P157, DOI 10.1161/CIRCHEARTFAILURE.109.899732; Campbell FM, 2002, J BIOL CHEM, V277, P4098, DOI 10.1074/jbc.M106054200; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chelu MG, 2009, J CLIN INVEST, V119, P1940, DOI 10.1172/JCI37059; Chen YJ, 2003, PHYSIOL GENOMICS, V14, P251, DOI 10.1152/physiolgenomics.00022.2003; Chirala SS, 2003, P NATL ACAD SCI USA, V100, P6358, DOI 10.1073/pnas.0931394100; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; DORN GW, 1994, AM J PHYSIOL, V267, pH400, DOI 10.1152/ajpheart.1994.267.1.H400; Du F, 2006, BIOCHEM BIOPH RES CO, V347, P814, DOI 10.1016/j.bbrc.2006.06.162; EVANS JR, 1964, CIRC RES, V15, P96; FEIN FS, 1994, CARDIOVASC DRUG THER, V8, P65, DOI 10.1007/BF00877091; Fiorentino M, 2008, LAB INVEST, V88, P1340, DOI 10.1038/labinvest.2008.97; Flagg TP, 2005, J MOL CELL CARDIOL, V39, P647, DOI 10.1016/j.yjmcc.2005.06.003; Flagg TP, 2004, AM J PHYSIOL-HEART C, V286, pH1361, DOI 10.1152/ajpheart.00676.2003; GANGULY PK, 1983, AM J PHYSIOL, V244, pE528, DOI 10.1152/ajpendo.1983.244.6.E528; Giarratana Nadia, 2007, Methods Mol Biol, V380, P285; Gilbertson J. R., 1977, LIPID METABOLISM MAM, V1, P367; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Haim TE, 2010, J MOL CELL CARDIOL, V48, P395, DOI 10.1016/j.yjmcc.2009.10.004; Hellerstein MK, 1999, EUR J CLIN NUTR, V53, pS53, DOI 10.1038/sj.ejcn.1600744; Hoch B, 1998, J CELL BIOCHEM, V68, P259, DOI 10.1002/(SICI)1097-4644(19980201)68:2<259::AID-JCB12>3.0.CO;2-A; HOIT BD, 1995, CIRC RES, V77, P632, DOI 10.1161/01.RES.77.3.632; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; Ikeda Y, 2008, PHYSIOLOGY, V23, P6, DOI 10.1152/physiol.00033.2007; Ishiguro K, 2006, MOL CELL BIOL, V26, P5497, DOI 10.1128/MCB.02469-05; Jones PL, 2000, MATRIX BIOL, V19, P581, DOI 10.1016/S0945-053X(00)00106-2; Kedzierski RM, 2003, MOL CELL BIOL, V23, P8226, DOI 10.1128/MCB.23.22.8226-8232.2003; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kittleson MM, 2004, CIRCULATION, V110, P3444, DOI 10.1161/01.CIR.0000148178.19465.11; Kraichely RE, 2009, AM J PHYSIOL-GASTR L, V296, pG833, DOI 10.1152/ajpgi.90610.2008; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; Liao RL, 2005, CIRCULATION, V111, P2416, DOI 10.1161/01.CIR.0000167557.59069.D9; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Nakamura A, 2001, AM J PHYSIOL-HEART C, V281, pH1104, DOI 10.1152/ajpheart.2001.281.3.H1104; ORAM JF, 1973, J BIOL CHEM, V248, P5299; Park HJ, 2008, J CLIN INVEST, V118, P259, DOI 10.1172/JCI32011; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; PetitJacques J, 1996, J PHYSIOL-LONDON, V493, P67, DOI 10.1113/jphysiol.1996.sp021365; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 2001, J BIOL CHEM, V276, P38121; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Remedi MS, 2009, CELL METAB, V9, P140, DOI 10.1016/j.cmet.2008.12.005; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Sakata Y, 1998, CIRCULATION, V97, P1488; Schneider JG, 2010, J BIOL CHEM, V285, P23396, DOI 10.1074/jbc.M110.100321; Semenkovich CF, 1997, PROG LIPID RES, V36, P43, DOI 10.1016/S0163-7827(97)00003-9; SHIMADA T, 1992, J GEN PHYSIOL, V100, P27, DOI 10.1085/jgp.100.1.27; Shimano H, 2009, FEBS J, V276, P616, DOI 10.1111/j.1742-4658.2008.06806.x; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Su HS, 2000, J NUTR, V130, p315S, DOI 10.1093/jn/130.2.315S; Tavi P, 2001, TRENDS PHARMACOL SCI, V22, P254, DOI 10.1016/S0165-6147(00)01679-5; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tian YR, 2008, AM J PHYSIOL-ENDOC M, V294, pE1178, DOI 10.1152/ajpendo.90237.2008; Topkara VK, 2009, CIRCULATION, V120, pS857; Tsui J, 2005, J BIOL CHEM, V280, P9210, DOI 10.1074/jbc.M407653200; Tucker SJ, 2008, J GEN PHYSIOL, V131, P431, DOI 10.1085/jgp.200709936; Ueno K, 2000, GENES CELLS, V5, P859, DOI 10.1046/j.1365-2443.2000.00369.x; van der Vusse GJ, 2000, CARDIOVASC RES, V45, P279, DOI 10.1016/S0008-6363(99)00263-1; VANDERVUSSE GJ, 1992, PHYSIOL REV, V72, P881, DOI 10.1152/physrev.1992.72.4.881; Weis MT, 2004, CARDIOVASC RES, V63, P338, DOI 10.1016/j.cardiores.2004.04.025; Wu YJ, 2002, CIRCULATION, V106, P1288, DOI 10.1161/01.CIR.0000027583.73268.E7; Wu YJ, 1999, AM J PHYSIOL-HEART C, V276, pH2168, DOI 10.1152/ajpheart.1999.276.6.H2168; Yamada S, 2006, J PHYSIOL-LONDON, V577, P1053, DOI 10.1113/jphysiol.2006.119511; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	86	49	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30949	30961		10.1074/jbc.M111.230508	http://dx.doi.org/10.1074/jbc.M111.230508			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757749	Green Published, hybrid			2022-12-25	WOS:000294283600073
J	Dominguez, MR; Silveira, ELV; de Vasconcelos, JRC; de Alencar, BCG; Machado, AV; Bruna-Romero, O; Gazzinelli, RT; Rodrigues, MM				Dominguez, Mariana R.; Silveira, Eduardo L. V.; de Vasconcelos, Jose Ronnie C.; de Alencar, Bruna C. G.; Machado, Alexandre V.; Bruna-Romero, Oscar; Gazzinelli, Ricardo T.; Rodrigues, Mauricio M.			Subdominant/Cryptic CD8 T Cell Epitopes Contribute to Resistance against Experimental Infection with a Human Protozoan Parasite	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTION; AMASTIGOTE SURFACE PROTEIN-2; SUSCEPTIBLE MOUSE STRAIN; CHAGAS HEART-DISEASE; PROTECTIVE IMMUNITY; TRANS-SIALIDASE; IMMUNODOMINANCE HIERARCHY; PRECURSOR FREQUENCIES; ADHESION MOLECULES; DOMINANT EPITOPE	During adaptive immune response, pathogen-specific CD8(+) T cells recognize preferentially a small number of epitopes, a phenomenon known as immunodominance. Its biological implications during natural or vaccine-induced immune responses are still unclear. Earlier, we have shown that during experimental infection, the human intracellular pathogen Trypanosoma cruzi restricts the repertoire of CD8(+) T cells generating strong immunodominance. We hypothesized that this phenomenon could be a mechanism used by the parasite to reduce the breath and magnitude of the immune response, favoring parasitism, and thus that artificially broadening the T cell repertoire could favor the host. Here, we confirmed our previous observation by showing that CD8(+) T cells of H-2(a) infected mice recognized a single epitope of an immunodominant antigen of the trans-sialidase super-family. In sharp contrast, CD8(+) T cells from mice immunized with recombinant genetic vaccines ( plasmid DNA and adenovirus) expressing this same T. cruzi antigen recognized, in addition to the immunodominant epitope, two other subdominant epitopes. This unexpected observation allowed us to test the protective role of the immune response to subdominant epitopes. This was accomplished by genetic vaccination of mice with mutated genes that did not express a functional immunodominant epitope. We found that these mice developed immune responses directed solely to the subdominant/cryptic CD8 T cell epitopes and a significant degree of protective immunity against infection mediated by CD8(+) T cells. We concluded that artificially broadening the T cell repertoire contributes to host resistance against infection, a finding that has implications for the host-parasite relationship and vaccine development.	[Dominguez, Mariana R.; Silveira, Eduardo L. V.; de Vasconcelos, Jose Ronnie C.; de Alencar, Bruna C. G.; Rodrigues, Mauricio M.] Univ Fed Sao Paulo, Escola Paulista Med, Ctr Terapia Celular & Mol CTCMol, Sao Paulo, Brazil; [Dominguez, Mariana R.; Silveira, Eduardo L. V.; de Vasconcelos, Jose Ronnie C.; de Alencar, Bruna C. G.; Rodrigues, Mauricio M.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Machado, Alexandre V.] Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Bruna-Romero, Oscar; Gazzinelli, Ricardo T.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil; [Gazzinelli, Ricardo T.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Gazzinelli, Ricardo T.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA USA	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of Massachusetts System; University of Massachusetts Worcester	Dominguez, MR (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Ctr Terapia Celular & Mol CTCMol, Sao Paulo, Brazil.	mrodrigues@unifesp.br	Dominguez, Mariana R/E-8407-2017; Alencar, Bruna/J-5089-2014; Rodrigues, Mauricio M./B-8512-2012; BRUNA-ROMERO, OSCAR/B-3918-2010; Alencar, Bruna/AGB-5949-2022; Silveira, Eduardo L V/E-5733-2014; Vasconcelos, José Ronnie C/I-5155-2012; Machado, Alexandre M Vieira/G-2468-2012	Alencar, Bruna/0000-0002-7711-1054; BRUNA-ROMERO, OSCAR/0000-0002-8855-4969; Silveira, Eduardo L V/0000-0001-8333-2884; Vasconcelos, José Ronnie C/0000-0003-1126-7563; Machado, Alexandre M Vieira/0000-0003-1506-4093; Dominguez, Mariana/0000-0002-3517-3599; Gazzinelli, Ricardo/0000-0003-2427-7699	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/06820-4]; The National Institute for Vaccine Technology (INCTV-CNPq); The Millennium Institute for Vaccine Development and Technology [CNPq - 420067/2005-1]; The Millennium Institute for Gene Therapy (Brazil); CNPq; FAPESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); The National Institute for Vaccine Technology (INCTV-CNPq); The Millennium Institute for Vaccine Development and Technology; The Millennium Institute for Gene Therapy (Brazil); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2009/06820-4), The National Institute for Vaccine Technology (INCTV-CNPq), The Millennium Institute for Vaccine Development and Technology (CNPq - 420067/2005-1) and The Millennium Institute for Gene Therapy (Brazil). EVLS, RTG and MMR are recipients of fellowships from CNPq. MRD and BCA are recipients of fellowships from FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo AFS, 2005, INFECT IMMUN, V73, P6017, DOI 10.1128/IAI.73.9.6017-6025.2005; Bixby LM, 2008, J IMMUNOL, V181, P2644, DOI 10.4049/jimmunol.181.4.2644; Blanchard N, 2008, NAT IMMUNOL, V9, P937, DOI 10.1038/ni.1629; Bonney KM, 2008, CURR MOL MED, V8, P510, DOI 10.2174/156652408785748004; Boscardin SB, 2010, J CELL MOL MED, V14, P1373, DOI 10.1111/j.1582-4934.2010.01007.x; Cazorla SI, 2010, J INFECT DIS, V202, P136, DOI 10.1086/652872; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; Claser C, 2007, MICROBES INFECT, V9, P1011, DOI 10.1016/j.micinf.2007.04.006; de Alencar BCG, 2009, INFECT IMMUN, V77, P4383, DOI 10.1128/IAI.01459-08; Freire-De-Lima L, 2010, J BIOL CHEM, V285, P13388, DOI 10.1074/jbc.M109.096305; Frickel EM, 2008, J INFECT DIS, V198, P1625, DOI 10.1086/593019; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Gutierrez FRS, 2009, PARASITE IMMUNOL, V31, P673, DOI 10.1111/j.1365-3024.2009.01108.x; Haolla FA, 2009, VACCINE, V27, P5644, DOI 10.1016/j.vaccine.2009.07.013; Holtappels R, 2008, J VIROL, V82, P5781, DOI 10.1128/JVI.00155-08; Irvine Kari, 2006, Expert Rev Clin Immunol, V2, P135, DOI 10.1586/1744666X.2.1.135; Jenkins MR, 2006, J IMMUNOL, V177, P2917, DOI 10.4049/jimmunol.177.5.2917; Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560; Kastenmuller W, 2007, J EXP MED, V204, P2187, DOI 10.1084/jem.20070489; Kierszenbaum F, 2005, TRENDS PARASITOL, V21, P513, DOI 10.1016/j.pt.2005.08.013; Kotturi MF, 2008, J IMMUNOL, V181, P2124, DOI 10.4049/jimmunol.181.3.2124; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; La Gruta NL, 2010, J CLIN INVEST, V120, P1885, DOI 10.1172/JCI41538; La Gruta NL, 2006, P NATL ACAD SCI USA, V103, P994, DOI 10.1073/pnas.0510429103; Lannes-Vieira J, 2009, MEM I OSWALDO CRUZ, V104, P226, DOI 10.1590/S0074-02762009000900029; LI SQ, 1993, P NATL ACAD SCI USA, V90, P5214, DOI 10.1073/pnas.90.11.5214; Machado AV, 2006, HUM GENE THER, V17, P898, DOI 10.1089/hum.2006.17.898; MacHugh ND, 2009, EUR J IMMUNOL, V39, P2459, DOI 10.1002/eji.200939227; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Martin DL, 2006, PLOS PATHOG, V2, P731, DOI 10.1371/journal.ppat.0020077; Mauduit M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007717; Miyahira Y, 2008, PARASITOL INT, V57, P38, DOI 10.1016/j.parint.2007.07.005; Newberg MH, 2006, J IMMUNOL, V176, P319, DOI 10.4049/jimmunol.176.1.319; Oukka M, 1996, J IMMUNOL, V157, P3039; Padilla AM, 2009, CURR OPIN IMMUNOL, V21, P385, DOI 10.1016/j.coi.2009.07.006; Pavelic V, 2009, EUR J IMMUNOL, V39, P704, DOI 10.1002/eji.200838901; Riedl P, 2009, J IMMUNOL, V183, P370, DOI 10.4049/jimmunol.0900505; RODRIGUES M, 1994, J IMMUNOL, V153, P4636; RODRIGUES M, 1992, J EXP MED, V175, P895, DOI 10.1084/jem.175.4.895; Rodrigues MM, 2009, BRAZ J MED BIOL RES, V42, P220, DOI 10.1590/S0100-879X2009000300001; Rosenberg CS, 2010, J IMMUNOL, V185, P560, DOI 10.4049/jimmunol.1000432; Ruckwardt TJ, 2010, J IMMUNOL, V185, P4673, DOI 10.4049/jimmunol.1001606; Sacha JB, 2008, J VIROL, V82, P9293, DOI 10.1128/JVI.00749-08; Scharfstein J, 2009, MEM I OSWALDO CRUZ, V104, P187, DOI 10.1590/S0074-02762009000900025; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Sedegah M, 1998, P NATL ACAD SCI USA, V95, P7648, DOI 10.1073/pnas.95.13.7648; Tarleton RL, 2007, CURR OPIN IMMUNOL, V19, P430, DOI 10.1016/j.coi.2007.06.003; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Tzelepis F, 2006, INFECT IMMUN, V74, P2477, DOI 10.1128/IAI.74.4.2477-2481.2006; Tzelepis F, 2008, J IMMUNOL, V180, P1737, DOI 10.4049/jimmunol.180.3.1737; Tzelepis F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000393; Vasconcelos JR, 2004, HUM GENE THER, V15, P878, DOI 10.1089/hum.2004.15.878; Willis RA, 2006, P NATL ACAD SCI USA, V103, P12063, DOI 10.1073/pnas.0605130103; Wilson DC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000815; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; [No title captured]	56	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22011	10.1371/journal.pone.0022011	http://dx.doi.org/10.1371/journal.pone.0022011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779365	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811300035
J	Guo, J; Dai, XW; Xu, JR; Wang, YL; Bai, PF; Liu, FR; Duan, YH; Zhang, H; Huang, LL; Kang, ZS				Guo, Jun; Dai, Xiwei; Xu, Jin-Rong; Wang, Yulin; Bai, Pengfei; Liu, Furong; Duan, Yinghui; Zhang, Hong; Huang, Lili; Kang, Zhensheng			Molecular Characterization of a Fus3/Kss1 Type MAPK from Puccinia striiformis f. sp tritici, PsMAPK1	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SINGLE-NUCLEOTIDE POLYMORPHISMS; FUSARIUM-GRAMINEARUM; USTILAGO-MAYDIS; INFECTIOUS GROWTH; GENE; WHEAT; RUST; PATHOGENICITY; CONIDIATION	Puccinia striiformis f. sp. tritici (Pst) is an obligate biotrophic fungus that causes the destructive wheat stripe rust disease worldwide. Due to the lack of reliable transformation and gene disruption method, knowledge about the function of Pst genes involved in pathogenesis is limited. Mitogen-activated protein kinase (MAPK) genes have been shown in a number of plant pathogenic fungi to play critical roles in regulating various infection processes. In the present study, we identified and characterized the first MAPK gene PsMAPK1 in Pst. Phylogenetic analysis indicated that PsMAPK1 is a YERK1 MAP kinase belonging to the Fus3/Kss1 class. Single nucleotide polymerphisms (SNPs) and insertion/deletion were detected in the coding region of PsMAPK1 among six Pst isolates. Real-time RT-PCR analyses revealed that PsMAPK1 expression was induced at early infection stages and peaked during haustorium formation. When expressed in Fusarium graminearum, PsMAPK1 partially rescued the map1 mutant in vegetative growth and pathogenicity. It also partially complemented the defects of the Magnaporthe oryzae pmk1 mutant in appressorium formation and plant infection. These results suggest that F. graminearum and M. oryzae can be used as surrogate systems for functional analysis of well-conserved Pst genes and PsMAPK1 may play a role in the regulation of plant penetration and infectious growth in Pst.	[Guo, Jun; Dai, Xiwei; Wang, Yulin; Bai, Pengfei; Liu, Furong; Duan, Yinghui; Zhang, Hong; Huang, Lili; Kang, Zhensheng] NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Guo, Jun; Dai, Xiwei; Wang, Yulin; Bai, Pengfei; Liu, Furong; Zhang, Hong; Huang, Lili; Kang, Zhensheng] NW A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Duan, Yinghui] NW A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Xu, Jin-Rong] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kang, ZS (corresponding author), NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	Kangzs@nwsuaf.edu.cn	Zhao, jing/B-7349-2008; Bai, Pengfei/GVU-7318-2022	Bai, Pengfei/0000-0002-2281-2881; Kang, Zhensheng/0000-0001-5575-0122	Ministry of Agriculture of China [200903035-02]; Ministry of Education of China [B07049]; Chinese Ministry of Education [107104]; Program for Excellent Young Scholars in Northwest AF University	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Ministry of Education of China(Ministry of Education, China); Chinese Ministry of Education(Ministry of Education, China); Program for Excellent Young Scholars in Northwest AF University	This work was supported by the Hangye Program from the Ministry of Agriculture of China (200903035-02), the 111 Project from Ministry of Education of China (No. B07049), the Key Project of Chinese Ministry of Education (No. 107104), and the Program for Excellent Young Scholars in Northwest A&F University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basse CW, 2004, MOL PLANT PATHOL, V5, P83, DOI [10.1111/j.1364-3703.2004.00210.x, 10.1111/j.1364-3703.2004.00210.X]; Bluhm BH, 2007, MOL PLANT MICROBE IN, V20, P627, DOI 10.1094/MPMI-20-6-0627; Brachmann A, 2003, EMBO J, V22, P2199, DOI 10.1093/emboj/cdg198; Bruno KS, 2004, EUKARYOT CELL, V3, P1525, DOI 10.1128/EC.3.6.1525-1532.2004; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Davidson RC, 2003, MOL MICROBIOL, V49, P469, DOI 10.1046/j.1365-2958.2003.03563.x; Ding SL, 2010, PLANT CELL, V22, P2495, DOI 10.1105/tpc.110.074302; Forche A, 2004, EUKARYOT CELL, V3, P705, DOI 10.1128/EC.3.3.705-714.2004; Gale LR, 2002, PHYTOPATHOLOGY, V92, P1315, DOI 10.1094/PHYTO.2002.92.12.1315; Gong XY, 2007, FUNGAL GENET BIOL, V44, P1368, DOI 10.1016/j.fgb.2007.07.007; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Hu GG, 2007, MOL PLANT MICROBE IN, V20, P637, DOI 10.1094/MPMI-20-6-0637; Jenczmionka NJ, 2003, CURR GENET, V43, P87, DOI 10.1007/s00294-003-0379-2; Kahmann R, 2004, NEW PHYTOL, V164, P31, DOI 10.1111/j.1469-8137.2004.01156.x; Kinane J, 2003, FUNGAL GENET BIOL, V39, P94, DOI 10.1016/S1087-1845(02)00587-X; Koch R, 2000, GENOME RES, V10, P1690, DOI 10.1101/gr.GR-1471R; Kultz D, 1998, J MOL EVOL, V46, P571, DOI 10.1007/PL00006338; Lev S, 1999, P NATL ACAD SCI USA, V96, P13542, DOI 10.1073/pnas.96.23.13542; Ling P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-145; Liu WD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001261; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mboup M, 2009, FUNGAL GENET BIOL, V46, P299, DOI 10.1016/j.fgb.2008.12.007; Mehrabi R, 2008, EUKARYOT CELL, V7, P791, DOI 10.1128/EC.00009-08; Menotta M, 2006, MOL GENET GENOMICS, V276, P126, DOI 10.1007/s00438-006-0128-6; Moldenhauer J, 2006, PLANT PATHOL, V55, P469, DOI 10.1111/j.1365-3059.2006.01385.x; Monge RA, 2006, MICROBIOL-SGM, V152, P905, DOI 10.1099/mic.0.28616-0; PETERSEN RH, 1974, BOT REV, V40, P453, DOI 10.1007/BF02860021; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Sakaeda T, 2004, CURR TOP MED CHEM, V4, P1385; Sambrook J., 1989, MOL CLONING LAB MANU; Seong K, 2006, FUNGAL GENET BIOL, V43, P34, DOI 10.1016/j.fgb.2005.10.002; Su ZG, 2002, EUR J PHARMACOL, V454, P9, DOI 10.1016/S0014-2999(02)02427-5; Szabo LJ, 2001, P NATL ACAD SCI USA, V98, P7654, DOI 10.1073/pnas.151262398; Takano Y, 2000, MOL PLANT MICROBE IN, V13, P374, DOI 10.1094/MPMI.2000.13.4.374; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Urban M, 2003, MOL PLANT PATHOL, V4, P347, DOI 10.1046/J.1364-3703.2003.00183.X; Voegele RT, 2003, NEW PHYTOL, V159, P93, DOI 10.1046/j.1469-8137.2003.00761.x; Voegele RT, 2001, P NATL ACAD SCI USA, V98, P8133, DOI 10.1073/pnas.131186798; Wang BT, 2010, PLANT DIS, V94, P221, DOI 10.1094/PDIS-94-2-0221; Wang CF, 2007, PHYSIOL MOL PLANT P, V71, P230, DOI 10.1016/j.pmpp.2008.02.006; Wang Y, 2011, MOL PLANT MICROBE IN, V24, P118, DOI 10.1094/MPMI-06-10-0129; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Xu JR, 1997, MOL PLANT MICROBE IN, V10, P187, DOI 10.1094/MPMI.1997.10.2.187; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237; Yang J, 2010, MOL PLANT MICROBE IN, V23, P112, DOI 10.1094/MPMI-23-1-0112; Zhang YH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-203; Zhao XH, 2007, EUKARYOT CELL, V6, P1701, DOI 10.1128/EC.00216-07; Zhao XH, 2007, MOL MICROBIOL, V63, P881, DOI 10.1111/j.1365-2958.2006.05548.x	53	22	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21895	10.1371/journal.pone.0021895	http://dx.doi.org/10.1371/journal.pone.0021895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779350	gold, Green Published, Green Submitted			2022-12-25	WOS:000292811300025
J	Alves, LR; Costa, ES; Sorgine, MHF; Nascimento-Silva, MCL; Teodosio, C; Barcena, P; Castro-Faria-Neto, HC; Bozza, PT; Orfao, A; Oliveira, PL; Maya-Monteiro, CM				Alves, Liliane R.; Costa, Elaine S.; Sorgine, Marcos H. F.; Nascimento-Silva, Maria Clara L.; Teodosio, Cristina; Barcena, Paloma; Castro-Faria-Neto, Hugo C.; Bozza, Patricia T.; Orfao, Alberto; Oliveira, Pedro L.; Maya-Monteiro, Clarissa M.			Heme-Oxygenases during Erythropoiesis in K562 and Human Bone Marrow Cells	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; ERYTHROID-DIFFERENTIATION; TRANSCRIPTION FACTORS; HEMATOPOIETIC CYTOKINES; ERYTHROLEUKEMIC CELLS; DEGRADATIVE ENZYMES; IRON-METABOLISM; GENE-EXPRESSION; POTENT INDUCER; RAT-LIVER	In mammalian cells, heme can be degraded by heme-oxygenases (HO). Heme-oxygenase 1 (HO-1) is known to be the heme inducible isoform, whereas heme-oxygenase 2 (HO-2) is the constitutive enzyme. Here we investigated the presence of HO during erythroid differentiation in human bone marrow erythroid precursors and K562 cells. HO-1 mRNA and protein expression levels were below limits of detection in K562 cells. Moreover, heme was unable to induce HO-1, at the protein and mRNA profiles. Surprisingly, HO-2 expression was inhibited upon incubation with heme. To evaluate the physiological relevance of these findings, we analyzed HO expression during normal erythropoiesis in human bone marrow. Erythroid precursors were characterized by lack of significant expression of HO-1 and by progressive reduction of HO-2 during differentiation. FLVCR expression, a recently described heme exporter found in erythroid precursors, was also analyzed. Interestingly, the disruption in the HO detoxification system was accompanied by a transient induction of FLVCR. It will be interesting to verify if the inhibition of HO expression, that we found, is preventing a futile cycle of concomitant heme synthesis and catabolism. We believe that a significant feature of erythropoiesis could be the replacement of heme breakdown by heme exportation, as a mechanism to prevent heme toxicity.	[Alves, Liliane R.; Sorgine, Marcos H. F.; Nascimento-Silva, Maria Clara L.; Oliveira, Pedro L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Costa, Elaine S.] Univ Fed Rio de Janeiro, Inst Pediat & Puericultura Martagao Gesteira, Rio De Janeiro, Brazil; [Teodosio, Cristina; Barcena, Paloma; Orfao, Alberto] Univ Salamanca, Ctr Invest Canc, Dept Med, E-37008 Salamanca, Spain; [Teodosio, Cristina; Barcena, Paloma; Orfao, Alberto] Univ Salamanca, Serv Citometria, E-37008 Salamanca, Spain; [Castro-Faria-Neto, Hugo C.; Bozza, Patricia T.; Maya-Monteiro, Clarissa M.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunofarmacol, Rio De Janeiro, Brazil; [Oliveira, Pedro L.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; Fundacao Oswaldo Cruz	Alves, LR (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.	pedro@bioqmed.ufrj.br; clarissa@ioc.fiocruz.br	Bozza, Patricia T./AAM-4537-2021; COSTA, ELAINE SOBRAL/AAE-9574-2021; Orfao, Alberto/B-5801-2017; Bozza, Patricia T./AAE-2933-2021; L. Oliveira, Pedro/A-9438-2010; Sobral da Costa, Elaine/O-6523-2014	Bozza, Patricia T./0000-0001-8349-9529; L. Oliveira, Pedro/0000-0003-0307-354X; Sobral da Costa, Elaine/0000-0002-5340-5816; Teodosio, Cristina/0000-0002-2097-7199	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Oswaldo Cruz (FIOCRUZ); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Howard Hughes Medical Institute (HHMI) [55005952]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Oswaldo Cruz (FIOCRUZ); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute)	This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), the Fundacao Oswaldo Cruz (FIOCRUZ), the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), and the Howard Hughes Medical Institute (HHMI) number 55005952 to Pedro Lagerblad de Oliveira. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CRAIK CS, 1980, P NATL ACAD SCI-BIOL, V77, P1384, DOI 10.1073/pnas.77.3.1384; Della Porta MG, 2006, LEUKEMIA, V20, P549, DOI 10.1038/sj.leu.2404142; FUJITA H, 1989, BRIT J HAEMATOL, V73, P557, DOI 10.1111/j.1365-2141.1989.tb00297.x; Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; HAMILTON JW, 1991, ARCH BIOCHEM BIOPHYS, V289, P387, DOI 10.1016/0003-9861(91)90428-L; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; HOFFMAN R, 1980, BLOOD, V56, P567; IBRAHIM NG, 1982, BRIT J HAEMATOL, V50, P17, DOI 10.1111/j.1365-2141.1982.tb01886.x; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lammers R, 2002, EXP HEMATOL, V30, P537, DOI 10.1016/S0301-472X(02)00798-1; LAVROVSKY Y, 1994, P NATL ACAD SCI USA, V91, P5987, DOI 10.1073/pnas.91.13.5987; LEDER A, 1975, CELL, V5, P319, DOI 10.1016/0092-8674(75)90107-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; MAINES MD, 1986, J BIOL CHEM, V261, P411; Mayerhofer M, 2004, CANCER RES, V64, P3148, DOI 10.1158/0008-5472.CAN-03-1200; MELEFORS O, 1993, J BIOL CHEM, V268, P5974; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Ponka P, 1997, BLOOD, V89, P1; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Rey MA, 2008, HAEMATOL-HEMATOL J, V93, P1617, DOI 10.3324/haematol.13359; RUTHERFORD TR, 1979, NATURE, V280, P164, DOI 10.1038/280164a0; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Sadlon TJ, 1999, INT J BIOCHEM CELL B, V31, P1153, DOI 10.1016/S1357-2725(99)00073-4; SASSA S, 1970, P NATL ACAD SCI USA, V67, P517, DOI 10.1073/pnas.67.2.517; SASSA S, 1976, J EXP MED, V143, P305, DOI 10.1084/jem.143.2.305; Schaer DJ, 2006, EUR J HAEMATOL, V77, P432, DOI 10.1111/j.1600-0609.2006.00730.x; Schranzhofer M, 2006, BLOOD, V107, P4159, DOI 10.1182/blood-2005-05-1809; Sharma HS, 2000, ACTA NEUROCHIR SUPPL, V76, P153; Shokawa T, 2006, J PHARMACOL SCI, V100, P162, DOI 10.1254/jphs.SC0040188; Soe-Lin S, 2009, P NATL ACAD SCI USA, V106, P5960, DOI 10.1073/pnas.0900808106; Sutherland BA, 2009, NEUROSCI RES, V65, P326, DOI 10.1016/j.neures.2009.08.007; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Tahara T, 2004, J BIOL CHEM, V279, P5480, DOI 10.1074/jbc.M302733200; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; TRAKSHEL GM, 1987, EXP HEMATOL, V15, P859; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; YAMAMOTO M, 1982, BIOCHEM BIOPH RES CO, V105, P985, DOI 10.1016/0006-291X(82)91067-1; YOSHIDA T, 1988, EUR J BIOCHEM, V171, P457, DOI 10.1111/j.1432-1033.1988.tb13811.x; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318	48	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21358	10.1371/journal.pone.0021358	http://dx.doi.org/10.1371/journal.pone.0021358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765894	Green Published, Green Submitted, gold			2022-12-25	WOS:000292781500004
J	Phan, KD; Croteau, LP; Kam, JWK; Kania, A; Cloutier, JF; Butler, SJ				Phan, Keith Dai; Croteau, Louis-Philippe; Kam, Joseph Wai Keung; Kania, Artur; Cloutier, Jean-Francois; Butler, Samantha Joanna			Neogenin May Functionally Substitute for Dcc in Chicken	PLOS ONE			English	Article							COLORECTAL-CANCER; ROOF PLATE; NEURONAL DIFFERENTIATION; REPULSIVE GUIDANCE; EXPRESSION; MOUSE; RECEPTOR; HOMOLOG; NETRIN-1; MOLECULE	Dcc is the key receptor that mediates attractive responses of axonal growth cones to netrins, a family of axon guidance cues used throughout evolution. However, a Dcc homolog has not yet been identified in the chicken genome, raising the possibility that Dcc is not present in avians. Here we show that the closely related family member neogenin may functionally substitute for Dcc in the developing chicken spinal cord. The expression pattern of chicken neogenin in the developing spinal cord is a composite of the distribution patterns of both rodent Dcc and neogenin. Moreover, whereas the loss of mouse neogenin has no effect on the trajectory of commissural axons, removing chicken neogenin by RNA interference results in a phenotype similar to the functional inactivation of Dcc in mouse. Taken together, these data suggest that the chick neogenin is functionally equivalent to rodent Dcc.	[Phan, Keith Dai; Butler, Samantha Joanna] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Croteau, Louis-Philippe; Kania, Artur] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Kam, Joseph Wai Keung; Cloutier, Jean-Francois] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Kam, Joseph Wai Keung; Cloutier, Jean-Francois] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Kania, Artur] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Kania, Artur] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Kania, Artur] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Southern California; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; McGill University; Universite de Montreal; McGill University; McGill University	Phan, KD (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	butlersj@usc.edu	Cloutier, Jean-François/K-2003-2012	Kania, Artur/0000-0002-5209-2520	Canadian Institutes of Health Research [MOP-97758, MOP-77571]; March of Dimes Foundation [1-FY07-458]; National Institutes of Health [NS 063999]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063999] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); March of Dimes Foundation(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from Canadian Institutes of Health Research to A.K. (MOP-97758) and J.-F.C. (MOP-77571) (http://www.cihr-irsc.gc.ca/e/193.html); and the March of Dimes Foundation (1-FY07-458) (http://www.marchofdimes.com/) and the National Institutes of Health (NS 063999) (http://www.nih.gov/) to S.J.B. J.-F.C. holds a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Bae GU, 2009, MOL BIOL CELL, V20, P4920, DOI 10.1091/mbc.E09-06-0491; Bennett KL, 1997, J BIOL CHEM, V272, P26940, DOI 10.1074/jbc.272.43.26940; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Cole SJ, 2007, INT J BIOCHEM CELL B, V39, P1569, DOI 10.1016/j.biocel.2006.11.009; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; Deiner MS, 1999, J NEUROSCI, V19, P9900; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Gad JM, 1997, DEV BIOL, V192, P258, DOI 10.1006/dbio.1997.8756; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; Guan W, 2003, GENE EXPR PATTERNS, V3, P369, DOI 10.1016/S1567-133X(03)00007-3; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Helms AW, 2000, DEVELOPMENT, V127, P1185; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hjorth JT, 2001, MECH DEVELOP, V109, P105, DOI 10.1016/S0925-4773(01)00513-5; HOLLEY JA, 1982, J COMP NEUROL, V205, P371, DOI 10.1002/cne.902050406; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Jiang Y, 2003, DEV BIOL, V258, P364, DOI 10.1016/S0012-1606(03)00136-2; Keeling SL, 1997, ONCOGENE, V15, P691, DOI 10.1038/sj.onc.1201225; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Klein SL, 2002, DEV DYNAM, V225, P384, DOI 10.1002/dvdy.10174; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Kruger RP, 2004, J NEUROSCI, V24, P10826, DOI 10.1523/JNEUROSCI.3715-04.2004; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Matsunaga E, 2006, J NEUROSCI, V26, P6082, DOI 10.1523/JNEUROSCI.4556-05.2006; Moore SW, 2007, ADV EXP MED BIOL, V621, P17, DOI 10.1007/978-0-387-76715-4_2; OPPENHEIM RW, 1988, J COMP NEUROL, V275, P159, DOI 10.1002/cne.902750202; Phan KD, 2010, J NEUROSCI, V30, P15430, DOI 10.1523/JNEUROSCI.4117-10.2010; PIERCEALL WE, 1994, DEV BIOL, V166, P654, DOI 10.1006/dbio.1994.1345; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; RUEGG MA, 1989, EMBO J, V8, P55, DOI 10.1002/j.1460-2075.1989.tb03348.x; Sander TL, 2003, GENE, V310, P29, DOI 10.1016/S0378-1119(03)00509-2; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shen H, 2002, MECH DEVELOP, V118, P219, DOI 10.1016/S0925-4773(02)00255-1; VIELMETTER J, 1994, J CELL BIOL, V127, P2009, DOI 10.1083/jcb.127.6.2009; Wang H, 1999, J NEUROSCI, V19, P4938; WENTWORTH LE, 1984, J COMP NEUROL, V222, P96, DOI 10.1002/cne.902220109; Wilson NH, 2007, INT J BIOCHEM CELL B, V39, P874, DOI 10.1016/j.biocel.2006.10.023; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018; Yamauchi K, 2008, DEVELOPMENT, V135, P1119, DOI 10.1242/dev.012989; Yang F, 2008, BIOCHEMISTRY-US, V47, P4237, DOI 10.1021/bi800036h	49	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e22072	10.1371/journal.pone.0022072	http://dx.doi.org/10.1371/journal.pone.0022072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779375	gold, Green Published, Green Submitted			2022-12-25	WOS:000292680900028
J	Esselstyn, JA; Maher, SP; Brown, RM				Esselstyn, Jacob A.; Maher, Sean P.; Brown, Rafe M.			Species Interactions during Diversification and Community Assembly in an Island Radiation of Shrews	PLOS ONE			English	Article							COMPETITIVE-EXCLUSION PRINCIPLE; BODY-SIZE EVOLUTION; GEOGRAPHIC DISTRIBUTIONS; NICHE CONSERVATISM; PHYLOGENETIC OVERDISPERSION; PHILIPPINE ARCHIPELAGO; CHARACTER DISPLACEMENT; HUXLEYS MODIFICATION; SORICIDAE CROCIDURA; ADAPTIVE RADIATION	Background: Closely related, ecologically similar species often have adjacent distributions, suggesting competitive exclusion may contribute to the structure of some natural communities. In systems such as island archipelagos, where speciation is often tightly associated with dispersal over oceanic barriers, competitive exclusion may prevent population establishment following inter-island dispersal and subsequent cladogenesis. Methodology/Principal Findings: Using a combination of tools, we test the hypothesis that the distributions of shrew (Crocidura) species in the Philippines are the result of competitive exclusion preventing secondary invasion of occupied islands. We first compare ecological niche models between two widespread, allopatric species and find statistical support for their ecological similarity, implying that competition for habitat between these species is possible. We then examine dispersion patterns among sympatric species and find some signal for overdispersion of body size, but not for phylogenetic branch length. Finally, we simulate the process of inter-island colonization under a stochastic model of dispersal lacking ecological forces. Results are dependent on the geographic scope and colonization probability employed. However, some combinations suggest that the number of inter-island dispersal events necessary to populate the archipelago may be much higher than the minimum number of colonization events necessary to explain current estimates of species richness and phylogenetic relationships. If our model is appropriate, these results imply that alternative factors, such as competitive exclusion, may have influenced the process of inter-island colonization and subsequent cladogenesis. Conclusions/Significance: We interpret the combined results as providing tenuous evidence that similarity in body size may prevent co-occurrence in Philippine shrews and that competitive exclusion among ecologically similar species, rather than an inability to disperse among islands, may have limited diversification in this group, and, possibly other clades endemic to island archipelagos.	[Esselstyn, Jacob A.] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Maher, Sean P.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Brown, Rafe M.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Brown, Rafe M.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	McMaster University; University System of Georgia; University of Georgia; University of Kansas; University of Kansas	Esselstyn, JA (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	jessel@mcmaster.ca	Maher, Sean/V-7553-2017	Maher, Sean/0000-0002-3430-0410; Esselstyn, Jacob/0000-0002-1823-4062	The United States National Science Foundation [DEB 0743491, 0640737, OISE 0965856]; American Society of Mammalogists; University of Kansas; Direct For Biological Sciences [0743491] Funding Source: National Science Foundation	The United States National Science Foundation; American Society of Mammalogists; University of Kansas; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The United States National Science Foundation (http://www.nsf.gov/) provided financial support through DEB 0743491 and 0640737 to RMB and Graduate Research and International Postdoctoral (OISE 0965856) fellowships to JAE. Additional financial support was provided by the American Society of Mammalogists and E. Raymond Hall Fund of the University of Kansas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Anderson RP, 2002, OIKOS, V98, P3, DOI 10.1034/j.1600-0706.2002.t01-1-980116.x; [Anonymous], 2009, ENCY ISLANDS; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Bintanja R, 2005, NATURE, V437, P125, DOI 10.1038/nature03975; Blackburn DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012090; Brown RM, 2002, BIOL J LINN SOC, V76, P393, DOI 10.1111/j.1095-8312.2002.tb01704.x; BROWN RM, 2002, SILLIMAN J, V42, P133; BROWN RM, 2009, ENCY ISLANDS, P723; Cardillo M, 2010, GLOBAL ECOL BIOGEOGR, V19, P465, DOI 10.1111/j.1466-8238.2010.00537.x; Case T., 1986, COMMUNITY ECOL, P98; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; CHAN RCY, 1985, INFECT IMMUN, V47, P84, DOI 10.1128/IAI.47.1.84-89.1985; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; Cooper N, 2008, P ROY SOC B-BIOL SCI, V275, P2031, DOI 10.1098/rspb.2008.0420; Darwin C., 1859, ORIGIN SPECIES MEANS; DENBOER PJ, 1986, TRENDS ECOL EVOL, V1, P25, DOI 10.1016/0169-5347(86)90064-9; DIAMOND J, 1989, AM NAT, V134, P675, DOI 10.1086/285006; Diamond J.M., 1975, P342; DIAMOND JM, 1983, OIKOS, V41, P307, DOI 10.2307/3544090; Dib L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040007; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Esselstyn JA, 2010, J MAMMAL, V91, P1467, DOI 10.1644/10-MAMM-A-002.1; Esselstyn JA, 2010, J BIOGEOGR, V37, P2054, DOI 10.1111/j.1365-2699.2010.02378.x; Esselstyn JA, 2010, J BIOGEOGR, V37, P1504, DOI 10.1111/j.1365-2699.2010.02295.x; Esselstyn JA, 2009, EVOLUTION, V63, P2595, DOI 10.1111/j.1558-5646.2009.00743.x; Esselstyn JA, 2009, MOL PHYLOGENET EVOL, V53, P171, DOI 10.1016/j.ympev.2009.05.034; Evans BJ, 2003, SYST BIOL, V52, P794, DOI 10.1080/10635150390251063; Gause G. F., 1934, STRUGGLE EXISTENCE; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Grant P., 1986, COMMUNITY ECOLOGY, P173; Grinnell J., 1904, AUK, V21, P364, DOI DOI 10.2307/4070199; GUREVITCH J, 1992, AM NAT, V140, P539, DOI 10.1086/285428; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Hall Robert, 1998, P99; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Heaney L.R., 1985, Modern Quaternary Research in Southeast Asia, V9, P127; Heaney L. R., 1998, FIELDIANA ZOOL, V88, P1, DOI DOI 10.5962/BHL.TITLE.3419; Heaney L. R., 2010, SYNOPSIS PHILIPPINE; Heaney Lawrence R., 2006, Fieldiana Zoology, P1; Heaney LR, 2005, J BIOGEOGR, V32, P229, DOI 10.1111/j.1365-2699.2004.01120.x; HEANEY LR, 1994, SPECIAL PUBLICATION, V18, P357; HEANEY LR, 2002, SYLVATROP, V10, P6; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Hutterer Rainer, 2007, Lynx (Prague), P5; Inger R. F., 1954, Fieldiana Zoology, V33, P181; Jimenez-Valverde Alberto, 2009, Biodiversity Informatics, V6, P28; Jordan DS, 1908, AM NAT, V42, P73, DOI 10.1086/278905; Kirkland Jr G. L., 1991, SPEC PUBL MUS SW BIO, P15; Lack D., 1947, DARWINS FINCHES; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; Losos JB, 2010, EVOLUTION DARWIN 1 1, V150, P381; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Mahler DL, 2010, EVOLUTION, V64, P2731, DOI 10.1111/j.1558-5646.2010.01026.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Miller G. S., 1910, Proceedings of the United States National Museum Smithsonian Institution Washington, V38; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Moen DS, 2009, EVOLUTION, V63, P195, DOI 10.1111/j.1558-5646.2008.00538.x; Neill C, 2009, OIKOS, V118, P1570, DOI 10.1111/j.1600-0706.2009.17522.x; Olson ME, 2009, BIOESSAYS, V31, P1337, DOI 10.1002/bies.200900102; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Passarge J, 2006, ECOL MONOGR, V76, P57, DOI 10.1890/04-1824; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Peterson AT, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P617; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Pritchard JR, 2001, EVOL ECOL RES, V3, P209; R Development Core Team, 2009, R FDN STAT COMP; Rabosky DL, 2007, OECOLOGIA, V154, P561, DOI 10.1007/s00442-007-0849-1; Rambaut A, 2014, TRACER V1 6; Roberts TE, 2006, BIOL J LINN SOC, V88, P329, DOI 10.1111/j.1095-8312.2006.00616.x; Roberts TE, 2006, MOL ECOL, V15, P2183, DOI 10.1111/j.1365-294X.2006.02928.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCHOENER TW, 1983, NATURE, V302, P332, DOI 10.1038/302332a0; SETIADI MI, 2011, AM NAT IN PRESS; Siler CD, 2010, MOL PHYLOGENET EVOL, V55, P699, DOI 10.1016/j.ympev.2010.01.027; SIMBERLOFF D, 1978, AM NAT, V112, P713, DOI 10.1086/283313; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stanley WT, 2010, BIOL J LINN SOC, V100, P669, DOI 10.1111/j.1095-8312.2010.01448.x; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Taylor EH, 1928, DISTRIBUTION LIFE PH, V21, P214; Vitt LJ, 2005, P NATL ACAD SCI USA, V102, P7877, DOI 10.1073/pnas.0501104102; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; WILEY EO, 1978, SYST ZOOL, V27, P17, DOI 10.2307/2412809; WILSON DS, 1975, AM NAT, V109, P769, DOI 10.1086/283042	99	26	26	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21885	10.1371/journal.pone.0021885	http://dx.doi.org/10.1371/journal.pone.0021885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760918	Green Published, Green Submitted, gold			2022-12-25	WOS:000292655400024
J	Grainger, SJ; Putnam, AJ				Grainger, Stephanie J.; Putnam, Andrew J.			Assessing the Permeability of Engineered Capillary Networks in a 3D Culture	PLOS ONE			English	Article							BLOOD-VESSELS; IN-VITRO; ENDOTHELIAL-CELLS; PROGENITOR CELLS; TISSUE; ANGIOGENESIS; MORPHOGENESIS; ABNORMALITIES; MICROVESSELS; VASCULATURE	Many pathologies are characterized by poor blood vessel growth and reduced nutrient delivery to the surrounding tissue, introducing a need for tissue engineered blood vessels. Our lab has developed a 3D co-culture method to grow interconnected networks of pericyte-invested capillaries, which can anastamose with host vasculature following implantation to restore blood flow to ischemic tissues. However, if the engineered vessels contain endothelial cells (ECs) that are misaligned or contain wide junctional gaps, they may function improperly and behave more like the pathologic vessels that nourish tumors. The purpose of this study was to test the resistance to permeability of these networks in vitro, grown with different stromal cell types, as a metric of vessel functionality. A fluorescent dextran tracer was used to visualize transport across the endothelium and the pixel intensity was quantified using a customized MATLAB algorithm. In fibroblast-EC co-cultures, the dextran tracer easily penetrated through the vessel wall and permeability was high through the first 5 days of culture, indicative of vessel immaturity. Beyond day 5, dextran accumulated at the periphery of the vessel, with very little transported across the endothelium. Quantitatively, permeability dropped from initial levels of 61% to 39% after 7 days, and to 7% after 2 weeks. When ECs were co-cultured with bone marrow-derived mesenchymal stem cells (MSCs) or adipose-derived stem cells (AdSCs), much tighter control of permeability was achieved. Relative to the EC-fibroblast co-cultures, permeabilities were reduced 41% for the EC-MSC co-cultures and 50% for the EC-AdSC co-cultures after 3 days of culture. By day 14, these permeabilities decreased by 68% and 77% over the EC-fibroblast cultures. Co-cultures containing stem cells exhibit elevated VE-cadherin levels and more prominent EC-EC junctional complexes when compared to cultures containing fibroblasts. These data suggest the stromal cell identity influences the functionality and physiologic relevance of engineered capillary networks.	[Grainger, Stephanie J.; Putnam, Andrew J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Grainger, SJ (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	putnam@umich.edu	Putnam, Andrew J./E-8643-2010	Putnam, Andrew J./0000-0002-1262-4377	National Heart, Lung, and Blood Institute [R01-HL-085339]; American Recovery and Reinvestment Act supplement [R01-HL-085339-03S1]; NIH [T32-GM-008353]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Recovery and Reinvestment Act supplement; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by Award Number R01-HL-085339 from the National Heart, Lung, and Blood Institute, and an American Recovery and Reinvestment Act supplement to that grant (R01-HL-085339-03S1). S.J.G. was supported by a predoctoral fellowship from NIH Cellular Biotechnology Training Grant (T32-GM-008353). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Blau HM, 2001, NAT MED, V7, P532, DOI 10.1038/87850; Brey EM, 2005, TISSUE ENG, V11, P567, DOI 10.1089/ten.2005.11.567; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314; Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005; CURRY FE, 1983, AM J PHYSIOL, V245, pH495, DOI 10.1152/ajpheart.1983.245.3.H495; Ghajar CM, 2008, CRIT REV EUKAR GENE, V18, P251, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.30; Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774; Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875; Ghajar CM, 2010, EXP CELL RES, V316, P813, DOI 10.1016/j.yexcr.2010.01.013; Griffith CK, 2005, TISSUE ENG, V11, P257, DOI 10.1089/ten.2005.11.257; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; KACHGAL S, 2010, ANGIOGENESIS; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; McDonald DM, 2002, CANCER RES, V62, P5381; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Merfeld-Clauss S, 2010, TISSUE ENG PT A, V16, P2953, DOI [10.1089/ten.tea.2009.0635, 10.1089/ten.TEA.2009.0635]; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; MONTESANO R, 1993, J CELL SCI, V105, P1013; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Neumann T, 2003, MICROVASC RES, V66, P59, DOI 10.1016/S0026-2862(03)00040-2; Nor JE, 2001, LAB INVEST, V81, P453, DOI 10.1038/labinvest.3780253; PAKWAI A, 2008, ENG FUNCTIONAL BLOOD; Price GM, 2010, BIOMATERIALS, V31, P6182, DOI 10.1016/j.biomaterials.2010.04.041; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Sandoval R, 2001, AM J PHYSIOL-LUNG C, V280, pL239, DOI 10.1152/ajplung.2001.280.2.L239; Shaterian A, 2009, BURNS, V35, P811, DOI 10.1016/j.burns.2008.12.012; Shepherd BR, 2009, TISSUE ENG PT A, V15, P165, DOI 10.1089/ten.tea.2008.0010; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475	36	47	47	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e22086	10.1371/journal.pone.0022086	http://dx.doi.org/10.1371/journal.pone.0022086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760956	Green Published, Green Submitted, gold			2022-12-25	WOS:000292655400044
J	Yamada, H; Ueda, T; Yano, A				Yamada, Hidetoshi; Ueda, Tomohiro; Yano, Akira			Water-Soluble Extract of Pacific Krill Prevents Triglyceride Accumulation in Adipocytes by Suppressing PPAR gamma and C/EBP alpha Expression	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; GENE-EXPRESSION; PROMOTES ADIPOGENESIS; 3T3-L1 PREADIPOCYTES; INSULIN-RESISTANCE; ADIPOSE-TISSUE; KEY REGULATOR; SERUM-LIPIDS; OBESE GENE; DIFFERENTIATION	Background: Pacific Krill (Euphausia pacifica) are small, red crustaceans, similar to shrimp, that flourish in the North Pacific and are eaten in Japan. Methods and Findings: We investigated the effect of a water-soluble extract of Pacific Krill on adipocytes and discovered that this extract suppressed triglyceride accumulation in adipocytes. Furthermore, the water-soluble extract of Pacific Krill suppressed the expression of two master regulators of adipocyte differentiation, peroxisome proliferator-activated receptor gamma (PPAR gamma) and CCAAT enhancer binding protein alpha (C/EBP alpha). C/EBP beta promotes PPAR gamma and C/EBP alpha expression, but the water-soluble extract of Pacific Krill did not inhibit the expression of C/EBP beta or C/EBP beta-mediated transcriptional activation. The Pacific Krill extract was more effective than a PPAR gamma antagonist in suppressing PPAR gamma and C/EBP alpha expression. Conclusions: These results indicated that the water-soluble extract of Pacific Krill was not simply a PPAR gamma antagonist, but that it prevented triglyceride accumulation in adipocytes by suppression of PPAR gamma and C/EBP alpha via a pathway that is independent of C/EBP beta.	[Yamada, Hidetoshi; Yano, Akira] Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan; [Ueda, Tomohiro] Iwate Fisheries Technol Ctr, Kamaishi, Iwate 0260001, Japan	Iwate Biotechnology Research Center	Yamada, H (corresponding author), Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan.	hyamada@ibrc.or.jp	Yano, Akira/AAL-3544-2020		Basic Biotechnology Project of Iwate Prefecture, Japan; Sanriku Foundation	Basic Biotechnology Project of Iwate Prefecture, Japan; Sanriku Foundation	This work was supported by a fund from the Basic Biotechnology Project of Iwate Prefecture, Japan, and Grants-in-Aid from the Sanriku Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batetta B, 2009, J NUTR, V139, P1495, DOI 10.3945/jn.109.104844; Bridges KM, 2010, J AGR FOOD CHEM, V58, P2830, DOI 10.1021/jf9036408; Bunea Ruxandra, 2004, Altern Med Rev, V9, P420; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Deutsch L, 2007, J AM COLL NUTR, V26, P39, DOI 10.1080/07315724.2007.10719584; FERRAMOSCA A, 2011, J ANIMAL PHYSL ANIMA; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gigliotti JC, 2011, UROL RES, V39, P59, DOI 10.1007/s00240-010-0261-x; Guo W, 2009, CELL RES, V19, P216, DOI 10.1038/cr.2008.319; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Han LK, 1999, INT J OBESITY, V23, P98, DOI 10.1038/sj.ijo.0800766; Hong KM, 2007, J BIOL CHEM, V282, P22910, DOI 10.1074/jbc.M703597200; Hutley L, 2004, DIABETES, V53, P3097, DOI 10.2337/diabetes.53.12.3097; Ierna M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-136; Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109; Kidd PM, 2007, ALTERN MED REV, V12, P207; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; Lowell BB, 1999, CELL, V99, P239, DOI 10.1016/S0092-8674(00)81654-2; Maeda H, 2005, BIOCHEM BIOPH RES CO, V332, P392, DOI 10.1016/j.bbrc.2005.05.002; Matsumura H, 2005, CELL MICROBIOL, V7, P11, DOI 10.1111/j.1462-5822.2004.00478.x; Matsumura H, 2003, P NATL ACAD SCI USA, V100, P15718, DOI 10.1073/pnas.2536670100; Matsumura H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012010; Mori TA, 1999, AM J CLIN NUTR, V70, P817; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Rochford JJ, 2004, MOL CELL BIOL, V24, P9863, DOI 10.1128/MCB.24.22.9863-9872.2004; Sakaue H, 2002, GENE DEV, V16, P908, DOI 10.1101/gad.983202; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tandy S, 2009, J AGR FOOD CHEM, V57, P9339, DOI 10.1021/jf9016042; Tang QQ, 1999, MOL CELL BIOL, V19, P4855; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Tou JC, 2007, NUTR REV, V65, P63, DOI 10.1301/nr.2007.feb.63-77; Ulven SM, 2011, LIPIDS, V46, P37, DOI 10.1007/s11745-010-3490-4; WAKABAYASHI S, 1995, J ENDOCRINOL, V144, P533, DOI 10.1677/joe.0.1440533; Widberg CH, 2009, AM J PHYSIOL-ENDOC M, V296, pE121, DOI 10.1152/ajpendo.90602.2008; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zhu JJ, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-30; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	45	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21952	10.1371/journal.pone.0021952	http://dx.doi.org/10.1371/journal.pone.0021952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760932	Green Submitted, gold, Green Published			2022-12-25	WOS:000292655400030
J	Zoppoli, G; Solier, S; Reinhold, WC; Liu, H; Connelly, JW; Monks, A; Shoemaker, RH; Abaan, OD; Davis, SR; Meltzer, PS; Doroshow, JH; Pommier, Y				Zoppoli, G.; Solier, S.; Reinhold, W. C.; Liu, H.; Connelly, J. W., Jr.; Monks, A.; Shoemaker, R. H.; Abaan, O. D.; Davis, S. R.; Meltzer, P. S.; Doroshow, J. H.; Pommier, Y.			CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute	ONCOGENE			English	Article						Chk2; centrosome; H2AX; p53; BRCA1; Fanconi anemia	DNA-DAMAGE RESPONSE; CHK2 PROTEIN-KINASE; LI-FRAUMENI-SYNDROME; TUMOR-SUPPRESSOR; BREAST-CANCER; THREONINE-68 PHOSPHORYLATION; CHECKPOINT PATHWAY; LUNG-CANCER; IN-VITRO; EXPRESSION	CHEK2 encodes a serine/threonine kinase (Chk2) activated by ATM in response to DNA double-strand breaks. On the one hand, CHEK2 has been described as a tumor suppressor with proapoptotic, cell-cycle checkpoint and mitotic functions. On the other hand, Chk2 is also commonly activated (phosphorylated at T68) in cancers and precancerous lesions. Here, we report an extensive characterization of CHEK2 across the panel of 60 established cancer cell lines from the NCI Anticancer Screen (the NCI-60) using genomic and proteomic analyses, including exon-specific mRNA expression, DNA copy-number variation (CNV) by aCGH, exome sequencing, as well as western blot analyses for total and activated (pT68-Chk2) Chk2. We show that the high heterogeneity of Chk2 levels in cancer cells is primarily due to its inactivation (owing to low gene expression, alternative splicing, point mutations, copy-number alterations and premature truncation) or reduction of protein levels. Moreover, we observe that a significant percentage of cancer cells (12% of the NCI-60 and HeLa cells) show high endogenous Chk2 activation, which is always associated with p53 inactivation, and which is accompanied by downregulation of the Fanconi anemia and homologous recombination pathways. We also report the presence of activated Chk2 (pT68-Chk2) along with histone gamma-H2AX in centrosomes. Oncogene (2012) 31, 403-418; doi: 10.1038/onc.2011.283; published online 18 July 2011	[Zoppoli, G.] Univ Genoa, Dept Internal Med DiMI, I-16132 Genoa, Italy; [Zoppoli, G.; Solier, S.; Reinhold, W. C.; Liu, H.; Doroshow, J. H.; Pommier, Y.] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Liu, H.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Connelly, J. W., Jr.; Monks, A.] SAIC Frederick Inc, Lab Funct Genom, NCI Frederick, Frederick, MD USA; [Shoemaker, R. H.] NCI, Screening Technol Branch, Dev Therapeut Program, Div Canc Treatment & Diag,NIH, Frederick, MD 21701 USA; [Abaan, O. D.; Davis, S. R.; Meltzer, P. S.] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Doroshow, J. H.] NCI, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA	University of Genoa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zoppoli, G (corresponding author), Univ Genoa, Dept Internal Med DiMI, Avancorpo 2 Piano,Vle Benedetto XV,Room 223,6, I-16132 Genoa, Italy.	gabriele.zoppoli@unige.it; pommier@nih.gov	Shoemaker, Robert/GPK-1314-2022; Zoppoli, Gabriele/B-6935-2016; SOLIER, STEPHANIE/AAA-6851-2020; Davis, Sean/AAD-1801-2021; Reinhold, William/J-6704-2017; Zoppoli, Gabriele/B-6935-2016	Zoppoli, Gabriele/0000-0003-3890-5588; Davis, Sean/0000-0002-8991-6458; Reinhold, William/0000-0001-5513-9323; Zoppoli, Gabriele/0000-0002-1619-1708; SOLIER, Stephanie/0000-0003-3867-4644	Center for Cancer Research; National Cancer Institute; Division of Cancer Treatment and Diagnosis; National Cancer Institute (National Institutes of Health); AIRC MFAG [10570]; University of Genova (Genova, Italy); NATIONAL CANCER INSTITUTE [ZIABC011091, ZIABC011078, ZIABC006150] Funding Source: NIH RePORTER	Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Cancer Treatment and Diagnosis(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Treatment & Diagnosis); National Cancer Institute (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AIRC MFAG(Fondazione AIRC per la ricerca sul cancro); University of Genova (Genova, Italy); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Center for Cancer Research, Intramural Program of the National Cancer Institute, and by the Division of Cancer Treatment and Diagnosis, Extramural Program of the National Cancer Institute (National Institutes of Health), and by AIRC MFAG grant no. 10570 (GZ). GZ was also supported by a PhD fellowship grant (XXIII Ciclo) from the University of Genova (Genova, Italy).	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Ahn J, 2002, J BIOL CHEM, V277, P48418, DOI 10.1074/jbc.M208321200; Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; Ahn JY, 2000, CANCER RES, V60, P5934; Albert JM, 2007, CLIN CANCER RES, V13, P3033, DOI 10.1158/1078-0432.CCR-06-2872; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Bahassi EM, 2008, ONCOGENE, V27, P3977, DOI 10.1038/onc.2008.17; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartkova J, 2004, ONCOGENE, V23, P8545, DOI 10.1038/sj.onc.1207878; Bartkova J, 2010, ONCOGENE, V29, P5095, DOI 10.1038/onc.2010.249; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2001, ONCOGENE, V20, P5897, DOI 10.1038/sj.onc.1204746; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Berge EO, 2010, BBA-MOL CELL RES, V1803, P386, DOI 10.1016/j.bbamcr.2010.01.005; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bussey KJ, 2006, MOL CANCER THER, V5, P853, DOI 10.1158/1535-7163.MCT-05-0155; Cao L, 2006, EMBO J, V25, P2167, DOI 10.1038/sj.emboj.7601115; Castedo M, 2004, ONCOGENE, V23, P4353, DOI 10.1038/sj.onc.1207573; Chehab NH, 2000, GENE DEV, V14, P278; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Eymin B, 2006, MOL CELL BIOL, V26, P4339, DOI 10.1128/MCB.02240-05; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Fan C, 2006, BBA-MOL CELL RES, V1763, P1090, DOI 10.1016/j.bbamcr.2006.08.026; Ghosh JC, 2006, CANCER RES, V66, P11576, DOI 10.1158/0008-5472.CAN-06-3095; Gire W, 2004, EMBO J, V23, P2554, DOI 10.1038/sj.emboj.7600259; Gmeiner WH, 2010, MOL CANCER THER, V9, P3105, DOI 10.1158/1535-7163.MCT-10-0674; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hattori H, 2004, PATHOL INT, V54, P26, DOI 10.1111/j.1440-1827.2004.01585.x; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Holbeck SL, 2010, MOL CANCER THER, V9, P1451, DOI 10.1158/1535-7163.MCT-10-0106; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Jobson AG, 2009, J PHARMACOL EXP THER, V331, P816, DOI 10.1124/jpet.109.154997; KESSIS TD, 1993, P NATL ACAD SCI USA, V90, P3988, DOI 10.1073/pnas.90.9.3988; Kim DS, 2009, LUNG CANCER, V65, P247, DOI 10.1016/j.lungcan.2009.03.011; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lee SB, 2001, CANCER RES, V61, P8062; Li J, 2005, J BIOL CHEM, V280, P12041, DOI 10.1074/jbc.M412445200; Li J, 2008, J BIOL CHEM, V283, P36019, DOI 10.1074/jbc.M804075200; Lukas C, 2001, CANCER RES, V61, P4990; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Nevanlinna H, 2006, ONCOGENE, V25, P5912, DOI 10.1038/sj.onc.1209877; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Niida H, 2010, EMBO J, V29, P3558, DOI 10.1038/emboj.2010.218; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Nuciforo PG, 2007, CARCINOGENESIS, V28, P2082, DOI 10.1093/carcin/bgm108; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Pfister TD, 2009, MOL CANCER THER, V8, P1878, DOI 10.1158/1535-7163.MCT-09-0016; Pommier Y, 2006, CLIN CANCER RES, V12, P2657, DOI 10.1158/1078-0432.CCR-06-0743; Pommier Y, 2005, CURR PHARM DESIGN, V11, P2855, DOI 10.2174/1381612054546716; Powers JT, 2004, MOL CANCER RES, V2, P203; Reinhold WC, 2010, CANCER RES, V70, P2191, DOI 10.1158/0008-5472.CAN-09-3528; Ribeiro-Silva A, 2006, HISTOL HISTOPATHOL, V21, P373, DOI 10.14670/HH-21.373; Rogoff HA, 2004, MOL CELL BIOL, V24, P2968, DOI 10.1128/MCB.24.7.2968-2977.2004; Roschke AV, 2003, CANCER RES, V63, P8634; Sarbia M, 2007, BRIT J CANCER, V97, P1404, DOI 10.1038/sj.bjc.6604037; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Schwarz JK, 2003, MOL CANCER RES, V1, P598; Sedelnikova OA, 2006, CELL CYCLE, V5, P2909, DOI 10.4161/cc.5.24.3569; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Solier S, 2009, CELL CYCLE, V8, P1853, DOI 10.4161/cc.8.12.8865; Solier S, 2009, MOL CELL BIOL, V29, P68, DOI 10.1128/MCB.00581-08; Staalesen V, 2004, ONCOGENE, V23, P8535, DOI 10.1038/sj.onc.1207928; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Stolz A, 2010, NAT CELL BIOL, V12, P492, DOI 10.1038/ncb2051; Sullivan A, 2002, ONCOGENE, V21, P1316, DOI 10.1038/sj.onc.1205207; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; Tsvetkov L, 2003, J BIOL CHEM, V278, P8468, DOI 10.1074/jbc.M211202200; Yang ST, 2006, J BIOL CHEM, V281, P26645, DOI 10.1074/jbc.M604391200; YEE C, 1985, AM J PATHOL, V119, P361; Yu Q, 2001, FEBS LETT, V505, P7, DOI 10.1016/S0014-5793(01)02756-9; Zhang SS, 2007, J CELL BIOCHEM, V101, P451, DOI 10.1002/jcb.21195; Zhao H, 2008, CYTOM PART A, V73A, P480, DOI 10.1002/cyto.a.20574; Zhao H, 2007, CYTOM PART A, V71A, P905, DOI 10.1002/cyto.a.20469; Zhou M, 2007, ANAL CHEM, V79, P7603, DOI 10.1021/ac071584r	84	16	16	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	4					403	418		10.1038/onc.2011.283	http://dx.doi.org/10.1038/onc.2011.283			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891LU	21765476	Green Accepted			2022-12-25	WOS:000300219300001
J	Diguet, N; Mallat, Y; Ladouce, R; Clodic, G; Prola, A; Tritsch, E; Blanc, J; Larcher, JC; Delcayre, C; Samuel, JL; Friguet, B; Bolbach, G; Li, ZL; Mericskay, M				Diguet, Nicolas; Mallat, Youssef; Ladouce, Romain; Clodic, Gilles; Prola, Alexandre; Tritsch, Eva; Blanc, Jocelyne; Larcher, Jean-Christophe; Delcayre, Claude; Samuel, Jane-Lise; Friguet, Bertrand; Bolbach, Gerard; Li, Zhenlin; Mericskay, Mathias			Muscle Creatine Kinase Deficiency Triggers Both Actin Depolymerization and Desmin Disorganization by Advanced Glycation End Products in Dilated Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; SERUM RESPONSE FACTOR; HEART-FAILURE; IN-VIVO; PROTEIN; GENE; SRF; CYTOSKELETON; DYSFUNCTION; MYOPATHY	Alterations in the balance of cytoskeleton as well as energetic proteins are involved in the cardiac remodeling occurring in dilated cardiomyopathy (DCM). We used two-dimensional DIGE proteomics as a discovery approach to identify key molecular changes taking place in a temporally controlled model of DCM triggered by cardiomyocyte-specific serum response factor (SRF) knock-out in mice. We identified muscle creatine kinase (MCK) as the primary down-regulated protein followed by alpha-actin and alpha-tropomyosin down-regulation leading to a decrease of polymerized F-actin. The early response to these defects was an increase in the amount of desmin intermediate filaments and phosphorylation of the alpha B-crystallin chaperone. We found that alpha B-crystallin and desmin progressively lose their striated pattern and accumulate at the intercalated disk and the sarcolemma, respectively. We further show that desmin is a preferential target of advanced glycation end products (AGE) in mouse and human DCM. Inhibition of CK in cultured cardiomyocytes is sufficient to recapitulate both the actin depolymerization defect and the modification of desmin by AGE. Treatment with either cytochalasin D or glyoxal, a cellular AGE, indicated that both actin depolymerization and AGE contribute to desmin disorganization. Heat shock-induced phosphorylation of alpha B-crystallin provides a transient protection of desmin against glyoxal in a p38 MAPK-dependent manner. Our results show that the strong down-regulation of MCK activity contributes to F-actin instability and induces post-translational modification of alpha B-crystallin and desmin. Our results suggest that AGE may play an important role in DCM because they alter the organization of desmin filaments that normally support stress response and mitochondrial functions in cardiomyocytes.	[Mericskay, Mathias] Univ Paris 06, UR4 Vieillissement, UPMC, Dept Aging Stress & Inflammat, F-75005 Paris, France; [Clodic, Gilles; Bolbach, Gerard] Univ Paris 06, Mass Spectrometry Facil IFR83, UPMC, F-75005 Paris, France; [Larcher, Jean-Christophe] Univ Paris 06, CNRS Dev Biol UMR7622, UPMC, F-75005 Paris, France; [Prola, Alexandre] Univ Paris 11, LabEx LERMIT, INSERM, UMR S 769, F-92296 Chatenay Malabry, France; [Delcayre, Claude; Samuel, Jane-Lise] Univ Paris 07, INSERM Biomarkers & Heart Dis U942, F-75010 Paris, France	UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mericskay, M (corresponding author), Univ Paris 06, UR4 Vieillissement, UPMC, Dept Aging Stress & Inflammat, Inflammat 7,BP 256, F-75005 Paris, France.	mathias.mericskay@upmc.fr	Li, Zhenlin/E-3937-2016; Prola, Alexandre/ABG-1623-2021; Diguet, Nicolas/H-3876-2017; MERICSKAY, Mathias/M-3477-2018	Diguet, Nicolas/0000-0001-9963-7623; Samuel, Jane-Lise/0000-0002-7346-2404; LI, Zhenlin/0000-0002-3706-4505; Prola, Alexandre/0000-0001-6667-7653; MERICSKAY, Mathias/0000-0002-6779-092X; Friguet, Bertrand/0000-0001-8085-1961	Agence Nationale pour la Recherche [ANR-05-PCOD-003, ANR-08-GENOPAT-038]; "Association Francaise contre les Myopathies" (AFM); French Ministry of Research	Agence Nationale pour la Recherche(French National Research Agency (ANR)); "Association Francaise contre les Myopathies" (AFM)(Association Francaise contre les Myopathies); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by "Agence Nationale pour la Recherche" Grants ANR-05-PCOD-003 and ANR-08-GENOPAT-038 and the "Association Francaise contre les Myopathies" (AFM).; Supported by a Ph.D. fellowship from the French Ministry of Research and AFM.	Ahmed EK, 2010, AGING CELL, V9, P252, DOI 10.1111/j.1474-9726.2010.00555.x; Balasubramanian S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011470; Biol AJ, 2007, J NEUROPATH EXP NEUR, V66, P711, DOI 10.1097/nen.0b013e3181256b4c; Camors E, 2006, J MOL CELL CARDIOL, V40, P47, DOI 10.1016/j.yjmcc.2005.08.009; Capetanaki Y, 2002, TRENDS CARDIOVAS MED, V12, P339, DOI 10.1016/S1050-1738(02)00184-6; Caron A, 1999, MUSCLE NERVE, V22, P1122, DOI 10.1002/(SICI)1097-4598(199908)22:8<1122::AID-MUS17>3.0.CO;2-T; Chang J, 2003, CIRCULATION, V108, P407, DOI 10.1161/01.CIR.0000084502.02147.83; Davis FJ, 2002, AM J PHYSIOL-HEART C, V282, pH1521, DOI 10.1152/ajpheart.00844.2001; Gary-Bobo G, 2008, EUR J HEART FAIL, V10, P635, DOI 10.1016/j.ejheart.2008.04.014; GEISLER N, 1988, EMBO J, V7, P15, DOI 10.1002/j.1460-2075.1988.tb02778.x; Ghelis T, 2008, PLANT PHYSIOL, V148, P1668, DOI 10.1104/pp.108.124594; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Goldfarb LG, 2008, ADV EXP MED BIOL, V642, P131; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Kaasik A, 2001, CIRC RES, V89, P153, DOI 10.1161/hh1401.093440; Kay L, 1997, BBA-BIOENERGETICS, V1322, P41, DOI 10.1016/S0005-2728(97)00071-6; KueperO T, 2007, J BIOL CHEM, V282, P23427, DOI 10.1074/jbc.M701586200; Kuiper JWP, 2008, PLOS BIOL, V6, P568, DOI 10.1371/journal.pbio.0060051; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Larcher JC, 1996, J BIOL CHEM, V271, P22117, DOI 10.1074/jbc.271.36.22117; Launay N, 2006, EXP CELL RES, V312, P3570, DOI 10.1016/j.yexcr.2006.07.025; Little WC, 2005, J CARD FAIL, V11, P191, DOI 10.1016/j.cardfail.2004.09.010; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Maloyan A, 2009, CIRC RES, V104, P1021, DOI 10.1161/CIRCRESAHA.108.193516; Maslov MY, 2007, AM J PHYSIOL-HEART C, V292, pH387, DOI 10.1152/ajpheart.00737.2006; Miano JM, 2010, LAB INVEST, V90, P1274, DOI 10.1038/labinvest.2010.104; O'Connor RS, 2008, J PHYSIOL-LONDON, V586, P2841, DOI 10.1113/jphysiol.2008.151027; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ohtakara K, 2000, BIOCHEM BIOPH RES CO, V272, P712, DOI 10.1006/bbrc.2000.2854; Parlakian A, 2005, CIRCULATION, V112, P2930, DOI 10.1161/CIRCULATIONAHA.105.533778; Poggioli S, 2002, EXP GERONTOL, V37, P1207, DOI 10.1016/S0531-5565(02)00145-6; RAPPAPORT L, 1988, FEBS LETT, V231, P421, DOI 10.1016/0014-5793(88)80863-9; Saupe KW, 1998, CIRC RES, V82, P898; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Singh BN, 2007, J MOL BIOL, V366, P756, DOI 10.1016/j.jmb.2006.12.012; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Szweda LI, 2000, METHOD ENZYMOL, V319, P562; Tang HL, 2008, BIOCHEM J, V410, P141, DOI 10.1042/BJ20071072; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Ventura-Clapier R, 2004, MOL CELL BIOCHEM, V256, P29, DOI 10.1023/B:MCBI.0000009857.69730.97; Ventura-Clapier R, 2011, BBA-MOL CELL RES, V1813, P1360, DOI 10.1016/j.bbamcr.2010.09.006; Verbeke P, 1997, J HISTOCHEM CYTOCHEM, V45, P1059, DOI 10.1177/002215549704500804; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Voziyan PA, 2005, CELL MOL LIFE SCI, V62, P1671, DOI 10.1007/s00018-005-5082-7; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32	47	47	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35007	35019		10.1074/jbc.M111.252395	http://dx.doi.org/10.1074/jbc.M111.252395			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21768101	Green Published, hybrid			2022-12-25	WOS:000295406300054
J	De Marchi, U; Castelbou, C; Demaurex, N				De Marchi, Umberto; Castelbou, Cyril; Demaurex, Nicolas			Uncoupling Protein 3 (UCP3) Modulates the Activity of Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA) by Decreasing Mitochondrial ATP Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WOLF-HIRSCHHORN-SYNDROME; OXYGEN SPECIES PRODUCTION; PERMEABILITY TRANSITION; ENDOPLASMIC-RETICULUM; CA2+ HOMEOSTASIS; CALCIUM SIGNALS; CELL-DEATH; INDICATORS; LETM1; GENE	The uncoupling proteins UCP2 and UCP3 have been postulated to catalyze Ca2+ entry across the inner membrane of mitochondria, but this proposal is disputed, and other, unrelated proteins have since been identified as the mitochondrial Ca2+ uniporter. To clarify the role of UCPs in mitochondrial Ca2+ handling, we down-regulated the expression of the only uncoupling protein of HeLa cells, UCP3, and measured Ca2+ and ATP levels in the cytosol and in organelles with genetically encoded probes. UCP3 silencing did not alter mitochondrial Ca2+ uptake in permeabilized cells. In intact cells, however, UCP3 depletion increased mitochondrial ATP production and strongly reduced the cytosolic and mitochondrial Ca2+ elevations evoked by histamine. The reduced Ca2+ elevations were due to inhibition of store-operated Ca2+ entry and reduced depletion of endoplasmic reticulum (ER) Ca2+ stores. UCP3 depletion accelerated the ER Ca2+ refilling kinetics, indicating that the activity of sarco/endoplasmic reticulum Ca2+ (SERCA) pumps was increased. Accordingly, SERCA inhibitors reversed the effects of UCP3 depletion on cytosolic, ER, and mitochondrial Ca2+ responses. Our results indicate that UCP3 is not a mitochondrial Ca2+ uniporter and that it instead negatively modulates the activity of SERCA by limiting mitochondrial ATP production. The effects of UCP3 on mitochondrial Ca2+ thus reflect metabolic alterations that impact on cellular Ca2+ homeostasis. The sensitivity of SERCA to mitochondrial ATP production suggests that mitochondria control the local ATP availability at ER Ca2+ uptake and release sites.	[De Marchi, Umberto; Castelbou, Cyril; Demaurex, Nicolas] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland	University of Geneva	Demaurex, N (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, Rue Michel Servet 1, CH-1211 Geneva, Switzerland.	Nicolas.Demaurex@unige.ch		De Marchi, Umberto/0000-0002-6011-5446; Demaurex, Nicolas/0000-0002-9933-6772	Swiss National Foundation [31-068317]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Foundation Grant 31-068317 (to N. D.).	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Baughman J. M., 2011, NATURE IN PRESS; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bezaire V, 2007, FASEB J, V21, P312, DOI 10.1096/fj.06-6966rev; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Brookes PS, 2008, NAT CELL BIOL, V10, P1235, DOI 10.1038/ncb1108-1235; Cadenas S, 2002, J BIOL CHEM, V277, P2773, DOI 10.1074/jbc.M109736200; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chan CB, 1999, DIABETES, V48, P1482, DOI 10.2337/diabetes.48.7.1482; Cioffi F, 2009, BIOFACTORS, V35, P417, DOI 10.1002/biof.54; Couplan E, 2002, J BIOL CHEM, V277, P26268, DOI 10.1074/jbc.M202535200; Csordas G, 2001, CELL CALCIUM, V29, P249, DOI 10.1054/ceca.2000.0191; Da Cruz S, 2010, CELL CALCIUM, V47, P11, DOI 10.1016/j.ceca.2009.10.005; De Marchi U, 2004, J BIOL CHEM, V279, P37415, DOI 10.1074/jbc.M314093200; De Stefani D., 2011, NATURE IN PRESS; Demaurex N, 2009, BBA-BIOENERGETICS, V1787, P1383, DOI 10.1016/j.bbabio.2008.12.012; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Endele S, 1999, GENOMICS, V60, P218, DOI 10.1006/geno.1999.5881; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Frieden M, 2004, J BIOL CHEM, V279, P22704, DOI 10.1074/jbc.M312366200; Goglia F, 2003, FASEB J, V17, P1585, DOI 10.1096/fj.03-0159hyp; Hajnoczky G, 2010, CURR BIOL, V20, pR888, DOI 10.1016/j.cub.2010.09.035; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Himms-Hagen J, 2001, EXP BIOL MED, V226, P78, DOI 10.1177/153537020122600204; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jousset H, 2008, CELL CALCIUM, V43, P83, DOI 10.1016/j.ceca.2007.04.006; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Landolfi B, 1998, J CELL BIOL, V142, P1235, DOI 10.1083/jcb.142.5.1235; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Poburko D, 2009, CIRC RES, V104, P104, DOI 10.1161/CIRCRESAHA.108.180612; Prakriya M, 2009, IMMUNOL REV, V231, P88, DOI 10.1111/j.1600-065X.2009.00820.x; Rimessi A, 2008, BBA-BIOENERGETICS, V1777, P808, DOI 10.1016/j.bbabio.2008.05.449; Rosado JA, 2006, MINI-REV MED CHEM, V6, P409, DOI 10.2174/138955706776361466; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Toime LJ, 2010, FREE RADICAL BIO MED, V49, P606, DOI 10.1016/j.freeradbiomed.2010.05.010; Trenker M, 2008, NAT CELL BIOL, V10, P1237, DOI 10.1038/ncb1108-1237; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Waldeck-Weiermair M, 2010, CELL CALCIUM, V48, P288, DOI 10.1016/j.ceca.2010.10.004; Waldeck-Weiermair M, 2010, CELL CALCIUM, V47, P433, DOI 10.1016/j.ceca.2010.03.004; Zotova L, 2010, J BIOL CHEM, V285, P14399, DOI 10.1074/jbc.M109.059956	51	59	59	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32533	32541		10.1074/jbc.M110.216044	http://dx.doi.org/10.1074/jbc.M110.216044			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775425	Green Published, hybrid			2022-12-25	WOS:000294726800063
J	Wu, SJ; Eiben, CB; Carra, JH; Huang, I; Zong, D; Liu, PX; Wu, CT; Nivala, J; Dunbar, J; Huber, T; Senft, J; Schokman, R; Smith, MD; Mills, JH; Friedlander, AM; Baker, D; Siegel, JB				Wu, Sean J.; Eiben, Christopher B.; Carra, John H.; Huang, Ivan; Zong, David; Liu, Peixian; Wu, Cindy T.; Nivala, Jeff; Dunbar, Josef; Huber, Tomas; Senft, Jeffrey; Schokman, Rowena; Smith, Matthew D.; Mills, Jeremy H.; Friedlander, Arthur M.; Baker, David; Siegel, Justin B.			Improvement of a Potential Anthrax Therapeutic by Computational Protein Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-ANTHRACIS; CAPSULE; TRANSPEPTIDASE; SEQUENCES; PLASMID; CAPD	Past anthrax attacks in the United States have highlighted the need for improved measures against bioweapons. The virulence of anthrax stems from the shielding properties of the Bacillus anthracis poly-gamma-D-glutamic acid capsule. In the presence of excess CapD, a B. anthracis gamma-glutamyl transpeptidase, the protective capsule is degraded, and the immune system can successfully combat infection. Although CapD shows promise as a next generation protein therapeutic against anthrax, improvements in production, stability, and therapeutic formulation are needed. In this study, we addressed several of these problems through computational protein engineering techniques. We show that circular permutation of CapD improved production properties and dramatically increased kinetic thermostability. At 45 degrees C, CapD was completely inactive after 5 min, but circularly permuted CapD remained almost entirely active after 30 min. In addition, we identify an amino acid substitution that dramatically decreased transpeptidation activity but not hydrolysis. Subsequently, we show that this mutant had a diminished capsule degradation activity, suggesting that CapD catalyzes capsule degradation through a transpeptidation reaction with endogenous amino acids and peptides in serum rather than hydrolysis.	[Wu, Sean J.; Eiben, Christopher B.; Huang, Ivan; Zong, David; Liu, Peixian; Wu, Cindy T.; Nivala, Jeff; Dunbar, Josef; Huber, Tomas; Smith, Matthew D.; Mills, Jeremy H.; Baker, David; Siegel, Justin B.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Carra, John H.; Senft, Jeffrey; Schokman, Rowena; Friedlander, Arthur M.] USA, Med Res Inst Infect Dis, Frederick, MD 21702 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Siegel, JB (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	siegeljb@uw.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Mills, Jeremy/0000-0003-2017-1846; Zong, David/0000-0002-8157-4780; Nivala, Jeff/0000-0002-8210-5417; Eiben, Christopher/0000-0002-2816-2277	Defense Advanced Research Projects Agency; Howard Hughes Medical Institute	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by a grant from the Defense Advanced Research Projects Agency and the Howard Hughes Medical Institute.	Candela T, 2005, MOL MICROBIOL, V57, P717, DOI 10.1111/j.1365-2958.2005.04718.x; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Institute of Medicine (United States). Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, 2002, ANTHR VACC IS IT SAF; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lowther WT, 2000, BBA-PROTEIN STRUCT M, V1477, P157, DOI 10.1016/S0167-4838(99)00271-X; MIKESELL P, 1983, INFECT IMMUN, V39, P371, DOI 10.1128/IAI.39.1.371-376.1983; Pomerantsev AP, 1997, VACCINE, V15, P1846, DOI 10.1016/S0264-410X(97)00132-1; Scorpio A, 2008, ANTIMICROB AGENTS CH, V52, P1014, DOI 10.1128/AAC.00741-07; Scorpio A, 2007, ANTIMICROB AGENTS CH, V51, P215, DOI 10.1128/AAC.00706-06; Scorpio A, 2010, MICROBIOL-SGM, V156, P1459, DOI 10.1099/mic.0.035857-0; Silverman R.B., 2002, ORGANIC CHEM ENZYME, V2nd; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Stepanov AV, 1996, J BIOTECHNOL, V44, P155, DOI 10.1016/0168-1656(95)00092-5; TATE SS, 1981, MOL CELL BIOCHEM, V39, P357, DOI 10.1007/BF00232585; Wu RY, 2009, J BIOL CHEM, V284, P24406, DOI 10.1074/jbc.M109.019034; Yu Y, 2011, TRENDS BIOTECHNOL, V29, P18, DOI 10.1016/j.tibtech.2010.10.004; Zakharian TY, 2001, COMPUT CHEM, V25, P135, DOI 10.1016/S0097-8485(00)00075-9	21	10	15	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32586	32592		10.1074/jbc.M111.251041	http://dx.doi.org/10.1074/jbc.M111.251041			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21768086	Green Published, hybrid			2022-12-25	WOS:000294726800068
J	Borbulevych, O; Kumarasiri, M; Wilson, B; Llarrull, LI; Lee, M; Hesek, D; Shi, QC; Peng, J; Baker, BM; Mobashery, S				Borbulevych, Oleg; Kumarasiri, Malika; Wilson, Brian; Llarrull, Leticia I.; Lee, Mijoon; Hesek, Dusan; Shi, Qicun; Peng, Jeffrey; Baker, Brian M.; Mobashery, Shahriar			Lysine N-zeta-Decarboxylation Switch and Activation of the beta-Lactam Sensor Domain of BlaR1 Protein of Methicillin-resistant Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETERONUCLEAR NMR-SPECTROSCOPY; MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; CRYSTAL-STRUCTURE; SIGNALING PATHWAY; CROSS-CORRELATION; ANTIBIOTICS; MACROMOLECULES; INSIGHTS; PROGRAM	The integral membrane protein BlaR1 of methicillin-resistant Staphylococcus aureus senses the presence of beta-lactam antibiotics in the milieu and transduces the information to the cytoplasm, where the biochemical events that unleash induction of antibiotic resistance mechanisms take place. We report herein by two-dimensional and three-dimensional NMR experiments of the sensor domain of BlaR1 in solution and by determination of an x-ray structure for the apo protein that Lys-392 of the antibiotic-binding site is posttranslationally modified by N-zeta-carboxylation. Additional crystallographic and NMR data reveal that on acylation of Ser-389 by antibiotics, Lys-392 experiences N-zeta-decarboxylation. This unique process, termed the lysine N-zeta-decarboxylation switch, arrests the sensor domain in the activated ("on") state, necessary for signal transduction and all the subsequent biochemical processes. We present structural information on how this receptor activation process takes place, imparting longevity to the antibiotic-receptor complex that is needed for the induction of the antibiotic-resistant phenotype in methicillin-resistant S. aureus.	[Borbulevych, Oleg; Kumarasiri, Malika; Wilson, Brian; Llarrull, Leticia I.; Lee, Mijoon; Hesek, Dusan; Shi, Qicun; Peng, Jeffrey; Baker, Brian M.; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame	Mobashery, S (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	mobashery@nd.edu	Lee, Mijoon/AFK-1543-2022; Baker, Brian/B-4584-2009	Lee, Mijoon/0000-0001-7432-0427; Baker, Brian/0000-0002-0864-0964	National Institutes of Health [AI33170, GM085109]; Pew Charitable Trusts; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI33170 (to S. M.) and GM085109 (to J. P.).; A Pew Latin American Fellow in the Biomedical Sciences, supported by The Pew Charitable Trusts.; Results shown in this study are derived from work performed at the Structural Biology Center and LS-CAT at the Advanced Photon Source of Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract Number DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor for the support of this research program (Grant 085P1000817).	Birck C, 2004, J AM CHEM SOC, V126, P13945, DOI 10.1021/ja044742u; Bou G, 2010, J AM CHEM SOC, V132, P13320, DOI 10.1021/ja104092z; Cooper DR, 2007, ACTA CRYSTALLOGR D, V63, P636, DOI 10.1107/S0907444907010931; DAYIE KT, 1994, J MAGN RESON SER A, V111, P121, DOI 10.1006/jmra.1994.1236; Docquier JD, 2010, ANTIMICROB AGENTS CH, V54, P2167, DOI 10.1128/AAC.01517-09; Docquier JD, 2009, CHEM BIOL, V16, P540, DOI 10.1016/j.chembiol.2009.04.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; Golemi D, 2000, J AM CHEM SOC, V122, P6132, DOI 10.1021/ja0013881; Golemi-Kotra D, 2003, J BIOL CHEM, V278, P18419, DOI 10.1074/jbc.M300611200; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; Johnson JW, 2010, J AM CHEM SOC, V132, P2558, DOI 10.1021/ja9086374; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kerff F, 2003, BIOCHEMISTRY-US, V42, P12835, DOI 10.1021/bi034976a; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu XS, 2004, PROTEINS, V54, P491, DOI 10.1002/prot.10514; Llarrull LI, 2010, CURR OPIN MICROBIOL, V13, P551, DOI 10.1016/j.mib.2010.09.008; Llarrull LI, 2010, BIOCHEMISTRY-US, V49, P7975, DOI 10.1021/bi101177a; Llarrull LI, 2009, ANTIMICROB AGENTS CH, V53, P4051, DOI 10.1128/AAC.00084-09; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Maveyraud L, 2000, STRUCTURE, V8, P1289, DOI 10.1016/S0969-2126(00)00534-7; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; PALMER AG, 1992, MOL PHYS, V75, P699, DOI 10.1080/00268979200100511; PENG JW, 1992, BIOCHEMISTRY-US, V31, P8571, DOI 10.1021/bi00151a027; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; ROLINSON GN, 1961, BRIT MED J, V1, P125, DOI 10.1136/bmj.1.5219.125; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Schneider KD, 2009, BIOCHEMISTRY-US, V48, P11840, DOI 10.1021/bi901690r; Sun T, 2003, PROTEIN SCI, V12, P82, DOI 10.1110/ps.0224303; Thumanu K, 2006, P NATL ACAD SCI USA, V103, P10630, DOI 10.1073/pnas.0601971103; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wilke MS, 2004, J BIOL CHEM, V279, P47278, DOI 10.1074/jbc.M407054200; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144	43	24	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31466	31472		10.1074/jbc.M111.252189	http://dx.doi.org/10.1074/jbc.M111.252189			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21775440	Green Published, hybrid			2022-12-25	WOS:000294487500041
J	Su, YC; Miller, TN; Navaneetham, D; Schoonmaker, RT; Sinha, D; Walsh, PN				Su, Ya-Chi; Miller, Tara N.; Navaneetham, Duraiswamy; Schoonmaker, Robert T.; Sinha, Dipali; Walsh, Peter N.			The Role of Factor XIa (FXIa) Catalytic Domain Exosite Residues in Substrate Catalysis and Inhibition by the Kunitz Protease Inhibitor Domain of Protease Nexin 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR-XIA; PLASMA THROMBOPLASTIN ANTECEDENT; X-ACTIVATING COMPLEX; FACTOR-IX; BLOOD-COAGULATION; SERINE PROTEASES; AUTOLYSIS LOOP; CRYSTAL-STRUCTURE; CHRISTMAS-FACTOR; BINDING-SITE	To select residues in coagulation factor XIa (FXIa) potentially important for substrate and inhibitor interactions, we examined the crystal structure of the complex between the catalytic domain of FXIa and the Kunitz protease inhibitor (KPI) domain of a physiologically relevant FXIa inhibitor, protease nexin 2 (PN2). Six FXIa catalytic domain residues (Glu(98), Tyr(143), Ile(151), Arg(3704), Lys(192), and Tyr(5901)) were subjected to mutational analysis to investigate the molecular interactions between FXIa and the small synthetic substrate (S-2366), the macromolecular substrate (factor IX (FIX)) and inhibitor PN2KPI. Analysis of all six Ala mutants demonstrated normal K-m values for S-2366 hydrolysis, indicating normal substrate binding compared with plasma FXIa; however, all except E98A and K192A had impaired values of k(cat) for S-2366 hydrolysis. All six Ala mutants displayed deficient k(cat) values for FIX hydrolysis, and all were inhibited by PN2KPI with normal values of K-i except for K192A, and Y5901A, which displayed increased values of K-i. The integrity of the S1 binding site residue, Asp(189), utilizing p-aminobenzamidine, was intact for all FXIa mutants. Thus, whereas all six residues are essential for catalysis of the macromolecular substrate (FIX), only four (Tyr(143), Ile(151), Arg(3704), and Tyr(5901)) are important for S-2366 hydrolysis; Glu(98) and Lys(192) are essential for FIX but not S-2366 hydrolysis; and Lys(192) and Tyr(5901) are required for both inhibitor and macromolecular substrate interactions.	[Su, Ya-Chi; Miller, Tara N.; Navaneetham, Duraiswamy; Schoonmaker, Robert T.; Sinha, Dipali; Walsh, Peter N.] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Su, Ya-Chi; Miller, Tara N.; Walsh, Peter N.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Walsh, Peter N.] Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Walsh, PN (corresponding author), Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, 3400 N Broad St, Philadelphia, PA 19140 USA.	pnw@temple.edu			National Institutes of Health [HL74124, HL46213]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074124, R01HL046213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL74124 and HL46213 (to P. N. W.).	Adler M, 2000, BIOCHEMISTRY-US, V39, P12534, DOI 10.1021/bi001477q; Badellino KO, 2000, BIOCHEMISTRY-US, V39, P4769, DOI 10.1021/bi9925468; BAGLIA FA, 1991, J BIOL CHEM, V266, P24190; Blouse GE, 2009, J BIOL CHEM, V284, P4647, DOI 10.1074/jbc.M804922200; BODE W, 1975, J MOL BIOL, V98, P693, DOI 10.1016/S0022-2836(75)80005-2; BOUMA BN, 1977, J BIOL CHEM, V252, P6432; Coleman P L, 1976, Methods Enzymol, V45, P12; DISCIPIO RG, 1978, J CLIN INVEST, V61, P1528, DOI 10.1172/JCI109073; EVANS SA, 1982, J BIOL CHEM, V257, P3014; FUJIKAWA K, 1974, BIOCHEMISTRY-US, V13, P4508, DOI 10.1021/bi00719a006; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; Halfon S., 1998, HDB PROTEOLYTIC ENZY, P12; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; JAMESON GW, 1973, BIOCHEM J, V131, P107, DOI 10.1042/bj1310107; Jin L, 2005, ACTA CRYSTALLOGR D, V61, P1418, DOI [10.1107/S0907444905024340, 10.1107/S090744905024340]; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; Krem MM, 2002, J BIOL CHEM, V277, P40260, DOI 10.1074/jbc.M206173200; LEBONNIEC BF, 1992, J BIOL CHEM, V267, P19341; LEBONNIEC BF, 1991, P NATL ACAD SCI USA, V88, P7371, DOI 10.1073/pnas.88.16.7371; LEIBA H, 1965, BRIT J HAEMATOL, V11, P654, DOI 10.1111/j.1365-2141.1965.tb00114.x; LINDQUIST PA, 1978, J BIOL CHEM, V253, P1902; Manithody C, 2002, BIOCHEMISTRY-US, V41, P6780, DOI 10.1021/bi0255367; NAITO K, 1991, J BIOL CHEM, V266, P7353; Narasimhan LS, 2000, J MED CHEM, V43, P361, DOI 10.1021/jm990216f; Navaneetham D, 2005, J BIOL CHEM, V280, P36165, DOI 10.1074/jbc.M504990200; Navaneetham D, 2010, J BIOCHEM, V148, P467, DOI 10.1093/jb/mvq080; Ogawa T, 2005, J BIOL CHEM, V280, P23523, DOI 10.1074/jbc.M500894200; OSTERUD B, 1977, P NATL ACAD SCI USA, V74, P5260, DOI 10.1073/pnas.74.12.5260; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Papagrigoriou E, 2006, NAT STRUCT MOL BIOL, V13, P557, DOI 10.1038/nsmb1095; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; RAPAPORT SI, 1961, BLOOD, V18, P149, DOI 10.1182/blood.V18.2.149.149; Rezaie AR, 2006, BIOCHEMISTRY-US, V45, P9427, DOI 10.1021/bi060820+; REZAIE AR, 1993, J BIOL CHEM, V268, P19943; Sandler B, 1998, J AM CHEM SOC, V120, P595, DOI 10.1021/ja972991v; Scandura JM, 1997, BIOCHEMISTRY-US, V36, P412, DOI 10.1021/bi9612576; Schmidt AE, 2004, J BIOL CHEM, V279, P29485, DOI 10.1074/jbc.M402971200; Shen L, 1999, THROMB HAEMOSTASIS, V82, P1078, DOI 10.1055/s-0037-1614332; SINHA D, 1985, J BIOL CHEM, V260, P714; SINHA D, 1987, BIOCHEMISTRY-US, V26, P3768, DOI 10.1021/bi00387a005; Sinha D, 2007, BIOCHEMISTRY-US, V46, P9830, DOI 10.1021/bi062296c; SMITH RP, 1990, SCIENCE, V248, P1126, DOI 10.1126/science.2111585; Sun MF, 1999, J BIOL CHEM, V274, P36373, DOI 10.1074/jbc.274.51.36373; Sun YH, 1996, J BIOL CHEM, V271, P29023, DOI 10.1074/jbc.271.46.29023; THOMPSON RE, 1977, J CLIN INVEST, V60, P1376, DOI 10.1172/JCI108898; VANNOSTRAND WE, 1990, SCIENCE, V248, P745, DOI 10.1126/science.2110384; Wilkinson FH, 2002, J BIOL CHEM, V277, P5734, DOI 10.1074/jbc.M107753200; Wilkinson FH, 2002, J BIOL CHEM, V277, P5725, DOI 10.1074/jbc.M107027200; Yang LK, 2003, J BIOL CHEM, V278, P25032, DOI 10.1074/jbc.M302174200; Yang X, 2005, BIOCHEM J, V390, P157, DOI 10.1042/BJ20050029	51	4	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31904	31914		10.1074/jbc.M111.257527	http://dx.doi.org/10.1074/jbc.M111.257527			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21778227	Green Published, hybrid			2022-12-25	WOS:000294487500083
J	Yoo, J; Ko, S; Kim, H; Sampson, H; Yun, JH; Choe, KM; Chang, I; Arrowsmith, CH; Krause, HM; Cho, HS; Lee, W				Yoo, Jiho; Ko, Sunggeon; Kim, Hyeyon; Sampson, Heidi; Yun, Ji-Hye; Choe, Kwang-Min; Chang, Iksoo; Arrowsmith, Cheryl H.; Krause, Henry M.; Cho, Hyun-Soo; Lee, Weontae			Crystal Structure of Fushi Tarazu Factor 1 Ligand Binding Domain/Fushi Tarazu Peptide Complex Identifies New Class of Nuclear Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROIDOGENIC FACTOR-I; FUNCTIONAL-CHARACTERIZATION; MACROMOLECULAR STRUCTURES; ESTROGEN-RECEPTOR; ORPHAN RECEPTORS; PROTEIN; GENE; EMBRYOGENESIS; SUPERFAMILY; LRH-1	The interaction between the orphan nuclear receptor FTZ-F1 (Fushi tarazu factor 1) and the segmentation gene protein FTZ is critical for specifying alternate parasegments in the Drosophila embryo. Here, we have determined the structure of the FTZ-F1 ligand-binding domain (LBD).FTZ peptide complex using x-ray crystallography. Strikingly, the ligand-binding pocket of the FTZ-F1LBD is completely occupied by helix 6 (H6) of the receptor, whereas the cofactor FTZ binds the co-activator cleft site of the FTZ-F1 LBD. Our findings suggest that H6 is essential for transcriptional activity of FTZ-F1; this is further supported by data from mutagenesis and activity assays. These data suggest that FTZ-F1 might belong to a novel class of ligand-independent nuclear receptors. Our findings are intriguing given that the highly homologous human steroidogenic factor-1 and liver receptor homolog-1 LBDs exhibit sizable ligand-binding pockets occupied by putative ligand molecules.	[Yoo, Jiho; Kim, Hyeyon; Choe, Kwang-Min; Cho, Hyun-Soo] Yonsei Univ, Dept Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Ko, Sunggeon; Yun, Ji-Hye; Lee, Weontae] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Sampson, Heidi] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Chang, Iksoo] Pusan Natl Univ, Dept Phys, Creat Res Initiat Ctr Proteome Biophys, Pusan 609735, South Korea; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Krause, Henry M.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada	Yonsei University; Yonsei University; McGill University; Pusan National University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Cho, HS (corresponding author), Yonsei Univ, Dept Biol, Coll Life Sci & Biotechnol, Seodaemun Gu 134, Seoul 120749, South Korea.	hscho8@yonsei.ac.kr; wlee@spin.yonsei.ac.kr	LEE, WEON TAE/AAQ-9088-2021; Yoo, Jiho/AAG-3529-2020	Yoo, Jiho/0000-0002-0864-2142; Lee, Weontae/0000-0003-2347-1262; Krause, Henry/0000-0002-6182-7074; Arrowsmith, Cheryl/0000-0002-4971-3250	World Class University [R33-2009-000-10123-0]; National Research Foundation/Ministry of Education, Science and Technology (MEST) of Korea [2008-0061984]; National Research Foundation (NRF) of Korea through the National Core Research Center [R15-2004-024-00000-0]; Korean government (MEST) [2009-0073145, 2009-0084897]; MEST [2011-0005000]	World Class University; National Research Foundation/Ministry of Education, Science and Technology (MEST) of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation (NRF) of Korea through the National Core Research Center; Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by World Class University Program R33-2009-000-10123-0 (to W. L.) and National Creative Research Initiatives Center for Proteome Biophysics Grant 2008-0061984 (to I. C.) from the National Research Foundation/Ministry of Education, Science and Technology (MEST) of Korea. This work was also supported by National Research Foundation (NRF) of Korea through the National Core Research Center Grant R15-2004-024-00000-0 and the Midcareer Researcher Program through an NRF grant funded by the Korean government (MEST) (2009-0073145 and 2009-0084897; to H.-S. C.) and by Basic Science Research Program through the NRF of Korea funded by MEST (to K.-M. C.) (Grant 2011-0005000).	Baker KD, 2003, CELL, V113, P731, DOI 10.1016/S0092-8674(03)00420-3; Beato M, 1985, Haematol Blood Transfus, V29, P217; Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; CARROLL SB, 1985, CELL, V43, P47, DOI 10.1016/0092-8674(85)90011-X; Chiang John Y L, 2005, Curr Opin Investig Drugs, V6, P994; DESPLAN C, 1988, CELL, V54, P1081, DOI 10.1016/0092-8674(88)90123-7; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Iwema T, 2007, EMBO J, V26, P3770, DOI 10.1038/sj.emboj.7601810; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kallenberger BC, 2003, NAT STRUCT BIOL, V10, P136, DOI 10.1038/nsb892; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LAVORGNA G, 1993, P NATL ACAD SCI USA, V90, P3004, DOI 10.1073/pnas.90.7.3004; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Mak HY, 1999, MOL CELL BIOL, V19, P3895; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OHNO CK, 1993, MECH DEVELOP, V40, P13, DOI 10.1016/0925-4773(93)90084-B; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearce KH, 2004, DRUG DISCOV TODAY, V9, P741, DOI 10.1016/S1359-6446(04)03201-5; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Sablin EP, 2003, MOL CELL, V11, P1575, DOI 10.1016/S1097-2765(03)00236-3; Schwartz CJE, 2001, EMBO J, V20, P510, DOI 10.1093/emboj/20.3.510; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; STRUHL G, 1985, NATURE, V318, P677, DOI 10.1038/318677a0; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THUMMEL CS, 1995, CELL, V83, P871, DOI 10.1016/0092-8674(95)90203-1; UEDA H, 1990, GENE DEV, V4, P624, DOI 10.1101/gad.4.4.624; WAKIMOTO BT, 1984, DEV BIOL, V102, P147, DOI 10.1016/0012-1606(84)90182-9; Wang W, 2005, P NATL ACAD SCI USA, V102, P7505, DOI 10.1073/pnas.0409482102; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Woo EJ, 2007, J MOL BIOL, V373, P735, DOI 10.1016/j.jmb.2007.08.037; WOODARD CT, 1994, CELL, V79, P607, DOI 10.1016/0092-8674(94)90546-0	43	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31225	31231		10.1074/jbc.M111.252916	http://dx.doi.org/10.1074/jbc.M111.252916			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21775434	Green Published, hybrid			2022-12-25	WOS:000294487500017
J	Illingworth, M; Ramsey, A; Zheng, ZD; Chen, LL				Illingworth, Melissa; Ramsey, Andrew; Zheng, Zhida; Chen, Lingling			Stimulating the Substrate Folding Activity of a Single Ring GroEL Variant by Modulating the Cochaperonin GroES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; CHAPERONIN GROEL; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ATP HYDROLYSIS; OLIGOMERIC STRUCTURE; POLYPEPTIDE BINDING; IN-VIVO; CYCLE; MECHANISM	In mediating protein folding, chaperonin GroEL and cochaperonin GroES form an enclosed chamber for substrate proteins in an ATP-dependent manner. The essential role of the double ring assembly of GroEL is demonstrated by the functional deficiency of the single ring GroEL(SR). The GroEL(SR)-GroES is highly stable with minimal ATPase activity. To restore the ATP cycle and the turnover of the folding chamber, we sought to weaken the GroEL(SR)-GroES interaction systematically by concatenating seven copies of groES to generate groES(7). GroES Ile-25, Val-26, and Leu-27, residues on the GroEL-GroES interface, were substituted with Asp on different groES modules of groES(7). GroES(7) variants activate ATP activity of GroEL(SR), but only some restore the substrate folding function of GroEL(SR), indicating a direct role of GroES in facilitating substrate folding through its dynamics with GroEL. Active GroEL(SR)-GroES(7) systems may resemble mammalian mitochondrial chaperonin systems.	[Illingworth, Melissa; Ramsey, Andrew; Zheng, Zhida; Chen, Lingling] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Chen, LL (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, 212 S Hawthome Dr,Simon Hall 400A, Bloomington, IN 47405 USA.	linchen@indiana.edu	Chen, Ling-Ling/AAY-3547-2021		National Institutes of Health [R01GM065260, R01GM065260-05S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM065260 and R01GM065260-05S1 (to L. C.).	Ben-Zvi AP, 1998, P NATL ACAD SCI USA, V95, P15275, DOI 10.1073/pnas.95.26.15275; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Buckle AM, 1997, P NATL ACAD SCI USA, V94, P3571, DOI 10.1073/pnas.94.8.3571; BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285; CHANDRASEKHAR GN, 1986, J BIOL CHEM, V261, P2414; Chatellier J, 2000, J MOL BIOL, V304, P897, DOI 10.1006/jmbi.2000.4278; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Cliff MJ, 2006, J BIOL CHEM, V281, P21266, DOI 10.1074/jbc.M601605200; Cliff MJ, 1999, J MOL BIOL, V293, P667, DOI 10.1006/jmbi.1999.3138; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; GRAY TE, 1991, FEBS LETT, V292, P254, DOI 10.1016/0014-5793(91)80878-7; Gupta Radhey S., 1996, P27, DOI 10.1016/B978-012237455-5/50003-8; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HAYERHARTL MK, 1995, SCIENCE, V269, P836, DOI 10.1126/science.7638601; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; JACKSON GS, 1993, BIOCHEMISTRY-US, V32, P2554, DOI 10.1021/bi00061a013; Kad NM, 1998, J MOL BIOL, V278, P267, DOI 10.1006/jmbi.1998.1704; Kawata Y, 1999, BIOCHEMISTRY-US, V38, P15731, DOI 10.1021/bi9909750; Kovacs E, 2010, J MOL BIOL, V396, P1271, DOI 10.1016/j.jmb.2009.11.074; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li YL, 2010, J PEPT SCI, V16, P693, DOI 10.1002/psc.1288; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; Liu H, 2009, FEBS LETT, V583, P2365, DOI 10.1016/j.febslet.2009.06.027; Lorimer G, 1997, NATURE, V388, P720, DOI 10.1038/41892; Mande SC, 1996, SCIENCE, V271, P203, DOI 10.1126/science.271.5246.203; Miyazaki T, 2002, J BIOL CHEM, V277, P50621, DOI 10.1074/jbc.M209183200; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; Nielsen KL, 1998, MOL CELL, V2, P93, DOI 10.1016/S1097-2765(00)80117-3; Nielsen KL, 1999, J BACTERIOL, V181, P5871, DOI 10.1128/JB.181.18.5871-5875.1999; Nojima T, 2008, J BIOL CHEM, V283, P18385, DOI 10.1074/jbc.M709825200; Ranson NA, 1997, J MOL BIOL, V266, P656, DOI 10.1006/jmbi.1996.0815; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Saibil HR, 2002, TRENDS BIOCHEM SCI, V27, P627, DOI 10.1016/S0968-0004(02)02211-9; Sakane I, 2007, J MOL BIOL, V367, P1171, DOI 10.1016/j.jmb.2007.01.037; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; Sun Z, 2003, J MOL BIOL, V332, P715, DOI 10.1016/S0022-2836(03)00830-1; Suzuki M, 2008, J BIOL CHEM, V283, P23931, DOI 10.1074/jbc.M804090200; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; TODD MJ, 1993, BIOCHEMISTRY-US, V32, P8560, DOI 10.1021/bi00084a024; TODD MJ, 1995, BIOCHEMISTRY-US, V34, P14932, DOI 10.1021/bi00045a038; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; Viani MB, 2000, NAT STRUCT BIOL, V7, P644, DOI 10.1038/77936; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; Viitanen PV, 1998, METHOD ENZYMOL, V290, P203, DOI 10.1016/S0076-6879(98)90020-9; VIITANEN PV, 1992, J BIOL CHEM, V267, P695; Weber F, 1998, NAT STRUCT BIOL, V5, P977, DOI 10.1038/2952; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	58	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30401	30408		10.1074/jbc.M111.255935	http://dx.doi.org/10.1074/jbc.M111.255935			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757689	Green Published, hybrid			2022-12-25	WOS:000294283600018
J	Kim, JS; Park, YY; Park, SY; Cho, H; Kang, D; Cho, H				Kim, Jo-Sun; Park, Yong-Yea; Park, Sun-Yi; Cho, Hyeseon; Kang, Dongmin; Cho, Hyeseong			The Auto-ubiquitylation of E3 Ubiquitin-protein Ligase Chfr at G(2) Phase Is Required for Accumulation of Polo-like Kinase 1 and Mitotic Entry in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRATE SOMATIC-CELLS; CHECKPOINT GENE; EPIGENETIC INACTIVATION; DAMAGE CHECKPOINT; STRESS CHECKPOINT; LUNG-CANCER; DNA-DAMAGE; CENP-F; MITOSIS; HYPERMETHYLATION	The E3 ubiquitin-protein ligase Chfr is a mitotic stress checkpoint protein that delays mitotic entry in response to microtubule damage; however, the molecular mechanism by which Chfr accomplishes this remains elusive. Here, we show that Chfr levels are elevated in response to microtubule-damaging stress. Moreover, G(2)/M transition is associated with cell cycle-dependent turnover of Chfr accompanied by high autoubiquitylation activity, suggesting that regulation of Chfr levels and auto-ubiquitylation activity are functionally significant. To test this, we generated Chfr mutants Chfr-K2A and Chfr-K5A in which putative lysine target sites of auto-ubiquitylation were replaced with alanine. Chfr-K2A did not undergo cell cycle-dependent degradation, and its levels remained high during G(2)/M phase. The elevated levels of Chfr-K2A caused a significant reduction in phosphohistone H3 levels and cyclinB1/Cdk1 kinase activities, leading to mitotic entry delay. Notably, polo-like kinase 1 levels at G(2) phase, but not at S phase, were similar to 2-3-fold lower in cells expressing Chfr-K2A than in wild-type Chfr-expressing cells. Consistent with this, ubiquitylation of Plk1 at G(2) phase was accelerated in Chfr-K2A-expressing cells. In contrast, Aurora A levels remained constant, indicating that Plk1 is a major target of Chfr in controlling the timing of mitotic entry. Indeed, overexpression of Plk1 in Chfr-K2A-expressing cells restored cyclin B1/Cdk1 kinase activity and promoted mitotic entry. Collectively, these data indicate that Chfr auto-ubiquitylation is required to allow Plk1 to accumulate to levels necessary for activation of cyclin B1/Cdk1 kinase and mitotic entry. Our results provide the first evidence that Chfr auto-ubiquitylation and degradation are important for the G(2)/M transition.	[Kim, Jo-Sun; Park, Yong-Yea; Park, Sun-Yi; Cho, Hyeseong] Ajou Univ, Sch Med, Dept Biochem, Suwon 443721, South Korea; [Kim, Jo-Sun; Park, Yong-Yea; Park, Sun-Yi; Cho, Hyeseong] Ajou Univ, Grad Sch Mol Sci & Technol, Suwon 443721, South Korea; [Cho, Hyeseon] NIH, Cell Mol Immunol Sect B, Immunoregulat Lab, Bethesda, MD 20892 USA; [Kang, Dongmin] Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Kang, Dongmin] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul 120750, South Korea	Ajou University; Ajou University; National Institutes of Health (NIH) - USA; Ewha Womans University; Ewha Womans University	Cho, H (corresponding author), Ajou Univ, Sch Med, Dept Biochem, 5 Wonchon Dong, Suwon 443721, South Korea.	hscho@ajou.ac.kr		Cho, Hyeseong/0000-0002-4672-8887; Kang, Dongmin/0000-0001-5997-625X	Ministry of Health and Welfare [0820060]; Ajon University	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Ajon University	This work was supported by National R&D Program for Cancer Control (0820060), Ministry of Health and Welfare. Y. Park is supported by the grant of "The Ajon University Excellence Research Program in 2011."	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Banno K, 2007, INT J ONCOL, V31, P713; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Canning M, 2004, J BIOL CHEM, V279, P38160, DOI 10.1074/jbc.M402885200; Chaturvedi P, 2002, CANCER RES, V62, P1797; Corn PG, 2003, CARCINOGENESIS, V24, P47, DOI 10.1093/carcin/24.1.47; Erson AE, 2004, MOL CARCINOGEN, V39, P26, DOI 10.1002/mc.10161; Hussein D, 2002, J CELL SCI, V115, P3403; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Kang Dongmin, 2004, Methods Mol Biol, V280, P229; Kwon YE, 2009, MOL CELLS, V27, P359, DOI 10.1007/s10059-009-0046-7; LIAO H, 1995, J CELL BIOL, V130, P507, DOI 10.1083/jcb.130.3.507; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Liu Q, 2006, P NATL ACAD SCI USA, V103, P5811, DOI 10.1073/pnas.0601425103; Loring GL, 2008, CELL CYCLE, V7, P96, DOI 10.4161/cc.7.1.5113; Mariatos G, 2003, CANCER RES, V63, P7185; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; Mizuno K, 2002, ONCOGENE, V21, P2328, DOI 10.1038/sj.onc.1205402; Oh YM, 2009, NAT CELL BIOL, V11, P295, DOI 10.1038/ncb1837; Rieder CL, 1998, J CELL BIOL, V142, P1013, DOI 10.1083/jcb.142.4.1013; Rieder CL, 2000, COLD SPRING HARB SYM, V65, P369, DOI 10.1101/sqb.2000.65.369; Satoh A, 2003, CANCER RES, V63, P8606; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Shtivelman E, 2003, MOL CANCER RES, V1, P959; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Yanokura M, 2007, ONCOL REP, V17, P41; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538; Yun C, 2004, MOL CANCER RES, V2, P159	31	10	10	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30615	30623		10.1074/jbc.M111.231803	http://dx.doi.org/10.1074/jbc.M111.231803			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21768102	Green Published, hybrid			2022-12-25	WOS:000294283600041
J	Mazzaferro, S; Benallegue, N; Carbone, A; Gasparri, F; Vijayan, R; Biggin, PC; Moroni, M; Bermudez, I				Mazzaferro, Simone; Benallegue, Nail; Carbone, Anna; Gasparri, Federica; Vijayan, Ranjit; Biggin, Philip C.; Moroni, Mirko; Bermudez, Isabel			Additional Acetylcholine (ACh) Binding Site at alpha 4/alpha 4 Interface of (alpha 4 beta 2)(2)alpha 4 Nicotinic Receptor Influences Agonist Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYS-LOOP RECEPTORS; ALTERNATE STOICHIOMETRIES; SUBUNIT INTERFACES; EXPRESSION; RESIDUES; CHANNELS; (ALPHA-4)(2)(BETA-2)(3); ANTAGONISTS	Nicotinic acetylcholine receptor (nAChR) alpha 4 and beta 2 subunits assemble in two alternate stoichiometries to produce (alpha 4 beta 2)(2)alpha 4 and (alpha 4 beta 2)(2)alpha 4, which display different agonist sensitivities. Functionally relevant agonist binding sites are thought to be located at alpha 4(+)/beta 2(-) subunit interfaces, but because these interfaces are present in both receptor isoforms, it is unlikely that they account for differences in agonist sensitivities. In contrast, incorporation of either alpha 4 or beta 2 as auxiliary subunits produces isoform-specific alpha 4(+)/alpha 4(-) or beta 2(+)/beta 2(-) interfaces. Using fully concatenated (alpha 4 beta 2)(2)alpha 4 nAChRs in conjunction with structural modeling, chimeric receptors, and functional mutagenesis, we have identified an additional site at the alpha 4(+)/alpha 4(-) interface that accounts for isoform-specific agonist sensitivity of the (alpha 4 beta 2)(2)alpha 4 nAChR. The additional site resides in a region that also contains a potentiating Zn2+ site but is engaged by agonists to contribute to receptor activation. By engineering alpha 4 subunits to provide a free cysteine in loop C at the alpha 4(+)alpha 4(-) interface, we demonstrated that the acetylcholine responses of the mutated receptors are attenuated or enhanced, respectively, following treatment with the sulfhydryl reagent [2-(trimethylammonium)ethyl] methanethiosulfonate or aminoethyl methanethiosulfonate. The findings suggest that agonist occupation of the site at the alpha 4(+)/(alpha 4(-) interface leads to channel gating through a coupling mechanism involving loop C. Overall, we propose that the additional agonist site at the alpha 4(+)/alpha 4(-) interface, when occupied by agonist, contributes to receptor activation and that this additional contribution underlies the agonist sensitivity signature of (alpha 4 beta 2)(2)alpha 4 nAChRs.	[Mazzaferro, Simone; Benallegue, Nail; Gasparri, Federica; Bermudez, Isabel] Oxford Brookes Univ, Sch Life Sci, Oxford OX3 0BP, England; [Carbone, Anna] Charite, Leibniz Inst Mol Pharmakol & Neurocure Initiat, D-13125 Berlin, Germany; [Vijayan, Ranjit; Biggin, Philip C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Moroni, Mirko] UCL, Dept Pharmacol, London WC1E 6BT, England	Oxford Brookes University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); University of Oxford; University of London; University College London	Bermudez, I (corresponding author), Oxford Brookes Univ, Sch Life Sci, Gipsy Lane, Oxford OX3 0BP, England.	ibermudez@brookes.ac.uk	Vijayan, Ranjit/AAH-6015-2019; Vijayan, Ranjit/GXF-4345-2022; Moroni, Mirko/Q-1524-2018	Vijayan, Ranjit/0000-0002-3830-7409; Vijayan, Ranjit/0000-0002-3830-7409; Benallegue, Nail/0000-0002-8931-4393; Mazzaferro, Simone/0000-0003-4402-5325; Biggin, Philip/0000-0001-5100-8836; Bermudez, Isabel/0000-0001-7692-1509	Royal Society; Brookes University	Royal Society(Royal Society of London); Brookes University	This work was supported by grants from the Royal Society and Brookes University.	Akk G, 1999, BRIT J PHARMACOL, V128, P1467, DOI 10.1038/sj.bjp.0702941; Akk G, 2001, J PHYSIOL-LONDON, V535, P729, DOI 10.1111/j.1469-7793.2001.00729.x; Brams M, 2011, J BIOL CHEM, V286, P4420, DOI 10.1074/jbc.M110.188730; Bren N, 1997, J BIOL CHEM, V272, P30793, DOI 10.1074/jbc.272.49.30793; CamposCaro A, 1996, P NATL ACAD SCI USA, V93, P6118, DOI 10.1073/pnas.93.12.6118; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Castaldo P, 2004, J BIOL CHEM, V279, P25598, DOI 10.1074/jbc.M311021200; GALZI JL, 1994, CURR OPIN STRUC BIOL, V4, P554, DOI 10.1016/S0959-440X(94)90218-6; Gay EA, 2007, J PHYSIOL-LONDON, V584, P727, DOI 10.1113/jphysiol.2007.142554; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Groot-Kormelink PJ, 2004, J GEN PHYSIOL, V123, P697, DOI 10.1085/jgp.200409042; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Hsiao B, 2008, J NEUROPHYSIOL, V99, P999, DOI 10.1152/jn.01040.2007; Hu XQ, 2003, J BIOL CHEM, V278, P46583, DOI 10.1074/jbc.M308974200; Iturriaga-Vasquez P, 2010, MOL PHARMACOL, V78, P366, DOI 10.1124/mol.110.065490; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Perkins DI, 2009, J BIOL CHEM, V284, P27304, DOI 10.1074/jbc.M109.023598; Purohit P, 2007, J GEN PHYSIOL, V130, P569, DOI 10.1085/jgp.200709858; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; ROGERS CJ, 1994, J PHYSIOL-LONDON, V475, P69, DOI 10.1113/jphysiol.1994.sp020050; Son CD, 2009, MOL PHARMACOL, V75, P1137, DOI 10.1124/mol.108.054494; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Wang HL, 2009, BIOPHYS J, V96, P3582, DOI 10.1016/j.bpj.2009.02.020; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; Zwart R, 2008, MOL PHARMACOL, V73, P1838, DOI 10.1124/mol.108.045104	35	99	99	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					31043	31054		10.1074/jbc.M111.262014	http://dx.doi.org/10.1074/jbc.M111.262014			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757735	hybrid, Green Published			2022-12-25	WOS:000294283600082
J	Derkow, K; Muller, A; Eickmeier, I; Seidel, D; Moreira, MVR; Kruse, N; Klugewitz, K; Mintern, J; Wiedenmann, B; Schott, E				Derkow, Katja; Mueller, Anja; Eickmeier, Ira; Seidel, Daniel; Moreira, Marcos Vicinius Rust; Kruse, Nils; Klugewitz, Katja; Mintern, Justine; Wiedenmann, Bertram; Schott, Eckart			Failure of CD4 T-Cells to Respond to Liver-Derived Antigen and to Provide Help to CD8 T-Cells	PLOS ONE			English	Article							SINUSOIDAL ENDOTHELIAL-CELLS; AUTOIMMUNE HEPATITIS; IN-VIVO; CYTOKINE PRODUCTION; CD8-T-CELL MEMORY; CD4-T-CELL HELP; DENDRITIC CELLS; SELF-ANTIGEN; MURINE LIVER; DIFFERENTIATION	CD4 T-cell help is required for the induction of efficient CD8 T-cells responses and the generation of memory cells. Lack of CD4 T-cell help may contribute to an exhausted CD8 phenotype and viral persistence. Little is known about priming of CD4 T-cells by liver-derived antigen. We used TF-OVA mice expressing ovalbumin in hepatocytes to investigate CD4 T-cell priming by liver-derived antigen and the impact of CD4 T-cell help on CD8 T-cell function. Naive and effector CD4 T-cells specific for ovalbumin were transferred into TF-OVA mice alone or together with naive ovalbumin-specific CD8 T-cells. T-cell activation and function were analyzed. CD4 T-cells ignored antigen presented by liver antigen-presenting cells (APCs) in vitro and in vivo but were primed in the liver-draining lymph node and the spleen. No priming occurred in the absence of bone-marrow derived APCs capable of presenting ovalbumin in vivo. CD4 T-cells primed in TF-OVA mice displayed defective Th1-effector function and caused no liver damage. CD4 T-cells were not required for the induction of hepatitis by CD8 T-cells. Th1-effector but not naive CD4 T-cells augmented the severity of liver injury caused by CD8 T-cells. Our data demonstrate that CD4 T-cells fail to respond to liver-derived antigen presented by liver APCs and develop defective effector function after priming in lymph nodes and spleen. The lack of CD4 T-cell help may be responsible for insufficient CD8 T-cell function against hepatic antigens.	[Derkow, Katja; Mueller, Anja; Eickmeier, Ira; Seidel, Daniel; Moreira, Marcos Vicinius Rust; Wiedenmann, Bertram; Schott, Eckart] Charite, Campus Virchow Klinikum, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany; [Derkow, Katja] Charite, Campus Charite Mitte, Dept Neurol, D-13353 Berlin, Germany; [Kruse, Nils; Klugewitz, Katja] Charite, Dept Gastroenterol & Infect Dis, D-13353 Berlin, Germany; [Mintern, Justine] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Melbourne	Derkow, K (corresponding author), Charite, Campus Virchow Klinikum, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany.	eckart.schott@charite.de		Wiedenmann, Bertram/0000-0002-7890-2552; Mintern, Justine/0000-0002-3797-8577	Deutsche Forschungsgemeinschaft [A10SFB633, A8SFB633]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by research grants from the Deutsche Forschungsgemeinschaft to ES (A10SFB633) and KK ( A8SFB633). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bertolino P, 2001, J IMMUNOL, V166, P5430, DOI 10.4049/jimmunol.166.9.5430; BERTOLINO P, 1995, EUR J IMMUNOL, V25, P1932, DOI 10.1002/eji.1830250721; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Buxbaum J, 2008, J AUTOIMMUN, V31, P208, DOI 10.1016/j.jaut.2008.04.015; Crispe IN, 2011, J HEPATOL, V54, P357, DOI 10.1016/j.jhep.2010.10.005; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Derkow K, 2007, HEPATOLOGY, V46, P1155, DOI 10.1002/HEP.21796; Elvevold K, 2008, AM J PHYSIOL-GASTR L, V294, pG391, DOI 10.1152/ajpgi.00167.2007; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Herkel J, 2003, HEPATOLOGY, V37, P1079, DOI 10.1053/jhep.2003.50191; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ichiki Y, 2005, AUTOIMMUN REV, V4, P315, DOI 10.1016/j.autrev.2005.01.005; Katz SC, 2004, J IMMUNOL, V173, P230, DOI 10.4049/jimmunol.173.1.230; Khanna A, 2000, J IMMUNOL, V164, P1346, DOI 10.4049/jimmunol.164.3.1346; Klugewitz K, 2002, HEPATOLOGY, V35, P568, DOI 10.1053/jhep.2002.31310; Knolle PA, 1999, GASTROENTEROLOGY, V116, P1428, DOI 10.1016/S0016-5085(99)70508-1; Kruse N, 2009, HEPATOLOGY, V50, P1904, DOI 10.1002/hep.23191; Limmer A, 1998, EUR J IMMUNOL, V28, P2395, DOI 10.1002/(SICI)1521-4141(199808)28:08<2395::AID-IMMU2395>3.0.CO;2-D; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; LOHR HF, 1994, LIVER, V14, P161; Luth S, 2008, J CLIN INVEST, V118, P3403, DOI 10.1172/JCI32132; Matsuno K, 1996, J EXP MED, V183, P1865, DOI 10.1084/jem.183.4.1865; Mintern J, 1999, IMMUNOL CELL BIOL, V77, P539, DOI 10.1046/j.1440-1711.1999.00868.x; O'Connell PJ, 2000, J IMMUNOL, V165, P795, DOI 10.4049/jimmunol.165.2.795; Onoe T, 2005, J IMMUNOL, V175, P139, DOI 10.4049/jimmunol.175.1.139; ROGOFF TM, 1980, J IMMUNOL, V124, P1740; SCHLAAK JF, 1993, CLIN EXP IMMUNOL, V94, P168; SENALDI G, 1992, ARCH DIS CHILD, V67, P1447, DOI 10.1136/adc.67.12.1447; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sprengers D, 2008, GASTROENTEROLOGY, V134, P2132, DOI 10.1053/j.gastro.2008.02.037; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Suzuki Y, 2004, J GASTROENTEROL, V39, P649, DOI 10.1007/s00535-003-1360-z; Wiegard C, 2007, GASTROENTEROLOGY, V133, P2010, DOI 10.1053/j.gastro.2007.09.007; Wuensch SA, 2006, J IMMUNOL, V177, P1689, DOI 10.4049/jimmunol.177.3.1689; Wuensch SA, 2010, HEPATOLOGY, V52, P1068, DOI 10.1002/hep.23745; Zierden M, 2010, GASTROENTEROLOGY, V139, P975, DOI 10.1053/j.gastro.2010.05.075	38	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21847	10.1371/journal.pone.0021847	http://dx.doi.org/10.1371/journal.pone.0021847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779338	gold, Green Submitted, Green Published			2022-12-25	WOS:000292811300017
J	Hanson, PC; Hamilton, DP; Stanley, EH; Preston, N; Langman, OC; Kara, EL				Hanson, Paul C.; Hamilton, David P.; Stanley, Emily H.; Preston, Nicholas; Langman, Owen C.; Kara, Emily L.			Fate of Allochthonous Dissolved Organic Carbon in Lakes: A Quantitative Approach	PLOS ONE			English	Article							HUMIC LAKE; MATTER; MINERALIZATION; SIMULATION; NUTRIENT; POLLEN; FOREST; MODEL	Inputs of dissolved organic carbon (DOC) to lakes derived from the surrounding landscape can be stored, mineralized or passed to downstream ecosystems. The balance among these OC fates depends on a suite of physical, chemical, and biological processes within the lake, as well as the degree of recalcintrance of the allochthonous DOC load. The relative importance of these processes has not been well quantified due to the complex nature of lakes, as well as challenges in scaling DOC degradation experiments under controlled conditions to the whole lake scale. We used a coupled hydrodynamic-water quality model to simulate broad ranges in lake area and DOC, two characteristics important to processing allochthonous carbon through their influences on lake temperature, mixing depth and hydrology. We calibrated the model to four lakes from the North Temperate Lakes Long Term Ecological Research site, and simulated an additional 12 'hypothetical' lakes to fill the gradients in lake size and DOC concentration. For each lake, we tested several mineralization rates (range: 0.001 d(-1) to 0.010 d(-1)) representative of the range found in the literature. We found that mineralization rates at the ecosystem scale were roughly half the values from laboratory experiments, due to relatively cool water temperatures and other lake-specific factors that influence water temperature and hydrologic residence time. Results from simulations indicated that the fate of allochthonous DOC was controlled primarily by the mineralization rate and the hydrologic residence time. Lakes with residence times < 1 year exported approximately 60% of the DOC, whereas lakes with residence times > 6 years mineralized approximately 60% of the DOC. DOC fate in lakes can be determined with a few relatively easily measured factors, such as lake morphometry, residence time, and temperature, assuming we know the recalcitrance of the DOC.	[Hanson, Paul C.; Stanley, Emily H.; Preston, Nicholas; Langman, Owen C.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Hamilton, David P.] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand	University of Wisconsin System; University of Wisconsin Madison; University of Waikato	Hanson, PC (corresponding author), Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA.	pchanson@wisc.edu	Hamilton, David/AAI-9851-2020; Hamilton, David/ABI-6870-2020; Hamilton, David P/F-5039-2012	Hamilton, David/0000-0002-9341-8777; Hamilton, David P/0000-0002-9341-8777; Stanley, Emily/0000-0003-4922-8121; Read, Emily/0000-0002-9617-9433	United States National Science Foundation; Global Lake Ecological Observatory Network	United States National Science Foundation(National Science Foundation (NSF)); Global Lake Ecological Observatory Network	This work was funded by the United States National Science Foundation through the Long Term Ecological Research project and the Global Lake Ecological Observatory Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN JA, 1993, THESIS U WISCONSIN; Algesten G, 2004, GLOBAL CHANGE BIOL, V10, P141, DOI 10.1111/j.1365-2486.2003.00721.x; [Anonymous], 2007, CLIM CHANG IMP AD VU; Bertilsson S, 2000, LIMNOL OCEANOGR, V45, P753, DOI 10.4319/lo.2000.45.4.0753; Bruce LC, 2006, ECOL MODEL, V193, P412, DOI 10.1016/j.ecolmodel.2005.09.008; BUFFAM I, 2010, J GEOPHYS RES-BIOGEO, V115, P1; Buffam I, 2011, GLOBAL CHANGE BIOL, V17, P1193, DOI 10.1111/j.1365-2486.2010.02313.x; Cardille JA, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000200; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Curtis P. J., 1998, AQUATIC HUMIC SUBSTA, P93; Dean WE, 1998, GEOLOGY, V26, P535, DOI 10.1130/0091-7613(1998)026<0535:MASOCB>2.3.CO;2; del Giorgio P. A., 2003, AQUATIC ECOSYSTEMS I, P399, DOI DOI 10.1016/B978-012256371-3/50018-4; DELGIORGIO PA, 2005, RESP AQUATIC ECOSYST, P266; Dillon PJ, 1997, BIOGEOCHEMISTRY, V36, P29, DOI 10.1023/A:1005731828660; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Downing JA, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002854; France RL, 1995, FRESHWATER BIOL, V34, P495, DOI 10.1111/j.1365-2427.1995.tb00907.x; GASITH A, 1976, LIMNOL OCEANOGR, V21, P253, DOI 10.4319/lo.1976.21.2.0253; Graham MD, 2006, LIMNOL OCEANOGR, V51, P1524, DOI 10.4319/lo.2006.51.3.1524; Graneli W, 1996, LIMNOL OCEANOGR, V41, P698, DOI 10.4319/lo.1996.41.4.0698; Hamilton DP, 2002, INT VER THEOR ANGEW, V28, P467; Hanson PC, 2007, FRESHWATER BIOL, V52, P814, DOI 10.1111/j.1365-2427.2007.01730.x; Hanson PC, 2004, GLOBAL CHANGE BIOL, V10, P1285, DOI 10.1111/j.1529-8817.2003.00805.x; Hanson PC, 2003, LIMNOL OCEANOGR, V48, P1112, DOI 10.4319/lo.2003.48.3.1112; Hernes PJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001421; Houser JN, 2006, CAN J FISH AQUAT SCI, V63, P2447, DOI 10.1139/F06-131; HOUSER JN, 2001, THESIS U WISCONSIN; Jonsson A, 2007, J HYDROL, V334, P141, DOI 10.1016/j.jhydrol.2006.10.003; Jonsson A, 2001, LIMNOL OCEANOGR, V46, P1691, DOI 10.4319/lo.2001.46.7.1691; Lee EJ, 1996, CAN J BOT, V74, P1265, DOI 10.1139/b96-153; Magnuson J.J., 2006, LONG TERM DYNAMICS L; Obernosterer I, 2004, LIMNOL OCEANOGR, V49, P117, DOI 10.4319/lo.2004.49.1.0117; Pace ML, 2004, NATURE, V427, P240, DOI 10.1038/nature02227; Prairie YT, 2008, CAN J FISH AQUAT SCI, V65, P543, DOI 10.1139/F08-011; Preston ND, 2008, AQUAT SCI, V70, P213, DOI 10.1007/s00027-008-8074-5; Reche I, 2000, ECOSYSTEMS, V3, P419, DOI 10.1007/s100210000038; Snucins E, 2000, LIMNOL OCEANOGR, V45, P1639, DOI 10.4319/lo.2000.45.7.1639; Sobek S, 2006, AMBIO, V35, P469, DOI 10.1579/0044-7447(2006)35[469:ACBOAS]2.0.CO;2; Stets EG, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003815; Tanentzap AJ, 2008, LIMNOL OCEANOGR, V53, P404, DOI 10.4319/lo.2008.53.1.0404; Tanentzap AJ, 2007, LIMNOL OCEANOGR-METH, V5, P484, DOI 10.4319/lom.2007.5.484; Vahatalo AV, 2008, LIMNOL OCEANOGR, V53, P1387, DOI 10.4319/lo.2008.53.4.1387; von Wachenfeldt E, 2008, ECOSYSTEMS, V11, P803, DOI 10.1007/s10021-008-9162-z; Weathers KC, 2001, CONSERV BIOL, V15, P1506, DOI 10.1046/j.1523-1739.2001.01090.x; Williamson CE, 1999, LIMNOL OCEANOGR, V44, P795, DOI 10.4319/lo.1999.44.3_part_2.0795; Williamson CE, 2009, LIMNOL OCEANOGR, V54, P2273, DOI 10.4319/lo.2009.54.6_part_2.2273; WISSMAR RC, 1977, J FISH RES BOARD CAN, V34, P1410, DOI 10.1139/f77-201; Xenopoulos MA, 2003, LIMNOL OCEANOGR, V48, P2321, DOI 10.4319/lo.2003.48.6.2321	48	88	90	4	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21884	10.1371/journal.pone.0021884	http://dx.doi.org/10.1371/journal.pone.0021884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779347	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811300023
J	Murillo-Rodriguez, E; Palomero-Rivero, M; Millan-Aldaco, D; Arias-Carrion, O; Drucker-Colin, R				Murillo-Rodriguez, Eric; Palomero-Rivero, Marcela; Millan-Aldaco, Diana; Arias-Carrion, Oscar; Drucker-Colin, Rene			Administration of URB597, Oleoylethanolamide or Palmitoylethanolamide Increases Waking and Dopamine in Rats	PLOS ONE			English	Article							SLEEP-WAKE CYCLE; RECEPTOR ANTAGONIST; ANANDAMIDE; MODULATION; PROJECTIONS; NUCLEUS	Background: Oleoylethanolamide (OEA) and palmitoylethanolamide (PEA) are amides of fatty acids and ethanolamine named N-acylethanolamines or acylethanolamides. The hydrolysis of OEA and PEA is catalyzed by the fatty acid amide hydrolase (FAAH). A number of FAAH inhibitors that increase the levels of OEA and PEA in the brain have been developed, including URB597. In the present report, we examined whether URB597, OEA or PEA injected into wake-related brain areas, such as lateral hypothalamus (LH) or dorsal raphe nuclei (DRN) would promote wakefulness (W) in rats. Methodology and Principal Findings: Male Wistar rats (250-300 g) were implanted for sleep studies with electrodes to record the electroencephalogram and electromyogram as well as a cannulae aimed either into LH or into DRN. Sleep stages were scored to determine W, slow wave sleep (SWS) and rapid eye movement sleep (REMS). Power spectra bands underly neurophysiological mechanisms of the sleep-wake cycle and provide information about quality rather than quantity of sleep, thus fast Fourier transformation analysis was collected after the pharmacological trials for alpha (for W; alpha = 8-12 Hz), delta (for SWS; delta = 0.5-4.0 Hz) and theta (for REMS; theta = 6.0-12.0 Hz). Finally, microdialysis samples were collected from a cannula placed into the nucleus accumbens (AcbC) and the levels of dopamine (DA) were determined by HPLC means after the injection of URB597, OEA or PEA. We found that microinjection of compounds (10, 20, 30 mu g/1 mu L; each) into LH or DRN during the lights-on period increased W and decreased SWS as well as REMS and enhanced DA extracellular levels. Conclusions: URB597, OEA or PEA promoted waking and enhanced DA if injected into LH or DRN. The wake-promoting effects of these compounds could be linked with the enhancement in levels of DA and indirectly mediated by anandamide.	[Murillo-Rodriguez, Eric] Univ Anahuac Mayab, Div Ciencias Salud, Escuela Med, Lab Neurociencias Mol & Integrat, Merida, Yucatan, Mexico; [Palomero-Rivero, Marcela; Millan-Aldaco, Diana; Drucker-Colin, Rene] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Mexico City 04510, DF, Mexico; [Arias-Carrion, Oscar] Univ Marburg, Dept Neurol, Marburg, Germany	Universidad Nacional Autonoma de Mexico; Philipps University Marburg	Murillo-Rodriguez, E (corresponding author), Univ Anahuac Mayab, Div Ciencias Salud, Escuela Med, Lab Neurociencias Mol & Integrat, Merida, Yucatan, Mexico.	eric.murillo@anahuac.mx	Arias-Carrion, Oscar/J-2801-2012; Arias-Carrion, Oscar/A-4248-2018	Arias-Carrion, Oscar/0000-0002-9982-7571	UNAM/DGAPA/PAPIIT [IN208206-2]; FIDEICOMISO UNAM; CONACyT [79009]	UNAM/DGAPA/PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); FIDEICOMISO UNAM; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Supported by UNAM/DGAPA/PAPIIT (IN208206-2) and FIDEICOMISO UNAM (R. D.-C.) and CONACyT (79009; E.M.-R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Calignano A, 2001, EUR J PHARMACOL, V419, P191, DOI 10.1016/S0014-2999(01)00988-8; Capasso R, 2001, BRIT J PHARMACOL, V134, P945, DOI 10.1038/sj.bjp.0704339; Corsi-Cabrera M, 2001, SLEEP, V24, P374, DOI 10.1093/sleep/24.4.374; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Dzirasa K, 2006, J NEUROSCI, V26, P10577, DOI 10.1523/JNEUROSCI.1767-06.2006; Fegley D, 2005, J PHARMACOL EXP THER, V313, P352, DOI 10.1124/jpet.104.078980; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Gaetani S, 2003, NEUROPSYCHOPHARMACOL, V28, P1311, DOI 10.1038/sj.npp.1300166; HABER SN, 1985, J COMP NEUROL, V235, P322, DOI 10.1002/cne.902350304; Hansen HS, 2010, EXP NEUROL, V224, P48, DOI 10.1016/j.expneurol.2010.03.022; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Monti JM, 2007, SLEEP MED REV, V11, P113, DOI 10.1016/j.smrv.2006.08.003; Monti JM, 2008, PROG BRAIN RES, V172, P625, DOI 10.1016/S0079-6123(08)00929-1; Mor M, 2004, J MED CHEM, V47, P4998, DOI 10.1021/jm031140x; Murillo-Rodniguez E, 2006, LIFE SCI, V79, P30, DOI 10.1016/j.lfs.2005.12.028; Murillo-Rodriguez E, 2008, NEUROSCIENCE, V157, P1, DOI 10.1016/j.neuroscience.2008.08.056; Murillo-Rodriguez E, 2003, SLEEP, V26, P943, DOI 10.1093/sleep/26.8.943; Murillo-Rodriguez E, 2001, NEUROREPORT, V12, P2131, DOI 10.1097/00001756-200107200-00018; Murillo-Rodriguez E, 1998, BRAIN RES, V812, P270, DOI 10.1016/S0006-8993(98)00969-X; Murillo-Rodriguez E, 2008, BEHAV NEUROSCI, V122, P1378, DOI 10.1037/a0013278; Murillo-Rodriguez E, 2007, EUR J PHARMACOL, V562, P82, DOI 10.1016/j.ejphar.2007.01.076; Murillo-Rodriguez E, 2009, CNS NEUROL DISORD-DR, V8, P245, DOI 10.2174/187152709788921654; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; Santucci V, 1996, LIFE SCI, V58, pPL103, DOI 10.1016/0024-3205(95)02319-4; Schmid HHO, 1996, CHEM PHYS LIPIDS, V80, P133, DOI 10.1016/0009-3084(96)02554-6; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; STRATFORD TR, 1990, BRAIN RES, V511, P173, DOI 10.1016/0006-8993(90)90239-8; Tarzia G, 2003, J MED CHEM, V46, P2352, DOI 10.1021/jm021119g; ZAHM DS, 1993, J COMP NEUROL, V327, P220, DOI 10.1002/cne.903270205	35	34	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e20766	10.1371/journal.pone.0020766	http://dx.doi.org/10.1371/journal.pone.0020766			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779318	gold, Green Submitted, Green Published			2022-12-25	WOS:000292811300003
J	Garred, MM; Wang, MM; Guo, X; Harrington, CA; Lein, PJ				Garred, Michelle M.; Wang, Michael M.; Guo, Xin; Harrington, Christina A.; Lein, Pamela J.			Transcriptional Responses of Cultured Rat Sympathetic Neurons during BMP-7-Induced Dendritic Growth	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; CEREBRAL CORTICAL-NEURONS; PROTEIN-KINASE-A; B-CELL FACTOR; OSTEOGENIC PROTEIN-1; NEURITE OUTGROWTH; MORPHOLOGICAL-DIFFERENTIATION; SYNAPTOTAGMIN-IV; NEWBORN NEURONS; DOWN-REGULATION	Background: Dendrites are the primary site of synapse formation in the vertebrate nervous system; however, relatively little is known about the molecular mechanisms that regulate the initial formation of primary dendrites. Embryonic rat sympathetic neurons cultured under defined conditions extend a single functional axon, but fail to form dendrites. Addition of bone morphogenetic proteins (BMPs) triggers these neurons to extend multiple dendrites without altering axonal growth or cell survival. We used this culture system to examine differential gene expression patterns in naive vs. BMP-treated sympathetic neurons in order to identify candidate genes involved in regulation of primary dendritogenesis. Methodology/Principal Findings: To determine the critical transcriptional window during BMP-induced dendritic growth, morphometric analysis of microtubule-associated protein (MAP-2)-immunopositive processes was used to quantify dendritic growth in cultures exposed to the transcription inhibitor actinomycin-D added at varying times after addition of BMP-7. BMP-7-induced dendritic growth was blocked when transcription was inhibited within the first 24 hr after adding exogenous BMP-7. Thus, total RNA was isolated from sympathetic neurons exposed to three different experimental conditions: (1) no BMP-7 treatment; (2) treatment with BMP-7 for 6 hr; and (3) treatment with BMP-7 for 24 hr. Affymetrix oligonucleotide microarrays were used to identify differential gene expression under these three culture conditions. BMP-7 significantly regulated 56 unique genes at 6 hr and 185 unique genes at 24 hr. Bioinformatic analyses implicate both established and novel genes and signaling pathways in primary dendritogenesis. Conclusions/Significance: This study provides a unique dataset that will be useful in generating testable hypotheses regarding transcriptional control of the initial stages of dendritic growth. Since BMPs selectively promote dendritic growth in central neurons as well, these findings may be generally applicable to dendritic growth in other neuronal cell types.	[Garred, Michelle M.; Harrington, Christina A.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Wang, Michael M.] Univ Michigan, Dept Neurol, VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Wang, Michael M.] Univ Michigan, Dept Mol & Integrat Physiol, VA Ann Arbor Healthcare Syst, Ann Arbor, MI 48109 USA; [Guo, Xin] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Lein, Pamela J.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA	Oregon Health & Science University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Davis	Garred, MM (corresponding author), Millennium Sci, Melbourne, Vic, Australia.	pjlein@ucdavis.edu		Lein, Pamela/0000-0001-7665-7584	National Institutes of Health [R21 NS45037, R01 ES014901, K02 NS054724]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS045037, K02NS054724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from the National Institutes of Health (grants R21 NS45037 to PJL and MMW; R01 ES014901 to PJL; and K02 NS054724 to MMW) and the Burroughs Wellcome Fund (Career Award in Biomedical Sciences to MMW). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Aglah C, 2008, NEUROPHARMACOLOGY, V55, P8, DOI 10.1016/j.neuropharm.2008.04.005; [Anonymous], [No title captured]; Appaiah H, 2010, CANCER BIOL THER, V10, P600, DOI 10.4161/cbt.10.6.12586; Banisadr G, 2002, EUR J NEUROSCI, V16, P1661, DOI 10.1046/j.1460-9568.2002.02237.x; Beck HN, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-12; Benson DL, 1996, J NEUROCYTOL, V25, P181, DOI 10.1007/BF02284795; BergerSweeney J, 1997, BEHAV BRAIN RES, V86, P121, DOI 10.1016/S0166-4328(96)02251-6; Bernstein HG, 1999, J NEUROCYTOL, V28, P655, DOI 10.1023/A:1007056731551; Bianchi LM, 2005, JARO-J ASSOC RES OTO, V6, P355, DOI 10.1007/s10162-005-0013-8; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brann AB, 1999, J NEUROSCI, V19, P8199; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; BRUCKENSTEIN DA, 1988, DEV BIOL, V128, P324, DOI 10.1016/0012-1606(88)90295-3; Chang CB, 2003, DEV BIOL, V255, P1, DOI 10.1016/S0012-1606(02)00075-1; CHIARAMELLO A, 1995, MOL CELL BIOL, V15, P6036; Choi WS, 2001, BIOCHEM BIOPH RES CO, V287, P656, DOI 10.1006/bbrc.2001.5649; CLEVELAND DW, 1981, CELL, V25, P537, DOI 10.1016/0092-8674(81)90072-6; Connors SL, 2008, PEDIATR NEUROL, V38, P163, DOI 10.1016/j.pediatrneurol.2007.10.009; Corty MM, 2009, DEVELOPMENT, V136, P1049, DOI 10.1242/dev.014423; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; DEBERNARDO AP, 1995, DEV BIOL, V169, P65, DOI 10.1006/dbio.1995.1127; DERUITER JP, 1987, BRAIN RES, V402, P217, DOI 10.1016/0006-8993(87)90028-X; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Dijkmans TF, 2009, BRAIN RES, V1249, P19, DOI 10.1016/j.brainres.2008.10.050; Drahushuk K, 2002, J NEUROSCI, V22, P6560; Esquenazi S, 2002, EXP NEUROL, V176, P41, DOI 10.1006/exnr.2002.7906; Flood D.G., 1990, PROG BRAIN RES, P435; Gao FB, 2003, TRENDS NEUROSCI, V26, P262, DOI 10.1016/S0166-2236(03)00078-X; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Gehler S, 2004, J NEUROSCI, V24, P4363, DOI 10.1523/JNEUROSCI.0404-04.2004; Gisler R, 2002, J IMMUNOL, V168, P5130, DOI 10.4049/jimmunol.168.10.5130; Gratacos E, 2002, J NEUROSCI RES, V70, P638, DOI 10.1002/jnr.10438; Guo X, 1998, NEUROSCI LETT, V245, P131, DOI 10.1016/S0304-3940(98)00192-X; Guo X, 2001, J NEUROBIOL, V48, P120, DOI 10.1002/neu.1046; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; Hartmann M, 2004, J CELL SCI, V117, P5803, DOI 10.1242/jcs.01511; Hay E, 2000, J CELL PHYSIOL, V183, P117, DOI 10.1002/(SICI)1097-4652(200004)183:1<117::AID-JCP14>3.0.CO;2-#; Higgins D, 1997, CURR OPIN NEUROBIOL, V7, P599, DOI 10.1016/S0959-4388(97)80078-5; Higgins D., 1991, CULTURING NERVE CELL, P177; Hocking JC, 2008, MOL CELL NEUROSCI, V37, P247, DOI 10.1016/j.mcn.2007.09.011; Ibata K, 2000, J NEUROCHEM, V74, P518, DOI 10.1046/j.1471-4159.2000.740518.x; Ibata K, 2002, NEUROSCI RES, V43, P401, DOI 10.1016/S0168-0102(02)00066-4; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; IWASAKI Y, 1994, J NEUROL SCI, V125, P11, DOI 10.1016/0022-510X(94)90235-6; JAGADHA V, 1989, CAN J NEUROL SCI, V16, P41, DOI 10.1017/S0317167100028493; Jin KL, 2006, J NEUROBIOL, V66, P236, DOI 10.1002/neu.20215; Kameda T, 1999, GENES CELLS, V4, P175, DOI 10.1046/j.1365-2443.1999.00250.x; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kim JH, 2005, FASEB J, V19, P109, DOI 10.1096/fj.05-4826fje; Kim WY, 2009, J NEUROCHEM, V108, P1057, DOI 10.1111/j.1471-4159.2008.05854.x; KIMURA H, 1992, J CELL BIOL, V116, P777, DOI 10.1083/jcb.116.3.777; Knofler M, 2002, BIOCHEM J, V361, P641, DOI 10.1042/0264-6021:3610641; KNUTSEN R, 1995, ENDOCRINOLOGY, V136, P857, DOI 10.1210/en.136.3.857; Lakshmana MK, 1998, BRAIN RES, V796, P38, DOI 10.1016/S0006-8993(98)00312-6; Lee MJ, 2003, J IMMUNOL, V170, P2557, DOI 10.4049/jimmunol.170.5.2557; Lein P, 1996, INT J DEV NEUROSCI, V14, P203, DOI 10.1016/0736-5748(96)00008-1; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; Lein PJ, 2007, J NEUROSCI, V27, P4725, DOI 10.1523/JNEUROSCI.5633-06.2007; Levkovitz Y, 2001, J NEUROSCI, V21, P45, DOI 10.1523/JNEUROSCI.21-01-00045.2001; Licht T, 2010, DEVELOPMENT, V137, P261, DOI 10.1242/dev.039636; Lonn P, 2005, NEUROCHEM RES, V30, P753, DOI 10.1007/s11064-005-6868-6; Lopez-Coviella I, 2005, P NATL ACAD SCI USA, V102, P6984, DOI 10.1073/pnas.0502097102; Maussion G, 2008, HUM MOL GENET, V17, P2541, DOI 10.1093/hmg/ddn154; McAvoy T, 2009, P NATL ACAD SCI USA, V106, P3531, DOI 10.1073/pnas.0813263106; Metzger F, 2010, Curr Mol Pharmacol, V3, P1; MILLER JP, 1984, J EXP BIOL, V112, P129; Miyashita M, 2004, MOL BIOL CELL, V15, P3950, DOI 10.1091/mbc.E04-01-0019; Miyazono Kohei, 2002, Sci STKE, V2002, ppe40, DOI 10.1126/stke.2002.151.pe40; Moon JI, 2008, DEV BIOL, V315, P404, DOI 10.1016/j.ydbio.2007.12.041; Ohno K, 2009, J NEUROCHEM, V111, P790, DOI 10.1111/j.1471-4159.2009.06370.x; Opatz J, 2009, MOL CELL NEUROSCI, V40, P293, DOI 10.1016/j.mcn.2008.11.002; Ou YM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-16; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Pavelock KA, 2007, J NEUROCHEM, V100, P603, DOI 10.1111/j.1471-4159.2006.04293.x; Prieto AL, 2007, NEUROSCIENCE, V150, P319, DOI 10.1016/j.neuroscience.2007.09.047; Purpura DP., 1967, NEUROSCIENCES A STUD, P372; PURVES D, 1975, J PHYSIOL-LONDON, V252, P429, DOI 10.1113/jphysiol.1975.sp011151; Quartu M, 2007, BRAIN RES, V1173, P36, DOI 10.1016/j.brainres.2007.07.064; Rao BSS, 1999, BRAIN RES, V821, P218, DOI 10.1016/S0006-8993(98)01362-6; Read DE, 2008, BRAIN RES, V1221, P14, DOI 10.1016/j.brainres.2008.05.028; Redmond L, 2001, CURR OPIN NEUROBIOL, V11, P111, DOI 10.1016/S0959-4388(00)00181-1; Salama-Cohen P, 2006, J NEUROCHEM, V97, P1269, DOI 10.1111/j.1471-4159.2006.03783.x; Schiller MR, 1996, J HISTOCHEM CYTOCHEM, V44, P1489, DOI 10.1177/44.12.8985141; Schuman EM, 1997, NEURON, V18, P339, DOI 10.1016/S0896-6273(00)81234-9; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Seijffers R, 2006, MOL CELL NEUROSCI, V32, P143, DOI 10.1016/j.mcn.2006.03.005; Sejnowski T, 1997, SCIENCE, V275, P178, DOI 10.1126/science.275.5297.178; SHARMA E, 1995, J BIOL CHEM, V270, P49, DOI 10.1074/jbc.270.1.49; Sikder H, 2003, CANCER CELL, V4, P291, DOI 10.1016/S1535-6108(03)00245-9; Sivertsen EA, 2007, EUR J IMMUNOL, V37, P2937, DOI 10.1002/eji.200636759; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; Smith EMK, 2002, J IMMUNOL, V169, P261, DOI 10.4049/jimmunol.169.1.261; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Sparrow DB, 1998, MECH DEVELOP, V71, P151, DOI 10.1016/S0925-4773(98)00010-0; Spilker C, 2003, MOL CELL NEUROSCI, V24, P766, DOI 10.1016/S1044-7431(03)00242-2; Svitkina T, 2010, J NEUROSCI, V30, P14937, DOI 10.1523/JNEUROSCI.4276-10.2010; Tan ZJ, 2010, P NATL ACAD SCI USA, V107, P9873, DOI 10.1073/pnas.1003480107; Thal MA, 2009, P NATL ACAD SCI USA, V106, P552, DOI 10.1073/pnas.0802550106; TROPEA M, 1988, GLIA, V1, P380, DOI 10.1002/glia.440010605; Urbanska M, 2008, ACTA NEUROBIOL EXP, V68, P264; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; VYAS S, 1994, FEBS LETT, V351, P53, DOI 10.1016/0014-5793(94)00821-3; Wang YQ, 2009, NEUROCHEM INT, V55, P629, DOI 10.1016/j.neuint.2009.06.007; Wei QZ, 1997, J NEUROSCI RES, V50, P618; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; Withers GS, 2000, EUR J NEUROSCI, V12, P106, DOI 10.1046/j.1460-9568.2000.00889.x; Wu XD, 2002, GENE EXPRESSION, V10, P279, DOI 10.3727/000000002783992361; Yabe T, 2002, J NEUROSCI RES, V68, P161, DOI 10.1002/jnr.10210; Yeh LCC, 1997, ENDOCRINOLOGY, V138, P4181, DOI 10.1210/en.138.10.4181; Yeh LCC, 1999, MOL CELL ENDOCRINOL, V153, P113, DOI 10.1016/S0303-7207(99)00076-3; Zheng Y, 2009, BIOCHEM BIOPH RES CO, V378, P371, DOI 10.1016/j.bbrc.2008.11.049; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	114	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21754	10.1371/journal.pone.0021754	http://dx.doi.org/10.1371/journal.pone.0021754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765909	Green Published, gold			2022-12-25	WOS:000292781500012
J	Mahowald, GK; Mahowald, MA; Moon, C; Khor, B; Sleckman, BP				Mahowald, Grace K.; Mahowald, Michael A.; Moon, Clara; Khor, Bernard; Sleckman, Barry P.			Out-of-Frame T Cell Receptor Beta Transcripts Are Eliminated by Multiple Pathways In Vivo	PLOS ONE			English	Article							NONSENSE-MEDIATED DECAY; CHROMOSOMAL V(D)J RECOMBINATION; EXON JUNCTION COMPLEX; MESSENGER-RNA DECAY; CYTOPLASMIC TRANSLATION; REGULATORY MECHANISM; PROTEIN-SYNTHESIS; CODONS; INTRON; GENES	Non-productive antigen receptor genes with frame shifts generated during the assembly of these genes are found in many mature lymphocytes. Transcripts from these genes have premature termination codons (PTCs) and could encode truncated proteins if they are not either inactivated or destroyed by nonsense-mediated decay (NMD). In mammalian cells, NMD can be activated by pathways that rely on the presence of an intron downstream of the PTC; however, NMD can also be activated by pathways that do not rely on these downstream introns, and pathways independent of NMD can inactivate PTC-containing transcripts. Here, through the generation and analysis of mice with gene-targeted modifications of the endogenous T cell receptor beta (Tcrb) locus, we demonstrate that in T cells in vivo, optimal clearance of PTC-containing Tcrb transcripts depends on the presence of an intron downstream of the PTC.	[Mahowald, Grace K.; Mahowald, Michael A.; Moon, Clara; Khor, Bernard; Sleckman, Barry P.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Mahowald, GK (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	Sleckman@immunology.wustl.edu		Mahowald, Grace/0000-0003-4541-4920; Khor, Bernard/0000-0003-4689-5092; Moon, Clara/0000-0003-2076-9282	National Institutes of Health (NIH) [AI47829]; National Center for Research Resources (NCRR) [RR012466]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is supported by National Institutes of Health (NIH) grant AI47829 (B. P. S.). Mice were produced by a transgenic core facility supported by the Rheumatic Diseases Core Center at Washington University (NIH P30-AR48335) and housed in a facility supported by National Center for Research Resources (NCRR) grant RR012466. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoufouchi S, 1996, CELL, V85, P415, DOI 10.1016/S0092-8674(00)81119-8; Bassing CH, 2000, NATURE, V405, P583, DOI 10.1038/35014635; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Brady BL, 2010, J IMMUNOL, V185, P3801, DOI 10.4049/jimmunol.1001158; Brocke KS, 2002, HUM MOL GENET, V11, P331, DOI 10.1093/hmg/11.3.331; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Buhler M, 2006, NAT STRUCT MOL BIOL, V13, P462, DOI 10.1038/nsmb1081; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Chang YF, 2007, J BIOL CHEM, V282, P29738, DOI 10.1074/jbc.M704372200; Chemin G, 2010, J IMMUNOL, V184, P5009, DOI 10.4049/jimmunol.0902949; CHENG J, 1994, MOL CELL BIOL, V14, P6317, DOI 10.1128/MCB.14.9.6317; Delpy L, 2004, P NATL ACAD SCI USA, V101, P7375, DOI 10.1073/pnas.0305586101; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Glusman G, 2001, IMMUNITY, V15, P337, DOI 10.1016/S1074-7613(01)00200-X; Imam JS, 2010, NUCLEIC ACIDS RES, V38, P1559, DOI 10.1093/nar/gkp1115; Khor B, 2005, EUR J IMMUNOL, V35, P964, DOI 10.1002/eji.200425806; Khor B, 2009, MOL IMMUNOL, V46, P321, DOI 10.1016/j.molimm.2008.10.030; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; LOZANO F, 1994, EMBO J, V13, P4617, DOI 10.1002/j.1460-2075.1994.tb06783.x; Mahowald GK, 2009, P NATL ACAD SCI USA, V106, P18339, DOI 10.1073/pnas.0902545106; Maquat LE, 2002, GENE DEV, V16, P1743, DOI 10.1101/gad.1014502; Maquat LE, 2001, RNA, V7, P445, DOI 10.1017/S1355838201002229; Matsuda D, 2007, NAT STRUCT MOL BIOL, V14, P974, DOI 10.1038/nsmb1297; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Neu-Yilik G, 2001, EMBO J, V20, P532, DOI 10.1093/emboj/20.3.532; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Valentine CR, 1998, MUTAT RES-REV MUTAT, V411, P87, DOI 10.1016/S1383-5742(98)00010-6; Wang J, 2002, MOL CELL, V10, P951, DOI 10.1016/S1097-2765(02)00635-4; Wang J, 2002, EMBO REP, V3, P274, DOI 10.1093/embo-reports/kvf036; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Zhang J, 1998, MOL CELL BIOL, V18, P5272, DOI 10.1128/MCB.18.9.5272; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849	34	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21627	10.1371/journal.pone.0021627	http://dx.doi.org/10.1371/journal.pone.0021627			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765899	Green Published, Green Submitted, gold			2022-12-25	WOS:000292781500005
J	Hammarfjord, O; Falet, H; Gurniak, C; Hartwig, JH; Wallin, RPA				Hammarfjord, Oscar; Falet, Herve; Gurniak, Christine; Hartwig, John H.; Wallin, Robert P. A.			Gelsolin-Independent Podosome Formation in Dendritic Cells	PLOS ONE			English	Article							ACTIVATED MACROPHAGES; ACTIN; INVADOPODIA; PROTEINS; CYTOSKELETON; ADHESIONS; CORTACTIN; IMMUNITY	Podosomes, important structures for adhesion and extracellular matrix degradation, are claimed to be involved in cell migration. In addition, podosomes are also reported to be of importance in tissue remodelling, e. g., in osteoclast-mediated bone resorption. Podosomes are highly dynamic actin-filament scaffolds onto which proteins important for their function, such as matrix metallo-proteases and integrins, attach. The dynamics of the podosomes require the action of many proteins regulating actin assembly and disassembly. One such protein, gelsolin, which associates to podosomes, has been reported to be important for podosome formation and function in osteoclasts. However, podosome-like structures have been reported in gelsolin-deficient dendritic cells, but the identity of these structures was not confirmed, and their dynamics and function was not investigated. Like many other cells, dendritic cells of the immune system also form matrix degrading podosomes. In the present study, we show that dendritic cells form podosomes independently of gelsolin, that there are no major alterations in their dynamics of formation and disassembly, and that they exhibit matrix-degrading function. Furthermore, we found that gelsolin is not required for TLR4-induced podosome disassembly. Thus, the actin cytoskeleton of podosomes involved in dendritic cell extracellular matrix degradation appears to be regulated differently than the cytoskeleton in podosomes of osteoclasts mediating bone resorption.	[Hammarfjord, Oscar; Wallin, Robert P. A.] Karolinska Univ Hosp, Karolinska Inst, Ctr Infect Med, Dept Med, Stockholm, Sweden; [Falet, Herve; Hartwig, John H.] Harvard Univ, Brigham & Womens Hosp, Translat Med Div, Dept Med,Sch Med, Boston, MA USA; [Gurniak, Christine] Univ Bonn, Inst Genet, D-5300 Bonn, Germany	Karolinska Institutet; Karolinska University Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Bonn	Hammarfjord, O (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Ctr Infect Med, Dept Med, Stockholm, Sweden.	Robert.Wallin@ki.se		Falet, Herve/0000-0003-0788-9204	Swedish Research Council; Swedish Foundation for Strategic Research; Magnus Bergvall Foundation; Swedish Dental Association; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Magnus Bergvall Foundation; Swedish Dental Association; Karolinska Institutet(Karolinska Institutet)	This work was supported by research grants from the Swedish Research Council, the Swedish Foundation for Strategic Research, the Magnus Bergvall Foundation, the Swedish Dental Association, and the Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Burns S, 2001, BLOOD, V98, P1142, DOI 10.1182/blood.V98.4.1142; Calle Y, 2006, J CELL SCI, V119, P2375, DOI 10.1242/jcs.02939; Campbell HD, 2002, MOL CELL BIOL, V22, P3518, DOI 10.1128/MCB.22.10.3518-3526.2002; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Crowley JL, 2009, MOL BIOL CELL, V20, P948, DOI 10.1091/mbc.E08-08-0867; Dovas A, 2009, J CELL SCI, V122, P3873, DOI 10.1242/jcs.051755; GAVAZZI I, 1989, J CELL SCI, V94, P85; Gawden-Bone C, 2010, J CELL SCI, V123, P1427, DOI 10.1242/jcs.056515; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Hammarfjord O, 2010, J LEUKOCYTE BIOL, V88, P747, DOI 10.1189/jlb.0310155; HARTWIG JH, 1992, J CELL BIOL, V118, P1421, DOI 10.1083/jcb.118.6.1421; HU S, J THEOR BIOL; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kaverina I, 2003, J CELL SCI, V116, P4915, DOI 10.1242/jcs.00818; Khurana S, 2008, FEBS LETT, V582, P2128, DOI 10.1016/j.febslet.2008.02.040; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; MA T, J BIOL CHEM; Ma Tao, 2008, J Mol Signal, V3, P4, DOI 10.1186/1750-2187-3-4; Marks PW, 1998, J CELL SCI, V111, P2129; Moreau V, 2003, MOL CELL BIOL, V23, P6809, DOI 10.1128/MCB.23.19.6809-6822.2003; SALTEL F, EUR J CELL BIOL; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; VANGOETHEM E, EUR J CELL BIOL; Webb BA, 2006, EXP CELL RES, V312, P760, DOI 10.1016/j.yexcr.2005.11.032; Weintz G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.29; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; West MA, 1999, EUR J IMMUNOL, V29, P3450, DOI 10.1002/(SICI)1521-4141(199911)29:11<3450::AID-IMMU3450>3.0.CO;2-A; West MA, 2008, J CELL BIOL, V182, P993, DOI 10.1083/jcb.200801022; Witke W, 2001, J CELL BIOL, V154, P775, DOI 10.1083/jcb.200101113	35	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21615	10.1371/journal.pone.0021615	http://dx.doi.org/10.1371/journal.pone.0021615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779330	gold, Green Submitted, Green Published			2022-12-25	WOS:000292680900008
J	van den Berg, G; Moorman, AFM				van den Berg, Gert; Moorman, Antoon F. M.			Development of the Pulmonary Vein and the Systemic Venous Sinus: An Interactive 3D Overview	PLOS ONE			English	Article							CARDIAC CHAMBER FORMATION; CHICK-EMBRYO; GENE-EXPRESSION; MESSENGER-RNA; HEART; ORIGIN; DIFFERENTIATION; LOCALIZATION; MYOCARDIUM; CONDUCTION	Knowledge of the normal formation of the heart is crucial for the understanding of cardiac pathologies and congenital malformations. The understanding of early cardiac development, however, is complicated because it is inseparably associated with other developmental processes such as embryonic folding, formation of the coelomic cavity, and vascular development. Because of this, it is necessary to integrate morphological and experimental analyses. Morphological insights, however, are limited by the difficulty in communication of complex 3D-processes. Most controversies, in consequence, result from differences in interpretation, rather than observation. An example of such a continuing debate is the development of the pulmonary vein and the systemic venous sinus, or "sinus venosus". To facilitate understanding, we present a 3D study of the developing venous pole in the chicken embryo, showing our results in a novel interactive fashion, which permits the reader to form an independent opinion. We clarify how the pulmonary vein separates from a greater vascular plexus within the splanchnic mesoderm. The systemic venous sinus, in contrast, develops at the junction between the splanchnic and somatic mesoderm. We discuss our model with respect to normal formation of the heart, congenital cardiac malformations, and the phylogeny of the venous tributaries.	[van den Berg, Gert; Moorman, Antoon F. M.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Anat Embryol & Physiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	van den Berg, G (corresponding author), Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Anat Embryol & Physiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	A.F.Moorman@amc.uva.nl			Netherlands Heart Foundation [NHS1996M002]	Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was funded by The Netherlands Heart Foundation (NHS1996M002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RH, 2006, DEV DYNAM, V235, P2, DOI 10.1002/dvdy.20578; BOURNE GH, 1980, HEARTS HEART ORGANS; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; BURROUGHS JT, 1960, AM HEART J, V59, P913, DOI 10.1016/0002-8703(60)90414-2; Christoffels VM, 2006, CIRC RES, V98, P1555, DOI 10.1161/01.RES.0000227571.84189.65; Colas JF, 2000, DEV DYNAM, V218, P316, DOI 10.1002/(SICI)1097-0177(200006)218:2<316::AID-DVDY6>3.0.CO;2-8; de Boer BA, 2011, DEVELOPMENT, V138, P159, DOI 10.1242/dev.051086; DEJONG F, 1990, ANAT REC, V226, P213, DOI 10.1002/ar.1092260211; DEJONG F, 1992, CIRC RES, V71, P240, DOI 10.1161/01.RES.71.2.240; DELACRUZ MV, 1989, J ANAT, V165, P121; DERUITER MC, 1993, CIRCULATION, V87, P1306, DOI 10.1161/01.CIR.87.4.1306; Farmer CG, 1999, ANNU REV PHYSIOL, V61, P573, DOI 10.1146/annurev.physiol.61.1.573; Galli D, 2008, DEVELOPMENT, V135, P1157, DOI 10.1242/dev.014563; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hall SM, 2002, AM J RESP CELL MOL, V26, P333, DOI 10.1165/ajrcmb.26.3.4698; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Houweling AC, 2002, ANAT RECORD, V266, P93, DOI 10.1002/ar.10042; Jongbloed MRM, 2008, THESCIENTIFICWORLDJO, V8, P239, DOI 10.1100/tsw.2008.40; KAMINO K, 1981, NATURE, V290, P595, DOI 10.1038/290595a0; Kruithof BPT, 2003, ANAT REC PART A, V271A, P303, DOI 10.1002/ar.a.10033; LILLIE FR, 1919, BODY CAVITIES MESENT, P333; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Manner J, 2007, ANAT REC, V290, P168, DOI 10.1002/ar.20418; MARTIN AW, 1980, HEARTS HEART LIKE OR, P11; Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Moorman AFM, 2007, ANAT REC, V290, P1046, DOI 10.1002/ar.20572; Moreno-Rodriguez RA, 2006, DEV DYNAM, V235, P191, DOI 10.1002/dvdy.20601; NEILL CA, 1956, PEDIATRICS, V18, P880; Patten BM, 1933, AM J ANAT, V53, P349, DOI 10.1002/aja.1000530302; Romanoff A.L., 1960, AVIAN EMBRYO STRUCTU; ROSENQUIST GC, 1971, ANAT RECORD, V169, P501, DOI 10.1002/ar.1091690303; ROSENQUIST GC, 1971, ANAT RECORD, V169, P65, DOI 10.1002/ar.1091690107; SISSMAN J, 1966, NATURE, V210, P504; SIZAROV A, 2010, 3 DIMENSION IN PRESS; Soufan AT, 2006, CIRC RES, V99, P545, DOI 10.1161/01.RES.0000239407.45137.97; Soufan AT, 2004, CIRC RES, V95, P1207, DOI 10.1161/01.RES.0000150852.04747.e1; TOKUYASU KT, 1987, J CELL BIOL, V105, P2795, DOI 10.1083/jcb.105.6.2795; van den Berg G, 2009, PEDIATR CARDIOL, V30, P580, DOI 10.1007/s00246-008-9369-y; van den Berg G, 2009, CIRC RES, V104, P179, DOI 10.1161/CIRCRESAHA.108.185843; Webb S, 1998, ANAT REC, V250, P325, DOI 10.1002/(SICI)1097-0185(199803)250:3<325::AID-AR7>3.0.CO;2-Z; Webb S, 2001, CARDIOL YOUNG, V11, P632, DOI 10.1017/S1047951101000993; Webb S, 2000, ANAT RECORD, V259, P67, DOI 10.1002/(SICI)1097-0185(20000501)259:1<67::AID-AR8>3.0.CO;2-5; Wiese C, 2009, CIRC RES, V104, P388, DOI 10.1161/CIRCRESAHA.108.187062	44	38	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e22055	10.1371/journal.pone.0022055	http://dx.doi.org/10.1371/journal.pone.0022055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779373	Green Published, Green Submitted, gold			2022-12-25	WOS:000292680900026
J	Seregin, SS; Aldhamen, YA; Appledorn, DM; Aylsworth, CF; Godbehere, S; Liu, CJJ; Quiroga, D; Amalfitano, A				Seregin, Sergey S.; Aldhamen, Yasser A.; Appledorn, Daniel M.; Aylsworth, Charles F.; Godbehere, Sarah; Liu, Chyong-Jy Joyce; Quiroga, Dionisia; Amalfitano, Andrea			TRIF Is a Critical Negative Regulator of TLR Agonist Mediated Activation of Dendritic Cells In Vivo	PLOS ONE			English	Article							ADAPTIVE IMMUNE-RESPONSES; ALUMINUM-CONTAINING ADJUVANTS; TOLL-LIKE RECEPTORS; EIMERIA-ACERVULINA; VACCINE ADJUVANTS; LIPOPOLYSACCHARIDE; MACROPHAGES; INFECTION; PATHWAYS; PROTEIN	Despite recent advances in developing and licensing adjuvants, there is a great need for more potent formulations to enhance immunogenicity of vaccines. An Eimeria tenella derived antigen (rEA) augments immune responses against several pathogens in animal models and recently was confirmed to be safe for human use. In this study, we have analyzed the molecular mechanisms underlying rEA activity in mice, and confirmed that rEA activates multiple immune cell types, including DCs, macrophages, NK, B, and T cells. The rEA adjuvant also elicits the induction of pleiotropic pro-inflammatory cytokines, responses that completely depend upon the presence of the TLR adaptor protein MyD88. Surprisingly, we also found that the TRIF adaptor protein acts as a potent negative regulator of TLR agonist-triggered immune responses. For example, IL12 production and the induction of co-stimulatory molecule expression by DCs and IFN gamma production by NK cells in vivo were significantly increased in rEA-treated TRIF-KO mice. Importantly, however, TRIF suppressive effects were not restricted to rEA-mediated responses, but were apparent in LPS- or ODN2006-activated DCs as well. Taken together, our findings confirm that rEA is a potent adjuvant, triggering robust activation of the innate immune system, in a manner that is augmented by MyD88 and inhibited by TRIF; thereby unveiling the potential complexities of modulating TLR activity to augment vaccine efficacy.	[Seregin, Sergey S.; Aldhamen, Yasser A.; Appledorn, Daniel M.; Aylsworth, Charles F.; Godbehere, Sarah; Liu, Chyong-Jy Joyce; Quiroga, Dionisia; Amalfitano, Andrea] Michigan State Univ, Coll Osteopath Med, Dept Pediat, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University College of Osteopathic Medicine	Seregin, SS (corresponding author), Michigan State Univ, Coll Osteopath Med, Dept Pediat, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	amalfit1@msu.edu	Quiroga, Dionisia/ABH-7893-2020	Quiroga, Dionisia/0000-0003-3388-7069; Aldhamen, Yasser/0000-0002-9560-8013	National Institutes of Health [RO1DK-069884, P01 CA078673]; MSU Foundation; Osteopathic Heritage Foundation; NATIONAL CANCER INSTITUTE [P01CA078673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSU Foundation; Osteopathic Heritage Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health grants RO1DK-069884, P01 CA078673, the MSU Foundation (http://www.msufoundation.msu.edu/) as well the Osteopathic Heritage Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appledorn DM, 2009, J INNATE IMMUN, V1, P376, DOI 10.1159/000207194; Appledorn DM, 2008, J IMMUNOL, V181, P2134, DOI 10.4049/jimmunol.181.3.2134; Appledorn DM, 2010, PLOS ONE, V5, pA130, DOI 10.1371/journal.pone.0009579; APPLEDORN DM, 2010, CLIN VACCINE IMMUNOL; Biswas SK, 2007, J IMMUNOL, V179, P4083, DOI 10.4049/jimmunol.179.6.4083; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Boonstra A, 2006, J IMMUNOL, V177, P7551, DOI 10.4049/jimmunol.177.11.7551; Choi YJ, 2010, J BIOL CHEM, V285, P21382, DOI 10.1074/jbc.M110.115022; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Conroy H, 2008, ONCOGENE, V27, P168, DOI 10.1038/sj.onc.1210910; Gowen BB, 2006, ANTIMICROB AGENTS CH, V50, P2023, DOI 10.1128/AAC.01473-05; Hartman ZC, 2007, J VIROL, V81, P1796, DOI 10.1128/JVI.01936-06; Hawlisch H, 2006, MOL IMMUNOL, V43, P13, DOI 10.1016/j.molimm.2005.06.028; Hedhli D, 2009, VACCINE, V27, P2274, DOI 10.1016/j.vaccine.2009.01.100; Hem SL, 2007, EXPERT REV VACCINES, V6, P685, DOI 10.1586/14760584.6.5.685; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; JENKINS MC, 1988, EXP PARASITOL, V66, P96, DOI 10.1016/0014-4894(88)90054-9; Juckett DA, 2008, MED HYPOTHESES, V71, P104, DOI 10.1016/j.mehy.2008.01.024; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kumar H, 2008, J IMMUNOL, V180, P683, DOI 10.4049/jimmunol.180.2.683; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; LAURENT F, 1994, MOL BIOCHEM PARASIT, V63, P79, DOI 10.1016/0166-6851(94)90010-8; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004; Loniewski KJ, 2007, MOL IMMUNOL, V44, P3715, DOI 10.1016/j.molimm.2007.04.002; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; McAleer JP, 2009, J IMMUNOL, V182, P5322, DOI 10.4049/jimmunol.0803616; Morefield GL, 2005, VACCINE, V23, P1588, DOI 10.1016/j.vaccine.2004.07.050; Parameswaran N, 2006, J BIOL CHEM, V281, P34159, DOI 10.1074/jbc.M605376200; Power MR, 2007, J IMMUNOL, V178, P3170, DOI 10.4049/jimmunol.178.5.3170; Rader JS, 2008, CLIN CANCER RES, V14, P3089, DOI 10.1158/1078-0432.CCR-07-4250; Rosenberg B, 2005, INT J CANCER, V114, P756, DOI 10.1002/ijc.20801; Seregin SS, 2010, BLOOD, V116, P1669, DOI 10.1182/blood-2010-03-276949; Seregin SS, 2009, MOL THER, V17, P685, DOI 10.1038/mt.2008.297; Tritto E, 2009, VACCINE, V27, P3331, DOI 10.1016/j.vaccine.2009.01.084; Williamson ED, 2002, BRIT MED BULL, V62, P163, DOI 10.1093/bmb/62.1.163; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893	42	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22064	10.1371/journal.pone.0022064	http://dx.doi.org/10.1371/journal.pone.0022064			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760953	Green Published, Green Submitted, gold			2022-12-25	WOS:000292657200043
J	Takeda, K; Mori, A; Yanagida, M				Takeda, Kojiro; Mori, Ayaka; Yanagida, Mitsuhiro			Identification of Genes Affecting the Toxicity of Anti-Cancer Drug Bortezomib by Genome-Wide Screening in S. pombe	PLOS ONE			English	Article							PHASE-PROMOTING FACTOR; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; UBIQUITIN LIGASE; PROTEASE SUBUNIT; PATHWAY; HETEROCHROMATIN; DESTRUCTION; MAINTENANCE; TRANSITION	Bortezomib/PS-341/Velcade, a proteasome inhibitor, is widely used to treat multiple myeloma. While several mechanisms of the cytotoxicity of the drug were proposed, the actual mechanism remains elusive. We aimed to identify genes affecting the cytotoxicity of Bortezomib in the fission yeast S. pombe as the drug inhibits this organism's cell division cycle like proteasome mutants. Among the 2815 genes screened (covering 56% of total ORFs), 19 genes, whose deletions induce strong synthetic lethality with Bortezomib, were identified. The products of the 19 genes included four ubiquitin enzymes and one nuclear proteasome factor, and 13 of them are conserved in humans. Our results will provide useful information for understanding the actions of Bortezomib within cells.	[Takeda, Kojiro; Mori, Ayaka; Yanagida, Mitsuhiro] Okinawa Inst Sci & Technol, Cell Unit G0, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University	Takeda, K (corresponding author), Okinawa Inst Sci & Technol, Cell Unit G0, Okinawa, Japan.	takeda@oist.jp			Astellas Foundation for Research on Metabolic Disorders	Astellas Foundation for Research on Metabolic Disorders	KT was financially supported by the research grant of Astellas Foundation for Research on Metabolic Disorders (http://www.astellas.com/jp/byoutai/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1999, CANCER RES, V59, P2615; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Chang HJ, 2004, GENETICS, V168, P1899, DOI 10.1534/genetics.104.032961; Chen SQ, 2010, CANCER RES, V70, P4318, DOI 10.1158/0008-5472.CAN-09-4428; D'Angiolella V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000247; Elliott PJ, 2001, AM J CLIN PATHOL, V116, P637; GOLDBERG AL, 1995, CHEM BIOL, V2, P503, DOI 10.1016/1074-5521(95)90182-5; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; Gordon C, 1996, J BIOL CHEM, V271, P5704, DOI 10.1074/jbc.271.10.5704; Grieco D, 1996, SCIENCE, V271, P1718, DOI 10.1126/science.271.5256.1718; Han TX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r60; Harada H, 2001, J HUM GENET, V46, P90, DOI 10.1007/s100380170115; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Kennedy PJ, 2008, TOXICOL SCI, V106, P124, DOI 10.1093/toxsci/kfn153; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kominami K, 1997, GENE DEV, V11, P1548, DOI 10.1101/gad.11.12.1548; Kouranti I, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000471; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; McConkey DJ, 2008, DRUG RESIST UPDATE, V11, P164, DOI 10.1016/j.drup.2008.08.002; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Ogiso Y, 2004, MOL CELL BIOL, V24, P2324, DOI 10.1128/MCB.24.6.2324-2331.2004; Takeda K, 2005, CELL, V122, P393, DOI 10.1016/j.cell.2005.05.023; Takeda K, 2010, P NATL ACAD SCI USA, V107, P3540, DOI 10.1073/pnas.0911055107; Tatebe H, 2000, CURR BIOL, V10, P1329, DOI 10.1016/S0960-9822(00)00773-9; Tatebe H, 2010, CURR BIOL, V20, P1975, DOI 10.1016/j.cub.2010.10.026; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Yamashita YM, 1996, NATURE, V384, P276, DOI 10.1038/384276a0	30	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22021	10.1371/journal.pone.0022021	http://dx.doi.org/10.1371/journal.pone.0022021			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760946	gold, Green Published, Green Submitted			2022-12-25	WOS:000292657200041
J	Katsouri, L; Georgopoulos, S				Katsouri, Loukia; Georgopoulos, Spiros			Lack of LDL Receptor Enhances Amyloid Deposition and Decreases Glial Response in an Alzheimer's Disease Mouse Model	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; APOLIPOPROTEIN-E; BETA DEPOSITION; TRANSGENIC MICE; BRAIN; PATHOLOGY; APOE; CHOLESTEROL; PATHWAYS; PEPTIDE	Background: Apolipoprotein E (ApoE), a cholesterol carrier associated with atherosclerosis, is a major risk factor for Alzheimer's disease (AD). The low-density lipoprotein receptor (LDLR) regulates ApoE levels in the periphery and in the central nervous system. LDLR has been identified on astrocytes and a number of studies show that it modulates amyloid deposition in AD transgenic mice. However these findings are controversial on whether LDLR deletion is beneficial or detrimental on the AD-like phenotype of the transgenic mice. Methodology/Principal Findings: To investigate the role of LDLR in the development of the amyloid related phenotype we used an APP/PS1 transgenic mouse (5XFAD) that develops an AD-like pathology with amyloid plaques, astrocytosis and microgliosis. We found that 4 months old 5XFAD transgenic mice on the LDLR deficient background (LDLR-/-) have increased amyloid plaque deposition. This increase is associated with a significant decrease in astrocytosis and microgliosis in the 5XFAD/LDLR-/- mice. To further elucidate the role of LDLR in relation with ApoE we have generated 5XFAD transgenic mice on the ApoE deficient (ApoE-/-) or the ApoE/LDLR double deficient background (ApoE-/-/LDLR -/-). We have found that ApoE deletion in the 4 months old 5XFAD/ApoE-/- mice decreases amyloid plaque formation as expected, but has no effect on astrocytosis or microgliosis. By comparison 5XFAD/ApoE-/- LDLR -/- double deficient mice of the same age have increased amyloid deposition with decreased astrocytosis and microgliosis. Conclusions: Our analysis shows that LDL deficiency regulates astrocytosis and microgliosis in an AD mouse model. This effect is independent of ApoE, as both 5XFAD/LDLR -/- and 5XFAD/ApoE-/- LDLR -/- mice show reduction in inflammatory response and increase in amyloid deposition compared to control mice. These results demonstrate that LDLR regulates glial response in this mouse model independently of ApoE and modifies amyloid deposition.	[Katsouri, Loukia; Georgopoulos, Spiros] Acad Athens, Biomed Res Fdn, Dept Cell Biol, Athens, Greece	Academy of Athens	Katsouri, L (corresponding author), Acad Athens, Biomed Res Fdn, Dept Cell Biol, Athens, Greece.	sgeorgopoulos@rics.bwh.harvard.edu		Katsouri, Loukia/0000-0003-0186-6116	Ministry of Development of Greece; Pfizer Hellas [PENED 03ED/464]	Ministry of Development of Greece; Pfizer Hellas	This work was supported by a Ministry of Development of Greece Grant and Pfizer Hellas to SG (PENED 03ED/464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abazov VM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.051601; ANDERSON JP, 1989, EMBO J, V8, P3627, DOI 10.1002/j.1460-2075.1989.tb08536.x; Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; BENJAMIN R, 1994, LANCET, V344, P473, DOI 10.1016/S0140-6736(94)91804-X; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Buttini M, 2002, J NEUROSCI, V22, P10539; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Cao DF, 2006, NEUROBIOL AGING, V27, P1632, DOI 10.1016/j.neurobiolaging.2005.09.011; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Fagan AM, 2004, AM J PATHOL, V165, P1413, DOI 10.1016/S0002-9440(10)63399-8; Fryer JD, 2005, J BIOL CHEM, V280, P25754, DOI 10.1074/jbc.M502143200; Herz J, 2000, NAT REV NEUROSCI, V1, P51, DOI 10.1038/35036221; Herz Joachim, 1993, Current Opinion in Lipidology, V4, P107, DOI 10.1097/00041433-199304000-00006; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Holtzman DM, 2000, ANN NEUROL, V47, P739, DOI 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8; Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Kashon ML, 2004, J ALZHEIMERS DIS, V6, P595; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Lamsa R, 2008, NEUROBIOL AGING, V29, P848, DOI 10.1016/j.neurobiolaging.2006.12.009; Leduc V, 2010, TRENDS MOL MED, V16, P469, DOI 10.1016/j.molmed.2010.07.008; Linton MF, 1999, J BIOL CHEM, V274, P19204, DOI 10.1074/jbc.274.27.19204; Mahley RW, 1999, J LIPID RES, V40, P1; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Thanopoulou K, 2010, P NATL ACAD SCI USA, V107, P20816, DOI 10.1073/pnas.1005888107; Vina J, 2010, J ALZHEIMERS DIS, V20, pS527, DOI 10.3233/JAD-2010-100501; Wahrle SE, 2005, J BIOL CHEM, V280, P43236, DOI 10.1074/jbc.M508780200; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Yancey PG, 2007, J LIPID RES, V48, P1140, DOI 10.1194/jlr.M600539-JLR200; Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x; Zou FG, 2008, HUM MOL GENET, V17, P929, DOI 10.1093/hmg/ddm365	40	43	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21880	10.1371/journal.pone.0021880	http://dx.doi.org/10.1371/journal.pone.0021880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755005	gold, Green Published, Green Submitted			2022-12-25	WOS:000292632000032
J	Pyenson, ND; Lindberg, DR				Pyenson, Nicholas D.; Lindberg, David R.			What Happened to Gray Whales during the Pleistocene? The Ecological Impact of Sea-Level Change on Benthic Feeding Areas in the North Pacific Ocean	PLOS ONE			English	Article							SHIFTING BASE-LINE; ESCHRICHTIUS-ROBUSTUS; MARINE MAMMALS; CHUKCHI SEAS; BERING-SEA; SHELF; RECORD; ISLAND; EXTINCTIONS; COMMUNITIES	Background: Gray whales (Eschrichtius robustus) undertake long migrations, from Baja California to Alaska, to feed on seasonally productive benthos of the Bering and Chukchi seas. The invertebrates that form their primary prey are restricted to shallow water environments, but global sea-level changes during the Pleistocene eliminated or reduced this critical habitat multiple times. Because the fossil record of gray whales is coincident with the onset of Northern Hemisphere glaciation, gray whales survived these massive changes to their feeding habitat, but it is unclear how. Methodology/Principal Findings: We reconstructed gray whale carrying capacity fluctuations during the past 120,000 years by quantifying gray whale feeding habitat availability using bathymetric data for the North Pacific Ocean, constrained by their maximum diving depth. We calculated carrying capacity based on modern estimates of metabolic demand, prey availability, and feeding duration; we also constrained our estimates to reflect current population size and account for glaciated and non-glaciated areas in the North Pacific. Our results show that key feeding areas eliminated by sea-level lowstands were not replaced by commensurate areas. Our reconstructions show that such reductions affected carrying capacity, and harmonic means of these fluctuations do not differ dramatically from genetic estimates of carrying capacity. Conclusions/Significance: Assuming current carrying capacity estimates, Pleistocene glacial maxima may have created multiple, weak genetic bottlenecks, although the current temporal resolution of genetic datasets does not test for such signals. Our results do not, however, falsify molecular estimates of pre-whaling population size because those abundances would have been sufficient to survive the loss of major benthic feeding areas (i.e., the majority of the Bering Shelf) during glacial maxima. We propose that gray whales survived the disappearance of their primary feeding ground by employing generalist filter-feeding modes, similar to the resident gray whales found between northern Washington State and Vancouver Island.	[Pyenson, Nicholas D.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; [Pyenson, Nicholas D.] Univ Washington, Dept Mammal, Burke Museum Nat Hist & Culture, Seattle, WA 98195 USA; [Pyenson, Nicholas D.] Univ Washington, Dept Paleontol, Burke Museum Nat Hist & Culture, Seattle, WA 98195 USA; [Lindberg, David R.] Univ Calif Berkeley, Dept Integrat Biol, Ctr Computat Biol, Berkeley, CA 94720 USA; [Lindberg, David R.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Pyenson, ND (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA.	pyensonn@si.edu	Lindberg, David R/D-8138-2011	Pyenson, Nicholas/0000-0003-4678-5782	Department of Integrative Biology; University of California Museum of Paleontology at the University of California, Berkeley; National Science Foundation; Natural Sciences and Engineering Research Council of Canada; Smithsonian Institution; Biodiversity Synthesis Center at the Field Museum, Chicago	Department of Integrative Biology; University of California Museum of Paleontology at the University of California, Berkeley; National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Smithsonian Institution(Smithsonian Institution); Biodiversity Synthesis Center at the Field Museum, Chicago	This research was supported with funding from the Department of Integrative Biology and the University of California Museum of Paleontology at the University of California, Berkeley, to DRL. Funding from a National Science Foundation Graduate Research Fellowship, a Natural Sciences and Engineering Research Council of Canada postdoctoral research fellowship and from the Smithsonian Institution supported NDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; For discussion and constructive comments at various manuscript stages, we thank S. E. Alter, P. K. Dayton, J. A. Estes, T. A. Demere, D. Jacobs, B. J. Le Boeuf, S. R. Palumbi, M. Slatkin, and D. Strong. We sincerely appreciate the perceptive and thorough comments from two anonymous reviewers, who greatly improved the quality of this paper. We also thank B. Eakins for assistance with the calculation of benthos area and E. B. Davis for help with pilot analyses in the early stages of this project. This study also benefited from valuable discussion at an Encyclopedia of Life synthesis meeting on the evolution and diversity of marine tetrapods, funded by the Biodiversity Synthesis Center at the Field Museum, Chicago, in 2009. We also thank the conveners and participants of a symposium at the Society of Vertebrate Paleontology's annual meeting on the physical drivers and the evolution of marine tetrapods, in 2010. This paper is University of California Museum of Paleontology contribution number 1982.	Addicott WO, 1966, US GEOL SURV PROF C, V523C, pC1; Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Alter SE, 2007, P NATL ACAD SCI USA, V104, P15162, DOI 10.1073/pnas.0706056104; Alter SE, 2009, INT MAR CONS C G MAS; Amante C., 2009, NGDC24 NOAA NESDIS; Anderson PK, 2001, J MAMMAL, V82, P623, DOI 10.1644/1545-1542(2001)082<0623:MMITNO>2.0.CO;2; Barnes LG, 1984, GRAY WHALE ESCHRICHT, P3; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Barrett-Lennard LG, 2011, MAR ECOL PROG SER, V421, P229, DOI 10.3354/meps08906; Berzin A.A., 1984, P409; Bigg GR, 2008, EARTH PLANET SC LETT, V265, P559, DOI 10.1016/j.epsl.2007.10.052; Bisconti M, 2008, ZOOL J LINN SOC-LOND, V153, P161, DOI 10.1111/j.1096-3642.2008.00374.x; Bisconti M, 2006, RIV ITAL PALEONTOL S, V112, P447, DOI 10.13130/2039-4942/6352; Bolger DT, 2008, ECOL LETT, V11, P63; Bradford AL, 2006, MAR ECOL PROG SER, V315, P293, DOI 10.3354/meps315293; Bradford Amanda L., 2008, Endangered Species Research, V6, P1, DOI 10.3354/esr00106; Brigham-Grette J, 2001, QUATERNARY SCI REV, V20, P15, DOI 10.1016/S0277-3791(00)00134-7; BRYANT PJ, 1995, J MAMMAL, V76, P857, DOI 10.2307/1382754; Burton RK, 2001, OECOLOGIA, V128, P107, DOI 10.1007/s004420100631; CACCHIONE DA, 1987, CONT SHELF RES, V7, P553, DOI 10.1016/0278-4343(87)90021-5; Calambokidis John, 2002, Journal of Cetacean Research and Management, V4, P267; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Clapham PJ, 1999, MAMMAL REV, V29, P35; Darling J.D., 1984, P267; DAYTON PK, 1969, SCIENCE, V163, P273, DOI 10.1126/science.163.3864.273; DAYTON PK, 1974, ECOL MONOGR, V44, P105, DOI 10.2307/1942321; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; Dearborn JH, 1963, B ECOL SOC AM, V44, P41; Demere Thomas A., 2005, Journal of Mammalian Evolution, V12, P99, DOI 10.1007/s10914-005-6944-3; Denton GH, 2010, SCIENCE, V328, P1652, DOI 10.1126/science.1184119; Domning DP., 1978, U CALIFORNIA PUBLICA, V118, P1; Dunham JS, 2002, MAR MAMMAL SCI, V18, P419, DOI 10.1111/j.1748-7692.2002.tb01046.x; Eakins B. W., 2010, VOLUMES WORLDS OCEAN; Erlandson JM, 1999, J FIELD ARCHAEOL, V26, P255, DOI 10.1179/jfa.1999.26.3.255; Erlandson JM, 2008, HUMAN IMPACTS ON ANCIENT MARINE ECOSYSTEMS: A GLOBAL PERSPECTIVE, P1; Erlandson JM, 2010, ANNU REV MAR SCI, V2, P231, DOI 10.1146/annurev.marine.010908.163749; Gardner SC, 2000, MAR MAMMAL SCI, V16, P728, DOI 10.1111/j.1748-7692.2000.tb00968.x; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; GREBMEIER JM, 1989, MAR ECOL PROG SER, V51, P253, DOI 10.3354/meps051253; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; GREBMEIER JM, 1988, MAR ECOL PROG SER, V48, P57, DOI 10.3354/meps048057; GREBMEIER JM, 1989, MAR ECOL PROG SER, V53, P79, DOI 10.3354/meps053079; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Henderson D.A., 1984, P159; Highsmith RC, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P303; Ichishima H, 2006, J PALEONTOL, V80, P367, DOI 10.1666/0022-3360(2006)080[0367:TOROEC]2.0.CO;2; ICUN, 2011, W GRAY WHAL MAK UN J; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P27; Jacobs SE, 2005, PROFESSIONAL SURVEY, P101; JOHNSON KR, 1984, SCIENCE, V225, P1150, DOI 10.1126/science.225.4667.1150; Johnston C, 2010, MAR MAMMAL SCI, V26, P186, DOI 10.1111/j.1748-7692.2009.00305.x; Jones M. L., 1984, GRAY WHALE ESCHRICHT, P309; KAUFFMAN TA, 1974, ANTARCT J US, V9, P307; Kaufman DS, 2004, DEV QUA SCI, V2, P9; KIM SL, 1989, CAN J ZOOL, V67, P1531, DOI 10.1139/z89-218; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Krupnik I.I., 1984, P103; LEBOEUF BJ, 1986, MAR MAMMAL SCI, V2, P70, DOI 10.1111/j.1748-7692.1986.tb00028.x; Liljeborg W, 1867, NOVA ACTA ROY SOC 3, VVI; Lindquist O, 2000, OCCASIONAL PAPERS U; Martin PS, 1984, QUATERNARY EXTINCTIO; Mead J.G., 1984, P33; Michel C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-49; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Mitchell E., 1979, REPORT INT WHALING C, V29, P307; Mitchell ED, 1990, ABORIGINAL WHALING G; Moore SE, 2003, CAN J ZOOL, V81, P734, DOI 10.1139/Z03-043; Moore SE, 2001, MAR MAMMAL SCI, V17, P954, DOI 10.1111/j.1748-7692.2001.tb01310.x; Moore SE, 2008, ECOL APPL, V18, pS157, DOI 10.1890/06-0571.1; MOORE TC, 1981, PALAEOGEOGR PALAEOCL, V35, P357, DOI 10.1016/0031-0182(81)90102-4; Muller RD, 2008, SCIENCE, V319, P1357, DOI 10.1126/science.1151540; National Research Council, 1996, BER SEA EC; Nerini M., 1984, P423; Newsome SD, 2007, P NATL ACAD SCI USA, V104, P9709, DOI 10.1073/pnas.0610986104; NOAA National Geophysical Data Center, 2011, BATH GLOB REL WEBP; Noakes SE, 2009, DIVING SCI 2009; O'Leary B.L., 1984, P79; Palsboll Per J, 2007, Proc Natl Acad Sci U S A, V104, pE3, DOI 10.1073/pnas.0710072105; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; PIKE GC, 1962, J FISH RES BOARD CAN, V19, P815, DOI 10.1139/f62-051; Reilly SB, 2010, IUCN 2010 IUCN RED L; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Rice D. W, 1971, Spec Publ Am Soc Mammal, VNo. 3, P1; Rick TC, 2005, J WORLD PREHIST, V19, P169, DOI 10.1007/s10963-006-9004-x; Rohling EJ, 2009, NAT GEOSCI, V2, P500, DOI 10.1038/ngeo557; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; Rugh David J., 2005, Journal of Cetacean Research and Management, V7, P1; Russell D, 2001, EYE WHALE EPIC PASSA; SANCETTA C, 1984, MAR GEOL, V62, P55, DOI 10.1016/0025-3227(84)90054-9; SANCETTA C, 1992, NATURE, V360, P249, DOI 10.1038/360249a0; SANCETTA C, 1983, DEEP-SEA RES, V30, P851, DOI 10.1016/0198-0149(83)90004-3; Sayers H., 1984, P121; Scammon C.M., 1874, MARINE MAMMALS N W C; Scheinin Aviad P., 2011, Marine Biodiversity Records, V4; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Shelden KEW, 2004, ECOL APPL, V14, P1789, DOI 10.1890/03-5349; SIMENSTAD CA, 1978, SCIENCE, V200, P403, DOI 10.1126/science.200.4340.403; Stafford KM, 2007, ARCTIC, V60, P167; Stelle LL, 2008, MAR MAMMAL SCI, V24, P462, DOI 10.1111/j.1748-7692.2008.00205.x; Stewart Brent S., 1994, P29; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; Swartz SL, 2006, MAMMAL REV, V36, P66, DOI 10.1111/j.1365-2907.2006.00082.x; Takahashi K, 2005, DEEP-SEA RES PT II, V52, P2080, DOI 10.1016/j.dsr2.2005.08.003; Thomas AL, 2009, SCIENCE, V324, P1186, DOI 10.1126/science.1168754; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Tynan CT, 2004, MAR ECOL PROG SER, V272, P281, DOI 10.3354/meps272281; Uhen MD, 2007, PALAEONTOL ELECTRON, V10; Wade Paul R., 2002, Journal of Cetacean Research and Management, V4, P85; Weber DS, 2004, J HERED, V95, P144, DOI 10.1093/jhered/esh018; Werth Alexander, 2000, P487, DOI 10.1016/B978-012632590-4/50017-4; Whitmore Frank C. Jr, 2008, Virginia Museum of Natural History Special Publication, V14, P181; Williams M., 1998, EVIDENCE DESERTS QUA, V2nd	114	55	55	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21295	10.1371/journal.pone.0021295	http://dx.doi.org/10.1371/journal.pone.0021295			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754984	Green Submitted, Green Published, gold			2022-12-25	WOS:000292632000008
J	Wang, D; Ning, W; Xie, D; Guo, L; DuBois, RN				Wang, D.; Ning, W.; Xie, D.; Guo, L.; DuBois, R. N.			Peroxisome proliferator-activated receptor delta confers resistance to peroxisome proliferator-activated receptor gamma-induced apoptosis in colorectal cancer cells	ONCOGENE			English	Article						peroxisome proliferator-activated receptors; colorectal cancer; survivin; apoptosis	INTESTINAL ADENOMA GROWTH; PPAR-GAMMA; COLON CARCINOGENESIS; SURVIVIN EXPRESSION; C57BL/6J-APC(MIN)/+ MICE; THERAPEUTIC TARGET; GENETIC DISRUPTION; PANCREATIC-CANCER; SIGNALING PATHWAY; PTEN EXPRESSION	Peroxisome proliferator-activated receptor gamma (PPAR gamma) may serve as a useful target for drug development in nondiabetic diseases. However, some colorectal cancer cells are resistant to PPAR gamma agonists by mechanisms that are poorly understood. Here, we provide the first evidence that elevated PPAR delta expression and/or activation of PPAR delta antagonize the ability of PPAR gamma to induce colorectal carcinoma cell death. More importantly, the opposing effects of PPAR delta and PPAR gamma in regulating programmed cell death are mediated by survivin and caspase-3. We found that activation of PPAR gamma results in decreased survivin expression and increased caspase-3 activity, whereas activation of PPAR delta counteracts these effects. Our findings suggest that PPAR delta and PPAR gamma coordinately regulate cancer cell fate by controlling the balance between the cell death and survival and demonstrate that inhibition of PPAR delta can reprogram PPAR gamma ligand-resistant cells to respond to PPAR gamma agonists. Oncogene (2012) 31, 1013-1023; doi:10.1038/onc.2011.299; published online 18 July 2011	[DuBois, R. N.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Unit 1492, Houston, TX 77030 USA; [Wang, D.; Xie, D.; Guo, L.; DuBois, R. N.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Ning, W.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University	DuBois, RN (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Unit 1492, 1515 Holcombe Blvd, Houston, TX 77030 USA.	rdubois@mdanderson.org	DuBois, Raymond N./AAX-8869-2020		National Colorectal Cancer Research Alliance (NCCRA); NIH MERIT [R37 DK47297, RO1 DK 62112, NCI P01 CA77839, CPRIT RP100960]; NATIONAL CANCER INSTITUTE [R01CA184820, P01CA077839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062112, R37DK047297] Funding Source: NIH RePORTER	National Colorectal Cancer Research Alliance (NCCRA); NIH MERIT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the National Colorectal Cancer Research Alliance (NCCRA) for its generous support (RND). This work is supported, in part, by the NIH MERIT award R37 DK47297, RO1 DK 62112, NCI P01 CA77839 and CPRIT RP100960.	Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Asanuma K, 2000, JPN J CANCER RES, V91, P1204, DOI 10.1111/j.1349-7006.2000.tb00906.x; Burstein HJ, 2003, BREAST CANCER RES TR, V79, P391, DOI 10.1023/A:1024038127156; Cellai I, 2006, BRIT J CANCER, V95, P879, DOI 10.1038/sj.bjc.6603344; Di-Poi N, 2003, J STEROID BIOCHEM, V85, P257, DOI 10.1016/S0960-0760(03)00215-2; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Farrow B, 2003, BIOCHEM BIOPH RES CO, V301, P50, DOI 10.1016/S0006-291X(02)02983-2; Fukuda S, 2002, BLOOD, V100, P2463, DOI 10.1182/blood.V100.7.2463; Girnun GD, 2002, P NATL ACAD SCI USA, V99, P13771, DOI 10.1073/pnas.162480299; Gupta RA, 2001, J BIOL CHEM, V276, P29681, DOI 10.1074/jbc.M103779200; Gupta RA, 2004, NAT MED, V10, P245, DOI 10.1038/nm993; Han SW, 2006, MOL CANCER THER, V5, P430, DOI 10.1158/1535-7163.MCT-05-0347; Hao CM, 2002, J BIOL CHEM, V277, P21341, DOI 10.1074/jbc.M200695200; Harman FS, 2004, NAT MED, V10, P481, DOI 10.1038/nm1026; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Kato Y, 2006, ONCOGENE, V25, P2736, DOI 10.1038/sj.onc.1209299; Kawasaki H, 1998, CANCER RES, V58, P5071; Kim EJ, 2003, J PHARMACOL EXP THER, V307, P505, DOI 10.1124/jpet.103.053876; Kulke MH, 2002, CANCER J, V8, P395, DOI 10.1097/00130404-200209000-00010; Kuo PC, 2004, J BIOL CHEM, V279, P55875, DOI 10.1074/jbc.M407985200; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; Li MY, 2005, J CELL BIOCHEM, V96, P760, DOI 10.1002/jcb.20474; Nadra K, 2006, MOL CELL BIOL, V26, P3266, DOI 10.1128/MCB.26.8.3266-3281.2006; O'Connor DS, 2002, CANCER CELL, V2, P43, DOI 10.1016/S1535-6108(02)00084-3; Olie RA, 2000, CANCER RES, V60, P2805; Osawa E, 2003, GASTROENTEROLOGY, V124, P361, DOI 10.1053/gast.2003.50067; Panigrahy D, 2005, CANCER BIOL THER, V4, P687, DOI 10.4161/cbt.4.7.2014; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Pino MV, 2004, TOXICOL PATHOL, V32, P58, DOI 10.1080/01926230490261320; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sarela AI, 2001, ANN SURG ONCOL, V8, P305; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Takayama O, 2006, BRIT J CANCER, V95, P889, DOI 10.1038/sj.bjc.6603343; Teresi RE, 2006, INT J CANCER, V118, P2390, DOI 10.1002/ijc.21799; Ueda Y, 2004, J BIOL CHEM, V279, P24505, DOI 10.1074/jbc.M400081200; Wang DZ, 2006, P NATL ACAD SCI USA, V103, P19069, DOI 10.1073/pnas.0607948103; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Wang DZ, 2005, CANCER RES, V65, P1822, DOI 10.1158/0008-5472.CAN-04-3671; Wang DZ, 2004, CANCER CELL, V6, P285, DOI 10.1016/j.ccr.2004.08.011; Williams CS, 1996, GASTROENTEROLOGY, V111, P1134, DOI 10.1016/S0016-5085(96)70083-5; Yin YZ, 2005, CANCER RES, V65, P3950, DOI 10.1158/0008-5472.CAN-04-3990; Zaffaroni N, 2002, DRUG RESIST UPDATE, V5, P65, DOI 10.1016/S1368-7646(02)00049-3; Zhang T, 2001, CANCER RES, V61, P8664; Zhao J, 2000, J CELL SCI, V113, P4363; Zuo XS, 2009, JNCI-J NATL CANCER I, V101, P762, DOI 10.1093/jnci/djp078	48	25	27	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2012	31	8					1013	1023		10.1038/onc.2011.299	http://dx.doi.org/10.1038/onc.2011.299			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	898BG	21765467	Green Accepted			2022-12-25	WOS:000300709700007
J	Lok, CN; Sy, LK; Liu, FL; Che, CM				Lok, Chun-Nam; Sy, Lai-King; Liu, Fuli; Che, Chi-Ming			Activation of Autophagy of Aggregation-prone Ubiquitinated Proteins by Timosaponin A-III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; PROTEASOME SYSTEM; MULTIVESICULAR BODIES; CANCER-CELLS; SELECTIVE AUTOPHAGY; MAMMALIAN AUTOPHAGY; K562 CELLS; CALCIUM; DEGRADATION; MTOR	Chemical modulators of autophagy provide useful pharmacological tools for examination of autophagic processes, and also may lead to new therapeutic agents for diseases in which control of cellular sequestration and degradation capacity are beneficial. We have identified that timosaponin A-III (TAIII), a medicinal saponin reported to exhibit anticancer properties and improve brain function, is a pronounced activator of autophagy. In this work, the salient features and functional role of TAIII-induced autophagy were investigated. In TAIII-treated cells, autophagic flux with increased formation of autophagosomes and conversion into autolysosomes is induced in association with inhibition of mammalian target of rapamycin activity and elevation of cytosolic free calcium. The TAIII-induced autophagy is distinct from conventional induction by rapamycin, exhibiting large autophagic vacuoles that appear to contain significant contents of endosomal membranes and multivesicular bodies. Furthermore, TAIII stimulates biosynthesis of cholesterol, which is incorporated to the autophagic vacuole membranes. The TAIII-induced autophagic vacuoles capture ubiquitinated proteins, and in proteasome-inhibited cells TAIII promotes autophagy of aggregation-prone ubiquitinated proteins. Our studies demonstrate that TAIII induced a distinct form of autophagy, and one of its pharmacological actions is likely to enhance the cellular quality control capacity via autophagic clearance of otherwise accumulated ubiquitinated protein aggregates.	[Che, Chi-Ming] Univ Hong Kong, Inst Mol Technol Drug Discovery & Synth, State Key Lab Synthet Chem, Dept Chem, Pokfulam, Hong Kong, Peoples R China; Univ Hong Kong, Inst Mol Technol Drug Discovery & Synth, Open Lab Chem Biol, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Che, CM (corresponding author), Univ Hong Kong, Inst Mol Technol Drug Discovery & Synth, State Key Lab Synthet Chem, Dept Chem, Pokfulam, Hong Kong, Peoples R China.	cmche@hku.hk	Che, Chi Ming/D-3055-2009	Che, Chi Ming/0000-0002-2554-7219	Area of Excellence Scheme under University Grants Committee [AoE/P10/01]; Department of Health of Hong Kong Special Administrative Region, People's Republic of China	Area of Excellence Scheme under University Grants Committee; Department of Health of Hong Kong Special Administrative Region, People's Republic of China	This work was supported by Area of Excellence Scheme AoE/P10/01, established under the University Grants Committee and Department of Health of Hong Kong Special Administrative Region, People's Republic of China.	Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Burman C, 2010, FEBS LETT, V584, P1302, DOI 10.1016/j.febslet.2010.01.011; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; de Medina P, 2009, AUTOPHAGY, V5, P1066, DOI 10.4161/auto.5.7.9820; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; FAWCETT DW, 1981, CELL, P487; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Fortun J, 2003, J NEUROSCI, V23, P10672; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Gies E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014410; GORDON PB, 1993, J BIOL CHEM, V268, P26107; Grotemeier A, 2010, CELL SIGNAL, V22, P914, DOI 10.1016/j.cellsig.2010.01.015; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; King FW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007283; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Lamark T, 2010, CURR OPIN CELL BIOL, V22, P192, DOI 10.1016/j.ceb.2009.11.002; Lee B, 2009, PHARMACOL BIOCHEM BE, V93, P121, DOI 10.1016/j.pbb.2009.04.021; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; LENK SE, 1992, J CELL BIOL, V118, P301, DOI 10.1083/jcb.118.2.301; Li TJ, 2007, NEUROSCI LETT, V421, P147, DOI 10.1016/j.neulet.2007.04.082; Link CD, 2006, J BIOL CHEM, V281, P1808, DOI 10.1074/jbc.M505581200; Luzio JP, 2007, BIOCHEM SOC T, V35, P1088, DOI 10.1042/BST0351088; Martina JA, 2009, TRAFFIC, V10, P1143, DOI 10.1111/j.1600-0854.2009.00935.x; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Mitra S, 2009, AUTOPHAGY, V5, P1037, DOI 10.4161/auto.5.7.9291; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Salomons FA, 2009, MOL CELL BIOL, V29, P1774, DOI 10.1128/MCB.01485-08; Sarkar S, 2008, MOL BIOSYST, V4, P895, DOI 10.1039/b804606a; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Sy LK, 2008, CANCER RES, V68, P10229, DOI 10.1158/0008-5472.CAN-08-1983; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Wang GJ, 2002, LIFE SCI, V71, P1081, DOI 10.1016/S0024-3205(02)01794-0; Wong ESP, 2008, HUM MOL GENET, V17, P2570, DOI 10.1093/hmg/ddn157; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104	64	22	26	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31684	31696		10.1074/jbc.M110.202531	http://dx.doi.org/10.1074/jbc.M110.202531			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757721	Green Published, hybrid			2022-12-25	WOS:000294487500061
J	Seidman, JS; Janssen, BD; Hayes, CS				Seidman, Jason S.; Janssen, Brian D.; Hayes, Christopher S.			Alternative Fates of Paused Ribosomes during Translation Termination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-MESSENGER RNA; ESCHERICHIA-COLI; PROTEIN L9; TRYPTOPHAN INDUCTION; AMINO-ACID; TRANS-TRANSLATION; OPERON EXPRESSION; NASCENT PEPTIDE; BINDING PROTEIN; TAGGING SYSTEM	The bacterial tmRNA.SmpB system facilitates recycling of stalled translational complexes in a process termed "ribosome rescue." During ribosome rescue, the nascent chain is tagged with the tmRNA-encoded ssrA peptide, which targets the tagged polypeptide for degradation. Translational pausing also induces a variety of recoding events such as frameshifts, ribosome hops, and stop codon readthrough. To examine the interplay between recoding and ribosome rescue, we determined the various fates of ribosomes that pause during translation termination. We expressed a model protein containing the C-terminal Asp-Pro nascent peptide motif (which interferes with translation termination) and quantified the protein chains produced by recoding and ssrA-peptide tagging. The nature and extent of translational recoding depended upon the codon for the C-terminal Pro residue, with CCU and CCC promoting efficient +1 frameshifting. In contrast, ssrA-peptide tagging was unaffected by C-terminal Pro coding. Moreover, +1 frameshifting was not suppressed by tmRNA.SmpB activity, suggesting that recoding and ribosome rescue are not competing events. However, cells lacking ribosomal protein L9 (Delta L9) exhibited a significant increase in recoding and a concomitant decrease in ssrA-peptide tagging. Pulse-chase analysis revealed that pre-termination ribosomes turn over more rapidly in Delta L9 cells, suggesting that increased recoding alleviates the translational arrest. Together, these results indicate that tmRNA.SmpB does not suppress transient ribosome pauses, but responds to prolonged translational arrest.	[Seidman, Jason S.; Janssen, Brian D.; Hayes, Christopher S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Hayes, Christopher S.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Hayes, CS (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Life Sci Technol Bldg,Room 3105, Santa Barbara, CA 93106 USA.	chayes@lifesci.ucsb.edu			National Institutes of Health [GM078634]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health through Grant GM078634.	Adamski FM, 1996, J MOL BIOL, V261, P357, DOI 10.1006/jmbi.1996.0469; Atkins JF, 2009, MICROBIOL MOL BIOL R, V73, P178, DOI 10.1128/MMBR.00010-08; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baranov PV, 2004, RNA, V10, P221, DOI 10.1261/rna.5122604; Bjornsson A, 1996, NUCLEIC ACIDS RES, V24, P1753, DOI 10.1093/nar/24.9.1753; Bjornsson A, 1996, EMBO J, V15, P1696, DOI 10.1002/j.1460-2075.1996.tb00515.x; Boycheva S, 2003, BIOINFORMATICS, V19, P987, DOI 10.1093/bioinformatics/btg082; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; CRAIGEN WJ, 1986, NATURE, V322, P273, DOI 10.1038/322273a0; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Garza-Sanchez F, 2008, J MOL BIOL, V378, P505, DOI 10.1016/j.jmb.2008.02.065; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Garza-Sanchez F, 2011, MOL MICROBIOL, V80, P1204, DOI 10.1111/j.1365-2958.2011.07638.x; Gesteland RF, 1996, ANNU REV BIOCHEM, V65, P741, DOI 10.1146/annurev.bi.65.070196.003521; Gong F, 2001, J BIOL CHEM, V276, P1974, DOI 10.1074/jbc.M008892200; Gong F, 2001, P NATL ACAD SCI USA, V98, P8997, DOI 10.1073/pnas.171299298; Gong M, 2007, J BACTERIOL, V189, P3147, DOI 10.1128/JB.01868-06; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Gurvich OL, 2003, EMBO J, V22, P5941, DOI 10.1093/emboj/cdg561; Gurvich OL, 2011, NUCLEIC ACIDS RES, V39, P3079, DOI 10.1093/nar/gkq1272; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Hayes CS, 2002, P NATL ACAD SCI USA, V99, P3440, DOI 10.1073/pnas.052707199; HERBST KL, 1994, P NATL ACAD SCI USA, V91, P12525, DOI 10.1073/pnas.91.26.12525; Herr AJ, 2000, EMBO J, V19, P2671, DOI 10.1093/emboj/19.11.2671; Herr AJ, 2001, J MOL BIOL, V309, P1029, DOI 10.1006/jmbi.2001.4717; HOFFMAN DW, 1994, EMBO J, V13, P205, DOI 10.1002/j.1460-2075.1994.tb06250.x; Ivanova N, 2004, J MOL BIOL, V338, P33, DOI 10.1016/j.jmb.2004.02.043; Jacob Y, 2005, J BIOL CHEM, V280, P5503, DOI 10.1074/jbc.M409277200; Janssen BD, 2009, J MOL BIOL, V394, P251, DOI 10.1016/j.jmb.2009.09.020; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Lecompte O, 2002, NUCLEIC ACIDS RES, V30, P5382, DOI 10.1093/nar/gkf693; Leipuviene R, 2007, J BACTERIOL, V189, P7024, DOI 10.1128/JB.00710-07; Lieberman KR, 2000, J MOL BIOL, V297, P1129, DOI 10.1006/jmbi.2000.3621; MOTTAGUITABAR S, 1994, EMBO J, V13, P249, DOI 10.1002/j.1460-2075.1994.tb06255.x; Nasvall SJ, 2009, J MOL BIOL, V385, P350, DOI 10.1016/j.jmb.2008.10.069; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Ruhe ZC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015207; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Shoji S, 2010, BIOCHIMIE, V92, P157, DOI 10.1016/j.biochi.2009.11.002; Sundermeier TR, 2005, P NATL ACAD SCI USA, V102, P2316, DOI 10.1073/pnas.0409694102; Trimble MJ, 2004, RNA, V10, P805, DOI 10.1261/rna.7010904	45	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31105	31112		10.1074/jbc.M111.268201	http://dx.doi.org/10.1074/jbc.M111.268201			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757758	Green Published, hybrid			2022-12-25	WOS:000294487500005
J	Stark, BC; Wen, KK; Allingham, JS; Rubenstein, PA; Lord, M				Stark, Benjamin C.; Wen, Kuo-Kuang; Allingham, John S.; Rubenstein, Peter A.; Lord, Matthew			Functional Adaptation between Yeast Actin and Its Cognate Myosin Motors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; SACCHAROMYCES-CEREVISIAE; HEAVY-CHAIN; ACTOMYOSIN INTERACTIONS; DICTYOSTELIUM ACTIN; PROTEIN-STRUCTURE; CONTRACTILE RING; BUDDING YEAST; LIGHT-CHAIN; N-TERMINUS	We employed budding yeast and skeletal muscle actin to examine the contribution of the actin isoform to myosin motor function. While yeast and muscle actin are highly homologous, they exhibit different charge density at their N termini (a proposed myosin-binding interface). Muscle myosin-II actin-activated ATPase activity is significantly higher with muscle versus yeast actin. Whether this reflects inefficiency in the ability of yeast actin to activate myosin is not known. Here we optimized the isolation of two yeast myosins to assess actin function in a homogenous system. Yeast myosin-II (Myo1p) and myosin-V (Myo2p) accommodate the reduced N-terminal charge density of yeast actin, showing greater activity with yeast over muscle actin. Increasing the number of negative charges at the N terminus of yeast actin from two to four (as in muscle) had little effect on yeast myosin activity, while other substitutions of charged residues at the myosin interface of yeast actin reduced activity. Thus, yeast actin functions most effectively with its native myosins, which in part relies on associations mediated by its outer domain. Compared with yeast myosin-II and myosin-V, muscle myosin-II activity was very sensitive to salt. Collectively, our findings suggest differing degrees of reliance on electrostatic interactions during weak actomyosin binding in yeast versus muscle. Our study also highlights the importance of native actin isoforms when considering the function of myosins.	[Stark, Benjamin C.; Lord, Matthew] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Wen, Kuo-Kuang; Rubenstein, Peter A.] Univ Iowa, Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Allingham, John S.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	University of Vermont; University of Iowa; Queens University - Canada	Lord, M (corresponding author), 149 Beaumont Ave,HSRF 108, Burlington, VT 05405 USA.	matthew.lord@uvm.edu	Stark, Benjamin/E-6095-2010; Allingham, John/AAW-9262-2020	Stark, Benjamin/0000-0002-1799-5361; Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [GM33689]; University of Vermont; American Heart Association [0835236N]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Vermont; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM33689 (to P. A. R.) and by a New Research Initiative Award (University of Vermont) and a Scientist Development Grant (0835236N) from the American Heart Association (to M. L.).	Bauer CB, 2000, J BIOL CHEM, V275, P38494, DOI 10.1074/jbc.M005585200; BERTRAND R, 1988, BIOCHEMISTRY-US, V27, P5728, DOI 10.1021/bi00415a050; Bi E, 1998, J CELL BIOL, V142, P1301, DOI 10.1083/jcb.142.5.1301; COOK RK, 1992, J BIOL CHEM, V267, P9430; COOK RK, 1993, J BIOL CHEM, V268, P2410; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; DASGUPTA G, 1989, J MOL BIOL, V207, P833, DOI 10.1016/0022-2836(89)90249-0; DASGUPTA G, 1992, BIOCHEMISTRY-US, V31, P1836, DOI 10.1021/bi00121a036; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Dunn BD, 2007, J CELL BIOL, V178, P1193, DOI 10.1083/jcb.200707080; Fang XD, 2010, J CELL BIOL, V191, P1333, DOI 10.1083/jcb.201005134; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HENKEL RD, 1988, ANAL BIOCHEM, V169, P312, DOI 10.1016/0003-2697(88)90290-4; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Huckaba TM, 2006, J CELL BIOL, V175, P957, DOI 10.1083/jcb.200609155; JOHARA M, 1993, P NATL ACAD SCI USA, V90, P2127, DOI 10.1073/pnas.90.6.2127; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KARLSSON R, 1991, MOL CELL BIOL, V11, P213, DOI 10.1128/MCB.11.1.213; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lippincott J, 1998, J CELL BIOL, V140, P355, DOI 10.1083/jcb.140.2.355; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lord M, 2008, P NATL ACAD SCI USA, V105, P8014, DOI 10.1073/pnas.0802874105; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; MILLER CJ, 1995, BIOCHEMISTRY-US, V34, P2694, DOI 10.1021/bi00008a037; Miller CJ, 1996, BIOCHEMISTRY-US, V35, P16557, DOI 10.1021/bi962388+; Milligan RA, 1996, P NATL ACAD SCI USA, V93, P21, DOI 10.1073/pnas.93.1.21; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Reck-Peterson SL, 2001, J CELL BIOL, V153, P1121, DOI 10.1083/jcb.153.5.1121; Rose MD., 1990, METHODS YEAST GENETI; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sellers J. R., 1999, MYOSINS; Sladewski TE, 2009, MOL BIOL CELL, V20, P3941, DOI 10.1091/mbc.E09-04-0346; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; SUTOH K, 1991, P NATL ACAD SCI USA, V88, P7711, DOI 10.1073/pnas.88.17.7711; SUTOH K, 1982, BIOCHEMISTRY-US, V21, P4800, DOI 10.1021/bi00262a043; SUTOH K, 1983, BIOCHEMISTRY-US, V22, P1579, DOI 10.1021/bi00276a009; Volkmann N, 2000, NAT STRUCT BIOL, V7, P1147; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; WATTS FZ, 1987, EMBO J, V6, P3499, DOI 10.1002/j.1460-2075.1987.tb02675.x; WATTS FZ, 1985, NATURE, V316, P83, DOI 10.1038/316083a0	50	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30384	30392		10.1074/jbc.M111.262899	http://dx.doi.org/10.1074/jbc.M111.262899			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757693	hybrid, Green Published			2022-12-25	WOS:000294283600016
J	Van Rechem, C; Black, JC; Abbas, T; Allen, A; Rinehart, CA; Yuan, GC; Dutta, A; Whetstine, JR				Van Rechem, Capucine; Black, Joshua C.; Abbas, Tarek; Allen, Andrew; Rinehart, Claire A.; Yuan, Guo-Cheng; Dutta, Anindya; Whetstine, Johnathan R.			The SKP1-Cul1-F-box and Leucine-rich Repeat Protein 4 (SCF-FbxL4) Ubiquitin Ligase Regulates Lysine Demethylase 4A (KDM4A)/Jumonji Domain-containing 2A (JMJD2A) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; MAMMALIAN-CELLS; HISTONE METHYLTRANSFERASE; DYNAMIC REGULATION; GENE-EXPRESSION; S PHASE; DEGRADATION; REPLICATION; CHROMATIN; PR-SET7	Chromatin-modifying enzymes play a fundamental role in regulating chromatin structure so that DNA replication is spatially and temporally coordinated. For example, the lysine demethylase 4A/Jumonji domain-containing2A(KDM4A/JMJD2A) is tightly regulated during the cell cycle. Overexpression of JMJD2A leads to altered replication timing and faster S phase progression. In this study, we demonstrate that degradation of JMJD2A is regulated by the proteasome. JMJD2A turnover is coordinated through the SKP1-Cul1-F-box ubiquitin ligase complex that contains cullin 1 and the F-box and leucine-rich repeat protein 4 (FbxL4). This complex interacted with JMJD2A. Ubiquitin overexpression restored turnover and blocked the JMJD2A-dependent faster S phase progression in a cullin 1-dependent manner. Furthermore, increased ubiquitin levels decreased JMJD2A occupancy and BrdU incorporation at target sites. This study highlights a finely tuned mechanism for regulating histone demethylase levels and emphasizes the need to tightly regulate chromatin modifiers so that the cell cycle occurs properly.	[Van Rechem, Capucine; Black, Joshua C.; Allen, Andrew; Whetstine, Johnathan R.] Harvard Univ, Sch Med, Dept Med, Charlestown, MA 02129 USA; [Van Rechem, Capucine; Black, Joshua C.; Allen, Andrew; Whetstine, Johnathan R.] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Abbas, Tarek; Dutta, Anindya] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Rinehart, Claire A.] Western Kentucky Univ, Dept Biol, Bowling Green, KY 42101 USA; [Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Yuan, Guo-Cheng] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard University; Massachusetts General Hospital; University of Virginia; Western Kentucky University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Whetstine, JR (corresponding author), Harvard Univ, Sch Med, Dept Med, Bldg 149,13th St,Rm 7-213, Charlestown, MA 02129 USA.	jwhetstine@hms.harvard.edu	Black, Joshua/Q-2484-2015; Dutta, Anindya/P-3203-2016	Dutta, Anindya/0000-0002-4319-0073; Black, Joshua/0000-0002-2491-8815; Van Rechem, Capucine/0000-0002-5408-6124	Ellison Medical Foundation [CA059267]; National Institutes of Health [R01CA60499, R01HG005085]; Jane Coffin Childs Memorial Fund for Medical Research; NCI National Institutes of Health [KCA140774A]; NATIONAL CANCER INSTITUTE [K99CA140774, R01CA060499, R00CA140774, C06CA059267] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005085] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund for Medical Research; NCI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by the Ellison Medical Foundation, Howard Goodman Fellowship, and Grant CA059267 (to J. R. W.). This work was also supported by National Institutes of Health Grants R01CA60499 (to A. D.) and R01HG005085 (to G. C. Y.). This work has also been aided by grants from The Jane Coffin Childs Memorial Fund for Medical Research (to J. C. B.) and from NCI National Institutes of Health Grant KCA140774A (to T. A.).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Black JC, 2010, MOL CELL, V40, P736, DOI 10.1016/j.molcel.2010.11.008; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Corpet A, 2009, TRENDS CELL BIOL, V19, P29, DOI 10.1016/j.tcb.2008.10.002; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Han JH, 2006, CELL, V127, P847, DOI 10.1016/j.cell.2006.09.030; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Jorgensen S, 2011, J CELL BIOL, V192, P43, DOI 10.1083/jcb.201009076; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Mendez J, 2009, CRIT REV BIOCHEM MOL, V44, P343, DOI 10.1080/10409230903232618; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Trojer P, 2009, J BIOL CHEM, V284, P8395, DOI 10.1074/jbc.M807818200; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wu SM, 2010, GENE DEV, V24, P2531, DOI 10.1101/gad.1984210; Yang CS, 2005, J BIOL CHEM, V280, P10083, DOI 10.1074/jbc.M413986200; Yin Y, 2008, CELL CYCLE, V7, P1423, DOI 10.4161/cc.7.10.5867	35	48	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30462	30470		10.1074/jbc.M111.273508	http://dx.doi.org/10.1074/jbc.M111.273508			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757720	hybrid, Green Published			2022-12-25	WOS:000294283600025
J	Gay, M; Pares, A; Carrascal, M; Bosch-i-Crespo, P; Gorga, M; Mas, A; Abian, J				Gay, Marina; Pares, Albert; Carrascal, Montserrat; Bosch-i-Crespo, Pau; Gorga, Marina; Mas, Antoni; Abian, Joaquin			Proteomic Analysis of Polypeptides Captured from Blood during Extracorporeal Albumin Dialysis in Patients with Cholestasis and Resistant Pruritus	PLOS ONE			English	Article							ADSORBENT RECIRCULATING SYSTEM; PROTEINS; SERUM; IDENTIFICATION; PEPTIDES; SLURP-1; MARS	Albumin dialysis using the molecular adsorbent recirculating system (MARS) is a new therapeutic approach for liver diseases. To gain insight into the mechanisms involved in albumin dialysis, we analyzed the peptides and proteins absorbed into the MARS strong anion exchange (SAX) cartridges as a result of the treatment of patients with cholestasis and resistant pruritus. Proteins extracted from the SAX MARS cartridges after patient treatment were digested with two enzymes. The resulting peptides were analyzed by multidimensional liquid chromatography coupled to tandem mass spectrometry. We identified over 1,500 peptide sequences corresponding to 144 proteins. In addition to the proteins that are present in control albumin-derived samples, this collection includes 60 proteins that were specific to samples obtained after patient treatment. Five of these proteins (neutrophil defensin 1 [HNP-1], secreted Ly-6/uPAR-related protein 1 [SLURP1], serum amyloid A, fibrinogen alpha chain and pancreatic prohormone) were confirmed to be removed by the dialysis procedure using targeted selected-reaction monitoring MS/MS. Furthermore, capture of HNP-1 and SLURP1 was also validated by Western blot. Interestingly, further analyses of SLURP1 in serum indicated that this protein was 3-fold higher in cholestatic patients than in controls. Proteins captured by MARS share certain structural and biological characteristics, and some of them have important biological functions. Therefore, their removal could be related either to therapeutic or possible adverse effects associated with albumin dialysis.	[Gay, Marina; Carrascal, Montserrat; Bosch-i-Crespo, Pau; Gorga, Marina; Abian, Joaquin] IDIBAPS, CSIC, IIBB, CSIC UAB Prote Lab, Bellaterra, Spain; [Pares, Albert; Bosch-i-Crespo, Pau; Gorga, Marina; Mas, Antoni] Univ Barcelona, IDIBAPS, Hosp Clin, CIBERehd,Liver Unit, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Gay, M (corresponding author), IDIBAPS, CSIC, IIBB, CSIC UAB Prote Lab, Bellaterra, Spain.	Joaquim.Abian.csic@uab.cat	Carrascal, Montserrat/M-1913-2014; Pares, Albert/M-6268-2019; Pares, Albert/G-1328-2011; BARCELO, DAMIA/O-4558-2016; Gay, Marina/D-8551-2019; Abian, Joaquin/M-1965-2014	Carrascal, Montserrat/0000-0002-0205-2176; Pares, Albert/0000-0002-5413-9687; Pares, Albert/0000-0002-5413-9687; BARCELO, DAMIA/0000-0002-8873-0491; Gay, Marina/0000-0002-8827-7092; Abian, Joaquin/0000-0003-2823-5429	GAMBRO AB (Hechingen, Germany); Spanish Ministry of Education [SAF2005-03649, SAF2008-04012]; Centro de Investigaciones Biomedicas en Red de Enfermedades Hepaticas y Digestivas (CIBERehd); Instituto de Salud Carlos III, Spain; CSIC	GAMBRO AB (Hechingen, Germany); Spanish Ministry of Education(Spanish Government); Centro de Investigaciones Biomedicas en Red de Enfermedades Hepaticas y Digestivas (CIBERehd); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); CSIC	This study was partially funded by GAMBRO AB (Hechingen, Germany), the Spanish Ministry of Education (SAF2005-03649 and SAF2008-04012), and the Centro de Investigaciones Biomedicas en Red de Enfermedades Hepaticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Spain. M. Gay was supported by a CSIC JAE-doc contract. LP CSIC/UAB is a member of ProteoRed, which was founded by Genome Spain and follows the quality criteria established by ProteoRed standards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following competing interest: This study was partially funded by GAMBRO AB (Hechingen, Germany). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Arredondo J, 2005, J INVEST DERMATOL, V125, P1236, DOI 10.1111/j.0022-202X.2005.23973.x; AUTH MK, 2004, J PEDIAT GASTROENTER, V40, P54; Carrascal M, 2008, J PROTEOME RES, V7, P5167, DOI 10.1021/pr800500r; Catalina MV, 2003, LIVER INT, V23, P39, DOI 10.1034/j.1478-3231.23.s.3.10.x; CHEN J, 2005, INTERNET J PHARM, V3; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Choi H, 2008, MOL CELL PROTEOMICS, V7, P2373, DOI 10.1074/mcp.M800203-MCP200; COHN EJ, 1946, J AM CHEM SOC, V68, P459, DOI 10.1021/ja01207a034; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fischer J, 2001, HUM MOL GENET, V10, P875, DOI 10.1093/hmg/10.8.875; Gay M, 2010, PROTEOMICS, V10, P172, DOI 10.1002/pmic.200900182; Gundry RL, 2007, PROTEOM CLIN APPL, V1, P73, DOI 10.1002/prca.200600276; Heemann U, 2002, HEPATOLOGY, V36, P949, DOI 10.1053/jhep.2002.36130; Heyer Gisela, 1997, Journal of Dermatology (Tokyo), V24, P621; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jalan R, 2001, Z Gastroenterol, V39 Suppl 2, P12, DOI 10.1055/s-2001-919023; Jones EA, 1999, HEPATOLOGY, V29, P1003, DOI 10.1002/hep.510290450; Kremer AE, 2008, DRUGS, V68, P2163, DOI 10.2165/00003495-200868150-00006; Laleman W, 2006, CRIT CARE, V10, DOI 10.1186/cc4985; Lowenthal MS, 2005, CLIN CHEM, V51, P1933, DOI 10.1373/clinchem.2005.052944; Mitzner SR, 2001, J AM SOC NEPHROL, V12, pS75; Pares A, 2004, AM J GASTROENTEROL, V99, P1105, DOI 10.1111/j.1572-0241.2004.30204.x; Pares A, 2010, J HEPATOL, V53, P307, DOI 10.1016/j.jhep.2010.02.031; Patzer JF, 2008, ARTIF ORGANS, V32, P499, DOI 10.1111/j.1525-1594.2008.00581.x; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Saliba F, 2006, CRIT CARE, V10, DOI 10.1186/cc4825; Sen S, 2005, AM J GASTROENTEROL, V100, P468, DOI 10.1111/j.1572-0241.2005.40864.x; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Stange J, 1999, ARTIF ORGANS, V23, P319; Tiss A, 2010, PROTEOMICS, V10, P3388, DOI 10.1002/pmic.201000100; Twycross R, 2003, QJM-INT J MED, V96, P7, DOI 10.1093/qjmed/hcg002; Williams R, 2007, ACTA GASTRO-ENT BELG, V70, P210; Yosipovitch G, 2003, LANCET, V361, P690, DOI 10.1016/S0140-6736(03)12570-6; Zheng XY, 2006, J CHROMATOGR A, V1120, P173, DOI 10.1016/j.chroma.2006.01.098; Ziganshin R, 2011, J PROTEOMICS, V74, P595, DOI 10.1016/j.jprot.2011.01.014	35	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21850	10.1371/journal.pone.0021850	http://dx.doi.org/10.1371/journal.pone.0021850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779339	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811300018
J	Chen, CH; Chen, CS; Moyzis, R; Stern, H; He, QH; Li, H; Li, J; Zhu, B; Dong, Q				Chen, Chunhui; Chen, Chuansheng; Moyzis, Robert; Stern, Hal; He, Qinghua; Li, He; Li, Jin; Zhu, Bi; Dong, Qi			Contributions of Dopamine-Related Genes and Environmental Factors to Highly Sensitive Personality: A Multi-Step Neuronal System-Level Approach	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; DEFICIT HYPERACTIVITY DISORDER; SENSORY-PROCESSING SENSITIVITY; WHOLE-GENOME ASSOCIATION; VAL158MET POLYMORPHISM; MONOAMINE-OXIDASE; CANDIDATE GENES; NOVELTY SEEKING; HARM AVOIDANCE; LIFE EVENTS	Traditional behavioral genetic studies (e. g., twin, adoption studies) have shown that human personality has moderate to high heritability, but recent molecular behavioral genetic studies have failed to identify quantitative trait loci (QTL) with consistent effects. The current study adopted a multi-step approach (ANOVA followed by multiple regression and permutation) to assess the cumulative effects of multiple QTLs. Using a system-level (dopamine system) genetic approach, we investigated a personality trait deeply rooted in the nervous system (the Highly Sensitive Personality, HSP). 480 healthy Chinese college students were given the HSP scale and genotyped for 98 representative polymorphisms in all major dopamine neurotransmitter genes. In addition, two environment factors (stressful life events and parental warmth) that have been implicated for their contributions to personality development were included to investigate their relative contributions as compared to genetic factors. In Step 1, using ANOVA, we identified 10 polymorphisms that made statistically significant contributions to HSP. In Step 2, these polymorphism's main effects and interactions were assessed using multiple regression. This model accounted for 15% of the variance of HSP (p < 0.001). Recent stressful life events accounted for an additional 2% of the variance. Finally, permutation analyses ascertained the probability of obtaining these findings by chance to be very low, p ranging from 0.001 to 0.006. Dividing these loci by the subsystems of dopamine synthesis, degradation/transport, receptor and modulation, we found that the modulation and receptor subsystems made the most significant contribution to HSP. The results of this study demonstrate the utility of a multi-step neuronal system-level approach in assessing genetic contributions to individual differences in human behavior. It can potentially bridge the gap between the high heritability estimates based on traditional behavioral genetics and the lack of reproducible genetic effects observed currently from molecular genetic studies.	[Chen, Chunhui; Li, Jin; Zhu, Bi; Dong, Qi] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA; [Moyzis, Robert] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Moyzis, Robert] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA USA; [Stern, Hal] Univ Calif Irvine, Dept Stat, Irvine, CA USA; [He, Qinghua] Univ So Calif, Brain & Creat Inst, Los Angeles, CA USA; [Li, He] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China	Beijing Normal University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Southern California; China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS	Chen, CH (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	dongqi@bnu.edu.cn	He, Qinghua/B-2573-2008	He, Qinghua/0000-0001-6396-6273; Chen, Chuansheng/0000-0002-8224-1005	111 Project [B07008]; Ministry of Education of China [10YJCXLX032]	111 Project(Ministry of Education, China - 111 Project); Ministry of Education of China(Ministry of Education, China)	This study was supported by the 111 Project (B07008) and the project for young people who are devoted to the researches of humanities and social sciences (10YJCXLX032) of the Ministry of Education of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Aron A, 2010, SOC COGN AFFECT NEUR, V5, P219, DOI 10.1093/scan/nsq028; Aron EN, 1997, J PERS SOC PSYCHOL, V73, P345, DOI 10.1037/0022-3514.73.2.345; Aron EN, 2005, PERS SOC PSYCHOL B, V31, P181, DOI 10.1177/0146167204271419; Austin J, 2000, MOL PSYCHIATR, V5, P552, DOI 10.1038/sj.mp.4000761; Benham G, 2006, PERS INDIV DIFFER, V40, P1433, DOI 10.1016/j.paid.2005.11.021; BOUCHARD TJ, 1994, SCIENCE, V264, P1700, DOI 10.1126/science.8209250; Boules M, 2007, CNS DRUGS, V21, P13, DOI 10.2165/00023210-200721010-00002; Caceda R, 2006, PEPTIDES, V27, P2385, DOI 10.1016/j.peptides.2006.04.024; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Chen C, ADDICTION B IN PRESS; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; COMPAS BE, 1987, CLIN PSYCHOL REV, V7, P275, DOI 10.1016/0272-7358(87)90037-7; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; Derringer J, 2010, PSYCHOL SCI, V21, P1282, DOI 10.1177/0956797610380699; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Distel MA, 2008, PSYCHOL MED, V38, P1219, DOI 10.1017/S0033291707002024; Distel MA, 2008, PSYCHIAT GENET, V18, P302, DOI 10.1097/YPG.0b013e3283118468; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Enoch MA, 2003, PSYCHIAT GENET, V13, P33, DOI 10.1097/00041444-200303000-00006; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gillespie NA, 2008, J PERS, V76, P1415, DOI 10.1111/j.1467-6494.2008.00527.x; Gonda X, 2009, EUR ARCH PSY CLIN N, V259, P106, DOI 10.1007/s00406-008-0842-7; Greenberger E, 2000, J CONSULT CLIN PSYCH, V68, P209, DOI 10.1037//0022-006X.68.2.209; Gregory AM, 2009, DEVELOPMENTAL SCI, V12, P165, DOI 10.1111/j.1467-7687.2008.00739.x; Gu DF, 2006, HYPERTENSION, V47, P1147, DOI 10.1161/01.HYP.0000219041.66702.45; Guan L, 2009, MOL PSYCHIATR, V14, P546, DOI 10.1038/sj.mp.4002139; Ham BJ, 2004, NEUROSCI LETT, V354, P2, DOI 10.1016/S0304-3940(03)00753-5; Hashimoto R, 2007, NEUROSCI LETT, V428, P17, DOI 10.1016/j.neulet.2007.09.036; Hawks J, 2007, P NATL ACAD SCI USA, V104, P20753, DOI 10.1073/pnas.0707650104; Hong XM, 2009, CURR OPIN PEDIATR, V21, P770, DOI 10.1097/MOP.0b013e32833252dc; Hosak L, 2006, NEUROENDOCRINOL LETT, V27, P799; Isen J, 2009, BEHAV GENET, V39, P36, DOI 10.1007/s10519-008-9244-x; Ishii G, 2007, EUR PSYCHIAT, V22, P462, DOI 10.1016/j.eurpsy.2007.05.005; Ivorra-Martinez J, 2007, REV NEUROLOGIA, V45, P418, DOI 10.33588/rn.4507.2007247; Jomphe C, 2006, EUR J NEUROSCI, V24, P2789, DOI 10.1111/j.1460-9568.2006.05151.x; Kim SJ, 2006, NEUROSCI LETT, V401, P154, DOI 10.1016/j.neulet.2006.03.006; Krueger RF, 2008, J PERS, V76, P1485, DOI 10.1111/j.1467-6494.2008.00529.x; Lee HJ, 2003, AM J MED GENET B, V121B, P44, DOI 10.1002/ajmg.b.20054; Light KJ, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-3; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCaffery JM, 2009, AM J CLIN NUTR, V89, P1011, DOI 10.3945/ajcn.2008.27170; McGuffin P, 2001, SCIENCE, V291, P1232, DOI 10.1126/science.1057264; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Murcray CE, 2009, AM J EPIDEMIOL, V169, P219, DOI 10.1093/aje/kwn353; Nilsson KW, 2009, UPSALA J MED SCI, V114, P100, DOI 10.1080/03009730902833406; Ohinata K, 2007, PEPTIDES, V28, P1470, DOI 10.1016/j.peptides.2007.06.002; Plomin R, 2009, J CHILD PSYCHOL PSYC, V50, P63, DOI 10.1111/j.1469-7610.2008.01978.x; Plomp E, 2009, NEUROSCIENCE, V164, P230, DOI 10.1016/j.neuroscience.2009.07.024; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian Q, 2004, AM J MED GENET B, V128B, P84, DOI 10.1002/ajmg.b.30079; Qian QJ, 2003, AM J MED GENET B, V118B, P103, DOI 10.1002/ajmg.b.10064; Ruchkin VV, 1998, COMPR PSYCHIAT, V39, P225, DOI 10.1016/S0010-440X(98)90065-7; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Samochowiec J, 2000, Psychiatr Pol, V34, P99; Shifman S, 2008, MOL PSYCHIATR, V13, P302, DOI 10.1038/sj.mp.4002048; Smillie LD, 2010, NEUROSCI LETT, V468, P234, DOI 10.1016/j.neulet.2009.10.095; St-Gelais F, 2006, J PSYCHIATR NEUROSCI, V31, P229; Torgersen S, 2008, PSYCHOL MED, V38, P1617, DOI 10.1017/S0033291708002924; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Wang LY, 2008, CLIN SCI, V115, P151, DOI 10.1042/CS20070335; Wermter AK, 2010, EUR CHILD ADOLES PSY, V19, P199, DOI 10.1007/s00787-009-0082-z; WILLS TA, 1992, AM J COMMUN PSYCHOL, V20, P349, DOI 10.1007/BF00937914; Wu J, 2010, GENET EPIDEMIOL, V34, P275, DOI 10.1002/gepi.20459; Wu XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004578; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	70	27	29	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21636	10.1371/journal.pone.0021636	http://dx.doi.org/10.1371/journal.pone.0021636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765900	Green Published, gold			2022-12-25	WOS:000292781500006
J	de Jong, PW; Hemerik, L; Gort, G; van Alphen, JJM				de Jong, Peter W.; Hemerik, Lia; Gort, Gerrit; van Alphen, Jacques J. M.			Rapid Establishment of a Regular Distribution of Adult Tropical Drosophila Parasitoids in a Multi-Patch Environment by Patch Defence Behaviour	PLOS ONE			English	Article							INTERSPECIFIC HOST DISCRIMINATION; ASOBARA-TABIDA NEES; TIME ALLOCATION; ADAPTIVE SUPERPARASITISM; SOLITARY PARASITOIDS; INSECT PARASITOIDS; WASPS; INTERFERENCE; STRATEGIES; EFFICIENCY	Females of the larval parasitoid of Drosophila, Asobara citri, from sub-Saharan Africa, defend patches with hosts by fighting and chasing conspecific females upon encounter. Females of the closely related, palearctic species Asobara tabida do not defend patches and often search simultaneously in the same patch. The effect of patch defence by A. citri females on their distribution in a multi-patch environment was investigated, and their distributions were compared with those of A. tabida. For both species 20 females were released from two release-points in replicate experiments. Females of A. citri quickly reached a regular distribution across 16 patches, with a small variance/mean ratio per patch. Conversely, A. tabida females initially showed a clumped distribution, and after gradual dispersion, a more Poisson-like distribution across patches resulted (variance/mean ratio was closer to 1 and higher than for A. citri). The dispersion of A. tabida was most probably an effect of exploitation: these parasitoids increasingly made shorter visits to already exploited patches. We briefly discuss hypotheses on the adaptive significance of patch defence behaviour or its absence in the light of differences in the natural history of both parasitoid species, notably the spatial distribution of their hosts.	[de Jong, Peter W.] Wageningen Univ, Entomol Lab, Wageningen, Netherlands; [Hemerik, Lia; Gort, Gerrit] Wageningen Univ, Dept Math & Stat Methods, Wageningen, Netherlands; [van Alphen, Jacques J. M.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	Wageningen University & Research; Wageningen University & Research; University of Amsterdam	de Jong, PW (corresponding author), Wageningen Univ, Entomol Lab, Wageningen, Netherlands.	lia.hemerik@wur.nl		Hemerik, Lia/0000-0002-6892-2840				Ardeh MJ, 2005, BIOL CONTROL, V33, P74, DOI 10.1016/j.biocontrol.2005.01.006; Bakker K., 1961, Archives Neerlandaises de Zoologie Leiden, V14, P200; BAKKER K, 1985, OECOLOGIA, V67, P572, DOI 10.1007/BF00790029; Bolker B, 2008, ECOLOGICAL MODELS DA; Field SA, 1997, ECOL ENTOMOL, V22, P142, DOI 10.1046/j.1365-2311.1997.t01-1-00057.x; Goubault M, 2005, BEHAV ECOL, V16, P693, DOI 10.1093/beheco/ari043; Hemerik L, 2002, ACTA BIOTHEOR, V50, P167, DOI 10.1023/A:1016543310896; HEMERIK L, 1993, J ANIM ECOL, V62, P33, DOI 10.2307/5480; JANSSEN A, 1989, FUNCT ECOL, V3, P469, DOI 10.2307/2389621; JANSSEN A, 1988, NETH J ZOOL, V38, P61, DOI 10.1163/156854288X00049; Pinheiro JC, 2000, STAT COMPUTING MIXED; SEVENSTER JG, 1992, THESIS LEIDEN U NETH; van der Hoeven N, 2002, ENVIRON ECOL STAT, V9, P201, DOI 10.1023/A:1015126322223; VANALPHEN JJM, 1992, FUNCT ECOL, V6, P528, DOI 10.2307/2390049; VANALPHEN JJM, 1982, NETH J ZOOL, V32, P232, DOI 10.1163/002829682X00157; VANALPHEN JJM, 1983, J ANIM ECOL, V52, P937, DOI 10.2307/4465; VANALPHEN JJM, 1990, ANNU REV ENTOMOL, V35, P59, DOI 10.1146/annurev.en.35.010190.000423; VANDERHOEVEN N, 1990, J THEOR BIOL, V146, P467, DOI 10.1016/S0022-5193(05)80373-X; VANSTRIENVANLIEMPT WTFH, 1981, NETH J ZOOL, V31, P701; VET LEM, 1983, PHYSIOL ENTOMOL, V8, P97, DOI 10.1111/j.1365-3032.1983.tb00338.x; VISSER ME, 1993, BEHAV ECOL, V4, P22, DOI 10.1093/beheco/4.1.22; VISSER ME, 1990, BEHAVIOUR, V114, P21, DOI 10.1163/156853990X00031; Visser ME, 1999, J ANIM ECOL, V68, P108, DOI 10.1046/j.1365-2656.1999.00269.x; VISSER ME, 1992, J ANIM ECOL, V61, P93, DOI 10.2307/5512; WAAGE JK, 1982, ECOL ENTOMOL, V7, P103, DOI 10.1111/j.1365-2311.1982.tb00648.x; Wajnberg E, 2004, J ANIM ECOL, V73, P1179, DOI 10.1111/j.0021-8790.2004.00892.x; WEISSER WW, 1993, FUNCT ECOL, V7, P27, DOI 10.2307/2389864	27	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e20870	10.1371/journal.pone.0020870	http://dx.doi.org/10.1371/journal.pone.0020870			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765889	Green Submitted, Green Published, gold			2022-12-25	WOS:000292699000002
J	Kaur, J; Mencl, S; Sahaboglu, A; Farinelli, P; van Veen, T; Zrenner, E; Ekstrom, P; Paquet-Durand, F; Arango-Gonzalez, B				Kaur, Jasvir; Mencl, Stine; Sahaboglu, Ayse; Farinelli, Pietro; van Veen, Theo; Zrenner, Eberhart; Ekstrom, Per; Paquet-Durand, Francois; Arango-Gonzalez, Blanca			Calpain and PARP Activation during Photoreceptor Cell Death in P23H and S334ter Rhodopsin Mutant Rats	PLOS ONE			English	Article							RETINITIS-PIGMENTOSA; POLY(ADP-RIBOSE) POLYMERASE; CLINICAL EXPRESSION; PROTEASE CALPAIN; TRANSGENIC RAT; APOPTOSIS; CALPASTATIN; MUTATION; MODEL; DEGENERATION	Retinitis pigmentosa (RP) is a heterogeneous group of inherited neurodegenerative diseases affecting photoreceptors and causing blindness. Many human cases are caused by mutations in the rhodopsin gene. An important question regarding RP pathology is whether different genetic defects trigger the same or different cell death mechanisms. To answer this question, we analysed photoreceptor degeneration in P23H and S334ter transgenic rats carrying rhodopsin mutations that affect protein folding and sorting respectively. We found strong activation of calpain and poly(ADP-ribose) polymerase (PARP) in both mutants, concomitant with calpastatin down-regulation, increased oxidative DNA damage and accumulation of PAR polymers. These parameters were strictly correlated with the temporal progression of photoreceptor degeneration, mirroring earlier findings in the phosphodiesterase-6 mutant rd1 mouse, and suggesting execution of non-apoptotic cell death mechanisms. Interestingly, activation of caspases-3 and -9 and cytochrome c leakage-key events in apoptotic cell death-were observed only in the S334ter mutant, which also showed increased expression of PARP-1. The identification of the same metabolic markers triggered by different mutations in two different species suggests the existence of common cell death mechanisms, which is a major consideration for any mutation independent treatment.	[Kaur, Jasvir; Mencl, Stine; Sahaboglu, Ayse; Farinelli, Pietro; van Veen, Theo; Zrenner, Eberhart; Paquet-Durand, Francois; Arango-Gonzalez, Blanca] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Tubingen, Germany; [Farinelli, Pietro; van Veen, Theo; Ekstrom, Per] Lund Univ, Dept Ophthalmol, Lund, Sweden	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Lund University	Arango-Gonzalez, B (corresponding author), Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Tubingen, Germany.	blanca.arango-gonzalez@klinikum.uni-tuebingen.de	Paquet-Durand, Francois/G-6709-2015; Farinelli, Pietro/G-8000-2017; Arango-Gonzalez, Blanca/AAR-7427-2021	Paquet-Durand, Francois/0000-0001-7355-5742; Farinelli, Pietro/0000-0002-4242-3090; Arango-Gonzalez, Blanca/0000-0002-9045-182X; Sahaboglu, Ayse/0000-0003-3241-0672	Tistou and Charlotte Kerstan Foundation; medical faculty of Lund University; German Research Council (DFG) [PA1751/1-1]; Centre for Integrative Neuroscience (CIN) [2009-20]	Tistou and Charlotte Kerstan Foundation; medical faculty of Lund University; German Research Council (DFG)(German Research Foundation (DFG)); Centre for Integrative Neuroscience (CIN)	This work was supported by the Tistou and Charlotte Kerstan Foundation, the medical faculty of Lund University, the German Research Council (DFG; PA1751/1-1), and the Centre for Integrative Neuroscience (CIN; pool project 2009-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma M, 2008, SURV OPHTHALMOL, V53, P150, DOI 10.1016/j.survophthal.2007.12.006; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gomez-Vicente V, 2005, CELL DEATH DIFFER, V12, P796, DOI 10.1038/sj.cdd.4401621; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Green ES, 2000, INVEST OPHTH VIS SCI, V41, P1546; Griciuc A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001075; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hurley JB, 1998, VISION RES, V38, P1341, DOI 10.1016/S0042-6989(97)00459-8; Jellinger Kurt A., 2006, Current Alzheimer Research, V3, P377, DOI 10.2174/156720506778249434; KOMEIMA K, 2008, FREE RADIC BIOL MED; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Liu CD, 1999, J NEUROSCI, V19, P4778; Lockshin RA, 2004, ONCOGENE, V23, P2766, DOI 10.1038/sj.onc.1207514; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; MAKI M, 1989, J BIOL CHEM, V264, P18866; MAKI M, 1987, BIOCHEM BIOPH RES CO, V143, P300, DOI 10.1016/0006-291X(87)90665-6; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; MENDOZAALVAREZ H, 1993, J BIOL CHEM, V268, P22575; Oh KT, 2003, AM J OPHTHALMOL, V136, P306, DOI 10.1016/S0002-9394(03)00206-X; Oka S, 2008, EMBO J, V27, P421, DOI 10.1038/sj.emboj.7601975; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Paquet-Durand F, 2006, J NEUROCHEM, V96, P802, DOI 10.1111/j.1471-4159.2005.03628.x; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Paquet-Durand F, 2010, J NEUROCHEM, V115, P930, DOI 10.1111/j.1471-4159.2010.06983.x; Paquet-Durand F, 2009, J NEUROCHEM, V108, P796, DOI 10.1111/j.1471-4159.2008.05822.x; Phelan JK, 2000, MOL VIS, V6, P116; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; Sahaboglu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015495; Sancho-Pelluz J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.4; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; SANDBERG MA, 1995, INVEST OPHTH VIS SCI, V36, P1934; Sanz MM, 2007, NEUROSCIENCE, V145, P1120, DOI 10.1016/j.neuroscience.2006.12.034; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Struthers L, 1998, ANAL BIOCHEM, V255, P20, DOI 10.1006/abio.1997.2354; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; Vosler PS, 2009, EXP NEUROL, V218, P213, DOI 10.1016/j.expneurol.2009.04.032; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Yoshizawa K, 2002, GRAEF ARCH CLIN EXP, V240, P214, DOI 10.1007/s00417-002-0427-5; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103	46	70	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22181	10.1371/journal.pone.0022181	http://dx.doi.org/10.1371/journal.pone.0022181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765948	Green Published, gold, Green Submitted			2022-12-25	WOS:000292699000027
J	May, D; Djonov, V; Zamir, G; Bala, M; Safadi, R; Sklair-Levy, M; Keshet, E				May, Dalit; Djonov, Valentin; Zamir, Gideon; Bala, Miklosh; Safadi, Rifaat; Sklair-Levy, Miriam; Keshet, Eli			A Transgenic Model for Conditional Induction and Rescue of Portal Hypertension Reveals a Role of VEGF-Mediated Regulation of Sinusoidal Fenestrations	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RAT HEPATIC LIPOCYTES; GENE-EXPRESSION; LIVER; CELLS; CIRRHOSIS; ADULT; PERMEABILITY; ACTIVATION; INSIGHTS	Portal hypertension (PH) is a common complication and a leading cause of death in patients with chronic liver diseases. PH is underlined by structural and functional derangement of liver sinusoid vessels and its fenestrated endothelium. Because in most clinical settings PH is accompanied by parenchymal injury, it has been difficult to determine the precise role of microvascular perturbations in causing PH. Reasoning that Vascular Endothelial Growth Factor (VEGF) is required to maintain functional integrity of the hepatic microcirculation, we developed a transgenic mouse system for a liver-specific-, reversible VEGF inhibition. The system is based on conditional induction and de-induction of a VEGF decoy receptor that sequesters VEGF and preclude signaling. VEGF blockade results in sinusoidal endothelial cells (SECs) fenestrations closure and in accumulation and transformation of the normally quiescent hepatic stellate cells, i.e. provoking the two processes underlying sinusoidal capillarization. Importantly, sinusoidal capillarization was sufficient to cause PH and its typical sequela, ascites, splenomegaly and venous collateralization without inflicting parenchymal damage or fibrosis. Remarkably, these dramatic phenotypes were fully reversed within few days from lifting-off VEGF blockade and resultant re-opening of SECs' fenestrations. This study not only uncovered an indispensible role for VEGF in maintaining structure and function of mature SECs, but also highlights the vasculo-centric nature of PH pathogenesis. Unprecedented ability to rescue PH and its secondary manifestations via manipulating a single vascular factor may also be harnessed for examining the potential utility of de-capillarization treatment modalities.	[May, Dalit; Keshet, Eli] Hebrew Univ Jerusalem, Hadassah Univ Hosp, Dept Mol Biol, Jerusalem, Israel; [Djonov, Valentin] Univ Bern, Dept Anat, CH-3000 Bern, Switzerland; [Zamir, Gideon; Bala, Miklosh] Hebrew Univ Jerusalem, Hadassah Univ Hosp, Dept Surg, Jerusalem, Israel; [Safadi, Rifaat] Hebrew Univ Jerusalem, Hadassah Univ Hosp, Dept Med, Jerusalem, Israel; [Sklair-Levy, Miriam] Hebrew Univ Jerusalem, Hadassah Univ Hosp, Dept Radiol, Jerusalem, Israel	Hebrew University of Jerusalem; University of Bern; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	May, D (corresponding author), Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA.	keshet@cc.huji.ac.il	Keshet, Eli/GQR-0445-2022	Djonov, Valentin/0000-0002-5062-1169				ARIMOTO J, 2009, J GASTROENTEROL; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005; Baruch Y, 2004, HEPATO-GASTROENTEROL, V51, P684; BOSCH J, J HEPATOL, V53, P558; Bosch J, 2007, J CLIN GASTROENTEROL, V41, pS247, DOI 10.1097/MCG.0b013e3181572357; Cao S, 2010, J CLIN INVEST, V120, P2379, DOI 10.1172/JCI41203; Carpenter B, 2005, DEVELOPMENT, V132, P3293, DOI 10.1242/dev.01902; Djonov V, 2000, CIRC RES, V86, P286, DOI 10.1161/01.RES.86.3.286; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; FRIEDMAN SL, 1989, J CLIN INVEST, V84, P1780, DOI 10.1172/JCI114362; Funyu J, 2001, BIOCHEM BIOPH RES CO, V280, P481, DOI 10.1006/bbrc.2000.4148; Garcia-Tsao G, 2009, AM J GASTROENTEROL, V104, P1802, DOI 10.1038/ajg.2009.191; Hollestellel MJ, 2004, THROMB HAEMOSTASIS, V91, P267, DOI 10.1160/TH03-05-0310; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Maharaj ASR, 2007, MICROVASC RES, V74, P100, DOI 10.1016/j.mvr.2007.03.004; Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834; May D, 2008, P NATL ACAD SCI USA, V105, P282, DOI 10.1073/pnas.0707778105; Menon KVN, 2004, NEW ENGL J MED, V350, P578, DOI 10.1056/NEJMra020282; Sanyal AJ, 2008, GASTROENTEROLOGY, V134, P1715, DOI 10.1053/j.gastro.2008.03.007; ULBRICH G, 2010, J HEPATOLOGY S; WONG L, 1994, J CLIN INVEST, V94, P1563, DOI 10.1172/JCI117497; YAMANE A, 1994, ONCOGENE, V9, P2683; Yokomori H, 2003, LIVER INT, V23, P467, DOI 10.1111/j.1478-3231.2003.00880.x	26	38	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21478	10.1371/journal.pone.0021478	http://dx.doi.org/10.1371/journal.pone.0021478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779329	gold, Green Submitted, Green Published			2022-12-25	WOS:000292680900007
J	Takeuchi, T; Puntous, T; Tuladhar, A; Yoshimoto, S; Shirama, A				Takeuchi, Tatsuto; Puntous, Theodore; Tuladhar, Anup; Yoshimoto, Sanae; Shirama, Aya			Estimation of Mental Effort in Learning Visual Search by Measuring Pupil Response	PLOS ONE			English	Article							PERFORMANCE; LOAD	Perceptual learning refers to the improvement of perceptual sensitivity and performance with training. In this study, we examined whether learning is accompanied by a release from mental effort on the task, leading to automatization of the learned task. For this purpose, we had subjects conduct a visual search for a target, defined by a combination of orientation and spatial frequency, while we monitored their pupil size. It is well known that pupil size reflects the strength of mental effort invested in a task. We found that pupil size increased rapidly as the learning proceeded in the early phase of training and decreased at the later phase to a level half of its maximum value. This result does not support the simple automatization hypothesis. Instead, it suggests that the mental effort and behavioral performance reflect different aspects of perceptual learning. Further, mental effort would be continued to be invested to maintain good performance at a later stage of training.	[Takeuchi, Tatsuto; Yoshimoto, Sanae] Japan Womens Univ, Dept Psychol, Kawasaki, Kanagawa, Japan; [Puntous, Theodore] Univ Lyon, ENISE, LTDS, CNRS UMR 5513, St Etienne, France; [Tuladhar, Anup] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada; [Yoshimoto, Sanae; Shirama, Aya] NTT Commun Sci Labs, Percept & Emot Res Grp, Atsugi, Kanagawa, Japan; [Shirama, Aya] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol JST CREST, Tokyo, Japan	Japan Womens University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); University of Waterloo; Nippon Telegraph & Telephone Corporation; Japan Science & Technology Agency (JST)	Takeuchi, T (corresponding author), Japan Womens Univ, Dept Psychol, Kawasaki, Kanagawa, Japan.	tatsutot@gmail.com	Tuladhar, Anup/AAL-7139-2020	Shirama, Aya/0000-0003-4174-5175; Tuladhar, Anup/0000-0002-3942-2732	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This study was supported by Japan Science and Technology Agency (http://www.jst.go.jp/EN/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baluchg F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009127; BARBUR JL, 2004, VISUAL NEUROSCIENCES, V1, P641; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Boucsein W., 1992, ELECTRODERMAL ACTIVI; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; DAWSON ME, 2000, HDB PSYCHOPHYSIOLOGY, P200; Hampson RE, 2010, BEHAV BRAIN RES, V212, P1, DOI 10.1016/j.bbr.2010.03.011; Hugdahl K., 1995, PSYCHOPHYSIOLOGY MIN; KAHNEMAN D, 1969, J EXP PSYCHOL, V79, P312, DOI 10.1037/h0026912; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Karni A, 1996, COGNITIVE BRAIN RES, V5, P39, DOI 10.1016/S0926-6410(96)00039-0; Leonards U, 2002, VISION RES, V42, P2193, DOI 10.1016/S0042-6989(02)00134-7; Leonards U, 1998, COGNITIVE BRAIN RES, V7, P207, DOI 10.1016/S0926-6410(98)00026-3; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Porter G, 2007, Q J EXP PSYCHOL, V60, P211, DOI 10.1080/17470210600673818; Rosenzweig M. R., 2002, BIOL PSYCHOL; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; Sireteanu R, 2000, VISION RES, V40, P2925, DOI 10.1016/S0042-6989(00)00145-0; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Tsodyks M, 2004, NATURE, V431, P775, DOI 10.1038/nature03013; Van Orden KF, 2000, BIOL PSYCHOL, V52, P221, DOI 10.1016/S0301-0511(99)00043-5; Van Orden KF, 2001, HUM FACTORS, V43, P111, DOI 10.1518/001872001775992570; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034	29	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21973	10.1371/journal.pone.0021973	http://dx.doi.org/10.1371/journal.pone.0021973			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791IA	21760936	Green Submitted, gold, Green Published			2022-12-25	WOS:000292657200038
J	Li, J; Lau, GKK; Chen, LL; Dong, SS; Lan, HY; Huang, XR; Li, Y; Luk, JM; Yuan, YF; Guan, XY				Li, Jian; Lau, George Ka-Kit; Chen, Leilei; Dong, Sui-sui; Lan, Hui-Yao; Huang, Xiao-Ru; Li, Yan; Luk, John M.; Yuan, Yun-Fei; Guan, Xin-yuan			Interleukin 17A Promotes Hepatocellular Carcinoma Metastasis via NF-kB Induced Matrix Metalloproteinases 2 and 9 Expression	PLOS ONE			English	Article							T-CELLS; KAPPA-B; RHEUMATOID-ARTHRITIS; ACTIVATED MONOCYTES; TUMOR-GROWTH; TH17 CELLS; IL-17; CANCER; PROGRESSION; EXPANSION	Background: IL-17A is a pro-inflammatory cytokine that plays important role in inflammatory disease pathology and tumor microenvironment. The aim of this study is to investigate the effect of IL-17A on the progression of hepatocellular carcinoma (HCC). Methodology and Principal Finding: Expression pattern of IL-17A in clinical HCC samples (n = 43) was determined by immunohistochemistry staining. Transcript levels of MMP2, MMP9 and IL-17A were measured in another 50 pairs (including tumor and related non-tumor tissues) HCC samples. Cell growth, focus formation, cell migration, invasion and western blot assays were used to characterize the functional and signaling mechanisms in IL-17A-treated HCC. Association study was used to identify clinical significance of IL-17A in HCC. Compared with paired non-tumor tissue, higher frequency of IL-17A-positive cells was detected in tumor tissues in HCCs with metastasis, and the frequency of IL-17A-positive cells was also significantly associated with poor prognosis of HCC (P = 0.01). Functional study found that IL-17A could promote HCC cell migration and invasion. Further molecular analysis also showed that IL-17A could upregulate MMP2 and MMP9 expression via NF-kappa B signaling activation. Conclusions: IL-17A could promote HCC metastasis by the upregulation of MMP2 and MMP9 expression via activating NF-kB signaling pathway.	[Li, Jian; Chen, Leilei; Dong, Sui-sui; Li, Yan; Guan, Xin-yuan] Univ Hong Kong, Dept Clin Oncol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Lau, George Ka-Kit] Univ Hong Kong, Dept Med, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Chen, Leilei; Dong, Sui-sui; Li, Yan; Guan, Xin-yuan] Univ Hong Kong, State Key Lab Liver Res, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Lan, Hui-Yao; Huang, Xiao-Ru] Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Lan, Hui-Yao; Huang, Xiao-Ru] Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Luk, John M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Canc Sci Inst, Singapore 117595, Singapore; [Luk, John M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Canc Sci Inst, Singapore 117595, Singapore; [Yuan, Yun-Fei; Guan, Xin-yuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; National University of Singapore; National University of Singapore; Sun Yat Sen University	Li, J (corresponding author), Univ Hong Kong, Dept Clin Oncol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	xyguan@hkucc.hku.hk	Lan, Hui Yao/C-9734-2015; Luk, John/A-4085-2008; Lau, George/AAQ-2085-2021; Chen, Leilei/F-7668-2011; Guan, Xin-Yuan/A-3639-2009; /A-3639-2009	Lan, Hui Yao/0000-0003-4283-9755; Luk, John/0000-0002-6323-7940; Guan, Xin-Yuan/0000-0002-4485-6017; /0000-0003-1874-9805; Yuan, Yunfei/0000-0003-2467-3683; Chen, Polly Leilei/0000-0002-1987-3878	Hong Kong Research Grant Council [HKU 7656/07M]; Hong Kong RGC [HKU5/CRF/08, HKU7/CRG09]; Sun Yat-sen University [85000-3171311]	Hong Kong Research Grant Council(Hong Kong Research Grants Council); Hong Kong RGC(Hong Kong Research Grants Council); Sun Yat-sen University	This work was supported by a Hong Kong Research Grant Council Grant (HKU 7656/07M), Hong Kong RGC Collaborative Research Grants (HKU5/CRF/08 and HKU7/CRG09) and the "Hundred Talents Program'' at Sun Yat-sen University (85000-3171311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Bu W, 1997, Zhonghua Yi Xue Za Zhi, V77, P661; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Ding T, 2009, HUM PATHOL, V40, P381, DOI 10.1016/j.humpath.2008.08.011; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.102; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gao C, 2009, CELL MOL NEUROBIOL, V29, P1161, DOI 10.1007/s10571-009-9409-z; He DG, 2006, J IMMUNOL, V177, P6852, DOI 10.4049/jimmunol.177.10.6852; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Ikeguchi M, 2004, EJSO-EUR J SURG ONC, V30, P53, DOI 10.1016/j.ejso.2003.10.001; Inozume T, 2009, J IMMUNOTHER, V32, P109, DOI 10.1097/CJI.0b013e31819302da; Ito Y, 2009, ARTHRITIS RHEUM-US, V60, P2294, DOI 10.1002/art.24687; Kehlen A, 1999, J NEUROIMMUNOL, V101, P1, DOI 10.1016/S0165-5728(99)00111-3; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; Kuang DM, 2010, J IMMUNOL, V185, P1544, DOI 10.4049/jimmunol.0904094; Kuang DM, 2010, HEPATOLOGY, V51, P154, DOI 10.1002/hep.23291; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; LIFSCHITZMERCER B, 1987, CANCER, V59, P1494, DOI 10.1002/1097-0142(19870415)59:8<1494::AID-CNCR2820590817>3.0.CO;2-V; Littlepage LE, 2010, CANCER RES, V70, P2224, DOI 10.1158/0008-5472.CAN-09-3515; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; RAZ A, 1987, CANCER METAST REV, V6, P3, DOI 10.1007/BF00047606; Semela D, 2004, J HEPATOL, V41, P864, DOI 10.1016/j.jhep.2004.09.006; Shalom-Barak T, 1998, J BIOL CHEM, V273, P27467, DOI 10.1074/jbc.273.42.27467; Solinas G, 2010, CANCER METAST REV, V29, P243, DOI 10.1007/s10555-010-9227-2; Su XM, 2010, J IMMUNOL, V184, P1630, DOI 10.4049/jimmunol.0902813; Sun S, 2007, LIVER INT, V27, P1021, DOI 10.1111/j.1478-3231.2007.01533.x; Wang J B, 1981, Zhonghua Zhong Liu Za Zhi, V3, P241; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang P, 2009, HEPATOL RES, V39, P1169, DOI 10.1111/j.1872-034X.2009.00563.x; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhu XW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2195	45	133	148	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21816	10.1371/journal.pone.0021816	http://dx.doi.org/10.1371/journal.pone.0021816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760911	Green Submitted, Green Published, gold			2022-12-25	WOS:000292655400021
J	Truong, T; Altiok, E; Yuen, D; Ecoiffier, T; Chen, L				Truong, Tan; Altiok, Eda; Yuen, Don; Ecoiffier, Tatiana; Chen, Lu			Novel Characterization of Lymphatic Valve Formation during Corneal Inflammation	PLOS ONE			English	Article							MURINE CORNEA; LYMPHANGIOGENESIS; BLOOD; ANGIOGENESIS; MECHANISMS; INTEGRINS; BLOCKADE; VESSELS; SYSTEM	Lymphatic research has progressed rapidly in recent years. Though lymphatic dysfunction has been found in a wide array of disorders from transplant rejection to cancer metastasis, to date, there is still little effective treatment for lymphatic diseases. The cornea offers an optimal site for lymphatic research due to its accessible location, transparent nature, and lymphatic-free but inducible features. However, it still remains unknown whether lymphatic valves exist in newly formed lymphatic vessels in the cornea, and how this relates to an inflammatory response. In this study, we provide the first evidence showing that lymphatic valves were formed in mouse cornea during suture-induced inflammation with the up-regulation of integrin alpha 9. The number of corneal valves increased with the progression of inflammatory lymphangiogenesis. Moreover, we have detected lymphatic valves at various developmental stages, from incomplete to more developed ones. In addition to defining the average diameter of lymphatic vessels equipped with lymphatic valves, we also report that lymphatic valves were more often located near the branching points. Taken together, these novel findings not only provide new insights into corneal lymphatic formation and maturation, but also identify a new model for future investigation on lymphatic valve formation and possibly therapeutic intervention.	[Truong, Tan; Altiok, Eda; Yuen, Don; Ecoiffier, Tatiana; Chen, Lu] Univ Calif Berkeley, Ctr Eye Dis & Dev, Program Vis Sci, Sch Optometry, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Truong, T (corresponding author), Univ Calif Berkeley, Ctr Eye Dis & Dev, Program Vis Sci, Sch Optometry, Berkeley, CA 94720 USA.	chenlu@berkeley.edu			National Institutes of Health; University of California at Berkeley; NATIONAL EYE INSTITUTE [R01EY017392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at Berkeley; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by research grants from National Institutes of Health and the University of California at Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Berman AE, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1284, DOI 10.1023/B:BIRY.0000011649.03634.74; Brown P, 2005, NATURE, V436, P456, DOI 10.1038/436456a; Chen L, 2009, LYMPHOLOGY, V42, P66; Chen L, 2007, ARCH OPHTHALMOL-CHIC, V125, P783, DOI 10.1001/archopht.125.6.783; Chen L, 2011, J SURG ONCOL, V103, P475, DOI 10.1002/jso.21794; Cursiefen C, 2006, CORNEA, V25, P443, DOI 10.1097/01.ico.0000183485.85636.ff; Cursiefen C, 2003, CORNEA, V22, P273, DOI 10.1097/00003226-200304000-00021; Dietrich T, 2007, AM J PATHOL, V171, P361, DOI 10.2353/ajpath.2007.060896; Dietrich T, 2010, J IMMUNOL, V184, P535, DOI 10.4049/jimmunol.0903180; Ecoiffier T, 2010, INVEST OPHTH VIS SCI, V51, P2436, DOI 10.1167/iovs.09-4505; Folkman J, 2004, NAT IMMUNOL, V5, P11, DOI 10.1038/ni0104-11; GIMBRONE MA, 1974, J NATL CANCER I, V52, P413, DOI 10.1093/jnci/52.2.413; Gonzalo P, 2010, BIOFACTORS, V36, P248, DOI 10.1002/biof.99; GRIMALDO S, 2011, INVEST OPHTHALM 0302; Huang XZ, 2000, MOL CELL BIOL, V20, P5208, DOI 10.1128/MCB.20.14.5208-5215.2000; Oliver G, 2002, GENE DEV, V16, P773, DOI 10.1101/gad.975002; Rogers MS, 2007, NAT PROTOC, V2, P2545, DOI 10.1038/nprot.2007.368; Singh D, 2003, J CATARACT REFR SURG, V29, P632, DOI 10.1016/S0886-3350(03)00161-5; Stepp MA, 2006, EXP EYE RES, V83, P3, DOI 10.1016/j.exer.2006.01.010; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Yuen D, 2011, INVEST OPHTH VIS SCI, V52, P2593, DOI 10.1167/iovs.10-6408; Zawieja David C., 2009, Lymphatic Research and Biology, V7, P87, DOI 10.1089/lrb.2009.0007; Zhang H, 2011, INVEST OPHTH VIS SCI, V52, P334, DOI 10.1167/iovs.10-5404	24	17	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21918	10.1371/journal.pone.0021918	http://dx.doi.org/10.1371/journal.pone.0021918			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760922	Green Submitted, Green Published, gold			2022-12-25	WOS:000292655400027
J	Yeakel, JD; Novak, M; Guimaraes, PR; Dominy, NJ; Koch, PL; Ward, EJ; Moore, JW; Semmens, BX				Yeakel, Justin D.; Novak, Mark; Guimaraes, Paulo R., Jr.; Dominy, Nathaniel J.; Koch, Paul L.; Ward, Eric J.; Moore, Jonathan W.; Semmens, Brice X.			Merging Resource Availability with Isotope Mixing Models: The Role of Neutral Interaction Assumptions	PLOS ONE			English	Article							INTERACTION STRENGTHS; STABLE-ISOTOPES; NICHE; TOO	Background: Bayesian mixing models have allowed for the inclusion of uncertainty and prior information in the analysis of trophic interactions using stable isotopes. Formulating prior distributions is relatively straightforward when incorporating dietary data. However, the use of data that are related, but not directly proportional, to diet (such as prey availability data) is often problematic because such information is not necessarily predictive of diet, and the information required to build a reliable prior distribution for all prey species is often unavailable. Omitting prey availability data impacts the estimation of a predator's diet and introduces the strong assumption of consumer ultrageneralism (where all prey are consumed in equal proportions), particularly when multiple prey have similar isotope values. Methodology: We develop a procedure to incorporate prey availability data into Bayesian mixing models conditional on the similarity of isotope values between two prey. If a pair of prey have similar isotope values (resulting in highly uncertain mixing model results), our model increases the weight of availability data in estimating the contribution of prey to a predator's diet. We test the utility of this method in an intertidal community against independently measured feeding rates. Conclusions: Our results indicate that our weighting procedure increases the accuracy by which consumer diets can be inferred in situations where multiple prey have similar isotope values. This suggests that the exchange of formalism for predictive power is merited, particularly when the relationship between prey availability and a predator's diet cannot be assumed for all species in a system.	[Yeakel, Justin D.; Novak, Mark] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Guimaraes, Paulo R., Jr.] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, Brazil; [Dominy, Nathaniel J.] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA; [Dominy, Nathaniel J.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Koch, Paul L.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Ward, Eric J.; Semmens, Brice X.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA; [Moore, Jonathan W.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	University of California System; University of California Santa Cruz; Universidade de Sao Paulo; Dartmouth College; Dartmouth College; University of California System; University of California Santa Cruz; National Oceanic Atmospheric Admin (NOAA) - USA; Simon Fraser University	Yeakel, JD (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	jdyeakel@gmail.com	Guimarães-Junior, Paulo R/M-1298-2016; Guimaraes, Paulo/B-1099-2008; Novak, Mark/E-2194-2012; Guimaraes, Paulo R./E-1915-2016; Dominy, Nathaniel Jay/A-6151-2013	Novak, Mark/0000-0002-7881-4253; Guimaraes, Paulo R./0000-0001-9161-8305; Dominy, Nathaniel Jay/0000-0001-5916-418X; Yeakel, Justin/0000-0002-6597-3511	National Science Foundation [DEB-0608178]; U.S. Environmental Protection Agency; Department of Education; Sigma Xi; University of Chicago; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superioris	National Science Foundation(National Science Foundation (NSF)); U.S. Environmental Protection Agency(United States Environmental Protection Agency); Department of Education(US Department of Education); Sigma Xi; University of Chicago(University of Chicago); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superioris	Field work was supported by a National Science Foundation Doctoral Dissertation Improvement Grant (DEB-0608178), a U.S. Environmental Protection Agency Science To Achieve Results fellowship, a Department of Education Graduate Assistance in Areas of National Need training grant, Sigma Xi, and the University of Chicago Hinds Fund. Additional funding for this work was provided by a National Science Foundation Graduate Research Fellowship, a Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, and a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superioris research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; BOND A, 2011, ECOLOGICAL APPL; Chen Y, 2008, MAR FRESHWATER RES, V59, P145, DOI 10.1071/MF07126; Darimont CT, 2009, J ANIM ECOL, V78, P126, DOI 10.1111/j.1365-2656.2008.01473.x; Fry B., 2006, STABLE ISOTOPE ECOLO; Gelman A., 2004, BAYESIAN DATA ANAL; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hilborn Ray, 1997, V28; Hubbell Stephen P., 2001, V32, pi; Jeschke JM, 2004, BIOL REV, V79, P337, DOI 10.1017/S1464793103006286; Koch PL, 2007, ECOL METHOD CONCEPT, P99, DOI 10.1002/9780470691854.ch5; Koch PL, 1998, ANNU REV EARTH PL SC, V26, P573, DOI 10.1146/annurev.earth.26.1.573; Krishna A, 2008, OIKOS, V117, P1609, DOI 10.1111/j.1600-0706.2008.16540.x; LU RP, 1989, THEOR POPUL BIOL, V35, P1, DOI 10.1016/0040-5809(89)90007-5; Lubetkin SC, 2004, J APPL ECOL, V41, P996, DOI 10.1111/j.0021-8901.2004.00957.x; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Morisita M., 1959, MEM FS KYUSHU U    E, V3, P65, DOI DOI 10.18960/SEITAI.11.6_252_4; MURDOCH WW, 1973, J APPL ECOL, V10, P335; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; NOVAK M, 2008, TROPHIC OMNIVORY STR; Novak M, 2008, ECOLOGY, V89, P2083, DOI 10.1890/08-0033.1; Novak M, 2010, ECOLOGY, V91, P2394, DOI 10.1890/09-0275.1; PAINE RT, 1988, ECOLOGY, V69, P1648, DOI 10.2307/1941141; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Slade NA, 2000, J MAMMAL, V81, P1035, DOI 10.1644/1545-1542(2000)081<1035:AETOUC>2.0.CO;2; SOLE RV, 2006, SELF ORG COMPLEX ECO; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Williams RJ, 2002, P NATL ACAD SCI USA, V99, P12913, DOI 10.1073/pnas.192448799; Yeakel JD, 2009, P NATL ACAD SCI USA, V106, P19040, DOI 10.1073/pnas.0905309106	34	28	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e22015	10.1371/journal.pone.0022015	http://dx.doi.org/10.1371/journal.pone.0022015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760944	gold, Green Published, Green Submitted			2022-12-25	WOS:000292655400038
J	Blom, L; Poulsen, BC; Jensen, BM; Hansen, A; Poulsen, LK				Blom, Lars; Poulsen, Britta C.; Jensen, Bettina M.; Hansen, Anker; Poulsen, Lars K.			IL-33 Induces IL-9 Production in Human CD4(+) T Cells and Basophils	PLOS ONE			English	Article							ACTIVATED MAST-CELLS; TGF-BETA; TH2 CELLS; DIFFERENTIATION; EXPRESSION; CYTOKINES; PU.1; ST2; INFLAMMATION; RESPONSES	IL-33, an IL-1 family member and ligand for the IL-1 receptor-related protein ST2, has been associated with induction of Th2 cytokines such as IL-4, IL-5, and IL-13. Here, we report that IL-33 can initiate IL-9 protein secretion in vitro in human CD4+ T cells and basophils isolated from peripheral blood. TGF-beta has been described as a critical factor for IL-9 induction in Th2 cells; however, we found that TGF-beta also induces co-production of IL-9 in purified, naive (> 99%) CD4(+)CD45RA(+)CD45RO(-)CD25(-) T cells differentiated towards a Th1 profile. Subsequently, it was demonstrated that TGF-beta is important, although not an absolute requirement, for IL-9 production in CD4+ T cells. IL-9 production by purified (> 95%) human basophils, cultured for 24 h with IL-3 or IL-33, was found, with a strong synergy between the two, likely to be explained by the IL-3 upregulated ST2 expression. Collectively, these data indicate that barrier functioning cells are important for the regulation of IL-9 production by immune cells in inflamed tissue.	[Blom, Lars; Poulsen, Britta C.; Jensen, Bettina M.; Hansen, Anker; Poulsen, Lars K.] Copenhagen Univ Hosp, Dermato Allergol Dept K, Gentofte, Denmark; [Poulsen, Britta C.] Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Blom, L (corresponding author), Copenhagen Univ Hosp, Dermato Allergol Dept K, Gentofte, Denmark.	LBLO0015@geh.regionh.dk	Poulsen, Lars K/J-3065-2019	Poulsen, Lars K/0000-0002-1730-847X	allergy clinic at Gentofte Hospital Denmark as a part of the national public health care systems	allergy clinic at Gentofte Hospital Denmark as a part of the national public health care systems	This work was funded by the allergy clinic at Gentofte Hospital Denmark as a part of the national public health care systems. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Beriou G, 2010, J IMMUNOL, V185, P46, DOI 10.4049/jimmunol.1000356; Chang HC, 2005, IMMUNITY, V22, P693, DOI 10.1016/j.immuni.2005.03.016; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; HAAKFRENDSCHO M, 1988, J ALLERGY CLIN IMMUN, V81, P224, DOI 10.1016/0091-6749(88)90460-5; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Hultner L, 2000, J IMMUNOL, V164, P5556, DOI 10.4049/jimmunol.164.11.5556; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Kearley J, 2011, AM J RESP CRIT CARE, V183, P865, DOI 10.1164/rccm.200909-1462OC; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Lamkanfi M, 2009, IMMUNITY, V31, P5, DOI 10.1016/j.immuni.2009.06.011; Lecart S, 2002, EUR J IMMUNOL, V32, P2979, DOI 10.1002/1521-4141(2002010)32:10<2979::AID-IMMU2979>3.0.CO;2-5; Li HM, 2010, J NEUROIMMUNE PHARM, V5, P198, DOI 10.1007/s11481-009-9186-y; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; McMillan SJ, 2005, J IMMUNOL, V174, P5774, DOI 10.4049/jimmunol.174.9.5774; Noelle RJ, 2010, NAT REV IMMUNOL, V10, P683, DOI 10.1038/nri2848; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Putheti P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008706; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Slack JL, 2001, J MOL DIAGN, V3, P141, DOI 10.1016/S1525-1578(10)60665-4; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Tan CY, 2010, J IMMUNOL, V185, P6795, DOI 10.4049/jimmunol.1001676; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Veldhoen M, 2010, IMMUNITY, V33, P141, DOI 10.1016/j.immuni.2010.08.007; Wiener Z, 2004, CYTOKINE, V26, P122, DOI 10.1016/j.cyto.2004.01.006; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; YAMAGUCHI M, 1992, INT ARCH ALLERGY IMM, V97, P322, DOI 10.1159/000236140; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	36	68	71	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21695	10.1371/journal.pone.0021695	http://dx.doi.org/10.1371/journal.pone.0021695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21765905	Green Published, Green Submitted, gold			2022-12-25	WOS:000292632000020
J	Margam, VM; Coates, BS; Bayles, DO; Hellmich, RL; Agunbiade, T; Seufferheld, MJ; Sun, WL; Kroemer, JA; Ba, MN; Binso-Dabire, CL; Baoua, I; Ishiyaku, MF; Covas, FG; Srinivasan, R; Armstrong, J; Murdock, LL; Pittendrigh, BR				Margam, Venu M.; Coates, Brad S.; Bayles, Darrell O.; Hellmich, Richard L.; Agunbiade, Tolulope; Seufferheld, Manfredo J.; Sun, Weilin; Kroemer, Jeremy A.; Ba, Malick N.; Binso-Dabire, Clementine L.; Baoua, Ibrahim; Ishiyaku, Mohammad F.; Covas, Fernando G.; Srinivasan, Ramasamy; Armstrong, Joel; Murdock, Larry L.; Pittendrigh, Barry R.			Transcriptome Sequencing, and Rapid Development and Application of SNP Markers for the Legume Pod Borer Maruca vitrata (Lepidoptera: Crambidae)	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; EUROPEAN CORN-BORER; OSTRINIA-NUBILALIS; POPULATION-STRUCTURE; FLANKING REGIONS; CANDIDATE GENES; GENOME; TAGS; DNA; MICROSATELLITES	The legume pod borer, Maruca vitrata (Lepidoptera: Crambidae), is an insect pest species of crops grown by subsistence farmers in tropical regions of Africa. We present the de novo assembly of 3729 contigs from 454- and Sanger-derived sequencing reads for midgut, salivary, and whole adult tissues of this non-model species. Functional annotation predicted that 1320 M. vitrata protein coding genes are present, of which 631 have orthologs within the Bombyx mori gene model. A homology-based analysis assigned M. vitrata genes into a group of paralogs, but these were subsequently partitioned into putative orthologs following phylogenetic analyses. Following sequence quality filtering, a total of 1542 putative single nucleotide polymorphisms (SNPs) were predicted within M. vitrata contig assemblies. Seventy one of 1078 designed molecular genetic markers were used to screen M. vitrata samples from five collection sites in West Africa. Population substructure may be present with significant implications in the insect resistance management recommendations pertaining to the release of biological control agents or transgenic cowpea that express Bacillus thuringiensis crystal toxins. Mutation data derived from transcriptome sequencing is an expeditious and economical source for genetic markers that allow evaluation of ecological differentiation.	[Margam, Venu M.; Murdock, Larry L.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Coates, Brad S.; Bayles, Darrell O.; Hellmich, Richard L.; Kroemer, Jeremy A.] Iowa State Univ, USDA ARS, Corn Insect & Crop Genet Res Unit, Genet Lab, Ames, IA USA; [Agunbiade, Tolulope; Sun, Weilin; Pittendrigh, Barry R.] Univ Illinois, Dept Entomol, Champaign, IL USA; [Seufferheld, Manfredo J.] Univ Illinois, Dept Crop Sci, Champaign, IL USA; [Ba, Malick N.; Binso-Dabire, Clementine L.] Inst Environm & Rech Agr INERA, Stn Kamboinse, Ouagadougou, Burkina Faso; [Baoua, Ibrahim] Inst Natl Rech Agron Niger, Maradi, Niger; [Ishiyaku, Mohammad F.] Ahmadu Bello Univ, Dept Plant Sci, Inst Agr Res, Zaria, Nigeria; [Covas, Fernando G.] Univ Puerto Rico, Mayaguez, PR USA; [Srinivasan, Ramasamy] AVRDC World Vegetable Ctr, Tainan, Taiwan; [Armstrong, Joel] Commonwealth Sci & Ind Res Org, Black Mt, ACT, Australia	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Iowa State University; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Ahmadu Bello University; Institute for Agricultural Research, Samaru, Zaria; University of Puerto Rico; University of Puerto Rico Mayaguez; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Margam, VM (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	pittendr@illinois.edu	Armstrong, Joel/E-6873-2011; Margam, Venu M/E-5876-2010; Ba, Malick Niango/I-8557-2012; Ramasamy, Srinivasan/N-1686-2019	Ba, Malick Niango/0000-0001-7323-8739; Ramasamy, Srinivasan/0000-0002-8454-7331; Coates, Brad/0000-0001-8908-1529; Margam, Venu/0000-0001-6510-4618	Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development [EDH-A-00-07-00005]	Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development(United States Agency for International Development (USAID))	This research has been made possible through support provided to the Dry Grains Pulses Collaborative Research Support Program (CRSP) by the Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development, under the terms of Grant No. EDH-A-00-07-00005. The opinions expressed herein are those of the authors and do not necessarily reflect the views of the U.S. Agency for International Development or the U.S. government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ALGHALI AM, 1991, TROP PEST MANAGE, V37, P71, DOI 10.1080/09670879109371540; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson K., 2006, International Journal of Technology and Globalisation, V2, P65, DOI 10.1504/IJTG.2006.009127; ATACHI P, 1994, ANN SOC ENTOMOL FR, V30, P169; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Bailie DA, 2010, J CRUSTACEAN BIOL, V30, P664, DOI 10.1651/09-3252.1; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Beldade P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000366; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Bergeron A, 2002, BIOINFORMATICS, V18, pS54, DOI 10.1093/bioinformatics/18.suppl_2.S54; BINDRA OS, 1968, 2 ANN WORKSH PULS CR; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; Chen SH, 2004, WORLD BANK RES OBSER, V19, P141, DOI 10.1093/wbro/lkh020; CHINH NT, 2000, LEGUMES RICE BASED C, P111; Coates BS, 2008, INSECT MOL BIOL, V17, P607, DOI 10.1111/j.1365-2583.2008.00833.x; Coates BS, 2011, INSECT MOL BIOL, V20, P15, DOI 10.1111/j.1365-2583.2010.01046.x; Coates BS, 2010, J MOL EVOL, V70, P275, DOI 10.1007/s00239-010-9330-6; Coates BS, 2009, GENOME, V52, P57, DOI 10.1139/G08-104; COCKERHAM CC, 1984, BIOMETRICS, V40, P157, DOI 10.2307/2530754; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hawken RJ, 2004, MAMM GENOME, V15, P819, DOI 10.1007/s00335-004-2382-4; Hayes BJ, 2007, BIOINFORMATICS, V23, P1692, DOI 10.1093/bioinformatics/btm154; Heidel-Fischer HM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-506; Hoskeri H, 2010, J COMP SCI SYSTEMATI, V3, P5052; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Huntley D, 2006, BIOINFORMATICS, V22, P495, DOI 10.1093/bioinformatics/btk006; Jackai L.E.N., 1988, TROPICAL GRAIN LEGUM, V35, P2; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keane OM, 2009, GENET MOL RES, V8, P1013, DOI 10.4238/vol8-3gmr594; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Khajuria C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-286; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MCCOMBIE WR, 1992, NAT GENET, V1, P124, DOI 10.1038/ng0592-124; McInerney CE, 2011, HEREDITY, V106, P78, DOI 10.1038/hdy.2010.36; Meglecz E, 2004, MOL ECOL, V13, P1693, DOI 10.1111/j.1365-294X.2004.02163.x; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; Noda H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-117; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Oparaeke, 2006, Journal of Plant Sciences, V1, P132; OTA T, 1994, J MOL EVOL, V38, P642; Patnaik H. P., 1986, Legume Research, V9, P7; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pavy N, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-174; Picoult-Newberg L, 1999, GENOME RES, V9, P167; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; RAHEJA AJ, 1974, P 1 IITA GRAIN LEG I, P295; RAHMAN MM, 1989, BANG J SCI RES, V7, P27; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sharma HC, 1998, CROP PROT, V17, P373, DOI 10.1016/S0261-2194(98)00045-3; Siegfried BD, 2005, INSECT MOL BIOL, V14, P137, DOI 10.1111/j.1365-2583.2005.00538.x; Sobrino B, 2005, FORENSIC SCI INT, V154, P181, DOI 10.1016/j.forsciint.2004.10.020; Soeun M., 2001, Legumes in rice-based cropping systems in tropical Asia: constraints and opportunities, P4; Tamura K, 2011, MOL BIOL EV IN PRESS; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Tay WT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-144; Taylor T. A., 1967, Journal of the West African Science Association, V12, P111; Ulrichs Ch., 2001, Mitteilungen der Deutschen Gesellschaft fuer Allgemeine und Angewandte Entomologie, V13, P283; Useche F J, 2001, Genome Inform, V12, P194; Van't Hof AE, 2007, HEREDITY, V98, P320, DOI 10.1038/sj.hdy.6800944; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Wang P, 1997, P NATL ACAD SCI USA, V94, P6977, DOI 10.1073/pnas.94.13.6977; Wang SL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r8; WEIR BS, 1992, GENETICS, V130, P873; Wernersson R, 2006, NUCLEIC ACIDS RES, V34, pW385, DOI 10.1093/nar/gkl252; Wiedmann RT, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-81; Williams Larissa M, 2010, BMC Genet, V11, P32, DOI 10.1186/1471-2156-11-32; Xing C, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S29; Yamamoto K, 2006, GENETICS, V173, P151, DOI 10.1534/genetics.105.053801; Zhang DX, 2004, TRENDS ECOL EVOL, V19, P507, DOI 10.1016/j.tree.2004.07.020	83	24	27	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21388	10.1371/journal.pone.0021388	http://dx.doi.org/10.1371/journal.pone.0021388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754987	gold, Green Published, Green Submitted			2022-12-25	WOS:000292632000011
J	Heffernan-Stroud, LA; Helke, KL; Jenkins, RW; De Costa, AM; Hannun, YA; Obeid, LM				Heffernan-Stroud, L. A.; Helke, K. L.; Jenkins, R. W.; De Costa, A-M; Hannun, Y. A.; Obeid, L. M.			Defining a role for sphingosine kinase 1 in p53-dependent tumors	ONCOGENE			English	Article						ceramide; sphingosine-1-phosphate; p53; sphingosine kinase; cancer; senescence	PROGRAMMED CELL-DEATH; CERAMIDE-INDUCED APOPTOSIS; TANDEM MASS-SPECTROMETRY; BIOACTIVE SPHINGOLIPIDS; QUANTITATIVE-ANALYSIS; GENOTOXIC STRESS; HIGH EXPRESSION; DOWN-REGULATION; MICE DEFICIENT; CYCLE ARREST	p53 is a crucial tumor suppressor that is mutated or deleted in a majority of cancers. Exactly how p53 prevents tumor progression has proved elusive for many years; however, this information is crucial to define targets for chemotherapeutic development that can effectively restore p53 function. Bioactive sphingolipids have recently emerged as important regulators of proliferative, apoptotic and senescent cellular processes. In this study, we demonstrate that the enzyme sphingosine kinase 1 (SK1), a critical enzyme in the regulation of the key bioactive sphingolipids ceramide, sphingosine and sphingosine-1-phosphate (S1P), serves as a key downstream target for p53 action. Our results show that SK1 is proteolysed in response to genotoxic stress in a p53-dependent manner. p53 null mice display elevation of SK1 levels and a tumor-promoting dysregulation of bioactive sphingolipids in which the anti-growth sphingolipid ceramide is decreased and the pro-growth sphingolipid S1P is increased. Importantly, deletion of SK1 in p53 null mice completely abrogated thymic lymphomas in these mice and prolonged their life span by similar to 30%. Deletion of SK1 also significantly attenuated the formation of other cancers in p53 heterozygote mice. The mechanism of p53 tumor suppression by loss of SK1 is mediated by elevations of sphingosine and ceramide, which in turn were accompanied by increased expression of cell cycle inhibitors and tumor cell senescence. Thus, targeting SK1 may restore sphingolipid homeostasis in p53-dependent tumors and provide insights into novel therapeutic approaches to cancer. Oncogene (2012) 31, 1166-1175; doi:10.1038/onc.2011.302; published online 18 July 2011	[Obeid, L. M.] Med Univ S Carolina, Dept Med, Charleston, SC 29403 USA; [Heffernan-Stroud, L. A.; Obeid, L. M.] Med Univ S Carolina, Dept Mol & Cellular Biol & Pathobiol, Charleston, SC 29403 USA; [Helke, K. L.] Med Univ S Carolina, Dept Comparat Med Lab Anim Resources, Charleston, SC 29403 USA; [Jenkins, R. W.; Hannun, Y. A.; Obeid, L. M.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29403 USA; [De Costa, A-M] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29403 USA; [Obeid, L. M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Obeid, LM (corresponding author), Med Univ S Carolina, Dept Med, 114 Doughty St, Charleston, SC 29403 USA.	obeidl@musc.edu		Helke, Kris/0000-0001-9746-0764; obeid, lina/0000-0002-0734-0847	Biomedical Laboratory Research and Development Service of the VA Office of Research and Development [I01BX000156]; NIH/NIGMS [R01 GM062887]; NIH/NCI [P01 CA097132-project 3, P01 CA097132-project 1]; American Heart Association [AHA 081509E]; NIH MSTP [GM08716]; MUSC Hollings Cancer Center Abney Foundation; NIH/NIEHS [T32 ES012878, F30ES017379]; NCI [IPO1CA097132, P30 CA 138313]; NIH/NCRR SC COBRE [P20 RR017677]; NIH [C06 RR018823]; National Center for Research Resources; NATIONAL CANCER INSTITUTE [P30CA138313, P01CA097132] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677, C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES012878, F30ES017379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887, T32GM008716] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	Biomedical Laboratory Research and Development Service of the VA Office of Research and Development; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); NIH MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MUSC Hollings Cancer Center Abney Foundation; NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCRR SC COBRE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in part, by Award Number I01BX000156 from the Biomedical Laboratory Research and Development Service of the VA Office of Research and Development, NIH/NIGMS R01 GM062887, NIH/NCI P01 CA097132-project 3 (to LMO). NIH/NCI P01 CA097132-project 1 (to YAH). American Heart Association Pre-Doctoral Fellowship AHA 081509E (to RWJ), NIH MSTP Training Grant GM08716 (to RWJ, AMDC, LAHS), MUSC Hollings Cancer Center Abney Foundation Scholarship (to RWJ, LAHS), NIH/NIEHS TG T32 ES012878, and NIH/NIEHS National Research Service Award Individual Predoctoral Fellowship F30ES017379 (to LAHS). Liquid chromatography-mass spectrometry analysis of sphingolipids was performed by Lipidomics Shared Resource, MUSC (Methods 2006, 39: 82-91) supported by NCI Grants: IPO1CA097132 and P30 CA 138313 and NIH/NCRR SC COBRE Grant P20 RR017677 as specified in Supplementary Information. Laboratory space in the CRI building of MUSC was supported by the NIH, Grant C06 RR018823 from the Extramural Research Facilities Program of the National Center for Research Resources. Refer to Supplementary Information for individual acknowledgements and the VA disclaimer.	Akao Y, 2006, BIOCHEM BIOPH RES CO, V342, P1284, DOI 10.1016/j.bbrc.2006.02.070; Alesse E, 1998, CELL DEATH DIFFER, V5, P381, DOI 10.1038/sj.cdd.4400358; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Baptiste-Okoh N, 2008, CELL CYCLE, V7, P1133, DOI 10.4161/cc.7.9.5805; Bayerl MG, 2008, LEUKEMIA LYMPHOMA, V49, P948, DOI 10.1080/10428190801911654; Bergelin N, 2009, ENDOCRINOLOGY, V150, P2055, DOI 10.1210/en.2008-0625; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; CHAO R, 1992, J BIOL CHEM, V267, P23459; Cuenin S, 2008, ONCOGENE, V27, P387, DOI 10.1038/sj.onc.1210635; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Cuvillier O, 2003, PHARMACOL RES, V47, P439, DOI 10.1016/S1043-6618(03)00053-7; Dbaibo GS, 1998, J CLIN INVEST, V102, P329, DOI 10.1172/JCI1180; Debacq-Chainiaux F, 2010, ADV EXP MED BIOL, V694, P126; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; El-Assaad W, 2003, BIOCHEM J, V376, P725, DOI 10.1042/BJ20030888; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Heffernan-Stroud LA, 2011, ADV ENZYME REGUL, V51, P219, DOI 10.1016/j.advenzreg.2010.10.003; Hengst JA, 2010, BIOORG MED CHEM LETT, V20, P7498, DOI 10.1016/j.bmcl.2010.10.005; Ho LH, 2009, P NATL ACAD SCI USA, V106, P5336, DOI 10.1073/pnas.0811928106; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; JAYADEV S, 1995, J BIOL CHEM, V270, P2047, DOI 10.1074/jbc.270.5.2047; Johnson KR, 2005, J HISTOCHEM CYTOCHEM, V53, P1159, DOI 10.1369/jhc.4A6606.2005; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kang S, 2005, CELL CYCLE, V4, P578, DOI 10.4161/cc.4.4.1593; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Kim SS, 2002, ONCOGENE, V21, P2020, DOI 10.1038/sj.onc.1205037; Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702; Lee JY, 2000, EXP CELL RES, V261, P303, DOI 10.1006/excr.2000.5028; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lees JA, 1999, P NATL ACAD SCI USA, V96, P4221, DOI 10.1073/pnas.96.8.4221; Li W, 2009, CLIN CANCER RES, V15, P1393, DOI 10.1158/1078-0432.CCR-08-1158; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Long JS, 2010, MOL CELL BIOL, V30, P3827, DOI 10.1128/MCB.01133-09; Lopez-Marure R, 2000, EUR J BIOCHEM, V267, P4325, DOI 10.1046/j.1432-1327.2000.01436.x; Loveridge C, 2010, J BIOL CHEM, V285, P38841, DOI 10.1074/jbc.M110.127993; Lozano G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001115; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; Mathews TP, 2010, J MED CHEM, V53, P2766, DOI 10.1021/jm901860h; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Pchejetski D, 2008, MOL CANCER THER, V7, P1836, DOI 10.1158/1535-7163.MCT-07-2322; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; Pruschy M, 1999, BRIT J CANCER, V80, P693, DOI 10.1038/sj.bjc.6690411; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Ryland LK, 2011, CANCER BIOL THER, V11, P138, DOI 10.4161/cbt.11.2.14624; Sawada M, 2004, CELL DEATH DIFFER, V11, P997, DOI 10.1038/sj.cdd.4401438; Soussi T, 2007, ONCOGENE, V26, P2145, DOI 10.1038/sj.onc.1210280; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Taha TA, 2005, J BIOL CHEM, V280, P17196, DOI 10.1074/jbc.M413744200; Taha TA, 2004, J BIOL CHEM, V279, P20546, DOI 10.1074/jbc.M401259200; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Vadas M, 2008, BBA-MOL CELL BIOL L, V1781, P442, DOI 10.1016/j.bbalip.2008.06.007; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P555, DOI 10.1038/sj.cdd.4402286; Venable ME, 1999, BBA-MOL CELL BIOL L, V1439, P291, DOI 10.1016/S1388-1981(99)00101-8; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Watson C, 2010, AM J PATHOL, V177, P2205, DOI 10.2353/ajpath.2010.100220; Weigert A, 2009, INT J CANCER, V125, P2114, DOI 10.1002/ijc.24594; Weisz L, 2007, ONCOGENE, V26, P2202, DOI 10.1038/sj.onc.1210294; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Yoon CH, 2009, MOL CANCER RES, V7, P361, DOI 10.1158/1541-7786.MCR-08-0069; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	72	51	52	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	9					1166	1175		10.1038/onc.2011.302	http://dx.doi.org/10.1038/onc.2011.302			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	901EW	21765468	Green Accepted			2022-12-25	WOS:000300945900009
J	Polge, C; Heng, AE; Jarzaguet, M; Ventadour, S; Claustre, A; Combaret, L; Bechet, D; Matondo, M; Uttenweiler-Joseph, S; Monsarrat, B; Attaix, D; Taillandier, D				Polge, Cecile; Heng, Anne-Elisabeth; Jarzaguet, Marianne; Ventadour, Sophie; Claustre, Agnes; Combaret, Lydie; Bechet, Daniel; Matondo, Mariette; Uttenweiler-Joseph, Sandrine; Monsarrat, Bernard; Attaix, Didier; Taillandier, Daniel			Muscle actin is polyubiquitinylated in vitro and in vivo and targeted for breakdown by the E3 ligase MuRF1	FASEB JOURNAL			English	Article						proteasome; C2C12	RING FINGER PROTEINS; SKELETAL-MUSCLE; UBIQUITIN LIGASE; SOLEUS MUSCLE; STRIATED-MUSCLE; ATROPHY; PROTEASOME; DEGRADATION; ACTIVATION; EXPRESSION	Muscle atrophy prevails in numerous diseases (cancer cachexia, renal failure, infections, etc.), mainly results from elevated proteolysis, and is accelerated by bed rest. This largely contributes to increased health costs. Devising new strategies to prevent muscle wasting is a major clinical challenge. The ubiquitin proteasome system (UPS) degrades myofibrillar proteins, but the precise mechanisms responsible for actin breakdown are surprisingly poorly characterized. We report that chimeric flag-actin was destabilized and polyubiquitinylated in stably transfected C2C12 myotubes treated with the catabolic agent dexamethasone (1 mu M) and that only proteasome inhibitors blocked its breakdown. Actin polyubiquitinylation was also detected in wild-type C2C12 myotubes and human muscle biopsies from control participants and patients with cancer. The muscle-specific E3 ubiquitin ligase MuRF1 is up-regulated in catabolic conditions and polyubiquitinylates components of the thick filament. We also demonstrate that recombinant GST-MuRF1 physically interacted and polyubiquitinylated actin in vitro and that MuRF1 is a critical component for actin breakdown, since MuRF1 siRNA stabilized flag-actin. These data identify unambiguously the abundant contractile protein actin as a target of the UPS in skeletal muscle both in vitro and in vivo, further supporting the need for new strategies blocking specifically the activation of this pathway in muscle wasting conditions.-Polge, C., Heng, A.-E., Jarzaguet, M., Ventadour, S., Claustre, A., Combaret, L., Bechet, D., Matondo, M., Uttenweiler-Joseph, S., Monsarrat, B., Attaix, D., Taillandier, D. Muscle actin is polyubiquitinylated in vitro and in vivo and targeted for breakdown by the E3 ligase MuRF1. FASEB J. 25, 3790-3802 (2011). www.fasebj.org	[Polge, Cecile; Heng, Anne-Elisabeth; Jarzaguet, Marianne; Ventadour, Sophie; Claustre, Agnes; Combaret, Lydie; Bechet, Daniel; Attaix, Didier; Taillandier, Daniel] INRA, UMR 1019, UNH, Ctr Rech Nutr Humaine CNRH Auvergne, F-63000 Clermont Ferrand, France; [Polge, Cecile; Heng, Anne-Elisabeth; Jarzaguet, Marianne; Ventadour, Sophie; Claustre, Agnes; Combaret, Lydie; Bechet, Daniel; Attaix, Didier; Taillandier, Daniel] Univ Auvergne, Clermont Univ, UNH, Clermont Ferrand, France; [Heng, Anne-Elisabeth] Hyg Hosp REUNNIRH, Serv Nephrol Reanimat Med, Clermont Ferrand, France; [Matondo, Mariette; Uttenweiler-Joseph, Sandrine; Monsarrat, Bernard] CNRS, Toulouse, France; [Uttenweiler-Joseph, Sandrine; Monsarrat, Bernard; Attaix, Didier] Univ Toulouse 3, Univ Toulouse, IPBS, F-31062 Toulouse, France	INRAE; Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Taillandier, D (corresponding author), INRA, CRNH Auvergne, Unite Nutr Humaine, BP10448, F-63000 Clermont Ferrand, France.	daniel.taillandier@clermont.inra.fr	Matondo, Mariette/AAA-4163-2020; Bechet, Daniel/AAU-2874-2020; Polge, Cécile/AAM-2467-2020; Attaix, Didier/H-5247-2011	Matondo, Mariette/0000-0003-3958-7710; Bechet, Daniel/0000-0002-3812-8099; Polge, Cécile/0000-0002-8730-5776; Taillandier, Daniel/0000-0003-4520-0551; Attaix, Didier/0000-0002-0429-9957; Combaret, Lydie/0000-0001-6550-8700; Uttenweiler, Sandrine/0000-0001-9019-4766	Institut National de la Recherche Agronomique; Association Francaise contre les Myopathies	Institut National de la Recherche Agronomique; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	The authors thank Prof. Martin Rechsteiner and Dr. Patrick Young for the generous gift of the MLG clone. The authors are grateful to Dr. May Morris for providing the CADY peptide used for the KO experiments. This work was supported by grants to D.T., C.P., and/or D.A. from the Institut National de la Recherche Agronomique and the Association Francaise contre les Myopathies.	Adegoke OAJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE482, DOI 10.1152/ajpendo.00097.2002; Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; CAMPOS Y, PLOS ONE, V5, pE9866; Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448; Chen CS, 2007, FEBS LETT, V581, P1124, DOI 10.1016/j.febslet.2007.02.018; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Cosper PF, 2011, CANCER RES, V71, P1710, DOI 10.1158/0008-5472.CAN-10-3145; Crombez L, 2009, MOL THER, V17, P95, DOI 10.1038/mt.2008.215; Dammer EB, 2011, J BIOL CHEM, V286, P10457, DOI 10.1074/jbc.M110.149633; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gregorio CC, 2005, J MUSCLE RES CELL M, V26, P389, DOI 10.1007/s10974-005-9021-x; Heng AE, 2008, INT J BIOCHEM CELL B, V40, P2544, DOI 10.1016/j.biocel.2008.04.013; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kaneko-Oshikawa C, 2005, MOL CELL BIOL, V25, P10953, DOI 10.1128/MCB.25.24.10953-10964.2005; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Krawiec BJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1555, DOI 10.1152/ajpendo.00622.2006; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Mansoor O, 1996, P NATL ACAD SCI USA, V93, P2714, DOI 10.1073/pnas.93.7.2714; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; McElhinny AS, 2002, J CELL BIOL, V157, P125, DOI 10.1083/jcb.200108089; Menconi M, 2008, J CELL BIOCHEM, V105, P353, DOI 10.1002/jcb.21833; Nastasi T, 2004, DEV CELL, V6, P269, DOI 10.1016/S1534-5807(04)00020-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sassone J, 2006, EUR J HISTOCHEM, V50, P109; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Stawiecka-Mirota M, 2008, EXP CELL RES, V314, P3318, DOI 10.1016/j.yexcr.2008.08.017; Taillandier D, 2003, INT J BIOCHEM CELL B, V35, P665, DOI 10.1016/S1357-2725(03)00004-9; Taillandier D, 1996, BIOCHEM J, V316, P65, DOI 10.1042/bj3160065; Tsapara A, 1999, FEBS LETT, V455, P117, DOI 10.1016/S0014-5793(99)00848-0; Utsumi T, 2003, FEBS LETT, V539, P37, DOI 10.1016/S0014-5793(03)00180-7; Vazeille E, 2008, AM J PHYSIOL-ENDOC M, V295, pE1181, DOI 10.1152/ajpendo.90532.2008; Ventadour S, 2007, J BIOL CHEM, V282, P5302, DOI 10.1074/jbc.M610005200	46	102	112	1	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2011	25	11					3790	3802		10.1096/fj.11-180968	http://dx.doi.org/10.1096/fj.11-180968			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21764995				2022-12-25	WOS:000296723100005
J	Kashimada, K; Svingen, T; Feng, CW; Pelosi, E; Bagheri-Fam, S; Harley, VR; Schlessinger, D; Bowles, J; Koopman, P				Kashimada, Kenichi; Svingen, Terje; Feng, Chun-Wei; Pelosi, Emanuele; Bagheri-Fam, Stefan; Harley, Vincent R.; Schlessinger, David; Bowles, Josephine; Koopman, Peter			Antagonistic regulation of Cyp26b1 by transcription factors SOX9/SF1 and FOXL2 during gonadal development in mice	FASEB JOURNAL			English	Article						Forkhead box protein L2; germ cells; meiosis; retinoic acid; sex determination	STEROIDOGENIC FACTOR-I; GERM-CELL FATE; SEX DETERMINATION; RETINOIC-ACID; GENE-TRANSCRIPTION; TESTIS DEVELOPMENT; NUCLEAR RECEPTOR; MOUSE; DIFFERENTIATION; EXPRESSION	Sex determination in fetal germ cells depends on a balance between exposure to retinoic acid (RA) and the degradation of RA achieved by the testis-specific expression of the catabolic cytochrome P450 enzyme, CYP26B1. Therefore, identification of factors regulating the expression of the Cyp26b1 gene is an important goal in reproductive biology. We used in situ hybridization to demonstrate that Cyp26b1 and transcription factor genes steroidogenic factor-1 (Sf1) and Sry-related HMG box 9 (Sox9) are coexpressed in Sertoli cells, whereas Cyp26b1 and Sf1 are coexpressed in Leydig cells in mouse fetal testes. In the mouse gonadal somatic cell line TM3, transfection of constructs expressing SOX9 and SF1 activated Cyp26b1 expression, independently of the positive regulator RA. In embryonic gonads deficient in SOX9 or SF1, Cyp26b1 expression was decreased relative to wild-type (WT) controls, as measured by quantitative RT-PCR (qRT-PCR). Furthermore, qRT-PCR showed that Cyp26b1 up-regulation by SOX9/SF1 was attenuated by the ovarian transcription factor Forkhead box L2 (FOXL2) in TM3 cells, whereas in Foxl2-null mice, Cyp26b1 expression in XX gonads was increased similar to 20-fold relative to WT controls. These data support the hypothesis that SOX9 and SF1 ensure the male fate of germ cells by up-regulating Cyp26b1 and that FOXL2 acts to antagonize Cyp26b1 expression in ovaries.-Kashimada, K., Svingen, T., Feng, C.-W., Pelosi, E., Bagheri-Fam, S., Harley, V. R., Schlessinger, D., Bowles, J., Koopman, P. Antagonistic regulation of Cyp26b1 by transcription factors SOX9/SF1 and FOXL2 during gonadal development in mice. FASEB J. 25, 3561-3569 (2011). www.fasebj.org	[Kashimada, Kenichi; Svingen, Terje; Feng, Chun-Wei; Bowles, Josephine; Koopman, Peter] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Pelosi, Emanuele; Schlessinger, David] NIA, NIH, Biomed Res Ctr, Intramural Res Program,Lab Genet, Baltimore, MD 21224 USA; [Bagheri-Fam, Stefan; Harley, Vincent R.] Prince Henrys Inst Med Res, Clayton, Vic, Australia	University of Queensland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Prince Henry's Institute of Medical Research	Koopman, P (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	p.koopman@imb.uq.edu.au	Pelosi, Emanuele/D-2015-2017; Harley, Vincent/B-8092-2018; Svingen, Terje/A-5283-2010; Bowles, Josephine/B-6583-2013; Feng, Chun-Wei/I-8575-2017; Bowles, Josephine/AAG-4903-2020; Koopman, Peter A/C-9416-2009	Pelosi, Emanuele/0000-0003-1890-9821; Harley, Vincent/0000-0002-2405-1262; Svingen, Terje/0000-0003-4650-7651; Bowles, Josephine/0000-0003-2867-7438; Feng, Chun-Wei/0000-0001-9510-1012; Bowles, Josephine/0000-0003-2867-7438; Koopman, Peter A/0000-0001-6939-0914; Kashimada, Kenichi/0000-0003-2505-5932	Australian Research Council (ARC); National Health and Medical Research Council of Australia; U.S. National Institutes of Health, National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000647] Funding Source: NIH RePORTER	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank R. Chandraratna and K. Yin Tsang (Vitae Pharmaceuticals, Fort Washington, PA, USA) for providing AGN193109, Ken-Ichirou Morohashi (Kyushu University, Fukuoka, Japan) for providing SF1 antibody, and Sally L. Dunwoodie (Victor Chang Cardiac Research Institute, Sydney, NSW, Australia) for providing Cited2-knockout mice. The authors also thank C. Spiller and C. Harris for technical support. This work was supported by research grants from the Australian Research Council (ARC), the National Health and Medical Research Council of Australia, and the Intramural Research Program of the U.S. National Institutes of Health, National Institute on Aging. P.K. is a Federation Fellow of the ARC.	Agarwal C, 1996, J BIOL CHEM, V271, P12209, DOI 10.1074/jbc.271.21.12209; Barbera JPM, 2002, HUM MOL GENET, V11, P283, DOI 10.1093/hmg/11.3.283; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; Barrionuevo F, 2009, DEV BIOL, V327, P301, DOI 10.1016/j.ydbio.2008.12.011; Beverdam A, 2003, CYTOGENET GENOME RES, V101, P242, DOI 10.1159/000074344; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Bowles J, 2009, DEV DYNAM, V238, P2073, DOI 10.1002/dvdy.22024; Buaas FW, 2009, HUM MOL GENET, V18, P2989, DOI 10.1093/hmg/ddp237; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chuma S, 2001, DEV BIOL, V229, P468, DOI 10.1006/dbio.2000.9989; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; de Santa Barbara P, 1998, J BIOL CHEM, V273, P29654; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Garcia-Ortiz JE, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-36; Hadjantonakis AK, 1998, NAT GENET, V19, P220, DOI 10.1038/896; Haselbeck RJ, 1999, DEV GENET, V25, P353, DOI 10.1002/(SICI)1520-6408(1999)25:4<353::AID-DVG9>3.0.CO;2-G; HILSCHER B, 1974, CELL TISSUE RES, V154, P443, DOI 10.1007/BF00219667; IKEDA Y, 1994, MOL ENDOCRINOL, V8, P654, DOI 10.1210/me.8.5.654; Kashimada K, 2011, ENDOCRINOLOGY, V152, P272, DOI 10.1210/en.2010-0636; Kent J, 1996, DEVELOPMENT, V122, P2813; Kim Y, 2006, DEV DYNAM, V235, P2292, DOI 10.1002/dvdy.20894; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; MacLean G, 2001, MECH DEVELOP, V107, P195, DOI 10.1016/S0925-4773(01)00463-4; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; MATHER JP, 1980, BIOL REPROD, V23, P243, DOI 10.1095/biolreprod23.1.243; McLaren A, 1984, Symp Soc Exp Biol, V38, P7; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; McLaren A, 1995, PHILOS T R SOC B, V350, P229, DOI 10.1098/rstb.1995.0156; Morohashi KI, 1996, FASEB J, V10, P1569, DOI 10.1096/fasebj.10.14.9002548; Nef Serge, 2009, Journal of Biology (London), V8, P74, DOI 10.1186/jbiol173; Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235; Ottolenghi C, 2007, BIOESSAYS, V29, P15, DOI 10.1002/bies.20515; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; PALMER SJ, 1991, DEVELOPMENT, V112, P265; Park M, 2010, MOL ENDOCRINOL, V24, P1024, DOI 10.1210/me.2009-0375; Ray WJ, 1997, J BIOL CHEM, V272, P18702, DOI 10.1074/jbc.272.30.18702; Reijntjes S, 2005, DEV BIOL, V285, P224, DOI 10.1016/j.ydbio.2005.06.019; Sadovsky Y, 1998, J SOC GYNECOL INVEST, V5, P6, DOI 10.1016/S1071-5576(97)00096-8; SADOVSKY Y, 1995, P NATL ACAD SCI USA, V92, P10939, DOI 10.1073/pnas.92.24.10939; Schepers G, 2003, J BIOL CHEM, V278, P28101, DOI 10.1074/jbc.M304067200; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Svingen T, 2009, SEX DEV, V3, P194, DOI 10.1159/000228720; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Val P, 2007, DEVELOPMENT, V134, P2349, DOI 10.1242/dev.004390; Wang DS, 2007, MOL ENDOCRINOL, V21, P712, DOI 10.1210/me.2006-0248; Wilhelm D, 2005, DEV BIOL, V287, P111, DOI 10.1016/j.ydbio.2005.08.039; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006; Wilhelm D, 2009, MECH DEVELOP, V126, P324, DOI 10.1016/j.mod.2009.02.006; Wilson MJ, 2005, J BIOL CHEM, V280, P5917, DOI 10.1074/jbc.M412806200; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0	56	65	67	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3561	3569		10.1096/fj.11-184333	http://dx.doi.org/10.1096/fj.11-184333			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21757499	Green Published			2022-12-25	WOS:000295356400026
J	Lonetti, A; Szijgyarto, Z; Bosch, D; Loss, O; Azevedo, C; Saiardi, A				Lonetti, Annalisa; Szijgyarto, Zsolt; Bosch, Daniel; Loss, Omar; Azevedo, Cristina; Saiardi, Adolfo			Identification of an Evolutionarily Conserved Family of Inorganic Polyphosphate Endopolyphosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL HEXAKISPHOSPHATE KINASE; YEAST SACCHAROMYCES-CEREVISIAE; DIPHOSPHOINOSITOL POLYPHOSPHATES; BUDDING YEAST; PYROPHOSPHATES; METABOLISM; SURVIVAL; CELLS; GENE; PHOSPHOHYDROLASE	Inorganic polyphosphate (poly-P) consists of just a chain of phosphate groups linked by high energy bonds. It is found in every organism and is implicated in a wide variety of cellular processes (e.g. phosphate storage, blood coagulation, and pathogenicity). Its metabolism has been studied mainly in bacteria while remaining largely uncharacterized in eukaryotes. It has recently been suggested that poly-P metabolism is connected to that of highly phosphorylated inositol species (inositol pyrophosphates). Inositol pyrophosphates are molecules in which phosphate groups outnumber carbon atoms. Like poly-P they contain high energy bonds and play important roles in cell signaling. Here, we show that budding yeast mutants unable to produce inositol pyrophosphates have undetectable levels of poly-P. Our results suggest a prominent metabolic parallel between these two highly phosphorylated molecules. More importantly, we demonstrate that DDP1, encoding diadenosine and diphosphoinositol phosphohydrolase, possesses a robust poly-P endopolyphosphohydrolase activity. In addition, we prove that this is an evolutionarily conserved feature because mammalian Nudix hydrolase family members, the three Ddp1 homologues in human cells (DIPP1, DIPP2, and DIPP3), are also capable of degrading poly-P.	[Saiardi, Adolfo] UCL, Dept Cell & Dev Biol, MRC, Cell Biol Unit, London WC1E 6BT, England; UCL, Dept Cell & Dev Biol, Mol Cell Biol Lab, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Saiardi, A (corresponding author), UCL, Dept Cell & Dev Biol, MRC, Cell Biol Unit, Gower St, London WC1E 6BT, England.	dmcbado@ucl.ac.uk	Lonetti, Annalisa/AAB-3647-2019; Azevedo, Cristina/Y-4296-2019	Lonetti, Annalisa/0000-0002-3944-3090; Azevedo, Cristina/0000-0002-6997-1265	Medical Research Council; Human Frontier Science Program [RGP0048/2009-C]; Medical Research Council [MC_U122680443] Funding Source: researchfish; MRC [MC_U122680443] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontier Science Program(Human Frontier Science Program); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council funding to the Cell Biology Unit and by Human Frontier Science Program Grant RGP0048/2009-C.	Auesukaree C, 2005, J BIOL CHEM, V280, P25127, DOI 10.1074/jbc.M414579200; Azevedo C, 2006, NAT PROTOC, V1, P2416, DOI 10.1038/nprot.2006.337; Azevedo C, 2010, METHODS MOL BIOL, V645, P73, DOI 10.1007/978-1-60327-175-2_5; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Boer VM, 2010, MOL BIOL CELL, V21, P198, DOI 10.1091/mbc.E09-07-0597; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Brown MRW, 2004, P NATL ACAD SCI USA, V101, P16085, DOI 10.1073/pnas.0406909101; Burton A, 2009, J CELL PHYSIOL, V220, P8, DOI 10.1002/jcp.21763; Caffrey JJ, 2000, J BIOL CHEM, V275, P12730, DOI 10.1074/jbc.275.17.12730; CAMESELLE JC, 1982, BIOCHEM J, V201, P405, DOI 10.1042/bj2010405; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6; Draskovic P, 2008, CHEM BIOL, V15, P274, DOI 10.1016/j.chembiol.2008.01.011; Fisher DI, 2002, J BIOL CHEM, V277, P47313, DOI 10.1074/jbc.M209795200; Freimoser FM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r109; Gomez-Garcia MR, 2004, P NATL ACAD SCI USA, V101, P15876, DOI 10.1073/pnas.0406923101; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hidaka K, 2002, J BIOL CHEM, V277, P32730, DOI 10.1074/jbc.M205476200; Hooley P, 2008, TRENDS BIOCHEM SCI, V33, P577, DOI 10.1016/j.tibs.2008.09.007; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kulaev I. S., 2004, BIOCH INORGANIC POLY, P15; Kulaev IS, 2000, BIOCHEMISTRY-MOSCOW+, V65, P271; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lichko LP, 2008, BIOCHEMISTRY-MOSCOW+, V73, P985, DOI 10.1134/S0006297908090046; Lichko LP, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1404, DOI 10.1134/S0006297910110131; Lin HY, 2009, J BIOL CHEM, V284, P1863, DOI 10.1074/jbc.M805686200; Losito O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005580; Loss O., 2011, J VIS EXP IN PRESS; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Neef DW, 2003, MOL CELL BIOL, V23, P3788, DOI 10.1128/MCB.23.11.3788-3797.2003; Norbis F, 1997, J MEMBRANE BIOL, V156, P19, DOI 10.1007/s002329900183; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; OHandley SF, 1996, J BIOL CHEM, V271, P24649, DOI 10.1074/jbc.271.40.24649; Onnebo SMN, 2009, BIOCHEM J, V423, P109, DOI 10.1042/BJ20090241; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Safrany ST, 1998, EMBO J, V17, P6599, DOI 10.1093/emboj/17.22.6599; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Schell MJ, 1999, FEBS LETT, V461, P169, DOI 10.1016/S0014-5793(99)01462-3; Sethuraman A, 2001, P NATL ACAD SCI USA, V98, P8542, DOI 10.1073/pnas.151269398; Shears SB, 2009, MOL PHARMACOL, V76, P236, DOI 10.1124/mol.109.055897; Shi XB, 2005, FEBS LETT, V579, P2014, DOI 10.1016/j.febslet.2005.02.032; Trilisenko LV, 2003, BIOCHEMISTRY-MOSCOW+, V68, P577, DOI 10.1023/A:1023963927976; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; WURST H, 1995, J BACTERIOL, V177, P898, DOI 10.1128/jb.177.4.898-906.1995; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200; Zhang HY, 2007, P NATL ACAD SCI USA, V104, P16486, DOI 10.1073/pnas.0706847104	54	133	144	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					31966	31974		10.1074/jbc.M111.266320	http://dx.doi.org/10.1074/jbc.M111.266320			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775424	hybrid, Green Published			2022-12-25	WOS:000294726800005
J	Ahn, SY; Jamshidi, N; Mo, ML; Wu, W; Eraly, SA; Dnyanmote, A; Bush, KT; Gallegos, TF; Sweet, DH; Palsson, BO; Nigam, SK				Ahn, Sun-Young; Jamshidi, Neema; Mo, Monica L.; Wu, Wei; Eraly, Satish A.; Dnyanmote, Ankur; Bush, Kevin T.; Gallegos, Tom F.; Sweet, Douglas H.; Palsson, Bernhard O.; Nigam, Sanjay K.			Linkage of Organic Anion Transporter-1 to Metabolic Pathways through Integrated "Omics"-driven Network and Functional Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; MOLECULAR PHYSIOLOGY; ESCHERICHIA-COLI; OLFACTORY MUCOSA; URATE TRANSPORT; URIC-ACID; KIDNEY; CELLS; OAT1; RAT	The main kidney transporter of many commonly prescribed drugs (e. g. penicillins, diuretics, antivirals, methotrexate, and non-steroidal anti-inflammatory drugs) is organic anion transporter-1 (OAT1), originally identified as NKT (Lopez-Nieto, C. E., You, G., Bush, K. T., Barros, E. J., Beier, D. R., and Nigam, S. K. (1997) J. Biol. Chem. 272, 6471-6478). Targeted metabolomics in knockouts have shown that OAT1 mediates the secretion or reabsorption of many important metabolites, including intermediates in carbohydrate, fatty acid, and amino acid metabolism. This observation raises the possibility that OAT1 helps regulate broader metabolic activities. We therefore examined the potential roles of OAT1 in metabolic pathways using Recon 1, a functionally tested genome-scale reconstruction of human metabolism. A computational approach was used to analyze in vivo metabolomic as well as transcriptomic data from wild-type and OAT1 knock-out animals, resulting in the implication of several metabolic pathways, including the citric acid cycle, polyamine, and fatty acid metabolism. Validation by in vitro and ex vivo analysis using Xenopus oocyte, cell culture, and kidney tissue assays demonstrated interactions between OAT1 and key intermediates in these metabolic pathways, including previously unknown substrates, such as polyamines (e. g. spermine and spermidine). A genome-scale metabolic network reconstruction generated some experimentally supported predictions for metabolic pathways linked to OAT1-related transport. The data support the possibility that the SLC22 and other families of transporters, known to be expressed in many tissues and primarily known for drug and toxin clearance, are integral to a number of endogenous pathways and may be involved in a larger remote sensing and signaling system (Ahn, S. Y., and Nigam, S. K. (2009) Mol. Pharmacol. 76, 481-490, and Wu, W., Dnyanmote, A. V., and Nigam, S. K.(2011) Mol. Pharmacol. 79, 795-805). Drugs may alter metabolism by competing for OAT1 binding of metabolites.	[Wu, Wei; Eraly, Satish A.; Dnyanmote, Ankur; Bush, Kevin T.; Gallegos, Tom F.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Med, Div Nephrol & Hypertens, La Jolla, CA 92093 USA; [Ahn, Sun-Young; Wu, Wei; Dnyanmote, Ankur; Bush, Kevin T.; Gallegos, Tom F.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Jamshidi, Neema; Mo, Monica L.; Palsson, Bernhard O.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Wu, Wei; Dnyanmote, Ankur; Bush, Kevin T.; Gallegos, Tom F.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Sweet, Douglas H.] Virginia Commonwealth Univ, Dept Pharmaceut, Richmond, VA 23298 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Virginia Commonwealth University	Nigam, SK (corresponding author), Univ Calif San Diego, Dept Med, Div Nephrol & Hypertens, 9500 Gilman Dr, La Jolla, CA 92093 USA.	snigam@ucsd.edu	Sweet, Douglas H/H-7914-2013	Sweet, Douglas H/0000-0002-8911-9184; Palsson, Bernhard/0000-0003-2357-6785; Jamshidi, Neema/0000-0003-3857-9735; Ahn, Sun-Young/0000-0001-5571-6901	National Institutes of Health [3RO1GM088824, 5RO1DK079784, R01HL094728]; Society of Toxicology; Colgate Palmolive Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society of Toxicology; Colgate Palmolive Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 3RO1GM088824 and 5RO1DK079784 (to S. K. N.) and R01HL094728 (to S. A. E.).; Supported by a postdoctoral fellowship sponsored by the Society of Toxicology and Colgate Palmolive Inc.	Ahn SY, 2008, CURR OPIN NEPHROL HY, V17, P499, DOI 10.1097/MNH.0b013e32830b5d5d; Ahn SY, 2009, J BIOL CHEM, V284, P31422, DOI 10.1074/jbc.M109.024489; Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Beery E, 2003, ENDOCRINOLOGY, V144, P4519, DOI 10.1210/en.2002-221001; BRENNER BM, 2004, BRENNER RECTORS KIDN, P231; Burckhardt BC, 2003, REV PHYSIOL BIOCH P, V146, P95, DOI 10.1007/s10254-002-0003-8; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Enomoto A, 2007, THER APHER DIAL, V11, pS27, DOI 10.1111/j.1744-9987.2007.00515.x; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Eraly SA, 2004, PHYSIOL GENOMICS, V18, P12, DOI 10.1152/physiolgenomics.00014.2004; Eraly SA, 2003, CURR OPIN NEPHROL HY, V12, P551, DOI 10.1097/00041552-200309000-00011; Eraly SA, 2008, PHYSIOL GENOMICS, V33, P180, DOI 10.1152/physiolgenomics.00207.2007; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Hasegawa M, 2003, J PHARMACOL EXP THER, V305, P1087, DOI 10.1124/jpet.102.046847; Ichida K, 2003, KIDNEY INT, V63, P143, DOI 10.1046/j.1523-1755.2003.00710.x; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Kaler G, 2007, J BIOL CHEM, V282, P23841, DOI 10.1074/jbc.M703467200; Kaler G, 2006, BIOCHEM BIOPH RES CO, V351, P872, DOI 10.1016/j.bbrc.2006.10.136; KETTELER M, 1994, AM J PHYSIOL, V267, pF197, DOI 10.1152/ajprenal.1994.267.2.F197; Kumar VS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000308; Levillain O, 2004, AM J PHYSIOL-RENAL, V286, pF727, DOI 10.1152/ajprenal.00315.2003; Levillain O, 1998, AM J PHYSIOL-RENAL, V274, pF1020, DOI 10.1152/ajprenal.1998.274.6.F1020; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Monte JC, 2004, BIOCHEM BIOPH RES CO, V323, P429, DOI 10.1016/j.bbrc.2004.08.112; Mount DB, 2005, CURR OPIN NEPHROL HY, V14, P460, DOI 10.1097/01.mnh.0000170749.10785.04; Nagle MA, 2011, J BIOL CHEM, V286, P243, DOI 10.1074/jbc.M110.139949; Nigam SK, 2007, NAT CLIN PRACT NEPHR, V3, P443, DOI 10.1038/ncpneph0558; Nii-Kono T, 2007, KIDNEY INT, V71, P738, DOI 10.1038/sj.ki.5002097; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Reed JL, 2006, NAT REV GENET, V7, P130, DOI 10.1038/nrg1769; Sato M, 2008, PHARM RES-DORDR, V25, P639, DOI 10.1007/s11095-007-9401-6; SILVA P, 1990, SEMIN NEPHROL, V10, P432; Srimaroeng C, 2008, XENOBIOTICA, V38, P889, DOI [10.1080/00498250801927435, 10.1080/00498250801927435 ]; Sugiyama D, 2001, J PHARMACOL EXP THER, V298, P316; Suthers PF, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.56; Sweet DH, 2002, J BIOL CHEM, V277, P26934, DOI 10.1074/jbc.M203803200; Thiele I, 2005, J BIOL CHEM, V280, P11683, DOI 10.1074/jbc.M409072200; Truong DM, 2008, J BIOL CHEM, V283, P8654, DOI 10.1074/jbc.M708615200; UCHIDA S, 1988, AM J PHYSIOL, V255, pF977, DOI 10.1152/ajprenal.1988.255.5.F977; Vallon V, 2008, J AM SOC NEPHROL, V19, P1732, DOI 10.1681/ASN.2008020180; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF867, DOI 10.1152/ajprenal.00528.2007; VanWert AL, 2008, MOL PHARMACOL, V74, P122, DOI 10.1124/mol.107.042853; Wang J., 2006, P 1 WORKSH LARG SCAL, P169; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Wu W, 2011, MOL PHARMACOL, V79, P795, DOI 10.1124/mol.110.070607; You GF, 2002, MED RES REV, V22, P602, DOI 10.1002/med.10019; Zahedi K, 2007, AM J PHYSIOL-CELL PH, V292, pC1204, DOI 10.1152/ajpcell.00451.2006	50	51	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31522	31531		10.1074/jbc.M111.272534	http://dx.doi.org/10.1074/jbc.M111.272534			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757732	Green Published, hybrid			2022-12-25	WOS:000294487500047
J	Vilcaes, AA; Demichelis, VT; Daniotti, JL				Vilcaes, Aldo A.; Torres Demichelis, Vanina; Daniotti, Jose L.			Trans-activity of Plasma Membrane-associated Ganglioside Sialyltransferase in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-GLYCOSYLATION; GOLGI-COMPLEX; GD3 SYNTHASE; MEDIATED APOPTOSIS; BREFELDIN-A; GROWTH; GLYCOSPHINGOLIPIDS; EXPRESSION; PROTEIN; PHOSPHORYLATION	Gangliosides are acidic glycosphingolipids that contain sialic acid residues and are expressed in nearly all vertebrate cells. They are synthesized at the Golgi complex by a combination of glycosyltransferase activities followed by vesicular delivery to the plasma membrane, where they participate in a variety of physiological as well as pathological processes. Recently, a number of enzymes of ganglioside anabolism and catabolism have been shown to be associated with the plasma membrane. In particular, it was observed that CMP-NeuAc:GM3 sialyltransferase (Sial-T2) is able to sialylate GM3 at the plasma membrane (cis-catalytic activity). In this work, we demonstrated that plasma membrane-integrated ecto-Sial-T2 also displays a trans-catalytic activity at the cell surface of epithelial and melanoma cells. By using a highly sensitive enzyme-linked immunosorbent assay combined with confocal fluorescence microscopy, we observed that ecto-Sial-T2 was able to sialylate hydrophobically or covalently immobilized GM3 onto a solid surface. More interestingly, we observed that ecto-Sial-T2 was able to sialylate GM3 exposed on the membrane of neighboring cells by using both the exogenous and endogenous donor substrate (CMP-N-acetylneuraminic acid) available at the extracellular milieu. In addition, the trans-activity of ecto-Sial-T2 was considerably reduced when the expression of the acceptor substrate was inhibited by using a specific inhibitor of biosynthesis of glycolipids, indicating the lipidic nature of the acceptor. Our findings provide the first direct evidence that an ecto-sialyltransferase is able to trans-sialylate substrates exposed in the plasma membrane from mammalian cells, which represents a novel insight into the molecular events that regulate the local glycosphingolipid composition.	[Vilcaes, Aldo A.; Torres Demichelis, Vanina; Daniotti, Jose L.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, Ctr Invest Quim Biol Cordoba CIQUIBIC UNC CONICET, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Daniotti, JL (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, Ctr Invest Quim Biol Cordoba CIQUIBIC UNC CONICET, Ciudad Univ,X5000HUA, RA-5000 Cordoba, Argentina.	daniotti@dqb.fcq.unc.edu.ar			Secretaria de Ciencia y Tecnologia (SECyT); Universidad Nacional de Cordoba (UNC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina; CONICET (Argentina)	Secretaria de Ciencia y Tecnologia (SECyT)(Secretaria de Ciencia y Tecnologia (SECYT)); Universidad Nacional de Cordoba (UNC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported in part by grants from Secretaria de Ciencia y Tecnologia (SECyT), Universidad Nacional de Cordoba (UNC), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), and Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina.; A recipient of CONICET (Argentina) fellowship.	Colell A, 2002, FEBS LETT, V526, P135, DOI 10.1016/S0014-5793(02)03140-X; Crespo PM, 2010, J BIOL CHEM, V285, P29179, DOI 10.1074/jbc.M110.123422; Crespo PM, 2004, J BIOL CHEM, V279, P47610, DOI 10.1074/jbc.M407181200; Crespo PM, 2002, J BIOL CHEM, V277, P44731, DOI 10.1074/jbc.M204604200; Daniotti JL, 2000, J NEUROCHEM, V74, P1711, DOI 10.1046/j.1471-4159.2000.0741711.x; DANIOTTI JL, 1992, J NEUROCHEM, V59, P107, DOI 10.1111/j.1471-4159.1992.tb08881.x; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Gross HJ, 1996, BLOOD, V87, P5113, DOI 10.1182/blood.V87.12.5113.bloodjournal87125113; Hamamura K, 2005, P NATL ACAD SCI USA, V102, P11041, DOI 10.1073/pnas.0503658102; Handa Y, 2005, PAIN, V117, P271, DOI 10.1016/j.pain.2005.06.016; HARAGUCHI M, 1995, BIOCHEM J, V312, P273, DOI 10.1042/bj3120273; Iglesias-Bartolome R, 2006, FEBS J, V273, P1744, DOI 10.1111/j.1742-4658.2006.05194.x; Iglesias-Bartolome R, 2009, BBA-BIOMEMBRANES, V1788, P2526, DOI 10.1016/j.bbamem.2009.09.018; Inoue M, 2002, J BIOL CHEM, V277, P29881, DOI 10.1074/jbc.M201631200; Kawai H, 2001, J BIOL CHEM, V276, P6885, DOI 10.1074/jbc.C000847200; Kim JK, 2010, J KOREAN MED SCI, V25, P1492, DOI 10.3346/jkms.2010.25.10.1492; Kitazume S, 2009, GLYCOBIOLOGY, V19, P479, DOI 10.1093/glycob/cwp003; KOPITZ J, 1994, BIOCHEM BIOPH RES CO, V199, P1188, DOI 10.1006/bbrc.1994.1356; Daniotti JL, 2011, IUBMB LIFE, V63, P513, DOI 10.1002/iub.477; Maccioni HJF, 2007, J NEUROCHEM, V103, P81, DOI 10.1111/j.1471-4159.2007.04717.x; Malisan F, 2005, IUBMB LIFE, V57, P477, DOI 10.1080/15216540500167179; Martina JA, 1998, J BIOL CHEM, V273, P3725, DOI 10.1074/jbc.273.6.3725; Martina JA, 2000, NEUROCHEM RES, V25, P725, DOI 10.1023/A:1007527523734; MILJAN EA, 2002, SCI STKE, pRE15; Ohkawa Y, 2008, BIOCHEM BIOPH RES CO, V373, P14, DOI 10.1016/j.bbrc.2008.05.149; Okada M, 2002, J BIOL CHEM, V277, P1633, DOI 10.1074/jbc.C100395200; Prinetti A, 2007, J NEUROCHEM, V103, P113, DOI 10.1111/j.1471-4159.2007.04714.x; Proia RL, 2003, PHILOS T R SOC B, V358, P879, DOI 10.1098/rstb.2003.1268; Rao FV, 2009, NAT STRUCT MOL BIOL, V16, P1186, DOI 10.1038/nsmb.1685; Rifat S, 2008, J LEUKOCYTE BIOL, V84, P1075, DOI 10.1189/jlb.0706462; Sonnino S, 2010, FEBS LETT, V584, P1914, DOI 10.1016/j.febslet.2009.11.020; Spooner RA, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-26; Tajima O, 2010, BEHAV BRAIN RES, V206, P101, DOI 10.1016/j.bbr.2009.09.005; Tajima O, 2009, BEHAV BRAIN RES, V198, P74, DOI 10.1016/j.bbr.2008.10.024; Tettamanti G, 2003, GLYCOCONJUGATE J, V20, P301, DOI 10.1023/B:GLYC.0000033627.02765.cc; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; van Meer G, 2000, BBA-MOL CELL BIOL L, V1486, P145, DOI 10.1016/S1388-1981(00)00054-8; Yuyama K, 2011, J NEUROCHEM, V116, P845, DOI 10.1111/j.1471-4159.2010.07071.x; Zurita AR, 2001, BIOCHEM J, V355, P465, DOI 10.1042/0264-6021:3550465	39	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31437	31446		10.1074/jbc.M111.257196	http://dx.doi.org/10.1074/jbc.M111.257196			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768099	Green Published, hybrid			2022-12-25	WOS:000294487500038
J	Chowdhury, S; Howell, GM; Teggart, CA; Chowdhury, A; Person, JJ; Bowers, DM; Brattain, MG				Chowdhury, Sanjib; Howell, Gillian M.; Teggart, Carol A.; Chowdhury, Aparajita; Person, Jonathan J.; Bowers, Dawn M.; Brattain, Michael G.			Histone Deacetylase Inhibitor Belinostat Represses Survivin Expression through Reactivation of Transforming Growth Factor beta ( TGF beta) Receptor II Leading to Cancer Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CARCINOMA CELLS; DEPENDENT PROTEIN-KINASE; PANCREATIC-CANCER; INDUCED APOPTOSIS; TRANSCRIPTIONAL REPRESSION; PROTEASOME FUNCTION; COLORECTAL-CANCER; EPIGENETIC EVENTS; PROSTATE-CANCER; DOWN-REGULATION	Survivin is a cancer-associated gene that functions to promote cell survival, cell division, and angiogenesis and is a marker of poor prognosis. Histone deacetylase inhibitors induce apoptosis and re-expression of epigenetically silenced tumor suppressor genes in cancer cells. In association with increased expression of the tumor suppressor gene transforming growth factor beta receptor II (TGF beta RII) induced by the histone deacetylase inhibitor belinostat, we observed repressed survivin expression. We investigated the molecular mechanisms involved in survivin down-regulation by belinostat downstream of reactivation of TGF beta signaling. We identified two mechanisms. At early time points, survivin protein half-life was decreased with its proteasomal degradation. We observed that belinostat activated protein kinase A at early time points in a TGF beta signaling-dependent mechanism. After longer times (48 h), survivin mRNA was also decreased by belinostat. We made the novel observation that belinostat mediated cell death through the TGF beta/protein kinase A signaling pathway. Induction of TGF beta RII with concomitant survivin repression may represent a significant mechanism in the anticancer effects of this drug. Therefore, patient populations exhibiting high survivin expression with epigenetically silenced TGF beta RII might potentially benefit from the use of this histone deacetylase inhibitor.	[Chowdhury, Sanjib; Howell, Gillian M.; Teggart, Carol A.; Chowdhury, Aparajita; Person, Jonathan J.; Brattain, Michael G.] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA; [Bowers, Dawn M.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	University of Nebraska System; University of Nebraska Medical Center; Roswell Park Cancer Institute	Brattain, MG (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc, 987696 Nebraska Med Ctr, Omaha, NE 68198 USA.	mbrattain@unmc.edu			National Institutes of Health [CA72001, CA38173]; NATIONAL CANCER INSTITUTE [R37CA038173, R01CA038173, R01CA072001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA72001 and CA38173 (to M.G.B.).	Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Ammanamanchi S, 1998, J BIOL CHEM, V273, P16527, DOI 10.1074/jbc.273.26.16527; Ammanamanchi S, 2004, J BIOL CHEM, V279, P32620, DOI 10.1074/jbc.M402691200; Ammanamanchi S, 2003, J BIOL CHEM, V278, P35775, DOI 10.1074/jbc.M305961200; Ammanamanchi S, 2001, J BIOL CHEM, V276, P32854, DOI 10.1074/jbc.M103951200; Ammanamanchi S, 2001, J BIOL CHEM, V276, P3348, DOI 10.1074/jbc.M002462200; Arnold NB, 2007, CLIN CANCER RES, V13, P18, DOI 10.1158/1078-0432.CCR-06-0914; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Borczuk AC, 2005, AM J RESP CRIT CARE, V172, P729, DOI 10.1164/rccm.200504-615OC; Chiou SK, 2007, BIOCHEM PHARMACOL, V74, P1485, DOI 10.1016/j.bcp.2007.07.024; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Dowdy SC, 2006, MOL CANCER THER, V5, P2767, DOI 10.1158/1535-7163.MCT-06-0209; Fandy TE, 2005, NEOPLASIA, V7, P646, DOI 10.1593/neo.04655; Fotheringham S, 2009, CANCER CELL, V15, P57, DOI 10.1016/j.ccr.2008.12.001; Gobbi H, 2000, HISTOPATHOLOGY, V36, P168; Grady WM, 2005, BIOCHEM SOC T, V33, P684, DOI 10.1042/BST0330684; Heeres JT, 2007, CURR OPIN CHEM BIOL, V11, P644, DOI 10.1016/j.cbpa.2007.08.038; Heider U, 2008, EUR J HAEMATOL, V80, P133, DOI 10.1111/j.1600-0609.2007.00995.x; Hitomi T, 2003, FEBS LETT, V554, P347, DOI 10.1016/S0014-5793(03)01186-4; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; Jiang SJ, 2007, GYNECOL ONCOL, V105, P493, DOI 10.1016/j.ygyno.2007.01.012; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kang SH, 1999, ONCOGENE, V18, P7280, DOI 10.1038/sj.onc.1203146; Kim IY, 1996, CLIN CANCER RES, V2, P1255; Kleeff J, 2000, INT J CANCER, V86, P399, DOI 10.1002/(SICI)1097-0215(20000501)86:3<399::AID-IJC15>3.0.CO;2-G; Lehmann A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-395; Li FZ, 2005, ONCOGENE, V24, P1385, DOI 10.1038/sj.onc.1208330; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Marks PA, 2005, CELL CYCLE, V4, P549, DOI 10.4161/cc.4.4.1564; Matsushita M, 1999, BRIT J CANCER, V80, P194, DOI 10.1038/sj.bjc.6690339; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Monks A, 2009, ANTI-CANCER DRUG, V20, P682, DOI 10.1097/CAD.0b013e32832e14e1; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; Nawrocki ST, 2007, CANCER RES, V67, P6987, DOI 10.1158/0008-5472.CAN-07-0812; Okabe S, 2007, STEM CELLS DEV, V16, P503, DOI 10.1089/scd.2007.9994; Osada H, 2001, CANCER RES, V61, P8331; Park SH, 2002, J BIOL CHEM, V277, P5168, DOI 10.1074/jbc.M106451200; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; PEREIRA ME, 1990, ARCH BIOCHEM BIOPHYS, V283, P68, DOI 10.1016/0003-9861(90)90613-4; Periyasamy S, 2000, ONCOGENE, V19, P4660, DOI 10.1038/sj.onc.1203822; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; SUN LZ, 1994, J BIOL CHEM, V269, P26449; Taghiyev AF, 2006, CANCER BIOL THER, V5, P1199, DOI 10.4161/cbt.5.9.3168; Timmermann S, 2001, CELL MOL LIFE SCI, V58, P728, DOI 10.1007/PL00000896; Venkatasubbarao K, 2001, CANCER RES, V61, P6239; Wang J, 1996, J BIOL CHEM, V271, P17366, DOI 10.1074/jbc.271.29.17366; Wang J, 2004, J BIOL CHEM, V279, P40237, DOI 10.1074/jbc.M401665200; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Yamamoto S, 2008, ANTICANCER RES, V28, P1585; Yang J, 2008, ONCOGENE, V27, P5326, DOI 10.1038/onc.2008.165; Ye SC, 1999, CANCER RES, V59, P4725; Zhang FX, 2007, PHYSIOLOGY, V22, P373, DOI 10.1152/physiol.00026.2007; Zhang FX, 2007, J BIOL CHEM, V282, P22460, DOI 10.1074/jbc.M702439200; Zhang LZ, 2004, MOL CELL BIOL, V24, P2169, DOI 10.1128/MCB.24.5.2169-2180.2004; Zhao J, 2000, J CELL SCI, V113, P4363; Zhou YF, 2005, CANCER RES, V65, P5848, DOI 10.1158/0008-5472.CAN-04-3509; Zong C, 2006, CIRC RES, V99, P372, DOI 10.1161/01.RES.0000237389.40000.02	63	28	30	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30937	30948		10.1074/jbc.M110.212035	http://dx.doi.org/10.1074/jbc.M110.212035			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757750	Green Published, hybrid			2022-12-25	WOS:000294283600072
J	Purushothaman, A; Hurst, DR; Pisano, C; Mizumoto, S; Sugahara, K; Sanderson, RD				Purushothaman, Anurag; Hurst, Douglas R.; Pisano, Claudio; Mizumoto, Shuji; Sugahara, Kazuyuki; Sanderson, Ralph D.			Heparanase-mediated Loss of Nuclear Syndecan-1 Enhances Histone Acetyltransferase (HAT) Activity to Promote Expression of Genes That Drive an Aggressive Tumor Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-I ACTIVITY; FIBROBLAST-GROWTH-FACTOR; MULTIPLE-MYELOMA; SULFATE PROTEOGLYCANS; ACETYLATION; LOCALIZATION; CHROMATIN; METASTASIS; HEPARIN; CANCER	Heparanase acts as a master regulator of the aggressive tumor phenotype in part by enhancing expression of proteins known to drive tumor progression (e. g. VEGF, MMP-9, hepatocyte growth factor (HGF), and RANKL). However, the mechanism whereby this enzyme regulates gene expression remains unknown. We previously reported that elevation of heparanase levels in myeloma cells causes a dramatic reduction in the amount of syndecan-1 in the nucleus. Because syndecan-1 has heparan sulfate chains and because exogenous heparan sulfate has been shown to inhibit the activity of histone acetyltransferase (HAT) enzymes in vitro, we hypothesized that the reduction in nuclear syndecan-1 in cells expressing high levels of heparanase would result in increased HAT activity leading to stimulation of protein transcription. We found that myeloma cells or tumors expressing high levels of heparanase and low levels of nuclear syndecan-1 had significantly higher levels of HAT activity when compared with cells or tumors expressing low levels of heparanase. High levels of HAT activity in heparanase-high cells were blocked by SST0001, an inhibitor of heparanase. Restoration of high syndecan-1 levels in heparanase-high cells diminished nuclear HAT activity, establishing syndecan-1 as a potent inhibitor of HAT. Exposure of heparanase-high cells to anacardic acid, an inhibitor of HAT activity, significantly suppressed their expression of VEGF and MMP-9, two genes known to be up-regulated following elevation of heparanase. These results reveal a novel mechanistic pathway driven by heparanase expression, which leads to decreased nuclear syndecan-1, increased HAT activity, and up-regulation of transcription of multiple genes that drive an aggressive tumor phenotype.	[Hurst, Douglas R.; Sanderson, Ralph D.] Univ Alabama, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Purushothaman, Anurag; Hurst, Douglas R.; Sanderson, Ralph D.] Univ Alabama, Dept Pathol, Ctr Metab Bone Dis, Birmingham, AL 35294 USA; [Pisano, Claudio] Sigma Tau Ind Farmaceut Riunite SpA, I-00040 Pomezia, Italy; [Mizumoto, Shuji; Sugahara, Kazuyuki] Hokkaido Univ, Grad Sch Life Sci, Frontier Res Ctr Postgenom Sci & Technol, Lab Proteoglycan Signaling & Therapeut,Kita Ku, Sapporo, Hokkaido 0010021, Japan	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Hokkaido University	Sanderson, RD (corresponding author), 1530 3rd Ave S,SHEL 814, Birmingham, AL 35294 USA.	sanderson@uab.edu	Mizumoto, Shuji/F-8313-2018	Mizumoto, Shuji/0000-0002-4641-1505; pisano, claudio/0000-0001-8624-2980; Hurst, Douglas/0000-0002-1296-2210	National Institutes of Health [CA135075, CA138340]; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); NATIONAL CANCER INSTITUTE [R01CA138340, R01CA135075] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA135075 and CA138340 (to R. D. S.). This work was also supported by the Future Drug Discovery and Medical Care Innovation Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) (to K. S.). Dr. Claudio Pisano is an employee of sigma-tau Industrie Farmaceutiche Riunite S. p. A.; this company is developing SST0001 for clinical use.	Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Brockstedt U, 2002, EXP CELL RES, V274, P235, DOI 10.1006/excr.2002.5477; Buczek-Thomas JA, 2008, J CELL BIOCHEM, V105, P108, DOI 10.1002/jcb.21803; Chen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004947; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Dekker FJ, 2009, DRUG DISCOV TODAY, V14, P942, DOI 10.1016/j.drudis.2009.06.008; FEDARKO NS, 1986, J CELL BIOL, V102, P587, DOI 10.1083/jcb.102.2.587; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Hsia E, 2003, J CELL BIOCHEM, V88, P1214, DOI 10.1002/jcb.10470; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Isharwal S, 2008, PROSTATE, V68, P1097, DOI 10.1002/pros.20772; ISHIHARA M, 1986, J BIOL CHEM, V261, P3575; Kelly T, 2003, CANCER RES, V63, P8749; Kovalszky I, 1998, MOL CELL BIOCHEM, V183, P11, DOI 10.1023/A:1006898920637; LOIDL P, 1994, CHROMOSOMA, V103, P441; Mahlknecht U, 2000, MOL MED, V6, P623, DOI 10.1007/BF03402044; Mahtouk K, 2007, BLOOD, V109, P4914, DOI 10.1182/blood-2006-08-043232; Naggi A, 2005, J BIOL CHEM, V280, P12103, DOI 10.1074/jbc.M414217200; Nilsson U, 2010, CANCER RES, V70, P3771, DOI 10.1158/0008-5472.CAN-09-4331; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Ramani VC, 2011, J BIOL CHEM, V286, P6490, DOI 10.1074/jbc.M110.183277; Richardson TP, 2001, J CELL SCI, V114, P1613; Ritchie JP, 2011, CLIN CANCER RES, V17, P1382, DOI 10.1158/1078-0432.CCR-10-2476; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Schubert SY, 2004, LAB INVEST, V84, P535, DOI 10.1038/labinvest.3700084; Toth KF, 2004, J CELL SCI, V117, P4277, DOI 10.1242/jcs.01293; TURNER BM, 1995, SEMIN CELL BIOL, V6, P229, DOI 10.1006/scel.1995.0031; Vempati RK, 2010, J BIOL CHEM, V285, P28553, DOI 10.1074/jbc.M110.149393; VILLEPONTEAU B, 1992, BIOCHEM J, V288, P953, DOI 10.1042/bj2880953; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Watson K, 1999, J BIOL CHEM, V274, P21707, DOI 10.1074/jbc.274.31.21707; Yang Y, 2005, BLOOD, V105, P1303, DOI 10.1182/blood-200406-2141; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Yang Y, 2010, CANCER RES, V70, P8329, DOI 10.1158/0008-5472.CAN-10-2179; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zhang LX, 2010, MOL CANCER RES, V8, P278, DOI 10.1158/1541-7786.MCR-09-0375; Zong F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007346	42	88	94	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30377	30383		10.1074/jbc.M111.254789	http://dx.doi.org/10.1074/jbc.M111.254789			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757697	hybrid, Green Published			2022-12-25	WOS:000294283600015
J	Tsutsumi, K; Matsuda, M; Kotani, M; Mizokami, A; Murakami, A; Takahashi, I; Terada, Y; Kanematsu, T; Fukami, K; Takenawa, T; Jimi, E; Hirata, M				Tsutsumi, Koshiro; Matsuda, Miho; Kotani, Miho; Mizokami, Akiko; Murakami, Ayako; Takahashi, Ichiro; Terada, Yoshihiro; Kanematsu, Takashi; Fukami, Kiyoko; Takenawa, Tadaomi; Jimi, Eijiro; Hirata, Masato			Involvement of PRIP, Phospholipase C-related, but Catalytically Inactive Protein, in Bone Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INS(1,4,5)P-3 BINDING-PROTEIN; GABA(A) RECEPTOR; OSTEOBLAST DIFFERENTIATION; RAT-BRAIN; OSTEOCLAST DIFFERENTIATION; MORPHOGENETIC PROTEIN-2; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CELL-SURFACE; P130	PRIP (phospholipase C-related, but catalytically inactive protein) is a novel protein isolated in this laboratory. PRIP-deficient mice showed increased serum gonadotropins, but decreased gonadal steroid hormones. This imbalance was similar to that for the cause of bone disease, such as osteoporosis. In the present study, therefore, we analyzed mutant mice with special reference to the bone property. We first performed three-dimensional analysis of the femur of female mice. The bone mineral density and trabecular bone volume were higher in mutant mice. We further performed histomorphometrical assay of bone formation parameters: bone formation rate, mineral apposition rate, osteoid thickness, and osteoblast number were up-regulated in the mutant, indicating that increased bone mass is caused by the enhancement of bone formation ability. We then cultured primary cells isolated from calvaria prepared from both genotypes. In mutant mice, osteoblast differentiation, as assessed by alkaline phosphatase activity and the expression of osteoblast differentiation marker genes, was enhanced. Moreover, we analyzed the phosphorylation of Smad1/5/8 in response to bone morphogenetic protein, with longer phosphorylation in the mutant. These results indicate that PRIP is implicated in the negative regulation of bone formation.	[Tsutsumi, Koshiro; Matsuda, Miho; Kotani, Miho; Mizokami, Akiko; Kanematsu, Takashi; Hirata, Masato] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan; [Tsutsumi, Koshiro; Terada, Yoshihiro] Kyushu Univ, Fac Dent Sci, Div Fixed Prosthodont, Fukuoka 8128582, Japan; [Kotani, Miho; Murakami, Ayako; Takahashi, Ichiro] Kyushu Univ, Fac Dent Sci, Div Orthodont, Fukuoka 8128582, Japan; [Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignal, Tokyo 1920392, Japan; [Takenawa, Tadaomi] Kobe Univ, Grad Sch Med, Div Lipid Biochem, Kobe, Hyogo 6500017, Japan; [Jimi, Eijiro] Kyushu Dent Coll, Dept Mol Signaling & Biochem, Kitakyushu, Fukuoka 8038580, Japan	Kyushu University; Kyushu University; Kyushu University; Tokyo University of Pharmacy & Life Sciences; Kobe University; Kyushu Dental University	Hirata, M (corresponding author), Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan.	hirata1@dent.kyushu-u.ac.jp	Mizokami, Akiko/ABC-5448-2021; Mizokami, Akiko/AAY-2193-2020	Mizokami, Akiko/0000-0002-7490-5190	Ministry of Education, Culture, Science, Sports, and Technology of Japan; Kyushu University; Grants-in-Aid for Scientific Research [22659376] Funding Source: KAKEN	Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyushu University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Science, Sports, and Technology of Japan (to K. T., M. M., A. M., and M. H.), and by Kyushu University P&P program (to M. M.).	Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; Bengtsson L, 2009, J CELL SCI, V122, P1248, DOI 10.1242/jcs.039552; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Doira N, 2001, BIOMED RES-TOKYO, V22, P157, DOI 10.2220/biomedres.22.157; Fujii M, 2010, J BIOL CHEM, V285, P4837, DOI 10.1074/jbc.M109.070045; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Harada K, 2005, J CELL PHYSIOL, V202, P422, DOI 10.1002/jcp.20136; Hashiguchi D, 2011, J DENT RES, V90, P912, DOI 10.1177/0022034511407335; Hirata S, 2010, J CELL BIOCHEM, V111, P1445, DOI 10.1002/jcb.22872; Isogai Y, 1996, J BONE MINER RES, V11, P1384; Kanematsu T, 2005, MOL CELLS, V20, P305; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Kanematsu T, 2000, EUR J BIOCHEM, V267, P2731, DOI 10.1046/j.1432-1327.2000.01291.x; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; Kanematsu T, 2007, J NEUROCHEM, V101, P898, DOI 10.1111/j.1471-4159.2006.04399.x; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katagiri Takenobu, 2008, Clin Calcium, V18, P194, DOI CliCa0802194201; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; Lee J, 2006, BLOOD, V107, P2686, DOI 10.1182/blood-2005-07-2798; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lutter AH, 2010, J CELL BIOCHEM, V109, P1025, DOI 10.1002/jcb.22485; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Matsuda M, 1998, NEUROSCI LETT, V257, P97, DOI 10.1016/S0304-3940(98)00810-6; Matsuda M, 2009, BIOL REPROD, V81, P681, DOI 10.1095/biolreprod.109.076760; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Mizokami A, 2010, J NEUROCHEM, V114, P302, DOI 10.1111/j.1471-4159.2010.06754.x; Monfoulet L, 2010, CALCIFIED TISSUE INT, V86, P72, DOI 10.1007/s00223-009-9314-y; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Novack DV, 2011, AGEING RES REV, V10, P54, DOI 10.1016/j.arr.2009.09.005; Otsuki M, 1999, BIOCHEM BIOPH RES CO, V266, P97, DOI 10.1006/bbrc.1999.1784; Passeri G, 2008, EXP GERONTOL, V43, P79, DOI 10.1016/j.exger.2007.06.013; Richards JS, 2001, ENDOCRINOLOGY, V142, P2184, DOI 10.1210/en.142.6.2184; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; So H, 2003, J BIOL CHEM, V278, P24209, DOI 10.1074/jbc.M302940200; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takeuchi H, 2000, BIOCHEM J, V349, P357, DOI 10.1042/0264-6021:3490357; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Uji A, 2002, LIFE SCI, V72, P443, DOI 10.1016/S0024-3205(02)02275-0; Yamane H, 2009, BONE, V44, P1055, DOI 10.1016/j.bone.2008.05.010; Yamazaki M, 2009, J BIOL CHEM, V284, P35987, DOI 10.1074/jbc.M109.070540; Yanagihori S, 2006, ADV ENZYME REGUL, V46, P203, DOI 10.1016/j.advenzreg.2006.01.006; YOSHIDA M, 1994, J BIOCHEM, V115, P973, DOI 10.1093/oxfordjournals.jbchem.a124447; Yoshimura K, 2001, J BIOL CHEM, V276, P17908, DOI 10.1074/jbc.M009677200; Zhang FJ, 2009, J BONE MINER RES, V24, P1224, DOI [10.1359/JBMR.090204, 10.1359/jbmr.090204]	48	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					31032	31042		10.1074/jbc.M111.235903	http://dx.doi.org/10.1074/jbc.M111.235903			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757756	Green Published, hybrid			2022-12-25	WOS:000294283600081
J	Vu, TT; Stafford, AR; Leslie, BA; Kim, PY; Fredenburgh, JC; Weitz, JI				Vu, Trang T.; Stafford, Alan R.; Leslie, Beverly A.; Kim, Paul Y.; Fredenburgh, James C.; Weitz, Jeffrey I.			Histidine-rich Glycoprotein Binds Fibrin(ogen) with High Affinity and Competes with Thrombin for Binding to the gamma '-Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOT-BOUND THROMBIN; HUMAN-FIBRINOGEN; FACTOR-XIII; ZINC CONCENTRATIONS; PLASMA-PROTEIN; CELL-SURFACE; ALPHA; IDENTIFICATION; FIBRINOLYSIS; PLASMINOGEN	Histidine-rich glycoprotein (HRG) is an abundant protein that binds fibrinogen and other plasma proteins in a Zn2(+)-dependent fashion but whose function is unclear. HRG has antimicrobial activity, and its incorporation into fibrin clots facilitates bacterial entrapment and killing and promotes inflammation. Although these findings suggest that HRG contributes to innate immunity and inflammation, little is known about the HRG-fibrin(ogen) interaction. By immunoassay, HRG-fibrinogen complexes were detected in Zn2(+)-supplemented human plasma, a finding consistent with a high affinity interaction. Surface plasmon resonance determinations support this concept and show that in the presence of Zn2(+), HRG binds the predominant gamma(A)/gamma'-fibrinogen and the gamma-chain elongated isoform, gamma(A)/gamma'-fibrinogen, with K-d values of 9 nM. Likewise, I-125-labeled HRG binds gamma(A)/gamma(A)-or gamma(A)/gamma'-fibrin clots with similar K-d values when Zn2(+) is present. There are multiple HRG binding sites on fibrin(ogen) because HRG binds immobilized fibrinogen fragment D or E and gamma'-peptide, an analog of the COOH terminus of the gamma'-chain that mediates the high affinity interaction of thrombin with gamma(A)/gamma'-fibrin. Thrombin competes with HRG for gamma'-peptide binding and displaces I-125-HRG from gamma(A)/gamma'-fibrin clots and vice versa. Taken together, these data suggest that (a) HRG circulates in complex with fibrinogen and that the complex persists upon fibrin formation, and (b) by competing with thrombin for gamma(A)/gamma'-fibrin binding, HRG may modulate coagulation. Therefore, the HRG-fibrin interaction may provide a novel link between coagulation, innate immunity, and inflammation.	[Vu, Trang T.; Stafford, Alan R.; Leslie, Beverly A.; Kim, Paul Y.; Fredenburgh, James C.; Weitz, Jeffrey I.] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8L 2X2, Canada; [Vu, Trang T.; Weitz, Jeffrey I.] McMaster Univ, Dept Med Sci, Hamilton, ON L8L 2X2, Canada; [Stafford, Alan R.; Leslie, Beverly A.; Kim, Paul Y.; Fredenburgh, James C.; Weitz, Jeffrey I.] McMaster Univ, Dept Med, Hamilton, ON L8L 2X2, Canada	McMaster University; McMaster University; McMaster University	Weitz, JI (corresponding author), McMaster Univ, Thrombosis & Atherosclerosis Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	weitzj@taari.ca	Weitz, Jeffrey/AAD-1929-2019; Kim, Paul/GYV-3258-2022	Weitz, Jeffrey/0000-0002-1092-7550; Kim, Paul/0000-0003-0943-4924	Canadian Institutes of Health Research [MOP 3992, MOP 102735, CTP 79846]; Heart and Stroke Foundation of Ontario [T4792, T4730]; Heart and Stroke Foundation of Canada; Ontario Research and Development Challenge Fund; Heart and Stroke Foundation of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Ontario Research and Development Challenge Fund(General Electric); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported in part by the Canadian Institutes of Health Research (MOP 3992, MOP 102735, and CTP 79846), the Heart and Stroke Foundation of Ontario (T4792 and T4730), the Heart and Stroke Foundation of Canada (a Novel and Exploratory Research Fund grant), and the Ontario Research and Development Challenge Fund.; Supported by a Heart and Stroke Foundation of Ontario Graduate Student Award.	Borza DB, 1998, J BIOL CHEM, V273, P5493, DOI 10.1074/jbc.273.10.5493; Bosshart H, 2003, FEBS LETT, V553, P135, DOI 10.1016/S0014-5793(03)00997-9; CHUNG DW, 1984, BIOCHEMISTRY-US, V23, P4232, DOI 10.1021/bi00313a033; FOOTE JW, 1984, J CLIN PATHOL, V37, P1050, DOI 10.1136/jcp.37.9.1050; FORNACE AJ, 1984, J BIOL CHEM, V259, P2826; Fredenburgh JC, 2008, J BIOL CHEM, V283, P2470, DOI 10.1074/jbc.M707710200; Fredenburgh JC, 2001, J BIOL CHEM, V276, P44828, DOI 10.1074/jbc.M108710200; Gorgani NN, 1999, IMMUNOLOGY, V98, P456, DOI 10.1046/j.1365-2567.1999.00885.x; Guo F, 2009, BIOCHEM BIOPH RES CO, V390, P942, DOI 10.1016/j.bbrc.2009.10.082; HENSCHEN A, 1983, ANN NY ACAD SCI, V408, P28, DOI 10.1111/j.1749-6632.1983.tb23232.x; JACKMAN MP, 1992, J BIOL CHEM, V267, P15375; Jancso A, 2009, J INORG BIOCHEM, V103, P1634, DOI 10.1016/j.jinorgbio.2009.09.002; Jensen T, 2007, THROMB HAEMOSTASIS, V97, P822, DOI 10.1160/TH07-01-0039; Jones AL, 2005, IMMUNOL CELL BIOL, V83, P106, DOI 10.1111/j.1440-1711.2005.01320.x; Jones AL, 2004, J BIOL CHEM, V279, P38267, DOI 10.1074/jbc.M406027200; Jones AL, 2004, J BIOL CHEM, V279, P30114, DOI 10.1074/jbc.M401996200; KACZMAREK E, 1988, J BIOL CHEM, V263, P13896; Kretz CA, 2006, J BIOL CHEM, V281, P37477, DOI 10.1074/jbc.M607359200; KUMAR R, 1995, THROMB HAEMOSTASIS, V74, P962; LAKOMAA EL, 1982, TOXICOL APPL PHARM, V65, P286, DOI 10.1016/0041-008X(82)90011-4; Lamanna JC, 1996, ADV EXP MED BIOL, V388, P283; LEUNG LLK, 1986, J CLIN INVEST, V77, P1305, DOI 10.1172/JCI112435; LEUNG LLK, 1983, BLOOD, V62, P1016; LIJNEN HR, 1980, J BIOL CHEM, V255, P214; LIU LW, 1991, J BIOL CHEM, V266, P16977; Lorand L, 2001, ANN NY ACAD SCI, V936, P291; Lovely RS, 2010, CLIN CHEM, V56, P781, DOI 10.1373/clinchem.2009.138347; Lovely RS, 2003, J THROMB HAEMOST, V1, P124, DOI 10.1046/j.1538-7836.2003.00027.x; Lu PP, 2011, LIFE SCI, V88, P839, DOI 10.1016/j.lfs.2011.03.003; MacQuarrie JL, 2011, BLOOD, V117, P4134, DOI 10.1182/blood-2010-07-290551; MARDER VJ, 1969, J BIOL CHEM, V244, P2111; Maret W, 2004, J ANAL ATOM SPECTROM, V19, P15, DOI 10.1039/b307540k; MARX G, 1993, J CELL PHYSIOL, V156, P437, DOI 10.1002/jcp.1041560302; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; MORGAN WT, 1978, BIOCHIM BIOPHYS ACTA, V535, P319, DOI 10.1016/0005-2795(78)90098-3; Mutch NJ, 2001, THROMB HAEMOSTASIS, V86, P1028; NIKULA TK, 1995, MOL IMMUNOL, V32, P865, DOI 10.1016/0161-5890(95)00052-G; Olman MA, 1998, PROTEIN EXPRES PURIF, V14, P71, DOI 10.1006/prep.1998.0911; Petrera NS, 2009, J BIOL CHEM, V284, P25620, DOI 10.1074/jbc.M109.000042; Poon IKH, 2011, BLOOD, V117, P2093, DOI 10.1182/blood-2010-09-303842; Pospisil CH, 2003, J BIOL CHEM, V278, P21584, DOI 10.1074/jbc.M300545200; Rydengard V, 2006, FEBS J, V273, P2399, DOI 10.1111/j.1742-4658.2006.05246.x; Rydengard V, 2007, FEBS J, V274, P377, DOI 10.1111/j.1742-4658.2006.05586.x; Schaefer AVL, 2006, BIOCHEMISTRY-US, V45, P4257, DOI 10.1021/bi0525730; Shannon O, 2010, BLOOD, V116, P2365, DOI 10.1182/blood-2010-02-271858; Siebenlist KR, 1996, BIOCHEMISTRY-US, V35, P10448, DOI 10.1021/bi9606206; Stewart AJ, 2009, BIOCHIMIE, V91, P1518, DOI 10.1016/j.biochi.2009.08.002; Tsuchida-Straeten N, 2005, J THROMB HAEMOST, V3, P865, DOI 10.1111/j.1538-7836.2005.01238.x; TURCOTTE A, 1992, ANTIMICROB AGENTS CH, V36, P2211, DOI 10.1128/AAC.36.10.2211; van den Herik EG, 2011, THROMB HAEMOSTASIS, V105, P430, DOI 10.1160/TH10-09-0569; Weitz Jeffrey I, 2003, Cardiovasc Toxicol, V3, P13, DOI 10.1385/CT:3:1:13; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723; WOLFENSTEINTODEL C, 1981, BIOCHEMISTRY-US, V20, P6146, DOI 10.1021/bi00524a036	53	29	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30314	30323		10.1074/jbc.M111.253831	http://dx.doi.org/10.1074/jbc.M111.253831			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757718	Green Published, hybrid			2022-12-25	WOS:000294283600009
J	Wohlschlager, T; Butschi, A; Zurfluh, K; Vonesch, SC; Keller, UAD; Gehrig, P; Bleuler-Martinez, S; Hengartner, MO; Aebi, M; Kunzler, M				Wohlschlager, Therese; Butschi, Alex; Zurfluh, Katrin; Vonesch, Sibylle C.; Keller, Ulrich Auf Dem; Gehrig, Peter; Bleuler-Martinez, Silvia; Hengartner, Michael O.; Aebi, Markus; Kuenzler, Markus			Nematotoxicity of Marasmius oreades Agglutinin (MOA) Depends on Glycolipid Binding and Cysteine Protease Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSHROOM POLYPORUS-SQUAMOSUS; NEMATODE CAENORHABDITIS-ELEGANS; HIGH-AFFINITY LECTIN; ENDOPLASMIC-RETICULUM; PERITROPHIC MATRIX; FRUITING BODY; RESISTANCE; TOXIN; GAL-ALPHA-1,3GAL; IDENTIFICATION	Fruiting body lectins have been proposed to act as effector proteins in the defense of fungi against parasites and predators. The Marasmius oreades agglutinin (MOA) is a Gal alpha 1,3Gal/GalNAc-specific lectin from the fairy ring mushroom that consists of an N-terminal ricin B-type lectin domain and a C-terminal dimerization domain. The latter domain shows structural similarity to catalytically active proteins, suggesting that, in addition to its carbohydrate-binding activity, MOA has an enzymatic function. Here, we demonstrate toxicity of MOA toward the model nematode Caenorhabditis elegans. This toxicity depends on binding of MOA to glycosphingolipids of the worm via its lectin domain. We show further that MOA has cysteine protease activity and demonstrate a critical role of this catalytic function in MOA-mediated nematotoxicity. The proteolytic activity of MOA was dependent on high Ca2+ concentrations and favored by slightly alkaline pH, suggesting that these conditions trigger activation of the toxin at the target location. Our results suggest that MOA is a fungal toxin with intriguing similarities to bacterial binary toxins and has a protective function against fungivorous soil nematodes.	[Wohlschlager, Therese; Zurfluh, Katrin; Bleuler-Martinez, Silvia; Aebi, Markus; Kuenzler, Markus] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Keller, Ulrich Auf Dem] ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Butschi, Alex; Vonesch, Sibylle C.; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Gehrig, Peter] Univ Zurich, Funct Genom Ctr, CH-8057 Zurich, Switzerland; [Gehrig, Peter] ETH, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Kunzler, M (corresponding author), ETH, Inst Microbiol, Wolfgang Pauli Str 10,HCI F413, CH-8093 Zurich, Switzerland.	markus.kuenzler@micro.biol.ethz.ch	Keller, Ulrich auf dem/G-6004-2012; Hengartner, Michael O/E-6235-2011; Wohlschlager, Therese/G-4622-2016; Keller, Ulrich auf dem/X-2710-2019	Keller, Ulrich auf dem/0000-0002-3431-7415; Wohlschlager, Therese/0000-0001-9359-6744; Keller, Ulrich auf dem/0000-0002-3431-7415; Zurfluh, Katrin/0000-0002-8760-4768; Vonesch, Sibylle/0000-0003-2485-1048; Kunzler, Markus/0000-0003-1275-0629; Hengartner, Michael/0000-0002-7584-596X	European Commission; Swiss National Science Foundation [31003A-130671]; ETH Zurich	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	This work was supported by the European Commission Marie Curie Program (EuroGlycoArrays ITN), Swiss National Science Foundation Grant 31003A-130671 (to M. K., M.O.H., and M. A.), and ETH Zurich.	Barrows BD, 2006, METHOD ENZYMOL, V417, P340, DOI 10.1016/S0076-6879(06)17021-4; Barrows BD, 2007, J INVERTEBR PATHOL, V95, P198, DOI 10.1016/j.jip.2007.04.002; Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Bleuler-Martinez S, 2011, MOL ECOL, V20, P3056, DOI 10.1111/j.1365-294X.2011.05093.x; Butschi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000717; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Gerdt S, 1999, EUR J BIOCHEM, V266, P952, DOI 10.1046/j.1432-1327.1999.00937.x; Goldstein I. J., 2007, MUSHROOM LECTINS; Grahn E, 2007, J MOL BIOL, V369, P710, DOI 10.1016/j.jmb.2007.03.016; Grahn EM, 2009, J MOL BIOL, V390, P457, DOI 10.1016/j.jmb.2009.04.074; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; HALACHMI D, 1989, FEBS LETT, V256, P55, DOI 10.1016/0014-5793(89)81717-X; Hamshou M, 2010, INSECT BIOCHEM MOLEC, V40, P883, DOI 10.1016/j.ibmb.2010.08.008; Ideo H, 2009, J BIOL CHEM, V284, P26493, DOI 10.1074/jbc.M109.038257; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Kruger RP, 2002, J BIOL CHEM, V277, P15002, DOI 10.1074/jbc.M200165200; Kunzler M, 2010, METHOD ENZYMOL, V480, P141, DOI 10.1016/S0076-6879(10)80007-2; Lencer WI, 2005, BBA-MOL CELL RES, V1746, P314, DOI 10.1016/j.bbamcr.2005.07.007; Marroquin LD, 2000, GENETICS, V155, P1693; McGhee James D, 2007, WormBook, P1; Mo HQ, 2000, J BIOL CHEM, V275, P10623, DOI 10.1074/jbc.275.14.10623; Mohan S, 2006, J INSECT PHYSIOL, V52, P21, DOI 10.1016/j.jinsphys.2005.08.011; Mohan S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001786; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Ong DST, 2010, NAT CHEM BIOL, V6, P424, DOI 10.1038/nchembio.368; Pechan T, 2000, PLANT CELL, V12, P1031, DOI 10.1105/tpc.12.7.1031; Pechan T, 2002, P NATL ACAD SCI USA, V99, P13319, DOI 10.1073/pnas.202224899; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Suzuki T, 2005, METHODS, V35, P360, DOI 10.1016/j.ymeth.2004.10.008; Tateno H, 2004, BIOCHEM J, V382, P667, DOI 10.1042/BJ20040391; Tateno H, 2004, ARCH BIOCHEM BIOPHYS, V427, P101, DOI 10.1016/j.abb.2004.04.013; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Trigueros V, 2003, BBA-GEN SUBJECTS, V1621, P292, DOI 10.1016/S0304-4165(03)00098-9; van der Hoorn RAL, 2004, CURR OPIN PLANT BIOL, V7, P400, DOI 10.1016/j.pbi.2004.04.003; Varki A., 2009, ESSENTIALS GLYCOBIOL, P37; Warner RL, 2004, EXP MOL PATHOL, V77, P77, DOI 10.1016/j.yexmp.2004.04.003; Winter HC, 2002, J BIOL CHEM, V277, P14996, DOI 10.1074/jbc.M200161200; Zhang BY, 2001, GLYCOBIOLOGY, V11, P141, DOI 10.1093/glycob/11.2.141	39	33	33	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30337	30343		10.1074/jbc.M111.258202	http://dx.doi.org/10.1074/jbc.M111.258202			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757752	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000294283600011
J	Fussbroich, B; Wagener, N; Macher-Goeppinger, S; Benner, A; Falth, M; Sultmann, H; Holzer, A; Hoppe-Seyler, K; Hoppe-Seyler, F				Fussbroich, Bettina; Wagener, Nina; Macher-Goeppinger, Stephan; Benner, Axel; Faelth, Maria; Sueltmann, Holger; Holzer, Angela; Hoppe-Seyler, Karin; Hoppe-Seyler, Felix			EZH2 Depletion Blocks the Proliferation of Colon Cancer Cells	PLOS ONE			English	Article							METHYLTRANSFERASE GENE EZH2; HISTONE METHYLTRANSFERASE; COLORECTAL-CANCER; ENHANCER-OF-ZESTE-HOMOLOG-2 GENE; SOMATIC MUTATIONS; BREAST-CANCER; EXPRESSION; INVASION; DIFFERENTIATION; METHYLATION	The Enhancer of Zeste 2 (EZH2) protein has been reported to stimulate cell growth in some cancers and is therefore considered to represent an interesting new target for therapeutic intervention. Here, we investigated a possible role of EZH2 for the growth control of colon cancer cells. RNA interference (RNAi) mediated intracellular EZH2 depletion led to cell cycle arrest of colon carcinoma cells at the G1/S transition. This was associated with a reduction of cell numbers upon transient transfection of synthetic EZH2-targeting siRNAs and with inhibition of their colony formation capacity upon stable expression of vector-borne siRNAs. We furthermore tested whether EZH2 may repress the growth-inhibitory p27 gene, as reported for pancreatic cancer. However, expression analyses of colon cancer cell lines and colon cancer biopsies did not reveal a consistent correlation between EZH2 and p27 levels. Moreover, EZH2 depletion did not re-induce p27 expression in colon cancer cells, indicating that p27 repression by EZH2 may be cell- or tissue-specific. Whole genome transcriptome analyses identified cellular genes affected by EZH2 depletion in colon cancer cell lines. They included several cancer-associated genes linked to cellular proliferation or invasion, such as Dag1, MageD1, SDC1, Timp2, and Tob1. In conclusion, our results demonstrate that EZH2 depletion blocks the growth of colon cancer cells. These findings might provide benefits for the treatment of colon cancer.	[Fussbroich, Bettina; Wagener, Nina; Holzer, Angela; Hoppe-Seyler, Karin; Hoppe-Seyler, Felix] German Canc Res Ctr, Heidelberg, Germany; [Wagener, Nina] Heidelberg Univ, Dept Urol, D-6900 Heidelberg, Germany; [Macher-Goeppinger, Stephan] Heidelberg Univ, Inst Pathol, D-6900 Heidelberg, Germany; [Benner, Axel] German Canc Res Ctr, Div Biostat, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Fussbroich, B (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	hoppe-seyler@dkfz.de	Sültmann, Holger/E-4534-2013	Sültmann, Holger/0000-0002-5257-8600; Hoppe-Seyler, Felix/0000-0002-1864-300X				[Anonymous], 2010, GLOBOCAN 2008 CANC I; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894; BUTZ K, 1995, ONCOGENE, V10, P927; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Crnkovic-Mertens I, 2006, LUNG CANCER, V54, P135, DOI 10.1016/j.lungcan.2006.07.018; Cullmann C, 2009, INT J CANCER, V125, P2014, DOI 10.1002/ijc.24671; Du Q, 2009, ONCOL REP, V22, P659, DOI 10.3892/or_00000486; Dukers DF, 2004, AM J PATHOL, V164, P873, DOI 10.1016/S0002-9440(10)63175-6; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Fluge O, 2009, BRIT J CANCER, V101, P1282, DOI 10.1038/sj.bjc.6605333; FOX MH, 1980, CYTOMETRY, V1, P71, DOI 10.1002/cyto.990010114; Fujita T, 2008, AM J PATHOL, V173, P217, DOI 10.2353/ajpath.2008.070957; Holland D, 2008, CANCER RES, V68, P9964, DOI 10.1158/0008-5472.CAN-08-1134; JABBAR SAB, 1989, BRIT J CANCER, V60, P523, DOI 10.1038/bjc.1989.306; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kodach LL, 2010, CARCINOGENESIS, V31, P1567, DOI 10.1093/carcin/bgq147; LIEBERSBACH BF, 1994, J BIOL CHEM, V269, P20013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Martinez-Garcia E, 2010, NAT GENET, V42, P100, DOI 10.1038/ng0210-100; Mimori K, 2005, EJSO-EUR J SURG ONC, V31, P376, DOI 10.1016/j.ejso.2004.11.001; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Ougolkov AV, 2008, CLIN CANCER RES, V14, P6790, DOI 10.1158/1078-0432.CCR-08-1013; Palmqvist R, 1999, J PATHOL, V188, P18, DOI 10.1002/(SICI)1096-9896(199905)188:1<18::AID-PATH311>3.0.CO;2-T; Parsons BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008471; Peng LR, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-110; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; PETTY RD, 1995, J BIOLUM CHEMILUM, V10, P29, DOI 10.1002/bio.1170100105; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Rao ZY, 2010, CARCINOGENESIS, V31, P1576, DOI 10.1093/carcin/bgq150; Schneider G, 2006, EMBO J, V25, P3801, DOI 10.1038/sj.emboj.7601259; Sgambato A, 2003, AM J PATHOL, V162, P849, DOI 10.1016/S0002-9440(10)63881-3; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Sudo T, 2005, BRIT J CANCER, V92, P1754, DOI 10.1038/sj.bjc.6602531; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tukey JW, 1977, EXPLORATORY DATA ANA; Tuma RS, 2009, J NATL CANCER I, V101, P1300, DOI 10.1093/jnci/djp342; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wagener N, 2008, INT J CANCER, V123, P1545, DOI 10.1002/ijc.23683; Wang CG, 2010, WORLD J GASTROENTERO, V16, P2421, DOI 10.3748/wjg.v16.i19.2421; Wang PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010202; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162	57	88	95	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21651	10.1371/journal.pone.0021651	http://dx.doi.org/10.1371/journal.pone.0021651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765901	Green Published, gold, Green Submitted			2022-12-25	WOS:000292781500007
J	Shiao, YH; Leighty, RM; Wang, CJ; Ge, X; Crawford, EB; Spurrier, JM; McCann, SD; Fields, JR; Fornwald, L; Riffle, L; Driver, C; Quinones, OA; Wilson, RE; Kasprzak, KS; Travlos, GS; Alvord, WG; Anderson, LM				Shiao, Yih-Horng; Leighty, Robert M.; Wang, Cuiju; Ge, Xin; Crawford, Erik B.; Spurrier, Joshua M.; McCann, Sean D.; Fields, Janet R.; Fornwald, Laura; Riffle, Lisa; Driver, Craig; Quinones, Octavio A.; Wilson, Ralph E.; Kasprzak, Kazimierz S.; Travlos, Gregory S.; Alvord, W. Gregory; Anderson, Lucy M.			Ontogeny-Driven rDNA Rearrangement, Methylation, and Transcription, and Paternal Influence	PLOS ONE			English	Article							RNA-POLYMERASE-I; RIBOSOMAL-RNA; EPIGENETIC INHERITANCE; GENE-EXPRESSION; EVOLUTION; MICE; MECHANISMS; COMPONENT; PROMOTER; DISEASE	Gene rearrangement occurs during development in some cell types and this genome dynamics is modulated by intrinsic and extrinsic factors, including growth stimulants and nutrients. This raises a possibility that such structural change in the genome and its subsequent epigenetic modifications may also take place during mammalian ontogeny, a process undergoing finely orchestrated cell division and differentiation. We tested this hypothesis by comparing single nucleotide polymorphism-defined haplotype frequencies and DNA methylation of the rDNA multicopy gene between two mouse ontogenic stages and among three adult tissues of individual mice. Possible influences to the genetic and epigenetic dynamics by paternal exposures were also examined for Cr(III) and acid saline extrinsic factors. Variables derived from litters, individuals, and duplicate assays in large mouse populations were examined using linear mixed-effects model. We report here that active rDNA rearrangement, represented by changes of haplotype frequencies, arises during ontogenic progression from day 8 embryos to 6-week adult mice as well as in different tissue lineages and is modifiable by paternal exposures. The rDNA methylation levels were also altered in concordance with this ontogenic progression and were associated with rDNA haplotypes. Sperm showed highest level of methylation, followed by lungs and livers, and preferentially selected haplotypes that are positively associated with methylation. Livers, maintaining lower levels of rDNA methylation compared with lungs, expressed more rRNA transcript. In vitro transcription demonstrated haplotype-dependent rRNA expression. Thus, the genome is also dynamic during mammalian ontogeny and its rearrangement may trigger epigenetic changes and subsequent transcriptional controls, that are further influenced by paternal exposures.	[Shiao, Yih-Horng; Wang, Cuiju; Crawford, Erik B.; Spurrier, Joshua M.; McCann, Sean D.; Fields, Janet R.; Kasprzak, Kazimierz S.; Anderson, Lucy M.] NCI, Comparat Carcinogenesis Lab, Frederick, MD 21701 USA; [Leighty, Robert M.; Quinones, Octavio A.; Alvord, W. Gregory] Data Management Serv Inc, Frederick, MD USA; [Ge, Xin; Fornwald, Laura; Riffle, Lisa; Driver, Craig] Sci Applicat Int Corp Frederick, Frederick, MD USA; [Wilson, Ralph E.; Travlos, Gregory S.] NIEHS, Natl Toxicol Program, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Shiao, YH (corresponding author), NCI, Comparat Carcinogenesis Lab, Frederick, MD 21701 USA.	shiaoy@mail.nih.gov	Shiao, Yih-Horng/ABC-7262-2021	Spurrier, Joshua/0000-0002-6267-7231; Shiao, Yih-Horng/0000-0001-9841-7784	NIH, National Cancer Institute, Center for Cancer Research; National Cancer Institute, National Institutes of Health [HHSN261200800001E]	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. This project was also funded in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahmadian A, 2006, CLIN CHIM ACTA, V363, P83, DOI 10.1016/j.cccn.2005.04.038; Badyaev AV, 2005, P ROY SOC B-BIOL SCI, V272, P877, DOI 10.1098/rspb.2004.3045; BORST P, 1987, SCIENCE, V235, P658, DOI 10.1126/science.3544215; BOSTOCK C J, 1984, Journal of Embryology and Experimental Morphology, V83, P7; CATTANACH BM, 1995, INT J RADIAT BIOL, V67, P607, DOI 10.1080/09553009514550721; Cheng RYS, 2004, MOL CARCINOGEN, V40, P1, DOI 10.1002/mc.20022; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Fichelson P, 2009, NAT CELL BIOL, V11, P685, DOI 10.1038/ncb1874; Gagnon-Kugler T, 2009, MOL CELL, V35, P414, DOI 10.1016/j.molcel.2009.07.008; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; Honda K, 2005, J BIOL CHEM, V280, P20978, DOI 10.1074/jbc.M500526200; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; KUHN A, 1990, P NATL ACAD SCI USA, V87, P7527, DOI 10.1073/pnas.87.19.7527; Laferte A, 2006, GENE DEV, V20, P2030, DOI 10.1101/gad.386106; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; MERTZ W, 1993, J NUTR, V123, P626, DOI 10.1093/jn/123.4.626; Milliken GA, 1992, ANAL MESSY DATA, V1; Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106; Parlato R, 2008, J NEUROSCI, V28, P12759, DOI 10.1523/JNEUROSCI.2439-08.2008; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Shiao YH, 2005, TOXICOL APPL PHARM, V205, P290, DOI 10.1016/j.taap.2004.10.017; SHIAO YH, 2010, MINGCHUAN HLTH TECH, V1, pE2; Shiao YH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007505; Shiratori M, 2002, ONCOGENE, V21, P2447, DOI 10.1038/sj.onc.1205334; Stults DM, 2008, GENOME RES, V18, P13, DOI 10.1101/gr.6858507; Tjiong HL, 2009, PERITON DIALYSIS INT, V29, P384; White RJ, 2008, TRENDS GENET, V24, P622, DOI 10.1016/j.tig.2008.10.003; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Yu W, 1999, TOXICOL APPL PHARM, V158, P161, DOI 10.1006/taap.1999.8692	35	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22266	10.1371/journal.pone.0022266	http://dx.doi.org/10.1371/journal.pone.0022266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765958	gold, Green Submitted, Green Published			2022-12-25	WOS:000292699000034
J	Hoffmann, M; Kuska, JP; Zscharnack, M; Loeffler, M; Galle, J				Hoffmann, Martin; Kuska, Jens-Peer; Zscharnack, Matthias; Loeffler, Markus; Galle, Joerg			Spatial Organization of Mesenchymal Stem Cells In Vitro-Results from a New Individual Cell-Based Model with Podia	PLOS ONE			English	Article							HUMAN BONE-MARROW; MULTICELLULAR SYSTEMS; DIRECTIONAL CONTROL; OXYGEN-TENSION; STROMAL CELLS; MIAMI CELLS; DYNAMICS; GROWTH; DIFFERENTIATION; MIGRATION	Therapeutic application of mesenchymal stem cells (MSC) requires their extensive in vitro expansion. MSC in culture typically grow to confluence within a few weeks. They show spindle-shaped fibroblastoid morphology and align to each other in characteristic spatial patterns at high cell density. We present an individual cell-based model (IBM) that is able to quantitatively describe the spatio-temporal organization of MSC in culture. Our model substantially improves on previous models by explicitly representing cell podia and their dynamics. It employs podia-generated forces for cell movement and adjusts cell behavior in response to cell density. At the same time, it is simple enough to simulate thousands of cells with reasonable computational effort. Experimental sheep MSC cultures were monitored under standard conditions. Automated image analysis was used to determine the location and orientation of individual cells. Our simulations quantitatively reproduced the observed growth dynamics and cell-cell alignment assuming cell density-dependent proliferation, migration, and morphology. In addition to cell growth on plain substrates our model captured cell alignment on micro-structured surfaces. We propose a specific surface micro-structure that according to our simulations can substantially enlarge cell culture harvest. The 'tool box' of cell migratory behavior newly introduced in this study significantly enhances the bandwidth of IBM. Our approach is capable of accommodating individual cell behavior and collective cell dynamics of a variety of cell types and tissues in computational systems biology.	[Hoffmann, Martin] Maastricht Univ, Dept Knowledge Engn, Biomath & Bioinformat Grp, Maastricht, Netherlands; [Hoffmann, Martin; Kuska, Jens-Peer; Galle, Joerg] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Leipzig, Germany; [Zscharnack, Matthias] Univ Leipzig, Ctr Biotechnol & Biomed, Leipzig, Germany; [Loeffler, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany	Maastricht University; Leipzig University; Leipzig University; Leipzig University	Hoffmann, M (corresponding author), Maastricht Univ, Dept Knowledge Engn, Biomath & Bioinformat Grp, Maastricht, Netherlands.	martin.hoffmann@maastrichtuniversity.nl			German Research Foundation (DFG), IZBI [AU 132/3-1]; Federal Ministry of Education and Research of Germany [0313836]; DFG [BIZ-6 1/1]	German Research Foundation (DFG), IZBI(German Research Foundation (DFG)); Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	This study was supported by a joint grant from the German Research Foundation (DFG, http://www.dfg.de/en/index.jsp; AU 132/3-1, IZBI). MH, JPK and MZ were supported by the Federal Ministry of Education and Research of Germany (http://www.bmbf.de/en/index.php) through grant 0313836 (MS CartPro). JG was supported by DFG-grant BIZ-6 1/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakel N, 2009, EXP HEMATOL, V37, P504, DOI 10.1016/j.exphem.2008.12.005; Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Ball SG, 2007, J CELL MOL MED, V11, P1012, DOI 10.1111/j.1582-4934.2007.00120.x; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Benoit M, 2002, CELLS TISSUES ORGANS, V172, P174, DOI 10.1159/000066964; Beysens DA, 2000, P NATL ACAD SCI USA, V97, P9467, DOI 10.1073/pnas.97.17.9467; Block M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.248101; Byrne H, 2009, J MATH BIOL, V58, P657, DOI 10.1007/s00285-008-0212-0; Cai AQ, 2007, J THEOR BIOL, V245, P576, DOI 10.1016/j.jtbi.2006.10.024; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Chen CW, 2009, CYTOKINE GROWTH F R, V20, P429, DOI 10.1016/j.cytogfr.2009.10.014; Chen FH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2514; Cho HJ, 2007, PLOS BIOL, V5, P2614, DOI 10.1371/journal.pbio.0050302; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; D'Ippolito G, 2006, BONE, V39, P513, DOI 10.1016/j.bone.2006.02.061; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Dieterich P, 2008, P NATL ACAD SCI USA, V105, P459, DOI 10.1073/pnas.0707603105; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2009, SCIENCE, V324, P208, DOI 10.1126/science.1170107; Freyman TM, 2002, EXP CELL RES, V272, P153, DOI 10.1006/excr.2001.5408; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Galle J, 2005, BIOPHYS J, V88, P62, DOI 10.1529/biophysj.104.041459; Galle J, 2009, J MATH BIOL, V58, P261, DOI 10.1007/s00285-008-0172-4; Galle J, 2006, CYTOM PART A, V69A, P704, DOI 10.1002/cyto.a.20287; Guck J, 2001, BIOPHYS J, V81, P767, DOI 10.1016/S0006-3495(01)75740-2; Hastings A, 2011, BIOL LETTERS, V7, P163, DOI 10.1098/rsbl.2010.0948; Heng BC, 2004, STEM CELLS, V22, P1152, DOI 10.1634/stemcells.2004-0062; Hoehme S, 2010, BIOINFORMATICS, V26, P2641, DOI 10.1093/bioinformatics/btq437; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; Huang NF, 2008, REGEN MED, V3, P877, DOI 10.2217/17460751.3.6.877; Insall RH, 2010, NAT REV MOL CELL BIO, V11, P453, DOI 10.1038/nrm2905; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Kipper MJ, 2007, BIOPHYS J, V93, P1797, DOI 10.1529/biophysj.106.096800; Krinner A, 2009, CELL PROLIFERAT, V42, P471, DOI 10.1111/j.1365-2184.2009.00621.x; Krinner A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-73; Lan YH, 2008, BIOPHYS J, V94, P3839, DOI 10.1529/biophysj.107.123778; LANGE S, 2010, CELLULAR THERAPY TRA, V1, DOI DOI 10.3205/CTT-2010-EN-000051.000001; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Levine H, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.017101; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Mahaffy RE, 2000, PHYS REV LETT, V85, P880, DOI 10.1103/PhysRevLett.85.880; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Mancuso L, 2009, CELL PROLIFERAT, V42, P602, DOI 10.1111/j.1365-2184.2009.00626.x; Maree AFM, 2006, B MATH BIOL, V68, P1169, DOI 10.1007/s11538-006-9131-7; Mata A, 2007, INT J NANOMED, V2, P389; MERCURIEVA AA, 1992, MAKROMOL CHEM-THEOR, V1, P205; Merks RMH, 2006, NONLINEARITY, V19, pC1, DOI 10.1088/0951-7715/19/1/000; Merks RMH, 2006, DEV BIOL, V289, P44, DOI 10.1016/j.ydbio.2005.10.003; Merks RMH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000163; Meyer-Hermann M, 2009, TRENDS IMMUNOL, V30, P157, DOI 10.1016/j.it.2009.01.005; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Narayan V, 2007, SCIENCE, V317, P105, DOI 10.1126/science.1140414; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Newman TJ, 2008, CURR TOP DEV BIOL, V81, P157, DOI 10.1016/S0070-2153(07)81005-2; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106; Palomo LF, 1996, CELL IMMUNOL, V172, P43, DOI 10.1006/cimm.1996.0213; Palsson E, 2000, P NATL ACAD SCI USA, V97, P10448, DOI 10.1073/pnas.97.19.10448; Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Rappel WJ, 1999, PHYS REV LETT, V83, P1247, DOI 10.1103/PhysRevLett.83.1247; Ricci JL, 2008, J BIOMED MATER RES A, V85A, P313, DOI 10.1002/jbm.a.31379; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; SANDERSIUS SA, 2011, EMERGENT CELL TISSUE; Sandersius SA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015002; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Schaller G, 2007, J THEOR BIOL, V247, P554, DOI 10.1016/j.jtbi.2007.03.023; Simha RA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.058101; Sorrentino A, 2008, EXP HEMATOL, V36, P1035, DOI 10.1016/j.exphem.2008.03.004; Starruss J, 2007, J STAT PHYS, V128, P269, DOI 10.1007/s10955-007-9298-9; Stephanou A, 2008, J THEOR BIOL, V253, P701, DOI 10.1016/j.jtbi.2008.04.035; Stockholm D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014441; Suva D, 2004, J CELL PHYSIOL, V198, P110, DOI 10.1002/jcp.10396; Szabo B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.061908; Tamulonis C, 2011, DEV BIOL, V351, P217, DOI 10.1016/j.ydbio.2010.10.017; Toner J, 2005, ANN PHYS-NEW YORK, V318, P170, DOI 10.1016/j.aop.2005.04.011; Tosin A, 2006, B MATH BIOL, V68, P1819, DOI 10.1007/s11538-006-9071-2; VICSEK T, 2010, ARXIV10105017V1CONDM; Volfson D, 2008, P NATL ACAD SCI USA, V105, P15346, DOI 10.1073/pnas.0706805105; Wu YL, 2007, PLOS COMPUT BIOL, V3, P2546, DOI 10.1371/journal.pcbi.0030253; Xia N, 2008, FASEB J, V22, P1649, DOI 10.1096/fj.07-090571; Xu CY, 1997, LECT NOTES COMPUT SC, V1230, P399; Zhang HP, 2010, P NATL ACAD SCI USA, V107, P13626, DOI 10.1073/pnas.1001651107; Zhuravlev PI, 2009, P NATL ACAD SCI USA, V106, P11570, DOI 10.1073/pnas.0812746106; Zscharnack M, 2009, CELLS TISSUES ORGANS, V190, P81, DOI 10.1159/000178024; Zscharnack M, 2010, AM J SPORT MED, V38, P1857, DOI 10.1177/0363546510365296	95	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21960	10.1371/journal.pone.0021960	http://dx.doi.org/10.1371/journal.pone.0021960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760935	Green Published, gold, Green Submitted			2022-12-25	WOS:000292657200037
J	Pendt, LK; Reuter, I; Muller, H				Pendt, Lisa Katharina; Reuter, Iris; Mueller, Hermann			Motor Skill Learning, Retention, and Control Deficits in Parkinson's Disease	PLOS ONE			English	Article							BASAL GANGLIA; PRISM ADAPTATION; STRIATUM; CORTEX; TASK; VARIABILITY; MEMORY; DEGENERATION; PERFORMANCE; REFINEMENT	Parkinson's disease, which affects the basal ganglia, is known to lead to various impairments of motor control. Since the basal ganglia have also been shown to be involved in learning processes, motor learning has frequently been investigated in this group of patients. However, results are still inconsistent, mainly due to skill levels and time scales of testing. To bridge across the time scale problem, the present study examined de novo skill learning over a long series of practice sessions that comprised early and late learning stages as well as retention. 19 non-demented, medicated, mild to moderate patients with Parkinson's disease and 19 healthy age and gender matched participants practiced a novel throwing task over five days in a virtual environment where timing of release was a critical element. Six patients and seven control participants came to an additional long-term retention testing after seven to nine months. Changes in task performance were analyzed by a method that differentiates between three components of motor learning prominent in different stages of learning: Tolerance, Noise and Covariation. In addition, kinematic analysis related the influence of skill levels as affected by the specific motor control deficits in Parkinson patients to the process of learning. As a result, patients showed similar learning in early and late stages compared to the control subjects. Differences occurred in short-term retention tests; patients' performance constantly decreased after breaks arising from poorer release timing. However, patients were able to overcome the initial timing problems within the course of each practice session and could further improve their throwing performance. Thus, results demonstrate the intact ability to learn a novel motor skill in non-demented, medicated patients with Parkinson's disease and indicate confounding effects of motor control deficits on retention performance.	[Pendt, Lisa Katharina; Mueller, Hermann] Univ Giessen, Dept Psychol & Sport Sci, Giessen, Germany; [Reuter, Iris] Univ Giessen, Dept Neurol, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Pendt, LK (corresponding author), Univ Giessen, Dept Psychol & Sport Sci, Giessen, Germany.	lisa.k.pendt@sport.uni-giessen.de			German Research Foundation (DFG) [MU 1374/3-1]; German National Academic Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); German National Academic Foundation	This work was supported by grants from the German Research Foundation (DFG, http://www.dfg.de/en/index.jsp) [MU 1374/3-1] and the German National Academic Foundation (Studienstiftung des deutschen Volkes, http://www.studienstiftung.de/en/start.html) [to L.K.P.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino R, 1996, J NEUROL SCI, V139, P218; Agostino R, 2004, MOVEMENT DISORD, V19, P1285, DOI 10.1002/mds.20247; Behrman AL, 2000, J NEUROL SCI, V174, P127, DOI 10.1016/S0022-510X(00)00267-7; Brasted PJ, 2004, EUR J NEUROSCI, V19, P721, DOI 10.1111/j.0953-816X.2003.03181.x; CANAVAN AGM, 1990, NEUROPSYCHOLOGIA, V28, P969, DOI 10.1016/0028-3932(90)90112-2; Cohen RG, 2009, EXP BRAIN RES, V193, P69, DOI 10.1007/s00221-008-1596-1; Contreras-Vidal JL, 2003, EXP BRAIN RES, V150, P25, DOI 10.1007/s00221-003-1403-y; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Fernandez-Ruiz J, 2003, EUR J NEUROSCI, V18, P689, DOI 10.1046/j.1460-9568.2003.02785.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujii N, 2005, P NATL ACAD SCI USA, V102, P9032, DOI 10.1073/pnas.0503541102; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; HARRINGTON DL, 1990, J CLIN EXP NEUROPSYC, V12, P323, DOI 10.1080/01688639008400978; HEINDEL WC, 1989, J NEUROSCI, V9, P582; HUFSCHMIDT A, 1995, MOVEMENT DISORD, V10, P267, DOI 10.1002/mds.870100306; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Jessop RT, 2006, NEUROREHAB NEURAL RE, V20, P459, DOI 10.1177/1545968306287107; JORDAN N, 1994, INT J NEUROSCI, V77, P153, DOI 10.3109/00207459408986027; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Krebs HI, 2001, EXP BRAIN RES, V141, P425, DOI 10.1007/s002210100871; Mentis MJ, 2003, NEUROLOGY, V60, P612, DOI 10.1212/01.WNL.0000044154.92143.DC; Mochizuki-Kawai H, 2004, NEUROPSYCHOLOGIA, V42, P1858, DOI 10.1016/j.neuropsychologia.2004.03.012; Muller H, 2004, J EXP PSYCHOL HUMAN, V30, P212, DOI 10.1037/0096-1523.30.1.212; MULLER H, 2008, PROGR MOTOR CONTROL, P439; Muller H., 2004, J HUM KINET, V12, P31; Muslimovic D, 2007, BRAIN, V130, P2887, DOI 10.1093/brain/awm211; Nambu A, 2008, CURR OPIN NEUROBIOL, V18, P595, DOI 10.1016/j.conb.2008.11.001; PASCUALLEONE A, 1993, ANN NEUROL, V34, P594, DOI 10.1002/ana.410340414; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Platz T, 1998, BRAIN, V121, P505, DOI 10.1093/brain/121.3.505; Rauch SL, 1997, HUM BRAIN MAPP, V5, P124, DOI 10.1002/(SICI)1097-0193(1997)5:2<124::AID-HBM6>3.3.CO;2-P; Reed CL, 1998, COGNITIVE NEUROPSYCH, V15, P723, DOI 10.1080/026432998381078; Seitz R J, 1990, Neuroreport, V1, P57, DOI 10.1097/00001756-199009000-00016; SEITZ RJ, 1994, NEUROREPORT, V5, P2541, DOI 10.1097/00001756-199412000-00034; SHERIDAN MR, 1990, BRAIN, V113, P1149, DOI 10.1093/brain/113.4.1149; Smiley-Oyen AL, 2003, EXP BRAIN RES, V152, P453, DOI 10.1007/s00221-003-1570-x; Smiley-Oyen AL, 2002, MOVEMENT DISORD, V17, P1196, DOI 10.1002/mds.10278; Smiley-Oyen AL, 2006, MOVEMENT DISORD, V21, P1078, DOI 10.1002/mds.20906; Soliveri P, 1997, BRAIN, V120, P1325, DOI 10.1093/brain/120.8.1325; Swinnen SP, 2000, BEHAV BRAIN RES, V111, P45, DOI 10.1016/S0166-4328(00)00144-3; Wolpert DM, 2001, TRENDS COGN SCI, V5, P487, DOI 10.1016/S1364-6613(00)01773-3; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047	44	25	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21669	10.1371/journal.pone.0021669	http://dx.doi.org/10.1371/journal.pone.0021669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	791IA	21760898	gold, Green Published, Green Submitted			2022-12-25	WOS:000292657200016
J	Kawamata, N; Pennella, MA; Woo, JL; Berk, AJ; Koeffler, HP				Kawamata, N.; Pennella, M. A.; Woo, J. L.; Berk, A. J.; Koeffler, H. P.			Dominant-negative mechanism of leukemogenic PAX5 fusions	ONCOGENE			English	Article						PAX5 fusions; DNA binding; multimerization	ACUTE PROMYELOCYTIC LEUKEMIA; UNBALANCED TRANSLOCATIONS; INTRANUCLEAR MOBILITY; HISTONE DEACETYLASE; DECREASED MOBILITY; PAIRED DOMAIN; PROTEINS; BINDING; RAR; CHROMATIN	PAX5 encodes a master regulator of B-cell development. It fuses to other genes associated with acute lymphoblastoid leukemia (ALL). These fusion products are potent dominant-negative (DN) inhibitors of wild-type PAX5, resulting in a blockade of B-cell differentiation. Here, we show that multimerization of PAX5 DNA-binding domain (DBD) is necessary and sufficient to cause extremely stable chromatin binding and DN activity. ALL-associated PAX5-C20S results from fusion of the N-terminal region of PAX5, including its paired DBD, to the C-terminus of C20orf112, a protein of unknown function. We report that PAX5-C20S is a tetramer, which interacts extraordinarily stably with chromatin as determined by Fluorescence Recovery After Photobleaching in living cells. Tetramerization, stable chromatin binding and DN activity all require a putative five-turn amphipathic a-helix at the C-terminus of C20orf112, and does not require potential corepressor binding peptides elsewhere in the sequence. In vitro, the monomeric PAX5 DBD and PAX5-C20S binds a PAX5-binding site with equal affinity when it is at the center of an oligonucleotide too short to bind to more than one PAX5 DBD. But, PAX5-C20S binds the same sequence with 10-fold higher affinity than the monomeric PAX5 DBD when it is in a long DNA molecule. We suggest that the increased affinity results from interactions of one or more of the additional DBDs with neighboring non-specific sites in a long DNA molecule, and that this can account for the increased stability of PAX5-C20S chromatin binding compared with wild-type PAX5, resulting in DN activity by competition for binding to PAX5-target sites. Consistent with this model, the ALL-associated PAX5 fused to ETV6 or the multimerization domain of ETV6 SAM results in stable chromatin binding and DN activity. In addition, PAX5 DBD fused to artificial dimerization, trimerization and tetramerization domains results in parallel increases in the stability of chromatin binding and DN activity. Our studies suggest that oncogenic fusion proteins that retain the DBD of the transcription factor (TF) and the multimerization sequence of the partner protein can act in a DN manner by multimerizing and binding avidly to gene targets, preventing the normal TF from binding and inducing expression of its target genes. Inhibition of this multimeriztion may provide a novel therapeutic approach for cancers with this or similar fusion proteins. Oncogene (2012) 31, 966-977; doi:10.1038/onc.2011.291; published online 18 July 2011	[Kawamata, N.] Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Pennella, M. A.; Woo, J. L.; Berk, A. J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Inst Mol Biol, Los Angeles, CA 90048 USA; [Woo, J. L.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Koeffler, H. P.] Natl Univ Singapore, Natl Canc Inst, Singapore 117548, Singapore; [Koeffler, H. P.] Natl Univ Singapore, Canc Inst Singapore, Singapore 117548, Singapore	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Regeneron; National University of Singapore; National University of Singapore	Kawamata, N (corresponding author), Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Inst Med Genet, 8700 Beverly Blvd,Room D5068, Los Angeles, CA 90048 USA.	Norihiko.Kawamata@cshs.org; berk@mbi.ucla.edu	BERK, ARNOLD/AAF-7052-2020		NIH [R01CA026038-32, U54CA143930, GM008243]; A*STAR [R37CA25235]; Tower Cancer Foundation; ACS [PF0804801GMC]; NATIONAL CANCER INSTITUTE [U54CA143930, R01CA026038, R37CA025235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008243] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A*STAR(Agency for Science Technology & Research (A*STAR)); Tower Cancer Foundation; ACS(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01CA026038-32, U54CA143930, and A*STAR Investigator Grant to HPK and R37CA25235 to AJB, the Tower Cancer Foundation grant and NIH grant GM008243 to NK, and ACS postdoctoral fellowship PF0804801GMC to MAP. We thank Kolja A Wawrowsky in the Confocal Microscopy Unit, and BK Bernstein for Core Unit, Patricia Lin in the FACS Core Unit for their technical assistance. FRAP experiments were performed at the California Nano Systems Institute Advanced Light Microscopy/Spectroscopy (CNSI-ALMS) at UCLA.	An Q, 2008, P NATL ACAD SCI USA, V105, P17050, DOI 10.1073/pnas.0803494105; Antolini F, 2003, PROTEIN EXPRES PURIF, V29, P94, DOI 10.1016/S1046-5928(03)00004-4; Bousquet M, 2007, BLOOD, V109, P3417, DOI 10.1182/blood-2006-05-025221; Cazzaniga G, 2001, CANCER RES, V61, P4666; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Davison TS, 2001, J MOL BIOL, V307, P605, DOI 10.1006/jmbi.2001.4450; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dong S, 2004, MOL CELL BIOL, V24, P4465, DOI 10.1128/MCB.24.10.4465-4475.2004; Dorfler P, 1996, EMBO J, V15, P1971, DOI 10.1002/j.1460-2075.1996.tb00548.x; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Edwards PAW, 2010, J PATHOL, V220, P244, DOI 10.1002/path.2632; Elvenes J, 2010, CELL MOL LIFE SCI, V67, P4079, DOI 10.1007/s00018-010-0429-0; Fazio G, 2008, CANCER RES, V68, P181, DOI 10.1158/0008-5472.CAN-07-2778; Gasparini P, 2007, J CELL BIOCHEM, V102, P320, DOI 10.1002/jcb.21481; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Gruber M, 2005, NUCLEIC ACIDS RES, V33, pW239, DOI 10.1093/nar/gki405; Huang Y, 2008, BIOCHEM BIOPH RES CO, V365, P258, DOI 10.1016/j.bbrc.2007.10.184; Kamashev D, 2004, J EXP MED, V199, P1163, DOI 10.1084/jem.20032226; Kawamata N, 2008, P NATL ACAD SCI USA, V105, P11921, DOI 10.1073/pnas.0711039105; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Letarov AV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P817; Lin RJ, 2000, MOL CELL, V5, P821, DOI 10.1016/S1097-2765(00)80322-6; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; LIU P, 1993, SCIENCE, V261, P1041, DOI 10.1126/science.8351518; Martens JHA, 2010, CANCER CELL, V17, P173, DOI 10.1016/j.ccr.2009.12.042; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; O'Neil J, 2007, ONCOGENE, V26, P6838, DOI 10.1038/sj.onc.1210766; Pabst T, 2007, ONCOGENE, V26, P6829, DOI 10.1038/sj.onc.1210765; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Qiu J, 2006, ONCOGENE, V25, P3982, DOI 10.1038/sj.onc.1209431; Qiu JJ, 2011, ONCOGENE, V30, P967, DOI 10.1038/onc.2010.473; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Siegel R M, 2000, Sci STKE, V2000, ppl1, DOI 10.1126/stke.2000.38.pl1; So CW, 2004, BLOOD, V104, P919, DOI 10.1182/blood-2004-03-0992; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Strefford JC, 2009, CELL CYCLE, V8, P2175, DOI 10.4161/cc.8.14.9103; Wang G, 2001, MOL CELL BIOL, V21, P4604, DOI 10.1128/MCB.21.14.4604-4613.2001; Wichmann C, 2007, CANCER RES, V67, P2280, DOI 10.1158/0008-5472.CAN-06-3360; XU WG, 1995, CELL, V80, P639, DOI 10.1016/0092-8674(95)90518-9; Zhou J, 2006, P NATL ACAD SCI USA, V103, P9238, DOI 10.1073/pnas.0603324103	44	29	30	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	8					966	977		10.1038/onc.2011.291	http://dx.doi.org/10.1038/onc.2011.291			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	898BG	21765475	Green Accepted, Green Submitted			2022-12-25	WOS:000300709700003
J	Kim, K; Chadalapaka, G; Lee, SO; Yamada, D; Sastre-Garau, X; Defossez, PA; Park, YY; Lee, JS; Safe, S				Kim, K.; Chadalapaka, G.; Lee, S-O; Yamada, D.; Sastre-Garau, X.; Defossez, P-A; Park, Y-Y; Lee, J-S; Safe, S.			Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer	ONCOGENE			English	Article						ZBTB4; miR-17-92 cluster; breast cancer; prognostic; Sp transcription factors	MICRORNA EXPRESSION PROFILES; ZINC-FINGER PROTEINS; B-CELL LYMPHOMAS; REPRESSES TRANSCRIPTION; 5'-FLANKING REGION; GENE-EXPRESSION; METHYLATED DNA; MESSENGER-RNA; TUMOR-GROWTH; SP1	The human POK family members are transcription factors with a POZ domain and zinc-fingers that act primarily as transcriptional repressors. Several members of this family are involved in oncogenesis and this prompted us to assess whether expression levels of individual POK family members are associated with clinical outcomes in cancer. We have observed that ZBTB4 (zinc-finger and BTB domain containing 4) is downregulated in breast cancer patients, and that its expression is significantly correlated with relapse-free survival. Further integrative analysis of mRNA and microRNA (miR) expression data from the NCI-60 cell lines revealed an inverse correlation between ZBTB4 and oncogenic miRs derived from the miR-17-92 cluster and its paralogs. The experimental results using MDA-MB-231 and MCF-7 human breast cancer cells confirm that miRNAs derived from these clusters, containing miR-17-5p, miR-20a, miR-106a, miR-106b and miR-93, negatively regulate ZBTB4 expression. Overexpression of ZBTB4 or restoration of ZBTB4 by using an antagomir inhibit growth and invasion of breast cancer cells, and this effect is due, in part, to ZBTB4-dependent repression of the specificity protein 1 (Sp1), Sp3 and Sp4 genes, and subsequent downregulation of several Sp-dependent oncogenes, in part, through competition between ZBTB4 and Sp transcription factors for GC-rich promoter sequences. These results confirm that ZBTB4 functions as a novel tumor-suppressor gene with prognostic significance for breast cancer survival, and the oncogenic miR-17-92/ZBTB4/Sp axis may be a potential therapeutic target. Oncogene (2012) 31, 1034-1044; doi:10.1038/onc.2011.296; published online 18 July 2011	[Chadalapaka, G.; Safe, S.] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Kim, K.; Lee, S-O; Safe, S.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Yamada, D.; Defossez, P-A] Univ Paris 07, CNRS, UMR7216, Paris, France; [Sastre-Garau, X.] Inst Curie, Dept Tumor Biol, Paris, France; [Park, Y-Y; Lee, J-S] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Texas System; UTMD Anderson Cancer Center	Safe, S (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, Vet Res Bldg 410, College Stn, TX 77843 USA.	ssafe@cvm.tamu.edu		Sastre-Garau, Xavier/0000-0001-5992-2083; Defossez, Pierre-Antoine/0000-0002-6463-9263; Kim, Kyounghyun/0000-0002-7240-2768; Lee, Syng-Ook/0000-0002-8958-8634	National Institutes of Health [CA136571]; Association pour la Recherche sur le Cancer; Ligue contre le Cancer; Institut National du Cancer; NATIONAL CANCER INSTITUTE [R01CA136571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Institutes of Health (CA136571) and is gratefully acknowledged. PAD is supported by Association pour la Recherche sur le Cancer, Ligue contre le Cancer and Institut National du Cancer. DY was supported by a postdoctoral fellowship from Association pour la Recherche sur le Cancer.	Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Abdelrahim M, 2002, J BIOL CHEM, V277, P28815, DOI 10.1074/jbc.M203828200; Abdelrahim M, 2007, CANCER RES, V67, P3286, DOI 10.1158/0008-5472.CAN-06-3831; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Chadalapaka G, 2008, CANCER RES, V68, P5345, DOI 10.1158/0008-5472.CAN-07-6805; Chadalapaka G, 2010, MOL CANCER RES, V8, P739, DOI 10.1158/1541-7786.MCR-09-0493; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; Costoya Jose A., 2007, Briefings in Functional Genomics & Proteomics, V6, P8, DOI 10.1093/bfgp/elm002; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Inomata M, 2009, BLOOD, V113, P396, DOI 10.1182/blood-2008-07-163907; Jeon BN, 2009, J BIOL CHEM, V284, P17935, DOI 10.1074/jbc.M809559200; Jeon BN, 2008, J BIOL CHEM, V283, P33199, DOI 10.1074/jbc.M802935200; Jutooru I, 2010, MOL PHARMACOL, V78, P226, DOI 10.1124/mol.110.064451; Koh DI, 2009, J BIOL CHEM, V284, P19856, DOI 10.1074/jbc.M109.025817; Kojima S, 2001, DEVELOPMENT, V128, P57; Koutsodontis G, 2002, BIOCHEMISTRY-US, V41, P12771, DOI 10.1021/bi026141q; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee SO, 2010, CANCER RES, V70, P6824, DOI 10.1158/0008-5472.CAN-10-1992; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li HL, 2011, BREAST CANCER RES TR, V126, P565, DOI 10.1007/s10549-010-0954-4; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Nicolas M, 2001, J BIOL CHEM, V276, P22126, DOI 10.1074/jbc.M010740200; Niu HF, 2002, HEMATOL ONCOL, V20, P155, DOI 10.1002/hon.689; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Pendergrast PS, 2002, MOL BIOL CELL, V13, P915, DOI 10.1091/mbc.01-08-0383; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Sasai N, 2010, NUCLEIC ACIDS RES, V38, P5015, DOI 10.1093/nar/gkq280; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Tapias A, 2008, BBA-GENE REGUL MECH, V1779, P318, DOI 10.1016/j.bbagrm.2008.02.006; Tillotson LG, 1999, J BIOL CHEM, V274, P8123, DOI 10.1074/jbc.274.12.8123; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weber A, 2008, EMBO J, V27, P1563, DOI 10.1038/emboj.2008.85; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107	47	143	149	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2012	31	8					1034	1044		10.1038/onc.2011.296	http://dx.doi.org/10.1038/onc.2011.296			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	898BG	21765466	Green Accepted			2022-12-25	WOS:000300709700009
J	Chen, SW; Bellew, C; Yao, X; Stefkova, J; Dipp, S; Saifudeen, Z; Bachvarov, D; El-Dahr, SS				Chen, Shaowei; Bellew, Christine; Yao, Xiao; Stefkova, Jana; Dipp, Susana; Saifudeen, Zubaida; Bachvarov, Dimcho; El-Dahr, Samir S.			Histone Deacetylase (HDAC) Activity Is Critical for Embryonic Kidney Gene Expression, Growth, and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRANCHING MORPHOGENESIS; URETERAL BUD; TRANSCRIPTIONAL REPRESSION; MICE; ROLES; CELL; CATENIN; BIOLOGY; INHIBITORS; EPITHELIUM	Histone deacetylases (HDACs) regulate fundamental biological processes such as cellular proliferation, differentiation, and survival via genomic and nongenomic effects. This study examined the importance of HDAC activity in the regulation of gene expression and differentiation of the developing mouse kidney. Class I HDAC1-3 and class II HDAC4, -7, and -9 genes are developmentally regulated. Moreover, HDAC1-3 are highly expressed in nephron precursors. Short term treatment of cultured mouse embryonic kidneys with HDAC inhibitors (HDACi) induced global histone H3 and H4 hyperacetylation and H3K4 hypermethylation. However, genome-wide profiling revealed that the HDAC-regulated transcriptome is restricted and encompasses regulators of the cell cycle, Wnt/beta-catenin, TGF-beta/Smad, and PI3K-AKT pathways. Further analysis demonstrated that base-line expression of key developmental renal regulators, including Osr1, Eya1, Pax2/8, WT1, Gdnf, Wnt9b, Sfrp1/2, and Emx2, is dependent on intact HDAC activity. Treatment of cultured embryonic kidney cells with HDACi recapitulated these gene expression changes, and chromatin immunoprecipitation assays revealed that HDACi is associated with histone hyperacetylation of Pax2/Pax8, Gdnf, Sfrp1, and p21. Gene knockdown studies demonstrated that HDAC1 and HDAC2 play a redundant role in regulation of Pax2/8 and Sfrp1 but not Gdnf. Long term treatment of embryonic kidneys with HDACi impairs the ureteric bud branching morphogenesis program and provokes growth arrest and apoptosis. We conclude that HDAC activity is critical for normal embryonic kidney homeostasis, and we implicate class I HDACs in the regulation of early nephron gene expression, differentiation, and survival.	[Chen, Shaowei; Bellew, Christine; Yao, Xiao; Stefkova, Jana; Dipp, Susana; Saifudeen, Zubaida; El-Dahr, Samir S.] Tulane Univ, Hlth Sci Ctr, Sect Pediat Nephrol, Dept Pediat, New Orleans, LA 70112 USA; [Chen, Shaowei] Tulane Univ, Hlth Sci Ctr, Dept Physiol, New Orleans, LA 70112 USA; [Bachvarov, Dimcho] Univ Laval, Dept Mol Med, Quebec City, PQ G1R 2J6, Canada	Tulane University; Tulane University; Laval University	El-Dahr, SS (corresponding author), 1430 Tulane Ave,SL-37, New Orleans, LA 70112 USA.	seldahr@tulane.edu		Kauffman, Christine/0000-0002-2496-1987; Bachvarov, Dimcho/0000-0001-6509-9599	National Institutes of Health [DK-079886, DK-62550, DK56264]; National Kidney Foundation; Centers of Biomedical Research Excellence [1P20 RR-017659]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079886, R43DK062550, R01DK056264] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation; Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-079886, DK-62550, and DK56264 (to S. S. E.-D.).; Supported by a fellowship grant from the National Kidney Foundation.; Supported by Grant 1P20 RR-017659 from Centers of Biomedical Research Excellence.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Alarcon P, 2008, DEVELOPMENT, V135, P3197, DOI 10.1242/dev.023697; Basson MA, 2006, DEV BIOL, V299, P466, DOI 10.1016/j.ydbio.2006.08.051; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Bouchard M, 2004, DIFFERENTIATION, V72, P295, DOI 10.1111/j.1432-0436.2004.07207001.x; Boyle S, 2006, AM J PHYSIOL-RENAL, V291, pF1, DOI 10.1152/ajprenal.00447.2005; Bridgewater D, 2008, DEV BIOL, V317, P83, DOI 10.1016/j.ydbio.2008.02.010; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Challen G, 2005, PHYSIOL GENOMICS, V23, P159, DOI 10.1152/physiolgenomics.00043.2005; Chambers AE, 2003, EUR J CANCER, V39, P1165, DOI 10.1016/S0959-8049(03)00072-8; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chen YA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-101; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Costantini F, 2006, DIFFERENTIATION, V74, P402, DOI 10.1111/j.1432-0436.2006.00106.x; de Groh ED, 2010, J AM SOC NEPHROL, V21, P794, DOI 10.1681/ASN.2009080851; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Dudley AT, 1999, GENE DEV, V13, P1601, DOI 10.1101/gad.13.12.1601; Ferguson M, 2003, NUCLEIC ACIDS RES, V31, P3123, DOI 10.1093/nar/gkg403; Gao XB, 2005, DEVELOPMENT, V132, P5437, DOI 10.1242/dev.02095; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Godin RE, 1999, INT J DEV BIOL, V43, P405; Gong KQ, 2007, MOL CELL BIOL, V27, P7661, DOI 10.1128/MCB.00465-07; GROBSTEIN C, 1953, SCIENCE, V118, P52, DOI 10.1126/science.118.3054.52; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Haberland M, 2009, GENE DEV, V23, P1625, DOI 10.1101/gad.1809209; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hains D, 2008, PEDIATR RES, V64, P592, DOI 10.1203/PDR.0b013e318187cc12; Hartwig S, 2008, J AM SOC NEPHROL, V19, P117, DOI 10.1681/ASN.2007010080; Huang PH, 2011, MOL PHARMACOL, V79, P197, DOI 10.1124/mol.110.067702; Karner CM, 2011, DEVELOPMENT, V138, P1247, DOI 10.1242/dev.057646; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kopan R, 2007, J AM SOC NEPHROL, V18, P2014, DOI 10.1681/ASN.2007040453; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lu BC, 2009, NAT GENET, V41, P1295, DOI 10.1038/ng.476; Mariadason JM, 2005, GASTROENTEROLOGY, V128, P1081, DOI 10.1053/j.gastro.2005.01.054; Marose TD, 2008, DEV BIOL, V314, P112, DOI 10.1016/j.ydbio.2007.11.016; Mehnert JM, 2007, CANCER J, V13, P23, DOI 10.1097/PPO.0b013e31803c72ba; Miyamoto N, 1997, DEVELOPMENT, V124, P1653; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Nakai S, 2003, DEVELOPMENT, V130, P4751, DOI 10.1242/dev.00666; Partanen M, 1999, INT J DEV BIOL, V43, P487; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Potter SS, 2007, GENESIS, V45, P432, DOI 10.1002/dvg.20309; Reggiani L, 2007, GENE DEV, V21, P2358, DOI 10.1101/gad.450707; Reidy KJ, 2009, DEVELOPMENT, V136, P3979, DOI 10.1242/dev.037267; Reidy KJ, 2009, SEMIN NEPHROL, V29, P321, DOI 10.1016/j.semnephrol.2009.03.009; Rosenblum ND, 2008, SEMIN FETAL NEONAT M, V13, P125, DOI 10.1016/j.siny.2007.10.005; Ruf RG, 2004, P NATL ACAD SCI USA, V101, P8090, DOI 10.1073/pnas.0308475101; Saifudeen Z, 2009, J AM SOC NEPHROL, V20, P2328, DOI 10.1681/ASN.2008121224; Sajithlal G, 2005, DEV BIOL, V284, P323, DOI 10.1016/j.ydbio.2005.05.029; Sakamoto S, 2004, J BIOL CHEM, V279, P40362, DOI 10.1074/jbc.M406400200; Sakurai H, 2003, SEMIN CELL DEV BIOL, V14, P217, DOI 10.1016/S1084-9521(03)00024-7; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Schanstra JP, 2007, KIDNEY INT, V72, P442, DOI 10.1038/sj.ki.5002172; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Sharma M, 2009, GENE, V439, P87, DOI 10.1016/j.gene.2009.03.014; Shen B, 2007, J AM SOC NEPHROL, V18, P1140, DOI 10.1681/ASN.2006101127; Smith CL, 2008, BIOESSAYS, V30, P15, DOI 10.1002/bies.20687; Srinivas S, 1999, DEV GENET, V24, P241; Torres M, 1995, DEVELOPMENT, V121, P4057; Tou LQ, 2004, MOL CELL BIOL, V24, P3132, DOI 10.1128/MCB.24.8.3132-3139.2004; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842; Valerius M. Todd, 2002, Mechanisms of Development, V112, P219, DOI 10.1016/S0925-4773(02)00008-4; VanLint C, 1996, GENE EXPRESSION, V5, P245; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Waltregny D, 2004, AM J PATHOL, V165, P553, DOI 10.1016/S0002-9440(10)63320-2; Watanabe T, 2004, DEV BIOL, V271, P98, DOI 10.1016/j.ydbio.2004.03.025; Wellik DM, 2002, GENE DEV, V16, P1423, DOI 10.1101/gad.993302; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Yu J, 2004, CURR OPIN GENET DEV, V14, P550, DOI 10.1016/j.gde.2004.07.009; Zhang K, 2005, J CELL BIOCHEM, V96, P1137, DOI 10.1002/jcb.20615	77	66	74	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32775	32789		10.1074/jbc.M111.248278	http://dx.doi.org/10.1074/jbc.M111.248278			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778236	Green Published, hybrid			2022-12-25	WOS:000294726800085
J	Hara, T; Mimura, K; Abe, T; Shioi, G; Seiki, M; Sakamoto, T				Hara, Toshiro; Mimura, Kouhei; Abe, Takaya; Shioi, Go; Seiki, Motoharu; Sakamoto, Takeharu			Deletion of the Mint3/Apba3 Gene in Mice Abrogates Macrophage Functions and Increases Resistance to Lipopolysaccharide-induced Septic Shock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MT1-MMP; HYPOXIA; HIF-1-ALPHA; PROMOTES; PROTEIN; INTERACTS; FIH-1; CELLS	Two major metabolic systems are usually used to generate ATP: oxidative phosphorylation (OXPHOS) in the mitochondria and glycolysis. Most types of cells employ OXPHOS for ATP production during normoxia but then shift energy production from OXPHOS to glycolysis when exposed to hypoxia. Hypoxia-inducible factor-1 (HIF-1) is the master transcription factor regulating this metabolic shift. On the other hand, macrophages are unique in making use of glycolysis for ATP generation constitutively even during normoxia. We recently proposed that in macrophages, Mint3/APBA3 inhibits factor inhibiting HIF-1 (FIH-1) during normoxia, which in turn releases the suppression of HIF-1 activity by FIH-1. To demonstrate the physiological function of APBA3 in macrophages, we established Apba3(-/-) mice. The mutant mice presented no apparent gross phenotype but exhibited significant resistance against LPS-induced septic shock. The level of ATP in macrophages obtained from the mutant mice was reduced to 60% of the level observed in wild type cells, which in turn led to reduced ATP-dependent activities such as glycolysis, cytokine production, and motility. We also generated mutant mice with the Apba3 gene deleted specifically from cells of the myeloid lineage and confirmed that LPS-induced septic shock is mitigated significantly. Thus, we show cell type-specific regulation of energy production by APBA3 in macrophages using genetically manipulated mice. The specific function of APBA3 in macrophages might allow us to develop therapeutics to regulate aberrant macrophage function during infection and diseases.	[Hara, Toshiro; Mimura, Kouhei; Seiki, Motoharu; Sakamoto, Takeharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo, Japan; [Abe, Takaya; Shioi, Go] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Chuou Ku, Kobe, Hyogo, Japan	University of Tokyo; RIKEN	Seiki, M (corresponding author), 4-6-1 Shirokanedai,Minato Ku, Tokyo 1088639, Japan.	mseiki@ims.u-tokyo.ac.jp	Sakamoto, Takeharu/Y-6062-2019; Seiki, Motoharu/K-9443-2015	Sakamoto, Takeharu/0000-0002-1225-1902; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas and a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. S.), by Grant-in-Aid for Japan Society for the Promotion of Science Fellows from Japan Society for the Promotion of Science (to T. H.), and by a Grant-in-Aid for Scientific Research (S) and on Priority Areas, i.e. the "Integrative Research toward the Conquest of Cancer", from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M. S.).	Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Han JB, 2008, J CELL SCI, V121, P2217, DOI 10.1242/jcs.019745; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Imtiyaz HZ, 2010, J CLIN INVEST, V120, P2699, DOI 10.1172/JCI39506; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; MICHL J, 1976, J EXP MED, V144, P1465, DOI 10.1084/jem.144.6.1465; Miller CCJ, 2006, TRENDS NEUROSCI, V29, P280, DOI 10.1016/j.tins.2006.03.001; Okamoto M, 1998, EUR J CELL BIOL, V77, P161, DOI 10.1016/S0171-9335(98)80103-9; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; OZMEN L, 1994, J EXP MED, V180, P907, DOI 10.1084/jem.180.3.907; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Pulyaeva H, 1997, CLIN EXP METASTAS, V15, P111, DOI 10.1023/A:1018444609098; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Sakamoto T, 2011, J BIOL CHEM, V286, P14691, DOI 10.1074/jbc.M110.188714; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Sakamoto T, 2009, J BIOL CHEM, V284, P30350, DOI 10.1074/jbc.M109.019216; Sakamoto T, 2009, GENES CELLS, V14, P617, DOI 10.1111/j.1365-2443.2009.01293.x; Schneider F, 2008, CIRCULATION, V117, P931, DOI 10.1161/CIRCULATIONAHA.107.707448; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Tanahashi H, 1999, BIOCHEM BIOPH RES CO, V255, P663, DOI 10.1006/bbrc.1999.0265; Taniwaki K, 2007, CANCER RES, V67, P4311, DOI 10.1158/0008-5472.CAN-06-4761	33	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32542	32551		10.1074/jbc.M111.271726	http://dx.doi.org/10.1074/jbc.M111.271726			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778228	Green Published, hybrid			2022-12-25	WOS:000294726800064
J	Koyanagi, S; Hamdan, AM; Horiguchi, M; Kusunose, N; Okamoto, A; Matsunaga, N; Ohdo, S				Koyanagi, Satoru; Hamdan, Ahmed M.; Horiguchi, Michiko; Kusunose, Naoki; Okamoto, Akinori; Matsunaga, Naoya; Ohdo, Shigehiro			cAMP-response Element (CRE)-mediated Transcription by Activating Transcription Factor-4 (ATF4) Is Essential for Circadian Expression of the Period2 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED DISRUPTION; NERVOUS-SYSTEM; MOUSE-LIVER; CLOCK; PROTEIN; BINDING; OSTEOBLASTS; METABOLISM; STRESS; CELLS	Activating transcription factor (ATF)/cAMP-response element (CRE)-binding (CREB) proteins induce the CRE-mediated gene transcription depending on the cAMP stimulation. cAMP-dependent signaling oscillates in a circadian manner, which in turn also sustains core oscillation machinery of the circadian clock. Here, we show that among the ATF/CREB family proteins, ATF4 is essential for the circadian expression of the Period2 (Per2) gene, a key component of the circadian clock. Transcription of the Atf4 gene was regulated by core components of the circadian clock, and its expression exhibited circadian oscillation in mouse tissues as well as embryonic fibroblasts. ATF4 bound to the CRE of the Per2 promoter in a circadian time-dependent manner and periodically activated the transcription of the Per2 gene. Consequently, the oscillation of the Per2 expression was attenuated in embryonic cells prepared from Atf4-null mice. Furthermore, the loss of ATF4 also disrupted the rhythms in the expression of other clock genes. These results suggest that ATF4 is a component responsible for sustaining circadian oscillation of CRE-mediated gene expression and also constitute a molecular link connecting cAMP-dependent signaling to the circadian clock.	[Koyanagi, Satoru; Hamdan, Ahmed M.; Horiguchi, Michiko; Kusunose, Naoki; Okamoto, Akinori; Matsunaga, Naoya; Ohdo, Shigehiro] Kyushu Univ, Dept Pharmaceut, Grad Sch Pharmaceut Sci, Fukuoka 8128582, Japan	Kyushu University	Ohdo, S (corresponding author), Kyushu Univ, Dept Pharmaceut, Grad Sch Pharmaceut Sci, 3-1-1 Maidashi Higashi Ku, Fukuoka 8128582, Japan.	ohdo@phar.kyushu-u.ac.jp	Koyanagi, Satoru/AAE-6843-2020; Hamdan, Ahmed M/H-3794-2018	Hamdan, Ahmed M/0000-0003-4930-792X; Koyanagi, Satoru/0000-0003-4849-2377; matsunaga2, naoya2/0000-0001-6226-8473	Ministry of Education, Culture, Sport, Science, and Technology [20014016]; Japan Society for the Promotion of Science [21659041];  [21390047]	Ministry of Education, Culture, Sport, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported in part by Grant-in-aid for Scientific Research on Priority Areas (Cancer) 20014016 (to S. O.) from the Ministry of Education, Culture, Sport, Science, and Technology, Grant-in-aid for Scientific Research (B) 21390047 (to S. O.), and Grant-in-aid for Challenging Exploratory Research 21659041 (to S. O.) from the Japan Society for the Promotion of Science.	Adams CM, 2007, J BIOL CHEM, V282, P16744, DOI 10.1074/jbc.M610510200; Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Gachon F, 2001, FEBS LETT, V502, P57, DOI 10.1016/S0014-5793(01)02646-1; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Kato Y, 1999, MOL CELL ENDOCRINOL, V154, P151, DOI 10.1016/S0303-7207(99)00078-7; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Lemos DR, 2007, ENDOCRINOLOGY, V148, P5811, DOI 10.1210/en.2007-0610; LIN YS, 1989, P NATL ACAD SCI USA, V86, P109, DOI 10.1073/pnas.86.1.109; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Oishi K, 2005, DNA RES, V12, P191, DOI 10.1093/dnares/dsi003; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Shimamura M, 2003, BIOCHEM BIOPH RES CO, V300, P464, DOI 10.1016/S0006-291X(02)02807-3; Sowa H., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P326; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; TAN Y, 1994, MOL CELL BIOL, V14, P7546, DOI 10.1128/MCB.14.11.7546; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; Terazono H, 2003, P NATL ACAD SCI USA, V100, P6795, DOI 10.1073/pnas.0936797100; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366; Zhang XY, 2008, J CELL BIOCHEM, V105, P885, DOI 10.1002/jcb.21888	33	64	71	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32416	32423		10.1074/jbc.M111.258970	http://dx.doi.org/10.1074/jbc.M111.258970			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21768648	Green Published, hybrid			2022-12-25	WOS:000294726800051
J	Mangala, LS; Zhang, Y; He, ZH; Emami, K; Ramesh, GT; Story, M; Rohde, LH; Wu, HL				Mangala, Lingegowda S.; Zhang, Ye; He, Zhenhua; Emami, Kamal; Ramesh, Govindarajan T.; Story, Michael; Rohde, Larry H.; Wu, Honglu			Effects of Simulated Microgravity on Expression Profile of MicroRNA in Human Lymphoblastoid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GENE-EXPRESSION; MODELED MICROGRAVITY; HUMAN FIBROBLASTS; BREAST-CANCER; T-CELLS; TRANSCRIPTION; STRESS; SPACE; DIFFERENTIATION	This study explores the changes in expression of microRNA (miRNA) and related genes under simulated microgravity conditions. In comparison with static 1 x g, microgravity has been shown to alter global gene expression patterns and protein levels in cultured cells or animals. miRNA has recently emerged as an important regulator of gene expression, possibly regulating as many as one-third of all human genes. However, very little is known about the effect of altered gravity on miRNA expression. To test the hypothesis that the miRNA expression profile would be altered in zero gravity resulting in altered regulation of gene expression leading to metabolic or functional changes in cells, we cultured TK6 human lymphoblastoid cells in a high aspect ratio vessel (bioreactor) for 72 h either in the rotating condition to model microgravity in space or in the static condition as a control. Expression of several miRNAs was changed significantly in the simulated microgravity condition including miR150, miR-34a, miR-423-5p, miR-22, miR-141, miR-618, and miR-222. To confirm whether this altered miRNA expression correlates with gene expression and functional changes of the cells, we performed DNA microarray and validated the related genes using quantitative RT-PCR. Expression of several transcription factors including EGR2, ETS1, and c-REL was altered in simulated microgravity conditions. Taken together, the results reported here indicate that simulated microgravity alters the expression of miRNAs and genes in TK6 cells. To our knowledge, this study is the first to report the effects of simulated microgravity on the expression of miRNA and related genes.	[Mangala, Lingegowda S.; Zhang, Ye; Emami, Kamal; Wu, Honglu] NASA Johnson Space Ctr, Radiat Biophys Lab, Houston, TX 77058 USA; [Mangala, Lingegowda S.; He, Zhenhua; Rohde, Larry H.] Univ Houston Clear Lake, Dept Biol Sci, Houston, TX 77058 USA; [Zhang, Ye] Wyle Integrated Sci & Engn Grp, Houston, TX 77058 USA; [Ramesh, Govindarajan T.] Norfolk State Univ, Mol Toxicol Lab, Norfolk, VA 23504 USA; [Story, Michael] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Houston System; University of Houston; University of Houston Clear Lake; Norfolk State University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mangala, LS (corresponding author), NASA Johnson Space Ctr, Radiat Biophys Lab, 2101 NASA Pkwy, Houston, TX 77058 USA.	lingegowda.s.mangala@nasa.gov	Story, Michael/AAX-2864-2021	Story, Michael/0000-0001-6522-4169	University of Houston Institute for Space Systems Operations	University of Houston Institute for Space Systems Operations	This work was supported in part by the University of Houston Institute for Space Systems Operations Program.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baevsky RM, 2007, J APPL PHYSIOL, V103, P156, DOI 10.1152/japplphysiol.00137.2007; Barr YR, 2007, AVIAT SPACE ENVIR MD, V78, pA26; Boo LN, 2005, CANCER RES, V65, P6622, DOI 10.1158/0008-5472.CAN-05-0086; Canova S, 2005, RADIAT RES, V163, P191, DOI 10.1667/RR3304; Carter JH, 2007, J IMMUNOL, V178, P6796, DOI 10.4049/jimmunol.178.11.6796; Clement Jade Q., 2008, Genomics Proteomics & Bioinformatics, V6, P8, DOI 10.1016/S1672-0229(08)60017-0; Clement JQ., 2007, J GRAVIT PHYSL, V14, P121; Cooper D, 2001, IN VITRO CELL DEV-AN, V37, P63; Ding LH, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn234; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; GRILLI M, 1993, INT REV CYTOL, V143, P1; GRIMM S, 1993, BIOCHEM J, V290, P297, DOI 10.1042/bj2900297; Hammond TG, 2000, PHYSIOL GENOMICS, V3, P163, DOI 10.1152/physiolgenomics.2000.3.3.163; Hammond TG, 1999, NAT MED, V5, P359, DOI 10.1038/7331; Hammond TG, 2001, AM J PHYSIOL-RENAL, V281, pF12, DOI 10.1152/ajprenal.2001.281.1.F12; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; LEACH CS, 1990, ACTA ASTRONAUT, V21, P659, DOI 10.1016/0094-5765(90)90077-X; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Mackley JR, 2006, BIOCHEM J, V396, P307, DOI 10.1042/BJ20060057; Maes OC, 2008, J CELL BIOCHEM, V105, P824, DOI 10.1002/jcb.21878; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Molnar G, 1997, IN VITRO CELL DEV-AN, V33, P386; Nakatsuka H, 2006, AM J PHYSIOL-GASTR L, V291, pG26, DOI 10.1152/ajpgi.00467.2005; NISSEN MS, 1991, J BIOL CHEM, V266, P19945; Pietrzyk RA, 2007, AVIAT SPACE ENVIR MD, V78, pA9; Rocha S, 2007, TRENDS BIOCHEM SCI, V32, P389, DOI 10.1016/j.tibs.2007.06.005; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; Semov A, 2002, FASEB J, V16, P899, DOI 10.1096/fj.01-1002fje; Sharma CS, 2008, MOL CELL BIOCHEM, V313, P71, DOI 10.1007/s11010-008-9743-3; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Ting Y, 2010, BIOCHEM BIOPH RES CO, V394, P606, DOI 10.1016/j.bbrc.2010.03.030; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Unoki M, 2003, ONCOGENE, V22, P2172, DOI 10.1038/sj.onc.1206222; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Vico L, 2000, LANCET, V355, P1607, DOI 10.1016/S0140-6736(00)02217-0; Wang YG, 2010, BLOOD CELL MOL DIS, V44, P191, DOI 10.1016/j.bcmd.2009.12.010; Ward NE, 2006, J CELL BIOCHEM, V99, P1187, DOI 10.1002/jcb.20988; Wilson JW, 2002, APPL ENVIRON MICROB, V68, P5408, DOI 10.1128/AEM.68.11.5408-5416.2002; Wilson JW, 2002, P NATL ACAD SCI USA, V99, P13807, DOI 10.1073/pnas.212387899; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	46	43	54	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32483	32490		10.1074/jbc.M111.267765	http://dx.doi.org/10.1074/jbc.M111.267765			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775437	Green Published, hybrid			2022-12-25	WOS:000294726800058
J	Egeler, EL; Urner, LM; Rakhit, R; Liu, CW; Wandless, TJ				Egeler, Emily L.; Urner, Lorenz M.; Rakhit, Rishi; Liu, Corey W.; Wandless, Thomas J.			Ligand-switchable Substrates for a Ubiquitin-Proteasome System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-QUALITY CONTROL; PLASMODIUM-FALCIPARUM; TRANSITION-STATE; SMALL MOLECULES; DEGRADATION; STABILITY; CHAPERONE; FKBP12; IDENTIFICATION; RECOGNITION	Cellular maintenance of protein homeostasis is essential for normal cellular function. The ubiquitin-proteasome system (UPS) plays a central role in processing cellular proteins destined for degradation, but little is currently known about how misfolded cytosolic proteins are recognized by protein quality control machinery and targeted to the UPS for degradation in mammalian cells. Destabilizing domains (DDs) are small protein domains that are unstable and degraded in the absence of ligand, but whose stability is rescued by binding to a high affinity cell-permeable ligand. In the work presented here, we investigate the biophysical properties and cellular fates of a panel of FKBP12 mutants displaying a range of stabilities when expressed in mammalian cells. Our findings correlate observed cellular instability to both the propensity of the protein domain to unfold in vitro and the extent of ubiquitination of the protein in the non-permissive (ligand-free) state. We propose a model in which removal of stabilizing ligand causes the DD to unfold and be rapidly ubiquitinated by the UPS for degradation at the proteasome. The conditional nature of DD stability allows a rapid and non-perturbing switch from stable protein to unstable UPS substrate unlike other methods currently used to interrogate protein quality control, providing tunable control of degradation rates.	[Egeler, Emily L.; Urner, Lorenz M.; Rakhit, Rishi; Wandless, Thomas J.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Liu, Corey W.] Stanford Univ, Stanford Magnet Resonance Lab, Stanford, CA 94305 USA	Stanford University; Stanford University	Wandless, TJ (corresponding author), 318 Campus Dr,Clark Ctr W350A, Stanford, CA 94305 USA.	wandless@stanford.edu			National Institutes of Health [GM068589]; Canadian Institutes of Health Research; Stanford University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073046, R01GM068589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Stanford University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM068589.; Supported by a postdoctoral fellowship from the Canadian Institutes of Health Research.; Supported in part by the Stanford University School of Medicine.	Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Bence NF, 2005, METHOD ENZYMOL, V399, P481, DOI 10.1016/S0076-6879(05)99033-2; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; da Silva LM, 2009, P NATL ACAD SCI USA, V106, P7583, DOI 10.1073/pnas.0901698106; Dolan BP, 2011, J IMMUNOL, V186, P2065, DOI 10.4049/jimmunol.1003096; Dunlop RA, 2009, IUBMB LIFE, V61, P522, DOI 10.1002/iub.189; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fulton KF, 1999, J MOL BIOL, V291, P445, DOI 10.1006/jmbi.1999.2942; Hegde AN, 2011, BBA-GENE REGUL MECH, V1809, P128, DOI 10.1016/j.bbagrm.2010.07.006; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Huang QA, 2010, APOPTOSIS, V15, P1292, DOI 10.1007/s10495-010-0466-z; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Janse DM, 2004, J BIOL CHEM, V279, P21415, DOI 10.1074/jbc.M402954200; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Main ERG, 1998, BIOCHEMISTRY-US, V37, P6145, DOI 10.1021/bi973111s; Main ERG, 1999, J MOL BIOL, V291, P429, DOI 10.1006/jmbi.1999.2941; Matsuzawa S, 2005, P NATL ACAD SCI USA, V102, P14982, DOI 10.1073/pnas.0507512102; Maynard-Smith LA, 2007, J BIOL CHEM, V282, P24866, DOI 10.1074/jbc.M703902200; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Perng YC, 2011, J VIROL, V85, P4841, DOI 10.1128/JVI.02344-10; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; ROSEN MK, 1991, BIOCHEMISTRY-US, V30, P4774, DOI 10.1021/bi00233a020; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Sambrook J., 1989, MOL CLONING, pA1; Schoeber JPH, 2009, AM J PHYSIOL-RENAL, V296, pF204, DOI 10.1152/ajprenal.90473.2008; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Su L, 2006, J IMMUNOL, V177, P7559, DOI 10.4049/jimmunol.177.11.7559; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Venancio TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r33; Vernace VA, 2007, AGING CELL, V6, P599, DOI 10.1111/j.1474-9726.2007.00329.x; Wiseman RL, 2010, CELL, V140, P590, DOI 10.1016/j.cell.2010.02.006; Xu Q, 2004, MOL CANCER THER, V3, P1263; Yano M, 2004, BIOMACROMOLECULES, V5, P1465, DOI 10.1021/bm049957a; Ziv I, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009753	48	41	42	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31328	31336		10.1074/jbc.M111.264101	http://dx.doi.org/10.1074/jbc.M111.264101			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768107	Green Published, hybrid			2022-12-25	WOS:000294487500028
J	Rana, NA; Nita-Lazar, A; Takeuchi, H; Kakuda, S; Luther, KB; Haltiwanger, RS				Rana, Nadia A.; Nita-Lazar, Aleksandra; Takeuchi, Hideyuki; Kakuda, Shinako; Luther, Kelvin B.; Haltiwanger, Robert S.			O-Glucose Trisaccharide Is Present at High but Variable Stoichiometry at Multiple Sites on Mouse Notch1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-LIKE; FACTOR-LIKE REPEATS; HAMSTER OVARY CELLS; FACTOR-LIKE MODULES; FACTOR-LIKE DOMAIN; LIGAND-BINDING; LUNATIC-FRINGE; FUCOSYL-TRANSFERASE; LINKED FUCOSE; FACTOR-IX	Notch activity is regulated by both O-fucosylation and O-glucosylation, and Notch receptors contain multiple predicted sites for both. Here we examine the occupancy of the predicted O-glucose sites on mouse Notch1 (mN1) using the consensus sequence (CXSXPC2)-X-1. We show that all of the predicted sites are modified, although the efficiency of modifying O-glucose sites is site- and cell type-dependent. For instance, although most sites are modified at high stoichiometries, the site at EGF 27 is only partially glucosylated, and the occupancy of the site at EGF 4 varies with cell type. O-Glucose is also found at a novel, non-traditional consensus site at EGF 9. Based on this finding, we propose a revision of the consensus sequence for O-glucosylation to allow alanine N-terminal to cysteine 2: (CXSX)-X-1(A/P)C-2. We also show through biochemical and mass spectral analyses that serine is the only hydroxyamino acid that is modified with O-glucose on EGF repeats. The O-glucose at all sites is efficiently elongated to the trisaccharide Xyl-Xyl-Glc. To establish the functional importance of individual O-glucose sites in mN1, we used a cell-based signaling assay. Elimination of most individual sites shows little or no effect on mN1 activation, suggesting that the major effects of O-glucose are mediated by modification of multiple sites. Interestingly, elimination of the site in EGF 28, found in the Abruptex region of Notch, does significantly reduce activity. These results demonstrate that, like O-fucose, the O-glucose modifications of EGF repeats occur extensively on mN1, and they play important roles in Notch function.	[Rana, Nadia A.; Nita-Lazar, Aleksandra; Takeuchi, Hideyuki; Kakuda, Shinako; Luther, Kelvin B.; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Haltiwanger, RS (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA.	rhaltiwanger@ms.cc.sunysb.edu	Takeuchi, Hideyuki/AAZ-9210-2020; Nita-Lazar, Aleksandra/N-3740-2018	Nita-Lazar, Aleksandra/0000-0002-8523-605X; Luther, Kelvin/0000-0001-9438-9675	National Institutes of Health [GM61126]; NCI [T32 CA009176]; NATIONAL CANCER INSTITUTE [T32CA009176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001085, ZIAAI001084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM61126 and NCI T32 CA009176.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Chapman G, 2008, ADV EXP MED BIOL, V638, P95; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; de Celis JF, 2000, DEVELOPMENT, V127, P1291; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Ge CH, 2008, P NATL ACAD SCI USA, V105, P1539, DOI 10.1073/pnas.0702846105; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hambleton S, 2004, STRUCTURE, V12, P2173, DOI 10.1016/j.str.2004.09.012; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; HASE S, 1990, J BIOL CHEM, V265, P1858; HASE S, 1988, J BIOCHEM-TOKYO, V104, P867, DOI 10.1093/oxfordjournals.jbchem.a122571; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hiruma-Shimizu K, 2010, J AM CHEM SOC, V132, P14857, DOI 10.1021/ja105216u; IASCONE M, 2011, CLIN GENET IN PRESS; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krogh TN, 1997, EUR J BIOCHEM, V244, P334, DOI 10.1111/j.1432-1033.1997.00334.x; KUMAR R, 1989, MOL CELL BIOL, V9, P5713, DOI 10.1128/MCB.9.12.5713; Louvi A, 2006, DEV NEUROSCI-BASEL, V28, P5, DOI 10.1159/000090748; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Moloney DJ, 1997, J BIOL CHEM, V272, P19046, DOI 10.1074/jbc.272.30.19046; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moran JL, 1999, MAMM GENOME, V10, P535, DOI 10.1007/s003359901039; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; NISHIMURA H, 1989, J BIOL CHEM, V264, P20320; NISHIMURA H, 1992, J BIOCHEM-TOKYO, V111, P460, DOI 10.1093/oxfordjournals.jbchem.a123780; Nita-Lazar A, 2006, METHOD ENZYMOL, V417, P93, DOI 10.1016/S0076-6879(06)17008-1; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Rampal R, 2005, J BIOL CHEM, V280, P42454, DOI 10.1074/jbc.M509552200; Rampal R, 2005, J BIOL CHEM, V280, P32133, DOI 10.1074/jbc.M506104200; Rampal R, 2007, CURR MOL MED, V7, P427, DOI 10.2174/156652407780831593; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Serth K, 2003, GENE DEV, V17, P912, DOI 10.1101/gad.250603; Sethi MK, 2010, J BIOL CHEM, V285, P1582, DOI 10.1074/jbc.C109.065409; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shao L, 2002, GLYCOBIOLOGY, V12, P763, DOI 10.1093/glycob/cwf085; Shi SL, 2007, J BIOL CHEM, V282, P20133, DOI 10.1074/jbc.M702593200; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; STANLEY P, 1977, SOMAT CELL GENET, V3, P391, DOI 10.1007/BF01542968; Stanley P, 2009, IMMUNOL REV, V230, P201, DOI 10.1111/j.1600-065X.2009.00791.x; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Whitworth GE, 2010, GLYCOBIOLOGY, V20, P287, DOI 10.1093/glycob/cwp173; Wiweger MI, 2011, J PATHOL, V223, P531, DOI 10.1002/path.2824; Xu AG, 2005, J BIOL CHEM, V280, P30158, DOI 10.1074/jbc.M505569200; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19162, DOI 10.1073/pnas.0902834106	65	68	70	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31623	31637		10.1074/jbc.M111.268243	http://dx.doi.org/10.1074/jbc.M111.268243			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757702	hybrid, Green Published			2022-12-25	WOS:000294487500056
J	Nagashima, Y; Kowa, H; Tsuji, S; Iwata, A				Nagashima, Yu; Kowa, Hisatomo; Tsuji, Shoji; Iwata, Atsushi			FAT10 Protein Binds to Polyglutamine Proteins and Modulates Their Solubility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; HUNTINGTONS-DISEASE; DEGRADATION; GENE; NEURODEGENERATION; PATHWAYS; IDENTIFICATION; AGGREGATION; DEATH; SUMO	Expansion of polyglutamine (pQ) chain by expanded CAG repeat causes dominantly inherited neurodegeneration such as Huntington disease, dentatorubral-pallidoluysian atrophy (DRPLA), and numbers of other spinocerebellar ataxias. Expanded pQ disrupts the stability of the pQ-harboring protein and increases its susceptibility to aggregation. Aggregated pQ protein is recognized by the ubiquitin proteasome system, and the enzyme ubiquitin ligase covalently attaches ubiquitin, which serves as a degradation signal by the proteasome. However, accumulation of the aggregated proteins in the diseased brain suggests insufficient degradation machinery. Ubiquitin has several functionally related proteins that are similarly attached to target proteins through its C terminus glycine residue. They are called ubiquitin-like molecules, and some of them are similarly related to the protein degradation pathway. One of the ubiquitin- like molecules, FAT10, is known to accelerate protein degradation through a ubiquitin-independent manner, but its role in pQ aggregate degradation is completely unknown. Thus we investigated its role in a Huntington disease cellular model and found that FAT10 molecules were covalently attached to huntingtin through their C terminus glycine. FAT10 binds preferably to huntingtin with a short pQ chain and completely aggregated huntingtin was FAT10-negative. In addition, ataxin-1,3 and DRPLA proteins were both positive for FAT10, and aggregation enhancement was observed upon FAT10 knockdown. These findings were similar to those for huntingtin. Our new finding will provide a new role for FAT10 in the pathogenesis of polyglutamine diseases.	[Iwata, Atsushi] Univ Tokyo, Dept Mol Neurosci Neurodegenerat, Tokyo 1138655, Japan; [Nagashima, Yu; Tsuji, Shoji; Iwata, Atsushi] Univ Tokyo, Dept Neurol, Tokyo 1138655, Japan; [Iwata, Atsushi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kowa, Hisatomo] Kobe Univ, Dept Neurol, Kobe, Hyogo 6500017, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Kobe University	Iwata, A (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.	iwata-tky@umin.ac.jp	Iwata, Atsushi/A-9598-2013; Iwata, Atsushi/AAH-8924-2019	Iwata, Atsushi/0000-0001-7308-5314; Iwata, Atsushi/0000-0001-7308-5314	Japan Society for the Promotion of Science; Japan Ministry of Education, Culture, Sports, Science and Technology; Japan Science and Technology Agency; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Brain Science Foundation; Cell Science Research Foundation; Janssen Pharmaceuticals	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Brain Science Foundation; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	This work was supported by Kakenhi from the Japan Society for the Promotion of Science, the Japan Ministry of Education, Culture, Sports, Science and Technology; PRESTO from the Japan Science and Technology Agency, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Brain Science Foundation, the Cell Science Research Foundation, and Janssen Pharmaceuticals.	BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Canaan A, 2006, MOL CELL BIOL, V26, P5180, DOI 10.1128/MCB.00966-05; Chiu YH, 2007, MOL CELL, V27, P1014, DOI 10.1016/j.molcel.2007.08.020; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Fan WF, 1996, IMMUNOGENETICS, V44, P97, DOI 10.1007/s002510050095; Ferro A, 2007, BBA-MOL CELL RES, V1773, P1619, DOI 10.1016/j.bbamcr.2007.07.012; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Herrmann J, 2004, CARDIOVASC RES, V61, P11, DOI 10.1016/j.cardiores.2003.09.033; Hipp MS, 2005, MOL CELL BIOL, V25, P3483, DOI 10.1128/MCB.25.9.3483-3491.2005; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Liu YC, 1999, P NATL ACAD SCI USA, V96, P4313, DOI 10.1073/pnas.96.8.4313; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; ONODERA O, 1995, AM J HUM GENET, V57, P1050; Petroski MD, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S7; Raasi S, 2001, J BIOL CHEM, V276, P35334, DOI 10.1074/jbc.M105139200; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Ren JW, 2006, J BIOL CHEM, V281, P11413, DOI 10.1074/jbc.M507218200; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schmidtke G, 2009, FEBS LETT, V583, P591, DOI 10.1016/j.febslet.2009.01.006; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zhang DW, 2006, ONCOGENE, V25, P2318, DOI 10.1038/sj.onc.1209220; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	31	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29594	29600		10.1074/jbc.M111.261032	http://dx.doi.org/10.1074/jbc.M111.261032			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21757738	Green Published, hybrid			2022-12-25	WOS:000294046600017
J	Zheng, L; Xie, GF; Duan, GJ; Yan, XC; Li, QW				Zheng, Lei; Xie, Ganfeng; Duan, Guangjie; Yan, Xiaochu; Li, Qianwei			High Expression of Testes-Specific Protease 50 Is Associated with Poor Prognosis in Colorectal Carcinoma	PLOS ONE			English	Article							COLON-CANCER PATIENTS; CARCINOEMBRYONIC ANTIGEN; TUMOR-MARKERS; MICROSATELLITE INSTABILITY; HEPATOCELLULAR-CARCINOMA; CANCER/TESTIS ANTIGENS; ADJUVANT CHEMOTHERAPY; PREDICTING SURVIVAL; TISSUE MICROARRAY; PANCREATIC-CANCER	Background: Testes-specific protease 50 (TSP50) is normally expressed in testes and abnormally expressed in breast cancer, but whether TSP50 is expressed in colorectal carcinoma (CRC) and its clinical significance is unclear. We aimed to detect TSP50 expression in CRC, correlate it with clinicopathological factors, and assess its potential diagnostic and prognostic value. Methodology/Principal Findings: TSP50 mRNAs and proteins were detected in 7 CRC cell lines and 8 CRC specimens via RTPCR and Western blot analysis. Immunohistochemical analysis of TSP50, p53 and carcinoembryonic antigen (CEA) with tissue microarrays composed of 95 CRCs, 20 colorectal adenomas and 20 normal colorectal tissues were carried out and correlated with clinicopathological characteristics and disease-specific survival for CRC patients. There was no significant correlation between the expression levels of TSP50 and p53 (P = 0.751) or CEA (P = 0.663). Abundant expression of TSP50 protein was found in CRCs (68.4%) while it was poorly expressed in colorectal adenomas and normal tissues (P<0.0001). Thus, CRCs can be distinguished from them with high specificity (92.5%) and positive predictive value (PPV, 95.6%). The survival of CRC patients with high TSP50 expression was significantly shorter than that of the patients with low TSP50 expression (P = 0.010), specifically in patients who had early-stage tumors (stage I and II; P = 0.004). Multivariate Cox regression analysis indicated that high TSP50 expression was a statistically significant independent risk factor (hazard ratio = 2.205, 95% CI = 1.214-4.004, P = 0.009). Conclusion: Our data demonstrate that TSP50 is a potential effective indicator of poor survival for CRC patients, especially for those with early-stage tumors.	[Zheng, Lei; Li, Qianwei] Third Mil Med Univ, Southwest Hosp, Dept Nucl Med, Chongqing, Peoples R China; [Xie, Ganfeng] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China; [Xie, Ganfeng; Duan, Guangjie; Yan, Xiaochu] Third Mil Med Univ, Southwest Hosp, SW Canc Ctr, Chongqing, Peoples R China; [Duan, Guangjie; Yan, Xiaochu] Third Mil Med Univ, Southwest Hosp, Dept Pathol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Li, QW (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Nucl Med, Chongqing, Peoples R China.	lqw_swhospital@163.com	Ganfeng, Xie/C-8218-2012	Zheng, Lei/0000-0002-5343-5249; Duan, Guang-jie/0000-0002-5564-4394	National Natural Science Foundation of China [30870726]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (Grant No. 30870726; URL: http://www.nsfc.gov.cn/PortalO/default124.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatnagar J, 1999, ANTICANCER RES, V19, P2181; Bourdon JC, 2007, BRIT J CANCER, V97, P277, DOI 10.1038/sj.bjc.6603886; Bouzourene H, 2000, EUR J CANCER, V36, P1008, DOI 10.1016/S0959-8049(00)00036-8; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Chang SC, 2006, INT J CANCER, V118, P1721, DOI 10.1002/ijc.21563; Chen MF, 2010, INT J RADIAT ONCOL, V78, P868, DOI 10.1016/j.ijrobp.2010.05.025; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Chen ZG, 2010, DIS COLON RECTUM, V53, P31, DOI 10.1007/DCR.0b013e3181bdca3a; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Conlin A, 2005, GUT, V54, P1283, DOI 10.1136/gut.2005.066514; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; de Jong KP, 2005, CLIN CANCER RES, V11, P4067, DOI 10.1158/1078-0432.CCR-04-2389; Duan Guang-Jie, 2004, Zhonghua Bing Li Xue Za Zhi, V33, P518; Duffy MJ, 2007, EUR J CANCER, V43, P1348, DOI 10.1016/j.ejca.2007.03.021; El-Serafi MM, 2010, CANCER-AM CANCER SOC, V116, P4954, DOI 10.1002/cncr.25417; Elsaleh H, 2000, ONCOLOGY-BASEL, V58, P52, DOI 10.1159/000012079; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Gaber A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-498; Galizia G, 2004, DIS COLON RECTUM, V47, P1904, DOI 10.1007/s10350-004-0695-8; Gallego MG, 2000, DIS COLON RECTUM, V43, P971; Hilska M, 2005, DIS COLON RECTUM, V48, P2197, DOI 10.1007/s10350-005-0202-x; Houet L, 2006, EUR J CANCER, V42, P1653, DOI 10.1016/j.ejca.2006.03.008; Huang Y, 2008, BIOCHEM BIOPH RES CO, V374, P658, DOI 10.1016/j.bbrc.2008.07.087; Kalejs M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-4; Katkoori VR, 2009, CLIN CANCER RES, V15, P2406, DOI 10.1158/1078-0432.CCR-08-1719; Kato K, 2009, INT J ONCOL, V35, P467, DOI 10.3892/ijo_00000358; Kim J, 2006, INT J CANCER, V118, P2269, DOI 10.1002/ijc.21656; Kwak JM, 2010, WORLD J GASTROENTERO, V16, P3897, DOI 10.3748/wjg.v16.i31.3897; Lagerstedt KK, 2005, INT J ONCOL, V27, P1707; Lan YT, 2007, INT J COLORECTAL DIS, V22, P499, DOI 10.1007/s00384-006-0194-6; Li M, 2009, COLORECTAL DIS, V11, P276, DOI 10.1111/j.1463-1318.2008.01591.x; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Loriot A, 2003, INT J CANCER, V105, P371, DOI 10.1002/ijc.11104; Lyall MS, 2006, CLIN CANCER RES, V12, P1184, DOI 10.1158/1078-0432.CCR-05-1864; Machado-Silva A, 2010, SEMIN CANCER BIOL, V20, P57, DOI 10.1016/j.semcancer.2010.02.005; Marcel V, 2010, FEBS LETT, V584, P4463, DOI 10.1016/j.febslet.2010.10.005; Martelange V, 2000, CANCER RES, V60, P3848; Matta A, 2008, J PROTEOME RES, V7, P2078, DOI 10.1021/pr7007797; Matta A, 2009, INT J CANCER, V125, P1398, DOI 10.1002/ijc.24517; Mollevi DG, 2007, CARCINOGENESIS, V28, P1241, DOI 10.1093/carcin/bgm012; Noske A, 2009, ONCOL REP, V22, P3, DOI 10.3892/or_00000398; Ogino S, 2008, CLIN CANCER RES, V14, P8221, DOI 10.1158/1078-0432.CCR-08-1841; Pancione M, 2010, HUM PATHOL, V41, P867, DOI 10.1016/j.humpath.2009.09.019; Peng JR, 2005, CANCER LETT, V219, P223, DOI 10.1016/j.canlet.2004.07.028; Pereira H, 1997, WORLD J SURG, V21, P210, DOI 10.1007/s002689900218; Resnick MB, 2004, CLIN CANCER RES, V10, P3069, DOI 10.1158/1078-0432.CCR-03-0462; Riener MO, 2009, INT J CANCER, V124, P352, DOI 10.1002/ijc.23966; Russo A, 2005, J CLIN ONCOL, V23, P7518, DOI 10.1200/JCO.2005.00.471; Samowitz WS, 2002, INT J CANCER, V99, P597, DOI 10.1002/ijc.10405; Scanlan MJ, 2000, CANCER LETT, V150, P155, DOI 10.1016/S0304-3835(99)00385-7; Shan JD, 2002, CANCER RES, V62, P290; Smyth EF, 2004, DIS COLON RECTUM, V47, P2086, DOI 10.1007/s10350-004-0710-0; SONG Z, 2011, BIOCH J; Starzynska T, 1997, EUR J GASTROEN HEPAT, V9, P183, DOI 10.1097/00042737-199702000-00014; Sun LC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-288; Takikita M, 2009, CANCER RES, V69, P2950, DOI 10.1158/0008-5472.CAN-08-3879; Tamada S, 2006, CLIN CANCER RES, V12, P4257, DOI 10.1158/1078-0432.CCR-05-2814; Tureci O, 2002, ONCOGENE, V21, P3879, DOI 10.1038/sj.onc.1205481; Tureci O, 1998, P NATL ACAD SCI USA, V95, P5211, DOI 10.1073/pnas.95.9.5211; VandenEynde BJ, 1997, CURR OPIN IMMUNOL, V9, P684, DOI 10.1016/S0952-7915(97)80050-7; Velazquez Elsa F, 2007, Cancer Immun, V7, P11; Vidaurreta M, 2008, INT J COLORECTAL DIS, V23, P581, DOI 10.1007/s00384-008-0454-8; Wang M, 2008, DNA CELL BIOL, V27, P307, DOI 10.1089/dna.2007.0692; Wang M, 2010, J CELL BIOCHEM, V111, P75, DOI 10.1002/jcb.22664; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Westra JL, 2005, J CLIN ONCOL, V23, P5635, DOI 10.1200/JCO.2005.04.096; Xu HP, 2007, CANCER RES, V67, P1239, DOI 10.1158/0008-5472.CAN-06-3688; Xu HP, 2004, UROLOGY, V64, P826, DOI 10.1016/j.urology.2004.05.012; Yokoe T, 2008, CANCER RES, V68, P1074, DOI 10.1158/0008-5472.CAN-07-0964; Yuan LM, 1999, CANCER RES, V59, P3215; Zhou LA, 2010, IUBMB LIFE, V62, P825, DOI 10.1002/iub.390	72	24	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22203	10.1371/journal.pone.0022203	http://dx.doi.org/10.1371/journal.pone.0022203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765952	Green Published, gold, Green Submitted			2022-12-25	WOS:000292699000029
J	Chen, M; Zou, M; Fu, BD; Li, X; Vibranovski, MD; Gan, XN; Wang, DQ; Wang, W; Long, MY; He, SP				Chen, Ming; Zou, Ming; Fu, Beide; Li, Xin; Vibranovski, Maria D.; Gan, Xiaoni; Wang, Dengqiang; Wang, Wen; Long, Manyuan; He, Shunping			Evolutionary Patterns of RNA-Based Duplication in Non-Mammalian Chordates	PLOS ONE			English	Article							NON-LTR RETROTRANSPOSONS; GENOMIC DNA; GENE; REVEALS; RETROGENES; SELECTION; MODEL; FISH; CHROMOSOMES; ORIGINATION	The role of RNA-based duplication, or retroposition, in the evolution of new gene functions in mammals, plants, and Drosophila has been widely reported. However, little is known about RNA-based duplication in non-mammalian chordates. In this study, we screened ten non-mammalian chordate genomes for retrocopies and investigated their evolutionary patterns. We identified numerous retrocopies in these species. Examination of the age distribution of these retrocopies revealed no burst of young retrocopies in ancient chordate species. Upon comparing these non-mammalian chordate species to the mammalian species, we observed that a larger fraction of the non-mammalian retrocopies was under strong evolutionary constraints than mammalian retrocopies are, as evidenced by signals of purifying selection and expression profiles. For the Western clawed frog, Medaka, and Sea squirt, many retrogenes have evolved gonad and brain expression patterns, similar to what was observed in human. Testing of retrogene movement in the Medaka genome, where the nascent sex chrosomes have been well assembled, did not reveal any significant gene movement. Taken together, our analyses demonstrate that RNA-based duplication generates many functional genes and can make a significant contribution to the evolution of non-mammalian genomes.	[Chen, Ming; Zou, Ming; Fu, Beide; Gan, Xiaoni; Wang, Dengqiang; He, Shunping] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Li, Xin; Wang, Wen] Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan Province, Peoples R China; [Vibranovski, Maria D.; Long, Manyuan] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Chen, Ming; Zou, Ming; Fu, Beide; Gan, Xiaoni; Wang, Dengqiang] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Wang, Dengqiang] Chinese Acad Fisheries Sci, Yangtze River Fisheries Res Inst, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; University of Chicago; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Fishery Sciences; Yangtze River Fisheries Research Institute, CAFS	Chen, M (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	mlong@uchicago.edu; clad@ihb.ac.cn	Li, Xin/A-4137-2011; FU, Beide/I-3072-2019; Vibranovski, Maria D./C-5599-2013	Li, Xin/0000-0001-8328-4894; FU, Beide/0000-0002-0264-5262; Vibranovski, Maria/0000-0001-8313-9726	National Natural Science Foundation of China [2007CB411601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China [2007CB411601] (http://www.nsfc.gov.cn/Portal0/default124.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida T, 1921, GENETICS, V6, P554; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bai YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r11; Betran E, 2004, CELL CYCLE, V3, P873; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; BROSIUS J, 1991, SCIENCE, V251, P753, DOI 10.1126/science.1990437; CHARLESWORTH B, 1991, SCIENCE, V251, P1030, DOI 10.1126/science.1998119; Dai HZ, 2006, GENE, V385, P96, DOI 10.1016/j.gene.2006.04.033; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; Fontanillas P, 2007, PLOS GENET, V3, P2256, DOI 10.1371/journal.pgen.0030210; Force A, 1999, GENETICS, V151, P1531; Fu BD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-657; Haas NB, 1997, GENE, V197, P305, DOI 10.1016/S0378-1119(97)00276-X; Haas NB, 2001, GENE, V265, P175, DOI 10.1016/S0378-1119(01)00344-4; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jurka J, 1998, CURR OPIN STRUC BIOL, V8, P333, DOI 10.1016/S0959-440X(98)80067-5; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kleene KC, 2001, MECH DEVELOP, V106, P3, DOI 10.1016/S0925-4773(01)00413-0; Kruiswijk CP, 2002, J IMMUNOL, V169, P1936, DOI 10.4049/jimmunol.169.4.1936; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; LONG MY, 1993, SCIENCE, V260, P91, DOI 10.1126/science.7682012; Marques AC, 2005, PLOS BIOL, V3, P1970, DOI 10.1371/journal.pbio.0030357; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Morin RD, 2006, GENOME RES, V16, P796, DOI 10.1101/gr.4871006; PAMILO P, 1993, MOL BIOL EVOL, V10, P271; Pan D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005040; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Petrov DA, 2002, THEOR POPUL BIOL, V61, P531, DOI 10.1006/tpbi.2002.1605; Petrov DA, 2000, SCIENCE, V287, P1060, DOI 10.1126/science.287.5455.1060; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Potrzebowski L, 2008, PLOS BIOL, V6, P709, DOI 10.1371/journal.pbio.0060080; Rychel AL, 2006, MOL BIOL EVOL, V23, P541, DOI 10.1093/molbev/msj055; Steinke D, 2006, J MOL EVOL, V62, P772, DOI 10.1007/s00239-005-0170-8; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; Wang W, 2006, PLANT CELL, V18, P1791, DOI 10.1105/tpc.106.041905; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yi SJ, 2002, MOL BIOL EVOL, V19, P2191, DOI 10.1093/oxfordjournals.molbev.a004043; Zhang JM, 2004, P NATL ACAD SCI USA, V101, P16246, DOI 10.1073/pnas.0407066101; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Zhu ZL, 2009, PLANT PHYSIOL, V151, P1943, DOI 10.1104/pp.109.142984	52	39	39	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21466	10.1371/journal.pone.0021466	http://dx.doi.org/10.1371/journal.pone.0021466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779328	Green Published, gold, Green Submitted			2022-12-25	WOS:000292680900006
J	Holliday, KL; Pye, SR; Thomson, W; Boonen, S; Borghs, H; Vanderschueren, D; Gielen, E; Huhtaniemi, IT; Adams, JE; Ward, KA; Bartfai, G; Casanueva, F; Finn, JD; Forti, G; Giwercman, A; Han, TS; Kula, K; Labrie, F; Lean, MEJ; Pendleton, N; Punab, M; Wu, FCW; O'Neill, TW				Holliday, Kate L.; Pye, Stephen R.; Thomson, Wendy; Boonen, Steven; Borghs, Herman; Vanderschueren, Dirk; Gielen, Evelien; Huhtaniemi, Ilpo T.; Adams, Judith E.; Ward, Kate A.; Bartfai, Gyorgy; Casanueva, Felipe; Finn, Joseph D.; Forti, Gianni; Giwercman, Aleksander; Han, Thang S.; Kula, Krzysztof; Labrie, Fernand; Lean, Michael E. J.; Pendleton, Neil; Punab, Margus; Wu, Frederick C. W.; O'Neill, Terence W.		EMAS Study Grp	The ESR1 (6q25) Locus Is Associated with Calcaneal Ultrasound Parameters and Radial Volumetric Bone Mineral Density in European Men	PLOS ONE			English	Article							AUTOMATED SERUM ASSAY; QUANTITATIVE ULTRASOUND; GENE POLYMORPHISMS; I COLLAGEN; OLDER MEN; TURNOVER; OSTEOPOROSIS; ESTROGEN; RISK; TESTOSTERONE	Purpose: Genome-wide association studies (GWAS) have identified 6q25, which incorporates the oestrogen receptor alpha gene (ESR1), as a quantitative trait locus for areal bone mineral density (BMDa) of the hip and lumbar spine. The aim of this study was to determine the influence of this locus on other bone health outcomes; calcaneal ultrasound (QUS) parameters, radial peripheral quantitative computed tomography (pQCT) parameters and markers of bone turnover in a population sample of European men. Methods: Eight single nucleotide polymorphisms (SNP) in the 6q25 locus were genotyped in men aged 40-79 years from 7 European countries, participating in the European Male Ageing Study (EMAS). The associations between SNPs and measured bone parameters were tested under an additive genetic model adjusting for centre using linear regression. Results: 2468 men, mean (SD) aged 59.9 (11.1) years had QUS measurements performed and bone turnover marker levels measured. A subset of 628 men had DXA and pQCT measurements. Multiple independent SNPs showed significant associations with BMD using all three measurement techniques. Most notably, rs1999805 was associated with a 0.10 SD (95%CI 0.05, 0.16; p = 0.0001) lower estimated BMD at the calcaneus, a 0.14 SD (95%CI 0.05, 0.24; p = 0.004) lower total hip BMDa, a 0.12 SD (95%CI 0.02, 0.23; p = 0.026) lower lumbar spine BMDa and a 0.18 SD (95%CI 0.06, 0.29; p = 0.003) lower trabecular BMD at the distal radius for each copy of the minor allele. There was no association with serum levels of bone turnover markers and a single SNP which was associated with cortical density was also associated with cortical BMC and thickness. Conclusions: Our data replicate previous associations found between SNPs in the 6q25 locus and BMDa at the hip and extend these data to include associations with calcaneal ultrasound parameters and radial volumetric BMD.	[Boonen, Steven] Katholieke Univ Leuven, Leuven Univ, Div Geriatr Med, Louvain, Belgium; [Boonen, Steven; Borghs, Herman; Vanderschueren, Dirk; Gielen, Evelien] Katholieke Univ Leuven, Leuven Univ, Ctr Metab Bone Dis, Louvain, Belgium; [Vanderschueren, Dirk] Katholieke Univ Leuven, Dept Androl & Endocrinol, Louvain, Belgium; [Huhtaniemi, Ilpo T.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Adams, Judith E.] Manchester Royal Infirm, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Ward, Kate A.] Elsie Widdowson Lab, MRC Human Nutr Res, Cambridge, England; [Bartfai, Gyorgy] Albert Szent Gyorgy Med Univ, Dept Obstet Gynaecol & Androl, Szeged, Hungary; [Casanueva, Felipe] Univ Santiago de Compostela, Dept Med, CHUS, Inst Salud Carlos III,CIBER Fisiopatol Obesidad &, Santiago De Compostela, Spain; [Finn, Joseph D.; Wu, Frederick C. W.] Univ Manchester, Manchester Royal Infirm, Manchester Acad Hlth Sci Ctr, Androl Res Unit,Dev & Regenerat Biomed Res Grp, Manchester M13 9WL, Lancs, England; [Forti, Gianni] Univ Florence, Endocrinol Unit, Dept Clin Physiopathol, Florence, Italy; [Giwercman, Aleksander] Lund Univ, Reprod Med Ctr, Skane Univ Hosp, Malmo, Sweden; [Han, Thang S.] UCL, Dept Endocrinol, London, England; [Kula, Krzysztof] Med Univ Lodz, Dept Androl & Reprod Endocrinol, Lodz, Poland; [Labrie, Fernand] Univ Laval, Lab Mol Endocrinol & Oncol, Quebec City, PQ, Canada; [Lean, Michael E. J.] Univ Glasgow, Dept Human Nutr, Glasgow, Lanark, Scotland; [Pendleton, Neil] Univ Manchester, Salford Royal NHS Trust, Sch Community Based Med, Salford, Lancs, England; [Punab, Margus] Tartu Univ Clin, United Labs, Androl Unit, Tartu, Estonia; [Holliday, Kate L.; Pye, Stephen R.; Thomson, Wendy; O'Neill, Terence W.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England	KU Leuven; KU Leuven; KU Leuven; Imperial College London; University of Manchester; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Szeged University; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Complexo Hospitalario Universitario de Santiago de Compostela; Instituto de Salud Carlos III; Universidade de Santiago de Compostela; University of Manchester; University of Florence; Lund University; Skane University Hospital; University of London; University College London; Medical University Lodz; Laval University; University of Glasgow; Salford Royal NHS Foundation Trust; University of Manchester; University of Tartu; University of Manchester	Holliday, KL (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England.	kata.holliday@manchester.ac.uk	Pendleton, Neil/F-2333-2015; Pye, Stephen R/D-9236-2011	Pendleton, Neil/0000-0003-0794-2386; Pye, Stephen R/0000-0002-7263-2897; Ward, Kate/0000-0001-7034-6750; Han, Thang/0000-0003-2570-0938; vanderschueren, dirk/0000-0003-1395-0104; Thomson, Wendy/0000-0002-9022-5179; Punab, Margus/0000-0001-9601-6311; O'Neill, Terence/0000-0002-8896-4677	Commission of the European Communities [QLK6-CT-2001-00258]; Arthritis Research UK; University Hospitals Leuven, Belgium; Scientific Research-Flanders, Belgium, (F.W.O.-Vlaanderen); Medical Research Council [MC_U105960371] Funding Source: researchfish; MRC [MC_U105960371] Funding Source: UKRI	Commission of the European Communities(European Commission); Arthritis Research UK(Versus Arthritis); University Hospitals Leuven, Belgium; Scientific Research-Flanders, Belgium, (F.W.O.-Vlaanderen)(FWO); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The European Male Ageing Study (EMAS) is funded by the Commission of the European Communities Fifth Framework Programme "Quality of Life and Management of Living Resources'' Grant QLK6-CT-2001-00258 and supported by funding from the Arthritis Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The EMAS principal investigator is Professor Frederick Wu, MD; Dept of Endocrinology, Manchester Royal Infirmary, UK. The authors wish to thank the men who participated in the eight countries, the research/nursing staff in the eight centres: C Pott, Manchester, E Wouters, Leuven, M Nilsson, Malmo, M del Mar Fernandez, Santiago de Compostela, M Jedrzejowska, Lodz, H-M Tabo, Tartu, A Heredi, Szeged, for their data collection and C Moseley, Manchester, for data entry and project coordination. Dr Vanderschueren is a senior clinical investigator supported by the Clinical Research Fund of the University Hospitals Leuven, Belgium. Dr. Boonen is a senior clinical investigator of the Fund for Scientific Research-Flanders, Belgium, (F.W.O.-Vlaanderen). Dr. Boonen is holder of the Leuven University Chair in Metabolic Bone Diseases.	Bachrach LK, 2001, TRENDS ENDOCRIN MET, V12, P22, DOI 10.1016/S1043-2760(00)00336-2; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bauer DC, 2007, OSTEOPOROSIS INT, V18, P771, DOI 10.1007/s00198-006-0317-5; Bauer DC, 2009, J BONE MINER RES, V24, P2032, DOI [10.1359/jbmr.090526, 10.1359/JBMR.090526]; Bland R, 2000, CLIN SCI, V98, P217, DOI 10.1042/CS19990252; Chaitou A, 2010, J BONE MINER RES, V25, P2313, DOI 10.1002/jbmr.124; Compston JE, 2001, PHYSIOL REV, V81, P419, DOI 10.1152/physrev.2001.81.1.419; Dennison E, 1999, OSTEOPOROSIS INT, V10, P384, DOI 10.1007/s001980050244; Falahati-Nini A, 2000, J CLIN INVEST, V106, P1553, DOI 10.1172/JCI10942; Garnero P, 2001, CLIN CHEM, V47, P694; Garnero P, 2008, CLIN CHEM, V54, P188, DOI 10.1373/clinchem.2007.094953; Gauderman W, QUANTO 1 1 COMPUTER; Gennari L, 2005, AM J EPIDEMIOL, V161, P307, DOI 10.1093/aje/kwi055; Ichikawa S, 2010, J BONE MINER RES, V25, P1821, DOI 10.1002/jbmr.62; Ioannidis JPA, 2004, JAMA-J AM MED ASSOC, V292, P2105, DOI 10.1001/jama.292.17.2105; Kenny AM, 1998, J GERONTOL A-BIOL, V53, pM419, DOI 10.1093/gerona/53A.6.M419; Khosla S, 2002, J CLIN ENDOCR METAB, V87, P1443, DOI 10.1210/jc.87.4.1443; Khosla S, 1998, J CLIN ENDOCR METAB, V83, P2266, DOI 10.1210/jc.83.7.2266; Labrie F, 2007, J STEROID BIOCHEM, V103, P178, DOI 10.1016/j.jsbmb.2006.09.034; Leder Benjamin, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P241, DOI 10.1097/MED.0b013e32814db87b; Leder BZ, 2003, J CLIN ENDOCR METAB, V88, P204, DOI 10.1210/jc.2002-021036; Lee DM, 2009, INT J ANDROL, V32, P11, DOI 10.1111/j.1365-2605.2008.00879.x; Limer KL, 2009, J BONE MINER RES, V24, P314, DOI [10.1359/jbmr.080912, 10.1359/JBMR.080912]; Liu JM, 2010, J CLIN ENDOCR METAB, V95, pE112, DOI 10.1210/jc.2009-2768; Marin F, 2006, J BONE MINER RES, V21, P1126, DOI 10.1359/JBMR.060417; Mellstrom D, 2008, J BONE MINER RES, V23, P1552, DOI 10.1359/JBMR.080518; Meszaros S, 2007, JOINT BONE SPINE, V74, P79, DOI 10.1016/j.jbspin.2006.04.008; Moayyeri A, 2009, J BONE MINER RES, V24, P1319, DOI [10.1359/jbmr.090212, 10.1359/JBMR.090212]; Ongphiphadhanakul B, 1998, CLIN ENDOCRINOL, V49, P803, DOI 10.1046/j.1365-2265.1998.00631.x; Paternoster L, 2010, J CLIN ENDOCR METAB, V95, P3940, DOI 10.1210/jc.2010-0025; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013217; Szulc P, 2008, ANN RHEUM DIS, V67, P1249, DOI 10.1136/ard.2007.077941; Van Pottelbergh I, 2003, J CLIN ENDOCR METAB, V88, P3075, DOI 10.1210/jc.2002-021691; Vanderschueren D, 2010, OSTEOPOROSIS INT, V21, P1331, DOI 10.1007/s00198-009-1144-2; Vanderschueren D, 2004, ENDOCR REV, V25, P389, DOI 10.1210/er.2003-0003; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Ward KA, 2011, OSTEOPOROSIS INT, V22, P1513, DOI 10.1007/s00198-010-1437-5; Wu FCW, 2008, J CLIN ENDOCR METAB, V93, P2737, DOI 10.1210/jc.2007-1972	41	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e22037	10.1371/journal.pone.0022037	http://dx.doi.org/10.1371/journal.pone.0022037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760950	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000292655400042
J	Itzhaki, Z				Itzhaki, Zohar			Domain-Domain Interactions Underlying Herpesvirus-Human Protein-Protein Interaction Networks	PLOS ONE			English	Article							MOLECULAR INTERACTION DATABASE; EPSTEIN-BARR-VIRUS; CODON USAGE; PATHOGENS; IL-10; HOST	Protein-domains play an important role in mediating protein-protein interactions. Furthermore, the same domain-pairs mediate different interactions in different contexts and in various organisms, and therefore domain-pairs are considered as the building blocks of interactome networks. Here we extend these principles to the host-virus interface and find the domain-pairs that potentially mediate human-herpesvirus interactions. Notably, we find that the same domain-pairs used by other organisms for mediating their interactions underlie statistically significant fractions of human-virus protein inter-interaction networks. Our analysis shows that viral domains tend to interact with human domains that are hubs in the human domain-domain interaction network. This may enable the virus to easily interfere with a variety of mechanisms and processes involving various and different human proteins carrying the relevant hub domain. Comparative genomics analysis provides hints at a molecular mechanism by which the virus acquired some of its interacting domains from its human host.	Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, IMRIC, Fac Med, Jerusalem, Israel	Hebrew University of Jerusalem	Itzhaki, Z (corresponding author), Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, IMRIC, Fac Med, Jerusalem, Israel.	zohari@ekmd.huji.ac.il	Barnett-Itzhaki, Zohar/AAA-4029-2021	Barnett-Itzhaki, Zohar/0000-0001-9891-9397	Israel Science Foundation [1171/09]	Israel Science Foundation(Israel Science Foundation)	This study was supported by grant 1171/09 from the Israel Science Foundation administered by the Israeli Academy for Sciences and Humanities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Bahir I, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.71; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739; Costa S., 2008, V186, P383, DOI 10.1007/978-3-540-72843-6_16; Driscoll T, 2009, NUCLEIC ACIDS RES, V37, pD647, DOI 10.1093/nar/gkn799; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fossum E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000570; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Itzhaki Z, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r125; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-29; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Navratil V, 2009, NUCLEIC ACIDS RES, V37, pD661, DOI 10.1093/nar/gkn794; Nye TMW, 2005, BIOINFORMATICS, V21, P993, DOI 10.1093/bioinformatics/bti086; Pawson T, 2002, FEBS LETT, V513, P2, DOI 10.1016/S0014-5793(01)03292-6; PITMAN E. J. G., 1937, J. Roy. Statist. Soc. 1937., (Suppl.), V4, P119; Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3; Schlicker A, 2007, BIOINFORMATICS, V23, P859, DOI 10.1093/bioinformatics/btm012; Schuster-Bockler B, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-259; Stein A, 2009, NUCLEIC ACIDS RES, V37, pD300, DOI 10.1093/nar/gkn690; Verschuren EW, 2004, J GEN VIROL, V85, P1347, DOI 10.1099/vir.0.79812-0; Yoon SI, 2005, STRUCTURE, V13, P551, DOI 10.1016/j.str.2005.01.016	29	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21724	10.1371/journal.pone.0021724	http://dx.doi.org/10.1371/journal.pone.0021724			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760902	Green Submitted, Green Published, gold			2022-12-25	WOS:000292655400013
J	Schluter, A; Ruiz-Trillo, I; Pujol, A				Schlueter, Agatha; Ruiz-Trillo, Inaki; Pujol, Aurora			Phylogenomic Evidence for a Myxococcal Contribution to the Mitochondrial Fatty Acid Beta-Oxidation	PLOS ONE			English	Article							GENE-TRANSFER; SYNTROPHUS-ACIDITROPHICUS; BACTERIAL GENOMES; EVOLUTION; PROTEIN; ORIGIN; BIOLOGY; PROTEOBACTERIA; MICROORGANISMS; VISUALIZATION	Background: The origin of eukaryotes remains a fundamental question in evolutionary biology. Although it is clear that eukaryotic genomes are a chimeric combination of genes of eubacterial and archaebacterial ancestry, the specific ancestry of most eubacterial genes is still unknown. The growing availability of microbial genomes offers the possibility of analyzing the ancestry of eukaryotic genomes and testing previous hypotheses on their origins. Methodology/Principal Findings: Here, we have applied a phylogenomic analysis to investigate a possible contribution of the Myxococcales to the first eukaryotes. We conducted a conservative pipeline with homologous sequence searches against a genomic sampling of 40 eukaryotic and 357 prokaryotic genomes. The phylogenetic reconstruction showed that several eukaryotic proteins traced to Myxococcales. Most of these proteins were associated with mitochondrial lipid intermediate pathways, particularly enzymes generating reducing equivalents with pivotal roles in fatty acid beta-oxidation metabolism. Our data suggest that myxococcal species with the ability to oxidize fatty acids transferred several genes to eubacteria that eventually gave rise to the mitochondrial ancestor. Later, the eukaryotic nucleocytoplasmic lineage acquired those metabolic genes through endosymbiotic gene transfer. Conclusions/Significance: Our results support a prokaryotic origin, different from alpha-proteobacteria, for several mitochondrial genes. Our data reinforce a fluid prokaryotic chromosome model in which the mitochondrion appears to be an important entry point for myxococcal genes to enter eukaryotes.	[Schlueter, Agatha; Pujol, Aurora] Inst Invest Biomed Bellvitge IDIBELL, Neurometabol Dis Lab, Barcelona, Spain; [Schlueter, Agatha; Pujol, Aurora] Univ Barcelona, Hosp Univ Bellvitge, Inst Neuropathol, Barcelona, Spain; [Schlueter, Agatha; Pujol, Aurora] Ctr Invest Red Enfermedades Raras CIBERER, Valencia, Spain; [Ruiz-Trillo, Inaki] Univ Barcelona, Dept Genet, Barcelona, Spain; [Ruiz-Trillo, Inaki] Univ Barcelona, Inst Recerca Biodiversitat Irbio, Barcelona, Spain; [Ruiz-Trillo, Inaki; Pujol, Aurora] ICREA, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of Barcelona; ICREA	Schluter, A (corresponding author), Inst Invest Biomed Bellvitge IDIBELL, Neurometabol Dis Lab, Barcelona, Spain.	apujol@idibell.cat	Ruiz-Trillo, Iñaki/H-3217-2019; Pujol, Aurora/N-4990-2014; Ruiz-Trillo, Iñaki/C-1360-2008; Schlüter, Agatha/N-4097-2014; Schluter, Agatha/AAA-9665-2021	Ruiz-Trillo, Iñaki/0000-0001-6547-5304; Pujol, Aurora/0000-0002-9606-0600; Ruiz-Trillo, Iñaki/0000-0001-6547-5304; Schlüter, Agatha/0000-0001-6732-1528; 	Ministerio de Ciencia e Innovacion (MICINN) [BFU2008-02839/BMC]; Fondo de Investigacion Sanitaria (FIS) [ECA07/055]; ICREA Funding Source: Custom	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); ICREA(ICREA)	A. Schluter is a recipient of Fondo de Investigacion Sanitaria (FIS) (ECA07/055). Centro de Investigacion en Red sobre Enfermedades Raras (CIBERER) is an initiative of the Instituto de Salud Carlos III. IR-T's contribution was supported by a Ministerio de Ciencia e Innovacion (MICINN) grant awarded to IR-T (BFU2008-02839/BMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JF, 2003, PHILOS T R SOC B, V358, P19, DOI 10.1098/rstb.2002.1191; Alvarez HM, 2002, APPL MICROBIOL BIOT, V60, P367, DOI 10.1007/s00253-002-1135-0; Azad RK, 2007, NUCLEIC ACIDS RES, V35, P4629, DOI 10.1093/nar/gkm204; Boussau B, 2004, P NATL ACAD SCI USA, V101, P9722, DOI 10.1073/pnas.0400975101; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Dworkin M, 1996, MICROBIOL REV, V60, P70, DOI 10.1128/MMBR.60.1.70-102.1996; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Ensenauer R, 2005, J BIOL CHEM, V280, P32309, DOI 10.1074/jbc.M504460200; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Esser C, 2007, BIOL LETT-UK, V3, P180, DOI 10.1098/rsbl.2006.0582; Gabaldon T, 2003, SCIENCE, V301, P609, DOI 10.1126/science.1085463; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Jackson BE, 1999, ARCH MICROBIOL, V171, P107, DOI 10.1007/s002030050685; Javaux Emmanuelle, 2011, P414, DOI 10.1017/CBO9780511933875.028; Karlin S, 2000, J BACTERIOL, V182, P5238, DOI 10.1128/JB.182.18.5238-5250.2000; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; LANE N, NATURE, V467, P929; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Leonardy S, 2010, EMBO J, V29, P2276, DOI 10.1038/emboj.2010.114; Lopez-Garcia P, 2006, BIOESSAYS, V28, P525, DOI 10.1002/bies.20413; Margulis L, 2006, P NATL ACAD SCI USA, V103, P13080, DOI 10.1073/pnas.0604985103; Martin W, 1999, BIOESSAYS, V21, P99, DOI 10.1002/(SICI)1521-1878(199902)21:2<99::AID-BIES3>3.3.CO;2-2; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; MCDANIEL LD, SCIENCE, V330, P50; McInerney MJ, 2007, P NATL ACAD SCI USA, V104, P7600, DOI 10.1073/pnas.0610456104; McInerney MJ, 2009, CURR OPIN BIOTECH, V20, P623, DOI 10.1016/j.copbio.2009.10.001; Miller M. A., 2010, CIPRES PORTALS; Moreira D, 1998, J MOL EVOL, V47, P517, DOI 10.1007/PL00006408; Mrazek J, 1999, ANN NY ACAD SCI, V870, P314, DOI 10.1111/j.1749-6632.1999.tb08893.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pereto J, 2005, J MOL EVOL, V61, P65, DOI 10.1007/s00239-004-0280-8; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; RICHARDS TA, CURR BIOL, V21, pR112; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Searcy DG, 2003, CELL RES, V13, P229, DOI 10.1038/sj.cr.7290168; Shen YQ, 2009, NUCLEIC ACIDS RES, V37, P5619, DOI 10.1093/nar/gkp566; Sousa DZ, 2009, FEMS MICROBIOL ECOL, V68, P257, DOI 10.1111/j.1574-6941.2009.00680.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Watkins PA, 1997, PROG LIPID RES, V36, P55, DOI 10.1016/S0163-7827(97)00004-0; Winkler U, 2003, PLANT PHYSIOL, V131, P753, DOI 10.1104/pp.013151	52	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21989	10.1371/journal.pone.0021989	http://dx.doi.org/10.1371/journal.pone.0021989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760940	Green Published, Green Submitted, gold			2022-12-25	WOS:000292655400035
J	Perrot-Applanat, M; Vacher, S; Toullec, A; Pelaez, I; Velasco, G; Cormier, F; Saad, HE; Lidereau, R; Baud, V; Bieche, I				Perrot-Applanat, Martine; Vacher, Sophie; Toullec, Aurore; Pelaez, Irma; Velasco, Guillaume; Cormier, Francoise; Saad, Hanan El Sheikh; Lidereau, Rosette; Baud, Veronique; Bieche, Ivan			Similar NF-kappa B Gene Signatures in TNF-alpha Treated Human Endothelial Cells and Breast Tumor Biopsies	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INFLAMMATORY CYTOKINES; SIGNAL-TRANSDUCTION; GM-CSF; EXPRESSION; CANCER; ACTIVATION; TRANSCRIPTION; TARGET; ROLES	Background: Endothelial dysfunction has been implicated in the pathogenesis of diverse pathologies ranging from vascular and immune diseases to cancer. TNF-alpha is one of the mediators of endothelial dysfunction through the activation of transcription factors, including NF-kappa B. While HUVEC (macrovascular cells) have been largely used in the past, here, we documented an NF-kappa B gene signature in TNF alpha-stimulated microvascular endothelial cells HMEC often used in tumor angiogenesis studies. Methodology/Principal Findings: We measured mRNA expression of 55 NF-kappa B related genes using quantitative RT-PCR in HUVEC and HMEC. Our study identified twenty genes markedly up-regulated in response to TNF alpha, including adhesion molecules, cytokines, chemokines, and apoptosis regulators, some of them being identified as TNF-alpha-inducible genes for the first time in endothelial cells (two apoptosis regulators, TNFAIP3 and TNFRSF10B/Trail R2 (DR5), the chemokines GM-CSF/CSF2 and MCF/CSF1, and CD40 and TNF-alpha itself, as well as NF-kappa B components (RELB, NFKB1or 50/p105 and NFKB2 or p52/p100). For eight genes, the fold induction was much higher in HMEC, as compared to HUVEC. Most importantly, our study described for the first time a connection between NF-kappa B activation and the induction of most, if not all, of these genes in HMEC as evaluated by pharmacological inhibition and RelA expression knock-down by RNA interference. Moreover, since TNF-alpha is highly expressed in tumors, we further applied the NF-kappa B gene signature documented in TNF alpha-stimulated endothelial cells to human breast tumors. We found a significant positive correlation between TNF and the majority (85 %) of the identified endothelial TNF-induced genes in a well-defined series of 96 (48 ER alpha positive and 48 ER alpha negative) breast tumors. Conclusion/Significance: Taken together these data suggest the potential use of this NF-kappa B gene signature in analyzing the role of TNF-alpha in the endothelial dysfunction, as well as in breast tumors independently of the presence of ER alpha.	[Perrot-Applanat, Martine; Toullec, Aurore; Pelaez, Irma; Velasco, Guillaume; Saad, Hanan El Sheikh] INSERM, U965, Paris, France; [Perrot-Applanat, Martine; Toullec, Aurore; Pelaez, Irma; Velasco, Guillaume; Saad, Hanan El Sheikh] Univ Paris Diderot, Paris, France; [Vacher, Sophie; Lidereau, Rosette; Bieche, Ivan] Hop Rene Huguenin, FNCLCC, Inst Curie, INSERM,U735, St Cloud, France; [Cormier, Francoise; Baud, Veronique] Inst Cochin, INSERM, U1016, Paris, France; [Cormier, Francoise; Baud, Veronique] CNRS, UMR8104, Paris, France; [Cormier, Francoise; Baud, Veronique; Bieche, Ivan] Univ Paris 05, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Perrot-Applanat, M (corresponding author), INSERM, U965, Paris, France.	martine.applanat@inserm.fr	Velasco, Guillaume/AAM-2447-2020; Baud, Veronique/F-7699-2013; Baud, Veronique/AAL-3950-2020; Bièche, Ivan/O-7399-2017	Baud, Veronique/0000-0002-4090-718X; Baud, Veronique/0000-0002-4090-718X; Bièche, Ivan/0000-0002-2430-5429; Cormier, Francoise/0000-0002-6904-5122	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Centre Rene Huguenin (Saint-Cloud, France); Universite Paris Diderot, France; Region Ile de France; Agence Nationale pour la Recherche; Association pour la Recherche sur le Cancer; Belgian InterUniversity Attraction Pole; Canceropole Ile-de-France; Institut National du Cancer; Universite Paris Descartes, France	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Centre Rene Huguenin (Saint-Cloud, France); Universite Paris Diderot, France; Region Ile de France(Region Ile-de-France); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Belgian InterUniversity Attraction Pole(Belgian Federal Science Policy Office); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer(Institut National du Cancer (INCA) France); Universite Paris Descartes, France	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National de la Recherche Scientifique (CNRS), the Centre Rene Huguenin (Saint-Cloud, France) and Universite Paris Diderot, France. A. Toullec is supported by a grant from Region Ile de France. V. Baud is supported by grants from Agence Nationale pour la Recherche, Association pour la Recherche sur le Cancer, Belgian InterUniversity Attraction Pole, Canceropole Ile-de-France, Institut National du Cancer and Universite Paris Descartes, France. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation in the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bernardini G, 2003, J IMMUNOL METHODS, V273, P83, DOI 10.1016/S0022-1759(02)00420-9; Bieche I, 2001, ONCOGENE, V20, P8109, DOI 10.1038/sj.onc.1204917; Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Bieche I, 2007, ENDOCR-RELAT CANCER, V14, P1039, DOI 10.1677/erc.1.01301; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Cao YX, 2003, J MAMMARY GLAND BIOL, V8, P215, DOI 10.1023/A:1025905008934; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gasparini C, 2009, EUR J IMMUNOL, V39, P2215, DOI 10.1002/eji.200939209; Goebeler M, 2001, BLOOD, V97, P46, DOI 10.1182/blood.V97.1.46; Hamilton JA, 2002, TRENDS IMMUNOL, V23, P403, DOI 10.1016/S1471-4906(02)02260-3; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HOU JZ, 1994, P NATL ACAD SCI USA, V91, P11641, DOI 10.1073/pnas.91.24.11641; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karl E, 2005, CANCER RES, V65, P5063, DOI 10.1158/0008-5472.CAN-05-0140; Karsan A, 1996, J BIOL CHEM, V271, P27201, DOI 10.1074/jbc.271.44.27201; Karsan A, 1996, BLOOD, V87, P3089, DOI 10.1182/blood.V87.8.3089.bloodjournal8783089; Kieusseian A, 2006, BLOOD, V107, P492, DOI 10.1182/blood-2005-02-0529; Kim DW, 2000, CARCINOGENESIS, V21, P871, DOI 10.1093/carcin/21.5.871; Krishnaswamy G, 1998, MICROVASC RES, V55, P189, DOI 10.1006/mvre.1998.2079; Kuldo JM, 2005, AM J PHYSIOL-CELL PH, V289, pC1229, DOI 10.1152/ajpcell.00620.2004; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Lenhoff S, 1996, CYTOKINE, V8, P702, DOI 10.1006/cyto.1996.0093; Levkau B, 1999, NAT CELL BIOL, V1, P227, DOI 10.1038/12050; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Marui N, 2005, BIOCHEM J, V390, P317, DOI 10.1042/BJ20041659; Mocellin S, 2005, CYTOKINE GROWTH F R, V16, P35, DOI 10.1016/j.cytogfr.2004.11.001; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; QUESENBERRY PJ, 1980, BLOOD, V56, P1060, DOI 10.1182/blood.V56.6.1060.1060; Rossol M, 2007, J IMMUNOL, V179, P4239, DOI 10.4049/jimmunol.179.6.4239; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Schumm K, 2006, EMBO J, V25, P4820, DOI 10.1038/sj.emboj.7601343; Shishodia Shishir, 2004, Cancer Treat Res, V119, P139; Sors A, 2008, CLIN CANCER RES, V14, P901, DOI 10.1158/1078-0432.CCR-07-1419; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Stroka DM, 1999, BLOOD, V93, P3803, DOI 10.1182/blood.V93.11.3803.411a27_3803_3810; ten Hagen TLM, 2008, IMMUNOL REV, V222, P299, DOI 10.1111/j.1600-065X.2008.00619.x; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Wosik K, 2007, J NEUROL SCI, V259, P53, DOI 10.1016/j.jns.2006.08.018; Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015; Zha R, 2005, BIOCHEM BIOPH RES CO, V327, P985, DOI 10.1016/j.bbrc.2004.12.109; Zhou J, 2002, INFLAMM RES, V51, P332, DOI 10.1007/PL00000312	57	34	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21589	10.1371/journal.pone.0021589	http://dx.doi.org/10.1371/journal.pone.0021589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754991	gold, Green Published, Green Submitted			2022-12-25	WOS:000292632000015
J	van Abel, D; Holzel, DR; Jain, S; Lun, FMF; Zheng, YMWL; Chen, EZ; Sun, H; Chiu, RWK; Lo, YMD; van Dijk, M; Oudejans, CBM				van Abel, Daan; Holzel, Dennis R.; Jain, Shushant; Lun, Fiona M. F.; Zheng, Yama W. L.; Chen, Eric Z.; Sun, Hao; Chiu, Rossa W. K.; Lo, Y. M. Dennis; van Dijk, Marie; Oudejans, Cees B. M.			SFRS7-Mediated Splicing of Tau Exon 10 Is Directly Regulated by STOX1A in Glial Cells	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DIFFERENTIAL EXPRESSION; 9G8; PREECLAMPSIA; ENHANCER; BIOLOGY; INTRON; GROWTH; BRAIN; DNA	Background: In this study, we performed a genome-wide search for effector genes bound by STOX1A, a winged helix transcription factor recently demonstrated to be involved in late onset Alzheimer's disease and affecting the amyloid processing pathway. Methodology/Principal Findings: Our results show that out of 218 genes bound by STOX1A as identified by chromatin-immunoprecipitation followed by sequencing (ChIP-Seq), the serine/arginine-rich splicing factor 7 (SFRS7) was found to be induced, both at the mRNA and protein levels, by STOX1A after stable transfection in glial cells. The increase in SFRS7 was followed by an increase in the 4R/3R ratios of the microtubule-associated protein tau (MAPT) by differential exon 10 splicing. Secondly, STOX1A also induced expression of total tau both at the mRNA and protein levels. Upregulation of total tau expression (SFRS7-independent) and tau exon 10 splicing (SFRS7-independent), as shown in this study to be both affected by STOX1A, is known to have implications in neurodegeneration. Conclusions: Our data further supports the functional importance and central role of STOX1A in neurodegeneration.	[van Abel, Daan; van Dijk, Marie; Oudejans, Cees B. M.] Vrije Univ Amsterdam Med Ctr, Dept Clin Chem, Amsterdam, Netherlands; [Holzel, Dennis R.; Jain, Shushant] Vrije Univ Amsterdam Med Ctr, Sect Med Genom, Dept Clin Genet, Amsterdam, Netherlands; [Lun, Fiona M. F.; Zheng, Yama W. L.; Chen, Eric Z.; Sun, Hao; Chiu, Rossa W. K.; Lo, Y. M. Dennis] Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Chinese University of Hong Kong; Prince of Wales Hospital	van Abel, D (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Chem, Amsterdam, Netherlands.	cbm.oudejans@vumc.nl	Sun, Hao/J-9964-2013; c, c/I-5855-2016; van Dijk, Marie/L-1901-2014; sun, hao/GRS-7732-2022; Lo, Yuk Ming Dennis/D-4468-2011; Sun, Hao/T-5576-2019	Sun, Hao/0000-0002-5547-9501; Lo, Yuk Ming Dennis/0000-0001-8746-0293; Sun, Hao/0000-0002-5547-9501; Oudejans, Cees/0000-0003-0717-4946; van Dijk, Marie/0000-0003-1461-3441	University Grants Committee of the Government of the Hong Kong Special Administrative Region, China [AoE/M-04/06]	University Grants Committee of the Government of the Hong Kong Special Administrative Region, China	This study was partially supported by the University Grants Committee of the Government of the Hong Kong Special Administrative Region, China, under the Areas of Excellence Scheme (AoE/M-04/06). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-12; Arai T, 2001, ACTA NEUROPATHOL, V101, P167; Armstrong RA, 2009, FOLIA NEUROPATHOL, V47, P289; BARNES EN, 1981, IN VITRO CELL DEV B, V17, P619, DOI 10.1007/BF02618461; BIEDLER JL, 1973, CANCER RES, V33, P2643; BRENNAN RG, 1993, CELL, V74, P773, DOI 10.1016/0092-8674(93)90456-Z; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Ding S, 2011, NEUROBIOL AGING; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Galiana-Arnoux D, 2003, J BIOL CHEM, V278, P32943, DOI 10.1074/jbc.M301090200; Gao L, 2007, MOL CELL NEUROSCI, V34, P48, DOI 10.1016/j.mcn.2006.10.004; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; KSIEZAKREDING H, 1995, J NEUROSCI RES, V41, P583, DOI 10.1002/jnr.490410504; Li XL, 2000, RNA, V6, P1847, DOI 10.1017/S1355838200000674; Newman M, 2007, BBA-MOL BASIS DIS, V1772, P285, DOI 10.1016/j.bbadis.2006.12.001; ROSS RA, 1983, J NATL CANCER I, V71, P741; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; SONG WH, 1995, NUCLEIC ACIDS RES, V23, P3609, DOI 10.1093/nar/23.17.3609; van Dijk M, 2005, NAT GENET, V37, P514, DOI 10.1038/ng1541; van Dijk M, 2010, J ALZHEIMERS DIS, V19, P673, DOI 10.3233/JAD-2010-1265	22	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21994	10.1371/journal.pone.0021994	http://dx.doi.org/10.1371/journal.pone.0021994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755018	Green Published, gold			2022-12-25	WOS:000292632000045
J	Gandotra, S; Lim, K; Girousse, A; Saudek, V; O'Rahilly, S; Savage, DB				Gandotra, Sheetal; Lim, Koini; Girousse, Amandine; Saudek, Vladimir; O'Rahilly, Stephen; Savage, David B.			Human Frame Shift Mutations Affecting the Carboxyl Terminus of Perilipin Increase Lipolysis by Failing to Sequester the Adipose Triglyceride Lipase (ATGL) Coactivator AB-hydrolase-containing 5 (ABHD5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; LIPID DROPLETS; STIMULATED LIPOLYSIS; ADIPOCYTE LIPOLYSIS; PROTEIN; CGI-58; TRANSLOCATION; ACTIVATION; EXPRESSION; RESISTANCE	Perilipin (PLIN1) is a constitutive adipocyte lipid droplet coat protein. N-terminal amphipathic helices and central hydrophobic stretches are thought to anchor it on the lipid droplet, where it appears to function as a scaffold protein regulating lipase activity. We recently identified two different C-terminal PLIN1 frame shift mutations (Leu-404fs and Val-398fs) in patients with a novel subtype of partial lipodystrophy, hypertriglyceridemia, severe insulin resistance, and type 2 diabetes (Gandotra, S., Le Dour, C., Bottomley, W., Cervera, P., Giral, P., Reznik, Y., Charpentier, G., Auclair, M., Delepine, M., Barroso, I., Semple, R. K., Lathrop, M., Lascols, O., Capeau, J., O'Rahilly, S., Magre, J., Savage, D. B., and Vigouroux, C. (2011) N. Engl. J. Med. 364, 740-748.) When overexpressed in preadipocytes, both mutants fail to inhibit basal lipolysis. Here we used bimolecular fluorescence complementation assays to show that the mutants fail to bind ABHD5, permitting its constitutive coactivation of ATGL, resulting in increased basal lipolysis. siRNA-mediated knockdown of either ABHD5 or ATGL expression in the stably transfected cells expressing mutant PLIN1 reduced basal lipolysis. These insights from naturally occurring human variants suggest that the C terminus sequesters ABHD5 and thus inhibits basal ATGL activity. The data also suggest that pharmacological inhibition of ATGL could have therapeutic potential in patients with this rare but metabolically serious disorder.	[Gandotra, Sheetal] Univ Cambridge, Addenbrookes Hosp, IMS MRL, Cambridge CB2 0QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Gandotra, S (corresponding author), Univ Cambridge, Addenbrookes Hosp, IMS MRL, Hills Rd,,Box 289,Level 4, Cambridge CB2 0QQ, England.	gandotrasheetal@gmail.com; dbs23@medschl.cam.ac.uk	O'Rahilly, Stephen/ABF-6509-2020; girousse, amandine/GYD-3740-2022	O'Rahilly, Stephen/0000-0003-2199-4449; girousse, amandine/0000-0001-6142-4710; Savage, David Bousfield/0000-0002-7857-7032	Wellcome Trust; United Kingdom National Institute for Health Research Cambridge Biomedical Research Centre; Medical Research Council Centre for Obesity and Related Metabolic Disease; Medical Research Council [G0600717B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council Centre for Obesity and Related Metabolic Disease(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Wellcome Trust (to S. G., S. O., and D. B. S.), the United Kingdom National Institute for Health Research Cambridge Biomedical Research Centre, and the Medical Research Council Centre for Obesity and Related Metabolic Disease.	Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Chong BM, 2011, J BIOL CHEM, V286, P23254, DOI 10.1074/jbc.M110.217091; Clifford GM, 1997, BIOCHEM SOC T, V25, pS672, DOI 10.1042/bst025s672; Gandotra S, 2011, NEW ENGL J MED, V364, P740, DOI 10.1056/NEJMoa1007487; Garcia A, 2004, J BIOL CHEM, V279, P8409, DOI 10.1074/jbc.M311198200; Garcia A, 2003, J BIOL CHEM, V278, P625, DOI 10.1074/jbc.M206602200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hall AM, 2010, J LIPID RES, V51, P554, DOI 10.1194/jlr.M000976; Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kemena C, 2009, BIOINFORMATICS, V25, P2455, DOI 10.1093/bioinformatics/btp452; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Moore HPH, 2005, J BIOL CHEM, V280, P43109, DOI 10.1074/jbc.M506336200; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shen WJ, 2009, J LIPID RES, V50, P2306, DOI 10.1194/jlr.M900176-JLR200; Subramanian V, 2004, J LIPID RES, V45, P1983, DOI 10.1194/jlr.M400291-JLR200; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zhai W, 2010, HORM METAB RES, V42, P247, DOI 10.1055/s-0029-1243599; Zhang HH, 2003, J BIOL CHEM, V278, P51535, DOI 10.1074/jbc.M309591200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	32	64	65	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34998	35006		10.1074/jbc.M111.278853	http://dx.doi.org/10.1074/jbc.M111.278853			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21757733	hybrid, Green Published			2022-12-25	WOS:000295406300053
J	Murai, MJ; Chruszcz, M; Reddy, G; Grembecka, J; Cierpicki, T				Murai, Marcelo J.; Chruszcz, Maksymilian; Reddy, Gireesh; Grembecka, Jolanta; Cierpicki, Tomasz			Crystal Structure of Menin Reveals Binding Site for Mixed Lineage Leukemia (MLL) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; HISTONE METHYLTRANSFERASE COMPLEX; ENDOCRINE-NEOPLASIA TYPE-1; X-RAY-DIFFRACTION; GENE; MODEL; INTERACTS; PRODUCT; JUND	Menin is a tumor suppressor protein that is encoded by the MEN1 (multiple endocrine neoplasia 1) gene and controls cell growth in endocrine tissues. Importantly, menin also serves as a critical oncogenic cofactor of MLL (mixed lineage leukemia) fusion proteins in acute leukemias. Direct association of menin with MLL fusion proteins is required for MLL fusion protein-mediated leukemogenesis in vivo, and this interaction has been validated as a new potential therapeutic target for development of novel anti-leukemia agents. Here, we report the first crystal structure of menin homolog from Nematostella vectensis. Due to a very high sequence similarity, the Nematostella menin is a close homolog of human menin, and these two proteins likely have very similar structures. Menin is predominantly an alpha-helical protein with the protein core comprising three tetratricopeptide motifs that are flanked by two alpha-helical bundles and covered by a beta-sheet motif. A very interesting feature of menin structure is the presence of a large central cavity that is highly conserved between Nematostella and human menin. By employing site-directed mutagenesis, we have demonstrated that this cavity constitutes the binding site for MLL. Our data provide a structural basis for understanding the role of menin as a tumor suppressor protein and as an oncogenic co-factor of MLL fusion proteins. It also provides essential structural information for development of inhibitors targeting the menin-MLL interaction as a novel therapeutic strategy in MLL-related leukemias.	[Murai, Marcelo J.; Reddy, Gireesh; Grembecka, Jolanta; Cierpicki, Tomasz] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Chruszcz, Maksymilian] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University of Michigan System; University of Michigan; University of Virginia	Cierpicki, T (corresponding author), Univ Michigan, Dept Pathol, 1150 W Med Ctr Dr,MSRB1,Room 4510, Ann Arbor, MI 48109 USA.	tomaszc@umich.edu	Chruszcz, Maksymilian/E-6407-2011	Chruszcz, Maksymilian/0000-0001-7521-5485	American Chemical Society [RSG-11-082-01-DMC]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA160467] Funding Source: NIH RePORTER	American Chemical Society(American Chemical Society); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Research Scholar Grant RSG-11-082-01-DMC from the American Chemical Society (to T. C.) and a Leukemia and Lymphoma Society Translational Research Program grant (to J. G.).	Agarwal SK, 1999, CELL, V96, P143, DOI 10.1016/S0092-8674(00)80967-8; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balogh K, 2010, MOL CELL ENDOCRINOL, V326, P80, DOI 10.1016/j.mce.2010.04.011; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Caslini C, 2007, CANCER RES, V67, P7275, DOI 10.1158/0008-5472.CAN-06-2369; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen YX, 2006, P NATL ACAD SCI USA, V103, P1018, DOI 10.1073/pnas.0510347103; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; Cox MC, 2004, AM J CLIN PATHOL, V122, P298, DOI 10.1309/RX27R8GJQM330C22; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Grembecka J, 2010, J BIOL CHEM, V285, P40690, DOI 10.1074/jbc.M110.172783; Guru SC, 1998, P NATL ACAD SCI USA, V95, P1630, DOI 10.1073/pnas.95.4.1630; Heppner C, 2001, ONCOGENE, V20, P4917, DOI 10.1038/sj.onc.1204529; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jin SH, 2003, CANCER RES, V63, P4204; Kaji H, 2001, P NATL ACAD SCI USA, V98, P3837, DOI 10.1073/pnas.061358098; Kim H, 2003, CANCER RES, V63, P6135; Lemos MC, 2008, HUM MUTAT, V29, P22, DOI 10.1002/humu.20605; MacConaill LE, 2006, MOL CANCER RES, V4, P793, DOI 10.1158/1541-7786.MCR-06-0123; Marx SJ, 2005, NAT REV CANCER, V5, P367, DOI 10.1038/nrc1610; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM; Parashar V, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000589; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SORENSEN PHB, 1994, J CLIN INVEST, V93, P429, DOI 10.1172/JCI116978; Sukhodolets KE, 2003, MOL CELL BIOL, V23, P493, DOI 10.1128/MCB.23.2.493-509.2003; Sullivan JC, 2006, NUCLEIC ACIDS RES, V34, pD495, DOI 10.1093/nar/gkj020; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Veeramalai M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-358; Wang J, 2009, NAT STRUCT MOL BIOL, V16, P987, DOI 10.1038/nsmb.1645; Yaguchi H, 2004, MOL CELL BIOL, V24, P6569, DOI 10.1128/mcb.24.15.6569-6580.2004; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Yang YQ, 2007, MOL CELL ENDOCRINOL, V265, P34, DOI 10.1016/j.mce.2006.12.032; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003	48	68	70	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31742	31748		10.1074/jbc.M111.258186	http://dx.doi.org/10.1074/jbc.M111.258186			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757704	hybrid, Green Published			2022-12-25	WOS:000294487500067
J	Lu, M; Wang, J; Ives, HE; Pearce, D				Lu, Ming; Wang, Jian; Ives, Harlan E.; Pearce, David			mSIN1 Protein Mediates SGK1 Protein Interaction with mTORC2 Protein Complex and Is Required for Selective Activation of the Epithelial Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-ZIPPER PROTEIN; VACUOLAR H+-ATPASE; NA+ CHANNEL; KINASE; PHOSPHORYLATION; SERUM; TOR; TRANSPORT; RAPTOR; AKT	The mammalian target of rapamycin (mTOR) plays a central role in the regulation of a number of cellular processes including growth, metabolism, and ion transport. mTOR is found in two multiprotein complexes, mTORC1 and mTORC2, which phosphorylate distinct substrates and regulate distinct cellular processes. SGK1 is an mTORC2 substrate, which is a key regulator of epithelial Na+ transport mediated by the epithelial sodium channel. Although it is known that SGK1 physically interacts with mTORC2, it is unknown which mTORC2 component mediates this interaction or whether this interaction plays a physiologically relevant role in specific activation of SGK1. Here we identify mSIN1 as the mTORC2 component that mediates interaction with SGK1 and demonstrate that this interaction is required for SGK1 phosphorylation and epithelial sodium channel activation. We used the yeast two-hybrid system coupled with random mutagenesis to identify a mutant mSIN1 (mSIN1/Q68H), which does not interact with SGK1. Expression of this mutant does not restore SGK1 phosphorylation to wild-type levels in mSIN1-deficient murine embryo fibroblasts. Furthermore, in kidney epithelial cells, mSIN1/Q68H has a dominant-negative effect on SGK1 phosphorylation and on SGK1-dependent Na+ transport. Interestingly, this interaction appears to be specific in that another mTORC2 substrate, Akt, does not interact with mSIN1, and its phosphorylation and activity are unaffected by the Q68H mutation. These data support the conclusion that mTORC2 uses distinct strategies to phosphorylate different substrates and suggest a mechanism for mTORC2 specificity in the regulation of diverse cellular processes.	[Lu, Ming; Wang, Jian; Ives, Harlan E.; Pearce, David] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Pearce, David] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pearce, D (corresponding author), 600 16th St, San Francisco, CA 94107 USA.	david.pearce@ucsf.edu			National Institutes of Health [DK056695, DK085101]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085101, R01DK056695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK056695 and DK085101 (to D. P.).	Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lang F, 2001, Sci STKE, V2001, pre17, DOI 10.1126/stke.2001.108.re17; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; LinGoerke JL, 1997, BIOTECHNIQUES, V23, P409, DOI 10.2144/97233bm12; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; Lu M, 2010, J AM SOC NEPHROL, V21, P811, DOI 10.1681/ASN.2009111168; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Pearce LR, 2011, BIOCHEM J, V436, P169, DOI 10.1042/BJ20102103; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Soundararajan R, 2005, J BIOL CHEM, V280, P39970, DOI 10.1074/jbc.M508658200; Soundararajan R, 2007, J BIOL CHEM, V282, P36303, DOI 10.1074/jbc.M707287200; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wang J, 2001, AM J PHYSIOL-RENAL, V280, pF303, DOI 10.1152/ajprenal.2001.280.2.F303; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang LM, 2006, J BIOL CHEM, V281, P9859, DOI 10.1074/jbc.M512046200; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	45	39	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30647	30654		10.1074/jbc.M111.257592	http://dx.doi.org/10.1074/jbc.M111.257592			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757730	Green Published, hybrid			2022-12-25	WOS:000294283600044
J	Jelinek, J; Gharibyan, V; Estecio, MRH; Kondo, K; He, R; Chung, W; Lu, Y; Zhang, NX; Liang, SD; Kantarjian, HM; Cortes, JE; Issa, JPJ				Jelinek, Jaroslav; Gharibyan, Vazganush; Estecio, Marcos R. H.; Kondo, Kimie; He, Rong; Chung, Woonbok; Lu, Yue; Zhang, Nianxiang; Liang, Shoudan; Kantarjian, Hagop M.; Cortes, Jorge E.; Issa, Jean-Pierre J.			Aberrant DNA Methylation Is Associated with Disease Progression, Resistance to Imatinib and Shortened Survival in Chronic Myelogenous Leukemia	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; CPG ISLAND METHYLATION; LOW-DOSE DECITABINE; GENOME-WIDE SCREEN; CELL-LINE; HEMATOPOIETIC NEOPLASMS; PHILADELPHIA-CHROMOSOME; PROMOTER METHYLATION; COLORECTAL-CANCER	The epigenetic impact of DNA methylation in chronic myelogenous leukemia (CML) is not completely understood. To elucidate its role we analyzed 120 patients with CML for methylation of promoter-associated CpG islands of 10 genes. Five genes were identified by DNA methylation screening in the K562 cell line and 3 genes in patients with myeloproliferative neoplasms. The CDKN2B gene was selected for its frequent methylation in myeloid malignancies and ABL1 as the target of BCR-ABL translocation. Thirty patients were imatinib-naive (mostly treated by interferon-alpha before the imatinib era), 30 were imatinib-responsive, 50 were imatinib-resistant, and 10 were imatinib-intolerant. We quantified DNA methylation by bisulfite pyrosequencing. The average number of methylated genes was 4.5 per patient in the chronic phase, increasing significantly to 6.2 in the accelerated and 6.4 in the blastic phase. Higher numbers of methylated genes were also observed in patients resistant or intolerant to imatinib. These patients also showed almost exclusive methylation of a putative transporter OSCP1. Abnormal methylation of a Src suppressor gene PDLIM4 was associated with shortened survival independently of CML stage and imatinib responsiveness. We conclude that aberrant DNA methylation is associated with CML progression and that DNA methylation could be a marker associated with imatinib resistance. Finally, DNA methylation of PDLIM4 may help identify a subset of CML patients that would benefit from treatment with Src/Abl inhibitors.	[Jelinek, Jaroslav; Gharibyan, Vazganush; Estecio, Marcos R. H.; Kondo, Kimie; He, Rong; Chung, Woonbok; Lu, Yue; Kantarjian, Hagop M.; Cortes, Jorge E.; Issa, Jean-Pierre J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Zhang, Nianxiang; Liang, Shoudan] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Jelinek, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	jjelinek@mdanderson.org	Jelinek, Jaroslav/D-2282-2012; Jelinek, Jaroslav/O-6876-2019	Jelinek, Jaroslav/0000-0002-2533-0220; Issa, Jean-Pierre/0000-0003-2258-5030; Lu, Yue/0000-0002-5479-9095; Estecio, Marcos/0000-0002-6874-7413; Cortes, Jorge/0000-0002-8636-1071	National Institutes of Health [CA046939, CA100632]; National Cancer Institute [2P01CA049639-20A2]; NATIONAL CANCER INSTITUTE [P01CA049639, K25CA123344, P50CA100632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by CA046939 and CA100632 grants from the National Institutes of Health. J-P.J.I. is an American Cancer Society Clinical Research Professor supported by a generous gift from the F. M. Kirby Foundation. This work was also supported by the grant 2P01CA049639-20A2 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avramouli A, 2009, LEUKEMIA RES, V33, P1130, DOI 10.1016/j.leukres.2009.01.003; Baylin SB, 1998, ADV CANCER RES, V72, P141; Boumber YA, 2007, CANCER RES, V67, P1997, DOI 10.1158/0008-5472.CAN-06-3093; Chung W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002079; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; Dunwell T, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-44; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Estecio MRH, 2007, GENOME RES, V17, P1529, DOI 10.1101/gr.6417007; Feng W, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1762; Herman JG, 1996, CANCER RES, V56, P722; Herman JG, 1997, CANCER RES, V57, P837; Inoue A, 2010, FASEB J, V24, P485, DOI 10.1096/fj.09-143370; Issa JPJ, 2005, J CLIN ONCOL, V23, P3948, DOI 10.1200/JCO.2005.11.981; Issa JPJ, 1996, CANCER RES, V56, P973; Issa JPJ, 1997, CANCER RES, V57, P1678; Jabbour E, 2009, TARGET ONCOL, V4, P3, DOI 10.1007/s11523-008-0100-y; Jelinek J, 2004, BLOOD, V104, p319A; Jelinek J, 2003, BLOOD, V102, p660A; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Kanduri M, 2010, BLOOD, V115, P296, DOI 10.1182/blood-2009-07-232868; Kobayashi Y, 2005, J BIOL CHEM, V280, P32332, DOI 10.1074/jbc.M504246200; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Kondo Y, 2007, HEPATOL RES, V37, P974, DOI 10.1111/j.1872-034X.2007.00141.x; Kroeger H, 2008, BLOOD, V112, P1366, DOI 10.1182/blood-2007-11-126227; Kuang SQ, 2008, LEUKEMIA, V22, P1529, DOI 10.1038/leu.2008.130; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liu TH, 2006, CANCER RES, V66, P653, DOI 10.1158/0008-5472.CAN-05-3712; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; NELKIN BD, 1991, BLOOD, V77, P2431; Nguyen TT, 2000, BLOOD, V95, P2990, DOI 10.1182/blood.V95.9.2990.009k08_2990_2992; Nie XM, 2003, J CANCER RES CLIN, V129, P410, DOI 10.1007/s00432-003-0451-9; Oki Y, 2007, CANCER, V109, P899, DOI 10.1002/cncr.22470; Pehlivan M, 2009, LEUKEMIA RES, V33, P1062, DOI 10.1016/j.leukres.2008.11.013; Quintas-Cardama A, 2009, NAT REV CLIN ONCOL, V6, P535, DOI 10.1038/nrclinonc.2009.112; Roman-Gomez J, 2005, ONCOGENE, V24, P7213, DOI 10.1038/sj.onc.1208866; Roman-Gomez J, 2003, J CLIN ONCOL, V21, P1472, DOI 10.1200/JCO.2003.08.166; Roman-Gomez J, 2008, LEUKEMIA RES, V32, P487, DOI 10.1016/j.leukres.2007.07.021; Rush LJ, 2004, CANCER RES, V64, P2424, DOI 10.1158/0008-5472.CAN-03-2870; Shen LL, 2010, J CLIN ONCOL, V28, P605, DOI 10.1200/JCO.2009.23.4781; Strathdee G, 2007, CLIN CANCER RES, V13, P5048, DOI 10.1158/1078-0432.CCR-07-0919; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tellez CS, 2009, MELANOMA RES, V19, P146, DOI 10.1097/CMR.0b013e32832b274e; Toyota M, 1999, CANCER RES, V59, P2307; Toyota M, 2005, SEMIN ONCOL, V32, P521, DOI 10.1053/j.seminoncol.2005.07.003; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Vanaja DK, 2009, CANCER INVEST, V27, P264, DOI 10.1080/07357900802406319; Widschwendter A, 2004, CLIN CANCER RES, V10, P565, DOI 10.1158/1078-0432.CCR-0825-03; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zhang YJ, 2009, J CELL BIOL, V184, P785, DOI 10.1083/jcb.200810155; ZION M, 1994, P NATL ACAD SCI USA, V91, P10722, DOI 10.1073/pnas.91.22.10722	51	85	95	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22110	10.1371/journal.pone.0022110	http://dx.doi.org/10.1371/journal.pone.0022110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760961	Green Published, Green Submitted, gold			2022-12-25	WOS:000292657200050
J	Puspasari, N; Rowley, SM; Gordon, L; Lockhart, PJ; Ioannou, PA; Delatycki, MB; Sarsero, JP				Puspasari, Novita; Rowley, Simone M.; Gordon, Lavinia; Lockhart, Paul J.; Ioannou, Panos A.; Delatycki, Martin B.; Sarsero, Joseph P.			Long Range Regulation of Human FXN Gene Expression	PLOS ONE			English	Article							OCT-1 TRANSCRIPTION FACTOR; FRIEDREICH ATAXIA; EPIGENETIC CHANGES; GENOME BROWSER; FRATAXIN GENE; BINDING-SITE; DNA; PROMOTER; PROTEIN; MOUSE	Background: Friedreich ataxia (FRDA) is the most common form of hereditary ataxia characterized by the presence of a GAA trinucleotide repeat expansion within the first intron of the FXN gene. The expansion inhibits FXN gene expression resulting in an insufficiency of frataxin protein. Methodology/Principal Finding: In this study, computational analyses were performed on the 21.3 kb region upstream of exon 1 of the human FXN gene and orthologs from other species in order to identify conserved non-coding DNA sequences with potential regulatory functions. The conserved non-coding regions identified were individually analyzed in two complementing assay systems, a conventional luciferase reporter system and a novel Bacterial Artificial Chromosome (BAC)-based genomic reporter. The BAC system allows the evaluation of gene expression to be made in the context of its entire genomic locus and preserves the normal location and spacing of many regulatory elements which may be positioned over large distances from the initiation codon of the gene. Conclusions/Significance: The two approaches were used to identify a region of 17 bp located approximately 4.9 kb upstream of the first exon of the FXN gene that plays an important role in FXN gene expression. Modulation of FXN gene expression was found to be mediated by the action of the Oct-1 transcription factor at this site. A better understanding of cis-acting regulatory elements that control FXN gene expression has the potential to develop new strategies for the upregulation of the FXN gene as a therapy for FRDA.	[Puspasari, Novita; Rowley, Simone M.; Lockhart, Paul J.; Delatycki, Martin B.; Sarsero, Joseph P.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth Res, Parkville, Vic 3052, Australia; [Gordon, Lavinia] Royal Childrens Hosp, Murdoch Childrens Res Inst, Bioinformat Unit, Parkville, Vic 3052, Australia; [Puspasari, Novita; Lockhart, Paul J.; Ioannou, Panos A.; Delatycki, Martin B.; Sarsero, Joseph P.] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Delatycki, Martin B.] Austin Hlth, Dept Clin Genet, Heidelberg, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Puspasari, N (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth Res, Flemington Rd, Parkville, Vic 3052, Australia.	joe@sarsero.com	Lockhart, Paul J/E-7753-2011; Gordon, Lavinia C/L-1310-2016; Delatycki, Martin B/A-5409-2013	Lockhart, Paul J/0000-0003-2531-8413; Gordon, Lavinia C/0000-0003-3469-8489; Rowley, Simone/0000-0002-5897-7979; Puspasari, Novita/0000-0002-1398-805X	Friedreich Ataxia Research Association (Australasia); Friedreich's Ataxia Research Alliance (USA); National Ataxia Foundation (USA); Victorian Government	Friedreich Ataxia Research Association (Australasia); Friedreich's Ataxia Research Alliance (USA); National Ataxia Foundation (USA); Victorian Government	This work was supported by the Friedreich Ataxia Research Association (Australasia), the Friedreich's Ataxia Research Alliance (USA), the National Ataxia Foundation (USA) and the Victorian Government's Operational Infrastructure Support Program. NP was the recipient of a Ph.D. stipend from the Friedreich Ataxia Research Association (Australasia). MBD is a National Health and Medical Research Council Practitioner Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Castaldo I, 2008, J MED GENET, V45, P808, DOI 10.1136/jmg.2008.058594; Cheng CK, 2002, ENDOCRINOLOGY, V143, P4693, DOI 10.1210/en.2002-220576; Chiaromonte F, 2002, Pac Symp Biocomput, P115; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; Dong B, 2007, BIOCHEM J, V401, P57, DOI 10.1042/BJ20060570; Filla A, 1992, Acta Neurol (Napoli), V14, P420; Frengen E, 1999, GENOMICS, V58, P250, DOI 10.1006/geno.1998.5693; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gambari R, 2004, CURR DRUG TARGETS, V5, P419, DOI 10.2174/1389450043345416; Gottesfeld JM, 2007, PHARMACOL THERAPEUT, V116, P236, DOI 10.1016/j.pharmthera.2007.06.014; Greene E, 2005, GENOMICS, V85, P221, DOI 10.1016/j.ygeno.2004.10.013; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; HARDING AE, 1981, J MED GENET, V18, P285, DOI 10.1136/jmg.18.4.285; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Jegga AG, 2007, NUCLEIC ACIDS RES, V35, pD116, DOI 10.1093/nar/gkl1011; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Kolbe D, 2004, GENOME RES, V14, P700, DOI 10.1101/gr.1976004; Leclerc GM, 2005, MOL CELL ENDOCRINOL, V245, P86, DOI 10.1016/j.mce.2005.10.026; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Li KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012286; Lins K, 2003, EMBO J, V22, P2188, DOI 10.1093/emboj/cdg199; Matheos DD, 1998, J CELL BIOCHEM, V68, P309, DOI 10.1002/(SICI)1097-4644(19980301)68:3<309::AID-JCB3>3.0.CO;2-Y; NAKSHATRI H, 1995, J BIOL CHEM, V270, P19613, DOI 10.1074/jbc.270.33.19613; Oktay Y, 2007, J BIOL CHEM, V282, P11750, DOI 10.1074/jbc.M611133200; Pandolfo M, 2006, METH MOLEC MED, V126, P197; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; ROMEO G, 1983, AM J HUM GENET, V35, P523; Sarsero JP, 2004, MAMM GENOME, V15, P370, DOI 10.1007/s00335-004-3019-3; Sarsero JP, 2003, J GENE MED, V5, P72, DOI 10.1002/jgm.320; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; Tantin D, 2005, CANCER RES, V65, P10750, DOI 10.1158/0008-5472.CAN-05-2399; Taylor J, 2006, GENOME RES, V16, P1596, DOI 10.1101/gr.4537706; USHEVA A, 1994, CELL, V76, P1115, DOI 10.1016/0092-8674(94)90387-5; Wang VEH, 2004, MOL CELL BIOL, V24, P1022, DOI 10.1128/MCB.24.3.1022-1032.2004; Wu GD, 1997, J BIOL CHEM, V272, P2396; Xu XXS, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-15; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200	45	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22001	10.1371/journal.pone.0022001	http://dx.doi.org/10.1371/journal.pone.0022001			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760943	gold, Green Published			2022-12-25	WOS:000292657200039
J	Toombs, JA; Liss, NM; Cobble, KR; Ben-Musa, Z; Ross, ED				Toombs, James A.; Liss, Nathan M.; Cobble, Kacy R.; Ben-Musa, Zobaida; Ross, Eric D.			[PSI+] Maintenance Is Dependent on the Composition, Not Primary Sequence, of the Oligopeptide Repeat Domain	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; CHAPERONE PROTEIN HSP104; INHERITED PRION DISEASE; PAIR GENE INSERTION; GUANIDINE-HYDROCHLORIDE; STRAIN VARIANTS; PROPAGATION; AGGREGATION; PSI(+); REGION	[PSI+], the prion form of the yeast Sup35 protein, results from the structural conversion of Sup35 from a soluble form into an infectious amyloid form. The infectivity of prions is thought to result from chaperone-dependent fiber cleavage that breaks large prion fibers into smaller, inheritable propagons. Like the mammalian prion protein PrP, Sup35 contains an oligopeptide repeat domain. Deletion analysis indicates that the oligopeptide repeat domain is critical for [PSI+] propagation, while a distinct region of the prion domain is responsible for prion nucleation. The PrP oligopeptide repeat domain can substitute for the Sup35 oligopeptide repeat domain in supporting [PSI+] propagation, suggesting a common role for repeats in supporting prion maintenance. However, randomizing the order of the amino acids in the Sup35 prion domain does not block prion formation or propagation, suggesting that amino acid composition is the primary determinant of Sup35's prion propensity. Thus, it is unclear what role the oligopeptide repeats play in [PSI+] propagation: the repeats could simply act as a non-specific spacer separating the prion nucleation domain from the rest of the protein; the repeats could contain specific compositional elements that promote prion propagation; or the repeats, while not essential for prion propagation, might explain some unique features of [PSI+]. Here, we test these three hypotheses and show that the ability of the Sup35 and PrP repeats to support [PSI+] propagation stems from their amino acid composition, not their primary sequences. Furthermore, we demonstrate that compositional requirements for the repeat domain are distinct from those of the nucleation domain, indicating that prion nucleation and propagation are driven by distinct compositional features.	[Toombs, James A.; Liss, Nathan M.; Cobble, Kacy R.; Ross, Eric D.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Ben-Musa, Zobaida; Ross, Eric D.] Colorado State Univ, Grad Program Cell & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Toombs, JA (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	eric.ross@colostate.edu		Ross, Eric/0000-0002-6473-9977; Toombs, James/0000-0002-1601-5675	National Sciences Foundation [MCB-1023771]; March of Dimes Basil O'Connor Award [5-FY07-104]	National Sciences Foundation(National Science Foundation (NSF)); March of Dimes Basil O'Connor Award(March of Dimes)	This work was supported by National Sciences Foundation grant MCB-1023771 to EDR and a March of Dimes Basil O'Connor Award (#5-FY07-104) to EDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov IM, 2008, J BIOL CHEM, V283, P15185, DOI 10.1074/jbc.M802071200; Antzutkin ON, 2002, BIOCHEMISTRY-US, V41, P15436, DOI 10.1021/bi0204185; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; COLLINGE J, 1992, BRAIN, V115, P687, DOI 10.1093/brain/115.3.687; COX BS, 1971, HEREDITY, V26, P211, DOI 10.1038/hdy.1971.28; Crist CG, 2003, GENES CELLS, V8, P603, DOI 10.1046/j.1365-2443.2003.00661.x; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derdowski A, 2010, SCIENCE, V330, P680, DOI 10.1126/science.1197785; Dong JJ, 2007, J BIOL CHEM, V282, P34204, DOI 10.1074/jbc.M704952200; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Esteras-Chopo A, 2005, P NATL ACAD SCI USA, V102, P16672, DOI 10.1073/pnas.0505905102; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Jung GM, 2002, P NATL ACAD SCI USA, V99, P9936, DOI 10.1073/pnas.152333299; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kalastavadi Tejas, 2008, BMC Biochemistry, V9, P7, DOI 10.1186/1471-2091-9-7; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Nakayashiki T, 2001, MOL CELL, V7, P1121, DOI 10.1016/S1097-2765(01)00259-3; Nemecek J, 2009, P NATL ACAD SCI USA, V106, P1892, DOI 10.1073/pnas.0812470106; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Ohhashi Y, 2010, NAT CHEM BIOL, V6, P225, DOI 10.1038/NCHEMBIO.306; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Parham SN, 2001, EMBO J, V20, P2111, DOI 10.1093/emboj/20.9.2111; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; POULTER M, 1992, BRAIN, V115, P675, DOI 10.1093/brain/115.3.675; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Romanova NV, 2009, PROTEIN PEPTIDE LETT, V16, P598, DOI 10.2174/092986609788490078; Ross CD, 2009, GENETICS, V183, P929, DOI 10.1534/genetics.109.109322; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2010, PRION, V4, DOI 10.4161/pri.4.2.12190; Schlumpberger M, 2001, MOL CELL BIOL, V21, P7035, DOI 10.1128/MCB.21.20.7035-7046.2001; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shkundina IS, 2006, GENETICS, V172, P827, DOI 10.1534/genetics.105.048660; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2008, NEUROSIGNALS, V16, P63, DOI 10.1159/000109760; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Street AG, 1999, P NATL ACAD SCI USA, V96, P9074, DOI 10.1073/pnas.96.16.9074; Tank EMH, 2007, MOL CELL BIOL, V27, P5445, DOI 10.1128/MCB.02127-06; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Tessier PM, 2009, NAT STRUCT MOL BIOL, V16, P598, DOI 10.1038/nsmb.1617; Toombs JA, 2010, MOL CELL BIOL, V30, P319, DOI 10.1128/MCB.01140-09; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; TUITE MF, 1981, GENETICS, V98, P691; Vitrenko YA, 2007, CURR GENET, V51, P309, DOI 10.1007/s00294-007-0127-0; Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2010, FEMS YEAST RES, V10, P980, DOI 10.1111/j.1567-1364.2010.00666.x; Yuan C, 2007, FEBS LETT, V581, P241, DOI 10.1016/j.febslet.2006.12.019; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	54	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21953	10.1371/journal.pone.0021953	http://dx.doi.org/10.1371/journal.pone.0021953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760933	Green Submitted, Green Published, gold			2022-12-25	WOS:000292657200036
J	Phillips, JE; Huang, EY; Shaulsky, G; Gomer, RH				Phillips, Jonathan E.; Huang, Eryong; Shaulsky, Gad; Gomer, Richard H.			The Putative bZIP Transcripton Factor BzpN Slows Proliferation and Functions in the Regulation of Cell Density by Autocrine Signals in Dictyostelium	PLOS ONE			English	Article							GENE-EXPRESSION; PRIMARY TUMOR; DISCOIDEUM; CHALONE; SIZE; PROTEINS; DORMANCY; GROWTH; DIFFERENTIATION; DISEASE	The secreted proteins AprA and CfaD function as autocrine signals that inhibit cell proliferation in Dictyostelium discoideum, thereby regulating cell numbers by a negative feedback mechanism. We report here that the putative basic leucine zipper transcription factor BzpN plays a role in the inhibition of proliferation by AprA and CfaD. Cells lacking BzpN proliferate more rapidly than wild-type cells but do not reach a higher stationary density. Recombinant AprA inhibits wild-type cell proliferation but does not inhibit the proliferation of cells lacking BzpN. Recombinant CfaD also inhibits wild-type cell proliferation, but promotes the proliferation of cells lacking BzpN. Overexpression of BzpN results in a reduced cell density at stationary phase, and this phenotype requires AprA, CfaD, and the kinase QkgA. Conditioned media from high-density cells stops the proliferation of wild-type but not bzpN(-) cells and induces a nuclear localization of a BzpN-GFP fusion protein, though this localization does not require AprA or CfaD. Together, the data suggest that BzpN is necessary for some but not all of the effects of AprA and CfaD, and that BzpN may function downstream of AprA and CfaD in a signal transduction	[Phillips, Jonathan E.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Huang, Eryong; Shaulsky, Gad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gomer, Richard H.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Rice University; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station	Phillips, JE (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	rgomer@bio.tamu.edu		Phillips, Jonathan/0000-0001-9896-5895; Shaulsky, Gad/0000-0002-0532-0551; Gomer, Richard/0000-0003-2361-4307	NIH [GM074990]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074990] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM074990. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHERN KG, 1988, NUCLEIC ACIDS RES, V16, P6825; Aubry L, 1999, ANNU REV CELL DEV BI, V15, P469, DOI 10.1146/annurev.cellbio.15.1.469; Bakthavatsalam D, 2008, J CELL SCI, V121, P2473, DOI 10.1242/jcs.026682; Bakthavatsalam D, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-44; Bokko PB, 2007, MOL BIOL CELL, V18, P1874, DOI 10.1091/mbc.E06-09-0881; Brock DA, 2005, DEVELOPMENT, V132, P4553, DOI 10.1242/dev.02032; Brock DA, 1999, GENE DEV, V13, P1960, DOI 10.1101/gad.13.15.1960; BULLOUGH WS, 1964, EXP CELL RES, V36, P192, DOI 10.1016/0014-4827(64)90172-7; BUSCH SJ, 1990, TRENDS GENET, V6, P36, DOI 10.1016/0168-9525(90)90071-D; Chen GK, 2004, DEVELOPMENT, V131, P2619, DOI 10.1242/dev.01151; Choe JM, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-4; Demicheli R, 2001, SEMIN CANCER BIOL, V11, P297, DOI 10.1006/scbi.2001.0385; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; GARCIAGIRALT E, 1970, EUR J CLIN BIOL RES, V15, P1012; GOMER RH, 1991, DEVELOPMENT, V112, P269; Gomer RH, 2001, NAT REV MOL CELL BIO, V2, P48, DOI 10.1038/35048058; Guba M, 2001, CANCER RES, V61, P5575; HOUCK JC, 1972, NATURE-NEW BIOL, V240, P210, DOI 10.1038/newbio240210a0; Huang EY, 2006, DEVELOPMENT, V133, P449, DOI 10.1242/dev.02240; JAIN R, 1992, GENE DEV, V6, P390, DOI 10.1101/gad.6.3.390; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Kagaya Y, 2002, PLANT CELL, V14, P3177, DOI 10.1105/tpc.005272; Kango-Singh M, 2009, DEV DYNAM, V238, P1627, DOI 10.1002/dvdy.21996; KERR L D, 1992, Current Opinion in Cell Biology, V4, P496, DOI 10.1016/0955-0674(92)90017-7; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Manahan CL, 2004, ANNU REV CELL DEV BI, V20, P223, DOI 10.1146/annurev.cellbio.20.011303.132633; MANSTEIN DJ, 1995, GENE, V162, P129, DOI 10.1016/0378-1119(95)00351-6; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Peeters CFJM, 2008, ANN SURG ONCOL, V15, P3308, DOI 10.1245/s10434-008-0029-5; Phillips JE, 2010, EUKARYOT CELL, V9, P1557, DOI 10.1128/EC.00121-10; Rot G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-265; Souza GM, 1998, DEVELOPMENT, V125, P2291; Su TT, 1998, CURR BIOL, V8, pR687, DOI 10.1016/S0960-9822(98)70436-1; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Thompson CRL, 2004, DEVELOPMENT, V131, P513, DOI 10.1242/dev.00939; Veltman DM, 2009, PLASMID, V61, P110, DOI 10.1016/j.plasmid.2008.11.003; VOADEN MJ, 1968, EXP EYE RES, V7, P326, DOI 10.1016/S0014-4835(68)80045-4; YARGER J, 1974, J CELL SCI, V14, P681; Zhukovskaya NV, 2006, DEVELOPMENT, V133, P439, DOI 10.1242/dev.02190	41	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21765	10.1371/journal.pone.0021765	http://dx.doi.org/10.1371/journal.pone.0021765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760904	Green Published, Green Submitted, gold			2022-12-25	WOS:000292655400017
J	Proverbio, AM; Riva, F; Paganelli, L; Cappa, SF; Canessa, N; Perani, D; Zani, A				Proverbio, Alice Mado; Riva, Federica; Paganelli, Laura; Cappa, Stefano F.; Canessa, Nicola; Perani, Daniela; Zani, Alberto			Neural Coding of Cooperative vs. Affective Human Interactions: 150 ms to Code the Action's Purpose	PLOS ONE			English	Article							EXTRASTRIATE BODY AREA; SEX-DIFFERENCES; MIRROR-NEURON; GENDER-DIFFERENCES; CORTICAL RESPONSE; FACE PERCEPTION; PARIETAL AREAS; BRAIN; HAND; RECOGNITION	The timing and neural processing of the understanding of social interactions was investigated by presenting scenes in which 2 people performed cooperative or affective actions. While the role of the human mirror neuron system (MNS) in understanding actions and intentions is widely accepted, little is known about the time course within which these aspects of visual information are automatically extracted. Event-Related Potentials were recorded in 35 university students perceiving 260 pictures of cooperative (e. g., 2 people dragging a box) or affective (e. g., 2 people smiling and holding hands) interactions. The action's goal was automatically discriminated at about 150-170 ms, as reflected by occipito/temporal N170 response. The swLORETA inverse solution revealed the strongest sources in the right posterior cingulate cortex (CC) for affective actions and in the right pSTS for cooperative actions. It was found a right hemispheric asymmetry that involved the fusiform gyrus (BA37), the posterior CC, and the medial frontal gyrus (BA10/11) for the processing of affective interactions, particularly in the 155-175 ms time window. In a later time window (200-250 ms) the processing of cooperative interactions activated the left post-central gyrus (BA3), the left parahippocampal gyrus, the left superior frontal gyrus (BA10), as well as the right premotor cortex (BA6). Women showed a greater response discriminative of the action's goal compared to men at P300 and anterior negativity level (220-500 ms). These findings might be related to a greater responsiveness of the female vs. male MNS. In addition, the discriminative effect was bilateral in women and was smaller and left-sided in men. Evidence was provided that perceptually similar social interactions are discriminated on the basis of the agents' intentions quite early in neural processing, differentially activating regions devoted to face/body/action coding, the limbic system and the MNS.	[Proverbio, Alice Mado; Riva, Federica; Paganelli, Laura] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Zani, Alberto] CNR, Inst Mol Bioimaging & Physiol, I-20133 Milan, Italy; [Cappa, Stefano F.; Canessa, Nicola; Perani, Daniela] Univ Vita Salute San Raffaele, Milan, Italy; [Cappa, Stefano F.; Canessa, Nicola; Perani, Daniela] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy	University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Proverbio, AM (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	mado.proverbio@unimib.it	Zani, Alberto/ABG-8894-2020; Cappa, Stefano/B-1874-2014; Perani, Daniela/AAN-3221-2020; Canessa, Nicola/K-3223-2016; Zani, Alberto/ABI-3498-2020	Cappa, Stefano/0000-0003-1003-3925; Canessa, Nicola/0000-0002-0179-6384; Zani, Alberto/0000-0002-3906-7988; Proverbio, Alice Mado/0000-0002-5138-1523	University of Milano-Bicocca; CNR	University of Milano-Bicocca; CNR(Consiglio Nazionale delle Ricerche (CNR))	This work was funded by FAR 2008 grants from the University of Milano-Bicocca to AMP and CNR grants to AZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell F, 2000, COGNITIVE DEV, V15, P1, DOI 10.1016/S0885-2014(00)00014-9; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Avikainen S, 2002, NEUROIMAGE, V15, P640, DOI 10.1006/nimg.2001.1029; Bach P, 2009, SOC NEUROSCI-UK, V4, P212, DOI 10.1080/17470910802362546; Baron-Cohen S, 2003, J AUTISM DEV DISORD, V33, P509, DOI 10.1023/A:1025879411971; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bourne VJ, 2005, NEUROPSYCHOLOGIA, V43, P953, DOI 10.1016/j.neuropsychologia.2004.08.007; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Caldara R, 2004, NEUROREPORT, V15, P905, DOI 10.1097/00001756-200404090-00034; CAPPA S, I SEE WHAT YOU UNPUB; Carter EJ, 2011, NEUROIMAGE, V54, P1634, DOI 10.1016/j.neuroimage.2010.08.077; Centelles L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015749; Cheng Y, 2009, NEUROSCIENCE, V158, P713, DOI 10.1016/j.neuroscience.2008.10.026; Cheng YW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002113; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Downing PE, 2006, SOC NEUROSCI, V1, P52, DOI 10.1080/17470910600668854; Fecteau S, 2004, NEUROREPORT, V15, P2625, DOI 10.1097/00001756-200412030-00013; Freeman JB, 2010, NEUROREPORT, V21, P24, DOI 10.1097/WNR.0b013e3283320d54; George N, 2005, COGNITIVE BRAIN RES, V24, P663, DOI 10.1016/j.cogbrainres.2005.03.017; Gliga T, 2005, J COGNITIVE NEUROSCI, V17, P1328, DOI 10.1162/0898929055002481; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Gunter TC, 2004, NEUROSCI LETT, V372, P52, DOI 10.1016/j.neulet.2004.09.011; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Hamilton AFD, 2008, CEREB CORTEX, V18, P1160, DOI 10.1093/cercor/bhm150; Hari R, 1998, NEUROSCI LETT, V240, P131, DOI 10.1016/S0304-3940(97)00945-2; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Henson RN, 2003, CEREB CORTEX, V13, P793, DOI 10.1093/cercor/13.7.793; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; Johnson BW, 2002, NEUROREPORT, V13, P1929, DOI 10.1097/00001756-200210280-00020; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kaplan JT, 2006, SOC NEUROSCI-UK, V1, P175, DOI 10.1080/17470910600985605; Kemp AH, 2004, NEUROIMAGE, V21, P632, DOI 10.1016/j.neuroimage.2003.09.055; Kokal I, 2009, NEUROIMAGE, V47, P2046, DOI 10.1016/j.neuroimage.2009.06.010; Kovalev VA, 2003, NEUROIMAGE, V19, P895, DOI 10.1016/S1053-8119(03)00140-X; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Molnar-Szakacs I, 2006, NEUROIMAGE, V33, P923, DOI 10.1016/j.neuroimage.2006.07.035; Mottonen R, 2005, NEUROIMAGE, V24, P731, DOI 10.1016/j.neuroimage.2004.10.011; Newman-Norlund R, 2010, BRAIN RES, V1315, P63, DOI 10.1016/j.brainres.2009.11.065; O Scalaidhe SP, 1999, CEREB CORTEX, V9, P459, DOI 10.1093/cercor/9.5.459; Ortigue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012160; Palmero-Soler E, 2007, PHYS MED BIOL, V52, P1783, DOI 10.1088/0031-9155/52/7/002; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; PAVLOVA M, 2010, CEREB CORTEX; Pavlova M, 2010, NEUROIMAGE, V50, P1327, DOI 10.1016/j.neuroimage.2009.12.096; Pelphrey KA, 2004, J COGNITIVE NEUROSCI, V16, P1706, DOI 10.1162/0898929042947900; Pelphrey KA, 2003, J NEUROSCI, V23, P6819; Perry A, 2009, BRAIN RES, V1282, P126, DOI 10.1016/j.brainres.2009.05.059; Phillips ML, 1998, PSYCHIAT RES-NEUROIM, V83, P127, DOI 10.1016/S0925-4927(98)00036-5; Pineda JA, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-47; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; Proverbio AM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-44; Proverbio AM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-56; Proverbio AM, 2007, SCAND J PSYCHOL, V48, P477, DOI 10.1111/j.1467-9450.2007.00616.x; Proverbio AM, 2006, NEUROPSYCHOLOGIA, V44, P2987, DOI 10.1016/j.neuropsychologia.2006.06.015; Proverbio AM, 2010, NEUROPSYCHOLOGIA, V48, P1454, DOI 10.1016/j.neuropsychologia.2010.01.015; Proverbio AM, 2009, NEUROPSYCHOLOGIA, V47, P2374, DOI 10.1016/j.neuropsychologia.2008.10.030; Proverbio AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005389; Puce A, 1998, J NEUROSCI, V18, P2188; Rilea SL, 2004, BRAIN COGNITION, V56, P332, DOI 10.1016/j.bandc.2004.09.002; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Schneider F, 2000, HUM BRAIN MAPP, V9, P226, DOI 10.1002/(SICI)1097-0193(200004)9:4<226::AID-HBM4>3.0.CO;2-K; Schubotz RI, 2004, J NEUROSCI, V24, P5467, DOI 10.1523/JNEUROSCI.1169-04.2004; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; SHAYWITZ BA, 1995, NATURE, V373, P607, DOI 10.1038/373607a0; Shibata H, 2009, NEUROSCI LETT, V452, P189, DOI 10.1016/j.neulet.2009.01.042; Shmuelof L, 2007, NEUROSCIENTIST, V13, P667, DOI 10.1177/1073858407302457; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Takahashi H, 2008, PSYCHIAT CLIN NEUROS, V62, P214, DOI 10.1111/j.1440-1819.2008.01757.x; Taylor MJ, 2011, BRAIN RES, V1381, P167, DOI 10.1016/j.brainres.2010.12.083; Tremoulet PD, 2006, PERCEPT PSYCHOPHYS, V68, P1047, DOI 10.3758/BF03193364; Ulloa ER, 2007, BEHAV BRAIN RES, V183, P188, DOI 10.1016/j.bbr.2007.06.007; Vogt BA, 2006, NEUROIMAGE, V29, P452, DOI 10.1016/j.neuroimage.2005.07.048; Yang CY, 2009, BRAIN RES, V1251, P176, DOI 10.1016/j.brainres.2008.11.062; Zanow F, 2004, BRAIN TOPOGR, V16, P287	84	25	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e22026	10.1371/journal.pone.0022026	http://dx.doi.org/10.1371/journal.pone.0022026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760948	Green Published, gold, Green Submitted			2022-12-25	WOS:000292655400040
J	Barber, LJ; Rosa, JMR; Kozarewa, I; Fenwick, K; Assiotis, I; Mitsopoulos, C; Sims, D; Hakas, J; Zvelebil, M; Lord, CJ; Ashworth, A				Barber, Louise J.; Rosa, Juan M. Rosa; Kozarewa, Iwanka; Fenwick, Kerry; Assiotis, Ioannis; Mitsopoulos, Costas; Sims, David; Hakas, Jarle; Zvelebil, Marketa; Lord, Christopher J.; Ashworth, Alan			Comprehensive Genomic Analysis of a BRCA2 Deficient Human Pancreatic Cancer	PLOS ONE			English	Article							HOMOLOGY-DIRECTED REPAIR; COLORECTAL-CANCER; HUMAN BREAST; CELL-LINES; GENE; MUTATIONS; PROTEIN; DCC; DNA; SEQUENCE	Capan-1 is a well-characterised BRCA2-deficient human cell line isolated from a liver metastasis of a pancreatic adenocarcinoma. Here we report a genome-wide assessment of structural variations and high-depth exome characterization of single nucleotide variants and small insertion/deletions in Capan-1. To identify potential somatic and tumour-associated variations in the absence of a matched-normal cell line, we devised a novel method based on the analysis of HapMap samples. We demonstrate that Capan-1 has one of the most rearranged genomes sequenced to date. Furthermore, small insertions and deletions are detected more frequently in the context of short sequence repeats than in other genomes. We also identify a number of novel mutations that may represent genetic changes that have contributed to tumour progression. These data provide insight into the genomic effects of loss of BRCA2 function.	[Barber, Louise J.; Rosa, Juan M. Rosa; Kozarewa, Iwanka; Fenwick, Kerry; Assiotis, Ioannis; Mitsopoulos, Costas; Sims, David; Hakas, Jarle; Zvelebil, Marketa; Lord, Christopher J.; Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Barber, LJ (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England.	Chris.Lord@icr.ac.uk; Alan.Ashworth@icr.ac.uk	Lord, Christopher J/B-3295-2012; Lord, Christopher/AAX-7130-2021; Barber, Louise J./L-8579-2019	Lord, Christopher J/0000-0002-3226-0515; Barber, Louise J./0000-0001-9265-3516; Mitsopoulos, Costas/0000-0002-9116-5921; Zvelebil, Marketa/0000-0001-8018-5591	Breakthrough Breast Cancer, Cancer Research UK; American Association for Cancer Research/Stand Up to Cancer	Breakthrough Breast Cancer, Cancer Research UK(Cancer Research UK); American Association for Cancer Research/Stand Up to Cancer	The authors thank Breakthrough Breast Cancer, Cancer Research UK, and the American Association for Cancer Research/Stand Up to Cancer for funding this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Bartsch D, 1999, CANCER LETT, V139, P43, DOI 10.1016/S0304-3835(98)00380-2; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chen ZH, 1996, CANCER RES, V56, P1083; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Ghadimi BM, 1999, AM J PATHOL, V154, P525, DOI 10.1016/S0002-9440(10)65298-4; Goggins M, 1996, CANCER RES, V56, P5360; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Herath NI, 2010, INT J CANCER, V126, P2003, DOI 10.1002/ijc.25147; Hilgers W, 2000, GENE CHROMOSOME CANC, V27, P353, DOI 10.1002/(SICI)1098-2264(200004)27:4<353::AID-GCC3>3.3.CO;2-X; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hsiang D, 1997, AM J SURG, V174, P242, DOI 10.1016/S0002-9610(97)00133-5; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; KALTHOFF H, 1993, ONCOGENE, V8, P289; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Koike J, 1999, BIOCHEM BIOPH RES CO, V262, P39, DOI 10.1006/bbrc.1999.1161; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; Mackay A, 2009, BREAST CANCER RES TR, V118, P481, DOI 10.1007/s10549-008-0296-7; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Meriane M, 2004, J CELL BIOL, V167, P687, DOI 10.1083/jcb.200405053; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; Natrajan R, 2010, BREAST CANCER RES TR, V121, P575, DOI 10.1007/s10549-009-0501-3; Natsume W, 2006, MOL BIOL CELL, V17, P2592, DOI 10.1091/mbc.E05-10-0909; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Rehn M, 1998, TRENDS BIOCHEM SCI, V23, P415, DOI 10.1016/S0968-0004(98)01290-0; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Spain BH, 1999, P NATL ACAD SCI USA, V96, P13920, DOI 10.1073/pnas.96.24.13920; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Tai YC, 2007, J NATL CANCER I, V99, P1811, DOI 10.1093/jnci/djm203; Teng DHF, 1997, CANCER RES, V57, P4177; Terasaki H, 2002, INT J MOL MED, V9, P107; Turnbull C, 2005, CLIN MED, V5, P491, DOI 10.7861/clinmedicine.5-5-491; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Weinstock DM, 2006, BLOOD, V107, P777, DOI 10.1182/blood-2005-06-2437; Wong HH, 2009, NAT REV GASTRO HEPAT, V6, P412, DOI 10.1038/nrgastro.2009.89; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yamasaki N, 2010, ONCOGENE, V29, P1963, DOI 10.1038/onc.2009.475; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yuan SSF, 1999, CANCER RES, V59, P3547; Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607	64	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21639	10.1371/journal.pone.0021639	http://dx.doi.org/10.1371/journal.pone.0021639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750719	Green Submitted, gold, Green Published			2022-12-25	WOS:000292512000018
J	Saha, B; Adhikary, A; Ray, P; Saha, S; Chakraborty, S; Mohanty, S; Das, K; Mukherjee, S; Mazumdar, M; Lahiri, L; Hossain, DMS; Sa, G; Das, T				Saha, B.; Adhikary, A.; Ray, P.; Saha, S.; Chakraborty, S.; Mohanty, S.; Das, K.; Mukherjee, S.; Mazumdar, M.; Lahiri, L.; Hossain, D. M. S.; Sa, G.; Das, T.			Restoration of tumor suppressor p53 by differentially regulating pro- and anti-p53 networks in HPV-18-infected cervical cancer cells	ONCOGENE			English	Article						apoptosis; celecoxib; Cox-2; HPV-18; E6; p53	HUMAN-PAPILLOMAVIRUS TYPE-16; WILD-TYPE P53; CARCINOMA-CELLS; CYCLOOXYGENASE-2 EXPRESSION; CYTOPLASMIC SEQUESTRATION; SIGNALING PATHWAY; DOWN-REGULATION; POSTTRANSLATIONAL MODIFICATIONS; NITRIC-OXIDE; COLON-CANCER	Abrogation of functional p53 is responsible for malignant cell transformation and maintenance of human papilloma virus (HPV)-infected cancer cells. Restoration of p53 has, therefore, been regarded as an important strategy for molecular intervention of HPV-associated malignancies. Here we report that differential regulation of pro-and anti-p53 setups not only upregulates p53 transcription but also stabilizes and activates p53 protein to ensure p53-induced apoptosis in HPV-18-infected cervical cancer. Functional restoration of p53 can be achieved by nonsteroidal anti-inflammatory drug celecoxib via multiple molecular mechanisms: (i) inhibition of p53 degradation by suppressing viral oncoprotein E6 expression, (ii) promoting p53 transcription by downmodulating cycloxygenase-2 (Cox-2) and simultaneously retrieving p53 from Cox-2 association and (iii) activation of p53 via ataxia telangiectasia mutated-/p38 mitogen-activated protein kinase-mediated phosphorylations at serine-15/-46 residues. That restored p53 is functional has been confirmed by its ability of transactivating Bax and p53-upregulated modulator of apoptosis, which in turn switch on the apoptotic machinery in these cells. Studies undertaken in biopsy samples of cervical carcinoma further validated celecoxib effect. Our approaches involving gene manipulation and pharmacological interference finally highlight that celecoxib alters pro-and anti-p53 networks, not in isolation but in concert, to rejuvenate p53-dependent apoptotic program in HPV-infected cervical cancer cells. Oncogene (2012) 31, 173-186; doi:10.1038/onc.2011.234; published online 18 July 2011	[Saha, B.; Adhikary, A.; Ray, P.; Saha, S.; Chakraborty, S.; Mohanty, S.; Das, K.; Mukherjee, S.; Mazumdar, M.; Lahiri, L.; Hossain, D. M. S.; Sa, G.; Das, T.] Bose Inst, Div Mol Med, Kolkata 700054, W Bengal, India	Department of Science & Technology (India); Bose Institute	Das, T (corresponding author), Bose Inst, Div Mol Med, P-1-12 Calcutta Improvement Trust Scheme VIIM, Kolkata 700054, W Bengal, India.	tanya@boseinst.ernet.in	Chakraborty, Samik/Q-1779-2018	Chakraborty, Samik/0000-0002-5232-0474	DST; CSIR; UGC, Govt of India	DST(Department of Science & Technology (India)); CSIR(Council of Scientific & Industrial Research (CSIR) - India); UGC, Govt of India(University Grants Commission, India)	We gratefully acknowledge Dr S Biswas, Department of Surgery, SSKM Hospital, Kolkata, for providing primary lesions of cervical cancer and normal cervical tissues. We are thankful to R Sarkar for editing the manuscript. Thanks are also due to U Ghosh and R Dutta for technical help. This work was supported by the grants from DST, CSIR and UGC, Govt of India.	Adhikary A, 2010, FEBS LETT, V584, P7, DOI 10.1016/j.febslet.2009.10.081; Amano T, 2009, J NEURO-ONCOL, V92, P357, DOI 10.1007/s11060-009-9844-1; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Becker K, 2007, CELL DEATH DIFFER, V14, P1350, DOI 10.1038/sj.cdd.4402126; Bhattacharyya S, 2007, J BIOL CHEM, V282, P15954, DOI 10.1074/jbc.M608189200; Blagosklonny MV, 2000, FASEB J, V14, P1901, DOI 10.1096/fj.99-1078rev; Butz K, 2000, P NATL ACAD SCI USA, V97, P6693, DOI 10.1073/pnas.110538897; Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894; Chakrabarti O, 2003, J BIOSCIENCES, V28, P337, DOI 10.1007/BF02970152; Chakraborty J, 2010, J BIOL CHEM, V285, P33104, DOI 10.1074/jbc.M110.122705; Choudhuri T, 2005, J BIOL CHEM, V280, P20059, DOI 10.1074/jbc.M410670200; Corcoran CA, 2005, ONCOGENE, V24, P1634, DOI 10.1038/sj.onc.1208353; Das T, 2008, J IMMUNOL, V180, P4687, DOI 10.4049/jimmunol.180.7.4687; Das T, 2008, CANCER RES, V68, P2014, DOI 10.1158/0008-5472.CAN-07-6037; de Moraes E, 2007, INT J CANCER, V121, P929, DOI 10.1002/ijc.22899; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Frank S, 2006, EXP DERMATOL, V15, P130, DOI 10.1111/j.1600-0625.2005.00397.x; Fuster JJ, 2007, TRENDS MOL MED, V13, P192, DOI 10.1016/j.molmed.2007.03.002; Grosch S, 2005, BIOCHEM PHARMACOL, V69, P831, DOI 10.1016/j.bcp.2004.11.026; Han JA, 2002, EMBO J, V21, P5635, DOI 10.1093/emboj/cdf591; Hengstermann A, 2005, J VIROL, V79, P9296, DOI 10.1128/JVI.79.14.9296-9300.2005; Horner SM, 2004, J VIROL, V78, P4063, DOI 10.1128/JVI.78.8.4063-4073.2004; Ichwan SJA, 2006, ONCOGENE, V25, P1216, DOI 10.1038/sj.onc.1209158; Ishida K, 2003, BIOCHEM BIOPH RES CO, V300, P201, DOI 10.1016/S0006-291X(02)02790-0; Jeong SJ, 2005, J BIOL CHEM, V280, P10326, DOI 10.1074/jbc.M412643200; Kang KB, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-66; Kastan MB, 2007, CELL, V128, P837, DOI 10.1016/j.cell.2007.02.022; Kawamata Y, 2002, INT J ONCOL, V21, P561; Kuperwasser C, 2000, CANCER RES, V60, P2723; Lahiry L, 2008, APOPTOSIS, V13, P771, DOI 10.1007/s10495-008-0213-x; Lahiry L, 2010, CARCINOGENESIS, V31, P259, DOI 10.1093/carcin/bgp240; Lee HC, 2008, MOL CANCER RES, V6, P996, DOI 10.1158/1541-7786.MCR-08-0113; Malanchi I, 2002, ONCOGENE, V21, P5665, DOI 10.1038/sj.onc.1205617; Mestre JR, 1997, CANCER RES, V57, P2890; Meulmeester E, 2008, CURR CANCER DRUG TAR, V8, P87, DOI 10.2174/156800908783769337; Molina MA, 1999, CANCER RES, V59, P4356; Moody CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000605; Munkarah A, 2005, CURR OPIN OBSTET GYN, V17, P49; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Narayanan BA, 2006, MOL CANCER THER, V5, P1117, DOI 10.1158/1535-7163.MCT-05-0520; Park SW, 2005, ONCOGENE, V24, P6689, DOI 10.1038/sj.onc.1208816; Perfettini JL, 2005, J EXP MED, V201, P279, DOI 10.1084/jem.20041502; Prince ME, 2007, HEAD NECK-J SCI SPEC, V29, P465, DOI 10.1002/hed.20547; Reddy BS, 2000, CANCER RES, V60, P293; ROMANCZUK H, 1991, J VIROL, V65, P2739, DOI 10.1128/JVI.65.5.2739-2744.1991; Royds JA, 2006, CELL DEATH DIFFER, V13, P1017, DOI 10.1038/sj.cdd.4401913; Ryu HS, 2000, GYNECOL ONCOL, V76, P320, DOI 10.1006/gyno.1999.5690; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Sato T, 1997, PROSTAGLANDINS, V53, P355, DOI 10.1016/0090-6980(97)00036-1; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sigal A, 2000, CANCER RES, V60, P6788; Subbaramaiah K, 2007, CANCER RES, V67, P3976, DOI 10.1158/0008-5472.CAN-06-4273; Swamy MV, 2003, CANCER RES, V63, P5239; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Walker C, 2006, AM J PATHOL, V168, P1526, DOI 10.2353/ajpath.2006.050603; Wang WG, 2003, MOL CELL BIOL, V23, P2171, DOI 10.1128/MCB.23.6.2171-2181.2003; YASUMOTO S, 1991, J VIROL, V65, P2000, DOI 10.1128/JVI.65.4.2000-2009.1991; Zhao CY, 2010, CANCER RES, V70, P3372, DOI 10.1158/0008-5472.CAN-09-2787; Zhao LY, 2003, J VIROL, V77, P13171, DOI 10.1128/JVI.77.24.13171-13181.2003	60	25	25	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	2					173	186		10.1038/onc.2011.234	http://dx.doi.org/10.1038/onc.2011.234			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	879CN	21765464				2022-12-25	WOS:000299307400004
J	Qi, YP; Tsuda, K; Nguyen, LV; Wang, X; Lin, JS; Murphy, AS; Glazebrook, J; Thordal-Christensen, H; Katagiri, F				Qi, Yiping; Tsuda, Kenichi; Nguyen, Le V.; Wang, Xia; Lin, Jinshan; Murphy, Angus S.; Glazebrook, Jane; Thordal-Christensen, Hans; Katagiri, Fumiaki			Physical Association of Arabidopsis Hypersensitive Induced Reaction Proteins (HIRs) with the Immune Receptor RPS2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT-RESISTANT MEMBRANES; PLANT-PATHOGEN INTERACTIONS; RPS2-MEDIATED DISEASE RESISTANCE; DOWNY MILDEW RESISTANCE; PROGRAMMED CELL-DEATH; RICH REPEAT DOMAIN; LIPID RAFTS; PLASMA-MEMBRANE; SPFH DOMAIN; FLAGELLIN PERCEPTION	Arabidopsis RPS2 is a typical nucleotide-binding leucine-rich repeat resistance protein, which indirectly recognizes the bacterial effector protein AvrRpt2 and thereby activates effector-triggered immunity (ETI). Previously, we identified two hypersensitive induced reaction (AtHIR) proteins, AtHIR1 (At1g09840) and AtHIR2 (At3g01290), as potential RPS2 complex components. AtHIR proteins contain the stomatin/prohibitin/flotillin/HflK/C domain (also known as the prohibitin domain or band 7 domain). In this study, we confirmed that AtHIR1 and AtHIR2 form complexes with RPS2 in Arabidopsis and Nicotiana benthamiana using a pulldown assay and fluorescence resonance energy transfer (FRET) analysis. Arabidopsis has four HIR family genes (AtHIR1-4). All AtHIR proteins could form homo- and hetero-oligomers in vivo and were enriched in membrane microdomains of the plasma membrane. The mRNA levels of all except AtHIR4 were significantly induced by microbe-associated molecular patterns, such as the bacterial flagellin fragment flg22. Athir2-1 and Athir3-1 mutants allowed more growth of Pto DC3000 AvrRpt2, but not Pto DC3000, indicating that these mutations reduce RPS2-mediated ETI but do not affect basal resistance to the virulent strain. Overexpression of AtHIR1 and AtHIR2 reduced growth of Pto DC3000. Taken together, the results show that the AtHIR proteins are physically associated with RPS2, are localized in membrane microdomains, and quantitatively contribute to RPS2-mediated ETI.	[Qi, Yiping; Tsuda, Kenichi; Nguyen, Le V.; Glazebrook, Jane; Katagiri, Fumiaki] Univ Minnesota, Dept Plant Biol, Microbial & Plant Genom Inst, St Paul, MN 55108 USA; [Wang, Xia; Lin, Jinshan; Murphy, Angus S.] Purdue Univ, Dept Hort, W Lafayette, IN 47907 USA; [Thordal-Christensen, Hans] Univ Copenhagen, Fac Life Sci, Dept Agr & Ecol, DK-1871 Frederiksberg C, Denmark	University of Minnesota System; University of Minnesota Twin Cities; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Copenhagen	Katagiri, F (corresponding author), Univ Minnesota, Dept Plant Biol, Microbial & Plant Genom Inst, 1500 Gortner Ave, St Paul, MN 55108 USA.	katagiri@umn.edu	Qi, Yiping/AAZ-3976-2020; Thordal-Christensen, Hans/F-6281-2014; Tsuda, Kenichi/A-2453-2009	Qi, Yiping/0000-0002-9556-6706; Thordal-Christensen, Hans/0000-0001-8813-0157; Tsuda, Kenichi/0000-0001-7074-0731; Glazebrook, Jane/0000-0001-5167-736X; Katagiri, Fumiaki/0000-0001-6893-3788	National Science Foundation [IOS-0419648, MCB-0918908]; University of Minnesota	National Science Foundation(National Science Foundation (NSF)); University of Minnesota(University of Minnesota System)	This work was supported by Grants IOS-0419648 (Arabidopsis 2010 Program) and MCB-0918908 from the National Science Foundation (to F. K.).; Supported by a Hamm Memorial Graduate Student fellowship and a PBS doctoral dissertation fellowship from the University of Minnesota.	Ahn CS, 2006, PLANT J, V46, P658, DOI 10.1111/j.1365-313X.2006.02726.x; Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Back JW, 2002, PROTEIN SCI, V11, P2471, DOI 10.1110/ps.0212602; Banerjee D, 2001, GENETICS, V158, P439; Bassham DC, 2008, PLANT PHYSIOL, V147, P1504, DOI 10.1104/pp.108.121129; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; Bhat RA, 2005, PLANTA, V223, P5, DOI 10.1007/s00425-005-0096-9; Borner GHH, 2005, PLANT PHYSIOL, V137, P104, DOI 10.1104/pp.104.053041; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Choi HW, 2011, MOL PLANT MICROBE IN, V24, P68, DOI 10.1094/MPMI-02-10-0030; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DANGL JL, 1992, PLANT CELL, V4, P1359, DOI 10.1105/tpc.4.11.1359; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Day B, 2005, PLANT CELL, V17, P1292, DOI 10.1105/tpc.104.030163; Desveaux D, 2006, CURR OPIN PLANT BIOL, V9, P376, DOI 10.1016/j.pbi.2006.05.005; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fujiwara M, 2009, PLANT CELL PHYSIOL, V50, P1191, DOI 10.1093/pcp/pcp077; Glazebrook J, 1997, GENETICS, V146, P381; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Greenberg JT, 1997, ANNU REV PLANT PHYS, V48, P525, DOI 10.1146/annurev.arplant.48.1.525; Grennan AK, 2007, PLANT PHYSIOL, V143, P1083, DOI 10.1104/pp.104.900218; He P, 2007, CELL MICROBIOL, V9, P1385, DOI 10.1111/j.1462-5822.2007.00944.x; Hinderhofer M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-10; Hink MA, 2002, PLANT MOL BIOL, V50, P871, DOI 10.1023/A:1021282619035; Holt BF, 2005, SCIENCE, V309, P929, DOI 10.1126/science.1109977; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Jin HL, 2002, DEV CELL, V3, P291, DOI 10.1016/S1534-5807(02)00205-8; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jung HW, 2008, PLANTA, V227, P409, DOI 10.1007/s00425-007-0628-6; Jung HW, 2007, MOL PLANT PATHOL, V8, P503, DOI 10.1111/J.1364-3703.2007.00410.X; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Karrer EE, 1998, PLANT MOL BIOL, V36, P681, DOI 10.1023/A:1005949304445; Keinath NF, 2010, J BIOL CHEM, V285, P39140, DOI 10.1074/jbc.M110.160531; Kwon C, 2008, TRENDS IMMUNOL, V29, P159, DOI 10.1016/j.it.2008.01.004; Lafont F, 2004, CURR OPIN MICROBIOL, V7, P4, DOI 10.1016/j.mib.2003.12.007; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Li YZ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001111; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Magee AI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-234; Martin SW, 2005, TRENDS PLANT SCI, V10, P263, DOI 10.1016/j.tplants.2005.04.004; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; Mishra S, 2005, TRENDS MOL MED, V11, P192, DOI 10.1016/j.molmed.2005.02.004; Mongrand S, 2004, J BIOL CHEM, V279, P36277, DOI 10.1074/jbc.M403440200; Morel J, 2006, MOL CELL PROTEOMICS, V5, P1396, DOI 10.1074/mcp.M600044-MCP200; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nadimpalli R, 2000, J BIOL CHEM, V275, P29579, DOI 10.1074/jbc.M002339200; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Pollok BA, 1999, TRENDS CELL BIOL, V9, P57, DOI 10.1016/S0962-8924(98)01434-2; Qi YP, 2011, MOL PLANT PATHOL, V12, P702, DOI 10.1111/J.1364-3703.2010.00704.X; Qi YP, 2010, MOL PLANT MICROBE IN, V23, P1573, DOI 10.1094/MPMI-05-10-0106; Qi YP, 2009, PLANT J, V57, P932, DOI 10.1111/j.1365-313X.2008.03736.x; Rivera-Milla E, 2006, CELL MOL LIFE SCI, V63, P343, DOI 10.1007/s00018-005-5434-3; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Rostoks N, 2003, THEOR APPL GENET, V107, P1094, DOI 10.1007/s00122-003-1351-8; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Shahollari B, 2007, PLANT J, V50, P1, DOI 10.1111/j.1365-313X.2007.03028.x; Snyers L, 1998, J BIOL CHEM, V273, P17221, DOI 10.1074/jbc.273.27.17221; STASKAWICZ B, 1987, J BACTERIOL, V169, P5789, DOI 10.1128/jb.169.12.5789-5794.1987; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; Tornero P, 2002, PLANT CELL, V14, P1005, DOI 10.1105/tpc.001032; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; van der Goot FG, 2004, J BIOL CHEM, V279, P47792, DOI 10.1074/jbc.M406824200; Wang L, 2008, MOL PLANT MICROBE IN, V21, P1408, DOI 10.1094/MPMI-21-11-1408; Wang Y, 2010, PLANT CELL, V22, P249, DOI 10.1105/tpc.109.072066; Warren RF, 1998, PLANT CELL, V10, P1439, DOI 10.1105/tpc.10.9.1439; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yu XM, 2008, GENE, V407, P193, DOI 10.1016/j.gene.2007.10.010; Zaas DW, 2005, BBA-MOL CELL RES, V1746, P305, DOI 10.1016/j.bbamcr.2005.10.003; Zhang ZG, 2008, MOL PLANT, V1, P510, DOI 10.1093/mp/ssn011; Zhang ZG, 2007, PLANT J, V49, P302, DOI 10.1111/j.1365-313X.2006.02961.x; Zhou LA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-290; Zhou L, 2009, PLANT CELL ENVIRON, V32, P1804, DOI 10.1111/j.1365-3040.2009.02039.x; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	95	75	83	7	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31297	31307		10.1074/jbc.M110.211615	http://dx.doi.org/10.1074/jbc.M110.211615			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757708	Green Published, hybrid			2022-12-25	WOS:000294487500025
J	Xue, Z; He, Y; Ye, KX; Gu, ZL; Mao, YX; Qi, L				Xue, Zhen; He, Yin; Ye, Kaixiong; Gu, Zhenglong; Mao, Yuxin; Qi, Ling			A Conserved Structural Determinant Located at the Interdomain Region of Mammalian Inositol-requiring Enzyme 1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA; TRANSCRIPTION FACTOR; DIMERIZATION DOMAIN; IRE1; IRE1-ALPHA; KINASE; SIGNALS; XBP1	Inositol-requiring enzyme 1 alpha (IRE1 alpha), an endoplasmic reticulum-resident sensor for mammalian unfolded protein response, is a bifunctional enzyme containing kinase and RNase domains critical for trans-autophosphorylation and Xbp1 mRNA splicing, respectively, in response to endoplasmic reticulum stress. However, the amino acid residues important for its function and activation remain largely unexplored. Here, through analysis of IRE1 alpha mutants associated with human somatic cancers, we have identified a highly conserved proline residue at position 830 (Pro(830)) that is critical for its structural integrity and hence, the activation of both kinase and RNase domains. Structural analysis revealed that Pro(830) may form a highly conserved structural linker with adjacent tryptophan and tyrosine residues at positions 833 and 945 (Trp(833) and Tyr(945)), thereby bridging the kinase and RNase domains. Indeed, mutation of Pro(830) to leucine (P830L) completely abolished the kinase and RNase activities, significantly decreased protein stability, and prevented oligomerization of IRE1 alpha upon ER stress; similar observations were made for mutations of Trp(833) to alanine (W833A) and to a lesser extent for Y945A. Our finding may facilitate the identification of small molecules to compromise IRE1 alpha function specifically.	[Xue, Zhen; Ye, Kaixiong; Gu, Zhenglong; Qi, Ling] Cornell Univ, Grad Program Nutr, Ithaca, NY 14853 USA; [He, Yin; Gu, Zhenglong; Qi, Ling] Cornell Univ, Grad Program Genet & Dev, Ithaca, NY 14853 USA; [Xue, Zhen; Ye, Kaixiong; Gu, Zhenglong; Qi, Ling] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Mao, Yuxin] Cornell Univ, Weill Inst Mol & Cell Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University	Qi, L (corresponding author), Cornell Univ, Grad Program Nutr, Ithaca, NY 14853 USA.	lq35@cornell.edu	Ye, Kaixiong/C-2297-2017	Ye, Kaixiong/0000-0003-4658-7292; Qi, Ling/0000-0001-8229-0184; Mao, Yuxin/0000-0002-5064-1397	NIDDK, National Institutes of Health [R01DK082582]; American Diabetes Association [7-08-JF-47]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082582] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by NIDDK, National Institutes of Health Grant R01DK082582 (to L.Q.). This work was also supported by Cornell startup packages (to L.Q., Z.G., and Y.M.) American Diabetes Association Grant 7-08-JF-47 (to L.Q.).	Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen H, 2010, BIOCHEM J, V429, P95, DOI 10.1042/BJ20100193; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Liu CY, 2003, J BIOL CHEM, V278, P17680, DOI 10.1074/jbc.M300418200; Liu CY, 2002, J BIOL CHEM, V277, P18346, DOI 10.1074/jbc.M112454200; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Qi L, 2011, METHOD ENZYMOL, V490, P137, DOI 10.1016/B978-0-12-385114-7.00008-8; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Yang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011621; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	26	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30859	30866		10.1074/jbc.M111.273714	http://dx.doi.org/10.1074/jbc.M111.273714			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757700	Green Published, hybrid			2022-12-25	WOS:000294283600065
J	Mora-Santos, M; Limon-Mortes, MC; Giraldez, S; Herrero-Ruiz, J; Saez, C; Japon, MA; Tortolero, M; Romero, F				Mora-Santos, Mar; Cristina Limon-Mortes, M.; Giraldez, Servando; Herrero-Ruiz, Joaquin; Saez, Carmen; Japon, Miguela A.; Tortolero, Maria; Romero, Francisco			Glycogen Synthase Kinase-3 beta (GSK3 beta) Negatively Regulates PTTG1/Human Securin Protein Stability, and GSK3 beta Inactivation Correlates with Securin Accumulation in Breast Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID SEPARATION; ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE; TRANSFORMING GENE; BETA-CATENIN/TCF; UBIQUITIN LIGASE; XENOPUS EMBRYOS; PHOSPHORYLATION; PROTEOLYSIS; DEGRADATION	PTTG1, also known as securin, is an inactivating partner of separase, the major effector for chromosome segregation during mitosis. At the metaphase-to-anaphase transition, securin is targeted for proteasomal destruction by the anaphase-promoting complex or cyclosome, allowing activation of separase. In addition, securin is overexpressed in metastatic or genomically instable tumors, suggesting a relevant role for securin in tumor progression. Stability of securin is regulated by phosphorylation; some phosphorylated forms are degraded out of mitosis, by the action of the SKP1-CUL1-F-box protein (SCF) complex. The kinases targeting securin for proteolysis have not been identified, and mechanistic insight into the cause of securin accumulation in human cancers is lacking. Here, we demonstrate that glycogen synthase kinase-3 beta (GSK3 beta) phosphorylates securin to promote its proteolysis via SCF beta TrCP E3 ubiquitin ligase. Importantly, a strong correlation between securin accumulation and GSK3 beta inactivation was observed in breast cancer tissues, indicating that GSK3 beta inactivation may account for securin accumulation in breast cancers.	[Mora-Santos, Mar; Cristina Limon-Mortes, M.; Giraldez, Servando; Herrero-Ruiz, Joaquin; Tortolero, Maria; Romero, Francisco] Univ Seville, Fac Biol, Dept Microbiol, E-41080 Seville, Spain; [Saez, Carmen; Japon, Miguela A.] Univ Seville, CSIC, IBIS, Hosp Univ Virgen del Rocio, Seville 41013, Spain; [Saez, Carmen; Japon, Miguela A.] Hosp Univ Virgen del Rocio, Dept Anat Patol, Seville 41013, Spain	University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Virgen del Rocio University Hospital	Romero, F (corresponding author), Univ Seville, Fac Biol, Dept Microbiol, Apartado Correos 1095, E-41080 Seville, Spain.	frport@us.es	del Mar Mora-Santos, Maria/V-3495-2017; IBIS, TUMORIGENESIS/P-3506-2015; Tortolero, Maria/K-5744-2014; Sáez, Carmen/B-9468-2015; Japón, Miguel A/L-2555-2017; GIRALDEZ, SERVANDO/K-3927-2014; Ruiz, Joaquin Herrero/AAP-5598-2020; Romero, Francisco/K-2101-2014; Limon-Mortes, M Cristina/K-4397-2014	del Mar Mora-Santos, Maria/0000-0002-8042-0886; Tortolero, Maria/0000-0003-1797-9940; Sáez, Carmen/0000-0002-8600-0508; Japón, Miguel A/0000-0002-5980-5044; GIRALDEZ, SERVANDO/0000-0001-9543-9347; Ruiz, Joaquin Herrero/0000-0002-4120-139X; Romero, Francisco/0000-0002-9588-6881; Limon-Mortes, M Cristina/0000-0003-3720-814X	Ministerio de Ciencia e Innovacion, Spain [SAF2008-03095, SAF2008-05046]; Ministerio de Sanidad, Spain [ISCIII-RETIC-RD06/0020-FEDER]; Direccion General de Investigacion, Tecnologia y Empresa, Junta de Andalucia [P08-CVI-03603, PI09-0589]; Ministerio de Ciencia e Innovacion (MICINN); Junta de Andalucia; Instituto de Salud Carlos III/Fondo de Investigacion Sanitaria (FIS); Fundacion Progreso y Salud, Consejeria de Salud, Junta de Andalucia	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Sanidad, Spain(Spanish Government); Direccion General de Investigacion, Tecnologia y Empresa, Junta de Andalucia(Junta de AndaluciaSpanish Government); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); Instituto de Salud Carlos III/Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Fundacion Progreso y Salud, Consejeria de Salud, Junta de Andalucia(Junta de Andalucia)	This work was supported by grants from Ministerio de Ciencia e Innovacion, Spain (Grants SAF2008-03095 and SAF2008-05046), Ministerio de Sanidad, Spain (Grant ISCIII-RETIC-RD06/0020-FEDER), and Direccion General de Investigacion, Tecnologia y Empresa, Junta de Andalucia (Grants P08-CVI-03603 and PI09-0589).; Supported by a fellowship from Ministerio de Ciencia e Innovacio'n (MICINN).; Supported by a fellowship from Junta de Andalucia.; Supported by a contract from Instituto de Salud Carlos III/Fondo de Investigacion Sanitaria (FIS) and Fundacion Progreso y Salud, Consejeria de Salud, Junta de Andalucia.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bernal JA, 2008, CELL DEATH DIFFER, V15, P202, DOI 10.1038/sj.cdd.4402254; Bernal JA, 2002, NAT GENET, V32, P306, DOI 10.1038/ng997; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dominguez A, 1998, ONCOGENE, V17, P2187, DOI 10.1038/sj.onc.1202140; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gil-Bernabe AM, 2006, MOL CELL BIOL, V26, P4017, DOI 10.1128/MCB.01904-05; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Harper JW, 2002, TRENDS CELL BIOL, V12, P104, DOI 10.1016/S0962-8924(01)02238-3; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Heaney AP, 2000, LANCET, V355, P716, DOI 10.1016/S0140-6736(99)10238-1; Hlubek F, 2006, BRIT J CANCER, V94, P1672, DOI 10.1038/sj.bjc.6603155; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Lee JY, 2007, MOL CELL BIOL, V27, P3187, DOI 10.1128/MCB.01461-06; Limon-Mortes MC, 2008, J CELL SCI, V121, P1825, DOI 10.1242/jcs.020552; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Marangos P, 2008, NAT CELL BIOL, V10, P445, DOI 10.1038/ncb1707; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Martinez A, 2002, J MED CHEM, V45, P1292, DOI 10.1021/jm011020u; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ramos-Morales F, 2000, ONCOGENE, V19, P403, DOI 10.1038/sj.onc.1203320; Romero F, 2004, MOL CELL BIOL, V24, P2720, DOI 10.1128/MCB.24.7.2720-2733.2004; Romero F, 1998, J BIOL CHEM, V273, P5923, DOI 10.1074/jbc.273.10.5923; Romero F, 2001, NUCLEIC ACIDS RES, V29, P1300, DOI 10.1093/nar/29.6.1300; Saez C, 2006, J CLIN ENDOCR METAB, V91, P1404, DOI 10.1210/jc.2005-2532; Saez C, 1999, ONCOGENE, V18, P5473, DOI 10.1038/sj.onc.1202914; Saez C, 2002, ONCOGENE, V21, P8173, DOI 10.1038/sj.onc.1205954; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Wasch R, 2005, ONCOGENE, V24, P1, DOI 10.1038/sj.onc.1208017; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhou CQ, 2005, INT J CANCER, V113, P891, DOI 10.1002/ijc.20642; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	47	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30047	30056		10.1074/jbc.M111.232330	http://dx.doi.org/10.1074/jbc.M111.232330			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21757741	hybrid, Green Published			2022-12-25	WOS:000294046600063
J	Engelen, K; Fu, Q; Meysman, P; Sanchez-Rodriguez, A; De Smet, R; Lemmens, K; Fierro, AC; Marchal, K				Engelen, Kristof; Fu, Qiang; Meysman, Pieter; Sanchez-Rodriguez, Aminael; De Smet, Riet; Lemmens, Karen; Fierro, Ana Carolina; Marchal, Kathleen			COLOMBOS: Access Port for Cross-Platform Bacterial Expression Compendia	PLOS ONE			English	Article							MICROARRAY EXPERIMENT MIAME; ESCHERICHIA-COLI; MINIMUM INFORMATION; GENE-REGULATION; DATABASE; FUR; NORMALIZATION; TRANSCRIPTION; TRANSPORTER; COLLECTION	Background: Microarrays are the main technology for large-scale transcriptional gene expression profiling, but the large bodies of data available in public databases are not useful due to the large heterogeneity. There are several initiatives that attempt to bundle these data into expression compendia, but such resources for bacterial organisms are scarce and limited to integration of experiments from the same platform or to indirect integration of per experiment analysis results. Methodology/Principal Findings: We have constructed comprehensive organism-specific cross-platform expression compendia for three bacterial model organisms (Escherichia coli, Bacillus subtilis, and Salmonella enterica serovar Typhimurium) together with an access portal, dubbed COLOMBOS, that not only provides easy access to the compendia, but also includes a suite of tools for exploring, analyzing, and visualizing the data within these compendia. It is freely available at http://bioi.biw.kuleuven.be/colombos. The compendia are unique in directly combining expression information from different microarray platforms and experiments, and we illustrate the potential benefits of this direct integration with a case study: extending the known regulon of the Fur transcription factor of E. coli. The compendia also incorporate extensive annotations for both genes and experimental conditions; these heterogeneous data are functionally integrated in the COLOMBOS analysis tools to interactively browse and query the compendia not only for specific genes or experiments, but also metabolic pathways, transcriptional regulation mechanisms, experimental conditions, biological processes, etc. Conclusions/Significance: We have created cross-platform expression compendia for several bacterial organisms and developed a complementary access port COLOMBOS, that also serves as a convenient expression analysis tool to extract useful biological information. This work is relevant to a large community of microbiologists by facilitating the use of publicly available microarray experiments to support their research.	[Engelen, Kristof; Fu, Qiang; Meysman, Pieter; Sanchez-Rodriguez, Aminael; De Smet, Riet; Lemmens, Karen; Fierro, Ana Carolina; Marchal, Kathleen] Katholieke Univ Leuven, Dept Microbial & Mol Syst, B-3001 Heverlee, Belgium	KU Leuven	Engelen, K (corresponding author), Katholieke Univ Leuven, Dept Microbial & Mol Syst, B-3001 Heverlee, Belgium.	kristof.engelen@biw.kuleuven.be; kathleen.marchal@biw.kuleuven.be	Meysman, Pieter/I-1891-2019; Marchal, Kathleen/B-5001-2013; Marchal, Kathleen/O-7936-2017	Meysman, Pieter/0000-0001-5903-633X; Marchal, Kathleen/0000-0002-2169-4588; Marchal, Kathleen/0000-0002-2169-4588; Sanchez-Rodriguez, Aminael/0000-0002-9269-0621; Engelen, Kristof/0000-0001-6215-1689	KULeuven Research Council [PF/10/010 - NATAR, GOA/08/011, CoE EF/05/007 - SymBioSys, CREA/08/023, OT 05-33, OT09/022]; agency for Innovation by Science and Technology (SBO-BioFrame) [SB-81297]; Interuniversity Attraction Poles [P6/25 - BioMaGNet]; Research Foundation - Flanders [IOK-B9725-G.0329.09]; Human Frontier Science Program [RGY0079/2007C]	KULeuven Research Council(KU Leuven); agency for Innovation by Science and Technology (SBO-BioFrame); Interuniversity Attraction Poles(Belgian Federal Science Policy Office); Research Foundation - Flanders(FWO); Human Frontier Science Program(Human Frontier Science Program)	This work is supported by the KULeuven Research Council (PF/10/010 - NATAR, GOA/08/011, CoE EF/05/007 - SymBioSys, CREA/08/023, OT 05-33, OT09/022); the agency for Innovation by Science and Technology (SBO-BioFrame, SB-81297); Interuniversity Attraction Poles (P6/25 - BioMaGNet); Research Foundation - Flanders (IOK-B9725-G.0329.09); and the Human Frontier Science Program (RGY0079/2007C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brazma A, 2009, THESCIENTIFICWORLDJO, V9, P420, DOI 10.1100/tsw.2009.57; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Chen Z, 2007, NUCLEIC ACIDS RES, V35, P6762, DOI 10.1093/nar/gkm631; Elfilali A, 2006, NUCLEIC ACIDS RES, V34, pD613, DOI 10.1093/nar/gkj022; Engelen K, 2006, BIOINFORMATICS, V22, P1251, DOI 10.1093/bioinformatics/btl068; Fadda A, 2009, MOL BIOSYST, V5, P1840, DOI 10.1039/b907310h; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Fierro AC, 2008, CURR GENOMICS, V9, P525, DOI 10.2174/138920208786847935; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Grosse C, 2006, MOL MICROBIOL, V62, P120, DOI 10.1111/j.1365-2958.2006.05326.x; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Kuo WP, 2006, NAT BIOTECHNOL, V24, P832, DOI 10.1038/nbt1217; Lemmens K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r27; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Meysman P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1071; Nandal A, 2010, MOL MICROBIOL, V75, P637, DOI 10.1111/j.1365-2958.2009.06977.x; Pan F, 2007, NUCLEIC ACIDS RES, V35, pD756, DOI 10.1093/nar/gkl798; Panina EM, 2001, NUCLEIC ACIDS RES, V29, P5195, DOI 10.1093/nar/29.24.5195; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Patzer SI, 2001, J BACTERIOL, V183, P4806, DOI 10.1128/JB.183.16.4806-4813.2001; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S12; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zarrineh P, 2010, NUCL ACIDS IN PRESS; Zhang ZG, 2005, J BACTERIOL, V187, P980, DOI 10.1128/JB.187.3.980-990.2005	43	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e20938	10.1371/journal.pone.0020938	http://dx.doi.org/10.1371/journal.pone.0020938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779320	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811300005
J	Penna-Coutinho, J; Cortopassi, WA; Oliveira, AA; Franca, TCC; Krettli, AU				Penna-Coutinho, Julia; Cortopassi, Wilian Augusto; Oliveira, Aline Alves; Costa Franca, Tanos Celmar; Krettli, Antoniana Ursine			Antimalarial Activity of Potential Inhibitors of Plasmodium falciparum Lactate Dehydrogenase Enzyme Selected by Docking Studies	PLOS ONE			English	Article							IN-VITRO; QUINOLINE ANTIMALARIALS; MOLECULAR DOCKING; DRUG-SENSITIVITY; NATURAL-PRODUCTS; CHLOROQUINE; RESISTANCE; MALARIA; CULTURE; PARASITES	The Plasmodium falciparum lactate dehydrogenase enzyme (PfLDH) has been considered as a potential molecular target for antimalarials due to this parasite's dependence on glycolysis for energy production. Because the LDH enzymes found in P. vivax, P. malariae and P. ovale (pLDH) all exhibit similar to 90% identity to PfLDH, it would be desirable to have new anti-pLDH drugs, particularly ones that are effective against P. falciparum, the most virulent species of human malaria. Our present work used docking studies to select potential inhibitors of pLDH, which were then tested for antimalarial activity against P. falciparum in vitro and P. berghei malaria in mice. A virtual screening in DrugBank for analogs of NADH (an essential cofactor to pLDH) and computational studies were undertaken, and the potential binding of the selected compounds to the PfLDH active site was analyzed using Molegro Virtual Docker software. Fifty compounds were selected based on their similarity to NADH. The compounds with the best binding energies (itraconazole, atorvastatin and posaconazole) were tested against P. falciparum chloroquine-resistant blood parasites. All three compounds proved to be active in two immunoenzymatic assays performed in parallel using monoclonals specific to PfLDH or a histidine rich protein (HRP2). The IC(50) values for each drug in both tests were similar, were lowest for posaconazole (< 5 mu M) and were 40- and 100-fold less active than chloroquine. The compounds reduced P. berghei parasitemia in treated mice, in comparison to untreated controls; itraconazole was the least active compound. The results of these activity trials confirmed that molecular docking studies are an important strategy for discovering new antimalarial drugs. This approach is more practical and less expensive than discovering novel compounds that require studies on human toxicology, since these compounds are already commercially available and thus approved for human use.	[Penna-Coutinho, Julia; Krettli, Antoniana Ursine] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil; [Penna-Coutinho, Julia; Krettli, Antoniana Ursine] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Malaria, Belo Horizonte, MG, Brazil; [Cortopassi, Wilian Augusto; Oliveira, Aline Alves; Costa Franca, Tanos Celmar] Mil Inst Engn, Lab Mol Modeling Appl Chem & Biol Def LMCBD, Rio De Janeiro, Brazil	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Penna-Coutinho, J (corresponding author), Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.	tanos@ime.eb.br; akrettli@cpqrr.fiocruz.br	Cortopassi, Wilian/P-3136-2014; Oliveira, Aline/O-1698-2013; França, Tanos Celmar Costa/I-9519-2012	Cortopassi, Wilian/0000-0001-8038-7847; Oliveira, Aline/0000-0001-9605-6276; França, Tanos Celmar Costa/0000-0002-6048-8103	MCT/CNPq/CT-Saude/MS/SCTIE/DECIT; FIOCRUZ-PAPES; FAPEMIG; FAPERJ; CNPq	MCT/CNPq/CT-Saude/MS/SCTIE/DECIT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FIOCRUZ-PAPES; FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Brazilian funding agencies MCT/CNPq/CT-Saude/MS/SCTIE/DECIT, FIOCRUZ-PAPES, FAPEMIG and FAPERJ, and by CNPq fellowships to AUK, JPC, AAO and WAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Badr AA, 2009, PROF DRUG SUB EXCIP, V34, P193, DOI [10.1016/S1871-5125(09)34005-4, 10.1016/S0099-5428(08)00005-1]; [Anonymous], GUID TREATM MAL; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Brown WM, 2004, BIOCHEMISTRY-US, V43, P6219, DOI 10.1021/bi049892w; CARVALHO LH, 1991, MEM I OSWALDO CRUZ, V86, P181, DOI 10.1590/S0074-02761991000600041; CARVALHO LH, 1991, BRAZ J MED BIOL RES, V24, P1113; de Andrade-Neto VF, 2004, BIOORG MED CHEM LETT, V14, P1145, DOI 10.1016/j.bmcl.2003.12.069; Druilhe P, 2001, AM J TROP MED HYG, V64, P233, DOI 10.4269/ajtmh.2001.64.233; Egan TJ, 2005, J INORG BIOCHEM, V99, P1532, DOI 10.1016/j.jinorgbio.2005.04.013; Ferraz ML, 2009, ANTIMICROB AGENTS CH, V53, P174, DOI 10.1128/AAC.00779-08; Foley M, 1998, PHARMACOL THERAPEUT, V79, P55, DOI 10.1016/S0163-7258(98)00012-6; Krettli AU, 2009, CURR DRUG TARGETS, V10, P261, DOI 10.2174/138945009787581203; Krettli AU, 2009, EXPERT OPIN DRUG DIS, V4, P95, DOI 10.1517/17530050802678127; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; *MAL SVS MIN SAUD, 2009, MAL DOENC A Z; Menting JG, 1997, MOL BIOCHEM PARASIT, V88, P215, DOI 10.1016/S0166-6851(97)00095-9; Ncokazi KK, 2005, ANAL BIOCHEM, V338, P306, DOI 10.1016/j.ab.2004.11.022; Noedl H, 2002, EXP PARASITOL, V102, P157, DOI 10.1016/S0014-4894(03)00051-1; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Parquet V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-139; PETERS W, 1965, EXP PARASITOL, V17, P80, DOI 10.1016/0014-4894(65)90012-3; Read JA, 1999, J BIOL CHEM, V274, P10213, DOI 10.1074/jbc.274.15.10213; RIECKMANN KH, 1978, LANCET, V1, P22; Taoufiq Z, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-52; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041; Vennerstrom JL, 1999, ANTIMICROB AGENTS CH, V43, P598, DOI 10.1128/AAC.43.3.598; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Yang JM, 2004, PROTEINS, V55, P288, DOI 10.1002/prot.20035; Yohannes AM, 2011, AM J TROP MED HYG, V84, P137, DOI 10.4269/ajtmh.2011.09-0723	32	85	86	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21237	10.1371/journal.pone.0021237	http://dx.doi.org/10.1371/journal.pone.0021237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779323	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811300007
J	Robidart, JC; Roque, A; Song, PF; Girguis, PR				Robidart, Julie C.; Roque, Annelys; Song, Pengfei; Girguis, Peter R.			Linking Hydrothermal Geochemistry to Organismal Physiology: Physiological Versatility in Riftia pachyptila from Sedimented and Basalt-hosted Vents	PLOS ONE			English	Article							EAST PACIFIC RISE; TUBE-WORM; GUAYMAS BASIN; ROSE GARDEN; CHEMOAUTOTROPHIC SYMBIONTS; CARBONIC-ANHYDRASE; METABOLITE UPTAKE; INORGANIC CARBON; ACID CYCLE; SULFIDE	Much of what is known regarding Riftia pachyptila physiology is based on the wealth of studies of tubeworms living at diffuse flows along the fast-spreading, basalt-hosted East Pacific Rise (EPR). These studies have collectively suggested that Riftia pachyptila and its chemoautotrophic symbionts are physiologically specialized, highly productive associations relying on hydrogen sulfide and oxygen to generate energy for carbon fixation, and the symbiont's nitrate reduction to ammonia for energy and biosynthesis. However, Riftia also flourish in sediment-hosted vents, which are markedly different in geochemistry than basalt-hosted systems. Here we present data from shipboard physiological studies and global quantitative proteomic analyses of Riftia pachyptila trophosome tissue recovered from tubeworms residing in the EPR and the Guaymas basin, a sedimented, hydrothermal vent field. We observed marked differences in symbiont nitrogen metabolism in both the respirometric and proteomic data. The proteomic data further suggest that Riftia associations in Guaymas may utilize different sulfur compounds for energy generation, may have an increased capacity for energy storage, and may play a role in degrading exogenous organic carbon. Together these data reveal that Riftia symbionts are far more physiologically plastic than previously considered, and that contrary to previous assertions-Riftia do assimilate reduced nitrogen in some habitats. These observations raise new hypotheses regarding adaptations to the geochemical diversity of habitats occupied by Riftia, and the degree to which the environment influences symbiont physiology and evolution.	[Robidart, Julie C.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Roque, Annelys] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Song, Pengfei; Girguis, Peter R.] Harvard Univ, Cambridge, MA 02138 USA	University of California System; University of California Santa Cruz; National Institutes of Health (NIH) - USA; Harvard University	Robidart, JC (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA.	pgirguis@oeb.harvard.edu		Girguis, Peter/0000-0002-3599-8160; Robidart, Julie/0000-0001-9805-3570	National Science Foundation [OCE-0623383, OCE-0732369]	National Science Foundation(National Science Foundation (NSF))	This project was supported by grants from the National Science Foundation to PRG (OCE-0623383 and OCE-0732369, http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARP AJ, 1987, J EXP BIOL, V128, P139; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; BAZYLINSKI DA, 1988, ORG GEOCHEM, V12, P547, DOI 10.1016/0146-6380(88)90146-5; BEH M, 1993, ARCH MICROBIOL, V160, P306, DOI 10.1007/BF00292082; Bright M, 2000, MAR BIOL, V136, P621, DOI 10.1007/s002270050722; BUCHANAN BB, 1990, PHOTOSYNTH RES, V24, P47, DOI 10.1007/BF00032643; Butterfield DA, 1997, PHILOS T R SOC A, V355, P369, DOI 10.1098/rsta.1997.0013; CAMPBELL AC, 1988, J GEOPHYS RES-SOLID, V93, P4537, DOI 10.1029/JB093iB05p04537; CAVANAUGH CM, 1981, SCIENCE, V213, P340, DOI 10.1126/science.213.4505.340; Childress JJ, 2011, J EXP BIOL, V214, P312, DOI 10.1242/jeb.049023; CHILDRESS JJ, 1992, OCEANOGR MAR BIOL, V30, P337; CHILDRESS JJ, 1991, BIOL BULL-US, V180, P135, DOI 10.2307/1542437; CHILDRESS JJ, 1980, DEEP-SEA RES, V27, P965, DOI 10.1016/0198-0149(80)90008-4; CHILDRESS JJ, 1984, MAR BIOL, V83, P109, DOI 10.1007/BF00394718; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; De Cian MC, 2003, MAR BIOL, V142, P141, DOI 10.1007/s00227-002-0931-5; Deguchi S, 2008, GREEN CHEM, V10, P623, DOI 10.1039/b803384f; Deguchi S, 2008, GREEN CHEM, V10, P191, DOI 10.1039/B713655B; Duperron S, 2006, ENVIRON MICROBIOL, V8, P1441, DOI 10.1111/j.1462-2920.2006.01038.x; Elderfield H, 1999, EARTH PLANET SC LETT, V172, P151, DOI 10.1016/S0012-821X(99)00191-0; Felbeck H, 2004, DEEP-SEA RES PT I, V51, P401, DOI 10.1016/j.dsr.2003.10.012; FELBECK H, 1981, SCIENCE, V213, P336, DOI 10.1126/science.213.4505.336; FISHER C, 1995, GEOPHYS MONOGRAPH AM, P297; FISHER CR, 1988, DEEP-SEA RES, V35, P1745, DOI 10.1016/0198-0149(88)90047-7; FISHER CR, 1989, BIOL BULL, V177, P372, DOI 10.2307/1541597; Ghosh W, 2009, FEMS MICROBIOL REV, V33, P999, DOI 10.1111/j.1574-6976.2009.00187.x; Girguis PR, 2006, J EXP BIOL, V209, P3516, DOI 10.1242/jeb.02404; Girguis PR, 2000, APPL ENVIRON MICROB, V66, P2783, DOI 10.1128/AEM.66.7.2783-2790.2000; Girguis PR, 2002, J EXP BIOL, V205, P3055; Goffredi SK, 1999, BIOL BULL-US, V196, P257, DOI 10.2307/1542950; Goffredi SK, 1997, J EXP BIOL, V200, P883; Goffredi SK, 2001, MAR BIOL, V138, P259, DOI 10.1007/s002270000462; Govenar B, 2005, MAR ECOL PROG SER, V305, P67, DOI 10.3354/meps305067; Gru C, 1998, ANALYST, V123, P1289, DOI 10.1039/a800032h; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; HENTSCHEL U, 1993, NATURE, V366, P338, DOI 10.1038/366338a0; HESSLER RR, 1988, DEEP-SEA RES, V35, P1681, DOI 10.1016/0198-0149(88)90044-1; Hourdez S, 2005, J INORG BIOCHEM, V99, P130, DOI 10.1016/j.jinorgbio.2004.09.017; Hugler M, 2005, J BACTERIOL, V187, P3020, DOI 10.1128/JB.187.9.3020-3027.2005; Hurtado LA, 2004, MOL ECOL, V13, P2603, DOI 10.1111/j.1365-294X.2004.02287.x; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; JOHNSON KS, 1988, DEEP-SEA RES, V35, P1711, DOI 10.1016/0198-0149(88)90045-3; JOHNSON KS, 1988, DEEP-SEA RES, V35, P1723, DOI 10.1016/0198-0149(88)90046-5; KARLSSON M, 1995, ANAL CHIM ACTA, V312, P107, DOI 10.1016/0003-2670(95)00179-4; Kochevar RE, 1996, MAR BIOL, V125, P375, DOI 10.1007/BF00346318; Le Bris N, 2006, MAR CHEM, V98, P167, DOI 10.1016/j.marchem.2005.08.008; LEE RW, 1994, APPL ENVIRON MICROB, V60, P1852, DOI 10.1128/AEM.60.6.1852-1858.1994; Luther GW, 2001, NATURE, V410, P813, DOI 10.1038/35071069; Markert S, 2007, SCIENCE, V315, P247, DOI 10.1126/science.1132913; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; Minic Z, 2001, J BIOL CHEM, V276, P23777, DOI 10.1074/jbc.M102249200; Nees HA, 2009, DEEP-SEA RES PT II, V56, P1607, DOI 10.1016/j.dsr2.2009.05.007; Nyholm SV, 2008, BIOL BULL-US, V214, P255, DOI 10.2307/25470667; Pospesel MA, 1998, DEEP-SEA RES PT I, V45, P2189, DOI 10.1016/S0967-0637(98)00054-5; Robidart JC, 2008, ENVIRON MICROBIOL, V10, P727, DOI 10.1111/j.1462-2920.2007.01496.x; Rouse GW, 2001, ZOOL J LINN SOC-LOND, V132, P55, DOI 10.1111/j.1096-3642.2001.tb02271.x; SCHAAF M, 1998, SPECIAL PUBLICATIONS, P101; Schulze A, 2003, HYDROBIOLOGIA, V496, P199, DOI 10.1023/A:1026192715095; SEEWALD JS, 1994, GEOCHIM COSMOCHIM AC, V58, P5065, DOI 10.1016/0016-7037(94)90232-1; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; SILVER M, 1976, J GEN MICROBIOL, V97, P277, DOI 10.1099/00221287-97-2-277; SOUTHWARD AJ, 1981, NATURE, V293, P616, DOI 10.1038/293616a0; Stewart Frank J., 2006, V41, P197; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Uda K, 2005, INT J BIOL MACROMOL, V37, P54, DOI 10.1016/j.ijbiomac.2005.08.009; VONDAMM KL, 1990, ANNU REV EARTH PL SC, V18, P173, DOI 10.1146/annurev.ea.18.050190.001133; VONDAMM KL, 1985, GEOCHIM COSMOCHIM AC, V49, P2221, DOI 10.1016/0016-7037(85)90223-6; Vrijenhoek RC, 2010, MOL ECOL, V19, P4391, DOI 10.1111/j.1365-294X.2010.04789.x; Wheat CG, 2000, J GEOPHYS RES-SOL EA, V105, P13437, DOI 10.1029/2000JB900070; WILLASON SW, 1986, MAR BIOL, V91, P285, DOI 10.1007/BF00569445; WILLIAMS NA, 1993, J MAR BIOL ASSOC UK, V73, P437, DOI 10.1017/S0025315400032987; Zal F, 1997, PROTEINS, V29, P562, DOI 10.1002/(SICI)1097-0134(199712)29:4<562::AID-PROT15>3.0.CO;2-K	74	21	21	23	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21692	10.1371/journal.pone.0021692	http://dx.doi.org/10.1371/journal.pone.0021692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779334	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000292811300012
J	Tomasi, S; Sarmientos, P; Giorda, G; Gurewich, V; Vercelli, A				Tomasi, Simone; Sarmientos, Paolo; Giorda, Giada; Gurewich, Victor; Vercelli, Alessandro			Mutant Prourokinase with Adjunctive C1-Inhibitor Is an Effective and Safer Alternative to tPA in Rat Stroke	PLOS ONE			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; CEREBRAL-ARTERY OCCLUSION; ACUTE ISCHEMIC-STROKE; BLOOD-BRAIN-BARRIER; HEMORRHAGIC TRANSFORMATION; PRO-UROKINASE; CLOT LYSIS; THROMBOEMBOLIC STROKE; THROMBOLYTIC THERAPY; EMBOLIC STROKE	A single-site mutant (M5) of native urokinase plasminogen activator (prouPA) induces effective thrombolysis in dogs with venous or arterial thrombosis with a reduction in bleeding complications compared to tPA. This effect, related to inhibition of two-chain M5 (tcM5) by plasma C1-inhibitor (C1I), thereby preventing non-specific plasmin generation, was augmented by the addition of exogenous C1I to plasma in vitro. In the present study, tPA, M5 or placebo +/- C1I were administered in two rat stroke models. In Part-I, permanent MCA occlusion was used to evaluate intracranial hemorrhage (ICH) by the thrombolytic regimens. In Part II, thromboembolic occlusion was used with thrombolysis administered 2 h later. Infarct and edema volumes, and ICH were determined at 24 h, and neuroscore pre (2 h) and post (24 h) treatment. In Part I, fatal ICH occurred in 57% of tPA and 75% of M5 rats. Adjunctive C1I reduced this to 25% and 17% respectively. Similarly, semiquantitation of ICH by neuropathological examination showed significantly less ICH in rats given adjunctive C1I compared with tPA or M5 alone. In Part-II, tPA, M5, and M5+C1I induced comparable ischemic volume reductions (>55%) compared with the saline or C1I controls, indicating the three treatments had a similar fibrinolytic effect. ICH was seen in 40% of tPA and 50% of M5 rats, with 1 death in the latter. Only 17% of the M5+C1I rats showed ICH, and the bleeding score in this group was significantly less than that in either the tPA or M5 group. The M5+C1I group had the best Benefit Index, calculated by dividing percent brain salvaged by the ICH visual score in each group. In conclusion, adjunctive C1I inhibited bleeding by M5, induced significant neuroscore improvement and had the best Benefit Index. The C1I did not compromise fibrinolysis by M5 in contrast with tPA, consistent with previous in vitro findings.	[Tomasi, Simone; Giorda, Giada; Vercelli, Alessandro] San Luigi Gonzaga Hosp, NICO, Turin, Italy; [Tomasi, Simone; Giorda, Giada; Vercelli, Alessandro] Univ Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy; [Sarmientos, Paolo] Primm Srl, Milan, Italy; [Gurewich, Victor] Beth Israel Deaconess Med Ctr, Vasc Res Lab, Boston, MA 02215 USA	Azienda Ospedaliero-Universitaria San Luigi Gonzaga; University of Turin; Harvard University; Beth Israel Deaconess Medical Center	Tomasi, S (corresponding author), San Luigi Gonzaga Hosp, NICO, Turin, Italy.	simone.tomasi@unito.it	Vercelli, Alessandro E/A-1926-2012; Tomasi, Simone/D-8427-2011	Vercelli, Alessandro E/0000-0002-5909-2128; 	Compagnia di San Paolo; MIUR; Regione Piemonte; Pharming Technologies B.V. (Leiden, The Netherlands)	Compagnia di San Paolo(Compagnia di San Paolo); MIUR(Ministry of Education, Universities and Research (MIUR)); Regione Piemonte(Regione Piemonte); Pharming Technologies B.V. (Leiden, The Netherlands)(Netherlands Government)	The study was supported by grants from Compagnia di San Paolo (charity grant), MIUR (governmental grant) and Regione Piemonte (local governmental grant) to AV. The study was partly funded by Pharming Technologies B.V. (Leiden, The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adibhatla RM, 2008, CNS NEUROL DISORD-DR, V7, P243, DOI 10.2174/187152708784936608; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P452, DOI 10.1097/00004647-200003000-00002; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; BENNETT WR, 1987, J AM COLL CARDIOL, V10, P627, DOI 10.1016/S0735-1097(87)80206-1; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Busch E, 1997, BRAIN RES, V778, P16, DOI 10.1016/S0006-8993(97)01008-1; Choudhri TF, 1997, STROKE, V28, P2296, DOI 10.1161/01.STR.28.11.2296; Clark WM, 1997, NEUROL RES, V19, P641; Cronin CA, 2010, J EMERG MED, V38, P99, DOI 10.1016/j.jemermed.2009.08.004; Dijkhuizen RM, 2002, STROKE, V33, P2100, DOI 10.1161/01.STR.0000023534.37670.F7; Dohare P, 2008, BEHAV BRAIN RES, V193, P289, DOI 10.1016/j.bbr.2008.06.012; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Gurewich V, 2006, J THROMB HAEMOST, V4, P1559, DOI 10.1111/j.1538-7836.2006.01993.x; GUREWICH V, 1984, J CLIN INVEST, V73, P1731, DOI 10.1172/JCI111381; Gurewich V, 2009, THROMB HAEMOSTASIS, V102, P279, DOI 10.1160/TH08-09-0598; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Henninger N, 2009, EXP NEUROL, V215, P290, DOI 10.1016/j.expneurol.2008.10.013; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; HUISMAN LGM, 1995, THROMB HAEMOSTASIS, V73, P466; Kaur J, 2004, J CEREBR BLOOD F MET, V24, P945, DOI 10.1097/01.WCB.0000137868.50767.E8; Kleindorfer D, 2008, STROKE, V39, P924, DOI 10.1161/STROKEAHA.107.490375; KORNINGER C, 1981, THROMB HAEMOSTASIS, V46, P561; LIU JN, 1992, BIOCHEMISTRY-US, V31, P6311, DOI 10.1021/bi00142a021; Liu JN, 2002, CIRC RES, V90, P757, DOI 10.1161/01.RES.0000014825.71092.BD; Liu JN, 1996, BIOCHEMISTRY-US, V35, P14070, DOI 10.1021/bi9605393; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MONTONEY M, 1995, CIRCULATION, V91, P1540, DOI 10.1161/01.CIR.91.5.1540; Murata Y, 2008, STROKE, V39, P3372, DOI 10.1161/STROKEAHA.108.514026; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; NIEUWENHUIZEN W, 1983, BIOCHIM BIOPHYS ACTA, V748, P86, DOI 10.1016/0167-4838(83)90030-4; PANNELL R, 1986, BLOOD, V67, P1215; Pannell R, 2007, J THROMB HAEMOST, V5, P1047, DOI 10.1111/j.1538-7836.2007.02453.x; PANNELL R, 1988, J CLIN INVEST, V81, P853, DOI 10.1172/JCI113394; PETERSEN LC, 1988, BIOCHIM BIOPHYS ACTA, V952, P245, DOI 10.1016/0167-4838(88)90123-9; Poland B, 2009, CLIN PHARMACOL THER, V86, P105, DOI 10.1038/clpt.2009.71; Renolleau S, 1998, STROKE, V29, P1454, DOI 10.1161/01.STR.29.7.1454; Rosell A, 2006, STROKE, V37, P1399, DOI 10.1161/01.STR.0000223001.06264.af; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Strbian D, 2007, CIRCULATION, V116, P411, DOI 10.1161/CIRCULATIONAHA.106.655423; Sun ZY, 1997, J BIOL CHEM, V272, P23818, DOI 10.1074/jbc.272.38.23818; Tejima E, 2001, STROKE, V32, P1336, DOI 10.1161/01.STR.32.6.1336; Wang XY, 2004, STROKE, V35, P2726, DOI 10.1161/01.STR.0000143219.16695.af; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Wardlaw JM, 2003, STROKE, V34, P1437, DOI 10.1161/01.STR.0000072513.72262.7E; WEAVER WD, 1994, J AM COLL CARDIOL, V24, P1242, DOI 10.1016/0735-1097(94)90105-8; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006; ZARICH SW, 1995, J AM COLL CARDIOL, V26, P374, DOI 10.1016/0735-1097(95)80009-6; Zhang L, 2006, THROMB HAEMOSTASIS, V95, P166, DOI 10.1160/TH05-07-0477; 1989, LANCET, V333, P863	52	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21999	10.1371/journal.pone.0021999	http://dx.doi.org/10.1371/journal.pone.0021999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779364	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811300034
J	Zhang, XM; Zhong, R; Liu, L; Wang, Y; Yuan, JX; Wang, P; Sun, C; Zhang, Z; Song, WG; Miao, XP				Zhang, Xue-Mei; Zhong, Rong; Liu, Li; Wang, Ying; Yuan, Ju-Xiang; Wang, Peng; Sun, Chuang; Zhang, Zhi; Song, Wen-Guang; Miao, Xiao-Ping			Smoking and COX-2 Functional Polymorphisms Interact to Increase the Risk of Gastric Cardia Adenocarcinoma in Chinese Population	PLOS ONE			English	Article							CYCLOOXYGENASE-2 EXPRESSION; KAPPA-B; ESOPHAGEAL; CANCER; CARCINOGENESIS; ACTIVATION; INDUCTION; VARIANTS; HAMSTERS; ACID	Background: Over-expression and increased activity of cyclooxygenase (COX)-2 induced by smoking has been implicated in the development of cancer. This study aimed to explore the interaction between smoking and functional polymorphisms of COX-2 in modulation of gastric cardia adenocarcinoma (GCA) risk. Methods and Findings: Three COX-2 polymorphisms, including -1195G > A (rs689466), -765G > C (rs20417), and 587Gly > Arg (rs3218625), were genotyped in 357 GCA patients and 985 controls. In the multivariate logistic regression analysis, we found that the -1195AA, -765GC, and 587Arg/Arg genotypes were associated with increased risk of GCA (OR = 1.50, 95% Cl = 1.05-2.13; OR = 2.06, 95% Cl = 1.29-3.29 and OR = 1.67, 95% Cl = 1.04-2.66, respectively). Haplotype association analysis showed that compared with G(-1195)-G(-765)-G(Gly587Arg), the A(-1195)-C-765-A(Gly587Arg) conferred an increased risk of GCA (OR = 2.49, 95% Cl = 1.54-4.01). Moreover, significant multiplicative interactions were observed between smoking and these three polymorphisms of -1195G > A, -765G > C, and 587Gly > Arg, even after correction by false discovery rate (FDR) method for multiple comparisons (FDR-P-interaction = 0.006, 5.239x10(-4) and 0.017, respectively). Similarly, haplotypes incorporating these three polymorphisms also showed significant interaction with smoking in the development of GCA (P for multiplicative interaction = 2.65x10(-6)). Conclusion: These findings indicated that the functional polymorphisms of COX-2, in interaction with smoking, may play a substantial role in the development of GCA.	[Zhang, Xue-Mei] Hebei United Univ, Dept Mol Biol, Coll Life Sci, Tangshan, Peoples R China; [Zhong, Rong; Liu, Li; Wang, Ying; Wang, Peng; Sun, Chuang; Miao, Xiao-Ping] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Key Lab Environm & Hlth, Tongji Med Coll,Sch Publ Hlth,Minist Educ, Wuhan 430074, Peoples R China; [Yuan, Ju-Xiang] Hebei United Univ, Dept Epidemiol, Coll Publ Hlth, Tangshan, Peoples R China; [Zhang, Zhi; Song, Wen-Guang] Tangshan Gongren Hosp, Dept Oncol, Tangshan, Peoples R China	North China University of Science & Technology; Huazhong University of Science & Technology; North China University of Science & Technology	Zhang, XM (corresponding author), Hebei United Univ, Dept Mol Biol, Coll Life Sci, Tangshan, Peoples R China.	jyxuemei@gmail.com; miaoxp@mail.hust.edu.cn	miao, xiaoping/C-4336-2011; Zhong, Rong/Q-1813-2019	miao, xiaoping/0000-0002-6818-9722; Zhong, Rong/0000-0002-5060-895X	Program for New Century Excellent Talents in University [NCET-10-0388]; National Natural Science Foundation [81001275]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by Program for New Century Excellent Talents in University NCET-10-0388 and the National Natural Science Foundation 81001275 to Xiaoping Miao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anto RJ, 2002, CARCINOGENESIS, V23, P1511, DOI 10.1093/carcin/23.9.1511; Badawi AF, 2002, CANCER INVEST, V20, P651, DOI 10.1081/CNV-120002490; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benamouzig R, 2010, GUT, V59, P622, DOI 10.1136/gut.2008.175406; Buskens CJ, 2003, GUT, V52, P1678, DOI 10.1136/gut.52.12.1678; Corley DA, 2004, J NATL CANCER I, V96, P1383, DOI 10.1093/jnci/djh265; Duffield-Lillico AJ, 2009, CANCER PREV RES, V2, P322, DOI 10.1158/1940-6207.CAPR-09-0005; HEIN DW, 1993, CANCER RES, V53, P509; Huang RY, 2011, BBA-REV CANCER, V1815, P158, DOI 10.1016/j.bbcan.2010.11.005; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Laheij RJF, 1999, INT J EPIDEMIOL, V28, P391, DOI 10.1093/ije/28.3.391; LI JY, 1989, INT J CANCER, V43, P755, DOI 10.1002/ijc.2910430502; Lin CC, 2010, FREE RADICAL BIO MED, V48, P240, DOI 10.1016/j.freeradbiomed.2009.10.047; Pereira RD, 2009, RECENT PAT ANTI-CANC, V4, P157, DOI 10.2174/157489209788452849; Savage SA, 2004, CANCER EPIDEM BIOMAR, V13, P2251; Schuller HM, 2002, J CANCER RES CLIN, V128, P525, DOI 10.1007/s00432-002-0365-y; Shin VY, 2008, TOXICOL APPL PHARM, V233, P254, DOI 10.1016/j.taap.2008.08.012; Si J, 2007, J BIOL CHEM, V282, P16244, DOI 10.1074/jbc.M700297200; Sonoda R, 2010, HISTOPATHOLOGY, V57, P90, DOI 10.1111/j.1365-2559.2010.03594.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tramacere I, 2011, EPIDEMIOLOGY, V22, P344, DOI 10.1097/EDE.0b013e31821092cd; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Vial M, 2010, RECENT RESULTS CANC, V182, P1, DOI 10.1007/978-3-540-70579-6_1; Yang M, 2007, CARCINOGENESIS, V28, P1996, DOI 10.1093/carcin/bgm168; Yoav Benjamini, 2001, Behavioural Brain Research, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003; Zhao D, 2009, MOL CARCINOGEN, V48, P934, DOI 10.1002/mc.20543; Zhao D, 2009, GASTROENTEROLOGY, V136, P1659, DOI 10.1053/j.gastro.2009.01.071	28	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21894	10.1371/journal.pone.0021894	http://dx.doi.org/10.1371/journal.pone.0021894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779349	gold, Green Published, Green Submitted			2022-12-25	WOS:000292811300024
J	Zhu, X; Chen, LZ; Fan, WG; Lin, MCM; Tian, LW; Wang, M; Lin, S; Wang, ZF; Zhang, JF; Wang, JL; Yao, H; Kung, HF; Li, DP				Zhu, Xiao; Chen, Lianzhou; Fan, Wenguo; Lin, Marie C. M.; Tian, Linwei; Wang, Min; Lin, Sheng; Wang, Zifeng; Zhang, Jinfang; Wang, Jinlong; Yao, Hong; Kung, Hsiangfu; Li, Dongpei			An Intronic Variant in the GRP78, a Stress-Associated Gene, Improves Prediction for Liver Cirrhosis in Persistent HBV Carriers	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; GENOME-WIDE ASSOCIATION; SINGLE NUCLEOTIDE POLYMORPHISM; ENDOPLASMIC-RETICULUM STRESS; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; DISEASE PROGRESSION; INFECTION; CHAPERONE; PROTEIN	Background: Our previous study indicated that a common variant (rs430397 G > A) in the intron 5 of glucose-regulated protein 78 (GRP78) gene was associated with risk and prognosis of primary hepatocellular carcinoma (HCC), including HBV and cirrhosis-related HCC. rs430397 polymorphism may be a contributing factor or biomarker of HBV infection or HBV-related cirrhosis. Methodology/Principal Findings: 539 non-HBV-infected individuals, 205 self-limited infection and 496 persistent HBV infection were recruited between January 2001 and April 2005 from the hospitals in Southern China. Genomic DNA was genotyped for rs430397. The associations between the variation and susceptibility to liver cirrhosis (LC) in persistent HBV infection were examined. We observed that individuals carrying allele rs430397A were more likely to become HBV-related LC. When persistently infected patients were divided into four subgroups, patients with phase IV had an increased allele A and genotype AG compared with phase I and/or phase III. Decreased serum albumin and prolonged plasma prothrombin time (PT) were showed in LC patients carrying genotype AA. Furthermore, rs430397 genotype had an increased susceptibility to LC with dose-dependent manners (P-trend = 0.005), and the genotype did constitute a risk factor for the development of advanced LC (Child-Pugh classification C and B, P-trend = 0.021). Conclusions/Significance: rs430397 polymorphism may be a contributing factor to LC in persistent HBV carriers.	[Zhu, Xiao; Wang, Min; Wang, Jinlong] Guangzhou Med Univ, Affiliated Tumor Hosp, Inst Canc, Guangzhou, Guangdong, Peoples R China; [Zhu, Xiao] Guangdong Med Coll, Inst Biochem & Mol Biol, Key Lab Mol Diag, Dongguan, Peoples R China; [Chen, Lianzhou] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China; [Fan, Wenguo; Li, Dongpei] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Marie C. M.; Lin, Sheng; Wang, Zifeng; Yao, Hong] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Tian, Linwei] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Dept Epidemiol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Jinfang; Yao, Hong; Kung, Hsiangfu] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Zhang, Jinfang; Yao, Hong; Kung, Hsiangfu] Chinese Univ Hong Kong, Li Ka Shing Inst Med Sci, Hong Kong, Hong Kong, Peoples R China	Guangzhou Medical University; Guangdong Medical University; Sun Yat Sen University; Sun Yat Sen University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Zhu, X (corresponding author), Guangzhou Med Univ, Affiliated Tumor Hosp, Inst Canc, Guangzhou, Guangdong, Peoples R China.	bioxzhu@yahoo.com; lidp@mail.sysu.edu.cn	Tian, Linwei/A-9736-2009; Lin, Sheng/AAC-9465-2022	Tian, Linwei/0000-0002-4739-1534; Li, Dongpei/0000-0002-4734-6776; Tian, Linwei/0000-0003-2240-8886	National Nature Science Foundation of China [81071697]; Education Bureau of Guangzhou City [10A192]; Health Bureau of Guangzhou City [201102A213005]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Bureau of Guangzhou City; Health Bureau of Guangzhou City	This work was supported by the National Nature Science Foundation of China (Grant No. 81071697), the Research Project of Education Bureau of Guangzhou City (Grant No. 10A192) and the Research Project of Health Bureau of Guangzhou City (Grant No. 201102A213005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awe K, 2008, FEBS LETT, V582, P3179, DOI 10.1016/j.febslet.2008.07.062; Chen CJ, 2009, HEPATOLOGY, V49, pS72, DOI 10.1002/hep.22884; Fabris C, 2009, J INFECTION, V59, P144, DOI 10.1016/j.jinf.2009.06.005; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Hsing CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017598; Jackson AL, 1998, P NATL ACAD SCI USA, V95, P12468, DOI 10.1073/pnas.95.21.12468; Jang JW, 2007, J VIRAL HEPATITIS, V14, P169, DOI 10.1111/j.1365-2893.2006.00788.x; Jeng WJ, 2010, CLIN GASTROENTEROL H, V8, P541, DOI 10.1016/j.cgh.2010.02.023; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Klopstock N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005025; Lai CL, 2007, ANN INTERN MED, V147, P58, DOI 10.7326/0003-4819-147-1-200707030-00010; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Lei RX, 2009, HEPATOLOGY, V50, P763, DOI 10.1002/hep.23062; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Lim SO, 2005, WORLD J GASTROENTERO, V11, P2072, DOI 10.3748/wjg.v11.i14.2072; Liu ZM, 2008, CANCER LETT, V263, P212, DOI 10.1016/j.canlet.2008.01.006; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Maniratanachote R, 2005, TOXICOL SCI, V83, P293, DOI 10.1093/toxsci/kfi022; Mohamadnejad M, 2006, AM J GASTROENTEROL, V101, P2537, DOI 10.1111/j.1572-0241.2006.00788.x; Muriel P., 2009, HEPATOL INT; Nishida T, 2008, J GASTROEN HEPATOL, V23, P794, DOI 10.1111/j.1440-1746.2007.05240.x; OBATA H, 1980, INT J CANCER, V25, P741, DOI 10.1002/ijc.2910250609; Pungpapong S, 2007, MAYO CLIN PROC, V82, P967, DOI 10.4065/82.8.967; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Toniutto P, 2010, J MED VIROL, V82, P224, DOI 10.1002/jmv.21642; Truelove AL, 2008, INT J IMMUNOGENET, V35, P255, DOI 10.1111/j.1744-313X.2008.00770.x; Vanlemmens C, 2009, ANN INTERN MED, V150, P153, DOI 10.7326/0003-4819-150-3-200902030-00004; Wolfson JJ, 2008, CELL MICROBIOL, V10, P1775, DOI 10.1111/j.1462-5822.2008.01164.x; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Yuen MF, 2000, J GASTROEN HEPATOL, V15, pE20, DOI 10.1046/j.1440-1746.2000.02123.x; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zhu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017783, 10.1371/journal.pone.0027081]; Zhu X, 2010, HEPATO-GASTROENTEROL, V57, P1191; Zhu X, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-83; Zhu X, 2009, WORLD J GASTROENTERO, V15, P4958, DOI 10.3748/wjg.15.4958; Zhu X, 2009, INT J CANCER, V125, P1352, DOI 10.1002/ijc.24487; Zipprich A, 2010, GUT, V59, P963, DOI 10.1136/gut.2010.208595	42	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21997	10.1371/journal.pone.0021997	http://dx.doi.org/10.1371/journal.pone.0021997			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779363	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811300033
J	Qu, J; Myhr, KL				Qu, Juan; Myhr, Karen L.			The Morphology and Intrinsic Excitability of Developing Mouse Retinal Ganglion Cells	PLOS ONE			English	Article							MUDPUPPY NECTURUS MACULOSUS; CATS RETINA; VISUAL EXPERIENCE; CLASSIFICATION; ORGANIZATION; DIVERSITY; PATHWAYS; PATTERNS; MUTANT; BRISK	The retinal ganglion cells (RGCs) have diverse morphology and physiology. Although some studies show that correlations between morphological properties and physiological properties exist in cat RGCs, these properties are much less distinct and their correlations are unknown in mouse RGCs. In this study, using three-dimensional digital neuron reconstruction, we systematically analyzed twelve morphological parameters of mouse RGCs as they developed in the first four postnatal weeks. The development of these parameters fell into three different patterns and suggested that contact from bipolar cells and eye opening might play important roles in RGC morphological development. Although there has been a general impression that the morphological parameters are not independent, such as RGCs with larger dendritic fields usually have longer but sparser dendrites, there was not systematic study and statistical analysis proving it. We used Pearson's correlation coefficients to determine the relationship among these morphological parameters and demonstrated that many morphological parameters showed high statistical correlation. In the same cells we also measured seven physiological parameters using whole-cell patch-clamp recording, focusing on intrinsic excitability. We previously reported the increase in intrinsic excitability in mouse RGCs during early postnatal development. Here we showed that strong correlations also existed among many physiological parameters that measure the intrinsic excitability. However, Pearson's correlation coefficient revealed very limited correlation across morphological and physiological parameters. In addition, principle component analysis failed to separate RGCs into clusters using combined morphological and physiological parameters. Therefore, despite strong correlations within the morphological parameters and within the physiological parameters, postnatal mouse RGCs had only limited correlation between morphology and physiology. This may be due to developmental immaturity, or to selection of parameters.	[Qu, Juan; Myhr, Karen L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Myhr, Karen L.] Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI USA	Wayne State University; Wayne State University	Qu, J (corresponding author), Harvard Univ, Sch Med, Howe Lab Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA 02115 USA.	kmyhr@wayne.edu			Wayne State University	Wayne State University	This work was supported by Wayne State University Startup funds to Dr. Karen Myhr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2002, NAT NEUROSCI, V5, P391, DOI 10.1038/nn0502-391; Anishchenko A, 2010, J NEUROPHYSIOL, V103, P1856, DOI 10.1152/jn.00896.2009; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; BALKEMA GW, 1982, J NEUROPHYSIOL, V48, P968, DOI 10.1152/jn.1982.48.4.968; BOYCOTT BB, 1974, J PHYSIOL-LONDON, V240, P397, DOI 10.1113/jphysiol.1974.sp010616; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P257, DOI 10.1113/jphysiol.1978.sp012232; Carcieri SM, 2003, J NEUROPHYSIOL, V90, P1704, DOI 10.1152/jn.00127.2003; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; CLELAND BG, 1974, J PHYSIOL-LONDON, V240, P421, DOI 10.1113/jphysiol.1974.sp010617; CLELAND BG, 1974, J PHYSIOL-LONDON, V240, P457, DOI 10.1113/jphysiol.1974.sp010618; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; Coombs JL, 2007, J COMP NEUROL, V503, P803, DOI 10.1002/cne.21429; Demas J, 2003, J NEUROSCI, V23, P2851; Diao L, 2004, J NEUROBIOL, V61, P236, DOI 10.1002/neu.20041; DOI M, 1995, J COMP NEUROL, V356, P368, DOI 10.1002/cne.903560305; DOWLING JE, 1969, J NEUROPHYSIOL, V32, P315, DOI 10.1152/jn.1969.32.3.315; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Farrow K, 2011, J NEUROPHYSIOL, V105, P1516, DOI 10.1152/jn.00331.2010; FUKUDA Y, 1984, J NEUROPHYSIOL, V52, P999, DOI 10.1152/jn.1984.52.6.999; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; LEVICK WR, 1967, J PHYSIOL-LONDON, V188, P285, DOI 10.1113/jphysiol.1967.sp008140; Margolis DJ, 2007, J NEUROSCI, V27, P5994, DOI 10.1523/JNEUROSCI.0130-07.2007; Margolis DJ, 2010, J NEUROSCI, V30, P7127, DOI 10.1523/JNEUROSCI.5694-09.2010; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Myhr KL, 2001, J NEUROSCI, V21, P8664, DOI 10.1523/JNEUROSCI.21-21-08664.2001; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; Pandarinath C, 2010, J NEUROSCI, V30, P10006, DOI 10.1523/JNEUROSCI.5616-09.2010; Qu J, 2008, DEV NEUROBIOL, V68, P1196, DOI 10.1002/dneu.20653; Robinson DW, 1997, CURR BIOL, V7, P366, DOI 10.1016/S0960-9822(06)00184-9; RODIECK RW, 1983, BRAIN BEHAV EVOLUT, V23, P121, DOI 10.1159/000121492; SAITO HA, 1983, J COMP NEUROL, V221, P279, DOI 10.1002/cne.902210304; STONE C, 1992, J PHYSIOL-LONDON, V456, P125, DOI 10.1113/jphysiol.1992.sp019330; STONE C, 1993, VISUAL NEUROSCI, V10, P31, DOI 10.1017/S0952523800003205; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; THIBOS LN, 1983, EXP BRAIN RES, V51, P16; Van Wyk M, 2009, VISUAL NEUROSCI, V26, P297, DOI 10.1017/S0952523809990137; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Wong RC, 2011, INVEST OPHTHALMOL VI, V43; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; Zeck GM, 2007, EUR J NEUROSCI, V26, P367, DOI 10.1111/j.1460-9568.2007.05670.x	41	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21777	10.1371/journal.pone.0021777	http://dx.doi.org/10.1371/journal.pone.0021777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765913	Green Published, gold, Green Submitted			2022-12-25	WOS:000292781500015
J	Ragon, M; Restoux, G; Moreira, D; Moller, AP; Lopez-Garcia, P				Ragon, Marie; Restoux, Gwendal; Moreira, David; Moller, Anders Pape; Lopez-Garcia, Purificacion			Sunlight-Exposed Biofilm Microbial Communities Are Naturally Resistant to Chernobyl Ionizing-Radiation Levels	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; ANCIENT WALL PAINTINGS; SEA HYDROTHERMAL VENTS; RUBROBACTER-RADIOTOLERANS; DEINOCOCCUS-RADIODURANS; SP-NOV.; MOLECULAR PHYLOGENETICS; ULTRAVIOLET-RADIATION; EXTREME ENVIRONMENT; RADIOACTIVE IMPACT	Background: The Chernobyl accident represents a long-term experiment on the effects of exposure to ionizing radiation at the ecosystem level. Though studies of these effects on plants and animals are abundant, the study of how Chernobyl radiation levels affect prokaryotic and eukaryotic microbial communities is practically non-existent, except for a few reports on human pathogens or soil microorganisms. Environments enduring extreme desiccation and UV radiation, such as sunlight exposed biofilms could in principle select for organisms highly resistant to ionizing radiation as well. Methodology/Principal Findings: To test this hypothesis, we explored the diversity of microorganisms belonging to the three domains of life by cultivation-independent approaches in biofilms developing on concrete walls or pillars in the Chernobyl area exposed to different levels of radiation, and we compared them with a similar biofilm from a non-irradiated site in Northern Ireland. Actinobacteria, Alphaproteobacteria, Bacteroidetes, Acidobacteria and Deinococcales were the most consistently detected bacterial groups, whereas green algae (Chlorophyta) and ascomycete fungi (Ascomycota) dominated within the eukaryotes. Close relatives to the most radio-resistant organisms known, including Rubrobacter species, Deinococcales and melanized ascomycete fungi were always detected. The diversity of bacteria and eukaryotes found in the most highly irradiated samples was comparable to that of less irradiated Chernobyl sites and Northern Ireland. However, the study of mutation frequencies in non-coding ITS regions versus SSU rRNA genes in members of a same actinobacterial operational taxonomic unit (OTU) present in Chernobyl samples and Northern Ireland showed a positive correlation between increased radiation and mutation rates. Conclusions/Significance: Our results show that biofilm microbial communities in the most irradiated samples are comparable to non-irradiated samples in terms of general diversity patterns, despite increased mutation levels at the single-OTU level. Therefore, biofilm communities growing in sunlight exposed substrates are capable of coping with increased mutation rates and appear pre-adapted to levels of ionizing radiation in Chernobyl due to their natural adaptation to periodical desiccation and ambient UV radiation.	[Ragon, Marie; Restoux, Gwendal; Moreira, David; Moller, Anders Pape; Lopez-Garcia, Purificacion] Univ Paris 11, CNRS, UMR8079, Unite Ecol Systemat & Evolut, F-91405 Orsay, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay	Ragon, M (corresponding author), Univ Paris 11, CNRS, UMR8079, Unite Ecol Systemat & Evolut, F-91405 Orsay, France.	puri.lopez@u-psud.fr	Lopez-Garcia, Purificacion/B-6775-2012; Moller, Anders/O-6665-2016; Moreira, David/F-7445-2012	Lopez-Garcia, Purificacion/0000-0002-0927-0651; Moller, Anders/0000-0003-3739-4675; Moreira, David/0000-0002-2064-5354	"Convention Industrielle de Formation par la REcherche" (CIFRE)	"Convention Industrielle de Formation par la REcherche" (CIFRE)	M. R. and this work were financed by a "Convention Industrielle de Formation par la REcherche" (CIFRE) fellowship and its accompanying research contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Asgarani E, 2000, J RADIAT RES, V41, P19, DOI 10.1269/jrr.41.19; Backor M, 2008, SYMBIOSIS, V46, P1; BARR DJS, 1978, BIOSYSTEMS, V10, P153, DOI 10.1016/0303-2647(78)90037-0; Berry D, 2006, CURR OPIN BIOTECH, V17, P297, DOI 10.1016/j.copbio.2006.05.007; BROOKS BW, 1981, INT J SYST BACTERIOL, V31, P353, DOI 10.1099/00207713-31-3-353; BUBRICK P, 1984, NEW PHYTOL, V97, P455, DOI 10.1111/j.1469-8137.1984.tb03611.x; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Cadet J, 2010, FREE RADICAL BIO MED, V49, P9, DOI 10.1016/j.freeradbiomed.2010.03.025; Cappitelli F, 2007, SCI TOTAL ENVIRON, V385, P172, DOI 10.1016/j.scitotenv.2007.06.022; Chanal A, 2006, ENVIRON MICROBIOL, V8, P514, DOI 10.1111/j.1462-2920.2005.00921.x; Charmasson S, 2009, J ENVIRON RADIOACTIV, V100, P522, DOI 10.1016/j.jenvrad.2009.02.002; Czirjak GA, 2010, MICROB ECOL, V60, P373, DOI 10.1007/s00248-010-9716-4; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; Dadachova E, 2008, CURR OPIN MICROBIOL, V11, P525, DOI 10.1016/j.mib.2008.09.013; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; de Groot A, 2005, INT J SYST EVOL MICR, V55, P2441, DOI 10.1099/ijs.0.63717-0; de la Torre JR, 2003, APPL ENVIRON MICROB, V69, P3858, DOI 10.1128/AEM.69.7.3858-3867.2003; Dighton J, 2008, FEMS MICROBIOL LETT, V281, P109, DOI 10.1111/j.1574-6968.2008.01076.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ettenauer J, 2010, INT J ASTROBIOL, V9, P59, DOI 10.1017/S1473550409990383; Ferreira AC, 1999, EXTREMOPHILES, V3, P235, DOI 10.1007/s007920050121; Fow J, 2003, J STAT SOFTW, V8, P1; Fredrickson JK, 2008, ISME J, V2, P393, DOI 10.1038/ismej.2007.116; FREDRICKSON JK, 1995, APPL ENVIRON MICROB, V61, P1917, DOI 10.1128/AEM.61.5.1917-1922.1995; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; Gallego V, 2006, INT J SYST EVOL MICR, V56, P2291, DOI 10.1099/ijs.0.64379-0; Garvie LAJ, 2008, NATURWISSENSCHAFTEN, V95, P705, DOI 10.1007/s00114-008-0373-0; Geras'kin SA, 2008, ENVIRON INT, V34, P880, DOI 10.1016/j.envint.2007.12.012; Gremion F, 2003, ENVIRON MICROBIOL, V5, P896, DOI 10.1046/j.1462-2920.2003.00484.x; Harutyunyan S, 2008, STUD MYCOL, P83, DOI 10.3114/sim.2008.61.08; Horn M, 2004, J EUKARYOT MICROBIOL, V51, P509, DOI 10.1111/j.1550-7408.2004.tb00278.x; Hughes KA, 2003, ENVIRON MICROBIOL, V5, P555, DOI 10.1046/j.1462-2920.2003.00439.x; Imperi F, 2007, ENVIRON MICROBIOL, V9, P2894, DOI 10.1111/j.1462-2920.2007.01393.x; Jaccard P., 1901, B SOC VAUD SCI NAT, V37, P241, DOI DOI 10.5169/SEALS-266440; Janse I, 2004, J MICROBIOL METH, V57, P279, DOI 10.1016/j.mimet.2003.12.006; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Jolivet E, 2004, EXTREMOPHILES, V8, P219, DOI 10.1007/s00792-004-0380-9; Jolivet E, 2003, INT J SYST EVOL MICR, V53, P847, DOI 10.1099/ijs.0.02503-0; Karsten U, 2007, PLANTA, V225, P991, DOI 10.1007/s00425-006-0406-x; Karsten U, 2005, J PHYCOL, V41, P557, DOI 10.1111/j.1529-8817.2005.00081.x; Kausar J, 1997, INT J SYST BACTERIOL, V47, P684, DOI 10.1099/00207713-47-3-684; Kimura S, 2006, BIOCHEM BIOPH RES CO, V346, P51, DOI 10.1016/j.bbrc.2006.05.126; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Lopez-Garcia P, 2008, RES MICROBIOL, V159, P67, DOI 10.1016/j.resmic.2007.11.019; MADIGAN MT, 2002, BROCK BIOL MICROORGA; MCAULAY I R, 1989, Journal of Radiological Protection, V9, P29, DOI 10.1088/0952-4746/9/1/004; McCullagh P, 1989, GEN LINEAR MODELS; Moller AP, 2006, TRENDS ECOL EVOL, V21, P200, DOI 10.1016/j.tree.2006.01.008; Nascimbene J, 2009, SCI TOTAL ENVIRON, V407, P5001, DOI 10.1016/j.scitotenv.2009.06.012; Nercessian O, 2005, APPL ENVIRON MICROB, V71, P6885, DOI 10.1128/AEM.71.11.6885-6899.2005; Pellerin A, 2009, ASTROBIOLOGY, V9, P807, DOI 10.1089/ast.2008.0302; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Pinar G, 2001, FEMS MICROBIOL ECOL, V37, P45, DOI 10.1016/S0168-6496(01)00144-1; Pinar G, 2009, INT BIODETER BIODEGR, V63, P851, DOI 10.1016/j.ibiod.2009.02.004; Pinto FL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-79; Pointing SB, 2007, ENVIRON MICROBIOL, V9, P414, DOI 10.1111/j.1462-2920.2006.01153.x; Rainey FA, 2005, APPL ENVIRON MICROB, V71, P5225, DOI 10.1128/AEM.71.9.5225-5235.2005; Romanovskaia V A, 2000, Mikrobiol Z, V62, P40; Romanovskaya V. A., 1999, Mikrobiologiya, V68, P534; Romanovskaya VA, 1998, MICROBIOLOGY+, V67, P226; RPII, 2008, RAD MON IR ENV; Sait M, 2002, ENVIRON MICROBIOL, V4, P654, DOI 10.1046/j.1462-2920.2002.00352.x; SAITO T, 1994, ARCH MICROBIOL, V162, P414, DOI 10.1007/s002030050159; Schabereiter-Gurtner C, 2001, J MICROBIOL METH, V47, P345, DOI 10.1016/S0167-7012(01)00344-X; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sert H, 2007, MYCOL RES, V111, P1235, DOI 10.1016/j.mycres.2007.06.011; Sette LD, 2010, FUNGAL DIVERS, V44, P53, DOI 10.1007/s13225-010-0048-y; Sghaier H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-297; Shestopalov V. M., 1996, ATLAS CHERNOBYL EXCL; Shi T, 2001, J IND MICROBIOL BIOT, V26, P283, DOI 10.1038/sj.jim.7000130; Shravage BV, 2007, MICROBIOL RES, V162, P15, DOI 10.1016/j.micres.2006.01.005; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; SUZUKI K, 1988, FEMS MICROBIOL LETT, V52, P33, DOI 10.1111/j.1574-6968.1988.tb02568.x; Tanabe Y, 2005, J GEN APPL MICROBIOL, V51, P267, DOI 10.2323/jgam.51.267; Team R. D. C, 2011, R LANG ENV STAT COMP; Tian B, 2010, TRENDS MICROBIOL, V18, P512, DOI 10.1016/j.tim.2010.07.007; Trefault N, 2004, ENVIRON MICROBIOL, V6, P655, DOI 10.1111/j.1462-2920.2004.00596.x; Tugay T, 2006, MYCOLOGIA, V98, P521, DOI 10.3852/mycologia.98.4.521; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Wong FKY, 2010, MICROB ECOL, V60, P730, DOI 10.1007/s00248-010-9653-2; Wornik S, 2010, MICROB ECOL, V59, P150, DOI 10.1007/s00248-009-9584-y; Yablokov AV, 2009, ANN NY ACAD SCI, V1181, P223, DOI [10.1111/j.1749-6632.2009.04831.x, 10.1111/j.1749-6632.2009.04830.x]; Yablokov AV, 2009, ANN NY ACAD SCI, V1181, P237, DOI [10.1111/j.1749-6632.2009.04832.x, 10.1111/j.1749-6632.2009.04830.x]; Yablokov AV, 2009, ANN NY ACAD SCI, V1181, P281, DOI 10.1111/j.1749-6632.2009.04830.x; Zavilgelsky GB, 1998, J PHOTOCH PHOTOBIO B, V43, P152, DOI 10.1016/S1011-1344(98)00099-2; Zhdanova NN, 2004, MYCOL RES, V108, P1089, DOI 10.1017/S0953756204000966; Zhdanova NN, 2003, J ENVIRON RADIOACTIV, V67, P119, DOI 10.1016/S0265-931X(02)00164-9; ZHDANOVA NN, 1994, MYCOL RES, V98, P789, DOI 10.1016/S0953-7562(09)81057-5; Zhdanova NN, 2000, MYCOL RES, V104, P1421, DOI 10.1017/S0953756200002756	94	49	49	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21764	10.1371/journal.pone.0021764	http://dx.doi.org/10.1371/journal.pone.0021764			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765911	Green Submitted, Green Published, gold			2022-12-25	WOS:000292781500013
J	Oshima, M; Mizuno, M; Imamura, A; Ogawa, M; Yasukawa, M; Yamazaki, H; Morita, R; Ikeda, E; Nakao, K; Takano-Yamamoto, T; Kasugai, S; Saito, M; Tsuji, T				Oshima, Masamitsu; Mizuno, Mitsumasa; Imamura, Aya; Ogawa, Miho; Yasukawa, Masato; Yamazaki, Hiromichi; Morita, Ritsuko; Ikeda, Etsuko; Nakao, Kazuhisa; Takano-Yamamoto, Teruko; Kasugai, Shohei; Saito, Masahiro; Tsuji, Takashi			Functional Tooth Regeneration Using a Bioengineered Tooth Unit as a Mature Organ Replacement Regenerative Therapy	PLOS ONE			English	Article							STEM-CELLS; IN-VIVO; TRANSPLANTATION; GENERATION; REPAIR; LIVER; TEETH; ORGANOGENESIS; PERIODONTIUM; PROMISE	Donor organ transplantation is currently an essential therapeutic approach to the replacement of a dysfunctional organ as a result of disease, injury or aging in vivo. Recent progress in the area of regenerative therapy has the potential to lead to bioengineered mature organ replacement in the future. In this proof of concept study, we here report a further development in this regard in which a bioengineered tooth unit comprising mature tooth, periodontal ligament and alveolar bone, was successfully transplanted into a properly-sized bony hole in the alveolar bone through bone integration by recipient bone remodeling in a murine transplantation model system. The bioengineered tooth unit restored enough the alveolar bone in a vertical direction into an extensive bone defect of murine lower jaw. Engrafted bioengineered tooth displayed physiological tooth functions such as mastication, periodontal ligament function for bone remodeling and responsiveness to noxious stimulations. This study thus represents a substantial advance and demonstrates the real potential for bioengineered mature organ replacement as a next generation regenerative therapy.	[Oshima, Masamitsu; Mizuno, Mitsumasa; Ogawa, Miho; Morita, Ritsuko; Nakao, Kazuhisa; Saito, Masahiro; Tsuji, Takashi] Tokyo Univ Sci, Res Inst Sci & Technol, Chiba, Japan; [Mizuno, Mitsumasa; Ikeda, Etsuko; Takano-Yamamoto, Teruko] Tohoku Univ, Div Orthodont & Dentofacial Orthoped, Grad Sch Dent, Sendai, Miyagi, Japan; [Imamura, Aya; Yasukawa, Masato; Yamazaki, Hiromichi; Saito, Masahiro; Tsuji, Takashi] Tokyo Univ Sci, Dept Biol Sci & Technol, Grad Sch Ind Sci & Technol, Chiba, Japan; [Ogawa, Miho; Tsuji, Takashi] Organ Technol Inc, Tokyo, Japan; [Kasugai, Shohei] Tokyo Med & Dent Univ, Oral Implantol & Regenerat Dent Med Grad Sch, Bunkyo Ku, Tokyo, Japan	Tokyo University of Science; Tohoku University; Tokyo University of Science; Tokyo Medical & Dental University (TMDU)	Oshima, M (corresponding author), Tokyo Univ Sci, Res Inst Sci & Technol, Chiba, Japan.	t-tsuji@rs.noda.tus.ac.jp	Tsuji, Takashi/N-6086-2015; Morita, Ritsuko/AAY-6642-2021	Morita, Ritsuko/0000-0001-6550-8778	Ministry of Health, Labour, and Welfare [21040101]; Ministry of Education, Culture, Sports and Technology, Japan [50339131]; Grants-in-Aid for Scientific Research [21390509, 23249085] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by Health and Labour Sciences Research Grants from the Ministry of Health, Labour, and Welfare (No. 21040101) to T.T., a Grant-in Aid for Scientific Research in Priority Areas (No. 50339131) to T.T., a Grant-in-Aid for Scientific Research (A) to T.T. and a Grant-in-Aid for Young Scientists (B) to M. Oshima from Ministry of Education, Culture, Sports and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atala A, 2005, EXPERT OPIN BIOL TH, V5, P879, DOI 10.1517/14712598.5.7.879; Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228; Byers MR, 1999, CRIT REV ORAL BIOL M, V10, P4, DOI 10.1177/10454411990100010101; Cai JL, 2007, DEV BIOL, V304, P499, DOI 10.1016/j.ydbio.2007.01.002; Cho MI, 2000, PERIODONTOL 2000, V24, P9, DOI 10.1034/j.1600-0757.2000.2240102.x; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; GEERTMAN ME, 1994, J DENT RES, V73, P1858, DOI 10.1177/00220345940730121101; Gridelli B, 2000, NEW ENGL J MED, V343, P404, DOI 10.1056/NEJM200008103430606; Hu B, 2006, TISSUE ENG, V12, P2069, DOI 10.1089/ten.2006.12.2069; Ikeda E, 2008, EXPERT OPIN BIOL TH, V8, P735, DOI [10.1517/14712598.8.6.735, 10.1517/14712598.8.6.735 ]; Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106; Ishida K, 2011, BIOCHEM BIOPH RES CO, V405, P455, DOI 10.1016/j.bbrc.2011.01.052; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Kallu R, 2005, INT J ORAL MAX SURG, V34, P745, DOI 10.1016/j.ijom.2005.03.009; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Kinoshita M, 2010, INT J DEV BIOL, V54, P851, DOI 10.1387/ijdb.093036mk; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Layer PG, 2002, TRENDS NEUROSCI, V25, P131, DOI 10.1016/S0166-2236(00)02036-1; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Moers C, 2009, NEW ENGL J MED, V360, P7, DOI 10.1056/NEJMoa0802289; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; Nickel JC, 2003, J DENT RES, V82, P212, DOI 10.1177/154405910308200312; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576; Purnell B, 2008, SCIENCE, V322, P1489, DOI 10.1126/science.322.5907.1489; Sedohara A, 2003, DEV GROWTH DIFFER, V45, P463; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sharpe PT, 2005, SCI AM, V293, P34, DOI 10.1038/scientificamerican0805-34; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Tyler D, 2003, BIOESSAYS, V25, P5, DOI 10.1002/bies.10211; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Van der Weijden F, 2009, J CLIN PERIODONTOL, V36, P1048, DOI 10.1111/j.1600-051X.2009.01482.x; Wang XH, 2010, TISSUE ENG PART B-RE, V16, P189, DOI [10.1089/ten.teb.2009.0576, 10.1089/ten.TEB.2009.0576]; Yelick P.C., 2006, DENT CLIN N AM, V50, pviii; Yelick Pamela C, 2006, Dent Clin North Am, V50, P191, DOI 10.1016/j.cden.2005.11.005; Yen AHH, 2006, EXPERT OPIN BIOL TH, V6, P9, DOI 10.1517/14712598.6.1.9; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x	39	127	135	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21531	10.1371/journal.pone.0021531	http://dx.doi.org/10.1371/journal.pone.0021531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765896	Green Published, Green Submitted, gold			2022-12-25	WOS:000292699000006
J	Bouchami, O; Ben Hassen, A; de Lencastre, H; Miragaia, M				Bouchami, Ons; Ben Hassen, Assia; de Lencastre, Herminia; Miragaia, Maria			Molecular Epidemiology of Methicillin-Resistant Staphylococcus hominis (MRSHo): Low Clonality and Reservoirs of SCCmec Structural Elements	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; COAGULASE-NEGATIVE STAPHYLOCOCCI; FIELD GEL-ELECTROPHORESIS; PANDEMIC CLONES; AUREUS STRAINS; EPIDERMIDIS; SEQUENCE; IDENTIFICATION; EVOLUTION; GENOME	Background: Methicillin resistant Staphylococcus hominis (MRSHo) are important human pathogens in immunocompromised patients. However, little is known regarding its population structure and staphylococcal chromosomal cassette mec (SCCmec) content. Methodology/Principal Findings: To assess the population structure and the SCCmec content of S. hominis, 34 MRSHo and 11 methicillin-susceptible S. hominis (MSSHo) from neutropenic patients collected over a 3-year period were studied. The genetic backgrounds of S. hominis isolates were analyzed by pulsed-field gel electrophoresis (PFGE) and SCCmec types were determined by PCR. Cassette chromosome recombinases (ccr) were characterized by PCR and ccrB sequencing. The 34 S. hominis isolates were classified into as many as 28 types and 32 subtypes (SID = 99.82%); clonal dissemination was occasionally observed. The main SCCmec structures identified were SCCmec type VI (4B) (20%), SCCmec VIII (4A) (15%), and a new SCCmec composed of mec complex A in association with ccrAB1 (38%); 27% of the isolates harbored non-typeable SCCmec. Overall, a high prevalence of mec complex A (73.5%), ccrAB1 (50%) and ccrAB4 (44%) were found. Importantly, ccrB1 and ccrB4 from both MRSHo and MSSHo showed a high nucleotide sequence homology with those found in S. aureus SCCmec I, VI and VIII respectively (>95%). Conclusions/Significance: The S. hominis population showed a limited clonality and a low genetic diversity in the allotypes of ccr and classes of mec complex. Moreover, our data suggest that S. hominis might have been a privileged source of mec complex A, ccrB1 and ccrB4, for the assembly of primordial SCCmec types.	[Bouchami, Ons; de Lencastre, Herminia; Miragaia, Maria] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Bouchami, Ons; Ben Hassen, Assia] Bone Marrow Transplant Ctr Tunisia, Tunis, Tunisia; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Universidade Nova de Lisboa; Universite de Tunis-El-Manar; Centre Nationale de Greffe de la Moelle Osseuse; Rockefeller University	Bouchami, O (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal.	miragaia@itqb.unl.pt	Miragaia, Maria/J-2704-2015	Miragaia, Maria/0000-0002-1323-7184; /0000-0001-6816-8932; Bouchami, Ons/0000-0002-9425-3513	European Community [F3-2008-222718, 053/BI-BTI/2009]; Tunisia-Portugal MESRST/GRICES [Proc<SUP>o</SUP>4. 1. 5]	European Community(European Commission); Tunisia-Portugal MESRST/GRICES	This work was partially supported by Project CONCORD (Ref. FP7-Health-F3-2008-222718) from the European Community to HL and by grant Ref: 053/BI-BTI/2009 from the same Project to OB. Additional funding was provided by project Tunisia-Portugal MESRST/GRICES ref. Proc<SUP>o</SUP>4. 1. 5. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Chongtrakool P, 2006, ANTIMICROB AGENTS CH, V50, P1001, DOI 10.1128/AAC.50.3.1001-1012.2006; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; Couto I, 1996, MICROB DRUG RESIST, V2, P377, DOI 10.1089/mdr.1996.2.377; Couto I, 2001, J CLIN MICROBIOL, V39, P3099, DOI 10.1128/JCM.39.9.3099-3103.2001; DELENCASTRE H, 1994, EUR J CLIN MICROBIOL, V13, P64, DOI 10.1007/BF02026129; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frebourg NB, 2000, J CLIN MICROBIOL, V38, P877, DOI 10.1128/JCM.38.2.877-880.2000; Garza-Gonzalez E, 2010, EPIDEMIOL INFECT, V138, P645, DOI 10.1017/S0950268809991361; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; GILL VJ, 1983, J CLIN MICROBIOL, V18, P1314, DOI 10.1128/JCM.18.6.1314-1319.1983; Ham JS, 2010, MOL CELLS, V30, P71, DOI 10.1007/s10059-010-0090-3; Hanssen AM, 2004, ANTIMICROB AGENTS CH, V48, P285, DOI 10.1128/AAC.48.1.285-296.2004; Hanssen AM, 2007, ANTIMICROB AGENTS CH, V51, P1671, DOI 10.1128/AAC.00978-06; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; Ibrahem S, 2009, J CLIN MICROBIOL, V47, P32, DOI 10.1128/JCM.01085-08; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Ito T, 1999, ANTIMICROB AGENTS CH, V43, P1449, DOI 10.1128/AAC.43.6.1449; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Katayama Y, 2003, J BACTERIOL, V185, P2711, DOI 10.1128/JB.185.9.2711-2722.2003; Katayama Y, 2001, ANTIMICROB AGENTS CH, V45, P1955, DOI 10.1128/AAC.45.7.1955-1963.2001; Kennedy HF, 2000, J MED MICROBIOL, V49, P367, DOI 10.1099/0022-1317-49-4-367; Kloos WE., 1997, STAPHYLOCOCCI HUMAN, P113; Kuroda M, 2005, P NATL ACAD SCI USA, V102, P13272, DOI 10.1073/pnas.0502950102; Li SS, 2011, ANTIMICROB AGENTS CH, V55, P3046, DOI 10.1128/AAC.01475-10; Liakopoulos V, 2008, NEPHROL DIAL TRANSPL, V23, P2599, DOI 10.1093/ndt/gfn101; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Miragaia M, 2005, MICROB DRUG RESIST, V11, P83, DOI 10.1089/mdr.2005.11.83; Miragaia M, 2002, J CLIN MICROBIOL, V40, P430, DOI 10.1128/JCM.40.2.430-438.2002; Machado ABP, 2007, J MED MICROBIOL, V56, P1328, DOI 10.1099/jmm.0.47294-0; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; MUSSER JM, 1992, J CLIN MICROBIOL, V30, P2058, DOI 10.1128/JCM.30.8.2058-2063.1992; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; Oliveira DC, 2001, MICROB DRUG RESIST, V7, P349, DOI 10.1089/10766290152773365; Oliveira DC, 2008, J ANTIMICROB CHEMOTH, V61, P959, DOI 10.1093/jac/dkn021; Oliveira DC, 2006, ANTIMICROB AGENTS CH, V50, P3457, DOI 10.1128/AAC.00629-06; Oliveira DC, 2006, J ANTIMICROB CHEMOTH, V58, P23, DOI 10.1093/jac/dkl208; Ruppe E, 2009, ANTIMICROB AGENTS CH, V53, P442, DOI 10.1128/AAC.00724-08; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Takeuchi F, 2005, J BACTERIOL, V187, P7292, DOI 10.1128/JB.187.21.7292-7308.2005; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Wisplinghoff H, 2003, ANTIMICROB AGENTS CH, V47, P3574, DOI 10.1128/AAC.47.11.3574-3579.2003; Wu SW, 1996, MICROB DRUG RESIST, V2, P435, DOI 10.1089/mdr.1996.2.435; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x	46	36	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21940	10.1371/journal.pone.0021940	http://dx.doi.org/10.1371/journal.pone.0021940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760926	Green Published, gold, Green Submitted			2022-12-25	WOS:000292657200030
J	Boutros, PC; Moffat, ID; Okey, AB; Pohjanvirta, R				Boutros, Paul C.; Moffat, Ivy D.; Okey, Allan B.; Pohjanvirta, Raimo			mRNA Levels in Control Rat Liver Display Strain-Specific, Hereditary, and AHR-Dependent Components	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; HUMAN GENE-EXPRESSION; CELL LUNG-CANCER; PROBE LEVEL; NULL MICE; GENOME; MOUSE; RESISTANT; TCDD; TOXICOGENOMICS	Rat is a major model organism in toxicogenomics and pharmacogenomics. Hepatic mRNA profiles after treatment with xenobiotic chemicals are used to predict and understand drug toxicity and mechanisms. Surprisingly, neither inter- and intra-strain variability of mRNA abundances in control rats nor the heritability of rat mRNA abundances yet been established. We address these issues by studying five populations: the popular Sprague-Dawley strain, sub-strains of Long-Evans and Wistar rats, and two lines derived from crosses between the Long-Evans and Wistar sub-strains. Using three independent techniques - variance analysis, linear modelling, and unsupervised pattern recognition - we characterize extensive intra- and inter- strain variability in mRNA levels. We find that both sources of variability are non-random and are enriched for specific functional groups. Specific transcription-factor binding-sites are enriched in their promoter regions and these genes occur in "islands" scattered throughout the rat genome. Using the two lines generated by crossbreeding we tested heritability of hepatic mRNA levels: the majority of rat genes appear to exhibit directional genetics, with only a few interacting loci. Finally, a comparison of inter- strain heterogeneity between mouse and rat orthologs shows more heterogeneity in rats than mice; thus rat and mouse heterogeneity are uncorrelated. Our results establish that control hepatic mRNA levels are relatively homogeneous within rat strains but highly variable between strains. This variability may be related to increased activity of specific transcription-factors and has clear functional consequences. Future studies may take advantage of this phenomenon by surveying panels of rat strains.	[Boutros, Paul C.; Moffat, Ivy D.; Okey, Allan B.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Boutros, Paul C.] Ontario Inst Canc Res, Toronto, ON, Canada; [Pohjanvirta, Raimo] Univ Helsinki, Dept Food & Environm Hyg, Helsinki, Finland; [Pohjanvirta, Raimo] Natl Inst Hlth & Welf, Toxicol Lab, Kuopio, Finland	University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Helsinki; Finland National Institute for Health & Welfare	Boutros, PC (corresponding author), Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada.	Paul.Boutros@utoronto.ca	Pohjanvirta, Raimo/I-4509-2019	Pohjanvirta, Raimo/0000-0003-0952-5746; Boutros, Paul/0000-0003-0553-7520	Canadian Institutes of Health Research [FRN-57903, MOP-57903]; Academy of Finland [211120, 123345]; Government of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Academy of Finland(Academy of Finland); Government of Ontario	This work was financially supported by the Canadian Institutes of Health Research (Grants number FRN-57903 to ABO and MOP-57903 to ABO and PCB) and the Academy of Finland (Grant numbers 211120 and 123345 to RP). This study was conducted with the support of the Ontario Institute for Cancer Research to PCB through funding provided by the Government of Ontario. The funding agencies had no role in study design, data collection, analysis or interpretation, nor the writing of or decision to submit the manuscript for publication.	Amin RP, 2002, TOXICOLOGY, V181, P555, DOI 10.1016/S0300-483X(02)00481-X; Bachtiary B, 2006, CLIN CANCER RES, V12, P5632, DOI 10.1158/1078-0432.CCR-06-0357; Boedigheimer MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-285; Boorman GA, 2005, TOXICOL SCI, V86, P185, DOI 10.1093/toxsci/kfi166; Boorman GA, 2005, TOXICOL PATHOL, V33, P102, DOI 10.1080/01926230590522211; Boutros PC, 2009, TOXICOL SCI, V112, P245, DOI 10.1093/toxsci/kfp191; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Boutros PC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-419; Boutros PC, 2005, BRIEF BIOINFORM, V6, P331, DOI 10.1093/bib/6.4.331; Boverhof DR, 2006, TOXICOL SCI, V94, P398, DOI 10.1093/toxsci/kfl100; Burgoon LD, 2006, TOXICOL SCI, V90, P558, DOI 10.1093/toxsci/kfj097; Cerutti C, 2006, PHYSIOL GENOMICS, V27, P295, DOI 10.1152/physiolgenomics.00318.2005; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; Daniels GM, 2002, GENES BRAIN BEHAV, V1, P35, DOI 10.1046/j.1601-1848.2001.00008.x; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Fernandes C, 2004, EUR J NEUROSCI, V19, P2576, DOI 10.1111/j.0953-816X.2004.03358.x; Franc MA, 2008, ARCH TOXICOL, V82, P809, DOI 10.1007/s00204-008-0303-0; Frijters R, 2007, PHARMACOGENOMICS, V8, P1521, DOI 10.2217/14622416.8.11.1521; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Lazar J, 2005, GENOME RES, V15, P1717, DOI 10.1101/gr.3744005; Lund AK, 2003, TOXICOL APPL PHARM, V193, P177, DOI 10.1016/j.taap.2003.08.008; Martin R, 2006, PHARMACOGENOMICS, V7, P1003, DOI 10.2217/14622416.7.7.1003; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Moffat ID, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-263; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; OKEY AB, 1994, TRENDS PHARMACOL SCI, V15, P226, DOI 10.1016/0165-6147(94)90316-6; Okey AB, 2007, TOXICOL SCI, V98, P5, DOI 10.1093/toxsci/kfm096; Pohjanvirta R, 1998, MOL PHARMACOL, V54, P86, DOI 10.1124/mol.54.1.86; Pohjanvirta R, 1990, Toxicol Appl Pharmacol, V105, P508, DOI 10.1016/0041-008X(90)90154-M; Pohjanvirta R, 1999, TOXICOL APPL PHARM, V155, P82, DOI 10.1006/taap.1998.8565; Pohjanvirta R, 2008, TOXICOL APPL PHARM, V230, P41, DOI 10.1016/j.taap.2008.02.002; Pritchard C, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r26; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Seidel SD, 2006, TOXICOL SCI, V94, P226, DOI 10.1093/toxsci/kfl082; SMYTH GK, 2003, STAT APPL GENET MOL, V3, P1; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Tuomisto JT, 1999, TOXICOL APPL PHARM, V155, P71, DOI 10.1006/taap.1998.8564; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	58	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e18337	10.1371/journal.pone.0018337	http://dx.doi.org/10.1371/journal.pone.0018337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760882	Green Published, Green Submitted, gold			2022-12-25	WOS:000292657200001
J	Carbajo, V; den Braber, B; van der Putten, WH; De Deyn, GB				Carbajo, Vanesa; den Braber, Bowy; van der Putten, Wim H.; De Deyn, Gerlinde B.			Enhancement of Late Successional Plants on Ex-Arable Land by Soil Inoculations	PLOS ONE			English	Article							SPECIES-RICH GRASSLAND; RESTORATION; COMMUNITIES; FERTILITY; CHRONOSEQUENCE; MICROBES; FEEDBACK; NEMATODE	Restoration of species-rich grasslands on ex-arable land can help the conservation of biodiversity but faces three big challenges: absence of target plant propagules, high residual soil fertility and restoration of soil communities. Seed additions and top soil removal can solve some of these constraints, but restoring beneficial biotic soil conditions remains a challenge. Here we test the hypotheses that inoculation of soil from late secondary succession grasslands in arable receptor soil enhances performance of late successional plants, especially after top soil removal but pending on the added dose. To test this we grew mixtures of late successional plants in arable top (organic) soil or in underlying mineral soil mixed with donor soil in small or large proportions. Donor soils were collected from different grasslands that had been under restoration for 5 to 41 years, or from semi-natural grassland that has not been used intensively. Donor soil addition, especially when collected from older restoration sites, increased plant community biomass without altering its evenness. In contrast, addition of soil from semi-natural grassland promoted plant community evenness, and hence its diversity, but reduced community biomass. Effects of donor soil additions were stronger in mineral than in organic soil and larger with bigger proportions added. The variation in plant community composition was explained best by the abundances of nematodes, ergosterol concentration and soil pH. We show that in controlled conditions inoculation of soil from secondary succession grassland into ex-arable land can strongly promote target plant species, and that the role of soil biota in promoting target plant species is greatest when added after top soil removal. Together our results point out that transplantation of later secondary succession soil can promote grassland restoration on ex-arable land.	[Carbajo, Vanesa; den Braber, Bowy; van der Putten, Wim H.; De Deyn, Gerlinde B.] Netherlands Inst Ecol, Dept Terr Ecol, Wageningen, Netherlands; [Carbajo, Vanesa] Alcala Univ, Dept Ecol, Madrid, Spain; [den Braber, Bowy] Univ Wageningen & Res Ctr, Nat Conservat & Plant Ecol Grp, Wageningen, Netherlands; [van der Putten, Wim H.] Univ Wageningen & Res Ctr, Nematol Lab, Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Universidad de Alcala; Wageningen University & Research; Wageningen University & Research	Carbajo, V (corresponding author), Netherlands Inst Ecol, Dept Terr Ecol, Wageningen, Netherlands.	g.dedeyn@nioo.knaw.nl	van der Putten, Wim H/C-3707-2011; De Deyn, Gerlinde B/C-1593-2009; De Deyn, Gerlinde/AFI-8702-2022; De Deyn, Gerlinde/F-7080-2017	van der Putten, Wim H/0000-0002-9341-4442; De Deyn, Gerlinde B/0000-0003-4823-6912; De Deyn, Gerlinde/0000-0003-4823-6912; De Deyn, Gerlinde/0000-0003-4823-6912	ALW-Vici [865.05.002]	ALW-Vici	This study was funded by ALW-Vici, project number 865.05.002, to WHvdP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baath E, 2001, SOIL BIOL BIOCHEM, V33, P2011, DOI 10.1016/S0038-0717(01)00137-7; Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Blumenthal DM, 2003, ECOL APPL, V13, P605, DOI 10.1890/1051-0761(2003)013[0605:SCACWA]2.0.CO;2; Collins CD, 2009, ECOLOGY, V90, P2567, DOI 10.1890/08-1560.1; de Bello F, 2010, BIOL CONSERV, V143, P9, DOI 10.1016/j.biocon.2009.04.022; De Deyn GB, 2004, J ECOL, V92, P824, DOI 10.1111/j.0022-0477.2004.00924.x; De Deyn GB, 2003, NATURE, V422, P711, DOI 10.1038/nature01548; Eschen R, 2007, J APPL ECOL, V44, P95, DOI 10.1111/j.1365-2664.2006.01240.x; Eviner VT, 2008, RESTOR ECOL, V16, P713, DOI 10.1111/j.1526-100X.2008.00482.x; Fagan KC, 2008, J APPL ECOL, V45, P1293, DOI 10.1111/j.1365-2664.2008.01492.x; Frouz J, 2009, BIODIVERS CONSERV, V18, P3963, DOI 10.1007/s10531-009-9692-5; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Harris J, 2009, SCIENCE, V325, P573, DOI 10.1126/science.1172975; Hoeksema JD, 2010, ECOL LETT, V13, P394, DOI 10.1111/j.1461-0248.2009.01430.x; Hol WHG, 2010, ECOL LETT, V13, P292, DOI 10.1111/j.1461-0248.2009.01424.x; HOUBA VJG, 1985, SOIL ANAL 2; Johnson NC, 2003, ECOLOGY, V84, P1895, DOI 10.1890/0012-9658(2003)084[1895:NEAMAA]2.0.CO;2; Kardol P, 2005, BIOL CONSERV, V126, P317, DOI 10.1016/j.biocon.2005.06.005; Kardol P, 2008, BIOL CONSERV, V141, P2208, DOI 10.1016/j.biocon.2008.06.011; Kardol P, 2006, ECOL LETT, V9, P1080, DOI 10.1111/j.1461-0248.2006.00953.x; Kardol P, 2010, TRENDS ECOL EVOL, V25, P670, DOI 10.1016/j.tree.2010.09.001; Kardol P, 2009, RESTOR ECOL, V17, P258, DOI 10.1111/j.1526-100X.2007.00351.x; Kiehl K, 2010, BASIC APPL ECOL, V11, P285, DOI 10.1016/j.baae.2009.12.004; Lindborg R, 2004, ECOLOGY, V85, P1840, DOI 10.1890/04-0367; MARRS RH, 1993, ADV ECOL RES, V24, P241, DOI 10.1016/S0065-2504(08)60044-6; MIDDLETON EL, 2011, RESTORATION IN PRESS, DOI DOI 10.1111/J.1526-100X.2010.00752.X; NOVOZAMSKY I, 1984, NETH J AGR SCI, V32, P322; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; Oostenbrink I.C., 1960, NEMATOLOGY, P439; Ozinga WA, 2009, ECOL LETT, V12, P66, DOI 10.1111/j.1461-0248.2008.01261.x; Piotrowski JS, 2008, ADV AGRON, V97, P111, DOI 10.1016/S0065-2113(07)00003-X; Pywell RF, 2002, J APPL ECOL, V39, P294, DOI 10.1046/j.1365-2664.2002.00718.x; Pywell RF, 2007, J APPL ECOL, V44, P81, DOI 10.1111/j.1365-2664.2006.01260.x; Reynolds HL, 2009, APPL VEG SCI, V12, P33, DOI 10.1111/j.1654-109X.2009.01020.x; Schaminû«e J., 1996, VEGETATIE NEDERLAND; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; TERBRAAK CJF, 1998, CANOCO WINDOWS 4 5 B; van der Wal A, 2006, SOIL BIOL BIOCHEM, V38, P51, DOI 10.1016/j.soilbio.2005.04.017; Walker KJ, 2004, BIOL CONSERV, V119, P1, DOI 10.1016/j.biocon.2003.10.020; Walters DR, 2007, ANN APPL BIOL, V151, P307, DOI 10.1111/j.1744-7348.2007.00176.x; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; YEATES GW, 1993, J NEMATOL, V25, P315	46	30	31	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21943	10.1371/journal.pone.0021943	http://dx.doi.org/10.1371/journal.pone.0021943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760929	Green Published, gold, Green Submitted			2022-12-25	WOS:000292657200033
J	Ferraris, J; Radl, DB; Zarate, S; Jaita, G; Eijo, G; Zaldivar, V; Clapp, C; Seilicovich, A; Pisera, D				Ferraris, Jimena; Betiana Radl, Daniela; Zarate, Sandra; Jaita, Gabriela; Eijo, Guadalupe; Zaldivar, Veronica; Clapp, Carmen; Seilicovich, Adriana; Pisera, Daniel			N-Terminal Prolactin-Derived Fragments, Vasoinhibins, Are Proapoptoptic and Antiproliferative in the Anterior Pituitary	PLOS ONE			English	Article							CATHEPSIN-D; ANTIANGIOGENIC FACTOR; APOPTOSIS; ESTROGENS; CELLS; PROLIFERATION; ANGIOGENESIS; LACTOTROPHS; EXPRESSION; INHIBITOR	The anterior pituitary is under a constant cell turnover modulated by gonadal steroids. In the rat, an increase in the rate of apoptosis occurs at proestrus whereas a peak of proliferation takes place at estrus. At proestrus, concomitant with the maximum rate of apoptosis, a peak in circulating levels of prolactin is observed. Prolactin can be cleaved to different N-terminal fragments, vasoinhibins, which are proapoptotic and antiproliferative factors for endothelial cells. It was reported that a 16 kDa vasoinhibin is produced in the rat anterior pituitary by cathepsin D. In the present study we investigated the anterior pituitary production of N-terminal prolactin-derived fragments along the estrous cycle and the involvement of estrogens in this process. In addition, we studied the effects of a recombinant vasoinhibin, 16 kDa prolactin, on anterior pituitary apoptosis and proliferation. We observed by Western Blot that N-terminal prolactin-derived fragments production in the anterior pituitary was higher at proestrus with respect to diestrus and that the content and release of these prolactin forms from anterior pituitary cells in culture were increased by estradiol. A recombinant preparation of 16 kDa prolactin induced apoptosis (determined by TUNEL assay and flow cytometry) of cultured anterior pituitary cells and lactotropes from ovariectomized rats only in the presence of estradiol, as previously reported for other proapoptotic factors in the anterior pituitary. In addition, 16 kDa prolactin decreased forskolin-induced proliferation (evaluated by BrdU incorporation) of rat total anterior pituitary cells and lactotropes in culture and decreased the proportion of cells in S-phase of the cell cycle (determined by flow cytometry). In conclusion, our study indicates that the anterior pituitary production of 16 kDa prolactin is variable along the estrous cycle and increased by estrogens. The antiproliferative and estradiol-dependent proapoptotic actions of this vasoinhibin may be involved in the control of anterior pituitary cell renewal.	[Ferraris, Jimena; Betiana Radl, Daniela; Zarate, Sandra; Jaita, Gabriela; Eijo, Guadalupe; Zaldivar, Veronica; Seilicovich, Adriana; Pisera, Daniel] Univ Buenos Aires, Fac Med, Inst Invest Reprod, Buenos Aires, DF, Argentina; [Clapp, Carmen] Univ Nacl Autonoma Mexico, Inst Neurobiol, Juriquilla, Mexico	University of Buenos Aires; Universidad Nacional Autonoma de Mexico	Ferraris, J (corresponding author), Univ Buenos Aires, Fac Med, Inst Invest Reprod, Buenos Aires, DF, Argentina.	dpisera@fmed.uba.ar		JAITA, GABRIELA/0000-0002-6513-0514; Ferraris, Jimena/0000-0001-7472-0439; Pisera, Daniel/0000-0001-8795-1551	Agencia Nacional de Promocion Cientifica Tecnologica-ANPCYT (National Agency for Scientific and Technologic Promotion) [2005- PICT 38223, PICT 2006-92]; Consejo Nacional de investigaciones Cientificas y Tecnologicas-CONICET (National Council for Scientific and Technologic Research) [PIP 5368]; Universidad de Buenos Aires-UBA (University of Buenos Aires) [UBACyT 2008-2010 M057]	Agencia Nacional de Promocion Cientifica Tecnologica-ANPCYT (National Agency for Scientific and Technologic Promotion); Consejo Nacional de investigaciones Cientificas y Tecnologicas-CONICET (National Council for Scientific and Technologic Research)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires-UBA (University of Buenos Aires)(University of Buenos Aires)	This study was supported by Agencia Nacional de Promocion Cientifica Tecnologica-ANPCYT (National Agency for Scientific and Technologic Promotion)(2005- PICT 38223), Agencia Nacional de Promocion Cientifica Tecnologica-ANPCYT (National Agency for Scientific and Technologic Promotion)(PICT 2006-92), Consejo Nacional de investigaciones Cientificas y Tecnologicas-CONICET (National Council for Scientific and Technologic Research) (PIP 5368) and Universidad de Buenos Aires-UBA (University of Buenos Aires)(UBACyT 2008-2010 M057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRIES M, 1992, BIOCHEM J, V281, P393, DOI 10.1038/355393a0; Candolfi M, 2002, ENDOCRINOLOGY, V143, P3611, DOI 10.1210/en.2002-220377; Castino R, 2008, ENDOCRINOLOGY, V149, P4095, DOI 10.1210/en.2008-0249; CLAPP C, 1993, ENDOCRINOLOGY, V133, P1292, DOI 10.1210/en.133.3.1292; Clapp C, 2006, TRENDS ENDOCRIN MET, V17, P301, DOI 10.1016/j.tem.2006.08.002; Cruz-Soto ME, 2009, ENDOCRINOLOGY, V150, P5446, DOI 10.1210/en.2009-0390; ELANGOVAN S, 1980, J BIOL CHEM, V255, P7474; Erdmann S, 2007, AM J PHYSIOL-ENDOC M, V293, pE1365, DOI 10.1152/ajpendo.00280.2007; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Galfione M, 2003, PROTEIN EXPRES PURIF, V28, P252, DOI 10.1016/S1046-5928(02)00639-3; Ge GX, 2007, P NATL ACAD SCI USA, V104, P10010, DOI 10.1073/pnas.0704179104; HASHI A, 1995, ENDOCRINOLOGY, V136, P4665, DOI 10.1210/en.136.10.4665; Jaita G, 2005, ENDOCRINOLOGY, V146, P4737, DOI 10.1210/en.2005-0279; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Lkhider M, 2004, J CELL SCI, V117, P5155, DOI 10.1242/jcs.01396; Martini JF, 2000, MOL ENDOCRINOL, V14, P1536, DOI 10.1210/me.14.10.1536; Mendez I, 2010, FRONT HORM RES, V38, P184, DOI 10.1159/000318509; Pisera D, 2004, AM J PHYSIOL-ENDOC M, V287, pE767, DOI 10.1152/ajpendo.00052.2004; Piwnica D, 2004, MOL ENDOCRINOL, V18, P2522, DOI 10.1210/me.2004-0200; Piwnica D, 2006, MOL ENDOCRINOL, V20, P3263, DOI 10.1210/me.2006-0044; Radl DB, 2008, NEUROENDOCRINOLOGY, V88, P43, DOI 10.1159/000116117; Rochefort H, 2001, J STEROID BIOCHEM, V76, P119, DOI 10.1016/S0960-0760(00)00142-4; SINHA YN, 1995, ENDOCR REV, V16, P354, DOI 10.1210/er.16.3.354; Suzuki S, 1999, ENDOCRINOLOGY, V140, P2850, DOI 10.1210/en.140.6.2850; Tabruyn SP, 2005, MOL ENDOCRINOL, V19, P1932, DOI 10.1210/me.2004-0515; Tabruyn SP, 2003, MOL ENDOCRINOL, V17, P1815, DOI 10.1210/me.2003-0132; TURNER HE, 2000, J CLIN ENDOCR METAB, V85, P131; Yin P, 2002, NEUROENDOCRINOLOGY, V76, P272, DOI 10.1159/000066626; Zaldivar V, 2009, NEUROENDOCRINOLOGY, V90, P292, DOI 10.1159/000235618; Zarate S, 2010, FRONT HORM RES, V38, P25, DOI 10.1159/000318491; Zarate S, 2009, AM J PHYSIOL-ENDOC M, V296, pE664, DOI 10.1152/ajpendo.90785.2008	31	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21806	10.1371/journal.pone.0021806	http://dx.doi.org/10.1371/journal.pone.0021806			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760910	Green Published, gold, Green Submitted			2022-12-25	WOS:000292655400020
J	Kraeussling, M; Wagner, TU; Schartl, M				Kraeussling, Michael; Wagner, Toni Ulrich; Schartl, Manfred			Highly Asynchronous and Asymmetric Cleavage Divisions Accompany Early Transcriptional Activity in Pre-Blastula Medaka Embryos	PLOS ONE			English	Article							RNA-POLYMERASE-II; MAJOR DEVELOPMENTAL TRANSITION; EARLY DROSOPHILA DEVELOPMENT; EARLY XENOPUS-EMBRYOS; MIDBLASTULA TRANSITION; CELL-CYCLE; TERMINAL DOMAIN; ZEBRAFISH; PHOSPHORYLATION; EMBRYOGENESIS	In the initial phase of development of fish embryos, a prominent and critical event is the midblastula transition (MBT). Before MBT cell cycle is rapid, highly synchronous and zygotic gene transcription is turned off. Only during MBT the cell cycle desynchronizes and transcription is activated. Multiple mechanisms, primarily the nucleocytoplasmic ratio, are supposed to control MBT activation. Unexpectedly, we find in the small teleost fish medaka (Oryzias latipes) that at very early stages, well before midblastula, cell division becomes asynchronous and cell volumes diverge. Furthermore, zygotic transcription is extensively activated already after the 64-cell stage. Thus, at least in medaka, the transition from maternal to zygotic transcription is uncoupled from the midblastula stage and not solely controlled by the nucleocytoplasmic ratio.				toni.wagner@biozentrum.uni-wuerzburg.de		Schartl, Manfred/0000-0001-9882-5948	German Research Foundation (DFG); EU through Plurigenes [018673]; University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); EU through Plurigenes; University of Wuerzburg	This study was supported by German Research Foundation (DFG) via the "pecial research group 1048''(http://www.gk-1048.uni-wuerzburg.de/) and by the EU through Plurigenes (FP6 project 018673)(http://www.plurigenes.org/). This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa K, 2003, GENE EXPR PATTERNS, V3, P43, DOI 10.1016/S1567-133X(02)00075-3; ANDERSON KV, 1980, CELL, V21, P717, DOI 10.1016/0092-8674(80)90435-3; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Ashworth R, 2007, J BIOL CHEM, V282, P13984, DOI 10.1074/jbc.M700940200; BISSEN ST, 1989, DEVELOPMENT, V106, P105; CADENA DL, 1987, J BIOL CHEM, V262, P12468; CLUTE P, 1995, DEV BIOL, V171, P273, DOI 10.1006/dbio.1995.1280; Dirks RW, 1999, HISTOCHEM CELL BIOL, V111, P405, DOI 10.1007/s004180050374; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; GRAHAM CF, 1966, DEV BIOL, V14, P439, DOI 10.1016/0012-1606(66)90024-8; HARTL P, 1993, J CELL BIOL, V120, P613, DOI 10.1083/jcb.120.3.613; HOWE JA, 1995, GENE DEV, V9, P1164, DOI 10.1101/gad.9.10.1164; Howe JA, 1996, P NATL ACAD SCI USA, V93, P2060, DOI 10.1073/pnas.93.5.2060; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; KANE DA, 1993, DEVELOPMENT, V119, P447; KIMELMAN D, 1987, CELL, V48, P399, DOI 10.1016/0092-8674(87)90191-7; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KOBAYAKAWA Y, 1981, J EMBRYOL EXP MORPH, V62, P83; LIEDTKE D, 2010, SNAIL GENE EXPRESSIO; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; MITA I, 1984, J EXP ZOOL, V229, P215, DOI 10.1002/jez.1402290206; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; NONCHEV S, 1990, MOL REPROD DEV, V25, P72, DOI 10.1002/mrd.1080250113; OBRIEN T, 1994, NATURE, V370, P75, DOI 10.1038/370075a0; Okazaki K., 1975, P177; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; VALAY JG, 1995, J MOL BIOL, V249, P535, DOI 10.1006/jmbi.1995.0316; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704	31	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21741	10.1371/journal.pone.0021741	http://dx.doi.org/10.1371/journal.pone.0021741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750728	Green Published, gold, Green Submitted			2022-12-25	WOS:000292655400015
J	Li, TN; Chin, KH; Fung, KM; Yang, MT; Wang, AHJ; Chou, SH				Li, Tso-Ning; Chin, Ko-Hsin; Fung, Kit-Man; Yang, Ming-Te; Wang, Andrew H. -J.; Chou, Shan-Ho			A Novel Tetrameric PilZ Domain Structure from Xanthomonads	PLOS ONE			English	Article							C-DI-GMP; COILED-COIL TETRAMER; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; ANALYTICAL ULTRACENTRIFUGATION; PROTEIN INTERACTIONS; TWITCHING MOTILITY; BINDING-PROTEIN; CAMPESTRIS; RECEPTOR	PilZ domain is one of the key receptors for the newly discovered secondary messenger molecule cyclic di-GMP (c-di-GMP). To date, several monomeric PilZ domain proteins have been identified. Some exhibit strong c-di-GMP binding activity, while others have barely detectable c-di-GMP binding activity and require an accessory protein such as FimX to indirectly respond to the c-di-GMP signal. We now report a novel tetrameric PilZ domain structure of XCC6012 from the plant pathogen Xanthomonas campestris pv. campestris (Xcc). It is one of the four PilZ domain proteins essential for Xcc pathogenicity. Although the monomer adopts a structure similar to those of the PilZ domains with very weak c-di-GMP binding activity, it is nevertheless interrupted in the middle by two extra long helices. Four XCC6012 proteins are thus self-assembled into a tetramer via the extra heptad repeat alpha 3 helices to form a parallel four-stranded coiled-coil, which is further enclosed by two sets of inclined alpha 2 and alpha 4 helices. We further generated a series of XCC6012 variants and measured the unfolding temperatures and oligomeric states in order to investigate the nature of this novel tetramer. Discovery of this new PilZ domain architecture increases the complexity of c-di-GMP-mediated regulation.	[Li, Tso-Ning; Chou, Shan-Ho] Natl Chung Hsing Univ, Inst Biochem, Taichung 40227, Taiwan; [Chin, Ko-Hsin] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan; [Fung, Kit-Man; Yang, Ming-Te] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Chou, Shan-Ho] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; Academia Sinica - Taiwan; China Medical University Taiwan	Li, TN (corresponding author), Natl Chung Hsing Univ, Inst Biochem, Taichung 40227, Taiwan.	shchou@nchu.edu.tw	Yang, Ming-Te/B-5626-2017	Yang, Ming-Te/0000-0002-7644-0964; CHOU, Shan-Ho/0000-0002-5202-8238	National Science Council, Taiwan [97-2113-M005-005-MY3]; Ministry of Education, Taiwan; National Science Council, Taiwan, ROC; National Research Program for Genomic Medicine, Taiwan, ROC	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan); National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan); National Research Program for Genomic Medicine, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	National Science Council, Taiwan (97-2113-M005-005-MY3), and Ministry of Education, Taiwan. The funders had no role in study desing, data collection and analysis, decision to publish, or preparation of the manuscript.r We appreciate the services of the Structural Genomics Databases provided by the GMBD Bioinformatics Core (http//www.tbi.org.tw), NRPGM, Taiwan. We would like to thank the Core Facilities for Protein X-ray Crystallography in the Academia Sinica, Taiwan for their assistance in crystal screening, the National Synchrotron Radiation Research Center (NSRRC) in Taiwan for their assistance in X-ray data collection. The National Synchrotron Radiation Research Center is a user facility supported by the National Science Council, Taiwan, ROC, and the Protein Crystallography Facility is supported by the National Research Program for Genomic Medicine, Taiwan, ROC. We also thank Bonnie Levitt for her help in reviewing this manuscript.	Alm RA, 1996, J BACTERIOL, V178, P46, DOI 10.1128/jb.178.1.46-53.1996; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Apostolovic B, 2010, CHEM SOC REV, V39, P3541, DOI 10.1039/b914339b; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruylants G, 2005, CURR MED CHEM, V12, P2011, DOI 10.2174/0929867054546564; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chin KH, 2010, J MOL BIOL, V396, P646, DOI 10.1016/j.jmb.2009.11.076; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P685, DOI 10.1107/S0365110X53001952; DALAHAY RM, 2002, MOL MICROBIOL, V45; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Gruber M, 2003, TRENDS BIOCHEM SCI, V28, P679, DOI 10.1016/j.tibs.2003.10.008; Guzzo CR, 2009, J MOL BIOL, V393, P848, DOI 10.1016/j.jmb.2009.07.065; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; He YW, 2007, MOL MICROBIOL, V64, P281, DOI 10.1111/j.1365-2958.2007.05670.x; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003; Huguet E, 1998, MOL MICROBIOL, V29, P1379, DOI 10.1046/j.1365-2958.1998.01019.x; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x; Kohn WD, 1998, J MOL BIOL, V283, P993, DOI 10.1006/jmbi.1998.2125; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Leduc JL, 2009, J BACTERIOL, V191, P7121, DOI 10.1128/JB.00845-09; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Li TN, 2009, ACTA CRYSTALLOGR F, V65, P1056, DOI 10.1107/S1744309109036239; Li TN, 2009, PROTEINS, V75, P282, DOI 10.1002/prot.22330; Liu J, 2007, BIOCHEMISTRY-US, V46, P14951, DOI 10.1021/bi701930d; Liu J, 2006, BIOCHEMISTRY-US, V45, P15224, DOI 10.1021/bi061914m; Lu J, 2006, EMBO J, V25, P2930, DOI 10.1038/sj.emboj.7601151; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Mccarthy Y, 2008, MOL PLANT PATHOL, V9, P819, DOI [10.1111/j.1364-3703.2008.00495.x, 10.1111/J.1364-3703.2008.00495.X]; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Mittl PRE, 2000, P NATL ACAD SCI USA, V97, P2562, DOI 10.1073/pnas.97.6.2562; Moutevelis E, 2009, J MOL BIOL, V385, P726, DOI 10.1016/j.jmb.2008.11.028; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Pratt JT, 2007, J BIOL CHEM, V282, P12860, DOI 10.1074/jbc.M611593200; Ramelot TA, 2007, PROTEINS, V66, P266, DOI 10.1002/prot.21199; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Rose A, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-66; Rose A, 2004, CELL MOL LIFE SCI, V61, P1996, DOI 10.1007/s00018-004-4039-6; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; Stafford Walter F. III, 2009, V490, P83, DOI 10.1007/978-1-59745-367-7_4; Stetefeld J, 2000, NAT STRUCT BIOL, V7, P772, DOI 10.1038/79006; Tao F, 2010, J BACTERIOL, V192, P1020, DOI 10.1128/JB.01253-09; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; TERWILLIGER TC, 2002, ACTA CRYSTALLOGR D, V59, P3444; VANDEYAR MA, 1988, GENE, V65, P129, DOI 10.1016/0378-1119(88)90425-8; Wu YY, 2005, ACTA CRYSTALLOGR F, V61, P902, DOI 10.1107/S1744309105027132	64	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e22036	10.1371/journal.pone.0022036	http://dx.doi.org/10.1371/journal.pone.0022036			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760949	Green Published, Green Submitted, gold			2022-12-25	WOS:000292655400041
J	Wheeler, HE; Gorsic, LK; Welsh, M; Stark, AL; Gamazon, ER; Cox, NJ; Dolan, ME				Wheeler, Heather E.; Gorsic, Lidija K.; Welsh, Marleen; Stark, Amy L.; Gamazon, Eric R.; Cox, Nancy J.; Dolan, M. Eileen			Genome-Wide Local Ancestry Approach Identifies Genes and Variants Associated with Chemotherapeutic Susceptibility in African Americans	PLOS ONE			English	Article							INDUCED CYTOTOXICITY; JAB1 EXPRESSION; MOLECULAR-BASIS; PHASE-II; CARBOPLATIN; CYTARABINE; RESISTANCE; CISPLATIN; PROLIFERATION; MECHANISMS	Chemotherapeutic agents are used in the treatment of many cancers, yet variable resistance and toxicities among individuals limit successful outcomes. Several studies have indicated outcome differences associated with ancestry among patients with various cancer types. Using both traditional SNP-based and newly developed gene-based genome-wide approaches, we investigated the genetics of chemotherapeutic susceptibility in lymphoblastoid cell lines derived from 83 African Americans, a population for which there is a disparity in the number of genome-wide studies performed. To account for population structure in this admixed population, we incorporated local ancestry information into our association model. We tested over 2 million SNPs and identified 325, 176, 240, and 190 SNPs that were suggestively associated with cytarabine-, 5'-deoxyfluorouridine (5'-DFUR)-, carboplatin-, and cisplatin-induced cytotoxicity, respectively (p <= 10(-4)). Importantly, some of these variants are found only in populations of African descent. We also show that cisplatin-susceptibility SNPs are enriched for carboplatin- susceptibility SNPs. Using a gene-based genome-wide association approach, we identified 26, 11, 20, and 41 suggestive candidate genes for association with cytarabine-, 5'-DFUR-, carboplatin-, and cisplatin-induced cytotoxicity, respectively (p <= 10(-3)). Fourteen of these genes showed evidence of association with their respective chemotherapeutic phenotypes in the Yoruba from Ibadan, Nigeria (p < 0.05), including TP53/11, COPS5 and GAS8, which are known to be involved in tumorigenesis. Although our results require further study, we have identified variants and genes associated with chemotherapeutic susceptibility in African Americans by using an approach that incorporates local ancestry information.	[Wheeler, Heather E.; Gorsic, Lidija K.; Welsh, Marleen; Dolan, M. Eileen] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Stark, Amy L.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Gamazon, Eric R.; Cox, Nancy J.] Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Wheeler, HE (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA.	edolan@medicine.bsd.uchicago.edu	Gamazon, Eric/I-6873-2018; Wheeler, Heather/I-9279-2019	Gamazon, Eric/0000-0003-4204-8734; Wheeler, Heather/0000-0003-1365-9667	NIH/NIGMS [U01GM61393]; University of Chicago Breast Cancer SPORE [P50 CA125183]; Department of Defense [BC087674]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P50CA125183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Chicago Breast Cancer SPORE(University of Chicago); Department of Defense(United States Department of Defense); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by NIH/NIGMS Pharmacogenomics of Anticancer grant U01GM61393 (MED, NJC), by the University of Chicago Breast Cancer SPORE grant P50 CA125183 (MED, NJC), by the Department of Defense Breast Cancer Research Program grant BC087674 (MW), and by a Specialized Center of Research Grant from the Leukemia and Lymphoma Society (MED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; ACS, 2005, CANC FACTS FIG AFR A; Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Aplenc R, 2006, BLOOD, V108, P74, DOI 10.1182/blood-2005-10-4004; BAKER WJ, 1991, J CLIN ONCOL, V9, P679, DOI 10.1200/JCO.1991.9.4.679; Bonilla C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016044; Borghaei H, 2008, J THORAC ONCOL, V3, P1286, DOI 10.1097/JTO.0b013e318189f50e; Briasoulis E, 2001, ONCOLOGIST, V6, P153, DOI 10.1634/theoncologist.6-2-153; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Celik I, 1996, J CLIN ONCOL, V14, P1043, DOI 10.1200/JCO.1996.14.3.1043; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Deo RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000342; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dong YY, 2005, CLIN CANCER RES, V11, P259; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; Galmarini CM, 2002, BRIT J HAEMATOL, V117, P860, DOI 10.1046/j.1365-2141.2002.03538.x; Gamazon ER, 2010, P NATL ACAD SCI USA, V107, P9287, DOI 10.1073/pnas.1001827107; Hao K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-27; Harada K, 2006, ANTICANCER RES, V26, P1615; Hartford CM, 2009, BLOOD, V113, P2145, DOI 10.1182/blood-2008-05-154302; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huang RS, 2008, MOL CANCER THER, V7, P3038, DOI 10.1158/1535-7163.MCT-08-0248; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Kaiser J, 2008, SCIENCE, V319, P395, DOI 10.1126/science.319.5862.395; Kang SJ, 2010, HUM MOL GENET, V19, P2725, DOI 10.1093/hmg/ddq154; Kouvaraki MA, 2003, CANCER RES, V63, P2977; Li L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007765; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; McMurrough J, 1996, BRIT J CLIN PHARMACO, V41, P425, DOI 10.1046/j.1365-2125.1996.34212.x; McWhinney SR, 2009, MOL CANCER THER, V8, P10, DOI 10.1158/1535-7163.MCT-08-0840; Micheletti E, 1997, AM J CLIN ONCOL-CANC, V20, P613, DOI 10.1097/00000421-199712000-00017; Need AC, 2009, TRENDS GENET, V25, P489, DOI 10.1016/j.tig.2009.09.012; Niu N, 2011, CLIN PHARMACOL THER, V89, pS66; Pasaniuc B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001371; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Polite BN, 2006, J CLIN ONCOL, V24, P2179, DOI 10.1200/JCO.2005.05.4775; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Rassidakis GZ, 2003, CLIN CANCER RES, V9, P1121; REYKDAL S, 1995, LEUKEMIA RES, V19, P141, DOI 10.1016/0145-2126(94)00123-R; Rotimi CN, 2010, NEW ENGL J MED, V363, P1551, DOI 10.1056/NEJMra0911564; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI 10.1016/j.ajhg.2007.09.022; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Shain SA, 2004, MOL CANCER RES, V2, P653; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Stark A, 2010, CANCER; STARK AL, 2010, PHARMACOGENOMICS J; Stark AL, 2010, AM J HUM GENET, V87, P829, DOI 10.1016/j.ajhg.2010.10.018; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Styczynski J, 2007, CURR PHARM BIOTECHNO, V8, P59, DOI 10.2174/138920107780487465; Sui L, 2001, CLIN CANCER RES, V7, P4130; Sundquist A, 2008, GENOME RES, V18, P676, DOI 10.1101/gr.072850.107; Tian L, 2010, ONCOGENE, V29, P6125, DOI 10.1038/onc.2010.345; VANGLABBEKE M, 1988, EUR J CANCER CLIN ON, V24, P255, DOI 10.1016/0277-5379(88)90262-3; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Watters JW, 2004, P NATL ACAD SCI USA, V101, P11809, DOI 10.1073/pnas.0404580101; Wei XX, 1996, J CLIN INVEST, V98, P610, DOI 10.1172/JCI118830; Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461; Whitmore SA, 1998, GENOMICS, V52, P325, DOI 10.1006/geno.1998.5457; Wu Y, 2009, PATHOL ONCOL RES, V15, P411, DOI 10.1007/s12253-008-9138-5; Ziliak D, 2011, TRANSL RES, V157, P265, DOI 10.1016/j.trsl.2011.01.005	67	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21920	10.1371/journal.pone.0021920	http://dx.doi.org/10.1371/journal.pone.0021920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755009	Green Published, gold, Green Submitted			2022-12-25	WOS:000292632000036
J	Sinha, S; Miller, LM; Subramanian, S; Burrows, GG; Vandenbark, AA; Offner, H				Sinha, Sushmita; Miller, Lisa M.; Subramanian, Sandhya; Burrows, Gregory G.; Vandenbark, Arthur A.; Offner, Halina			RTL551 Treatment of EAE Reduces CD226 and T-bet+CD4 T Cells in Periphery and Prevents Infiltration of T-bet+ IL-17, IFN-gamma Producing T Cells into CNS	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; RECEPTOR LIGANDS; ADHESION MOLECULE; CYTOKINE SWITCH; TH1 CELLS; SJL MICE; DIFFERENTIATION; EXPRESSION; DISEASE	Recombinant T cell receptor ligands (RTLs) that target encephalitogenic T-cells can reverse clinical and histological signs of EAE, and are currently in clinical trials for treatment of multiple sclerosis. To evaluate possible regulatory mechanisms, we tested effects of RTL therapy on expression of pathogenic and effector T-cell maturation markers, CD226, T-bet and CD44, by CD4+ Th1 cells early after treatment of MOG-35-55 peptide-induced EAE in C57BL/6 mice. We showed that 1-5 daily injections of RTL551 (two-domain I-A(b) covalently linked to MOG-35-55 peptide), but not the control RTL550 ("empty'' two-domain I-A(b) without a bound peptide) or Vehicle, reduced clinical signs of EAE, prevented trafficking of cells outside the spleen, significantly reduced the frequency of CD226 and T-bet expressing CD4+ T-cells in blood and inhibited expansion of CD44 expressing CD4+ T-cells in blood and spleen. Concomitantly, RTL551 selectively reduced CNS inflammatory lesions, absolute numbers of CNS infiltrating T-bet expressing CD4+ T-cells and IL-17 and IFN-gamma secretion by CNS derived MOG-35-55 reactive cells cultured ex vivo. These novel results demonstrate that a major effect of RTL therapy is to attenuate Th1 specific changes in CD4+ T-cells during EAE and prevent expansion of effector T-cells that mediate clinical signs and CNS inflammation in EAE.	[Sinha, Sushmita; Miller, Lisa M.; Subramanian, Sandhya; Vandenbark, Arthur A.; Offner, Halina] Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA; [Sinha, Sushmita; Miller, Lisa M.; Burrows, Gregory G.; Vandenbark, Arthur A.; Offner, Halina] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Burrows, Gregory G.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Vandenbark, Arthur A.] Dept Vet Affairs Med Ctr, Res Serv, Portland, OR USA; [Vandenbark, Arthur A.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Offner, Halina] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; Oregon Health & Science University	Sinha, S (corresponding author), Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA.	offnerva@ohsu.edu		sinha, sushmita/0000-0003-3385-1023	National Multiple Sclerosis Society [FG1749-A-1, RG3794-A-4, RG3794-B-6]; NIH [NS47661]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047661] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Sinha is a Postdoctoral Fellow of the National Multiple Sclerosis Society and this work was supported in part by the National Multiple Sclerosis Society Postdoctoral Fellowship FG1749-A-1, grants RG3794-A-4 and RG3794-B-6; NIH Grant NS47661. This material is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. The contents do not represent the views of the Department of Veterans Affairs or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bebo BF, 1996, J NEUROSCI RES, V45, P680, DOI 10.1002/(SICI)1097-4547(19960915)45:6<680::AID-JNR4>3.0.CO;2-4; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Burrows GG, 2001, J IMMUNOL, V167, P4386, DOI 10.4049/jimmunol.167.8.4386; Burrows GG, 1999, PROTEIN ENG, V12, P771, DOI 10.1093/protein/12.9.771; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Dardalhon V, 2005, J IMMUNOL, V175, P1558, DOI 10.4049/jimmunol.175.3.1558; Fontenot AP, 2006, J IMMUNOL, V177, P3874, DOI 10.4049/jimmunol.177.6.3874; Frisullo G, 2006, J NEUROSCI RES, V84, P1027, DOI 10.1002/jnr.20995; GOCKE AR, 2007, T BET REGULATES FATE, P1341; Hafler JP, 2009, GENES IMMUN, V10, P5, DOI 10.1038/gene.2008.82; Huan JY, 2004, J IMMUNOL, V172, P4556, DOI 10.4049/jimmunol.172.7.4556; Lovett-Racke AE, 2004, IMMUNITY, V21, P719, DOI 10.1016/j.immuni.2004.09.010; Nath N, 2006, IMMUNOLOGY, V118, P384, DOI 10.1111/j.1365-2567.2006.02385.x; Offner H, 2005, J IMMUNOL, V175, P4103, DOI 10.4049/jimmunol.175.6.4103; OFFNER H, 1993, J IMMUNOL, V151, P506; Offner H, 2008, REV NEUROSCIENCE, V19, P327; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Sinha S, 2007, J NEUROSCI, V27, P12531, DOI 10.1523/JNEUROSCI.3599-07.2007; Sinha S, 2010, J NEUROIMMUNOL, V225, P52, DOI 10.1016/j.jneuroim.2010.04.013; Sinha S, 2010, J NEUROIMMUNE PHARM, V5, P231, DOI 10.1007/s11481-009-9175-1; Sinha S, 2009, J NEUROSCI, V29, P3816, DOI 10.1523/JNEUROSCI.5812-08.2009; SWANBORG RH, 1995, CLIN IMMUNOL IMMUNOP, V77, P4, DOI 10.1016/0090-1229(95)90130-2; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; TAMURA T, 1995, J IMMUNOL, V155, P4692; Tamura T, 2001, J IMMUNOL, V167, P1962, DOI 10.4049/jimmunol.167.4.1962; Vandenbark AA, 2003, J IMMUNOL, V171, P127, DOI 10.4049/jimmunol.171.1.127; Wang CH, 2003, J IMMUNOL, V171, P1934, DOI 10.4049/jimmunol.171.4.1934; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584	32	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21868	10.1371/journal.pone.0021868	http://dx.doi.org/10.1371/journal.pone.0021868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750737	gold, Green Published, Green Submitted			2022-12-25	WOS:000292512000029
J	Wanyenze, RK; Kamya, MR; Fatch, R; Mayanja-Kizza, H; Baveewo, S; Sawires, S; Bangsberg, DR; Coates, T; Hahn, JA				Wanyenze, Rhoda K.; Kamya, Moses R.; Fatch, Robin; Mayanja-Kizza, Harriet; Baveewo, Steven; Sawires, Sharif; Bangsberg, David R.; Coates, Thomas; Hahn, Judith A.			Missed Opportunities for HIV Testing and Late-Stage Diagnosis among HIV-Infected Patients in Uganda	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SEXUAL-BEHAVIOR; TRANSMISSION; PREVENTION; STRATEGIES; DISCLOSURE; COUNTRIES; PROGRAMS; OUTCOMES; RISK	Background: Late diagnosis of HIV infection is a major challenge to the scale-up of HIV prevention and treatment. In 2005 Uganda adopted provider-initiated HIV testing in the health care setting to ensure earlier HIV diagnosis and linkage to care. We provided HIV testing to patients at Mulago hospital in Uganda, and performed CD4 tests to assess disease stage at diagnosis. Methods: Patients who had never tested for HIV or tested negative over one year prior to recruitment were enrolled between May 2008 and March 2010. Participants who tested HIV positive had a blood draw for CD4. Late HIV diagnosis was defined as CD4 <= 250 cells/mm. Predictors of late HIV diagnosis were analyzed using multi-variable logistic regression. Results: Of 1966 participants, 616 (31.3%) were HIV infected; 47.6% of these (291) had CD4 counts <= 250. Overall, 66.7% (408) of the HIV infected participants had never received care in a medical clinic. Receiving care in a non-medical setting (home, traditional healer and drug stores) had a threefold increase in the odds of late diagnosis (OR = 3.2; 95% CI: 2.1-4.9) compared to receiving no health care. Conclusions: Late HIV diagnosis remains prevalent five years after introducing provider-initiated HIV testing in Uganda. Many individuals diagnosed with advanced HIV did not have prior exposure to medical clinics and could not have benefitted from the expansion of provider initiated HIV testing within health facilities. In addition to provider-initiated testing, approaches that reach individuals using non-hospital based encounters should be expanded to ensure early HIV diagnosis.	[Wanyenze, Rhoda K.] Makerere Univ, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda; [Kamya, Moses R.; Mayanja-Kizza, Harriet; Baveewo, Steven] Makerere Univ, Sch Med, Dept Med, Kampala, Uganda; [Fatch, Robin; Baveewo, Steven; Hahn, Judith A.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA; [Sawires, Sharif; Coates, Thomas] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Bangsberg, David R.] Harvard Univ, Sch Med, Boston, MA USA; [Bangsberg, David R.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA	Makerere University; Makerere University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Wanyenze, RK (corresponding author), Makerere Univ, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda.	rwanyenze@hotmail.com	Mayanja-Kizza, Harriet/AAM-5372-2020; Hahn, Judith/J-5813-2014	Mayanja-Kizza, Harriet/0000-0002-9297-6208; Hahn, Judith/0000-0002-2697-8264	National Institute of Mental Health, Division of AIDS and Health and Behavior Research, Center for Mental Health Research on AIDS [1 R01 MH077512]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077512, K24MH087227, R01MH054907] Funding Source: NIH RePORTER	National Institute of Mental Health, Division of AIDS and Health and Behavior Research, Center for Mental Health Research on AIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by National Institute of Mental Health (1 R01 MH077512), Division of AIDS and Health and Behavior Research, Center for Mental Health Research on AIDS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Government of Malawi Office of the President and Cabinet NAC, 2003, NAT HIV AIDS POL CAL; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hladik W, 2008, AIDS, V22, P503, DOI 10.1097/QAD.0b013e3282f470be; Joint United Nations Programme on HIV/AIDS, 2009, AIDS EP; Kiene SM, 2010, AIDS PATIENT CARE ST, V24, P117, DOI 10.1089/apc.2009.0269; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Nakanjako Damalie, 2007, Afr Health Sci, V7, P124; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Okwero P, 2010, WOR BANK WORK PAPER, P1, DOI 10.1596/978-0-8213-8290-5; *REP KEN MIN HLTH, 2006, GUID HIV TEST CLIN S; *REP S AFR, 2010, CLIN GUID MAN HIV AI; *REP UG MIN HLTH, 2005, UGAND NAT POL HIV CO; *REP UG MIN HLTH, 2008, PERF REP STD AIDS CO; Sobrino-Vegas P, 2009, CURR HIV RES, V7, P224, DOI 10.2174/157016209787581535; *UG BUR STAT MAC I, 2001, UG DEM HLTH SURV 200; *UG BUR STAT MAC I, 2006, UG DEM HLTH SURV 200; UN, MILL DEV GOALS; Wanyenze RK, 2008, B WORLD HEALTH ORGAN, V86, P302, DOI 10.2471/BLT.07.042580; WANYENZE RK, 2010, LINKAGE HIV CARE SUR, P31933; World Health Organization, 2009, RAP ADV ANT THER HIV; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	29	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21794	10.1371/journal.pone.0021794	http://dx.doi.org/10.1371/journal.pone.0021794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750732	Green Submitted, gold, Green Published			2022-12-25	WOS:000292512000024
J	Araki, K; Nagata, K				Araki, Kazutaka; Nagata, Kazuhiro			Functional in Vitro Analysis of the ERO1 Protein and Protein-disulfide Isomerase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; BOND FORMATION; PH-DEPENDENCE; ACTIVE-SITE; OXIDATIVE ACTIVITY; QUALITY-CONTROL; ERO1-ALPHA; SUBSTRATE; FAMILY; PDI	Oxidative protein folding in the endoplasmic reticulum is supported by efficient electron relays driven by enzymatic reactions centering on the ERO1-protein-disulfide isomerase (PDI) pathway. A controlled in vitro oxygen consumption assay was carried out to analyze the ERO1-PDI reaction. The results showed the pH-dependent oxidation of PDI by ERO1 alpha. Among several possible disulfide bonds regulating ERO1 alpha activity, Cys(94)-Cys(131) and Cys(99)-Cys(104) disulfide bonds are dominant regulators by excluding the involvement of the Cys(85)-Cys(391) disulfide in the regulation. The fine-tuned species specificity of the ERO1-PDI pathway was demonstrated by functional in vitro complementation assays using yeast and mammalian oxidoreductases. Finally, the results provide experimental evidence for the intramolecular electron transfer from the a domain to the a' domain within PDI during its oxidation by ERO1 alpha.	[Araki, Kazutaka; Nagata, Kazuhiro] Kyoto Sangyo Univ, Fac Life Sci, Lab Mol & Cellular Biol, Kita Ku, Kyoto 8038555, Japan; [Araki, Kazutaka] Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto 6068507, Japan	Kyoto Sangyo University; Kyoto University	Nagata, K (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Lab Mol & Cellular Biol, Kita Ku, Kyoto 8038555, Japan.	nagata@cc.kyoto-su.ac.jp	Araki, Kazutaka/L-6296-2018	Araki, Kazutaka/0000-0003-2901-2454	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [19G0314, 19058008]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [19GS0314] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Creative Scientific Research (19G0314) and for Scientific Research on Priority Area (19058008) from Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to K. N.) and by a fellowship from the Japan Society for the Promotion of Science (to K. A.).	Alanen HI, 2006, ANTIOXID REDOX SIGN, V8, P283, DOI 10.1089/ars.2006.8.283; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Berntsson M, 1997, ANAL CHIM ACTA, V355, P43, DOI 10.1016/S0003-2670(97)81610-8; Bertoli G, 2004, J BIOL CHEM, V279, P30047, DOI 10.1074/jbc.M403192200; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Chambers JE, 2010, J BIOL CHEM, V285, P29200, DOI 10.1074/jbc.M110.156596; CLARK LC, 1953, J APPL PHYSIOL, V6, P189, DOI 10.1152/jappl.1953.6.3.189; Dempsey JL, 2010, CHEM REV, V110, P7024, DOI 10.1021/cr100182b; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; HAWKINS HC, 1991, BIOCHEM J, V275, P335, DOI 10.1042/bj2750335; Heldman N, 2010, PROTEIN SCI, V19, P1863, DOI 10.1002/pro.473; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Koivunen P, 2005, J BIOL CHEM, V280, P5227, DOI 10.1074/jbc.M412480200; Kortemme T, 1996, BIOCHEMISTRY-US, V35, P14503, DOI 10.1021/bi9617724; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Mossner E, 1998, PROTEIN SCI, V7, P1233; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Ruddock LW, 1996, BIOCHEM J, V315, P1001, DOI 10.1042/bj3151001; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Vitu E, 2010, J BIOL CHEM, V285, P18155, DOI 10.1074/jbc.M109.064931; Wang C, 2010, J BIOL CHEM, V285, P26788, DOI 10.1074/jbc.M110.107839; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Wang YH, 2008, PROTEIN J, V27, P181, DOI 10.1007/s10930-007-9121-0	37	59	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32705	32712		10.1074/jbc.M111.227181	http://dx.doi.org/10.1074/jbc.M111.227181			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21757736	Green Published, hybrid			2022-12-25	WOS:000294726800079
J	Richards, CI; Srinivasan, R; Xiao, C; Mackey, EDW; Miwa, JM; Lester, HA				Richards, Christopher I.; Srinivasan, Rahul; Xiao, Cheng; Mackey, Elisha D. W.; Miwa, Julie M.; Lester, Henry A.			Trafficking of alpha 4* Nicotinic Receptors Revealed by Superecliptic Phluorinn	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ACETYLCHOLINE-RECEPTORS; PHARMACOLOGICAL CHAPERONE; SUBUNIT STOICHIOMETRY; MIDBRAIN; INHIBITION; EXPRESSION; INSERTION; EXPOSURE; BINDING	We employed a pH-sensitive GFP analog, superecliptic phluorin, to observe aspects of nicotinic acetylcholine receptor (nAChR) trafficking to the plasma membrane (PM) in cultured mouse cortical neurons. The experiments exploit differences in the pH among endoplasmic reticulum (ER), trafficking vesicles, and the extracellular solution. The data confirm that few alpha 4 beta 4 nAChRs, but many alpha 4 beta 2 nAChRs, remain in neutral intracellular compartments, mostly the ER. We observed fusion events between nAChR-containing vesicles and PM; these could be quantified in the dendritic processes. We also studied the beta 4R348C polymorphism, linked to amyotrophic lateral sclerosis (ALS). This mutation depressed fusion rates of alpha 4 beta 4 receptor-containing vesicles with the PM by similar to 2-fold, with only a small decrease in the number of nAChRs per vesicle. The mutation also decreased the number of ER exit sites, showing that the reduced receptor insertion results from a change at an early stage in trafficking. We confirm the previous report that the mutation leads to reduced agonist-induced currents; in the cortical neurons studied, the reduction amounts to 2-3-fold. Therefore, the reduced agonist-induced currents are caused by the reduced number of alpha 4 beta 4-containing vesicles reaching the membrane. Chronic nicotine exposure (0.2 mu M) did not alter the PM insertion frequency or trafficking behavior of alpha 4 beta 4-laden vesicles. In contrast, chronic nicotine substantially increased the number of alpha 4 beta 2-containing vesicle fusions at the PM; this stage in alpha 4 beta 2 nAChR up-regulation is presumably downstream from increased ER exit. Superecliptic phluorin provides a tool to monitor trafficking dynamics of nAChRs in disease and addiction.	[Richards, Christopher I.; Srinivasan, Rahul; Xiao, Cheng; Mackey, Elisha D. W.; Miwa, Julie M.; Lester, Henry A.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Lester, HA (corresponding author), CALTECH, Div Biol, MC 156-29, Pasadena, CA 91125 USA.	lester@caltech.edu	Srinivasan, Rahul/H-3065-2012; Xiao, Cheng/O-5696-2015	Srinivasan, Rahul/0000-0003-0237-6602; Xiao, Cheng/0000-0001-9649-7450; Miwa, Julie/0000-0002-4418-3756	National Institutes of Health [AG033954, DA17279, NS11756]; California Tobacco-related Disease Research Program [19KT-0032]; National Institutes of Health Kirschstein NRSA [DA030877]; Beckman Institute; Tobacco-related Disease Research Program [18FT-0066]; Michael J. Fox Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017279, F32DA030877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Tobacco-related Disease Research Program(University of California System); National Institutes of Health Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Institute; Tobacco-related Disease Research Program(University of California System); Michael J. Fox Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants AG033954, DA17279, and NS11756. This work was also supported by the California Tobacco-related Disease Research Program Grant 19KT-0032 and by a gift from Louis and Janet Fletcher.; Supported by National Institutes of Health Kirschstein NRSA DA030877 and a Beckman Institute fellowship.; Supported by a Tobacco-related Disease Research Program Postdoctoral Fellowship 18FT-0066 and by a Rapid Response grant from the Michael J. Fox Foundation.	Araki Y, 2010, P NATL ACAD SCI USA, V107, P11080, DOI 10.1073/pnas.1006584107; Asokan A, 2002, J PHARM SCI-US, V91, P903, DOI 10.1002/jps.10095; Bueno OF, 1998, MOL BRAIN RES, V59, P165, DOI 10.1016/S0169-328X(98)00129-6; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Cadugan DJ, 2010, BIOPHYS J, V99, P798, DOI 10.1016/j.bpj.2010.05.008; Cheng SB, 2009, J BIOL CHEM, V284, P23251, DOI 10.1074/jbc.M109.017384; Connor JX, 1998, J BIOL CHEM, V273, P28906, DOI 10.1074/jbc.273.44.28906; David-Watine B, 1999, NEUROPHARMACOLOGY, V38, P785, DOI 10.1016/S0028-3908(99)00015-5; Drenan RM, 2008, MOL PHARMACOL, V73, P27, DOI 10.1124/mol.107.039180; Fucile S, 2002, P NATL ACAD SCI USA, V99, P3956, DOI 10.1073/pnas.052699599; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; Graham AJ, 2003, J CHEM NEUROANAT, V25, P97, DOI 10.1016/S0891-0618(02)00100-X; Grailhe R, 2004, EUR J NEUROSCI, V19, P855, DOI 10.1111/j.1460-9568.2004.03153.x; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Jaskolski F, 2009, J BIOL CHEM, V284, P12491, DOI 10.1074/jbc.M808401200; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Khakh BS, 2005, J NEUROSCI, V25, P6911, DOI 10.1523/JNEUROSCI.0561-05.2005; Kittler JT, 2000, MOL CELL NEUROSCI, V16, P440, DOI 10.1006/mcne.2000.0882; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Lester HA, 2009, AAPS J, V11, P167, DOI 10.1208/s12248-009-9090-7; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lin L, 2002, J BIOL CHEM, V277, P41872, DOI 10.1074/jbc.M206857200; Mani M, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.003.2009; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moriconi C, 2011, PFLUG ARCH EUR J PHY, V461, P225, DOI 10.1007/s00424-010-0905-2; Nashmi R, 2003, J NEUROSCI, V23, P11554; Nashmi R, 2007, J NEUROSCI, V27, P8202, DOI 10.1523/JNEUROSCI.2199-07.2007; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Ren XQ, 2005, J NEUROSCI, V25, P6676, DOI 10.1523/JNEUROSCI.1079-05.2005; Ritz B, 2007, ARCH NEUROL-CHICAGO, V64, P990, DOI 10.1001/archneur.64.7.990; Sabatelli M, 2009, HUM MOL GENET, V18, P3997, DOI 10.1093/hmg/ddp339; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Simpson CL, 2006, BBA-MOL BASIS DIS, V1762, P973, DOI 10.1016/j.bbadis.2006.08.001; Son CD, 2009, MOL PHARMACOL, V75, P1137, DOI 10.1124/mol.108.054494; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; Stephens DJ, 2000, J CELL SCI, V113, P2177; Sutedja NA, 2009, AMYOTROPH LATERAL SC, V10, P302, DOI 10.3109/17482960802455416; Thorns J, 2010, EXP NEUROL, V224, P389, DOI 10.1016/j.expneurol.2010.04.014; Wu J, 2004, J PHARMACOL EXP THER, V311, P80, DOI 10.1124/jpet.104.070417; Xiao C, 2009, J NEUROSCI, V29, P12428, DOI 10.1523/JNEUROSCI.2939-09.2009; Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006; Ziemann U, 1997, NEUROLOGY, V49, P1292, DOI 10.1212/WNL.49.5.1292	44	44	45	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31241	31249		10.1074/jbc.M111.256024	http://dx.doi.org/10.1074/jbc.M111.256024			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768117	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000294487500019
J	Bamberger, M; Santos, AM; Goncalves, CM; Oliveira, MI; James, JR; Moreira, A; Lozano, F; Davis, SJ; Carmo, AM				Bamberger, Martina; Santos, Ana Mafalda; Goncalves, Carine M.; Oliveira, Marta I.; James, John R.; Moreira, Alexandra; Lozano, Franscisco; Davis, Simon J.; Carmo, Alexandre M.			A New Pathway of CD5 Glycoprotein-mediated T Cell Inhibition Dependent on Inhibitory Phosphorylation of Fyn Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; PROTEIN-TYROSINE-PHOSPHATASE; TERMINAL SRC KINASE; ANTIGEN RECEPTOR; SIGNAL-TRANSDUCTION; NEGATIVE REGULATION; LIPID RAFTS; B-CELLS; TRANSMEMBRANE ADAPTER; MONOCLONAL-ANTIBODIES	Triggering of the T cell receptor initiates a signaling cascade resulting in the activation of the T cell. These signals are integrated alongside those resulting from the triggering of other receptors whose function is to modulate the overall response. CD5 is an immunotyrosine-based inhibition motif-bearing receptor that antagonizes the overt T cell receptor activation response by recruiting inhibitory intracellular mediators such as SHP-1, RasGAP, or Cbl. We now propose that the inhibitory effects of CD5 are also mediated by a parallel pathway that functions at the level of inhibition of Fyn, a kinase generally associated with T cell receptor-mediated activation. After CD5 ligation, phosphorylation of the negative regulatory tyrosine (Tyr(531)) of Fyn increases, and this correlates with a substantial reduction in the kinase activity of Fyn and a profound inhibition of ZAP-70 activation. The effect requires the last 23 amino acids of the cytoplasmic domain of the receptor, strongly implying the involvement of a new CD5-interacting signaling or adaptor protein. Furthermore, we show that upon CD5 ligation there is a profound shift in its distribution from the bulk fluid phase to the lipid raft environment, where it associates with Fyn, Lck, and PAG. We suggest that the relocation of CD5, which we also show is capable of forming homodimers, to the proximity of raft-resident molecules enables CD5 to inhibit membrane proximal signaling by controlling the phosphorylation and activity of Fyn, possibly by interfering with the disassembly of C-terminal Src kinase (Csk)-PAG-Fyn complexes during T cell activation.	[Bamberger, Martina; Santos, Ana Mafalda; Goncalves, Carine M.; Oliveira, Marta I.; Moreira, Alexandra; Carmo, Alexandre M.] Univ Porto, Inst Biol Mol & Celular, Grp Cell Activat & Gene Express, P-4150180 Oporto, Portugal; [Bamberger, Martina; Santos, Ana Mafalda; Goncalves, Carine M.; Oliveira, Marta I.; Carmo, Alexandre M.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4150180 Oporto, Portugal; [James, John R.; Davis, Simon J.] Univ Oxford, Nuffield Dept Clin Med, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England; [Lozano, Franscisco] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Hosp Clin Barcelona, Dept Immunol, E-08036 Barcelona, Spain; [Lozano, Franscisco] Univ Barcelona, Fac Med, Dept Cell Biol Immunol & Neurosci, Barcelona 08036, Spain	Universidade do Porto; Universidade do Porto; University of Oxford; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona	Carmo, AM (corresponding author), Univ Porto, Inst Biol Mol & Celular, Grp Cell Activat & Gene Express, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	acarmo@ibmc.up.pt	Lozano-Soto, Francisco/AAB-7930-2019; Carmo, Alexandre/B-5191-2011; Moreira, Alexandra/B-4803-2011; LOZANO, FRANCISCO/AAB-7888-2019; James, John R/B-5547-2008; Oliveira, Marta I A/M-9386-2013; James, John/AAP-3607-2021	Lozano-Soto, Francisco/0000-0003-3714-2304; Carmo, Alexandre/0000-0002-2508-9799; Moreira, Alexandra/0000-0001-9853-7575; LOZANO, FRANCISCO/0000-0003-1119-4368; James, John R/0000-0003-1452-7578; Oliveira, Marta I A/0000-0002-0578-9202; James, John/0000-0003-1452-7578; Santos, Ana Mafalda/0000-0002-0015-5286; Goncalves, Carine/0000-0002-4512-6147	European Regional Development Fund (FEDER); Portuguese government [SAU-MII/98041/2008]; Federation of European Biochemical Societies, Boehringer Ingelheim Fonds; American Portuguese Biomedical Research Fund; Fundacao para a Ciencia e a Tecnologia; Wellcome Trust; Spanish Ministry of Education and Science [SAF2007-62193]	European Regional Development Fund (FEDER)(European Commission); Portuguese government(Portuguese Foundation for Science and Technology); Federation of European Biochemical Societies, Boehringer Ingelheim Fonds(Boehringer Ingelheim); American Portuguese Biomedical Research Fund; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Spanish Ministry of Education and Science(Spanish Government)	This work is supported by the European Regional Development Fund (FEDER) through Programa Operacional Factores de Competitividade-COMPETE, and by the Portuguese government through FCT-Fundacao para a Ciencia e a Tecnologia, project SAU-MII/98041/2008. Additional support was from the Federation of European Biochemical Societies, Boehringer Ingelheim Fonds, and the American Portuguese Biomedical Research Fund.; Recipients of studentships from Fundacao para a Ciencia e a Tecnologia.; Funded by the Wellcome Trust.; Supported by Spanish Ministry of Education and Science Grant SAF2007-62193.	ANTIN JH, 1986, J IMMUNOL, V136, P505; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Baumgartner M, 2003, BLOOD, V101, P1874, DOI 10.1182/blood-2002-02-0456; Biancone L, 1996, J EXP MED, V184, P811, DOI 10.1084/jem.184.3.811; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brockdorff J, 1999, EUR J IMMUNOL, V29, P2539, DOI 10.1002/(SICI)1521-4141(199908)29:08<2539::AID-IMMU2539>3.0.CO;2-M; Brossard U, 2003, J IMMUNOL, V170, P4623, DOI 10.4049/jimmunol.170.9.4623; Brown MH, 2010, J IMMUNOL, V185, P6068, DOI 10.4049/jimmunol.0903823; BURGESS KE, 1992, P NATL ACAD SCI USA, V89, P9311, DOI 10.1073/pnas.89.19.9311; Calvo J, 1999, EUR J IMMUNOL, V29, P2119, DOI 10.1002/(SICI)1521-4141(199907)29:07<2119::AID-IMMU2119>3.3.CO;2-6; CARMO AM, 1993, EUR J IMMUNOL, V23, P2196, DOI 10.1002/eji.1830230922; Carmo AM, 1999, J IMMUNOL, V163, P4238; Castro MAA, 2003, J LEUKOCYTE BIOL, V73, P183, DOI 10.1189/jlb.0902437; Castro MAA, 2002, EUR J IMMUNOL, V32, P1509, DOI 10.1002/1521-4141(200205)32:5<1509::AID-IMMU1509>3.0.CO;2-T; CEUPPENS JL, 1986, J IMMUNOL, V137, P1816; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; Dennehy KM, 1998, EUR J IMMUNOL, V28, P1617, DOI 10.1002/(SICI)1521-4141(199805)28:05<1617::AID-IMMU1617>3.0.CO;2-7; Dennehy KM, 1997, EUR J IMMUNOL, V27, P679, DOI 10.1002/eji.1830270316; Dennehy KM, 2001, INT IMMUNOL, V13, P149, DOI 10.1093/intimm/13.2.149; Denny MF, 2000, MOL CELL BIOL, V20, P1426, DOI 10.1128/MCB.20.4.1426-1435.2000; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Fernandes RA, 2010, CELL, V142, P668, DOI 10.1016/j.cell.2010.08.018; Gary-Gouy H, 2000, J BIOL CHEM, V275, P548, DOI 10.1074/jbc.275.1.548; Gary-Gouy H, 2002, J IMMUNOL, V168, P232, DOI 10.4049/jimmunol.168.1.232; Giurisato E, 2003, J BIOL CHEM, V278, P6771, DOI 10.1074/jbc.M210758200; Goncalves CM, 2009, MOL IMMUNOL, V46, P2585, DOI 10.1016/j.molimm.2009.05.006; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; JONES NH, 1986, NATURE, V323, P346, DOI 10.1038/323346a0; JUNE CH, 1987, J IMMUNOL, V138, P2782; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; KUNG PC, 1979, SCIENCE, V206, P347, DOI 10.1126/science.314668; Lozano F, 2000, CRIT REV IMMUNOL, V20, P347; MCFARLAND EDC, 1993, P NATL ACAD SCI USA, V90, P1402, DOI 10.1073/pnas.90.4.1402; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Nunes RJ, 2008, J IMMUNOL, V180, P988, DOI 10.4049/jimmunol.180.2.988; Nunes RJ, 2006, ADV EXP MED BIOL, V584, P127; OKADA M, 1991, J BIOL CHEM, V266, P24249; Pani G, 1996, J EXP MED, V184, P839, DOI 10.1084/jem.184.3.839; Paster W, 2009, J IMMUNOL, V182, P2160, DOI 10.4049/jimmunol.0802639; Pena-Rossi C, 1999, J IMMUNOL, V163, P6494; Perez-Villar JJ, 1999, MOL CELL BIOL, V19, P2903; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; Pospisil R, 2000, LEUKEMIA LYMPHOMA, V36, P353, DOI 10.3109/10428190009148857; RAAB M, 1994, MOL CELL BIOL, V14, P2862, DOI 10.1128/MCB.14.5.2862; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Schade AE, 2002, J IMMUNOL, V168, P2233, DOI 10.4049/jimmunol.168.5.2233; Sen G, 1999, EUR J IMMUNOL, V29, P3319; Simarro M, 1997, J IMMUNOL, V159, P4307; Solheim SA, 2008, J BIOL CHEM, V283, P2773, DOI 10.1074/jbc.M705215200; Takeuchi S, 2000, J BIOL CHEM, V275, P29183, DOI 10.1074/jbc.C000326200; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; THOMAS Y, 1984, J IMMUNOL, V133, P724; Timson, 1992, MOL CELL BIOL, V12, P5438; Torgersen KM, 2001, J BIOL CHEM, V276, P29313, DOI 10.1074/jbc.C100014200; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VAN DE VELDE H, 1991, NATURE, V351, P662; VEILLETTE A, 1990, ONCOGENE, V5, P1455; Vila JM, 2001, EUR J IMMUNOL, V31, P1191, DOI 10.1002/1521-4141(200104)31:4<1191::AID-IMMU1191>3.3.CO;2-8; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yasuda K, 2002, J IMMUNOL, V169, P2813, DOI 10.4049/jimmunol.169.6.2813; Zikherman J, 2010, IMMUNITY, V32, P342, DOI 10.1016/j.immuni.2010.03.006	67	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30324	30336		10.1074/jbc.M111.230102	http://dx.doi.org/10.1074/jbc.M111.230102			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757751	Green Published, hybrid			2022-12-25	WOS:000294283600010
J	Waardenberg, AJ; Bernardo, BC; Ng, DCH; Shepherd, PR; Cemerlang, N; Sbroggio, M; Wells, CA; Dalrymple, BP; Brancaccio, M; Lin, RCY; McMullen, JR				Waardenberg, Ashley J.; Bernardo, Bianca C.; Ng, Dominic C. H.; Shepherd, Peter R.; Cemerlang, Nelly; Sbroggio, Mauro; Wells, Christine A.; Dalrymple, Brian P.; Brancaccio, Mara; Lin, Ruby C. Y.; McMullen, Julie R.			Phosphoinositide 3-Kinase (PI3K(p110 alpha)) Directly Regulates Key Components of the Z-disc and Cardiac Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DILATED CARDIOMYOPATHY; SEVERE FORM; MUSCLE; EXPRESSION; PROTEIN; MELUSIN; FAMILY; GROWTH; P110-ALPHA; INSULIN-LIKE-GROWTH-FACTOR-1	Maintenance of cardiac structure and Z-disc signaling are key factors responsible for protecting the heart in a setting of stress, but how these processes are regulated is not well defined. We recently demonstrated that PI3K(p110 alpha) protects the heart against myocardial infarction. The aim of this study was to determine whether PI3K(p110 alpha) directly regulates components of the Z-disc and cardiac structure. To address this question, a unique three-dimensional virtual muscle model was applied to gene expression data from transgenic mice with increased or decreased PI3K(p110 alpha) activity under basal conditions (sham) and in a setting of myocardial infarction to display the location of structural proteins. Key findings from this analysis were then validated experimentally. The three-dimensional virtual muscle model visually highlighted reciprocally regulated transcripts associated with PI3K activation that encoded key components of the Z-disc and costamere, including melusin. Studies were performed to assess whether PI3K and melusin interact in the heart. Here, we identify a novel melusin-PI3K interaction that generates lipid kinase activity. The direct impact of PI3K(p110 alpha) on myocyte structure was assessed by treating neonatal rat ventricular myocytes with PI3K(p110 alpha) inhibitors and examining the myofiber morphology of hearts from PI3K transgenic mice. Results demonstrate that PI3K is critical for myofiber maturation and Z-disc alignment. In summary, PI3K regulates the expression of genes essential for cardiac structure and Z-disc signaling, interacts with melusin, and is critical for Z-disc alignment.	[Bernardo, Bianca C.; Cemerlang, Nelly; McMullen, Julie R.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 8008, Australia; [Waardenberg, Ashley J.; Wells, Christine A.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Waardenberg, Ashley J.; Dalrymple, Brian P.] CSIRO, Food Futures Flagship, Queensland Biosci Precinct, St Lucia, Qld 4067, Australia; [Ng, Dominic C. H.] Univ Melbourne, Dept Biochem & Mol Biol, Inst Bio21, Melbourne, Vic 3010, Australia; [Shepherd, Peter R.] Univ Auckland, Dept Mol Med, Auckland 1142, New Zealand; [Shepherd, Peter R.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand; [Sbroggio, Mauro; Brancaccio, Mara] Univ Turin, Dept Genet Biol & Biochem, Ctr Mol Biotechnol, I-10126 Turin, Italy; [Wells, Christine A.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia; [Lin, Ruby C. Y.] Univ New S Wales, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia; [Lin, Ruby C. Y.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	Baker Heart and Diabetes Institute; Griffith University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Melbourne; University of Auckland; University of Auckland; University of Turin; University of Queensland; University of New South Wales Sydney; University of New South Wales Sydney	McMullen, JR (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic 8008, Australia.	julie.mcmullen@bakeridi.edu.au	Lin, Ruby CY/A-1636-2009; Ng, Dominic/C-7291-2015; Dalrymple, Brian P/F-8721-2010; Waardenberg, Ashley/D-2595-2012; Wells, Christine A/A-5071-2010	Lin, Ruby CY/0000-0003-4163-511X; Ng, Dominic/0000-0003-4657-159X; Dalrymple, Brian P/0000-0003-3891-5233; Wells, Christine A/0000-0003-3133-3628; Sbroggio, Mauro/0000-0002-8266-661X; Bernardo, Bianca Christine/0000-0002-4534-0549; Waardenberg, Ashley/0000-0002-9382-7490	Griffith University; Commonwealth Scientific and Industrial Research Organisation Food Futures National Research Flagship; National Health and Medical Research Council (NHMRC) [367600, 586604, 351012]; Victorian Government; Australian Research Council [FT0001657]; University of New South Wales; University of Melbourne	Griffith University(Griffith University); Commonwealth Scientific and Industrial Research Organisation Food Futures National Research Flagship; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government; Australian Research Council(Australian Research Council); University of New South Wales; University of Melbourne(University of Melbourne)	This work was supported by postgraduate scholarships from Griffith University and the Commonwealth Scientific and Industrial Research Organisation Food Futures National Research Flagship (to A.J.W.) and by National Health and Medical Research Council (NHMRC) Project Grant 367600 (to J.R.M.). This work was supported in part by the Victorian Government Operational Infrastructure Support Program. This work was also supported by Australian Research Council Future Fellowship FT0001657 (to J.R.M.), Honorary NHMRC Senior Research Fellowship 586604 (to J.R.M.), NHMRC Peter Doherty Fellowship 351012 (to R.C.Y.L.), University of New South Wales Vice Chancellor Research Fellowship (to R.C.Y.L.), and by an University of Melbourne Roper fellowship (to D.C.H.N.).	Barash IA, 2007, AM J PHYSIOL-CELL PH, V293, pC218, DOI 10.1152/ajpcell.00055.2007; BARNARD GA, 1947, BIOMETRIKA, V34, P123, DOI 10.2307/2332517; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Brancaccio M, 1999, J BIOL CHEM, V274, P29282, DOI 10.1074/jbc.274.41.29282; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Cheng H, 2010, CIRC RES, V106, P21, DOI 10.1161/CIRCRESAHA.109.206920; De Acetis M, 2005, CIRC RES, V96, P1087, DOI 10.1161/01.RES.0000168028.36081.e0; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; ITO H, 1993, CIRCULATION, V87, P1715, DOI 10.1161/01.CIR.87.5.1715; Jamieson S, 2011, BIOCHEM J, V438, P53, DOI 10.1042/BJ20110502; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin RCY, 2010, ARTERIOSCL THROM VAS, V30, P724, DOI 10.1161/ATVBAHA.109.201988; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; McMullen JR, 2008, CLIN EXP PHARMACOL P, V35, P349, DOI 10.1111/j.1440-1681.2007.04873.x; McMullen JR, 2007, CELL CYCLE, V6, P910, DOI 10.4161/cc.6.8.4124; McMullen JR, 2007, P NATL ACAD SCI USA, V104, P612, DOI 10.1073/pnas.0606663104; Michele DE, 2009, CIRC RES, V105, P984, DOI 10.1161/CIRCRESAHA.109.199489; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Murray JT, 2004, BIOCHEM J, V384, P489, DOI 10.1042/BJ20041058; Ng DCH, 2008, CELL MOTIL CYTOSKEL, V65, P40, DOI 10.1002/cm.20242; Ng DCH, 2011, J BIOL CHEM, V286, P1576, DOI 10.1074/jbc.M110.128157; Nishiyama A, 1998, CARDIOVASC RES, V40, P343, DOI 10.1016/S0008-6363(98)00135-7; Pretorius L, 2009, AM J PATHOL, V175, P998, DOI 10.2353/ajpath.2009.090126; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; Sbroggio M, 2008, FEBS LETT, V582, P1788, DOI 10.1016/j.febslet.2008.04.058; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Shyu KG, 2005, CARDIOVASC RES, V68, P405, DOI 10.1016/j.cardiores.2005.06.028; Sun MH, 2010, P NATL ACAD SCI USA, V107, P15547, DOI 10.1073/pnas.1009652107; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Waardenberg AJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-88; Zheng M, 2009, HUM MOL GENET, V18, P701, DOI 10.1093/hmg/ddn400; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	37	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30837	30846		10.1074/jbc.M111.271684	http://dx.doi.org/10.1074/jbc.M111.271684			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757757	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000294283600063
J	Yang, CT; Yang, ZL; Zhang, MF; Dong, Q; Wang, XY; Lan, AP; Zeng, FQ; Chen, PX; Wang, CH; Feng, JQ				Yang, Chuntao; Yang, Zhanli; Zhang, Meifen; Dong, Qi; Wang, Xiuyu; Lan, Aiping; Zeng, Fanqin; Chen, Peixi; Wang, Chuhuai; Feng, Jianqiang			Hydrogen Sulfide Protects against Chemical Hypoxia-Induced Cytotoxicity and Inflammation in HaCaT Cells through Inhibition of ROS/NF-kappa B/COX-2 Pathway	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; NF-KAPPA-B; HUMAN ENDOTHELIAL-CELLS; PC12 CELLS; OXIDATIVE STRESS; INDUCIBLE FACTOR; HEME PROTEIN; EXPRESSION; OXYGEN; ACTIVATION	Hydrogen sulfide (H(2)S) has been shown to protect against oxidative stress injury and inflammation in various hypoxia-induced insult models. However, it remains unknown whether H(2)S protects human skin keratinocytes (HaCaT cells) against chemical hypoxia-induced damage. In the current study, HaCaT cells were treated with cobalt chloride (CoCl(2)), a well known hypoxia mimetic agent, to establish a chemical hypoxia-induced cell injury model. Our findings showed that pretreatment of HaCaT cells with NaHS (a donor of H(2)S) for 30 min before exposure to CoCl(2) for 24 h significantly attenuated CoCl(2)-induced injuries and inflammatory responses, evidenced by increases in cell viability and GSH level and decreases in ROS generation and secretions of IL-1 beta, IL-6 and IL-8. In addition, pretreatment with NaHS markedly reduced CoCl(2)-induced COX-2 overexpression and PGE(2) secretion as well as intranuclear NF-kappa B p65 subunit accumulation (the central step of NF-kappa B activation). Similar to the protective effect of H(2)S, both NS-398 (a selective COX-2 inhibitor) and PDTC (a selective NF-kappa B inhibitor) depressed not only CoCl(2)-induced cytotoxicity, but also the secretions of IL-1 beta, IL-6 and IL-8. Importantly, PDTC obviously attenuated overexpression of COX-2 induced by CoCl(2). Notably, NAC, a ROS scavenger, conferred a similar protective effect of H(2)S against CoCl(2)-induced insults and inflammatory responses. Taken together, the findings of the present study have demonstrated for the first time that H(2)S protects HaCaT cells against CoCl(2)-induced injuries and inflammatory responses through inhibition of ROS-activated NF-kappa B/COX-2 pathway.	[Yang, Chuntao; Yang, Zhanli; Wang, Xiuyu; Lan, Aiping; Chen, Peixi; Feng, Jianqiang] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Physiol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Meifen] Sun Yat Sen Univ, Sch Nursing, Guangzhou 510275, Guangdong, Peoples R China; [Dong, Qi] Guangzhou Med Coll, Dept Physiol, Guangzhou, Guangdong, Peoples R China; [Zeng, Fanqin] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Chuhuai] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Rehabil, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University	Yang, CT (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Physiol, Guangzhou 510275, Guangdong, Peoples R China.	rehab@163.com; fengjq-sums@163.com	Yang, Zhan/GQG-9995-2022; wang, chu/GYJ-2191-2022; lan, A/HHZ-6588-2022; Yang, Chuntao/AAF-7687-2019	Yang, Chuntao/0000-0002-5640-0930; Wang, Chu-huai/0000-0002-8071-9298	Science and Technology Planning Project of Guangdong Province in China [2010B080701035, 2008B080703053]	Science and Technology Planning Project of Guangdong Province in China	This work was supported by Science and Technology Planning Project of Guangdong Province in China (2010B080701035, 2008B080703053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El-Aleem SA, 2001, J PATHOL, V195, P616, DOI 10.1002/path.992; Altenburger R, 1999, PHARMACEUT RES, V16, P766, DOI 10.1023/A:1011945212831; Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138; Bian JS, 2006, J PHARMACOL EXP THER, V316, P670, DOI 10.1124/jpet.105.092023; Birnbaum Y, 2005, CARDIOVASC RES, V65, P345, DOI 10.1016/j.cardiores.2004.10.018; Bolajoko EB, 2008, SAMJ S AFR MED J, V98, P614; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Calvert JW, 2010, ANTIOXID REDOX SIGN, V12, P1203, DOI 10.1089/ars.2009.2882; Chen SL, 2010, CLIN EXP PHARMACOL P, V37, P316, DOI 10.1111/j.1440-1681.2009.05289.x; Chi YS, 2005, PROSTAG LEUKOTR ESS, V72, P59, DOI 10.1016/j.plefa.2004.04.009; Fiorucci S, 2005, HEPATOLOGY, V42, P539, DOI 10.1002/hep.20817; Floreani M, 1997, FREE RADICAL RES, V26, P449, DOI 10.3109/10715769709084481; Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094; Gobbi G, 2009, LAB INVEST, V89, P994, DOI 10.1038/labinvest.2009.61; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Gordillo GM, 2003, AM J SURG, V186, P259, DOI 10.1016/S0002-9610(03)00211-3; Henderson PW, 2010, J SURG RES, V159, P451, DOI 10.1016/j.jss.2009.05.010; Houwing R, 2000, J Wound Care, V9, P36; Hu LF, 2008, PFLUG ARCH EUR J PHY, V455, P971, DOI 10.1007/s00424-007-0346-8; Hu LF, 2007, J NEUROCHEM, V100, P1121, DOI 10.1111/j.1471-4159.2006.04283.x; Huang CY, 2001, J CEREBR BLOOD F MET, V21, P163, DOI 10.1097/00004647-200102000-00008; Huber Jacqueline, 2008, Adv Skin Wound Care, V21, P37, DOI 10.1097/01.ASW.0000284968.07982.26; Jeong HJ, 2005, HEARING RES, V207, P59, DOI 10.1016/j.heares.2005.04.003; Jha S, 2008, AM J PHYSIOL-HEART C, V295, pH801, DOI 10.1152/ajpheart.00377.2008; Jung JY, 2007, LIFE SCI, V80, P1355, DOI 10.1016/j.lfs.2006.11.033; Kang YJ, 2006, J IMMUNOL, V177, P8111, DOI 10.4049/jimmunol.177.11.8111; Kim KS, 2006, J IMMUNOL, V177, P7211, DOI 10.4049/jimmunol.177.10.7211; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kloesch B, 2010, CELL BIOL INT, V34, P477, DOI 10.1042/CBI20090436; Lazarides M K, 2007, Int J Low Extrem Wounds, V6, P254, DOI 10.1177/1534734607306878; Li B, 2009, J SURG RES, V157, P43, DOI 10.1016/j.jss.2008.12.020; Li L, 2009, FREE RADICAL BIO MED, V47, P103, DOI 10.1016/j.freeradbiomed.2009.04.014; Lu M, 2008, FREE RADICAL BIO MED, V45, P1705, DOI 10.1016/j.freeradbiomed.2008.09.014; Meng JL, 2011, CLIN EXP PHARMACOL P, V38, P42, DOI 10.1111/j.1440-1681.2010.05462.x; Montopoli M, 2007, PLANTA MED, V73, P285, DOI 10.1055/s-2007-967118; Mustoe TA, 2006, PLAST RECONSTR SURG, V117, p35S, DOI 10.1097/01.prs.0000225431.63010.1b; Pae HO, 2009, ARCH PHARM RES, V32, P1155, DOI 10.1007/s12272-009-1806-9; Pieper GM, 2001, ANTIOXID REDOX SIGN, V3, P81, DOI 10.1089/152308601750100542; Sener G, 2006, INT IMMUNOPHARMACOL, V6, P724, DOI 10.1016/j.intimp.2005.10.010; Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408; SWAROOP M, 1992, J BIOL CHEM, V267, P11455; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; Tripatara P, 2009, EUR J PHARMACOL, V606, P205, DOI 10.1016/j.ejphar.2009.01.041; Tsutakawa S, 2009, BRIT J DERMATOL, V161, P1020, DOI 10.1111/j.1365-2133.2009.09349.x; Wagner M, 1997, PATHOBIOLOGY, V65, P241, DOI 10.1159/000164135; Wallace JL, 2010, ANTIOXID REDOX SIGN, V12, P1125, DOI 10.1089/ars.2009.2900; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Whiteman M, 2010, ANTIOXID REDOX SIGN, V12, P1147, DOI 10.1089/ars.2009.2899; Yang CT, 2011, MOL CELLS, V31, P531, DOI 10.1007/s10059-011-1025-3; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zhang HL, 2008, J IMMUNOL, V181, P4320, DOI 10.4049/jimmunol.181.6.4320; Zou WG, 2001, J NEUROSCI RES, V64, P646, DOI 10.1002/jnr.1118	52	91	96	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21971	10.1371/journal.pone.0021971	http://dx.doi.org/10.1371/journal.pone.0021971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779360	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811300031
J	Crooks, KR; Allingham, RR; Qin, XJ; Liu, YT; Gibson, JR; Santiago-Turla, C; Larocque-Abramson, KR; Del Bono, E; Challa, P; Herndon, LW; Akafo, S; Wiggs, JL; Schmidt, S; Hauser, MA				Crooks, Kristy R.; Allingham, R. Rand; Qin, Xuejun; Liu, Yutao; Gibson, Jason R.; Santiago-Turla, Cecilia; Larocque-Abramson, Karen R.; Del Bono, Elizabeth; Challa, Pratap; Herndon, Leon W.; Akafo, Stephen; Wiggs, Janey L.; Schmidt, Silke; Hauser, Michael A.			Genome-Wide Linkage Scan for Primary Open Angle Glaucoma: Influences of Ancestry and Age at Diagnosis	PLOS ONE			English	Article							ORDERED SUBSET ANALYSIS; GENETIC-LINKAGE; LOCUS; MAPS; REGION; IDENTIFICATION; DISEQUILIBRIUM; LOCALIZATION; MUTATIONS	Primary open-angle glaucoma (POAG) is the most common form of glaucoma and one of the leading causes of vision loss worldwide. The genetic etiology of POAG is complex and poorly understood. The purpose of this work is to identify genomic regions of interest linked to POAG. This study is the largest genetic linkage study of POAG performed to date: genomic DNA samples from 786 subjects (538 Caucasian ancestry, 248 African ancestry) were genotyped using either the Illumina GoldenGate Linkage 4 Panel or the Illumina Infinium Human Linkage-12 Panel. A total of 5233 SNPs was analyzed in 134 multiplex POAG families (89 Caucasian ancestry, 45 African ancestry). Parametric and non-parametric linkage analyses were performed on the overall dataset and within race-specific datasets (Caucasian ancestry and African ancestry). Ordered subset analysis was used to stratify the data on the basis of age of glaucoma diagnosis. Novel linkage regions were identified on chromosomes 1 and 20, and two previously described loci-GLC1D on chromosome 8 and GLC1I on chromosome 15-were replicated. These data will prove valuable in the context of interpreting results from genome-wide association studies for POAG.	[Crooks, Kristy R.; Allingham, R. Rand; Qin, Xuejun; Liu, Yutao; Gibson, Jason R.; Larocque-Abramson, Karen R.; Schmidt, Silke; Hauser, Michael A.] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; [Allingham, R. Rand; Santiago-Turla, Cecilia; Challa, Pratap; Herndon, Leon W.; Hauser, Michael A.] Duke Univ, Med Ctr, Dept Ophthalmol, Ctr Eye, Durham, NC 27710 USA; [Del Bono, Elizabeth; Wiggs, Janey L.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Del Bono, Elizabeth; Wiggs, Janey L.] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [Akafo, Stephen] Univ Ghana, Sch Med, Dept Surg, Unit Ophthalmol, Accra, Ghana	Duke University; Duke University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; University of Ghana	Crooks, KR (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA.	mike.hauser@duke.edu			NCRR/NIH [1 UL1 RR024128-01]; NIH [R01EY013315, R01EY019126, RO1EY015543, R01EY015872, P30EY014104]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013315, R01EY015872, R01EY015543, P30EY014104, R01EY019126] Funding Source: NIH RePORTER	NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported in part by a generous donation by Roger Milliken, Spartanburg, South Carolina and by the research infrastructure of the Duke Center for Human Genetics. This work was also supported by CTSA grant 1 UL1 RR024128-01 from NCRR/NIH, NIH grants R01EY013315 (MAH), R01EY019126 (MAH), RO1EY015543 (RRA), R01EY015872 (JLW), and P30EY014104 (Core support at the Massachusetts Eye and Ear Infirmary).	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Allingham RR, 2005, INVEST OPHTH VIS SCI, V46, P2002, DOI 10.1167/iovs.04-1477; Alward WLM, 1998, NEW ENGL J MED, V338, P1022, DOI 10.1056/NEJM199804093381503; Baird PN, 2005, HUM GENET, V117, P249, DOI 10.1007/s00439-005-1296-x; Boyles AL, 2005, HUM HERED, V59, P220, DOI 10.1159/000087122; Broman KW, 2001, GENET EPIDEMIOL, V20, P307, DOI 10.1002/gepi.2; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Hauser ER, 2004, GENET EPIDEMIOL, V27, P53, DOI 10.1002/gepi.20000; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; Lin Y, 2008, MOL VIS, V14, P739; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pang CP, 2006, MOL VIS, V12, P85; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Sarfarazi M, 1998, AM J HUM GENET, V62, P641, DOI 10.1086/301767; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; Stoilova D, 1996, GENOMICS, V36, P142, DOI 10.1006/geno.1996.0434; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Sud A, 2008, MOL VIS, V14, P1319; Suriyapperuma SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P86, DOI 10.1001/archopht.125.1.86; Trifan OC, 1998, AM J OPHTHALMOL, V126, P17, DOI 10.1016/S0002-9394(98)00073-7; Wang DY, 2006, INVEST OPHTH VIS SCI, V47, P5315, DOI 10.1167/iovs.06-0179; Wiggs JL, 2004, AM J HUM GENET, V74, P1314, DOI 10.1086/421533; Wirtz MK, 1997, AM J HUM GENET, V60, P296; Wirtz MK, 1999, ARCH OPHTHALMOL-CHIC, V117, P237; Woodroffe A, 2006, EXP EYE RES, V82, P1068, DOI 10.1016/j.exer.2005.10.008	31	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21967	10.1371/journal.pone.0021967	http://dx.doi.org/10.1371/journal.pone.0021967			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765929	Green Published, gold, Green Submitted			2022-12-25	WOS:000292699000017
J	Azevedo, AS; Yamamura, AMY; Freire, MS; Trindade, GF; Bonaldo, M; Galler, R; Alves, AMB				Azevedo, Adriana S.; Yamamura, Anna M. Y.; Freire, Marcos S.; Trindade, Gisela F.; Bonaldo, Myrna; Galler, Ricardo; Alves, Ada M. B.			DNA Vaccines against Dengue Virus Type 2 Based on Truncate Envelope Protein or Its Domain III	PLOS ONE			English	Article							NEUTRALIZING ANTIBODY-RESPONSE; JAPANESE ENCEPHALITIS; PROTECTIVE IMMUNITY; SIGNAL SEQUENCES; NS1 GENE; T-CELLS; MICE; CHALLENGE; IMMUNIZATION; FLAVIVIRUS	Two DNA vaccines were constructed encoding the ectodomain (domains I, II and III) of the DENV2 envelope protein (pE1D2) or only its domain III (pE2D2), fused to the human tissue plasminogen activator signal peptide (t-PA). The expression and secretion of recombinant proteins was confirmed in vitro in BHK cells transfected with the two plasmids, detected by immunofluorescence or immunoprecipitation of metabolically labeled gene products, using polyclonal and monoclonal antibodies against DENV2. Besides, results reveal that the ectodomain of the E protein can be efficiently expressed in vivo, in a mammalian system, without the prM protein that is hypothesized to act as a chaperonin during dengue infection. Balb/c mice were immunized with the DNA vaccines and challenged with a lethal dose of DENV2. All pE1D2-vaccinated mice survived challenge, while 45% of animals immunized with the pE2D2 died after infection. Furthermore, only 10% of pE1D2-immunized mice presented some clinical signs of infection after challenge, whereas most of animals inoculated with the pE2D2 showed effects of the disease with high morbidity degrees. Levels of neutralizing antibodies were significantly higher in pE1D2-vaccinated mice than in pE2D2-immunized animals, also suggesting that the pE1D2 vaccine was more protective than the pE2D2.	[Azevedo, Adriana S.; Alves, Ada M. B.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil; [Yamamura, Anna M. Y.; Freire, Marcos S.; Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Lab Tecnol Virol, Rio De Janeiro, Brazil; [Trindade, Gisela F.; Bonaldo, Myrna] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Alves, AMB (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil.	ada@ioc.fiocruz.br	Bonaldo, Myrna/AAE-2799-2021; Bonaldo, Myrna C/D-9494-2013; Galler, Ricardo/B-3280-2014	Souza Azevedo, Adriana/0000-0001-7401-5107; Trindade, Gisela/0000-0002-1630-4143	PDTIS-FIOCRUZ; IOC-FIOCRUZ; FAPERJ; CNPq; CNPq-PRONEX	PDTIS-FIOCRUZ; IOC-FIOCRUZ; FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq-PRONEX(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by PDTIS-FIOCRUZ, IOC-FIOCRUZ, FAPERJ, CNPq and CNPq-PRONEX grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999; Ashok MS, 2002, VACCINE, V20, P1563, DOI 10.1016/S0264-410X(01)00492-3; BONALDO MC, 2007, J VIROL, V30, P115; Boyle JS, 1997, INT IMMUNOL, V9, P1897, DOI 10.1093/intimm/9.12.1897; Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8; Chambers TJ, 2003, J VIROL, V77, P3655, DOI 10.1128/JVI.77.6.3655-3668.2003; Chang GJJ, 2000, J VIROL, V74, P4244, DOI 10.1128/JVI.74.9.4244-4252.2000; Chang GJJ, 2001, ANN NY ACAD SCI, V951, P272; Chen L, 2007, J VIROL, V81, P11634, DOI 10.1128/JVI.00996-07; Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022; COELHO GE, 2010, SECRETARIA VIGILANCI; Colombage G, 1998, VIROLOGY, V250, P151, DOI 10.1006/viro.1998.9357; Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052; Costa SM, 2006, VACCINE, V24, P4562, DOI 10.1016/j.vaccine.2005.08.022; Costa SM, 2006, VACCINE, V24, P195, DOI 10.1016/j.vaccine.2005.07.059; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; De Paula SO, 2008, ARCH VIROL, V153, P2215, DOI 10.1007/s00705-008-0250-3; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Edelman R, 2005, J INFECT DIS, V191, P650, DOI 10.1086/427784; Edelman R, 2007, CLIN INFECT DIS, V45, pS56, DOI 10.1086/518148; ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; Inchauspe G, 1997, DNA CELL BIOL, V16, P185, DOI 10.1089/dna.1997.16.185; IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7; Jaiswal S, 2004, PROTEIN EXPRES PURIF, V33, P80, DOI 10.1016/j.pep.2003.09.009; Jimenez RO, 2000, VACCINE, V19, P648, DOI 10.1016/S0264-410X(00)00247-4; Kinney RM, 2001, INTERVIROLOGY, V44, P176, DOI 10.1159/000050045; Kochel T, 1997, VACCINE, V15, P547, DOI 10.1016/S0264-410X(97)00215-6; Kochel TJ, 2000, VACCINE, V18, P3166, DOI 10.1016/S0264-410X(00)00105-5; Konishi E, 1999, J VIROL, V73, P5527, DOI 10.1128/JVI.73.7.5527-5534.1999; Konishi E, 2000, VACCINE, V18, P1133, DOI 10.1016/S0264-410X(99)00376-X; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; KURANE I, 1990, ARCH VIROL, V110, P91, DOI 10.1007/BF01310705; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Lu Y, 2003, VACCINE, V21, P2178, DOI 10.1016/S0264-410X(03)00009-4; Miller N, 2010, CURR OPIN MOL THER, V12, P31; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; MONATH TP, 1997, CLIN VIROLOGY, P1133; Mota J, 2005, VACCINE, V23, P3469, DOI 10.1016/j.vaccine.2004.12.028; Phillpotts RJ, 1996, ARCH VIROL, V141, P743, DOI 10.1007/BF01718332; Porter KR, 1998, ARCH VIROL, V143, P997, DOI 10.1007/s007050050348; Putnak R, 2003, AM J TROP MED HYG, V68, P469, DOI 10.4269/ajtmh.2003.68.469; Ramanathan MP, 2009, VACCINE, V27, P6444, DOI 10.1016/j.vaccine.2009.06.061; Raviprakash K, 2000, VACCINE, V18, P2426, DOI 10.1016/S0264-410X(99)00570-8; Raviprakash K, 2000, J GEN VIROL, V81, P1659, DOI 10.1099/0022-1317-81-7-1659; Raviprakash K, 2001, VIROLOGY, V290, P74, DOI 10.1006/viro.2001.1136; Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009; Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200; Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823; Simmons M, 2001, AM J TROP MED HYG, V65, P420, DOI 10.4269/ajtmh.2001.65.420; Stefano I, 1999, VACCINE, V17, P1042, DOI 10.1016/S0264-410X(98)00320-X; Suksanpaisan L, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-17; Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002; Valdes I, 2009, VIROLOGY, V394, P249, DOI 10.1016/j.virol.2009.08.029; Van Der Most RG, 2000, J VIROL, V74, P8094, DOI 10.1128/JVI.74.17.8094-8101.2000; van der Most RG, 2003, INT IMMUNOL, V15, P119, DOI 10.1093/intimm/dxg009; Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709	62	35	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e20528	10.1371/journal.pone.0020528	http://dx.doi.org/10.1371/journal.pone.0020528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779317	Green Submitted, Green Published, gold			2022-12-25	WOS:000292680900001
J	Dudley, KJ; Sloboda, DM; Connor, KL; Beltrand, J; Vickers, MH				Dudley, Kevin J.; Sloboda, Deborah M.; Connor, Kristin L.; Beltrand, Jacques; Vickers, Mark H.			Offspring of Mothers Fed a High Fat Diet Display Hepatic Cell Cycle Inhibition and Associated Changes in Gene Expression and DNA Methylation	PLOS ONE			English	Article							HEPATOCYTE PROLIFERATION; MATERNAL OBESITY; LIVER-DISEASE; FETAL-RAT; MICE; P21; HYPERMETHYLATION; REGENERATION; EPIGENETICS; PROMOTER	The association between an adverse early life environment and increased susceptibility to later-life metabolic disorders such as obesity, type 2 diabetes and cardiovascular disease is described by the developmental origins of health and disease hypothesis. Employing a rat model of maternal high fat (MHF) nutrition, we recently reported that offspring born to MHF mothers are small at birth and develop a postnatal phenotype that closely resembles that of the human metabolic syndrome. Livers of offspring born to MHF mothers also display a fatty phenotype reflecting hepatic steatosis and characteristics of non-alcoholic fatty liver disease. In the present study we hypothesised that a MHF diet leads to altered regulation of liver development in offspring; a derangement that may be detectable during early postnatal life. Livers were collected at postnatal days 2 (P2) and 27 (P27) from male offspring of control and MHF mothers (n = 8 per group). Cell cycle dynamics, measured by flow cytometry, revealed significant G0/G1 arrest in the livers of P2 offspring born to MHF mothers, associated with an increased expression of the hepatic cell cycle inhibitor Cdkn1a. In P2 livers, Cdkn1a was hypomethylated at specific CpG dinucleotides and first exon in offspring of MHF mothers and was shown to correlate with a demonstrable increase in mRNA expression levels. These modifications at P2 preceded observable reductions in liver weight and liver: brain weight ratio at P27, but there were no persistent changes in cell cycle dynamics or DNA methylation in MHF offspring at this time. Since Cdkn1a up-regulation has been associated with hepatocyte growth in pathologic states, our data may be suggestive of early hepatic dysfunction in neonates born to high fat fed mothers. It is likely that these offspring are predisposed to long-term hepatic dysfunction.	[Dudley, Kevin J.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; Univ Auckland, Natl Res Ctr Growth & Dev, Auckland 1, New Zealand	University of Auckland; University of Auckland	Dudley, KJ (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	m.vickers@auckland.ac.nz	beltrand, jacques/AAV-6455-2021	beltrand, jacques/0000-0002-3759-3490; Vickers, Mark/0000-0003-4876-9356; Dudley, Kevin/0000-0001-5762-1068	National Research Centre for Growth and Development; Health Research Council of New Zealand	National Research Centre for Growth and Development; Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was funded by the the National Research Centre for Growth and Development and the Health Research Council of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan LA, 2000, MOL CELL BIOL, V20, P1291, DOI 10.1128/MCB.20.4.1291-1298.2000; Belkacemi L, 2011, J MATERN-FETAL NEO M, V24, P752, DOI 10.3109/14767058.2010.521870; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Campion J, 2009, OBES REV, V10, P383, DOI 10.1111/j.1467-789X.2009.00595.x; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; Child ES, 2006, CELL CYCLE, V5, P1313, DOI 10.4161/cc.5.12.2863; Crary GS, 1998, HEPATOLOGY, V28, P738, DOI 10.1002/hep.510280320; CURRAN TR, 1993, EXP CELL RES, V209, P53, DOI 10.1006/excr.1993.1284; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fu Q, 2009, FASEB J, V23, P2438, DOI 10.1096/fj.08-124768; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Ghouri N, 2010, HEPATOLOGY, V52, P1156, DOI 10.1002/hep.23789; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; GREENGARD O, 1972, J CELL BIOL, V52, P261, DOI 10.1083/jcb.52.2.261; Grigoriu A, 2011, EPIGENETICS-US, V6, P368, DOI 10.4161/epi.6.3.14196; Gruppuso PA, 1997, IN VITRO CELL DEV-AN, V33, P562; Gruppuso PA, 2005, PEDIATR RES, V57, P185, DOI 10.1203/01.PDR.0000151646.55587.0F; Hale TK, 1999, J BIOL CHEM, V274, P23777, DOI 10.1074/jbc.274.34.23777; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Joulie M, 2010, BIOESSAYS, V32, P1025, DOI 10.1002/bies.201000057; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Lindroth AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000145; Mark PJ, 2011, J DEV ORIG HLTH DIS, V2, P63, DOI 10.1017/S2040174410000681; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042; Ozanne SE, 2007, NAT CLIN PRACT ENDOC, V3, P539, DOI 10.1038/ncpendmet0531; Roman-Gomez J, 2002, BLOOD, V99, P2291, DOI 10.1182/blood.V99.7.2291; Savage DB, 2010, CURR OPIN LIPIDOL, V21, P329, DOI 10.1097/MOL.0b013e32833b7782; Sloboda DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006744; Turner BM, 2009, PHILOS T R SOC B, V364, P3403, DOI 10.1098/rstb.2009.0125; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Woodall SM, 1996, J ENDOCRINOL, V150, P231, DOI 10.1677/joe.0.1500231; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245; Yuan Joshua S., 2008, Biotechnology Journal, V3, P112, DOI 10.1002/biot.200700169; Zellmer S, 2010, HEPATOLOGY, V52, P2127, DOI 10.1002/hep.23930; Zhang CS, 2008, INT J CANCER, V123, P998, DOI 10.1002/ijc.23650	39	119	129	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21662	10.1371/journal.pone.0021662	http://dx.doi.org/10.1371/journal.pone.0021662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779332	Green Submitted, gold, Green Published			2022-12-25	WOS:000292680900010
J	Sparks, LM; Moro, C; Ukropcova, B; Bajpeyi, S; Civitarese, AE; Hulver, MW; Thoresen, GH; Rustan, AC; Smith, SR				Sparks, Lauren M.; Moro, Cedric; Ukropcova, Barbara; Bajpeyi, Sudip; Civitarese, Anthony E.; Hulver, Matthew W.; Thoresen, G. Hege; Rustan, Arild C.; Smith, Steven R.			Remodeling Lipid Metabolism and Improving Insulin Responsiveness in Human Primary Myotubes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HORMONE-SENSITIVE LIPASE; INDUCED MITOCHONDRIAL BIOGENESIS; ADIPOSE TRIGLYCERIDE LIPASE; MUSCLE GLYCOGEN-SYNTHESIS; HUMAN SKELETAL-MUSCLE; FATTY-ACID OXIDATION; GENE-EXPRESSION; EXERCISE; RESISTANCE	Objective: Disturbances in lipid metabolism are strongly associated with insulin resistance and type 2 diabetes (T2D). We hypothesized that activation of cAMP/PKA and calcium signaling pathways in cultured human myotubes would provide further insight into regulation of lipid storage, lipolysis, lipid oxidation and insulin responsiveness. Methods: Human myoblasts were isolated from vastus lateralis, purified, cultured and differentiated into myotubes. All cells were incubated with palmitate during differentiation. Treatment cells were pulsed 1 hour each day with forskolin and ionomycin (PFI) during the final 3 days of differentiation to activate the cAMP/PKA and calcium signaling pathways. Control cells were not pulsed (control). Mitochondrial content, C-14 lipid oxidation and storage were measured, as well as lipolysis and insulin-stimulated glycogen storage. Myotubes were stained for lipids and gene expression measured. Results: PFI increased oxidation of oleate and palmitate to CO2 (p < 0.001), isoproterenol-stimulated lipolysis (p = 0.01), triacylglycerol (TAG) storage (p < 0.05) and mitochondrial DNA copy number (p = 0.01) and related enzyme activities. Candidate gene and microarray analysis revealed increased expression of genes involved in lipolysis, TAG synthesis and mitochondrial biogenesis. PFI increased the organization of lipid droplets along the myofibrillar apparatus. These changes in lipid metabolism were associated with an increase in insulin-mediated glycogen storage (p < 0.001). Conclusions: Activation of cAMP/PKA and calcium signaling pathways in myotubes induces a remodeling of lipid droplets and functional changes in lipid metabolism. These results provide a novel pharmacological approach to promote lipid metabolism and improve insulin responsiveness in myotubes, which may be of therapeutic importance for obesity and type 2 diabetes.	[Sparks, Lauren M.; Moro, Cedric; Bajpeyi, Sudip; Smith, Steven R.] Pennington Biomed Res Ctr, Mol & Expt Endocrinol Lab, Baton Rouge, LA USA; [Ukropcova, Barbara] Slovak Acad Sci, Inst Expt Endocrinol, Diabet Lab, Bratislava, Slovakia; [Civitarese, Anthony E.] Arizona State Univ, Dept Metab Physiol, Phoenix, AZ USA; [Hulver, Matthew W.] Virginia Polytech Inst & State Univ, Dept Human Nutr Food & Exercise, Blacksburg, VA 24061 USA; [Thoresen, G. Hege; Rustan, Arild C.] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Slovak Academy of Sciences; Arizona State University; Arizona State University-Downtown Phoenix; Virginia Polytechnic Institute & State University; University of Oslo	Sparks, LM (corresponding author), Maastricht Univ, Dept Human Biol, Nutr & Toxicol Res Inst Maastricht NUTRIM, Maastricht, Netherlands.	steven.r.smith.md@flhosp.org	Smith, Steven/HDM-9496-2022; Ukropcova, Barbara/ABE-6186-2020; Moro, Cedric/N-5754-2017; Ukropcova, Barbara/E-7644-2018	Ukropcova, Barbara/0000-0002-3309-7713; Bajpeyi, Sudip/0000-0002-5336-8330; Moro, Cedric/0000-0003-4294-0597; Smith, Steven/0000-0002-5098-8147; Sparks, Lauren/0000-0002-9257-5666	Health and Performance Enhancement Division of the Pennington Biomedical Research Center PBRC [011-61-0114]; PBRC CNRU [P30-DK072476]; USDA [2003-34323-14010];  [R01AG030226]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030226] Funding Source: NIH RePORTER	Health and Performance Enhancement Division of the Pennington Biomedical Research Center PBRC; PBRC CNRU; USDA(United States Department of Agriculture (USDA)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported in part by a pilot and feasibility grant (BU) from the Health and Performance Enhancement Division of the Pennington Biomedical Research Center PBRC 011-61-0114, and by grants from PBRC CNRU P30-DK072476, USDA 2003-34323-14010 and R01AG030226 (SRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsted TJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE445, DOI 10.1152/ajpendo.90912.2008; Baar K, 2004, P NUTR SOC, V63, P269, DOI 10.1079/PNS2004334; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Belfort R, 2005, DIABETES, V54, P1640, DOI 10.2337/diabetes.54.6.1640; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Boschmann M, 2010, J CLIN ENDOCR METAB, V95, P1634, DOI 10.1210/jc.2009-1293; Civitarese AE, 2006, CELL METAB, V4, P75, DOI 10.1016/j.cmet.2006.05.002; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; COSTFORD SR, 2009, AM J PHYSL ENDOCRINO; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fediuc S, 2006, J LIPID RES, V47, P412, DOI 10.1194/jlr.M500438-JLR200; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Goodpaster Bret H, 2002, Curr Diab Rep, V2, P216, DOI 10.1007/s11892-002-0086-2; Hebert TL, 2009, J TISSUE ENG REGEN M, V3, P553, DOI 10.1002/term.198; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Hsieh K, 2004, PLANT PHYSIOL, V136, P3427, DOI 10.1104/pp.104.051060; Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002; Ikeo K, 2003, CR BIOL, V326, P1079, DOI 10.1016/j.crvi.2003.09.034; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Kelley DE, 2001, DIABETES CARE, V24, P933, DOI 10.2337/diacare.24.5.933; Kelley DE, 2002, ANNU REV NUTR, V22, P325, DOI 10.1146/annurev.nutr.22.010402.102912; Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Langfort J, 2000, BIOCHEM J, V351, P207, DOI 10.1042/0264-6021:3510207; Langfort J, 1999, BIOCHEM J, V340, P459, DOI 10.1042/0264-6021:3400459; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Mairal A, 2006, DIABETOLOGIA, V49, P1629, DOI 10.1007/s00125-006-0272-x; Ohsaki Y, 2005, HISTOCHEM CELL BIOL, V124, P445, DOI 10.1007/s00418-005-0061-5; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Petersen KF, 2002, AM J CARDIOL, V90, p11G; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Prats C, 2006, J LIPID RES, V47, P2392, DOI 10.1194/jlr.M600247-JLR200; Roden M, 2005, INT J OBESITY, V29, pS111, DOI 10.1038/sj.ijo.0803102; Savage DB, 2005, HYPERTENSION, V45, P828, DOI 10.1161/01.HYP.0000163475.04421.e4; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, pR1271, DOI 10.1152/ajpregu.00472.2006; Ukropcova B, 2005, J CLIN INVEST, V115, P1934, DOI 10.1172/JCI24332; Votruba SB, 2003, OBES RES, V11, P1509, DOI 10.1038/oby.2003.202; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Watt MJ, 2003, J PHYSIOL-LONDON, V547, P301, DOI 10.1113/jphysiol.2002.034595; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	50	42	42	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21068	10.1371/journal.pone.0021068	http://dx.doi.org/10.1371/journal.pone.0021068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760887	Green Published, gold, Green Submitted			2022-12-25	WOS:000292657200006
J	Schiff, M; Benoist, JF; Aissaoui, S; Boepsflug-Tanguy, O; Mouren, MC; de Baulny, HO; Delorme, R				Schiff, Manuel; Benoist, Jean-Francois; Aissaoui, Sofiane; Boepsflug-Tanguy, Odile; Mouren, Marie-Christine; de Baulny, Helene Ogier; Delorme, Richard			Should Metabolic Diseases Be Systematically Screened in Nonsyndromic Autism Spectrum Disorders?	PLOS ONE			English	Article							SANFILIPPO-SYNDROME; MENTAL-RETARDATION; CLINICAL SPECTRUM; NATURAL-HISTORY; DEFICIENCY; CHILDREN; PHENYLKETONURIA; DYSFUNCTION; PREVALENCE; GENETICS	Background: In the investigation of autism spectrum disorders (ASD), a genetic cause is found in approximately 10-20%. Among these cases, the prevalence of the rare inherited metabolic disorders (IMD) is unknown and poorly evaluated. An IMD responsible for ASD is usually identified by the associated clinical phenotype such as dysmorphic features, ataxia, microcephaly, epilepsy, and severe intellectual disability (ID). In rare cases, however, ASD may be considered as nonsyndromic at the onset of a related IMD. Objectives: To evaluate the utility of routine metabolic investigations in nonsyndromic ASD. Patients and Methods: We retrospectively analyzed the results of a metabolic workup (urinary mucopolysaccharides, urinary purines and pyrimidines, urinary creatine and guanidinoacetate, urinary organic acids, plasma and urinary amino acids) routinely performed in 274 nonsyndromic ASD children. Results: The metabolic parameters were in the normal range for all but 2 patients: one with unspecific creatine urinary excretion and the other with persistent 3-methylglutaconic aciduria. Conclusions: These data provide the largest ever reported cohort of ASD patients for whom a systematic metabolic workup has been performed; they suggest that such a routine metabolic screening does not contribute to the causative diagnosis of nonsyndromic ASD. They also emphasize that the prevalence of screened IMD in nonsyndromic ASD is probably not higher than in the general population (<0.5%). A careful clinical evaluation is probably more reasonable and of better medical practice than a costly systematic workup.	[Schiff, Manuel; Benoist, Jean-Francois; de Baulny, Helene Ogier] Hop Robert Debre, Reference Ctr Inherited Metab Dis, APHP, F-75019 Paris, France; [Schiff, Manuel; Boepsflug-Tanguy, Odile; de Baulny, Helene Ogier] Hop Robert Debre, Child Neurol & Metab Dis Dept, APHP, F-75019 Paris, France; [Schiff, Manuel; Benoist, Jean-Francois; Boepsflug-Tanguy, Odile] INSERM, U676, Paris, France; [Delorme, Richard] Inst Pasteur, Paris, France; [Aissaoui, Sofiane; Mouren, Marie-Christine; Delorme, Richard] Hop Robert Debre, Child Psychiat Dept, APHP, F-75019 Paris, France; [Schiff, Manuel; Boepsflug-Tanguy, Odile; Mouren, Marie-Christine; de Baulny, Helene Ogier; Delorme, Richard] Univ Paris 07, IFR02, Fac Med Denis Diderot, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Schiff, M (corresponding author), Hop Robert Debre, Reference Ctr Inherited Metab Dis, APHP, F-75019 Paris, France.	manuel.schiff@rdb.aphp.fr	Schiff, Manuel/G-3596-2017	Schiff, Manuel/0000-0001-8272-232X; benoist, jean-francois/0000-0002-5389-8585; Delorme, Richard/0000-0002-5614-3663				Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Arias A, 2007, CLIN BIOCHEM, V40, P1328, DOI 10.1016/j.clinbiochem.2007.07.010; Baieli S, 2003, J AUTISM DEV DISORD, V33, P201, DOI 10.1023/A:1022999712639; Brockmann K, 2003, NEURORADIOLOGY, V45, P137, DOI 10.1007/s00234-002-0931-7; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Cohen D, 2005, J AUTISM DEV DISORD, V35, P103, DOI 10.1007/s10803-004-1038-2; Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012; Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866; Filipek PA, 2000, NEUROLOGY, V55, P468, DOI 10.1212/WNL.55.4.468; Gorker I, 2005, J PSYCHIATR NEUROSCI, V30, P133; Haas RH, 2010, DEV DISABIL RES REV, V16, P144, DOI 10.1002/ddrr.112; HACKNEY IM, 1968, J PEDIATR-US, V72, P646, DOI 10.1016/S0022-3476(68)80007-1; Heron B, 2011, AM J MED GENET A, V155A, P58, DOI 10.1002/ajmg.a.33779; Jabourian A, 2011, ANN MED-PSYCHOL, V160, P421; Jurecka A, 2009, J INHERIT METAB DIS, V32, P247, DOI 10.1007/s10545-009-1094-z; Kayser MA, 2008, SEMIN PEDIATR NEUROL, V15, P127, DOI 10.1016/j.spen.2008.05.006; Kosinovsky B, 2005, J NEURAL TRANSM, V112, P587, DOI 10.1007/s00702-004-0198-8; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; LONGO N, 2011, AM J MED GENET C; Manzi B, 2008, J CHILD NEUROL, V23, P307, DOI 10.1177/0883073807308698; Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P212, DOI 10.1016/j.bbadis.2009.10.007; MUDD SH, 1985, AM J HUM GENET, V37, P1; NIDIFFER FD, 1983, J MENT DEFIC RES, V27, P185; Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332; Pearl PL, 2003, NEUROLOGY, V60, P1413, DOI 10.1212/01.WNL.0000059549.70717.80; Rosenberg EH, 2007, HUM MUTAT, V28, P890, DOI 10.1002/humu.20532; Rosenberg EH, 2004, AM J HUM GENET, V75, P97, DOI 10.1086/422102; Rossignol D.A., 2011, MOL PSYCHIAT; Salomons GS, 2003, J INHERIT METAB DIS, V26, P309, DOI 10.1023/A:1024405821638; Sanderson S, 2006, ARCH DIS CHILD, V91, P896, DOI 10.1136/adc.2005.091637; Schaefer GB, 2006, GENET MED, V8, P549, DOI 10.1097/01.gim.0000237789.98842.f1; Schiff M, 2010, ARCH PEDIATRIE, V17, P802, DOI 10.1016/S0929-693X(10)70119-6; Skuse DH, 2007, TRENDS GENET, V23, P387, DOI 10.1016/j.tig.2007.06.003; Smith W, 2005, CRIT CARE CLIN, V21, pS9, DOI 10.1016/j.ccc.2005.05.007; Spiegel EK, 2006, MOL GENET METAB, V89, P19, DOI 10.1016/j.ymgme.2006.04.018; State MW, 2010, NEURON, V68, P254, DOI 10.1016/j.neuron.2010.10.004; Steerneman P, 1997, J AUTISM DEV DISORD, V27, P177, DOI 10.1023/A:1025843908339; Stockler Sylvia, 2007, V46, P149; Touati G, 1997, ARCH DIS CHILD, V76, P16, DOI 10.1136/adc.76.1.16; Wang L, 2010, AUTISM RES, V3, P268, DOI 10.1002/aur.145; Weissman JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003815; Wortmann S.B., 2010, J INHERIT METAB DIS; Zecavati N, 2009, CURR NEUROL NEUROSCI, V9, P129, DOI 10.1007/s11910-009-0021-x	44	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21932	10.1371/journal.pone.0021932	http://dx.doi.org/10.1371/journal.pone.0021932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760924	Green Submitted, gold, Green Published			2022-12-25	WOS:000292655400028
J	Wu, LJ; Xu, LR; Liao, JM; Chen, J; Liang, Y				Wu, Ling-Jia; Xu, Li-Rong; Liao, Jun-Ming; Chen, Jie; Liang, Yi			Both the C-Terminal Polylysine Region and the Farnesylation of K-RasB Are Important for Its Specific Interaction with Calmodulin	PLOS ONE			English	Article							GTP-BINDING; H-RAS; TARGET RECOGNITION; IDENTIFICATION; ACTIVATION; PROTEINS; PURIFICATION; CANCER; DOMAIN; RAB3A	Background: Ras protein, as one of intracellular signal switches, plays various roles in several cell activities such as differentiation and proliferation. There is considerable evidence showing that calmodulin (CaM) binds to K-RasB and dissociates K-RasB from membrane and that the inactivation of CaM is able to induce K-RasB activation. However, the mechanism for the interaction of CaM with K-RasB is not well understood. Methodology/Principal Findings: Here, by applying fluorescence spectroscopy and isothermal titration calorimetry, we have obtained thermodynamic parameters for the interaction between these two proteins and identified the important elements of K-RasB for its interaction with Ca2+/CaM. One K-RasB molecule interacts with one CaM molecule in a GTP dependent manner with moderate, micromolar affinity at physiological pH and physiologic ionic strength. Mutation in the polybasic domain of K-Ras decreases the binding affinity. By using a chimera in which the C-terminal polylysine region of K-RasB has been replaced with that of H-Ras and vice versa, we find that at physiological pH, H-Ras-(KKKKKK) and Ca2+/CaM formed a 1:1 complex with an equilibrium association constant around 10(5) M-1, whereas no binding reaction of K-RasB( DESGPC) with Ca2+/CaM is detected. Furthermore, the interaction of K-RasB with Ca2+/CaM is found to be enhanced by the farnesylation of K-RasB. Conclusions/Significance: We demonstrate that the polylysine region of K-RasB not only contributes importantly to the interaction of K-RasB with Ca2+/CaM, but also defines its isoform specific interaction with Ca2+/CaM. The farnesylation of K-RasB is also important for its specific interaction with Ca2+/CaM. Information obtained here can enhance our understanding of how CaM interacts with K-RasB in physiological environments.	[Wu, Ling-Jia; Xu, Li-Rong; Liao, Jun-Ming; Chen, Jie; Liang, Yi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hubei, Peoples R China	Wuhan University	Wu, LJ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hubei, Peoples R China.	liangyi@whu.edu.cn	Liang, Yi/V-1396-2017; Liao, Jun-Ming/G-3788-2012	Liang, Yi/0000-0002-7349-8300; 	National Key Basic Research Foundation of China [2006CB910301]; National Natural Science Foundation of China [30970599, 30770421]; Fundamental Research Funds for the Central Universities [1104006]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by National Key Basic Research Foundation of China (http://www.most.gov.cn/, Grant no. 2006CB910301, YL), National Natural Science Foundation of China (http://www.nsfc.gov.cn/, Grant nos. 30970599 and 30770421, YL), and Fundamental Research Funds for the Central Universities (http://www.moe.edu.cn/, Grant no. 1104006, YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SJ, 2009, BIOCHEMISTRY-US, V48, P7575, DOI 10.1021/bi900769j; Alvarez-Moya B, 2010, ONCOGENE, V29, P5911, DOI 10.1038/onc.2010.298; Ashery U, 2006, TRAFFIC, V7, P1119, DOI 10.1111/j.1600-0854.2006.00459.x; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Beguin P, 2006, J MOL BIOL, V355, P34, DOI 10.1016/j.jmb.2005.10.013; Beguin P, 2005, BIOCHEM J, V390, P67, DOI 10.1042/BJ20050414; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Bofill-Cardona E, 2000, J BIOL CHEM, V275, P32672, DOI 10.1074/jbc.M002780200; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BOS JL, 1989, CANCER RES, V49, P4682; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Fischer R, 1996, J BIOL CHEM, V271, P25067, DOI 10.1074/jbc.271.41.25067; Fivaz M, 2005, J CELL BIOL, V170, P429, DOI 10.1083/jcb.200409157; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hileman RE, 1998, BIOCHEMISTRY-US, V37, P15231, DOI 10.1021/bi980212x; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hoshino M, 2003, J CELL BIOL, V163, P1067, DOI 10.1083/jcb.200308070; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; JOHNSON JD, 1983, BIOCHEM J, V211, P473, DOI 10.1042/bj2110473; KLEE CB, 1980, ANNU REV BIOCHEM, V49, P489, DOI 10.1146/annurev.bi.49.070180.002421; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Liang Y, 2003, J BIOL CHEM, V278, P30098, DOI 10.1074/jbc.M304050200; Liao JM, 2008, BBA-PROTEINS PROTEOM, V1784, P1560, DOI 10.1016/j.bbapap.2008.08.009; Lopez-Alcala C, 2008, J BIOL CHEM, V283, P10621, DOI 10.1074/jbc.M706238200; MAYER MP, 1993, GENE, V132, P41, DOI 10.1016/0378-1119(93)90512-2; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Moyers JS, 1997, J BIOL CHEM, V272, P11832, DOI 10.1074/jbc.272.18.11832; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Park JB, 1997, J BIOL CHEM, V272, P20857, DOI 10.1074/jbc.272.33.20857; Park JB, 2002, BIOCHEM J, V362, P651, DOI 10.1042/0264-6021:3620651; Park JB, 1999, BIOCHEM BIOPH RES CO, V263, P765, DOI 10.1006/bbrc.1999.1463; Potenza N, 2005, EMBO REP, V6, P432, DOI 10.1038/sj.embor.7400397; Sidhu RS, 2005, BIOCHEM BIOPH RES CO, V336, P105, DOI 10.1016/j.bbrc.2005.08.053; Sidhu RS, 2003, BIOCHEM BIOPH RES CO, V304, P655, DOI 10.1016/S0006-291X(03)00635-1; van Holde K.E., 2006, PRINCIPLES PHYS BIOC, P91; Villalonga P, 2002, J BIOL CHEM, V277, P37929, DOI 10.1074/jbc.M202245200; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Wang KL, 1999, J BIOL CHEM, V274, P14525, DOI 10.1074/jbc.274.21.14525; Wang KL, 1997, J BIOL CHEM, V272, P16002, DOI 10.1074/jbc.272.25.16002; WEINSTEIN H, 1994, ANNU REV PHYSIOL, V56, P213, DOI 10.1146/annurev.ph.56.030194.001241; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x; Wu N, 2006, J MOL BIOL, V364, P955, DOI 10.1016/j.jmb.2006.09.075; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200; Zhou YB, 2009, BIOPHYS J, V96, P2832, DOI 10.1016/j.bpj.2008.12.3941; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691	50	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21929	10.1371/journal.pone.0021929	http://dx.doi.org/10.1371/journal.pone.0021929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750741	Green Published, gold, Green Submitted			2022-12-25	WOS:000292512000033
J	Bodoor, K; Lontay, B; Safi, R; Weitzel, DH; Loiselle, D; Wei, ZZ; Lengyel, S; McDonnell, DP; Haystead, TA				Bodoor, Khaldon; Lontay, Beata; Safi, Rachid; Weitzel, Douglas H.; Loiselle, David; Wei, Zhengzheng; Lengyel, Szabolcs; McDonnell, Donald P.; Haystead, Timothy A.			Smoothelin-like 1 Protein Is a Bifunctional Regulator of the Progesterone Receptor during Pregnancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; METABOLIZING ENZYME CYP26A1; MYOSIN PHOSPHATASE; RAT MYOMETRIUM; CONTRACTILE FP; MICE LACKING; EXPRESSION; ESTROGEN; ACTIVATION; BINDING	During pregnancy, uterine smooth muscle (USM) coordinately adapts its contractile phenotype in order to accommodate the developing fetus and then prepare for delivery. Herein we show that SMTNL1 plays a major role in pregnancy to promote adaptive responses in USM and that this process is specifically mediated through interactions of SMTNL1 with the steroid hormone receptor PR-B. In vitro and in vivo SMTNL1 selectively binds PR and not other steroid hormone receptors. The physiological relationship between the two proteins was also established in global gene expression and transcriptional reporter studies in pregnant smtnl1(-/-) mice and by RNA interference in progesterone-sensitive cell lines. We show that the contraction-associated and progestin-sensitive genes (oxytocin receptor, connexin 43, and cyclooxygenase-2) and prolactins are down-regulated in pregnant smtnl1(-/-) mice. We suggest that SMTNL1 is a bifunctional co-regulator of PR-B signaling and thus provides a molecular mechanism whereby PR-B is targeted to alter gene expression patterns within USM cells to coordinately promote alterations in USM function during pregnancy.	[Haystead, Timothy A.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, LSRC, Durham, NC 27710 USA; [Wei, Zhengzheng] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Lontay, Beata] Univ Debrecen, Dept Med Chem, H-4032 Debrecen, Hungary; [Lengyel, Szabolcs] Univ Debrecen, Dept Ecol, H-4032 Debrecen, Hungary	Duke University; Duke University; University of Debrecen; University of Debrecen	Haystead, TA (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, LSRC, Res Dr,C119,Box 3, Durham, NC 27710 USA.	hayst001@mc.duke.edu	Safi, Rachid/A-5909-2010; Lengyel, Szabolcs/A-3483-2011	Lengyel, Szabolcs/0000-0002-7049-0100	National Institutes of Health [R56DK065954-05]; King Hussein Institute for Biotechnology and Cancer, Amman, Jordan; J. Bolyai Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048807, R56DK065954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); King Hussein Institute for Biotechnology and Cancer, Amman, Jordan; J. Bolyai Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R56DK065954-05 (to T. A. J. H.).; Supported by a postdoctoral fellowship from the King Hussein Institute for Biotechnology and Cancer, Amman, Jordan. Currently on a sabbatical leave from the Department of Applied Biology-Faculty of Science and Arts at the Jordan University of Science and Technology, Irbid 21110, Jordan.; Supported by the J. Bolyai Fellowship.	Aleman G, 2005, AM J PHYSIOL-ENDOC M, V289, pE172, DOI 10.1152/ajpendo.00584.2004; Allport VC, 2001, MOL HUM REPROD, V7, P581, DOI 10.1093/molehr/7.6.581; Ballare C, 2003, MOL CELL BIOL, V23, P1994, DOI 10.1128/MCB.23.6.1994-2008.2003; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Borman MA, 2004, FEBS LETT, V573, P207, DOI 10.1016/j.febslet.2004.08.002; Brodt-Eppley J, 1998, BIOL REPROD, V59, P878, DOI 10.1095/biolreprod59.4.878; CHALLIS JRG, 1986, OXFORD REV REPROD B, V8, P61; Chappell PE, 1999, ENDOCRINOLOGY, V140, P3653, DOI 10.1210/en.140.8.3653; Condon JC, 2003, P NATL ACAD SCI USA, V100, P9518, DOI 10.1073/pnas.1633616100; Dong XS, 2005, J BIOL CHEM, V280, P13329, DOI 10.1074/jbc.M409187200; Dong XS, 2009, MOL ENDOCRINOL, V23, P1147, DOI 10.1210/me.2008-0357; Dong YL, 2000, BIOL REPROD, V62, P533, DOI 10.1095/biolreprod62.3.533; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Fang X, 1997, ENDOCRINOLOGY, V138, P2763, DOI 10.1210/en.138.7.2763; Fritzsche B, 2007, MOL REPROD DEV, V74, P258, DOI 10.1002/mrd.20526; Giangrande PH, 1999, RECENT PROG HORM RES, V54, P291; Giangrande PH, 2000, MOL CELL BIOL, V20, P3102, DOI 10.1128/MCB.20.9.3102-3115.2000; Goldenberg RL, 2002, OBSTET GYNECOL, V100, P1020, DOI 10.1016/S0029-7844(02)02212-3; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; Han BC, 2010, J CELL PHYSIOL, V223, P471, DOI 10.1002/jcp.22056; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HENDRIX EM, 1995, BIOL REPROD, V52, P547, DOI 10.1095/biolreprod52.3.547; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Ishida H, 2008, J BIOL CHEM, V283, P20569, DOI 10.1074/jbc.M800627200; Jaffer S, 2009, ENDOCRINOLOGY, V150, P4672, DOI 10.1210/en.2009-0419; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Kim J, 2006, YONSEI MED J, V47, P558, DOI 10.3349/ymj.2006.47.4.558; Leite RS, 2004, FASEB J, V18, P1418, DOI 10.1096/fj.04-1684fje; Lontay B, 2010, J BIOL CHEM, V285, P29357, DOI 10.1074/jbc.M110.143966; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Merlino AA, 2007, J CLIN ENDOCR METAB, V92, P1927, DOI 10.1210/jc.2007-0077; Mesiano S, 2002, J CLIN ENDOCR METAB, V87, P2924, DOI 10.1210/jc.87.6.2924; Mesiano S, 2007, SEMIN CELL DEV BIOL, V18, P321, DOI 10.1016/j.semcdb.2007.05.003; Mesiano S, 2011, REPROD SCI, V18, P6, DOI 10.1177/1933719110382922; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; Mulac-Jericevic B, 2000, SCIENCE, V289, P1751, DOI 10.1126/science.289.5485.1751; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; Ogren L, 1988, Int Rev Cytol, V112, P1; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Ou CW, 2000, AM J OBSTET GYNECOL, V182, P919, DOI 10.1016/S0002-9378(00)70347-4; Patel FA, 2003, J CLIN ENDOCR METAB, V88, P2922, DOI 10.1210/jc.2002-021710; Plevin MJ, 2005, TRENDS BIOCHEM SCI, V30, P66, DOI 10.1016/j.tibs.2004.12.001; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; Richards JS, 2005, BIOL REPROD, V72, P1241, DOI 10.1095/biolreprod.104.038083; Roizen JD, 2008, MOL ENDOCRINOL, V22, P105, DOI 10.1210/me.2007-0178; Rowan BG, 2000, MOL CELL BIOL, V20, P8720, DOI 10.1128/MCB.20.23.8720-8730.2000; Shynlova O, 2006, BIOL REPROD, V74, P839, DOI 10.1095/biolreprod.105.048124; Shynlova O, 2007, BIOL REPROD, V76, P571, DOI 10.1095/biolreprod.106.056929; Shynlova O, 2009, EUR J OBSTET GYN R B, V144, pS2, DOI 10.1016/j.ejogrb.2009.02.044; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Soares Michael J, 2004, Reprod Biol Endocrinol, V2, P51, DOI 10.1186/1477-7827-2-51; Somlyo AV, 2007, CIRC RES, V101, P645, DOI 10.1161/CIRCRESAHA.107.161893; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Tsuboi K, 2000, ENDOCRINOLOGY, V141, P315, DOI 10.1210/en.141.1.315; Ulke-Lemee A, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-10; VEGETO E, 1992, CELL, V69, P703, DOI 10.1016/0092-8674(92)90234-4; Ward RM, 2003, BJOG-INT J OBSTET GY, V110, P8, DOI 10.1016/S1470-0328(03)00012-0; WEIGEL NL, 1995, J STEROID BIOCHEM, V53, P509, DOI 10.1016/0960-0760(95)00098-K; Wooldridge AA, 2008, J BIOL CHEM, V283, P11850, DOI 10.1074/jbc.M708628200; Xia HF, 2010, HUM REPROD, V25, P2985, DOI 10.1093/humrep/deq268; Xu JM, 1996, P NATL ACAD SCI USA, V93, P12195, DOI 10.1073/pnas.93.22.12195; Zhao K, 1996, BIOL REPROD, V54, P607, DOI 10.1095/biolreprod54.3.607	67	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31839	31851		10.1074/jbc.M111.270397	http://dx.doi.org/10.1074/jbc.M111.270397			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21771785	hybrid, Green Published			2022-12-25	WOS:000294487500077
J	Popa, I; Fernandez, JM; Garcia-Manyes, S				Popa, Ionel; Fernandez, Julio M.; Garcia-Manyes, Sergi			Direct Quantification of the Attempt Frequency Determining the Mechanical Unfolding of Ubiquitin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE FORCE SPECTROSCOPY; SINGLE-DOMAIN PROTEINS; NON-ARRHENIUS KINETICS; SPEED LIMIT; CLAMP SPECTROSCOPY; FOLDING KINETICS; TRANSITION-STATE; IMMUNOGLOBULIN DOMAINS; TEMPERATURE-DEPENDENCE; BIMOLECULAR REACTIONS	Understanding protein dynamics requires a comprehensive knowledge of the underlying potential energy surface that governs the motion of each individual protein molecule. Single molecule mechanical studies have provided the unprecedented opportunity to study the individual unfolding pathways along a well defined coordinate, the end-to-end length of the protein. In these experiments, unfolding requires surmounting an energy barrier that separates the native from the extended state. The calculation of the absolute value of the barrier height has traditionally relied on the assumption of an attempt frequency, upsilon*. Here we used single molecule force-clamp spectroscopy to directly determine the value of upsilon* for mechanical unfolding by measuring the unfolding rate of the small protein ubiquitin at varying temperatures. Our experiments demonstrate a significant effect of the temperature on the mechanical rate of unfolding. By extrapolating the unfolding rate in the absence of force for different temperatures, varying within the range spanning from 5 to 45 degrees C, we measured a value for the activation barrier of Delta G* = 71 +/- 5 kJ/mol and an exponential prefactor upsilon* similar to 4 x 10(9) s(-1). Although the measured prefactor value is 3 orders of magnitude smaller than the value predicted by the transition state theory (similar to 6 x 10(12) s(-1)), it is 400-fold higher than that encountered in analogous experiments studying the effect of temperature on the reactivity of a protein-embedded disulfide bond (similar to 10(7) M-1 s(-1)). This approach will allow quantitative characterization of the complete energy landscape of a folding polypeptide from highly extended states, of capital importance for proteins with elastic function.	[Popa, Ionel; Fernandez, Julio M.; Garcia-Manyes, Sergi] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Fernandez, JM (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.	jfernandez@columbia.edu; sergi.garcia-manes@kcl.ac.uk	Popa, Ionel/P-4739-2016; Popa, Ionel/N-1428-2014	Popa, Ionel/0000-0003-3111-4716; Popa, Ionel/0000-0003-3111-4716; Garcia-Manyes, Sergi/0000-0001-5140-2606	Swiss National Science Foundation; Fundacion IberCaja; National Institutes of Health [HL66030, HL61228]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061228, R01HL066030] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fundacion IberCaja; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Swiss National Science Foundation through a postdoctoral fellowship (to I. P.), by the Fundacion IberCaja (to S. G. M.), and by National Institutes of Health Grants HL66030 and HL61228 (to J. M. F.).	Ainavarapu SRK, 2008, J AM CHEM SOC, V130, P6479, DOI 10.1021/ja800180u; Akmal A, 2004, PROTEINS, V57, P142, DOI 10.1002/prot.20172; Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P18961, DOI 10.1074/jbc.R109.011932; Banachewicz W, 2011, P NATL ACAD SCI USA, V108, P569, DOI 10.1073/pnas.1017832108; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BERKOVICH R, 2010, BIOPHYS J, V2692, P2701; Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597; Botello E, 2009, J PHYS CHEM B, V113, P10845, DOI 10.1021/jp9002356; Brujic J, 2006, NAT PHYS, V2, P282, DOI 10.1038/nphys269; Brujic J, 2007, BIOPHYS J, V92, P2896, DOI 10.1529/biophysj.106.099481; Bullard B, 2006, P NATL ACAD SCI USA, V103, P4451, DOI 10.1073/pnas.0509016103; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; CARRION V, 2007, P NATL ACAD SCI USA, V163, P245; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Cellmer T, 2008, P NATL ACAD SCI USA, V105, P18320, DOI 10.1073/pnas.0806154105; Chan HS, 1998, PROTEINS, V30, P2, DOI 10.1002/(SICI)1097-0134(19980101)30:1<2::AID-PROT2>3.0.CO;2-R; Chung HS, 2008, PROTEINS, V72, P474, DOI 10.1002/prot.22043; Collet O, 2003, J AM CHEM SOC, V125, P6573, DOI 10.1021/ja029075o; Dougan L, 2008, P NATL ACAD SCI USA, V105, P3185, DOI 10.1073/pnas.0706075105; Dougan L, 2011, P NATL ACAD SCI USA, V108, P9759, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Duy C, 2005, J BIOL CHEM, V280, P37360, DOI 10.1074/jbc.M507530200; Estape D, 1999, J BIOL CHEM, V274, P34083, DOI 10.1074/jbc.274.48.34083; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; FERNANDEZ JM, 2009, SINGLE MOL SPECTROSC, P317; Fernandez-Ramos A, 2006, CHEM REV, V106, P4518, DOI 10.1021/cr050205w; Ferrer S, 2006, J AM CHEM SOC, V128, P16851, DOI 10.1021/ja0653977; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Frauenfelder H, 2006, P NATL ACAD SCI USA, V103, P15469, DOI 10.1073/pnas.0607168103; Garcia-Manyes S, 2007, BIOPHYS J, V93, P2436, DOI 10.1529/biophysj.107.104422; Garcia-Manyes S, 2011, J AM CHEM SOC, V133, P3104, DOI 10.1021/ja109865z; Garcia-Manyes S, 2009, NAT CHEM, V1, P236, DOI [10.1038/NCHEM.207, 10.1038/nchem.207]; Garcia-Manyes S, 2009, P NATL ACAD SCI USA, V106, P10534, DOI 10.1073/pnas.0901213106; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; Hagen SJ, 2010, CURR PROTEIN PEPT SC, V11, P385; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; HERSCHBACH DR, 1956, J CHEM PHYS, V25, P736, DOI 10.1063/1.1743039; Hyeon CB, 2003, P NATL ACAD SCI USA, V100, P10249, DOI 10.1073/pnas.1833310100; Irback A, 2005, P NATL ACAD SCI USA, V102, P13427, DOI 10.1073/pnas.0501581102; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Janovjak H, 2003, EMBO J, V22, P5220, DOI 10.1093/emboj/cdg509; Karplus M, 2000, J PHYS CHEM B, V104, P11, DOI 10.1021/jp993555t; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kuo TL, 2010, P NATL ACAD SCI USA, V107, P11336, DOI 10.1073/pnas.1006517107; Law R, 2003, BIOPHYS J, V85, P3286, DOI 10.1016/S0006-3495(03)74747-X; Lednev IK, 1999, J AM CHEM SOC, V121, P8074, DOI 10.1021/ja991382f; Li JY, 2010, P NATL ACAD SCI USA, V107, P19284, DOI 10.1073/pnas.1013159107; Li MS, 2004, POLYMER, V45, P573, DOI 10.1016/j.polymer.2003.10.066; Liang J, 2011, J AM CHEM SOC, V133, P3528, DOI 10.1021/ja109684q; Liu RC, 2009, BIOPHYS J, V96, P3810, DOI 10.1016/j.bpj.2009.01.043; Lu H, 2000, BIOPHYS J, V79, P51, DOI 10.1016/S0006-3495(00)76273-4; Matagne A, 2000, J MOL BIOL, V297, P193, DOI 10.1006/jmbi.2000.3540; MILLA ME, 1994, BIOCHEMISTRY-US, V33, P1125, DOI 10.1021/bi00171a011; Noronha M, 2010, J PHYS CHEM B, V114, P9912, DOI 10.1021/jp104167h; Oberhauser AF, 2008, J BIOL CHEM, V283, P6617, DOI 10.1074/jbc.R700050200; Perez-Jimenez R, 2006, J BIOL CHEM, V281, P40010, DOI 10.1074/jbc.M609890200; Plaxco KW, 1999, NAT STRUCT BIOL, V6, P554; Pollak E, 2005, CHAOS, V15, DOI 10.1063/1.1858782; Pu JZ, 2006, CHEM REV, V106, P3140, DOI 10.1021/cr050308e; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Sadqi M, 2003, P NATL ACAD SCI USA, V100, P12117, DOI 10.1073/pnas.2033863100; Scalley ML, 1997, P NATL ACAD SCI USA, V94, P10636, DOI 10.1073/pnas.94.20.10636; Schlierf M, 2005, J MOL BIOL, V354, P497, DOI 10.1016/j.jmb.2005.09.070; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Schlierf M, 2010, BIOPHYS J, V99, P1620, DOI 10.1016/j.bpj.2010.06.039; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Taniguchi Y, 2008, BIOPHYS J, V95, P5296, DOI 10.1529/biophysj.108.141275; TRUHLAR DG, 1983, J PHYS CHEM-US, V87, P2664, DOI 10.1021/j100238a003; Walther KA, 2007, P NATL ACAD SCI USA, V104, P7916, DOI 10.1073/pnas.0702179104; West DK, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2185100; Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609; Yew ZT, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031923; Zaman MH, 2003, PHYS CHEM CHEM PHYS, V5, P2589, DOI 10.1039/b212671k	75	43	44	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31072	31079		10.1074/jbc.M111.264093	http://dx.doi.org/10.1074/jbc.M111.264093			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768096	Green Published, hybrid			2022-12-25	WOS:000294487500002
J	Sharma, A; Sharma, A				Sharma, Ashwani; Sharma, Amit			Fatty Acid Induced Remodeling within the Human Liver Fatty Acid-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGE; CRYSTAL-STRUCTURE; HIGH-AFFINITY; LONG-CHAIN; EXPRESSION; RECEPTORS; COMPLEX; HEART	We crystallized human liver fatty acid-binding protein (LFABP) in apo, holo, and intermediate states of palmitic acid engagement. Structural snapshots of fatty acid recognition, entry, and docking within LFABP support a heads-in mechanism for ligand entry. Apo-LFABP undergoes structural remodeling, where the first palmitate ingress creates the atomic environment for placement of the second palmitate. These new mechanistic insights will facilitate development of pharmacological agents against LFABP.	[Sharma, Ashwani; Sharma, Amit] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Aruna Asaf Ali Rd, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Sharma, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Aruna Asaf Ali Rd, New Delhi 110067, India.	amit.icgeb@gmail.com			University Grants Commission, Government of India; EU, DBT (Govt. of India)	University Grants Commission, Government of India(University Grants Commission, India); EU, DBT (Govt. of India)(Department of Biotechnology (DBT) India)	This work was supported, in whole or in part, by University Grants Commission, Government of India (to Ashwani Sharma) and grants from EU, DBT (Govt. of India, to Amit Sharma).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Atshaves BP, 2010, J NUTR BIOCHEM, V21, P1015, DOI 10.1016/j.jnutbio.2010.01.005; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Coe NR, 1998, BBA-LIPID LIPID MET, V1391, P287, DOI 10.1016/S0005-2760(97)00205-1; De Geronimo E, 2010, BBA-MOL CELL BIOL L, V1801, P1082, DOI 10.1016/j.bbalip.2010.05.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engels W, 1999, MOL CELL BIOCHEM, V192, P53, DOI 10.1023/A:1006855214237; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; He Y, 2007, BIOCHEMISTRY-US, V46, P12543, DOI 10.1021/bi701092r; He Y, 2011, BIOCHEMISTRY-US, V50, P1283, DOI 10.1021/bi101307h; HONMA Y, 1994, J BIOCHEM, V116, P1025, DOI 10.1093/oxfordjournals.jbchem.a124623; Hostetler HA, 2005, J BIOL CHEM, V280, P18667, DOI 10.1074/jbc.M412062200; Hostetler HA, 2006, BIOCHEMISTRY-US, V45, P7669, DOI 10.1021/bi060198l; JAMISON RS, 1994, BIOCHEMISTRY-US, V33, P2873, DOI 10.1021/bi00176a017; Kamijo-Ikemori A, 2009, NEPHROL DIAL TRANSPL, V24, P788, DOI 10.1093/ndt/gfn573; Lucke C, 1999, MOL CELL BIOCHEM, V192, P109, DOI 10.1023/A:1006834708786; Magnusson AL, 2004, J CLIN ENDOCR METAB, V89, P4607, DOI 10.1210/jc.2003-032234; Martin GG, 2009, AM J PHYSIOL-GASTR L, V297, pG1053, DOI 10.1152/ajpgi.00116.2009; Newberry EP, 2008, AM J PHYSIOL-GASTR L, V294, pG307, DOI 10.1152/ajpgi.00377.2007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rolf B, 1995, BBA-LIPID LIPID MET, V1259, P245, DOI 10.1016/0005-2760(95)00170-0; Schroeder F, 2008, LIPIDS, V43, P1, DOI 10.1007/s11745-007-3111-z; Sharma A, 2008, J BIOL CHEM, V283, P24077, DOI 10.1074/jbc.M801946200; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; TREVASKIS NL, 2011, PHARM RES IN PRESS; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Velkov T, 2008, J CHROMATOGR B, V867, P238, DOI 10.1016/j.jchromb.2008.04.011; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898	32	40	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31924	31928		10.1074/jbc.M111.270165	http://dx.doi.org/10.1074/jbc.M111.270165			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757748	hybrid, Green Published			2022-12-25	WOS:000294487500085
J	Akha, AAS; Harper, JM; Salmon, AB; Schroeder, BA; Tyra, HM; Rutkowski, DT; Miller, RA				Akha, Amir A. Sadighi; Harper, James M.; Salmon, Adam B.; Schroeder, Bethany A.; Tyra, Heather M.; Rutkowski, D. Thomas; Miller, Richard A.			Heightened Induction of Proapoptotic Signals in Response to Endoplasmic Reticulum Stress in Primary Fibroblasts from a Mouse Model of Longevity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; LIFE-SPAN EXTENSION; ER STRESS; CELL-DEATH; TRANSCRIPTION FACTOR; MULTIPLE FORMS; MESSENGER-RNA; DWARF MICE; RESISTANCE; XBP1	Previous work from our laboratory has shown that primary fibroblasts from long-lived Snell dwarf mice display a higher sensitivity to the lethal effects of endoplasmic reticulum (ER) stressors, such as thapsigargin, than cells from normal mice. Here we show that thapsigargin induces higher expression of CHOP, enhanced cleavage of caspase-12, higher caspase-3 activity, and increased phosphorylation of c-JUN, all indicators of enhanced apoptosis, in dwarf fibroblasts. Dwarf and normal fibroblasts show no genotypic difference in up-regulating BiP, GRP94, and ERp72 proteins after exposure to thapsigargin. However, dwarf fibroblasts express lower basal levels of a number of putative XBP1 target genes including Armet, Edem1, Erdj3, p58(IPK) and Sec61a1, as well as Ire1 alpha itself. Furthermore, when exposed to thapsigargin, dwarf fibroblasts display attenuated splicing of Xbp1, but similar phosphorylation of eIF2 alpha, in comparison to normal fibroblasts. These data support the notion that IRE1/XBP1 signaling is set at a lower level in dwarf fibroblasts. Diminished Xbp1 splicing in dwarf-derived fibroblasts may tilt the balance between prosurvival and proapoptotic signals in favor of apoptosis, thereby leading to higher induction of proapoptotic signals in these cells and ultimately their increased sensitivity to ER stressors. These results, together with recent findings in Caenorhabditis elegans daf-2 mutants, point to a potential interplay between insulin/IGF-1 signals and unfolded protein response signaling.	[Akha, Amir A. Sadighi; Harper, James M.; Salmon, Adam B.; Schroeder, Bethany A.; Miller, Richard A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Miller, Richard A.] Univ Michigan, Sch Med, Geriatr Ctr, Ann Arbor, MI 48109 USA; [Miller, Richard A.] Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI 48105 USA; [Tyra, Heather M.; Rutkowski, D. Thomas] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Iowa	Akha, AAS (corresponding author), 6240 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	asadighi@umich.edu		Rutkowski, Thomas/0000-0001-6586-4449; Harper, James/0000-0003-0765-8828	National Institutes of Health [AG031736, AG024824, AG019899, DK084058]; Carver Trust Medical Research Initiative; University of Michigan Nathan Shock Center; University of Michigan Claude Pepper Older Americans Independence Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024824, R01AG019899, P01AG031736] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver Trust Medical Research Initiative; University of Michigan Nathan Shock Center; University of Michigan Claude Pepper Older Americans Independence Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG031736, AG024824, AG019899 (to R. A. M.), and DK084058 and a Carver Trust Medical Research Initiative award (to D. T. R.), a University of Michigan Nathan Shock Center Pilot grant (to J. M. H.), and a University of Michigan Claude Pepper Older Americans Independence Center RCDC Junior faculty award (to A. A. S. A.).	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Gupta S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000410; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Henis-Korenblit S, 2010, P NATL ACAD SCI USA, V107, P9730, DOI 10.1073/pnas.1002575107; Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Leiser SF, 2006, MECH AGEING DEV, V127, P821, DOI 10.1016/j.mad.2006.08.003; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; MAZZARELLA RA, 1990, J BIOL CHEM, V265, P1094; Miller RA, 2011, AGEING RES REV, V10, P181, DOI 10.1016/j.arr.2010.01.002; Miller RA, 2009, J GERONTOL A-BIOL, V64, P179, DOI 10.1093/gerona/gln072; Murakami S, 2003, FASEB J, V17, P1565, DOI 10.1096/fj.02-1092fje; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004; Salmon AB, 2008, J GERONTOL A-BIOL, V63, P232, DOI 10.1093/gerona/63.3.232; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sierra F, 2006, J GERONTOL A-BIOL, V61, P557, DOI 10.1093/gerona/61.6.557; Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Xu CY, 2008, J BIOL CHEM, V283, P11477, DOI 10.1074/jbc.M708385200; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	47	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30344	30351		10.1074/jbc.M111.220541	http://dx.doi.org/10.1074/jbc.M111.220541			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757703	hybrid, Green Published			2022-12-25	WOS:000294283600012
J	Limpert, E; Stahel, WA				Limpert, Eckhard; Stahel, Werner A.			Problems with Using the Normal Distribution - and Ways to Improve Quality and Efficiency of Data Analysis	PLOS ONE			English	Article							SELECTION; INFLAMMATION; VARIABILITY; PHEROMONE; HEALTH; CELLS; MAP	Background: The Gaussian or normal distribution is the most established model to characterize quantitative variation of original data. Accordingly, data are summarized using the arithmetic mean and the standard deviation, by (x) over bar +/- SD, or with the standard error of the mean, (x) over bar +/- 6 SEM. This, together with corresponding bars in graphical displays has become the standard to characterize variation. Methodology/Principal Findings: Here we question the adequacy of this characterization, and of the model. The published literature provides numerous examples for which such descriptions appear inappropriate because, based on the "95% range check", their distributions are obviously skewed. In these cases, the symmetric characterization is a poor description and may trigger wrong Conclusions. To solve the problem, it is enlightening to regard causes of variation. Multiplicative causes are by far more important than additive ones, in general, and benefit from a multiplicative (or log-) normal approach. Fortunately, quite similar to the normal, the log-normal distribution can now be handled easily and characterized at the level of the original data with the help of both, a new sign, (x)/, times-divide, and notation. Analogous to (x) over bar +/- SD, it connects the multiplicative (or geometric) mean (x) over bar +/- * and the multiplicative standard deviation s* in the form (x) over bar +/-(*) (x)/s*, that is advantageous and recommended. Conclusions/Significance: The corresponding shift from the symmetric to the asymmetric view will substantially increase both, recognition of data distributions, and interpretation quality. It will allow for savings in sample size that can be considerable. Moreover, this is in line with ethical responsibility. Adequate models will improve concepts and theories, and provide deeper insight into science and life.	[Limpert, Eckhard] ELI O Res, Life Sci, Zurich, Switzerland; [Stahel, Werner A.] ETH, Swiss Fed Inst Technol, Seminar Stat, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Limpert, E (corresponding author), ELI O Res, Life Sci, Zurich, Switzerland.	stahel@stat.math.ethz.ch						Aitchison J, 1996, LOG NORMAL DISTRIBUT; [Anonymous], 2007, MATH STAT METASTATIS; [Anonymous], 2011, HDB CHEM PHYS, V91, P2; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur P, 1997, PLANT CELL ENVIRON, V20, P167, DOI 10.1046/j.1365-3040.1997.d01-66.x; Bendel M, 2006, EUR J PLANT PATHOL, V116, P85, DOI 10.1007/s10658-006-9028-1; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Durand C, 2007, P NATL ACAD SCI USA, V104, P20838, DOI 10.1073/pnas.0706923105; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Factor VM, 2000, P NATL ACAD SCI USA, V97, P2196, DOI 10.1073/pnas.040428797; Fisher R.A., 1958, STAT METHODS RES WOR; Fisher RA, 1923, J AGR SCI, V13, P311, DOI 10.1017/S0021859600003592; Galton F, 1889, NATURAL INHERITANCE, P1; Godet F, 1998, PESTIC SCI, V54, P244, DOI 10.1002/(SICI)1096-9063(1998110)54:3&lt;244::AID-PS818&gt;3.0.CO;2-8; Griffin BM, 2007, SCIENCE, V316, P1870, DOI 10.1126/science.1139478; Hattis D, 1999, RISK ANAL, V19, P711, DOI 10.1111/j.1539-6924.1999.tb00441.x; HEATH DF, 1967, NATURE, V213, P1159, DOI 10.1038/2131159a0; Ji HT, 2006, NATURE, V444, P343, DOI 10.1038/nature05323; Johnson N, 1994, CONTINUOUS UNIVARIAT, V1, P761; Kelly BC, 2007, SCIENCE, V317, P236, DOI 10.1126/science.1138275; Lawrence D, 2007, P NATL ACAD SCI USA, V104, P20696, DOI 10.1073/pnas.0705005104; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Limpert E, 1999, MODERN FUNGICIDES AND ANTIFUNGAL COMPOUNDS II, P187; Limpert E, 2003, INT BREED C AUSTR GU, P15; Machi G, 2006, PLANT PATHOL, V55, P614; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; MERTON RC, 1973, BELL J ECON, V4, P141, DOI 10.2307/3003143; MERTON RC, 1971, J ECON THEORY, V3, P373, DOI 10.1016/0022-0531(71)90038-X; MERTON RC, 1969, REV ECON STAT, V51, P247, DOI 10.2307/1926560; Morrison DA, 2004, PARASITOL RES, V94, P361, DOI 10.1007/s00436-004-1225-2; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; Pina-Ochoa E, 2010, P NATL ACAD SCI USA, V107, P1148, DOI 10.1073/pnas.0908440107; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; RENNER E, 1970, MATH STAT METHODEN P; Rinsoz T, 2006, 8 INT C AER, P253; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Sales KU, 2010, NAT GENET, V42, P676, DOI 10.1038/ng.629; SAMUELSON PA, 1965, IMR-IND MANAG REV, V6, P13; Schaper M, 2010, BAUTECHNIK, V87, P541, DOI 10.1002/bate.201010036; Smith KL, 2007, SCIENCE, V317, P478, DOI 10.1126/science.1142834; Snedecor G.W., 1989, AMES IOWA STATE U PR; Sorrentino RP, 2007, DEV BIOL, V311, P311, DOI 10.1016/j.ydbio.2007.08.011; Sorrentino RP, 2010, FLY, V4, P327, DOI 10.4161/fly.4.4.13260; Sorrentino RP, 2004, GENETICS, V166, P1343, DOI 10.1534/genetics.166.3.1343; Stehmann C, 1996, EUR J PLANT PATHOL, V102, P171, DOI 10.1007/BF01877104; Tjamos EC, 2004, EUR J PLANT PATHOL, V110, P35, DOI 10.1023/B:EJPP.0000010132.91241.cb; Tondeur S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008990; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Wilson CG, 2010, SCIENCE, V327, P574, DOI 10.1126/science.1179252; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177	61	109	109	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21403	10.1371/journal.pone.0021403	http://dx.doi.org/10.1371/journal.pone.0021403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779325	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811300008
J	Hasgall, PA; Hoogewijs, D; Faza, MB; Panse, VG; Wenger, RH; Camenisch, G				Hasgall, Philippe A.; Hoogewijs, David; Faza, Marius B.; Panse, Vikram G.; Wenger, Roland H.; Camenisch, Gieri			The Putative RNA Helicase HELZ Promotes Cell Proliferation, Translation Initiation and Ribosomal Protein S6 Phosphorylation	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; POLY(A) BINDING-PROTEIN; TUMOR-SUPPRESSOR PROTEIN; PROLYL 4-HYDROXYLASES; MOLECULAR-MECHANISMS; GENE-EXPRESSION; POLY(A)-BINDING PROTEIN; SHUTTLING PROTEIN; HYDROXYLATION; HIF	The hypoxia-inducible transcription factor (HIF) is a key component of the cellular adaptation mechanisms to hypoxic conditions. HIF alpha subunits are degraded by prolyl-4-hydroxylase domain (PHD) enzyme-dependent prolyl-4-hydroxylation of LxxLAP motifs that confer oxygen-dependent proteolytic degradation. Interestingly, only three non-HIF alpha proteins contain two conserved LxxLAP motifs, including the putative RNA helicase with a zinc finger domain HELZ. However, HELZ proteolytic regulation was found to be oxygen-independent, supporting the notion that a LxxLAP sequence motif alone is not sufficient for oxygen-dependent protein destruction. Since biochemical pathways involving RNA often require RNA helicases to modulate RNA structure and activity, we used luciferase reporter gene constructs and metabolic labeling to demonstrate that HELZ overexpression activates global protein translation whereas RNA-interference mediated HELZ suppression had the opposite effect. Although HELZ interacted with the poly(A)-binding protein (PABP) via its PAM2 motif, PABP was dispensable for HELZ function in protein translation. Importantly, downregulation of HELZ reduced translational initiation, resulting in the disassembly of polysomes, in a reduction of cell proliferation and hypophosphorylation of ribosomal protein S6.	[Hasgall, Philippe A.; Hoogewijs, David; Wenger, Roland H.; Camenisch, Gieri] Univ Zurich UZH, Inst Physiol, Zurich, Switzerland; [Hasgall, Philippe A.; Hoogewijs, David; Wenger, Roland H.; Camenisch, Gieri] Univ Zurich UZH, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Faza, Marius B.; Panse, Vikram G.] ETH, Inst Biochem, Zurich, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Swiss Federal Institutes of Technology Domain; ETH Zurich	Hasgall, PA (corresponding author), ITIS Fdn, Zurich, Switzerland.	roland.wenger@access.uzh.ch	Hoogewijs, David/L-5144-2016; Wenger, Roland H./B-7953-2009	Wenger, Roland H./0000-0001-7592-4839; Panse, Vikram/0000-0001-7950-5746	Swiss National Science Foundation [31003A_129962/1]; European Commission [PIEF-GA-2009-236157-HYDRELZ]; ETH Zurich; European Research Council [EURIBIO-260676]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); ETH Zurich(ETH Zurich); European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Swiss National Science Foundation (31003A_129962/1). D. Hoogewijs is a recipient of a Marie Curie Intra-European Fellowship from the European Commission (PIEF-GA-2009-236157-HYDRELZ). V. G. Panse is supported by the Swiss National Science Foundation, the ETH Zurich and the European Research Council (EURIBIO-260676). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2004, BIOCHEM BIOPH RES CO, V316, P129, DOI 10.1016/j.bbrc.2004.02.024; Atayar C, 2006, HUM PATHOL, V37, P675, DOI 10.1016/j.humpath.2006.01.018; Balamurugan K, 2009, ONCOGENE, V28, P3274, DOI 10.1038/onc.2009.186; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Camenisch G, 1999, FASEB J, V13, P81, DOI 10.1096/fasebj.13.1.81; Collart MA, 2004, PROG NUCLEIC ACID RE, V77, P289, DOI 10.1016/S0079-6603(04)77008-7; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Czaplinski K, 2000, RNA, V6, P730, DOI 10.1017/S1355838200992392; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Diehl F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009748; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Estrada L, 2001, HUM MOL GENET, V10, P485, DOI 10.1093/hmg/10.5.485; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Khaleghpour K, 2001, MOL CELL BIOL, V21, P5200, DOI 10.1128/MCB.21.15.5200-5213.2001; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Kozlov G, 2004, EMBO J, V23, P272, DOI 10.1038/sj.emboj.7600048; Li DX, 2004, J BIOL CHEM, V279, P55051, DOI 10.1074/jbc.M410287200; Luking A, 1998, CRIT REV BIOCHEM MOL, V33, P259, DOI 10.1080/10409239891204233; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MADER S, 1995, MOL CELL BIOL, V15, P4990; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Marti HH, 1996, EUR J NEUROSCI, V8, P666, DOI 10.1111/j.1460-9568.1996.tb01252.x; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MCDONALD WJ, J CELL BIOCH, V110, P1123; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Mikhaylova O, 2008, MOL CELL BIOL, V28, P2701, DOI 10.1128/MCB.01231-07; Nagai H, 2003, CANCER LETT, V193, P41, DOI 10.1016/S0304383502006882; Okochi K, 2005, GENES CELLS, V10, P151, DOI 10.1111/j.1365-2443.2005.00826.x; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Popowski K, 2005, MOL PHARMACOL, V67, P1629, DOI 10.1124/mol.104.010223; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Roy G, 2002, MOL CELL BIOL, V22, P3769, DOI 10.1128/MCB.22.11.3769-3782.2002; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Sanchez-Puig N, 2005, MOL CELL, V17, P11, DOI 10.1016/j.molcel.2004.11.019; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Smillie DA, 2002, J CELL SCI, V115, P395; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Wang HZ, 2009, CELL RES, V19, P1388, DOI 10.1038/cr.2009.113; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev	55	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22107	10.1371/journal.pone.0022107	http://dx.doi.org/10.1371/journal.pone.0022107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765940	Green Published, gold, Green Submitted			2022-12-25	WOS:000292781500032
J	Chatterjee, A; Drews, L; Mehra, S; Takano, E; Kaznessis, YN; Hu, WS				Chatterjee, Anushree; Drews, Laurie; Mehra, Sarika; Takano, Eriko; Kaznessis, Yiannis N.; Hu, Wei-Shou			Convergent Transcription in the Butyrolactone Regulon in Streptomyces coelicolor Confers a Bistable Genetic Switch for Antibiotic Biosynthesis	PLOS ONE			English	Article							AUTOREGULATOR RECEPTOR PROTEIN; ANTISENSE-RNA; GAMMA-BUTYROLACTONE; SECONDARY METABOLISM; SIGNALING MOLECULES; MATHEMATICAL-MODEL; ESCHERICHIA-COLI; REGULATORY GENE; A-FACTOR; INTERFERENCE	cis-encoded antisense RNAs (cis asRNA) have been reported to participate in gene expression regulation in both eukaryotic and prokaryotic organisms. Its presence in Streptomyces coelicolor has also been reported recently; however, its role has yet to be fully investigated. Using mathematical modeling we explore the role of cis asRNA produced as a result of convergent transcription in scbA-scbR genetic switch. scbA and scbR gene pair, encoding repressor-amplifier proteins respectively, mediates the synthesis of a signaling molecule, the gamma-butyrolactone SCB1 and controls the onset of antibiotic production. Our model considers that transcriptional interference caused by convergent transcription of two opposing RNA polymerases results in fatal collision and transcriptional termination, which suppresses transcription efficiency. Additionally, convergent transcription causes sense and antisense interactions between complementary sequences from opposing strands, rendering the full length transcript inaccessible for translation. We evaluated the role of transcriptional interference and the antisense effect conferred by convergent transcription on the behavior of scbA-scbR system. Stability analysis showed that while transcriptional interference affects the system, it is asRNA that confers scbA-scbR system the characteristics of a bistable switch in response to the signaling molecule SCB1. With its critical role of regulating the onset of antibiotic synthesis the bistable behavior offers this two gene system the needed robustness to be a genetic switch. The convergent two gene system with potential of transcriptional interference is a frequent feature in various genomes. The possibility of asRNA regulation in other such gene-pairs is yet to be examined.	[Chatterjee, Anushree; Drews, Laurie; Kaznessis, Yiannis N.; Hu, Wei-Shou] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [Mehra, Sarika] Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India; [Takano, Eriko] Univ Groningen, Dept Microbial Physiol, Groningen, Netherlands	University of Minnesota System; University of Minnesota Twin Cities; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; University of Groningen	Chatterjee, A (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	acre@umn.edu	Kaznessis, Yiannis N/H-1795-2015	Mehra, Sarika/0000-0003-3844-4726; Takano, Eriko/0000-0002-6791-3256; Kaznessis, Yiannis/0000-0002-5088-1104	National Institutes of Health [GM081888]; Graduate School at University of Minnesota; University of Groningen	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate School at University of Minnesota; University of Groningen	This work was supported in part by a grant from the National Institutes of Health (GM081888) to WSH. AC was supported by Doctoral Dissertation fellowship from Graduate School at University of Minnesota. ET was supported by a Rosalind Franklin Fellowship, University of Groningen. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre G, 2008, NUCLEIC ACIDS RES, V36, P5955, DOI 10.1093/nar/gkn601; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Brantl S, 2002, PLASMID, V48, P165, DOI 10.1016/S0147-619X(02)00108-7; Brantl S, 2002, BBA-GENE STRUCT EXPR, V1575, P15, DOI 10.1016/S0167-4781(02)00280-4; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Callen BP, 2004, MOL CELL, V14, P647, DOI 10.1016/j.molcel.2004.05.010; Chatterjee A, 2008, CURR OPIN BIOTECH, V19, P475, DOI 10.1016/j.copbio.2008.08.010; Chatterjee A, 2011, P NATL ACAD SCI USA, V108, P9721, DOI 10.1073/pnas.1101569108; Chen J, 2010, P NATL ACAD SCI USA, V107, P12523, DOI 10.1073/pnas.1003533107; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; COXRA, 2004, MICROBIOLOGY, V150, P1413; D'Alia D, 2010, J BACTERIOL, V192, P1160, DOI 10.1128/JB.01374-09; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Ding Y, 2003, NUCLEIC ACIDS RES, V31, P7280, DOI 10.1093/nar/gkg938; Dodd IB, 2007, J MOL BIOL, V369, P1200, DOI 10.1016/j.jmb.2007.04.041; Dornenburg JE, 2010, MBIO, V1; EGUCHI Y, 1991, ANNU REV BIOCHEM, V60, P631, DOI 10.1146/annurev.bi.60.070191.003215; Georg J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.63; Goryachev AB, 2005, PLOS COMPUT BIOL, V1, P265, DOI 10.1371/journal.pcbi.0010037; Gottelt M, 2010, MICROBIOL-SGM, V156, P2343, DOI 10.1099/mic.0.038281-0; Hernandez JA, 2006, J MOL BIOL, V355, P325, DOI 10.1016/j.jmb.2005.10.079; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Horinouchi S, 2002, FRONT BIOSCI-LANDMRK, V7, pD2045, DOI 10.2741/horinouc; Hsiao NH, 2007, MICROBIOL-SGM, V153, P1394, DOI 10.1099/mic.0.2006/004432-0; Hsiao NH, 2009, CHEM BIOL, V16, P951, DOI 10.1016/j.chembiol.2009.08.010; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kato JY, 2007, P NATL ACAD SCI USA, V104, P2378, DOI 10.1073/pnas.0607472104; Kim HS, 2004, ARCH MICROBIOL, V182, P44, DOI 10.1007/s00203-004-0697-x; Kinoshita H, 1997, J BACTERIOL, V179, P6986, DOI 10.1128/jb.179.22.6986-6993.1997; Kitani S, 2001, J BACTERIOL, V183, P4357, DOI 10.1128/JB.183.14.4357-4363.2001; Kiyosawa H, 2005, GENOME RES, V15, P463, DOI 10.1101/gr.3155905; KRINKE L, 1987, GENE DEV, V1, P1005, DOI 10.1101/gad.1.9.1005; Lee EJ, 2010, MOL MICROBIOL, V76, P1020, DOI 10.1111/j.1365-2958.2010.07161.x; LIAO SM, 1987, GENE DEV, V1, P197, DOI 10.1101/gad.1.2.197; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Mehra S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002724; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; Natsume R, 2004, J MOL BIOL, V336, P409, DOI 10.1016/j.jmb.2003.12.040; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Onaka H, 1997, J BACTERIOL, V179, P2748, DOI 10.1128/jb.179.8.2748-2752.1997; Palmer AC, 2009, MOL CELL, V34, P545, DOI 10.1016/j.molcel.2009.04.018; Panek J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-217; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; RUENGJITCHATCHAWALYA M, 1995, J BACTERIOL, V177, P551, DOI 10.1128/jb.177.3.551-557.1995; Santillan M, 2001, P NATL ACAD SCI USA, V98, P1364, DOI 10.1073/pnas.98.4.1364; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Shokeen S, 2010, PLASMID, V64, P26, DOI 10.1016/j.plasmid.2010.03.002; Sneppen K, 2005, J MOL BIOL, V346, P399, DOI 10.1016/j.jmb.2004.11.075; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Swiercz JP, 2008, NUCLEIC ACIDS RES, V36, P7240, DOI 10.1093/nar/gkn898; Takano E, 2000, J BIOL CHEM, V275, P11010, DOI 10.1074/jbc.275.15.11010; Takano E, 2001, MOL MICROBIOL, V41, P1015, DOI 10.1046/j.1365-2958.2001.02562.x; Takano E, 2005, MOL MICROBIOL, V56, P465, DOI 10.1111/j.1365-2958.2005.04543.x; Tang GQ, 2009, P NATL ACAD SCI USA, V106, P22175, DOI 10.1073/pnas.0906979106; THISTED T, 1992, J MOL BIOL, V223, P41, DOI 10.1016/0022-2836(92)90714-U; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Tian TH, 2004, J THEOR BIOL, V227, P229, DOI 10.1016/j.jtbi.2003.11.003; TOMIZAWA JI, 1981, P NATL ACAD SCI-BIOL, V78, P6096, DOI 10.1073/pnas.78.10.6096; Vo NV, 2003, BIOCHEMISTRY-US, V42, P3798, DOI 10.1021/bi026962v; Voigt CA, 2005, GENETICS, V169, P1187, DOI 10.1534/genetics.104.031955; Wang L, 2009, P NATL ACAD SCI USA, V106, P6638, DOI 10.1073/pnas.0806137106; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; WARD DF, 1979, J MOL BIOL, V133, P249, DOI 10.1016/0022-2836(79)90533-3; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wong P, 1997, BIOTECHNOL PROGR, V13, P132, DOI 10.1021/bp970003o; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	73	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21974	10.1371/journal.pone.0021974	http://dx.doi.org/10.1371/journal.pone.0021974			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765930	gold, Green Published, Green Submitted			2022-12-25	WOS:000292699000018
J	Houben, R; Hesbacher, S; Schmid, CP; Kauczok, CS; Flohr, U; Haferkamp, S; Muller, CSL; Schrama, D; Wischhusen, J; Becker, JC				Houben, Roland; Hesbacher, Sonja; Schmid, Corinna P.; Kauczok, Claudia S.; Flohr, Ulrike; Haferkamp, Sebastian; Mueller, Cornelia S. L.; Schrama, David; Wischhusen, Joerg; Becker, Juergen C.			High-Level Expression of Wild-Type p53 in Melanoma Cells is Frequently Associated with Inactivity in p53 Reporter Gene Assays	PLOS ONE			English	Article							HUMAN-MALIGNANT MELANOMA; NECROSIS-FACTOR-ALPHA; MUTATIONS; CANCER; ACTIVATION; GAIN; STABILIZATION; PROGRESSION; MOLECULES; MUTANTS	Background: Inactivation of the p53 pathway that controls cell cycle progression, apoptosis and senescence, has been proposed to occur in virtually all human tumors and p53 is the protein most frequently mutated in human cancer. However, the mutational status of p53 in melanoma is still controversial; to clarify this notion we analysed the largest series of melanoma samples reported to date. Methodology/Principal Findings: Immunohistochemical analysis of more than 180 melanoma specimens demonstrated that high levels of p53 are expressed in the vast majority of cases. Subsequent sequencing of the p53 exons 5-8, however, revealed only in one case the presence of a mutation. Nevertheless, by means of two different p53 reporter constructs we demonstrate transcriptional inactivity of wild type p53 in 6 out of 10 melanoma cell lines; the 4 other p53 wild type melanoma cell lines exhibit p53 reporter gene activity, which can be blocked by shRNA knock down of p53. Conclusions/Significance: In melanomas expressing high levels of wild type p53 this tumor suppressor is frequently inactivated at transcriptional level.	[Houben, Roland; Hesbacher, Sonja; Schmid, Corinna P.; Kauczok, Claudia S.; Flohr, Ulrike; Haferkamp, Sebastian; Schrama, David] Univ Hosp Wurzburg, Dept Dermatol, Wurzburg, Germany; [Wischhusen, Joerg] Univ Wurzburg, Dept Obstet & Gynecol, Wurzburg, Germany; [Mueller, Cornelia S. L.] Univ Saarland, Dept Dermatol, D-6650 Homburg, Germany; [Schrama, David; Becker, Juergen C.] Med Univ Graz, Dept Gen Dermatol, Graz, Austria	University of Wurzburg; University of Wurzburg; Saarland University; Medical University of Graz	Houben, R (corresponding author), Univ Hosp Wurzburg, Dept Dermatol, Wurzburg, Germany.	juergen.becker@medunigraz.at	Haferkamp, Sebastian/AAN-3649-2021; Haferkamp, Sebastian/ABD-7390-2021	Haferkamp, Sebastian/0000-0002-3894-8345; Houben, Roland/0000-0003-4538-2324; Schrama, David/0000-0002-6931-8194	Deutsche Krebshilfe [108551]; German Research Foundation (DFG); University of Wuerzburg	Deutsche Krebshilfe(Deutsche Krebshilfe); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by the Deutsche Krebshilfe (grant 108551 project 11) and also funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINO AP, 1994, MELANOMA RES, V4, P35, DOI 10.1097/00008390-199402000-00006; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Bakker ABH, 1998, J IMMUNOL, V160, P5239; BECKER JC, 1991, J IMMUNOL, V147, P4398; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Blagosklonny MV, 1997, ONCOGENE, V15, P1889, DOI 10.1038/sj.onc.1201374; Box NF, 2008, PIGM CELL MELANOMA R, V21, P525, DOI 10.1111/j.1755-148X.2008.00495.x; CASTRESANA JS, 1993, INT J CANCER, V55, P562, DOI 10.1002/ijc.2910550407; CROOK T, 1991, CELL, V67, P547, DOI 10.1016/0092-8674(91)90529-8; Daniotti M, 2004, ONCOGENE, V23, P5968, DOI 10.1038/sj.onc.1207780; Dickopp A, 2000, CANCER GENE THER, V7, P1043, DOI 10.1038/sj.cgt.7700206; Green DR, 2006, CELL, V126, P30, DOI 10.1016/j.cell.2006.06.032; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Haapajarvi T, 1999, CELL GROWTH DIFFER, V10, P163; Haferkamp S, 2009, J INVEST DERMATOL, V129, P1983, DOI 10.1038/jid.2009.5; Homer C, 2005, ONCOGENE, V24, P8314, DOI 10.1038/sj.onc.1208998; Kastan MB, 2007, NAT CELL BIOL, V9, P489, DOI 10.1038/ncb0507-489; Kern SE, 2006, CANCER BIOL THER, V5, P349, DOI 10.4161/cbt.5.4.2551; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; LEHMANN JM, 1989, P NATL ACAD SCI USA, V86, P9891, DOI 10.1073/pnas.86.24.9891; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Papp T, 1996, J CANCER RES CLIN, V122, P541, DOI 10.1007/BF01213550; Ragnarsson-Olding BK, 2002, MELANOMA RES, V12, P453, DOI 10.1097/00008390-200209000-00007; Riebeling C, 2003, MELANOMA RES, V13, P555, DOI 10.1097/00008390-200312000-00003; Roemer K, 1999, BIOL CHEM, V380, P879, DOI 10.1515/BC.1999.108; Satyamoorthy K, 2000, CELL GROWTH DIFFER, V11, P467; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Smith SL, 2009, J VIROL METHODS, V157, P47, DOI 10.1016/j.jviromet.2008.12.002; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Song H, 2007, CELL CYCLE, V6, P1570, DOI 10.4161/cc.6.13.4456; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Terzian T, 2010, PIGM CELL MELANOMA R, V23, P781, DOI 10.1111/j.1755-148X.2010.00773.x; van Oijen MGCT, 2000, CLIN CANCER RES, V6, P2138; VANMUIJEN GNP, 1991, CLIN EXP METASTAS, V9, P259, DOI 10.1007/BF01753729; Verhaegen M, 2006, CANCER RES, V66, P11348, DOI 10.1158/0008-5472.CAN-06-1748; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Wischhusen J, 2003, ONCOGENE, V22, P8233, DOI 10.1038/sj.onc.1207198; Yang RC, 1999, J IMMUNOL, V163, P1037; YU H, 2009, AM J PATHOL; Zerp SF, 1999, BRIT J CANCER, V79, P921, DOI 10.1038/sj.bjc.6690147	43	42	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22096	10.1371/journal.pone.0022096	http://dx.doi.org/10.1371/journal.pone.0022096			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760960	Green Published, gold, Green Submitted			2022-12-25	WOS:000292657200049
J	Zeitzer, JM; Ruby, NF; Fisicaro, RA; Heller, HC				Zeitzer, Jamie M.; Ruby, Norman F.; Fisicaro, Ryan A.; Heller, H. Craig			Response of the Human Circadian System to Millisecond Flashes of Light	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; BRIGHT LIGHT; PHASE; MELATONIN; RHYTHMS; PULSES; SLEEP; PHOTORECEPTORS; TEMPERATURE; SENSITIVITY	Ocular light sensitivity is the primary mechanism by which the central circadian clock, located in the suprachiasmatic nucleus (SCN), remains synchronized with the external geophysical day. This process is dependent on both the intensity and timing of the light exposure. Little is known about the impact of the duration of light exposure on the synchronization process in humans. In vitro and behavioral data, however, indicate the circadian clock in rodents can respond to sequences of millisecond light flashes. In a cross-over design, we tested the capacity of humans (n = 7) to respond to a sequence of 60 2-msec pulses of moderately bright light (473 lux) given over an hour during the night. Compared to a control dark exposure, after which there was a 3.5 +/- 7.3 min circadian phase delay, the millisecond light flashes delayed the circadian clock by 45 +/- 13 min (p<0.01). These light flashes also concomitantly increased subjective and objective alertness while suppressing delta and sigma activity (p<0.05) in the electroencephalogram (EEG). Our data indicate that phase shifting of the human circadian clock and immediate alerting effects can be observed in response to brief flashes of light. These data are consistent with the hypothesis that the circadian system can temporally integrate extraordinarily brief light exposures.	[Zeitzer, Jamie M.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Zeitzer, Jamie M.] VA Palo Alto Hlth Care Syst, Mental Illness Res Educ & Clin Ctr, Palo Alto, CA USA; [Ruby, Norman F.; Heller, H. Craig] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Fisicaro, Ryan A.] Stanford Univ, Sch Humanities & Sci, Stanford, CA 94305 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Zeitzer, JM (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	jzeitzer@stanford.edu	Zeitzer, Jamie M/A-1168-2007; Zeitzer, Jamie/AAO-2103-2020	Zeitzer, Jamie M/0000-0001-6174-5282; Zeitzer, Jamie/0000-0001-6174-5282; Heller, H Craig/0000-0003-4479-5880	Air Force Office of Scientific Research [F2-4506]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	Work described in this manuscript was supported by the Air Force Office of Scientific Research (F2-4506). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Arvanitogiannis A, 1999, NEUROSCI LETT, V261, P159, DOI 10.1016/S0304-3940(99)00021-X; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Borbely A. A., 2005, PRINCIPLES PRACTICE, P405; Brown TM, 2011, J PHYSIOL-LONDON, V589, P1173, DOI 10.1113/jphysiol.2010.199877; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cajochen C, 2000, BEHAV BRAIN RES, V115, P75, DOI 10.1016/S0166-4328(00)00236-9; Chang A, 2011, SLEEP, V34, pA162; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Duffy JF, 2009, SLEEP MED CLIN, V4, P165, DOI 10.1016/j.jsmc.2009.01.004; Duffy JF, 1999, J INVEST MED, V47, P141; Gronfier C, 2004, AM J PHYSIOL-ENDOC M, V287, pE174, DOI 10.1152/ajpendo.00385.2003; GROOS GA, 1985, ANN NY ACAD SCI, V453, P134, DOI 10.1111/j.1749-6632.1985.tb11806.x; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; JEWETT ME, 1994, J BIOL RHYTHM, V9, P295, DOI 10.1177/074873049400900310; JUNG CM, 2010, J SLEEP RES IN PRESS; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; MEIJER JH, 1991, SUPRACHIASMATIC NUCL, P107; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; Morin LP, 2009, J BIOL RHYTHM, V24, P497, DOI 10.1177/0748730409349059; Murphy Patricia J., 1996, Physiology and Behavior, V59, P133, DOI 10.1016/0031-9384(95)02036-5; NELSON DE, 1991, J PHYSIOL-LONDON, V439, P115, DOI 10.1113/jphysiol.1991.sp018660; Paul KN, 2009, REV ENDOCR METAB DIS, V10, P271, DOI 10.1007/s11154-009-9120-x; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Van den Pol AN, 1998, AM J PHYSIOL-REG I, V275, pR654, DOI 10.1152/ajpregu.1998.275.2.R654; Vidal L, 2007, J NEUROSCI, V27, P3375, DOI 10.1523/JNEUROSCI.5496-06.2007; Voultsios A, 1997, J BIOL RHYTHM, V12, P457, DOI 10.1177/074873049701200507; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695, DOI 10.1111/j.1469-7793.2000.00695.x	32	59	60	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22078	10.1371/journal.pone.0022078	http://dx.doi.org/10.1371/journal.pone.0022078			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760955	Green Published, gold, Green Submitted			2022-12-25	WOS:000292657200045
J	Oliveira, R; de Morais, ZM; Goncales, AP; Romero, EC; Vasconcellos, SA; Nascimento, ALTO				Oliveira, Rosane; de Morais, Zenaide Maria; Goncales, Amane Paldes; Romero, Eliete Calo; Vasconcellos, Silvio Arruda; Nascimento, Ana L. T. O.			Characterization of Novel OmpA-Like Protein of Leptospira interrogans That Binds Extracellular Matrix Molecules and Plasminogen	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; IMMUNOGLOBULIN-LIKE PROTEINS; OUTER-MEMBRANE PROTEINS; ESCHERICHIA-COLI; VIRULENCE DETERMINANTS; PATHOGENIC LEPTOSPIRA; FLAGELLAR MOTOR; SURFACE; IDENTIFICATION; LIPOPROTEIN	Leptospira interrogans is the etiological agent of leptospirosis, a zoonotic disease of human and veterinary concern. The identification of novel proteins that mediate host-pathogen interactions is important for understanding the bacterial pathogenesis as well as to identify protective antigens that would help fight the disease. We describe in this work the cloning, expression, purification and characterization of three predicted leptospiral membrane proteins, LIC10258, LIC12880 (Lp30) and LIC12238. We have employed Escherichia coli BL21 (SI) strain as a host expression system. Recently, we have identified LIC12238 as a plasminogen (PLG)-binding receptor. We show now that Lp30 and rLIC10258 are also PLG-receptors of Leptospira, both exhibiting dose-dependent and saturating binding (K(D), 68.8 +/- 25.2 nM and 167.39 +/- 60.1 nM, for rLIC10258 and rLIC12880, respectively). In addition, LIC10258, which is a novel OmpA-like protein, binds laminin and plasma fibronectin ECM molecules and hence, it was named Lsa66 (Leptospiral surface adhesin of 66 kDa). Binding of Lsa66 to ECM components was determined to be specific, dose-dependent and saturable, with a KD of 55.4 +/- 15.9 nM to laminin and of 290.8 +/- 11.8 nM to plasma fibronectin. Binding of the recombinant proteins to PLG or ECM components was assessed by using antibodies against each of the recombinant proteins obtained in mice and confirmed by monoclonal anti-polyhistidine antibodies. Lsa66 caused partial inhibition on leptospiral adherence to immobilized ECM and PLG. Moreover, this adhesin and rLIC12238 are recognized by antibodies in serum samples of confirmed leptospirosis cases. Thus, Lsa66 is a novel OmpA-like protein with dual activity that may promote the attachment of Leptospira to host tissues and may contribute to the leptospiral invasion. To our knowledge, this is the first leptospiral protein with ECM and PLG binding properties reported to date.	[Oliveira, Rosane; Nascimento, Ana L. T. O.] Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil; [Oliveira, Rosane; Nascimento, Ana L. T. O.] Univ Sao Paulo, Inst Ciencias Biomed, Interunidades Biotecnol, BR-05508 Sao Paulo, Brazil; [de Morais, Zenaide Maria; Goncales, Amane Paldes; Vasconcellos, Silvio Arruda] Univ Sao Paulo, Fac Med Vet & Zootecnia, Lab Zoonoses Bacterianas VPS, Sao Paulo, Brazil; [Romero, Eliete Calo] Inst Adolfo Lutz Registro, Ctr Bacteriol, Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Adolfo Lutz	Oliveira, R (corresponding author), Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil.	tabet@butantan.gov.br	GONÇALES, AMANE P/D-9409-2015; Nascimento, Ana L. T. O./E-8488-2012; Romero, Eliete C/H-6976-2012	Nascimento, Ana L. T. O./0000-0003-4851-0870; Romero, Eliete C/0000-0002-8635-439X	FAPESP; CNPq; Fundacao Butantan, Brazil	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Butantan, Brazil	This work was supported by FAPESP, CNPq and Fundacao Butantan, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atzingen MV, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-70; ATZINGEN MV, 2009, J INFECT; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; BOLIN CA, 1989, AM J VET RES, V50, P161; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Carvalho E, 2009, FEBS LETT; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Coleman JL, 1999, J LAB CLIN MED, V134, P567, DOI 10.1016/S0022-2143(99)90095-1; Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Fenno JC, 2000, INFECT IMMUN, V68, P1884, DOI 10.1128/IAI.68.4.1884-1892.2000; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001; Fraga TR, 2010, J BIOTECHNOL, V148, P156, DOI 10.1016/j.jbiotec.2010.04.007; GALAN JE, 1991, INFECT IMMUN, V59, P2901; Grizot S, 2004, MOL MICROBIOL, V51, P1027, DOI 10.1111/j.1365-2958.2003.03903.x; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Haake DA, 2002, INFECT IMMUN, V70, P4936, DOI 10.1128/IAI.70.9.4936-4945.2002; Hoke DE, 2008, INFECT IMMUN, V76, P2063, DOI 10.1128/IAI.01643-07; Hsieh WJ, 2005, FEMS MICROBIOL LETT, V243, P339, DOI 10.1016/j.femsle.2004.12.021; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Klempner MS, 1996, J INFECT DIS, V174, P97, DOI 10.1093/infdis/174.1.97; Kojima S, 2004, INT REV CYTOL, V233, P93, DOI 10.1016/S0074-7696(04)33003-2; Kojima S, 2008, P NATL ACAD SCI USA, V105, P7696, DOI 10.1073/pnas.0800308105; LeBouder F, 2008, J VIROL, V82, P6820, DOI 10.1128/JVI.00246-08; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; Ljungh A, 1996, FEMS IMMUNOL MED MIC, V16, P117, DOI 10.1016/S0928-8244(96)00073-9; Longhi MT, 2009, J MED MICROBIOL, V58, P1275, DOI 10.1099/jmm.0.011916-0; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06; MEKALANOS JJ, 1992, J BACTERIOL, V174, P1; Merien F, 2000, FEMS MICROBIOL LETT, V185, P17, DOI 10.1111/j.1574-6968.2000.tb09034.x; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; Nascimento ALTO, 2004, BRAZ J MED BIOL RES, V37, P459, DOI 10.1590/S0100-879X2004000400003; Neves FO, 2007, ARCH MICROBIOL, V188, P523, DOI 10.1007/s00203-007-0273-2; Oliveira TR, 2010, MICROBES INFECT, V12, P207, DOI 10.1016/j.micinf.2009.12.004; Parsons LM, 2006, BIOCHEMISTRY-US, V45, P2122, DOI 10.1021/bi052227i; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Pinne M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000815; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Rojas M, 2008, ACTA TROP, V107, P54, DOI 10.1016/j.actatropica.2008.04.013; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; TURNER LH, 1970, T ROY SOC TROP MED H, V64, P623, DOI 10.1016/0035-9203(70)90087-8; Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006; Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09; Vieira ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011259; Vieira ML, 2010, J INFECTION, V60, P52, DOI 10.1016/j.jinf.2009.10.047; Vieira ML, 2009, INFECT IMMUN, V77, P4092, DOI 10.1128/IAI.00353-09; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; Yan WW, 2010, VACCINE, V28, P2277, DOI 10.1016/j.vaccine.2009.12.071; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Zhang Y, 2010, ACTA BIOCH BIOPH SIN, V42, P70, DOI 10.1093/abbs/gmp109	64	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21962	10.1371/journal.pone.0021962	http://dx.doi.org/10.1371/journal.pone.0021962			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755014	Green Published, gold, Green Submitted			2022-12-25	WOS:000292632000041
J	Martens-Uzunova, ES; Jalava, SE; Dits, NF; van Leenders, GJLH; Moller, S; Trapman, J; Bangma, CH; Litman, T; Visakorpi, T; Jenster, G				Martens-Uzunova, E. S.; Jalava, S. E.; Dits, N. F.; van Leenders, G. J. L. H.; Moller, S.; Trapman, J.; Bangma, C. H.; Litman, T.; Visakorpi, T.; Jenster, G.			Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer	ONCOGENE			English	Article						prostate cancer; microRNA; snoRNA; microarray; deep sequencing; Q-PCR	MICRORNA EXPRESSION; GENE-EXPRESSION; UP-REGULATION; RECEPTOR; SNORNA; ACTIVATION; INVASION; REVEALS; PROFILE; KINASE	Prostate cancer (PCa) is the most frequent male malignancy and the second most common cause of cancer-related death in Western countries. Current clinical and pathological methods are limited in the prediction of postoperative outcome. It is becoming increasingly evident that small non-coding RNA (ncRNA) species are associated with the development and progression of this malignancy. To assess the diversity and abundance of small ncRNAs in PCa, we analyzed the composition of the entire small transcriptome by Illumina/Solexa deep sequencing. We further analyzed the microRNA (miRNA) expression signatures of 102 fresh-frozen patient samples during PCa progression by miRNA microarrays. Both platforms were cross-validated by quantitative reverse transcriptase-PCR. Besides the altered expression of several miRNAs, our deep sequencing analyses revealed strong differential expression of small nucleolar RNAs (snoRNAs) and transfer RNAs (tRNAs). From microarray analysis, we derived a miRNA diagnostic classifier that accurately distinguishes normal from cancer samples. Furthermore, we were able to construct a PCa prognostic predictor that independently forecasts postoperative outcome. Importantly, the majority of miRNAs included in the predictor also exhibit high sequence counts and concordant differential expression in Illumina PCa samples, supported by quantitative reverse transcriptase-PCR. Our findings provide miRNA expression signatures that may serve as an accurate tool for the diagnosis and prognosis of PCa. Oncogene (2012) 31, 978-991; doi:10.1038/onc.2011.304; published online 18 July 2011	[Martens-Uzunova, E. S.; Dits, N. F.; Bangma, C. H.; Jenster, G.] Erasmus MC, Dept Urol, Josephine Nefkens Inst, NL-3000 CA Rotterdam, Netherlands; [Jalava, S. E.; Visakorpi, T.] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Jalava, S. E.; Visakorpi, T.] Tampere Univ Hosp, Tampere, Finland; [van Leenders, G. J. L. H.; Trapman, J.] Erasmus MC, Dept Pathol, Josephine Nefkens Inst, NL-3000 CA Rotterdam, Netherlands; [Moller, S.; Litman, T.] Exiqon AS, Vedbaek, Denmark	Erasmus University Rotterdam; Erasmus MC; Tampere University; Tampere University; Tampere University Hospital; Erasmus University Rotterdam; Erasmus MC; Exiqon	Jenster, G (corresponding author), Erasmus MC, Dept Urol, Josephine Nefkens Inst, Room BE362A,POB 2040, NL-3000 CA Rotterdam, Netherlands.	g.jenster@erasmusmc.nl	Martens-Uzunova, Elena/D-9768-2012	Martens-Uzunova, Elena/0000-0002-5363-2525; Visakorpi, Tapio/0000-0002-5004-0364; Litman, Thomas/0000-0002-6068-901X	European Community [HEALTH-F2-2007-201438]; Academy of Finland; Cancer Society of Finland; Reino Lahtikari Foundation; Sigrid Juselius Foundation; Tampere University Hospital	European Community(European Commission); Academy of Finland(Academy of Finland); Cancer Society of Finland; Reino Lahtikari Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere University Hospital	We thank Theo van der Kwast for histo-pathological examination of patient samples. We also thank Mark Wildhagen for providing the coded clinical data. We acknowledge the European Community's Seventh Framework Program (FP7/2007-2013), grant agreement No HEALTH-F2-2007-201438, the Academy of Finland; Cancer Society of Finland; Reino Lahtikari Foundation; Sigrid Juselius Foundation; and the Medical Research Fund of Tampere University Hospital for their support.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Bin Hafeez B, 2009, CLIN CANCER RES, V15, P452, DOI 10.1158/1078-0432.CCR-08-1631; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; de Wit E, 2009, GENOME RES, V19, P2064, DOI 10.1101/gr.093781.109; Dong XY, 2008, HUM MOL GENET, V17, P1031, DOI 10.1093/hmg/ddm375; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Gillies JK, 2007, CELL CYCLE, V6, P2005, DOI 10.4161/cc.6.16.4526; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Lee JT, 2008, CELL CYCLE, V7, P1745, DOI 10.4161/cc.7.12.6166; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Majid S, 2010, CANCER-AM CANCER SOC, V116, P5637, DOI 10.1002/cncr.25488; Marberger M, 2009, EUR UROL SUPPL, V8, P89, DOI 10.1016/j.eursup.2008.10.003; Marshall L, 2008, NAT REV CANCER, V8, P911, DOI 10.1038/nrc2539; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Michael MZ, 2003, MOL CANCER RES, V1, P882; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mukherjee R, 2011, BRIT J CANCER, V104, P1920, DOI 10.1038/bjc.2011.163; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Paronetto MP, 2004, AM J PATHOL, V164, P1243, DOI 10.1016/S0002-9440(10)63212-9; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Prueitt RL, 2008, PROSTATE, V68, P1152, DOI 10.1002/pros.20786; Radmacher MD, 2002, J COMPUT BIOL, V9, P505, DOI 10.1089/106652702760138592; Reis EM, 2004, ONCOGENE, V23, P6684, DOI 10.1038/sj.onc.1207880; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Royo H, 2006, CYTOGENET GENOME RES, V113, P99, DOI 10.1159/000090820; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443; Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Waltering KK, 2011, PROSTATE, V71, P604, DOI 10.1002/pros.21276; Wang SH, 2009, INT J ONCOL, V34, P1461, DOI 10.3892/ijo_00000275; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Willenbrock H, 2009, RNA, V15, P2028, DOI 10.1261/rna.1699809; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200	50	197	213	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	8					978	991		10.1038/onc.2011.304	http://dx.doi.org/10.1038/onc.2011.304			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	898BG	21765474				2022-12-25	WOS:000300709700004
J	Rao, S; Lyons, LS; Fahrenholtz, CD; Wu, F; Farooq, A; Balkan, W; Burnstein, KL				Rao, S.; Lyons, L. S.; Fahrenholtz, C. D.; Wu, F.; Farooq, A.; Balkan, W.; Burnstein, K. L.			A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer	ONCOGENE			English	Article						Vav3; pleckstrin homology; coactivator; androgen receptor; castration-resistant prostate cancer; guanine nucleotide exchange factor	PLECKSTRIN-HOMOLOGY DOMAINS; MOLECULAR DETERMINANTS; STRUCTURAL BASIS; ACTIVATION; BINDING; RECOGNITION; PROGRESSION; ONCOGENE; FAMILY; PH	Increased androgen receptor (AR) transcriptional activity mediated by coactivator proteins may drive castration-resistant prostate cancer (CRPC) growth. Vav3, a Rho GTPase guanine nucleotide exchange factor (GEF), is overexpressed in human prostate cancers, particularly in models of CRPC progression. Vav3 coactivates AR in a Vav3 pleckstrin homology (PH) domain-dependent but GEF-independent manner. Ectopic expression of Vav3 in androgen-dependent human prostate cancer cells conferred robust castration-resistant xenograft tumor growth. Vav3 but not a Vav3 PH mutant greatly stimulated interaction between the AR amino and carboxyl termini (N-C interaction), which is required for maximal receptor transcriptional activity. Vav3 was distributed between the cytoplasm and nucleus with nuclear localization-dependent on the Vav3 PH domain. Membrane targeting of Vav3 abolished Vav3 potentiation of AR activity, whereas nuclear targeting of a Vav3 PH mutant rescued AR coactivation, suggesting that nuclear localization is an important function of the Vav3 PH domain. A nuclear role for Vav3 was further demonstrated by sequential chromatin immunoprecipitation assays, which revealed that Vav3 and AR were recruited to the same transcriptional complexes of an AR target gene enhancer. These data demonstrate the importance of Vav3 in CRPC and define a novel nuclear function of Vav3 in regulating AR activity. Oncogene (2012) 31, 716-727; doi:10.1038/onc.2011.273; published online 18 July 2011	[Rao, S.; Fahrenholtz, C. D.; Wu, F.; Burnstein, K. L.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Lyons, L. S.] Nova SE Univ, Ft Lauderdale, FL 33314 USA; [Farooq, A.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Balkan, W.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA	University of Miami; Nova Southeastern University; University of Miami; University of Miami	Burnstein, KL (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, 1600 NW 10th Ave,R-189, Miami, FL 33136 USA.	kburnstein@med.miami.edu	Rao, Shuyun/AAE-9724-2019; Fahrenholtz, Cale/GWZ-4512-2022; Farooq, Amjad/B-5084-2012		National Institutes of Health [RO1CA132200]; US Department of Defense [PC060504];  [T32-HL007188];  [R01GM083897]; NATIONAL CANCER INSTITUTE [R01CA132200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr Zafar Nawaz and his laboratory for advice on ChIP assays. We thank Drs Adena Rosenblatt, Omar Flores and Carlos Perez-Stable for helpful suggestions. Zhe Ma provided assistance with the mammalian two-hybrid assays. A National Institutes of Health Grant RO1CA132200 (to KLB) supported this work. LSL and FW were supported by US Department of Defense post-doctoral fellowship (PC060504); SR was an American Heart Association Pre-doctoral Fellow; CDF was supported by T32-HL007188 and AF acknowledges funding from R01GM083897.	Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; Banach-Petrosky W, 2007, CANCER RES, V67, P9089, DOI 10.1158/0008-5472.CAN-07-2887; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Brantley-Sieders DM, 2009, MOL CANCER RES, V7, P615, DOI 10.1158/1541-7786.MCR-08-0401; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Dong ZY, 2006, MOL ENDOCRINOL, V20, P2315, DOI 10.1210/me.2006-0048; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Hornstein I, 2003, J PATHOL, V199, P526, DOI 10.1002/path.1314; Houlard M, 2002, J EXP MED, V195, P1115, DOI 10.1084/jem.20011701; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; John B, 2003, NUCLEIC ACIDS RES, V31, P3982, DOI 10.1093/nar/gkg460; Korenchuk S, 2001, IN VIVO, V15, P163; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 2002, FEBS LETT, V513, P71, DOI 10.1016/S0014-5793(01)03243-4; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; Lemmon MA, 1999, BIOCHEM SOC T, V27, P617, DOI 10.1042/bst0270617; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Liu Y, 2008, CANCER RES, V68, P6396, DOI 10.1158/0008-5472.CAN-08-0645; Liu Y, 2010, INT J ONCOL, V36, P623, DOI 10.3892/ijo_00000538; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; Lyons LS, 2008, MOL ENDOCRINOL, V22, P597, DOI 10.1210/me.2007-0158; Lyons LS, 2006, MOL ENDOCRINOL, V20, P1061, DOI 10.1210/me.2005-0346; Maffucci T, 2003, MOL ENDOCRINOL, V17, P1568, DOI 10.1210/me.2001-0211; Mahadevan D, 2008, MOL CANCER THER, V7, P2621, DOI 10.1158/1535-7163.MCT-07-2276; Marques RB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013500; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Miller SL, 2005, MOL ENDOCRINOL, V19, P939, DOI 10.1210/me.2004-0443; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Movilla N, 1999, MOL CELL BIOL, V19, P7870; O'Malley BW, 2009, CANCER RES, V69, P8217, DOI 10.1158/0008-5472.CAN-09-2223; Ouyang X, 2008, CANCER RES, V68, P2132, DOI 10.1158/0008-5472.CAN-07-6055; Palmby TR, 2002, J BIOL CHEM, V277, P39350, DOI 10.1074/jbc.M202641200; Patel V, 2007, CARCINOGENESIS, V28, P1145, DOI 10.1093/carcin/bgm008; Rapley J, 2008, EMBO REP, V9, P655, DOI 10.1038/embor.2008.80; Sartor O, 2002, UROLOGY, V60, P138; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Schmidt LJ, 2009, PROSTATE, V69, P1730, DOI 10.1002/pros.21022; Shen HC, 2005, BIOL CHEM, V386, P69, DOI 10.1515/BC.2005.009; Tindall DJ, 2001, UROLOGY, V57, P28, DOI 10.1016/S0090-4295(00)00932-8; Trenkle T, 2000, GENE, V245, P139, DOI 10.1016/S0378-1119(00)00026-3; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Xi SL, 2010, FEBS LETT, V584, P1223, DOI 10.1016/j.febslet.2010.02.036; Zeng LY, 2000, MOL CELL BIOL, V20, P9212, DOI 10.1128/MCB.20.24.9212-9224.2000	57	36	39	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	6					716	727		10.1038/onc.2011.273	http://dx.doi.org/10.1038/onc.2011.273			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MU	21765461	Green Accepted			2022-12-25	WOS:000300222100005
J	Tisserand, J; Khetchoumian, K; Thibault, C; Dembele, D; Chambon, P; Losson, R				Tisserand, Johan; Khetchoumian, Konstantin; Thibault, Christelle; Dembele, Doulaye; Chambon, Pierre; Losson, Regine			Tripartite Motif 24 (Trim24/Tif1 alpha) Tumor Suppressor Protein Is a Novel Negative Regulator of Interferon (IFN)/Signal Transducers and Activators of Transcription (STAT) Signaling Pathway Acting through Retinoic Acid Receptor alpha (Rar alpha) Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; NUCLEAR RECEPTORS; UP-REGULATION; ARGININE METHYLTRANSFERASE-1; TRIM24 TIF1-ALPHA; TIF1 FAMILY; HEPATITIS-C; GROWTH; LIVER	Recent genetic studies in mice have established that the nuclear receptor coregulator Trim24/Tif1 alpha suppresses hepatocarcinogenesis by inhibiting retinoic acid receptor alpha (Rara)-dependent transcription and cell proliferation. However, Rara targets regulated by Trim24 remain unknown. We report that the loss of Trim24 resulted in interferon (IFN)/STAT pathway overactivation soon after birth (week 5). Despite a transient attenuation of this pathway by the induction of several IFN/STAT pathway repressors later in the disease, this phenomenon became more pronounced in tumors. Remarkably, Rara haplo-deficiency, which suppresses tumorigenesis in Trim24(-/-) mice, prevented IFN/STAT overactivation. Moreover, together with Rara, Trim24 bound to the retinoic acid-responsive element of the Stat1 promoter and repressed its retinoic acid-induced transcription. Altogether, these results identify Trim24 as a novel negative regulator of the IFN/STAT pathway and suggest that this repression through Rara inhibition may prevent liver cancer.	[Tisserand, Johan; Khetchoumian, Konstantin; Thibault, Christelle; Dembele, Doulaye; Chambon, Pierre; Losson, Regine] Univ Strasbourg 1, Dept Funct Genom, Inst Genet & Biol Mol & Cellulaire IGBMC, CNRS,INSERM, F-67404 Illkirch Graffenstaden, Communaute Urba, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Chambon, P (corresponding author), Univ Strasbourg 1, Dept Funct Genom, Inst Genet & Biol Mol & Cellulaire IGBMC, CNRS,INSERM, BP 10142, F-67404 Illkirch Graffenstaden, Communaute Urba, France.	chambon@igbmc.fr	Dembélé, Doulaye/O-6513-2017	Dembélé, Doulaye/0000-0003-3879-6940; Thibault-Carpentier, Christelle/0000-0003-1562-1451	CNRS; INSERM; Agence Nationale de la Recherche [ANR06-BLAN-0377]; Association pour la Recherche contre le Cancer (ARC); Ligue Nationale Contre le Cancer; Institut National du Cancer (INCa); ARTOn; Ministere de la Recherche et des Technologies; ARC; INCa; ARI (Agence Regionale de l'Innovation)	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); ARTOn; Ministere de la Recherche et des Technologies; ARC(Australian Research Council); INCa(Institut National du Cancer (INCA) France); ARI (Agence Regionale de l'Innovation)	This work was supported in part by the CNRS, INSERM, Agence Nationale de la Recherche Grant ANR06-BLAN-0377, Association pour la Recherche contre le Cancer (ARC), Ligue Nationale Contre le Cancer, and the Institut National du Cancer (INCa; Project ARTOn).; Supported by fellowships from the Ministere de la Recherche et des Technologies, ARC, INCa, and ARI (Agence Regionale de l'Innovation).	Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Beckstead R, 2001, MOL CELL, V7, P753, DOI 10.1016/S1097-2765(01)00220-9; Breuhahn K, 2004, CANCER RES, V64, P6058, DOI 10.1158/0008-5472.CAN-04-0292; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Buettner R, 2002, CLIN CANCER RES, V8, P945; Chambon P, 2005, MOL ENDOCRINOL, V19, P1418, DOI 10.1210/me.2005-0125; Chelbi-Alix MK, 1999, LEUKEMIA, V13, P1167, DOI 10.1038/sj.leu.2401469; Chen L., 2011, INT J BIOCH IN PRESS; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; Desmet VJ, 2009, HEPATOLOGY, V49, P355, DOI 10.1002/hep.22681; Duex JE, 2011, J BIOL CHEM, V286, P25377, DOI 10.1074/jbc.M111.222760; Duong FHT, 2005, J VIROL, V79, P15342, DOI 10.1128/JVI.79.24.15342-15350.2005; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gupta S, 2000, SEMIN CANCER BIOL, V10, P161; Hanada T, 2006, J EXP MED, V203, P1391, DOI 10.1084/jem.20060436; Herquel B, 2011, P NATL ACAD SCI USA, V108, P8212, DOI 10.1073/pnas.1101544108; Huynh H, 2010, BIOCHEM PHARMACOL, V80, P550, DOI 10.1016/j.bcp.2010.03.034; Kensler TW, 2003, NAT REV CANCER, V3, P321, DOI 10.1038/nrc1076; Khetchoumian K, 2004, J BIOL CHEM, V279, P48329, DOI 10.1074/jbc.M404779200; Khetchoumian K, 2007, NAT GENET, V39, P1500, DOI 10.1038/ng.2007.15; Khetchoumian K, 2008, CELL CYCLE, V7, P3647, DOI 10.4161/cc.7.23.7123; Khodarev NN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005821; Kolla V, 1996, J BIOL CHEM, V271, P10508, DOI 10.1074/jbc.271.18.10508; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Lehner F, 2007, FASEB J, V21, P1445, DOI 10.1096/fj.06-6575com; Lehner F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013344; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Lukasiak S, 2008, ONCOGENE, V27, P6068, DOI 10.1038/onc.2008.201; Matsuda M, 2005, LAB INVEST, V85, P655, DOI 10.1038/labinvest.3700257; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MIKI T, 1991, P NATL ACAD SCI USA, V88, P5167, DOI 10.1073/pnas.88.12.5167; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Onitsuka A, 1996, SURG TODAY, V26, P126, DOI 10.1007/BF00311777; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Potu H, 2010, CANCER RES, V70, P655, DOI 10.1158/0008-5472.CAN-09-1942; RESAR LMS, 1993, MOL CELL BIOL, V13, P1130, DOI 10.1128/MCB.13.2.1130; Roberts D, 2005, BRIT J CANCER, V92, P1149, DOI 10.1038/sj.bjc.6602447; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sugawara I, 2004, TOHOKU J EXP MED, V202, P41, DOI 10.1620/tjem.202.41; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Teyssier C, 2006, MOL ENDOCRINOL, V20, P1276, DOI 10.1210/me.2005-0393; Thorgeirsson SS, 2006, HEPATOLOGY, V43, pS145, DOI 10.1002/hep.21063; Trevisani F, 2008, CARCINOGENESIS, V29, P1299, DOI 10.1093/carcin/bgn113; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674; Xiao WH, 1997, J BIOL CHEM, V272, P9742, DOI 10.1074/jbc.272.15.9742; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/88225; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x; Zhong S, 1999, NAT GENET, V23, P287, DOI 10.1038/15463	56	51	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33369	33379		10.1074/jbc.M111.225680	http://dx.doi.org/10.1074/jbc.M111.225680			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21768647	Green Published, hybrid			2022-12-25	WOS:000294968800055
J	Brown, NG; Chow, DC; Sankaran, B; Zwart, P; Prasad, BVV; Palzkill, T				Brown, Nicholas G.; Chow, Dar-Chone; Sankaran, Banumathi; Zwart, Peter; Prasad, B. V. Venkataram; Palzkill, Timothy			Analysis of the Binding Forces Driving the Tight Interactions between beta-Lactamase Inhibitory Protein-II (BLIP-II) and Class A beta-Lactamases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS PC1; SITE-DIRECTED MUTAGENESIS; ACYL-ENZYME INTERMEDIATE; CRYSTAL-STRUCTURE; CRYSTALLOGRAPHIC STRUCTURE; MODULAR ARCHITECTURE; PHAGE DISPLAY; COMPLEX; INTERFACE; TEM-1	beta-Lactamases hydrolyze beta-lactam antibiotics to provide drug resistance to bacteria. beta-Lactamase inhibitory protein-II (BLIP-II) is a potent proteinaceous inhibitor that exhibits low picomolar affinity for class A beta-lactamases. This study examines the driving forces for binding between BLIP-II and beta-lactamases using a combination of presteady state kinetics, isothermal titration calorimetry, and x-ray crystallography. The measured dissociation rate constants for BLIP-II and various beta-lactamases ranged from 10(-4) to 10(-7) s(-1) and are comparable with those found in some of the tightest known protein-protein interactions. The crystal structures of BLIP-II alone and in complex with Bacillus anthracis Bla1 beta-lactamase revealed no significant side-chain movement in BLIP-II in the complex versus the monomer. The structural rigidity of BLIP-II minimizes the loss of the entropy upon complex formation and, as indicated by thermodynamics experiments, may be a key determinant of the observed potent inhibition of beta-lactamases.	[Brown, Nicholas G.; Palzkill, Timothy] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Brown, Nicholas G.; Chow, Dar-Chone; Prasad, B. V. Venkataram; Palzkill, Timothy] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Prasad, B. V. Venkataram; Palzkill, Timothy] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Sankaran, Banumathi; Zwart, Peter] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Palzkill, T (corresponding author), 1 Baylor Plaza, Houston, TX 77030 USA.	timothyp@bcm.tmc.edu	Zwart, Peter/F-7123-2013	Brown, Nicholas/0000-0002-6141-0164; Prasad, B.V.Venkataram/0000-0002-1172-2071	National Institutes of Health from the Keck Center Biomedical Discovery [T90 DA 022885];  [AI32956];  [AI092963]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI032956, R37AI032956, R01AI032956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022885] Funding Source: NIH RePORTER	National Institutes of Health from the Keck Center Biomedical Discovery(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants T90 DA 022885 (a training fellowship from the Keck Center Biomedical Discovery from the Large Scale Data Sets Training Program of the Gulf Coast Consortia) and AI32956 and AI092963 (to T. P.).	ADACHI H, 1991, J BIOL CHEM, V266, P3186; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Albeck S, 1999, BIOCHEMISTRY-US, V38, P11, DOI 10.1021/bi981772z; Ali Shah A, 2004, RES MICROBIOL, V155, P409, DOI 10.1016/j.resmic.2004.02.009; Andujar-Sanchez M, 2004, BIOPHYS CHEM, V111, P183, DOI 10.1016/j.bpc.2004.05.011; Babu MM, 2003, NUCLEIC ACIDS RES, V31, P3345, DOI 10.1093/nar/gkg528; Bai HJ, 2011, PROTEINS, V79, P720, DOI 10.1002/prot.22904; Bebrone C, 2001, ANTIMICROB AGENTS CH, V45, P1868, DOI 10.1128/AAC.45.6.1868-1871.2001; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Brown NG, 2010, PROTEIN ENG DES SEL, V23, P469, DOI 10.1093/protein/gzq017; Brown NG, 2010, J MOL BIOL, V404, P832, DOI 10.1016/j.jmb.2010.10.008; Brown NG, 2009, J BIOL CHEM, V284, P33703, DOI 10.1074/jbc.M109.053819; Camacho CJ, 2000, BIOPHYS J, V78, P1094, DOI 10.1016/S0006-3495(00)76668-9; Castro MJM, 1996, BIOCHEMISTRY-US, V35, P11435, DOI 10.1021/bi960515w; Chaibi EB, 1999, J ANTIMICROB CHEMOTH, V43, P447, DOI 10.1093/jac/43.4.447; Chen CC, 1996, BIOCHEMISTRY-US, V35, P12251, DOI 10.1021/bi961153v; CHRISTENSEN H, 1990, BIOCHEM J, V266, P853; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DORAN JL, 1990, J BACTERIOL, V172, P4909, DOI 10.1128/jb.172.9.4909-4918.1990; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Drawz SM, 2009, BIOCHEMISTRY-US, V48, P4557, DOI 10.1021/bi9003292; Durchschlag H, 2003, RADIAT PHYS CHEM, V67, P479, DOI 10.1016/S0969-806X(03)00089-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESCOBAR WA, 1994, BIOCHEMISTRY-US, V33, P7619, DOI 10.1021/bi00190a015; FONZE E, 1995, ACTA CRYSTALLOGR D, V51, P682, DOI 10.1107/S0907444994014496; FRERE JM, 1995, MOL MICROBIOL, V16, P385, DOI 10.1111/j.1365-2958.1995.tb02404.x; Frisch C, 1997, J MOL BIOL, V267, P696, DOI 10.1006/jmbi.1997.0892; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Gretes M, 2009, J MOL BIOL, V389, P289, DOI 10.1016/j.jmb.2009.03.058; Grunberg R, 2006, STRUCTURE, V14, P683, DOI 10.1016/j.str.2006.01.014; Guharoy M, 2010, PROTEINS, V78, P3219, DOI 10.1002/prot.22821; Guillaume G, 1997, J BIOL CHEM, V272, P5438, DOI 10.1074/jbc.272.9.5438; Hadjebi O, 2008, BBA-MOL CELL RES, V1783, P1467, DOI 10.1016/j.bbamcr.2008.03.015; Hanes MS, 2009, BIOCHEMISTRY-US, V48, P9185, DOI 10.1021/bi9007963; Harel M, 2007, J MOL BIOL, V371, P180, DOI 10.1016/j.jmb.2007.05.032; HERZBERG O, 1991, J MOL BIOL, V217, P701, DOI 10.1016/0022-2836(91)90527-D; Huang WZ, 1998, ANTIMICROB AGENTS CH, V42, P2893, DOI 10.1128/AAC.42.11.2893; Huang WZ, 2000, J BIOL CHEM, V275, P14964, DOI 10.1074/jbc.M001285200; JELESAROV I, 1994, BIOCHEMISTRY-US, V33, P13321, DOI 10.1021/bi00249a019; Kuzin AP, 1999, BIOCHEMISTRY-US, V38, P5720, DOI 10.1021/bi990136d; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Lim D, 2001, NAT STRUCT BIOL, V8, P848, DOI 10.1038/nsb1001-848; Livermore DM, 2006, TRENDS MICROBIOL, V14, P413, DOI 10.1016/j.tim.2006.07.008; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Materon IC, 2003, ANTIMICROB AGENTS CH, V47, P2040, DOI 10.1128/AAC.47.6.2040-2042.2003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page M. I., 1999, CURR PHARM DESIGN, V5, P915; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Paoli M, 2001, PROG BIOPHYS MOL BIO, V76, P103, DOI 10.1016/S0079-6107(01)00007-4; Park HU, 1998, MICROBIOL-SGM, V144, P2161, DOI 10.1099/00221287-144-8-2161; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pearce KH, 1999, BIOCHEMISTRY-US, V38, P81, DOI 10.1021/bi9817008; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Pons T, 2003, CURR MED CHEM, V10, P505, DOI 10.2174/0929867033368204; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Reichmann D, 2007, J MOL BIOL, V365, P663, DOI 10.1016/j.jmb.2006.09.076; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Reichmann D, 2008, BIOCHEMISTRY-US, V47, P1051, DOI 10.1021/bi7019639; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; Reynolds KA, 2008, J MOL BIOL, V382, P1265, DOI 10.1016/j.jmb.2008.05.051; Ruvinsky AM, 2011, J MOL BIOL, V408, P356, DOI 10.1016/j.jmb.2011.02.030; Schreiber F, 2005, BIOINFORMATICS, V21, P3572, DOI 10.1093/bioinformatics/bti556; SCHREIBER G, 1993, BIOCHEMISTRY-US, V32, P5145, DOI 10.1021/bi00070a025; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Sevcik J, 1996, ACTA CRYSTALLOGR D, V52, P327, DOI 10.1107/S0907444995007669; Shaul Y, 2005, PROTEINS, V60, P341, DOI 10.1002/prot.20489; Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P290, DOI 10.1038/nsb0396-290; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Takagi J, 2003, NATURE, V424, P969, DOI 10.1038/nature01873; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Thomson JM, 2006, J BIOL CHEM, V281, P26734, DOI 10.1074/jbc.M603222200; WALLIS R, 1995, BIOCHEMISTRY-US, V34, P13751, DOI 10.1021/bi00042a005; WALLIS R, 1995, BIOCHEMISTRY-US, V34, P13743, DOI 10.1021/bi00042a004; Walsh TR, 2008, CURR OPIN INFECT DIS, V21, P367, DOI 10.1097/QCO.0b013e328303670b; Walther-Rasmussen J, 2007, J ANTIMICROB CHEMOTH, V60, P470, DOI 10.1093/jac/dkm226; Wang JH, 2007, J BIOL CHEM, V282, P17676, DOI 10.1074/jbc.M611548200; Wang JH, 2009, J BIOL CHEM, V284, P595, DOI 10.1074/jbc.M804089200; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Yuan J, 2011, J MOL BIOL, V406, P730, DOI 10.1016/j.jmb.2011.01.014; Yuan J, 2009, J MOL BIOL, V389, P401, DOI 10.1016/j.jmb.2009.04.028; Zawadzke LE, 1995, PROTEIN ENG, V8, P1275, DOI 10.1093/protein/8.12.1275; Zhang Z, 2004, J BIOL CHEM, V279, P42860, DOI 10.1074/jbc.M406157200; Zhang Z, 2003, J BIOL CHEM, V278, P45706, DOI 10.1074/jbc.M308572200; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	94	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32723	32735		10.1074/jbc.M111.265058	http://dx.doi.org/10.1074/jbc.M111.265058			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775426	Green Published, hybrid			2022-12-25	WOS:000294726800081
J	Hodson, C; Cole, AR; Lewis, LPC; Miles, JA; Purkiss, A; Walden, H				Hodson, Charlotte; Cole, Ambrose R.; Lewis, Laurence P. C.; Miles, Jennifer A.; Purkiss, Andrew; Walden, Helen			Structural Analysis of Human FANCL, the E3 Ligase in the Fanconi Anemia Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPAIR; PROTEINS; COMPLEX; GENE; CLONING; DOMAIN; UBE2T; E2	The Fanconi anemia (FA) pathway is essential for the repair of DNA interstrand cross-links. At the heart of this pathway is the monoubiquitination of the FANCI-FANCD2 (ID) complex by the multiprotein "core complex" containing the E3 ubiquitin ligase FANCL. Vertebrate organisms have the eight-protein core complex, whereas invertebrates apparently do not. We report here the structure of the central domain of human FANCL in comparison with the recently solved Drosophila melanogaster FANCL. Our data represent the first structural detail into the catalytic core of the human system and reveal that the central fold of FANCL is conserved between species. However, there are macromolecular differences between the FANCL proteins that may account for the apparent distinctions in core complex requirements between the vertebrate and invertebrate FA pathways. In addition, we characterize the binding of human FANCL with its partners, Ube2t, FANCD2, and FANCI. Mutational analysis reveals which residues are required for substrate binding, and we also show the domain required for E2 binding.	[Hodson, Charlotte; Cole, Ambrose R.; Lewis, Laurence P. C.; Miles, Jennifer A.; Purkiss, Andrew; Walden, Helen] Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Prot Struct & Funct Lab, London WC2A 3LY, England	Cancer Research UK	Walden, H (corresponding author), Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Prot Struct & Funct Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	Helen.Walden@cancer.org.uk		Miles, Jennifer/0000-0001-8839-9201	Protein Structure and Function laboratory; Cancer Research UK	Protein Structure and Function laboratory; Cancer Research UK(Cancer Research UK)	We thank Michael Way for discussions and criticisms on the manuscript and members of the Protein Structure and Function laboratory for suggestions and support. We also thank K. J. Patel for the plasmid for HIS-FANCD2 and P. Knipscheer and J. C. Walter for the FLAG-FANCI plasmid. We thank the protein production facility for generating the viruses for the insect cell protein expression.; This work was supported by a grant from Cancer Research UK.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Alter BP, 1996, AM J HEMATOL, V53, P99, DOI 10.1002/(SICI)1096-8652(199610)53:2<99::AID-AJH7>3.3.CO;2-M; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Burroughs AM, 2008, J STRUCT BIOL, V162, P205, DOI 10.1016/j.jsb.2007.12.006; Cole AR, 2010, NAT STRUCT MOL BIOL, V17, P294, DOI 10.1038/nsmb.1759; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; de Winter JP, 2000, NAT GENET, V24, P15, DOI 10.1038/71626; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garcia-Higuera I, 2000, BLOOD, V96, P3224, DOI 10.1182/blood.V96.9.3224.h8003224_3224_3230; Garcia-Higuera I, 1999, BLOOD, V93, P1430, DOI 10.1182/blood.V93.4.1430.404a36a_1430_1432; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Geng LY, 2010, J CELL BIOL, V191, P249, DOI 10.1083/jcb.201005101; GERMAN J, 1987, BLOOD, V69, P1637; Gurtan AM, 2006, J BIOL CHEM, V281, P10896, DOI 10.1074/jbc.M511411200; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Marek LR, 2006, DNA REPAIR, V5, P1317, DOI 10.1016/j.dnarep.2006.05.044; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mcvey M, 2010, ENVIRON MOL MUTAGEN, V51, P646, DOI 10.1002/em.20551; Medhurst AL, 2001, HUM MOL GENET, V10, P423, DOI 10.1093/hmg/10.4.423; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Mosedale G, 2005, NAT STRUCT MOL BIOL, V12, P763, DOI 10.1038/nsmb981; Nameki N, 2004, PROTEIN SCI, V13, P2089, DOI 10.1110/ps.04751804; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Titus TA, 2006, GENE, V371, P211, DOI 10.1016/j.gene.2005.11.038; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Zhang XY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000645; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	39	37	42	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32628	32637		10.1074/jbc.M111.244632	http://dx.doi.org/10.1074/jbc.M111.244632			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775430	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000294726800072
J	McVicker, G; Sun, L; Sohanpal, BK; Gashi, K; Williamson, RA; Plumbridge, J; Blomfield, IC				McVicker, Gareth; Sun, Lei; Sohanpal, Baljinder K.; Gashi, Krishna; Williamson, Richard A.; Plumbridge, Jacqueline; Blomfield, Ian C.			SlyA Protein Activates fimB Gene Expression and Type 1 Fimbriation in Escherichia coli K-12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-NS; PHASE VARIATION; SALMONELLA-ENTERICA; ACQUIRED GENES; URINARY-TRACT; SIALIC-ACID; VIRULENCE; DNA; TRANSCRIPTION; TYPHIMURIUM	We have demonstrated that SlyA activates fimB expression and hence type 1 fimbriation, a virulence factor in Escherichia coli. SlyA is shown to bind to two operator sites (O-SA1 and O-SA2), situated between 194 and 167 base pairs upstream of the fimB transcriptional start site. fimB expression is derepressed in an hns mutant and diminished by a slyA mutation in the presence of H-NS only. H-NS binds to multiple sites in the promoter region, including two sites (H-NS2 and H-NS3) that overlap O-SA1 and O-SA2, respectively. Mutations that disrupt either O-SA1 or O-SA2 eliminate or reduce the activating effect of SlyA but have different effects on the level of expression. We interpret these results as reflecting the relative competition between SlyA and H-NS binding. Moreover we show that SlyA is capable of displacing H-NS from its binding sites in vitro. We suggest SlyA binding prevents H-NS binding to H-NS2 and H-NS3 and the subsequent oligomerization of H-NS necessary for full inhibition of fimB expression. In addition, we show that SlyA activates fimB expression independently of two other known regulators of fimB expression, NanR and NagC. It is demonstrated that the rarely used UUG initiation codon limits slyA expression and that low SlyA levels limit fimB expression. Furthermore, Western blot analysis shows that cells grown in rich-defined medium contain similar to 1000 SlyA dimers per cell whereas those grown in minimal medium contain >20% more SlyA. This study extends our understanding of the role that SlyA plays in the host-bacterial relationship.	[McVicker, Gareth; Sun, Lei; Sohanpal, Baljinder K.; Gashi, Krishna; Williamson, Richard A.; Blomfield, Ian C.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Plumbridge, Jacqueline] CNRS, Inst Biol Physicochim, Unite Propre Rech 9073, F-75005 Paris, France	University of Kent; Centre National de la Recherche Scientifique (CNRS)	Blomfield, IC (corresponding author), Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England.	i.c.blomfield@kent.ac.uk		McVicker, Gareth/0000-0002-6967-5968	Wellcome Trust [GR076360/Z/05/Z, 085931/Z/08/Z]; CNRS [UPR9073]	Wellcome Trust(Wellcome Trust); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Grants GR076360/Z/05/Z and 085931/Z/08/Z from the Wellcome Trust. The work in Paris was supported by funds from the CNRS (UPR9073).	Aberg A, 2006, MOL MICROBIOL, V60, P1520, DOI 10.1111/j.1365-2958.2006.05191.x; ABRAHAM JM, 1985, P NATL ACAD SCI USA, V82, P5724, DOI 10.1073/pnas.82.17.5724; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bahrani-Mougeot FK, 2002, MOL MICROBIOL, V45, P1079, DOI 10.1046/j.1365-2958.2002.03078.x; Barnich N, 2007, WORLD J GASTROENTERO, V13, P5571, DOI 10.3748/wjg.v13.i42.5571; BLOMFIELD IC, 1991, J BACTERIOL, V173, P5298, DOI 10.1128/jb.173.17.5298-5307.1991; BLOMFIELD IC, 1993, J BACTERIOL, V175, P27, DOI 10.1128/JB.175.1.27-36.1993; Blomfield IC, 2001, ADV MICROB PHYSIOL, V45, P1, DOI 10.1016/S0065-2911(01)45001-6; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1447, DOI 10.1111/j.1365-2958.1991.tb00791.x; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Bremer H, 1996, ESCHERICHIA COLI SAL; Bryan A, 2006, INFECT IMMUN, V74, P1072, DOI 10.1128/IAI.74.2.1072-1083.2006; Connell H, 1996, P NATL ACAD SCI USA, V93, P9827, DOI 10.1073/pnas.93.18.9827; Corbett D, 2007, J BIOL CHEM, V282, P33326, DOI 10.1074/jbc.M703465200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dhakal BK, 2008, EUR J CLIN INVEST, V38, P2, DOI 10.1111/j.1365-2362.2008.01986.x; Donato GM, 1997, J BACTERIOL, V179, P6618, DOI 10.1128/jb.179.21.6618-6625.1997; Dorman CJ, 2009, FEMS MICROBIOL REV, V33, P587, DOI 10.1111/j.1574-6976.2008.00155.x; El-Labany S, 2003, MOL MICROBIOL, V49, P1109, DOI 10.1046/j.1365-2958.2003.03624.x; Fang FC, 2008, CURR OPIN MICROBIOL, V11, P113, DOI 10.1016/j.mib.2008.02.011; Fass E, 2009, CURR OPIN MICROBIOL, V12, P199, DOI 10.1016/j.mib.2009.01.004; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; GALLY DL, 1993, J BACTERIOL, V175, P6186, DOI 10.1128/JB.175.19.6186-6193.1993; Gally DL, 1996, MOL MICROBIOL, V21, P725, DOI 10.1046/j.1365-2958.1996.311388.x; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; Haider F, 2009, INT MICROBIOL, V11, P245, DOI 10.2436/20.1501.01.68; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; Kawakami T, 1999, MICROBIOL IMMUNOL, V43, P351, DOI 10.1111/j.1348-0421.1999.tb02415.x; KLEMM P, 1986, EMBO J, V5, P1389, DOI 10.1002/j.1460-2075.1986.tb04372.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lahooti M, 2005, J BACTERIOL, V187, P6273, DOI 10.1128/JB.187.18.6273-6280.2005; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; Liang ST, 2000, J BACTERIOL, V182, P3037, DOI 10.1128/JB.182.11.3037-3044.2000; Lithgow JK, 2007, MOL MICROBIOL, V66, P685, DOI 10.1111/j.1365-2958.2007.05950.x; Liu YJ, 2010, GENE DEV, V24, P339, DOI 10.1101/gad.1883510; MCCLAIN MS, 1993, J BACTERIOL, V175, P4335, DOI 10.1128/JB.175.14.4335-4344.1993; MCCLAIN MS, 1991, J BACTERIOL, V173, P5308, DOI 10.1128/jb.173.17.5308-5314.1991; Mossman KL, 2008, J IMMUNOL, V181, P6702, DOI 10.4049/jimmunol.181.10.6702; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Oscarsson J, 1996, MOL MICROBIOL, V20, P191, DOI 10.1111/j.1365-2958.1996.tb02500.x; Perez JC, 2008, J BIOL CHEM, V283, P10773, DOI 10.1074/jbc.M709843200; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Silhavy T.J., 1984, EXPT GENE FUSIONS; Simms AN, 2008, J BACTERIOL, V190, P3747, DOI 10.1128/JB.01870-07; Sohanpal B. K., 2007, MOL MICROBIOL, V101, P16322; Sohanpal BK, 2004, P NATL ACAD SCI USA, V101, P16322, DOI 10.1073/pnas.0405821101; Song HW, 2008, J BIOL CHEM, V283, P28158, DOI 10.1074/jbc.M801058200; Spory A, 2002, J BACTERIOL, V184, P3549, DOI 10.1128/JB.184.13.3549-3559.2002; Stapleton MR, 2002, J BIOL CHEM, V277, P17630, DOI 10.1074/jbc.M110178200; Stoebel DM, 2008, MICROBIOL-SGM, V154, P2533, DOI 10.1099/mic.0.2008/020693-0; Teng CH, 2006, INFECT IMMUN, V74, P5609, DOI 10.1128/IAI.00321-06; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Westermark M, 2000, J BACTERIOL, V182, P6347, DOI 10.1128/JB.182.22.6347-6357.2000; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Wyborn NR, 2004, J BACTERIOL, V186, P1620, DOI 10.1128/JB.186.6.1620-1628.2004; Xie Y, 2006, INFECT IMMUN, V74, P4039, DOI 10.1128/IAI.02058-05; Zhao G, 2008, P NATL ACAD SCI USA, V105, P20924, DOI 10.1073/pnas.0807071106	61	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32026	32035		10.1074/jbc.M111.266619	http://dx.doi.org/10.1074/jbc.M111.266619			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21768111	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000294726800012
J	Zhang, L; Chen, XJ; Lu, HB; Xie, ZP; Staehelin, C				Zhang, Ling; Chen, Xue-Jiao; Lu, Huang-Bin; Xie, Zhi-Ping; Staehelin, Christian			Functional Analysis of the Type 3 Effector Nodulation Outer Protein L (NopL) from Rhizobium sp NGR234 SYMBIOTIC EFFECTS, PHOSPHORYLATION, AND INTERFERENCE WITH MITOGEN-ACTIVATED PROTEIN KINASE SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN NGR234; HOST-SPECIFICITY; ARABIDOPSIS; SYSTEM; BIOSYNTHESIS; RESPONSES; LEGUMES; AVRPTOB; FAMILY; CELLS	Pathogenic bacteria use type 3 secretion systems to deliver virulence factors (type 3 effector proteins) directly into eukaryotic host cells. Similarly, type 3 effectors of certain nitrogen-fixing rhizobial strains affect nodule formation in the symbiosis with host legumes. Nodulation outer protein L (NopL) of Rhizobium sp. strain NGR234 is a Rhizobium-specific type 3 effector. Nodulation tests and microscopic analysis showed that distinct necrotic areas were rapidly formed in ineffective nodules of Phaseolus vulgaris (cv. Tendergreen) induced by strain NGR Omega nopL (NGR234 mutated in nopL), indicating that NopL antagonized nodule senescence. Further experiments revealed that NopL interfered with mitogen-activated protein kinase (MAPK) signaling in yeast and plant cells (Nicotiana tabacum). Expression of nopL in yeast disrupted the mating pheromone (alpha-factor) response pathway, whereas nopL expression in N. tabacum suppressed cell death induced either by overexpression of the MAPK gene SIPK (salicylic acid-induced protein kinase) or by SIPKDD (mutation in the TXY motif resulting in constitutive MAPK activity). These data indicate that NopL impaired function of MAPK proteins or MAPK substrates. Furthermore, we demonstrate that NopL was multiply phosphorylated either in yeast or N. tabacum cells that expressed nopL. Four phosphorylated serines were confirmed by mass spectrometry. All four phosphorylation sites exhibit a Ser-Pro pattern, a typical motif in MAPK substrates. Taken together, data suggest that NopL mimics a MAPK substrate and that NopL suppresses premature nodule senescence by impairing MAPK signaling in host cells.	[Zhang, Ling; Chen, Xue-Jiao; Lu, Huang-Bin; Xie, Zhi-Ping; Staehelin, Christian] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510006, Guangdong, Peoples R China	Sun Yat Sen University	Xie, ZP (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510006, Guangdong, Peoples R China.	xiez@mail.sysu.edu.cn; cst@mail.sysu.edu.cn			National Basic Research Program of China (973 program) [2010CB126501]; National Natural Science Foundation of China [30771150]; Science Foundation of the Key Laboratory of Biocontrol [SKLBC09B05]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of the Key Laboratory of Biocontrol	This work was supported by the National Basic Research Program of China (973 program) Grant 2010CB126501, National Natural Science Foundation of China Grant 30771150, and Science Foundation of the Key Laboratory of Biocontrol Grant SKLBC09B05.	Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; Ausmees N, 2004, J BACTERIOL, V186, P4774, DOI 10.1128/JB.186.14.4774-4780.2004; Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; Bartsev AV, 2004, PLANT PHYSIOL, V134, P871, DOI 10.1104/pp.103.031740; Bartsev AV, 2003, FEBS LETT, V554, P271, DOI 10.1016/S0014-5793(03)01145-1; Block A, 2008, CURR OPIN PLANT BIOL, V11, P396, DOI 10.1016/j.pbi.2008.06.007; Cardinale F, 2000, J BIOL CHEM, V275, P36734, DOI 10.1074/jbc.M007418200; Chaudhuri B, 1997, GENETICS, V145, P75; Dai WJ, 2008, J BACTERIOL, V190, P5101, DOI 10.1128/JB.00306-08; Fauvart M, 2008, FEMS MICROBIOL LETT, V285, P1, DOI 10.1111/j.1574-6968.2008.01254.x; Fernandez-Pascual M, 2006, J EXP BOT, V57, P2735, DOI 10.1093/jxb/erl038; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Hann DR, 2010, CURR OPIN PLANT BIOL, V13, P388, DOI 10.1016/j.pbi.2010.04.003; Kambara K, 2009, MOL MICROBIOL, V71, P92, DOI 10.1111/j.1365-2958.2008.06507.x; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Marie C, 2003, MOL PLANT MICROBE IN, V16, P743, DOI 10.1094/MPMI.2003.16.9.743; Minic Z, 2007, J EXP BOT, V58, P2503, DOI 10.1093/jxb/erm082; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Munkvold KR, 2009, MOL PLANT PATHOL, V10, P777, DOI 10.1111/j.1364-3703.2009.00586.x; Pedley KF, 2005, CURR OPIN PLANT BIOL, V8, P541, DOI 10.1016/j.pbi.2005.07.006; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Puppo A, 2005, NEW PHYTOL, V165, P683, DOI 10.1111/j.1469-8137.2004.01285.x; Ren DT, 2002, J BIOL CHEM, V277, P559, DOI 10.1074/jbc.M109495200; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Schechter LM, 2010, APPL ENVIRON MICROB, V76, P3758, DOI 10.1128/AEM.03122-09; Schmeisser C, 2009, APPL ENVIRON MICROB, V75, P4035, DOI 10.1128/AEM.00515-09; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; Skorpil P, 2005, MOL MICROBIOL, V57, P1304, DOI 10.1111/j.1365-2958.2005.04768.x; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Staehelin C, 2006, J BACTERIOL, V188, P6168, DOI 10.1128/JB.00365-06; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Viprey V, 1998, MOL MICROBIOL, V28, P1381, DOI 10.1046/j.1365-2958.1998.00920.x; Wenzel M, 2010, MOL PLANT MICROBE IN, V23, P124, DOI 10.1094/MPMI-23-1-0124; Xiao F, 2007, J BIOL CHEM, V282, P30737, DOI 10.1074/jbc.M705565200; Yang SM, 2010, P NATL ACAD SCI USA, V107, P18735, DOI 10.1073/pnas.1011957107; Zhang SQ, 2001, PLANT CELL, V13, P1877, DOI 10.1105/tpc.13.8.1877; Zhou JM, 2008, CURR OPIN MICROBIOL, V11, P179, DOI 10.1016/j.mib.2008.02.004	40	51	53	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32178	32187		10.1074/jbc.M111.265942	http://dx.doi.org/10.1074/jbc.M111.265942			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775427	hybrid, Green Published			2022-12-25	WOS:000294726800028
J	Jin, LH; Lin, SC; Rong, H; Zheng, SY; Jin, SK; Wang, R; Li, Y				Jin, Lihua; Lin, Shengchen; Rong, Hui; Zheng, Songyang; Jin, Shikan; Wang, Rui; Li, Yong			Structural Basis for Iloprost as a Dual Peroxisome Proliferator-activated Receptor alpha/delta Agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STABLE PROSTACYCLIN ANALOG; FATTY-ACIDS; DIFFERENTIAL ACTIVATION; PULMONARY-HYPERTENSION; PLATELET-AGGREGATION; UP-REGULATION; PPAR; ANGIOGENESIS; EICOSANOIDS; LIGANDS	Iloprost is a prostacyclin analog that has been used to treat many vascular conditions. Peroxisome proliferator-activated receptors (PPARs) are ligand-regulated transcription factors with various important biological effects such as metabolic and cardiovascular physiology. Here, we report the crystal structures of the PPAR alpha ligand-binding domain and PPAR delta ligand-binding domain bound to iloprost, thus providing unambiguous evidence for the direct interaction between iloprost and PPARs and a structural basis for the recognition of PPAR alpha/delta by this prostacyclin analog. In addition to conserved contacts for all PPAR alpha ligands, iloprost also initiates several specific interactions with PPARs using its unique structural groups. Structural and functional studies of receptor-ligand interactions reveal strong functional correlations of the iloprost-PPAR alpha/delta interactions as well as the molecular basis of PPAR subtype selectivity toward iloprost ligand. As such, the structural mechanism may provide a more rational template for designing novel compounds targeting PPARs with more favorable pharmacologic impact based on existing iloprost drugs.	[Jin, Lihua; Lin, Shengchen; Jin, Shikan; Wang, Rui; Li, Yong] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361005, Peoples R China; [Lin, Shengchen; Rong, Hui; Zheng, Songyang; Li, Yong] Univ Pittsburgh, Ctr Pharmacogenet, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA	Xiamen University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Li, Y (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361005, Peoples R China.	yongli@ymail.com	Lin, Shengchen/T-3529-2018; Jin, Lihua/AAN-5177-2020	Lin, Shengchen/0000-0003-1488-8680; Jin, Lihua/0000-0002-2685-6048	National Institutes of Health [DK081757]; American Heart Association; Fundamental Research Funds for the Central Universities [2010121083, 2011121029]; Science Planning Program of Fujian Province [2009J1010]; Office of Science of the United States Department of Energy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK081757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Science Planning Program of Fujian Province; Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK081757. This work was also supported by an award from the American Heart Association, the Fundamental Research Funds for the Central Universities Grants 2010121083 and 2011121029, and Grant 2009J1010 from the Science Planning Program of Fujian Province.; We thank E. Kondrashkina and Z. Wawrzak for assistance in data collection at sector 21 (LS-CAT) of the Advance Photo Source and staff at BL17U of Shanghai Synchrotron Radiation Source for help. Use of the Advanced Photon Source was supported by the Office of Science of the United States Department of Energy.	Barger PM, 2002, J MOL CELL CARDIOL, V34, P713, DOI 10.1006/jmcc.2002.2029; Barger PM, 2000, TRENDS CARDIOVAS MED, V10, P238, DOI 10.1016/S1050-1738(00)00077-3; Biscetti F, 2008, CIRC RES, V103, P7, DOI 10.1161/CIRCRESAHA.108.180224; Biscetti F, 2009, J VASC RES, V46, P103, DOI 10.1159/000143793; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Glass CK, 2006, J CLIN INVEST, V116, P556, DOI 10.1172/JCI27913; Hertz R, 1996, EUR J BIOCHEM, V235, P242, DOI 10.1111/j.1432-1033.1996.00242.x; Hoeper MM, 2000, NEW ENGL J MED, V342, P1866, DOI 10.1056/NEJM200006223422503; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Li Y, 2003, STRUCTURE, V11, P741, DOI 10.1016/S0969-2126(03)00133-3; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Liou JY, 2006, ARTERIOSCL THROM VAS, V26, P1481, DOI 10.1161/01.ATV.0000223875.14120.93; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; MONCADA S, 1977, LANCET, V1, P18; NAMBA T, 1994, J BIOL CHEM, V269, P9986; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pola R, 2004, J MOL CELL CARDIOL, V36, P363, DOI 10.1016/j.yjmcc.2003.10.016; Sierra ML, 2007, J MED CHEM, V50, P685, DOI 10.1021/jm058056x; STURZEBECHER S, 1986, PROSTAGLANDINS, V31, P95, DOI 10.1016/0090-6980(86)90228-5; TOWN MH, 1982, PROSTAG OTH LIPID M, V24, P61, DOI 10.1016/0090-6980(82)90177-0; WHITTLE BJR, 1980, PROSTAGLANDINS, V19, P605, DOI 10.1016/S0090-6980(80)80010-4; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975	29	23	23	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31473	31479		10.1074/jbc.M111.266023	http://dx.doi.org/10.1074/jbc.M111.266023			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21775429	hybrid, Green Published			2022-12-25	WOS:000294487500042
J	Levet-Paulo, M; Lazzaroni, JC; Gilbert, C; Atlan, D; Doublet, P; Vianney, A				Levet-Paulo, Melanie; Lazzaroni, Jean-Claude; Gilbert, Christophe; Atlan, Daniele; Doublet, Patricia; Vianney, Anne			The Atypical Two-component Sensor Kinase Lpl0330 from Legionella pneumophila Controls the Bifunctional Diguanylate Cyclase-Phosphodiesterase Lpl0329 to Modulate Bis-(3 '-5 ')-cyclic Dimeric GMP Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-DI-GMP; BIOFILM FORMATION; HISTIDINE KINASE; SYSTEM; ACTIVATION; PHOSPHORYLATION; IDENTIFICATION; DETERMINANTS; TURNOVER; PROTEINS	A significant part of bacterial two-component system response regulators contains effector domains predicted to be involved in metabolism of bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di-GMP), a second messenger that plays a key role in many physiological processes. The intracellular level of c-di-GMP is controlled by diguanylate cyclase and phosphodiesterases activities associated with GGDEF and EAL domains, respectively. The Legionella pneumophila Lens genome displays 22 GGDEF/EAL domain-encoding genes. One of them, lpl0329, encodes a protein containing a two-component system receiver domain and both GGDEF and EAL domains. Here, we demonstrated that the GGDEF and EAL domains of Lpl0329 are both functional and lead to simultaneous synthesis and hydrolysis of c-di-GMP. Moreover, these two opposite activities are finely regulated by Lpl0329 phosphorylation due to the atypical histidine kinase Lpl0330. Indeed, Lpl0330 was found to autophosphorylate on a histidine residue in an atypical H box, which is conserved in various bacteria species and thus defines a new histidine kinase subfamily. Lpl0330 also catalyzes the phosphotranfer to Lpl0329, which results in a diguanylate cyclase activity decrease whereas phosphodiesterase activity remains efficient. Altogether, these data present (i) a new histidine kinase subfamily based on the conservation of an original H box that we named HGN H box, and (ii) the first example of a bifunctional enzyme that modulates synthesis and turnover of c-di-GMP in response to phosphorylation of its receiver domain.	[Levet-Paulo, Melanie; Lazzaroni, Jean-Claude; Gilbert, Christophe; Atlan, Daniele; Doublet, Patricia; Vianney, Anne] Univ Lyon 1, CNRS, Microbiol Adaptat & Pathogenie UMR5240, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Vianney, A (corresponding author), UMR 5240, Bat Lwoff R 3,10 Rue Dubois, F-69622 Villeurbanne, France.	anne.vianney@univ-lyon1.fr	Vianney, Anne/L-9544-2014; Doublet, Patricia/L-9480-2014; Gilbert, Christophe/M-6005-2014	Doublet, Patricia/0000-0001-5848-4317; Gilbert, Christophe/0000-0003-3021-7350	Ministere de l'Enseignement Superieur et de la Recherche	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research Council)	Supported by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barakat M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-315; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Bordeleau E, 2010, ENVIRON MICROBIOL, V12, P510, DOI 10.1111/j.1462-2920.2009.02094.x; Bouche S, 1998, MOL MICROBIOL, V27, P787, DOI 10.1046/j.1365-2958.1998.00725.x; Bruggemann H, 2006, CELL MICROBIOL, V8, P1228, DOI 10.1111/j.1462-5822.2006.00703.x; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De N, 2009, J MOL BIOL, V393, P619, DOI 10.1016/j.jmb.2009.08.030; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Fang X, 2010, MOL MICROBIOL, V76, P1295, DOI 10.1111/j.1365-2958.2010.07179.x; Ferreira RBR, 2008, J BACTERIOL, V190, P851, DOI 10.1128/JB.01462-07; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fritsch F, 2011, MICROBIOL-SGM, V157, P373, DOI 10.1099/mic.0.044776-0; Galperin MY, 2007, METHOD ENZYMOL, V422, P47, DOI 10.1016/S0076-6879(06)22003-2; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gilles-Gonzalez MA, 2008, METHOD ENZYMOL, V437, P173, DOI 10.1016/S0076-6879(07)37010-9; GILLESGONZALEZ MA, 1993, J BIOL CHEM, V268, P16293; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kenney LJ, 2010, CURR OPIN MICROBIOL, V13, P168, DOI 10.1016/j.mib.2010.01.013; Kumar M, 2008, MICROBIOL-SGM, V154, P2942, DOI 10.1099/mic.0.2008/017806-0; Lai TH, 2009, J BACTERIOL, V191, P693, DOI 10.1128/JB.01218-08; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Martinez-Wilson HF, 2008, J BACTERIOL, V190, P6439, DOI 10.1128/JB.00541-08; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200; Russo F D, 1993, Trends Microbiol, V1, P306, DOI 10.1016/0966-842X(93)90007-E; Ryan RP, 2006, J BACTERIOL, V188, P8327, DOI 10.1128/JB.01079-06; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Seshasayee ASN, 2010, NUCLEIC ACIDS RES, V38, P5970, DOI 10.1093/nar/gkq382; Sommerfeldt N, 2009, MICROBIOL-SGM, V155, P1318, DOI 10.1099/mic.0.024257-0; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tarutina M, 2006, J BIOL CHEM, V281, P34751, DOI 10.1074/jbc.M604819200; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Wan XH, 2009, J MOL BIOL, V388, P262, DOI 10.1016/j.jmb.2009.03.015; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Wolanin PM, 2002, GENOME BIOL, V3	45	30	30	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31136	31144		10.1074/jbc.M111.231340	http://dx.doi.org/10.1074/jbc.M111.231340			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757706	Green Published, hybrid			2022-12-25	WOS:000294487500008
J	O'Leary, H; Liu, WH; Rorabaugh, JM; Coultrap, SJ; Bayer, KU				O'Leary, Heather; Liu, Wallace H.; Rorabaugh, Jacki M.; Coultrap, Steven J.; Bayer, K. Ulrich			Nucleotides and Phosphorylation Bi-directionally Modulate Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) Binding to the N-Methyl-D-aspartate (NMDA) Receptor Subunit GluN2B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; RATE-DETERMINING STEP; NR2B SUBUNIT; SYNAPTIC PLASTICITY; SELF-ASSOCIATION; INHIBITORY AUTOPHOSPHORYLATION; CATALYTIC SUBUNIT; DENDRITIC SPINES; MOLECULAR MEMORY; ALPHA-ACTININ	The Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) and the NMDA-type glutamate receptor are key regulators of synaptic plasticity underlying learning and memory. Direct binding of CaMKII to the NMDA receptor subunit GluN2B (formerly known as NR2B) (i) is induced by Ca2+/CaM but outlasts this initial Ca2+-stimulus, (ii) mediates CaMKII translocation to synapses, and (iii) regulates synaptic strength. CaMKII binds to GluN2B around S1303, the major CaMKII phosphorylation site on GluN2B. We show here that a phosphomimetic S1303D mutation inhibited CaM-induced CaMKII binding to GluN2B in vitro, presenting a conundrum how binding can occur within cells, where high ATP concentration should promote S1303 phosphorylation. Surprisingly, addition of ATP actually enhanced the binding. Mutational analysis revealed that this positive net effect was caused by four modulatory effects of ATP, two positive (direct nucleotide binding and CaMKII T286 autophosphorylation) and two negative (GluN2B S1303 phosphorylation and CaMKII T305/6 autophosphorylation). Imaging showed positive regulation by nucleotide binding also within transfected HEK cells and neurons. In fact, nucleotide binding was a requirement for efficient CaMKII interaction with GluN2B in cells, while T286 autophosphorylation was not. Kinetic considerations support a model in which positive regulation by nucleotide binding and T286 autophosphorylation occurs faster than negative modulation by GluN2B S1303 and CaMKII T305/6 phosphorylation, allowing efficient CaMKII binding to GluN2B despite the inhibitory effects of the two slower reactions.	[O'Leary, Heather; Liu, Wallace H.; Rorabaugh, Jacki M.; Coultrap, Steven J.; Bayer, K. Ulrich] Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Bayer, KU (corresponding author), Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA.	ulli.bayer@ucdenver.edu			National Institutes of Health [T32GM007635, R01NS052644]; National Institutes of Health (UCD Center) [P30NS048154]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS048154, R01NS052644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (UCD Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research was supported, in whole or in part, by National Institutes of Health Grants T32GM007635 (to H. O'L., W. H. L., and J. M. R.), P30NS048154 (UCD Center Grant), and R01NS052644 (to K. U. B.).	Aubol BE, 2003, BIOCHEMISTRY-US, V42, P12813, DOI 10.1021/bi035200c; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BHATNAGAR D, 1983, BIOCHEMISTRY-US, V22, P6310, DOI 10.1021/bi00295a042; Bradshaw JM, 2002, J BIOL CHEM, V277, P20991, DOI 10.1074/jbc.M202154200; Buard I, 2010, J NEUROSCI, V30, P8214, DOI 10.1523/JNEUROSCI.1469-10.2010; Cheriyan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016495; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Coultrap SJ, 2010, J BIOL CHEM, V285, P17930, DOI 10.1074/jbc.M109.069351; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Hudmon A, 1996, J BIOL CHEM, V271, P8800, DOI 10.1074/jbc.271.15.8800; Hudmon A, 2001, J NEUROCHEM, V76, P1364, DOI 10.1046/j.1471-4159.2001.00119.x; KITAMURA Y, 1993, J NEUROCHEM, V61, P100, DOI 10.1111/j.1471-4159.1993.tb03542.x; KOLAJ M, 1994, J NEUROPHYSIOL, V72, P2525, DOI 10.1152/jn.1994.72.5.2525; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Leonard AS, 2002, J BIOL CHEM, V277, P48441, DOI 10.1074/jbc.M205164200; Lew J, 1997, BIOCHEMISTRY-US, V36, P6717, DOI 10.1021/bi963164u; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman JE, 2001, CURR BIOL, V11, pR788, DOI 10.1016/S0960-9822(01)00472-9; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; Lu CS, 2003, NEURON, V40, P1185, DOI 10.1016/S0896-6273(03)00786-4; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; O'Leary H, 2006, MOL BIOL CELL, V17, P4656, DOI 10.1091/mbc.E06-03-0252; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Opazo P, 2010, NEURON, V67, P239, DOI 10.1016/j.neuron.2010.06.007; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Pradeep KK, 2009, BIOCHEM J, V419, P123, DOI 10.1042/BJ20081707; Raveendran R, 2009, J NEUROCHEM, V110, P92, DOI 10.1111/j.1471-4159.2009.06108.x; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; Robison AJ, 2005, J BIOL CHEM, V280, P39316, DOI 10.1074/jbc.M508189200; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; Sessoms-Sikes S, 2005, MOL CELL NEUROSCI, V29, P139, DOI 10.1016/j.mcn.2005.01.006; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SMITH MK, 1992, J BIOL CHEM, V267, P1761; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6404, DOI 10.1021/bi036224m; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Vest RS, 2009, FEBS LETT, V583, P3577, DOI 10.1016/j.febslet.2009.10.028; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhou J, 1997, BIOCHEMISTRY-US, V36, P15733, DOI 10.1021/bi971438n; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007	63	47	48	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31272	31281		10.1074/jbc.M111.233668	http://dx.doi.org/10.1074/jbc.M111.233668			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768120	Green Published, hybrid			2022-12-25	WOS:000294487500022
J	Pamren, A; Wanngren, J; Tjernberg, LO; Winblad, B; Bhat, R; Naslund, J; Karlstrom, H				Pamren, Annelie; Wanngren, Johanna; Tjernberg, Lars O.; Winblad, Bengt; Bhat, Ratan; Naslund, Jan; Karlstrom, Helena			Mutations in Nicastrin Protein Differentially Affect Amyloid beta-Peptide Production and Notch Protein Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE ACTIVITY; INTRAMEMBRANE PROTEOLYSIS; PRECURSOR PROTEIN; ALZHEIMER-DISEASE; PRESENILIN; COMPLEX; PEN-2; IDENTIFICATION; TRAFFICKING; MECHANISM	The gamma-secretase complex is responsible for intramembrane processing of over 60 substrates and is involved in Notch signaling as well as in the generation of the amyloid beta-peptide (A beta). Aggregated forms of A beta have a pathogenic role in Alzheimer disease and, thus, reducing the A beta levels by inhibiting gamma-secretase is a possible treatment strategy for Alzheimer disease. Regrettably, clinical trials have shown that inhibition of gamma-secretase results in Notch-related side effects. Therefore, it is of great importance to find ways to inhibit amyloid precursor protein (APP) processing without disturbing vital signaling pathways such as Notch. Nicastrin (Nct) is part of the gamma-secretase complex and has been proposed to be involved in substrate recognition and selection. We have investigated how the four evenly spaced and conserved cysteine residues in the Nct ectodomain affect APP and Notch processing. We mutated these cysteines to serines and analyzed them in cells lacking endogenous Nct. We found that two mutants, C213S (C2) and C230S (C3), differentially affected APP and Notch processing. Both the formation of A beta and the intracellular domain of amyloid precursor protein (AICD) were reduced, whereas the production of Notch intracellular domain (NICD) was maintained on a high level, although C230S (C3) showed impaired complex assembly. Our data demonstrate that single residues in a gamma-secretase component besides presenilin are able to differentially affect APP and Notch processing.	[Pamren, Annelie; Wanngren, Johanna; Tjernberg, Lars O.; Winblad, Bengt; Karlstrom, Helena] Karolinska Inst, Dept Neurobiol Caring Sci & Soc, Novum, Alzheimer Dis Res Ctr, SE-14186 Stockholm, Sweden; [Bhat, Ratan; Naslund, Jan] AstraZeneca CNS, Pain Res Area, SE-15185 Sodertalje, Sweden	Karolinska Institutet; AstraZeneca	Karlstrom, H (corresponding author), Karolinska Inst, Dept Neurobiol Caring Sci & Soc, Novum, 5th Fl, SE-14157 Stockholm, Sweden.	Helena.Karlstrom@ki.se		Karlstrom, Helena/0000-0002-0498-2473	Swedish Brain Power; Wallenberg's Foundation; Loo och Hans Ostermans Stiftelse; Stiftelsen Gamla Tjanarinnor; KI stiftelsen for aldersforskning; Swedish Medical Society; Gun och Bertil Stohnes Stiftelse; Strategic Research Area: Neuroscience [2009-1077]	Swedish Brain Power; Wallenberg's Foundation; Loo och Hans Ostermans Stiftelse; Stiftelsen Gamla Tjanarinnor; KI stiftelsen for aldersforskning; Swedish Medical Society; Gun och Bertil Stohnes Stiftelse; Strategic Research Area: Neuroscience	This work was supported by grants from Swedish Brain Power, Wallenberg's Foundation, Loo och Hans Ostermans Stiftelse, Stiftelsen Gamla Tjanarinnor, KI stiftelsen for aldersforskning, Swedish Medical Society, Gun och Bertil Stohnes Stiftelse, and Strategic Research Area: Neuroscience (Regulation Number 2009-1077).	Bergman A, 2004, J BIOL CHEM, V279, P16744, DOI 10.1074/jbc.M313999200; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Dries DR, 2009, J BIOL CHEM, V284, P29714, DOI 10.1074/jbc.M109.038737; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; Fagan R, 2001, TRENDS BIOCHEM SCI, V26, P213, DOI 10.1016/S0968-0004(01)01789-3; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Franberg J, 2011, BIOCHEM BIOPH RES CO, V404, P564, DOI 10.1016/j.bbrc.2010.12.029; Futai E, 2009, J BIOL CHEM, V284, P13013, DOI 10.1074/jbc.M807653200; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Karlstrom H, 2002, J BIOL CHEM, V277, P6763, DOI 10.1074/jbc.C100649200; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Li T, 2003, J NEUROSCI, V23, P3272; Martin L, 2009, J BIOL CHEM, V284, P5662, DOI 10.1074/jbc.M807485200; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Morais VA, 2008, FEBS LETT, V582, P427, DOI 10.1016/j.febslet.2008.01.003; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Shirotani K, 2003, J BIOL CHEM, V278, P16474, DOI 10.1074/jbc.C300095200; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Teranishi Y, 2010, J CELL MOL MED, V14, P2675, DOI 10.1111/j.1582-4934.2009.00907.x; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Walker ES, 2005, J NEUROCHEM, V92, P294, DOI 10.1111/j.1471-4159.2004.02858.x; Wanngren J, 2010, J BIOL CHEM, V285, P8527, DOI 10.1074/jbc.M109.055590; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	33	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31153	31158		10.1074/jbc.C111.235267	http://dx.doi.org/10.1074/jbc.C111.235267			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768095	hybrid, Green Published			2022-12-25	WOS:000294487500010
J	Wang, Y; Huang, YX; Xue, CL; He, Y; He, ZG				Wang, Yi; Huang, Yuanxia; Xue, Chaolun; He, Yang; He, Zheng-Guo			ClpR Protein-like Regulator Specifically Recognizes RecA Protein-independent Promoter Motif and Broadly Regulates Expression of DNA Damage-inducible Genes in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORYNEBACTERIUM-GLUTAMICUM; FACTOR SIGMA(H); TUBERCULOSIS; CLGR; TRANSCRIPTION; IDENTIFICATION; NETWORKS; SURVIVAL; SYSTEM; REPAIR	The RecA-dependent DNA damage response pathway (SOS response) appears to be the major DNA repair mechanism in most bacteria, but it has been suggested that a RecA-independent mechanism is responsible for controlling expression of most damage-inducible DNA repair genes in Mycobacterium tuberculosis. The specific reparative responses and molecular mediators involved in the DNA repair mechanism remain largely unclear in this pathogen and its related species. In this study, a mycobacterial ClpR-like regulator, corresponding to Rv2745c in M. tuberculosis and to Ms2694 in M. smegmatis mc(2)155, was found to interact with the promoter regions of multiple damage-inducible DNA repair genes. Specific binding of the ClpR-like factor to the conserved RecA-independent promoter RecA-NDp motif was then confirmed using in vitro electrophoretic mobility shift assays as well as in vivo chromatin immunoprecipitation experiments. The ClpR knock-out experiments, in combination with quantitative real time PCR assays, demonstrated that the expression of these RecA-independent genes were significantly down-regulated in the mutant strain of M. smegmatis in response to a DNA-damaging agent compared with the wild type strain. Furthermore, the ClpR-like factor was shown to contribute to mycobacterial genomic stability. These results enhance our understanding of the function of the ClpR regulator and the regulatory mechanism of RecA-independent DNA repair in mycobacteria.	[Wang, Yi; Huang, Yuanxia; Xue, Chaolun; He, Yang; He, Zheng-Guo] Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Prote Res, Natl Key Lab Agr Microbiol, Wuhan 430070, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Prote Res, Natl Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	he.zhengguo@hotmail.com	He, Zheng-Guo/P-3647-2014		National Natural Science Foundation of China [30930003, 31025002]; Hubei Chutian Scholar Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Chutian Scholar Program	This work was supported by the National Natural Science Foundation of China (Grants 30930003 and 31025002) and the Hubei Chutian Scholar Program (to Z.-G. H.).	Adams LB, 1997, TUBERCLE LUNG DIS, V78, P237, DOI 10.1016/S0962-8479(97)90004-6; Baumbach J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-24; Bellier A, 2004, J BACTERIOL, V186, P3238, DOI 10.1128/JB.186.10.3238-3248.2004; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Brooks PC, 2006, J BACTERIOL, V188, P6034, DOI 10.1128/JB.00340-06; Brooks PC, 2001, J BACTERIOL, V183, P4459, DOI 10.1128/JB.183.15.4459-4467.2001; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Davis EO, 2002, MOL MICROBIOL, V46, P791, DOI 10.1046/j.1365-2958.2002.03199.x; Dawson LF, 2010, J BACTERIOL, V192, P599, DOI 10.1128/JB.01066-09; Dutta NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010069; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Engels S, 2005, MOL MICROBIOL, V57, P576, DOI 10.1111/j.1365-2958.2005.04710.x; Engels S, 2004, MOL MICROBIOL, V52, P285, DOI 10.1111/j.1365-2958.2003.03979.x; Estorninho M, 2010, MICROBIOL-SGM, V156, P3445, DOI 10.1099/mic.0.042275-0; Fontan PA, 2008, J INFECT DIS, V198, P877, DOI 10.1086/591098; Gamulin V, 2004, FEMS MICROBIOL LETT, V238, P57, DOI 10.1016/j.femsle.2004.07.017; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Krawczyk J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp453; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; LITTLE JW, 1982, BIOCHIMIE, V64, P585, DOI 10.1016/S0300-9084(82)80092-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machowski EE, 2007, J BACTERIOL, V189, P2190, DOI 10.1128/JB.01647-06; Mehra S, 2010, J INFECT DIS, V202, P943, DOI 10.1086/654820; Mehra S, 2009, J BACTERIOL, V191, P3965, DOI 10.1128/JB.00064-09; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Rand L, 2003, MOL MICROBIOL, V50, P1031, DOI 10.1046/j.1365-2958.2003.03765.x; Rauch PJG, 1996, MICROBIOL-UK, V142, P1025, DOI 10.1099/00221287-142-4-1025; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Sherrid AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011622; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Ventura M, 2005, J BACTERIOL, V187, P8411, DOI 10.1128/JB.187.24.8411-8426.2005; World Health Organization, 2010, GLOB TUB CONTR REP 2; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672	36	36	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31159	31167		10.1074/jbc.M111.241802	http://dx.doi.org/10.1074/jbc.M111.241802			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21771781	Green Published, hybrid			2022-12-25	WOS:000294487500011
J	Suzuki, M; Kiga, K; Kersulyte, D; Cok, J; Hooper, CC; Mimuro, H; Sanada, T; Suzuki, S; Oyama, M; Kozuka-Hata, H; Kamiya, S; Zou, QM; Gilman, RH; Berg, DE; Sasakawa, C				Suzuki, Masato; Kiga, Kotaro; Kersulyte, Dangeruta; Cok, Jaime; Hooper, Catherine C.; Mimuro, Hitomi; Sanada, Takahito; Suzuki, Shiho; Oyama, Masaaki; Kozuka-Hata, Hiroko; Kamiya, Shigeru; Zou, Quan-Ming; Gilman, Robert H.; Berg, Douglas E.; Sasakawa, Chihiro			Attenuated CagA Oncoprotein in Helicobacter pylori from Amerindians in Peruvian Amazon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; KINASE; HOST; MECHANISMS; INFECTION; POLARITY; STOMACH; TARGETS; HUMANS; CANCER	Population genetic analyses of bacterial genes whose products interact with host tissues can give new understanding of infection and disease processes. Here we show that strains of the genetically diverse gastric pathogen Helicobacter pylori from Amerindians from the remote Peruvian Amazon contain novel alleles of cagA, a major virulence gene, and reveal distinctive properties of their encoded CagA proteins. CagA is injected into the gastric epithelium where it hijacks pleiotropic signaling pathways, helps Hp exploit its special gastric mucosal niche, and affects the risk that infection will result in overt gastroduodenal diseases including gastric cancer. The Amerindian CagA proteins contain unusual but functional tyrosine phosphorylation motifs and attenuated CRPIA motifs, which affect gastric epithelial proliferation, inflammation, and bacterial pathogenesis. Amerindian CagA proteins induced less production of IL-8 and cancer-associated Mucin 2 than did those of prototype Western or East Asian strains and behaved as dominant negative inhibitors of action of prototype CagA during mixed infection of Mongolian gerbils. We suggest that Amerindian cagA is of relatively low virulence, that this may have been selected in ancestral strains during infection of the people who migrated from Asia into the Americas many thousands of years ago, and that such attenuated CagA proteins could be useful therapeutically.	[Kersulyte, Dangeruta; Berg, Douglas E.] Washington Univ, Sch Med, Dept Med Microbiol, St Louis, MO 63110 USA; [Suzuki, Masato; Kiga, Kotaro; Mimuro, Hitomi; Sanada, Takahito; Suzuki, Shiho; Sasakawa, Chihiro] Univ Tokyo, Dept Microbiol & Immunol, Tokyo 1088639, Japan; [Oyama, Masaaki; Kozuka-Hata, Hiroko] Univ Tokyo, Med Prote Lab, Inst Med Sci, Tokyo 1088639, Japan; [Sasakawa, Chihiro] Univ Tokyo, Dept Infect Dis Control, Int Res Ctr Infect Dis, Inst Med Sci, Tokyo 1088639, Japan; [Berg, Douglas E.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Berg, Douglas E.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Cok, Jaime; Hooper, Catherine C.; Gilman, Robert H.] Univ Peruana Cayetano Heredia, Fac Med, Dept Microbiol, Lima 31, Peru; [Kamiya, Shigeru] Kyorin Univ, Sch Med, Dept Infect Dis, Tokyo 1818611, Japan; [Zou, Quan-Ming] Third Mil Med Univ, Coll Med Lab Sci, Dept Clin Microbiol & Immunol, Chongqing 400038, Peoples R China; [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA	Washington University (WUSTL); University of Tokyo; University of Tokyo; University of Tokyo; Washington University (WUSTL); Washington University (WUSTL); Universidad Peruana Cayetano Heredia; Kyorin University; Army Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Berg, DE (corresponding author), Washington Univ, Sch Med, Dept Med Microbiol, St Louis, MO 63110 USA.	berg@borcim.wustl.edu; sasakawa@ims.u-tokyo.ac.jp	Suzuki, Shiho/Z-4458-2019; Suzuki, Masato/B-7568-2013	Suzuki, Masato/0000-0001-8975-2193; Oyama, Masaaki/0000-0001-6478-3735; Suzuki, Shiho/0000-0003-3168-1729; Kozuka-Hata, Hiroko/0000-0002-9286-6594	National Institutes of Health [RO1 DK63041, R21 AI078237, R21 AI088337, T53 1007646, D43TW006581]; Japanese Government (Ministry of Education, Culture, Sports, Science, and Technology) [23000012, 20229006, 23390102, 18073003]; FOGARTY INTERNATIONAL CENTER [D43TW006581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088337, R21AI078237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063041] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23590518] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese Government (Ministry of Education, Culture, Sports, Science, and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK63041, R21 AI078237, R21 AI088337, T53 1007646, and D43TW006581. This work was also supported by grants for Specially Promoted Research (23000012), Scientific Research (S) (20229006), Scientific Research (B) (23390102), and Scientific Research on Priority Areas (18073003) from the Japanese Government (Ministry of Education, Culture, Sports, Science, and Technology).	Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Backert S, 2010, HELICOBACTER, V15, P163, DOI 10.1111/j.1523-5378.2010.00759.x; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Fischer W, 2009, CURR TOP MICROBIOL, V337, P129, DOI 10.1007/978-3-642-01846-6_5; Gerrits MM, 2006, LANCET INFECT DIS, V6, P699, DOI 10.1016/S1473-3099(06)70627-2; Hatakeyama M, 2008, CURR OPIN MICROBIOL, V11, P30, DOI 10.1016/j.mib.2007.12.003; HIERRO SHP, 1998, LIBERATION LAND RIGH; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Jimenez-Soto LF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000684; Kersulyte D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015076; Kersulyte D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006859; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; Lamb A, 2009, EMBO REP, V10, P1242, DOI 10.1038/embor.2009.210; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Mane SP, 2010, J BACTERIOL, V192, P3078, DOI 10.1128/JB.00063-10; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Mimuro H, 2008, BIOESSAYS, V30, P515, DOI 10.1002/bies.20768; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; Ogura M, 2007, PLOS COMPUT BIOL, V3, P1455, DOI 10.1371/journal.pcbi.0030151; Olbermann P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001069; Pelz C, 2011, J BIOL CHEM, V286, P8999, DOI 10.1074/jbc.M110.166504; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004; Soto G, 2003, J INFECT DIS, V188, P1263, DOI 10.1086/379046; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Terabayashi T, 2007, J NEUROSCI, V27, P13098, DOI 10.1523/JNEUROSCI.3986-07.2007; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vogelmann R, 2007, CURR OPIN MICROBIOL, V10, P76, DOI 10.1016/j.mib.2006.12.004; WERNER L, 2001, DIARY POLL WATCHER P; Yamaoka Y, 2000, EPIDEMIOL INFECT, V124, P91, DOI 10.1017/S0950268899003209; Yamaoka Y, 2002, FEBS LETT, V517, P180, DOI 10.1016/S0014-5793(02)02617-0; Yamaoka Y, 2008, INTERNAL MED, V47, P1077, DOI 10.2169/internalmedicine.47.0975; Yuasa Y, 2003, NAT REV CANCER, V3, P592, DOI 10.1038/nrc1141	40	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29964	29972		10.1074/jbc.M111.263715	http://dx.doi.org/10.1074/jbc.M111.263715			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21757722	Green Published, hybrid			2022-12-25	WOS:000294046600055
J	Liang, LH; Woodward, OM; Chen, ZH; Cotter, R; Guggino, WB				Liang, Lihua; Woodward, Owen M.; Chen, Zhaohui; Cotter, Robert; Guggino, William B.			A Novel Role of Protein Tyrosine Kinase2 in Mediating Chloride Secretion in Human Airway Epithelial Cells	PLOS ONE			English	Article							FOCAL ADHESION KINASE; PYK2; RECEPTORS; SPIPERONE; CALCIUM; PHOSPHORYLATION; CHANNEL; INVASION; BINDING; LIGAND	Ca2+ activated Cl- channels (CaCC) are up-regulated in cystic fibrosis (CF) airway surface epithelia. The presence and functional properties of CaCC make it a possible therapeutic target to compensate for the deficiency of Cl- secretion in CF epithelia. CaCC is activated by an increase in cytosolic Ca2+, which not only activates epithelial CaCCs, but also inhibits epithelial Na+ hyperabsorption, which may also be beneficial in CF. Our previous study has shown that spiperone, a known antipsychotic drug, activates CaCCs and stimulates Cl- secretion in polarized human non-CF and CF airway epithelial cell monolayers in vitro, and in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) knockout mice in vivo. Spiperone activates CaCC not by acting in its well-known role as an antagonist of either 5-HT2 or D2 receptors, but through a protein tyrosine kinase-coupled phospholipase C-dependent pathway. Moreover, spiperone independently activates CFTR through a novel mechanism. Herein, we performed a mass spectrometry analysis and identified the signaling molecule that mediates the spiperone effect in activating chloride secretion through CaCC and CFTR. Proline-rich tyrosine kinase 2 (PYK2) is a nonreceptor protein tyrosine kinase, which belongs to the focal adhesion kinase family. The inhibition of PYK2 notably reduced the ability of spiperone to increase intracellular Ca2+ and Cl- secretion. In conclusion, we have identified the tyrosine kinase, PYK2, as the modulator, which plays a crucial role in the activation of CaCC and CFTR by spiperone. The identification of this novel role of PYK2 reveals a new signaling pathway in human airway epithelial cells.	[Liang, Lihua; Woodward, Owen M.; Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Chen, Zhaohui; Cotter, Robert] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Liang, LH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	wguggino@jhmi.edu		Woodward, Owen M./0000-0001-9514-2180	National Institutes of Health [P01 DK72074]; Cystic Fibrosis Foundation [R025-CR07]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	Funding was provided by the National Institutes of Health (P01 DK72074) and Cystic Fibrosis Foundation Grant R025-CR07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; Anitei M, 2010, NAT CELL BIOL, V12, P330, DOI 10.1038/ncb2034; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Chien LT, 2006, J GEN PHYSIOL, V128, P247, DOI 10.1085/jgp.200609581; CREESE I, 1978, EUR J PHARMACOL, V49, P201, DOI 10.1016/0014-2999(78)90080-8; Dahan D, 2001, PFLUG ARCH EUR J PHY, V443, pS92, DOI 10.1007/s004240100652; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Esen M, 2001, INFECT IMMUN, V69, P281, DOI 10.1128/IAI.69.1.281-287.2001; Giachini FRC, 2008, J AM SOC HYPERTENS, V2, P431, DOI 10.1016/j.jash.2008.05.001; Glennon Richard A., 2002, Current Topics in Medicinal Chemistry, V2, P539, DOI 10.2174/1568026023393787; GUNDLACH AL, 1984, LIFE SCI, V35, P1981, DOI 10.1016/0024-3205(84)90479-X; Kohno T, 2008, BIOCHEM J, V410, P513, DOI 10.1042/BJ20070665; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LEYSEN JE, 1978, BIOCHEM PHARMACOL, V27, P307, DOI 10.1016/0006-2952(78)90233-2; Li W, 2001, ONCOGENE, V20, P6403, DOI 10.1038/sj.onc.1204782; Liang L, 2009, AM J PHYSIOL-CELL PH, V296, pC131, DOI 10.1152/ajpcell.00346.2008; Lu Desheng, 2009, BMC Pharmacology, V9, P13, DOI 10.1186/1471-2210-9-13; Marshall WS, 2009, J EXP BIOL, V212, P2365, DOI 10.1242/jeb.030015; Matsui A, 2007, CIRCULATION, V116, P1041, DOI 10.1161/CIRCULATIONAHA.106.645416; Mohler PJ, 1999, J CELL BIOL, V147, P879, DOI 10.1083/jcb.147.4.879; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Rufanova VA, 2009, J CELL PHYSIOL, V219, P45, DOI 10.1002/jcp.21649; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Selvaraj NG, 2000, MOL ENDOCRINOL, V14, P2054, DOI 10.1210/me.14.12.2054; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Silva JM, 2009, CELL, V137, P1047, DOI 10.1016/j.cell.2009.04.013; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313; Zheng LT, 2008, J NEUROCHEM, V107, P1225, DOI 10.1111/j.1471-4159.2008.05675.x	29	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21991	10.1371/journal.pone.0021991	http://dx.doi.org/10.1371/journal.pone.0021991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765932	gold, Green Published, Green Submitted			2022-12-25	WOS:000292781500025
J	Ho, JY; Lin, TL; Li, CY; Lee, A; Cheng, AN; Chen, MC; Wu, SH; Wang, JT; Li, TL; Tsai, MD				Ho, Jin-Yuan; Lin, Tzu-Lung; Li, Chun-Yen; Lee, Arwen; Cheng, An-Ning; Chen, Ming-Chuan; Wu, Shih-Hsiung; Wang, Jin-Town; Li, Tsung-Lin; Tsai, Ming-Daw			Functions of Some Capsular Polysaccharide Biosynthetic Genes in Klebsiella pneumoniae NTUH K-2044	PLOS ONE			English	Article							PYOGENIC LIVER-ABSCESS; GROUP-B STREPTOCOCCUS; ESCHERICHIA-COLI; O-ACETYLATION; VIRULENCE; BACTERIA; SEROTYPE; TRANSDUCTION; RESISTANCE; PATHWAY	The growing number of Klebsiella pneumoniae infections, commonly acquired in hospitals, has drawn great concern. It has been shown that the K1 and K2 capsular serotypes are the most detrimental strains, particularly to those with diabetes. The K1 cps (capsular polysaccharide) locus in the NTUH-2044 strain of the pyogenic liver abscess (PLA) K. pneumoniae has been identified recently, but little is known about the functions of the genes therein. Here we report characterization of a group of cps genes and their roles in the pathogenesis of K1 K. pneumoniae. By sequential gene deletion, the cps gene cluster was first re-delimited between genes galF and ugd, which serve as up- and down-stream ends, respectively. Eight gene products were characterized in vitro and in vivo to be involved in the syntheses of UDP-glucose, UDP-glucuronic acid and GDP-fucose building units. Twelve genes were identified as virulence factors based on the observation that their deletion mutants became avirulent or lost K1 antigenicity. Furthermore, deletion of kp3706, kp3709 or kp3712 (Delta wcal, Delta wcaG or Delta atf, respectively), which are all involved in fucose biosynthesis, led to a broad range of transcriptional suppression for 52 upstream genes. The genes suppressed include those coding for unknown regulatory membrane proteins and six multidrug efflux system proteins, as well as proteins required for the K1 CPS biosynthesis. In support of the suppression of multidrug efflux genes, we showed that these three mutants became more sensitive to antibiotics. Taken together, the results suggest that kp3706, kp3709 or kp3712 genes are strongly related to the pathogenesis of K. pneumoniae K1.	[Ho, Jin-Yuan; Lee, Arwen; Cheng, An-Ning; Chen, Ming-Chuan; Wu, Shih-Hsiung; Tsai, Ming-Daw] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Ho, Jin-Yuan; Li, Chun-Yen; Lee, Arwen; Chen, Ming-Chuan; Li, Tsung-Lin; Tsai, Ming-Daw] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Ho, Jin-Yuan; Li, Tsung-Lin; Tsai, Ming-Daw] Acad Sinica, Chem Biol & Mol Biophys Program, Taiwan Int Grad Program, Inst Biochem, Taipei, Taiwan; [Ho, Jin-Yuan; Tsai, Ming-Daw] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10764, Taiwan; [Lin, Tzu-Lung; Wang, Jin-Town] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan; [Cheng, An-Ning] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Wang, Jin-Town] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Tsing Hua University; National Taiwan University; National Taiwan University Hospital	Ho, JY (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	wangjt@ccms.ntu.edu.tw; tlli@gate.sinica.edu.tw; mdtsai@gate.sinica.edu.tw	Tsai, Ming-Daw/G-4689-2019	Tsai, Ming-Daw/0000-0003-1374-0414	National Science Council of Taiwan [94-3112-B-002-024, 97-3112-B-001-003]; Academia Sinica	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	National Science Council of Taiwan (Grants 94-3112-B-002-024 to JW, and 97-3112-B-001-003 to SW, MT, and JTW) and Academia Sinica intramural funding. The work has also benefited from Biophysics Core and Mass Core of Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER SA, 1963, NATURE, V197, P899, DOI 10.1038/197899a0; Bergfeld AK, 2009, J BIOL CHEM, V284, P6, DOI 10.1074/jbc.M807518200; Bina XR, 2008, INFECT IMMUN, V76, P3595, DOI 10.1128/IAI.01620-07; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Chang KC, 1997, BIOCHEM BIOPH RES CO, V236, P785, DOI 10.1006/bbrc.1997.7050; Chou HC, 2004, INFECT IMMUN, V72, P3783, DOI 10.1128/IAI.72.7.3783-3792.2004; Chuang YP, 2006, J INFECT DIS, V193, P645, DOI 10.1086/499968; Chung DR, 2007, J INFECTION, V54, P578, DOI 10.1016/j.jinf.2006.11.008; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; Dambach MD, 2009, CURR OPIN MICROBIOL, V12, P161, DOI 10.1016/j.mib.2009.01.012; FRANKLIN NC, 1961, VIROLOGY, V15, P299, DOI 10.1016/0042-6822(61)90362-2; Fung CP, 2000, J INFECT DIS, V181, P2075, DOI 10.1086/315488; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Lederman ER, 2005, AM J GASTROENTEROL, V100, P322, DOI 10.1111/j.1572-0241.2005.40310.x; Lewis AL, 2004, P NATL ACAD SCI USA, V101, P11123, DOI 10.1073/pnas.0403010101; Lewis AL, 2007, J BIOL CHEM, V282, P27562, DOI 10.1074/jbc.M700340200; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; LIU TW, 2009, P NATL ACAD SCI US; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; MIZUTA K, 1983, INFECT IMMUN, V40, P56, DOI 10.1128/IAI.40.1.56-61.1983; Morona JK, 1997, MOL MICROBIOL, V23, P751, DOI 10.1046/j.1365-2958.1997.2551624.x; Narberhaus F, 2006, FEMS MICROBIOL REV, V30, P3, DOI 10.1111/j.1574-6976.2005.004.x; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Pan YJ, 2008, J CLIN MICROBIOL, V46, P2231, DOI 10.1128/JCM.01716-07; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Rahn A, 2003, MOL MICROBIOL, V47, P1045, DOI 10.1046/j.1365-2958.2003.03354.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Woodford N, 2004, ANTIMICROB AGENTS CH, V48, P4793, DOI 10.1128/AAC.48.12.4793-4799.2004; Wu JH, 2008, EXP BIOL MED, V233, P64, DOI 10.3181/0706-RM-170; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yang Ching-Cheng, 2004, Journal of Microbiology Immunology and Infection, V37, P176; Zamze S, 2002, J BIOL CHEM, V277, P41613, DOI 10.1074/jbc.M207057200	38	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21664	10.1371/journal.pone.0021664	http://dx.doi.org/10.1371/journal.pone.0021664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765903	Green Published, gold, Green Submitted			2022-12-25	WOS:000292699000009
J	Moore, RD; Bartlett, JG; Gallant, JE				Moore, Richard D.; Bartlett, John G.; Gallant, Joel E.			Association between Use of HMG CoA Reductase Inhibitors and Mortality in HIV-Infected Patients	PLOS ONE			English	Article							IMMUNE ACTIVATION; ANTIRETROVIRAL THERAPY; STATINS; INFLAMMATION; IMMUNOSENESCENCE; OUTCOMES; MARKERS; SEPSIS; ANEMIA; AIDS	Introduction: HIV infection is a disease associated with chronic inflammation and immune activation. Antiretroviral therapy reduces inflammation, but not to levels in comparable HIV-negative individuals. The HMG-coenzyme A reductase inhibitors (statins) inhibit several pro-inflammatory processes and suppress immune activation, and are a logical therapy to assess for a possible salutary effect on HIV disease progression and outcomes. Methods: Eligible patients were patients enrolled in the Johns Hopkins HIV Clinical Cohort who achieved virologic suppression within 180 days of starting a new highly active antiretroviral therapy (HAART) regimen after January 1, 1998. Assessment was continued until death in patients who maintained a virologic suppression, with right-censoring of their follow-up time if they had an HIV RNA > 500 copies/ml. Cox proportional hazards regression was used to assess statin use as a time-varying covariate, as well as other demographic and clinical factors. Results: A total of 1538 HIV-infected patients fulfilled eligibility criteria, of whom 238 (15.5%) received a statin while taking HAART. There were 85 deaths (7 in statin users, 78 in non-users). By multivariate Cox regression, statin use was associated with a relative hazard of 0.33 (95% CI: 0.14, 0.76; P = 0.009) after adjusting for CD4, HIV-1 RNA, hemoglobin and cholesterol levels at the start of HAART, age, race, HIV risk group, prior use of ART, year of HAART start, NNRTI vs. PI-based ART, prior AIDS-defining illness, and viral hepatitis coinfection. Malignancy, non-AIDS-defining infection and liver failure were particularly prominent causes of death. Discussion: Statin use was associated with significantly lower hazard of dying in these HIV-infected patients who were being effectively treated with HAART as determined by virologic suppression. Our results suggest the need for confirmation in other observational cohorts, and if confirmed, the need for a clinical trial of statin use in HIV infection.	[Moore, Richard D.; Bartlett, John G.; Gallant, Joel E.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University	Moore, RD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	rdmoore@jhmi.edu			National Institutes of Health [R01 DA11602, K24DA00432, R01A16893]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA000432, R01DA011602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants (R01 DA11602, K24DA00432, R01A16893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amet T, 2008, MICROBES INFECT, V10, P471, DOI 10.1016/j.micinf.2008.01.009; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Deeks Steven G, 2009, Top HIV Med, V17, P118; Dulak J, 2005, CURR CANCER DRUG TAR, V5, P579, DOI 10.2174/156800905774932824; Fedson DS, 2008, LANCET INFECT DIS, V8, P571, DOI 10.1016/S1473-3099(08)70070-7; Ganesan A, 2011, J INFECT DIS, V203, P756, DOI 10.1093/infdis/jiq115; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Harris RJ, 2008, ANTIVIR THER, V13, P959; Hunt Peter W, 2007, Curr HIV/AIDS Rep, V4, P42, DOI 10.1007/s11904-007-0007-8; Jadhav SB, 2006, J PHARM PHARMACOL, V58, P3, DOI 10.1211/jpp.58.1.0002; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Janda S, 2010, J CRIT CARE, V25; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kopterides P, 2009, CLIN MICROBIOL INFEC, V15, P325, DOI 10.1111/j.1469-0691.2009.02750.x; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Longenecker CT, 2009, AIDS, V23, P1089, DOI 10.1097/QAD.0b013e32832a3f24; *MD DEP HLTH MENT, 2010, MAR HIV AIDS EP PROF; Mira Emilia, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P237; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Molina-Pinelo S, 2009, J ANTIMICROB CHEMOTH, V64, P579, DOI 10.1093/jac/dkp248; Moncunill G, 2005, AIDS, V19, P1697, DOI 10.1097/01.aids.0000183517.60384.db; Monforte AD, 2008, AIDS, V22, P2143, DOI 10.1097/QAD.0b013e3283112b77; Moore RD, 1998, J ACQ IMMUN DEF SYND, V17, pS38, DOI 10.1097/00042560-199801001-00011; Moore RD, 2008, CLIN INFECT DIS, V47, P1102, DOI 10.1086/592115; Negredo E, 2006, AIDS, V20, P619, DOI 10.1097/01.aids.0000210617.90954.0e; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; PRICE EA, 2010, ADV HEMATOL, P8739; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Thomsen RW, 2008, ARCH INTERN MED, V168, P2081, DOI 10.1001/archinte.168.19.2081; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286; Yasuda H, 2006, KIDNEY INT, V69, P1535, DOI 10.1038/sj.ki.5000300; Yokota N, 2003, AM J NEPHROL, V23, P13, DOI 10.1159/000066301	35	63	63	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21843	10.1371/journal.pone.0021843	http://dx.doi.org/10.1371/journal.pone.0021843			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765919	Green Published, Green Submitted, gold			2022-12-25	WOS:000292699000012
J	China, A; Mishra, S; Nagaraja, V				China, Arnab; Mishra, Sonakshi; Nagaraja, Valakunja			A Transcript Cleavage Factor of Mycobacterium tuberculosis Important for Its Survival	PLOS ONE			English	Article							RNA-POLYMERASE-II; ESCHERICHIA-COLI; FACTORS GREA; ELONGATION-FACTOR; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; IN-VIVO; INITIATION; GENES; MECHANISMS	After initiation of transcription, a number of proteins participate during elongation and termination modifying the properties of the RNA polymerase (RNAP). Gre factors are one such group conserved across bacteria. They regulate transcription by projecting their N-terminal coiled-coil domain into the active center of RNAP through the secondary channel and stimulating hydrolysis of the newly synthesized RNA in backtracked elongation complexes. Rv1080c is a putative gre factor (MtbGre) in the genome of Mycobacterium tuberculosis. The protein enhanced the efficiency of promoter clearance by lowering abortive transcription and also rescued arrested and paused elongation complexes on the GC rich mycobacterial template. Although MtbGre is similar in domain organization and shares key residues for catalysis and RNAP interaction with the Gre factors of Escherichia coli, it could not complement an E. coli gre deficient strain. Moreover, MtbGre failed to rescue E. coli RNAP stalled elongation complexes, indicating the importance of specific protein-protein interactions for transcript cleavage. Decrease in the level of MtbGre reduced the bacterial survival by several fold indicating its essential role in mycobacteria. Another Gre homolog, Rv3788 was not functional in transcript cleavage activity indicating that a single Gre is sufficient for efficient transcription of the M. tuberculosis genome.	[China, Arnab; Mishra, Sonakshi; Nagaraja, Valakunja] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Nagaraja, Valakunja] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	China, A (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	vraj@mcbl.iisc.ernet.in		China, Arnab/0000-0003-2832-2338	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India; Department of Science and Technology	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology(Department of Science & Technology (India))	The Phosphorimager Facility of IISc is supported by the Department of Biotechnology, Government of India, and is acknowledged. AC was a recipient of Senior Research Fellowship from Council of Scientific and Industrial Research, Government of India. VN is a recipient of J.C. Bose Fellowship from the Department of Science and Technology and a Center for Excellence in Tuberculosis Research grant from Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belotserkovskii BP, 2010, P NATL ACAD SCI USA, V107, P12816, DOI 10.1073/pnas.1007580107; Borukhov S, 2005, MOL MICROBIOL, V55, P1315, DOI 10.1111/j.1365-2958.2004.04481.x; BORUKHOV S, 1992, P NATL ACAD SCI USA, V89, P8899, DOI 10.1073/pnas.89.19.8899; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Borukhov S, 2001, METHOD ENZYMOL, V342, P64, DOI 10.1016/S0076-6879(01)42536-5; Campbell GRO, 2003, J BACTERIOL, V185, P3853, DOI 10.1128/JB.185.13.3853-3862.2003; China A, 2010, MICROBIOL-SGM, V156, P1942, DOI 10.1099/mic.0.038620-0; China A, 2010, PROTEIN EXPRES PURIF, V69, P235, DOI 10.1016/j.pep.2009.09.022; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; HARSHEY RM, 1977, J BACTERIOL, V129, P616, DOI 10.1128/JB.129.2.616-622.1977; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; Hogan BP, 2002, J BIOL CHEM, V277, P967, DOI 10.1074/jbc.M108737200; Hsu LM, 2009, METHODS, V47, P25, DOI 10.1016/j.ymeth.2008.10.010; HSU LM, 1995, P NATL ACAD SCI USA, V92, P11588, DOI 10.1073/pnas.92.25.11588; Garcia MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011575; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Koulich D, 1998, J MOL BIOL, V276, P379, DOI 10.1006/jmbi.1997.1545; Koulich D, 1997, J BIOL CHEM, V272, P7201, DOI 10.1074/jbc.272.11.7201; Kulish D, 2000, J BIOL CHEM, V275, P12789, DOI 10.1074/jbc.275.17.12789; Lamour V, 2006, J MOL BIOL, V356, P179, DOI 10.1016/j.jmb.2005.10.083; Laptenko O, 2003, METHOD ENZYMOL, V371, P219; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; Laptenko O, 2006, EMBO J, V25, P2131, DOI 10.1038/sj.emboj.7601094; Len ACL, 2004, MICROBIOL-SGM, V150, P1339, DOI 10.1099/mic.0.27008-0; Loizos N, 1999, J BIOL CHEM, V274, P23378, DOI 10.1074/jbc.274.33.23378; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Marr MT, 2000, MOL CELL, V6, P1275, DOI 10.1016/S1097-2765(00)00126-X; Mukherjee R, 2008, BIOCHEM BIOPH RES CO, V369, P899, DOI 10.1016/j.bbrc.2008.02.118; Nogales J, 2002, MOL PLANT MICROBE IN, V15, P225, DOI 10.1094/MPMI.2002.15.3.225; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; REINES D, 1989, J BIOL CHEM, V264, P10799; Roberts JW, 2008, ANNU REV MICROBIOL, V62, P211, DOI 10.1146/annurev.micro.61.080706.093422; Rodrigue S, 2006, FEMS MICROBIOL REV, V30, P926, DOI 10.1111/j.1574-6976.2006.00040.x; Rutherford ST, 2007, J MOL BIOL, V366, P1243, DOI 10.1016/j.jmb.2006.12.013; Sen R, 2001, GENES CELLS, V6, P389, DOI 10.1046/j.1365-2443.2001.00436.x; Sharbati S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-31; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Singh VK, 2001, FEMS MICROBIOL LETT, V199, P79, DOI 10.1016/S0378-1097(01)00163-X; Smith I, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P219; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sun J, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008769, 10.1371/journal.pone.0011351]; Susa M, 2006, MOL MICROBIOL, V59, P1807, DOI 10.1111/j.1365-2958.2006.05058.x; Vassylyev DG, 2009, CURR OPIN STRUC BIOL, V19, P691, DOI 10.1016/j.sbi.2009.10.004; Vassylyeva MN, 2007, EMBO REP, V8, P1038, DOI 10.1038/sj.embor.7401079; Wu SP, 2004, MOL MICROBIOL, V51, P1551, DOI 10.1111/j.1365-2958.2003.03922.x; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	52	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21941	10.1371/journal.pone.0021941	http://dx.doi.org/10.1371/journal.pone.0021941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760927	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000292657200031
J	Han, XL; Yu, RT; Zhen, DY; Tao, S; Schmidt, M; Han, L				Han, Xuelin; Yu, Rentao; Zhen, Dongyu; Tao, Sha; Schmidt, Martina; Han, Li			beta-1,3-Glucan-Induced Host Phospholipase D Activation Is Involved in Aspergillus fumigatus Internalization into Type II Human Pneumocyte A549 Cells	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; BETA-GLUCAN RECEPTOR; BINDING LECTIN SITE; MOUSE PERITONEAL-MACROPHAGES; STRESS FIBER FORMATION; TOLL-LIKE RECEPTORS; PHOSPHATIDIC-ACID; MAST-CELLS; LYSOPHOSPHATIDIC ACID; MURINE MACROPHAGES	The internalization of Aspergillus fumigatus into lung epithelial cells is a process that depends on host cell actin dynamics. The host membrane phosphatidylcholine cleavage driven by phospholipase D (PLD) is closely related to cellular actin dynamics. However, little is known about the impact of PLD on A. fumigatus internalization into lung epithelial cells. Here, we report that once germinated, A. fumigatus conidia were able to stimulate host PLD activity and internalize more efficiently in A549 cells without altering PLD expression. The internalization of A. fumigatus in A549 cells was suppressed by the downregulation of host cell PLD using chemical inhibitors or siRNA interference. The heat-killed swollen conidia, but not the resting conidia, were able to activate host PLD. Further, beta-1,3-glucan, the core component of the conidial cell wall, stimulated host PLD activity. This PLD activation and conidia internalization were inhibited by anti-dectin-1 antibody. Indeed, dectin-1, a beta-1,3-glucan receptor, was expressed in A549 cells, and its expression profile was not altered by conidial stimulation. Finally, host cell PLD1 and PLD2 accompanied A. fumigatus conidia during internalization. Our data indicate that host cell PLD activity induced by beta-1,3-glucan on the surface of germinated conidia is important for the efficient internalization of A. fumigatus into A549 lung epithelial cells.	[Han, Xuelin; Yu, Rentao; Zhen, Dongyu; Tao, Sha; Han, Li] Acad Mil Med Sci, Inst Dis Control & Prevent PLA, Dept Hosp Infect Control & Res, Beijing, Peoples R China; [Schmidt, Martina] Univ Groningen, Dept Mol Pharmacol, Groningen, Netherlands	Academy of Military Medical Sciences - China; University of Groningen	Han, XL (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent PLA, Dept Hosp Infect Control & Res, Beijing, Peoples R China.	hanli@bmi.ac.cn	Hu, Mandong/AAH-1140-2019; Schmidt, Martina/C-5339-2018	Schmidt, Martina/0000-0003-3075-0630	Chinese National Scientific Foundation Committee [30772029]; University of Groningen	Chinese National Scientific Foundation Committee; University of Groningen	This work was supported by grant No. 30772029 from Chinese National Scientific Foundation Committee and a Rosalind Franklin Fellowship from the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseeva L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-33; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Bernard M, 2001, MED MYCOL, V39, P9, DOI 10.1080/mmy.39.1.9.17; Brandenburg LO, 2009, MOL MEMBR BIOL, V26, P371, DOI 10.1080/09687680903188340; Brown FD, 1998, CURR BIOL, V8, P835, DOI 10.1016/S0960-9822(98)70326-4; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; Cross MJ, 1996, CURR BIOL, V6, P588, DOI 10.1016/S0960-9822(02)00545-6; DeHart DJ, 1997, J INFECT DIS, V175, P146, DOI 10.1093/infdis/175.1.146; Denmat-Ouisse LA, 2001, J BIOL CHEM, V276, P48840, DOI 10.1074/jbc.M104276200; DUBYAK GR, 1993, BIOCHEM J, V292, P121, DOI 10.1042/bj2920121; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Filler SG, 2006, PLOS PATHOG, V2, P1099, DOI 10.1371/journal.ppat.0020129; Fontaine T, 2000, J BIOL CHEM, V275, P41528; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Garrido JL, 2009, MOL ENDOCRINOL, V23, P2048, DOI 10.1210/me.2008-0436; Gastebois A, 2009, FUTURE MICROBIOL, V4, P583, DOI 10.2217/FMB.09.29; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; GIAIMIS J, 1993, J LEUKOCYTE BIOL, V54, P564, DOI 10.1002/jlb.54.6.564; Goldfine H, 2000, INFECT IMMUN, V68, P5735, DOI 10.1128/IAI.68.10.5735-5741.2000; Gomez-Cambronero J, 2007, J LEUKOCYTE BIOL, V82, P272, DOI 10.1189/jlb.0107033; Gomez-Munoz A, 1999, J LIPID RES, V40, P988; HA KS, 1993, J CELL BIOL, V123, P1789, DOI 10.1083/jcb.123.6.1789; Han L, 2007, EMBO J, V26, P4189, DOI 10.1038/sj.emboj.7601852; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Huang P, 2007, EXPERT OPIN THER TAR, V11, P707, DOI 10.1517/14728222.11.5.707; Iyer SS, 2006, J IMMUNOL, V176, P3686, DOI 10.4049/jimmunol.176.6.3686; Iyer SS, 2004, J IMMUNOL, V173, P2615, DOI 10.4049/jimmunol.173.4.2615; Iyer SS, 1999, J BIOL CHEM, V274, P2350, DOI 10.1074/jbc.274.4.2350; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kam Y, 2001, MOL CELL BIOL, V21, P4055, DOI 10.1128/MCB.21.12.4055-4066.2001; Komati H, 2005, MOL BIOL CELL, V16, P1232, DOI 10.1091/mbc.E04-06-0459; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; Kusner DJ, 1999, J IMMUNOL, V162, P2266; Kusner DJ, 1996, J EXP MED, V184, P585, DOI 10.1084/jem.184.2.585; Lee HY, 2004, EXP MOL MED, V36, P135, DOI 10.1038/emm.2004.20; Lee HM, 2009, J CLIN IMMUNOL, V29, P795, DOI 10.1007/s10875-009-9319-3; Lee HM, 2009, CELL MICROBIOL, V11, P678, DOI 10.1111/j.1462-5822.2009.01285.x; Lee S, 2001, J BIOL CHEM, V276, P28252, DOI 10.1074/jbc.M008521200; Lisboa FA, 2009, J IMMUNOL, V183, P5104, DOI 10.4049/jimmunol.0802728; Loegering DJ, 2004, INFLAMMATION, V28, P23, DOI 10.1023/B:IFLA.0000014708.87440.45; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Mambula SS, 2002, J BIOL CHEM, V277, P39320, DOI 10.1074/jbc.M201683200; Melkamu T, 2009, J MEMBRANE BIOL, V229, P101, DOI 10.1007/s00232-009-9175-3; O'Luanaigh N, 2002, MOL BIOL CELL, V13, P3730, DOI 10.1091/mbc.E02-04-0213; Olynych TJ, 2006, J ALLERGY CLIN IMMUN, V118, P837, DOI 10.1016/j.jaci.2006.06.008; Osherov N, 2001, FEMS MICROBIOL LETT, V199, P153, DOI 10.1111/j.1574-6968.2001.tb10667.x; Paris S, 2003, APPL ENVIRON MICROB, V69, P1581, DOI 10.1128/AEM.69.3.1581-1588.2003; Paris S, 1997, INFECT IMMUN, V65, P1510, DOI 10.1128/IAI.65.4.1510-1514.1997; Park JB, 2000, J BIOL CHEM, V275, P21295, DOI 10.1074/jbc.M002463200; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Porcelli AM, 2002, CELL SIGNAL, V14, P75, DOI 10.1016/S0898-6568(01)00222-4; Rand TG, 2010, ARCH TOXICOL, V84, P205, DOI 10.1007/s00204-009-0481-4; Ross GD, 1999, IMMUNOPHARMACOLOGY, V42, P61, DOI 10.1016/S0162-3109(99)00013-2; Schmidt M, 1999, J BIOL CHEM, V274, P14648, DOI 10.1074/jbc.274.21.14648; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Serrander L, 1996, INFLAMMATION, V20, P439, DOI 10.1007/BF01486745; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; SUNG SSJ, 1983, J CELL BIOL, V96, P160, DOI 10.1083/jcb.96.1.160; Thornton BP, 1996, J IMMUNOL, V156, P1235; Torosantucci A, 2005, J EXP MED, V202, P597, DOI 10.1084/jem.20050749; VAN BR, 2009, MOL IMMUNOL, V47, P575, DOI DOI 10.1016/J.MOLIMM.2009.09.018; Wang JE, 2001, INFECT IMMUN, V69, P2402, DOI 10.1128/IAI.69.4.2402-2406.2001; Wasylnka JA, 2003, J CELL SCI, V116, P1579, DOI 10.1242/jcs.00329; Wasylnka JA, 2002, INFECT IMMUN, V70, P3156, DOI 10.1128/IAI.70.6.3156-3163.2002; Weernink PAO, 2000, J BIOL CHEM, V275, P10168, DOI 10.1074/jbc.275.14.10168; Weernink PAO, 2004, EUR J PHARMACOL, V500, P87, DOI 10.1016/j.ejphar.2004.07.014; Weernink PAO, 2007, BBA-BIOMEMBRANES, V1768, P888, DOI 10.1016/j.bbamem.2006.09.012; Weernink PAO, 2007, N-S ARCH PHARMACOL, V374, P399, DOI 10.1007/s00210-007-0131-4; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; Willment JA, 2005, EUR J IMMUNOL, V35, P1539, DOI 10.1002/eji.200425725; Xia Y, 1999, J IMMUNOL, V162, P7285; Xia Y, 1999, J IMMUNOL, V162, P2281; Yeung T, 2007, IMMUNOL REV, V219, P17, DOI 10.1111/j.1600-065X.2007.00546.x; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zhang ZH, 2005, J INFECTION, V51, P375, DOI 10.1016/j.jinf.2004.12.012	78	33	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21468	10.1371/journal.pone.0021468	http://dx.doi.org/10.1371/journal.pone.0021468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760893	Green Published, gold, Green Submitted			2022-12-25	WOS:000292657200012
J	Paterson, NG; Baker, EN				Paterson, Neil G.; Baker, Edward N.			Structure of the Full-Length Major Pilin from Streptococcus pneumoniae: Implications for Isopeptide Bond Formation in Gram-Positive Bacterial Pili	PLOS ONE			English	Article							STABILIZING ISOPEPTIDE; VIRULENCE FACTORS; SURFACE; PROTEIN; ADHESIN; SORTASES	The surface of the pneumococcal cell is adorned with virulence factors including pili. The major pilin RrgB, which forms the pilus shaft on pathogenic Streptococcus pneumoniae, comprises four immunoglobulin (Ig)-like domains, each with a common CnaB topology. The three C-terminal domains are each stabilized by internal Lys-Asn isopeptide bonds, formed autocatalytically with the aid of an essential Glu residue. The structure and orientation of the crucial N-terminal domain, which provides the covalent linkage to the next pilin subunit in the shaft, however, remain incompletely characterised. We report the crystal structure of full length RrgB, solved by X-ray crystallography at 2.8 angstrom resolution. The N-terminal (D1) domain makes few contacts with the rest of the RrgB structure, and has higher B-factors. This may explain why D1 is readily lost by proteolysis, as are the N-terminal domains of many major pilins. D1 is also found to have a triad of Lys, Asn and Glu residues in the same topological positions as in the other domains, yet mass spectrometry and the crystal structure show that no internal isopeptide bond is formed. We show that this is because beta-strand G of D1, which carries the Asn residue, diverges from beta-strand A, carrying the Lys residue, such that these residues are too far apart for bond formation. Strand G also carries the YPKN motif that provides the essential Lys residue for the sortase-mediated intermolecular linkages along the pilus shaft. Interaction with the sortase and formation of the intermolecular linkage could result in a change in the orientation of this strand, explaining why isopeptide bond formation in the N-terminal domains of some major pilins appears to take place only upon assembly of the pili.	[Paterson, Neil G.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Auckland; University of Auckland	Paterson, NG (corresponding author), Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand.	ted.baker@auckland.ac.nz		Paterson, Neil/0000-0003-4292-6971; Baker, Edward/0000-0003-2456-7661	Marsden Fund of New Zealand; Health Research Council of New Zealand; Tertiary Education Commission through Maurice Wilkins Centre for Molecular Biodiscovery	Marsden Fund of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council of New Zealand(Health Research Council of New Zealand); Tertiary Education Commission through Maurice Wilkins Centre for Molecular Biodiscovery	This research was supported by the Marsden Fund of New Zealand, the Health Research Council of New Zealand and the Tertiary Education Commission through its funding of the Maurice Wilkins Centre for Molecular Biodiscovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962; ALONSODEVELASCO E, 1995, MICROBIOL REV, V59, P591, DOI 10.1128/MMBR.59.4.591-603.1995; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Budzik JM, 2009, J BIOL CHEM, V284, P12989, DOI 10.1074/jbc.M900927200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; El Mortaji L, 2010, J BIOL CHEM, V285, P12405, DOI 10.1074/jbc.M109.082776; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gentile MA, 2011, J BIOL CHEM, V286, P14588, DOI 10.1074/jbc.M110.202739; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Hava DL, 2003, J BACTERIOL, V185, P413, DOI 10.1128/JB.185.2.413-421.2003; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2011, TRENDS BIOCHEM SCI, V36, P227, DOI 10.1016/j.tibs.2010.09.007; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, BIOPOLYMERS, V91, P1126, DOI 10.1002/bip.21170; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Linke C, 2010, J BIOL CHEM, V285, P20381, DOI 10.1074/jbc.M109.089680; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moreland N, 2005, ACTA CRYSTALLOGR D, V61, P1378, DOI 10.1107/S090744905023590; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obaro SK, 1996, BMJ-BRIT MED J, V312, P1521, DOI 10.1136/bmj.312.7045.1521; Oh SY, 2008, P NATL ACAD SCI USA, V105, P13703, DOI 10.1073/pnas.0807334105; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Riboldi-Tunnicliffe A, 1999, J APPL CRYSTALLOGR, V32, P1003, DOI 10.1107/S0021889899008584; Spraggon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010919; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Vengadesan K, 2011, J MOL BIOL, V407, P731, DOI 10.1016/j.jmb.2011.02.024; Yeates TO, 2007, SCIENCE, V318, P1558, DOI 10.1126/science.1151398	49	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22095	10.1371/journal.pone.0022095	http://dx.doi.org/10.1371/journal.pone.0022095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760959	Green Submitted, Green Published, gold			2022-12-25	WOS:000292657200048
J	Sehgal, L; Thorat, R; Khapare, N; Mukhopadhaya, A; Sawant, M; Dalal, SN				Sehgal, Lalit; Thorat, Rahul; Khapare, Nileema; Mukhopadhaya, Amitabha; Sawant, Mugdha; Dalal, Sorab N.			Lentiviral Mediated Transgenesis by In Vivo Manipulation of Spermatogonial Stem Cells	PLOS ONE			English	Article							RNA-INTERFERENCE; RETROVIRAL TRANSDUCTION; CRE RECOMBINASE; MICE; VECTOR; INTEGRATION; SPERMATOGENESIS; EXPRESSION; DELIVERY; EMBRYOS	This report describes a technique for the generation of transgenic mice by in vivo manipulation of spermatogonial stem cells with a high rate of success. Spermatogonial stem cells (SSCs) in pre-pubescent animals were infected in vivo with recombinant lentiviruses expressing EGFP-f and mated with normal females. All male pre-founder mice produced transgenic pups with an overall success rate of over 60%. The transgene was heritable and the pre-founder mice could be used in multiple mating experiments. This technology could be used to perform overexpression/knockdown screens in vivo using bar-coded lentiviruses, thus permitting the design of genetic screens in the mouse. Further, this technology could be adapted to other laboratory animals resulting in the generation of model systems that closely approximate human development and disease.	[Sehgal, Lalit; Thorat, Rahul; Khapare, Nileema; Mukhopadhaya, Amitabha; Sawant, Mugdha; Dalal, Sorab N.] Tata Mem Hosp, Adv Ctr Treatment Res Educ & Canc, Kharghar Node, Navi Mumbai, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Sehgal, L (corresponding author), Tata Mem Hosp, Adv Ctr Treatment Res Educ & Canc, KS-215, Kharghar Node, Navi Mumbai, India.	sdalal@actrec.gov.in		Sehgal, lalit/0000-0002-1151-5427	Department of Biotechnology [BT/PR6521/Med/14/828/2005, BT/PR12578/MED/31/75/2009]; Advanced Centre for Treatment Research and Education in Cancer (ACTREC); UGC	Department of Biotechnology; Advanced Centre for Treatment Research and Education in Cancer (ACTREC); UGC(University Grants Commission, India)	Funding was provided by the Department of Biotechnology grants BT/PR6521/Med/14/828/2005 and BT/PR12578/MED/31/75/2009, Advanced Centre for Treatment Research and Education in Cancer (ACTREC) core funds to SND, and a UGC fellowship for AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; De Rooij DG, 2000, J ANDROL, V21, P776; Dhup S, 2008, NAT METHODS, V5, P601, DOI 10.1038/nmeth.1225; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; GOSSLER A, 1986, P NATL ACAD SCI USA, V83, P9065, DOI 10.1073/pnas.83.23.9065; Hamra FK, 2002, P NATL ACAD SCI USA, V99, P14931, DOI 10.1073/pnas.222561399; Kanatsu-Shinohara M, 2004, BIOL REPROD, V71, P1202, DOI 10.1095/biolreprod.104.031294; Kanatsu-Shinohara M, 2002, P NATL ACAD SCI USA, V99, P1383, DOI 10.1073/pnas.022646399; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; Nagano M, 1998, APMIS, V106, P47, DOI 10.1111/j.1699-0463.1998.tb01318.x; Nagano M, 2002, FEBS LETT, V524, P111, DOI 10.1016/S0014-5793(02)03010-7; Nagano M, 2001, P NATL ACAD SCI USA, V98, P13090, DOI 10.1073/pnas.231473498; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Rao MK, 2006, GENE DEV, V20, P147, DOI 10.1101/gad1367806; RONEN K, 2011, MOL THER; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tiscornia G, 2004, P NATL ACAD SCI USA, V101, P7347, DOI 10.1073/pnas.0402107101; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101	24	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21975	10.1371/journal.pone.0021975	http://dx.doi.org/10.1371/journal.pone.0021975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760937	gold, Green Published, Green Submitted			2022-12-25	WOS:000292655400032
J	Antignano, F; Hamilton, M; Patterson, S; Ho, V; Cohen, C; Levings, MK; Krystal, G				Antignano, Frann; Hamilton, Melisa; Patterson, Scott; Ho, Victor; Cohen, Carla; Levings, Megan K.; Krystal, Gerald			SHIP-Deficient Dendritic Cells, Unlike Wild Type Dendritic Cells, Suppress T Cell Proliferation via a Nitric Oxide-Independent Mechanism	PLOS ONE			English	Article							BONE-MARROW; INDOLEAMINE 2,3-DIOXYGENASE; GM-CSF; MACROPHAGES; INHIBITION; GENERATION; INDUCTION; TOLERANCE; CANCER; ACTIVATION	Background: Dendritic cells (DCs) not only play a crucial role in activating immune cells but also suppressing them. We recently investigated SHIP's role in murine DCs in terms of immune cell activation and found that TLR agonist-stimulated SHIP-/- GM-CSF-derived DCs (GM-DCs) were far less capable than wild type (WT, SHIP+/+) GM-DCs at activating T cell proliferation. This was most likely because SHIP-/- GM-DCs could not up-regulate MHCII and/or co-stimulatory receptors following TLR stimulation. However, the role of SHIP in DC-induced T cell suppression was not investigated. Methodology/Principal Findings: In this study we examined SHIP's role in DC-induced T cell suppression by co-culturing WT and SHIP-/- murine DCs, derived under different conditions or isolated from spleens, with alpha CD3+ alpha CD28 activated WT T cells and determined the relative suppressive abilities of the different DC subsets. We found that, in contrast to SHIP+/+ and -/- splenic or Flt3L-derived DCs, which do not suppress T cell proliferation in vitro, both SHIP+/+ and -/- GM-DCs were capable of potently suppressing T cell proliferation. However, WT GM-DC suppression appeared to be mediated, at least in part, by nitric oxide (NO) production while SHIP-/- GM-DCs expressed high levels of arginase 1 and did not produce NO. Following exhaustive studies to ascertain the mechanism of SHIP-/- DC-mediated suppression, we could conclude that cell-cell contact was required and the mechanism may be related to their relative immaturity, compared to SHIP+/+ GM-DCs. Conclusions: These findings suggest that although both SHIP+/+ and -/- GM-DCs suppress T cell proliferation, the mechanism(s) employed are different. WT GM-DCs suppress, at least in part, via IFN gamma-induced NO production while SHIP-/- GM-DCs do not produce NO and suppression can only be alleviated when contact is prevented.	[Antignano, Frann; Hamilton, Melisa; Ho, Victor; Cohen, Carla; Krystal, Gerald] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Antignano, Frann] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Patterson, Scott; Levings, Megan K.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada; [Patterson, Scott; Levings, Megan K.] BC Childrens Hosp, Immun Hlth & Dis Child & Family Res Inst, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; BC Childrens Hospital; Child & Family Research Institute; University of British Columbia	Antignano, F (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	gkrystal@bccrc.ca		Cohen, Carla/0000-0002-8398-0010; Levings, Megan/0000-0002-0305-5790; Krystal, Gerald/0000-0002-1961-6281; Antignano, Frann/0000-0003-0502-5330	Terry Fox Foundation; Canadian Institute of Health Research [MOP 57834]; Natural Science and Engineering Research Council; Michael Smith Foundation for Health Research; Canadian Cancer Society Research Institute	Terry Fox Foundation; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported by the Canadian Cancer Society Research Institute with funds from the Terry Fox Foundation and core support by the BC Cancer Foundation and the BC Cancer Agency (GK). It was also supported by the Canadian Institute of Health Research (MOP 57834 to MKL). MKL holds a Canada Research Chair in Transplantation. FA was supported by Natural Science and Engineering Research Council and Michael Smith Foundation for Health Research. MH was supported by Canadian Institute of Health Research and Michael Smith Foundation for Health Research. VH was supported by Natural Sciences and Engineering Research Council. SP holds a CIHR Training Program in Transplantation award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antignano F, 2010, J IMMUNOL, V184, P2805, DOI 10.4049/jimmunol.0903170; Bonham CA, 1996, TRANSPLANTATION, V62, P1871, DOI 10.1097/00007890-199612270-00033; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Bronte V, 2003, J IMMUNOL, V170, P270, DOI 10.4049/jimmunol.170.1.270; Carr G, 2008, J MED CHEM, V51, P2634, DOI 10.1021/jm800143h; Fallarino F, 2002, INT IMMUNOL, V14, P65, DOI 10.1093/intimm/14.1.65; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Griess P, 1879, CHEM BER, V12, P428; Griess P., 1879, BER DTSCH CHEM GES, V12, P426, DOI DOI 10.1002/CBER.187901201117; Hamad ARA, 2003, J IMMUNOL, V171, P2421, DOI 10.4049/jimmunol.171.5.2421; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Hoffman R A, 1994, Transpl Immunol, V2, P313, DOI 10.1016/0966-3274(94)90008-6; Huber S, 2010, BLOOD, V116, P3311, DOI 10.1182/blood-2010-02-271981; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Kuang DM, 2008, J IMMUNOL, V181, P3089, DOI 10.4049/jimmunol.181.5.3089; Kuroda E, 2009, J IMMUNOL, V183, P3652, DOI 10.4049/jimmunol.0900864; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Lange C, 2007, IMMUNOL CELL BIOL, V85, P575, DOI 10.1038/sj.icb.7100088; Lu LN, 1996, J IMMUNOL, V157, P3577; Lutz MB, 2007, IMMUNOBIOLOGY, V212, P855, DOI 10.1016/j.imbio.2007.09.001; Lutz MB, 2000, EUR J IMMUNOL, V30, P1048, DOI 10.1002/(SICI)1521-4141(200004)30:4<1048::AID-IMMU1048>3.0.CO;2-W; Lutz MB, 2000, EUR J IMMUNOL, V30, P1813, DOI 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8; Mellor AL, 1999, IMMUNOL TODAY, V20, P469, DOI 10.1016/S0167-5699(99)01520-0; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Powell TJ, 2003, IMMUNOLOGY, V109, P197, DOI 10.1046/j.1365-2567.2003.01639.x; Rauh MJ, 2005, IMMUNITY, V23, P361, DOI 10.1016/j.immuni.2005.09.003; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Rossner S, 2005, EUR J IMMUNOL, V35, P3533, DOI 10.1002/eji.200526172; Saharinen J, 1999, CYTOKINE GROWTH F R, V10, P99, DOI 10.1016/S1359-6101(99)00010-6; Sato K, 2003, BLOOD, V101, P3581, DOI 10.1182/blood-2002-09-2712; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Taieb A, 2007, CLIN IMMUNOL, V123, P176, DOI 10.1016/j.clim.2006.12.007; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Yamazaki S, 2006, IMMUNOL REV, V212, P314, DOI 10.1111/j.0105-2896.2006.00422.x; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505; Zou T, 2010, J IMMUNOL, V185, P2790, DOI 10.4049/jimmunol.0903740	48	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21893	10.1371/journal.pone.0021893	http://dx.doi.org/10.1371/journal.pone.0021893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755007	Green Submitted, Green Published, gold			2022-12-25	WOS:000292632000034
J	Xiao, L; Fu, ZR; Liu, F; Zhang, LD; Shi, XM; Shen, XY; Ni, ZJ; Fu, H; Li, RD; Cao, XT; Ding, GS; Wang, QX				Xiao, Liang; Fu, Zhi-ren; Liu, Fang; Zhang, Lu-ding; Shi, Xiao-min; Shen, Xiao-yun; Ni, Zhi-jia; Fu, Hong; Li, Rui-dong; Cao, Xue-tao; Ding, Guo-shan; Wang, Quan-xing			Suppression of Allograft Rejection by Tim-1-Fc through Cross-Linking with a Novel Tim-1 Binding Partner on T Cells	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; ACTIVATING RECEPTOR; GENE FAMILY; CLASS-II; DOMAIN; MOUSE; TOLERANCE; RESPONSES; LIGAND; MODEL	Engagement of T-cell immunoglobulin mucin (Tim)-1 on T cells with its ligand, Tim-4, on antigen presenting cells delivers positive costimulatory signals to T cells. However, the molecular mechanisms for Tim-1-mediated regulation of T-cell activation and differentiation are relatively poorly understood. Here we investigated the role of Tim-1 in T-cell responses and allograft rejection using recombinant human Tim-1 extracellular domain and IgG1-Fc fusion proteins (Tim-1-Fc). In vitro assays confirmed that Tim-1-Fc selectively binds to CD4(+) effector T cells, but not dendritic cells or natural regulatory T cells (nTregs). Tim-1-Fc was able to inhibit the responses of purified CD4(+) T cells that do not express Tim-4 to stimulation by anti-CD3/CD28 mAbs, and this inhibition was associated with reduced AKT and ERK1/2 phosphorylation, but it had no influence on nTregs. Moreover, Tim-1-Fc inhibited the proliferation of CD4(+) T cells stimulated by allogeneic dendritic cells. Treatment of recipient mice with Tim-1-Fc significantly prolonged cardiac allograft survival in a fully MHC-mismatched strain combination, which was associated with impaired Th1 response and preserved Th2 and nTregs function. Importantly, the frequency of Foxp3(+) cells in splenic CD4(+) T cells was increased, thus shifting the balance toward regulators, even though Tim-1-Fc did not induce Foxp3 expression in CD4(+)CD25(-) T cells directly. These results indicate that Tim-1-Fc can inhibit T-cell responses through an unknown Tim-1 binding partner on T cells, and it is a promising immunosuppressive agent for preventing allograft rejection.	[Xiao, Liang; Fu, Zhi-ren; Liu, Fang; Zhang, Lu-ding; Shi, Xiao-min; Ni, Zhi-jia; Fu, Hong; Li, Rui-dong; Ding, Guo-shan] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Organ Transplantat, Shanghai, Peoples R China; [Shen, Xiao-yun; Cao, Xue-tao; Wang, Quan-xing] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Xiao, L (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Organ Transplantat, Shanghai, Peoples R China.	dingguoshanmail@163.com; wangqx64@yahoo.com.cn		shen, xiaoyun/0000-0003-2098-9728	National Key Basic Research Program of China [2009CB522402]; National Nature Science Foundation of China [30772056, 30772046, 81072444, U0832009]; Science and Technology Foundation of Shanghai, China [09411951900]	National Key Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Shanghai, China	This work was supported by grants from the National Key Basic Research Program of China (2009CB522402, http://www.973.gov.cn), the National Nature Science Foundation of China (30772056, 30772046, 81072444, U0832009, http://www.nsfc.gov.cn) and the Science and Technology Foundation of Shanghai, China (09411951900, http://www.stcsm.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; Bayer AL, 2009, BLOOD, V113, P733, DOI 10.1182/blood-2008-08-173179; Binne LL, 2007, J IMMUNOL, V178, P4342, DOI 10.4049/jimmunol.178.7.4342; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Degauque N, 2008, J CLIN INVEST, V118, P735, DOI 10.1172/JCI32562; Delgado P, 2000, NATURE, V406, P426, DOI 10.1038/35019102; Encinas JA, 2005, J ALLERGY CLIN IMMUN, V116, P1343, DOI 10.1016/j.jaci.2005.08.031; Grazia TJ, 2004, J IMMUNOL, V172, P7451, DOI 10.4049/jimmunol.172.12.7451; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Kim HS, 2010, J IMMUNOL, V184, P4095, DOI 10.4049/jimmunol.0901991; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kramer JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000569; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mariat C, 2009, TRANSPLANTATION, V87, pS84, DOI 10.1097/TP.0b013e3181a2ba83; Mariat C, 2009, J IMMUNOL, V182, P1379, DOI 10.4049/jimmunol.182.3.1379; Mesri M, 2006, INT IMMUNOL, V18, P473, DOI 10.1093/intimm/dxh388; Meyers JH, 2005, TRENDS MOL MED, V11, P362, DOI 10.1016/j.molmed.2005.06.008; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Mizui M, 2008, INT IMMUNOL, V20, P695, DOI 10.1093/intimm/dxn029; Pietra BA, 2000, J CLIN INVEST, V106, P1003, DOI 10.1172/JCI10467; RACIOPPI L, 1993, J EXP MED, V177, P1047, DOI 10.1084/jem.177.4.1047; Rathmell JC, 2003, EUR J IMMUNOL, V33, P2223, DOI 10.1002/eji.200324048; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; Rodriguez-Manzanet R, 2008, J IMMUNOL, V180, P4706, DOI 10.4049/jimmunol.180.7.4706; Song SH, 2010, INT IMMUNOPHARMACOL, V10, P679, DOI 10.1016/j.intimp.2010.03.011; Su EW, 2008, CYTOKINE, V44, P9, DOI 10.1016/j.cyto.2008.06.013; THORBORN G, PLOS ONE, V5, pE9254; Ueno T, 2008, J CLIN INVEST, V118, P742, DOI 10.1172/JCI32451; Umetsu SE, 2005, NAT IMMUNOL, V6, P447, DOI 10.1038/ni1186; Wang QX, 2006, J IMMUNOL, V177, P2175, DOI 10.4049/jimmunol.177.4.2175; Wang QX, 2005, MICROSURG, V25, P76, DOI 10.1002/micr.20082; Xiao S, 2007, J EXP MED, V204, P1691, DOI 10.1084/jem.20062498; Xie AN, 2011, TRANSPLANTATION, V91, P27, DOI 10.1097/TP.0b013e3181fdd948; Yamanishi Y, 2008, BLOOD, V111, P688, DOI 10.1182/blood-2007-04-085787; Yamanishi Y, 2010, J EXP MED, V207, P1501, DOI 10.1084/jem.20090581; Yang PC, 2007, GASTROENTEROLOGY, V133, P1522, DOI 10.1053/j.gastro.2007.08.006	39	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21697	10.1371/journal.pone.0021697	http://dx.doi.org/10.1371/journal.pone.0021697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750723	Green Published, gold, Green Submitted			2022-12-25	WOS:000292512000020
J	Xu, N; Libertini, S; Black, EJ; Lao, Y; Hegarat, N; Walker, M; Gillespie, DA				Xu, N.; Libertini, S.; Black, E. J.; Lao, Y.; Hegarat, N.; Walker, M.; Gillespie, D. A.			Cdk-mediated phosphorylation of Chk1 is required for efficient activation and full checkpoint proficiency in response to DNA damage	ONCOGENE			English	Article						Chk1; RPA; Cdk; DNA damage; checkpoint; cell cycle	END RESECTION; HOMOLOGOUS RECOMBINATION; REPAIR; CTIP; SURVIVAL	Here, we show that activation of the checkpoint effector kinase Chk1 in response to irradiation-induced DNA damage is minimal in G1, maximal during S-phase and diminishes as cells enter G2. In addition, formation of irradiation-induced replication protein A (RPA)-coated single-stranded DNA (RPA-ssDNA), a structure required for ATM and Rad3-related (ATR)-Chk1 activation, occurs in a broadly similar pattern. Cyclin-dependent kinase (Cdk) activity is thought to promote RPA-ssDNA formation by stimulating DNA strand resection at double-strand breaks (DSBs), providing one possible mechanism of imposing cell cycle dependence on DNA damage signaling. However, it has recently been shown that Chk1 itself is also subject to Cdk-mediated phosphorylation at serines 286 and 301 (S286 and 301). We show that Chk1 S301 phosphorylation increases as cells progress through S and G2 and that both Cdk1 and Cdk2 are likely to contribute to this modification in vivo. We also find that substitution of S286 and S301 with non-phosphorylatable alanine residues strongly attenuates DNA damage-induced Chk1 activation and G2 checkpoint proficiency, but does not eliminate the underlying cell cycle dependence of Chk1 regulation. Taken together, these data indicate that Cdk activity regulates multiple steps in the DNA damage response pathway including full activation of Chk1 and checkpoint proficiency. Oncogene (2012) 31, 1086-1094; doi:10.1038/onc.2011.310; published online 18 July 2011	[Xu, N.] Tsinghua Univ, Div Life Sci, Grad Sch Shenzhen, Shenzhen 518055, Guang Dong, Peoples R China; [Xu, N.; Libertini, S.; Black, E. J.; Lao, Y.; Walker, M.; Gillespie, D. A.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Gillespie, D. A.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Beatson Institute; University of Glasgow	Xu, N (corresponding author), Tsinghua Univ, Div Life Sci, Grad Sch Shenzhen, Room 409,Bldg L,Tsinghua Campus, Shenzhen 518055, Guang Dong, Peoples R China.	xu.naihan@sz.tsinghua.edu.cn; d.gillespie@beatson.gla.ac.uk	Xu, Naihan/C-2778-2018; Libertini, Silvana/A-3531-2011; Gillespie, David/R-4771-2019; , Yuanzhi/D-3936-2015	Libertini, Silvana/0000-0003-2633-1564; Gillespie, David/0000-0002-6338-0544; , Yuanzhi/0000-0002-7803-4484; Lao, Yuanzhi/0000-0002-0994-8303	Cancer Research UK (CR-UK); Medical Research Council of the United Kingdom (MRC); CR-UK China Fellowships; Marie Curie Fellowship	Cancer Research UK (CR-UK)(Cancer Research UK); Medical Research Council of the United Kingdom (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CR-UK China Fellowships; Marie Curie Fellowship(European Commission)	We wish to thank Cancer Research UK (CR-UK) and the Medical Research Council of the United Kingdom (MRC) for financial support. N Xu and Y Lao were the recipients of CR-UK China Fellowships, S Libertini was the recipient of a Marie Curie Fellowship. We thank Helfrid Hochegger for many stimulating discussions.	Bourke E, 2010, ONCOGENE, V29, P616, DOI 10.1038/onc.2009.340; Cerqueira A, 2009, J CELL BIOL, V187, P773, DOI 10.1083/jcb.200903033; Deans AJ, 2006, CANCER RES, V66, P8219, DOI 10.1158/0008-5472.CAN-05-3945; Enomoto M, 2009, J BIOL CHEM, V284, P34223, DOI 10.1074/jbc.C109.051540; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Hochegger H, 2007, J CELL BIOL, V178, P257, DOI 10.1083/jcb.200702034; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Ikegami Y, 2008, BIOCHEM BIOPH RES CO, V377, P1227, DOI 10.1016/j.bbrc.2008.10.119; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; Rainey MD, 2008, ONCOGENE, V27, P896, DOI 10.1038/sj.onc.1210702; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Satyanarayana A, 2008, MOL BIOL CELL, V19, P65, DOI 10.1091/mbc.E07-06-0525; Shiromizu T, 2006, GENES CELLS, V11, P477, DOI 10.1111/j.1365-2443.2006.00955.x; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Walker M, 2009, ONCOGENE, V28, P2314, DOI 10.1038/onc.2009.102; Wohlbold L, 2009, DNA REPAIR, V8, P1018, DOI 10.1016/j.dnarep.2009.04.009; Xu NH, 2010, J CELL BIOL, V190, P297, DOI 10.1083/jcb.201003004; Yata K, 2009, DNA REPAIR, V8, P6, DOI 10.1016/j.dnarep.2008.09.002; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060	27	27	27	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	9					1086	1094		10.1038/onc.2011.310	http://dx.doi.org/10.1038/onc.2011.310			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	901EW	21765472				2022-12-25	WOS:000300945900002
J	Gatei, M; Jakob, B; Chen, P; Kijas, AW; Becherel, OJ; Gueven, N; Birrell, G; Lee, JH; Paull, TT; Lerenthal, Y; Fazry, S; Taucher-Scholz, G; Kalb, R; Schindler, D; Waltes, R; Dork, T; Lavin, MF				Gatei, Magtouf; Jakob, Burkhard; Chen, Philip; Kijas, Amanda W.; Becherel, Olivier J.; Gueven, Nuri; Birrell, Geoff; Lee, Ji-Hoon; Paull, Tanya T.; Lerenthal, Yaniv; Fazry, Shazrul; Taucher-Scholz, Gisela; Kalb, Reinhard; Schindler, Detlev; Waltes, Regina; Doerk, Thilo; Lavin, Martin F.			ATM Protein-dependent Phosphorylation of Rad50 Protein Regulates DNA Repair and Cell Cycle Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIJMEGEN-BREAKAGE-SYNDROME; DOUBLE-STRAND BREAKS; ATAXIA-TELANGIECTASIA; MRN COMPLEX; S-PHASE; AUTOPHOSPHORYLATION SITES; MRE11 COMPLEX; NBS1; DAMAGE; ACTIVATION	The Mre11/Rad50/NBN complex plays a central role in coordinating the cellular response to DNA double-strand breaks. The importance of Rad50 in that response is evident from the recent description of a patient with Rad50 deficiency characterized by chromosomal instability and defective ATM-dependent signaling. We report here that ATM (defective in ataxia-telangiectasia) phosphorylates Rad50 at a single site (Ser-635) that plays an important adaptor role in signaling for cell cycle control and DNA repair. Although a Rad50 phosphosite-specific mutant (S635G) supported normal activation of ATM in Rad50-deficient cells, it was defective in correcting DNA damage-induced signaling through the ATM-dependent substrate SMC1. This mutant also failed to correct radiosensitivity, DNA double-strand break repair, and an S-phase checkpoint defect in Rad50-deficient cells. This was not due to disruption of the Mre11/Rad50/NBN complex revealing for the first time that phosphorylation of Rad50 plays a key regulatory role as an adaptor for specific ATM-dependent downstream signaling through SMC1 for DNA repair and cell cycle checkpoint control in the maintenance of genome integrity.	[Gatei, Magtouf; Chen, Philip; Kijas, Amanda W.; Becherel, Olivier J.; Gueven, Nuri; Birrell, Geoff; Fazry, Shazrul; Lavin, Martin F.] Queensland Inst Med Res, Radiat Biol & Oncol Lab, Brisbane, Qld 4029, Australia; [Jakob, Burkhard; Taucher-Scholz, Gisela] Helmholtzzentrum Schwerionenforsch, D-64291 Darmstadt, Germany; [Becherel, Olivier J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Lee, Ji-Hoon; Paull, Tanya T.] Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA; [Lee, Ji-Hoon; Paull, Tanya T.] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [Lerenthal, Yaniv] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Kalb, Reinhard; Schindler, Detlev] Univ Wurzburg, Dept Human Genet, D-97074 Wurzburg, Germany; [Waltes, Regina] Hannover Med Sch, Dept Radiat Oncol, D-30625 Hannover, Germany; [Doerk, Thilo] Hannover Med Sch, Dept Gynecol, D-30625 Hannover, Germany; [Lavin, Martin F.] Univ Queensland, Clin Res Ctr, Brisbane, Qld 4029, Australia	QIMR Berghofer Medical Research Institute; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; University of Queensland; Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Tel Aviv University; Sackler Faculty of Medicine; University of Wurzburg; Hannover Medical School; Hannover Medical School; University of Queensland	Lavin, MF (corresponding author), Queensland Inst Med Res, 300 Herston Rd, Herston, Qld 4006, Australia.	martin.lavin@qimr.edu.au	Kalb, Reinhard/AAR-3249-2021; Dörk, Thilo/J-8620-2012; Lavin, Martin F/F-5961-2014; Lee, Jihoon/AAK-3497-2021; Jakob, Burkhard/D-2047-2013	Kalb, Reinhard/0000-0003-3906-6907; Dörk, Thilo/0000-0002-9458-0282; Lavin, Martin F/0000-0002-5940-4769; Lee, Jihoon/0000-0001-7387-935X; Jakob, Burkhard/0000-0003-2404-377X; Fazry, Shazrul/0000-0002-7072-8609; Paull, Tanya/0000-0002-2991-651X; Kijas, Amanda/0000-0001-8538-7766; Guven, Nuri/0000-0003-3782-767X	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the Australian National Health and Medical Research Council.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; BARBI G, 1991, AM J MED GENET, V40, P44, DOI 10.1002/ajmg.1320400109; BEAMISH H, 1994, INT J RADIAT BIOL, V65, P175, DOI 10.1080/09553009414550211; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Buscemi G, 2001, MOL CELL BIOL, V21, P5214, DOI 10.1128/MCB.21.15.5214-5222.2001; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cerosaletti K, 2004, J BIOL CHEM, V279, P38813, DOI 10.1074/jbc.M404294200; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Daniel JA, 2008, J CELL BIOL, V183, P777, DOI 10.1083/jcb.200805154; Deriano L, 2009, MOL CELL, V34, P13, DOI 10.1016/j.molcel.2009.03.009; Di Virgilio M, 2005, J CELL BIOL, V171, P765, DOI 10.1083/jcb.200506029; Di Virgilio M, 2009, DNA REPAIR, V8, P1311, DOI 10.1016/j.dnarep.2009.07.006; Difilippantonio S, 2007, J EXP MED, V204, P1003, DOI 10.1084/jem.20070319; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Dong ZW, 1999, J BIOL CHEM, V274, P19513, DOI 10.1074/jbc.274.28.19513; Dzikiewicz-Krawczyk A, 2008, MUTAT RES-REV MUTAT, V659, P262, DOI 10.1016/j.mrrev.2008.05.005; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Helmink BA, 2009, J EXP MED, V206, P669, DOI 10.1084/jem.20081326; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; HOULDSWORTH J, 1980, NUCLEIC ACIDS RES, V8, P3709, DOI 10.1093/nar/8.16.3709; Huang JR, 2002, NUCLEIC ACIDS RES, V30, P667, DOI 10.1093/nar/30.3.667; Jakob B, 2003, RADIAT RES, V159, P676, DOI 10.1667/0033-7587(2003)159[0676:BIOHCT]2.0.CO;2; Jakob B, 2005, RADIAT RES, V163, P681, DOI 10.1667/RR3374; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Kozlov SV, 2011, J BIOL CHEM, V286, P9107, DOI 10.1074/jbc.M110.204065; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee JH, 2003, MOL CANCER RES, V1, P674; Lee JH, 2010, EMBO J, V29, P574, DOI 10.1038/emboj.2009.372; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Lloyd J, 2009, CELL, V139, P100, DOI 10.1016/j.cell.2009.07.043; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Manthey KC, 2007, J CELL SCI, V120, P4221, DOI 10.1242/jcs.004580; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Mirzoeva OK, 2003, MOL CANCER RES, V1, P207; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Nakanishi K, 2002, NAT CELL BIOL, V4, P913, DOI 10.1038/ncb879; Olson E, 2007, J BIOL CHEM, V282, P22939, DOI 10.1074/jbc.M702162200; PARRA I, 1993, NAT GENET, V5, P17, DOI 10.1038/ng0993-17; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Quennet V, 2011, NUCLEIC ACIDS RES, V39, P2144, DOI 10.1093/nar/gkq1175; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Robison JG, 2004, J BIOL CHEM, V279, P34802, DOI 10.1074/jbc.M404750200; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Tobias F, 2010, MUTAT RES-REV MUTAT, V704, P54, DOI 10.1016/j.mrrev.2009.11.004; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; van den Bosch M, 2003, EMBO REP, V4, P844, DOI 10.1038/sj.embor.embor925; Waltes R, 2009, AM J HUM GENET, V84, P605, DOI 10.1016/j.ajhg.2009.04.010; Wang HC, 2006, CANCER RES, V66, P1391, DOI 10.1158/0008-5472.CAN-05-3270; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; You ZS, 2007, NAT CELL BIOL, V9, P311, DOI 10.1038/ncb1651; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	81	56	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31542	31556		10.1074/jbc.M111.258152	http://dx.doi.org/10.1074/jbc.M111.258152			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757780	Green Published, hybrid			2022-12-25	WOS:000294487500049
J	Lawrence, SA; Hackett, JC; Moran, RG				Lawrence, Scott A.; Hackett, John C.; Moran, Richard G.			Tetrahydrofolate Recognition by the Mitochondrial Folate Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATION; GAMMA-GLUTAMATE SYNTHETASE; SUBSTRATE-BINDING SITE; ADP/ATP CARRIER; OXOGLUTARATE CARRIER; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; PROTEIN; IDENTIFICATION; DENSITY	A mitochondrial carrier family (MCF) of transport proteins facilitates the transfer of charged small molecules across the inner mitochondrial membrane. The human genome has similar to 50 genes corresponding to members of this family. All MCF proteins contain three repeats of a characteristic and conserved PX(D/E)XX(K/R) motif thought to be central to the mechanism of these transporters. The mammalian mitochondrial folate transporter (MFT) is one of a few MCF members, known as the P(I/L) W subfamily, that have evolved a tryptophan residue in place of the (D/E) in the second conserved motif; the function of this substitution (Trp-142) is unclear. Molecular dynamics simulations of the MFT in its explicit membrane environment identified this tryptophan, as well as several other residues lining the transport cavity, to be involved in a series of sequential interactions that coordinated the movement of the tetrahydrofolate substrate within the transport cavity. We probed the function of these residues by mutagenesis. The mutation of every residue identified by molecular dynamics to interact with tetrahydrofolate during simulated transit into the aqueous channel severely impaired folate transport. Mutation of the subfamily-defining tryptophan residue in the MFT to match the MCF consensus at this position (W142D) was incompatible with cell survival. These studies indicate that MFT Trp-142, as well as other residues lining the transporter interior, coordinate tetrahydrofolate descent and positioning of the substrate in the transporter basin. Overall, we identified residues in the walls and at the base of the transport cavity that are involved in substrate recognition by the MFT.	[Lawrence, Scott A.; Moran, Richard G.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; [Hackett, John C.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Hackett, John C.] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA; [Moran, Richard G.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Moran, RG (corresponding author), 401 Coll St,POB 980035, Richmond, VA 23298 USA.	rmoran@vcu.edu	Hackett, John/J-3871-2019	Hackett, John/0000-0002-4923-2668	National Institutes of Health [R01-CA104279]; NATIONAL CANCER INSTITUTE [R01CA104279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA104279 (to R. G. M.).	Aksimentiev A, 2005, BIOPHYS J, V88, P3745, DOI 10.1529/biophysj.104.058727; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BECKE AD, 1993, J CHEM PHYS, V98, P1372, DOI 10.1063/1.464304; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cappello AR, 2006, J MOL BIOL, V363, P51, DOI 10.1016/j.jmb.2006.08.041; David C, 2008, BIOCHEMISTRY-US, V47, P13223, DOI 10.1021/bi8012565; Dehez F, 2008, J AM CHEM SOC, V130, P12725, DOI 10.1021/ja8033087; Della Rocca BM, 2005, MOL MEMBR BIOL, V22, P443, DOI 10.1080/09687860500269335; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Falconi M, 2006, PROTEINS, V65, P681, DOI 10.1002/prot.21102; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; FREEMANTLE SJ, 1995, J BIOL CHEM, V270, P9579, DOI 10.1074/jbc.270.16.9579; Frisch M.J., 2009, GAUSSIAN 09 REV A02; Garcia-Viloca M, 2003, BIOCHEMISTRY-US, V42, P13558, DOI 10.1021/bi034824f; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnston JM, 2008, MOL MEMBR BIOL, V25, P506, DOI 10.1080/09687680802459271; KAO FT, 1969, P NATL ACAD SCI USA, V64, P1284, DOI 10.1073/pnas.64.4.1284; Kieseritzky G, 2008, PROTEINS, V71, P1335, DOI 10.1002/prot.21820; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LIN BF, 1993, J BIOL CHEM, V268, P21674; Ma CL, 2007, J BIOL CHEM, V282, P17210, DOI 10.1074/jbc.M611268200; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marobbio CMT, 2006, BIOCHEM J, V393, P441, DOI 10.1042/BJ20051284; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; McCarty EA, 2004, J BIOL CHEM, V279, P33829, DOI 10.1074/jbc.M403677200; NELSON DR, 1993, J MOL BIOL, V230, P1159, DOI 10.1006/jmbi.1993.1233; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Perchiniak E, 2007, BIOCHEMISTRY-US, V46, P1557, DOI 10.1021/bi062191+; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; SANBROOK J, 2001, MOL CLONING LAB MANU, P3; Spaan AN, 2005, MOL GENET METAB, V86, P441, DOI 10.1016/j.ymgme.2005.07.014; Stipani V, 2001, BIOCHEMISTRY-US, V40, P15805, DOI 10.1021/bi011616j; Titus SA, 2000, J BIOL CHEM, V275, P36811, DOI 10.1074/jbc.M005163200; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Tonazzi A, 2005, BBA-BIOMEMBRANES, V1718, P53, DOI 10.1016/j.bbamem.2005.10.007; *TRIP INT, 2008, SYB 8 0 ORCHESTRAR; Tzagoloff A, 1996, J BIOL CHEM, V271, P7392, DOI 10.1074/jbc.271.13.7392; Walters DE, 2004, BIOPHYS J, V87, P907, DOI 10.1529/biophysj.104.042127; Wang Y, 2008, P NATL ACAD SCI USA, V105, P9598, DOI 10.1073/pnas.0801786105	46	24	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31480	31489		10.1074/jbc.M111.272187	http://dx.doi.org/10.1074/jbc.M111.272187			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768094	hybrid, Green Published			2022-12-25	WOS:000294487500043
J	Misztal, K; Wisniewska, MB; Ambrozkiewicz, M; Nagalski, A; Kuznicki, J				Misztal, Katarzyna; Wisniewska, Marta B.; Ambrozkiewicz, Mateusz; Nagalski, Andrzej; Kuznicki, Jacek			WNT Protein-independent Constitutive Nuclear Localization of beta-Catenin Protein and Its Low Degradation Rate in Thalamic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE THALAMUS; EXPRESSION; DIFFERENTIATION; PROLIFERATION; CORTEX; CELLS; BRAIN; MICE; TELENCEPHALON; GASTRULATION	Nuclear localization of beta-catenin is a hallmark of canonical Wnt signaling, a pathway that plays a crucial role in brain development and the neurogenesis of the adult brain. We recently showed that beta-catenin accumulates specifically in mature thalamic neurons, where it regulates the expression of the Ca(v)3.1 voltage-gated calcium channel gene. Here, we investigated the mechanisms underlying beta-catenin accumulation in thalamic neurons. Wereport that a lack of soluble factors produced either by glia or cortical neurons does not impair nuclear beta-catenin accumulation in thalamic neurons. We next found that the number of thalamic neurons with beta-catenin nuclear localization did not change when the Wnt/Dishevelled signaling pathway was inhibited by Dickkopf1 or a dominant negative mutant of Dishevelled3. These results suggest a WNT-independent cell-autonomous mechanism. We found that the protein levels of APC, AXIN1, and GSK3 beta, components of the beta-catenin degradation complex, were lower in the thalamus than in the cortex of the adult rat brain. Reduced levels of these proteins were also observed in cultured thalamic neurons compared with cortical cultures. Finally, pulse-chase experiments confirmed that cytoplasmic beta-catenin turnover was slower in thalamic neurons than in cortical neurons. Altogether, our data indicate that the nuclear localization of beta-catenin in thalamic neurons is their cell-intrinsic feature, which was WNT-independent but associated with low levels of proteins involved in beta-catenin labeling for ubiquitination and subsequent degradation.	[Misztal, Katarzyna; Wisniewska, Marta B.; Ambrozkiewicz, Mateusz; Nagalski, Andrzej; Kuznicki, Jacek] Int Inst Mol & Cell Biol, Lab Neurodegenerat, PL-02109 Warsaw, Poland; [Kuznicki, Jacek] Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Kuznicki, J (corresponding author), Int Inst Mol & Cell Biol, Lab Neurodegenerat, 4 Ks Trojdena St, PL-02109 Warsaw, Poland.	jacek.kuznicki@iimcb.gov.pl	Ambrozkiewicz, Mateusz/O-9547-2019; Kuznicki, Jacek/AAW-9239-2020; Nagalski, Andrzej/AAH-3366-2019; Nagalski, Andrzej/O-3173-2015; Wisniewska, Marta B./A-6691-2009	Kuznicki, Jacek/0000-0001-6486-0657; Nagalski, Andrzej/0000-0002-4864-5604; Nagalski, Andrzej/0000-0002-4864-5604; Wisniewska, Marta B./0000-0002-1593-0361; Misztal, Katarzyna/0000-0001-6575-2500; Ambrozkiewicz, Mateusz/0000-0001-5225-5230	European Community [229676]; Polish Ministry of Science and Higher Education [4245/B/P01/2010/38, 1917/B/P01/2010/39]	European Community(European Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the European Community Seventh Framework Programme FP7/2007-2013 under Grant Agreement 229676 and Polish Ministry of Science and Higher Education Grants 4245/B/P01/2010/38 and 1917/B/P01/2010/39.	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Agarwala S, 1998, J COMP NEUROL, V392, P252, DOI 10.1002/(SICI)1096-9861(19980309)392:2<252::AID-CNE7>3.0.CO;2-1; Asavaritikrai P, 2003, EXP NEUROL, V181, P39, DOI 10.1016/S0014-4886(03)00025-6; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bluske KK, 2009, DEV DYNAM, V238, P3297, DOI 10.1002/dvdy.22167; Boulos S, 2006, BRAIN RES, V1102, P27, DOI 10.1016/j.brainres.2006.04.089; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Braun MM, 2003, DEVELOPMENT, V130, P5579, DOI 10.1242/dev.00685; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Galceran J, 2000, DEVELOPMENT, V127, P469; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Imura T, 2010, STEM CELLS, V28, P2053, DOI 10.1002/stem.524; Jones EG, 2004, J COMP NEUROL, V477, P55, DOI 10.1002/cne.20234; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kohler EM, 2010, ONCOGENE, V29, P1663, DOI 10.1038/onc.2009.447; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Kuwahara A, 2010, DEVELOPMENT, V137, P1035, DOI 10.1242/dev.046417; Lee S, 2009, J COMP NEUROL, V517, P925, DOI 10.1002/cne.22199; Li B, 2009, DEVELOPMENT, V136, P3267, DOI 10.1242/dev.036954; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Louvi A, 2007, J COMP NEUROL, V504, P550, DOI 10.1002/cne.21461; Lucas JJ, 1999, NEUROREPORT, V10, P2699, DOI 10.1097/00001756-199909090-00002; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Moriyama A, 2007, GENESIS, V45, P90, DOI 10.1002/dvg.20268; Piccin D, 2011, STEM CELLS, V29, P528, DOI 10.1002/stem.589; Schmeisser MJ, 2009, J BIOL CHEM, V284, P29146, DOI 10.1074/jbc.M109.020628; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Shimogori T, 2004, J COMP NEUROL, V473, P496, DOI 10.1002/cne.20135; Solberg N, 2008, DEV DYNAM, V237, P1799, DOI 10.1002/dvdy.21586; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Sousa KM, 2010, J BIOL CHEM, V285, P7246, DOI 10.1074/jbc.M109.079822; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wexler EM, 2009, STEM CELLS, V27, P1130, DOI 10.1002/stem.36; Wisniewska MB, 2010, J NEUROSCI, V30, P4957, DOI 10.1523/JNEUROSCI.1425-09.2010; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Zhou CJ, 2006, NEUROSCIENCE, V142, P1119, DOI 10.1016/j.neuroscience.2006.07.007; Zhou CJ, 2004, J NEUROSCI, V24, P7632, DOI 10.1523/JNEUROSCI.2123-04.2004	51	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31781	31788		10.1074/jbc.M111.229666	http://dx.doi.org/10.1074/jbc.M111.229666			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757747	Green Published, hybrid			2022-12-25	WOS:000294487500071
J	Bjornsdottir, US; Holgate, ST; Reddy, PS; Hill, AA; McKee, CM; Csimma, CI; Weaver, AA; Legault, HM; Small, CG; Ramsey, RC; Ellis, DK; Burke, CM; Thompson, PJ; Howarth, PH; Wardlaw, AJ; Bardin, PG; Bernstein, DI; Irving, LB; Chupp, GL; Bensch, GW; Bensch, GW; Stahlman, JE; Karetzky, M; Baker, JW; Miller, RL; Goodman, BH; Raible, DG; Goldman, SJ; Miller, DK; Ryan, JL; Dorner, AJ; Immermann, FW; O'Toole, M				Bjornsdottir, Unnur S.; Holgate, Stephen T.; Reddy, Padmalatha S.; Hill, Andrew A.; McKee, Charlotte M.; Csimma, Cristina I.; Weaver, Amy A.; Legault, Holly M.; Small, Clayton G.; Ramsey, Renee C.; Ellis, Debra K.; Burke, Conor M.; Thompson, Philip J.; Howarth, Peter H.; Wardlaw, Andrew J.; Bardin, Phillip G.; Bernstein, David I.; Irving, Louis B.; Chupp, Geoffrey L.; Bensch, George W.; Bensch, Gregory W.; Stahlman, Jon E.; Karetzky, Monroe; Baker, James W.; Miller, Rachel L.; Goodman, Brad H.; Raible, Donald G.; Goldman, Samuel J.; Miller, Douglas K.; Ryan, John L.; Dorner, Andrew J.; Immermann, Frederick W.; O'Toole, Margot			Pathways Activated during Human Asthma Exacerbation as Revealed by Gene Expression Patterns in Blood	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; REGULATORY FACTOR-1 POLYMORPHISMS; ATOPIC ASTHMA; T-CELLS; MONONUCLEAR-CELLS; CLUSTER-ANALYSIS; INNATE IMMUNITY; CD14 GENE; B-CELL; ASSOCIATION	Background: Asthma exacerbations remain a major unmet clinical need. The difficulty in obtaining airway tissue and bronchoalveolar lavage samples during exacerbations has greatly hampered study of naturally occurring exacerbations. This study was conducted to determine if mRNA profiling of peripheral blood mononuclear cells (PBMCs) could provide information on the systemic molecular pathways involved during asthma exacerbations. Methodology/Principal Findings: Over the course of one year, gene expression levels during stable asthma, exacerbation, and two weeks after an exacerbation were compared using oligonucleotide arrays. For each of 118 subjects who experienced at least one asthma exacerbation, the gene expression patterns in a sample of peripheral blood mononuclear cells collected during an exacerbation episode were compared to patterns observed in multiple samples from the same subject collected during quiescent asthma. Analysis of covariance identified genes whose levels of expression changed during exacerbations and returned to quiescent levels by two weeks. Heterogeneity among visits in expression profiles was examined using K-means clustering. Three distinct exacerbation-associated gene expression signatures were identified. One signature indicated that, even among patients without symptoms of respiratory infection, genes of innate immunity were activated. Antigen-independent T cell activation mediated by IL15 was also indicated by this signature. A second signature revealed strong evidence of lymphocyte activation through antigen receptors and subsequent downstream events of adaptive immunity. The number of genes identified in the third signature was too few to draw conclusions on the mechanisms driving those exacerbations. Conclusions/Significance: This study has shown that analysis of PBMCs reveals systemic changes accompanying asthma exacerbation and has laid the foundation for future comparative studies using PBMCs.	[Bjornsdottir, Unnur S.] Univ Iceland, Dept Allergy Clin Immunol, Reykjavik, Iceland; [Holgate, Stephen T.; Howarth, Peter H.] Univ Southampton, Southampton, Hants, England; [Reddy, Padmalatha S.; Hill, Andrew A.; Weaver, Amy A.; Ramsey, Renee C.; Raible, Donald G.; Goldman, Samuel J.; Miller, Douglas K.; Immermann, Frederick W.; O'Toole, Margot] Pfizer, Cambridge, MA USA; [McKee, Charlotte M.; Csimma, Cristina I.; Legault, Holly M.; Small, Clayton G.; Ellis, Debra K.; Ryan, John L.; Dorner, Andrew J.] Wyeth Res, Cambridge, MA USA; [Burke, Conor M.] James Connolly Mem Hosp, Dublin, Ireland; [Thompson, Philip J.] Univ Western Australia, Lung Inst WA, Crawley, Australia; [Thompson, Philip J.] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Crawley, Australia; [Wardlaw, Andrew J.] Univ Leicester, Leicester, Leics, England; [Bardin, Phillip G.] Monash Univ, Melbourne, Vic 3004, Australia; [Bardin, Phillip G.] Med Ctr, Melbourne, Vic, Australia; [Bernstein, David I.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Irving, Louis B.] Royal Melbourne Hosp, Parkville, Vic 3050, Australia; [Chupp, Geoffrey L.] Yale Univ, Sch Med, New Haven, CT USA; [Bensch, George W.; Bensch, Gregory W.] Bensch Clin Res, Stockton, CA USA; [Stahlman, Jon E.] Ctr Asthma & Allergy, Conyers, GA USA; [Karetzky, Monroe] Newark Beth Israel Med Ctr, Newark, NJ USA; [Baker, James W.] Baker Allergy Asthma & Dermatol, Lake Oswego, OR USA; [Miller, Rachel L.] Columbia Univ, Med Ctr, New York, NY USA; [Goodman, Brad H.] Coastal Allergy & Asthma, Savannah, GA USA	University of Iceland; University of Southampton; Pfizer; Pfizer; University of Western Australia; University of Western Australia; University of Leicester; Monash University; University System of Ohio; University of Cincinnati; Royal Melbourne Hospital; Yale University; Newark Beth Israel Medical Center; Columbia University	Bjornsdottir, US (corresponding author), Univ Iceland, Dept Allergy Clin Immunol, Reykjavik, Iceland.	S.Holgate@soton.ac.uk; margot.otoole@pfizer.com		Howarth, Peter/0000-0003-0619-7927; Wardlaw, Andrew/0000-0001-6583-0791	Pfizer, formerly Wyeth; Medical Research Council [G0900453, G0800766, G0400473, G19/34] Funding Source: researchfish; MRC [G0900453, G0800766, G0400473, G19/34] Funding Source: UKRI	Pfizer, formerly Wyeth(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Pfizer, formerly Wyeth. This is an observational study with no investigational drugs involved. Therefore, there is no issue related to potential bias due to financial interests in drug development. The study was designed by Pfizer (formerly Wyeth) scientists and clinicians in collaboration with the academic authors. Data collection and analyses were performed by Pfizer (formerly Wyeth) and the academic co-authors and publication was always the intent. The work done within the company was done by employees of the company, who generally own stock or stock oprions. Proceeds from any patents accrue to the company and not the employees. The publication does not have any relationship to products in development or marketed protducts. The names of the authors who were company employess during the conduct of this study are: Padmalatha S. Reddy, Andrew A. Hill, Charlotte M. McKee, Cristina I. Csimma, Amy A. Weaver, Holly M. Legault, Clayton G. Small, Renee C. Ramsey, Debra K. Ellis, Donald G. Raible, Samuel J. Goldman, Douglas K. Miller, John L. Ryan, Andrew J. Dorner, Frederick W. Immermann, Margot O'Toole.	Aoki T, 2009, CLIN EXP ALLERGY, V39, P213, DOI 10.1111/j.1365-2222.2008.03186.x; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Barnes PJ, 2007, EUR RESPIR J, V29, P587, DOI 10.1183/09031936.00080306; Becker S, 2005, TOXICOL APPL PHARM, V203, P45, DOI 10.1016/j.taap.2004.07.007; Belda J, 2007, EUR RESPIR J, V30, P1143, DOI 10.1183/09031936.00050306; Benjamini Y., 1995, J R STAT SOC, V57, P289, DOI [10.1111/j.2517-6161.1995.tb02031.x, DOI 10.1111/J.2517-6161.1995.TB02031.X]; Bierbaum S, 2006, ALLERGY, V61, P576, DOI 10.1111/j.1398-9995.2006.01059.x; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Bottcher MF, 2004, J ALLERGY CLIN IMMUN, V114, P561, DOI 10.1016/j.jaci.2004.04.050; Boyce JA, 2009, J ALLERGY CLIN IMMUN, V123, P569, DOI 10.1016/j.jaci.2009.01.041; Boyman O, 2007, CURR OPIN IMMUNOL, V19, P320, DOI 10.1016/j.coi.2007.04.015; Burgel PR, 2008, EUR RESPIR J, V32, P1068, DOI 10.1183/09031936.00172007; Deng J, 2002, INT IMMUNOL, V14, P513, DOI 10.1093/intimm/14.5.513; Eder W, 2004, J ALLERGY CLIN IMMUN, V113, P482, DOI 10.1016/j.jaci.2003.12.374; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Guillot L, 2002, J IMMUNOL, V168, P5989, DOI 10.4049/jimmunol.168.12.5989; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Harrison TW, 2004, LANCET, V363, P271, DOI 10.1016/S0140-6736(03)15384-6; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Iwamura C, 2008, CURR ALLERGY ASTHM R, V8, P7, DOI 10.1007/s11882-008-0003-0; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kasaian MT, 2007, AM J RESP CELL MOL, V36, P368, DOI 10.1165/rcmb.2006-0244OC; Kasprowicz DJ, 2000, J IMMUNOL, V165, P680, DOI 10.4049/jimmunol.165.2.680; Koppelman GH, 2001, AM J RESP CRIT CARE, V163, P965, DOI 10.1164/ajrccm.163.4.2004164; Kurz T, 2004, J ALLERGY CLIN IMMUN, V113, P896, DOI 10.1016/j.jaci.2004.03.004; Lazarus R, 2004, AM J RESP CRIT CARE, V170, P594, DOI 10.1164/rccm.200404-491OC; Le Souef PN, 2009, CURR OPIN ALLERGY CL, V9, P123, DOI 10.1097/ACI.0b013e3283292283; Liu KB, 2002, P NATL ACAD SCI USA, V99, P6192, DOI 10.1073/pnas.092675799; Makela MJ, 1999, EUR J CLIN MICROBIOL, V18, P665, DOI 10.1007/s100960050370; Mariani TJ, 2002, FASEB J, V16, P321, DOI 10.1096/fj.02-0351fje; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; McShane LM, 2002, BIOINFORMATICS, V18, P1462, DOI 10.1093/bioinformatics/18.11.1462; MURPHY S, 1997, GUIDELINES DIAGNOSIS; Nakao F, 2001, J ALLERGY CLIN IMMUN, V107, P499, DOI 10.1067/mai.2001.113051; O'Toole MM, 2009, J ALLERGY CLIN IMMUN, V123, pS154, DOI 10.1016/j.jaci.2008.12.576; Ohteki T, 1998, J EXP MED, V187, P967, DOI 10.1084/jem.187.6.967; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Qiu YS, 2007, THORAX, V62, P475, DOI 10.1136/thx.2006.066670; Reed CE, 2001, J ALLERGY CLIN IMMUN, V108, P157, DOI 10.1067/mai.2001.116862; Rice-McDonald G, 2005, INTERN MED J, V35, P693, DOI 10.1111/j.1445-5994.2005.00972.x; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Saemann MD, 2005, J CLIN INVEST, V115, P468, DOI 10.1172/JCI200522720; Sears MR, 2007, J ALLERGY CLIN IMMUN, V120, P526, DOI 10.1016/j.jaci.2007.05.047; Sharma M, 2004, IMMUNOGENETICS, V56, P544, DOI 10.1007/s00251-004-0721-y; Simpson JL, 2008, PAEDIATR RESPIR REV, V9, P263, DOI 10.1016/j.prrv.2008.05.007; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Smit LAM, 2009, AM J RESP CRIT CARE, V179, P363, DOI 10.1164/rccm.200810-1533OC; Sutherland ER, 2007, CHEST, V132, P1962, DOI 10.1378/chest.06-2415; Sykes A, 2008, J ALLERGY CLIN IMMUN, V122, P685, DOI 10.1016/j.jaci.2008.08.017; Sykes A, 2008, THORAX, V63, P758, DOI 10.1136/thx.2008.099036; Tamari M, 2009, RECENT PATENTS INFLA, V3, P17, DOI 10.2174/187221309787158380; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Wang TN, 2006, CLIN EXP ALLERGY, V36, P1147, DOI 10.1111/j.1365-2222.2006.02551.x; Wenzel SE, 2009, NEW ENGL J MED, V360, P1026, DOI 10.1056/NEJMe0900334; Whalen KA, 2008, CLIN EXP ALLERGY, V38, P1590, DOI 10.1111/j.1365-2222.2008.03059.x; Williams AS, 2007, J APPL PHYSIOL, V103, P1189, DOI 10.1152/japplphysiol.00172.2007; Wills-Karp M, 2004, CURR ALLERGY ASTHM R, V4, P123; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Woo JG, 2003, J ALLERGY CLIN IMMUN, V112, P438, DOI 10.1067/mai.2003.1634; Wos M, 2008, AM J RESP CRIT CARE, V177, P1082, DOI 10.1164/rccm.200607-973OC; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Xatzipsaiti M, 2005, AM J RESP CRIT CARE, V172, P1037, DOI 10.1164/rccm.200502-315OC; Yang IA, 2006, CURR OPIN ALLERGY CL, V6, P23, DOI 10.1097/01.all.0000200503.77295.bb; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	67	46	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21902	10.1371/journal.pone.0021902	http://dx.doi.org/10.1371/journal.pone.0021902			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779351	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000292811300026
J	Han, XL; Rozen, S; Boyle, SH; Hellegers, C; Cheng, H; Burke, JR; Welsh-Bohmer, KA; Doraiswamy, PM; Kaddurah-Daouk, R				Han, Xianlin; Rozen, Steve; Boyle, Stephen H.; Hellegers, Caroline; Cheng, Hua; Burke, James R.; Welsh-Bohmer, Kathleen A.; Doraiswamy, P. Murali; Kaddurah-Daouk, Rima			Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics	PLOS ONE			English	Article							MULTIDIMENSIONAL MASS-SPECTROMETRY; BIOLOGICAL SAMPLES; INTRASOURCE SEPARATION; APOLIPOPROTEIN-E; RISK-FACTORS; IONIZATION; CERAMIDE; DEMENTIA; EXTRACTS; DEFICIENCY	Background: The development of plasma biomarkers could facilitate early detection, risk assessment and therapeutic monitoring in Alzheimer's disease (AD). Alterations in ceramides and sphingomyelins have been postulated to play a role in amyloidogensis and inflammatory stress related neuronal apoptosis; however few studies have conducted a comprehensive analysis of the sphingolipidome in AD plasma using analytical platforms with accuracy, sensitivity and reproducibility. Methods and Findings: We prospectively analyzed plasma from 26 AD patients (mean MMSE 21) and 26 cognitively normal controls in a non-targeted approach using multi-dimensional mass spectrometry-based shotgun lipidomics [1,2] to determine the levels of over 800 molecular species of lipids. These data were then correlated with diagnosis, apolipoprotein E4 genotype and cognitive performance. Plasma levels of species of sphingolipids were significantly altered in AD. Of the 33 sphingomyelin species tested, 8 molecular species, particularly those containing long aliphatic chains such as 22 and 24 carbon atoms, were significantly lower (p<0.05) in AD compared to controls. Levels of 2 ceramide species (N16:0 and N21:0) were significantly higher in AD (p<0.05) with a similar, but weaker, trend for 5 other species. Ratios of ceramide to sphingomyelin species containing identical fatty acyl chains differed significantly between AD patients and controls. MMSE scores were correlated with altered mass levels of both N20:2 SM and OH-N25:0 ceramides (p<0.004) though lipid abnormalities were observed in mild and moderate AD. Within AD subjects, there were also genotype specific differences. Conclusions: In this prospective study, we used a sensitive multimodality platform to identify and characterize an essentially uniform but opposite pattern of disruption in sphingomyelin and ceramide mass levels in AD plasma. Given the role of brain sphingolipids in neuronal function, our findings provide new insights into the AD sphingolipidome and the potential use of metabolomic signatures as peripheral biomarkers.	[Han, Xianlin; Cheng, Hua] Sanford Burnham Med Res Inst, Orlando, FL USA; [Rozen, Steve] Duke NUS Grad Med Sch, Dept Med, Singapore, Singapore; [Boyle, Stephen H.; Hellegers, Caroline; Welsh-Bohmer, Kathleen A.; Doraiswamy, P. Murali; Kaddurah-Daouk, Rima] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Burke, James R.; Welsh-Bohmer, Kathleen A.] Duke Univ, Med Ctr, Bryan Alzheimer Dis Res Ctr, Durham, NC USA; [Doraiswamy, P. Murali] Duke Univ, Med Ctr, Duke Inst Brain Sci, Durham, NC USA	Sanford Burnham Prebys Medical Discovery Institute; National University of Singapore; Duke University; Duke University; Duke University	Han, XL (corresponding author), Sanford Burnham Med Res Inst, Orlando, FL USA.	kaddu001@mc.duke.edu	Welsh-Bohmer, Kathleen/AAA-3178-2020; Burke, James R/E-4245-2016; Rozen, Steven G./J-5939-2013	Burke, James R/0000-0002-3408-7787; Rozen, Steven G./0000-0002-4288-0056; Kaddurah-Daouk, Rima/0000-0003-1858-5732	NIH [R24 GM078233, R01 NS054008-01A2]; NIA/NIDDK [R01AG031675]; Bryan ADRC [P50 AG01528, P30 AG028377]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM078233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028377, R01AG031675] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)NIH National Institute on Aging (NIA)); Bryan ADRC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported in part by NIH R24 GM078233, "The Metabolomics Research Network'' (R.K.-D.), R01 NS054008-01A2, (R.K.-D.), NIA/NIDDK R01AG031675 (X. H.) and the Bryan ADRC P50 AG01528 and P30 AG028377. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Cheng H, 2007, J NEUROCHEM, V101, P57, DOI 10.1111/j.1471-4159.2006.04342.x; Christi W.W., 2010, CHEM BIOL, DOI [10.1533/9780857097866, DOI 10.1533/9780857097866]; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; Han XL, 2008, RAPID COMMUN MASS SP, V22, P2115, DOI 10.1002/rcm.3595; Han Xianlin, 2005, Current Alzheimer Research, V2, P65, DOI 10.2174/1567205052772786; Han XL, 2010, BBA-MOL CELL BIOL L, V1801, P774, DOI 10.1016/j.bbalip.2010.01.010; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; Han XL, 2006, J AM SOC MASS SPECTR, V17, P264, DOI 10.1016/j.jasms.2005.11.003; Han XL, 2001, ANAL BIOCHEM, V295, P88, DOI 10.1006/abio.2001.5178; Han XL, 2005, J LIPID RES, V46, P1548, DOI 10.1194/jlr.D500007-JLR200; Han XL, 2004, ANAL BIOCHEM, V330, P317, DOI 10.1016/j.ab.2004.04.004; Han XL, 2003, ANN NEUROL, V54, P115, DOI 10.1002/ana.10618; Han XL, 2002, ANAL BIOCHEM, V302, P199, DOI 10.1006/abio.2001.5536; Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Ichi I, 2006, LIPIDS, V41, P859, DOI 10.1007/s11745-006-5041-6; Ji Y, 2011, CLIN PHARMACOL THER, V89, P97, DOI 10.1038/clpt.2010.250; Jiang XT, 2007, ANAL BIOCHEM, V371, P135, DOI 10.1016/j.ab.2007.08.019; Jones L, 2010, BBA-MOL CELL BIOL L, V1801, P754, DOI 10.1016/j.bbalip.2010.04.005; Kaddurah-Daouk R, 2007, MOL PSYCHIATR, V12, P934, DOI 10.1038/sj.mp.4002000; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Katsel P, 2007, NEUROCHEM RES, V32, P845, DOI 10.1007/s11064-007-9297-x; Klein J, 2000, J NEURAL TRANSM, V107, P1027, DOI 10.1007/s007020070051; Mannelli P, 2009, HUM PSYCHOPHARM CLIN, V24, P666, DOI 10.1002/hup.1068; Mayeux R, 2011, ALZHEIMERS DEMENT, V7, P15, DOI 10.1016/j.jalz.2010.11.005; Merrill AH, 1997, TOXICOL APPL PHARM, V142, P208, DOI 10.1006/taap.1996.8029; Mielke MM, 2010, NEUROBIOL AGING, V31, P17, DOI 10.1016/j.neurobiolaging.2008.03.011; Nagata Y, 2006, J HISTOCHEM CYTOCHEM, V54, P375, DOI 10.1369/jhc.5A6675.2006; Nelson J, 2006, AM J EPIDEMIOL, V163, P903, DOI 10.1093/aje/kwj140; Paige LA, 2007, INT J GERIATR PSYCH, V22, P418, DOI 10.1002/gps.1690; Patkar AA, 2009, PSYCHOPHARMACOLOGY, V206, P479, DOI 10.1007/s00213-009-1625-1; Pettegrew JW, 2001, NEUROCHEM RES, V26, P771, DOI 10.1023/A:1011603916962; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Rozen S, 2005, METABOLOMICS, V1, P101, DOI 10.1007/s11306-005-4810-1; Satoi H, 2005, NEUROSCIENCE, V130, P657, DOI 10.1016/j.neuroscience.2004.08.056; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Schneider JA, 2009, J ALZHEIMERS DIS, V18, P691, DOI 10.3233/JAD-2009-1227; Silva LC, 2009, BIOPHYS J, V96, P3210, DOI 10.1016/j.bpj.2008.12.3923; Steffens DC, 2010, J GERIATR PSYCH NEUR, V23, P138, DOI 10.1177/0891988709358592; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; SVENNERHOLM L, 1994, J NEUROCHEM, V62, P1039; Vemuri P, 2009, NEUROLOGY, V73, P287, DOI 10.1212/WNL.0b013e3181af79e5; Viswanathan A, 2009, NEUROLOGY, V72, P368, DOI 10.1212/01.wnl.0000341271.90478.8e; Yang K, 2009, J CHROMATOGR B, V877, P2924, DOI 10.1016/j.jchromb.2009.01.016; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u; Yao JK, 2010, MOL PSYCHIATR, V15, P938, DOI 10.1038/mp.2009.33; Yao JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009508; [No title captured]; [No title captured]; [No title captured]	57	163	175	5	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21643	10.1371/journal.pone.0021643	http://dx.doi.org/10.1371/journal.pone.0021643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779331	Green Submitted, Green Published, gold			2022-12-25	WOS:000292680900009
J	Sperandeo, MP; Tosco, A; Izzo, V; Tucci, F; Troncone, R; Auricchio, R; Romanos, J; Trynka, G; Auricchio, S; Jabri, B; Greco, L				Sperandeo, Maria Pia; Tosco, Antonella; Izzo, Valentina; Tucci, Francesca; Troncone, Riccardo; Auricchio, Renata; Romanos, Jihane; Trynka, Gosia; Auricchio, Salvatore; Jabri, Bana; Greco, Luigi			Potential Celiac Patients: A Model of Celiac Disease Pathogenesis	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; RISK VARIANTS; HLA; INFLAMMATION; CONTRIBUTES; ACTIVATION; MUCOSA; CELLS; IL-21	Background and Aim: Potential celiacs have the 'celiactype' HLA, positive anti-transglutaminase antibodies but no damage at small intestinal mucosa. Only a minority of them develops mucosal lesion. More than 40 genes were associated to Celiac Disease (CD) but we still do not know how those pathways transform a genetically predisposed individual into an affected person. The aim of the study is to explore the genetic features of Potential CD individuals. Methods: 127 'potential' CD patients entered the study because of positive anti-tissue transglutaminase and no mucosal lesions; about 30% of those followed for four years become frankly celiac. They were genotyped for 13 polymorphisms of 'candidate genes' and compared to controls and celiacs. Moreover, 60 biopsy specimens were used for expression studies. Results: Potential CD bear a lighter HLA-related risk, compared to celiac (chi(2) = 48.42; p value = 1x10(-8)). They share most of the polymorphisms of the celiacs, but the frequency of c-REL* G allele was suggestive for a difference compared to celiac (chi(2) = 5.42; p value = 0.02). One marker of the KIAA1109/IL-2/IL-21 candidate region differentiated potentials from celiac (rs4374642: chi(2) = 7.17, p value = 0.01). The expression of IL-21 was completely suppressed in potentials compared to celiacs (p value = 0.02) and to controls (p value = 0.02), in contrast IL-2, KIAA1109 and c-REL expression were over-expressed. Conclusions: Potential CD show genetic features slightly different from celiacs. Genetic and expression markers help to differentiate this condition. Potential CD is a precious biological model of the pathways leading to the small intestinal mucosal damage in genetically predisposed individuals.	[Sperandeo, Maria Pia; Tosco, Antonella; Izzo, Valentina; Tucci, Francesca; Troncone, Riccardo; Auricchio, Renata; Auricchio, Salvatore] Univ Naples Federico 2, European Lab Food Induced Dis, Naples, Italy; [Romanos, Jihane] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Jabri, Bana] Univ Chicago, Dept Med, Dept Pathol, Chicago, IL 60637 USA; [Jabri, Bana] Univ Chicago, Dept Paediat, Chicago, IL 60637 USA; [Greco, Luigi] Univ Naples Federico 2, Dept Pediat, Naples, Italy	University of Naples Federico II; University of Groningen; University of Chicago; University of Chicago; University of Naples Federico II	Sperandeo, MP (corresponding author), Univ Naples Federico 2, European Lab Food Induced Dis, Naples, Italy.	ydongre@unina.it	Tucci, Francesca/AAB-2184-2022; Romanos, Jihane/F-7372-2012; AURICCHIO, RENATA/AAC-7718-2022; TOSCO, Antonella/U-7052-2017	Tucci, Francesca/0000-0001-8798-8987; TOSCO, Antonella/0000-0003-0470-6839; Trynka, Gosia/0000-0002-6955-9529	PREVENT CD [036383]	PREVENT CD	This work was supported by PREVENT CD (project: EU-FP6-2005-FOOD4B-contract no. 036383). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bourgey M, 2007, GUT, V56, P1054, DOI 10.1136/gut.2006.108530; Caruso R, 2007, J IMMUNOL, V178, P5957, DOI 10.4049/jimmunol.178.9.5957; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fina D, 2008, GUT, V57, P887, DOI 10.1136/gut.2007.129882; Greco L, 1998, J PEDIATR GASTR NUTR, V26, P286, DOI 10.1097/00005176-199803000-00009; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Koskinen O, 2008, J PEDIATR GASTR NUTR, V47, P436, DOI 10.1097/MPG.0b013e31817b6dec; Kurppa K, 2010, J PEDIATR-US, V157, P373, DOI 10.1016/j.jpeds.2010.02.070; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Maiuri MC, 2003, N-S ARCH PHARMACOL, V368, P63, DOI 10.1007/s00210-003-0771-y; Maiuri MC, 2003, J MOL MED-JMM, V81, P373, DOI 10.1007/s00109-003-0440-0; Meresse B, 2009, MUCOSAL IMMUNOL, V2, P8, DOI 10.1038/mi.2008.75; Romanos J, 2009, GASTROENTEROLOGY, V137, P834, DOI 10.1053/j.gastro.2009.05.040; Strengell M, 2004, J LEUKOCYTE BIOL, V76, P416, DOI 10.1189/jlb.1003488; TOSCO A, 2010, CLIN GASTROENTE 0917; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909	21	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21281	10.1371/journal.pone.0021281	http://dx.doi.org/10.1371/journal.pone.0021281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760890	Green Published, gold, Green Submitted			2022-12-25	WOS:000292657200009
J	Saha, R; Suthers, PF; Maranas, CD				Saha, Rajib; Suthers, Patrick F.; Maranas, Costas D.			Zea mays iRS1563: A Comprehensive Genome-Scale Metabolic Reconstruction of Maize Metabolism	PLOS ONE			English	Article							BROWN-MIDRIB MUTANTS; BIOFUEL PRODUCTION; ESCHERICHIA-COLI; SYSTEMS BIOLOGY; DRAFT SEQUENCE; PLANT; ARABIDOPSIS; PHOTOSYNTHESIS; BIOSYNTHESIS; DATABASE	The scope and breadth of genome-scale metabolic reconstructions have continued to expand over the last decade. Herein, we introduce a genome-scale model for a plant with direct applications to food and bioenergy production (i.e., maize). Maize annotation is still underway, which introduces significant challenges in the association of metabolic functions to genes. The developed model is designed to meet rigorous standards on gene-protein-reaction (GPR) associations, elementally and charged balanced reactions and a biomass reaction abstracting the relative contribution of all biomass constituents. The metabolic network contains 1,563 genes and 1,825 metabolites involved in 1,985 reactions from primary and secondary maize metabolism. For approximately 42% of the reactions direct literature evidence for the participation of the reaction in maize was found. As many as 445 reactions and 369 metabolites are unique to the maize model compared to the AraGEM model for A. thaliana. 674 metabolites and 893 reactions are present in Zea mays iRS1563 that are not accounted for in maize C4GEM. All reactions are elementally and charged balanced and localized into six different compartments (i.e., cytoplasm, mitochondrion, plastid, peroxisome, vacuole and extracellular). GPR associations are also established based on the functional annotation information and homology prediction accounting for monofunctional, multifunctional and multimeric proteins, isozymes and protein complexes. We describe results from performing flux balance analysis under different physiological conditions, (i.e., photosynthesis, photorespiration and respiration) of a C4 plant and also explore model predictions against experimental observations for two naturally occurring mutants (i.e., bm1 and bm3). The developed model corresponds to the largest and more complete to-date effort at cataloguing metabolism for a plant species.	[Saha, Rajib; Suthers, Patrick F.; Maranas, Costas D.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Saha, R (corresponding author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.	costas@psu.edu	Maranas, Costas D/A-4774-2011	Maranas, Costas D/0000-0002-1508-1398; Suthers, Patrick/0000-0002-5560-9986; Saha, Rajib/0000-0002-2974-0243	United States Department of Energy (DOE) [DE-FG02-05ER25684]	United States Department of Energy (DOE)(United States Department of Energy (DOE))	This work was supported by United States Department of Energy (DOE) Grant DE-FG02-05ER25684. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson M, 2010, PLANT SCI, V178, P61, DOI 10.1016/j.plantsci.2009.11.003; Allen JF, 2002, CELL, V110, P273, DOI 10.1016/S0092-8674(02)00870-X; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bennett MD, 2003, ANN BOT-LONDON, V91, P547, DOI 10.1093/aob/mcg057; BENNETZEN J, 2009, HDB MAIZE GENETICS G; DAI ZY, 1995, PLANT PHYSIOL, V107, P815, DOI 10.1104/pp.107.3.815; Dal'Molin CGD, 2010, PLANT PHYSIOL, V154, P1871, DOI 10.1104/pp.110.166488; Dal'Molin CGD, 2010, PLANT PHYSIOL, V152, P579, DOI 10.1104/pp.109.148817; Dennis C, 2000, NATURE, V408, P791; DENNIS DT, 1982, ANNU REV PLANT PHYS, V33, P27, DOI 10.1146/annurev.pp.33.060182.000331; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Grabber JH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-114; Grafahrend-Belau E, 2009, PLANT PHYSIOL, V149, P585, DOI 10.1104/pp.108.129635; Gregory R. P. F., 1989, BIOCH PHOTOSYNTHESIS; Guillaumie S, 2007, PLANTA, V226, P235, DOI 10.1007/s00425-006-0468-9; Gutierrez RA, 2005, PLANT PHYSIOL, V138, P550, DOI 10.1104/pp.104.900150; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Hervas M, 2003, ACCOUNTS CHEM RES, V36, P798, DOI 10.1021/ar020084b; Hisano H, 2009, IN VITRO CELL DEV-PL, V45, P306, DOI 10.1007/s11627-009-9219-5; Hong SJ, 2007, BIOTECHNOL BIOPROC E, V12, P165, DOI 10.1007/BF03028644; Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56; JOLIVETTOURNIER P, 1984, PLANT PHYSIOL, V74, P108, DOI 10.1104/pp.74.1.108; Kim J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-53; KUC J, 1964, ARCH BIOCHEM BIOPHYS, V105, P103, DOI 10.1016/0003-9861(64)90240-1; Kumar VS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-212; Li X, 2008, PLANT J, V54, P569, DOI 10.1111/j.1365-313X.2008.03457.x; Liang CZ, 2009, GENOME RES, V19, P1912, DOI 10.1101/gr.088997.108; Marita JM, 2003, J AGR FOOD CHEM, V51, P1313, DOI 10.1021/jf0260592; Mechin V, 2005, J AGR FOOD CHEM, V53, P5872, DOI 10.1021/jf050722f; Milne Caroline B., 2009, Biotechnology Journal, V4, P1653, DOI 10.1002/biot.200900234; Muller F., 1970, AGR RES REPORT, V736, P1; Notebaart RA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-296; Ouzounis CA, 2000, GENOME RES, V10, P568, DOI 10.1101/gr.10.4.568; Park JM, 2009, BIOTECHNOL ADV, V27, P979, DOI 10.1016/j.biotechadv.2009.05.019; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; PENNINGDEVRIES FW, 1974, J THEOR BIOL, V45, P339; Pilalis E, 2011, BIOTECHNOL BIOENG, V108, P1673, DOI 10.1002/bit.23107; Poolman MG, 2009, PLANT PHYSIOL, V151, P1570, DOI 10.1104/pp.109.141267; Ranganathan S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000744; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sanchez OJ, 2008, BIORESOURCE TECHNOL, V99, P5270, DOI 10.1016/j.biortech.2007.11.013; Sattler SE, 2010, PLANT SCI, V178, P229, DOI 10.1016/j.plantsci.2010.01.001; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Smidansky ED, 2003, PLANTA, V216, P656, DOI 10.1007/s00425-002-0897-z; Spector WS, 1956, HDB BIOL DATA, pxxxvi; Stewart CN, 2007, NAT BIOTECHNOL, V25, P283, DOI 10.1038/nbt0307-283; Sticklen MB, 2008, NAT REV GENET, V9, P433, DOI 10.1038/nrg2336; Sticklen MB, 2009, BIOFUEL BIOPROD BIOR, V3, P448, DOI 10.1002/bbb.157; STYLES ED, 1975, PHYTOCHEMISTRY, V14, P413, DOI 10.1016/0031-9422(75)85101-6; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Suthers PF, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000285; Sweetlove LJ, 2003, PLANT PHYSIOL, V132, P420, DOI 10.1104/pp.103.022004; Taiz L., 2002, PLANT PHYSIOL; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Torney F, 2007, CURR OPIN BIOTECH, V18, P193, DOI 10.1016/j.copbio.2007.03.006; TSAFTARIS AS, 1983, P NATL ACAD SCI-BIOL, V80, P4455, DOI 10.1073/pnas.80.14.4455; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; Vega-Sanchez ME, 2010, CURR OPIN BIOTECH, V21, P218, DOI 10.1016/j.copbio.2010.02.002; VOLK RJ, 1972, PLANT PHYSIOL, V49, P218, DOI 10.1104/pp.49.2.218; Wedig C, 1987, J AGR FOOD CHEM, V35, P23; Wei YL, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-7; WEIDEMANN C, 1991, PLANT CELL REP, V10, P371, DOI 10.1007/BF00193162; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; WISE RR, 2007, STRUCTURE FUNCTION P, V23, P274; Xavier A, 2010, NATURE P, DOI [10.1038/npre.2010.4908.1, DOI 10.1038/NPRE.2010.4908.1]; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	72	139	139	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21784	10.1371/journal.pone.0021784	http://dx.doi.org/10.1371/journal.pone.0021784			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755001	Green Published, Green Submitted, gold			2022-12-25	WOS:000292632000028
J	Fontaine, F; Fuchs, RT; Storz, G				Fontaine, Fanette; Fuchs, Ryan T.; Storz, Gisela			Membrane Localization of Small Proteins in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CYTOPLASMIC MEMBRANE; SIGNAL RECOGNITION PARTICLE; F1F0 ATP SYNTHASE; SUBUNIT-C; TOPOLOGY PREDICTION; YIDC; INNER; INSERTION; TRANSLOCASE; PATHWAY	Escherichia coli synthesize over 60 poorly understood small proteins of less than 50 amino acids. A striking feature of these proteins is that 65% contain a predicted alpha-helical transmembrane (TM) domain. This prompted us to examine the localization, topology, and membrane insertion of the small proteins. Biochemical fractionation showed that, consistent with the predicted TM helix, the small proteins generally are most abundant in the inner membrane fraction. Examples of both N-in-C-out and N-out-C-in orientations were found in assays of topology-reporter fusions to representative small TM proteins. Interestingly, however, three of nine tested proteins display dual topology. Positive residues close to the transmembrane domains are conserved, and mutational analysis of one small protein, YohP, showed that the positive inside rule applies for single transmembrane domain proteins as has been observed for larger proteins. Finally, fractionation analysis of small protein localization in strains depleted of the Sec or YidC membrane insertion pathways uncovered differential requirements. Some small proteins appear to be affected by both Sec and YidC depletion, others showed more dependence on one or the other insertion pathway, whereas one protein was not affected by depletion of either Sec or YidC. Thus, despite their diminutive size, small proteins display considerable diversity in topology, biochemical features, and insertion pathways.	[Fontaine, Fanette; Fuchs, Ryan T.; Storz, Gisela] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Storz, G (corresponding author), 18 Lib Dr, Bethesda, MD 20892 USA.	storz@helix.nih.gov		Storz, Gisela/0000-0001-6698-1241	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008855] Funding Source: NIH RePORTER	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Alix E, 2008, EMBO J, V27, P546, DOI 10.1038/sj.emboj.7601983; Baars L, 2008, J BACTERIOL, V190, P3505, DOI 10.1128/JB.01631-07; Chen MY, 2003, J BIOL CHEM, V278, P23295, DOI 10.1074/jbc.M301008200; Chen MY, 2002, J BIOL CHEM, V277, P7670, DOI 10.1074/jbc.M110644200; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; de Gier JWL, 1998, P NATL ACAD SCI USA, V95, P14646, DOI 10.1073/pnas.95.25.14646; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Facey SJ, 2003, EUR J BIOCHEM, V270, P1724, DOI 10.1046/j.1432-1033.2003.03531.x; Garbis S, 2005, J CHROMATOGR A, V1077, P1, DOI 10.1016/j.chroma.2005.04.059; Gassel M, 1999, J BIOL CHEM, V274, P37901, DOI 10.1074/jbc.274.53.37901; Hatzixanthis K, 2003, MOL MICROBIOL, V49, P1377, DOI 10.1046/j.1365-2958.2003.03642.x; Hemm MR, 2008, MOL MICROBIOL, V70, P1487, DOI 10.1111/j.1365-2958.2008.06495.x; Hobbs EC, 2011, CURR OPIN MICROBIOL, V14, P167, DOI 10.1016/j.mib.2011.01.007; Ikeda Masami, 2002, In Silico Biology, V2, P19; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Lippa AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000788; MANOIL C, 1991, METHOD CELL BIOL, V34, P61; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; Pop OI, 2009, FEBS J, V276, P4891, DOI 10.1111/j.1742-4658.2009.07188.x; Qi HY, 1999, J BIOL CHEM, V274, P8993, DOI 10.1074/jbc.274.13.8993; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; Rapp M, 2004, PROTEIN SCI, V13, P937, DOI 10.1110/ps.03553804; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; RHOADS DB, 1984, J BACTERIOL, V159, P63, DOI 10.1128/JB.159.1.63-70.1984; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Rowland SL, 2004, MOL CELL, V13, P689, DOI 10.1016/S1097-2765(04)00084-X; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Sargent F, 2007, BIOCHEM SOC T, V35, P835, DOI 10.1042/BST0350835; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Thomason L., 2007, CURRENT PROTOCOLS MO, V79, P1171; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	38	52	74	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32464	32474		10.1074/jbc.M111.245696	http://dx.doi.org/10.1074/jbc.M111.245696			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778229	hybrid, Green Published			2022-12-25	WOS:000294726800056
J	Christensen, QH; Hagar, JA; O'Riordan, MXD; Cronan, JE				Christensen, Quin H.; Hagar, Jon A.; O'Riordan, Mary X. D.; Cronan, John E.			A Complex Lipoate Utilization Pathway in Listeria monocytogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOIC ACID SYNTHESIS; INTRACELLULAR GROWTH; ESCHERICHIA-COLI; FATTY-ACIDS; CLONING; LPLA; METABOLISM; ATTACHMENT; EXPRESSION; FAMILY	Although a complete pathway of lipoic acid metabolism has been established in Escherichia coli, lipoic acid metabolism in other bacteria is more complex and incompletely understood. Listeria monocytogenes has been shown to utilize two lipoate-protein ligases for lipoic acid scavenging, whereas only one of the ligases can function in utilization of host-derived lipoic acid-modified peptides. We report that lipoic acid scavenging requires not only ligation of lipoic acid but also a lipoyl relay pathway in which an amidotransferase transfers lipoyl groups to the enzyme complexes that require the cofactor for activity. In addition, we provide evidence for a new lipoamidase activity that could allow utilization of lipoyl peptides by lipoate-protein ligase. These data support a model of an expanded, three-enzyme pathway for lipoic acid scavenging that seems widespread in the Firmicutes phylum of bacteria.	[Cronan, John E.] Univ Illinois, Dept Microbiol, Chem & Life Sci Lab, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Christensen, Quin H.; Cronan, John E.] Univ Illinois, Chem Biol Interface Training Program, Urbana, IL 61801 USA; [Hagar, Jon A.; O'Riordan, Mary X. D.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Michigan System; University of Michigan	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab, B103,601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019	O'Riordan, Mary/0000-0001-6014-4637	National Institutes of Health Ruth L. Kirschstein National Research Service [5 T32 GM070421 (NIGMS)]; NIAID [AI15650, AI064540]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064540, R37AI015650, R01AI015650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421] Funding Source: NIH RePORTER	National Institutes of Health Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Ruth L. Kirschstein National Research Service Award 5 T32 GM070421 (NIGMS) and Grants AI15650 (NIAID, to J. E. C.) and AI064540 (NIAID, to M. X. D. O.).	Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; Christensen QH, 2011, MOL MICROBIOL, V80, P350, DOI 10.1111/j.1365-2958.2011.07598.x; Christensen QH, 2010, BIOCHEMISTRY-US, V49, P10024, DOI 10.1021/bi101215f; Christensen QH, 2009, J BIOL CHEM, V284, P21317, DOI 10.1074/jbc.M109.015016; Cronan JE, 2005, ADV MICROB PHYSIOL, V50, P103, DOI 10.1016/S0065-2911(05)50003-1; Dowd GC, 2011, INFECT IMMUN, V79, P369, DOI 10.1128/IAI.00330-10; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fujiwara K, 2007, J MOL BIOL, V371, P222, DOI 10.1016/j.jmb.2007.05.059; GOLOLOBOV MY, 1989, J THEOR BIOL, V140, P193, DOI 10.1016/S0022-5193(89)80128-6; Hassan BH, 2011, J BIOL CHEM, V286, P8263, DOI 10.1074/jbc.M110.194191; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jiang YF, 2005, J BIOL CHEM, V280, P2244, DOI 10.1074/jbc.M408612200; Keeney K, 2009, J BACTERIOL, V191, P2187, DOI 10.1128/JB.01179-08; Keeney KM, 2007, MOL MICROBIOL, V66, P758, DOI 10.1111/j.1365-2958.2007.05956.x; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kim Youngchang, 2004, Journal of Structural and Functional Genomics, V5, P111, DOI 10.1023/B:JSFG.0000029206.07778.fc; KUKSIS A, 1976, ANAL BIOCHEM, V70, P302, DOI 10.1016/0003-2697(76)90451-6; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; LIU SJ, 1995, ARCH BIOCHEM BIOPHYS, V316, P926, DOI 10.1006/abbi.1995.1124; Martin N, 2011, MOL MICROBIOL, V80, P335, DOI 10.1111/j.1365-2958.2011.07597.x; MORRIS TW, 1995, J BACTERIOL, V177, P1; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; O'Riordan M, 2003, SCIENCE, V302, P462, DOI 10.1126/science.1088170; PRATT KJ, 1989, BIOCHEM J, V258, P749, DOI 10.1042/bj2580749; Sambrook J, 2001, MOL CLONING LAB MANU; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; SUZUKI K, 1963, J BIOL CHEM, V238, P4021; Zhao X, 2003, CHEM BIOL, V10, P1293, DOI 10.1016/j.chembiol.2003.11.016	29	21	24	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31447	31456		10.1074/jbc.M111.273607	http://dx.doi.org/10.1074/jbc.M111.273607			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768091	hybrid, Green Published			2022-12-25	WOS:000294487500039
J	Spinnler, K; Frohlich, T; Arnold, GJ; Kunz, L; Mayerhofer, A				Spinnler, Katrin; Froehlich, Thomas; Arnold, Georg J.; Kunz, Lars; Mayerhofer, Artur			Human Tryptase Cleaves Pro-Nerve Growth Factor (Pro-NGF) HINTS OF LOCAL, MAST CELL-DEPENDENT REGULATION OF NGF/PRO-NGF ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TESTICULAR PERITUBULAR CELLS; PRECURSOR PROTEIN EXPRESSION; HUMAN GRANULOSA-CELLS; MALE-INFERTILITY; HUMAN TESTIS; RECEPTORS; DEGRADATION; ACTIVATION; TRKA; P75	Several factors regulate nerve growth factor (NGF), which is formed from pro-NGF by intracellular and extracellular enzymatic cleavage. The close proximity between mast cells expressing the protease tryptase and NGF-producing smooth muscle-like peritubular cells in the testes of infertile patients led us to examine whether tryptase is among those factors. Human peritubular cells express functional tryptase receptors (PAR-2). Recombinant enzymatically active beta-tryptase increased NGF levels in the culture medium of primary human peritubular cells, but the peptide agonist for PAR-2 (SLIGKV) did not. Neither tryptase nor the peptide increased NGF mRNA levels. To test whether the increase in NGF is due to enzymatic activity of tryptase acting on pro-NGF, supernatants of peritubular cells and synthetic pro-NGF were treated with tryptase. Results of Western blot studies indicate enzymatic cleavage of pro-NGF by active tryptase. Heat-inactivated tryptase or SLIGKV was not effective. Mass spectrometry analysis of in vitro cleavage products from recombinant tryptase and synthetic pro-NGF revealed multiple cleavage sites within the pro-NGF sequence. The results also indicate the generation of mature NGF and smaller NGF fragments as a result of tryptase action. Thus, tryptase-secreting mast cells in the vicinity of pro-NGF/NGF-secreting cells in any human tissue are likely able to alter the ratios of pro-NGF/NGF. As NGF and pro-NGF have different affinities for their receptors, this indicates a novel way by which mast cells, via tryptase, can modify the microenvironment in human tissues with regard to neurotrophin actions.	[Spinnler, Katrin; Mayerhofer, Artur] Univ Munich, Inst Cell Biol & Anat, D-80802 Munich, Germany; [Froehlich, Thomas; Arnold, Georg J.] Univ Munich, Gene Ctr, Lab Funct Genome Anal, D-81377 Munich, Germany; [Kunz, Lars] Univ Munich, Dept Biol 2, Div Neurobiol, D-82152 Planegg Martinsried, Germany	University of Munich; University of Munich; University of Munich	Mayerhofer, A (corresponding author), Univ Munich, Inst Cell Biol & Anat, Biedersteiner Str 29, D-80802 Munich, Germany.	mayerhofer@lrz.uni-muenchen.de	Fröhlich, Thomas/C-6735-2011	Fröhlich, Thomas/0000-0002-4709-3211; Mayerhofer, Artur/0000-0002-9388-4639	Deutsche Forschungsgemeinschaft (DFG) [MA 1080/16-3, MA 1080/17-3, MA 1080/20-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant MA 1080/16-3 and in part by DFG Grants MA 1080/17-3 and MA 1080/20-1.	ADAM M, 2011, HUM REPROD IN PRESS; Albrecht M, 2006, J CLIN ENDOCR METAB, V91, P1956, DOI 10.1210/jc.2005-2169; Aloe L, 2001, Arch Physiol Biochem, V109, P354, DOI 10.1076/apab.109.3.354.9339; Anaf V, 2006, FERTIL STERIL, V86, P1336, DOI 10.1016/j.fertnstert.2006.03.057; Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Bose Chinmoy K, 2009, J Stem Cells, V4, P217, DOI jsc.2010.4.4.217; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Caroleo MC, 2001, J NEUROIMMUNOL, V113, P193, DOI 10.1016/S0165-5728(00)00441-0; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; CAUGHEY GH, 1988, J PHARMACOL EXP THER, V244, P133; CHAKRABARTI S, 1990, BRAIN RES, V523, P11, DOI 10.1016/0006-8993(90)91630-Y; Chen Y, 1997, MOL CELL ENDOCRINOL, V127, P129, DOI 10.1016/S0303-7207(96)04001-4; Clewes O, 2008, J NEUROCHEM, V107, P1124, DOI 10.1111/j.1471-4159.2008.05698.x; Delsite R, 1999, PROSTATE, V41, P39, DOI 10.1002/(SICI)1097-0045(19990915)41:1<39::AID-PROS6>3.0.CO;2-E; DISSEN GA, 1995, ENDOCRINOLOGY, V136, P4681, DOI 10.1210/en.136.10.4681; Fahnestock M, 2004, PROG BRAIN RES, V146, P101, DOI 10.1016/S0079-6123(03)46007-X; Fajardo I, 2003, BIOCHEM J, V369, P603, DOI 10.1042/BJ20021418; Frungieri MB, 2002, P NATL ACAD SCI USA, V99, P15072, DOI 10.1073/pnas.232422999; Frungieri MB, 2002, FERTIL STERIL, V78, P298, DOI 10.1016/S0015-0282(02)03206-5; FURUKAWA S, 1987, BIOCHEM BIOPH RES CO, V147, P1048, DOI 10.1016/S0006-291X(87)80176-6; Girard BM, 2011, AM J PHYSIOL-RENAL, V300, pF345, DOI 10.1152/ajprenal.00515.2010; GRUBER BL, 1989, J CLIN INVEST, V84, P1657, DOI 10.1172/JCI114344; Hallgren J, 2006, FEBS J, V273, P1871, DOI 10.1111/j.1742-4658.2006.05211.x; Hallgren J, 2001, J BIOL CHEM, V276, P42774, DOI 10.1074/jbc.M105531200; Harris JL, 2001, J BIOL CHEM, V276, P34941, DOI 10.1074/jbc.M102997200; Hayashi K, 2007, EUR J ORAL SCI, V115, P344, DOI 10.1111/j.1600-0722.2007.00480.x; Heider U, 2001, FERTIL STERIL, V75, P1141, DOI 10.1016/S0015-0282(01)01805-2; Imamura T, 1996, LAB INVEST, V74, P861; Julio-Pieper M, 2009, J CLIN ENDOCR METAB, V94, P3065, DOI 10.1210/jc.2009-0542; Kaminska R, 1999, J INVEST DERMATOL, V113, P567, DOI 10.1046/j.1523-1747.1999.00738.x; Kendall TJ, 2009, HEPATOLOGY, V49, P901, DOI 10.1002/hep.22701; Labouyrie E, 1999, AM J PATHOL, V154, P405, DOI 10.1016/S0002-9440(10)65287-X; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Li XD, 2006, ENDOCRINOLOGY, V147, P1271, DOI 10.1210/en.2005-0654; Lipnik-Stangelj M, 2006, BIOCHEM PHARMACOL, V72, P1375, DOI 10.1016/j.bcp.2006.06.028; LOHI J, 1992, J CELL BIOCHEM, V50, P337, DOI 10.1002/jcb.240500402; MATSUOKA I, 1991, J NEUROSCI, V11, P3165; Mayerhofer A, 1996, ENDOCRINOLOGY, V137, P5662, DOI 10.1210/en.137.12.5662; Mayerhofer A, 1999, J ANDROL, V20, P341; Meineke V, 2000, FERTIL STERIL, V74, P239, DOI 10.1016/S0015-0282(00)00626-9; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pagadala PC, 2006, P NATL ACAD SCI USA, V103, P17939, DOI 10.1073/pnas.0604139103; Palardini A, 2008, NEUROPEPTIDES, V42, P205, DOI 10.1016/j.npep.2007.11.004; Rattenholl A, 2001, EUR J BIOCHEM, V268, P3296, DOI 10.1046/j.1432-1327.2001.02232.x; Rauter I, 2008, J ALLERGY CLIN IMMUN, V121, P197, DOI 10.1016/j.jaci.2007.08.015; Reinshagen M, 2000, J NEUROCHEM, V74, P2127, DOI 10.1046/j.1471-4159.2000.0742127.x; Rey-Ares V, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-40; Saller S, 2010, HUM REPROD, V25, P969, DOI 10.1093/humrep/dep467; Schell C, 2010, ENDOCRINOLOGY, V151, P1257, DOI 10.1210/en.2009-1325; Schell C, 2008, ENDOCRINOLOGY, V149, P1678, DOI 10.1210/en.2007-1064; SCHWARTZ LB, 1985, J IMMUNOL, V135, P2762; SCHWARTZ LB, 1987, J IMMUNOL, V138, P2611; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; Spinnler K, 2010, HUM REPROD, V25, P2181, DOI 10.1093/humrep/deq170; Strauss L, 2009, ENDOCRINOLOGY, V150, P2865, DOI 10.1210/en.2008-1311; SUTER U, 1991, EMBO J, V10, P2395, DOI 10.1002/j.1460-2075.1991.tb07778.x; TAM EK, 1990, AM J RESP CELL MOL, V3, P27, DOI 10.1165/ajrcmb/3.1.27; Welker P, 2000, IMMUNOLOGY, V99, P418, DOI 10.1046/j.1365-2567.2000.00984.x; Yardley G, 2000, EXP DERMATOL, V9, P283, DOI 10.1034/j.1600-0625.2000.009004283.x; Yoon SO, 1998, J NEUROSCI, V18, P3273	61	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31707	31713		10.1074/jbc.M111.233486	http://dx.doi.org/10.1074/jbc.M111.233486			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768088	Green Published, hybrid			2022-12-25	WOS:000294487500063
J	Wu, XN; Wang, XK; Wu, SQ; Lu, JW; Zheng, M; Wang, YH; Zhou, HM; Zhang, HB; Han, JH				Wu, Xiao-Nan; Wang, Xue-Kun; Wu, Su-Qin; Lu, Jiawei; Zheng, Min; Wang, Yan-Hai; Zhou, Huamin; Zhang, Hongbing; Han, Jiahuai			Phosphorylation of Raptor by p38 beta Participates in Arsenite-induced Mammalian Target of Rapamycin Complex 1 (mTORC1) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P38 MAP-KINASES; PROTEIN-KINASES; TUBEROUS SCLEROSIS; IMMUNE-RESPONSE; CELL-GROWTH; RAG GTPASES; S6 KINASE; TSC2; PATHWAY; STRESS	Cell growth is influenced by environmental stress. Mammalian target of rapamycin (mTOR), the central regulator of cell growth, can be positively or negatively regulated by various stresses through different mechanisms. The p38 MAP kinase pathway is essential in cellular stress responses. Activation of MK2, a downstream kinase of p38 alpha, enhances mTOR complex 1 (mTORC1) activity by preventing TSC2 from inhibiting mTOR activation. The p38 beta-PRAK cascade targets Rheb to inhibit mTORC1 activity upon glucose depletion. Here we show the activation of p38 beta participates in activation of mTOR complex 1 (mTORC1) induced by arsenite but not insulin, nutrients, anisomycin, or H2O2. Arsenite treatment of cells activates p38 beta and induces interaction between p38 beta and Raptor, a regulatory component of mTORC1, resulting in phosphorylation of Raptor on Ser(863) and Ser(771). The phosphorylation of Raptor on these sites enhances mTORC1 activity, and contributes largely to arsenite-induced mTORC1 activation. Our results shown here and in previous work demonstrate that the p38 pathway can regulate different components of the mTORC1 pathway, and that p38 beta can target different substrates to either positively or negatively regulate mTORC1 activation when a cell encounters different environmental stresses.	[Wu, Xiao-Nan; Wang, Xue-Kun; Wu, Su-Qin; Zheng, Min; Wang, Yan-Hai; Zhou, Huamin; Han, Jiahuai] Xiamen Univ, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China; [Wu, Xiao-Nan; Wang, Xue-Kun; Wu, Su-Qin; Zheng, Min; Wang, Yan-Hai; Zhou, Huamin; Han, Jiahuai] Xiamen Univ, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China; [Lu, Jiawei] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Zhang, Hongbing] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Physiol, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Zhang, Hongbing] Peking Union Med Coll, Beijing 100005, Peoples R China	Xiamen University; Xiamen University; Scripps Research Institute; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Han, JH (corresponding author), Xiamen Univ, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China.	jhan@xmu.edu.cn	Han, J/G-4671-2010		National Institutes of Health [AI41637, AI68896]; NSF China [30830092, 30921005, 30828219, 31070688]; Fujian Provincial Department of Science Technology [2010J01228]; Science Planning Program of Fujian Province, 973 program [2009J1010, 2009CB522200]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068896, R01AI041637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF China(National Natural Science Foundation of China (NSFC)); Fujian Provincial Department of Science Technology; Science Planning Program of Fujian Province, 973 program(National Basic Research Program of China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants National Institutes of Health AI41637 and AI68896, and NSF China Grant 30830092, 30921005, 30828219, and 31070688, Fujian Provincial Department of Science & Technology Grant 2010J01228, and Science Planning Program of Fujian Province Grant 2009J1010, 973 program 2009CB522200.	BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; English JM, 2002, TRENDS PHARMACOL SCI, V23, P40, DOI 10.1016/S0165-6147(00)01865-4; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Gaestel M, 2008, FRONT BIOSCI, V13, P6050, DOI 10.2741/3136; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Gwinn DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009197; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Huang S, 1997, IMMUNITY, V6, P739, DOI 10.1016/S1074-7613(00)80449-5; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Li Y, 2003, J BIOL CHEM, V278, P13663, DOI 10.1074/jbc.M300862200; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Wang L, 2009, J BIOL CHEM, V284, P14693, DOI 10.1074/jbc.C109.002907; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zheng M, 2011, NAT CELL BIOL, V13, P263, DOI 10.1038/ncb2168	42	41	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31501	31511		10.1074/jbc.M111.233122	http://dx.doi.org/10.1074/jbc.M111.233122			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757713	Green Published, hybrid			2022-12-25	WOS:000294487500045
J	Atsak, P; Orre, M; Bakker, P; Cerliani, L; Roozendaal, B; Gazzola, V; Moita, M; Keysers, C				Atsak, Piray; Orre, Marie; Bakker, Petra; Cerliani, Leonardo; Roozendaal, Benno; Gazzola, Valeria; Moita, Marta; Keysers, Christian			Experience Modulates Vicarious Freezing in Rats: A Model for Empathy	PLOS ONE			English	Article							SEX-DIFFERENCES; ACTION REPRESENTATION; SOCIAL TRANSMISSION; ULTRASONIC CALLS; MIRROR NEURONS; ESTROUS-CYCLE; FEMALE RATS; PAIN; FEAR; RESPONSES	The study of the neural basis of emotional empathy has received a surge of interest in recent years but mostly employing human neuroimaging. A simpler animal model would pave the way for systematic single cell recordings and invasive manipulations of the brain regions implicated in empathy. Recent evidence has been put forward for the existence of empathy in rodents. In this study, we describe a potential model of empathy in female rats, in which we studied interactions between two rats: a witness observes a demonstrator experiencing a series of footshocks. By comparing the reaction of witnesses with or without previous footshock experience, we examine the role of prior experience as a modulator of empathy. We show that witnesses having previously experienced footshocks, but not naive ones, display vicarious freezing behavior upon witnessing a cage-mate experiencing footshocks. Strikingly, the demonstrator's behavior was in turn modulated by the behavior of the witness: demonstrators froze more following footshocks if their witness froze more. Previous experiments have shown that rats emit ultrasonic vocalizations (USVs) when receiving footshocks. Thus, the role of USV in triggering vicarious freezing in our paradigm is examined. We found that experienced witness-demonstrator pairs emitted more USVs than naive witness-demonstrator pairs, but the number of USVs was correlated with freezing in demonstrators, not in witnesses. Furthermore, playing back the USVs, recorded from witness-demonstrator pairs during the empathy test, did not induce vicarious freezing behavior in experienced witnesses. Thus, our findings confirm that vicarious freezing can be triggered in rats, and moreover it can be modulated by prior experience. Additionally, our result suggests that vicarious freezing is not triggered by USVs per se and it influences back onto the behavior of the demonstrator that had elicited the vicarious freezing in witnesses, introducing a paradigm to study empathy as a social loop.	[Atsak, Piray; Orre, Marie; Bakker, Petra; Cerliani, Leonardo; Roozendaal, Benno; Gazzola, Valeria; Keysers, Christian] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [Orre, Marie; Cerliani, Leonardo; Gazzola, Valeria; Keysers, Christian] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Moita, Marta] Inst Gulbenkian Ciencias, Champalimaud Neurosci Programme, Oeiras, Portugal	University of Groningen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Fundacao Champalimaud; Instituto Gulbenkian de Ciencia	Atsak, P (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands.	c.keysers@nin.knaw.nl	Roozendaal, Benno/B-8403-2013; Atsak, Piray/GPX-9702-2022; Atsak, piray/I-5880-2013; Atsak, Piray/AAB-1451-2019; Keysers, Christian/H-6251-2013	Atsak, Piray/0000-0003-1828-2061; Keysers, Christian/0000-0002-2845-5467; Moita, Marta/0000-0002-5144-6905; cerliani, leonardo/0000-0002-2655-6133; Gazzola, Valeria/0000-0003-0324-0619; Bakker, Petra/0000-0001-7019-0258	NWO VIDI [452-04-305]; European Marie Curie Excellence grant [MEXT-CT-2005-023253]	NWO VIDI(Netherlands Organization for Scientific Research (NWO)); European Marie Curie Excellence grant	This work was supported by the NWO VIDI grant (452-04-305) and European Marie Curie Excellence grant (MEXT-CT-2005-023253) to CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2002, EVOL HUM BEHAV, V23, P467, DOI 10.1016/S1090-5138(02)00107-1; Allen TA, 2007, BEHAV BRAIN RES, V182, P327, DOI 10.1016/j.bbr.2007.03.009; Avenanti A, 2006, NEUROIMAGE, V32, P316, DOI 10.1016/j.neuroimage.2006.03.010; Bang SJ, 2008, NEUROBIOL LEARN MEM, V90, P200, DOI 10.1016/j.nlm.2008.02.009; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Bastiaansen JACJ, 2009, PHILOS T R SOC B, V364, P2391, DOI 10.1098/rstb.2009.0058; BLANCHARD RJ, 1991, PHYSIOL BEHAV, V50, P967, DOI 10.1016/0031-9384(91)90423-L; Brechbuhl J, 2008, SCIENCE, V321, P1092, DOI 10.1126/science.1160770; Bredy TW, 2009, LEARN MEMORY, V16, P12, DOI 10.1101/lm.1226009; Bruchey AK, 2010, BEHAV BRAIN RES, V214, P80, DOI 10.1016/j.bbr.2010.04.047; Brudzynski S, 1995, PHYSL BEHAV; Brudzynski SM, 2005, BEHAV GENET, V35, P85, DOI 10.1007/s10519-004-0858-3; Brudzynski SM, 2007, BEHAV BRAIN RES, V182, P261, DOI 10.1016/j.bbr.2007.03.004; Burgdorf J, 2005, BEHAV GENET, V35, P67, DOI 10.1007/s10519-004-0856-5; Caggiano V, 2009, SCIENCE, V324, P403, DOI 10.1126/science.1166818; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chen QL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004387; Chen W, 2009, BEHAV BRAIN RES, V201, P8, DOI 10.1016/j.bbr.2009.01.019; Cheng Y, 2009, NEUROSCIENCE, V158, P713, DOI 10.1016/j.neuroscience.2008.10.026; Cheng YW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002113; CHURCH RM, 1959, J COMP PHYSIOL PSYCH, V52, P132, DOI 10.1037/h0043531; Connellan J, 2000, INFANT BEHAV DEV; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; Decety J, 2006, CURR DIR PSYCHOL SCI, V15, P54, DOI 10.1111/j.0963-7214.2006.00406.x; Ehret G, 2005, BEHAV GENET, V35, P19, DOI 10.1007/s10519-004-0853-8; EISENBERG N, 1983, PSYCHOL BULL, V94, P100, DOI 10.1037/0033-2909.94.1.100; Etzel JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003690; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Frye CA, 2000, PHARMACOL BIOCHEM BE, V67, P587, DOI 10.1016/S0091-3057(00)00392-0; Fujii N, 2008, SOC NEUROSCI-UK, V3, P250, DOI 10.1080/17470910701434610; GALEF BG, 1985, BEHAV NEURAL BIOL, V43, P298, DOI 10.1016/S0163-1047(85)91645-0; GALEF BG, 1985, ANN NY ACAD SCI, V443, P203, DOI 10.1111/j.1749-6632.1985.tb27074.x; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Hiroi R, 2006, BEHAV BRAIN RES, V166, P93, DOI 10.1016/j.bbr.2005.07.021; HOFFMAN ML, 1977, PSYCHOL BULL, V84, P712, DOI 10.1037/0033-2909.84.4.712; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Jabbi M, 2007, NEUROIMAGE, V34, P1744, DOI 10.1016/j.neuroimage.2006.10.032; Jabbi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002939; Jabbi M, 2008, EMOTION, V8, P775, DOI 10.1037/a0014194; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Keysers C, 2003, EXP BRAIN RES, V153, P628, DOI 10.1007/s00221-003-1603-5; Keysers C, 2006, PROG BRAIN RES, V156, P379, DOI 10.1016/S0079-6123(06)56021-2; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Keysers C, 2009, CURR OPIN NEUROBIOL, V19, P666, DOI 10.1016/j.conb.2009.10.006; Kim EJ, 2010, PLOS ONE, V5; Kiyokawa Y, 2004, BEHAV NEUROSCI, V118, P798, DOI 10.1037/0735-7044.118.4.798; Knapska E, 2006, P NATL ACAD SCI USA, V103, P3858, DOI 10.1073/pnas.0511302103; Knapska E, 2010, LEARN MEMORY, V17, P824, DOI 10.1101/lm.1670910; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; KOHN B, 1972, J COMP PHYSIOL PSYCH, V78, P292, DOI 10.1037/h0032298; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Marcondes FK, 2001, PHYSIOL BEHAV, V74, P435, DOI 10.1016/S0031-9384(01)00593-5; Masuda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006794; Mongeau R, 2003, J NEUROSCI, V23, P3855; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Panksepp J, 2000, BEHAV BRAIN RES, V115, P25, DOI 10.1016/S0166-4328(00)00238-2; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rozzi S, 2008, EUR J NEUROSCI, V28, P1569, DOI 10.1111/j.1460-9568.2008.06395.x; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Stack A, 2010, NEUROPSYCHOPHARMACOL, V35, P570, DOI 10.1038/npp.2009.163; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; WATANABE S, 1986, BEHAV PROCESS, V13, P269, DOI 10.1016/0376-6357(86)90089-6; Westenbroek C, 2005, HORM BEHAV, V47, P620, DOI 10.1016/j.yhbeh.2005.01.004; Westenbroek C, 2003, PROG NEURO-PSYCHOPH, V27, P21, DOI 10.1016/S0278-5846(02)00310-X; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Wohr M, 2005, NEUROBIOL LEARN MEM, V84, P228, DOI 10.1016/j.nlm.2005.07.004; Yee JR, 2010, BRAIN BEHAV IMMUN, V24, P942, DOI 10.1016/j.bbi.2010.03.006; ZENTALL TR, 1972, SCIENCE, V178, P1220, DOI 10.1126/science.178.4066.1220	80	110	110	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21855	10.1371/journal.pone.0021855	http://dx.doi.org/10.1371/journal.pone.0021855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765921	Green Published, Green Submitted, gold			2022-12-25	WOS:000292781500020
J	Rassouli, O; Liapakis, G; Lazaridis, I; Sakellaris, G; Gkountelias, K; Gravanis, A; Margioris, AN; Karalis, KP; Venihaki, M				Rassouli, Olga; Liapakis, George; Lazaridis, Iakovos; Sakellaris, George; Gkountelias, Kostas; Gravanis, Achille; Margioris, Andrew N.; Karalis, Katia P.; Venihaki, Maria			A Novel Role of Peripheral Corticotropin-Releasing Hormone (CRH) on Dermal Fibroblasts	PLOS ONE			English	Article							HUMAN LUNG FIBROBLASTS; IL-6-DEFICIENT MICE; KNOCKOUT MICE; MOUSE SKIN; EXPRESSION; INTERLEUKIN-6; RECEPTOR; SYSTEM; CELLS; PROLIFERATION	Corticotropin-releasing hormone, or factor, (CRH or CRF) exerts important biological effects in multiple peripheral tissues via paracrine/autocrine actions. The aim of our study was to assess the effects of endogenous CRH in the biology of mouse and human skin fibroblasts, the primary cell type involved in wound healing. We show expression of CRH and its receptors in primary fibroblasts, and we demonstrate the functionality of fibroblast CRH receptors by induction of cAMP. Fibroblasts genetically deficient in Crh (Crh-/-) had higher proliferation and migration rates and compromised production of IL-6 and TGF-b1 compared to the wildtype (Crh+/+) cells. Human primary cultures of foreskin fibroblasts exposed to the CRF(1) antagonist antalarmin recapitulated the findings in the Crh-/- cells, exhibiting altered proliferative and migratory behavior and suppressed production of IL-6. In conclusion, our findings show an important role of fibroblast-expressed CRH in the proliferation, migration, and cytokine production of these cells, processes associated with the skin response to injury. Our data suggest that the immunomodulatory effects of CRH may include an important, albeit not explored yet, role in epidermal tissue remodeling and regeneration and maintenance of tissue homeostasis.	[Rassouli, Olga; Margioris, Andrew N.; Venihaki, Maria] Univ Crete, Sch Med, Dept Clin Chem, Iraklion, Crete, Greece; [Liapakis, George; Lazaridis, Iakovos; Gkountelias, Kostas; Gravanis, Achille] Univ Crete, Sch Med, Dept Pharmacol, Iraklion, Crete, Greece; [Sakellaris, George] Univ Hosp Herakl, Dept Pediat Surg, Iraklion, Greece; [Karalis, Katia P.] Acad Athens, Dev Biol Sect, Biomed Res Fdn, Athens, Greece; [Karalis, Katia P.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA	University of Crete; University of Crete; University Hospital of Heraklion; Academy of Athens; Harvard University; Boston Children's Hospital	Rassouli, O (corresponding author), Univ Crete, Sch Med, Dept Clin Chem, Iraklion, Crete, Greece.	venihaki@med.uoc.gr		Lazaridis, Iakovos/0000-0002-4578-2347	PENED; E.U.; Greek Ministry of Development-GSRT; Manasaki Fellowship	PENED(Greek Ministry of Development-GSRT); E.U.(European Commission); Greek Ministry of Development-GSRT(Greek Ministry of Development-GSRT); Manasaki Fellowship	This work was supported in part by PENED [grant cofinanced by E.U.-European Social Fund (75%) and the Greek Ministry of Development-GSRT (25%)] to KK and a Manasaki Fellowship to OR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGIONI S, 1993, LIFE SCI, V53, P1735, DOI 10.1016/0024-3205(93)90160-5; Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Berthier F, 1999, CLIN CHEM LAB MED, V37, P593, DOI 10.1515/CCLM.1999.092; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Crofford LJ, 1995, ANN NY ACAD SCI, V771, P459, DOI 10.1111/j.1749-6632.1995.tb44702.x; Crowe MJ, 2000, J INVEST DERMATOL, V115, P3, DOI 10.1046/j.1523-1747.2000.00010.x; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gallelli L, 2008, CELL PROLIFERAT, V41, P393, DOI 10.1111/j.1365-2184.2008.00538.x; Gallucci RM, 2006, J INVEST DERMATOL, V126, P561, DOI 10.1038/sj.jid.5700109; Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com; Ganceviciene R, 2009, BRIT J DERMATOL, V160, P345, DOI 10.1111/j.1365-2133.2008.08959.x; Gkountelias K, 2009, MOL PHARMACOL, V75, P793, DOI 10.1124/mol.108.052423; Itoi K, 2004, J NEUROENDOCRINOL, V16, P348, DOI 10.1111/j.0953-8194.2004.01172.x; Karalis K, 1997, J NEUROIMMUNOL, V72, P131, DOI 10.1016/S0165-5728(96)00178-6; KARALIS K, 1991, SCIENCE, V254, P421, DOI 10.1126/science.1925600; Karalis KP, 1999, P NATL ACAD SCI USA, V96, P7093, DOI 10.1073/pnas.96.12.7093; Kondo T, 1996, INT J LEGAL MED, V108, P231, DOI 10.1007/BF01369816; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Luckett-Chastain LR, 2009, BRIT J DERMATOL, V161, P237, DOI 10.1111/j.1365-2133.2009.09215.x; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MUGLIA L, 1995, NATURE, V373, P427, DOI 10.1038/373427a0; Papakonstanti EA, 1998, J CELL BIOCHEM, V70, P60, DOI 10.1002/(SICI)1097-4644(19980701)70:1<60::AID-JCB7>3.0.CO;2-1; Paquet P, 1996, INT ARCH ALLERGY IMM, V109, P308, DOI 10.1159/000237257; Pisarchik A, 2001, FASEB J, V15, P2754, DOI 10.1096/fj.01-0487fje; Roloff B, 1998, FASEB J, V12, P287, DOI 10.1096/fasebj.12.3.287; SEHGAL PB, 1990, J INVEST DERMATOL, V94, pS2, DOI 10.1111/1523-1747.ep12874963; SINGH VK, 1989, J NEUROIMMUNOL, V23, P257, DOI 10.1016/0165-5728(89)90058-1; SINGH VK, 1990, NEUROSCI LETT, V120, P151, DOI 10.1016/0304-3940(90)90025-5; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Slominski A, 2005, J NEUROIMMUNOL, V162, P97, DOI 10.1016/j.jneuroim.2005.01.014; Slominski A, 2001, FASEB J, V15, P1678, DOI 10.1096/fj.00-0850rev; Slominski A, 2006, J CELL PHYSIOL, V206, P780, DOI 10.1002/jcp.20530; Sugawara T, 2001, CYTOKINE, V15, P328, DOI 10.1006/cyto.2001.0946; Venihaki M, 2001, J CLIN INVEST, V108, P1159, DOI 10.1172/JCI12869; Venihaki M, 2003, J NEUROIMMUNOL, V141, P3, DOI 10.1016/S0165-5728(03)00183-8; Venihaki M, 2002, NEUROPEPTIDES, V36, P96, DOI 10.1054/npep.2002.0906; Venihaki M, 1996, PEPTIDES, V17, P413, DOI 10.1016/0196-9781(96)00023-X; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Yates CC, 2007, AM J PATHOL, V171, P484, DOI 10.2353/ajpath.2007.061092; Zbytek B, 2002, LIFE SCI, V70, P1013, DOI 10.1016/S0024-3205(01)01476-X	42	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21654	10.1371/journal.pone.0021654	http://dx.doi.org/10.1371/journal.pone.0021654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765902	Green Published, gold, Green Submitted			2022-12-25	WOS:000292781500008
J	Vinatier, F; Lescourret, F; Duyck, PF; Martin, O; Senoussi, R; Tixier, P				Vinatier, Fabrice; Lescourret, Francoise; Duyck, Pierre-Francois; Martin, Olivier; Senoussi, Rachid; Tixier, Philippe			Should I Stay or Should I Go? A Habitat-Dependent Dispersal Kernel Improves Prediction of Movement	PLOS ONE			English	Article							LEVEL PERCEPTUAL ABILITIES; FORAGING BEHAVIOR; SPACE USE; LANDSCAPE; RANGE; AVAILABILITY; SELECTION; INSECT; MODEL	The analysis of animal movement within different landscapes may increase our understanding of how landscape features affect the perceptual range of animals. Perceptual range is linked to movement probability of an animal via a dispersal kernel, the latter being generally considered as spatially invariant but could be spatially affected. We hypothesize that spatial plasticity of an animal's dispersal kernel could greatly modify its distribution in time and space. After radio tracking the movements of walking insects (Cosmopolites sordidus) in banana plantations, we considered the movements of individuals as states of a Markov chain whose transition probabilities depended on the habitat characteristics of current and target locations. Combining a likelihood procedure and pattern-oriented modelling, we tested the hypothesis that dispersal kernel depended on habitat features. Our results were consistent with the concept that animal dispersal kernel depends on habitat features. Recognizing the plasticity of animal movement probabilities will provide insight into landscape-level ecological processes.	[Vinatier, Fabrice; Duyck, Pierre-Francois; Tixier, Philippe] CIRAD, UPR26, Le Lamentin, Martinique, France; [Lescourret, Francoise] INRA, UR 1115, Avignon, France; [Martin, Olivier; Senoussi, Rachid] INRA, UR 546, Avignon, France	CIRAD; INRAE; INRAE	Vinatier, F (corresponding author), CIRAD, UPR26, Le Lamentin, Martinique, France.	fabrice.vinatier@grignon.inra.fr	Duyck, Pierre-François/C-2416-2008; Vinatier, Fabrice/AAF-7014-2020; Tixier, Philippe/C-2119-2008; Vinatier, Fabrice/B-4532-2011	Duyck, Pierre-François/0000-0001-5484-1970; Tixier, Philippe/0000-0001-5147-9777; Lescourret, Francoise/0000-0002-6576-8067; Vinatier, Fabrice/0000-0003-3693-4422	CIRAD [07-259/NH]; French Ministry of Ecology, Sustainable Development [CV070000779]; E.U. FEFER [30411]	CIRAD; French Ministry of Ecology, Sustainable Development; E.U. FEFER	This work is part of a Ph.D study funded by the CIRAD (http://www.cirad.fr) with the contract number: 07-259/NH. Project SYBAN from the French Ministry of Ecology, Sustainable Development (grant noCV070000779) and Project "sustainable cropping systems design" from E.U. FEFER (grant PRESAGE no30411) have also funded the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur SM, 1996, ECOLOGY, V77, P215, DOI 10.2307/2265671; Bianchi FJJA, 2009, OIKOS, V118, P1363, DOI 10.1111/j.1600-0706.2009.17319.x; Brouwers NC, 2009, LANDSCAPE ECOL, V24, P199, DOI 10.1007/s10980-008-9298-4; Chapman DS, 2007, OECOLOGIA, V154, P55, DOI 10.1007/s00442-007-0806-z; Flaherty EA, 2008, CAN J ZOOL, V86, P1050, DOI 10.1139/Z08-084; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Gold Clifford S., 2002, Integrated Pest Management Reviews, V6, P79, DOI 10.1023/A:1023330900707; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Huffaker CB, 1999, ECOLOGICAL ENTOMOLOG; JANDER R, 1975, ANNU REV ECOL SYST, V6, P171, DOI 10.1146/annurev.es.06.110175.001131; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Lenth R., 2019, Journal of Statistical Software, V60, P1; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Lindstrom T, 2008, ECOLOGY, V89, P1784, DOI 10.1890/07-1363.1; Lindstrom T, 2011, P ROY SOC B-BIOL SCI, V278, P1564, DOI 10.1098/rspb.2010.1902; Marzluff JM, 2004, ECOLOGY, V85, P1411, DOI 10.1890/03-0114; Matthiopoulos J, 2004, J APPL ECOL, V41, P476, DOI 10.1111/j.0021-8901.2004.00911.x; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Olden JD, 2004, J ANIM ECOL, V73, P1190, DOI 10.1111/j.0021-8790.2004.00889.x; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Phillips BL, 2008, AM NAT, V172, pS34, DOI 10.1086/588255; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; Prevedello JA, 2010, J ANIM ECOL, V79, P1315, DOI 10.1111/j.1365-2656.2010.01736.x; Rabasa SG, 2005, ECOGRAPHY, V28, P629, DOI 10.1111/j.2005.0906-7590.04229.x; Rhodes JR, 2005, ECOLOGY, V86, P1199, DOI 10.1890/04-0912; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Schooley RL, 2003, OIKOS, V102, P559, DOI 10.1034/j.1600-0706.2003.12490.x; Searle KR, 2005, OIKOS, V111, P417, DOI 10.1111/j.0030-1299.2005.13918.x; STEPHENS MA, 1970, J ROY STAT SOC B, V32, P115; Vinatier F, 2011, METHODS ECOL EVOL, V2, P11, DOI 10.1111/j.2041-210X.2010.00059.x; Vinatier F, 2010, ANIM BEHAV, V80, P221, DOI 10.1016/j.anbehav.2010.04.022; Vinatier F, 2009, ECOL MODEL, V220, P2244, DOI 10.1016/j.ecolmodel.2009.06.023; Walters RJ, 2006, P ROY SOC B-BIOL SCI, V273, P2017, DOI 10.1098/rspb.2006.3542; Zollner PA, 2005, OIKOS, V108, P219, DOI 10.1111/j.0030-1299.2005.13711.x; Zollner PA, 1997, OIKOS, V80, P51, DOI 10.2307/3546515; Zollner PA, 2000, LANDSCAPE ECOL, V15, P523, DOI 10.1023/A:1008154532512	36	23	23	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21115	10.1371/journal.pone.0021115	http://dx.doi.org/10.1371/journal.pone.0021115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765890	Green Published, gold			2022-12-25	WOS:000292699000003
J	Ganesh, BB; Bhattacharya, P; Gopisetty, A; Sheng, JR; Vasu, C; Prabhakar, BS				Ganesh, Balaji B.; Bhattacharya, Palash; Gopisetty, Anupama; Sheng, Jianrong; Vasu, Chenthamarakshan; Prabhakar, Bellur S.			IL-1 beta Promotes TGF-beta 1 and IL-2 Dependent Foxp3 Expression in Regulatory T Cells	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; GROWTH-FACTOR-BETA; DENDRITIC CELLS; TGF-BETA; TRANSCRIPTION FACTOR; CUTTING EDGE; INDUCTION; EXPANSION; SUPPRESSION; CYTOKINES	Earlier, we have shown that GM-CSF-exposed CD8 alpha- DCs that express low levels of pro-inflammatory cytokines IL-12 and IL-1 beta can induce Foxp3+ Tregs leading to suppression of autoimmunity. Here, we examined the differential effects of IL-12 and IL-1 beta on Foxp3 expression in T cells when activated in the presence and absence of DCs. Exogenous IL-12 abolished, but IL-1 beta enhanced, the ability of GM-CSF-exposed tolerogenic DCs to promote Foxp3 expression. Pre-exposure of DCs to IL-1 beta and IL-12 had only a modest effect on Foxp3- expressing T cells; however, T cells activated in the absence of DCs but in the presence of IL-1 beta or IL-12 showed highly significant increase and decrease in Foxp3+ T cell frequencies respectively suggesting direct effects of these cytokines on T cells and a role for IL-1 beta in promoting Foxp3 expression. Importantly, purified CD4+ CD25+ cells showed a significantly higher ability to maintain Foxp3 expression when activated in the presence of IL-1 beta. Further analyses showed that the ability of IL-1 beta to maintain Foxp3 expression in CD25+ T cells was dependent on TGF beta 1 and IL-2 expression in Foxp3+ Tregs and CD25- effectors T cells respectively. Exposure of CD4+ CD25+ T cells to IL-1 beta enhanced their ability to suppress effector T cell response in vitro and ongoing experimental autoimmune thyroidits in vivo. These results show that IL-1 beta can help enhance/maintain Tregs, which may play an important role in maintaining peripheral tolerance during inflammation to prevent and/or suppress autoimmunity.	[Ganesh, Balaji B.; Bhattacharya, Palash; Gopisetty, Anupama; Sheng, Jianrong; Prabhakar, Bellur S.] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Vasu, Chenthamarakshan] Univ Illinois, Coll Med, Dept Surg, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Ganesh, BB (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	bprabhak@uic.edu		vasu, chenthamarakshan/0000-0002-1772-6508	National Institutes of Health [RO1 AI058190, NIH R01AI073858]; University of Illinois at Chicago (UIC) Center for Clinical and Translational Science (CCTS) from the National Center For Research Resources [UL1RR029879]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058190, R01AI073858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois at Chicago (UIC) Center for Clinical and Translational Science (CCTS) from the National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by The National Institutes of Health grant RO1 AI058190 to BSP and NIH R01AI073858 to CV and by the University of Illinois at Chicago (UIC) Center for Clinical and Translational Science (CCTS), Award Number UL1RR029879 from the National Center For Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriamanalijaona R, 2003, ARTHRITIS RHEUM, V48, P1569, DOI 10.1002/art.11020; Awasthi A, 2009, INT IMMUNOL, V21, P489, DOI 10.1093/intimm/dxp021; Battaglia M, 2006, DIABETES, V55, P1571, DOI 10.2337/db05-1576; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Brahmachari S, 2009, J IMMUNOL, V183, P2045, DOI 10.4049/jimmunol.0800276; Brinster C, 2008, J LEUKOCYTE BIOL, V84, P480, DOI 10.1189/jlb.0208085; Cheatem D, 2009, CLIN IMMUNOL, V131, P260, DOI 10.1016/j.clim.2008.12.001; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Choi KC, 2006, NAT IMMUNOL, V7, P1057, DOI 10.1038/ni1383; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Eriksson U, 2001, J IMMUNOL, V167, P5464, DOI 10.4049/jimmunol.167.9.5464; ESQUIVEL PS, 1977, J EXP MED, V145, P1250, DOI 10.1084/jem.145.5.1250; Fazekas de St Groth B, 1998, IMMUNOL TODAY, V19, P448, DOI 10.1016/S0167-5699(98)01328-0; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Frick JS, 2010, INT J MED MICROBIOL, V300, P19, DOI 10.1016/j.ijmm.2009.08.010; Ganesh BB, 2009, INT IMMUNOL, V21, P269, DOI 10.1093/intimm/dxn147; Gangi E, 2005, J IMMUNOL, V174, P7006, DOI 10.4049/jimmunol.174.11.7006; Gianoukakis AG, 2008, THYROID, V18, P953, DOI 10.1089/thy.2007.0405; Grabie N, 2003, J CLIN INVEST, V111, P671, DOI 10.1172/JCI200316867; Grohmann U, 2001, J IMMUNOL, V167, P708, DOI 10.4049/jimmunol.167.2.708; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hawiger D, 2004, IMMUNITY, V20, P695, DOI 10.1016/j.immuni.2004.05.002; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hoffmann P, 2009, EUR J IMMUNOL, V39, P1088, DOI 10.1002/eji.200838904; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Johnson VJ, 2005, J ALLERGY CLIN IMMUN, V116, P851, DOI 10.1016/j.jaci.2005.07.008; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kudo O, 2003, BONE, V32, P1, DOI 10.1016/S8756-3282(02)00915-8; Lahoud MH, 2006, J IMMUNOL, V177, P372, DOI 10.4049/jimmunol.177.1.372; Lau AWT, 2008, J IMMUNOL, V180, P3889, DOI 10.4049/jimmunol.180.6.3889; Lee WW, 2010, BLOOD, V115, P530, DOI 10.1182/blood-2009-08-236521; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lim WH, 2009, J DENT RES, V88, P557, DOI 10.1177/0022034509336823; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lu T, 2007, P NATL ACAD SCI USA, V104, P4365, DOI 10.1073/pnas.0700118104; Luo XR, 2007, P NATL ACAD SCI USA, V104, P2821, DOI 10.1073/pnas.0611646104; Makino M, 2006, EUR J IMMUNOL, V36, P1443, DOI 10.1002/eji.200535727; Maldonado-Lopez R, 2001, J IMMUNOL, V167, P4345, DOI 10.4049/jimmunol.167.8.4345; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Matsumura T, 2004, J LEUKOCYTE BIOL, V75, P1056, DOI 10.1189/jlb.0104108; Nakagawa T, 2010, INT IMMUNOL, V22, P129, DOI 10.1093/intimm/dxp119; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; O'Sullivan BJ, 2006, J IMMUNOL, V176, P7278, DOI 10.4049/jimmunol.176.12.7278; PHAN SH, 1992, J IMMUNOL, V149, P103; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Sheng JR, 2008, CLIN IMMUNOL, V128, P172, DOI 10.1016/j.clim.2008.03.509; Sheng JR, 2006, J IMMUNOL, V177, P5296, DOI 10.4049/jimmunol.177.8.5296; STEINMAN RM, 1988, IMMUNOL LETT, V17, P197, DOI 10.1016/0165-2478(88)90028-4; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Trembleau S, 2003, J IMMUNOL, V170, P5491, DOI 10.4049/jimmunol.170.11.5491; TREMBLEAU S, 1995, IMMUNOL TODAY, V16, P383, DOI 10.1016/0167-5699(95)80006-9; TREMBLEAU S, 1995, J EXP MED, V181, P817, DOI 10.1084/jem.181.2.817; Turnquist HR, 2008, J IMMUNOL, V181, P62, DOI 10.4049/jimmunol.181.1.62; Verginis P, 2005, J IMMUNOL, V174, P7433, DOI 10.4049/jimmunol.174.11.7433; Yamagiwa S, 2001, J IMMUNOL, V166, P7282, DOI 10.4049/jimmunol.166.12.7282; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yamazaki S, 2006, P NATL ACAD SCI USA, V103, P2758, DOI 10.1073/pnas.0510606103; Yamazaki S, 2009, J DERMATOL SCI, V54, P69, DOI 10.1016/j.jdermsci.2009.02.001; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014; YUE TL, 1994, BIOCHEM BIOPH RES CO, V204, P1186, DOI 10.1006/bbrc.1994.2588; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183	73	14	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21949	10.1371/journal.pone.0021949	http://dx.doi.org/10.1371/journal.pone.0021949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779356	Green Published, Green Submitted, gold			2022-12-25	WOS:000292680900019
J	Kiliszek, M; Franaszczyk, M; Kozluk, E; Lodzinski, P; Piatkowska, A; Broda, G; Ploski, R; Opolski, G				Kiliszek, Marek; Franaszczyk, Maria; Kozluk, Edward; Lodzinski, Piotr; Piatkowska, Agnieszka; Broda, Grazyna; Ploski, Rafal; Opolski, Grzegorz			Association between Variants on Chromosome 4q25, 16q22 and 1q21 and Atrial Fibrillation in the Polish Population	PLOS ONE			English	Article							ABLATION; HEART; RISK	Background: Genome-wide studies have shown that polymorphisms on chromosome 4q25, 16q22 and 1q21 correlate with atrial fibrillation (AF). However, the distribution of these polymorphisms differs significantly among populations. Objective: To test the polymorphisms on chromosome 4q25, 16q22 and 1q21 in a group of patients (pts) that underwent catheter ablation of AF. Methods: Four hundred and ten patients with AF that underwent pulmonary vein isolation were included in the study. Control group (n = 550) was taken from healthy population, matched for age, sex and presence of hypertension. All participants were genotyped for the presence of the rs2200733, rs10033464, rs17570669, rs3853445, rs6838973 (4q25), rs7193343 (16q22) and rs13376333 (1q21) polymorphisms. Results: All the polymorphisms tested (except rs17570669) correlated significantly with AF in univariate analysis (p values between 0.039 for rs7193343 and 2.7e-27 for rs2200733), with the odds ratio (OR) 0.572 and 0.617 for rs3853445 and rs6838973, respectively (protective role) and OR 1.268 to 3.52 for the other polymorphisms. All 4q25 SNPs tested but rs3853445 were independently linked with AF in multivariate logistic regression analysis. In haplotype analysis six out of nine 4q25 haplotypes were significantly linked with AF. The T allele of rs2200733 favoured increased number of episodes of AF per month (p = 0.045) and larger pulmonary vein diameter (recessive model, p = 0.032). Conclusions: Patients qualified for catheter ablation of AF have a significantly higher frequency of 4q25, 16q22 and 1q21 variants than the control group. The T allele of rs2200733 favours larger pulmonary veins and increased number of episodes of AF.	[Kiliszek, Marek; Kozluk, Edward; Lodzinski, Piotr; Piatkowska, Agnieszka; Opolski, Grzegorz] Med Univ Warsaw, Dept Cardiol 1, Warsaw, Poland; [Franaszczyk, Maria; Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Broda, Grazyna] Natl Inst Cardiol, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Institute of Cardiology - Poland	Kiliszek, M (corresponding author), Med Univ Warsaw, Dept Cardiol 1, Warsaw, Poland.	kiliszek@mp.pl	; Kozluk, Edward/B-6950-2019	Opolski, Grzegorz/0000-0003-4744-2554; Kozluk, Edward/0000-0002-7829-653X; Lodzinski, Piotr/0000-0002-1747-5999; Ploski, Rafal/0000-0001-6286-5526	Medical University of Warsaw [1WY/N/10, 1WY/N/11]	Medical University of Warsaw	Medical University of Warsaw, grants 1WY/N/10 and 1WY/N/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry FB, 2001, J BIOL CHEM, V276, P25057, DOI 10.1074/jbc.M010378200; Calkins H, 2007, HEART RHYTHM, V4, P816, DOI 10.1016/j.hrthm.2007.04.005; Calkins H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P349, DOI 10.1161/CIRCEP.108.824789; Darbar D, 2008, CIRCULATION, V117, P1927, DOI 10.1161/CIRCULATIONAHA.107.757955; den Uijl DW, 2011, AM J CARDIOL, V107, P243, DOI 10.1016/j.amjcard.2010.08.069; Effinor PT, 2008, HEART RHYTHM, V5, P99, DOI [10.1016/j.hrthm.2007.09.015, 10.1016/j.hrthm.2008.01.014]; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Husser D, 2010, J AM COLL CARDIOL, V55, P747, DOI 10.1016/j.jacc.2009.11.041; Kaab S, 2009, EUR HEART J, V30, P813, DOI 10.1093/eurheartj/ehn578; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Lubitz SA, 2010, CIRCULATION, V122, P976, DOI 10.1161/CIRCULATIONAHA.109.886440; Mommersteeg MTM, 2007, CIRC RES, V101, P902, DOI 10.1161/CIRCRESAHA.107.161182; Ozgen N, 2007, CARDIOVASC RES, V75, P758, DOI 10.1016/j.cardiores.2007.05.008; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ringborg A, 2008, EUROPACE, V10, P403, DOI 10.1093/europace/eun048; Rywik S., 2005, KARDIOLOGIA POLSKA, V63, pS1; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yang YQ, 2004, AM J HUM GENET, V75, P899, DOI 10.1086/425342	21	24	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21790	10.1371/journal.pone.0021790	http://dx.doi.org/10.1371/journal.pone.0021790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760908	gold, Green Published, Green Submitted			2022-12-25	WOS:000292657200022
J	Moriscot, C; Gribaldo, S; Jault, JM; Krupovic, M; Arnaud, J; Jamin, M; Schoehn, G; Forterre, P; Weissenhorn, W; Renesto, P				Moriscot, Christine; Gribaldo, Simonetta; Jault, Jean-Michel; Krupovic, Mart; Arnaud, Julie; Jamin, Marc; Schoehn, Guy; Forterre, Patrick; Weissenhorn, Winfried; Renesto, Patricia			Crenarchaeal CdvA Forms Double-Helical Filaments Containing DNA and Interacts with ESCRT-III-Like CdvB	PLOS ONE			English	Article							ACTIN-LIKE FILAMENTS; AAA ATPASE VPS4; STRUCTURAL BASIS; CELL-DIVISION; PLASMID SEGREGATION; PROTEIN; ARCHAEA; EVOLUTION; MACHINERY; HOMOLOG	Background: The phylum Crenarchaeota lacks the FtsZ cell division hallmark of bacteria and employs instead Cdv proteins. While CdvB and CdvC are homologues of the eukaryotic ESCRT-III and Vps4 proteins, implicated in membrane fission processes during multivesicular body biogenesis, cytokinesis and budding of some enveloped viruses, little is known about the structure and function of CdvA. Here, we report the biochemical and biophysical characterization of the three Cdv proteins from the hyperthermophilic archaeon Metallospherae sedula. Methodology/ Principal Findings: Using sucrose density gradient ultracentrifugation and negative staining electron microscopy, we evidenced for the first time that CdvA forms polymers in association with DNA, similar to known bacterial DNA partitioning proteins. We also observed that, in contrast to full-lengh CdvB that was purified as a monodisperse protein, the C-terminally deleted CdvB construct forms filamentous polymers, a phenomenon previously observed with eukaryotic ESCRT-III proteins. Based on size exclusion chromatography data combined with detection by multi-angle laser light scattering analysis, we demonstrated that CdvC assembles, in a nucleotide-independent way, as homopolymers resembling dodecamers and endowed with ATPase activity in vitro. The interactions between these putative cell division partners were further explored. Thus, besides confirming the previous observations that CdvB interacts with both CdvA and CdvC, our data demonstrate that CdvA/CdvB and CdvC/CdvB interactions are not mutually exclusive. Conclusions/Significance: Our data reinforce the concept that Cdv proteins are closely related to the eukaryotic ESCRT-III counterparts and suggest that the organization of the ESCRT-III machinery at the Crenarchaeal cell division septum is organized by CdvA an ancient cytoskeleton protein that might help to coordinate genome segregation.	[Moriscot, Christine; Arnaud, Julie; Jamin, Marc; Schoehn, Guy; Weissenhorn, Winfried; Renesto, Patricia] CNRS EMBL UJF, UVHCI UMI 3265, Grenoble, France; [Moriscot, Christine; Jault, Jean-Michel; Schoehn, Guy] CEA CNRS UJF, Inst Biol Struct Jean Pierre Ebel, UMR 5075, Grenoble, France; [Gribaldo, Simonetta; Krupovic, Mart; Forterre, Patrick] Inst Pasteur, Biol Mol Gene Chez Extremophiles BMGE, Paris, France; [Forterre, Patrick] Univ Paris 11, CNRS, UMR 8621, Inst Genet & Microbiol, F-91405 Orsay, France	European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Moriscot, C (corresponding author), CNRS EMBL UJF, UVHCI UMI 3265, Grenoble, France.	prenesto@embl.fr	Krupovic, Mart/I-4209-2012; renesto, patricia/T-6446-2019; gribaldo, simonetta/AAW-4377-2020; Krupovic, Mart/ABD-6255-2021; Renesto, patricia/M-6105-2014; jault, jean-michel/G-2086-2012	Krupovic, Mart/0000-0001-5486-0098; renesto, patricia/0000-0002-6749-7862; gribaldo, simonetta/0000-0002-7662-021X; Krupovic, Mart/0000-0001-5486-0098; jault, jean-michel/0000-0003-1743-2777; Schoehn, Guy/0000-0002-1459-3201; Jamin, Marc/0000-0002-8677-2110; MORISCOT, Christine/0000-0001-5707-0999	University Joseph Fourier; CNRS; ANR (Agence Nationale pour la Recherche) [ANR-08-blan-0271]; DGCIS	University Joseph Fourier; CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR)); DGCIS	This work was funded in part by the University Joseph Fourier, the CNRS and the ANR (Agence Nationale pour la Recherche, ANR-08-blan-0271). C. M. was supported by a DGCIS grant. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedov AT, 1999, J BIOL CHEM, V274, P38216, DOI 10.1074/jbc.274.53.38216; Anantharaman V, 2002, GENOME BIOL, P3, DOI [DOI 10.1186/GB-2002-3-5-RESEARCH0023, 10.1186/gb-2002-3-11-research0061, 10.1186/gb-2002-3-5-research0023]; Aylett CHS, 2010, P NATL ACAD SCI USA, V107, P19766, DOI 10.1073/pnas.1010176107; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Baumann P, 1996, P NATL ACAD SCI USA, V93, P6726, DOI 10.1073/pnas.93.13.6726; Bernander R, 2010, CURR OPIN MICROBIOL, V13, P747, DOI 10.1016/j.mib.2010.10.005; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Brugger Kim, 2007, Archaea, V2, P127, DOI 10.1155/2007/745987; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elkins JG, 2008, P NATL ACAD SCI USA, V105, P8102, DOI 10.1073/pnas.0801980105; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; GARRETT R, 2007, ARCHAEA EVOLUTION PH; Gerard E, 1998, GENE, V222, P99, DOI 10.1016/S0378-1119(98)00471-5; Gerard FCA, 2007, BIOCHEMISTRY-US, V46, P10328, DOI 10.1021/bi7007799; Ghazi-Tabatabai S, 2008, STRUCTURE, V16, P1345, DOI 10.1016/j.str.2008.06.010; Ghazi-Tabatabai S, 2009, BIOCHEM SOC T, V37, P151, DOI 10.1042/BST0370151; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; Gribaldo S, 2010, NAT REV MICROBIOL, V8, P743, DOI 10.1038/nrmicro2426; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hartmann C, 2008, J MOL BIOL, V377, P352, DOI 10.1016/j.jmb.2008.01.010; Hobel CFV, 2008, BIOCHEM SOC T, V36, P94, DOI 10.1042/BST0360094; Hong Y, 2004, J STRUCT BIOL, V148, P251, DOI 10.1016/j.jsb.2004.06.004; Hui MP, 2010, P NATL ACAD SCI USA, V107, P4590, DOI 10.1073/pnas.0913060107; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; JAULT JM, 1991, J BIOL CHEM, V266, P8073; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kieffer C, 2008, DEV CELL, V15, P62, DOI 10.1016/j.devcel.2008.05.014; Landsberg MJ, 2009, STRUCTURE, V17, P427, DOI 10.1016/j.str.2008.12.020; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Lowe J, 2009, INT J BIOCHEM CELL B, V41, P323, DOI 10.1016/j.biocel.2008.08.010; Lundgren M, 2005, CURR OPIN MICROBIOL, V8, P662, DOI 10.1016/j.mib.2005.10.008; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Makarova Kira S, 2003, Genome Biol, V4, P115, DOI 10.1186/gb-2003-4-8-115; Makarova KS, 2010, NAT REV MICROBIOL, V8, P731, DOI 10.1038/nrmicro2406; Margolin W, 1996, J BACTERIOL, V178, P1320, DOI 10.1128/jb.178.5.1320-1327.1996; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Peel S, 2011, TRENDS BIOCHEM SCI, V36, P199, DOI 10.1016/j.tibs.2010.09.004; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Salje J, 2010, NAT REV MICROBIOL, V8, P683, DOI 10.1038/nrmicro2425; Samson RY, 2011, MOL CELL, V41, P186, DOI 10.1016/j.molcel.2010.12.018; Samson RY, 2009, TRENDS MICROBIOL, V17, P507, DOI 10.1016/j.tim.2009.08.003; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wyatt PJ, 1998, J COLLOID INTERF SCI, V197, P9, DOI 10.1006/jcis.1997.5215; Yu ZH, 2008, J MOL BIOL, V377, P364, DOI 10.1016/j.jmb.2008.01.009; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	67	30	31	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21921	10.1371/journal.pone.0021921	http://dx.doi.org/10.1371/journal.pone.0021921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760923	Green Published, Green Submitted, gold			2022-12-25	WOS:000292657200029
J	Delgado, O; Kaisani, AA; Spinola, M; Xie, XJ; Batten, KG; Minna, JD; Wright, WE; Shay, JW				Delgado, Oliver; Kaisani, Aadil A.; Spinola, Monica; Xie, Xian-Jin; Batten, Kimberly G.; Minna, John D.; Wright, Woodring E.; Shay, Jerry W.			Multipotent Capacity of Immortalized Human Bronchial Epithelial Cells	PLOS ONE			English	Article							HUMAN AIRWAY EPITHELIUM; STEM-CELLS; PROGENITOR CELLS; CLARA CELLS; BASAL-CELLS; EPIGENETIC REGULATION; HUMAN TISSUES; MOUSE LUNG; BETA-CELLS; II CELLS	While the adult murine lung utilizes multiple compartmentally restricted progenitor cells during homeostasis and repair, much less is known about the progenitor cells from the human lung. Translating the murine stem cell model to humans is hindered by anatomical differences between species. Here we show that human bronchial epithelial cells (HBECs) display characteristics of multipotent stem cells of the lung. These HBECs express markers indicative of several epithelial types of the adult lung when experimentally tested in cell culture. When cultured in three different three-dimensional (3D) systems, subtle changes in the microenvironment result in unique responses including the ability of HBECs to differentiate into multiple central and peripheral lung cell types. These new findings indicate that the adult human lung contains a multipotent progenitor cell whose differentiation potential is primarily dictated by the microenvironment. The HBEC system is not only important in understanding mechanisms for specific cell lineage differentiation, but also for examining changes that correlate with human lung diseases including lung cancer.	[Delgado, Oliver; Kaisani, Aadil A.; Batten, Kimberly G.; Wright, Woodring E.; Shay, Jerry W.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Spinola, Monica; Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Xie, Xian-Jin] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Delgado, O (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	jerry.shay@utsouthwestern.edu	Shay, Jerry W/F-7878-2011	Delgado, Oliver/0000-0003-2547-5857	National Cancer Institute (NCI) [SPORE P50CA70907]; National Aeronautics and Space Administration (NASA) [NSCOR NNJ05HD36GD]; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by National Cancer Institute (NCI) (www.cancer.gov) SPORE P50CA70907 and National Aeronautics and Space Administration (NASA) (www.nasa.gov) NSCOR NNJ05HD36GD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Blatt EN, 1999, AM J RESP CELL MOL, V21, P168, DOI 10.1165/ajrcmb.21.2.3691; Boers JE, 1998, AM J RESP CRIT CARE, V157, P2000, DOI 10.1164/ajrccm.157.6.9707011; Boers JE, 1999, AM J RESP CRIT CARE, V159, P1585, DOI 10.1164/ajrccm.159.5.9806044; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; Daniely Y, 2004, AM J PHYSIOL-CELL PH, V287, pC171, DOI 10.1152/ajpcell.00226.2003; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; EVANS MJ, 1975, EXP MOL PATHOL, V22, P142, DOI 10.1016/0014-4800(75)90059-3; Evans MJ, 2001, EXP LUNG RES, V27, P401, DOI 10.1080/019021401300317125; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Giangreco A, 2009, P NATL ACAD SCI USA, V106, P9286, DOI 10.1073/pnas.0900668106; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; Hovenberg HW, 1996, BIOCHEM J, V318, P319, DOI 10.1042/bj3180319; KALINA M, 1992, AM J RESP CELL MOL, V6, P594, DOI 10.1165/ajrcmb/6.6.594; Kohyama J, 2008, P NATL ACAD SCI USA, V105, P18012, DOI 10.1073/pnas.0808417105; Krane CM, 2001, P NATL ACAD SCI USA, V98, P14114, DOI 10.1073/pnas.231273398; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Liu Yuru, 2002, Gene Expression Patterns, V2, P229, DOI 10.1016/S1567-133X(02)00057-1; Lunyak VV, 2008, HUM MOL GENET, V17, pR28, DOI 10.1093/hmg/ddn149; MADRI JA, 1983, J CELL BIOL, V97, P153, DOI 10.1083/jcb.97.1.153; Madsen J, 2003, AM J RESP CELL MOL, V29, P591, DOI 10.1165/rcmb.2002-0274OC; Madsen J, 2000, J IMMUNOL, V164, P5866, DOI 10.4049/jimmunol.164.11.5866; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; ODOM MJ, 1987, ENDOCRINOLOGY, V121, P1155, DOI 10.1210/endo-121-3-1155; Park KS, 2006, AM J RESP CELL MOL, V34, P151, DOI 10.1165/rcmb.2005-0332OC; POLAK JM, 1993, ANAT REC, V236, P169, DOI 10.1002/ar.1092360120; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Rawlins Emma L, 2008, Proc Am Thorac Soc, V5, P675, DOI 10.1513/pats.200801-006AW; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Shi W, 2009, RESPIROLOGY, V14, P656, DOI 10.1111/j.1440-1843.2009.01565.x; Snyder JC, 2009, J PATHOL, V217, P254, DOI 10.1002/path.2473; TOMPKINS DH, 2010, AM J RESP C IN PRESS; Vaughan MB, 2006, DIFFERENTIATION, V74, P141, DOI 10.1111/j.1432-0436.2006.00069.x; Wuenschell CW, 1996, J HISTOCHEM CYTOCHEM, V44, P113, DOI 10.1177/44.2.8609367; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Yu W, 2007, MOL BIOL CELL, V18, P1693, DOI 10.1091/mbc.E06-11-1052	44	50	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e22023	10.1371/journal.pone.0022023	http://dx.doi.org/10.1371/journal.pone.0022023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760947	gold, Green Published, Green Submitted			2022-12-25	WOS:000292655400039
J	Takayama, K; Inamura, M; Kawabata, K; Tashiro, K; Katayama, K; Sakurai, F; Hayakawa, T; Furue, MK; Mizuguchi, H				Takayama, Kazuo; Inamura, Mitsuru; Kawabata, Kenji; Tashiro, Katsuhisa; Katayama, Kazufumi; Sakurai, Fuminori; Hayakawa, Takao; Furue, Miho Kusuda; Mizuguchi, Hiroyuki			Efficient and Directive Generation of Two Distinct Endoderm Lineages from Human ESCs and iPSCs by Differentiation Stage-Specific SOX17 Transduction	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DEFINITIVE ENDODERM; ADENOVIRUS VECTOR; VISCERAL ENDODERM; GENE-EXPRESSION; MOUSE; INDUCTION; PROMOTES; GASTRULATION; MAINTENANCE	The establishment of methods for directive differentiation from human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) is important for regenerative medicine. Although Sry-related HMG box 17 (SOX17) overexpression in ESCs leads to differentiation of either extraembryonic or definitive endoderm cells, respectively, the mechanism of these distinct results remains unknown. Therefore, we utilized a transient adenovirus vector-mediated overexpression system to mimic the SOX17 expression pattern of embryogenesis. The number of alpha-fetoprotein-positive extraembryonic endoderm (ExEn) cells was increased by transient SOX17 transduction in human ESC- and iPSC-derived primitive endoderm cells. In contrast, the number of hematopoietically expressed homeobox (HEX)-positive definitive endoderm (DE) cells, which correspond to the anterior DE in vivo, was increased by transient adenovirus vector-mediated SOX17 expression in human ESC- and iPSC-derived mesendoderm cells. Moreover, hepatocyte-like cells were efficiently generated by sequential transduction of SOX17 and HEX. Our findings show that a stage-specific transduction of SOX17 in the primitive endoderm or mesendoderm promotes directive ExEn or DE differentiation by SOX17 transduction, respectively.	[Takayama, Kazuo; Inamura, Mitsuru; Katayama, Kazufumi; Sakurai, Fuminori; Mizuguchi, Hiroyuki] Osaka Univ, Lab Biochem & Mol Biol, Grad Sch Pharmaceut Sci, Osaka, Japan; [Takayama, Kazuo; Inamura, Mitsuru; Kawabata, Kenji; Tashiro, Katsuhisa; Mizuguchi, Hiroyuki] Natl Inst Biomed Innovat, Lab Stem Cell Regulat, Osaka, Japan; [Kawabata, Kenji] Osaka Univ, Lab Biomed Innovat, Grad Sch Pharmaceut Sci, Osaka, Japan; [Hayakawa, Takao] Pharmaceut & Med Devices Agcy, Chiyoda Ku, Tokyo, Japan; [Hayakawa, Takao] Kinki Univ, Pharmaceut Res & Technol Inst, Osaka, Japan; [Furue, Miho Kusuda] Natl Inst Biomed Innovat, JCRB Cell Bank, Div Bioresources, Osaka, Japan; [Furue, Miho Kusuda] Kyoto Univ, Lab Cell Proc, Inst Frontier Med Sci, Sakyo Ku, Kyoto, Japan; [Mizuguchi, Hiroyuki] Osaka Univ, Ctr Adv Med Engn & Informat, Osaka, Japan	Osaka University; National Institute of Health Sciences - Japan; Osaka University; Kindai University (Kinki University); National Institute of Health Sciences - Japan; Kyoto University; Osaka University	Takayama, K (corresponding author), Osaka Univ, Lab Biochem & Mol Biol, Grad Sch Pharmaceut Sci, Osaka, Japan.	mizuguch@phs.osaka-u.ac.jp	Takayama, Kazuo/U-2360-2019	Mizuguchi, Hiroyuki/0000-0003-0594-8178; Takayama, Kazuo/0000-0002-1132-2457; Furue, Miho/0000-0001-5032-9953	Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Sports, Science and Technology of Japan [20200076]; National Institute of Biomedical Innovation (NIBIO)	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Sports, Science and Technology of Japan(Core Research for Evolutional Science and Technology (CREST)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation)	HM, MKF, and TH were supported by grants from the Ministry of Health, Labor, and Welfare of Japan. K. Kawabata was supported by grants from the Ministry of Education, Sports, Science and Technology of Japan (20200076) and the Ministry of Health, Labor, and Welfare of Japan. K. Katayama was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; ENDERS AC, 1978, ANAT REC, V190, P65, DOI 10.1002/ar.1091900107; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; GARDNER RL, 1983, INT REV EXP PATHOL, V24, P63; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Grapin-Botton A, 2007, MECH DEVELOP, V124, P253, DOI 10.1016/j.mod.2007.01.001; Inamura M, 2011, MOL THER, V19, P400, DOI 10.1038/mt.2010.241; Ingelman-Sundberg M, 1999, TRENDS PHARMACOL SCI, V20, P342, DOI 10.1016/S0165-6147(99)01363-2; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kawabata K, 2005, MOL THER, V12, P547, DOI 10.1016/j.ymthe.2005.04.015; Koizumi N, 2003, J GENE MED, V5, P267, DOI 10.1002/jgm.348; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kunath T, 2004, PLACENTA, V25, pS32, DOI 10.1016/j.placenta.2004.01.015; LevinsonDushnik M, 1997, MOL CELL BIOL, V17, P3817, DOI 10.1128/MCB.17.7.3817; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Makino H, 2009, EXP CELL RES, V315, P2727, DOI 10.1016/j.yexcr.2009.06.016; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mizuguchi H, 1999, HUM GENE THER, V10, P2013, DOI 10.1089/10430349950017374; Mizuguchi H, 1998, HUM GENE THER, V9, P2577, DOI 10.1089/hum.1998.9.17-2577; Mizuguchi H, 2004, HUM GENE THER, V15, P1034, DOI 10.1089/hum.2004.15.1034; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nagata S, 2009, GENES CELLS, V14, P1395, DOI 10.1111/j.1365-2443.2009.01356.x; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Qu XB, 2008, DEV GROWTH DIFFER, V50, P585, DOI 10.1111/j.1440-169X.2008.01056.x; SASAKI H, 1993, DEVELOPMENT, V118, P47; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Shimoda M, 2007, J CELL SCI, V120, P3859, DOI 10.1242/jcs.007856; SHIOJIRI N, 1984, J EMBRYOL EXP MORPH, V79, P25; Spence JR, 2009, DEV CELL, V17, P62, DOI 10.1016/j.devcel.2009.05.012; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; Tashiro K, 2008, J GENE MED, V10, P498, DOI 10.1002/jgm.1171; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	45	39	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21780	10.1371/journal.pone.0021780	http://dx.doi.org/10.1371/journal.pone.0021780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760905	Green Published, gold			2022-12-25	WOS:000292655400018
J	Shang, PH; Xia, YY; Liu, FY; Wang, XM; Yuan, YL; Hu, DY; Tu, DH; Chen, YX; Deng, PY; Cheng, SM; Zhou, L; Ma, Y; Zhu, LZ; Gao, WW; Wang, HY; Chen, DF; Yang, L; He, PP; Wu, SS; Tang, SW; Lv, XZ; Shu, Z; Zhang, Y; Yang, ZR; Chen, Y; Li, N; Sun, F; Li, XT; He, YJ; Garner, P; Zhan, SY				Shang, Penghui; Xia, Yinyin; Liu, Feiying; Wang, Xiaomeng; Yuan, Yanli; Hu, Daiyu; Tu, Dehua; Chen, Yixin; Deng, Peiyuan; Cheng, Shiming; Zhou, Lin; Ma, Yu; Zhu, Lizhen; Gao, Weiwei; Wang, Hongyuan; Chen, Dafang; Yang, Li; He, Pingping; Wu, Shanshan; Tang, Shaowen; Lv, Xiaozhen; Shu, Zheng; Zhang, Yuan; Yang, Zhirong; Chen, Yan; Li, Na; Sun, Feng; Li, Xiaoting; He, Yingjian; Garner, Paul; Zhan, Siyan			Incidence, Clinical Features and Impact on Anti-Tuberculosis Treatment of Anti-Tuberculosis Drug Induced Liver Injury (ATLI) in China	PLOS ONE			English	Article							INDUCED HEPATOTOXICITY; SUSCEPTIBILITY; PYRAZINAMIDE; HEPATITIS	Background: Anti-tuberculosis drug induced liver injury (ATLI) is emerging as a significant threat to tuberculosis control in China, though limited data is available about the burden of ATLI at population level. This study aimed to estimate the incidence of ATLI, to better understand its clinical features, and to evaluate its impact on anti-tuberculosis (TB) treatment in China. Methodology/Principal Findings: In a population-based prospective study, we monitored 4,304 TB patients receiving directly observed treatment strategy (DOTS) treatment, and found that 106 patients developed ATLI with a cumulative incidence of 2.55% (95% Confidence Interval [CI], 2.04%-3.06%). Nausea, vomiting and anorexia were the top three most frequently observed symptoms. There were 35 (33.02%) ATLI patients with no symptoms, including 8 with severe hepatotoxicity. Regarding the prognosis of ATLI, 84 cases (79.25%) recovered, 18 (16.98%) improved, 2 (1.89%) failed to respond to the treatment with continued elevation of serum alanine aminotransferase, and 2 (1.89%) died as result of ATLI. Of all the ATLI cases, 74 (69.81%) cases changed their anti-TB treatment, including 4 (3.77%) cases with medication administration change, 21 (19.81%) cases with drugs replacement, 54 (50.94%) cases with therapy interruption, and 12 (11.32%) cases who discontinued therapy. In terms of treatment outcomes, 53 (51.46%) cases had TB cured in time, 48 (46.60%) cases had therapy prolonged, and 2 (1.94%) cases died. Compared with non-ATLI patients, ATLI patients had a 9.25-fold (95% CI, 5.69-15.05) risk of unsuccessful anti-TB treatment outcomes and a 2.11-fold (95% CI, 1.23-3.60) risk of prolonged intensive treatment phase. Conclusions/Significance: ATLI could considerably impact the outcomes of anti-TB treatment. Given the incidence of ATLI and the size of TB population in China, the negative impact is substantial. Therefore, more research and efforts are warranted in order to enhance the diagnosis and the prevention of ATLI.	[Shang, Penghui; Wang, Hongyuan; Chen, Dafang; Yang, Li; He, Pingping; Wu, Shanshan; Tang, Shaowen; Lv, Xiaozhen; Shu, Zheng; Zhang, Yuan; Yang, Zhirong; Sun, Feng; Zhan, Siyan] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Xia, Yinyin; Cheng, Shiming; Zhou, Lin] Chinese Ctr Dis Control & Prevent, Ctr TB Control & Prevent, Beijing, Peoples R China; [Liu, Feiying] Ctr Dis Control & Prevent Guangxi Zhuang Autonomo, Nanning, Peoples R China; [Wang, Xiaomeng] Ctr Dis Control & Prevent Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Yuan, Yanli] Ctr Dis Control & Prevent Jilin Prov, Changchun, Peoples R China; [Hu, Daiyu] Ctr Dis Control & Prevent Chongqing Municipal, Chongqing, Peoples R China; [Tu, Dehua] Beijing Inst TB Control, Beijing, Peoples R China; [Chen, Yixin; Deng, Peiyuan] State Food & Drug Adm, Ctr Drug Reassessment, Beijing, Peoples R China; [Ma, Yu; Zhu, Lizhen; Gao, Weiwei] Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China; [Chen, Yan] Indiana Univ, Sch Med, Dept Publ Hlth, Indianapolis, IN USA; [Li, Na] Ctr Dis Control & Prevent Fangshan Dist, Beijing, Peoples R China; [Li, Xiaoting; He, Yingjian] Beijing Inst Canc Res, Beijing, Peoples R China; [Garner, Paul] Univ Liverpool, Liverpool Sch Trop Med, Int Hlth Grp, Liverpool L3 5QA, Merseyside, England	Peking University; Chinese Center for Disease Control & Prevention; Indiana University System; Indiana University-Purdue University Indianapolis; Liverpool School of Tropical Medicine; University of Liverpool	Shang, PH (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China.	siyan-zhan@bjmu.edu.cn	Garner, Paul/HII-5856-2022; Garner, Paul/Y-8385-2019; Sun, Feng/AGF-7912-2022; Sun, Feng/E-8859-2010	Garner, Paul/0000-0002-0607-6941; Sun, Feng/0000-0003-4334-6805; Sun, Feng/0000-0001-9212-0496; Zhang, Yuan/0000-0002-4174-0641	China Program for the Global Fund [NO:TB07-030]	China Program for the Global Fund	This study was funded by the China Program for the Global Fund to Fight TB (NO:TB07-030). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Baghaei P, 2010, AM J THER, V17, P17, DOI 10.1097/MJT.0b013e31818f9eae; BENICHOU C, 1990, J HEPATOL, V11, P272; *BRIT THOR SOC JOI, 1998, CHEM MAN TUB UK REC, P536; Burman WJ, 2001, AM J RESP CRIT CARE, V164, P1112, DOI 10.1164/ajrccm.164.7.2109052; Chang KC, 2008, AM J RESP CRIT CARE, V177, P1391, DOI 10.1164/rccm.200802-355OC; Chen XY, 2004, LANCET, V364, P417; CHITTURI S, 2002, SCHIFFS DIS LIVER, P1059; GIRLING DJ, 1978, TUBERCLE, V59, P13; Gulbay BE, 2006, RESP MED, V100, P1834, DOI 10.1016/j.rmed.2006.01.014; Huang YS, 2003, HEPATOLOGY, V37, P924, DOI 10.1053/jhep.2003.50144; Kaona FAD, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-68; Khalili H, 2009, DARU, V17, P163; Larrey D, 2002, SEMIN LIVER DIS, V22, P145, DOI 10.1055/s-2002-30101; Migliori GB, 1999, EUR RESPIR J, V14, P978, DOI 10.1183/09031936.99.14497899; Ormerod LP, 1996, TUBERCLE LUNG DIS, V77, P37, DOI 10.1016/S0962-8479(96)90073-8; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Sharifzadeh M, 2005, PHARMACOL RES, V51, P353, DOI 10.1016/j.phrs.2004.10.009; Sun F, 2008, INT J TUBERC LUNG D, V12, P994; Teleman MD, 2002, INT J TUBERC LUNG D, V6, P699; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; Ungo JR, 1998, AM J RESP CRIT CARE, V157, P1871, DOI 10.1164/ajrccm.157.6.9711039; Wares DF, 2003, INT J TUBERC LUNG D, V7, P327; WHO, 2009, TREATM TUB GUID; WHO, 2002, EX SUMM NAT CANC CON, P1; World Health Organization, 2010, GLOB TUB CONTR WHO R; Xia YY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-267; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC	28	63	78	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21836	10.1371/journal.pone.0021836	http://dx.doi.org/10.1371/journal.pone.0021836			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750735	Green Published, Green Accepted, gold			2022-12-25	WOS:000292512000027
J	Piganis, RAR; De Weerd, NA; Gould, JA; Schindler, CW; Mansell, A; Nicholson, SE; Hertzog, PJ				Piganis, Rebecca A. R.; De Weerd, Nicole A.; Gould, Jodee A.; Schindler, Christian W.; Mansell, Ashley; Nicholson, Sandra E.; Hertzog, Paul J.			Suppressor of Cytokine Signaling (SOCS) 1 Inhibits Type I Interferon (IFN) Signaling via the Interferon alpha Receptor (IFNAR1)-associated Tyrosine Kinase Tyk2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX MOTIF; PROTEIN; ACTIVATION; DOMAIN; UBIQUITINATION; TRANSDUCTION; EXPRESSION; SUBUNIT-1; INTERACTS; COMPLEX	Type I IFNs are critical players in host innate and adaptive immunity. IFN signaling is tightly controlled to ensure appropriate immune responses as imbalance could result in uncontrolled inflammation or inadequate responses to infection. It is therefore important to understand how type I IFN signaling is regulated. Here we have investigated the mechanism by which suppressor of cytokine signaling 1 (SOCS1) inhibits type I IFN signaling. We have found that SOCS1 inhibits type I IFN signaling not via a direct interaction with the IFN alpha receptor 1 (IFNAR1) receptor component but through an interaction with the IFNAR1-associated kinase Tyk2. We have characterized the residues/regions involved in the interaction between SOCS1 and Tyk2 and found that SOCS1 associates via its SH2 domain with conserved phosphotyrosines 1054 and 1055 of Tyk2. The kinase inhibitory region of SOCS1 is also essential for its interaction with Tyk2 and inhibition of IFN signaling. We also found that Tyk2 is preferentially Lys-63 polyubiquitinated and that this activation reaction is inhibited by SOCS1. The consequent effect of SOCS1 inhibition of Tyk2 not only results in a reduced IFN response because of inhibition of Tyk2 kinase-mediated STAT signaling but also negatively impacts IFNAR1 surface expression, which is stabilized by Tyk2.	[Piganis, Rebecca A. R.; De Weerd, Nicole A.; Gould, Jodee A.; Mansell, Ashley; Hertzog, Paul J.] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia; [Schindler, Christian W.] Columbia Univ, Coll Phys & Surg, Hammer Hlth Sci Ctr, Dept Microbiol, New York, NY 10027 USA; [Schindler, Christian W.] Columbia Univ, Coll Phys & Surg, Hammer Hlth Sci Ctr, Dept Med, New York, NY 10027 USA; [Nicholson, Sandra E.] Walter & Elisa Hall Inst, Melbourne, Vic 3001, Australia	Monash University; Columbia University; Columbia University	Hertzog, PJ (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia.	Paul.Hertzog@monash.edu	de Weerd, Nicole/X-5886-2019; Hertzog, Paul J/G-6734-2013; Mansell, Ashley/B-9553-2008; Hertzog, Paul J/I-7053-2013	de Weerd, Nicole/0000-0002-7985-189X; Hertzog, Paul J/0000-0002-1373-8472; Mansell, Ashley/0000-0002-6540-1281; Hertzog, Paul J/0000-0002-1373-8472; Porritt, Rebecca/0000-0002-0973-5092; , Sandra/0000-0002-1314-2134	National Health and Medical Research Council; Victorian Government	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	This work was supported by funding from the National Health and Medical Research Council and the Victorian Government Infrastructure Support Program.	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Babon JJ, 2009, J MOL BIOL, V387, P162, DOI 10.1016/j.jmb.2009.01.024; BARBIERI G, 1994, EUR J BIOCHEM, V223, P427, DOI 10.1111/j.1432-1033.1994.tb19010.x; COLAMONICI OR, 1994, J BIOL CHEM, V269, P3518; CONSTANTINESCU SN, 1994, P NATL ACAD SCI USA, V91, P9602, DOI 10.1073/pnas.91.20.9602; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Domanski P, 1997, J BIOL CHEM, V272, P26388, DOI 10.1074/jbc.272.42.26388; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Gauzzi MC, 1997, P NATL ACAD SCI USA, V94, P11839, DOI 10.1073/pnas.94.22.11839; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; Giordanetto F, 2003, PROTEIN ENG, V16, P115, DOI 10.1093/proeng/gzg015; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Jin XJ, 2010, J BIOL CHEM, V285, P30539, DOI 10.1074/jbc.M110.129551; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Qing Y, 2005, J BIOL CHEM, V280, P1849, DOI 10.1074/jbc.M409863200; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Russell-Harde D, 2000, J BIOL CHEM, V275, P23981, DOI 10.1074/jbc.M002518200; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Trajanovska S, 2003, J INTERF CYTOK RES, V23, P351, DOI 10.1089/107999003322226005; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498; Zhao WL, 2008, J IMMUNOL, V180, P5483, DOI 10.4049/jimmunol.180.8.5483	33	104	119	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33811	33818		10.1074/jbc.M111.270207	http://dx.doi.org/10.1074/jbc.M111.270207			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21757742	Green Published, hybrid			2022-12-25	WOS:000295159200012
J	Kasaikina, MV; Fomenko, DE; Labunskyy, VM; Lachke, SA; Qiu, WY; Moncaster, JA; Zhang, J; Wojnarowicz, MW; Natarajan, SK; Malinouski, M; Schweizer, U; Tsuji, PA; Carlson, BA; Maas, RL; Lou, MF; Goldstein, LE; Hatfield, DL; Gladyshev, VN				Kasaikina, Marina V.; Fomenko, Dmitri E.; Labunskyy, Vyacheslav M.; Lachke, Salil A.; Qiu, Wenya; Moncaster, Juliet A.; Zhang, Jie; Wojnarowicz, Mark W., Jr.; Natarajan, Sathish Kumar; Malinouski, Mikalai; Schweizer, Ulrich; Tsuji, Petra A.; Carlson, Bradley A.; Maas, Richard L.; Lou, Marjorie F.; Goldstein, Lee E.; Hatfield, Dolph L.; Gladyshev, Vadim N.			Roles of the 15-kDa Selenoprotein (Sep15) in Redox Homeostasis and Cataract Development Revealed by the Analysis of Sep 15 Knockout Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; CELL-DEATH; SELENIUM; EXPRESSION; MUTATIONS; DISEASE; GENE; POLYMORPHISMS; SYSTEMS	The 15-kDa selenoprotein (Sep15) is a thioredoxin-like, endoplasmic reticulum-resident protein involved in the quality control of glycoprotein folding through its interaction with UDP-glucose: glycoprotein glucosyltransferase. Expression of Sep15 is regulated by dietary selenium and the unfolded protein response, but its specific function is not known. In this study, we developed and characterized Sep15 KO mice by targeted removal of exon 2 of the Sep15 gene coding for the cysteine-rich UDP-glucose: glycoprotein glucosyltransferase-binding domain. These KO mice synthesized a mutant mRNA, but the shortened protein product could be detected neither in tissues nor in Sep15 KO embryonic fibroblasts. Sep15 KO mice were viable and fertile, showed normal brain morphology, and did not activate endoplasmic reticulum stress pathways. However, parameters of oxidative stress were elevated in the livers of these mice. We found that Sep15 mRNA was enriched during lens development. Further phenotypic characterization of Sep15 KO mice revealed a prominent nuclear cataract that developed at an early age. These cataracts did not appear to be associated with severe oxidative stress or glucose dysregulation. We suggest that the cataracts resulted from an improper folding status of lens proteins caused by Sep15 deficiency.	[Kasaikina, Marina V.; Labunskyy, Vyacheslav M.; Lachke, Salil A.; Malinouski, Mikalai; Maas, Richard L.; Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Kasaikina, Marina V.; Labunskyy, Vyacheslav M.; Lachke, Salil A.; Malinouski, Mikalai; Maas, Richard L.; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kasaikina, Marina V.; Fomenko, Dmitri E.; Natarajan, Sathish Kumar; Malinouski, Mikalai] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Kasaikina, Marina V.; Fomenko, Dmitri E.; Natarajan, Sathish Kumar; Malinouski, Mikalai] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Lachke, Salil A.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Qiu, Wenya; Lou, Marjorie F.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA; [Moncaster, Juliet A.; Wojnarowicz, Mark W., Jr.; Goldstein, Lee E.] Boston Univ, Sch Med, Mol Aging & Dev Lab, Boston, MA 02118 USA; [Zhang, Jie; Schweizer, Ulrich] Charite Univ Med Berlin, Inst Expt Endokrinol, D-13353 Berlin, Germany; [Tsuji, Petra A.; Carlson, Bradley A.; Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Delaware; University of Nebraska System; University of Nebraska Lincoln; Boston University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gladyshev, VN (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, New Res Bldg,Room 435,77 Ave Louis Pasteur, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Gladyshev, Vadim N/A-9894-2013; Labunskyy, Vyacheslav/AAC-8489-2020; Schweizer, Ulrich/E-8105-2013; Gladyshev, Vadim N/J-6187-2013	Lachke, Salil/0000-0001-8845-010X; Schweizer, Ulrich/0000-0003-1380-4780; Goldstein, Lee/0000-0001-8419-9800; Gladyshev, Vadim/0000-0002-0372-7016; Labunskyy, Vyacheslav/0000-0001-9317-1076; Moncaster, Juliet/0000-0002-7849-4325	National Institutes of Health [CA080946]; Center for Cancer Research, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC005317, ZIABC010889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in whole or in part, by National Institutes of Health Grant CA080946 (to V. N. G.) and the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health (to D. L. H.).	Bahjat FR, 2000, J IMMUNOL, V165, P6559, DOI 10.4049/jimmunol.165.11.6559; Battin EE, 2009, CELL BIOCHEM BIOPHYS, V55, P1, DOI 10.1007/s12013-009-9054-7; Carlson BA, 2009, BIOCHEM J, V418, P61, DOI 10.1042/BJ20081304; Ferguson AD, 2006, J BIOL CHEM, V281, P3536, DOI 10.1074/jbc.M511386200; Gladyshev VN, 1998, J BIOL CHEM, V273, P8910, DOI 10.1074/jbc.273.15.8910; Gohla A, 2007, P NATL ACAD SCI USA, V104, P3003, DOI 10.1073/pnas.0611434104; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Gong XH, 1999, DEV GENET, V24, P27, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<27::AID-DVG4>3.0.CO;2-7; Graw J, 2009, J GENET, V88, P469, DOI 10.1007/s12041-009-0066-2; Hatfield DL, 2009, BBA-GEN SUBJECTS, V1790, P1541, DOI 10.1016/j.bbagen.2009.03.001; Hoffmann PR, 2008, MOL NUTR FOOD RES, V52, P1273, DOI 10.1002/mnfr.200700330; Hu YJ, 2001, CANCER RES, V61, P2307; Ikesugi K, 2006, EXP EYE RES, V83, P508, DOI 10.1016/j.exer.2006.01.033; Irons R, 2010, CANCER PREV RES, V3, P630, DOI 10.1158/1940-6207.CAPR-10-0003; Jackson MI, 2008, CURR OPIN CLIN NUTR, V11, P718, DOI 10.1097/MCO.0b013e3283139674; Korotkov KV, 2001, J BIOL CHEM, V276, P15330, DOI 10.1074/jbc.M009861200; Kumaraswamy E, 2000, J BIOL CHEM, V275, P35540, DOI 10.1074/jbc.M004014200; Kumaraswamy E, 2002, METHOD ENZYMOL, V347, P187; Labunskyy VM, 2007, IUBMB LIFE, V59, P1, DOI 10.1080/15216540601126694; Labunskyy VM, 2009, BIOCHEMISTRY-US, V48, P8458, DOI 10.1021/bi900717p; Lachke SA, 2011, SCIENCE, V331, P1571, DOI 10.1126/science.1195970; Lachke SA, 2010, WIRES SYST BIOL MED, V2, P305, DOI 10.1002/wsbm.59; LESKE MC, 1988, ARCH OPHTHALMOL-CHIC, V106, P327; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; Moncaster JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010659; Pfenniger A, 2011, EUR J CLIN INVEST, V41, P103, DOI 10.1111/j.1365-2362.2010.02378.x; Santhiya ST, 2010, MOL VIS, V16, P1837; Schomburg L, 2009, BBA-GEN SUBJECTS, V1790, P1453, DOI 10.1016/j.bbagen.2009.03.015; Schweizer U, 2004, BIOCHEM J, V378, P21, DOI 10.1042/BJ20031795; Schweizer U, 2004, BRAIN RES REV, V45, P164, DOI 10.1016/j.brainresrev.2004.03.004; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shinohara T, 2006, MED HYPOTHESES, V66, P365, DOI 10.1016/j.mehy.2005.08.044; Steinbrenner H, 2007, BIOL CHEM, V388, P1043, DOI 10.1515/BC.2007.136; TAYLOR HR, 1991, INVEST OPHTH VIS SCI, V32, P529; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Wang K, 2007, INVEST OPHTH VIS SCI, V48, P3719, DOI 10.1167/iovs.06-1487; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974; Zhang Y, 2008, J BIOL CHEM, V283, P2427, DOI 10.1074/jbc.M707951200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	39	74	78	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33203	33212		10.1074/jbc.M111.259218	http://dx.doi.org/10.1074/jbc.M111.259218			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21768092	Green Published, hybrid			2022-12-25	WOS:000294968800039
J	Vorontsov, II; Minasov, G; Kiryukhina, O; Brunzelle, JS; Shuvalova, L; Anderson, WF				Vorontsov, Ivan I.; Minasov, George; Kiryukhina, Olga; Brunzelle, Joseph S.; Shuvalova, Ludmilla; Anderson, Wayne F.			Characterization of the Deoxynucleotide Triphosphate Triphosphohydrolase (dNTPase) Activity of the EF1143 Protein from Enterococcus faecalis and Crystal Structure of the Activator-Substrate Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DEOXYGUANOSINE TRIPHOSPHATE; RIBONUCLEOTIDE REDUCTASE; DGTP TRIPHOSPHOHYDROLASE; GUANOSINE TRIPHOSPHATE; THERMUS-THERMOPHILUS; BACILLUS-SUBTILIS; HIGH-THROUGHPUT; DNA-DAMAGE; HYDROLYSIS	The EF1143 protein from Enterococcus faecalis is a distant homolog of deoxynucleotide triphosphate triphosphohydrolases (dNTPases) from Escherichia coli and Thermus thermophilus. These dNTPases are important components in the regulation of the dNTP pool in bacteria. Biochemical assays of the EF1143 dNTPase activity demonstrated nonspecific hydrolysis of all canonical dNTPs in the presence of Mn2+. In contrast, with Mg2+ hydrolysis required the presence of dGTP as an effector, activating the degradation of dATP and dCTP with dGTP also being consumed in the reaction with dATP. The crystal structure of EF1143 and dynamic light scattering measurements in solution revealed a tetrameric oligomer as the most probable biologically active unit. The tetramer contains four dGTP specific allosteric regulatory sites and four active sites. Examination of the active site with the dATP substrate suggests an in-line nucleophilic attack on the alpha-phosphate center as a possible mechanism of the hydrolysis and two highly conserved residues, His-129 and Glu-122, as an acid-base catalytic dyad. Structural differences between EF1143 apo and holo forms revealed mobility of the alpha 3 helix that can regulate the size of the active site binding pocket and could be stabilized in the open conformation upon formation of the tetramer and dGTP effector binding.	[Vorontsov, Ivan I.; Minasov, George; Kiryukhina, Olga; Shuvalova, Ludmilla; Anderson, Wayne F.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Brunzelle, Joseph S.] Argonne Natl Lab, Adv Photon Source, Life Sci Collaborat Access Team, Argonne, IL 60439 USA	Northwestern University; Feinberg School of Medicine; United States Department of Energy (DOE); Argonne National Laboratory	Anderson, WF (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Searle Bldg 8-459,303 E Chicago Ave, Chicago, IL 60611 USA.	wf-anderson@northwestern.edu		Minasov, George/0000-0001-5460-3462; Kiryukhina, Olga/0000-0001-5962-8423	National Institutes of Health for the Midwest Center for Structural Genomics [GM-62414]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585, P50GM062414] Funding Source: NIH RePORTER	National Institutes of Health for the Midwest Center for Structural Genomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM-62414 from the National Institutes of Health for the Midwest Center for Structural Genomics.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Amyes SGB, 2007, INT J ANTIMICROB AG, V29, pS43, DOI 10.1016/S0924-8579(07)72177-5; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; BEAUCHAMP BB, 1988, P NATL ACAD SCI USA, V85, P2563, DOI 10.1073/pnas.85.8.2563; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Cowtan K., 1994, CRYSTALLOGRAPHY, V31, P34; CUATRECA.P, 1967, J BIOL CHEM, V242, P1541; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dieckman L, 2002, PROTEIN EXPRES PURIF, V25, P1, DOI 10.1006/prep.2001.1602; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fortelle E., 1997, METHOD ENZYMOL, P472; FREY PA, 1982, TETRAHEDRON, V38, P1541, DOI 10.1016/0040-4020(82)80130-0; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Grigorenko BL, 2007, PROTEINS, V66, P456, DOI 10.1002/prot.21228; Grigorenko BL, 2005, PROTEINS, V60, P495, DOI 10.1002/prot.20472; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Harding SE, 1997, PROG BIOPHYS MOL BIO, V68, P207, DOI 10.1016/S0079-6107(97)00027-8; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; Huai Q, 2003, BIOCHEMISTRY-US, V42, P13220, DOI 10.1021/bi034653e; HUBER HE, 1988, J BIOL CHEM, V263, P13549; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Kondo N, 2004, J BIOCHEM, V136, P221, DOI 10.1093/jb/mvh115; Kondo N, 2008, EXTREMOPHILES, V12, P217, DOI 10.1007/s00792-007-0118-6; Kondo N, 2007, ACTA CRYSTALLOGR D, V63, P230, DOI 10.1107/S0907444906049262; KORNBERG SR, 1958, J BIOL CHEM, V233, P159; KREMMER T, 1989, J CHROMATOGR-BIOMED, V493, P45, DOI 10.1016/S0378-4347(00)82707-3; Letkiewicz S, 2009, FOLIA MICROBIOL, V54, P457, DOI 10.1007/s12223-009-0064-z; Madden TL, 1996, METHOD ENZYMOL, V266, P131; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mega R, 2009, FEBS J, V276, P3211, DOI 10.1111/j.1742-4658.2009.07035.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oganesyan V, 2007, ACTA CRYSTALLOGR F, V63, P369, DOI 10.1107/S1744309107018945; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; QUIRK S, 1991, J BACTERIOL, V173, P6665, DOI 10.1128/jb.173.21.6665-6669.1991; Rajan SS, 2004, BIOCHEMISTRY-US, V43, P15472, DOI 10.1021/bi048665r; Rajan SS, 2004, STRUCTURE, V12, P1619, DOI 10.1016/j.str.2004.06.020; ROUSSEL A, 1991, TURBO FRODO SILICON; Salter EA, 2007, J PHYS CHEM B, V111, P4547, DOI 10.1021/jp066582+; SETO D, 1988, J BIOL CHEM, V263, P1494; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Xu HL, 2003, ACTA CRYSTALLOGR A, V59, P60, DOI 10.1107/S0108767302022304; Zimmerman MD, 2008, J MOL BIOL, V378, P215, DOI 10.1016/j.jmb.2008.02.036	47	30	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33158	33166		10.1074/jbc.M111.250456	http://dx.doi.org/10.1074/jbc.M111.250456			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21757692	Green Published, hybrid			2022-12-25	WOS:000294968800035
J	Pedersen, JW; Bennett, EP; Schjoldager, KTBG; Meldal, M; Holmer, AP; Blixt, O; Clo, E; Levery, SB; Clausen, H; Wandall, HH				Pedersen, Johannes W.; Bennett, Eric P.; Schjoldager, Katrine T. -B. G.; Meldal, Morten; Holmer, Andreas P.; Blixt, Ola; Clo, Emiliano; Levery, Steven B.; Clausen, Henrik; Wandall, Hans H.			Lectin Domains of Polypeptide GalNAc Transferases Exhibit Glycopeptide Binding Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-D-GALACTOSAMINE; N-ACETYLGALACTOSAMINYLTRANSFERASE FAMILY; ELECTRON-TRANSFER DISSOCIATION; O-LINKED GLYCOSYLATION; UDP-GALNAC; CDNA CLONING; 3 MEMBERS; INITIATION; DROSOPHILA; IDENTIFICATION	UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferases (GalNAc-Ts) constitute a family of up to 20 transferases that initiate mucin-type O-glycosylation. The transferases are structurally composed of catalytic and lectin domains. Two modes have been identified for the selection of glycosylation sites by GalNAc-Ts: confined sequence recognition by the catalytic domain alone, and concerted recognition of acceptor sites and adjacent GalNAc-glycosylated sites by the catalytic and lectin domains, respectively. Thus far, only the catalytic domain has been shown to have peptide sequence specificity, whereas the primary function of the lectin domain is to increase affinity to previously glycosylated substrates. Whether the lectin domain also has peptide sequence selectivity has remained unclear. Using a glycopeptide array with a library of synthetic and recombinant glycopeptides based on sequences of mucins MUC1, MUC2, MUC4, MUC5AC, MUC6, and MUC7 as well as a random glycopeptide bead library, we examined the binding properties of four different lectin domains. The lectin domains of GalNAc-T1, -T2, -T3, and -T4 bound different subsets of small glycopeptides. These results indicate an additional level of complexity in the initiation step of O-glycosylation by GalNAc-Ts.	[Pedersen, Johannes W.; Schjoldager, Katrine T. -B. G.; Holmer, Andreas P.; Blixt, Ola; Clo, Emiliano; Levery, Steven B.; Clausen, Henrik; Wandall, Hans H.] Univ Copenhagen, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Bennett, Eric P.] Univ Copenhagen, Fac Hlth Sci, Sch Dent, DK-2200 Copenhagen N, Denmark; [Meldal, Morten] Univ Copenhagen, Carlsberg Lab, DK-2100 Copenhagen, Denmark; [Meldal, Morten] Univ Copenhagen, Nano Sci Ctr, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Wandall, HH (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	hhw@sund.ku.dk	Meldal, Morten/B-7626-2016; Bennett, Eric/AAG-6120-2020; clausen, henrik/AAD-8016-2021	Meldal, Morten/0000-0001-6114-9018; Bennett, Eric/0000-0002-4976-0647; Blixt, Ola/0000-0003-4143-6276; Clausen, Henrik/0000-0002-0915-5055; Wandall, Hans H./0000-0003-0240-9232	Novo Nordisk Foundation; Danish Medical Research Council; Danish Cancer Research Foundation; Agnes and Poul Friis Foundation; Danish Cancer Society; University of Copenhagen	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Research Foundation; Agnes and Poul Friis Foundation; Danish Cancer Society(Danish Cancer Society); University of Copenhagen	This work was supported by the Novo Nordisk Foundation, Danish Medical Research Council, Danish Cancer Research Foundation, Agnes and Poul Friis Foundation, Danish Cancer Society, and the University of Copenhagen (Program of Excellence).	Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Bertini I, 2008, J AM CHEM SOC, V130, P7011, DOI 10.1021/ja710491y; Blixt O, 2010, J PROTEOME RES, V9, P5250, DOI 10.1021/pr1005229; Clausen H, 1996, GLYCOBIOLOGY, V6, P635, DOI 10.1093/glycob/6.6.635; Collins BE, 2002, GLYCOBIOLOGY, V12, P563, DOI 10.1093/glycob/cwf067; Dupont C, 1998, BIOCHEM J, V330, P41, DOI 10.1042/bj3300041; Fakhro KA, 2011, P NATL ACAD SCI USA, V108, P2915, DOI 10.1073/pnas.1019645108; Fritz TA, 2006, J BIOL CHEM, V281, P8613, DOI 10.1074/jbc.M513590200; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Fujimoto Z, 2002, J MOL BIOL, V316, P65, DOI 10.1006/jmbi.2001.5338; Gerken TA, 2006, J BIOL CHEM, V281, P32403, DOI 10.1074/jbc.M605149200; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; Gerken TA, 2008, GLYCOBIOLOGY, V18, P861, DOI 10.1093/glycob/cwn073; Guda K, 2009, P NATL ACAD SCI USA, V106, P12921, DOI 10.1073/pnas.0901454106; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Heise N, 2009, GLYCOBIOLOGY, V19, P918, DOI 10.1093/glycob/cwp068; Herr P, 2008, DEVELOPMENT, V135, P1813, DOI 10.1242/dev.019323; Imberty A, 1997, PROTEIN ENG, V10, P1353, DOI 10.1093/protein/10.12.1353; Iwasaki H, 2003, J BIOL CHEM, V278, P5613, DOI 10.1074/jbc.M211097200; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Mandel U, 1999, GLYCOBIOLOGY, V9, P43, DOI 10.1093/glycob/9.1.43; McAlister GC, 2008, J PROTEOME RES, V7, P3127, DOI 10.1021/pr800264t; MELDAL M, 1992, TETRAHEDRON LETT, V33, P3077, DOI 10.1016/S0040-4039(00)79604-3; Meldal Morten, 1994, Methods (Orlando), V6, P417, DOI 10.1006/meth.1994.1044; Mirgorodskaya E, 1999, ANAL BIOCHEM, V269, P54, DOI 10.1006/abio.1998.3089; Miwa HE, 2010, J BIOL CHEM, V285, P1208, DOI 10.1074/jbc.M109.035436; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Pedersen JW, 2011, INT J CANCER, V128, P1860, DOI 10.1002/ijc.25778; Perrine CL, 2009, J BIOL CHEM, V284, P20387, DOI 10.1074/jbc.M109.017236; Raman J, 2008, J BIOL CHEM, V283, P22942, DOI 10.1074/jbc.M803387200; Rottger S, 1998, J CELL SCI, V111, P45; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Sheehan JK, 2004, J BIOL CHEM, V279, P15698, DOI 10.1074/jbc.M313241200; SORENSEN T, 1995, J BIOL CHEM, V270, P24166, DOI 10.1074/jbc.270.41.24166; Swaney DL, 2007, ANAL CHEM, V79, P477, DOI 10.1021/ac061457f; TENHAGEN KG, 2003, GLYCOBIOLOGY, V13, P1; Tenno M, 2002, J BIOL CHEM, V277, P47088, DOI 10.1074/jbc.M207369200; Tenno M, 2002, BIOCHEM BIOPH RES CO, V298, P755, DOI 10.1016/S0006-291X(02)02549-4; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thobhani S, 2003, J AM CHEM SOC, V125, P7154, DOI 10.1021/ja029759w; Tian E, 2007, J BIOL CHEM, V282, P606, DOI 10.1074/jbc.M606268200; Tian E, 2006, GLYCOBIOLOGY, V16, P83, DOI 10.1093/glycob/cwj051; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wandall HH, 2007, GLYCOBIOLOGY, V17, P374, DOI 10.1093/glycob/cwl082; Wandall HH, 2010, CANCER RES, V70, P1306, DOI 10.1158/0008-5472.CAN-09-2893; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; Wojczyk BS, 2003, MOL BIOCHEM PARASIT, V131, P93, DOI 10.1016/S0166-6851(03)00196-8; Zhang LP, 2008, J BIOL CHEM, V283, P34076, DOI 10.1074/jbc.M804267200; Zhang Y, 2009, J AM SOC MASS SPECTR, V20, P1425, DOI 10.1016/j.jasms.2009.03.019	56	46	47	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32684	32696		10.1074/jbc.M111.273722	http://dx.doi.org/10.1074/jbc.M111.273722			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21768105	Green Published, hybrid			2022-12-25	WOS:000294726800077
J	Skipsey, M; Knight, KM; Brazier-Hicks, M; Dixon, DP; Steel, PG; Edwards, R				Skipsey, Mark; Knight, Kathryn M.; Brazier-Hicks, Melissa; Dixon, David P.; Steel, Patrick G.; Edwards, Robert			Xenobiotic Responsiveness of Arabidopsis thaliana to a Chemical Series Derived from a Herbicide Safener	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE S-TRANSFERASES; REDOX REGULATION; PLANT DEFENSE; ACID; DETOXIFICATION; METABOLISM; IDENTIFICATION; EXPRESSION; INDUCTION; BINDING	Plants respond to synthetic chemicals by eliciting a xenobiotic response (XR) that enhances the expression of detoxifying enzymes such as glutathione transferases (GSTs). In agrochemistry, the ability of safeners to induce an XR is used to increase herbicide detoxification in cereal crops. Based on the responsiveness of the model plant Arabidopsis thaliana to the rice safener fenclorim (4,6-dichloro-2-phenylpyrimidine), a series of related derivatives was prepared and tested for the ability to induce GSTs in cell suspension cultures. The XR in Arabidopsis could be divided into rapid and slow types depending on subtle variations in the reactivity (electrophilicity) and chemical structure of the derivatives. In a comparative microarray study, Arabidopsis cultures were treated with closely related compounds that elicited rapid (fenclorim) and slow (4-chloro-6-methyl-2-phenylpyrimidine) XRs. Both chemicals induced major changes in gene expression, including a coordinated suppression in cell wall biosynthesis and an up-regulation in detoxification pathways, whereas only fenclorim selectively induced sulfur and phenolic metabolism. These transcriptome studies suggested several linkages between the XR and oxidative and oxylipin signaling. Confirming links with abiotic stress signaling, suppression of glutathione content enhanced GST induction by fenclorim, whereas fatty acid desaturase mutants, which were unable to synthesize oxylipins, showed an attenuated XR. Examining the significance of these studies to agrochemistry, only those fenclorim derivatives that elicited a rapid XR proved effective in increasing herbicide tolerance (safening) in rice.	[Skipsey, Mark; Brazier-Hicks, Melissa; Dixon, David P.; Edwards, Robert] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Knight, Kathryn M.; Steel, Patrick G.] Univ Durham, Dept Chem, Durham DH1 3LE, England	Durham University; Durham University	Edwards, R (corresponding author), Food & Environm Res Agcy, York YO41 1LZ, N Yorkshire, England.	robert.edwards@fera.gsi.gov.uk	Dixon, David P/B-5413-2008; Steel, Patrick/G-3187-2012	Dixon, David P/0000-0003-4644-8399; Steel, Patrick/0000-0002-2493-5826; Brazier-Hicks, Melissa/0000-0001-5993-1940; Edwards, Robert/0000-0003-0809-5991	Biotechnology and Biological Sciences Research Council [BBD0056201]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council Grant BBD0056201 and a Biotechnology and Biological Sciences Research Council research development fellowship (to R.E.).	Andersson MX, 2006, J BIOL CHEM, V281, P31528, DOI 10.1074/jbc.M604820200; Baerson SR, 2005, J BIOL CHEM, V280, P21867, DOI 10.1074/jbc.M500694200; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Brazier-Hicks M, 2008, J BIOL CHEM, V283, P21102, DOI 10.1074/jbc.M801998200; Cummins I, 2006, PHYTOCHEMISTRY, V67, P1722, DOI 10.1016/j.phytochem.2006.01.012; Cummins I, 2006, J MOL BIOL, V359, P422, DOI 10.1016/j.jmb.2006.03.048; Cummins I, 2009, PLANT BIOTECHNOL J, V7, P807, DOI 10.1111/j.1467-7652.2009.00445.x; Davies J, 1999, PESTIC SCI, V55, P1043, DOI 10.1002/(SICI)1096-9063(199911)55:11&lt;1043::AID-PS60&gt;3.0.CO;2-L; Deng F, 2002, PESTIC BIOCHEM PHYS, V72, P24, DOI 10.1006/pest.2001.2579; DeRidder BP, 2006, PLANT PHYSIOL, V140, P167, DOI 10.1104/pp.105.067199; DeRidder BP, 2002, PLANT PHYSIOL, V130, P1497, DOI 10.1104/pp.010066; Dixon DP, 2009, J BIOL CHEM, V284, P21249, DOI 10.1074/jbc.M109.020107; Dixon DP, 2009, J EXP BOT, V60, P1207, DOI 10.1093/jxb/ern365; Dixon DP, 2002, J BIOL CHEM, V277, P30859, DOI 10.1074/jbc.M202919200; Dixon DP, 2005, BIOCHEMISTRY-US, V44, P7696, DOI 10.1021/bi047324a; Dixon DP, 1998, PLANT MOL BIOL, V36, P75, DOI 10.1023/A:1005958711207; Edwards R, 2005, Z NATURFORSCH C, V60, P307; Edwards R, 2005, ADV BOT RES, V42, P1, DOI 10.1016/S0065-2296(05)42001-7; Esch SW, 2007, J LIPID RES, V48, P235, DOI 10.1194/jlr.D600034-JLR200; FARAGO S, 1990, PLANT PHYSIOL, V94, P1808, DOI 10.1104/pp.94.4.1808; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; HARDEN DB, 1988, J ORG CHEM, V53, P4137, DOI 10.1021/jo00252a057; Lee HW, 2005, EUR J MED CHEM, V40, P862, DOI 10.1016/j.ejmech.2005.03.019; Liebeskind LS, 2002, ORG LETT, V4, P979, DOI 10.1021/ol0200091; Loeffler C, 2005, PLANT PHYSIOL, V137, P328, DOI 10.1104/pp.104.051714; Loutre C, 2003, PLANT J, V34, P485, DOI 10.1046/j.1365-313X.2003.01742.x; Marcus Y, 2003, J BACTERIOL, V185, P1509, DOI 10.1128/JB.185.5.1509-1517.2003; Maruyama-Nakashita A, 2005, PLANT J, V42, P305, DOI 10.1111/j.1365-313X.2005.02363.x; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Mueller MJ, 2009, PHYTOCHEMISTRY, V70, P1511, DOI 10.1016/j.phytochem.2009.05.018; Mueller S, 2008, PLANT CELL, V20, P768, DOI 10.1105/tpc.107.054809; Ohkama-Ohtsu N, 2011, PLANT CELL PHYSIOL, V52, P205, DOI 10.1093/pcp/pcq181; Owen W.J., 2000, METABOLISM AGROCHEMI, P211; Riechers DE, 2010, PLANT PHYSIOL, V153, P3, DOI 10.1104/pp.110.153601; Rishi AS, 2004, PLANTA, V220, P296, DOI 10.1007/s00425-004-1356-9; Schaller F, 2004, J PLANT GROWTH REGUL, V23, P179, DOI 10.1007/s00344-004-0047-x; Schomaker JM, 2001, J ORG CHEM, V66, P7125, DOI 10.1021/jo010573+; Scott-Craig JS, 1998, PLANT PHYSIOL, V116, P1083, DOI 10.1104/pp.116.3.1083; Smith AP, 2004, J BIOL CHEM, V279, P26098, DOI 10.1074/jbc.M402807200; Theodoulou FL, 2005, PLANT PHYSIOL, V137, P835, DOI 10.1104/pp.105.059352; Thoma I, 2004, CHEM PHYS LIPIDS, V128, P135, DOI 10.1016/j.chemphyslip.2003.10.002; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Zhang O, 2004, PROTEOMICS, V4, P2058, DOI 10.1002/pmic.200300733; Zhang Q, 2007, PROTEOMICS, V7, P1261, DOI 10.1002/pmic.200600423	45	41	42	0	42	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32268	32276		10.1074/jbc.M111.252726	http://dx.doi.org/10.1074/jbc.M111.252726			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778235	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000294726800037
J	Wakita, Y; Kakimoto, T; Katoh, H; Negishi, M				Wakita, Yohei; Kakimoto, Tetsuhiro; Katoh, Hironori; Negishi, Manabu			The F-BAR Protein Rapostlin Regulates Dendritic Spine Formation in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE INVAGINATION; GTPASE-ACTIVATING PROTEIN; ALDRICH-SYNDROME PROTEIN; RAS GAP ACTIVITY; N-WASP; ACTIN CYTOSKELETON; R-RAS; RHO-FAMILY; ARP2/3 COMPLEX	Pombe Cdc15 homology proteins, characterized by Fer/CIP4 homology Bin-Amphiphysin-Rvs/extended Fer/CIP4 homology (F-BAR/EFC) domains with membrane invaginating property, play critical roles in a variety of membrane reorganization processes. Among them, Rapostlin/formin-binding protein 17 (FBP17) has attracted increasing attention as a critical coordinator of endocytosis. Here we found that Rapostlin was expressed in the developing rat brain, including the hippocampus, in late developmental stages when accelerated dendritic spine formation and maturation occur. In primary cultured rat hippocampal neurons, knockdown of Rapostlin by shRNA or overexpression of Rapostlin-QQ, an F-BAR domain mutant of Rapostlin that has no ability to induce membrane invagination, led to a significant decrease in spine density. Expression of shRNA-resistant wild-type Rapostlin effectively restored spine density in Rapostlin knockdown neurons, whereas expression of Rapostlin deletion mutants lacking the protein kinase C-related kinase homology region 1 (HR1) or Src homology 3 (SH3) domain did not. In addition, knockdown of Rapostlin or overexpression of Rapostlin-QQ reduced the uptake of transferrin in hippocampal neurons. Knockdown of Rnd2, which binds to the HR1 domain of Rapostlin, also reduced spine density and the transferrin uptake. These results suggest that Rapostlin and Rnd2 cooperatively regulate spine density. Indeed, Rnd2 enhanced the Rapostlin-induced tubular membrane invagination. We conclude that the F-BAR protein Rapostlin, whose activity is regulated by Rnd2, plays a key role in spine formation through the regulation of membrane dynamics.	[Wakita, Yohei; Kakimoto, Tetsuhiro; Katoh, Hironori; Negishi, Manabu] Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Negishi, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068501, Japan.	mnegishi@pharm.kyoto-u.ac.jp	kakimoto, tetsuhiro/W-1403-2019	Katoh, Hironori/0000-0002-8191-8117; Kakimoto, Tetsuhiro/0000-0003-1349-5690	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Armentano M, 2006, DEVELOPMENT, V133, P4151, DOI 10.1242/dev.02600; Aspenstrom P, 2006, TRENDS BIOCHEM SCI, V31, P670, DOI 10.1016/j.tibs.2006.10.001; Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chang L, 2002, P NATL ACAD SCI USA, V99, P12835, DOI 10.1073/pnas.202495599; Chang L, 2007, ENDOCRINOLOGY, V148, P27, DOI 10.1210/en.2006-1167; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Fujimoto S, 2009, MOL BIOL CELL, V20, P4941, DOI 10.1091/mbc.E09-03-0200; Fujita H, 2002, J BIOL CHEM, V277, P45428, DOI 10.1074/jbc.M208090200; Fujito T, 2005, J CELL BIOL, V171, P165, DOI 10.1083/jcb.200501090; Gray NW, 2005, J CELL SCI, V118, P1279, DOI 10.1242/jcs.01711; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hu JH, 2011, J BIOL CHEM, V286, P2261, DOI 10.1074/jbc.M110.157974; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Ishikawa Y, 2003, J NEUROSCI, V23, P11065; Ishikawa Y, 2006, NEUROSCI LETT, V400, P218, DOI 10.1016/j.neulet.2006.02.064; Ito Y, 2006, EMBO REP, V7, P704, DOI 10.1038/sj.embor.7400737; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Jaskolski F, 2009, J BIOL CHEM, V284, P12491, DOI 10.1074/jbc.M808401200; Kakimoto T, 2004, J BIOL CHEM, V279, P14104, DOI 10.1074/jbc.M312763200; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Katoh H, 2006, BRAIN RES, V1073, P103, DOI 10.1016/j.brainres.2005.12.085; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; Kim SH, 2006, GENES CELLS, V11, P1197, DOI 10.1111/j.1365-2443.2006.01008.x; Koduru S, 2010, P NATL ACAD SCI USA, V107, P16252, DOI 10.1073/pnas.1002747107; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Marie-Claire C, 2007, BRAIN RES, V1134, P12, DOI 10.1016/j.brainres.2006.11.065; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Miki H, 2003, J BIOCHEM, V134, P309, DOI 10.1093/jb/mvg146; MUNDIGL O, 1993, J CELL BIOL, V122, P1207, DOI 10.1083/jcb.122.6.1207; Nakamura K, 2006, NEUROSCI RES, V54, P149, DOI 10.1016/j.neures.2005.10.008; Negishi M, 2002, J BIOCHEM, V132, P157, DOI 10.1093/oxfordjournals.jbchem.a003205; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nishi M, 1999, MOL BRAIN RES, V67, P74, DOI 10.1016/S0169-328X(99)00039-X; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; Oinuma I, 2006, J CELL BIOL, V173, P601, DOI 10.1083/jcb.200508204; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Pichot CS, 2010, CANCER RES, V70, P8347, DOI 10.1158/0008-5472.CAN-09-4149; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Shimomura A, 2009, J VET MED SCI, V71, P1591, DOI 10.1292/jvms.001591; Suetsugu S, 2010, J BIOCHEM, V148, P1, DOI 10.1093/jb/mvq049; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tanaka H, 2006, J BIOL CHEM, V281, P10355, DOI 10.1074/jbc.M511314200; Thomas S, 2009, J BIOL CHEM, V284, P12410, DOI 10.1074/jbc.M809746200; Tsuboi S, 2009, J BIOL CHEM, V284, P8548, DOI 10.1074/jbc.M805638200; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Ueda S, 2008, J NEUROSCI RES, V86, P3052, DOI 10.1002/jnr.21763; Uesugi K, 2009, J BIOL CHEM, V284, P6743, DOI 10.1074/jbc.M805213200; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wu M, 2010, NAT CELL BIOL, V12, P902, DOI 10.1038/ncb2094; Yamaki N, 2007, EXP CELL RES, V313, P2821, DOI 10.1016/j.yexcr.2007.05.010; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005	71	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32672	32683		10.1074/jbc.M111.236265	http://dx.doi.org/10.1074/jbc.M111.236265			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21768103	hybrid, Green Published			2022-12-25	WOS:000294726800076
J	Li, Y; Si, R; Feng, Y; Chen, HH; Zou, L; Wang, E; Zhang, M; Warren, HS; Sosnovik, DE; Chao, W				Li, Yan; Si, Rui; Feng, Yan; Chen, Howard H.; Zou, Lin; Wang, E.; Zhang, Ming; Warren, H. Shaw; Sosnovik, David E.; Chao, Wei			Myocardial Ischemia Activates an Injurious Innate Immune Signaling via Cardiac Heat Shock Protein 60 and Toll-like Receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; NF-KAPPA-B; REPERFUSION INJURY; CARDIOMYOCYTE APOPTOSIS; SERUM DEPRIVATION; DEATH-DOMAIN; INFLAMMATION; TLR4; MACROPHAGES; PATHWAY	Innate immune response after transient ischemia is the most common cause of myocardial inflammation and may contribute to injury, yet the detailed signaling mechanisms leading to such a response are not well understood. Herein we tested the hypothesis that myocardial ischemia activates interleukin receptor-associated kinase-1 (IRAK-1), a kinase critical for the innate immune signaling such as that of Toll-like receptors (TLRs), via a mechanism that involves heat shock proteins (HSPs) and TLRs. Coronary artery occlusion induced a rapid myocardial IRAK-1 activation within 30 min in wild-type (WT), TLR2(-/-), or Trif(-/-) mice, but not in TLR4(def) or MyD88(-/-) mice. HSP60 protein was markedly increased in serum or in perfusate of isolated heart following ischemia/reperfusion (I/R). In vitro, recombinant HSP60 induced IRAK-1 activation in cells derived from WT, TLR2(-/-), or Trif(-/-) mice, but not from TLR4(def) or MyD88(-/-) mice. Both myocardial ischemia-and HSP60-induced IRAK-1 activation was abolished by anti-HSP60 antibody. Moreover, HSP60 treatment of cardiomyocytes (CMs) led to marked activation of caspase-8 and -3, but not -9. Expression of dominant-negative mutant of Fas-associated death domain protein or a caspase-8 inhibitor completely blocked HSP60-induced caspase-8 activation, suggesting that HSP60 likely activates an apoptotic program via the death-receptor pathway. In vivo, I/R-induced myocardial apoptosis and cytokine expression were significantly attenuated in TLR4def mice or in WT mice treated with anti-HSP60 antibody compared with WT controls. Taken together, the current study demonstrates that myocardial ischemia activates an innate immune signaling via HSP60 and TLR4, which plays an important role in mediating apoptosis and inflammation during I/R.	[Li, Yan; Si, Rui; Feng, Yan; Zou, Lin; Wang, E.; Zhang, Ming; Chao, Wei] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia & Crit Care, Boston, MA USA; [Chen, Howard H.; Sosnovik, David E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Martinos Ctr Biomed Imaging, Boston, MA USA; [Warren, H. Shaw] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Infect Dis Unit, Boston, MA USA; [Li, Yan] Huazhong Univ Sci & Technol, Union Hosp, Dept Pathol, Tongji Med Coll, Wuhan 430030, Peoples R China	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Huazhong University of Science & Technology	Chao, W (corresponding author), Massachusetts Gen Hosp, Room 4-212,149 13th St, Charlestown, MA 02129 USA.	wchao@partners.org	Feng, Yan/H-5808-2012	Chao, Wei/0000-0002-2505-1360; Chen, Howard H./0000-0002-5145-0584	National Institutes of Health [R01GM080906, R01HL093038]; American Heart Association [0755890T]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080906] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM080906 and R01HL093038. This work was also supported by American Heart Association Grant-in-Aid 0755890T.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BROWN JM, 1989, P NATL ACAD SCI USA, V86, P2516, DOI 10.1073/pnas.86.7.2516; Bulut Y, 2002, J IMMUNOL, V168, P1435, DOI 10.4049/jimmunol.168.3.1435; Chao W, 2005, AM J PHYSIOL-HEART C, V289, pH2073, DOI 10.1152/ajpheart.01216.2004; Chao W, 2005, J BIOL CHEM, V280, P21997, DOI 10.1074/jbc.M413676200; Chao W, 2002, J BIOL CHEM, V277, P31639, DOI 10.1074/jbc.M204104200; Chao W, 2009, AM J PHYSIOL-HEART C, V296, pH1, DOI 10.1152/ajpheart.00995.2008; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chong AJ, 2004, J THORAC CARDIOV SUR, V128, P170, DOI 10.1016/j.jtcvs.2003.11.036; Cohen-Sfady M, 2005, J IMMUNOL, V175, P3594, DOI 10.4049/jimmunol.175.6.3594; Feng Y, 2008, AM J PHYSIOL-HEART C, V295, pH1311, DOI 10.1152/ajpheart.00119.2008; Feng Y, 2010, AM J PHYSIOL-CELL PH, V299, pC760, DOI 10.1152/ajpcell.00155.2010; Gao BC, 2003, J BIOL CHEM, V278, P22523, DOI 10.1074/jbc.M303161200; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Ha T, 2008, CARDIOVASC RES, V78, P546, DOI 10.1093/cvr/cvn037; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Kaczorowski DJ, 2008, J LEUKOCYTE BIOL, V83, P546, DOI 10.1189/jlb.0607374; Kaczorowski DJ, 2009, TRANSPLANTATION, V87, P1455, DOI 10.1097/TP.0b013e3181a36e5e; Kajstura J, 1996, LAB INVEST, V74, P86; Katz M, 2003, BIOCHEM J, V375, P405, DOI 10.1042/BJ20030784; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kim SC, 2009, CIRC RES, V105, P1186, DOI 10.1161/CIRCRESAHA.109.209643; KNOWLTON AA, 1991, J CLIN INVEST, V87, P139, DOI 10.1172/JCI114963; Knuefermann P, 2008, CARDIOVASC RES, V78, P26, DOI 10.1093/cvr/cvn011; Koh JM, 2009, BONE, V45, P650, DOI 10.1016/j.bone.2009.06.007; Kol A, 1999, J CLIN INVEST, V103, P571, DOI 10.1172/JCI5310; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Lehnardt S, 2007, J NEUROIMMUNOL, V190, P28, DOI 10.1016/j.jneuroim.2007.07.023; Li HH, 2010, ANESTHESIOLOGY, V113, P619, DOI 10.1097/ALN.0b013e3181e89ab2; Lin L, 2007, AM J PHYSIOL-HEART C, V293, pH2238, DOI 10.1152/ajpheart.00740.2007; MacLellan WR, 1997, CIRC RES, V81, P137, DOI 10.1161/01.RES.81.2.137; MARBER MS, 1993, CIRCULATION, V88, P1264, DOI 10.1161/01.CIR.88.3.1264; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Meiler SE, 2002, J MOL CELL CARDIOL, V34, P349, DOI 10.1006/jmcc.2001.1519; NOVITSKY TJ, 1985, J CLIN MICROBIOL, V21, P211, DOI 10.1128/JCM.21.2.211-216.1985; Novo G, 2011, TRANSL RES, V157, P285, DOI 10.1016/j.trsl.2011.01.003; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Pockley AG, 2002, CIRCULATION, V105, P1012, DOI 10.1161/hc0802.103729; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prince JM, 2006, J AM COLL SURGEONS, V202, P407, DOI 10.1016/j.jamcollsurg.2005.11.021; Quintana FJ, 2005, J IMMUNOL, V175, P2777, DOI 10.4049/jimmunol.175.5.2777; Roelofs MF, 2006, J IMMUNOL, V176, P7021, DOI 10.4049/jimmunol.176.11.7021; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shishido T, 2003, CIRCULATION, V108, P2905, DOI 10.1161/01.CIR.0000101921.93016.1C; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Sosnovik DE, 2008, NAT CLIN PRACT CARD, V5, pS63, DOI 10.1038/ncpcardio1115; Sosnovik DE, 2005, MAGNET RESON MED, V54, P718, DOI 10.1002/mrm.20617; Szerafin T, 2008, ANN THORAC SURG, V85, P80, DOI 10.1016/j.athoracsur.2007.06.049; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Wang E, 2011, ANESTHESIOLOGY, V114, P603, DOI 10.1097/ALN.0b013e31820a4d5b; Wang Y, 2010, J MOL CELL CARDIOL, V48, P360, DOI 10.1016/j.yjmcc.2009.11.009; Willis MS, 2010, CIRCULATION, V122, P1740, DOI 10.1161/CIRCULATIONAHA.110.942250; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhu XS, 2006, AM J PHYSIOL-HEART C, V291, pH1900, DOI 10.1152/ajpheart.00112.2006	65	115	122	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31308	31319		10.1074/jbc.M111.246124	http://dx.doi.org/10.1074/jbc.M111.246124			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21775438	Green Published, hybrid			2022-12-25	WOS:000294487500026
J	Traver, MK; Henry, SC; Cantillana, V; Oliver, T; Hunn, JP; Howard, JC; Beer, S; Pfeffer, K; Coers, J; Taylor, GA				Traver, Maria K.; Henry, Stanley C.; Cantillana, Viviana; Oliver, Tim; Hunn, Julia P.; Howard, Jonathan C.; Beer, Sandra; Pfeffer, Klaus; Coers, Joern; Taylor, Gregory A.			Immunity-related GTPase M (IRGM) Proteins Influence the Localization of Guanylate-binding Protein 2 (GBP2) by Modulating Macroautophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLY EXPRESSED GTPASE; AUTOPHAGY-DEFICIENT MICE; P47 RESISTANCE GTPASES; INTERFERON-GAMMA; IFN-GAMMA; HOST-RESISTANCE; TOXOPLASMA-GONDII; CELLULAR-RESPONSE; MYCOBACTERIUM-TUBERCULOSIS; INTRACELLULAR PATHOGENS	The immunity-related GTPases (IRGs) are a family of proteins induced by interferon-gamma that play a crucial role in innate resistance to intracellular pathogens. The M subfamily of IRG proteins (IRGM) plays a profound role in this context, in part because of the ability of its members to regulate the localization and expression of other IRG proteins. We present here evidence that IRGM proteins affect the localization of the guanylate-binding proteins (GBPs), a second family of interferon-induced GTP-binding proteins that also function in innate immunity. Absence of Irgm1 or Irgm3 led to accumulation of Gbp2 in intracellular compartments that were positive for both the macroautophagy (hereafter referred to as autophagy) marker LC3 and the autophagic adapter molecule p62/Sqstm1. Gbp2 was similarly relocalized in cells in which autophagy was impaired because of the absence of Atg5. Both in Atg5- and IRGM-deficient cells, the IRG protein Irga6 relocalized to the same compartments as Gbp2, raising the possibility of a common regulatory mechanism. However, other data indicated that Irga6, but not Gbp2, was ubiquitinated in IRGM-deficient cells. Similarly, coimmunoprecipitation studies indicated that although Irgm3 did interact directly with Irgb6, it did not interact with Gbp2. Collectively, these data suggest that IRGM proteins indirectly modulate the localization of GBPs through a distinct mechanism from that through which they regulate IRG protein localization. Further, these results suggest that a core function of IRGM proteins is to regulate autophagic flux, which influences the localization of GBPs and possibly other factors that instruct cell-autonomous immune resistance.	[Traver, Maria K.; Coers, Joern; Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Oliver, Tim] Duke Univ, Med Ctr, Div Geriatr, Durham, NC 27710 USA; [Cantillana, Viviana; Taylor, Gregory A.] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA; [Henry, Stanley C.; Taylor, Gregory A.] VA Med Ctr, Geriatr Res Educ & Clin Ctr, Durham, NC 27705 USA; [Hunn, Julia P.; Howard, Jonathan C.] Univ Cologne, Dept Cell Genet, Inst Genet, D-50674 Cologne, Germany; [Beer, Sandra; Pfeffer, Klaus] Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany; [Beer, Sandra; Pfeffer, Klaus] Univ Dusseldorf, Hosp Hyg, D-40225 Dusseldorf, Germany	Duke University; Duke University; Duke University; Geriatric Research Education & Clinical Center; University of Cologne; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Taylor, GA (corresponding author), 508 Fulton St,Rm N3008, Durham, NC 27705 USA.	gregory.taylor@duke.edu		Howard, Jonathan/0000-0003-2756-5143; Coers, Jorn/0000-0001-8707-4608; Pfeffer, Klaus/0000-0002-5652-6330	NIAID NIH HHS [R01 AI057831] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057831] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boehm U, 1998, J IMMUNOL, V161, P6715; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; CHENG YSE, 1983, J BIOL CHEM, V258, P7746; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Coers J, 2008, J IMMUNOL, V180, P6237, DOI 10.4049/jimmunol.180.9.6237; Collazo CM, 2002, INFECT IMMUN, V70, P6933, DOI 10.1128/IAI.70.12.6933-6939.2002; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Danino D, 2001, CURR OPIN CELL BIOL, V13, P454, DOI 10.1016/S0955-0674(00)00236-2; de Souza AP, 2003, J PARASITOL, V89, P1237, DOI 10.1645/GE-3185RN; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Feng CG, 2008, CELL STEM CELL, V2, P83, DOI 10.1016/j.stem.2007.10.007; Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Ghosh A, 2004, MOL CELL, V15, P727, DOI 10.1016/j.molcel.2004.07.017; GUPTA SL, 1979, P NATL ACAD SCI USA, V76, P4817, DOI 10.1073/pnas.76.10.4817; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Halonen SK, 2006, J NEUROIMMUNOL, V175, P19, DOI 10.1016/j.jneuroim.2006.02.015; Henry SC, 2007, J IMMUNOL, V179, P6963, DOI 10.4049/jimmunol.179.10.6963; Henry SC, 2009, J LEUKOCYTE BIOL, V85, P877, DOI 10.1189/jlb.1008599; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Jacobson AD, 2009, J BIOL CHEM, V284, P35485, DOI 10.1074/jbc.M109.052928; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Khaminets A, 2010, CELL MICROBIOL, V12, P939, DOI 10.1111/j.1462-5822.2010.01443.x; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kota RS, 2006, BIOCHEM BIOPH RES CO, V342, P1137, DOI 10.1016/j.bbrc.2006.02.087; Kresse A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-158; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Martens S, 2004, J IMMUNOL, V173, P2594, DOI 10.4049/jimmunol.173.4.2594; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Taylor GA, 1997, J BIOL CHEM, V272, P10639; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; Taylor GA, 1996, J BIOL CHEM, V271, P20399, DOI 10.1074/jbc.271.34.20399; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200; Vestal DJ, 2000, J INTERF CYTOK RES, V20, P991, DOI 10.1089/10799900050198435; Vignola MJ, 2010, J BIOL CHEM, V285, P21625, DOI 10.1074/jbc.M110.103010; Waguri S, 2009, METHOD ENZYMOL, V453, P181, DOI 10.1016/S0076-6879(08)04009-3; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	58	57	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30471	30480		10.1074/jbc.M111.251967	http://dx.doi.org/10.1074/jbc.M111.251967			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757726	Green Published, hybrid			2022-12-25	WOS:000294283600026
J	Tranter, M; Helsley, RN; Paulding, WR; McGuinness, M; Brokamp, C; Haar, L; Liu, Y; Ren, XP; Jones, WK				Tranter, Michael; Helsley, Robert N.; Paulding, Waltke R.; McGuinness, Michael; Brokamp, Cole; Haar, Lauren; Liu, Yong; Ren, Xiaoping; Jones, W. Keith			Coordinated Post-transcriptional Regulation of Hsp70.3 Gene Expression by MicroRNA and Alternative Polyadenylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MESSENGER-RNA POLYADENYLATION; MYOCARDIAL-ISCHEMIA; STRESS-PROTEIN; HEAT-STRESS; INJURY; COX-2; TRANSCRIPTION; TRANSLATION; REPERFUSION	Heat shock protein 70 (Hsp70) is well documented to possess general cytoprotective properties in protecting the cell against stressful and noxious stimuli. We have recently shown that expression of the stress-inducible Hsp70.3 gene in the myocardium in response to ischemic preconditioning is NF-kappa B-dependent and necessary for the resulting late phase cardioprotection against a subsequent ischemia/reperfusion injury. Here we show that the Hsp70.3 gene product is subject to post-transcriptional regulation through parallel regulatory processes involving microRNAs and alternative polyadenylation of the mRNA transcript. First, we show that cardiac ischemic preconditioning of the in vivo mouse heart results in decreased levels of two Hsp70.3-targeting microRNAs: miR-378* and miR-711. Furthermore, an ischemic or heat shock stimulus induces alternative polyadenylation of the expressed Hsp70.3 transcript that results in the accumulation of transcripts with a shortened 3'-UTR. This shortening of the 3'-UTR results in the loss of the binding site for the suppressive miR-378* and thus renders the alternatively polyadenylated transcript insusceptible to miR-378*-mediated suppression. Results also suggest that the alternative polyadenylation-mediated shortening of the Hsp70.3 3'-UTR relieves translational suppression observed in the long 3'-UTR variant, allowing for a more robust increase in protein expression. These results demonstrate alternative polyadenylation of Hsp70.3 in parallel with ischemic or heat shock-induced up-regulation of mRNA levels and implicate the importance of this process in post-transcriptional control of Hsp70.3 expression.	[Tranter, Michael; Helsley, Robert N.; Paulding, Waltke R.; McGuinness, Michael; Brokamp, Cole; Haar, Lauren; Liu, Yong; Ren, Xiaoping; Jones, W. Keith] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA; [Paulding, Waltke R.] Xavier Univ, Dept Biol, Cincinnati, OH 45207 USA	University System of Ohio; University of Cincinnati; Xavier University	Jones, WK (corresponding author), Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA.	joneswk@uc.edu	Helsley, Robert/AAQ-6032-2021	Helsley, Robert/0000-0001-5000-3187; Tranter, Michael/0000-0002-0609-3717; Brokamp, Cole/0000-0002-0289-3151	National Institutes of Health [HL63034, HL091478, T32 HL007382]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063034, R01HL091478, T32HL007382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL63034 and HL091478 (to W. K. J.).; Supported by National Institutes of Health Grant T32 HL007382 (to A. Schwartz).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bolli R, 2002, CARDIOVASC RES, V55, P506, DOI 10.1016/S0008-6363(02)00414-5; Brown M, 2005, AM J PHYSIOL-HEART C, V289, pH466, DOI 10.1152/ajpheart.00170.2004; CURRIE RW, 1988, CIRC RES, V63, P543, DOI 10.1161/01.RES.63.3.543; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; Dawn B, 2001, J MOL CELL CARDIOL, V33, P161, DOI 10.1006/jmcc.2000.1291; DONNELLY TJ, 1992, CIRCULATION, V85, P769, DOI 10.1161/01.CIR.85.2.769; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hall-Pogar T, 2005, NUCLEIC ACIDS RES, V33, P2565, DOI 10.1093/nar/gki544; Hall-Pogar T, 2007, RNA, V13, P1103, DOI 10.1261/rna.577707; Harper KA, 2008, BIOCHEM SOC T, V36, P543, DOI 10.1042/BST0360543; Lau AG, 2010, P NATL ACAD SCI USA, V107, P15945, DOI 10.1073/pnas.1002929107; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; MARBER MS, 1993, CIRCULATION, V88, P1264, DOI 10.1161/01.CIR.88.3.1264; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; MESTRIL R, 1995, J MOL CELL CARDIOL, V27, P45, DOI 10.1016/S0022-2828(08)80006-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qu XL, 2002, ARCH BIOCHEM BIOPHYS, V400, P233, DOI 10.1016/S0003-9861(02)00016-4; Ren XP, 2004, J SURG RES, V121, P120, DOI 10.1016/j.jss.2004.03.010; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tranter M, 2010, J MOL CELL CARDIOL, V49, P664, DOI 10.1016/j.yjmcc.2010.07.001; Wilhide ME, 2011, J MOL CELL CARDIOL, V51, P82, DOI 10.1016/j.yjmcc.2011.03.011; WURST W, 1993, GENE TARGETING PRACT, P36; Xing HY, 2004, J BIOL CHEM, V279, P10551, DOI 10.1074/jbc.M311719200; Ye YM, 2011, PHYSIOL GENOMICS, V43, P534, DOI 10.1152/physiolgenomics.00130.2010; Yin C, 2009, CIRC RES, V104, P572, DOI 10.1161/CIRCRESAHA.108.193250; Yu MY, 2006, BIOCHEM BIOPH RES CO, V345, P479, DOI 10.1016/j.bbrc.2006.04.113	28	54	56	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29828	29837		10.1074/jbc.M111.221796	http://dx.doi.org/10.1074/jbc.M111.221796			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21757701	Green Published, hybrid			2022-12-25	WOS:000294046600042
J	Tchurikov, NA; Kretova, OV				Tchurikov, Nickolai A.; Kretova, Olga V.			Both piRNA and siRNA Pathways Are Silencing Transcripts of the Suffix Element in the Drosophila melanogaster Germline and Somatic Cells	PLOS ONE			English	Article							MESSENGER-RNA; CUT LOCUS; PIWI; HOMOLOG; PROTEIN; GENE; RETROTRANSPOSON; MATURATION; MECHANISM; AUBERGINE	In the Drosophila melanogaster germline, the piRNA pathway silences retrotransposons as well as other transcribed repetitive elements. Suffix is an unusual short retroelement that was identified both as an actively transcribed repetitive element and also as an element at the 39 ends of the Drosophila non-LTR F element. The copies of suffix that are F element-independent are far more actively transcribed than their counterparts on the F element. We studied the patterns of small RNAs targeting both strands of suffix in Drosophila ovaries using an RNase protection assay and the analysis of the corresponding RNA sequences from the libraries of total small RNAs. Our results indicate that suffix sense and antisense transcripts are targeted mainly by 23-29 nucleotides in length piRNAs and also by 21 nucleotides in length siRNAs. Suffix sense transcripts actively form longer RNA species, corresponding either to partial digestion products of the RNAi and Piwi pathways or to another RNA silencing mechanism. Both sense and antisense suffix transcripts accumulated in the ovaries of homozygous spn-E, piwi and aub mutants. These results provide evidence that suffix sense and antisense transcripts in the germ line and soma are targeted by both RNAi and Piwi pathways and that a Dicer-independent pathway of biogenesis of siRNAs could exist in Drosophila cells.	[Tchurikov, Nickolai A.; Kretova, Olga V.] Russian Acad Sci, Engelhardt Inst Mol Biol, Dept Genome Org, Moscow, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Tchurikov, NA (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Dept Genome Org, Moscow, Russia.	tchurikov@eimb.ru	Tchurikov, Nickolai A./R-4850-2016		Russian Foundation for Basic Research [11-04-00091-a]; CRDF [RUB2-2960-MO-09]; Russian Ministry of Science and Education [16.512.11.2058]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); CRDF; Russian Ministry of Science and Education(Ministry of Education and Science, Russian Federation)	The grant from the Russian Foundation for Basic Research (grant No. 11-04-00091-a); grant from CRDF (grant No. RUB2-2960-MO-09); grant from Russian Ministry of Science and Education (contract No. 16.512.11.2058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANANIEV EV, 1985, ELECT MICROSCOPIC MA; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; DINOCERA PP, 1987, P NATL ACAD SCI USA, V84, P5843; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; Finnegan D J, 1986, Oxf Surv Eukaryot Genes, V3, P1; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; GERASIMOVA TI, 1981, MOL GEN GENET, V184, P544, DOI 10.1007/BF00352537; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; GILLESPIE DE, 1995, GENE DEV, V9, P2495, DOI 10.1101/gad.9.20.2495; Gonzalez-Reyes A, 1997, DEVELOPMENT, V124, P4927; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; Kretova OV, 2002, RUSS J GENET+, V38, P918, DOI 10.1023/A:1016835828099; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; LIM JK, 1983, P NATL ACAD SCI-BIOL, V80, P6624, DOI 10.1073/pnas.80.21.6624; Lin HF, 1997, DEVELOPMENT, V124, P2463; Makunin IV, 1999, MOL GEN GENET, V261, P381, DOI 10.1007/s004380050979; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; PRUDHOMME N, 1995, GENETICS, V139, P697; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; TCHURIKOV NA, 1986, EMBO J, V5, P2341, DOI 10.1002/j.1460-2075.1986.tb04502.x; Tchurikov NA, 2005, BIOCHEMISTRY-MOSCOW+, V70, P406, DOI 10.1007/s10541-005-0131-2; TCHURIKOV NA, 1989, MOL GEN GENET, V219, P241, DOI 10.1007/BF00261183; TCHURIKOV NA, 1980, NUCLEIC ACIDS RES, V8, P1243, DOI 10.1093/nar/8.6.1243; TCHURIKOV NA, 2003, GENETIKA, V39, P300; TCHURIKOV NA, 1998, DOKL AKAD NAUK, V360, P124; TCHURIKOV NA, 1996, CYTOLOGIA GENETIKA, V30, P14; Tchurikov NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000476; Tchurikov NA, 2009, NUCLEIC ACIDS RES, V37, P111, DOI 10.1093/nar/gkn926; Usakin L, 2007, GENETICS, V176, P1343, DOI 10.1534/genetics.107.071720; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zamore PD, 2007, NATURE, V446, P864, DOI 10.1038/446864a	51	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21882	10.1371/journal.pone.0021882	http://dx.doi.org/10.1371/journal.pone.0021882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779345	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811300022
J	Takao, T; Asanoma, K; Kato, K; Fukushima, K; Tsunematsu, R; Hirakawa, T; Matsumura, S; Seki, H; Takeda, S; Wake, N				Takao, Tomoka; Asanoma, Kazuo; Kato, Kiyoko; Fukushima, Kotaro; Tsunematsu, Ryosuke; Hirakawa, Toshio; Matsumura, Sueo; Seki, Hiroyuki; Takeda, Satoru; Wake, Norio			Isolation and Characterization of Human Trophoblast Side-Population (SP) Cells in Primary Villous Cytotrophoblasts and HTR-8/SVneo Cell Line	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; GROWTH-FACTOR-I; EXTRAVILLOUS TROPHOBLAST; HUMAN PLACENTA; DIFFERENTIATION; EXPRESSION; RECEPTOR; GENE; ANTIBODY; PATHWAY	Recently, numerous studies have identified that immature cell populations including stem cells and progenitor cells can be found among "side-population'' (SP) cells. Although SP cells isolated from some adult tissues have been reported elsewhere, isolation and characterization of human trophoblast SP remained to be reported. In this study, HTR-8/SVneo cells and human primary villous cytotrophoblasts (vCTBs) were stained with Hoechst 33342 and SP and non-SP (NSP) fractions were isolated using a cell sorter. A small population of SP cells was identified in HTR-8/SVneo cells and in vCTBs. SP cells expressed several vCTB-specific markers and failed to express syncytiotrophoblast (STB) or extravillous cytotrophopblast (EVT)-specific differentiation markers. SP cells formed colonies and proliferated on mouse embryonic fibroblast (MEF) feeder cells or in MEF conditioned medium supplemented with heparin/FGF2, and they also showed long-term repopulating property. SP cells could differentiate into both STB and EVT cell lineages and expressed several differentiation markers. Microarray analysis revealed that IL7R and IL1R2 were exclusively expressed in SP cells and not in NSP cells. vCTB cells sorted as positive for both IL7R and IL1R2 failed to express trophoblast differentiation markers and spontaneously differentiated into both STB and EVT in basal medium. These features shown by the SP cells suggested that IL7R and IL1R2 are available as markers to detect the SP cells and that vCTB progenitor cells and trophoblast stem cells were involved in the SP cell population.	[Takao, Tomoka; Asanoma, Kazuo; Fukushima, Kotaro; Tsunematsu, Ryosuke; Wake, Norio] Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Higashi Ku, Fukuoka 812, Japan; [Kato, Kiyoko; Takeda, Satoru] Juntendo Univ, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo, Japan; [Hirakawa, Toshio] Sanada Womens Clin, Higashi Ku, Fukuoka, Japan; [Matsumura, Sueo] Univ Hyogo, Fac Hlth Sci, Dept Nutr Management, Kakogawa, Hyogo, Japan; [Seki, Hiroyuki] Saitama Med Univ, Saitama Med Ctr, Dept Obstet & Gynecol, Kawagoe, Saitama, Japan	Kyushu University; Juntendo University; University of Hyogo; Saitama Medical University	Takao, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Higashi Ku, Fukuoka 812, Japan.	asanoma@med.kyushu-u.ac.jp	Takao, Tomoka/K-1568-2015	Takeda, Satoru/0000-0001-9547-1435; Takao, Tomoka/0000-0002-6519-2301	Japanese Ministry of Education, Culture, Sports, Science and Technology (Japan) [20390435, 21659385]	Japanese Ministry of Education, Culture, Sports, Science and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid 20390435 and 21659385 from the Japanese Ministry of Education, Culture, Sports, Science and Technology (Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Alvi AJ, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr563; Aplin JD, 1999, BIOL REPROD, V60, P828, DOI 10.1095/biolreprod60.4.828; Baczyk D, 2006, PLACENTA, V27, P367, DOI 10.1016/j.placenta.2005.03.006; Bilban M, 2010, PLACENTA, V31, P989, DOI 10.1016/j.placenta.2010.08.011; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Blaschitz A, 2000, PLACENTA, V21, P733, DOI 10.1053/plac.2000.0559; Castrechini NM, 2010, PLACENTA, V31, P203, DOI 10.1016/j.placenta.2009.12.006; CAULFIELD JJ, 1992, J REPROD IMMUNOL, V21, P71, DOI 10.1016/0165-0378(92)90041-2; Chai N, 1998, DEV BIOL, V198, P105, DOI 10.1016/S0012-1606(98)80031-6; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; DAMSKY CH, 1992, J CLIN INVEST, V89, P210, DOI 10.1172/JCI115565; Das P, 2007, STEM CELL RES, V1, P61, DOI 10.1016/j.scr.2007.09.004; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; ELLIS SA, 1990, J IMMUNOL, V144, P731; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; FILLA MS, 1993, CELL GROWTH DIFFER, V4, P387; Forbes K, 2008, AM J PHYSIOL-CELL PH, V294, pC1313, DOI 10.1152/ajpcell.00035.2008; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; GRAHAM CH, 1992, BIOL REPROD, V46, P561, DOI 10.1095/biolreprod46.4.561; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Harun R, 2006, HUM REPROD, V21, P1349, DOI 10.1093/humrep/del017; Hemberger M, 2010, HUM MOL GENET, V19, P2456, DOI 10.1093/hmg/ddq128; Hirano T, 1999, MOL HUM REPROD, V5, P162, DOI 10.1093/molehr/5.2.162; IRVING JA, 1995, PLACENTA, V16, P413, DOI 10.1016/0143-4004(95)90100-0; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; James JL, 2007, HUM REPROD, V22, P2111, DOI 10.1093/humrep/dem144; Janatpour MJ, 2000, DEVELOPMENT, V127, P549; JONES CJP, 1991, ELECTRON MICROSC REV, V4, P129, DOI 10.1016/0892-0354(91)90019-9; Kabir-Salmani M, 2003, ENDOCRINOLOGY, V144, P1620, DOI 10.1210/en.2002-220886; Kato H, 2006, J REPROD MED, V51, P861; Kato K, 2007, HUM REPROD, V22, P1214, DOI 10.1093/humrep/del514; Kishino M, 1996, KIDNEY INT, V49, P1350, DOI 10.1038/ki.1996.191; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; Larderet G, 2006, STEM CELLS, V24, P965, DOI 10.1634/stemcells.2005-0196; Lassalle B, 2004, DEVELOPMENT, V131, P479, DOI 10.1242/dev.00918; Lewis MP, 1996, PLACENTA, V17, P137, DOI 10.1016/S0143-4004(96)80006-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maldonado-Estrada J, 2004, J IMMUNOL METHODS, V286, P21, DOI 10.1016/j.jim.2003.03.001; Manyonda IT, 2001, PLACENTA, V22, P262, DOI 10.1053/plac.2000.0600; MARUO T, 1992, J CLIN ENDOCR METAB, V75, P1362, DOI 10.1210/jcem.75.5.1430098; Maruo T, 1995, Early Pregnancy, V1, P54; Mayhew TM, 2001, HISTOL HISTOPATHOL, V16, P1213, DOI 10.14670/HH-16.1213; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; MOORE KL, 1993, PLACENTA FETAL MEMBR, P94; Morrish DW, 1997, PLACENTA, V18, P577, DOI 10.1016/0143-4004(77)90013-3; Muhlhauser J, 1996, CELL TISSUE RES, V285, P101, DOI 10.1007/s004410050625; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; Palmer MJ, 2008, CELL MOL IMMUNOL, V5, P79, DOI 10.1038/cmi.2008.10; Petroff MG, 2006, METH MOLEC MED, V121, P203; Rossant J, 2001, STEM CELLS, V19, P477, DOI 10.1634/stemcells.19-6-477; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Sacks GP, 2001, PLACENTA, V22, P550, DOI 10.1053/plac.2001.0686; Saito S, 1997, BIOCHEM BIOPH RES CO, V231, P429, DOI 10.1006/bbrc.1997.6121; SASAGAWA M, 1987, PLACENTA, V8, P515, DOI 10.1016/0143-4004(87)90080-4; Saxena A, 2003, PLACENTA, V24, P835, DOI 10.1016/S0143-4004(03)00130-9; Schugar RC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/789526; SCHULZ LC, 2008, PLACENTA SA, V29; Shimano K, 2003, AM J PATHOL, V163, P3, DOI 10.1016/S0002-9440(10)63624-3; SHORTER SC, 1993, PLACENTA, V14, P571, DOI 10.1016/S0143-4004(05)80210-3; Summer R, 2003, AM J PHYSIOL-LUNG C, V285, pL97, DOI 10.1152/ajplung.00009.2003; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tripathi V, 2009, J CLIN IMMUNOL, V29, P379, DOI 10.1007/s10875-008-9258-4; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	69	57	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21990	10.1371/journal.pone.0021990	http://dx.doi.org/10.1371/journal.pone.0021990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760941	gold, Green Published, Green Submitted			2022-12-25	WOS:000292655400036
J	Alameda, JP; Moreno-Maldonado, R; Fernandez-Acenero, MJ; Navarro, M; Page, A; Jorcano, JL; Bravo, A; Ramirez, A; Casanova, ML				Alameda, Josefa P.; Moreno-Maldonado, Rodolfo; Jesus Fernandez-Acenero, M.; Navarro, Manuel; Page, Angustias; Jorcano, Jose L.; Bravo, Ana; Ramirez, Angel; Llanos Casanova, M.			Increased IKK alpha Expression in the Basal Layer of the Epidermis of Transgenic Mice Enhances the Malignant Potential of Skin Tumors	PLOS ONE			English	Article							KAPPA-B-KINASE; TISSUE MICROARRAY ANALYSIS; DEPENDENT GENE-EXPRESSION; NUCLEAR MASPIN EXPRESSION; SQUAMOUS-CELL CARCINOMAS; BREAST-CANCER; ALPHA-6-BETA-4 INTEGRIN; COLORECTAL-CANCER; TWIST EXPRESSION; METASTASIS	Non-melanoma skin cancer is the most frequent type of cancer in humans. In this study we demonstrate that elevated IKK alpha expression in murine epidermis increases the malignancy potential of skin tumors. We describe the generation of transgenic mice overexpressing IKK alpha in the basal, proliferative layer of the epidermis and in the outer root sheath of hair follicles. The epidermis of K5-IKK alpha transgenic animals shows several alterations such as hyperproliferation, mislocalized expression of integrin-alpha 6 and downregulation of the tumor suppressor maspin. Treatment of the back skin of mice with the mitogenic agent 12-O-tetradecanoylphorbol-13-acetate causes in transgenic mice the appearance of different preneoplastic changes such as epidermal atypia with loss of cell polarity and altered epidermal tissue architecture, while in wild type littermates this treatment only leads to the development of benign epidermal hyperplasia. Moreover, in skin carcinogenesis assays, transgenic mice carrying active Ha-ras (K5-IKK alpha-Tg.AC mice) develop invasive tumors, instead of the benign papillomas arising in wild type-Tg-AC mice also bearing an active Ha-ras. Therefore we provide evidence for a tumor promoter role of IKK alpha in skin cancer, similarly to what occurs in other neoplasias, including hepatocarcinomas and breast, prostate and colorectal cancer. The altered expression of cyclin D1, maspin and integrin-alpha 6 in skin of transgenic mice provides, at least in part, the molecular bases for the increased malignant potential found in the K5-IKK alpha skin tumors.	[Alameda, Josefa P.; Moreno-Maldonado, Rodolfo; Navarro, Manuel; Page, Angustias; Jorcano, Jose L.; Ramirez, Angel; Llanos Casanova, M.] CIEMAT, Div Epithelial Biomed, E-28040 Madrid, Spain; [Jesus Fernandez-Acenero, M.] Fdn Jimenez Diaz, Dept Pathol, E-28040 Madrid, Spain; [Bravo, Ana] Univ Santiago de Compostela, Fac Vet, Dept Vet Clin Sci, Lugo, Spain	Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Universidade de Santiago de Compostela	Alameda, JP (corresponding author), CIEMAT, Div Epithelial Biomed, E-28040 Madrid, Spain.	llanos.casanova@ciemat.es	Moral, Ana María Bravo/AAD-3339-2021; Ramirez, Angel/A-4800-2018; Navarro, Manuel/S-1496-2019; Aceñero, M Jesús Fernández/ABC-5904-2020	Moral, Ana María Bravo/0000-0002-5282-8921; Ramirez, Angel/0000-0001-7745-5108; Navarro, Manuel/0000-0003-1118-8531; Aceñero, M Jesús Fernández/0000-0002-2439-3553; Page, Angustias/0000-0002-0231-8536; Casanova, M. Llanos/0000-0001-7742-8265	Ministerio de Ciencia e Innovacion [PI10/01480, SAF2010-22156]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was funded by grants from the Ministerio de Ciencia e Innovacion (PI10/01480, SAF2010-22156) to MLC and AR respectively. The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2003, J UROLOGY, V169, P1157, DOI 10.1097/01.ju.0000040245.70349.37; Alameda JP, 2010, ONCOGENE, V29, P6522, DOI 10.1038/onc.2010.378; Albanese C, 2003, MOL BIOL CELL, V14, P585, DOI 10.1091/mbc.02-06-0101; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bailey CM, 2006, J CELL PHYSIOL, V209, P617, DOI 10.1002/jcp.20782; BALMAIN A, 1983, NATURE, V303, P72, DOI 10.1038/303072a0; Boltze C, 2005, PATHOL RES PRACT, V200, P783, DOI 10.1016/j.prp.2004.10.004; Brown K, 1998, CURR BIOL, V8, P516, DOI 10.1016/S0960-9822(98)70203-9; Cao DF, 2007, MODERN PATHOL, V20, P570, DOI 10.1038/modpathol.3800772; Casanova ML, 2004, FASEB J, V18, P1556, DOI 10.1096/fj.04-1683fje; Casanova ML, 2002, CANCER RES, V62, P3402; Charalambous MP, 2009, BRIT J CANCER, V101, P106, DOI 10.1038/sj.bjc.6605120; Chua I, 2009, J AM ACAD DERMATOL, V60, P758, DOI 10.1016/j.jaad.2009.01.018; DeBusk LM, 2008, CANCER RES, V68, P10223, DOI 10.1158/0008-5472.CAN-08-1833; Dietmaier W, 2006, INT J CANCER, V118, P2247, DOI 10.1002/ijc.21620; Fernandez-Majada V, 2007, P NATL ACAD SCI USA, V104, P276, DOI 10.1073/pnas.0606476104; Futscher BW, 2004, NEOPLASIA, V6, P380, DOI 10.1593/neo.04115; Gareus R, 2007, NAT CELL BIOL, V9, P461, DOI 10.1038/ncb1560; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Jiang RQ, 2010, INT J CANCER, V126, P1263, DOI 10.1002/ijc.24854; Jost M, 2000, EUR J DERMATOL, V10, P505; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Khalkhali-Ellis Z, 2006, CLIN CANCER RES, V12, P7279, DOI 10.1158/1078-0432.CCR-06-1589; Lamberti C, 2001, J BIOL CHEM, V276, P42276, DOI 10.1074/jbc.M104227200; LEDER A, 1990, P NATL ACAD SCI USA, V87, P9178, DOI 10.1073/pnas.87.23.9178; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Liu BG, 2008, CANCER CELL, V14, P212, DOI 10.1016/j.ccr.2008.07.017; Liu BG, 2006, P NATL ACAD SCI USA, V103, P17202, DOI 10.1073/pnas.0604481103; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; MAHATO R, 2010, PHARM RES; Marinari B, 2008, P NATL ACAD SCI USA, V105, P17091, DOI 10.1073/pnas.0809288105; Marioni G, 2005, HISTOPATHOLOGY, V46, P576, DOI 10.1111/j.1365-2559.2005.02141.x; Merkhofer EC, 2010, ONCOGENE, V29, P1238, DOI 10.1038/onc.2009.410; Moreno-Maldonado R, 2008, CELL CYCLE, V7, P2021, DOI 10.4161/cc.7.13.6147; O'Donnell JD, 2010, GYNECOL ONCOL, V116, P262, DOI 10.1016/j.ygyno.2009.10.052; Ohuchida K, 2007, INT J CANCER, V120, P1634, DOI 10.1002/ijc.22295; Owens DM, 2003, J CELL SCI, V116, P3783, DOI 10.1242/jcs.00725; Park E, 2007, CANCER RES, V67, P9158, DOI 10.1158/0008-5472.CAN-07-0590; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; Rikimaru K, 1997, EXP DERMATOL, V6, P214, DOI 10.1111/j.1600-0625.1997.tb00165.x; Shi HY, 2001, CANCER RES, V61, P6945; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Stark AM, 2010, NEUROL RES, V32, P303, DOI 10.1179/016164109X12518779082192; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; TENNENBAUM T, 1993, CANCER RES, V53, P4803; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; WINTER H, 1990, DIFFERENTIATION, V43, P105, DOI 10.1111/j.1432-0436.1990.tb00436.x; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yoshizawa K, 2009, J ORAL PATHOL MED, V38, P535, DOI 10.1111/j.1600-0714.2009.00762.x; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; Zhang Z, 2007, HUM PATHOL, V38, P598, DOI 10.1016/j.humpath.2006.10.004; Zheng HC, 2008, APPL IMMUNOHISTO M M, V16, P459, DOI 10.1097/PAI.0b013e3181640bb1	63	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21984	10.1371/journal.pone.0021984	http://dx.doi.org/10.1371/journal.pone.0021984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755017	Green Published, Green Submitted, gold			2022-12-25	WOS:000292632000044
J	Xu, Y; Seven, A; Su, LJ; Jiang, QX; Rizo, J				Xu, Yi; Seven, Alpay; Su, Lijing; Jiang, Qiu-Xing; Rizo, Josep			Membrane Bridging and Hemifusion by Denaturated Munc18	PLOS ONE			English	Article							SNARE COMPLEX; 3-DIMENSIONAL STRUCTURE; CONFORMATIONAL SWITCH; PHOSPHOLIPID-VESICLES; CRYSTAL-STRUCTURE; FUSION ASSAY; BINDING; PROTEIN; SYNTAXIN; DOMAIN	Neuronal Munc18-1 and members of the Sec1/Munc18 (SM) protein family play a critical function(s) in intracellular membrane fusion together with SNARE proteins, but the mechanism of action of SM proteins remains highly enigmatic. During experiments designed to address this question employing a 7-nitrobenz-2-oxa-1,3-diazole (NBD) fluorescence dequenching assay that is widely used to study lipid mixing between reconstituted proteoliposomes, we observed that Munc18-1 from squid (sMunc18-1) was able to increase the apparent NBD fluorescence emission intensity even in the absence of SNARE proteins. Fluorescence emission scans and dynamic light scattering experiments show that this phenomenon arises at least in part from increased light scattering due to sMunc18-1-induced liposome clustering. Nuclear magnetic resonance and circular dichroism data suggest that, although native sMunc18-1 does not bind significantly to lipids, sMunc18-1 denaturation at 37 degrees C leads to insertion into membranes. The liposome clustering activity of sMunc18-1 can thus be attributed to its ability to bridge two membranes upon (perhaps partial) denaturation; correspondingly, this activity is hindered by addition of glycerol. Cryo-electron microscopy shows that liposome clusters induced by sMunc18-1 include extended interfaces where the bilayers of two liposomes come into very close proximity, and clear hemifusion diaphragms. Although the physiological relevance of our results is uncertain, they emphasize the necessity of complementing fluorescence de-quenching assays with alternative experiments in studies of membrane fusion, as well as the importance of considering the potential effects of protein denaturation. In addition, our data suggest a novel mechanism of membrane hemifusion induced by amphipathic macromolecules that does not involve formation of a stalk intermediate.	[Xu, Yi; Seven, Alpay; Su, Lijing; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Xu, Yi; Seven, Alpay; Su, Lijing; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Jiang, Qiu-Xing] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Xu, Y (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	jose@arnie.swmed.edu	Jiang, Qiu-Xing/ABF-1143-2021; Jiang, Qiu-Xing/AAI-8579-2020		Human Frontiers Science Program [RGP0035/2007-C]; Welch Foundation [I-1304]; National Institutes of Health [NS37200]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037200] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Human Frontiers Science Program (RGP0035/2007-C), Welch Foundation (I-1304), and the National Institutes of Health (NS37200) (to JR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arac D, 2003, BIOCHEMISTRY-US, V42, P2774, DOI 10.1021/bi0272050; Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Bowen ME, 2004, BIOPHYS J, V87, P3569, DOI 10.1529/biophysj.104.048637; Bracher A, 2000, STRUCTURE, V8, P685, DOI 10.1016/S0969-2126(00)00156-8; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Chan YHM, 2009, P NATL ACAD SCI USA, V106, P979, DOI 10.1073/pnas.0812356106; Chen XC, 2006, BIOPHYS J, V90, P2062, DOI 10.1529/biophysj.105.071415; Chen XC, 2008, J BIOMOL NMR, V41, P43, DOI 10.1007/s10858-008-9239-1; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Diao JJ, 2010, ACS CHEM NEUROSCI, V1, P168, DOI 10.1021/cn900034p; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Grote E, 2000, J CELL BIOL, V151, P439, DOI 10.1083/jcb.151.2.439; Guan R, 2008, BIOCHEMISTRY-US, V47, P1474, DOI 10.1021/bi702345m; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hu K, 2002, NATURE, V415, P646, DOI 10.1038/415646a; Hughson FM, 2009, ANNU REV CELL DEV BI; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Ji H, 2010, BIOPHYS J, V99, P553, DOI 10.1016/j.bpj.2010.04.060; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; KIM J, 1986, BIOCHEMISTRY-US, V25, P7867, DOI 10.1021/bi00372a012; Kweon DH, 2003, NAT STRUCT BIOL, V10, P440, DOI 10.1038/nsb928; Li LY, 2006, J BIOL CHEM, V281, P15845, DOI 10.1074/jbc.M600888200; Liu TT, 2005, BIOPHYS J, V89, P2458, DOI 10.1529/biophysj.105.062539; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Pei JM, 2009, J MOL BIOL, V391, P509, DOI 10.1016/j.jmb.2009.06.054; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Rodkey TL, 2008, MOL BIOL CELL, V19, P5422, DOI 10.1091/mbc.E08-05-0538; Scott BL, 2003, METHOD ENZYMOL, V372, P274; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tareste David, 2008, Proc Natl Acad Sci U S A, V105, P2380, DOI 10.1073/pnas.0712125105; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508; ZIMMERBERG J, 1993, ANNU REV BIOPH BIOM, V22, P433, DOI 10.1146/annurev.bb.22.060193.002245	55	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e22012	10.1371/journal.pone.0022012	http://dx.doi.org/10.1371/journal.pone.0022012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21765933	Green Submitted, gold, Green Published			2022-12-25	WOS:000292632000046
J	Darlington, Y; Nguyen, TA; Moon, SH; Herron, A; Rao, P; Zhu, C; Lu, X; Donehower, LA				Darlington, Y.; Nguyen, T-A; Moon, S-H; Herron, A.; Rao, P.; Zhu, C.; Lu, X.; Donehower, L. A.			Absence of Wip1 partially rescues Atm deficiency phenotypes in mice	ONCOGENE			English	Article						WIP1; PPM1D; ATM; ataxia telangiectasia; p53; thymic lymphoma	DNA-DAMAGE RESPONSE; ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; TUMOR-SUPPRESSOR; PHOSPHATASE; PPM1D; CELLS; P53; IDENTIFICATION; TUMORIGENESIS	Wild-type p53-induced phosphatase 1 (WIP1) is a serine/threonine phosphatase that dephosphorylates proteins in the ataxia telangiectasia mutated (ATM)-initiated DNA damage response pathway. WIP1 may have a homeostatic role in ATM signaling by returning the cell to a normal pre-stress state following completion of DNA repair. To better understand the effects of WIP1 on ATM signaling, we crossed Atm-deficient mice to Wip1-deficient mice and characterized phenotypes of the double knockout progeny. We hypothesized that the absence of Wip1 might rescue Atm deficiency phenotypes. Atm null mice, like ATM-deficient humans with the inherited syndrome ataxia telangiectasia, exhibit radiation sensitivity, fertility defects, and are T-cell lymphoma prone. Most double knockout mice were largely protected from lymphoma development and had a greatly extended lifespan compared with Atm null mice. Double knockout mice had increased p53 and H2AX phosphorylation and p21 expression compared with their Atm null counterparts, indicating enhanced p53 and DNA damage responses. Additionally, double knockout splenocytes displayed reduced chromosomal instability compared with Atm null mice. Finally, doubly null mice were partially rescued from gametogenesis defects observed in Atm null mice. These results indicate that inhibition of WIP1 may represent a useful strategy for cancer treatment in general and A-T patients in particular. Oncogene (2012) 31, 1155-1165; doi:10.1038/onc.2011.303; published online 18 July 2011	[Darlington, Y.; Nguyen, T-A; Moon, S-H; Donehower, L. A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Darlington, Y.; Nguyen, T-A; Donehower, L. A.] Interdept Grad Program Cell & Mol Biol, Houston, TX USA; [Moon, S-H; Donehower, L. A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Herron, A.] Dept Pathol & Immunol, Houston, TX USA; [Herron, A.] Ctr Comparat Med, Houston, TX USA; [Rao, P.; Donehower, L. A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Zhu, C.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Lu, X.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Donehower, LA (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza, Houston, TX 77030 USA.	larryd@bcm.tmc.edu	Nguyen, Thuy-Ai/Q-4082-2019	Nguyen, Thuy-Ai/0000-0001-8778-0078	NIH [R01 CA100420, R01 CA136549]; DOD [BC050781]; NATIONAL CANCER INSTITUTE [R01CA100420, R01CA136549] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Corrine Spencer and Yi- Jue Zhao for technical assistance. This work was supported by NIH grants (R01 CA100420) to LAD and (R01 CA136549) to XL, and a DOD Breast Cancer Research Program Predoctoral Traineeship Award (BC050781) to T-AN	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Belova GI, 2005, CANCER BIOL THER, V4, P1154, DOI 10.4161/cbt.4.10.2204; Borghesani PR, 2000, P NATL ACAD SCI USA, V97, P3336, DOI 10.1073/pnas.050584897; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Castellino RC, 2008, J NEURO-ONCOL, V86, P245, DOI 10.1007/s11060-007-9470-8; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; Chun HH, 2004, DNA REPAIR, V3, P1187, DOI 10.1016/j.dnarep.2004.04.010; Demidov ON, 2007, CELL STEM CELL, V1, P180, DOI 10.1016/j.stem.2007.05.020; Ehrbrecht A, 2006, J PATHOL, V208, P554, DOI 10.1002/path.1925; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Gurley KE, 2001, CURR BIOL, V11, P191, DOI 10.1016/S0960-9822(01)00048-3; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Harrison M, 2004, TRENDS MOL MED, V10, P359, DOI 10.1016/j.molmed.2004.06.010; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Le Guezennec X, 2010, TRENDS BIOCHEM SCI, V35, P109, DOI 10.1016/j.tibs.2009.09.005; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; Loukopoulos P, 2007, CANCER SCI, V98, P392, DOI 10.1111/j.1349-7006.2007.00395.x; Lu XB, 2005, CELL CYCLE, V4, P1060; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Macurek L, 2010, ONCOGENE, V29, P2281, DOI 10.1038/onc.2009.501; Moon SH, 2010, J BIOL CHEM, V285, P12935, DOI 10.1074/jbc.M109.071696; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Nannenga B, 2006, MOL CARCINOGEN, V45, P594, DOI 10.1002/mc.20195; Rao PH, 1998, BLOOD, V92, P1743; Rayter S, 2008, ONCOGENE, V27, P1036, DOI 10.1038/sj.onc.1210729; Rotman G, 1998, HUM MOL GENET, V7, P1555, DOI 10.1093/hmg/7.10.1555; Saito-Ohara F, 2003, CANCER RES, V63, P1876; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; Sedgwick R, 1991, HDB CLIN NEUROLOGY, P347; Shen KC, 2005, CANCER RES, V65, P8747, DOI 10.1158/0008-5472.CAN-05-1471; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Shreeram S, 2006, J EXP MED, V203, P2793, DOI 10.1084/jem.20061563; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Tan DSP, 2009, CLIN CANCER RES, V15, P2269, DOI 10.1158/1078-0432.CCR-08-2403; Westphal CH, 1997, NAT GENET, V16, P397, DOI 10.1038/ng0897-397; Williamson CT, 2010, MOL CANCER THER, V9, P347, DOI 10.1158/1535-7163.MCT-09-0872; Xia Y, 2009, J BIOL CHEM, V284, P17428, DOI 10.1074/jbc.M109.007823; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yamaguchi H, 2006, BIOCHEMISTRY-US, V45, P13193, DOI 10.1021/bi061356b; Yoda A, 2008, J BIOL CHEM, V283, P18969, DOI 10.1074/jbc.M800560200	54	10	11	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	9					1155	1165		10.1038/onc.2011.303	http://dx.doi.org/10.1038/onc.2011.303			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	901EW	21765465	Green Accepted			2022-12-25	WOS:000300945900008
J	Garcia-Perez, J; Rueda, P; Alcami, J; Rognan, D; Arenzana-Seisdedos, F; Lagane, B; Kellenberger, E				Garcia-Perez, Javier; Rueda, Patricia; Alcami, Jose; Rognan, Didier; Arenzana-Seisdedos, Fernando; Lagane, Bernard; Kellenberger, Esther			Allosteric Model of Maraviroc Binding to CC Chemokine Receptor 5 (CCR5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SMALL-MOLECULE INHIBITOR; PROTEIN-LIGAND DOCKING; 2ND EXTRACELLULAR LOOP; MONOCLONAL-ANTIBODIES; TRANSMEMBRANE HELIX; HIGHLY POTENT; HIV-INFECTION; ENTRY; ANTAGONISTS	Maraviroc is a nonpeptidic small molecule human immunodeficiency virus type 1 (HIV-1) entry inhibitor that has just entered the therapeutic arsenal for the treatment of patients. We recently demonstrated that maraviroc binding to the HIV-1 coreceptor, CC chemokine receptor 5 (CCR5), prevents it from binding the chemokine CCL3 and the viral envelope glycoprotein gp120 by an allosteric mechanism. However, incomplete knowledge of ligand-binding sites and the lack of CCR5 crystal structures have hampered an in-depth molecular understanding of how the inhibitor works. Here, we addressed these issues by combining site-directed mutagenesis (SDM) with homology modeling and docking. Six crystal structures of G-protein-coupled receptors were compared for their suitability for CCR5 modeling. All CCR5 models had equally good geometry, but that built from the recently reported dimeric structure of the other HIV-1 coreceptor CXCR4 bound to the peptide CVX15 (Protein Data Bank code 3OE0) best agreed with the SDM data and discriminated CCR5 from non-CCR5 binders in a virtual screening approach. SDM and automated docking predicted that maraviroc inserts deeply in CCR5 transmembrane cavity where it can occupy three different binding sites, whereas CCL3 and gp120 lie on distinct yet overlapped regions of the CCR5 extracellular loop 2. Data suggesting that the transmembrane cavity remains accessible for maraviroc in CCL3-bound and gp120-bound CCR5 help explain our previous observation that the inhibitor enhances dissociation of preformed ligand-CCR5 complexes. Finally, we identified residues in the predicted CCR5 dimer interface that are mandatory for gp120 binding, suggesting that receptor dimerization might represent a target for new CCR5 entry inhibitors.	[Garcia-Perez, Javier; Rueda, Patricia; Arenzana-Seisdedos, Fernando; Lagane, Bernard] Inst Pasteur, INSERM U819, F-75724 Paris 15, France; [Garcia-Perez, Javier; Rueda, Patricia; Arenzana-Seisdedos, Fernando; Lagane, Bernard] Inst Pasteur, Unite Pathogenie Virale, F-75724 Paris 15, France; [Garcia-Perez, Javier; Alcami, Jose] Inst Salud Carlos III, Madrid 28220, Spain; [Rognan, Didier; Kellenberger, Esther] Univ Strasbourg UMR7200, F-67400 Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Instituto de Salud Carlos III; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Garcia-Perez, J (corresponding author), Inst Pasteur, INSERM U819, 25 Rue Dr Roux, F-75724 Paris 15, France.	bernard.lagane@pasteur.fr; ekellen@unistra.fr	Kellenberger, Esther/AFN-2081-2022; Rognan, Didier/B-9939-2014; Arenzana-Seisdedos, Fernando/E-5835-2016; Lagane, Bernard/AAA-2205-2019; García-Pérez, Javier/F-9248-2019; Lagane, Bernard/K-8446-2016; Alcami, Pepe/T-2242-2018	Kellenberger, Esther/0000-0002-9320-4840; Lagane, Bernard/0000-0002-3459-7867; García-Pérez, Javier/0000-0001-7551-7803; Alcami, Pepe/0000-0003-0023-7377; Rueda, Patricia/0000-0003-1553-0840	Instituto de Salud Carlos III; Spanish Ministry of Health [FIS PI080752]; AIDS Network ISCIII-RETIC [RD06/0006]; Agence Nationale de Recherche sur le SIDA (ANRS); FIPSE [36633/07]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); AIDS Network ISCIII-RETIC; Agence Nationale de Recherche sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); FIPSE	This work was supported by Instituto de Salud Carlos III, Spanish Ministry of Health Grant FIS PI080752, AIDS Network ISCIII-RETIC Grant RD06/0006, Agence Nationale de Recherche sur le SIDA (ANRS), and FIPSE Grant 36633/07.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Amara A, 2003, J VIROL, V77, P2550, DOI 10.1128/JVI.77.4.2550-2558.2003; Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; Bissantz C, 2004, J CHEM INF COMP SCI, V44, P1162, DOI 10.1021/ci034181a; Blanpain C, 1999, BLOOD, V94, P1899; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Blanpain C, 1999, J BIOL CHEM, V274, P18902, DOI 10.1074/jbc.274.27.18902; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; de Graaf C, 2009, CURR PHARM DESIGN, V15, P4026, DOI 10.2174/138161209789824786; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Garcia-Perez J, 2011, J BIOL CHEM, V286, P4978, DOI 10.1074/jbc.M110.168955; Govaerts C, 2003, J BIOL CHEM, V278, P1892, DOI 10.1074/jbc.M205685200; Govaerts C, 2001, J BIOL CHEM, V276, P13217, DOI 10.1074/jbc.M011670200; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Kellenberger E, 2007, J MED CHEM, V50, P1294, DOI 10.1021/jm061389p; KIM JH, 1995, J BIOL CHEM, V270, P13987, DOI 10.1074/jbc.270.23.13987; Kleinau G, 2010, FASEB J, V24, P2347, DOI 10.1096/fj.09-149146; Kondru R, 2008, MOL PHARMACOL, V73, P789, DOI 10.1124/mol.107.042101; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; Labrecque J, 2011, VIROLOGY, V413, P231, DOI 10.1016/j.virol.2011.02.016; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Maeda K, 2004, J VIROL, V78, P8654, DOI 10.1128/JVI.78.16.8654-8662.2004; Maeda K, 2008, J MOL BIOL, V381, P956, DOI 10.1016/j.jmb.2008.06.041; Marcou G, 2007, J CHEM INF MODEL, V47, P195, DOI 10.1021/ci600342e; Mazna P, 2005, BIOCHEM BIOPH RES CO, V332, P726, DOI 10.1016/j.bbrc.2005.05.017; Muniz-Medina VM, 2009, MOL PHARMACOL, V75, P490, DOI 10.1124/mol.108.052555; Olson WC, 1999, J VIROL, V73, P4145, DOI 10.1128/JVI.73.5.4145-4155.1999; Perez-Nueno VI, 2008, J CHEM INF MODEL, V48, P2146, DOI 10.1021/ci800257x; Philip V, 2011, BIOCHEMISTRY-US, V50, P2939, DOI 10.1021/bi200066k; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Ray Neelanjana, 2009, Drug Des Devel Ther, V2, P151; Ross TM, 1998, J VIROL, V72, P1918, DOI 10.1128/JVI.72.3.1918-1924.1998; Safarian D, 2006, VIROLOGY, V352, P477, DOI 10.1016/j.virol.2006.05.016; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Thompson DAD, 2002, J VIROL, V76, P3059, DOI 10.1128/JVI.76.6.3059-3064.2002; Trkola A, 2001, J VIROL, V75, P579, DOI 10.1128/JVI.75.2.579-588.2001; Tsamis F, 2003, J VIROL, V77, P5201, DOI 10.1128/JVI.77.9.5201-5208.2003; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Wood A, 2005, PROGR MED CHEM, V43, P239, DOI 10.1016/S0079-6468(05)43007-6; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zhang J, 2007, ANTIMICROB AGENTS CH, V51, P1386, DOI 10.1128/AAC.01302-06	49	89	91	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33409	33421		10.1074/jbc.M111.279596	http://dx.doi.org/10.1074/jbc.M111.279596			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21775441	hybrid, Green Published			2022-12-25	WOS:000294968800059
J	Mao, XC; Gluck, N; Chen, BZ; Starokadomskyy, P; Li, HY; Maine, GN; Burstein, E				Mao, Xicheng; Gluck, Nathan; Chen, Baozhi; Starokadomskyy, Petro; Li, Haiying; Maine, Gabriel N.; Burstein, Ezra			COMMD1 (Copper Metabolism MURR1 Domain-containing Protein 1) Regulates Cullin RING Ligases by Preventing CAND1 (Cullin-associated Nedd8-dissociated Protein 1) Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASES; GENE MURR1; COMPLEX; TOXICOSIS; SCF; PROTEOLYSIS; ACTIVATION; PROMOTES; DISEASE; CUL1	Cullin RING ligases (CRLs), the most prolific class of ubiquitin ligase enzymes, are multimeric complexes that regulate a wide range of cellular processes. CRL activity is regulated by CAND1 (Cullin-associated Nedd8-dissociated protein 1), an inhibitor that promotes the dissociation of substrate receptor components from the CRL. We demonstrate here that COMMD1 (copper metabolism MURR1 domain-containing 1), a factor previously found to promote ubiquitination of various substrates, regulates CRL activation by antagonizing CAND1 binding. We show that COMMD1 interacts with multiple Cullins, that the COMMD1-Cul2 complex cannot bind CAND1, and that, conversely, COMMD1 can actively displace CAND1 from CRLs. These findings highlight a novel mechanism of CRL activation and suggest that CRL regulation may underlie the pleiotropic activities of COMMD1.	[Mao, Xicheng; Chen, Baozhi; Starokadomskyy, Petro; Li, Haiying; Maine, Gabriel N.; Burstein, Ezra] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Burstein, Ezra] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Gluck, Nathan; Burstein, Ezra] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Gluck, Nathan] Hebrew Univ Jerusalem, Sch Med, Dept Biochem, IL-91120 Jerusalem, Israel; [Maine, Gabriel N.] William Beaumont Hosp, Dept Clin Pathol, Royal Oak, MI 48073 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan; Hebrew University of Jerusalem; Beaumont Health	Burstein, E (corresponding author), 5323 Harry Hines Blvd,Rm J5-126, Dallas, TX 75390 USA.	ezra.burstein@utsouthwestern.edu	Li, Haiying/B-1879-2012; Burstein, Ezra/B-7247-2016	Burstein, Ezra/0000-0003-4341-6367	National Institutes of Health [R01 DK073639]; Crohn's and Colitis Foundation of America [SRA 2737]; University of Texas Southwestern Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; University of Texas Southwestern Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK073639. This work was also supported by Crohn's and Colitis Foundation of America Grant SRA 2737 and a University of Texas Southwestern Medical Center DOCS Award (to E.B.).	Biasio W, 2004, J BIOL CHEM, V279, P5429, DOI 10.1074/jbc.M311155200; Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Chua YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016071; Coronado VA, 2005, CLIN GENET, V68, P548, DOI 10.1111/j.1399-0004.2005.00524.x; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Drevillon L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018334; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Lee JE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006460; Li H., 2011, ONCOGENE IN PRESS; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Maine GN, 2007, CELL CYCLE, V6, P672, DOI 10.4161/cc.6.6.3989; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Maine Gabriel N, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5318; Mao XC, 2009, GENE DEV, V23, P849, DOI 10.1101/gad.1748409; Muller T, 2003, J HEPATOL, V38, P164, DOI 10.1016/S0168-8278(02)00356-2; Narindrasorasak S, 2007, BIOCHEMISTRY-US, V46, P3116, DOI 10.1021/bi0620656; Patterson Cam, 2002, Sci STKE, V2002, ppe4; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Schmidt MW, 2009, MOL CELL, V35, P586, DOI 10.1016/j.molcel.2009.07.024; Stuehler B, 2004, J MOL MED, V82, P629, DOI 10.1007/s00109-004-0557-9; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; van de Sluis B, 2007, CELL CYCLE, V6, P2091, DOI 10.4161/cc.6.17.4646; van de Sluis B, 2007, MOL CELL BIOL, V27, P4142, DOI 10.1128/MCB.01932-06; van de Sluis B, 2010, J CLIN INVEST, V120, P2119, DOI 10.1172/JCI40583; van de Sluis B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007332; Vonk WIM, 2010, J BIOL CHEM, V285, P28991, DOI 10.1074/jbc.M110.101477; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wilkinson Caroline R. M., 2002, Trends in Cell Biology, V12, P545, DOI 10.1016/S0962-8924(02)02397-8; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	40	29	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32355	32365		10.1074/jbc.M111.278408	http://dx.doi.org/10.1074/jbc.M111.278408			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21778237	Green Published, hybrid			2022-12-25	WOS:000294726800045
J	Ortiz-Ramirez, C; Mora, SI; Trejo, J; Pantoja, O				Ortiz-Ramirez, Carlos; Mora, Silvia I.; Trejo, Jorge; Pantoja, Omar			PvAMT1;1, a Highly Selective Ammonium Transporter That Functions as H+/NH4+ Symporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PLASMA-MEMBRANE; ION-TRANSPORT; RICE ROOTS; NH4+; PROTEINS; AMTB; ARABIDOPSIS; MECHANISMS	One of the main forms of nitrogen assimilated by microorganisms and plants is ammonium, despite its toxicity at low millimolar concentrations. Ammonium absorption has been demonstrated to be carried out by highly selective plasma membrane-located transporters of the AMT/MEP/Rh family and characterized by the presence of a well conserved hydrophobic pore through which ammonia is proposed to move. However, uncertainties exist regarding the exact chemical species transported by these membrane proteins, which can be in the form of either hydrophobic ammonia or charged ammonium. Here, we present the characterization of PvAMT1;1 from the common bean and demonstrate that it mediates the high affinity (micromolar), rapidly saturating (1 mM) electrogenic transport of ammonium. Activity of the transporter is enhanced by low extracellular pH, and associated with this acidic pH stimulation are changes in the reversal potential and cytoplasm acidification, indicating that PvAMT1; 1 functions as an H+/NH4+ symporter. Mutation analysis of a unique histidine present in PvAMT1; 1 (H125R) leads to the stimulation of ammonium transport by decreasing the K-m value by half and by increasing the V-max 3-fold, without affecting the pH dependence of the symporter. In contrast, mutation of the first conserved histidine within the channel modifies the properties of PvAMT1; 1, increasing its K-m and V-max values and transforming it into a pH-independent mechanism.	[Ortiz-Ramirez, Carlos; Mora, Silvia I.; Trejo, Jorge; Pantoja, Omar] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Biol Mol Plantas, Cuernavaca 62250, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Pantoja, O (corresponding author), Apdo Postal 510-3, Cuernavaca 62250, Mor, Mexico.	omar@ibt.unam.mx	Ortiz-Ramirez, Carlos/AAG-3118-2019; Pantoja, Omar/H-5981-2012	Pantoja, Omar/0000-0002-6538-9059; Ortiz-Ramirez, Carlos/0000-0002-5166-1955	Consejo Nacional de Ciencia y Tecnologia-Mexico [42664, 79191]; Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico [IN218308]; DGAPA-Universidad Nacional Autonoma de Mexico	Consejo Nacional de Ciencia y Tecnologia-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); DGAPA-Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	This work was supported in part by Grants 42664 and 79191 from Consejo Nacional de Ciencia y Tecnologia-Mexico and Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico, Grant IN218308 (to O. P.).; Supported by a scholarship from Consejo Nacional de Ciencia y Tecnologia-Mexico.; Recipient of a postdoctoral fellowship from Consejo Nacional de Ciencia y Tecnologia-Mexico and DGAPA-Universidad Nacional Autonoma de Mexico.	Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Bakouh N, 2004, J BIOL CHEM, V279, P15975, DOI 10.1074/jbc.M308528200; Boeckstaens M, 2008, J BIOL CHEM, V283, P21362, DOI 10.1074/jbc.M801467200; Boldt M, 2003, PFLUG ARCH EUR J PHY, V446, P652, DOI 10.1007/s00424-003-1122-z; Boogerd FC, 2011, FEBS LETT, V585, P23, DOI 10.1016/j.febslet.2010.11.055; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; Demidchik V, 2002, PLANT PHYSIOL, V128, P379, DOI 10.1104/pp.010524; Guether M, 2009, PLANT PHYSIOL, V150, P73, DOI 10.1104/pp.109.136390; HILLE B, 1992, IONIC CHANNELS EXCIT, P1; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; Javelle A, 2005, BIOCHEM J, V390, P215, DOI 10.1042/BJ20042094; Javelle A, 2007, J STRUCT BIOL, V158, P472, DOI 10.1016/j.jsb.2007.01.004; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Kronzucker HJ, 1997, NATURE, V385, P59, DOI 10.1038/385059a0; Lamoureux G, 2010, TRANSFUS CLIN BIOL, V17, P168, DOI 10.1016/j.tracli.2010.06.004; Lamoureux G, 2007, BIOPHYS J, V92, pL82, DOI 10.1529/biophysj.106.102756; Lanquar V, 2009, PLANT CELL, V21, P3610, DOI 10.1105/tpc.109.068593; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Ludewig U, 2006, TRANSFUS CLIN BIOL, V13, P111, DOI 10.1016/j.tracli.2006.02.012; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369; Mayer M, 2006, BIOCHEM J, V396, P431, DOI 10.1042/BJ20060051; Moroni A, 1998, J MEMBRANE BIOL, V163, P25, DOI 10.1007/s002329900367; Neuhauser B, 2007, PLANT PHYSIOL, V143, P1651, DOI 10.1104/pp.106.094243; Sogaard R, 2009, PFLUG ARCH EUR J PHY, V458, P733, DOI 10.1007/s00424-009-0665-z; Uehlein N, 2007, PHYTOCHEMISTRY, V68, P122, DOI 10.1016/j.phytochem.2006.09.033; WANG MY, 1994, PLANT PHYSIOL, V104, P899, DOI 10.1104/pp.104.3.899; WANG MY, 1993, PLANT PHYSIOL, V103, P1259, DOI 10.1104/pp.103.4.1463; Wiebe CA, 2001, BIOCHEM J, V357, P1, DOI 10.1042/0264-6021:3570001; Winkler F, 2006, PFLUG ARCH EUR J PHY, V451, P701, DOI 10.1007/s00424-005-1511-6; WIREN NV, 2004, TOP CURR GENET, V9, P1; Wood CC, 2006, FEBS LETT, V580, P3931, DOI 10.1016/j.febslet.2006.06.026; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	35	54	56	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31113	31122		10.1074/jbc.M111.261693	http://dx.doi.org/10.1074/jbc.M111.261693			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757699	Green Published, hybrid			2022-12-25	WOS:000294487500006
J	Tanjore, H; Cheng, DS; Degryse, AL; Zoz, DF; Abdolrasulnia, R; Lawson, WE; Blackwell, TS				Tanjore, Harikrishna; Cheng, Dong-Sheng; Degryse, Amber L.; Zoz, Donald F.; Abdolrasulnia, Rasul; Lawson, William E.; Blackwell, Timothy S.			Alveolar Epithelial Cells Undergo Epithelial-to-Mesenchymal Transition in Response to Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; PROTEIN TRANSLATION; PULMONARY-FIBROSIS; ALPHA-SUBUNIT; APOPTOSIS; KINASE; ACTIVATION; ER; EIF2-ALPHA; INDUCTION	Expression of mutant surfactant protein C (SFTPC) results in endoplasmic reticulum (ER) stress in type II alveolar epithelial cells (AECs). AECs have been implicated as a source of lung fibroblasts via epithelial-to-mesenchymal transition (EMT); therefore, we investigated whether ER stress contributes to EMT as a possible mechanism for fibrotic remodeling. ER stress was induced by tunicamyin administration or stable expression of mutant (L188Q) SFTPC in type II AEC lines. Both tunicamycin treatment and mutant SFTPC expression induced ER stress and the unfolded protein response. With tunicamycin or mutant SFTPC expression, phase contrast imaging revealed a change to a fibroblast-like appearance. During ER stress, expression of epithelial markers E-cadherin and Zonula occludens-1 decreased while expression of mesenchymal markers S100A4 and alpha-smooth muscle actin increased. Following induction of ER stress, we found activation of a number of pathways, including MAPK, Smad, beta-catenin, and Src kinase. Using specific inhibitors, the combination of a Smad2/3 inhibitor (SB431542) and a Src kinase inhibitor (PP2) blocked EMT with maintenance of epithelial appearance and epithelial marker expression. Similar results were noted with siRNA targeting Smad2 and Src kinase. Together, these studies reveal that induction of ER stress leads to EMT in lung epithelial cells, suggesting possible crosstalk between Smad and Src kinase pathways. Dissecting pathways involved in ER stress-induced EMT may lead to new treatment strategies to limit fibrosis.	[Tanjore, Harikrishna; Cheng, Dong-Sheng; Degryse, Amber L.; Zoz, Donald F.; Abdolrasulnia, Rasul; Lawson, William E.; Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Dept Med, Nashville, TN 37232 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Lawson, William E.; Blackwell, Timothy S.] Dept Vet Affairs Med Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Tanjore, H (corresponding author), Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Dept Med, T-1218 MCN, Nashville, TN 37232 USA.	harikrishna.tanjore@vanderbilt.edu			National Institutes of Health, NHBLI [HL85317, HL92870, HL85406, HL87738]; Department of Veterans Affairs; American Lung Association; American Thoracic Society/Coalition of Pulmonary Fibrosis Research; Francis Families Foundation; IPFNet; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL092870, R01HL085317, T32HL087738, K08HL085406] Funding Source: NIH RePORTER	National Institutes of Health, NHBLI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Veterans Affairs(US Department of Veterans Affairs); American Lung Association; American Thoracic Society/Coalition of Pulmonary Fibrosis Research; Francis Families Foundation; IPFNet; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL85317 from the NHBLI (to T.S.B.), HL92870 (to T.S.B.), HL85406 (to W.E.L.), and HL87738 (to A.L.D.) and the Department of Veterans Affairs (to T.S.B. and W.E.L.). This work was also supported by American Lung Association Dalsemer Research Grant (to W.E.L.), American Thoracic Society/Coalition of Pulmonary Fibrosis Research Grant (to H.T.), Francis Families Foundation (to H.T.), IPFNet Cowlin Career Development Award (to A.L.D.).	Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Crossno PF, 2010, CHEST, V137, P969, DOI 10.1378/chest.09-0790; Garamszegi N, 2010, ONCOGENE, V29, P2368, DOI 10.1038/onc.2009.514; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hitomi J, 2004, NEUROSCI LETT, V357, P127, DOI 10.1016/j.neulet.2003.12.080; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Lawson WE, 2005, AM J RESP CRIT CARE, V171, P899, DOI 10.1164/rccm.200311-1535OC; Lawson WE, 2008, AM J PHYSIOL-LUNG C, V294, pL1119, DOI 10.1152/ajplung.00382.2007; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lei S, 2004, J BIOL CHEM, V279, P42492, DOI 10.1074/jbc.M404025200; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Luo S, 2002, BIOCHEM J, V366, P787, DOI 10.1042/BJ20011802; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mulugeta S, 2005, AM J RESP CELL MOL, V32, P521, DOI 10.1165/rcmb.2005-0009OC; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Pallet N, 2008, AM J TRANSPLANT, V8, P2283, DOI 10.1111/j.1600-6143.2008.02396.x; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Ulianich L, 2008, J CELL SCI, V121, P477, DOI 10.1242/jcs.017202; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	40	165	174	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30972	30980		10.1074/jbc.M110.181164	http://dx.doi.org/10.1074/jbc.M110.181164			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757695	Green Published, hybrid			2022-12-25	WOS:000294283600075
J	Liu, KC; Anthony, BA; Yearsly, MM; Hamadani, M; Gaughan, A; Wang, JJ; Devine, SM; Hadley, GA				Liu, Kechang; Anthony, Bryan A.; Yearsly, Martha M.; Hamadani, Mehdi; Gaughan, Alice; Wang, Jiao-Jing; Devine, Steven M.; Hadley, Gregg A.			CD103 Deficiency Prevents Graft-versus-Host Disease but Spares Graft-versus-Tumor Effects Mediated by Alloreactive CD8 T Cells	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; INTESTINAL EPITHELIUM; SELECTIVE DEPLETION; CTL; LYMPHOCYTES; EXPRESSION; ANTIGENS; AFFINITY; BETA	Background: Graft-versus-host disease (GVHD) remains the main barrier to broader application of allogeneic hematopoietic stem cell transplantation (alloSCT) as a curative therapy for host malignancy. GVHD is mediated by allogeneic T cells directed against histocompatibility antigens expressed by host tissues. Based on previous studies, we postulated that the integrin CD103 is required for CD8-mediated GVHD, but not for graft-versus-tumor effects (GVT). Methodology/Principal Findings: We herein provide evidence in support of this hypothesis. To circumvent the potentially confounding influence of donor CD4 T cells, we developed an alloSCT model in which GVHD mortality is mediated by purified CD8 T cells. In this model, host-reactive CD8 T cells receive CD4 T cell help at the time of initial activation but not in the effector phase in which mature CD8 T effectors migrate into host tissues. We show that donor CD8 T cells from wildtype BALB/c mice primed to host alloantigens induce GVHD pathology and eliminate tumors of host origin in the absence of host CD4 T cells. Importantly, CD103 deficiency dramatically attenuated GVHD mortality, but had no detectable impact on the capacity to eliminate a tumor line of host origin. We provide evidence that CD103 is required for accumulation of donor CD8 T cells in the host intestinal epithelium but not in the tumor or host lymphoid compartments. Consistent with these data, CD103 was preferentially expressed by CD8 T cells infiltrating the host intestinal epithelium but not by those infiltrating the tumor, lamina propria, or lymphoid compartments. We further demonstrate that CD103 expression is not required for classic CD8 effector activities including cytokine production and cytotoxicity. Conclusions/Significance: These data indicate that CD103 deficiency inhibits GVHD pathology while sparing anti-tumor effects mediated by CD8 T cells, identifying CD103 blockade as an improved strategy for GVHD prophylaxis.	[Liu, Kechang] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Anthony, Bryan A.; Gaughan, Alice; Wang, Jiao-Jing; Hadley, Gregg A.] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; [Yearsly, Martha M.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Hamadani, Mehdi] W Virginia Univ, Dept Hematol & Oncol, Morgantown, WV 26506 USA; [Devine, Steven M.] Ohio State Univ, Dept Hematol & Oncol, Columbus, OH USA	University System of Maryland; University of Maryland Baltimore; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; West Virginia University; University System of Ohio; Ohio State University	Liu, KC (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	gregg.hadley@osumc.edu	Devine, Steven/AAS-7644-2021	Hamadani, Mehdi/0000-0001-5372-510X	National Institutes of Health [RO1 AI36532]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health, grant number: RO1 AI36532. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHAMPLIN R, 1990, BLOOD, V76, P418; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; DOGAN A, 1995, J CLIN PATHOL, V48, P143, DOI 10.1136/jcp.48.2.143; El-Asady R, 2005, J EXP MED, V201, P1647, DOI 10.1084/jem.20041044; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Franciszkiewicz K, 2009, CANCER RES, V69, P6249, DOI 10.1158/0008-5472.CAN-08-3571; Hamai A, 2008, CANCER RES, V68, P9854, DOI 10.1158/0008-5472.CAN-08-0719; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; KILSHAW PJ, 1990, EUR J IMMUNOL, V20, P2201, DOI 10.1002/eji.1830201008; Le Floc'h A, 2007, J EXP MED, V204, P559, DOI 10.1084/jem.20061524; Luznik Leo, 2002, Cancer Control, V9, P123; NIMER SD, 1994, TRANSPLANTATION, V57, P82, DOI 10.1097/00007890-199401000-00015; Oehen S, 1998, J IMMUNOL, V161, P5338; ROOPENIAN DC, 1992, IMMUNOL TODAY, V13, P7, DOI 10.1016/0167-5699(92)90197-F; Russell JQ, 1998, J EXP MED, V188, P1147, DOI 10.1084/jem.188.6.1147; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; WAHL SM, 1994, J EXP MED, V180, P1587, DOI 10.1084/jem.180.5.1587; Yu XZ, 2006, J IMMUNOL, V176, P3383, DOI 10.4049/jimmunol.176.6.3383; Zhang L, 2009, AM J TRANSPLANT, V9, P2012, DOI 10.1111/j.1600-6143.2009.02735.x	20	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21968	10.1371/journal.pone.0021968	http://dx.doi.org/10.1371/journal.pone.0021968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779359	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811300030
J	Proctor, CJ; Lorimer, IAJ				Proctor, Carole J.; Lorimer, Ian A. J.			Modelling the Role of the Hsp70/Hsp90 System in the Maintenance of Protein Homeostasis	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; HUMAN BJ FIBROBLASTS; ALZHEIMERS-DISEASE; HEAT-SHOCK; NEURODEGENERATIVE DISEASE; CELLULAR SENESCENCE; CHAPERONE OVERLOAD; REDOX-REGULATION; DEGRADATION; HSP90	Neurodegeneration is an age-related disorder which is characterised by the accumulation of aggregated protein and neuronal cell death. There are many different neurodegenerative diseases which are classified according to the specific proteins involved and the regions of the brain which are affected. Despite individual differences, there are common mechanisms at the sub-cellular level leading to loss of protein homeostasis. The two central systems in protein homeostasis are the chaperone system, which promotes correct protein folding, and the cellular proteolytic system, which degrades misfolded or damaged proteins. Since these systems and their interactions are very complex, we use mathematical modelling to aid understanding of the processes involved. The model developed in this study focuses on the role of Hsp70 (IPR00103) and Hsp90 (IPR001404) chaperones in preventing both protein aggregation and cell death. Simulations were performed under three different conditions: no stress; transient stress due to an increase in reactive oxygen species; and high stress due to sustained increases in reactive oxygen species. The model predicts that protein homeostasis can be maintained during short periods of stress. However, under long periods of stress, the chaperone system becomes overwhelmed and the probability of cell death pathways being activated increases. Simulations were also run in which cell death mediated by the JNK (P45983) and p38 (Q16539) pathways was inhibited. The model predicts that inhibiting either or both of these pathways may delay cell death but does not stop the aggregation process and that eventually cells die due to aggregated protein inhibiting proteasomal function. This problem can be overcome if the sequestration of aggregated protein into inclusion bodies is enhanced. This model predicts responses to reactive oxygen species-mediated stress that are consistent with currently available experimental data. The model can be used to assess specific interventions to reduce cell death due to impaired protein homeostasis.	[Proctor, Carole J.] Newcastle Univ, Inst Ageing & Hlth, Ctr Integrated Syst Biol Ageing & Nutr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Lorimer, Ian A. J.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Lorimer, Ian A. J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	Newcastle University - UK; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Proctor, CJ (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Ctr Integrated Syst Biol Ageing & Nutr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	c.j.proctor@ncl.ac.uk		Proctor, Carole/0000-0002-1366-1399	Alzheimer Scotland; Alzheimer's Research UK [ART/RF2008/3]; Canadian Cancer Society [020121]; Alzheimers Research UK [ART-RF2008-3] Funding Source: researchfish	Alzheimer Scotland; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	CJP is funded by Alzheimer Scotland and Alzheimer's Research UK (ART/RF2008/3). IAJL is supported by a grant from the Canadian Cancer Society (grant #020121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Csermely P, 2001, TRENDS GENET, V17, P701, DOI 10.1016/S0168-9525(01)02495-7; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; Friguet B, 2000, ANN NY ACAD SCI, V908, P143; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hendriks BS, 2008, BIOTECHNOL PROGR, V24, P96, DOI 10.1021/bp070084g; Hernandez F, 2008, FEBS LETT, V582, P3848, DOI 10.1016/j.febslet.2008.10.026; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kirkwood TBL, 2003, NAT REV MOL CELL BIO, V4, P243, DOI 10.1038/nrm1051; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Koli K, 2008, ANTIOXID REDOX SIGN, V10, P333, DOI 10.1089/ars.2007.1914; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Lee KH, 2005, J BIOL CHEM, V280, P13179, DOI 10.1074/jbc.M410059200; Lindner AB, 2009, BBA-GEN SUBJECTS, V1790, P980, DOI 10.1016/j.bbagen.2009.06.005; Liu RM, 2010, J BIOL CHEM, V285, P16239, DOI 10.1074/jbc.M110.111732; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nardai G, 2002, EXP GERONTOL, V37, P1257, DOI 10.1016/S0531-5565(02)00134-1; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Proctor CJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-7; Proctor CJ, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-17; Proctor CJ, 2005, MECH AGEING DEV, V126, P119, DOI 10.1016/j.mad.2004.09.031; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Sitte N, 2000, FASEB J, V14, P2503, DOI 10.1096/fj.00-0210com; Sitte N, 2000, FASEB J, V14, P2495, DOI 10.1096/fj.00-0209com; Soti C, 2003, EXP GERONTOL, V38, P1037, DOI 10.1016/S0531-5565(03)00185-2; Szweda PA, 2002, FREE RADICAL BIO MED, V33, P29, DOI 10.1016/S0891-5849(02)00837-7; Tang MY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000944; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Wilkinso D.J., 2006, STOCHASTIC MODELLING; Zheng A, 2005, P NATL ACAD SCI USA, V102, P12083, DOI 10.1073/pnas.0503374102; Zhu YG, 2006, BRAIN RES, V1090, P35, DOI 10.1016/j.brainres.2006.03.063	45	40	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22038	10.1371/journal.pone.0022038	http://dx.doi.org/10.1371/journal.pone.0022038			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779370	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811300037
J	Huang, WD; Zhang, YHP				Huang, Wei-Dong; Zhang, Y-H Percival			Energy Efficiency Analysis: Biomass-to-Wheel Efficiency Related with Biofuels Production, Fuel Distribution, and Powertrain Systems	PLOS ONE			English	Article							ESCHERICHIA-COLI; THERMOPHILIC BACTERIUM; HYDROGEN-PRODUCTION; LIFE-CYCLE; ETHANOL; CELL; GASIFICATION; ELECTRICITY; EMISSIONS; ECONOMY	Background: Energy efficiency analysis for different biomass-utilization scenarios would help make more informed decisions for developing future biomass-based transportation systems. Diverse biofuels produced from biomass include cellulosic ethanol, butanol, fatty acid ethyl esters, methane, hydrogen, methanol, dimethyether, Fischer-Tropsch diesel, and bioelectricity; the respective powertrain systems include internal combustion engine (ICE) vehicles, hybrid electric vehicles based on gasoline or diesel ICEs, hydrogen fuel cell vehicles, sugar fuel cell vehicles (SFCV), and battery electric vehicles (BEV). Methodology/Principal Findings: We conducted a simple, straightforward, and transparent biomass-to-wheel (BTW) analysis including three separate conversion elements - biomass-to-fuel conversion, fuel transport and distribution, and respective powertrain systems. BTW efficiency is a ratio of the kinetic energy of an automobile's wheels to the chemical energy of delivered biomass just before entering biorefineries. Up to 13 scenarios were analyzed and compared to a base line case - corn ethanol/ICE. This analysis suggests that BEV, whose electricity is generated from stationary fuel cells, and SFCV, based on a hydrogen fuel cell vehicle with an on-board sugar-to-hydrogen bioreformer, would have the highest BTW efficiencies, nearly four times that of ethanol-ICE. Significance: In the long term, a small fraction of the annual US biomass (e. g., 7.1%, or 700 million tons of biomass) would be sufficient to meet 100% of light-duty passenger vehicle fuel needs (i.e., 150 billion gallons of gasoline/ethanol per year), through up to four-fold enhanced BTW efficiencies by using SFCV or BEV. SFCV would have several advantages over BEV: much higher energy storage densities, faster refilling rates, better safety, and less environmental burdens.	[Huang, Wei-Dong; Zhang, Y-H Percival] Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA 24061 USA; [Huang, Wei-Dong] Univ Sci & Technol China, Environm Div, Coll Earth & Space Sci, Hefei 230026, Peoples R China; [Zhang, Y-H Percival] Virginia Tech, ICTAS, Blacksburg, VA USA; [Zhang, Y-H Percival] DOE BioEnergy Sci Ctr BESC, Oak Ridge, TN USA; [Zhang, Y-H Percival] Gate Fuels Inc, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC)	Huang, WD (corresponding author), Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA 24061 USA.	ypzhang@vt.edu			Air Force Office of Scientific Research; MURI [FA9550-08-1-0145]; USDA Biodesign and Bioprocess Center; DOE BESC; China Scholarship Council	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); MURI(MURI); USDA Biodesign and Bioprocess Center; DOE BESC(United States Department of Energy (DOE)); China Scholarship Council(China Scholarship Council)	This work was supported mainly by the Air Force Office of Scientific Research and MURI (FA9550-08-1-0145), partially by the USDA Biodesign and Bioprocess Center and DOE BESC to YPZ. WH as a visiting scholar was partially supported by the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia RK, 2005, J POWER SOURCES, V152, P233, DOI 10.1016/j.jpowsour.2005.01.052; Ahman M, 2001, ENERGY, V26, P973, DOI 10.1016/S0360-5442(01)00049-4; Albertazzi S, 2005, CATAL TODAY, V106, P297, DOI 10.1016/j.cattod.2005.07.160; Amon T, 2007, BIORESOURCE TECHNOL, V98, P3204, DOI 10.1016/j.biortech.2006.07.007; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; BANDIVADEKAR A, 2008, 200805 LFEE RE MIT; Berglund M, 2006, BIOMASS BIOENERG, V30, P254, DOI 10.1016/j.biombioe.2005.11.011; Borjesson P, 2009, APPL ENERG, V86, P589, DOI 10.1016/j.apenergy.2008.11.025; Campbell E, 2010, BIOTECHNOL BIOENG, V107, P763, DOI 10.1002/bit.22869; Campbell JE, 2009, SCIENCE, V324, P1055, DOI 10.1126/science.1168885; Caputo AC, 2005, BIOMASS BIOENERG, V28, P35, DOI 10.1016/j.biombioe.2004.04.009; Serrano-Ruiz JC, 2011, ENERG ENVIRON SCI, V4, P83, DOI 10.1039/c0ee00436g; Chou CJ, 2008, METAB ENG, V10, P394, DOI 10.1016/j.ymben.2008.06.007; Cleveland CJ, 2005, ENERGY, V30, P769, DOI 10.1016/j.energy.2004.05.023; Cooney MJ, 2008, ENERG ENVIRON SCI, V1, P320, DOI 10.1039/b809009b; Cortright RD, 2002, NATURE, V418, P964, DOI 10.1038/nature01009; Dale BE, 2007, BIOFUEL BIOPROD BIOR, V1, P1, DOI 10.1002/bbb.1; De Oliveira MED, 2005, BIOSCIENCE, V55, P593, DOI 10.1641/0006-3568(2005)055[0593:EAFECD]2.0.CO;2; Demirdoven N, 2004, SCIENCE, V305, P974, DOI 10.1126/science.1093965; Dominguez-Faus R, 2009, ENVIRON SCI TECHNOL, V43, P3005, DOI 10.1021/es802162x; Donolo G, 2006, J POWER SOURCES, V158, P1282, DOI 10.1016/j.jpowsour.2005.10.045; Eaves S, 2004, J POWER SOURCES, V130, P208, DOI 10.1016/j.jpowsour.2003.12.016; Eberhard M., 2006, 21 CENTURY ELECT CAR; EUCAR CONCAWE and JTC, 2007, WELL TO WHEELS AN FU; Evans A, 2010, RENEW SUST ENERG REV, V14, P1419, DOI 10.1016/j.rser.2010.01.010; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Hamelinck CN, 2006, ENERG POLICY, V34, P3268, DOI 10.1016/j.enpol.2005.06.012; Hamelinck CN, 2005, BIOMASS BIOENERG, V28, P384, DOI 10.1016/j.biombioe.2004.09.002; Hamelinck CN, 2002, J POWER SOURCES, V111, P1, DOI 10.1016/S0378-7753(02)00220-3; Hermann WA, 2006, ENERGY, V31, P1685, DOI 10.1016/j.energy.2005.09.006; Hicke JA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013578; Higo M, 2010, APPL ENERG, V87, P58, DOI 10.1016/j.apenergy.2009.08.030; Hill J, 2009, P NATL ACAD SCI USA, V106, P2077, DOI 10.1073/pnas.0812835106; Hillman Karl M., 2008, International Journal of Alternative Propulsion, V2, P1, DOI 10.1504/IJAP.2008.019689; Huang WD, 2011, ENERG ENVIRON SCI, V4, P784, DOI 10.1039/c0ee00069h; Jacobson MZ, 2009, ENERG ENVIRON SCI, V2, P148, DOI 10.1039/b809990c; Jacobson MZ, 2005, SCIENCE, V308, P1901, DOI 10.1126/science.1109157; JONES DT, 1986, MICROBIOL REV, V50, P484, DOI 10.1128/MMBR.50.4.484-524.1986; Kalscheuer R, 2006, MICROBIOL-SGM, V152, P2529, DOI 10.1099/mic.0.29028-0; Kobayashi S, 2009, ENERG EFFIC, V2, P125, DOI 10.1007/s12053-008-9037-3; Kumabe K, 2008, FUEL, V87, P1422, DOI 10.1016/j.fuel.2007.06.008; Larson E.D., 2006, ENERGY SUSTAIN DEV, V10, P109, DOI [10.1016/S0973-0826(08)60536-0, DOI 10.1016/S0973-0826(08)60536-0]; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Lynd LR, 2010, ENERG ENVIRON SCI, V3, P1150, DOI 10.1039/c002335n; LYND LR, 1991, SCIENCE, V251, P1318, DOI 10.1126/science.251.4999.1318; MacKay David J.C., 2009, SUSTAINABLE ENERGY H; Maclean HL, 2003, ENVIRON SCI TECHNOL, V37, P5445, DOI 10.1021/es034574q; Melamu R, 2009, INT J HYDROGEN ENERG, V34, P1126, DOI 10.1016/j.ijhydene.2008.11.020; Morey RV, 2006, APPL ENG AGRIC, V22, P723; Moxley G, 2007, ENERG FUEL, V21, P3684, DOI 10.1021/ef7003893; MYUNG S, 2011, BIOTECHNOL PROGR, DOI DOI 10.1002/BTPR.1606; Myung S, 2010, PROCESS BIOCHEM, V45, P1882, DOI 10.1016/j.procbio.2010.03.017; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; Pimentel D., 2005, NAT RESOUR RES, V14, P65, DOI [DOI 10.1007/S11053-005-4679-8, 10.1007/s11053-005-4679-8]; Ptasinski KJ, 2008, BIOFUEL BIOPROD BIOR, V2, P239, DOI 10.1002/bbb.65; Ryan JD, 2008, CHEMBIOCHEM, V9, P2579, DOI 10.1002/cbic.200800246; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; SCHWEIGER A, 2007, P 15 EUR BIOM C EXH; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Service RF, 2009, SCIENCE, V326, P516, DOI 10.1126/science.326_516; Shaw AJ, 2008, P NATL ACAD SCI USA, V105, P13769, DOI 10.1073/pnas.0801266105; Sheehan John, 2003, Journal of Industrial Ecology, V7, P117; Silko Leslie Marmon, 1998, OIL BEGINNERS GUIDE, P2; Smil V., 2010, ENERGY TRANSITIONS H; Smil Vaclav, 2008, ENERGY NATURE SOC; Smil Vaclav, 1999, ENERGIES ILLUSTRATED; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Sun JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010526; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Thomas CE, 2009, INT J HYDROGEN ENERG, V34, P6005, DOI 10.1016/j.ijhydene.2009.06.003; Tijmensen MJA, 2002, BIOMASS BIOENERG, V23, P129, DOI 10.1016/S0961-9534(02)00037-5; van Vliet OPR, 2009, ENERG CONVERS MANAGE, V50, P855, DOI 10.1016/j.enconman.2009.01.008; Wang Y, 2010, J APPL MICROBIOL, V108, P39, DOI 10.1111/j.1365-2672.2009.04396.x; Wang YR, 2011, CHEM BIOL, V18, P372, DOI 10.1016/j.chembiol.2010.12.019; Wang YR, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-30; Wetterlund E, 2010, INT J ENERG RES, V34, P1136, DOI 10.1002/er.1633; Williamson SS, 2005, IEEE T VEH TECHNOL, V54, P856, DOI 10.1109/TVT.2005.847444; Wyman CE, 2007, TRENDS BIOTECHNOL, V25, P153, DOI 10.1016/j.tibtech.2007.02.009; Ye XH, 2009, CHEMSUSCHEM, V2, P149, DOI 10.1002/cssc.200900017; Yoshida A, 2005, APPL ENVIRON MICROB, V71, P6762, DOI 10.1128/AEM.71.11.6762-6768.2005; Zhang KC, 2008, P NATL ACAD SCI USA, V105, P20653, DOI 10.1073/pnas.0807157106; Zhang YHP, 2008, J IND MICROBIOL BIOT, V35, P367, DOI 10.1007/s10295-007-0293-6; Zhang YHP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000456; Zhang YHP, 2011, ENERGIES, V4, P254, DOI 10.3390/en4020254; Zhang YHP, 2010, INT J HYDROGEN ENERG, V35, P10334, DOI 10.1016/j.ijhydene.2010.07.132; Zhang YHP, 2010, BIOTECHNOL BIOENG, V105, P663, DOI 10.1002/bit.22630; Zhang YHP, 2009, ENERG ENVIRON SCI, V2, P272, DOI 10.1039/b818694d; Zhang YHP, 2010, CURR OPIN BIOTECH, V21, P663, DOI 10.1016/j.copbio.2010.05.005; ZHANG YHP, 2011, BIOTECHNOL ADV, DOI DOI 10.1016/J.BIOTECHADV.2011.1005.1020; ZHANG YHP, 2011, J MATER CHEM, DOI DOI 10.1039/C1031JM12078F; Zhu XG, 2008, CURR OPIN BIOTECH, V19, P153, DOI 10.1016/j.copbio.2008.02.004	93	46	46	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22113	10.1371/journal.pone.0022113	http://dx.doi.org/10.1371/journal.pone.0022113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765941	Green Published, Green Submitted, gold			2022-12-25	WOS:000292781500033
J	Hunt, PR; Son, TG; Wilson, MA; Yu, QS; Wood, WH; Zhang, YQ; Becker, KG; Greig, NH; Mattson, MP; Camandola, S; Wolkow, CA				Hunt, Piper R.; Son, Tae Gen; Wilson, Mark A.; Yu, Quian-Sheng; Wood, William H.; Zhang, Yongqing; Becker, Kevin G.; Greig, Nigel H.; Mattson, Mark P.; Camandola, Simonetta; Wolkow, Catherine A.			Extension of Lifespan in C. elegans by Naphthoquinones That Act through Stress Hormesis Mechanisms	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; HEAT-SHOCK PROTEINS; OXIDATIVE-STRESS; SACCHAROMYCES-CEREVISIAE; ADAPTIVE RESPONSE; GENE-EXPRESSION; FACTOR SKN-1; LONGEVITY; RESISTANCE; DAF-16	Hormesis occurs when a low level stress elicits adaptive beneficial responses that protect against subsequent exposure to severe stress. Recent findings suggest that mild oxidative and thermal stress can extend lifespan by hormetic mechanisms. Here we show that the botanical pesticide plumbagin, while toxic to C. elegans nematodes at high doses, extends lifespan at low doses. Because plumbagin is a naphthoquinone that can generate free radicals in vivo, we investigated whether it extends lifespan by activating an adaptive cellular stress response pathway. The C. elegans cap'n'collar (CNC) transcription factor, SKN-1, mediates protective responses to oxidative stress. Genetic analysis showed that skn-1 activity is required for lifespan extension by low-dose plumbagin in C. elegans. Further screening of a series of plumbagin analogs identified three additional naphthoquinones that could induce SKN-1 targets in C. elegans. Naphthazarin showed skn-1dependent lifespan extension, over an extended dose range compared to plumbagin, while the other naphthoquinones, oxoline and menadione, had differing effects on C. elegans survival and failed to activate ARE reporter expression in cultured mammalian cells. Our findings reveal the potential for low doses of naturally occurring naphthoquinones to extend lifespan by engaging a specific adaptive cellular stress response pathway.	[Hunt, Piper R.; Son, Tae Gen; Wilson, Mark A.; Mattson, Mark P.; Camandola, Simonetta; Wolkow, Catherine A.] NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Yu, Quian-Sheng; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Wood, William H.; Zhang, Yongqing; Becker, Kevin G.] NIA, Gene Express & Genom Unit, Intramural Res Program, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Hunt, PR (corresponding author), NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	camandolasi@grc.nia.nih.gov; wolkowca@gmail.com	Hunt, Piper Reid/G-1555-2012; Mattson, Mark P/F-6038-2012	Hunt, Piper Reid/0000-0003-0538-7606; Becker, Kevin/0000-0002-6794-6656	National Institute of Aging [Z01 AG000320]; NATIONAL INSTITUTE ON AGING [ZICAG000616, ZIAAG000311, Z01AG000320] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the National Institute of Aging Intramural Research Program, Z01 AG000320. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Bejarano Eloy, 2010, Proc Am Thorac Soc, V7, P29, DOI 10.1513/pats.200909-102JS; BLUM J, 1983, ARCH BIOCHEM BIOPHYS, V222, P35, DOI 10.1016/0003-9861(83)90499-X; Bonda DJ, 2010, NEUROPHARMACOLOGY, V59, P290, DOI 10.1016/j.neuropharm.2010.04.005; BRENNER S, 1974, GENETICS, V77, P71; BURTON V, 1988, MOL CELL BIOL, V8, P3550, DOI 10.1128/MCB.8.8.3550; Calabrese EJ, 2007, TOXICOL APPL PHARM, V222, P122, DOI 10.1016/j.taap.2007.02.015; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Choksi KB, 2007, FREE RADICAL BIO MED, V43, P1423, DOI 10.1016/j.freeradbiomed.2007.07.027; COHEN SS, 1958, P NATL ACAD SCI USA, V44, P1004, DOI 10.1073/pnas.44.10.1004; Cypser JR, 2003, BIOGERONTOLOGY, V4, P203, DOI 10.1023/A:1025138800672; Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109, DOI 10.1093/gerona/57.3.B109; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; DONIACH T, 1984, DEV BIOL, V106, P223, DOI 10.1016/0012-1606(84)90077-0; Dudas Istvan, 2006, Congenital Anomalies, V46, P39, DOI 10.1111/j.1741-4520.2006.00100.x; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Garg R, 2008, CARCINOGENESIS, V29, P1022, DOI 10.1093/carcin/bgn064; Garigan D, 2002, GENETICS, V161, P1101; Gems D, 2000, GENETICS, V154, P1597; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Head E, 2002, J NEUROCHEM, V82, P375, DOI 10.1046/j.1471-4159.2002.00969.x; Heidler T, 2010, BIOGERONTOLOGY, V11, P183, DOI 10.1007/s10522-009-9239-x; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Higgins LG, 2009, TOXICOL APPL PHARM, V237, P267, DOI 10.1016/j.taap.2009.03.005; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; HOSONO R, 1978, EXP GERONTOL, V13, P369, DOI 10.1016/0531-5565(78)90047-5; Kahn NW, 2008, BIOCHEM J, V409, P205, DOI 10.1042/BJ20070521; Keaney M, 2004, FREE RADICAL BIO MED, V37, P239, DOI 10.1016/j.freeradbiomed.2004.04.005; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Le Bourg E, 2009, BBA-GEN SUBJECTS, V1790, P1030, DOI 10.1016/j.bbagen.2009.01.004; Leiers BR, 2003, FREE RADICAL BIO MED, V34, P1405, DOI 10.1016/S0891-5849(03)00102-3; Link CD, 2002, METHOD ENZYMOL, V353, P497; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; MCALISTER L, 1980, BIOCHEM BIOPH RES CO, V93, P819, DOI 10.1016/0006-291X(80)91150-X; MESSIER AA, 1990, UNDERSEA BIOMED RES, V17, P305; Munoz MJ, 2003, GENETICS, V163, P171; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Newton LAA, 2010, NEW J CHEM, V34, P395, DOI 10.1039/b9nj00534j; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Park SK, 2009, AGING CELL, V8, P258, DOI 10.1111/j.1474-9726.2009.00473.x; PLESSET J, 1982, BIOCHEM BIOPH RES CO, V108, P1340, DOI 10.1016/0006-291X(82)92147-7; Przybysz AJ, 2009, MECH AGEING DEV, V130, P357, DOI 10.1016/j.mad.2009.02.004; Rattan SIS, 2008, HUM EXP TOXICOL, V27, P151, DOI 10.1177/0960327107083409; Son TG, 2010, J NEUROCHEM, V112, P1316, DOI 10.1111/j.1471-4159.2009.06552.x; SUMMERS WC, 1993, J BACTERIOL, V175, P6049, DOI 10.1128/JB.175.18.6049-6051.1993; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Ungvari Z, 2008, FRONT BIOSCI-LANDMRK, V13, P5056, DOI 10.2741/3064; Castro FAV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003999; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Yashin AI, 2001, MECH AGEING DEV, V122, P1477, DOI 10.1016/S0047-6374(01)00273-1; Zenkova E, 2000, PHARM CHEM J, V34, P91	56	64	67	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21922	10.1371/journal.pone.0021922	http://dx.doi.org/10.1371/journal.pone.0021922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765926	Green Published, gold, Green Submitted			2022-12-25	WOS:000292781500023
J	Ross, SR; Vreeman, VM; Lonsdorf, EV				Ross, Stephen R.; Vreeman, Vivian M.; Lonsdorf, Elizabeth V.			Specific Image Characteristics Influence Attitudes about Chimpanzee Conservation and Use as Pets	PLOS ONE			English	Article								Chimpanzees are endangered in their native Africa but in the United States, they are housed not only in zoos and research centers but owned privately as pets and performers. In 2008, survey data revealed that the public is less likely to think that chimpanzees are endangered compared to other great apes, and that this is likely the result of media misportrayals in movies, television and advertisements. Here, we use an experimental survey paradigm with composite images of chimpanzees to determine the effects of specific image characteristics. We found that those viewing a photograph of a chimpanzee with a human standing nearby were 35.5% more likely to consider wild populations to be stable/healthy compared to those seeing the exact same picture without a human. Likewise, the presence of a human in the photograph increases the likelihood that they consider chimpanzees as appealing as a pet. We also found that respondents seeing images in which chimpanzees are shown in typically human settings (such as an office space) were more likely to perceive wild populations as being stable and healthy compared to those seeing chimpanzees in other contexts. These findings shed light on the way that media portrayals of chimpanzees influence public attitudes about this important and endangered species.	[Ross, Stephen R.; Vreeman, Vivian M.; Lonsdorf, Elizabeth V.] Lester E Fisher Ctr Study & Conservat Apes, Chicago, IL USA; [Lonsdorf, Elizabeth V.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA	University of Chicago	Ross, SR (corresponding author), Lester E Fisher Ctr Study & Conservat Apes, Lincoln Pk Zoo, Chicago, IL USA.	sross@lpzoo.org			Arcus Foundation	Arcus Foundation	The funding for this project came from the Arcus Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	C?lix M., 2018, EUROPEAN RED LIST SA; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Ross SR, 2008, SCIENCE, V319, P1487, DOI 10.1126/science.1154490; Saldana C., PROBABILITY MATCHING, DOI [10.17605/OSF.IO/QNM57(2022, DOI 10.17605/OSF.IO/QNM57(2022]; Sanchez-Fernandez R., 2007, MARKETING THEOR, V7, P427, DOI [10.1177/1470593107083165, DOI 10.1177/1470593107083165]	5	58	58	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22050	10.1371/journal.pone.0022050	http://dx.doi.org/10.1371/journal.pone.0022050			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21779372	Green Published, Green Submitted, gold			2022-12-25	WOS:000292781500027
J	Mak, MC; Lam, KM; Chan, PK; Lau, YB; Tang, WH; Yeung, PKK; Ko, BCB; Chung, SMS; Chung, SK				Mak, Man Chi; Lam, Ka Man; Chan, Ping Kei; Lau, Yu Bond; Tang, Wai Ho; Yeung, Patrick Ka Kit; Ko, Ben Chi Bun; Chung, Stephen Man Sum; Chung, Sookja Kim			Embryonic Lethality in Mice Lacking the Nuclear Factor of Activated T Cells 5 Protein Due to Impaired Cardiac Development and Function	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; STIMULATES TRANSCRIPTION; BINDING PROTEIN; NFAT5; EXPRESSION; HSP70; HYPERTONICITY; FAMILY; TONEBP/NFAT5; OSMOLALITY	Nuclear factor of activated T cells 5 protein (NFAT5) is thought to be important for cellular adaptation to osmotic stress by regulating the transcription of genes responsible for the synthesis or transport of organic osmolytes. It is also thought to play a role in immune function, myogenesis and cancer invasion. To better understand the function of NFAT5, we developed NFAT5 gene knockout mice. Homozygous NFAT5 null (NFAT5(-/-)) mouse embryos failed to develop normally and died after 14.5 days of embryonic development (E14.5). The embryos showed peripheral edema, and abnormal heart development as indicated by thinner ventricular wall and reduced cell density at the compact and trabecular areas of myocardium. This is associated with reduced level of proliferating cell nuclear antigen and increased caspase-3 in these tissues. Cardiomyocytes from E14.5 NFAT5(-/-) embryos showed a significant reduction of beating rate and abnormal Ca(2+) signaling profile as a consequence of reduced sarco(endo) plasmic reticulum Ca(2+)-ATPase (SERCA) and ryanodine receptor (RyR) expressions. Expression of NFAT5 target genes, such as HSP 70 and SMIT were reduced in NFAT5(-/-) cardiomyocytes. Our findings demonstrated an essential role of NFAT5 in cardiac development and Ca(2+) signaling. Cardiac failure is most likely responsible for the peripheral edema and death of NFAT5(-/-) embryos at E14.5 days.	[Mak, Man Chi; Lam, Ka Man; Chan, Ping Kei; Lau, Yu Bond; Yeung, Patrick Ka Kit; Chung, Sookja Kim] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Tang, Wai Ho; Chung, Stephen Man Sum] United Int Coll, Div Sci & Technol, Zhuhai, Guandong, Peoples R China; [Ko, Ben Chi Bun] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Beijing Normal University - Hong Kong Baptist University United International College; Chinese University of Hong Kong	Mak, MC (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China.	skchung@hkucc.hku.hk	Ko, Chi-bun/ACH-7514-2022	Ko, Ben Chi Bun/0000-0003-2027-5899	University of Hong Kong [7504/06M]	University of Hong Kong(University of Hong Kong)	This work was supported by the Research Grant Council Grants The University of Hong Kong 7504/06M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Cai Q, 2005, AM J PHYSIOL-RENAL, V289, pF803, DOI 10.1152/ajprenal.00448.2004; Cai Q, 2004, AM J PHYSIOL-RENAL, V286, pF58, DOI 10.1152/ajprenal.00037.2003; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; Dahl SC, 2001, AM J PHYSIOL-CELL PH, V280, pC248, DOI 10.1152/ajpcell.2001.280.2.C248; Drews-Elger K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005245; Evans HJ, 2003, AM J PHYSIOL-HEART C, V285, pH570, DOI 10.1152/ajpheart.01027.2002; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Ho HTB, 2000, MOL CELL BIOL, V20, P5840, DOI 10.1128/MCB.20.16.5840-5846.2000; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Kim K, 2000, P NATL ACAD SCI USA, V97, P1731, DOI 10.1073/pnas.040550097; Kim YK, 2006, CIRCULATION, V113, P2589, DOI 10.1161/CIRCULATIONAHA.105.598409; Liu J, 2006, AM J PHYSIOL-CELL PH, V290, pC583, DOI 10.1152/ajpcell.00145.2005; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Maouyo D, 2002, AM J PHYSIOL-RENAL, V282, pF802, DOI 10.1152/ajprenal.00123.2001; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RUSHLOW C, 1992, BIOESSAYS, V14, P89, DOI 10.1002/bies.950140204; Sconzo G, 1999, BIOCHEM BIOPH RES CO, V260, P143, DOI 10.1006/bbrc.1999.0782; Tong EHY, 2006, J BIOL CHEM, V281, P23870, DOI 10.1074/jbc.M602556200; Trama J, 2000, J IMMUNOL, V165, P4884, DOI 10.4049/jimmunol.165.9.4884; Trama J, 2002, J IMMUNOL, V169, P5477, DOI 10.4049/jimmunol.169.10.5477; Wang Y, 2005, J BIOL CHEM, V280, P19986, DOI 10.1074/jbc.M501689200; WILLIAMSON JR, 1985, AM J PHYSIOL, V248, pC203, DOI 10.1152/ajpcell.1985.248.3.C203; Woo SK, 2002, PFLUG ARCH EUR J PHY, V444, P579, DOI 10.1007/s00424-002-0849-2; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002	30	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e19186	10.1371/journal.pone.0019186	http://dx.doi.org/10.1371/journal.pone.0019186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765887	gold, Green Submitted, Green Published			2022-12-25	WOS:000292699000001
J	Ito, S; Umehara, M; Hanada, A; Kitahata, N; Hayase, H; Yamaguchi, S; Asami, T				Ito, Shinsaku; Umehara, Mikihisa; Hanada, Atsushi; Kitahata, Nobutaka; Hayase, Hiroki; Yamaguchi, Shinjiro; Asami, Tadao			Effects of Triazole Derivatives on Strigolactone Levels and Growth Retardation in Rice	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; BIOSYNTHESIS INHIBITORS; ANALOG GR24; BRASSINOSTEROIDS	We previously discovered a lead compound for strigolactone (SL) biosynthesis inhibitors, TIS13 (2,2-dimethyl-7-phenoxy-4(1H-1,2,4-triazol-1-yl)heptan-3-ol). Here, we carried out a structure-activity relationship study of TIS13 to discover more potent and specific SL biosynthesis inhibitor because TIS13 has a severe side effect at high concentrations, including retardation of the growth of rice seedlings. TIS108, a new TIS13 derivative, was found to be a more specific SL biosynthesis inhibitor than TIS13. Treatment of rice seedlings with TIS108 reduced SL levels in both roots and root exudates in a concentration-dependent manner and did not reduce plant height. In addition, root exudates of TIS108-treated rice seedlings stimulated Striga germination less than those of control plants. These results suggest that TIS108 has a potential to be applied in the control of root parasitic weeds germination.	[Ito, Shinsaku; Kitahata, Nobutaka; Hayase, Hiroki; Asami, Tadao] Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan; [Umehara, Mikihisa; Hanada, Atsushi; Yamaguchi, Shinjiro] RIKEN, Plant Sci Ctr, Yokohama, Kanagawa, Japan	University of Tokyo; RIKEN	Ito, S (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan.	asami@pgr1.ch.a.u-tokyo.ac.jp	Umehara, M/D-2416-2011; Yamaguchi, Shinjiro/F-9684-2010		Program for the Promotion of Basic Research Activities for Innovative Biosciences (PRO-BRAIN); Japan Society for the Promotion of Science	Program for the Promotion of Basic Research Activities for Innovative Biosciences (PRO-BRAIN); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant to T.A. from the Program for the Promotion of Basic Research Activities for Innovative Biosciences (PRO-BRAIN), and a Research Fellowship to S.I. from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Asami T, 2003, J PLANT GROWTH REGUL, V22, P336, DOI 10.1007/s00344-003-0065-0; Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Beveridge CA, 2010, CURR OPIN PLANT BIOL, V13, P34, DOI 10.1016/j.pbi.2009.10.003; Cardoso C, 2011, PLANT SCI, V180, P414, DOI 10.1016/j.plantsci.2010.11.007; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; Drummond RSM, 2009, PLANT PHYSIOL, V151, P1867, DOI 10.1104/pp.109.146720; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Ito S, 2010, PLANT CELL PHYSIOL, V51, P1143, DOI 10.1093/pcp/pcq077; Jamil M, 2010, ARCH BIOCHEM BIOPHYS, V504, P123, DOI 10.1016/j.abb.2010.08.005; Kapulnik Y, 2011, PLANTA, V233, P209, DOI 10.1007/s00425-010-1310-y; Komatsu T, 2010, PLANT J, V61, P409, DOI 10.1111/j.1365-313X.2009.04077.x; MANGNUS EM, 1992, J AGR FOOD CHEM, V40, P1230, DOI 10.1021/jf00019a031; Min YK, 1999, BIOORG MED CHEM LETT, V9, P425, DOI 10.1016/S0960-894X(99)00008-6; Parker C, 2009, PEST MANAG SCI, V65, P453, DOI 10.1002/ps.1713; Rani K, 2008, PLANT PHYSIOL BIOCH, V46, P617, DOI 10.1016/j.plaphy.2008.04.012; Ruyter-Spira C, 2011, PLANT PHYSIOL, V155, P721, DOI 10.1104/pp.110.166645; Sugimoto Y, 2008, PHYTOCHEMISTRY, V69, P212, DOI 10.1016/j.phytochem.2007.06.011; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Zhang AP, 2011, J AGR FOOD CHEM, V59, P4300, DOI 10.1021/jf104828q	21	35	36	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21723	10.1371/journal.pone.0021723	http://dx.doi.org/10.1371/journal.pone.0021723			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760901	Green Published, Green Submitted, gold			2022-12-25	WOS:000292657200019
J	Suguitan, AL; Cheng, X; Wang, WJ; Wang, SX; Jin, H; Lu, S				Suguitan, Amorsolo L., Jr.; Cheng, Xing; Wang, Weijia; Wang, Shixia; Jin, Hong; Lu, Shan			Influenza H5 Hemagglutinin DNA Primes the Antibody Response Elicited by the Live Attenuated Influenza A/Vietnam/1203/2004 Vaccine in Ferrets	PLOS ONE			English	Article							AVIAN INFLUENZA; A VIRUS; MF59-ADJUVANTED INFLUENZA; IMMUNOGENICITY; PROTECTION; IMMUNITY; BOOST; MICE; H1N1; CHALLENGE	Priming immunization plays a key role in protecting individuals or populations to influenza viruses that are novel to humans. To identify the most promising vaccine priming strategy, we have evaluated different prime-boost regimens using inactivated, DNA and live attenuated vaccines in ferrets. Live attenuated influenza A/Vietnam/1203/2004 (H5N1) candidate vaccine (LAIV, VN04 ca) primed ferrets efficiently while inactivated H5N1 vaccine could not prime the immune response in seronegative ferrets unless an adjuvant was used. However, the H5 HA DNA vaccine alone was as successful as an adjuvanted inactivated VN04 vaccine in priming the immune response to VN04 ca virus. The serum antibody titers of ferrets primed with H5 HA DNA followed by intranasal vaccination of VN04 ca virus were comparable to that induced by two doses of VN04 ca virus. Both LAIV-LAIV and DNA-LAIV vaccine regimens could induce antibody responses that cross-neutralized antigenically distinct H5N1 virus isolates including A/HongKong/213/2003 (HK03) and prevented nasal infection of HK03 vaccine virus. Thus, H5 HA DNA vaccination may offer an alternative option for pandemic preparedness.	[Suguitan, Amorsolo L., Jr.; Cheng, Xing; Wang, Weijia; Jin, Hong] MedImmune, Mountain View, CA USA; [Wang, Shixia; Lu, Shan] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA	AstraZeneca; Medimmune; University of Massachusetts System; University of Massachusetts Worcester	Suguitan, AL (corresponding author), MedImmune, Mountain View, CA USA.	jinh@medimmune.com		Lu, Shan/0000-0002-8417-7588	NIH/NIAID [AI078073]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI078073] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH/NIAID grant AI078073. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ambrose CS, 2008, PEDIATR INFECT DIS J, V27, P744, DOI 10.1097/INF.0b013e318174e0f8; Ambrose CS, 2010, PEDIATR INFECT DIS J, V29, P806, DOI 10.1097/INF.0b013e3181e2872f; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; Dejpichai R, 2009, EMERG INFECT DIS, V15, P756, DOI 10.3201/eid1505.080316; Epstein SL, 2002, EMERG INFECT DIS, V8, P796; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; GORSE GJ, 1995, J INFECT DIS, V172, P1, DOI 10.1093/infdis/172.1.1; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hauge S, 2007, CLIN VACCINE IMMUNOL, V14, P978, DOI 10.1128/CVI.00033-07; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Huber VC, 2009, VACCINE, V27, P1192, DOI 10.1016/j.vaccine.2008.12.023; Jennings LC, 2008, LANCET INFECT DIS, V8, P650, DOI 10.1016/S1473-3099(08)70232-9; Jin H, 2003, VIROLOGY, V306, P18, DOI 10.1016/S0042-6822(02)00035-1; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kongkasuriyachai D, 2004, VACCINE, V22, P3205, DOI 10.1016/j.vaccine.2003.11.060; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; Lalor PA, 2008, J INFECT DIS, V197, P1643, DOI 10.1086/588431; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Li YH, 2010, VACCINE, V28, P5370, DOI 10.1016/j.vaccine.2010.04.067; Lu S, 2008, HUM VACCINES, V4, P449, DOI 10.4161/hv.4.6.6179; MAASSAB HF, 1969, J IMMUNOL, V102, P728; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Octaviani CP, 2010, J VIROL, V84, P10918, DOI 10.1128/JVI.01140-10; POWERS DC, 1989, J CLIN MICROBIOL, V27, P2666, DOI 10.1128/JCM.27.12.2666-2671.1989; Santhia K, 2009, INFLUENZA OTHER RESP, V3, P81, DOI 10.1111/j.1750-2659.2009.00069.x; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948; Stephenson I, 2003, VACCINE, V21, P1687, DOI 10.1016/S0264-410X(02)00632-1; Stephenson I, 2008, NEW ENGL J MED, V359, P1631, DOI 10.1056/NEJMc0805274; Suguitan AL, 2006, PLOS MED, V3, P1541, DOI 10.1371/journal.pmed.0030360; Talaat KR, 2010, J INFECT DIS, V202, P1327, DOI 10.1086/656601; Tanghe A, 2001, INFECT IMMUN, V69, P3041, DOI 10.1128/IAI.69.5.3041-3047.2001; TOMODA T, 1995, VACCINE, V13, P185, DOI 10.1016/0264-410X(95)93134-U; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Ulmer JB, 1998, J VIROL, V72, P5648, DOI 10.1128/JVI.72.7.5648-5653.1998; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; Wang SX, 2008, VACCINE, V26, P2100, DOI 10.1016/j.vaccine.2008.02.033; Wang S, 2008, VACCINE, V26, P3946, DOI 10.1016/j.vaccine.2008.04.025; Wang S, 2008, VACCINE, V26, P3626, DOI 10.1016/j.vaccine.2008.04.073; Wang SX, 2006, J VIROL, V80, P11628, DOI 10.1128/JVI.01065-06; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; WHO, 2010, CUM NUMB CONF HUM CA; Xu GF, 2009, VACCINE, V27, P3821, DOI 10.1016/j.vaccine.2009.04.008; Zangwill KM, 2008, J INFECT DIS, V197, P580, DOI 10.1086/526537; Zhu YC, 2010, VACCINE, V28, P5347, DOI 10.1016/j.vaccine.2010.05.017	49	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21942	10.1371/journal.pone.0021942	http://dx.doi.org/10.1371/journal.pone.0021942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760928	gold, Green Published, Green Submitted			2022-12-25	WOS:000292657200032
J	Zhang, YP; Liu, YZ; Guo, Y; Liu, XG; Xu, XH; Guo, YF; Chen, Y; Zhang, F; Pan, F; Zhu, XZ; Deng, HW				Zhang, Yin-Ping; Liu, Yao-Zhong; Guo, Yan; Liu, Xiao-Gang; Xu, Xiang-Hong; Guo, Yan-Fang; Chen, Yuan; Zhang, Feng; Pan, Feng; Zhu, Xue-Zhen; Deng, Hong-Wen			Pathway-Based Association Analyses Identified TRAIL Pathway for Osteoporotic Fractures	PLOS ONE			English	Article							NF-KAPPA-B; APOPTOSIS-INDUCING LIGAND; GENOME-WIDE ASSOCIATION; HUMAN OSTEOCLAST APOPTOSIS; BONE-MINERAL DENSITY; TNF FAMILY; RECEPTOR; DIFFERENTIATION; ACTIVATION; OSTEOPROTEGERIN	Introduction: Hip OF carries the highest morbidity and mortality. Previous studies revealed that individual genes/loci in the Tumor Necrosis Factor (TNF) -Related Apoptosis-Inducing Ligand (TRAIL) pathway were associated with bone metabolism. This study aims to verify the potential association between hip OF and TRAIL pathway. Methods: Using genome-wide genotype data from Affymetrix 500 K SNP arrays, we performed novel pathway-based association analyses for hip OF in 700 elderly Chinese Han subjects (350 with hip OF and 350 healthy matched controls). Results: The TRAIL pathway achieved a significant p value (p = 0.01) for association with hip OF. Among the 38 genes in the TRAIL pathway, seven genes achieved nominally significant association with hip OF (p<0.05); the TNFSF10 (TRAIL) gene obtained the most significant p value (p = 1.7x10(-4)). SNPs (rs719126, rs6533015, rs9594738, rs1805034, rs11160706) from five genes (CFLAR, NFKB1, TNFSF11, TNFRSF11A, TRAF3) of the pathway had minor alleles that appear to be protective to hip OF. SNPs (rs6445063 and rs4259415) from two genes (TNFSF10 and TNFRSF10B) of the pathway had minor alleles (A) that are associated with an increased risk of hip OF, with the ORs (odds ratios) of 16.51 (95%CI:3.83-71.24) and 1.37 (95%CI:1.08-1.74), respectively. Conclusions: Our study supports the potential role of the TRAIL pathway in the pathogenesis of hip OF in Chinese Han population. Further functional study of this pathway will be pursued to determine the mechanism by which it confers risk to hip OF.	[Zhang, Yin-Ping; Zhang, Feng] Xi An Jiao Tong Univ, Coll Med, Minist Educ, Key Lab Environm & Genes Related Dis, Xian 710049, Shaanxi, Peoples R China; [Liu, Yao-Zhong; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat, New Orleans, LA USA; [Guo, Yan; Liu, Xiao-Gang; Xu, Xiang-Hong; Guo, Yan-Fang; Chen, Yuan; Pan, Feng; Deng, Hong-Wen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710049, Shaanxi, Peoples R China; [Guo, Yan; Liu, Xiao-Gang; Xu, Xiang-Hong; Guo, Yan-Fang; Chen, Yuan; Pan, Feng; Deng, Hong-Wen] Inst Mol Genet, Xian 710049, Shaanxi, Peoples R China; [Zhu, Xue-Zhen; Deng, Hong-Wen] Univ Shanghai Sci & Technol, Shanghai, Peoples R China	Xi'an Jiaotong University; Tulane University; Xi'an Jiaotong University; University of Shanghai for Science & Technology	Zhang, YP (corresponding author), Xi An Jiao Tong Univ, Coll Med, Minist Educ, Key Lab Environm & Genes Related Dis, Xian 710049, Shaanxi, Peoples R China.	cathyzh@mail.xjtu.edu.cn; hdeng2@tulane.edu	Guo, Yan/G-8742-2014; Liu, Yaozhong/ABD-5544-2020	Guo, Yan/0000-0002-7364-2392; Deng, Hong-Wen/0000-0002-0387-8818	National Institutes of Health [R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081, 5R03TW008221, 5R01AR057049, R21 AA015973]; Guanghua Foundation [GH0203416]; Xi'an Jiaotong University, Shaanxi Province [2010K16-01]; National Natural Science Foundation of China [81000363, 31000554]; Huo Ying Dong Education Foundation; China Scholarship Council; Programs Foundation of Ministry of Education of China [20100201120058]; Shanghai Leading Academic Discipline Project [S30501]; Ministry of Education; University of Shanghai for Science and Technology; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057049, P50AR055081, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG027110, R01AG026564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guanghua Foundation; Xi'an Jiaotong University, Shaanxi Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huo Ying Dong Education Foundation; China Scholarship Council(China Scholarship Council); Programs Foundation of Ministry of Education of China(Ministry of Education, China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Ministry of Education; University of Shanghai for Science and Technology; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Investigators of this work were partially supported by grants from National Institutes of Health (R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081, 5R03TW008221, 5R01AR057049, and R21 AA015973). The study was also benefited from grants from Guanghua Foundation (GH0203416), Xi'an Jiaotong University, Shaanxi Province (2010K16-01), National Natural Science Foundation of China (81000363, 31000554), Huo Ying Dong Education Foundation, and China Scholarship Council, Programs Foundation of Ministry of Education of China (20100201120058), Shanghai Leading Academic Discipline Project (S30501), a grant from Ministry of Education to ShangHai University of Science and Technology, and startup fund from University of Shanghai for Science and Technology. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chamoux E, 2008, J CELL PHYSIOL, V216, P536, DOI 10.1002/jcp.21430; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen Y, 2010, BONE, V46, P129, DOI 10.1016/j.bone.2009.09.025; Colucci S, 2007, APOPTOSIS, V12, P1623, DOI 10.1007/s10495-007-0095-3; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Feng X, 2005, GENE, V350, P1, DOI 10.1016/j.gene.2005.01.014; Grimaud E, 2003, AM J PATHOL, V163, P2021, DOI 10.1016/S0002-9440(10)63560-2; Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148; Hauer J, 2005, P NATL ACAD SCI USA, V102, P2874, DOI 10.1073/pnas.0500187102; HSU PN, 2009, J IMMUNOL, V182, P14; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Mogi M, 2004, BONE, V35, P507, DOI 10.1016/j.bone.2004.03.003; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Ross PD, 1998, ENDOCRIN METAB CLIN, V27, P289, DOI 10.1016/S0889-8529(05)70006-2; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Sedger LM, 2002, EUR J IMMUNOL, V32, P2246, DOI 10.1002/1521-4141(200208)32:8<2246::AID-IMMU2246>3.0.CO;2-6; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Tranah GJ, 2008, CALCIFIED TISSUE INT, V83, P155, DOI 10.1007/s00223-008-9165-y; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Wakeyama H, 2007, J BONE MINER RES, V22, P1631, DOI 10.1359/JBMR.070619; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Xu JK, 2009, CYTOKINE GROWTH F R, V20, P7, DOI 10.1016/j.cytogfr.2008.11.007; Yao GQ, 2000, ENDOCRINOLOGY, V141, P2914, DOI 10.1210/en.141.8.2914; Yen ML, 2008, MOL IMMUNOL, V45, P2205, DOI 10.1016/j.molimm.2007.12.003; Zauli G, 2004, BLOOD, V104, P2044, DOI 10.1182/blood-2004-03-1196; Zhang LS, 2010, J BONE MINER RES, V25, P1572, DOI 10.1002/jbmr.36	39	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21835	10.1371/journal.pone.0021835	http://dx.doi.org/10.1371/journal.pone.0021835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760914	Green Published, gold, Green Submitted			2022-12-25	WOS:000292657200026
J	Bergeron, MJ; Boggavarapu, R; Meury, M; Ucurum, Z; Caron, L; Isenring, P; Hediger, MA; Fotiadis, D				Bergeron, Marc J.; Boggavarapu, Rajendra; Meury, Marcel; Ucurum, Zoehre; Caron, Luc; Isenring, Paul; Hediger, Matthias A.; Fotiadis, Dimitrios			Frog Oocytes to Unveil the Structure and Supramolecular Organization of Human Transport Proteins	PLOS ONE			English	Article							K+-CL-COTRANSPORTERS; XENOPUS-LAEVIS; IDENTIFICATION; EXPRESSION; TERMINUS; SYSTEM	Structural analyses of heterologously expressed mammalian membrane proteins remain a great challenge given that microgram to milligram amounts of correctly folded and highly purified proteins are required. Here, we present a novel method for the expression and affinity purification of recombinant mammalian and in particular human transport proteins in Xenopus laevis frog oocytes. The method was validated for four human and one murine transporter. Negative stain transmission electron microscopy (TEM) and single particle analysis (SPA) of two of these transporters, i.e., the potassium-chloride cotransporter 4 (KCC4) and the aquaporin-1 (AQP1) water channel, revealed the expected quaternary structures within homogeneous preparations, and thus correct protein folding and assembly. This is the first time a cation-chloride cotransporter (SLC12) family member is isolated, and its shape, dimensions, low-resolution structure and oligomeric state determined by TEM, i.e., by a direct method. Finally, we were able to grow 2D crystals of human AQP1. The ability of AQP1 to crystallize was a strong indicator for the structural integrity of the purified recombinant protein. This approach will open the way for the structure determination of many human membrane transporters taking full advantage of the Xenopus laevis oocyte expression system that generally yields robust functional expression.	[Bergeron, Marc J.; Boggavarapu, Rajendra; Meury, Marcel; Ucurum, Zoehre; Hediger, Matthias A.; Fotiadis, Dimitrios] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Bergeron, Marc J.; Boggavarapu, Rajendra; Meury, Marcel; Ucurum, Zoehre; Hediger, Matthias A.; Fotiadis, Dimitrios] Univ Bern, Swiss Natl Ctr Competence Res NCCR TransCure, Bern, Switzerland; [Bergeron, Marc J.] Univ Laval Robert Giffard, Ctr Rech, Unite Neurobiol Cellulaire, Quebec City, PQ, Canada; [Caron, Luc; Isenring, Paul] Univ Laval, Fac Med, Dept Med, Nephrol Res Grp,CHUQ Hotel Dieu Quebec Inst, Quebec City, PQ G1K 7P4, Canada	University of Bern; University of Bern; Laval University; Laval University	Bergeron, MJ (corresponding author), Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland.	dimitrios.fotiadis@ibmm.unibe.ch		Boggavarapu, Venkata/0000-0001-6312-5722; Hediger, Matthias/0000-0003-1946-027X	Swiss National Foundation for Scientific Research [31003A_125150]; Bern University Research Foundation; National Centre of Competence in Research (NCCR) TransCure; Canadian Institutes of Health Research (CIHR)	Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF)); Bern University Research Foundation; National Centre of Competence in Research (NCCR) TransCure(Swiss National Science Foundation (SNSF)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research has been supported by the Swiss National Foundation for Scientific Research (Grant 31003A_125150 to DF), the Bern University Research Foundation and the National Centre of Competence in Research (NCCR) TransCure. MJB was supported by a Canadian Institutes of Health Research (CIHR) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur R, 2006, FEBS LETT, V580, P1616, DOI 10.1016/j.febslet.2006.02.002; Bergeron MJ, 2006, J BIOL CHEM, V281, P15959, DOI 10.1074/jbc.M600015200; Bergeron MJ, 2009, J CELL PHYSIOL, V219, P787, DOI 10.1002/jcp.21725; Bergeron MJ, 2003, AM J PHYSIOL-RENAL, V285, pF68, DOI 10.1152/ajprenal.00032.2003; Fotiadis D, 2002, J MOL BIOL, V318, P1381, DOI 10.1016/S0022-2836(02)00143-2; Hogg RC, 2008, J NEUROSCI METH, V169, P65, DOI 10.1016/j.jneumeth.2007.11.028; Lee JK, 2010, CURR OPIN STRUC BIOL, V20, P464, DOI 10.1016/j.sbi.2010.05.004; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MARKOVICH D, 2007, PROTOCOL EXCHANGE, DOI DOI 10.1038/NPROT.2007.1331; Quick M, 2002, P NATL ACAD SCI USA, V99, P8597, DOI 10.1073/pnas.132266599; Romero MF, 1998, METHOD ENZYMOL, V296, P17; Saxton WO, 1996, J STRUCT BIOL, V116, P230, DOI 10.1006/jsbi.1996.0035; Simard CF, 2007, J BIOL CHEM, V282, P18083, DOI 10.1074/jbc.M607811200; Theis S, 2001, PROTEIN EXPRES PURIF, V22, P436, DOI 10.1006/prep.2001.1455; Wagner CA, 2000, CELL PHYSIOL BIOCHEM, V10, P1, DOI 10.1159/000016341; WALZ T, 1994, EMBO J, V13, P2985, DOI 10.1002/j.1460-2075.1994.tb06597.x; WILEY HS, 1981, J BIOL CHEM, V256, P8626; Yang WB, 2002, J BIOL CHEM, V277, P38350, DOI 10.1074/jbc.M202052200	18	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21901	10.1371/journal.pone.0021901	http://dx.doi.org/10.1371/journal.pone.0021901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760919	Green Published, Green Submitted, gold			2022-12-25	WOS:000292655400025
J	Sheridan, R; Lampe, K; Shanmukhappa, SK; Putnam, P; Keddache, M; Divanovic, S; Bezerra, J; Hoebe, K				Sheridan, Rachel; Lampe, Kristin; Shanmukhappa, Shiva Kumar; Putnam, Patrick; Keddache, Mehdi; Divanovic, Senad; Bezerra, Jorge; Hoebe, Kasper			Lampe1: An ENU-Germline Mutation Causing Spontaneous Hepatosteatosis Identified through Targeted Exon-Enrichment and Next-Generation Sequencing	PLOS ONE			English	Article							ACYL-COA OXIDASE; ACTIVATED RECEPTOR-ALPHA; INFLAMMATORY RESPONSE; GENETIC-ANALYSIS; BETA-OXIDATION; PPAR-ALPHA; CELL-DEATH; MICE; LIVER; OBESITY	Using a small scale ENU mutagenesis approach we identified a recessive germline mutant, designated Lampe1 that exhibited growth retardation and spontaneous hepatosteatosis. Low resolution mapping based on 20 intercrossed Lampe1 mice revealed linkage to a similar to 14 Mb interval on the distal site of chromosome 11 containing a total of 285 genes. Exons and 50 bp flanking sequences within the critical region were enriched with sequence capture microarrays and subsequently analyzed by next-generation sequencing. Using this approach 98.1 percent of the targeted DNA was covered with a depth of 10 or more reads per nucleotide and 3 homozygote mutations were identified. Two mutations represented intronic nucleotide changes whereas one mutation affected a splice donor site in intron 11-12 of Palmitoyl Acetyl-coenzyme A oxygenase-1 (Acox1), causing skipping of exon 12. Phenotyping of Acox1(Lampe1) mutants revealed a progression from hepatosteatosis to steatohepatitis, and ultimately hepatocellular carcinoma. The current approach provides a highly efficient and affordable method to identify causative mutations induced by ENU mutagenesis and animal models relevant to human pathology.	[Sheridan, Rachel] Cincinnati Childrens Hosp Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH USA; [Lampe, Kristin; Divanovic, Senad; Hoebe, Kasper] Cincinnati Childrens Hosp Res Fdn, Dept Mol Immunol, Cincinnati, OH USA; [Shanmukhappa, Shiva Kumar] Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Div Comparat Med & Pathol, Southborough, MA 01772 USA; [Putnam, Patrick; Keddache, Mehdi] Cincinnati Childrens Hosp Res Fdn, Dept Human Genet, Cincinnati, OH USA; [Bezerra, Jorge] Cincinnati Childrens Hosp Res Fdn, Dept Gastroenterol Hepatol & Nutr, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Harvard University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Sheridan, R (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH USA.	kasper.hoebe@cchmc.org		Hoebe, Kasper/0000-0002-3626-8098; Sheridan, Rachel/0000-0002-8318-8920	NIH; NIH/NCI [00290411]; NIH/NIAID [00426912]; PHS (Integrative Morphology Core of the Cincinnati Digestive Disease Research Core Center) [P30 DK078392]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS (Integrative Morphology Core of the Cincinnati Digestive Disease Research Core Center)(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by grants from the NIH, including NIH/NCI R21 Grant 00290411, NIH/NIAID RO1 Grant 00426912, and PHS Grant P30 DK078392 (Integrative Morphology Core of the Cincinnati Digestive Disease Research Core Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no	Barker DL, 2004, GENOME RES, V14, P901, DOI 10.1101/gr.1949704; Barnes MJ, 2010, J IMMUNOL, V184, P3743, DOI 10.4049/jimmunol.0903164; Barnes MJ, 2009, PLOS BIOL, V7, P513, DOI 10.1371/journal.pbio.1000051; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Beutler B, 2007, NAT IMMUNOL, V8, P659, DOI 10.1038/ni0707-659; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bianchini F, 2002, LANCET ONCOL, V3, P565, DOI 10.1016/S1470-2045(02)00849-5; Caldwell SH, 2004, GASTROENTEROLOGY, V127, pS97, DOI 10.1053/j.gastro.2004.09.021; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Concepcion D, 2004, GENETICS, V168, P953, DOI 10.1534/genetics.104.029843; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Fan CY, 1996, J BIOL CHEM, V271, P24698, DOI 10.1074/jbc.271.40.24698; Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639; Fan CY, 1996, ANN NY ACAD SCI, V804, P530, DOI 10.1111/j.1749-6632.1996.tb18643.x; Gordon H, 1936, AM J PATHOL, V12, P545; GORDON H, 1936, AM J PATHOL, V12, P541; HARDWICK JP, 1987, J BIOL CHEM, V262, P801; Hashimoto T, 1999, J BIOL CHEM, V274, P19228, DOI 10.1074/jbc.274.27.19228; Hoebe Kasper, 2009, V517, P239, DOI 10.1007/978-1-59745-541-1_15; Hostetler HA, 2005, J BIOL CHEM, V280, P18667, DOI 10.1074/jbc.M412062200; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; Justice MJ, 2000, MAMM GENOME, V11, P484, DOI 10.1007/s003350010094; Kile BT, 2003, NATURE, V425, P81, DOI 10.1038/nature01865; Kim SO, 2003, J BIOL CHEM, V278, P7413, DOI 10.1074/jbc.M209279200; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Kurochkin IV, 2007, EMBO J, V26, P835, DOI 10.1038/sj.emboj.7601525; MIURA S, 1992, J BIOL CHEM, V267, P14405; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Rao MS, 2004, HEPATOLOGY, V40, P783, DOI 10.1002/hep.20453; REDDY JK, 1986, P NATL ACAD SCI USA, V83, P1747, DOI 10.1073/pnas.83.6.1747; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; WANLESS IR, 1995, HEPATOLOGY, V22, P983, DOI 10.1002/hep.1840220341; Yeldandi AV, 2000, MUTAT RES-FUND MOL M, V448, P159, DOI 10.1016/S0027-5107(99)00234-1	35	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21979	10.1371/journal.pone.0021979	http://dx.doi.org/10.1371/journal.pone.0021979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760938	Green Submitted, Green Published, gold			2022-12-25	WOS:000292655400033
J	Gamfeldt, L; Hillebrand, H				Gamfeldt, Lars; Hillebrand, Helmut			Effects of Total Resources, Resource Ratios, and Species Richness on Algal Productivity and Evenness at Both Metacommunity and Local Scales	PLOS ONE			English	Article							PRODUCER DIVERSITY; DRIVE DIVERSITY; VICE-VERSA; BIODIVERSITY; HETEROGENEITY; MARINE; AVAILABILITY; COMPETITION; PHOSPHORUS; LIMITATION	The study of the interrelationship between productivity and biodiversity is a major research field in ecology. Theory predicts that if essential resources are heterogeneously distributed across a metacommunity, single species may dominate productivity in individual metacommunity patches, but a mixture of species will maximize productivity across the whole metacommunity. It also predicts that a balanced supply of resources within local patches should favor species coexistence, whereas resource imbalance would favor the dominance of one species. We performed an experiment with five freshwater algal species to study the effects of total supply of resources, their ratios, and species richness on biovolume production and evenness at the scale of both local patches and metacommunities. Generally, algal biovolume increased, whereas algal resource use efficiency (RUE) and evenness decreased with increasing total supply of resources in mixed communities containing all five species. In contrast to predictions for biovolume production, the species mixtures did not outperform all monocultures at the scale of metacommunities. In other words, we observed no general transgressive overyielding. However, RUE was always higher in mixtures than predicted from monocultures, and analyses indicate that resource partitioning or facilitation in mixtures resulted in higher-than-expected productivity at high resource supply. Contrasting our predictions for the local scale, balanced supply of resources did not generally favor higher local evenness, however lowest evenness was confined to patches with the most imbalanced supply. Thus, our study provides mixed support for recent theoretical advancements to understand biodiversity-productivity relationships.	[Gamfeldt, Lars; Hillebrand, Helmut] Univ Cologne, Inst Bot, D-5000 Cologne, Germany; [Gamfeldt, Lars] Univ Gothenburg, Dept Marine Ecol, Gothenburg, Sweden; [Hillebrand, Helmut] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, D-26111 Oldenburg, Germany	University of Cologne; University of Gothenburg; Carl von Ossietzky Universitat Oldenburg	Gamfeldt, L (corresponding author), Univ Cologne, Inst Bot, Gyrhofstr 15, D-5000 Cologne, Germany.	lars.gamfeldt@marecol.gu.se	Hillebrand, Helmut/I-1717-2014	Hillebrand, Helmut/0000-0001-7449-1613	Swedish Research Council Formas [2006-1173]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by a postdoc grant (2006-1173) from the Swedish Research Council Formas (www.formas.se) to LG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; Braakhekke WG, 1999, J VEG SCI, V10, P187, DOI 10.2307/3237140; Bruno JF, 2005, ECOL LETT, V8, P1165, DOI 10.1111/j.1461-0248.2005.00823.x; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Cardinale BJ, 2009, ECOLOGY, V90, P1227, DOI 10.1890/08-1038.1; Cardinale BJ, 2009, ECOL LETT, V12, P475, DOI 10.1111/j.1461-0248.2009.01317.x; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Gamfeldt L, 2005, ECOL LETT, V8, P696, DOI 10.1111/j.1461-0248.2005.00765.x; Gause G. F., 1934, STRUGGLE EXISTENCE; Griffin JN, 2009, OIKOS, V118, P1335, DOI 10.1111/j.1600-0706.2009.17572.x; Gross K, 2007, AM NAT, V170, P207, DOI 10.1086/518950; Guildford SJ, 2000, LIMNOL OCEANOGR, V45, P1213, DOI 10.4319/lo.2000.45.6.1213; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hillebrand H, 2011, AM NATURALI IN PRESS; Hillebrand H, 2007, P NATL ACAD SCI USA, V104, P10904, DOI 10.1073/pnas.0701918104; Interlandi SJ, 2001, ECOLOGY, V82, P1270, DOI 10.2307/2679988; Kaiser J, 2000, SCIENCE, V289, P1282, DOI 10.1126/science.289.5483.1282; KANE TC, 1976, ECOLOGY, V57, P793, DOI 10.2307/1936192; Kolasa J., 1991, ECOLOGICAL HETEROGEN, V86, P1, DOI DOI 10.1007/978-1-4612-3062-5_1; Langenheder S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010834; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Magurran A E, 1988, ECOLOGICAL DIVERSITY; Matthiessen B, 2010, HYDROBIOLOGIA, V653, P65, DOI 10.1007/s10750-010-0349-x; MCQUAID CD, 1990, OECOLOGIA, V84, P142, DOI 10.1007/BF00665608; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Naeem S, 2002, ECOLOGY, V83, P2925; Naeem S., 2009, BIODIVERSITY ECOSYST; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; Ptacnik R, 2010, ADV ECOL RES, V43, P1, DOI 10.1016/S0065-2504(10)43001-9; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; REDFIELD AC, 1958, AM SCI, V46, P205; Replansky T, 2009, OIKOS, V118, P233, DOI 10.1111/j.1600-0706.2008.16948.x; Rosenzweig Michael L., 1993, P52; Salles JF, 2009, ECOLOGY, V90, P3324, DOI 10.1890/09-0188.1; Schmid B., 2009, BIODIVERSITY ECOSYST; Schnitzer SA, 2011, ECOLOGY, V92, P296, DOI 10.1890/10-0773.1; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; Tilman D., 1982, Monographs in Population Biology, pi; TITMAN D, 1976, SCIENCE, V192, P463, DOI 10.1126/science.192.4238.463; Tiunov AV, 2005, ECOL LETT, V8, P618, DOI 10.1111/j.1461-0248.2005.00757.x; Trenbath B. R., 1974, Advances in Agronomy, V26, P177, DOI 10.1016/S0065-2113(08)60871-8; Tylianakis JM, 2008, PLOS BIOL, V6, P947, DOI 10.1371/journal.pbio.0060122; Venail PA, 2008, NATURE, V452, P210, DOI 10.1038/nature06554; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Weis JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002825; Zhang QG, 2006, OIKOS, V114, P385, DOI 10.1111/j.2006.0030-1299.14723.x	50	28	28	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21972	10.1371/journal.pone.0021972	http://dx.doi.org/10.1371/journal.pone.0021972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755016	gold, Green Submitted, Green Published			2022-12-25	WOS:000292632000043
J	Henningsson, F; Ding, ZJ; Dahlin, JS; Linkevicius, M; Carlsson, F; Gronvik, KO; Hallgren, J; Heyman, B				Henningsson, Frida; Ding, Zhoujie; Dahlin, Joakim S.; Linkevicius, Marius; Carlsson, Fredrik; Gronvik, Kjell-Olov; Hallgren, Jenny; Heyman, Birgitta			IgE-Mediated Enhancement of CD4(+) T Cell Responses in Mice Requires Antigen Presentation by CD11c(+) Cells and Not by B Cells	PLOS ONE			English	Article							LOW-AFFINITY RECEPTOR; IN-VIVO; ANTIBODY-RESPONSES; PRESENTING CELLS; DENDRITIC CELLS; MARGINAL ZONE; IMMUNE-COMPLEXES; IMMUNOGLOBULIN-E; CD23; COMPLEMENT	IgE antibodies, administered to mice together with their specific antigen, enhance antibody and CD4(+) T cell responses to this antigen. The effect is dependent on the low affinity receptor for IgE, CD23, and the receptor must be expressed on B cells. In vitro, IgE-antigen complexes are endocytosed via CD23 on B cells, which subsequently present the antigen to CD4(+) T cells. This mechanism has been suggested to explain also IgE-mediated enhancement of immune responses in vivo. We recently found that CD23(+) B cells capture IgE-antigen complexes in peripheral blood and rapidly transport them to B cell follicles in the spleen. This provides an alternative explanation for the requirement for CD23(+) B cells. The aim of the present study was to determine whether B-cell mediated antigen presentation of IgE-antigen complexes explains the enhancing effect of IgE on immune responses in vivo. The ability of spleen cells, taken from mice 1-4 h after immunization with IgE-antigen, to present antigen to specific CD4(+) T cells was analyzed. Antigen presentation was intact when spleens were depleted of CD19(+) cells (i.e., primarily B cells) but was severely impaired after depletion of CD11c(+) cells (i.e., primarily dendritic cells). In agreement with this, the ability of IgE to enhance proliferation of CD4(+) T cells was abolished in CD11c-DTR mice conditionally depleted of CD11c(+) cells. Finally, the lack of IgE-mediated enhancemen of CD4(+) T cell responses in CD23(-/-) mice could be rescued by transfer of MHC-II-compatible as well as by MHC-II-incompatible CD23(+) B cells. These findings argue against the idea that IgE-mediated enhancement of specific CD4(+) T cell responses in vivo is caused by increased antigen presentation by B cells. A model where CD23(+) B cells act as antigen transporting cells, delivering antigen to CD11c(+) cells for presentation to T cells is consistent with available experimental data.	[Henningsson, Frida; Ding, Zhoujie; Dahlin, Joakim S.; Linkevicius, Marius; Gronvik, Kjell-Olov; Hallgren, Jenny; Heyman, Birgitta] Uppsala Univ, BMC, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Carlsson, Fredrik] Uppsala Univ, Dept Immunol Pathol & Genet, Uppsala, Sweden; [Gronvik, Kjell-Olov] Natl Vet Inst, S-75007 Uppsala, Sweden	Uppsala University; Uppsala University; National Veterinary Institute SVA	Henningsson, F (corresponding author), Uppsala Univ, BMC, Dept Med Biochem & Microbiol, Uppsala, Sweden.	birgitta.heyman@imbim.uu.se	Hallgren Martinsson, Jenny/AAZ-5937-2021; Dahlin, Joakim/J-1057-2019; Hallgren Martinsson, Jenny/AAZ-6356-2021	Hallgren Martinsson, Jenny/0000-0002-3685-5364; Dahlin, Joakim/0000-0003-3007-9875; Heyman, Birgitta/0000-0003-0869-0483; Linkevicius, Marius/0000-0001-5760-2721; Ding, Zhoujie/0000-0001-8765-8814	Swedish Research Council; King Gustaf V:s 80 Years Foundation; Ellen, Walter and Lennart Hesselman's Foundation; Hans von Kantzow's Foundation; Ollie and Elof Ericsson's Foundation; Linne Foundation; Ake Wiberg Foundation; Magnus Bergvall Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); King Gustaf V:s 80 Years Foundation; Ellen, Walter and Lennart Hesselman's Foundation; Hans von Kantzow's Foundation; Ollie and Elof Ericsson's Foundation; Linne Foundation; Ake Wiberg Foundation; Magnus Bergvall Foundation	This work was supported by grants from the Swedish Research Council (www.vr.se); King Gustaf V:s 80 Years Foundation (ams.orbelon.com/gv80/); Ellen, Walter and Lennart Hesselman's Foundation; Hans von Kantzow's Foundation; Ollie and Elof Ericsson's Foundation (oestiftelse.se/); Linne Foundation; Ake Wiberg Foundation (www.ake-wiberg.com/); and Magnus Bergvall Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attanavanich K, 2004, J IMMUNOL, V172, P803, DOI 10.4049/jimmunol.172.2.803; Bar-On L, 2010, METHODS MOL BIOL, V595, P429, DOI 10.1007/978-1-60761-421-0_28; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Boackle SA, 1997, EUR J IMMUNOL, V27, P122, DOI 10.1002/eji.1830270119; Bowman J M, 1988, Transfus Med Rev, V2, P129, DOI 10.1016/S0887-7963(88)70039-5; Carlsson F, 2007, SCAND J IMMUNOL, V66, P261, DOI 10.1111/j.1365-3083.2007.01953.x; Carlsson F, 2009, SCAND J IMMUNOL, V70, P77, DOI 10.1111/j.1365-3083.2009.02274.x; Cherukuri A, 2001, J IMMUNOL, V167, P163, DOI 10.4049/jimmunol.167.1.163; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; CLARKE C A, 1963, Br Med J, V1, P979; CONSTANT S, 1995, J IMMUNOL, V155, P3734; Constant SL, 1999, J IMMUNOL, V162, P5695; Crawford A, 2006, J IMMUNOL, V176, P3498, DOI 10.4049/jimmunol.176.6.3498; de Stahl TD, 2003, J EXP MED, V197, P1183, DOI 10.1084/jem.20022232; DIERKS SE, 1993, J IMMUNOL, V150, P2372; EYNON EE, 1992, J EXP MED, V175, P131, DOI 10.1084/jem.175.1.131; Ferguson AR, 2004, INT IMMUNOL, V16, P1411, DOI 10.1093/intimm/dxh142; Ford JW, 2009, CELL IMMUNOL, V254, P124, DOI 10.1016/j.cellimm.2008.08.003; FUCHS EJ, 1992, SCIENCE, V258, P1156, DOI 10.1126/science.1439825; FUJIWARA H, 1994, P NATL ACAD SCI USA, V91, P6835, DOI 10.1073/pnas.91.15.6835; Getahun A, 2005, J IMMUNOL, V175, P1473, DOI 10.4049/jimmunol.175.3.1473; Good A., 1980, SELECTED METHODS CEL, P343; Griffith QK, 2011, J IMMUNOL, V186, P1060, DOI 10.4049/jimmunol.1002709; Gustavsson S, 2000, J IMMUNOL, V164, P3990, DOI 10.4049/jimmunol.164.8.3990; GUSTAVSSON S, 1994, J IMMUNOL, V152, P4793; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; HEYMAN B, 1988, J EXP MED, V167, P1999, DOI 10.1084/jem.167.6.1999; HEYMAN B, 1993, EUR J IMMUNOL, V23, P1739, DOI 10.1002/eji.1830230754; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; Hjelm F, 2008, J IMMUNOL, V180, P6604, DOI 10.4049/jimmunol.180.10.6604; HJULSTROM S, 1995, EUR J IMMUNOL, V25, P1469, DOI 10.1002/eji.1830250552; Huang NN, 2005, J IMMUNOL, V175, P7125, DOI 10.4049/jimmunol.175.11.7125; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Karlsson MCI, 2001, J IMMUNOL, V167, P5558, DOI 10.4049/jimmunol.167.10.5558; Karlsson MCI, 1999, P NATL ACAD SCI USA, V96, P2244, DOI 10.1073/pnas.96.5.2244; KEHRY MR, 1989, P NATL ACAD SCI USA, V86, P7556, DOI 10.1073/pnas.86.19.7556; Lewis G, 2004, IMMUNOGENETICS, V56, P564, DOI 10.1007/s00251-004-0728-4; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; MAEDA K, 1992, J IMMUNOL, V148, P2340; Mathews JA, 2010, J BIOL CHEM, V285, P37531, DOI 10.1074/jbc.M110.141556; McGreal EP, 2005, CURR OPIN IMMUNOL, V17, P18, DOI 10.1016/j.coi.2004.12.001; Milich DR, 1997, P NATL ACAD SCI USA, V94, P14648, DOI 10.1073/pnas.94.26.14648; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Mwinzi PNM, 2009, J INFECT DIS, V199, P272, DOI 10.1086/595792; Palaniyandi S, 2011, J IMMUNOL, V186, P3484, DOI 10.4049/jimmunol.1002146; Payet ME, 1999, J IMMUNOL, V163, P217; PIRRON U, 1990, EUR J IMMUNOL, V20, P1547, DOI 10.1002/eji.1830200721; RAO M, 1987, J IMMUNOL, V138, P1845; Rechavi O, 2009, FEBS LETT, V583, P1792, DOI 10.1016/j.febslet.2009.03.014; RONCHESE F, 1993, J EXP MED, V177, P679, DOI 10.1084/jem.177.3.679; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; SANTAMARIA LF, 1993, HUM IMMUNOL, V37, P23, DOI 10.1016/0198-8859(93)90139-R; THORNTON BP, 1994, J IMMUNOL, V152, P1727; Tu Y, 2005, GASTROENTEROLOGY, V129, P928, DOI 10.1053/j.gastro.2005.06.014; VANDERHEIJDEN FL, 1993, J IMMUNOL, V150, P3643; von Behring E., 1892, Z HYG INFEKTIONSKR, V12, P10; Wernersson S, 1999, J IMMUNOL, V163, P618; Westman S, 1997, SCAND J IMMUNOL, V46, P10, DOI 10.1046/j.1365-3083.1997.d01-89.x; Yang PC, 2000, J CLIN INVEST, V106, P879, DOI 10.1172/JCI9258; Youd ME, 2002, EUR J IMMUNOL, V32, P2328, DOI 10.1002/1521-4141(200208)32:8<2328::AID-IMMU2328>3.0.CO;2-T; Yu LCH, 2003, AM J PHYSIOL-GASTR L, V285, pG223, DOI 10.1152/ajpgi.00445.2002; YU P, 1994, NATURE, V369, P753, DOI 10.1038/369753a0	63	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21760	10.1371/journal.pone.0021760	http://dx.doi.org/10.1371/journal.pone.0021760			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21765910	Green Submitted, Green Published, gold			2022-12-25	WOS:000292632000024
J	Millson, SH; Chua, CS; Roe, SM; Polier, S; Solovieva, S; Pearl, LH; Sim, TS; Prodromou, C; Piper, PW				Millson, Stefan H.; Chua, Chun-Song; Roe, S. Mark; Polier, Sigrun; Solovieva, Svetlana; Pearl, Laurence H.; Sim, Tiow-Suan; Prodromou, Chrisostomos; Piper, Peter W.			Features of the Streptomyces hygroscopicus HtpG reveal how partial geldanamycin resistance can arise with mutation to the ATP binding pocket of a eukaryotic Hsp90	FASEB JOURNAL			English	Article						cancer drug resistance; yeast; Plasmodium falciparum; TRAP1; macbecin	SHOCK-PROTEIN 90; MOLECULAR CHAPERONE; NAD(P)H-QUINONE OXIDOREDUCTASE-1; BENZOQUINONE ANSAMYCINS; STRUCTURAL BASIS; INHIBITORS; EXPRESSION; CANCER; CELLS; YEAST	Much attention is focused on the benzoquinone ansamycins as anticancer agents, with several derivatives of the natural product geldanamycin (GdA) now in clinical trials. These drugs are selective inhibitors of Hsp90, a molecular chaperone vital for many of the activities that drive cancer progression. Mutational changes to their interaction site, the extremely conserved ATP binding site of Hsp90, would mostly be predicted to inactivate the chaperone. As a result, drug resistance should not arise readily this way. Nevertheless, Streptomyces hygroscopicus, the actinomycete that produces GdA, has evolved an Hsp90 family protein (HtpG) that lacks GdA binding. It is altered in certain of the highly conserved amino acids making contacts to this antibiotic in crystal structures of GdA bound to eukaryotic forms of Hsp90. Two of these amino acid changes, located on one side of the nucleotide-binding cleft, weakened GdA/Hsp90 binding and conferred partial GdA resistance when inserted into the endogenous Hsp90 of yeast cells. Crystal structures revealed their main effect to be a weakening of interactions with the C-12 methoxy group of the GdA ansamycin ring. This is the first study to demonstrate that partial GdA resistance is possible by mutation within the ATP binding pocket of Hsp90.-Millson, S. H., Chua, C.-S., Roe, S. M., Polier, S., Solovieva, S., Pearl, L. H., Sim, T.-S., Prodromou, C., Piper, P. W. Features of the Streptomyces hygroscopicus HtpG reveal how partial geldanamycin resistance can arise with mutation to the ATP binding pocket of a eukaryotic Hsp90. FASEB J. 25, 3828-3837 (2011). www.fasebj.org	[Piper, Peter W.] Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Chua, Chun-Song; Sim, Tiow-Suan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Roe, S. Mark; Polier, Sigrun; Pearl, Laurence H.; Prodromou, Chrisostomos] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sheffield; National University of Singapore; University of Sussex	Piper, PW (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	chris.prodromou@sussex.ac.uk; peter.piper@sheffield.ac.uk	Prodromou, Chrisostomos/ABA-9133-2021	Prodromou, Chrisostomos/0000-0003-4320-1147; Millson, Stefan/0000-0001-5989-5759; Roe, Mark/0000-0002-7371-9855; Piper, Peter William/0000-0003-4019-2329; Pearl, Laurence/0000-0002-6910-1809	Cancer Research UK [C28248/A9058, C309/A8274]; Sir Stewart Halley Trust; Yorkshire Cancer Research	Cancer Research UK(Cancer Research UK); Sir Stewart Halley Trust; Yorkshire Cancer Research	This work was supported by Cancer Research UK project (C28248/A9058, C309/A8274) grants, the Sir Stewart Halley Trust, and Yorkshire Cancer Research. The authors are indebted to Swee Sharp and Paul Workman (Institute of Cancer Research, London, UK) for providing NVP-AUY922 and VER49009.	Bagatell R, 2000, CLIN CANCER RES, V6, P3312; Brough PA, 2008, J MED CHEM, V51, P196, DOI 10.1021/jm701018h; Chen B, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-156; Corbett KD, 2010, PROTEINS, V78, P2738, DOI 10.1002/prot.22799; David CL, 2003, CELL STRESS CHAPERON, V8, P93, DOI 10.1379/1466-1268(2003)8<93:EOAUDH>2.0.CO;2; DEBOER C, 1970, J ANTIBIOT, V23, P442, DOI 10.7164/antibiotics.23.442; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Gaspar N, 2009, CANCER RES, V69, P1966, DOI 10.1158/0008-5472.CAN-08-3131; Guo WC, 2005, CANCER RES, V65, P10006, DOI 10.1158/0008-5472.CAN-05-2029; Guo WC, 2006, MOL PHARMACOL, V70, P1194, DOI 10.1124/mol.106.025643; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kang MJ, 2010, J IND MICROBIOL BIOT, V37, P35, DOI 10.1007/s10295-009-0641-9; Kelland LR, 1999, J NATL CANCER I, V91, P1940, DOI 10.1093/jnci/91.22.1940; Krissinel EB, 2004, ACTA CRYSTALLOGR D, V60, P2250, DOI 10.1107/S0907444904027167; Louvion JF, 1996, P NATL ACAD SCI USA, V93, P13937, DOI 10.1073/pnas.93.24.13937; Martin CJ, 2008, J MED CHEM, V51, P2853, DOI 10.1021/jm701558c; McCollum AK, 2008, CANCER RES, V68, P7419, DOI 10.1158/0008-5472.CAN-07-5175; McCollum AK, 2006, CANCER RES, V66, P10967, DOI 10.1158/0008-5472.CAN-06-1629; McDonald E, 2006, CURR TOP MED CHEM, V6, P1193, DOI 10.2174/156802606777812086; McDonald E, 2006, CURR TOP MED CHEM, V6, P1091, DOI 10.2174/156802606777812004; Millson SH, 2010, BIOCHEM PHARMACOL, V79, P1581, DOI 10.1016/j.bcp.2010.01.031; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; PARDO JM, 1985, J GEN MICROBIOL, V131, P1289; Piper PW, 2003, GENE, V302, P165, DOI 10.1016/S0378-1119(02)01102-2; Porter JR, 2009, CURR TOP MED CHEM, V9, P1386, DOI 10.2174/156802609789895719; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Prodromou C, 2009, ACS CHEM BIOL, V4, P289, DOI 10.1021/cb9000316; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; SASAKI K, 1979, J ANTIBIOT, V32, P849, DOI 10.7164/antibiotics.32.849; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 1996, MOL ENDOCRINOL, V10, P705, DOI 10.1210/me.10.6.705; Zhang H, 2010, INT J CANCER, V126, P1226, DOI 10.1002/ijc.24825; Zurawska A, 2010, BBA-MOL CELL RES, V1803, P575, DOI 10.1016/j.bbamcr.2010.03.002	41	22	23	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2011	25	11					3828	3837		10.1096/fj.11-188821	http://dx.doi.org/10.1096/fj.11-188821			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21778327				2022-12-25	WOS:000296723100008
J	Carnini, C; Accomazzo, MR; Borroni, E; Vitellaro-Zuccarello, L; Durand, T; Folco, G; Rovati, GE; Capra, V; Sala, A				Carnini, Chiara; Accomazzo, Maria Rosa; Borroni, Emanuele; Vitellaro-Zuccarello, Laura; Durand, Thierry; Folco, Giancarlo; Rovati, G. Enrico; Capra, Valerie; Sala, Angelo			Synthesis of cysteinyl leukotrienes in human endothelial cells: subcellular localization and autocrine signaling through the CysLT(2) receptor	FASEB JOURNAL			English	Article						intracellular Ca2+; signal transduction; microsomal glutathione S-transferase-II	ISCHEMIA-REPERFUSION INJURY; TRANSCELLULAR BIOSYNTHESIS; C-4 SYNTHASE; 5-LIPOXYGENASE-ACTIVATING PROTEIN; POLYMORPHONUCLEAR LEUKOCYTES; MYOCARDIAL-INFARCTION; LIGAND-BINDING; IN-VIVO; EXPRESSION; INHIBITOR	The purpose of this study was to characterize enzyme, receptor, and signaling involved in the synthesis and the activity of cysteinyl leukotrienes (cys-LTs) in human umbilical vein endothelial cells (HUVECs). We used primary cultures of HUVECs and evaluated the formation of cys-LTs by RP-HPLC. Suicide inactivation and subcellular localization of the enzyme responsible for the conversion of leukotriene (LT) A(4) into LTC4 were studied by repeated incubations with LTA(4) and immunogold electron microscopy. The CysLT(2) receptor in HUVECs was characterized by equilibrium binding studies, Western blot analysis, and immunohistochemistry. Concentration-response curves in HUVECs and in transfected COS-7 cells were used to characterize a novel specific CysLT(2) receptor antagonist (pA(2) of 8.33 and 6.79 against CysLT(2) and CysLT(1) receptors, respectively). The results obtained provide evidence that the mGST-II synthesizing LTC4 in HUVECs is pharmacologically distinguishable from the LTC4-synthase (IC50 of MK886 <5 mu M for LTC4-synthase and >30 mu M for mGST-II), is not suicide-inactivated and is strategically located on endothelial transport vesicles. The CysLT(2) receptor is responsible for the increase in intracellular Ca2+ following exposure of HUVECs to cys-LTs and is coupled to a pertussis toxin-insensitive G(q) protein. The synthesis of cys-LTs from LTA(4) by endothelial cells is directly associated with the activation of the CysLT(2) receptor (EC50 0.64 mu M) in a typical autocrine fashion.-Carnini, C., Accomazzo, M. R., Borroni, E., Vitellaro-Zuccarello, L., Durand, T., Folco, G., Rovati, G. E., Capra, V., Sala, S. Synthesis of cysteinyl leukotrienes in human endothelial cells: subcellular localization and autocrine signaling through the CysLT(2) receptor. FASEB J. 25, 3519-3528 (2011). www.fasebj.org	[Carnini, Chiara; Accomazzo, Maria Rosa; Borroni, Emanuele; Folco, Giancarlo; Rovati, G. Enrico; Capra, Valerie; Sala, Angelo] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; [Vitellaro-Zuccarello, Laura] Univ Milan, Dept Biomol Sci & Biotechnol, I-20133 Milan, Italy; [Durand, Thierry] Univ Montpellier, CNRS, IBMM, Fac Pharm,UMR 5247,UM 1,UM 2, F-34059 Montpellier, France	University of Milan; University of Milan; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier	Sala, A (corresponding author), Univ Milan, Dept Pharmacol Sci, Via Balzaretti 9, I-20133 Milan, Italy.	angelo.sala@unimi.it	Sala, Angelo/H-5478-2019; Capra, Valérie/B-6225-2008	Capra, Valérie/0000-0003-3956-0833; Sala, Angelo/0000-0001-9290-0257; Rovati, G.Enrico/0000-0002-8788-9783	European Community [LSHM-CT-2004-005033]; Italian Ministry of University and Research	European Community(European Commission); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	The authors thank Dr. Alberto Prada (Azienda Ospedaliera, Garbagnate Milanese, Milan, Italy), Dr. Alberto Zanini (Ospedale Fatebenefratelli, Erba, Italy), and Prof. Luciana Mussoni (Universita di Milano, Milan, Italy) for the collaboration in obtaining the umbilical cords; informed consent was obtained from donors of the umbilical cords. This work was carried out with the support of the European Community (LSHM-CT-2004-005033 to A.S., G.E.R., and G.F.), and of the Italian Ministry of University and Research (FIRB 2001 to G.F. and A.S.; PRIN 2005 to A.S.).	Capra V, 1998, MOL PHARMACOL, V53, P750, DOI 10.1124/mol.53.4.750; Capra V, 2005, J CELL SCI, V118, P5625, DOI 10.1242/jcs.02668; Capra V, 2003, PROSTAG OTH LIPID M, V71, P235, DOI 10.1016/S1098-8823(03)00045-5; Capra V, 2007, MED RES REV, V27, P469, DOI 10.1002/med.20071; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; De Caterina R, 2010, EUR J CLIN INVEST, V40, P258, DOI 10.1111/j.1365-2362.2010.02261.x; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; Di Gennaro A, 2004, FASEB J, V18, P842, DOI 10.1096/fj.03-0599fje; FEINMARK SJ, 1986, J BIOL CHEM, V261, P6466; FITZPATRICK FA, 1994, ANN NY ACAD SCI, V744, P31, DOI 10.1111/j.1749-6632.1994.tb52721.x; Folco G, 2000, AM J RESP CRIT CARE, V161, pS112, DOI 10.1164/ajrccm.161.supplement_1.ltta-22; GORDON PB, 1983, IN VITRO CELL DEV B, V19, P661; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hakonarson H, 2005, JAMA-J AM MED ASSOC, V293, P2245, DOI 10.1001/jama.293.18.2245; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Helgadottir A, 2005, AM J HUM GENET, V76, P505, DOI 10.1086/428066; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Iovannisci DM, 2007, ARTERIOSCL THROM VAS, V27, P394, DOI 10.1161/01.ATV.0000252680.72734.10; Jiang W, 2008, AM J PATHOL, V172, P592, DOI 10.2353/ajpath.2008.070834; Kamohara M, 2001, BIOCHEM BIOPH RES CO, V287, P1088, DOI 10.1006/bbrc.2001.5695; LAM BK, 1989, J BIOL CHEM, V264, P12885; Lefer A M, 1988, Prog Clin Biol Res, V264, P101; Lotzer K, 2003, ARTERIOSCL THROM VAS, V23, pE32, DOI 10.1161/01.ATV.0000082690.23131.CB; MACIAG T, 1982, J BIOL CHEM, V257, P5333; Maekawa A, 2008, P NATL ACAD SCI USA, V105, P16695, DOI 10.1073/pnas.0808993105; MCINTYRE TM, 1986, P NATL ACAD SCI USA, V83, P2204, DOI 10.1073/pnas.83.7.2204; Mechiche H, 2004, J CARDIOVASC PHARM, V43, P113, DOI 10.1097/00005344-200401000-00017; Mellor EA, 2003, P NATL ACAD SCI USA, V100, P11589, DOI 10.1073/pnas.2034927100; Mita H, 2001, CLIN EXP ALLERGY, V31, P1714, DOI 10.1046/j.1365-2222.2001.01184.x; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MURPHY RC, 1979, P NATL ACAD SCI USA, V76, P4275, DOI 10.1073/pnas.76.9.4275; PATSCHEKE H, 1981, HAEMOSTASIS, V10, P14; Poeckel D, 2010, CARDIOVASC RES, V86, P243, DOI 10.1093/cvr/cvq016; Riccioni G, 2008, J LEUKOCYTE BIOL, V84, P1374, DOI 10.1189/jlb.0808476; Rossoni G, 1996, J PHARMACOL EXP THER, V276, P335; Rovati GE, 2007, THESCIENTIFICWORLDJO, V7, P1375, DOI 10.1100/tsw.2007.185; Rovati GE, 1998, TRENDS PHARMACOL SCI, V19, P365; Sala A, 1996, J BIOL CHEM, V271, P17944, DOI 10.1074/jbc.271.30.17944; Sala A, 1997, BIOCHEM J, V328, P225, DOI 10.1042/bj3280225; Sala A, 2000, CIRCULATION, V101, P1436, DOI 10.1161/01.CIR.101.12.1436; Schroder O, 2003, BIOCHEM BIOPH RES CO, V312, P271, DOI 10.1016/j.bbrc.2003.10.115; Sjostrom M, 2003, ARTERIOSCL THROM VAS, V23, pE37, DOI 10.1161/01.ATV.0000082689.46538.DF; Sjostrom M, 2001, EUR J BIOCHEM, V268, P2578, DOI 10.1046/j.1432-1327.2001.02142.x; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tardif JC, 2010, CIRC-CARDIOVASC IMAG, V3, P298, DOI 10.1161/CIRCIMAGING.110.937169; Uzonyi B, 2006, P NATL ACAD SCI USA, V103, P6326, DOI 10.1073/pnas.0601223103; Welt K, 2000, EXP TOXICOL PATHOL, V52, P27, DOI 10.1016/S0940-2993(00)80012-3; Woszczek G, 2007, J IMMUNOL, V178, P5262, DOI 10.4049/jimmunol.178.8.5262; Yuan YM, 2009, J PHARMACOL SCI, V109, P285, DOI 10.1254/jphs.08321FP; Zarini S, 2009, P NATL ACAD SCI USA, V106, P8296, DOI 10.1073/pnas.0903851106; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099; Zhou GY, 2009, VASC PHARMACOL, V50, P171, DOI 10.1016/j.vph.2009.01.006	52	25	25	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2011	25	10					3519	3528		10.1096/fj.10-177030	http://dx.doi.org/10.1096/fj.10-177030			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21753081				2022-12-25	WOS:000295356400022
J	Hoffmann, BR; Annis, DS; Mosher, DF				Hoffmann, Brian R.; Annis, Douglas S.; Mosher, Deane F.			Reactivity of the N-terminal Region of Fibronectin Protein to Transglutaminase 2 and Factor XIIIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLASMA FIBRONECTIN; COAGULATION-FACTOR-XIIIA; COLD-INSOLUBLE GLOBULIN; GELATIN-BINDING DOMAIN; ACTIVATED FACTOR-XIII; BETA-SANDWICH DOMAIN; CROSS-LINKING; TISSUE TRANSGLUTAMINASE; CONFORMATIONAL-CHANGE; GLUTAMINE RESIDUES	Transglutaminase 2 (TG2) is secreted by a non-classical pathway into the extracellular space, where it has several activities pertinent to fibronectin (FN), including binding to the gelatin-binding domain of FN and acting as an integrin co-receptor. Glutamines in the N-terminal tail of FN are known to be susceptible to transamidation by both TG2 and activated blood coagulation factor XIII (FXIIIa). We used immunoblotting, limited proteolysis, and mass spectrometry to localize glutamines within FN that are subject to TG2-catalyzed incorporation of dansylcadaverine in comparison to residues modified by FXIIIa. Such analysis of plasma FN indicated that Gln-3, Gln-7, and Gln-9 in the N-terminal tail and Gln-246 of the linker between fifth and sixth type I modules ((5)F1 and (6)F1) are transamidated by both enzymes. Only minor incorporation of dansylcadaverine was detected elsewhere. Labeling of C-terminally truncated FN constructs revealed efficient TG2- or FXIIIa-catalyzed dansylcadaverine incorporation into the N-terminal residues of constructs as small as the 29-kDa fragment that includes (1-5)F1 and lacks modules from the adjacent gelatin-binding domain. However, when only (1-3)F1 were present, dansylcadaverine incorporation into the N-terminal residues of FN was lost and instead was in the enzymes, near the active site of TG2 and terminal domains of FXIIIa. Thus, these results demonstrate that FXIIIa and TG2 act similarly on glutamines at either end of (1-5)F1 and transamidation specificity of both enzymes is achieved through interactions with the intact 29K fragment.	Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), 1300 Univ Ave,4285 MSC, Madison, WI 53706 USA.	dfmosher@wisc.edu			National Institutes of Health [R01HL021644, T32-HL007899, NCRR 1S10RR024601-1]; Wisconsin Partnership Fund for a Healthy Future and the Department of Chemistry; Northwestern University; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024601] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021644, T32HL007899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin Partnership Fund for a Healthy Future and the Department of Chemistry; Northwestern University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL021644 (to D.F.M.) and T32-HL007899 (to B.R.H.).; We thank Dr. Prasanna Murthy for TG2, and the support and suggestions of Dr. Laszlo Lorand; both are at Northwestern University. The MS studies were performed on instruments of the University of Wisconsin-Madison Human Proteomics Program facility funded by the Wisconsin Partnership Fund for a Healthy Future and the Department of Chemistry Mass Spectrometry facility funded in part by National Institutes of Health NCRR 1S10RR024601-1. We gratefully acknowledge the advice and support of the facility directors, Drs. Ying Ge and Martha Vestling.	AESCHLIMANN D, 1995, J CELL BIOL, V129, P881, DOI 10.1083/jcb.129.3.881; Aeschlimann D, 2000, CONNECT TISSUE RES, V41, P1, DOI 10.3109/03008200009005638; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Akimov SS, 2001, J CELL SCI, V114, P2989; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Atkin KE, 2010, J BIOL CHEM, V285, P36977, DOI 10.1074/jbc.M110.156935; Bark SJ, 2001, J AM CHEM SOC, V123, P1774, DOI 10.1021/ja002909n; Berry H, 1998, ANN NY ACAD SCI, V864, P198, DOI 10.1111/j.1749-6632.1998.tb10304.x; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; Cho JH, 2006, BLOOD, V107, P3555, DOI 10.1182/blood-2005-10-4168; Cleary DB, 2006, BBA-PROTEINS PROTEOM, V1764, P1207, DOI 10.1016/j.bbapap.2006.05.003; Corbett SA, 1997, J BIOL CHEM, V272, P24999, DOI 10.1074/jbc.272.40.24999; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; FESUS L, 1986, EUR J BIOCHEM, V154, P371, DOI 10.1111/j.1432-1033.1986.tb09407.x; Forsprecher J, 2009, AMINO ACIDS, V36, P747, DOI 10.1007/s00726-008-0125-7; Fox BA, 1999, J BIOL CHEM, V274, P4917, DOI 10.1074/jbc.274.8.4917; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; GORMAN JJ, 1980, J BIOL CHEM, V255, P1175; GORMAN JJ, 1981, J BIOL CHEM, V256, P2712; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Hang J, 2005, J BIOL CHEM, V280, P23675, DOI 10.1074/jbc.M503323200; Haroon ZA, 1999, FASEB J, V13, P1787, DOI 10.1096/fasebj.13.13.1787; Hevessy Z, 2000, THROMB RES, V99, P399, DOI 10.1016/S0049-3848(00)00261-9; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; HOHENADL C, 1995, J BIOL CHEM, V270, P23415, DOI 10.1074/jbc.270.40.23415; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; JEONG JM, 1995, J BIOL CHEM, V270, P5654, DOI 10.1074/jbc.270.10.5654; Jobe SM, 2005, BLOOD, V106, P4146, DOI 10.1182/blood-2005-03-1223; Jones RA, 1997, J CELL SCI, V110, P2461; Karimi M, 2009, SEMIN THROMB HEMOST, V35, P426, DOI 10.1055/s-0029-1225765; KESKIOJA J, 1976, CELL, V9, P29, DOI 10.1016/0092-8674(76)90049-0; Lee KN, 2000, J BIOL CHEM, V275, P37382, DOI 10.1074/jbc.M003375200; Lee KN, 2001, ANN NY ACAD SCI, V936, P335; LEMOSY EK, 1992, J BIOL CHEM, V267, P7880; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Liu XY, 2003, MATRIX BIOL, V22, P393, DOI 10.1016/S0945-053X(03)00071-4; LORAND L, 1986, BIOCHEM BIOPH RES CO, V134, P685, DOI 10.1016/S0006-291X(86)80474-0; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lorand L, 2007, FASEB J, V21, P1627, DOI 10.1096/fj.07-0602ufm; Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Matsuka YV, 1997, J PROTEIN CHEM, V16, P739, DOI 10.1023/A:1026307731751; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; McDonagh J, 1987, HEMOSTASIS THROMBOSI, P289; MCDONAGH RP, 1981, FEBS LETT, V127, P174, DOI 10.1016/0014-5793(81)80198-6; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Mitkevich OV, 1998, J BIOL CHEM, V273, P14387, DOI 10.1074/jbc.273.23.14387; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; MOSESSON MW, 1970, J BIOL CHEM, V245, P5728; MOSHER DF, 1975, J BIOL CHEM, V250, P6614; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; MOSHER DF, 1979, J CLIN INVEST, V64, P781, DOI 10.1172/JCI109524; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; Murthy SNP, 1998, EXP EYE RES, V67, P273; MURTHY SNP, 1991, P NATL ACAD SCI USA, V88, P10601, DOI 10.1073/pnas.88.23.10601; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; PARAMESWARAN KN, 1990, P NATL ACAD SCI USA, V87, P8472, DOI 10.1073/pnas.87.21.8472; Pastor MT, 1999, FEBS LETT, V451, P231, DOI 10.1016/S0014-5793(99)00572-4; Pickford AR, 2004, CHEM REV, V104, P3557, DOI 10.1021/cr0304018; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; POTTS JR, 1995, NAT STRUCT BIOL, V2, P946, DOI 10.1038/nsb1195-946; RADEK JT, 1993, P NATL ACAD SCI USA, V90, P3152, DOI 10.1073/pnas.90.8.3152; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; Sane DC, 2007, FRONT BIOSCI-LANDMRK, V12, P2530, DOI 10.2741/2253; Sarang Z, 2009, AMINO ACIDS, V36, P625, DOI 10.1007/s00726-008-0130-x; Sato H, 2000, ANAL BIOCHEM, V281, P68, DOI 10.1006/abio.2000.4551; SEKIGUCHI K, 1983, BIOCHEMISTRY-US, V22, P1415, DOI 10.1021/bi00275a015; SHAINOFF JR, 1991, J BIOL CHEM, V266, P6429; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Staunton David, 2009, V522, P73, DOI 10.1007/978-1-59745-413-1_5; STENBERG P, 1975, BIOCHEM J, V147, P155; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; WILLIAMS EC, 1983, J BIOL CHEM, V258, P5911; Xu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004113	75	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32220	32230		10.1074/jbc.M111.255562	http://dx.doi.org/10.1074/jbc.M111.255562			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21757696	hybrid, Green Published			2022-12-25	WOS:000294726800032
J	Karunakaran, S; Ramachandran, S; Coothankandaswamy, V; Elangovan, S; Babu, E; Periyasamy-Thandavan, S; Gurav, A; Gnanaprakasam, JP; Singh, N; Schoenlein, PV; Prasad, PD; Thangaraju, M; Ganapathy, V				Karunakaran, Senthil; Ramachandran, Sabarish; Coothankandaswamy, Veena; Elangovan, Selvakumar; Babu, Ellappan; Periyasamy-Thandavan, Sudharsan; Gurav, Ashish; Gnanaprakasam, Jaya P.; Singh, Nagendra; Schoenlein, Patricia V.; Prasad, Puttur D.; Thangaraju, Muthusamy; Ganapathy, Vadivel			SLC6A14 (ATB(0,+)) Protein, a Highly Concentrative and Broad Specific Amino Acid Transporter, Is a Novel and Effective Drug Target for Treatment of Estrogen Receptor-positive Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED ACTIVE-TRANSPORT; ARGININE DEPRIVATION; UP-REGULATION; CELL-DEATH; EXPRESSION; NA+; TRYPTOPHAN; SYSTEM	SLC6A14, also known as ATB(0,+), is an amino acid transporter with unique characteristics. It transports 18 of the 20 proteinogenic amino acids. However, this transporter is expressed only at low levels in normal tissues. Here, we show that the transporter is up-regulated specifically in estrogen receptor (ER)-positive breast cancer, demonstrable with primary human breast cancer tissues and human breast cancer cell lines. SLC6A14 is an estrogen/ER target. The transport features of SLC6A14 include concentrative transport of leucine (an activator of mTOR), glutamine (an essential amino acid for nucleotide biosynthesis and substrate for glutaminolysis), and arginine (an essential amino acid for tumor cells), suggesting that ER-positive breast cancer cells up-regulate SLC6A14 to meet their increased demand for these amino acids. Consequently, treatment of ER-positive breast cancer cells in vitro with alpha-methyl-DL-tryptophan (alpha-MT), a selective blocker of SLC6A14, induces amino acid deprivation, inhibits mTOR, and activates autophagy. Prolongation of the treatment with alpha-MT causes apoptosis. Addition of an autophagy inhibitor (3-methyladenine) during alpha-MT treatment also induces apoptosis. These effects of alpha-MT are specific to ER-positive breast cancer cells, which express the transporter. The ability of alpha-MT to cause amino acid deprivation is significantly attenuated in MCF-7 cells, an ER-positive breast cancer cell line, when SLC6A14 is silenced with shRNA. In mouse xenograft studies, alpha-MT by itself is able to reduce the growth of the ER-positive ZR-75-1 breast cancer cells. These studies identify SLC6A14 as a novel and effective drug target for the treatment of ER-positive breast cancer.	[Karunakaran, Senthil; Ramachandran, Sabarish; Coothankandaswamy, Veena; Elangovan, Selvakumar; Babu, Ellappan; Periyasamy-Thandavan, Sudharsan; Gurav, Ashish; Gnanaprakasam, Jaya P.; Singh, Nagendra; Schoenlein, Patricia V.; Prasad, Puttur D.; Thangaraju, Muthusamy; Ganapathy, Vadivel] Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Ganapathy, V (corresponding author), Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA.	vganapat@georgiahealth.edu	Ramachandran, Sabarish/K-8146-2016; Periyasamy-Thandavan, Sudharsan/C-8406-2012; Elangovan, Selvakumar/ABB-9558-2021	Elangovan, Selvakumar/0000-0001-9906-5477; Gnana-Prakasam, Jaya P/0000-0003-2259-9213	National Institutes of Health [CA152396]; NATIONAL CANCER INSTITUTE [R21CA152396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA152396.	DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Delage B, 2010, INT J CANCER, V126, P2762, DOI 10.1002/ijc.25202; Feun L, 2008, CURR PHARM DESIGN, V14, P1049, DOI 10.2174/138161208784246199; Ganapathy M. E., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P357, DOI 10.2174/156800805774912953; GANAPATHY V, 2004, METABOLIC THERAPEUTI, P63; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Gupta N, 2006, GYNECOL ONCOL, V100, P8, DOI 10.1016/j.ygyno.2005.08.016; Gupta N, 2005, BBA-MOL BASIS DIS, V1741, P215, DOI 10.1016/j.bbadis.2005.04.002; Hatanaka T, 2004, J PHARMACOL EXP THER, V308, P1138, DOI 10.1124/jpet.103.057109; Hatanaka T, 2002, BIOCHEM BIOPH RES CO, V291, P291, DOI 10.1006/bbrc.2002.6441; Hatanaka T, 2001, J CLIN INVEST, V107, P1035, DOI 10.1172/JCI12060; Karunakaran S, 2008, BIOCHEM J, V414, P343, DOI 10.1042/BJ20080622; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kousidou OC, 2008, MOL ONCOL, V2, P223, DOI 10.1016/j.molonc.2008.06.002; Laich A, 2002, CLIN CHEM, V48, P579; Nakanishi T, 2001, J PHYSIOL-LONDON, V532, P297, DOI 10.1111/j.1469-7793.2001.0297f.x; Periyasamy-Thandavan S, 2010, AUTOPHAGY, V6, P19, DOI 10.4161/auto.6.1.10323; Samaddar JS, 2008, MOL CANCER THER, V7, P2977, DOI 10.1158/1535-7163.MCT-08-0447; Sloan JL, 1999, J BIOL CHEM, V274, P23740, DOI 10.1074/jbc.274.34.23740; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; Umapathy NS, 2004, PHARM RES-DORDR, V21, P1303, DOI 10.1023/B:PHAM.0000033019.49737.28; Wang X, 2009, TRENDS CELL BIOL, V19, P260, DOI 10.1016/j.tcb.2009.03.005	22	122	125	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31830	31838		10.1074/jbc.M111.229518	http://dx.doi.org/10.1074/jbc.M111.229518			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21771784	Green Published, hybrid			2022-12-25	WOS:000294487500076
J	Rahman, MA; Oomori, T; Worheide, G				Rahman, M. Azizur; Oomori, Tamotsu; Woerheide, Gert			Calcite Formation in Soft Coral Sclerites Is Determined by a Single Reactive Extracellular Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIELD INFRARED MICROSPECTROSCOPY; CARBONATE MINERALOGY; SPICULE FORMATION; SHELL PROTEINS; ORGANIC MATRIX; ARAGONITE; GROWTH; CHEMISTRY; MAGNESIUM; ANHYDRASE	Calcium carbonate exists in two main forms, calcite and aragonite, in the skeletons of marine organisms. The primary mineralogy of marine carbonates has changed over the history of the earth depending on the magnesium/calcium ratio in seawater during the periods of the so-called "calcite and aragonite seas." Organisms that prefer certain mineralogy appear to flourish when their preferred mineralogy is favored by seawater chemistry. However, this rule is not without exceptions. For example, some octocorals produce calcite despite living in an aragonite sea. Here, we address the unresolved question of how organisms such as soft corals are able to form calcitic skeletal elements in an aragonite sea. We show that an extracellular protein called ECMP-67 isolated from soft coral sclerites induces calcite formation in vitro even when the composition of the calcifying solution favors aragonite precipitation. Structural details of both the surface and the interior of single crystals generated upon interaction with ECMP-67 were analyzed with an apertureless-type near-field IR microscope with high spatial resolution. The results show that this protein is the main determining factor for driving the production of calcite instead of aragonite in the bio-calcification process and that -OH, secondary structures (e. g. alpha-helices and amides), and other necessary chemical groups are distributed over the center of the calcite crystals. Using an atomic force microscope, we also explored how this extracellular protein significantly affects the molecular-scale kinetics of crystal formation. We anticipate that a more thorough investigation of the proteinaceous skeleton content of different calcite-producing marine organisms will reveal similar components that determine the mineralogy of the organisms. These findings have significant implications for future models of the crystal structure of calcite in nature.	[Rahman, M. Azizur; Woerheide, Gert] Univ Munich, Dept Earth & Environm Sci, D-80333 Munich, Germany; [Woerheide, Gert] Univ Munich, GeoBioctr, D-80333 Munich, Germany; [Oomori, Tamotsu] Univ Ryukyus, Fac Sci, Dept Chem, Nishihara, Okinawa 9030213, Japan; [Woerheide, Gert] Bavarian State Collect Palaeontol & Geol, D-80333 Munich, Germany	University of Munich; University of Munich; University of the Ryukyus	Rahman, MA (corresponding author), Univ Munich, Dept Earth & Environm Sci, D-80333 Munich, Germany.	a.rahman@lrz.uni-muenchen.de	Rahman, Dr. Azizur/A-9413-2018; Wörheide, Gert/C-1080-2008	Rahman, Dr. Azizur/0000-0002-7648-8642; Wörheide, Gert/0000-0002-6380-7421	Japan Society for the Promotion of Science (JSPS); Alexander von Humboldt Foundation; German Science Foundation (DFG)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Japan Society for the Promotion of Science (JSPS) and the Alexander von Humboldt Foundation.; Supported by the German Science Foundation (DFG).	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Amos FF, 2010, CRYST GROWTH DES, V10, P4211, DOI 10.1021/cg100363m; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562; D'Souza SM, 1999, NATURE, V398, P312, DOI 10.1038/18636; Dauphin Y, 2006, COMP BIOCHEM PHYS A, V145, P54, DOI 10.1016/j.cbpa.2006.04.029; Davis KJ, 2000, SCIENCE, V290, P1134, DOI 10.1126/science.290.5494.1134; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; GOLDBERG WM, 1987, B MAR SCI, V40, P287; Jackson DJ, 2007, SCIENCE, V316, P1893, DOI 10.1126/science.1141560; Kebukawa Y, 2009, CHEM LETT, V38, P22, DOI 10.1246/cl.2009.22; KINGSLEY RJ, 1982, CELL TISSUE RES, V223, P325, DOI 10.1007/BF01258493; Koga S, 2010, J MEMBRANE SCI, V355, P208, DOI 10.1016/j.memsci.2010.03.032; Kupka T, 2010, J RAMAN SPECTROSC, V41, P651, DOI 10.1002/jrs.2502; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Metzler RA, 2010, J AM CHEM SOC, V132, P6329, DOI 10.1021/ja909735y; NARITA Y, 2001, ANAL SCI           S, V17, pI685; Prange A, 1999, BBA-GEN SUBJECTS, V1428, P446, DOI 10.1016/S0304-4165(99)00095-1; Rahman MA, 2006, MAR BIOTECHNOL, V8, P415, DOI 10.1007/s10126-005-6150-6; Rahman MA, 2005, PROTEOMICS, V5, P885, DOI 10.1002/pmic.200401130; Rivadeneyra MA, 2006, FOLIA MICROBIOL, V51, P445, DOI 10.1007/BF02931589; SANDBERG PA, 1983, NATURE, V305, P19, DOI 10.1038/305019a0; Segrest JP, 1972, METHOD ENZYMOL, V28, P54, DOI DOI 10.1016/0076-6879(72)28007-7; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; Stephenson AE, 2008, SCIENCE, V322, P724, DOI 10.1126/science.1159417; Thompson JB, 2000, BIOPHYS J, V79, P3307, DOI 10.1016/S0006-3495(00)76562-3; VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309; WEBER JN, 1974, AM J SCI, V274, P84, DOI 10.2475/ajs.274.1.84; WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379; YANG SY, 1985, PLANT CELL PHYSIOL, V26, P25; Zhuravlev AY, 2008, GEOLOGY, V36, P923, DOI 10.1130/G25094A.1	33	26	26	4	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31638	31649		10.1074/jbc.M109.070185	http://dx.doi.org/10.1074/jbc.M109.070185			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768106	Green Published, hybrid			2022-12-25	WOS:000294487500057
J	Seong, HA; Jung, H; Manoharan, R; Ha, H				Seong, Hyun-A; Jung, Haiyoung; Manoharan, Ravi; Ha, Hyunjung			Positive Regulation of Apoptosis Signal-regulating Kinase 1 Signaling by ZPR9 Protein, a Zinc Finger Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED PROTEIN; CELL-DEATH; NEGATIVE REGULATION; ASK1; PHOSPHORYLATION; STRESS; ACTIVATION; GROWTH; THIOREDOXIN; INHIBITOR	A zinc finger protein, ZPR9, has been identified as a physiological substrate of murine protein serine/threonine kinase 38 (MPK38), which is involved in various cellular responses, including the cell cycle, apoptosis, embryonic development, and oncogenesis. Here, ZPR9 was found to physically interact with apoptosis signal-regulating kinase 1 (ASK1) through a disulfide linkage involving Cys(1351) and Cys(1360) of ASK1 and Cys(305) and Cys(308) of ZPR9. ASK1 directly phosphorylated ZPR9 at Ser(314) and Thr(318), suggesting that ZPR9 can act as an ASK1 substrate. Ectopic expression of wild-type ZPR9, but not an S314A/T318A mutant, stimulated ASK1 kinase activity and positively regulated ASK1-mediated signaling to both JNK and p38 kinases by destabilizing complex formation between ASK1 and its negative regulators, Trx and 14-3-3, or by increasing complex formation between ASK1 and its substrate MKK3. ZPR9 functionally stimulated ASK1-induced AP-1 transcriptional activity as well as H2O2-mediated apoptosis in a phosphorylation-dependent manner. ASK1-mediated phosphorylation of ZPR9 at Ser(314) and Thr(318) was also responsible for ZPR9-induced apoptosis. Moreover, ZPR9 inhibited PDK1-mediated signaling through ASK1 activation. These results suggest that ZPR9 functions as a novel positive regulator of ASK1.	[Seong, Hyun-A; Manoharan, Ravi; Ha, Hyunjung] Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Cheongju 361763, South Korea; [Jung, Haiyoung] Korea Res Inst Biosci & Biotechnol, Cell Therapy Res Ctr, Taejon 305806, South Korea	Chungbuk National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Ha, H (corresponding author), Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr	Manoharan, Ravi/AAI-4139-2021	Manoharan, Ravi/0000-0002-3494-2173	National Research Foundation of Korea [R0A-2007-000-20006-0]; Chungbuk National University	National Research Foundation of Korea(National Research Foundation of Korea); Chungbuk National University	This work was supported by National Research Foundation of Korea Grant R0A-2007-000-20006-0 and in part by Chungbuk National University Grant 2010.	Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Chen ZH, 1999, ONCOGENE, V18, P173, DOI 10.1038/sj.onc.1202276; Cho SG, 2001, J BIOL CHEM, V276, P12749, DOI 10.1074/jbc.M005561200; Gil M, 1997, GENE, V195, P295, DOI 10.1016/S0378-1119(97)00181-9; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jung HY, 2008, J BIOL CHEM, V283, P20383, DOI 10.1074/jbc.M800050200; Jung HY, 2010, J BIOL CHEM, V285, P54, DOI 10.1074/jbc.M109.045229; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; Matsuura H, 2002, J BIOL CHEM, V277, P40703, DOI 10.1074/jbc.M202004200; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Park HS, 2002, MOL CELL BIOL, V22, P7721, DOI 10.1128/MCB.22.22.7721-7730.2002; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2002, BIOCHEM J, V361, P597, DOI 10.1042/0264-6021:3610597; Seong HA, 2003, J BIOL CHEM, V278, P9655, DOI 10.1074/jbc.M207478200; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Seong HA, 2010, J BIOL CHEM, V285, P30959, DOI 10.1074/jbc.M110.138370; Seong HA, 2010, J BIOL CHEM, V285, P2397, DOI 10.1074/jbc.M109.064295; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Zhan J, 2007, MOL CELL BIOL, V27, P3530, DOI 10.1128/MCB.00086-06; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	27	12	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31123	31135		10.1074/jbc.M111.248674	http://dx.doi.org/10.1074/jbc.M111.248674			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21771788	Green Published, hybrid			2022-12-25	WOS:000294487500007
J	Wang, DY; Yuen, EY; Zhou, Y; Yan, Z; Xiang, YK				Wang, Dayong; Yuen, Eunice Y.; Zhou, Yuan; Yan, Zhen; Xiang, Yang K.			Amyloid beta Peptide-(1-42) Induces Internalization and Degradation of beta(2) Adrenergic Receptors in Prefrontal Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ALZHEIMERS-DISEASE; BETA(2)-ADRENERGIC RECEPTOR; LOCUS-CERULEUS; A-BETA; BETA-2-ADRENERGIC RECEPTOR; SYNAPTIC PLASTICITY; CEREBROSPINAL-FLUID; PLAQUE-FORMATION; TRANSGENIC MICE	Emerging evidence indicates that amyloid beta peptide (A beta) initially induces subtle alterations in synaptic function in Alzheimer disease. We have recently shown that A beta binds to beta(2) adrenergic receptor (beta(2)AR) and activates protein kinase A (PKA) signaling for glutamatergic regulation of synaptic activities. Here we show that in the cerebrums of mice expressing human familial mutant presenilin 1 and amyloid precursor protein genes, the levels of beta(2)AR are drastically reduced. Moreover, A beta induces internalization of transfected human beta(2)AR in fibroblasts and endogenous beta(2)AR in primary prefrontal cortical neurons. In fibroblasts, A beta treatment also induces transportation of beta(2)AR into lysosome, and prolonged A beta treatment causes beta(2)AR degradation. The A beta-induced beta(2)AR internalization requires the N terminus of the receptor containing the peptide binding sites and phosphorylation of beta(2)AR by G protein-coupled receptor kinase, not by PKA. However, the G protein-coupled receptor kinase phosphorylation of beta(2)AR and the receptor internalization are much slower than that induced by beta AR agonist isoproterenol. The A beta-induced beta(2)AR internalization is also dependent on adaptor protein arrestin 3 and GTPase dynamin, but not arrestin 2. Functionally, pretreatment of primary prefrontal cortical neurons with A beta induces desensitization of beta(2)AR, which leads to attenuated response to subsequent stimulation with isoproterenol, including decreased cAMP levels, PKA activities, PKA phosphorylation of serine 845 on alpha-amino-2,3-di-hydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor subunit 1 (GluR1), and AMPA receptor-mediated miniature excitatory postsynaptic currents. This study indicates that A beta induces beta(2)AR internalization and degradation leading to impairment of adrenergic and glutamatergic activities.	[Wang, Dayong; Zhou, Yuan; Xiang, Yang K.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Xiang, Yang K.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Yuen, Eunice Y.; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Xiang, YK (corresponding author), 407 S Goodwin Ave, Urbana, IL 61801 USA.	kevinyx@illinois.edu		Wang, Dayong/0000-0002-2086-1663	National Institutes of Health [HL082846]; Alzheimer Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH077823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by the National Institutes of Health HL082846 (to Y. X.). This work was also supported by an Alzheimer Association New Investigator Research grant (to Y. X.).	ASANUMA M, 1991, NEUROCHEM RES, V16, P1253, DOI 10.1007/BF00966654; Bahadoran P, 2003, J BIOL CHEM, V278, P11386, DOI 10.1074/jbc.M211996200; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Bondareff W, 1987, Alzheimer Dis Assoc Disord, V1, P256, DOI 10.1097/00002093-198701040-00005; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Cervantes D, 2010, CIRC RES, V106, P79, DOI 10.1161/CIRCRESAHA.109.198580; Chen CJ, 2003, J NEUROCHEM, V85, P443, DOI 10.1046/j.1471-4159.2003.01691.x; CSIKSZENTMIHALY.M, 1997, FINDING FLOW PSYCHOL, P1; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DOCHERTY K, 1979, BIOCHEM J, V178, P361, DOI 10.1042/bj1780361; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Echeverria V, 2005, NEUROSCIENCE, V135, P1193, DOI 10.1016/j.neuroscience.2005.06.057; Englund H, 2007, DEMENT GERIATR COGN, V24, P369, DOI 10.1159/000109215; Feinstein DL, 1998, J NEUROCHEM, V70, P1484; Friedman JI, 1999, BIOL PSYCHIAT, V46, P1243, DOI 10.1016/S0006-3223(99)00232-2; Gallardo G, 2008, NAT NEUROSCI, V11, P301, DOI 10.1038/nn2058; GERMAN DC, 1992, ANN NEUROL, V32, P667, DOI 10.1002/ana.410320510; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Heneka MT, 2010, P NATL ACAD SCI USA, V107, P6058, DOI 10.1073/pnas.0909586107; Heneka MT, 2006, J NEUROSCI, V26, P1343, DOI 10.1523/JNEUROSCI.4236-05.2006; Henley JR, 1999, FASEB J, V13, pS243, DOI 10.1096/fasebj.13.9002.S243; Hichami A, 1996, MEDIAT INFLAMM, V5, P425, DOI 10.1155/S0962935196000580; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; HU XX, 1991, J NEUROIMMUNOL, V31, P35, DOI 10.1016/0165-5728(91)90084-K; HUANG HM, 1993, J BIOL CHEM, V268, P14616; Igbavboa U, 2006, NEUROSCIENCE, V142, P655, DOI 10.1016/j.neuroscience.2006.06.056; Jadot M, 1997, EUR J BIOCHEM, V249, P862, DOI 10.1111/j.1432-1033.1997.t01-1-00862.x; Joiner MLA, 2010, EMBO J, V29, P482, DOI 10.1038/emboj.2009.344; Khachaturian AS, 2006, ARCH NEUROL-CHICAGO, V63, P686, DOI 10.1001/archneur.63.5.noc60013; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; LaFerla FM, 2005, TRENDS MOL MED, V11, P170, DOI 10.1016/j.molmed.2005.02.009; Liu RJ, 2009, J BIOL CHEM, V284, P32279, DOI 10.1074/jbc.M109.021428; Matthews KL, 2002, BIOL PSYCHIAT, V51, P407, DOI 10.1016/S0006-3223(01)01235-5; Millar RP, 2010, MOL ENDOCRINOL, V24, P261, DOI 10.1210/me.2009-0473; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Ramos BP, 2008, NEUROBIOL AGING, V29, P1060, DOI 10.1016/j.neurobiolaging.2007.02.003; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; Raskind MA, 1999, BIOL PSYCHIAT, V46, P756, DOI 10.1016/S0006-3223(99)00008-6; Reiner S, 2010, J BIOL CHEM, V285, P36188, DOI 10.1074/jbc.M110.175604; Rosenberg PB, 2008, AM J GERIAT PSYCHIAT, V16, P883, DOI 10.1097/JGP.0b013e318181276a; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Satler C, 2007, ACTA NEUROL SCAND, V116, P355, DOI 10.1111/j.1600-0404.2007.00897.x; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Soto D, 2009, CIRC RES, V104, P770, DOI 10.1161/CIRCRESAHA.108.187880; Szot P, 2006, J NEUROSCI, V26, P467, DOI 10.1523/JNEUROSCI.4265-05.2006; Tong LQ, 2001, J BIOL CHEM, V276, P17301, DOI 10.1074/jbc.M010450200; Tran TM, 2007, BIOCHEMISTRY-US, V46, P14438, DOI 10.1021/bi700922h; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Wang DY, 2010, FASEB J, V24, P3511, DOI 10.1096/fj.10-156661; Wang Y, 2008, J BIOL CHEM, V283, P1799, DOI 10.1074/jbc.M705747200; Westbroek W, 2003, J INVEST DERMATOL, V120, P465, DOI 10.1046/j.1523-1747.2003.12068.x; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Yu JT, 2008, BRAIN RES, V1210, P216, DOI 10.1016/j.brainres.2008.03.019; Yuen EY, 2010, J PHYSIOL-LONDON, V588, P2361, DOI 10.1113/jphysiol.2009.186353; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140	60	60	63	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31852	31863		10.1074/jbc.M111.244335	http://dx.doi.org/10.1074/jbc.M111.244335			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757762	hybrid, Green Published			2022-12-25	WOS:000294487500078
J	Cui, J; Eldredge, JB; Xu, Y; Puett, D				Cui, Juan; Eldredge, Joanna B.; Xu, Ying; Puett, David			MicroRNA Expression and Regulation in Human Ovarian Carcinoma Cells by Luteinizing Hormone	PLOS ONE			English	Article							CANCER; GENES; GONADOTROPINS; SIGNATURES; PROGNOSIS; IDENTIFICATION; PROFILES; INVASION; GROWTH; SITES	Background: MicroRNAs have been widely-studied with regard to their aberrant expression and high correlation with tumorigenesis and progression in various solid tumors. With the major goal of assessing gonadotropin (luteinizing hormone, LH) contributions to LH receptor (LHR)-positive ovarian cancer cells, we have conducted a genome-wide transcriptomic analysis on human epithelial ovarian cancer cells to identify the microRNA-associated cellular response to LH-mediated activation of LHR. Methods: Human ovarian cancer cells (SKOV3) were chosen as negative control (LHR-) and stably transfected to express functional LHR (LHR+), followed by incubation with LH (0-20 h). At different times of LH-mediated activation of LHR the cancer cells were analyzed by a high-density Ovarian Cancer Disease-Specific-Array (DSA, ALMAC (TM)), which profiled similar to 100,000 transcripts with similar to 400 non-coding microRNAs. Findings: In total, 65 microRNAs were identified to exhibit differential expression in either LHR expressing SKOV3 cells or LH-treated cells, a few of which have been found in the genomic fragile regions that are associated with abnormal deletion or amplification in cancer, such as miR-21, miR-101-1, miR-210 and miR-301a. By incorporating the dramatic expression changes observed in mRNAs, strong microRNA/mRNA regulatory pairs were predicted through statistical analyses coupled with collective computational prediction. The role of each microRNA was then determined through a functional analysis based on the highly-confident microRNA/mRNA pairs. Conclusion: The overall impact on the transcriptome-level expression indicates that LH may regulate apoptosis and cell growth of LHR+ SKOV3 cells, particularly by reducing cancer cell proliferation, with some microRNAs involved in regulatory roles.	[Cui, Juan; Eldredge, Joanna B.; Xu, Ying; Puett, David] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Jilin, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Jilin University	Cui, J (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	puett@bmb.uga.edu	Puett, J. David/AIE-8612-2022		NIH [DK069711, DK033973, GM075331]; NSF [DEB-0830024, DBI-0542119]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033973, R01DK069711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075331] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH (DK069711, DK033973, GM075331) and by NSF (DEB-0830024, DBI-0542119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; ASCOLI M, 2009, GONADOTROPIN HORMONE; Barlund M, 2000, CANCER RES, V60, P5340; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Choi JH, 2007, ENDOCR REV, V28, P440, DOI 10.1210/er.2006-0036; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; CUI J, 2011, BMC CANC IN PRESS; Dai Yang, 2010, Open Access Bioinformatics, V2, P29; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Huhtaniemi I, 2010, MOL CELL ENDOCRINOL, V329, P56, DOI 10.1016/j.mce.2010.04.028; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kramer S, 1998, INT J BIOL MARKER, V13, P165; Kwintkiewicz J, 2009, SEMIN REPROD MED, V27, P43, DOI 10.1055/s-0028-1108009; Leung PCK, 2007, HUM REPROD UPDATE, V13, P143, DOI 10.1093/humupd/dml002; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li J, 2010, GYNECOL ONCOL, V119, P543, DOI 10.1016/j.ygyno.2010.08.034; Li SD, 2010, J CELL MOL MED, V14, P2240, DOI 10.1111/j.1582-4934.2010.01058.x; Marchini S, 2011, LANCET ONCOL, V12, P273, DOI 10.1016/S1470-2045(11)70012-2; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mosgaard BJ, 1997, FERTIL STERIL, V67, P1005, DOI 10.1016/S0015-0282(97)81431-8; Ness RB, 2002, AM J EPIDEMIOL, V155, P217, DOI 10.1093/aje/155.3.217; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; Pan Q, 2008, J CELL MOL MED, V12, P227, DOI 10.1111/j.1582-4934.2007.00207.x; Peng HQ, 2000, INT J CANCER, V86, P690, DOI 10.1002/(SICI)1097-0215(20000601)86:5<690::AID-IJC14>3.0.CO;2-K; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Sanner K, 2009, FERTIL STERIL, V91, P1152, DOI 10.1016/j.fertnstert.2008.01.073; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Tingulstad S, 2003, OBSTET GYNECOL, V101, P885, DOI 10.1016/S0029-7844(03)00123-6; Wang YH, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000866; Warrenfeltz SW, 2008, MOL CANCER RES, V6, P1775, DOI 10.1158/1541-7786.MCR-08-0214; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	45	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21730	10.1371/journal.pone.0021730	http://dx.doi.org/10.1371/journal.pone.0021730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765906	gold, Green Published			2022-12-25	WOS:000292699000010
J	Fan, HF; Cox, MM; Li, HW				Fan, Hsiu-Fang; Cox, Michael M.; Li, Hung-Wen			Developing Single-Molecule TPM Experiments for Direct Observation of Successful RecA-Mediated Strand Exchange Reaction	PLOS ONE			English	Article							TETHERED PARTICLE MOTION; RECOMBINATIONAL DNA-REPAIR; ATP HYDROLYSIS; ESCHERICHIA-COLI; DUPLEX DNA; HOMOLOGOUS RECOMBINATION; PROTEIN-BINDING; NUCLEOPROTEIN FILAMENTS; BRANCH MIGRATION; MECHANISM	RecA recombinases play a central role in homologous recombination. Once assembled on single-stranded (ss) DNA, RecA nucleoprotein filaments mediate the pairing of homologous DNA sequences and strand exchange processes. We have designed two experiments based on tethered particle motion (TPM) to investigate the fates of the invading and the outgoing strands during E. coli RecA-mediated pairing and strand exchange at the single-molecule level in the absence of force. TPM experiments measure the tethered bead Brownian motion indicative of the DNA tether length change resulting from RecA binding and dissociation. Experiments with beads labeled on either the invading strand or the outgoing strand showed that DNA pairing and strand exchange occurs successfully in the presence of either ATP or its non-hydrolyzable analog, ATP gamma S. The strand exchange rates and efficiencies are similar under both ATP and ATP gamma S conditions. In addition, the Brownian motion time-courses suggest that the strand exchange process progresses uni-directionally in the 5'-to-3' fashion, using a synapse segment with a wide and continuous size distribution.	[Fan, Hsiu-Fang; Li, Hung-Wen] Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan; [Fan, Hsiu-Fang] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Fan, Hsiu-Fang] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; University of Wisconsin System; University of Wisconsin Madison	Fan, HF (corresponding author), Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan.	hwli@ntu.edu.tw		LI, HUNG-WEN/0000-0002-5614-3727	National Science Council of Taiwan; United States National Institutes of Health [GM32335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032335] Funding Source: NIH RePORTER	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project is supported by National Science Council of Taiwan to HWL and the United States National Institutes of Health (GM32335) to MMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DG, 1999, J BIOL CHEM, V274, P27139, DOI 10.1074/jbc.274.38.27139; Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; Bazemore LR, 1997, J BIOL CHEM, V272, P14672, DOI 10.1074/jbc.272.23.14672; Bedale WA, 1996, J BIOL CHEM, V271, P5725, DOI 10.1074/jbc.271.10.5725; Bell CE, 2005, MOL MICROBIOL, V58, P358, DOI 10.1111/j.1365-2958.2005.04876.x; BERLINER E, 1995, NATURE, V373, P718, DOI 10.1038/373718a0; Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; Cox JM, 2005, PLOS BIOL, V3, P231, DOI 10.1371/journal.pbio.0030052; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; Fan HF, 2009, BIOPHYS J, V96, P1875, DOI [10.1016/j.bpj.2008.11.048, 10.1016/j.bpj.2()08.11.048]; Fulconis R, 2006, EMBO J, V25, P4293, DOI 10.1038/sj.emboj.7601260; Hegner M, 1999, P NATL ACAD SCI USA, V96, P10109, DOI 10.1073/pnas.96.18.10109; JAIN SK, 1994, J BIOL CHEM, V269, P20653; KIM JI, 1992, J BIOL CHEM, V267, P16444; KIM JI, 1992, J BIOL CHEM, V267, P16438; KOWALCZYKOWSKI SC, 1995, P NATL ACAD SCI USA, V92, P3478, DOI 10.1073/pnas.92.8.3478; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; LINDSLEY JE, 1989, J MOL BIOL, V205, P695, DOI 10.1016/0022-2836(89)90315-X; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; McGrew DA, 2003, CRIT REV BIOCHEM MOL, V38, P385, DOI 10.1080/10409230390242489; MENETSKI JP, 1987, J BIOL CHEM, V262, P2093; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; MENETSKI JP, 1988, BIOCHEMISTRY-US, V27, P1205, DOI 10.1021/bi00404a021; Nelson PC, 2006, J PHYS CHEM B, V110, P17260, DOI 10.1021/jp0630673; PUGH BF, 1988, J MOL BIOL, V203, P479, DOI 10.1016/0022-2836(88)90014-9; PUGH BF, 1987, J BIOL CHEM, V262, P1326; PUGH BF, 1987, J BIOL CHEM, V262, P1337; REDDY G, 1995, BIOCHEMISTRY-US, V34, P10194, DOI 10.1021/bi00032a013; REGISTER JC, 1987, J BIOL CHEM, V262, P12812; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; Schlacher K, 2006, CHEM REV, V106, P406, DOI 10.1021/cr0404951; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; SILVER MS, 1982, BIOCHEMISTRY-US, V21, P6066, DOI 10.1021/bi00267a007; ULLSPERGER CJ, 1995, BIOCHEMISTRY-US, V34, P10859, DOI 10.1021/bi00034a019; van der Heijden T, 2008, MOL CELL, V30, P530, DOI 10.1016/j.molcel.2008.03.010; YIN H, 1994, BIOPHYS J, V67, P2468, DOI 10.1016/S0006-3495(94)80735-0	39	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21359	10.1371/journal.pone.0021359	http://dx.doi.org/10.1371/journal.pone.0021359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765895	Green Submitted, Green Published, gold			2022-12-25	WOS:000292699000005
J	Gottlieb, GS; Smith, RA; Badiane, NMD; Ba, S; Hawes, SE; Toure, M; Starling, AK; Traore, F; Sall, F; Cherne, SL; Stern, J; Wong, KG; Lu, P; Kim, M; Raugi, DN; Lam, A; Mullins, JI; Kiviat, NB; Sow, PS				Gottlieb, Geoffrey S.; Smith, Robert A.; Badiane, Ndeye Mery Dia; Ba, Selly; Hawes, Stephen E.; Toure, Macoumba; Starling, Alison K.; Traore, Fatou; Sall, Fatima; Cherne, Stephen L.; Stern, Joshua; Wong, Kim G.; Lu, Paul; Kim, Moon; Raugi, Dana N.; Lam, Airin; Mullins, James I.; Kiviat, Nancy B.; Sow, Papa Salif		UW-Dakar HIV-2 Study Grp	HIV-2 Integrase Variation in Integrase Inhibitor-Naive Adults in Senegal, West Africa	PLOS ONE			English	Article							VITRO PHENOTYPIC SUSCEPTIBILITY; IN-VITRO; RESISTANCE PROFILE; CONTROLLED-TRIALS; DRUG-RESISTANCE; GENITAL-TRACT; RALTEGRAVIR; INFECTION; TRANSMISSION; INDIVIDUALS	Background: Antiretroviral therapy for HIV-2 infection is hampered by intrinsic resistance to many of the drugs used to treat HIV-1. Limited studies suggest that the integrase inhibitors (INIs) raltegravir and elvitegravir have potent activity against HIV-2 in culture and in infected patients. There is a paucity of data on genotypic variation in HIV-2 integrase that might confer intrinsic or transmitted INI resistance. Methods: We PCR amplified and analyzed 122 HIV-2 integrase consensus sequences from 39 HIV-2-infected, INI-naive adults in Senegal, West Africa. We assessed genetic variation and canonical mutations known to confer INI-resistance in HIV-1. Results: No amino acid-altering mutations were detected at sites known to be pivotal for INI resistance in HIV-1 (integrase positions 143, 148 and 155). Polymorphisms at several other HIV-1 INI resistance-associated sites were detected at positions 72, 95, 125, 154, 165, 201, 203, and 263 of the HIV-2 integrase protein. Conclusion: Emerging genotypic and phenotypic data suggest that HIV-2 is susceptible to the new class of HIV integrase inhibitors. We hypothesize that intrinsic HIV-2 integrase variation at "secondary'' HIV-1 INI-resistance sites may affect the genetic barrier to HIV-2 INI resistance. Further studies will be needed to assess INI efficacy as part of combination antiretroviral therapy in HIV-2-infected patients.	[Gottlieb, Geoffrey S.; Raugi, Dana N.; Mullins, James I.; Kiviat, Nancy B.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Smith, Robert A.; Starling, Alison K.; Cherne, Stephen L.; Stern, Joshua; Kiviat, Nancy B.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Badiane, Ndeye Mery Dia; Ba, Selly; Toure, Macoumba; Traore, Fatou; Sall, Fatima; Sow, Papa Salif] Univ Cheikh Anta Diop Dakar, Ctr Hosp Univ Fann, Clin Malad Infect Ibrahima DIOP Mar, Dakar, Senegal; [Hawes, Stephen E.] Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; [Wong, Kim G.; Lu, Paul; Kim, Moon; Lam, Airin; Mullins, James I.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University Cheikh Anta Diop Dakar; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gottlieb, GS (corresponding author), Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.	gottlieb@uw.edu		Lu, Paul Matthew/0000-0002-7519-9689; Gottlieb, Geoffrey/0000-0002-5749-481X	National Institutes of Health/National Institute of Allergy and Infectious Diseases [2R01-AI060466]; University of Washington Center for AIDS Research [213]; University of Washington; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060466] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington Center for AIDS Research; University of Washington(University of Washington); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by grants to GSG from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (2R01-AI060466), the University of Washington Center 213 for AIDS Research, and the University of Washington Royalty Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong-James D, 2010, ANTIVIR RES, V86, P224, DOI 10.1016/j.antiviral.2010.02.324; Bercoff DP, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-98; Boyer PL, 2006, PLOS PATHOG, V2, P101, DOI 10.1371/journal.ppat0020010; Charpentier C, 2011, ANTIMICROB AGENTS CH, V55, P1293, DOI 10.1128/AAC.00942-10; Charpentier C, 2010, AIDS, V24, P2753, DOI 10.1097/QAD.0b013e32833f9e36; Damond F, 2008, AIDS, V22, P665, DOI 10.1097/QAD.0b013e3282f51203; DECOCK KM, 1993, JAMA-J AM MED ASSOC, V270, P2083, DOI 10.1001/jama.270.17.2083; Desbois D, 2008, ANTIMICROB AGENTS CH, V52, P1545, DOI 10.1128/AAC.01284-07; Garrett N, 2008, AIDS, V22, P1091, DOI 10.1097/QAD.0b013e3282f9b165; Goethals O, 2010, VIROLOGY, V402, P338, DOI 10.1016/j.virol.2010.03.034; Gottlieb GS, 2008, AIDS, V22, P2069, DOI 10.1097/QAD.0b013e32830edd44; Gottlieb GS, 2008, AIDS RES HUM RETROV, V24, P857, DOI 10.1089/aid.2008.0015; Gottlieb GS, 2009, CLIN INFECT DIS, V48, P476, DOI 10.1086/596504; Gottlieb GS, 2006, AIDS, V20, P895, DOI 10.1097/01.aids.0000218554.59531.80; Gottlieb GS, 2002, J INFECT DIS, V185, P905, DOI 10.1086/339295; Hawes SE, 2008, AIDS, V22, P2517, DOI 10.1097/QAD.0b013e328315cdbc; KANKI PJ, 1994, LANCET, V343, P943, DOI 10.1016/S0140-6736(94)90065-5; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; Matheron S, 2003, AIDS, V17, P2593, DOI 10.1097/00002030-200312050-00006; Matheron S, 2008, AIDS, V22, P2073, DOI 10.1097/QAD.0b013e32830edd59; Poveda E, 2004, AIDS RES HUM RETROV, V20, P347, DOI 10.1089/088922204322996590; Roquebert B, 2008, J ANTIMICROB CHEMOTH, V62, P914, DOI 10.1093/jac/dkn335; Roquebert B, 2008, AIDS, V22, P2045, DOI 10.1097/QAD.0b013e32830f4c7d; Salgado M, 2009, J CLIN VIROL, V46, P173, DOI 10.1016/j.jcv.2009.06.020; Shimura K, 2008, J VIROL, V82, P764, DOI 10.1128/JVI.01534-07; SIMON F, 1993, AIDS, V7, P1411, DOI 10.1097/00002030-199311000-00002; Smith RA, 2008, ANTIMICROB AGENTS CH, V52, P329, DOI 10.1128/AAC.01004-07; Smith RA, 2009, J INFECT DIS, V199, P1323, DOI 10.1086/597802; Witvrouw M, 2004, ANTIVIR THER, V9, P57; Xu L, 2008, AIDS RES HUM RETROV, V24, P1003, DOI 10.1089/aid.2007.0303; Xu L, 2009, AIDS RES HUM RETROV, V25, P843, DOI 10.1089/aid.2009.0039	32	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22204	10.1371/journal.pone.0022204	http://dx.doi.org/10.1371/journal.pone.0022204			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765953	Green Submitted, Green Published, gold			2022-12-25	WOS:000292699000030
J	Guan, XY; Lee, JJ; Pang, MX; Shi, XL; Stelly, DM; Chen, ZJ				Guan, Xueying; Lee, Jinsuk J.; Pang, Mingxiong; Shi, Xiaoli; Stelly, David M.; Chen, Z. Jeffrey			Activation of Arabidopsis Seed Hair Development by Cotton Fiber-Related Genes	PLOS ONE			English	Article							LASER CAPTURE MICRODISSECTION; TRICHOME CELL FATE; COAT DEVELOPMENT; IN-VITRO; EXPRESSION; ELONGATION; INITIATION; TRIPTYCHON; ENCODES; GROWTH	Each cotton fiber is a single-celled seed trichome or hair, and over 20,000 fibers may develop semi-synchronously on each seed. The molecular basis for seed hair development is unknown but is likely to share many similarities with leaf trichome development in Arabidopsis. Leaf trichome initiation in Arabidopsis thaliana is activated by GLABROUS1 (GL1) that is negatively regulated by TRIPTYCHON (TRY). Using laser capture microdissection and microarray analysis, we found that many putative MYB transcription factor and structural protein genes were differentially expressed in fiber and non-fiber tissues. Gossypium hirsutum MYB2 (GhMYB2), a putative GL1 homolog, and its downstream gene, GhRDL1, were highly expressed during fiber cell initiation. GhRDL1, a fiber-related gene with unknown function, was predominately localized around cell walls in stems, sepals, seed coats, and pollen grains. GFP:GhRDL1 and GhMYB2:YFP were co-localized in the nuclei of ectopic trichomes in siliques. Overexpressing GhRDL1 or GhMYB2 in A. thaliana Columbia-0 (Col-0) activated fiber-like hair production in 4-6% of seeds and had on obvious effects on trichome development in leaves or siliques. Co-overexpressing GhRDL1 and GhMYB2 in A. thaliana Col-0 plants increased hair formation in similar to 8% of seeds. Overexpressing both GhRDL1 and GhMYB2 in A. thaliana Col-0 try mutant plants produced seed hair in similar to 10% of seeds as well as dense trichomes inside and outside siliques, suggesting synergistic effects of GhRDL1 and GhMYB2 with try on development of trichomes inside and outside of siliques and seed hair in A. thaliana. These data suggest that a different combination of factors is required for the full development of trichomes (hairs) in leaves, siliques, and seeds. A. thaliana can be developed as a model a system for discovering additional genes that control seed hair development in general and cotton fiber in particular.	[Guan, Xueying; Lee, Jinsuk J.; Pang, Mingxiong; Shi, Xiaoli; Chen, Z. Jeffrey] Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Guan, Xueying; Lee, Jinsuk J.; Pang, Mingxiong; Shi, Xiaoli; Chen, Z. Jeffrey] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Stelly, David M.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Texas A&M University System; Texas A&M University College Station	Guan, XY (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA.	zjchen@mail.utexas.edu	Stelly, David/ABC-7400-2020	Stelly, David/0000-0002-3468-4119	National Science Foundation [DBI1025947]; Cotton Incorporated [07-161]; Division Of Integrative Organismal Systems [1025947] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Cotton Incorporated(Cotton R&D Corp); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by the grants from the National Science Foundation Plant Genome Research Program (DBI1025947) and Cotton Incorporated (07-161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; Batchelor AK, 2002, PLANTA, V215, P523, DOI 10.1007/s00425-002-0798-1; BEASLEY CA, 1971, BIOSCIENCE, V21, P906, DOI 10.2307/1295669; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cai SQ, 2006, PLANT J, V48, P628, DOI 10.1111/j.1365-313X.2006.02886.x; Casson S, 2005, PLANT J, V42, P111, DOI 10.1111/j.1365-313X.2005.02355.x; Clark G, 2010, PLANT PHYSIOL, V152, P1073, DOI 10.1104/pp.109.147637; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dai XB, 2010, PLANT PHYSIOL, V152, P44, DOI 10.1104/pp.109.145813; Esch JJ, 2004, PLANT J, V40, P860, DOI 10.1111/j.1365-313X.2004.02259.x; Guan XY, 2008, PHYSIOL PLANTARUM, V134, P174, DOI 10.1111/j.1399-3054.2008.01115.x; Haughn G, 2005, TRENDS PLANT SCI, V10, P472, DOI 10.1016/j.tplants.2005.08.005; Herwig R, 1999, GENOME RES, V9, P1093, DOI 10.1101/gr.9.11.1093; Hovav R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040025; Hulskamp M, 2004, NAT REV MOL CELL BIO, V5, P471, DOI 10.1038/nrm1404; HULSKAMP M, 1994, CELL, V76, P555, DOI 10.1016/0092-8674(94)90118-X; Humphries JA, 2005, PLANT MOL BIOL, V57, P67, DOI 10.1007/s11103-004-6768-1; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; Jakoby MJ, 2008, PLANT PHYSIOL, V148, P1583, DOI 10.1104/pp.108.126979; Ji SJ, 2002, BIOCHEM BIOPH RES CO, V296, P1245, DOI 10.1016/S0006-291X(02)02069-7; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kirik V, 2004, DEV BIOL, V268, P506, DOI 10.1016/j.ydbio.2003.12.037; Lee J.K, 2005, PROC 2005 IEEE RUSSI, P1; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Li CH, 2002, PLANT SCI, V163, P1113, DOI 10.1016/S0168-9452(02)00320-5; Li SF, 2009, PLANT CELL, V21, P72, DOI 10.1105/tpc.108.063503; Loguercio LL, 1999, MOL GEN GENET, V261, P660; Luschnig C, 2002, TRENDS PLANT SCI, V7, P329, DOI 10.1016/S1360-1385(02)02292-6; Machado A, 2009, PLANT J, V59, P52, DOI 10.1111/j.1365-313X.2009.03847.x; Marks MD, 2009, MOL PLANT, V2, P803, DOI 10.1093/mp/ssp037; MEINERT MC, 1977, PLANT PHYSIOL, V59, P1088, DOI 10.1104/pp.59.6.1088; Murai K, 2002, PLANT J, V29, P169, DOI 10.1046/j.0960-7412.2001.01203.x; Payne T, 1999, DEVELOPMENT, V126, P671; Pesch M, 2009, CURR OPIN PLANT BIOL, V12, P587, DOI 10.1016/j.pbi.2009.07.015; Pu L, 2008, GENETICS, V180, P811, DOI 10.1534/genetics.108.093070; RERIE WG, 1994, GENE DEV, V8, P1388, DOI 10.1101/gad.8.12.1388; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Schellmann S, 2002, EMBO J, V21, P5036, DOI 10.1093/emboj/cdf524; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Szymanski DB, 2000, TRENDS PLANT SCI, V5, P214, DOI 10.1016/S1360-1385(00)01597-1; Szymanski DB, 1998, PLANT CELL, V10, P2047, DOI 10.1105/tpc.10.12.2047; Taliercio EW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-22; Tian L, 2003, GENETICS, V165, P399; Udall JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-81; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang S, 2004, PLANT CELL, V16, P2323, DOI 10.1105/tpc.104.024844; Western TL, 2004, PLANT PHYSIOL, V134, P296, DOI 10.1104/pp.103.035519; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wu J, 2007, PLANT PHYSIOL, V144, P961, DOI 10.1104/pp.107.097568; Wu Y, 2007, PLANTA, V226, P1475, DOI 10.1007/s00425-007-0580-5; Wu YR, 2006, PLANT CELL PHYSIOL, V47, P107, DOI 10.1093/pcp/pci228; YAMAGUCHISHINOZAKI K, 1993, MOL GEN GENET, V238, P17, DOI 10.1007/BF00279525; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhao M, 2008, DEVELOPMENT, V135, P1991, DOI 10.1242/dev.016873	55	52	58	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21301	10.1371/journal.pone.0021301	http://dx.doi.org/10.1371/journal.pone.0021301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779324	Green Published, Green Submitted, gold			2022-12-25	WOS:000292680900004
J	Jusup, M; Klanjscek, T; Matsuda, H; Kooijman, SALM				Jusup, Marko; Klanjscek, Tin; Matsuda, Hiroyuki; Kooijman, S. A. L. M.			A Full Lifecycle Bioenergetic Model for Bluefin Tuna	PLOS ONE			English	Article							DYNAMIC ENERGY BUDGET; THUNNUS-ORIENTALIS; METABOLIC-RATES; ATLANTIC; THYNNUS; GROWTH; PERFORMANCE; ADAPTATION; MATURATION; FLATFISH	We formulated a full lifecycle bioenergetic model for bluefin tuna relying on the principles of Dynamic Energy Budget theory. Traditional bioenergetic models in fish research deduce energy input and utilization from observed growth and reproduction. In contrast, our model predicts growth and reproduction from food availability and temperature in the environment. We calibrated the model to emulate physiological characteristics of Pacific bluefin tuna (Thunnus orientalis, hereafter PBT), a species which has received considerable scientific attention due to its high economic value. Computer simulations suggest that (i) the main cause of different growth rates between cultivated and wild PBT is the difference in average body temperature of approximately 6.5 degrees C, (ii) a well-fed PBT individual can spawn an average number of 9 batches per spawning season, (iii) food abundance experienced by wild PBT is rather constant and sufficiently high to provide energy for yearly reproductive cycle, (iv) energy in reserve is exceptionally small, causing the weight-length relationship of cultivated and wild PBT to be practically indistinguishable and suggesting that these fish are poorly equipped to deal with starvation, (v) accelerated growth rate of PBT larvae is connected to morphological changes prior to metamorphosis, while (vi) deceleration of growth rate in the early juvenile stage is related to efficiency of internal heat production. Based on these results, we discuss a number of physiological and ecological traits of PBT, including the reasons for high Feed Conversion Ratio recorded in bluefin tuna aquaculture.	[Jusup, Marko; Matsuda, Hiroyuki] Yokohama Natl Univ, Fac Environm & Informat Sci, Yokohama, Kanagawa 240, Japan; [Jusup, Marko; Klanjscek, Tin] Rudjer Boskovic Inst, Dept Marine & Environm Res, Zagreb, Croatia; [Kooijman, S. A. L. M.] Vrije Univ Amsterdam, Dept Theoret Biol, Amsterdam, Netherlands	Yokohama National University; Rudjer Boskovic Institute; Vrije Universiteit Amsterdam	Jusup, M (corresponding author), Yokohama Natl Univ, Fac Environm & Informat Sci, Yokohama, Kanagawa 240, Japan.	mjusup@gmail.com	Jusup, Marko/S-8567-2018	Jusup, Marko/0000-0002-0777-0425; Klanjscek, Tin/0000-0002-9341-344X	Society for Conservation of Fisheries Resources and Marine Environment (CoFRaME); Unity Through Knowledge Fund (UKF) [21/08]; Croatian Ministry of Science, Education and Sports [098-0982934-2719]; Strategic Funds for the Promotion of Science and Technology, Japan; Japanese Ministry of Education, Culture, Sports, Science & Technology (MEXT) [080755]	Society for Conservation of Fisheries Resources and Marine Environment (CoFRaME); Unity Through Knowledge Fund (UKF); Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); Strategic Funds for the Promotion of Science and Technology, Japan; Japanese Ministry of Education, Culture, Sports, Science & Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was financially supported by the Society for Conservation of Fisheries Resources and Marine Environment (CoFRaME) grant to project ''Modeling approach for efficient bluefin tuna aquaculture'', Unity Through Knowledge Fund (UKF) grant (no. 21/08) to project ''Finfish mariculture dynamic energy budget model (FiMDEB)'', the Croatian Ministry of Science, Education and Sports grant (no. 098-0982934-2719) to project '' Ecological modelling for sustainable management of resources'', and Yokohama National University International Environmental Leaders Program in Sustainable Living with Environmental Risk (SLER) funded by the Strategic Funds for the Promotion of Science and Technology, Japan. Scholarship (no. 080755) from the Japanese Ministry of Education, Culture, Sports, Science & Technology (MEXT) enabled ?MJ to conduct this research in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal FJ, 2004, FISH B-NOAA, V102, P407; Aguado-Gimenez F, 2005, AQUAC RES, V36, P610, DOI 10.1111/j.1365-2109.2005.01210.x; AGUADOGIMENEZ F, 2003, CAHIERS OPTIONS MEDI, V60; Bayliff W. H., 1994, FAO FISH TECH PAP, V336, P244; Bernal D, 2001, COMP BIOCHEM PHYS A, V129, P695, DOI 10.1016/S1095-6433(01)00333-6; Blank JM, 2007, PHYSIOL BIOCHEM ZOOL, V80, P167, DOI 10.1086/510637; Bodiguel X, 2009, J SEA RES, V62, P124, DOI 10.1016/j.seares.2009.02.006; BOGGS CH, 1991, PHYSIOL ZOOL, V64, P502, DOI 10.1086/physzool.64.2.30158188; Butler CM, 2010, FISH B-NOAA, V108, P56; CATON AE, 1994, FAO FISH TECH PAP, V336, P296; Chen KS, 2006, FISHERIES SCI, V72, P985, DOI 10.1111/j.1444-2906.2006.01247.x; Clarke A, 2004, FUNCT ECOL, V18, P252, DOI 10.1111/j.0269-8463.2004.00842.x; Collette BB, 1995, GUIA FAO IDENTIFICAT, P1521; de Roos A., 1988, NUMER METH PART D E, V4, P173, DOI [10.1002/num.1690040303, DOI 10.1002/NUM.1690040303]; DEWAR H, 1994, J EXP BIOL, V192, P13; Einen O, 1997, AQUACULT NUTR, V3, P115, DOI 10.1046/j.1365-2095.1997.00084.x; Fitzgibbon QP, 2007, J EXP BIOL, V210, P290, DOI 10.1242/jeb.02641; Forster I, 1999, AQUACULT NUTR, V5, P143, DOI 10.1046/j.1365-2095.1999.00082.x; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Graham JB, 2004, J EXP BIOL, V207, P4015, DOI 10.1242/jeb.01267; Graham Jeffrey B., 2001, Fish Physiology, V19, P121; HIROTA H, 1976, B JPN SOC SCI FISH, V42, P939; Ip YK, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00134; ITANO DG, 2000, JIMAR CONTRIBUTION, V328; KAJI T, 2003, CAHIERS OPTIONS MEDI, V60; Katz SL, 2002, J EXP BIOL, V205, P2251; Kitagawa T, 2006, FISHERIES SCI, V72, P149, DOI 10.1111/j.1444-2906.2006.01129.x; KITAGAWA T, 2005, FISHERIES ENG, V41, P257; Kitagawa Takashi, 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P69; Kitagawa T, 2007, FISHERIES SCI, V73, P98, DOI 10.1111/j.1444-2906.2007.01307.x; Klaniscek T, 2006, ECOL MODEL, V196, P407, DOI 10.1016/j.ecolmodel.2006.02.023; Klanjscek T, 2007, ECOL APPL, V17, P2233, DOI 10.1890/06-0426.1; Klok C, 2008, ENVIRON SCI TECHNOL, V42, P8803, DOI 10.1021/es8016599; KOOIJMAN S, J SEA RES IN PRESS; Kooijman SALM, 2009, J MATH BIOL, V58, P377, DOI 10.1007/s00285-008-0195-x; Kooijman SALM, 2008, BIOL REV, V83, P533, DOI 10.1111/j.1469-185X.2008.00053.x; Kooijman S.A.L.M., 2010, DYNAMIC ENERGY BUDGE; Korsmeyer K.E., 2001, TUNA PHYSL ECOLOGY E, P35, DOI DOI 10.1016/S1546-5098(01)19003-5; Korsmeyer KE, 1996, COMP BIOCHEM PHYS A, V113, P17, DOI 10.1016/0300-9629(95)02061-6; Kubo T, 2008, FISHERIES SCI, V74, P995, DOI 10.1111/j.1444-2906.2008.01617.x; Lupatsch I, 2001, AQUACULT NUTR, V7, P71, DOI 10.1046/j.1365-2095.2001.00150.x; Masuma Shukei, 2009, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V63, P207; Medina A, 2002, J FISH BIOL, V60, P203, DOI [10.1111/j.1095-8649.2002.tb02398.x, 10.1006/jfbi.2001.1835]; Miyashita S, 2001, FISH B-NOAA, V99, P601; MIYASHITA S, 2002, B FISHERIES LAB KINK, V8, P171; Miyashita Shigeru, 2000, Suisan Zoshoku, V48, P199; Mori M, 2001, POPUL ECOL, V43, P125, DOI 10.1007/PL00012023; Motani R, 2002, NATURE, V415, P309, DOI 10.1038/415309a; Nash RDM, 2006, FISHERIES, V31, P236; Nisbet RM, 2000, J ANIM ECOL, V69, P913, DOI 10.1046/j.1365-2656.2000.00448.x; OTTOLENGHI F, 2008, FAO FISHERIES TECHNI, V508, P169; Pecquerie L, 2008, THESIS AGROCAMPUS RE; Pecquerie L, 2009, J SEA RES, V62, P93, DOI 10.1016/j.seares.2009.06.002; Rooker JR, 2007, REV FISH SCI, V15, P265, DOI 10.1080/10641260701484135; Sawada Y, 2005, AQUAC RES, V36, P413, DOI 10.1111/j.1365-2109.2005.01222.x; Sawada Y, 2007, FISHERIES SCI, V73, P1070, DOI 10.1111/j.1444-2906.2007.01438.x; *SCRS, 2009, VOL SCI PAP ICCAT, V64, P1; Secor David H., 2007, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V60, P1141; Shimose T, 2009, FISH RES, V100, P134, DOI 10.1016/j.fishres.2009.06.016; SMART A, 2003, CAHIERS OPTIONS MEDI, V60; Sousa T, 2008, PHILOS T R SOC B, V363, P2453, DOI 10.1098/rstb.2007.2230; Sterner RW, 2000, ECOLOGY, V81, P127, DOI 10.1890/0012-9658(2000)081[0127:CNAPSO]2.0.CO;2; van der Meer J, 2006, J SEA RES, V56, P85, DOI 10.1016/j.seares.2006.03.001; van der Veer HW, 2009, J SEA RES, V62, P83, DOI 10.1016/j.seares.2009.02.001; van der Veer HW, 2003, J SEA RES, V50, P255, DOI 10.1016/j.seares.2003.05.001; van der Veer HW, 2001, J SEA RES, V45, P303, DOI 10.1016/S1385-1101(01)00061-2; Walli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006151	67	65	65	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21903	10.1371/journal.pone.0021903	http://dx.doi.org/10.1371/journal.pone.0021903			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779352	Green Published, gold, Green Submitted			2022-12-25	WOS:000292680900015
J	Iglesias, ALH; Kudo, K; Manabe, T; Berdugo, AEC; Baeza, AC; Ramos, LA; Gutierrez, RG; Zavala, MEM; Takasaki, J; Izumi, S; Bautista, E; Padilla, JRP				Higuera Iglesias, Anjarath Lorena; Kudo, Koichiro; Manabe, Toshie; Corcho Berdugo, Alexander Enrique; Corrales Baeza, Ariel; Alfaro Ramos, Leticia; Guevara Gutierrez, Rene; Manjarrez Zavala, Maria Eugenia; Takasaki, Jin; Izumi, Shinyu; Bautista, Edgar; Perez Padilla, Jose Rogelio			Reducing Occurrence and Severity of Pneumonia Due to Pandemic H1N1 2009 by Early Oseltamivir Administration: A Retrospective Study in Mexico	PLOS ONE			English	Article							INFLUENZA-A H1N1; CRITICALLY-ILL PATIENTS; VIRUS-INFECTION; A(H1N1) INFECTION; NEURAMINIDASE	Background: Anti-viral treatment has been used to treat severe or progressive illness due to pandemic H1N1 2009. A main cause of severe illness in pandemic H1N1 2009 is viral pneumonia; however, it is unclear how effective antiviral treatment is against pneumonia when administered >48 hours after symptom onset. Therefore, we aimed to determine how time from symptom onset to antiviral administration affected the effectiveness of antiviral treatment against pneumonia due to pandemic (H1N1) 2009. Methods/Principal Findings: A retrospective medical chart review of 442 patients was conducted in a hospital in Mexico. Subjects had tested positive for pandemic H1N1 2009 virus by real-time reverse-transcriptase-polymerase-chain-reaction and were administered oseltamivir. Median time from symptom onset to oseltamivir administration was 5.0 days (range, 0-43). 442 subjects, 71 (16.1%) had severe pneumonia which required mechanical ventilation, 191 (43.2%) had mild to moderate pneumonia, and 180 (40%) did not have pneumonia. Subjects were divided into four groups based on time to oseltamivir administration: >= 2, 3-7, 8-14, and >14 days. Severity of respiratory features was associated with time to treatment, and multivariate analysis indicated that time to oseltamivir administration was associated with severity of respiratory features. A proportional odds model indicated that 50% probability for occurrence of pneumonia of any severity and that of severe pneumonia in patients who would develop pneumonia reached at approximately 3.4 and 21 days, respectively, after symptom onset. Patients with a shorter time to oseltamivir administration were discharged earlier from the hospital. Conclusions: Earlier initiation of oseltamivir administration after symptom onset significantly reduced occurrence and severity of pneumonia and shortened hospitalization due to pandemic H1N1 2009. Even when administered >48 hours after symptom onset, oseltamivir showed considerable potential for reducing pneumonia. Application of these results would benefit patients affected by future influenza pandemics.	[Higuera Iglesias, Anjarath Lorena; Corcho Berdugo, Alexander Enrique; Corrales Baeza, Ariel; Alfaro Ramos, Leticia; Guevara Gutierrez, Rene; Manjarrez Zavala, Maria Eugenia; Bautista, Edgar; Perez Padilla, Jose Rogelio] Natl Inst Resp Dis, Mexico City, DF, Mexico; [Kudo, Koichiro; Manabe, Toshie; Takasaki, Jin; Izumi, Shinyu] Natl Ctr Global Hlth & Med, Tokyo, Japan	National Center for Global Health & Medicine - Japan	Iglesias, ALH (corresponding author), Natl Inst Resp Dis, Mexico City, DF, Mexico.	kudo@dcc.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan at http://www.crnid.riken.jp/pfrc/indexE.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2010, ANAL ORDINAL CATEGOR, DOI [DOI 10.1002/9780470594001, 10.1002/9780470594001]; [Anonymous], 2010, WHO GUID PHARM MAN P; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Center for Disease Control and Prevention, 2010, UPD INT REC US ANT M; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lee N, 2010, THORAX, V65, P510, DOI 10.1136/thx.2009.130799; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; *ROCH LAB INC, 2010, TAM PROD INF PRES IN; Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10; SALUDE, 2010, SIT ACT EP; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Slopen M. E., 2010, Morbidity and Mortality Weekly Report, V58, P1436; Su B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008495; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; WHO (World Health Organization), 2010, PAND H1N1 2009 UPD 9	20	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21838	10.1371/journal.pone.0021838	http://dx.doi.org/10.1371/journal.pone.0021838			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760915	gold, Green Submitted, Green Published			2022-12-25	WOS:000292657200027
J	Welsh, MM; Karagas, MR; Kuriger, JK; Houseman, A; Spencer, SK; Perry, AE; Nelson, HH				Welsh, Marleen M.; Karagas, Margaret R.; Kuriger, Jacquelyn K.; Houseman, Andres; Spencer, Steven K.; Perry, Ann E.; Nelson, Heather H.			Genetic Determinants of UV-Susceptibility in Non-Melanoma Skin Cancer	PLOS ONE			English	Article							INTERLEUKIN-10 PROMOTER POLYMORPHISMS; DELAYED-TYPE HYPERSENSITIVITY; SYSTEMIC IMMUNE SUPPRESSION; NECROSIS-FACTOR-ALPHA; CONTACT HYPERSENSITIVITY; EPIDERMODYSPLASIA-VERRUCIFORMIS; REGION POLYMORPHISMS; LANGERHANS CELLS; RECEPTOR-ALPHA; BETA-ESTRADIOL	A milieu of cytokines and signaling molecules are involved in the induction of UV-induced immune suppression and thus the etiology of non-melanoma skin cancer (NMSC). Targeting the UV-induced immunosuppression pathway, and using a large population based study of NMSC, we have investigated the risk associated with functional variants in 10 genes (IL10, IL4, IL4R, TNF, TNFR2, HTR2A, HRH2, IL12B, PTGS2, and HAL). The most prominent single genetic effect was observed for IL10. There was increasing risk for both basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) with increasing number of variant IL10 haplotypes (BCC: p(trend) = 0.0048; SCC: p(trend) = 0.031). Having two IL10 GC haplotypes was associated with increased odds ratios of BCC and SCC (OR(BCC) = 1.5, 95% CI 1.1-1.9; OR(SCC) = 1.4, 95% CI 1.0-1.9), and these associations were largely confined to women (OR(BCC) = 2.2, 95% CI 1.4-3.4; SCC: OR(SCC) = 1.8, 95% CI 1.1-3.0). To examine how combinations of these variants contribute to risk of BCC and SCC, we used multifactor dimensionality reduction (MDR) and classification and regression trees (CART). Results from both of these methods found that in men, a combination of skin type, burns, IL10, IL4R, and possibly TNFR2 were important in both BCC and SCC. In women, skin type, burns, and IL10 were the most critical risk factors in SCC, with risk of BCC involving these same factors plus genetic variants in HTR2A, IL12B and IL4R. These data suggest differential genetic susceptibility to UV-induced immune suppression and skin cancer risk by gender.	[Welsh, Marleen M.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Karagas, Margaret R.] Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH USA; [Karagas, Margaret R.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH USA; [Kuriger, Jacquelyn K.; Nelson, Heather H.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA; [Nelson, Heather H.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Houseman, Andres] Brown Univ, Dept Community Hlth, Providence, RI 02912 USA; [Houseman, Andres] Brown Univ, Ctr Environm Hlth & Technol, Providence, RI 02912 USA; [Spencer, Steven K.] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA; [Perry, Ann E.] Dartmouth Hitchcock Med Ctr, Dept Pathol, Lebanon, NH 03766 USA	Uniformed Services University of the Health Sciences - USA; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Brown University; Brown University; Dartmouth College; Dartmouth College	Welsh, MM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA.	hhnelson@umn.edu		Nelson, Heather/0000-0003-1901-9513; Houseman, Eugene Andres/0000-0003-0703-1830	NIH [CA082354, CA057494]; NATIONAL CANCER INSTITUTE [R01CA057494, R01CA082354] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants CA082354 and CA057494. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ACS, 2005, CANC FACTS FIG 2005; Alamartine E, 2003, J INVEST DERMATOL, V120, P99, DOI 10.1046/j.1523-1747.2003.12016.x; Allen MH, 1998, BRIT J DERMATOL, V139, P225; Andrews RP, 2001, CLIN IMMUNOL, V100, P298, DOI 10.1006/clim.2001.5082; Balic A, 2006, INT IMMUNOL, V18, P1421, DOI 10.1093/intimm/dxl075; Borchers A, 2000, SEMIN ARTHRITIS RHEU, V29, P385, DOI 10.1053/sarh.2000.7173; Bouma G, 1996, SCAND J IMMUNOL, V43, P456, DOI 10.1046/j.1365-3083.1996.d01-65.x; Braun N, 1996, NEUROSCI LETT, V215, P75, DOI 10.1016/0304-3940(96)12920-7; BREIMAN L., 1984, CRC PRESS; COOPER KD, 1992, P NATL ACAD SCI USA, V89, P8497, DOI 10.1073/pnas.89.18.8497; de Oliveira WRP, 2003, J AM ACAD DERMATOL, V49, P639, DOI 10.1067/S0190-9622(03)01567-6; English DR, 1998, CANCER EPIDEM BIOMAR, V7, P857; Ide A, 2002, HUM IMMUNOL, V63, P690, DOI 10.1016/S0198-8859(02)00417-2; JESSUP JM, 1978, CELL IMMUNOL, V38, P105, DOI 10.1016/0008-8749(78)90036-9; Karagas M, 2006, CANC EPIDEMIOLOGY PR; Karagas MR, 1999, INT J CANCER, V81, P555, DOI 10.1002/(SICI)1097-0215(19990517)81:4<555::AID-IJC9>3.0.CO;2-R; MAJEWSKI S, 1995, ARCH DERMATOL, V131, P1312, DOI 10.1001/archderm.131.11.1312; MATSUSHIMA GK, 1989, CELL IMMUNOL, V119, P171, DOI 10.1016/0008-8749(89)90233-5; Mitsuyasu H, 1998, NAT GENET, V19, P119, DOI 10.1038/472; Miyazoe S, 2002, AM J GASTROENTEROL, V97, P2086, DOI 10.1111/j.1572-0241.2002.05926.x; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; MORISON WL, 1984, IMMUNOLOGY, V52, P299; Morita C, 2001, ARTHRITIS RHEUM-US, V44, P2819, DOI 10.1002/1529-0131(200112)44:12<2819::AID-ART469>3.0.CO;2-2; Myers RL, 2007, BIOL PSYCHIAT, V61, P167, DOI 10.1016/j.biopsych.2005.12.018; Nagano T, 2008, PHOTOCHEM PHOTOBIOL, V84, P63, DOI 10.1111/j.1751-1097.2007.00245.x; Noonan FP, 2003, J INVEST DERMATOL, V121, P1175, DOI 10.1046/j.1523-1747.2003.12560.x; NOONAN FP, 1994, IMMUNOGENETICS, V39, P29, DOI 10.1007/BF00171794; NOONAN FP, 1984, J IMMUNOL, V132, P2408; Origuchi T, 2003, ANN RHEUM DIS, V62, P1117, DOI 10.1136/ard.62.11.1117; Risma KA, 2002, J IMMUNOL, V169, P1604, DOI 10.4049/jimmunol.169.3.1604; ROSENWASSER LJ, 1995, CLIN EXP ALLERGY, V25, P74, DOI 10.1111/j.1365-2222.1995.tb00428.x; Rosso S, 2002, INT J EPIDEMIOL, V31, P439, DOI 10.1093/ije/31.2.439; Saijo S, 1996, PHOTODERMATOL PHOTO, V12, P145, DOI 10.1111/j.1600-0781.1996.tb00191.x; Salem ML, 2000, INT ARCH ALLERGY IMM, V121, P161, DOI 10.1159/000024312; Salem ML, 2000, INT ARCH ALLERGY IMM, V121, P235, DOI 10.1159/000024323; Seegers D, 2002, GENES IMMUN, V3, P419, DOI 10.1038/sj.gene.6363919; Shreedhar V, 1998, J IMMUNOL, V160, P3783; Steinberg D., 1997, CART CLASSIFICATION; SUCHI M, 1995, GENOMICS, V29, P98, DOI 10.1006/geno.1995.1219; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; ULLRICH SE, 1984, J IMMUNOL, V133, P2786; VERMEER M, 1991, J INVEST DERMATOL, V97, P729, DOI 10.1111/1523-1747.ep12484259; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; WELSH MM, 2008, CARCINOGENESIS; Wilkening S, 2006, BRIT J DERMATOL, V155, P1139, DOI 10.1111/j.1365-2133.2006.07440.x; YOSHIKAWA T, 1990, J INVEST DERMATOL, V95, P530, DOI 10.1111/1523-1747.ep12504877; Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003; [No title captured]	48	34	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e20019	10.1371/journal.pone.0020019	http://dx.doi.org/10.1371/journal.pone.0020019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760883	Green Submitted, Green Published, gold			2022-12-25	WOS:000292657200002
J	Hoile, SP; Lillycrop, KA; Thomas, NA; Hanson, MA; Burdge, GC				Hoile, Samuel P.; Lillycrop, Karen A.; Thomas, Nicola A.; Hanson, Mark A.; Burdge, Graham C.			Dietary Protein Restriction during F-0 Pregnancy in Rats Induces Transgenerational Changes in the Hepatic Transcriptome in Female Offspring	PLOS ONE			English	Article							FOLIC-ACID SUPPLEMENTATION; DUTCH FAMINE; IN-UTERO; GENERATION; DISEASE; GENE; LIFE; METHYLATION; EXPOSURE; GLUCOSE	There is considerable evidence for non-genomic transmission between generations of phenotypes induced by environmental exposures during development, although the mechanism is poorly understood. We investigated whether alterations in expression of the liver transcriptome induced in F1 offspring by feeding F0 dams a protein-restricted (PR) diet during pregnancy were passed with or without further change to two subsequent generations. The number of genes that differed between adult female offspring of F0 protein-restricted (PR) and protein-sufficient (PS) dams was F1 1,684 genes, F2 1,680 and F3 2,062. 63/113 genes that were altered in all three generations showed directionally opposite differences between generations. There was a trend toward increased proportions of up-regulated genes in F3 compared to F1. KEGG analysis showed that only the Adherens Junctions pathway was altered in all three generations. PR offspring showed altered fasting glucose homeostasis and changes in phosphoenolpyruvate carboxykinase promoter methylation and expression in all three generations. These findings show that dietary challenge during F0 pregnancy induced altered gene expression in all three generations, but relatively few genes showed transmission of altered expression between generations. For the majority of altered genes, these changes were not found in all generations, including some genes that were changed in F3 but not F1, or the direction and magnitude of difference between PR and PS differed between generations. Such variation may reflect differences between generations in the signals received by the fetus from the mother as a consequence of changes in the interaction between her phenotype and the environment.	[Hoile, Samuel P.; Thomas, Nicola A.; Hanson, Mark A.; Burdge, Graham C.] Univ Southampton, Acad Unit Human Dev & Hlth, Fac Med, Southampton SO9 5NH, Hants, England; [Lillycrop, Karen A.] Univ Southampton, Fac Nat & Environm Sci, Southampton SO9 5NH, Hants, England	University of Southampton; University of Southampton	Hoile, SP (corresponding author), Univ Southampton, Acad Unit Human Dev & Hlth, Fac Med, Southampton SO9 5NH, Hants, England.	g.c.burdge@southampton.ac.uk	Hanson, Mark/AAE-8236-2019; Burdge, Graham/A-2370-2014	Hanson, Mark/0000-0002-6907-613X; Burdge, Graham/0000-0002-7665-2967; Lillycrop, Karen/0000-0001-7350-5489	BBSRC [BB/F013043/1]; Wessex Medical Research; British Heart Foundation [CH/02/01]; Biotechnology and Biological Sciences Research Council [BB/F013043/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wessex Medical Research; British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the BBSRC (BB/F013043/1) (www.bbsrc.ac.uk) to GCB, KAL and MAH, and Wessex Medical Research (www.wesmed.org.uk) to GCB. MAH receives salary support from the British Heart Foundation (CH/02/01) (www.bhf.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2008, GENOMICS, V91, P30, DOI 10.1016/j.ygeno.2007.10.002; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Badyaev AV, 2008, ANN NY ACAD SCI, V1133, P151, DOI 10.1196/annals.1438.009; BEALE EG, 1985, J BIOL CHEM, V260, P748; BENVENISTY N, 1985, BIOCHEMISTRY-US, V24, P5015, DOI 10.1021/bi00340a009; Benyshek DC, 2006, DIABETOLOGIA, V49, P1117, DOI 10.1007/s00125-006-0196-5; Bertram CE, 2001, BRIT MED BULL, V60, P103, DOI 10.1093/bmb/60.1.103; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Burdge GC, 2007, PROSTAG LEUKOTR ESS, V77, P59, DOI 10.1016/j.plefa.2007.06.003; Burdge GC, 2008, BRIT J NUTR, V99, P540, DOI 10.1017/S0007114507815819; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Burdge GC, 2009, J NUTR, V139, P1054, DOI 10.3945/jn.109.104653; Burns SP, 1997, J CLIN INVEST, V100, P1768, DOI 10.1172/JCI119703; CHANDRA RK, 1975, SCIENCE, V190, P289, DOI 10.1126/science.1179211; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; Drake AJ, 2005, AM J PHYSIOL-REG I, V288, pR34, DOI 10.1152/ajpregu.00106.2004; Gluckman PD, 2005, NESTLE NUTR WORKS SE, V55, P17, DOI 10.1159/000082591; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gluckman PD, 2007, BIOESSAYS, V29, P145, DOI 10.1002/bies.20522; HERRERA E, 1968, BIOCHIM BIOPHYS ACTA, V170, P244, DOI 10.1016/0304-4165(68)90004-4; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Koyama I, 2001, ELECTROPHORESIS, V22, P12, DOI 10.1002/1522-2683(200101)22:1<12::AID-ELPS12>3.0.CO;2-6; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lillycrop KA, 2010, BRIT J NUTR, V103, P1711, DOI 10.1017/S0007114509993795; Martin JF, 2000, J NUTR, V130, P741, DOI 10.1093/jn/130.4.741; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003745; Stein AD, 2000, HUM BIOL, V72, P641; Torrens C, 2008, BRIT J NUTR, V100, P760, DOI 10.1017/S0007114508921747; Waterland RA, 2008, INT J OBESITY, V32, P1373, DOI 10.1038/ijo.2008.100; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Zambrano E, 2005, J PHYSIOL-LONDON, V566, P225, DOI 10.1113/jphysiol.2005.086462; ZAMENHOF S, 1971, SCIENCE, V172, P850, DOI 10.1126/science.172.3985.850	37	53	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21668	10.1371/journal.pone.0021668	http://dx.doi.org/10.1371/journal.pone.0021668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750721	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000292655400010
J	Khan, SH; Ling, J; Kumar, R				Khan, Shagufta H.; Ling, Jun; Kumar, Raj			TBP Binding-Induced Folding of the Glucocorticoid Receptor AF1 Domain Facilitates Its Interaction with Steroid Receptor Coactivator-1	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; NUCLEAR HORMONE-RECEPTORS; ESTROGEN-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; TRANSACTIVATION DOMAIN; INTRINSIC DISORDER; IN-VITRO; UNSTRUCTURED PROTEINS; SMALL REGION; DNA-BINDING	The precise mechanism by which glucocorticoid receptor (GR) regulates the transcription of its target genes is largely unknown. This is, in part, due to the lack of structural and functional information about GR's N-terminal activation function domain, AF1. Like many steroid hormone receptors (SHRs), the GR AF1 exists in an intrinsically disordered (ID) conformation or an ensemble of conformers that collectively appears to be unstructured. The GR AF1 is known to recruit several coregulatory proteins, including those from the basal transcriptional machinery, e. g., TATA box binding protein (TBP) that forms the basis for the multiprotein transcription initiation complex. However, the precise mechanism of this process is unknown. We have earlier shown that conditional folding of the GR AF1 is the key for its interactions with critical coactivator proteins. We hypothesize that binding of TBP to AF1 results in the structural rearrangement of the ID AF1 domain such that its surfaces become easily accessible for interaction with other coactivators. To test this hypothesis, we determined whether TBP binding-induced structure formation in the GR AF1 facilitates its interaction with steroid receptor coactivator-1 (SRC-1), a critical coactivator that is important for GR-mediated transcriptional activity. Our data show that stoichiometric binding of TBP induces significantly higher helical content at the expense of random coil configuration in the GR AF1. Further, we found that this induced AF1 conformation facilitates its interaction with SRC-1, and subsequent AF1-mediated transcriptional activity. Our results may provide a potential mechanism through which GR and by large other SHRs may regulate the expression of the GR-target genes.	[Khan, Shagufta H.; Ling, Jun; Kumar, Raj] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA	Geisinger Commonwealth School of Medicine	Khan, SH (corresponding author), Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA.	rkumar@tcmedc.org			NIH, NIDDK [RO1 DK058829]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058829] Funding Source: NIH RePORTER	NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from NIH, NIDDK RO1 DK058829 (R K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almlof T, 1998, BIOCHEMISTRY-US, V37, P9586, DOI 10.1021/bi973029x; ARCHER TK, 1995, J STEROID BIOCHEM, V53, P421, DOI 10.1016/0960-0760(95)00088-H; Bain DL, 2000, J BIOL CHEM, V275, P7313, DOI 10.1074/jbc.275.10.7313; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Chen H, 1997, J BIOL CHEM, V272, P25873, DOI 10.1074/jbc.272.41.25873; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Copik AJ, 2006, MOL ENDOCRINOL, V20, P1218, DOI 10.1210/me.2005-0257; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; DAHLMANWRIGHT K, 1995, P NATL ACAD SCI USA, V92, P1699, DOI 10.1073/pnas.92.5.1699; DAHLMANWRIGHT K, 1994, P NATL ACAD SCI USA, V91, P1619, DOI 10.1073/pnas.91.5.1619; Deroo BJ, 2001, ONCOGENE, V20, P3039, DOI 10.1038/sj.onc.1204328; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2008, NAT CHEM BIOL, V4, P229, DOI 10.1038/nchembio0408-229; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Ford J, 1997, MOL ENDOCRINOL, V11, P1467, DOI 10.1210/me.11.10.1467; Fujita T, 2003, J BIOL CHEM, V278, P26704, DOI 10.1074/jbc.M301031200; Garza AMS, 2010, MOL CELL BIOL, V30, P220, DOI 10.1128/MCB.00552-09; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; Juo ZS, 1996, J MOL BIOL, V261, P239, DOI 10.1006/jmbi.1996.0456; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Kumar R, 1999, STEROIDS, V64, P310, DOI 10.1016/S0039-128X(99)00014-8; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Kumar R, 2004, P NATL ACAD SCI USA, V101, P16425, DOI 10.1073/pnas.0407160101; Kumar R, 2001, J BIOL CHEM, V276, P18146, DOI 10.1074/jbc.M100825200; LEES JA, 1989, NUCLEIC ACIDS RES, V17, P5477, DOI 10.1093/nar/17.14.5477; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Loven MA, 2003, MOL ENDOCRINOL, V17, P67, DOI 10.1210/me.2002-0280; Ma H, 1999, MOL CELL BIOL, V19, P6164; McEwan IJ, 1996, BIOCHEMISTRY-US, V35, P9584, DOI 10.1021/bi960793v; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; MIESFELD R, 1987, SCIENCE, V236, P423, DOI 10.1126/science.3563519; Namba K, 2001, GENES CELLS, V6, P1, DOI 10.1046/j.1365-2443.2001.00384.x; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Qu YX, 2002, BIOPHYS CHEM, V101, P155, DOI 10.1016/S0301-4622(02)00148-5; Reid J, 2002, J BIOL CHEM, V277, P20079, DOI 10.1074/jbc.M201003200; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Romero Pedro, 2004, Appl Bioinformatics, V3, P105, DOI 10.2165/00822942-200403020-00005; Shen F, 1996, J BIOL CHEM, V271, P4827; SIGLER PB, 1988, NATURE, V333, P210, DOI 10.1038/333210a0; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Warnmark A, 2001, J BIOL CHEM, V276, P45939, DOI 10.1074/jbc.M107875200; Yamamoto KR, 1998, COLD SPRING HARB SYM, V63, P587, DOI 10.1101/sqb.1998.63.587	58	18	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21939	10.1371/journal.pone.0021939	http://dx.doi.org/10.1371/journal.pone.0021939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760925	Green Published, gold, Green Submitted			2022-12-25	WOS:000292655400029
J	Smith, MA; Eveleigh, ES; McCann, KS; Merilo, MT; McCarthy, PC; Van Rooyen, KI				Smith, M. Alex; Eveleigh, Eldon S.; McCann, Kevin S.; Merilo, Mark T.; McCarthy, Peter C.; Van Rooyen, Kathleen I.			Barcoding a Quantified Food Web: Crypsis, Concepts, Ecology and Hypotheses	PLOS ONE			English	Article							CHORISTONEURA SPECIES LEPIDOPTERA; PARASITOID FLIES DIPTERA; DNA BARCODES; HYPERPARASITOIDS HYMENOPTERA; BIODIVERSITY ASSESSMENT; SECONDARY STRUCTURE; MOLECULAR METHODS; HOST-SPECIFICITY; IDENTIFICATION; DIVERSITY	The efficient and effective monitoring of individuals and populations is critically dependent on correct species identification. While this point may seem obvious, identifying the majority of the more than 100 natural enemies involved in the spruce budworm (Choristoneura fumiferana - SBW) food web remains a non-trivial endeavor. Insect parasitoids play a major role in the processes governing the population dynamics of SBW throughout eastern North America. However, these species are at the leading edge of the taxonomic impediment and integrating standardized identification capacity into existing field programs would provide clear benefits. We asked to what extent DNA barcoding the SBW food web would alter our understanding of the diversity and connectence of the food web and the frequency of generalists vs. specialists in different forest habitats. We DNA barcoded over 10% of the insects collected from the SBW food web in three New Brunswick forest plots from 1983 to 1993. For 30% of these specimens, we amplified at least one additional nuclear region. When the nodes of the food web were estimated based on barcode divergences (using molecular operational taxonomic units (MOTU) or phylogenetic diversity (PD) - the food web became much more diverse and connectence was reduced. We tested one measure of food web structure (the "bird feeder effect") and found no difference compared to the morphologically based predictions. Many, but not all, of the presumably polyphagous parasitoids now appear to be morphologically-cryptic host-specialists. To our knowledge, this project is the first to barcode a food web in which interactions have already been well-documented and described in space, time and abundance. It is poised to be a system in which field-based methods permit the identification capacity required by forestry scientists. Food web barcoding provided an effective tool for the accurate identification of all species involved in the cascading effects of future budworm outbreaks. Integrating standardized barcodes within food webs may ultimately change the face of community ecology. This will be most poignantly felt in food webs that have not yet been quantified. Here, more accurate and precise connections will be within the grasp of any researcher for the first time.	[Smith, M. Alex; Merilo, Mark T.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Smith, M. Alex; McCann, Kevin S.; Merilo, Mark T.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Eveleigh, Eldon S.; McCarthy, Peter C.; Van Rooyen, Kathleen I.] Nat Resources Canada, Canadian Forest Serv, Atlantic Forestry Ctr, Fredericton, NB, Canada; [Eveleigh, Eldon S.] Univ New Brunswick, Populat Ecol Grp, Fredericton, NB, Canada	University of Guelph; University of Guelph; Natural Resources Canada; Canadian Forest Service; University of New Brunswick	Smith, MA (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	salex@uoguelph.ca	Smith, M Alex/B-4468-2013	Smith, M Alex/0000-0002-8650-2575	Canadian Forest Service; Genome Canada through the Ontario Genomics Institute; Genome Canada through Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Forest Service(Natural Resources CanadaCanadian Forest Service); Genome Canada through the Ontario Genomics Institute(Genome Canada); Genome Canada through Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The field study was funded by the Canadian Forest Service to ESE and laboratory reagents were funded by Genome Canada through the Ontario Genomics Institute and through a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to MAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs Z, 2010, MOL PHYLOGENET EVOL, V55, P210, DOI 10.1016/j.ympev.2009.12.004; Agapow P.-M., 2008, CONSERVE 4; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Bennett AMR, 2008, CAN ENTOMOL, V140, P1; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Birky CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010609; Brown JH, 2003, P NATL ACAD SCI USA, V100, P1467, DOI 10.1073/pnas.0630310100; Canada H, 2005, PRINC SPRUC BUDW INT; Canada NR, 2009, STAT CAN FOR ANN REP; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; COHEN JE, 1978, FOOD WEBS NICHE SPAC; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Corse E, 2010, MOL ECOL RESOUR, V10, P96, DOI 10.1111/j.1755-0998.2009.02795.x; Cracraft J., 1989, P28; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Crozier RH, 1999, FEMS MICROBIOL ECOL, V28, P325; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dunne JA, 2004, MAR ECOL PROG SER, V273, P291, DOI 10.3354/meps273291; Emmerson MC, 2004, J ANIM ECOL, V73, P399, DOI 10.1111/j.0021-8790.2004.00818.x; Eveleigh ES, 2007, P NATL ACAD SCI USA, V104, P16976, DOI 10.1073/pnas.0704301104; Eveleigh ES, 2003, CAN ENTOMOL, V135, P677; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fernanez-Triana JL, 2010, CAN ENTOMOL, V142, P1; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Frankham R, 2010, CONSERV GENET, V11, P661, DOI 10.1007/s10592-009-0010-2; Gariepy T, 2008, J APPL ECOL, V45, P708, DOI 10.1111/j.1365-2664.2007.01451.x; Garros C, 2008, MOL ECOL RESOUR, V8, P512, DOI 10.1111/j.1471-8286.2007.02013.x; Godfray H. C. J., 1994, Parasitoids: behavioral and evolutionary ecology.; Greenstone MH, 2006, B ENTOMOL RES, V96, P1, DOI 10.1079/BER2005402; Hardy CM, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04411.x; Higgs PG, 2000, Q REV BIOPHYS, V33, P199, DOI 10.1017/S0033583500003620; Huber JT, 1996, CAN ENTOMOL, V128, P1167, DOI 10.4039/Ent1281167-6; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; Kaartinen R, 2010, ECOL ENTOMOL, V35, P623, DOI 10.1111/j.1365-2311.2010.01224.x; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; LaSalle J., 1991, Redia, V74, P315; Locke SA, 2010, MOL ECOL, V19, P2813, DOI 10.1111/j.1365-294X.2010.04713.x; MacLean DA, 2001, CAN J FOREST RES, V31, P1742, DOI 10.1139/cjfr-31-10-1742; MARTINEZ ND, 1993, OIKOS, V66, P403, DOI 10.2307/3544934; May RM, 1983, NATURE, V301, P566; Mayr E., 1942, P1; McCann K, 2007, NATURE, V446, P29, DOI 10.1038/446029a; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; O'Hara JE, 2005, ZOOTAXA, P1; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Rougerie R, 2010, MOL ECOLOGY IN PRESS; Royama T., 1992, Analytical population dynamics.; Ruhl MW, 2010, MOL PHYLOGENET EVOL, V54, P664, DOI 10.1016/j.ympev.2009.07.036; SAMWAYS MJ, 1993, BIODIVERS CONSERV, V2, P258, DOI 10.1007/BF00056672; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-31; Smith MA, 2009, MOL ECOL RESOUR, V9, P208, DOI 10.1111/j.1755-0998.2009.02646.x; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Van Veen FJF, 2003, EUR J ENTOMOL, V100, P449, DOI 10.14411/eje.2003.067; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; WILEY EO, 1978, SYST ZOOL, V27, P17, DOI 10.2307/2412809; Yoon I, 2004, P SOC PHOTO-OPT INS, V5295, P124, DOI 10.1117/12.526956; Zhang AB, 2010, MOL PHYLOGENET EVOL, V54, P1035, DOI 10.1016/j.ympev.2009.09.014; Zhou X, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-30	70	69	75	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e14424	10.1371/journal.pone.0014424	http://dx.doi.org/10.1371/journal.pone.0014424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754977	Green Submitted, Green Published, gold			2022-12-25	WOS:000292632000001
J	Forshammar, J; Block, L; Lundborg, C; Biber, B; Hansson, E				Forshammar, Johan; Block, Linda; Lundborg, Christopher; Biber, Bjoern; Hansson, Elisabeth			Naloxone and Ouabain in Ultralow Concentrations Restore Na+/K+-ATPase and Cytoskeleton in Lipopolysaccharide-treated Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; TOLL-LIKE RECEPTORS; NITRIC-OXIDE; PRIMARY CULTURES; HIPPOCAMPAL ASTROCYTES; NA+,K+-ATPASE ACTIVITY; CALCIUM OSCILLATIONS; ACTIN CYTOSKELETON; INFLAMMATORY PAIN	Astrocytes respond to inflammatory stimuli and may be important modulators of the inflammatory response in the nervous system. This study aimed first to assess how astrocytes in primary culture behave in response to inflammatory stimuli concerning intracellular Ca2+ responses, expression of Toll-like receptor 4 (TLR4), Na+/K+-ATPase, actin filament organization, and expression of cytokines. In a cell culture model with lipopolysaccharide (LPS), astrocyte response was assessed first in the acute phase and then after incubation with LPS for 1-48 h. The concentration curve for LPS-stimulated Ca2+ responses was bell-shaped, and the astrocytes expressed TLR4, which detects LPS and evokes intracellular Ca2+ transients. After a long incubation with LPS, TLR4 was up-regulated, LPS-evoked Ca2+ transients were expressed as oscillations, Na+/K+-ATPase was down-regulated, and the actin filaments were disorganized. Interleukin-1 beta(IL-1 beta) release was increased after 24 h in LPS. A second aim was to try to restore the LPS-induced changes in astrocytes with substances that may have dose-dependent anti-inflammatory properties. Naloxone and ouabain were tested separately in ultralow or high concentrations. Both substances evoked intracellular Ca2+ transients for all of the concentrations from 10(-15) up to 10(-4) M. Neither substance blocked the TLR4-evoked Ca2+ responses. Naloxone and ouabain prevented the LPS-induced down-regulation of Na+/K+-ATPase and restored the actin filaments. Ouabain, in addition, reduced the IL-1 beta release from reactive astrocytes. Notably, ultralow concentrations (10(-12) M) of naloxone and ouabain showed these qualities. Ouabain seems to be more potent in these effects of the two tested substances.	[Hansson, Elisabeth] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, SE-41345 Gothenburg, Sweden; [Forshammar, Johan; Block, Linda; Lundborg, Christopher; Biber, Bjoern] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Anesthesiol & Intens Care Med, SE-41345 Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Hansson, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Dubbsgatan 14,1Tr, SE-41345 Gothenburg, Sweden.	elisabeth.hansson@neuro.gu.se		Block, Linda/0000-0002-7736-0093	Jacobson's Foundation; Arvid Carlsson's Foundation; Sahlgrenska University Hospital (LUA/ALF) (Gothenburg, Sweden) [GBG-11587]	Jacobson's Foundation; Arvid Carlsson's Foundation; Sahlgrenska University Hospital (LUA/ALF) (Gothenburg, Sweden)	This work was supported by Edit Jacobson's Foundation, Arvid Carlsson's Foundation, and the Sahlgrenska University Hospital (LUA/ALF GBG-11587) (Gothenburg, Sweden).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; ABBOTT NJ, 1992, NEUROPATH APPL NEURO, V18, P424, DOI 10.1111/j.1365-2990.1992.tb00808.x; Allansson L, 2001, J NEUROCHEM, V76, P472, DOI 10.1046/j.1471-4159.2001.00097.x; Andersson AK, 2009, NEUROCHEM RES, V34, P556, DOI 10.1007/s11064-008-9819-1; Berridge MJ, 2007, BIOCHEM SOC SYMP, V74, P1, DOI 10.1002/9780470514696.ch1; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Blomstrand F, 1999, NEUROSCIENCE, V88, P1241, DOI 10.1016/S0306-4522(98)00351-0; Boran MS, 2007, J NEUROCHEM, V102, P216, DOI 10.1111/j.1471-4159.2007.04464.x; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Carpentier PA, 2005, GLIA, V49, P360, DOI 10.1002/glia.20117; Cimen B, 2004, MOL CELL BIOCHEM, V259, P53, DOI 10.1023/B:MCBI.0000021344.64317.a2; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Delbro D, 2009, NEUROSCIENCE, V159, P770, DOI 10.1016/j.neuroscience.2009.01.005; Hansson E, 2008, NEUROSCIENCE, V155, P1237, DOI 10.1016/j.neuroscience.2008.04.027; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Hansson E, 2006, ACTA PHYSIOL, V187, P321, DOI 10.1111/j.1748-1716.2006.01568.x; HANSSON E, 1984, BRAIN RES, V300, P9, DOI 10.1016/0006-8993(84)91335-0; HANSSON E, 2004, ADV MOL CEL, V31, P475; Hansson E, 2010, SCAND J PAIN, V1, P67, DOI 10.1016/j.sjpain.2010.01.002; Holthouser KA, 2010, AM J PHYSIOL-RENAL, V299, pF77, DOI 10.1152/ajprenal.00581.2009; Huber JD, 2001, AM J PHYSIOL-HEART C, V280, pH1241, DOI 10.1152/ajpheart.2001.280.3.H1241; Hutchinson MR, 2008, EUR J NEUROSCI, V28, P20, DOI 10.1111/j.1460-9568.2008.06321.x; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; Kimelberg HK, 2006, GLIA, V54, P747, DOI 10.1002/glia.20423; Krasowska-Zoladek A, 2007, J NEUROSCI RES, V85, P205, DOI 10.1002/jnr.21088; Lencesova L, 2004, J BIOL CHEM, V279, P2885, DOI 10.1074/jbc.M310365200; Liu X, 2008, J BIOL CHEM, V283, P11461, DOI 10.1074/jbc.M706942200; Liu XL, 2007, NEUROREPORT, V18, P597, DOI 10.1097/WNR.0b013e3280b07bc9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manunta P, 2010, BBA-MOL BASIS DIS, V1802, P1214, DOI 10.1016/j.bbadis.2010.03.001; Morita M, 2003, J NEUROSCI, V23, P10944; Nakamura Y, 2002, BIOL PHARM BULL, V25, P945, DOI 10.1248/bpb.25.945; O'Neill LA, 2003, CURR OPIN PHARMACOL, V3, P396, DOI 10.1016/S1471-4892(03)00080-8; O'Shea RD, 2006, NEUROCHEM INT, V48, P604, DOI 10.1016/j.neuint.2005.12.028; Parpura V, 2010, BRAIN RES REV, V63, P83, DOI 10.1016/j.brainresrev.2009.11.008; Persson M, 2005, GLIA, V51, P111, DOI 10.1002/glia.20191; Qureshi N, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P687; Salkeni MA, 2009, J NEUROIMMUNE PHARM, V4, P276, DOI 10.1007/s11481-008-9138-y; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Schmidt C, 2007, J AM SOC NEPHROL, V18, P1072, DOI 10.1681/ASN.2006050454; Sergeeva M, 2000, NEUROSCIENCE, V97, P765, DOI 10.1016/S0306-4522(00)00062-2; Seven I, 2005, MOL CELL BIOCHEM, V271, P107, DOI 10.1007/s11010-005-5616-1; Sharma G, 2001, P NATL ACAD SCI USA, V98, P4148, DOI 10.1073/pnas.071540198; Simi A, 2007, NEUROPHARMACOLOGY, V52, P1563, DOI 10.1016/j.neuropharm.2007.02.011; Sowa G, 1997, IMMUNOPHARMACOLOGY, V36, P95, DOI 10.1016/S0162-3109(96)00159-2; Suzuki Y, 2005, INT J MOL MED, V15, P871; Takahashi S, 2000, EUR J PHARMACOL, V408, P127, DOI 10.1016/S0014-2999(00)00790-1; Tsai RY, 2009, NEUROSCIENCE, V159, P1244, DOI 10.1016/j.neuroscience.2009.01.058; Vallejo R, 2010, PAIN PRACT, V10, P167, DOI 10.1111/j.1533-2500.2010.00367.x; Willis CL, 2008, CURR PHARM DESIGN, V14, P1625, DOI 10.2174/138161208784705414; Yang L, 2010, EPILEPSIA, V51, P344, DOI 10.1111/j.1528-1167.2009.02250.x; Zhang LN, 2008, FUND CLIN PHARMACOL, V22, P615, DOI 10.1111/j.1472-8206.2008.00620.x	53	53	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31586	31597		10.1074/jbc.M111.247767	http://dx.doi.org/10.1074/jbc.M111.247767			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21757727	Green Published, hybrid			2022-12-25	WOS:000294487500053
J	Mulepati, S; Bailey, S				Mulepati, Sabin; Bailey, Scott			Structural and Biochemical Analysis of Nuclease Domain of Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated Protein 3 (Cas3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMAL SHIFT ASSAYS; ESCHERICHIA-COLI; HD-DOMAIN; DNTP TRIPHOSPHOHYDROLASE; IMMUNE-SYSTEM; DNA; IDENTIFICATION; MODEL; BACTERIOPHAGE; SPECIFICITY	RNA transcribed from clustered regularly interspaced short palindromic repeats (CRISPRs) protects many pro-karyotes from invasion by foreign DNA such as viruses, conjugative plasmids, and transposable elements. Cas3 (CRISPR-associated protein 3) is essential for this CRISPR protection and is thought to mediate cleavage of the foreign DNA through its N-terminal histidine-aspartate (HD) domain. We report here the 1.8 angstrom crystal structure of the HD domain of Cas3 from Thermus thermophilus HB8. Structural and biochemical studies predict that this enzyme binds two metal ions at its active site. We also demonstrate that the single-stranded DNA endonuclease activity of this T. thermophilus domain is activated not by magnesium but by transition metal ions such as manganese and nickel. Structure-guided mutagenesis confirms the importance of the metal-binding residues for the nuclease activity and identifies other active site residues. Overall, these results provide a framework for understanding the role of Cas3 in the CRISPR system.	[Mulepati, Sabin; Bailey, Scott] Johns Hopkins Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bailey, S (corresponding author), 615 N Wolfe St,W8704, Baltimore, MD 21205 USA.	scbailey@jhsph.edu	Bailey, Scott/N-7248-2019		National Institutes of Health [GM097330]; Department of Biochemistry and Molecular Biology; Johns Hopkins Malaria Research Institute; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Biochemistry and Molecular Biology; Johns Hopkins Malaria Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM097330. This work was also supported by start-up funds provided by the Department of Biochemistry and Molecular Biology and the Johns Hopkins Malaria Research Institute.	Afonine PV, 2010, J APPL CRYSTALLOGR, V43, P669, DOI 10.1107/S0021889810015608; Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; AN G, 1979, J BACTERIOL, V137, P1100, DOI 10.1128/JB.137.3.1100-1110.1979; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cady KC, 2011, J BACTERIOL, V193, P3433, DOI 10.1128/JB.01411-10; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FREEMONT PS, 1988, P NATL ACAD SCI USA, V85, P8924, DOI 10.1073/pnas.85.23.8924; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Han D, 2009, FEBS LETT, V583, P771, DOI 10.1016/j.febslet.2009.01.024; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kondo N, 2008, EXTREMOPHILES, V12, P217, DOI 10.1007/s00792-007-0118-6; Kondo N, 2007, ACTA CRYSTALLOGR D, V63, P230, DOI 10.1107/S0907444906049262; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; NAKATA A, 1989, J BACTERIOL, V171, P3553, DOI 10.1128/jb.171.6.3553-3556.1989; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Proudfoot M, 2004, J BIOL CHEM, V279, P54687, DOI 10.1074/jbc.M411023200; SETO D, 1988, J BIOL CHEM, V263, P1494; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Yakunin AF, 2004, J BIOL CHEM, V279, P36819, DOI 10.1074/jbc.M405120200; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Zimmerman MD, 2008, J MOL BIOL, V378, P215, DOI 10.1016/j.jmb.2008.02.036	41	87	94	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31896	31903		10.1074/jbc.M111.270017	http://dx.doi.org/10.1074/jbc.M111.270017			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21775431	Green Published, hybrid			2022-12-25	WOS:000294487500082
J	Runkle, EA; Sundstrom, JM; Runkle, KB; Liu, XW; Antonetti, DA				Runkle, E. Aaron; Sundstrom, Jeffrey M.; Runkle, Kristin B.; Liu, Xuwen; Antonetti, David A.			Occludin Localizes to Centrosomes and Modifies Mitotic Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT JUNCTION PROTEIN; EPITHELIAL-CELLS; BETA-CATENIN; PARACELLULAR PERMEABILITY; ENDOTHELIAL-CELLS; FACTOR ZONAB/DBPA; MEMBRANE-PROTEIN; EXPRESSION; GROWTH; ZO-1	Proper control of cell cycle progression and barrier function are essential processes to the maintenance of epithelial cell homeostasis. The contribution of tight junction proteins to barrier function is well established, whereas their contribution to cell cycle control is only beginning to be understood. Centrosomes are the principal microtubule organizing centers in eukaryotic cells and centrosome duplication and separation are linked to the cell cycle and mitotic entry. Here we demonstrate that occludin localizes with centrosomes in Madin-Darby canine kidney cells. Immunocytochemistry and biochemical fractionation studies reveal occludin localizes with centrosomes during interphase and occludin Ser-490 phosphorylation at centrosomes increases with mitotic entry. Stable expression of aspartic acid phosphomimetic (S490D) results in centrosomal localization of occludin and increases cell numbers. Furthermore, we provide evidence that occludin regulates centrosome separation and mitotic entry as the nonphosphorylatable alanine mutation (S490A) impedes centrosome separation, delays mitotic entry, and reduces proliferation. Collectively, these studies demonstrate a novel location and function for occludin in centrosome separation and mitosis.	[Liu, Xuwen; Antonetti, David A.] Univ Michigan, Kellogg Eye Ctr, Ann Arbor, MI 48105 USA; Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Sundstrom, Jeffrey M.] Penn State Univ, Coll Med, Dept Ophthalmol, Hershey, PA 17033 USA	University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Antonetti, DA (corresponding author), Univ Michigan, Kellogg Eye Ctr, Ann Arbor, MI 48105 USA.	dantonet@umich.edu	LIU, XUWEN/AAR-9250-2020	Sundstrom, Jeffrey/0000-0003-2738-2224; antonetti, david/0000-0003-1130-6577	National Institutes of Health [R01 EY012021]; American Heart Association (AHA) [0815468D]; NATIONAL EYE INSTITUTE [R01EY012021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY012021 (to D.A.A.), the Jules and Doris Stein Professorship (to D.A.A.), and American Heart Association (AHA) Great Rivers Affiliate Predoctoral Fellowship award 0815468D (to E.A.R.).	Aijaz S, 2006, INT REV CYTOL, V248, P261, DOI 10.1016/S0074-7696(06)48005-0; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; AndoAkatsuka Y, 1996, J CELL BIOL, V133, P43, DOI 10.1083/jcb.133.1.43; Antonetti DA, 1998, DIABETES, V47, P1953, DOI 10.2337/diabetes.47.12.1953; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Balda MS, 2000, EMBO J, V19, P2024, DOI 10.1093/emboj/19.9.2024; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Barber AJ, 2003, INVEST OPHTH VIS SCI, V44, P5410, DOI 10.1167/iovs.03-0244; Don ASA, 2006, EXP CELL RES, V312, P4181, DOI 10.0116/j.yexcr.2006.09.023; Du D, 2010, DEV CELL, V18, P52, DOI 10.1016/j.devcel.2009.12.008; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Hadjihannas MV, 2010, EMBO REP, V11, P317, DOI 10.1038/embor.2010.23; Harhaj NS, 2006, INVEST OPHTH VIS SCI, V47, P5106, DOI 10.1167/iovs.06-0322; Harhaj NS, 2002, J CELL PHYSIOL, V193, P349, DOI 10.1002/jcp.10183; Hirase T, 1997, J CELL SCI, V110, P1603; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Itoh M, 1999, J BIOL CHEM, V274, P5981, DOI 10.1074/jbc.274.9.5981; Kaplan DD, 2004, J BIOL CHEM, V279, P10829, DOI 10.1074/jbc.C400035200; Lemieux E, 2009, INT J CANCER, V125, P1575, DOI 10.1002/ijc.24485; Li YH, 2005, J MOL BIOL, V352, P151, DOI 10.1016/j.jmb.2005.07.017; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Nie M, 2009, EMBO REP, V10, P1125, DOI 10.1038/embor.2009.182; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Oomen PHN, 2004, SCAND J CLIN LAB INV, V64, P119, DOI 10.1080/00365510410004704; Osanai M, 2006, CANCER RES, V66, P9125, DOI 10.1158/0008-5472.CAN-06-1864; Phillips BE, 2008, INVEST OPHTH VIS SCI, V49, P2568, DOI 10.1167/iovs.07-1204; Rusan NM, 2009, TRAFFIC, V10, P472, DOI 10.1111/j.1600-0854.2009.00880.x; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P599, DOI 10.1016/S0968-0004(02)02229-6; Schulzke JD, 2005, BBA-BIOMEMBRANES, V1669, P34, DOI 10.1016/j.bbamem.2005.01.008; Sourisseau T, 2006, MOL CELL BIOL, V26, P2387, DOI 10.1128/MCB.26.6.2387-2398.2006; Sundstrom JM, 2009, J PROTEOME RES, V8, P808, DOI 10.1021/pr7007913; Tapia R, 2009, MOL BIOL CELL, V20, P1102, DOI 10.1091/mbc.E08-03-0277; Tobioka H, 2004, HUM PATHOL, V35, P159, DOI 10.1016/j.humpath.2003.09.013; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Turksen K, 2004, J CELL SCI, V117, P2435, DOI 10.1242/jcs.01235; Tzelepi VN, 2008, MODERN PATHOL, V21, P22, DOI 10.1038/modpathol.3800959; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Wang Z, 2007, ONCOGENE, V26, P1222, DOI 10.1038/sj.onc.1209902; Wang ZL, 2005, ONCOGENE, V24, P4412, DOI 10.1038/sj.onc.1208634; Wittchen ES, 2000, J CELL BIOL, V151, P825, DOI 10.1083/jcb.151.4.825; Yu ASL, 2005, AM J PHYSIOL-CELL PH, V288, pC1231, DOI 10.1152/ajpcell.00581.2004	50	29	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30847	30858		10.1074/jbc.M111.262857	http://dx.doi.org/10.1074/jbc.M111.262857			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757728	hybrid, Green Published			2022-12-25	WOS:000294283600064
J	Tachezy, R; Smahelova, J; Salakova, M; Arbyn, M; Rob, L; Skapa, P; Jirasek, T; Hamsikova, E				Tachezy, Ruth; Smahelova, Jana; Salakova, Martina; Arbyn, Marc; Rob, Lukas; Skapa, Petr; Jirasek, Tomas; Hamsikova, Eva			Human Papillomavirus Genotype Distribution in Czech Women and Men with Diseases Etiologically Linked to HPV	PLOS ONE			English	Article							INVASIVE CERVICAL-CANCER; PARTICLE VACCINE; PCR DETECTION; END-POINTS; INFECTION; LESIONS; PREVALENCE; VULVAR; DNA; WORLDWIDE	Background: The HPV prevalence and genotype distribution are important for the estimation of the impact of HPV-based cervical cancer screening and HPV vaccination on the incidence of diseases etiologically linked to HPVs. The HPV genotype distribution varies across different geographical regions. Therefore, we investigated the type-specific HPV prevalence in Czech women and men with anogenital diseases. Methods: We analyzed 157 squamous cell carcinoma samples, 695 precancerous lesion samples and 64 cervical, vulvar and anal condylomata acuminate samples. HPV detection and typing were performed by PCR with GP5+/6+ primers, reverse line blot assay and sequencing. Results: Thirty different HPV genotypes were detected in our study, HPV 16 being the most prevalent type both in precancerous lesions (45%) and squamous cell carcinomas (59%). In benign lesions, HPV 6 (72%) was the most common type. Altogether, 61% of carcinoma samples and 43% of precancerous lesion samples contained HPV 16 and/or 18. The presence of HPV types related to the vaccinal ones (HPV 31, 45, 33, 52, 58) were detected in 16% of carcinoma samples and 18% of precancerous lesion samples. HPV 16 and/or 18 were present in 76% of cervical cancer samples, 33% of CIN1, 43% CIN2 and 71% of CIN3 samples. HPV types 6 and/or 11 were detected in 84% samples of condylomata acuminate samples. Conclusions: The prevalence of vaccinal and related HPV types in patients with HPV-associated diseases in the Czech Republic is very high. We may assume that the implementation of routine vaccination against HPV would greatly reduce the burden of HPV-associated diseases in the Czech Republic.	[Tachezy, Ruth; Smahelova, Jana; Salakova, Martina; Hamsikova, Eva] Inst Hematol & Blood Transfus, Dept Expt Virol, CR-12820 Prague, Czech Republic; [Arbyn, Marc] Sci Inst Publ Hlth, Canc Epidemiol Unit, Brussels, Belgium; [Rob, Lukas] Charles Univ Prague, Dept Obstet & Gynecol, Fac Med 2, Prague, Czech Republic; [Skapa, Petr] Charles Univ Prague, Dept Pathol & Mol Med, Fac Med 2, Prague, Czech Republic; [Jirasek, Tomas] Charles Univ Prague, Dept Pathol, Fac Med 3, Prague, Czech Republic	Institute of Hematology Prague; Charles University Prague; Charles University Prague; Charles University Prague	Tachezy, R (corresponding author), Inst Hematol & Blood Transfus, Dept Expt Virol, CR-12820 Prague, Czech Republic.	rutach@uhkt.cz	Šmahelová, Jana/N-4284-2017; Tachezy, Ruth/H-3785-2017; Škapa, Petr/W-4830-2018; Rob, Lukas/AFQ-9215-2022; Jirásek, Tomáš/AAH-5957-2020; Salakova, Martina/N-4288-2017	Šmahelová, Jana/0000-0002-9164-4279; Tachezy, Ruth/0000-0001-7689-9727; Škapa, Petr/0000-0002-7722-3718; Rob, Lukas/0000-0003-3770-651X; Salakova, Martina/0000-0003-0827-1211	Ministry of Health of the Czech Republic [NS 10/656-3/2009]; European Commission (DG of SANCO, Luxembourg, Grand-Duchy of Luxembourg); DG Research of the European Commission [242061]; Sanofi-Pasteur MSD (manufacturer of a quadrivalent HPV vaccine)	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); European Commission (DG of SANCO, Luxembourg, Grand-Duchy of Luxembourg)(European CommissionEuropean Commission Joint Research Centre); DG Research of the European Commission(European CommissionEuropean Commission Joint Research Centre); Sanofi-Pasteur MSD (manufacturer of a quadrivalent HPV vaccine)	This work was supported by grant NS 10/656-3/2009 from the Ministry of Health of the Czech Republic). M. Arbyn was supported by the European Commission (DG of SANCO, Luxembourg, Grand-Duchy of Luxembourg), through the ECCG project (European Cooperation on development and implementation of Cancer screening and prevention Guidelines, IARC, Lyon, France) and the 7th Framework Programme of DG Research of the European Commission through the PREHDICT project (grant No. 242061, coordinated by the Vrije Universiteit Amsterdam, the Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and RT, LR, and EH have the following conflicts: membership in the Czech GSK advisory board for the prevention of cervical carcinoma. MA had membership in the Belgian advisory board up to 2008 for Cervarix (bivalent HPV vaccine, produced by GSK) and received travel funding from Sanofi-Pasteur MSD (manufacturer of a quadrivalent HPV vaccine). MS, JS, TJ, and PS have declared that no competing interests exist.	[Anonymous], 2007, IARC MON EV CARC RIS; [Anonymous], 2010, CANC INCIDENCE 2007; Arbyn M, 2007, ANN ONCOL, V18, P1423, DOI 10.1093/annonc/mdm377; Arbyn M, 2010, ANN ONCOL, V21, P448, DOI 10.1093/annonc/mdp471; Arbyn M, 2010, INT J BIOL MARKER, V25, P117, DOI 10.1177/172460081002500301; Bardin A, 2008, EUR J CANCER, V44, P557, DOI 10.1016/j.ejca.2007.12.001; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; Clifford GM, 2005, CANCER EPIDEM BIOMAR, V14, P1157, DOI 10.1158/1055-9965.EPI-04-0812; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Eklund C, 2010, J CLIN MICROBIOL, V48, P4147, DOI 10.1128/JCM.00918-10; Garland SM, 2009, CANCER EPIDEM BIOMAR, V18, P1777, DOI 10.1158/1055-9965.EPI-09-0067; Gillison Maura L, 2003, J Natl Cancer Inst Monogr, P57; HO GYF, 1995, JNCI-J NATL CANCER I, V87, P1365, DOI 10.1093/jnci/87.18.1365; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; Jenkins D, 2008, GYNECOL ONCOL, V110, pS18, DOI 10.1016/j.ygyno.2008.06.027; Kornya L, 2002, EUR J OBSTET GYN R B, V100, P231, DOI 10.1016/S0301-2115(01)00474-2; Kowalewska M, 2010, INT J GYNECOL CANCER, V20, P434, DOI 10.1111/IGC.0b013e3181d320f1; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kuhmala SMA, 2007, J MED VIROL, V79, P771, DOI 10.1002/jmv.20839; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2006, VACCINE S3, V24, pS3/11; Remmerbach TW, 2004, J CLIN VIROL, V30, P302, DOI 10.1016/j.jcv.2003.12.011; Sabol I, 2008, J CLIN MICROBIOL, V46, P1606, DOI 10.1128/JCM.02328-07; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Shipitsyna E, 2011, CANCER EPIDEMIOL, V35, P160, DOI 10.1016/j.canep.2010.08.010; Skapa P, 2007, AM J SURG PATHOL, V31, P1834, DOI 10.1097/PAS.0b013e3180686d10; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Smith JS, 2009, OBSTET GYNECOL, V113, P917, DOI 10.1097/AOG.0b013e31819bd6e0; Speich N, 2004, J MED MICROBIOL, V53, P125, DOI 10.1099/jmm.0.05447-0; Szostek S, 2008, ACTA BIOCHIM POL, V55, P687; Tachezy R, 2007, APMIS, V115, P195, DOI 10.1111/j.1600-0463.2007.apm_526.x; Tachezy R, 2006, EUR J CLIN MICROBIOL, V25, P492, DOI 10.1007/s10096-006-0172-5; Tachezy R, 1999, J MED VIROL, V58, P378, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;378::AID-JMV10&gt;3.0.CO;2-P; van den Brule AJC, 2002, J CLIN MICROBIOL, V40, P779, DOI 10.1128/JCM.40.3.779-787.2002; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wentzensen N, 2009, INT J CANCER, V125, P2151, DOI 10.1002/ijc.24528; Wheeler CM, 2009, J INFECT DIS, V199, P936, DOI 10.1086/597309; zur Hausen H, 1975, Bibl Haematol, P569	46	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21913	10.1371/journal.pone.0021913	http://dx.doi.org/10.1371/journal.pone.0021913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765924	Green Published, gold, Green Submitted			2022-12-25	WOS:000292781500021
J	Zhou, Y; Wei, Y; Zhu, J; Wang, QY; Bao, L; Ma, Y; Chen, Y; Feng, DQ; Zhang, AJ; Sun, J; Nallar, SC; Shen, K; Kalvakolanu, DV; Xiao, WH; Ling, B				Zhou, Ying; Wei, Ying; Zhu, Jing; Wang, Qingyuan; Bao, Liang; Ma, Yang; Chen, Yu; Feng, Dingqing; Zhang, Aijin; Sun, Jie; Nallar, Shreeram C.; Shen, Keng; Kalvakolanu, Dhananjaya V.; Xiao, Weihua; Ling, Bin			GRIM-19 Disrupts E6/E6AP Complex to Rescue p53 and Induce Apoptosis in Cervical Cancers	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; UBIQUITIN-PROTEIN LIGASE; CELL-DEATH; E6-ASSOCIATED PROTEIN; E2 PROTEINS; E6-MEDIATED DEGRADATION; NUCLEAR-LOCALIZATION; E6 ONCOPROTEIN; GENE; E6-AP	Background: Our previous studies showed a down-regulation of GRIM-19 in primary human cervical cancers, and restoration of GRIM-19 induced tumor regression. The induction of tumor suppressor protein p53 ubiquitination and degradation by E6 oncoportein of high risk-HPV through forming a stable complex with E6AP is considered as a critical mechanism for cervical tumor development. The aims of this study were to determine the potential role of GRIM-19 in rescuing p53 protein and inducing cervical cancer cell apoptosis. Methodology/Principal Findings: The protein levels of GRIM-19 and p53 were detected in normal cervical tissues from 45 patients who underwent hysterectomy for reasons other than neoplasias of either the cervix or endometrium, and cervical cancer tissues from 60 patients with non-metastatic squamous epithelial carcinomas. Coimmunoprecipitation and GST pull-down assay were performed to examine the interaction of GRIM-19 with 18E6 and E6AP in vivo and in vitro respectively. The competition of 18E6 with E6AP in binding GRIM-19 by performing competition pull-down assays was designed to examine the disruption of E6/E6AP complex by GRIM-19. The augment of E6AP ubiquitination by GRIM-19 was detected in vivo and in vitro ubiquitination assay. The effects of GRIM-19-dependent p53 accumulation on cell proliferation, cell cycle, apoptosis were explored by MTT, flow cytometry and transmission electron microscopy respectively. The tumor suppression was detected by xenograft mouse model. Conclusion/Significance: The levels of GRIM-19 and p53 were concurrently down regulated in cervical cancers. The restoration of GRIM-19 can induce ubiquitination and degradation of E6AP, and disrupt the E6/E6AP complex through the interaction of N-terminus of GRIM-19 with both E6 and E6AP, which protected p53 from degradation and promoted cell apoptosis. Tumor xenograft studies also revealed the suppression of p53 degradation in presence of GRIM-19. These data suggest that GRIM-19 can block E6/E6AP complex; and synergistically suppress cervical tumor growth with p53.	[Zhou, Ying; Wei, Ying; Zhu, Jing; Wang, Qingyuan; Chen, Yu; Feng, Dingqing; Ling, Bin] Anhui Med Univ, Dept Obstet & Gynecol, Anhui Prov Hosp Affiliated, Hefei, Anhui, Peoples R China; [Bao, Liang; Ma, Yang; Zhang, Aijin; Sun, Jie; Xiao, Weihua] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Bao, Liang; Ma, Yang; Zhang, Aijin; Sun, Jie; Xiao, Weihua] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Nallar, Shreeram C.; Kalvakolanu, Dhananjaya V.] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Shen, Keng] Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China	Anhui Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University System of Maryland; University of Maryland Baltimore; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Zhou, Y (corresponding author), Anhui Med Univ, Dept Obstet & Gynecol, Anhui Prov Hosp Affiliated, Hefei, Anhui, Peoples R China.	xiaow@ustc.edu.cn; lingbin.ling@gmail.com	Xiao, Weihua/N-2775-2013	Xiao, Weihua/0000-0001-9102-6326	National Basic Research Program of China (973 Program) [2007CB914503]; National Natural Science Foundation of China [81071683, 81001168 81072127, 91029710]; National Technology Support Programme [2008BAI57B03]; National Institutes of Health [CA105005, CA78282, P30-CA134274]; Anhui Provincial Natural Science Foundation [20090413117, 11040606M178]; Anhui Provincial Higher University Education [KJ2010B375]; NATIONAL CANCER INSTITUTE [R01CA105005, P30CA134274, R01CA078282] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Technology Support Programme; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Anhui Provincial Higher University Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Basic Research Program of China (973 Program): 2007CB914503 http://www.973.gov.cn, National Natural Science Foundation of China (No. 81071683, 81001168 81072127 and 91029710) http://www.nsfc.gov.cn, "Eleventh Five-Year" National Technology Support Programme (2008BAI57B03) http://kjzc.jhgl.org, National Institutes of Health grants CA105005, CA78282 and P30-CA134274 http://grants.nih.gov. Anhui Provincial Natural Science Foundation project (20090413117, 11040606M178) http://www.ahkjt.gov.cn, and Provincial Natural Science Research Project of Anhui Provincial Higher University Education (KJ2010B375) http://www.ahedu.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alchanati I, 2006, ONCOGENE, V25, P7138, DOI 10.1038/sj.onc.1209708; Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Baleja JD, 2006, ANTIVIR RES, V72, P49, DOI 10.1016/j.antiviral.2006.03.014; Beaudenon S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S4; Blachon S, 2003, BIOCHIMIE, V85, P813, DOI 10.1016/j.biochi.2003.09.008; Castellsague X, 2008, GYNECOL ONCOL, V110, pS4, DOI 10.1016/j.ygyno.2008.07.045; El-Mofty SK, 2007, HEAD NECK PATHOL, V1, P181, DOI 10.1007/s12105-007-0021-6; Fang P, 1999, HUM MOL GENET, V8, P129, DOI 10.1093/hmg/8.1.129; Gewin L, 2004, GENE DEV, V18, P2269, DOI 10.1101/gad.1214704; Hegde RS, 2002, ANNU REV BIOPH BIOM, V31, P343, DOI 10.1146/annurev.biophys.31.100901.142129; Hengstermann A, 2001, P NATL ACAD SCI USA, V98, P1218, DOI 10.1073/pnas.031470698; Hodge DR, 2004, CANCER BIOL THER, V3, P188, DOI 10.4161/cbt.3.2.621; Hou SY, 2002, J BIOL CHEM, V277, P45619, DOI 10.1074/jbc.M206829200; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kelley ML, 2005, J VIROL, V79, P3737, DOI 10.1128/JVI.79.6.3737-3747.2005; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kuballa P, 2007, J BIOL CHEM, V282, P65, DOI 10.1074/jbc.M605117200; Lee D, 2010, CANCER LETT, V292, P125, DOI 10.1016/j.canlet.2009.11.015; Lee TL, 2008, INT J CANCER, V122, P1987, DOI 10.1002/ijc.23324; Lin J, 2002, ONCOGENE, V21, P3082, DOI 10.1038/sj.onc.1205426; Louria-Hayon I, 2009, CELL DEATH DIFFER, V16, P1156, DOI 10.1038/cdd.2009.31; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Ma X, 2007, ONCOGENE, V26, P4842, DOI 10.1038/sj.onc.1210287; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Masson M, 2003, J GEN VIROL, V84, P2099, DOI 10.1099/vir.0.18961-0; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Moscicki AB, 2006, VACCINE S3, V24; Mou H Z, 1994, Zhonghua Fu Chan Ke Za Zhi, V29, P162; Murph MM, 2007, MOL CANCER RES, V5, P1201, DOI 10.1158/1541-7786.MCR-06-0338; Narisawa-Saito M, 2007, CANCER SCI, V98, P1505, DOI 10.1111/j.1349-7006.2007.00546.x; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Nguyen M, 2002, J VIROL, V76, P13039, DOI 10.1128/JVI.76.24.13039-13048.2002; Niu GL, 2005, MOL CELL BIOL, V25, P7432, DOI 10.1128/MCB.25.17.7432-7440.2005; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Oda H, 1999, P NATL ACAD SCI USA, V96, P9557, DOI 10.1073/pnas.96.17.9557; Ramamoorthy Sivapriya, 2008, Nucl Recept Signal, V6, pe006, DOI 10.1621/nrs.06006; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Scheffner M, 1998, PHARMACOL THERAPEUT, V78, P129, DOI 10.1016/S0163-7258(98)00003-5; Sehr P, 2007, J BIOMOL SCREEN, V12, P560, DOI 10.1177/1087057107301246; Seo T, 2002, J VIROL, V76, P8797, DOI 10.1128/JVI.76.17.8797-8807.2002; Shai A, 2010, CANCER RES, V70, P5064, DOI 10.1158/0008-5472.CAN-09-3307; Song SY, 1999, J VIROL, V73, P5887, DOI 10.1128/JVI.73.7.5887-5893.1999; Sun G, 2008, INT J ONCOL, V32, P1065; Sun P, 2009, ONCOGENE, V28, P1339, DOI 10.1038/onc.2008.480; Sun P, 2010, J BIOL CHEM, V285, P27545, DOI 10.1074/jbc.M110.105767; Syrjanen KJ, 2002, J CLIN PATHOL, V55, P885, DOI 10.1136/jcp.55.12.885; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; Tommasino M, 2003, HUM MUTAT, V21, P307, DOI 10.1002/humu.10178; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang HB, 2010, J BIOL CHEM, V285, P13201, DOI 10.1074/jbc.M109.058669; Yamamoto Y, 1997, GENOMICS, V41, P263, DOI 10.1006/geno.1997.4617; Yang YC, 2006, BIOCHEM BIOPH RES CO, V343, P428, DOI 10.1016/j.bbrc.2006.02.166; Yeo WM, 2008, J VIROL, V82, P1011, DOI 10.1128/JVI.01156-07; Zaaroor-Regev D, 2010, P NATL ACAD SCI USA, V107, P6788, DOI 10.1073/pnas.1003108107; Zhang HFM, 2005, MOL CELL BIOL, V25, P6247, DOI 10.1128/MCB.25.14.6247-6258.2005; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhang L, 2008, CLIN CANCER RES, V14, P559, DOI 10.1158/1078-0432.CCR-07-1176; Zhao CY, 2010, CANCER RES, V70, P3372, DOI 10.1158/0008-5472.CAN-09-2787; Zhou Y, 2009, J INTERF CYTOK RES, V29, P695, DOI 10.1089/jir.2009.0003	60	20	23	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22065	10.1371/journal.pone.0022065	http://dx.doi.org/10.1371/journal.pone.0022065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765936	Green Published, gold, Green Submitted			2022-12-25	WOS:000292699000022
J	Hemmers, S; Teijaro, JR; Arandjelovic, S; Mowen, KA				Hemmers, Saskia; Teijaro, John R.; Arandjelovic, Sanja; Mowen, Kerri A.			PAD4-Mediated Neutrophil Extracellular Trap Formation Is Not Required for Immunity against Influenza Infection	PLOS ONE			English	Article							VIRUS-INFECTION; HISTONE DEIMINATION; ARGININE METHYLATION; CYSTIC-FIBROSIS; HUMAN PAD4; MICE; DISEASE; CELL; LOCALIZATION; PATHOGENESIS	During an inflammatory response, neutrophils migrate to the site of infection where they can kill invading pathogens by phagocytosis, secretion of anti-microbicidal mediators or the release of neutrophil extracellular traps (NETs). NETs are specialized anti-microbial structures comprised of decondensed chromatin decorated with microbicidal agents. Increased amount of NETs have been found in patients suffering from the chronic lung inflammatory disease cystic fibrosis, correlating with increased severity of pulmonary obstruction. Furthermore, acute lung inflammation during influenza A infection is characterized by a massive influx of neutrophils into the lung. The role of NETs during virus-mediated lung inflammation is unknown. Peptidylarginine deiminase 4 (PAD4)-mediated deimination of histone H3 and H4 is required for NET formation. Therefore, we generated a PAD4-deficient mouse strain that has a striking inability to form NETs. These mice were infected with influenza A/WSN, and the disease was monitored at the level of leukocytic lung infiltration, lung pathology, viral replication, weight loss and mortality. PAD4 KO fared comparable to WT mice in all the parameters tested, but they displayed slight but statistically different weight loss kinetics during infection that was not reflected in enhanced survival. Overall, we conclude that PAD4-mediated NET formation is dispensable in a mouse model of influenza A infection.	[Hemmers, Saskia; Arandjelovic, Sanja; Mowen, Kerri A.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Hemmers, Saskia; Teijaro, John R.; Arandjelovic, Sanja; Mowen, Kerri A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Hemmers, S (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	kmowen@scripps.edu			National Institutes of Health [AI067460, AI09484, AI74564, AI007354]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007354, R37AI009484, U01AI074564, R01AI009484, R01AI067460] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI067460 (K. A. M.), AI09484 (J.R.T.), and AI74564 (J.R.T.) and an Institutional Training Grant (AI007354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzilotti C, 2010, AUTOIMMUN REV, V9, P158, DOI 10.1016/j.autrev.2009.06.002; Arita K, 2004, NAT STRUCT MOL BIOL, V11, P777, DOI 10.1038/nsmb799; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Chang XT, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-7; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Ermert David, 2009, V470, P293, DOI 10.1007/978-1-59745-204-5_21; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Grau AJ, 2010, NAT REV NEUROL, V6, P681, DOI 10.1038/nrneurol.2010.163; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Lindemann SW, 2004, P NATL ACAD SCI USA, V101, P7076, DOI 10.1073/pnas.0401901101; Lipatov AS, 2005, J GEN VIROL, V86, P1121, DOI 10.1099/vir.0.80663-0; Luo Yi, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0320s22; Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; O'Donnell R, 2006, THORAX, V61, P448, DOI 10.1136/thx.2004.024463; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Seki M, 2010, J IMMUNOL, V184, P1410, DOI 10.4049/jimmunol.0901709; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Tate MD, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-57; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Wardini AB, 2010, J GEN VIROL, V91, P259, DOI 10.1099/vir.0.014613-0; Wareing MD, 2007, VIRAL IMMUNOL, V20, P369, DOI 10.1089/vim.2006.0101; Wareing MD, 2004, J LEUKOCYTE BIOL, V76, P886, DOI 10.1189/jlb.1203644; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Wood DD, 2008, LAB INVEST, V88, P354, DOI 10.1038/labinvest.3700748	43	179	184	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e22043	10.1371/journal.pone.0022043	http://dx.doi.org/10.1371/journal.pone.0022043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779371	Green Published, Green Submitted, gold			2022-12-25	WOS:000292680900024
J	Li, F; Glinskii, OV; Zhou, JJ; Wilson, LS; Barnes, S; Anthony, DC; Glinsky, VV				Li, Feng; Glinskii, Olga V.; Zhou, Jianjun; Wilson, Landon S.; Barnes, Stephen; Anthony, Douglas C.; Glinsky, Vladislav V.			Identification and Analysis of Signaling Networks Potentially Involved in Breast Carcinoma Metastasis to the Brain	PLOS ONE			English	Article							DIFFERENCE GEL-ELECTROPHORESIS; CANCER METASTASIS; CELLS; GENES; BONE	Brain is a common site of breast cancer metastasis associated with significant neurologic morbidity, decreased quality of life, and greatly shortened survival. However, the molecular and cellular mechanisms underpinning brain colonization by breast carcinoma cells are poorly understood. Here, we used 2D-DIGE (Difference in Gel Electrophoresis) proteomic analysis followed by LC-tandem mass spectrometry to identify the proteins differentially expressed in brain-targeting breast carcinoma cells (MB231-Br) compared with parental MDA-MB-231 cell line. Between the two cell lines, we identified 12 proteins consistently exhibiting greater than 2-fold (p<0.05) difference in expression, which were associated by the Ingenuity Pathway Analysis (IPA) with two major signaling networks involving TNF alpha/TGF beta-, NF kappa B-, HSP-70-, TP53-, and IFN gamma-associated pathways. Remarkably, highly related networks were revealed by the IPA analysis of a list of 19 brain-metastasis-associated proteins identified recently by the group of Dr. A. Sierra using MDA-MB-435-based experimental system (Martin et al., J Proteome Res 2008 7: 908-20), or a 17-gene classifier associated with breast cancer brain relapse reported by the group of Dr. J. Massague based on a microarray analysis of clinically annotated breast tumors from 368 patients (Bos et al., Nature 2009 459: 1005-9). These findings, showing that different experimental systems and approaches (2D-DIGE proteomics used on brain targeting cell lines or gene expression analysis of patient samples with documented brain relapse) yield highly related signaling networks, suggest strongly that these signaling networks could be essential for a successful colonization of the brain by metastatic breast carcinoma cells.	[Li, Feng; Zhou, Jianjun; Anthony, Douglas C.; Glinsky, Vladislav V.] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO 65211 USA; [Li, Feng; Glinskii, Olga V.; Zhou, Jianjun; Glinsky, Vladislav V.] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA; [Glinskii, Olga V.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO USA; [Wilson, Landon S.; Barnes, Stephen] Univ Alabama, Dept Pharmacol & Toxicol, Birmingham, AL USA; [Wilson, Landon S.; Barnes, Stephen] Univ Alabama, Targeted Metab & Prote Lab, Birmingham, AL USA; [Anthony, Douglas C.] Univ Missouri, Dept Neurol, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Missouri System; University of Missouri Columbia; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Missouri System; University of Missouri Columbia	Li, F (corresponding author), Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO 65211 USA.	glinskiivl@missouri.edu		Glinsky, Vladislav/0000-0003-0893-4388; Anthony, Douglas/0000-0002-3815-2240; Glinskii, Olga/0000-0002-8302-0597	Biomedical Laboratory Research and Development Service of the VA Office of Research and Development [1I01BX000609]; American Heart Association National [SDG 0830287N]; National Center for Research Resources [S10 RR19231]; UAB Lung Health Center;  [U54 CA100949];  [P30 AT050948];  [P30 DK079337]; NATIONAL CANCER INSTITUTE [U54CA163167, P30CA008748, U54CA100949] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000609] Funding Source: NIH RePORTER	Biomedical Laboratory Research and Development Service of the VA Office of Research and Development; American Heart Association National(American Heart Association); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UAB Lung Health Center; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by Award Number 1I01BX000609 from the Biomedical Laboratory Research and Development Service of the VA Office of Research and Development to WG, and the American Heart Association National SDG 0830287N to OVG. The mass spectrometer used in this study was purchased with funds from a Shared Instrumentation grant from the National Center for Research Resources (S10 RR19231, S. Barnes, PI). The operation of the UAB Targeted Metabolomics and Proteomics Laboratory is additionally supported by federal grants (U54 CA100949, S. Barnes, PI; P30 AT050948, C. Elmets, PI; and P30 DK079337, A. Agarwal, PI) and the UAB Lung Health Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chen EI, 2007, CANCER RES, V67, P1472, DOI 10.1158/0008-5472.CAN-06-3137; Cheng X, 2007, CANCER METAST REV, V26, P635, DOI 10.1007/s10555-007-9083-x; Eichler AF, 2008, CURR TREAT OPTION NE, V10, P308, DOI 10.1007/s11940-008-0033-x; Eichler AF, 2008, CANCER, V112, P2359, DOI 10.1002/cncr.23468; Fidler IJ, 2002, DIFFERENTIATION, V70, P498, DOI 10.1046/j.1432-0436.2002.700904.x; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Martin B, 2008, J PROTEOME RES, V7, P908, DOI 10.1021/pr070426d; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Timms JF, 2008, PROTEOMICS, V8, P4886, DOI 10.1002/pmic.200800298; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486	19	16	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21977	10.1371/journal.pone.0021977	http://dx.doi.org/10.1371/journal.pone.0021977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779361	Green Published, Green Submitted, gold			2022-12-25	WOS:000292680900020
J	Abdel-Haleem, AM; El-Zeiry, MI; Mahran, LG; Abou-Aisha, K; Rady, MH; Rohde, J; Mostageer, M; Spahn-Langguth, H				Abdel-Haleem, Alyaa M.; El-Zeiry, Maha I.; Mahran, Laila G.; Abou-Aisha, Khaled; Rady, Mona H.; Rohde, Jan; Mostageer, Marwa; Spahn-Langguth, Hilde			Expression of RFC/SLC19A1 is Associated with Tumor Type in Bladder Cancer Patients	PLOS ONE			English	Article							REDUCED FOLATE CARRIER; ACUTE LYMPHOBLASTIC-LEUKEMIA; GENE-EXPRESSION; ANTIFOLATE RESISTANCE; CELLULAR PHARMACOLOGY; TRANSCRIPTION FACTORS; MEMBRANE-TRANSPORT; METHOTREXATE; CELLS; OSTEOSARCOMA	Urinary bladder cancer (UBC) ranks ninth in worldwide cancer. In Egypt, the pattern of bladder cancer is unique in that both the transitional and squamous cell types prevail. Despite much research on the topic, it is still difficult to predict tumor progression, optimal therapy and clinical outcome. The reduced folate carrier (RFC/SLC19A1) is the major transport system for folates in mammalian cells and tissues. RFC is also the primary means of cellular uptake for antifolate cancer chemotherapeutic drugs, however, membrane transport of antifolates by RFC is considered as limiting to antitumor activity. The purpose of this study was to compare the mRNA expression level of RFC/SLC19A1 in urothelial and non-urothelial variants of bladder carcinomas. Quantification of RFC mRNA in the mucosa of 41 untreated bladder cancer patients was performed using RT-qPCR. RFC mRNA steady-state levels were similar to 9-fold higher (N = 39; P < 0.0001) in bladder tumor specimens relative to normal bladder mRNA. RFC upregulation was strongly correlated with tumor type (urothelial vs. non-urothelial; p < 0.05) where median RFC mRNA expression was significantly (p < 0.05) higher in the urothelial (similar to 14-fold) compared to the non-urothelial (similar to 4-fold) variant. This may account for the variation in response to antifolate-containing regimens used in the treatment of either type. RFC mRNA levels were not associated with tumor grade (I, II and III) or stage (muscle-invasive vs. non-muscle invasive) implying that RFC cannot be used for prognostic purposes in bladder carcinomas and its increased expression is an early event in human bladder tumors pathogenesis. Further, RFC can be considered as a potential marker for predicting response to antifolate chemotherapy in urothelial carcinomas.	[Abdel-Haleem, Alyaa M.; El-Zeiry, Maha I.; Mahran, Laila G.; Abou-Aisha, Khaled; Rady, Mona H.; Rohde, Jan; Mostageer, Marwa; Spahn-Langguth, Hilde] German Univ Cairo, Dept Pharmacol & Toxicol, Cairo, Egypt; [Spahn-Langguth, Hilde] Graz Univ, Inst Pharmaceut Sci, Dept Pharmaceut Chem, Graz, Austria	Egyptian Knowledge Bank (EKB); German University in Cairo; University of Graz	Abdel-Haleem, AM (corresponding author), German Univ Cairo, Dept Pharmacol & Toxicol, Cairo, Egypt.	alyaa.abdelhaleem@guc.edu; egspahnlan@uni-graz.at		Rady, Mona/0000-0002-7561-853X	DAAD; GUC	DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); GUC	This work was funded by the DAAD as well as GUC as MSC project funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; BRADELY D, 2010, MVAC NEW IMPROVED 3, P247; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129; Eissa S, 2000, CLIN CHIM ACTA, V300, P159, DOI 10.1016/S0009-8981(00)00317-X; Erdemir F, 2007, INT UROL NEPHROL, V39, P803, DOI 10.1007/s11255-006-9151-0; Felix AS, 2008, CANCER CAUSE CONTROL, V19, P421, DOI 10.1007/s10552-007-9104-7; Flatley RM, 2004, CLIN CANCER RES, V10, P5111, DOI 10.1158/1078-0432.CCR-04-0116; Frisch M, 2009, NUCLEIC ACIDS RES, V37, pW135, DOI 10.1093/nar/gkp303; GOLDMAN ID, 1985, PHARMACOL THERAPEUT, V28, P77, DOI 10.1016/0163-7258(85)90083-X; Goldman ID, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.37461; GORLICK R, 2000, MIL DRUG TH, P9; GREENE FL, AJCC CANC STAGING AT; Guo W, 1999, CLIN CANCER RES, V5, P621; Haitel A, 2001, J UROLOGY, V165, P1481, DOI 10.1016/S0022-5347(05)66332-X; Matherly LH, 2008, VITAM HORM, V79, P145, DOI 10.1016/S0083-6729(08)00405-6; Matherly LH, 2007, CANCER METAST REV, V26, P111, DOI 10.1007/s10555-007-9046-2; Matherly LH, 2003, VITAM HORM, V66, P403, DOI 10.1016/S0083-6729(03)01012-4; MATHERLY LH, 2008, STRUCTURE FUNCTION R; Memon AA, 2004, BRIT J CANCER, V91, P2034, DOI 10.1038/sj.bjc.6602251; Ohl F, 2006, J UROLOGY, V175, P1915, DOI 10.1016/S0022-5347(05)00919-5; Parkin DM, 2008, SCAND J UROL NEPHROL, V42, P12, DOI 10.1080/03008880802285032; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Reznikoff CA, 2000, UROL ONCOL, V5, P191, DOI 10.1016/S1078-1439(00)00079-X; Rothem L, 2004, MOL PHARMACOL, V66, P1536, DOI 10.1124/mol.104.004135; Rothem L, 2003, J BIOL CHEM, V278, P8935, DOI 10.1074/jbc.M209578200; Schabath MB, 2005, NUTR CANCER, V53, P144, DOI 10.1207/s15327914nc5302_3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sirotnak FM, 1999, ANNU REV NUTR, V19, P91, DOI 10.1146/annurev.nutr.19.1.91; Sowers R, 2003, MOL CANCER THER, V2, P535; UEKI O, 1992, CANCER CHEMOTH PHARM, V30, pS72, DOI 10.1007/BF00686947; Whetstine JR, 2001, J BIOL CHEM, V276, P6350, DOI 10.1074/jbc.M008074200; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Zhang L, 1998, CLIN CANCER RES, V4, P2169	35	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21820	10.1371/journal.pone.0021820	http://dx.doi.org/10.1371/journal.pone.0021820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760912	Green Published, gold, Green Submitted			2022-12-25	WOS:000292657200024
J	Kang, HY; Wang, Y; Fedak, G; Cao, WG; Zhang, HQ; Fan, X; Sha, LN; Xu, LL; Zheng, YL; Zhou, YH				Kang, Houyang; Wang, Yi; Fedak, George; Cao, Wenguang; Zhang, Haiqin; Fan, Xing; Sha, Lina; Xu, Lili; Zheng, Youliang; Zhou, Yonghong			Introgression of Chromosome 3Ns from Psathyrostachys huashanica into Wheat Specifying Resistance to Stripe Rust	PLOS ONE			English	Article							F-SP TRITICI; BREAD WHEAT; CYTOGENETIC CHARACTERIZATION; CONFERRING RESISTANCE; DISEASE RESISTANCE; SUBSTITUTION LINES; GENES; TRANSLOCATIONS; LOCATION; MARKERS	Wheat stripe rust is a destructive disease in the cool and humid wheat-growing areas of the world. Finding diverse sources of stripe rust resistance is critical for increasing genetic diversity of resistance for wheat breeding programs. Stripe rust resistance was identified in the alien species Psathyrostachys huashanica, and a wheat- P. huashanica amphiploid line (PHWSA) with stripe rust resistance was reported previously. In this study, a P. huashanica 3Ns monosomic addition line (PW11) with superior resistance to stripe rust was developed, which was derived from the cross between PHW-SA and wheat J-11. We evaluated the alien introgressions PW11-2, PW11-5 and PW11-8 which were derived from line PW11 for reaction to new Pst race CYR32, and used molecular and cytogenetic tools to characterize these lines. The introgressions were remarkably resistant to CYR32, suggesting that the resistance to stripe rust of the introgressions thus was controlled by gene(s) located on P. huashanica chromosome 3Ns. All derived lines were cytologically stable in term of meiotic chromosome behavior. Two 3Ns chromosomes of P. huashanica were detected in the disomic addition line PW11-2. Chromosomes 1B of substitution line PW11-5 had been replaced by a pair of P. huashanica 3Ns chromosomes. In PW11-8, a small terminal segment from P. huashanica chromosome arm 3NsS was translocated to the terminal region of wheat chromosomes 3BL. Thus, this translocated chromosome is designated T3BL-3NsS. These conclusions were further confirmed by SSR analyses. Two 3Ns-specific markers Xgwm181 and Xgwm161 will be useful to rapidly identify and trace the translocated fragments. These introgressions, which had significant characteristics of resistance to stripe rust, could be utilized as novel germplasms for wheat breeding.	[Kang, Houyang; Wang, Yi; Zhang, Haiqin; Fan, Xing; Sha, Lina; Xu, Lili; Zheng, Youliang; Zhou, Yonghong] Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Sichuan, Peoples R China; [Wang, Yi; Fedak, George; Cao, Wenguang] Eastern Cereal & Oilseed Res Ctr, Dept Agr & Agr Food Canada, Ottawa, ON, Canada; [Zheng, Youliang; Zhou, Yonghong] Sichuan Agr Univ, Minist Educ, Key Lab Crop Genet Resources & Improvement, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Kang, HY (corresponding author), Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Sichuan, Peoples R China.	zhouyhdavid@126.com	xu, li/GNH-3667-2022; Haiqin, Zhang/ABC-4056-2020	Cao, Guangwen/0000-0002-8094-1278	State Transgenic Project [2008zx08009-001, 2011zx08009-001]; National Natural Science Foundation of China [30870154, 30900087]; Natural Science Foundation for Young Scientists of Sichuan Province, China [2010JQ0046]; Education Bureau and Science and Technology Bureau of Sichuan Province, China	State Transgenic Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for Young Scientists of Sichuan Province, China; Education Bureau and Science and Technology Bureau of Sichuan Province, China	The authors are thankful to the State Transgenic Project (numbers 2008zx08009-001, 2011zx08009-001), the National Natural Science Foundation of China (numbers 30870154, 30900087), the Natural Science Foundation for Young Scientists of Sichuan Province, China (number 2010JQ0046), and the Education Bureau and Science and Technology Bureau of Sichuan Province, China for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, J NW AGR U; BADEN C, 1991, NORD J BOT, V11, P3, DOI 10.1111/j.1756-1051.1991.tb01790.x; BARIANA HS, 1993, GENOME, V36, P476, DOI 10.1139/g93-065; BAYLISS MW, 1980, INT REV CYTOL 11A, P113; CHEN Q, 1988, CHINESE SCI BULL, V33, P2071; CHEN S, 1991, Acta Genetica Sinica, V18, P508; Cheng P, 2010, THEOR APPL GENET, V121, P195, DOI 10.1007/s00122-010-1302-0; Chhuneja P, 2008, THEOR APPL GENET, V116, P313, DOI 10.1007/s00122-007-0668-0; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Faris JD, 2008, CHROMOSOME RES, V16, P1097, DOI 10.1007/s10577-008-1261-3; Fedak G, 2000, GENOME, V43, P712, DOI 10.1139/gen-43-4-712; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; [傅杰 Fu Jie], 2003, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V23, P1905; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; Jing JinXue, 1999, Acta Phytopathologica Sinica, V29, P147; Kang HY, 2009, PLANT BREEDING, V128, P36, DOI 10.1111/j.1439-0523.2008.01542.x; Kang HY, 2008, EUPHYTICA, V162, P441, DOI 10.1007/s10681-007-9608-y; Kang HY, 2010, GENET RESOUR CROP EV, V57, P111, DOI 10.1007/s10722-009-9455-x; Korzun V, 1997, EUPHYTICA, V95, P149, DOI 10.1023/A:1002922706905; Kuo P. C., 1987, FLORA REIPUBLICAE PO, P51; Kuraparthy V, 2007, THEOR APPL GENET, V114, P1379, DOI 10.1007/s00122-007-0524-2; Line RF, 2002, ANNU REV PHYTOPATHOL, V40, P75, DOI 10.1146/annurev.phyto.40.020102.111645; Luan Y, 2010, PLANTA, V232, P501, DOI 10.1007/s00425-010-1187-9; Lukaszewski A. J., 1987, Plant Breeding Reviews, V5, P41; Luo PG, 2008, CAN J PLANT PATHOL, V30, P254, DOI 10.1080/07060661.2008.10540540; Luo PG, 2005, PHYTOPATHOLOGY, V95, P1266, DOI 10.1094/PHYTO-95-1266; Ma H, 1997, EUPHYTICA, V94, P279, DOI 10.1023/A:1002979706378; McIntosh R, 2008, P 11 INT WHEAT GEN S; Molnar-Lang M, 2000, EUPHYTICA, V112, P117, DOI 10.1023/A:1003840200744; Pestsova E, 2000, THEOR APPL GENET, V101, P95, DOI 10.1007/s001220051455; PLOURDE A, 1990, THEOR APPL GENET, V79, P45, DOI 10.1007/BF00223785; Pu ZJ, 2010, PLANT BREEDING, V129, P53, DOI 10.1111/j.1439-0523.2009.01649.x; Qi ZJ, 2010, THEOR APPL GENET, V121, P589, DOI 10.1007/s00122-010-1332-7; READER SM, 1994, TRENDS GENET, V10, P265, DOI 10.1016/0168-9525(90)90007-S; REN Z, 1991, Acta Genetica Sinica, V18, P228; Ren ZL, 1997, SCI CHINA SER C, V40, P323, DOI 10.1007/BF02879094; RILEY R, 1968, GENET RES, V12, P199, DOI 10.1017/S0016672300011800; Roder MS, 1998, GENETICS, V149, P2007; SEARS E R, 1972, P23; SEARS ER, 1993, CROP SCI, V33, P897, DOI 10.2135/cropsci1993.0011183X003300050004x; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Stubbs R, 1988, BREEDING STRATEGIES, V8, P23; Wan AM, 2004, PLANT DIS, V88, P896, DOI 10.1094/PDIS.2004.88.8.896; Wang Xiue, 1998, Journal of Nanjing Agricultural University, V21, P10; Yang ZuoMin, 2003, Acta Agronomica Sinica, V29, P161; Zhao JX, 2010, GENET RESOUR CROP EV, V57, P387, DOI 10.1007/s10722-009-9477-4; Zhao JiXin, 2004, Acta Botanica Boreali-Occidentalia Sinica, V24, P2277; [赵继新 Zhao Jixin], 2004, [西北农林科技大学学报. 自然科学版, Journal of northwest sci-tech university of agriculture and forestry], V32, P105	50	38	50	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21802	10.1371/journal.pone.0021802	http://dx.doi.org/10.1371/journal.pone.0021802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760909	Green Published, Green Submitted, gold			2022-12-25	WOS:000292657200023
J	Yu, ZH; Kastenmuller, G; He, Y; Belcredi, P; Moller, G; Prehn, C; Mendes, J; Wahl, S; Roemisch-Margl, W; Ceglarek, U; Polonikov, A; Dahmen, N; Prokisch, H; Xie, L; Li, YX; Wichmann, HE; Peters, A; Kronenberg, F; Suhre, K; Adamski, J; Illig, T; Wang-Sattler, R				Yu, Zhonghao; Kastenmueller, Gabi; He, Ying; Belcredi, Petra; Moeller, Gabriele; Prehn, Cornelia; Mendes, Joaquim; Wahl, Simone; Roemisch-Margl, Werner; Ceglarek, Uta; Polonikov, Alexey; Dahmen, Norbert; Prokisch, Holger; Xie, Lu; Li, Yixue; Wichmann, H. -Erich; Peters, Annette; Kronenberg, Florian; Suhre, Karsten; Adamski, Jerzy; Illig, Thomas; Wang-Sattler, Rui			Differences between Human Plasma and Serum Metabolite Profiles	PLOS ONE			English	Article							CHROMATOGRAPHY; METABOLOMICS; COLLECTION; SAMPLES; ISSUES; ACID	Background: Human plasma and serum are widely used matrices in clinical and biological studies. However, different collecting procedures and the coagulation cascade influence concentrations of both proteins and metabolites in these matrices. The effects on metabolite concentration profiles have not been fully characterized. Methodology/Principal Findings: We analyzed the concentrations of 163 metabolites in plasma and serum samples collected simultaneously from 377 fasting individuals. To ensure data quality, 41 metabolites with low measurement stability were excluded from further analysis. In addition, plasma and corresponding serum samples from 83 individuals were re-measured in the same plates and mean correlation coefficients (r) of all metabolites between the duplicates were 0.83 and 0.80 in plasma and serum, respectively, indicating significantly better stability of plasma compared to serum (p = 0.01). Metabolite profiles from plasma and serum were clearly distinct with 104 metabolites showing significantly higher concentrations in serum. In particular, 9 metabolites showed relative concentration differences larger than 20%. Despite differences in absolute concentration between the two matrices, for most metabolites the overall correlation was high (mean r = 0.81 +/- 0.10), which reflects a proportional change in concentration. Furthermore, when two groups of individuals with different phenotypes were compared with each other using both matrices, more metabolites with significantly different concentrations could be identified in serum than in plasma. For example, when 51 type 2 diabetes (T2D) patients were compared with 326 non-T2D individuals, 15 more significantly different metabolites were found in serum, in addition to the 25 common to both matrices. Conclusions/Significance: Our study shows that reproducibility was good in both plasma and serum, and better in plasma. Furthermore, as long as the same blood preparation procedure is used, either matrix should generate similar results in clinical and biological studies. The higher metabolite concentrations in serum, however, make it possible to provide more sensitive results in biomarker detection.	[Yu, Zhonghao; He, Ying; Wahl, Simone; Illig, Thomas; Wang-Sattler, Rui] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany; [Kastenmueller, Gabi; Roemisch-Margl, Werner; Suhre, Karsten] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [He, Ying; Xie, Lu; Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [He, Ying; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Bioinformat Ctr, Shanghai, Peoples R China; [Belcredi, Petra; Peters, Annette] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Moeller, Gabriele; Prehn, Cornelia; Adamski, Jerzy] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Genome Anal Ctr, Inst Expt Genet, Neuherberg, Germany; [Mendes, Joaquim] Tech Univ Munich, Dept Chem, Solid State NMR Spect, D-8046 Garching, Germany; [Mendes, Joaquim] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci, D-8046 Garching, Germany; [Mendes, Joaquim] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Biol Struct, Neuherberg, Germany; [Ceglarek, Uta] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Polonikov, Alexey] Kursk State Med Univ, Dept Biol Med Genet & Ecol, Kursk, Russia; [Dahmen, Norbert] Johannes Gutenberg Univ Mainz, Dept Psychiat, D-6500 Mainz, Germany; [Prokisch, Holger] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, Neuherberg, Germany; [Wichmann, H. -Erich] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol, Neuherberg, Germany; [Wichmann, H. -Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria; [Suhre, Karsten] Univ Munich, Fac Biol, Planegg Martinsried, Germany; [Suhre, Karsten] Educ City Qatar Fdn, Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar; [Adamski, Jerzy] Tech Univ Munich, Lehrstuhl Expt Genet, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leipzig University; Kursk State Medical University; Johannes Gutenberg University of Mainz; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Medical University of Innsbruck; University of Munich; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Technical University of Munich	Yu, ZH (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany.	rui.wang-sattler@helmholtz-muenchen.de	Prokisch, Holger/N-8964-2013; Kastenmüller, Gabi/ABF-5987-2020; Ceglarek, Uta/GOE-5561-2022; Peters, Annette/A-6117-2011; Wichmann, Heinz Erich/AAA-5695-2022; Kronenberg, Florian/B-1736-2008; Polonikov, Alexey/R-7537-2016; Suhre, Karsten/AAF-1778-2020; Yu, Zhonghao/F-5459-2011; Wang-Sattler, Rui/B-5354-2014	Peters, Annette/0000-0001-6645-0985; Kronenberg, Florian/0000-0003-2229-1120; Polonikov, Alexey/0000-0001-6280-247X; Suhre, Karsten/0000-0001-9638-3912; Yu, Zhonghao/0000-0001-7144-9356; Wang-Sattler, Rui/0000-0002-8794-8229; Moller, Gabriele/0000-0002-2730-1351; Kastenmuller, Gabi/0000-0002-2368-7322; Adamski, Jerzy/0000-0001-9259-0199; Prokisch, Holger/0000-0003-2379-6286; Prehn, Cornelia/0000-0002-1274-4715	German Federal Ministry of Education and Research (BMBF)	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (BMBF) by funding the Project "SysMBo: Systems Biology of Metabotypes" (FKZ: 0315494A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Bando K, 2010, J BIOSCI BIOENG, V110, P491, DOI 10.1016/j.jbiosc.2010.04.010; Barelli S, 2007, EXPERT REV PROTEOMIC, V4, P363, DOI 10.1586/14789450.4.3.363; Denery JR, 2011, ANAL CHEM, V83, P1040, DOI 10.1021/ac102806p; Dettmer K, 2010, ELECTROPHORESIS, V31, P2365, DOI 10.1002/elps.200900778; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Jaffe AS, 2000, CIRCULATION, V102, P1216, DOI 10.1161/01.CIR.102.11.1216; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Kronenberg F, 1998, KIDNEY INT, V54, P1385, DOI 10.1046/j.1523-1755.1998.00086.x; LADENSON JH, 1974, AM J CLIN PATHOL, V62, P545; Liu LS, 2010, ANAL BIOCHEM, V406, P105, DOI 10.1016/j.ab.2010.07.015; Mannello F, 2008, ARTERIOSCL THROM VAS, V28, P611, DOI 10.1161/ATVBAHA.107.159608; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Romisch-Margl W, 2011, METABOLOMICS; Sacks DB, 2002, CLIN CHEM, V48, P436; Schnabel RB, 2010, BLOOD, V115, P5289, DOI 10.1182/blood-2009-05-221382; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Teahan O, 2006, ANAL CHEM, V78, P4307, DOI 10.1021/ac051972y; Teerlink T, 2002, ANAL BIOCHEM, V303, P131, DOI 10.1006/abio.2001.5575; Wang-Sattler R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003863; Yatomi Y, 1997, J BIOCHEM, V121, P969; Zhai G, 2010, ANN RHEUM DIS, V69, P1227, DOI 10.1136/ard.2009.120857	26	164	167	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e21230	10.1371/journal.pone.0021230	http://dx.doi.org/10.1371/journal.pone.0021230			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760889	Green Published, gold, Green Submitted			2022-12-25	WOS:000292657200008
J	Brents, LK; Reichard, EE; Zimmerman, SM; Moran, JH; Fantegrossi, WE; Prather, PL				Brents, Lisa K.; Reichard, Emily E.; Zimmerman, Sarah M.; Moran, Jeffery H.; Fantegrossi, William E.; Prather, Paul L.			Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity	PLOS ONE			English	Article							PENTYLENETETRAZOLE-INDUCED SEIZURE; CANNABIMIMETIC INDOLES; CB2; ANTICONVULSANT; ACTIVATION; AGONIST; SPICE; BRAIN; IDENTIFICATION; PHARMACOLOGY	Background: K2 products are synthetic cannabinoid-laced, marijuana-like drugs of abuse, use of which is often associated with clinical symptoms atypical of marijuana use, including hypertension, agitation, hallucinations, psychosis, seizures and panic attacks. JWH-018, a prevalent K2 synthetic cannabinoid, is structurally distinct from Delta(9)-THC, the main psychoactive ingredient in marijuana. Since even subtle structural differences can lead to differential metabolism, formation of novel, biologically active metabolites may be responsible for the distinct effects associated with K2 use. The present study proposes that K2's high adverse effect occurrence is due, at least in part, to distinct JWH-018 metabolite activity at the cannabinoid 1 receptor (CB1R). Methods/Principal Findings: JWH-018, five potential monohydroxylated metabolites (M1-M5), and one carboxy metabolite (M6) were examined in mouse brain homogenates containing CB1Rs, first for CB1R affinity using a competition binding assay employing the cannabinoid receptor radioligand [H-3]CP-55,940, and then for CB1R intrinsic efficacy using an [S-35]GTP gamma S binding assay. JWH-018 and M1-M5 bound CB1Rs with high affinity, exhibiting K-i values that were lower than or equivalent to Delta(9)-THC. These molecules also stimulated G-proteins with equal or greater efficacy relative to Delta(9)-THC, a CB1R partial agonist. Most importantly, JWH-018, M2, M3, and M5 produced full CB1R agonist levels of activation. CB1R-mediated activation was demonstrated by blockade with O-2050, a CB1R-selective neutral antagonist. Similar to Delta 9-THC, JWH-018 and M1 produced a marked depression of locomotor activity and core body temperature in mice that were both blocked by the CB1R-preferring antagonist/inverse agonist AM251. Conclusions/Significance: Unlike metabolites of most drugs, the studied JWH-018 monohydroxylated compounds, but not the carboxy metabolite, retain in vitro and in vivo activity at CB1Rs. These observations, combined with higher CB1R affinity and activity relative to Delta(9)-THC, may contribute to the greater prevalence of adverse effects observed with JWH-018-containing products relative to cannabis.	[Brents, Lisa K.; Reichard, Emily E.; Zimmerman, Sarah M.; Moran, Jeffery H.; Fantegrossi, William E.; Prather, Paul L.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Moran, Jeffery H.] Arkansas Dept Hlth, Publ Hlth Lab, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Brents, LK (corresponding author), Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA.	PratherPaulL@uams.edu			Association of Public Health Laboratories; US PHS [RR020146]; UAMS; University of Arkansas for Medical Sciences Center for Clinical and Translational Research; National Center For Research Resources [1UL1RR029884]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884, P20RR020146] Funding Source: NIH RePORTER	Association of Public Health Laboratories; US PHS(United States Department of Health & Human ServicesUnited States Public Health Service); UAMS; University of Arkansas for Medical Sciences Center for Clinical and Translational Research; National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Association of Public Health Laboratories Award (JHM), US PHS Grant RR020146 (WEF), UAMS Pilot Study Award (PLP), and a Pilot Research Award from the University of Arkansas for Medical Sciences Center for Clinical and Translational Research, supported by a grant from the National Center For Research Resources, 1UL1RR029884 (JHM, WEF, and PLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WORLD DRUG REPORT; Atwood BK, 2010, BRIT J PHARMACOL, V160, P585, DOI 10.1111/j.1476-5381.2009.00582.x; Aung MM, 2000, DRUG ALCOHOL DEPEN, V60, P133, DOI 10.1016/S0376-8716(99)00152-0; Auwarter V, 2009, J MASS SPECTROM, V44, P832, DOI 10.1002/jms.1558; Bahremand A, 2008, EPILEPSY RES, V81, P44, DOI 10.1016/j.eplepsyres.2008.04.010; Bari M, 2011, FRONT BIOSCI-LANDMRK, V16, P498, DOI 10.2741/3701; Bisogno T, 2010, CNS NEUROL DISORD-DR, V9, P564, DOI 10.2174/187152710793361568; Cascio MG, 2006, BRIT J PHARMACOL, V149, P431, DOI 10.1038/sj.bjp.0706888; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Childers SR, 2006, AAPS J, V8, pE112, DOI 10.1208/aapsj080113; Chin CN, 1999, J PHARMACOL EXP THER, V291, P837; Dennis I, 2008, BRIT J PHARMACOL, V154, P1349, DOI 10.1038/bjp.2008.190; Deyama S, 2010, J PHARMACOL SCI, V114, P123, DOI 10.1254/jphs.10139SC; Durant C, 2010, CURR TOP BEHAV NEURO, V2, P303, DOI 10.1007/7854_2009_8; EISSENSTAT MA, 1995, J MED CHEM, V38, P3094, DOI 10.1021/jm00016a013; *EMCDDA EUR, 2008, ADD EUR EMCFDAD; Every-Palmer S, 2010, ADDICTION, V105, P1859, DOI 10.1111/j.1360-0443.2010.03119.x; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gholizadeh S, 2007, NEUROPHARMACOLOGY, V53, P763, DOI 10.1016/j.neuropharm.2007.08.005; GORZALKA BB, 2010, PROG NEUROPSYCHOPHAR; Halberstadt A.L., 2011, NEUROPHARMACOLOGY; Heinz A, 2010, SCHIZOPHRENIA BULL, V36, P472, DOI 10.1093/schbul/sbq031; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hill AJ, 2010, EPILEPSIA, V51, P1522, DOI 10.1111/j.1528-1167.2010.02523.x; Holtkamp M, 2007, CELL MOL LIFE SCI, V64, P2023, DOI 10.1007/s00018-007-7021-2; HUFFMAN JW, 1994, BIOORG MED CHEM LETT, V4, P563, DOI 10.1016/S0960-894X(01)80155-4; Hurlemann R, 2010, PSYCHOL MED, V40, P1839, DOI 10.1017/S0033291709992376; Javitt DC, 2010, ISR J PSYCHIATR REL, V47, P4; Jones NA, 2010, J PHARMACOL EXP THER, V332, P569, DOI 10.1124/jpet.109.159145; Karst M, 2010, DRUGS, V70, P2409, DOI 10.2165/11585260-000000000-00000; Leonhart M., 2010, FED REGISTER, P71635; LI C, 2011, PHARM THER; Liu JG, 2001, MOL PHARMACOL, V60, P53, DOI 10.1124/mol.60.1.53; Lutz B, 2004, BIOCHEM PHARMACOL, V68, P1691, DOI 10.1016/j.bcp.2004.07.007; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; Mares P, 2010, EPILEPSIA, V51, P24, DOI 10.1111/j.1528-1167.2010.02604.x; Maurer HH, 2006, THER DRUG MONIT, V28, P447, DOI 10.1097/01.ftd.0000211812.27558.6e; MOLLER I, 2010, DRUG TEST ANAL; MORAN CL, 2011, ANAL CHEM; Muller H, 2010, PHARMACOPSYCHIATRY, V43, P152, DOI 10.1055/s-0029-1243252; Muller H, 2010, SCHIZOPHR RES, V118, P309, DOI 10.1016/j.schres.2009.12.001; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Prather PL, 2000, MOL PHARMACOL, V57, P1000; ROSSI F, 2011, BONE; SCHNEIR AB, 2010, J EMERG MED; Shoemaker JL, 2005, J PHARMACOL EXP THER, V314, P868, DOI 10.1124/jpet.105.085282; Showalter VM, 1996, J PHARMACOL EXP THER, V278, P989; SMITH PB, 1994, J PHARMACOL EXP THER, V270, P219; Sobolevsky T, 2010, FORENSIC SCI INT, V200, P141, DOI 10.1016/j.forsciint.2010.04.003; STJAMES J, 2010, DOCTORS CONCERNED PO; Uchiyama N, 2010, FORENSIC SCI INT, V198, P31, DOI 10.1016/j.forsciint.2010.01.004; Uchiyama N, 2009, CHEM PHARM BULL, V57, P439, DOI 10.1248/cpb.57.439; Vardakou I, 2010, TOXICOL LETT, V197, P157, DOI 10.1016/j.toxlet.2010.06.002; Vearrier D, 2010, PEDIATR EMERG CARE, V26, P462, DOI 10.1097/PEC.0b013e3181e4f416; Watkins BA, 2010, J NUTR BIOCHEM, V21, P1141, DOI 10.1016/j.jnutbio.2010.04.011; Wehrman J., 2010, FAKE MARIJUANA SPURS; Wiley JL, 1998, J PHARMACOL EXP THER, V285, P995; Wintermeyer A, 2010, ANAL BIOANAL CHEM, V398, P2141, DOI 10.1007/s00216-010-4171-0; Zhang Q, 2006, ANAL BIOANAL CHEM, V386, P1345, DOI 10.1007/s00216-006-0717-6; Zimmermann US, 2009, DTSCH ARZTEBL INT, V106, P464, DOI 10.3238/arztebl.2009.0464	61	172	173	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21917	10.1371/journal.pone.0021917	http://dx.doi.org/10.1371/journal.pone.0021917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755008	gold, Green Submitted, Green Published			2022-12-25	WOS:000292632000035
J	Ishizu, T; Zeki, S				Ishizu, Tomohiro; Zeki, Semir			Toward A Brain-Based Theory of Beauty	PLOS ONE			English	Article							MEDIAL ORBITOFRONTAL CORTEX; FACIAL ATTRACTIVENESS; ROMANTIC LOVE; REWARD VALUE; PREFERENCE; RESPONSES; EMOTION; SYSTEMS	We wanted to learn whether activity in the same area(s) of the brain correlate with the experience of beauty derived from different sources. 21 subjects took part in a brain-scanning experiment using functional magnetic resonance imaging. Prior to the experiment, they viewed pictures of paintings and listened to musical excerpts, both of which they rated on a scale of 1-9, with 9 being the most beautiful. This allowed us to select three sets of stimuli-beautiful, indifferent and ugly-which subjects viewed and heard in the scanner, and rated at the end of each presentation. The results of a conjunction analysis of brain activity showed that, of the several areas that were active with each type of stimulus, only one cortical area, located in the medial orbito-frontal cortex (mOFC), was active during the experience of musical and visual beauty, with the activity produced by the experience of beauty derived from either source overlapping almost completely within it. The strength of activation in this part of the mOFC was proportional to the strength of the declared intensity of the experience of beauty. We conclude that, as far as activity in the brain is concerned, there is a faculty of beauty that is not dependent on the modality through which it is conveyed but which can be activated by at least two sources-musical and visual-and probably by other sources as well. This has led us to formulate a brain-based theory of beauty.	[Ishizu, Tomohiro] UCL, Wellcome Lab Neurobiol, London, England; UCL, Wellcome Dept Imaging Neurosci, London, England	University of London; University College London; University of London; University College London	Ishizu, T (corresponding author), UCL, Wellcome Lab Neurobiol, London, England.	zeki.pa@ucl.ac.uk	Zeki, Semir/AAA-1789-2020; Ishizu, Tomohiro/Q-2155-2019	Ishizu, Tomohiro/0000-0001-7107-657X	Wellcome Trust, London	Wellcome Trust, London(Wellcome Trust)	This work was supported by the Wellcome Trust, London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron A, 2005, J NEUROPHYSIOL, V94, P327, DOI 10.1152/jn.00838.2004; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; BELL C, 1921, ART LONDON CHATTO WI; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Bray S, 2010, J NEUROPHYSIOL, V103, P2506, DOI 10.1152/jn.01030.2009; Burke E., 1757, PHILOS ENQUIRY ORIGI; Carretie L, 2009, NEUROSCIENCE, V164, P1615, DOI 10.1016/j.neuroscience.2009.09.031; Cela-Conde CJ, 2009, P NATL ACAD SCI USA, V106, P3847, DOI 10.1073/pnas.0900304106; Cloutier J, 2008, J COGNITIVE NEUROSCI, V20, P941, DOI 10.1162/jocn.2008.20062; Di Dio C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001201; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Gordon G., 1997, PHILOS ARTS; GOTSHALK DW, 1935, J PHILOS, V32, P604; Grabenhorst F, 2011, TRENDS COGN SCI, V15, P56, DOI 10.1016/j.tics.2010.12.004; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Kant I., 1952, CRITIQUE JUDGMENT; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kawabata H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003027; Kim H, 2011, CEREB CORTEX, V21, P769, DOI 10.1093/cercor/bhq145; Kirk U, 2009, NEUROIMAGE, V44, P1125, DOI 10.1016/j.neuroimage.2008.10.009; Kornysheva K, 2010, HUM BRAIN MAPP, V31, P48, DOI 10.1002/hbm.20844; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Peters J, 2010, BEHAV BRAIN RES, V213, P135, DOI 10.1016/j.bbr.2010.04.031; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Schultz W, 2010, EUR J NEUROSCI, V31, P2124, DOI 10.1111/j.1460-9568.2010.07282.x; Sescousse G, 2010, J NEUROSCI, V30, P13095, DOI 10.1523/JNEUROSCI.3501-10.2010; TSUKIURA T, 2011, SOC COGN AFFECT NEUR; Vartanian O, 2004, NEUROREPORT, V15, P893, DOI 10.1097/00001756-200404090-00032; Winston JS, 2007, NEUROPSYCHOLOGIA, V45, P195, DOI 10.1016/j.neuropsychologia.2006.05.009; Zeki S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015802; Zeki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002180	34	250	255	6	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21852	10.1371/journal.pone.0021852	http://dx.doi.org/10.1371/journal.pone.0021852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21755004	Green Published, gold, Green Submitted			2022-12-25	WOS:000292632000031
J	Stany, MP; Vathipadiekal, V; Ozbun, L; Stone, RL; Mok, SC; Xue, H; Kagami, T; Wang, YW; McAlpine, JN; Bowtell, D; Gout, PW; Miller, DM; Gilks, CB; Huntsman, DG; Ellard, SL; Wang, YZ; Vivas-Mejia, P; Lopez-Berestein, G; Sood, AK; Birrer, MJ				Stany, Michael P.; Vathipadiekal, Vinod; Ozbun, Laurent; Stone, Rebecca L.; Mok, Samuel C.; Xue, Hui; Kagami, Takashi; Wang, Yuwei; McAlpine, Jessica N.; Bowtell, David; Gout, Peter W.; Miller, Dianne M.; Gilks, C. Blake; Huntsman, David G.; Ellard, Susan L.; Wang, Yu-Zhuo; Vivas-Mejia, Pablo; Lopez-Berestein, Gabriel; Sood, Anil K.; Birrer, Michael J.			Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; INTERFERING RNA DELIVERY; IN-VIVO; FACTOR EXPRESSION; GENE-EXPRESSION; ANTITUMOR-ACTIVITY; TYROSINE KINASE; FACTOR RECEPTOR; CARCINOMA	Clear cell ovarian cancer is an epithelial ovarian cancer histotype that is less responsive to chemotherapy and carries poorer prognosis than serous and endometrioid histotypes. Despite this, patients with these tumors are treated in a similar fashion as all other ovarian cancers. Previous genomic analysis has suggested that clear cell cancers represent a unique tumor subtype. Here we generated the first whole genomic expression profiling using epithelial component of clear cell ovarian cancers and normal ovarian surface specimens isolated by laser capture microdissection. All the arrays were analyzed using BRB ArrayTools and PathwayStudio software to identify the signaling pathways. Identified pathways validated using serous, clear cell cancer cell lines and RNAi technology. In vivo validations carried out using an orthotopic mouse model and liposomal encapsulated siRNA. Patient-derived clear cell and serous ovarian tumors were grafted under the renal capsule of NOD-SCID mice to evaluate the therapeutic potential of the identified pathway. We identified major activated pathways in clear cells involving in hypoxic cell growth, angiogenesis, and glucose metabolism not seen in other histotypes. Knockdown of key genes in these pathways sensitized clear cell ovarian cancer cell lines to hypoxia/glucose deprivation. In vivo experiments using patient derived tumors demonstrate that clear cell tumors are exquisitely sensitive to antiangiogenesis therapy (i.e. sunitinib) compared with serous tumors. We generated a histotype specific, gene signature associated with clear cell ovarian cancer which identifies important activated pathways critical for their clinicopathologic characteristics. These results provide a rational basis for a radically different treatment for ovarian clear cell patients.	[Stany, Michael P.] Walter Reed Army Med Ctr, Washington, DC 20307 USA; [Vathipadiekal, Vinod; Birrer, Michael J.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Vathipadiekal, Vinod; Birrer, Michael J.] Harvard Univ, Sch Med, Boston, MA USA; [Ozbun, Laurent] NCI, Cell & Canc Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Stone, Rebecca L.; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Mok, Samuel C.] Harvard Univ, Brigham & Womens Hosp, Sch Publ Hlth, Boston, MA 02115 USA; [Xue, Hui; Kagami, Takashi; Wang, Yuwei; Gout, Peter W.; Wang, Yu-Zhuo] British Columbia Canc Agcy, Living Tumor Lab, Vancouver, BC V5Z 4E6, Canada; [McAlpine, Jessica N.; Miller, Dianne M.] Univ British Columbia, Dept Obstet & Gynecol, Div Gynecol Oncol, Vancouver, BC V5Z 1M9, Canada; [Bowtell, David] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Gilks, C. Blake; Huntsman, David G.] British Columbia Canc Agcy, Ctr Translat & Appl Genom, Vancouver Gen Hosp, Dept Pathol,Genet Pathol Evaluat Ctr, Vancouver, BC V5Z 4E6, Canada; [Ellard, Susan L.] British Columbia Canc Agcy So Interior, Dept Med Oncol, Kelowna, BC, Canada; [Wang, Yu-Zhuo] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Wang, Yu-Zhuo] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada; [Vivas-Mejia, Pablo; Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Lopez-Berestein, Gabriel; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Lopez-Berestein, Gabriel; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA	United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; British Columbia Cancer Agency; University of British Columbia; Peter Maccallum Cancer Center; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Stany, MP (corresponding author), Walter Reed Army Med Ctr, Washington, DC 20307 USA.	mbirrer@partners.org	Bowtell, David/H-1007-2016; Huntsman, David/ABE-6082-2020	Bowtell, David/0000-0001-9089-7525; Ellard, Susan/0000-0001-5757-9787; /0000-0002-8181-6890; Wang, Yuzhuo/0000-0002-9749-8591	National Cancer Institute at the National Institutes of the Health; OvCaRe (an initiative of the Vancouver General Hospital and University of BC Hospital Foundation and the BC Cancer Foundation); BC Cancer Foundation; Pfizer Canada	National Cancer Institute at the National Institutes of the Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OvCaRe (an initiative of the Vancouver General Hospital and University of BC Hospital Foundation and the BC Cancer Foundation); BC Cancer Foundation; Pfizer Canada(Pfizer)	This work was supported in part by the Intramural Research Program of the National Cancer Institute at the National Institutes of the Health (MJB) and OvCaRe (an initiative of the Vancouver General Hospital and University of BC Hospital Foundation and the BC Cancer Foundation) (YZW), the BC Cancer Foundation and Pfizer Canada (Investigator-initiated project, SLE and YZW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aponte M, 2008, CANCER RES, V68, P5839, DOI 10.1158/0008-5472.CAN-07-5771; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Cappellini Maria Domenica, 2007, Hematology Am Soc Hematol Educ Program, P74; Chen J, 2003, AM J PATHOL, V162, P1283, DOI 10.1016/S0002-9440(10)63924-7; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; CROZIER MA, 1989, GYNECOL ONCOL, V35, P199, DOI 10.1016/0090-8258(89)90043-7; CRUTCHLEY DJ, 1995, CIRCULATION, V92, P238, DOI 10.1161/01.CIR.92.2.238; Cuadrado MJ, 2006, J THROMB HAEMOST, V4, P2461, DOI 10.1111/j.1538-7836.2006.02193.x; DICKERSIN GR, 1980, CANCER-AM CANCER SOC, V45, P1615, DOI 10.1002/1097-0142(19800401)45:7<1615::AID-CNCR2820450717>3.0.CO;2-E; Donninger H, 2004, ONCOGENE, V23, P8065, DOI 10.1038/sj.onc.1207959; Ebos JML, 2007, P NATL ACAD SCI USA, V104, P17069, DOI 10.1073/pnas.0708148104; Frede S, 2005, CANCER RES, V65, P4690, DOI 10.1158/0008-5472.CAN-04-3877; GENTON CY, 1979, VIRCHOWS ARCH A, V385, P77, DOI 10.1007/BF00433543; Gitlits VM, 2001, J INVEST MED, V49, P138, DOI 10.2310/6650.2001.34040; Gwak GY, 2005, J HEPATOL, V42, P358, DOI 10.1016/j.jhep.2004.11.020; Halder J, 2006, CLIN CANCER RES, V12, P4916, DOI 10.1158/1078-0432.CCR-06-0021; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ito N, 2001, CELL SIGNAL, V13, P849, DOI 10.1016/S0898-6568(01)00209-1; JENISON EL, 1989, GYNECOL ONCOL, V32, P65, DOI 10.1016/0090-8258(89)90852-4; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; KENNEDY AW, 1989, GYNECOL ONCOL, V32, P342, DOI 10.1016/0090-8258(89)90637-9; Kilic M, 2007, ONCOGENE, V26, P2027, DOI 10.1038/sj.onc.1210008; Kobel M, 2010, INT J GYNECOL PATHOL, V29, P203, DOI 10.1097/PGP.0b013e3181c042b6; Landen CN, 2007, CANCER RES, V67, P10389, DOI 10.1158/0008-5472.CAN-07-0858; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Lee CH, 2005, GYNECOL ONCOL, V96, P48, DOI 10.1016/j.ygyno.2004.09.025; Maeshima K, 2004, ENDOCRINOLOGY, V145, P3739, DOI 10.1210/en.2004-0213; Matsuura Y, 2007, GYNECOL ONCOL, V104, P406, DOI 10.1016/j.ygyno.2006.08.026; Medina P, 2007, THROMB HAEMOSTASIS, V98, P564, DOI 10.1160/TH07-01-0071; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Mok SC, 2009, CANCER CELL, V16, P521, DOI 10.1016/j.ccr.2009.10.018; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; Nordback I, 1980, Int J Gynaecol Obstet, V18, P85; Pectasides D, 2006, ONCOLOGIST, V11, P1089, DOI 10.1634/theoncologist.11-10-1089; Pollard PJ, 2006, J CLIN ENDOCR METAB, V91, P4593, DOI 10.1210/jc.2006-0920; Poulaki V, 2004, AM J PATHOL, V165, P457, DOI 10.1016/S0002-9440(10)63311-1; Press JZ, 2008, GYNECOL ONCOL, V110, P256, DOI 10.1016/j.ygyno.2008.03.011; Schiller W., 1939, AM J CANCER, V35, P1; Schwartz DR, 2002, CANCER RES, V62, P4722; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; SILVERBERG SG, 1973, AM J OBSTET GYNECOL, V115, P394, DOI 10.1016/0002-9378(73)90596-6; SPRECHER CA, 1994, P NATL ACAD SCI USA, V91, P3353, DOI 10.1073/pnas.91.8.3353; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.3.CO;2-X; Sun L, 2003, J MED CHEM, V46, P1116, DOI 10.1021/jm0204183; Tsao MS, 1997, CLIN CANCER RES, V3, P1807; Walter M, 1995, J AUTOIMMUN, V8, P931, DOI 10.1016/S0896-8411(95)80027-1; Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281; Welsh S, 2004, MOL CANCER THER, V3, P233; Wu MH, 2007, AM J PATHOL, V170, P590, DOI 10.2353/ajpath.2007.060477; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Yamaguchi K, 2010, ONCOGENE, V29, P1741, DOI 10.1038/onc.2009.470; Zorn KK, 2003, CLIN CANCER RES, V9, P4811; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05-0508	53	60	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21121	10.1371/journal.pone.0021121	http://dx.doi.org/10.1371/journal.pone.0021121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754983	Green Published, Green Submitted, gold			2022-12-25	WOS:000292632000007
J	Falord, M; Mader, U; Hiron, A; Debarbouille, M; Msadek, T				Falord, Melanie; Maeder, Ulrike; Hiron, Aurelia; Debarbouille, Michel; Msadek, Tarek			Investigation of the Staphylococcus aureus GraSR Regulon Reveals Novel Links to Virulence, Stress Response and Cell Wall Signal Transduction Pathways	PLOS ONE			English	Article							BACILLUS-SUBTILIS; TRANSCRIPTIONAL REGULATION; ANTIMICROBIAL PEPTIDES; 2-COMPONENT SYSTEM; BIOFILM FORMATION; TEICHOIC-ACID; RESISTANCE; GENE; EXPRESSION; IDENTIFICATION	The GraS/GraR two-component system has been shown to control cationic antimicrobial peptide (CAMP) resistance in the major human pathogen Staphylococcus aureus. We demonstrated that graX, also involved in CAMP resistance and cotranscribed with graRS, encodes a regulatory cofactor of the GraSR signaling pathway, effectively constituting a three-component system. We identified a highly conserved ten base pair palindromic sequence (5' ACAAA TTTGT 3') located upstream from GraR-regulated genes (mprF and the dlt and vraFG operons), which we show to be essential for transcriptional regulation by GraR and induction in response to CAMPs, suggesting it is the likely GraR binding site. Genome-based predictions and transcriptome analysis revealed several novel GraR target genes. We also found that the GraSR TCS is required for growth of S. aureus at high temperatures and resistance to oxidative stress. The GraSR system has previously been shown to play a role in S. aureus pathogenesis and we have uncovered previously unsuspected links with the AgrCA peptide quorum-sensing system controlling virulence gene expression. We also show that the GraSR TCS controls stress reponse and cell wall metabolism signal transduction pathways, sharing an extensive overlap with the WalKR regulon. This is the first report showing a role for the GraSR TCS in high temperature and oxidative stress survival and linking this system to stress response, cell wall and pathogenesis control pathways.	[Falord, Melanie; Hiron, Aurelia; Debarbouille, Michel; Msadek, Tarek] Inst Pasteur, Dept Microbiol, Paris, France; [Falord, Melanie; Hiron, Aurelia; Debarbouille, Michel; Msadek, Tarek] CNRS, URA 2172, Paris, France; [Maeder, Ulrike] Ernst Moritz Arndt Univ Greifswald, Dept Funct Genom, Interfac Inst Genet & Funct Genom, Greifswald, Germany	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Ernst Moritz Arndt Universitat Greifswald	Falord, M (corresponding author), Inst Pasteur, Dept Microbiol, Paris, France.	tmsadek@pasteur.fr	Hiron, Aurélia/AAC-8048-2020		European Commission [LHSM-CT-2006-019064, LSHG-CT-2006-037469]; Centre National de la Recherche Scientifique [CNRS URA 2172]; Agence Nationale de la Recherche (ANR GrabIron and NaBab); Institut Pasteur [PTR Nu256, PTR Nu336]; Conseil Pasteur-Weizmann	European Commission(European CommissionEuropean Commission Joint Research Centre); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR GrabIron and NaBab)(French National Research Agency (ANR)); Institut Pasteur(European Commission); Conseil Pasteur-Weizmann	This work was supported by research funds from the European Commission (StaphDynamics [LHSM-CT-2006-019064] and BaSysBio [LSHG-CT-2006-037469] grants), the Centre National de la Recherche Scientifique (CNRS URA 2172), Agence Nationale de la Recherche (ANR GrabIron and NaBab), and the Institut Pasteur (PTR Nu256 and PTR Nu336). Melanie Falord received a Young Scientist Fellowship from the Conseil Pasteur-Weizmann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAISSE H, 1994, MOL MICROBIOL, V13, P97, DOI 10.1111/j.1365-2958.1994.tb00405.x; Archambaud C, 2005, MOL MICROBIOL, V56, P383, DOI 10.1111/j.1365-2958.2005.04551.x; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Belcheva A, 2009, BIOCHEMISTRY-US, V48, P5592, DOI 10.1021/bi900478b; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunskill EW, 1996, J BACTERIOL, V178, P611, DOI 10.1128/jb.178.3.611-618.1996; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; Chastanet A, 2001, J BACTERIOL, V183, P7295, DOI 10.1128/JB.183.24.7295-7307.2001; Cheung GYC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001133; Cui LZ, 2005, ANTIMICROB AGENTS CH, V49, P3404, DOI 10.1128/AAC.49.8.3404-3413.2005; de Been M, 2008, ENVIRON MICROBIOL, V10, P2796, DOI 10.1111/j.1462-2920.2008.01700.x; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; Even S, 2006, J BACTERIOL, V188, P2184, DOI 10.1128/JB.188.6.2184-2197.2006; Gillaspy A.F., 2006, GRAM POSITIVE PATHOG, P381; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hancock R E, 2001, Lancet Infect Dis, V1, P156, DOI 10.1016/S1473-3099(01)00092-5; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Harris RM, 2001, J BACTERIOL, V183, P5008, DOI 10.1128/JB.183.17.5008-5014.2001; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; Herbert S, 2007, PLOS PATHOG, V3, P981, DOI 10.1371/journal.ppat.0030102; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Joanne P, 2009, BIOCHEMISTRY-US, V48, P9372, DOI 10.1021/bi901222p; Kobayashi K, 2001, J BACTERIOL, V183, P7365, DOI 10.1128/JB.183.24.7365-7370.2001; Koprivnjak T, 2006, J BACTERIOL, V188, P3622, DOI 10.1128/JB.188.10.3622-3630.2006; Kraus D, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-85; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Kurokawa K, 2007, METHOD ENZYMOL, V422, P233, DOI 10.1016/S0076-6879(06)22011-1; Li M, 2007, MOL MICROBIOL, V66, P1136, DOI 10.1111/j.1365-2958.2007.05986.x; Li M, 2007, P NATL ACAD SCI USA, V104, P9469, DOI 10.1073/pnas.0702159104; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mandin P, 2005, MOL MICROBIOL, V57, P1367, DOI 10.1111/j.1365-2958.2005.04776.x; MartinezHackert E, 1997, J MOL BIOL, V269, P301, DOI 10.1006/jmbi.1997.1065; Mascher T, 2006, FEMS MICROBIOL LETT, V264, P133, DOI 10.1111/j.1574-6968.2006.00444.x; Meehl M, 2007, ANTIMICROB AGENTS CH, V51, P2679, DOI 10.1128/AAC.00209-07; Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06; Miller JH., 1972, EXPT MOL GENETICS; MSADEK T, 1991, J BACTERIOL, V173, P2366, DOI 10.1128/JB.173.7.2366-2377.1991; Msadek T, 1999, TRENDS MICROBIOL, V7, P201, DOI 10.1016/S0966-842X(99)01479-1; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Ohki R, 2003, MOL MICROBIOL, V49, P1135, DOI 10.1046/j.1365-2958.2003.03653.x; Perichon B, 2009, ANTIMICROB AGENTS CH, V53, P4580, DOI 10.1128/AAC.00346-09; PERKINS JB, 1986, P NATL ACAD SCI USA, V83, P140, DOI 10.1073/pnas.83.1.140; Pietiainen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-429; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sass P, 2009, INT J MED MICROBIOL, V299, P313, DOI 10.1016/j.ijmm.2008.10.005; Shanks RMQ, 2008, INFECT IMMUN, V76, P2469, DOI 10.1128/IAI.01370-07; Sharma-Kuinkel BK, 2009, J BACTERIOL, V191, P4767, DOI 10.1128/JB.00348-09; SULLIVAN MA, 1984, GENE, V29, P21, DOI 10.1016/0378-1119(84)90161-6; Tabuchi Y, 2010, J IMMUNOL, V185, P2424, DOI 10.4049/jimmunol.1000625; Tamber S, 2010, INFECT IMMUN, V78, P4384, DOI 10.1128/IAI.00401-10; Vergara-Irigaray M, 2008, MICROBIOL-SGM, V154, P865, DOI 10.1099/mic.0.2007/013292-0; Wei HR, 2008, NUCLEIC ACIDS RES, V36, P2926, DOI 10.1093/nar/gkn133; WEINRAUCH Y, 1990, GENE DEV, V4, P860, DOI 10.1101/gad.4.5.860; Wernersson R, 2005, NUCLEIC ACIDS RES, V33, pW611, DOI 10.1093/nar/gki399; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Xia GQ, 2010, J BIOL CHEM, V285, P13405, DOI 10.1074/jbc.M109.096172; ZOCK J, 1994, GENE, V151, P37, DOI 10.1016/0378-1119(94)90630-0; ZUBER P, 1983, CELL, V35, P275, DOI 10.1016/0092-8674(83)90230-1	71	112	114	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21323	10.1371/journal.pone.0021323	http://dx.doi.org/10.1371/journal.pone.0021323			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21765893	Green Published, gold, Green Submitted			2022-12-25	WOS:000292293400010
J	Keimling, M; Volcic, M; Csernok, A; Wieland, B; Dork, T; Wiesmuller, L				Keimling, Marlen; Volcic, Meta; Csernok, Andreea; Wieland, Britta; Doerk, Thilo; Wiesmueller, Lisa			Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways	FASEB JOURNAL			English	Article						breast cancer; Nibrin; BRCA1	HOMOLOGOUS RECOMBINATION; GENE-MUTATIONS; CANCER-RISK; CELLS; BRCA1; INHIBITION; PHOSPHORYLATION; PROTEINS; MISSENSE; DEFECTS	Ataxia telangiectasia mutated (ATM) has multiple functions in homologous recombination (HR) and nonhomologous end joining (NHEJ), which lead to conflicting data regarding its DNA double-strand break-repair (DSBR) functions in previous studies. To explore the effect of clinically relevant ATM mutations, we characterized DSBR between mutated EGFP genes and ATM kinase signaling in 9 lymphoblastoid cell lines (LCLs) derived from patients with ataxia telangiectasia (AT) with defined vs. 3 control LCLs without ATM mutations. Our study revealed that the DSBR phenotype in AT cells is not uniform but appears to depend on the mutation, causing up to 32-fold increased or up to 3-fold decreased activities in particular pathways. Comparison with a further 10 LCLs mutated in downstream factors (BRCA1, BRCA2, Nibrin, Rad50, and Chk2) showed that the most diametrically opposed DSBR patterns in AT cells phenocopied NBN/RAD50 or BRCA1 mutations. Notably, reexpressing wild-type ATM reversed these defects by 2.3- to 3.5-fold. Our data suggest that ATM stimulates repair proteins such as Nibrin, which execute HR, single-strand annealing (SSA), and NHEJ. Concomitantly, ATM minimizes error-prone repair (SSA and NHEJ) through activation of surveillance factors such as BRCA1. Since the outcome of the individual defect can be diametrically opposed, distinguishing repair patterns in patients with ATM mutations may also be relevant regarding therapeutic responses.-Keimling, M., Volcic, M., Csernok, A., Wieland, B., Dork, T., Wiesmuller, L. Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways. FASEB J. 25, 3849-3860 (2011). www.fasebj.org	[Keimling, Marlen; Volcic, Meta; Csernok, Andreea; Wiesmueller, Lisa] Univ Ulm, Dept Obstet & Gynecol, D-89075 Ulm, Germany; [Wieland, Britta; Doerk, Thilo] Hannover Med Sch, Gynecol Res Unit, D-3000 Hannover, Germany; [Wieland, Britta] Hannover Med Sch, Dept Radiat Oncol, D-3000 Hannover, Germany	Ulm University; Hannover Medical School; Hannover Medical School	Wiesmuller, L (corresponding author), Univ Ulm, Dept Obstet & Gynecol, Prittwitzstr 43, D-89075 Ulm, Germany.	lisa.wiesmueller@uni-ulm.de	Dörk, Thilo/J-8620-2012	Dörk, Thilo/0000-0002-9458-0282	Deutsche Krebshilfe [107744]; Bundesministerium fur Bildung und Forschung, Germany (BRENDA) [012P0505]; Deutsche Forschungsgemeinschaft (DFG) [167, WI 3099/7-1, WI 3099/7-2]	Deutsche Krebshilfe(Deutsche Krebshilfe); Bundesministerium fur Bildung und Forschung, Germany (BRENDA)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors are grateful to Yosef Shiloh (Tel Aviv University, Tel Aviv, Israel) for providing the ATM expression vector. The authors cordially thank Natalia Bogdanova (Hannover Medical School), for performing mutational studies on CHEK2 and for providing material of mutation carriers, as well as Lisa Dohrn and Annabelle Schwan (Ulm University), for help with the DSBR analyses in HeLa cell lines. The authors gratefully acknowledge Peter Hillemanns and Rolf Kreienberg for the continuous support of their molecular oncological studies. The authors thank the Deutsche Krebshilfe (grant 107744), the Bundesministerium fur Bildung und Forschung, Germany (BRENDA, grant 012P0505), and the Deutsche Forschungsgemeinschaft (DFG Klinische Forschergruppe 167: Apoptoseregulation und ihre Storungen bei Krankheiten, grants WI 3099/7-1 and -2) for financial support.	Akyuz N, 2002, MOL CELL BIOL, V22, P6306, DOI 10.1128/MCB.22.17.6306-6317.2002; Albert MH, 2010, BONE MARROW TRANSPL, V45, P622, DOI 10.1038/bmt.2009.207; Alterman N, 2007, AM J MED GENET A, V143A, P1827, DOI 10.1002/ajmg.a.31853; Bahassi EM, 2008, ONCOGENE, V27, P3977, DOI 10.1038/onc.2008.17; Baldeyron C, 2002, ONCOGENE, V21, P1401, DOI 10.1038/sj.onc.1205200; Barone G, 2009, HUM MUTAT, V30, P1222, DOI 10.1002/humu.21034; Bishop AJR, 2000, CANCER RES, V60, P395; Bogdanova N, 2005, INT J CANCER, V116, P263, DOI 10.1002/ijc.21022; Bogdanova N, 2009, BREAST CANCER RES TR, V118, P207, DOI 10.1007/s10549-008-0189-9; Callen E, 2007, ONCOGENE, V26, P7759, DOI 10.1038/sj.onc.1210873; Cavaciuti E, 2005, GENE CHROMOSOME CANC, V42, P1, DOI 10.1002/gcc.20101; Choi S, 2010, CELL CYCLE, V9, P4052, DOI 10.4161/cc.9.20.13471; Demuth I, 2007, ONCOGENE, V26, P7792, DOI 10.1038/sj.onc.1210876; Dork T, 2004, AM J MED GENET A, V126A, P272, DOI 10.1002/ajmg.a.20601; Dork T, 2001, CANCER RES, V61, P7608; Drexler GA, 2004, DNA REPAIR, V3, P1345, DOI 10.1016/j.dnarep.2004.05.001; Gatti RA, 1999, MOL GENET METAB, V68, P419, DOI 10.1006/mgme.1999.2942; Gatz SA, 2008, CARCINOGENESIS, V29, P519, DOI 10.1093/carcin/bgm283; Golding SE, 2004, J BIOL CHEM, V279, P15402, DOI 10.1074/jbc.M314191200; Howlett NG, 2006, DNA REPAIR, V5, P251, DOI 10.1016/j.dnarep.2005.10.004; Joubert A, 2008, INT J RADIAT BIOL, V84, P107, DOI 10.1080/09553000701797039; Keimling M, 2008, INT J CANCER, V123, P730, DOI 10.1002/ijc.23551; Kim MS, 2009, J BIOL CHEM, V284, P9733, DOI 10.1074/jbc.M808097200; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lavin MF, 2007, BRIT MED BULL, V81-82, P129, DOI 10.1093/bmb/ldm012; Lavin MF, 2004, DNA REPAIR, V3, P1197, DOI 10.1016/j.dnarep.2004.03.011; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Morrison C, 2000, EMBO J, V19, P463, DOI 10.1093/emboj/19.3.463; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; O'Connor MJ, 2007, ONCOGENE, V26, P7816, DOI 10.1038/sj.onc.1210879; Restle A, 2008, NUCLEIC ACIDS RES, V36, P5362, DOI 10.1093/nar/gkn503; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Sandoval N, 1999, HUM MOL GENET, V8, P69, DOI 10.1093/hmg/8.1.69; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Speit G, 2000, CYTOGENET CELL GENET, V91, P261, DOI 10.1159/000056855; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Steinmann D, 2001, BRIT J CANCER, V85, P850, DOI 10.1054/bjoc.2001.2016; Tauchi H, 2002, NATURE, V420, P93, DOI 10.1038/nature01125; Uhl M, 2010, DNA REPAIR, V9, P383, DOI 10.1016/j.dnarep.2009.12.020; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Waltes R, 2009, AM J HUM GENET, V84, P605, DOI 10.1016/j.ajhg.2009.04.010; Wang HC, 2004, ONCOGENE, V23, P824, DOI 10.1038/sj.onc.1207168; Wang X, 2003, RADIAT RES, V159, P426, DOI 10.1667/0033-7587(2003)159[0426:CIRIIO]2.0.CO;2; Watrin E, 2006, EXP CELL RES, V312, P2687, DOI 10.1016/j.yexcr.2006.06.024; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; White JS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000758; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Williamson CT, 2010, MOL CANCER THER, V9, P347, DOI 10.1158/1535-7163.MCT-09-0872; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004; Zhuang J, 2009, J BIOL CHEM, V284, P30565, DOI 10.1074/jbc.M109.059444; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	52	44	44	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2011	25	11					3849	3860		10.1096/fj.11-185546	http://dx.doi.org/10.1096/fj.11-185546			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21778326				2022-12-25	WOS:000296723100010
J	Kasiviswanathan, R; Copeland, WC				Kasiviswanathan, Rajesh; Copeland, William C.			Ribonucleotide Discrimination and Reverse Transcription by the Human Mitochondrial DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I KLENOW FRAGMENT; ESCHERICHIA-COLI; RNA-POLYMERASE; SIDE-CHAINS; GAMMA; REPLICATION; MUTATIONS; DEPLETION; FIDELITY; PURIFICATION	During DNA synthesis, DNA polymerases must select against ribonucleotides, present at much higher levels compared with deoxyribonucleotides. Most DNA polymerases are equipped to exclude ribonucleotides from their active site through a bulky side chain residue that can sterically block the 2'-hydroxyl group of the ribose ring. However, many nuclear replicative and repair DNA polymerases incorporate ribonucleotides into DNA, suggesting that the exclusion mechanism is not perfect. In this study, we show that the human mitochondrial DNA polymerase gamma discriminates ribonucleotides efficiently but differentially based on the base identity. Whereas UTP is discriminated by 77,000-fold compared with dTTP, the discrimination drops to 1,100-fold for GTP versus dGTP. In addition, the efficiency of the enzyme was reduced 3-14-fold, depending on the identity of the incoming nucleotide, when it extended from a primer containing a 3'-terminal ribonucleotide. DNA polymerase gamma is also proficient in performing single-nucleotide reverse transcription reactions from both DNA and RNA primer terminus, although its bypass efficiency is significantly diminished with increasing stretches of ribonucleotides in template DNA. Furthermore, we show that the E895A mutant enzyme is compromised in its ability to discriminate ribonucleotides, mainly due to its defects in deoxyribonucleoside triphosphate binding, and is also a poor reverse transcriptase. The potential biochemical defects of a patient harboring a disease mutation in the same amino acid (E895G) are discussed.	[Kasiviswanathan, Rajesh; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.	copelan1@niehs.nih.gov	Copeland, William/C-4242-2019; Kasiviswanathan, Rajesh/D-2744-2012	Copeland, William/0000-0002-0359-0953; 	National Institutes of Health, NIEHS [ES 065078, ES 065080]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065078, ZIAES065080, Z01ES065080, ZIAES065078] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, NIEHS, Grants ES 065078 and ES 065080.	Astatke M, 1998, J MOL BIOL, V278, P147, DOI 10.1006/jmbi.1998.1672; Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200; Boyer PL, 2000, P NATL ACAD SCI USA, V97, P3056, DOI 10.1073/pnas.97.7.3056; Brown JA, 2010, J MOL BIOL, V395, P282, DOI 10.1016/j.jmb.2009.11.003; Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105; Cavanaugh NA, 2010, J BIOL CHEM, V285, P24457, DOI 10.1074/jbc.M110.132407; Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; COPELAND WC, 1993, J BIOL CHEM, V268, P11041; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Fuste JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021; GALLO RC, 1970, NATURE, V228, P927, DOI 10.1038/228927a0; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Kasiviswanathan R, 2010, METHODS, V51, P379, DOI 10.1016/j.ymeth.2010.02.015; KORNBERG A, 1992, DNA REPLICATION, P54; Lee HR, 2007, J BIOL CHEM, V282, P31982, DOI 10.1074/jbc.M705392200; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303; Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w; McElhinny SAN, 2003, MOL CELL BIOL, V23, P2309, DOI 10.1128/MCB.23.7.2309-2315.2003; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; MOSBAUGH DW, 1988, NUCLEIC ACIDS RES, V16, P5645, DOI 10.1093/nar/16.12.5645; Murakami E, 2003, J BIOL CHEM, V278, P36403, DOI 10.1074/jbc.M306236200; POLESKY AH, 1992, J BIOL CHEM, V267, P8417; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z; Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4; Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089; Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105; Wheeler LJ, 2011, J BIOL CHEM, V286, P16992, DOI 10.1074/jbc.M111.236968; Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824; Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9	44	52	52	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31490	31500		10.1074/jbc.M111.252460	http://dx.doi.org/10.1074/jbc.M111.252460			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21778232	hybrid, Green Published			2022-12-25	WOS:000294487500044
J	Wilson, CM; Magnaudeix, A; Yardin, C; Terro, F				Wilson, Cornelia M.; Magnaudeix, Amandine; Yardin, Catherine; Terro, Faraj			DC2 and Keratinocyte-associated Protein 2 (KCP2), Subunits of the Oligosaccharyltransferase Complex, Are Regulators of the gamma-Secretase-directed Processing of Amyloid Precursor Protein (APP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOPHORIN-I; ALZHEIMERS-DISEASE; BETA-SECRETASE; MAMMALIAN OLIGOSACCHARYLTRANSFERASE; SIGNALING PATHWAY; PRESENILIN-1; CELLS; PEN-2; NOTCH; ENDOPROTEOLYSIS	The oligosaccharyltransferase complex catalyzes the transfer of oligosaccharide from a dolichol pyrophosphate donor en bloc onto a free asparagine residue of a newly synthesized nascent chain during the translocation in the endoplasmic reticulum lumen. The role of the less known oligosaccharyltransferase (OST) subunits, DC2 and KCP2, recently identified still remains to be determined. Here, we have studied DC2 and KCP2, and we have established that DC2 and KCP2 are substrate-specific, affecting amyloid precursor protein (APP), indicating that they are not core components required for N-glycosylation and OST activity per se. We show for the first time that DC2 and KCP2 depletion affects APP processing, leading to an accumulation of C-terminal fragments, both C99 and C83, and a reduction in full-length mature APP. This reduction in mature APP levels was not due to a block in secretion because the levels of sAPP alpha secreted into the media were unaffected. We discover that DC2 and KCP2 depletion affects only the gamma-secretase complex, resulting in a reduction of the PS1 active fragment blocking A beta production. Conversely, we show that the overexpression of DC2 and KCP2 causes an increase in the active gamma-secretase complex, particularly the N-terminal fragment of PS1 that is generated by endoproteolysis, leading to a stimulation of A beta production upon overexpression of DC2 and KCP2. Our findings reveal that components of the OST complex for the first time can interact with the gamma-secretase and affect the APP processing pathway.	[Wilson, Cornelia M.; Magnaudeix, Amandine; Yardin, Catherine; Terro, Faraj] Univ Limoges, Fac Med, Grp Neurobiol Cellulaire, Homeostasie Cellulaire & Pathol EA3842, F-87025 Limoges, France; [Wilson, Cornelia M.; Yardin, Catherine; Terro, Faraj] Hop Mere & Enfant, Lab Histol & Cytogenet, F-87042 Limoges, France	Universite de Limoges; CHU Limoges	Wilson, CM (corresponding author), Univ Limoges, Fac Med, Grp Neurobiol Cellulaire, Homeostasie Cellulaire & Pathol EA3842, 2 Rue Dr Raymond Marcland, F-87025 Limoges, France.	cornelia.wilson@unilim.fr	TERRO, FARAJ/O-8423-2016	TERRO, FARAJ/0000-0002-3655-3964; Wilson, Cornelia/0000-0001-6584-6179; Magnaudeix, Amandine/0000-0002-2806-1177	BQR Actions Internationales (Region Limousin)	BQR Actions Internationales (Region Limousin)	This project was supported by a BQR Actions Internationales (Region Limousin) (to C. M. W.).	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Busciglio J, 1997, J NEUROSCI, V17, P5101, DOI 10.1523/jneurosci.17-13-05101.1997; Campbell WA, 2002, BIOCHEMISTRY-US, V41, P3372, DOI 10.1021/bi015810h; Chavan M, 2006, P NATL ACAD SCI USA, V103, P8947, DOI 10.1073/pnas.0603262103; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; Greenfield JJA, 1999, J CELL SCI, V112, P1477; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Holtzman DM, 1997, NAT MED, V3, P954, DOI 10.1038/nm0997-954; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Kelleher DJ, 1997, P NATL ACAD SCI USA, V94, P4994, DOI 10.1073/pnas.94.10.4994; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; Kim SH, 2005, J BIOL CHEM, V280, P1992, DOI 10.1074/jbc.M412404200; Kim TW, 1997, SCIENCE, V277, P373, DOI 10.1126/science.277.5324.373; Kohda D, 2007, GLYCOBIOLOGY, V17, P1175, DOI 10.1093/glycob/cwm087; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; Kudo T, 2006, BIOCHEM BIOPH RES CO, V344, P525, DOI 10.1016/j.bbrc.2006.03.173; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Pahlsson P, 1996, ARCH BIOCHEM BIOPHYS, V331, P177, DOI 10.1006/abbi.1996.0296; Price DL, 1998, SCIENCE, V282, P1079, DOI 10.1126/science.282.5391.1079; Prokop S, 2005, J NEUROCHEM, V94, P57, DOI 10.1111/j.1471-4159.2005.03165.x; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Ratovitski T, 1997, J BIOL CHEM, V272, P24536, DOI 10.1074/jbc.272.39.24536; Sannerud R, 2009, SEMIN CELL DEV BIOL, V20, P183, DOI 10.1016/j.semcdb.2008.11.004; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Shibatani T, 2005, BIOCHEMISTRY-US, V44, P5982, DOI 10.1021/bi047328f; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2009, SEMIN CELL DEV BIOL, V20, P211, DOI 10.1016/j.semcdb.2008.10.007; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wakabayashi T, 2009, NAT CELL BIOL, V11, P1340, DOI 10.1038/ncb1978; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Wilson CM, 2005, J BIOL CHEM, V280, P4195, DOI 10.1074/jbc.M410329200; Wilson CM, 2008, P NATL ACAD SCI USA, V105, P9534, DOI 10.1073/pnas.0711846105; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; Wilson CM, 2010, METHODS MOL BIOL, V619, P389, DOI 10.1007/978-1-60327-412-8_23; Xie ZC, 2004, J BIOL CHEM, V279, P34130, DOI 10.1074/jbc.M401094200; Yan AX, 2005, GLYCOBIOLOGY, V15, P1407, DOI 10.1093/glycob/cwj026; Zhang JM, 1998, J BIOL CHEM, V273, P12436, DOI 10.1074/jbc.273.20.12436; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	55	14	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31080	31091		10.1074/jbc.M111.249748	http://dx.doi.org/10.1074/jbc.M111.249748			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21768116	Green Published, hybrid			2022-12-25	WOS:000294487500003
J	Laroui, H; Yan, YT; Narui, Y; Ingersoll, SA; Ayyadurai, S; Charania, MA; Zhou, F; Wang, BH; Salaita, K; Sitaraman, SV; Merlin, D				Laroui, Hamed; Yan, Yutao; Narui, Yoshie; Ingersoll, Sarah A.; Ayyadurai, Saravanan; Charania, Moiz A.; Zhou, Feimeng; Wang, Binghe; Salaita, Khalid; Sitaraman, Shanthi V.; Merlin, Didier			L-Ala-gamma-D-Glu-meso-diaminopimelic Acid (DAP) Interacts Directly with Leucine-rich Region Domain of Nucleotide-binding Oligomerization Domain 1, Increasing Phosphorylation Activity of Receptor-interacting Serine/Threonine-protein Kinase 2 and Its Interaction with Nucleotide-binding Oligomerization Domain 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; BACTERIAL TRIPEPTIDE FMLP; MACROMOLECULAR INTERACTIONS; MOLECULAR-INTERACTIONS; CROHNS-DISEASE; NOD1; PEPTIDOGLYCAN; RECOGNITION	The oligopeptide transporter PepT1 expressed in inflamed colonic epithelial cells transports small bacterial peptides, such as muramyl dipeptide (MDP) and L-Ala-gamma-D-Glu-meso-diaminopimelic acid (Tri-DAP) into cells. The innate immune system uses various proteins to sense pathogen-associated molecular patterns. Nucleotide-binding oligomerization domain (NOD)like receptors of which there are more than 20 related family members are present in the cytosol and recognize intracellular ligands. NOD proteins mediate NF-kappa B activation via receptor-interacting serine/threonine-protein kinase 2 (RICK or RIPK). The specific ligands for some NOD-like receptors have been identified. NOD type 1 (NOD1) is activated by peptides that contain a diaminophilic acid, such as the PepT1 substrate Tri-DAP. In other words, PepT1 transport activity plays an important role in controlling intracellular loading of ligands for NOD1 in turn determining the activation level of downstream inflammatory pathways. However, no direct interaction between Tri-DAP and NOD1 has been identified. In the present work, surface plasmon resonance and atomic force microscopy experiments showed direct binding between NOD1 and Tri-DAP with a K-d value of 34.5 mu M. In contrast, no significant binding was evident between muramyl dipeptide and NOD1. Furthermore, leucine-rich region (LRR)-truncated NOD1 did not interact with Tri-DAP, indicating that Tri-DAP interacts with the LRR domain of NOD1. Next, we examined binding between RICK and NOD1 proteins and found that such binding was significant with a K-d value of 4.13 mu M. However, NOD1/RICK binding was of higher affinity (K-d of 3.26 mu M) when NOD1 was prebound to Tri-DAP. Furthermore, RICK phosphorylation activity was increased when NOD was prebound to Tri-DAP. In conclusion, we have shown that Tri-DAP interacts directly with the LRR domain of NOD1 and consequently increases RICK/NOD1 association and RICK phosphorylation activity.	[Laroui, Hamed; Yan, Yutao; Ingersoll, Sarah A.; Ayyadurai, Saravanan; Charania, Moiz A.; Sitaraman, Shanthi V.; Merlin, Didier] Emory Univ, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Narui, Yoshie; Salaita, Khalid] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Zhou, Feimeng] Calif State Univ Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90032 USA; [Wang, Binghe] Georgia State Univ, Dept Chem, Atlanta, GA 30302 USA; [Merlin, Didier] Vet Affairs Med Ctr, Decatur, GA 30033 USA	Emory University; Emory University; California State University System; California State University Los Angeles; University System of Georgia; Georgia State University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Laroui, H (corresponding author), Emory Univ, Dept Med, Div Digest Dis, 615 Michael St, Atlanta, GA 30322 USA.	hlaroui@emory.edu	Wang, Binghe/D-4257-2009; salaita, khalid/C-4414-2008	Wang, Binghe/0000-0002-2200-5270; 	National Institutes of Health [RO1-DK-071594]; NIDDK [RO1-DK-55850]; California State University, Los Angeles [P20-MD001824-01]; NINDS [SC1MS070155-01]; Department of Veterans Affairs; Crohn's and Colitis Foundation of America; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK084987, R01DK071594, R01DK055850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); California State University, Los Angeles; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Veterans Affairs(US Department of Veterans Affairs); Crohn's and Colitis Foundation of America; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK-071594 and RO1-DK-55850 from the NIDDK (to D. M.) and Grant P20-MD001824-01 from the Research Infrastructure in Minority Institutions Program at California State University, Los Angeles and Grant SC1MS070155-01 from the NINDS (to F. Z.). This work was also supported by the Department of Veterans Affairs.; Recipient of a senior research award from the Crohn's and Colitis Foundation of America.	Amano A, 1999, INFECT IMMUN, V67, P2399, DOI 10.1128/IAI.67.5.2399-2405.1999; Buyse M, 2003, AM J PATHOL, V163, P1969, DOI 10.1016/S0002-9440(10)63555-9; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Charrier L, 2006, LAB INVEST, V86, P490, DOI 10.1038/labinvest.3700413; Dalmasso G, 2010, AM J PHYSIOL-GASTR L, V299, pG687, DOI 10.1152/ajpgi.00527.2009; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Dziarski R, 2003, CELL MOL LIFE SCI, V60, P1793, DOI 10.1007/s00018-003-3019-6; Enoksson M, 2011, J INNATE IMMUN, V3, P142, DOI 10.1159/000321933; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Inohara N, 2001, ONCOGENE, V20, P6473, DOI 10.1038/sj.onc.1204787; Kufer TA, 2006, ANN NY ACAD SCI, V1072, P19, DOI 10.1196/annals.1326.020; Lahiri J, 1999, LANGMUIR, V15, P7186, DOI 10.1021/la9815650; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Masumoto J, 2006, J EXP MED, V203, P203, DOI 10.1084/jem.20051229; Merlin D, 1998, J CLIN INVEST, V102, P2011, DOI 10.1172/JCI4179; Merlin D, 2001, GASTROENTEROLOGY, V120, P1666, DOI 10.1053/gast.2001.24845; O'Shannessy D J, 1994, Curr Opin Biotechnol, V5, P65, DOI 10.1016/S0958-1669(05)80072-2; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; OSHANNESSY DJ, 1994, METHOD ENZYMOL, V240, P323; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Torreri Paola, 2005, Ann Ist Super Sanita, V41, P437; Uehara A, 2005, CELL MICROBIOL, V7, P53, DOI 10.1111/j.1462-5822.2004.00433.x; van Heel DA, 2005, EUR J IMMUNOL, V35, P2471, DOI 10.1002/eji.200526296; van Heel DA, 2005, GUT, V54, P1553, DOI 10.1136/gut.2005.065888; van Heel DA, 2006, EUR J IMMUNOL, V36, P1629, DOI 10.1002/eji.200535636; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Vollmer W, 1999, J BIOL CHEM, V274, P6726, DOI 10.1074/jbc.274.10.6726; Watanabe T, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/476482; Yao X, 2006, ANAL BIOCHEM, V354, P220, DOI 10.1016/j.ab.2006.04.011; Zhu R, 2009, CHEMPHYSCHEM, V10, P1478, DOI 10.1002/cphc.200900245; Zucchelli M, 2009, INFLAMM BOWEL DIS, V15, P1562, DOI 10.1002/ibd.20963	38	69	71	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					31003	31013		10.1074/jbc.M111.257501	http://dx.doi.org/10.1074/jbc.M111.257501			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21757725	Green Published, hybrid			2022-12-25	WOS:000294283600078
J	Berginski, ME; Vitriol, EA; Hahn, KM; Gomez, SM				Berginski, Mathew E.; Vitriol, Eric A.; Hahn, Klaus M.; Gomez, Shawn M.			High-Resolution Quantification of Focal Adhesion Spatiotemporal Dynamics in Living Cells	PLOS ONE			English	Article								Focal adhesions (FAs) are macromolecular complexes that provide a linkage between the cell and its external environment. In a motile cell, focal adhesions change size and position to govern cell migration, through the dynamic processes of assembly and disassembly. To better understand the dynamic regulation of focal adhesions, we have developed an analysis system for the automated detection, tracking, and data extraction of these structures in living cells. This analysis system was used to quantify the dynamics of fluorescently tagged Paxillin and FAK in NIH 3T3 fibroblasts followed via Total Internal Reflection Fluorescence Microscopy (TIRF). High content time series included the size, shape, intensity, and position of every adhesion present in a living cell. These properties were followed over time, revealing adhesion lifetime and turnover rates, and segregation of properties into distinct zones. As a proof-of-concept, we show how a single point mutation in Paxillin at the Jun-kinase phosphorylation site Serine 178 changes FA size, distribution, and rate of assembly. This study provides a detailed, quantitative picture of FA spatiotemporal dynamics as well as a set of tools and methodologies for advancing our understanding of how focal adhesions are dynamically regulated in living cells. A full, open-source software implementation of this pipeline is provided at http://gomezlab.bme.unc.edu/tools.	[Berginski, Mathew E.; Gomez, Shawn M.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27515 USA; [Vitriol, Eric A.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Gomez, Shawn M.] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC USA; [Hahn, Klaus M.; Gomez, Shawn M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Hahn, Klaus M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Berginski, ME (corresponding author), Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27515 USA.	khahn@med.unc.edu; smgomez@unc.edu		Gomez, Shawn/0000-0002-8251-4552; Hahn, Klaus/0000-0002-1970-7562; Vitriol, Eric/0000-0003-3398-1450	NIH [GM57464, P01 HL080166, F31 NS062487]; UNC School of Medicine; NSF; United States Environmental Protection Agency [RD833825]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM057464, R01GM057464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS062487] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC School of Medicine; NSF(National Science Foundation (NSF)); United States Environmental Protection Agency(United States Environmental Protection Agency); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants GM57464, P01 HL080166 (KMH), and F31 NS062487 (EAV), startup funds from the UNC School of Medicine (SMG) and the NSF Graduate Research Fellowship Program (MEB). Financial support for these studies was also provided, in part, by the United States Environmental Protection Agency grant (RD833825). However, the research described in this article has not been subjected to the Agency's peer review and policy review and therefore does not necessarily reflect the views of the Agency and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; BROWN MC, 2004, PHYSL REV, V84; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Huang C, 2004, J CELL BIOL, V164, P593, DOI 10.1083/jcb.200307081; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; HUANG Z, 2008, CELLULAR SIGNALLING, V20; JI L, 2005, J MICROSCOPY, V220; KIMURA K, 2008, INVESTIGATIVE OPHTHA, V49; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Mattheyses AL, 2010, J CELL SCI, V123, P3621, DOI 10.1242/jcs.056218; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; OWEN KA, 2007, J CELL BIOL; PARAN Y, 2007, J STRUCTURAL BIOL, V158; Rajfur Z, 2002, NAT CELL BIOL, V4, P286, DOI 10.1038/ncb772; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Saengsawang W, 2006, MOL BIOL CELL, V17; VALLOTTON P, 2004, PNAS, V101; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; WEBB DJ, 2004, NATURE CELL BIOL, V6; Winograd-Katz SE, 2009, J CELL BIOL, V186, P423, DOI 10.1083/jcb.200901105; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; ZAIDELBAR R, 2004, BIOCH SOC T, V32; Zamir E, 1999, J CELL SCI, V112, P1655; Zamir E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001901	30	115	116	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22025	10.1371/journal.pone.0022025	http://dx.doi.org/10.1371/journal.pone.0022025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779367	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811300036
J	Favier, B; HoWangYin, KY; Wu, J; Caumartin, J; Daouya, M; Horuzsko, A; Carosella, ED; LeMaoult, J				Favier, Benoit; HoWangYin, Kiave-Yune; Wu, Juan; Caumartin, Julien; Daouya, Marina; Horuzsko, Anatolij; Carosella, Edgardo D.; LeMaoult, Joel			Tolerogenic Function of Dimeric Forms of HLA-G Recombinant Proteins: A Comparative Study In Vivo	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; NATURAL-KILLER-CELLS; INHIBITORY RECEPTOR; DENDRITIC CELLS; G EXPRESSION; G MOLECULE; T-CELLS; MYELOMONOCYTIC CELLS; PATHWAY; SURFACE	HLA-G is a natural tolerogenic molecule involved in the best example of tolerance to foreign tissues there is: the maternalfetal tolerance. The further involvement of HLA-G in the tolerance of allogeneic transplants has also been demonstrated and some of its mechanisms of action have been elucidated. For these reasons, therapeutic HLA-G molecules for tolerance induction in transplantation are actively investigated. In the present study, we studied the tolerogenic functions of three different HLA-G recombinant proteins: HLA-G heavy chain fused to beta 2-microglobulin (B2M), HLA-G heavy chain fused to B2M and to the Fc portion of an immunoglobulin, and HLA-G alpha-1 domain either fused to the Fc part of an immunoglobulin or as a synthetic peptide. Our results demonstrate the tolerogenic function of B2M-HLA-G fusion proteins, and especially of B2M-HLA-G5, which were capable of significantly delaying allogeneic skin graft rejection in a murine in vivo transplantation model. The results from our studies suggest that HLA-G recombinant proteins are relevant candidates for tolerance induction in human transplantation.	[Favier, Benoit; HoWangYin, Kiave-Yune; Caumartin, Julien; Daouya, Marina; Carosella, Edgardo D.; LeMaoult, Joel] CEA, I2BM, Serv Rech Hemato Immunol, Paris, France; [Favier, Benoit; HoWangYin, Kiave-Yune; Caumartin, Julien; Daouya, Marina; Carosella, Edgardo D.; LeMaoult, Joel] Hop St Louis, Inst Univ Hematol, Paris, France; [HoWangYin, Kiave-Yune] Univ Paris 07, Biol & Biotechnol PhD Program, Paris, France; [Wu, Juan; Horuzsko, Anatolij] Georgia Hlth Sci Univ, Ctr Mol Chaperone Radiobiol & Canc Virol, Augusta, GA USA	CEA; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University System of Georgia; Augusta University	Favier, B (corresponding author), CEA, I2BM, Serv Rech Hemato Immunol, Paris, France.	Joel.LeMaoult@cea.fr	FAVIER, Benoit/W-7379-2019; LeMaoult, Joel/E-9583-2011	LeMaoult, Joel/0000-0002-4513-9482	Commissariat a l'Energie Atomique; Agence de la Biomedecine; HLA-G Technologies; National Institute of Health [R56 AI055923]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI055923] Funding Source: NIH RePORTER	Commissariat a l'Energie Atomique(French Atomic Energy Commission); Agence de la Biomedecine; HLA-G Technologies; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Commissariat a l'Energie Atomique, by the Agence de la Biomedecine, in part by HLA-G Technologies (to A. H.), and by National Institute of Health grant R56 AI055923 (to A. H.). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The commercial source HLA-G Technologies has partially funded this study by contributing to the expenses of in vivo experiments. They did not take any part in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aractingi S, 2001, AM J PATHOL, V159, P71, DOI 10.1016/S0002-9440(10)61675-6; Bahri R, 2006, J IMMUNOL, V176, P1331, DOI 10.4049/jimmunol.176.3.1331; Boyson JE, 2002, P NATL ACAD SCI USA, V99, P16180, DOI 10.1073/pnas.212643199; Carosella ED, 2008, BLOOD, V111, P4862, DOI 10.1182/blood-2007-12-127662; Carosella ED, 2008, TRENDS IMMUNOL, V29, P125, DOI 10.1016/j.it.2007.11.005; Caumartin J, 2007, EMBO J, V26, P1423, DOI 10.1038/sj.emboj.7601570; CHEN HX, 2010, HUMAN IMMUNOLO UNPUB; Colonna M, 1998, J IMMUNOL, V160, P3096; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Gonen-Gross T, 2003, J IMMUNOL, V171, P1343, DOI 10.4049/jimmunol.171.3.1343; Gregori S, 2010, BLOOD, V116, P935, DOI 10.1182/blood-2009-07-234872; Greten TF, 2002, J IMMUNOL METHODS, V271, P125, DOI 10.1016/S0022-1759(02)00346-0; Horuzsko A, 2001, INT IMMUNOL, V13, P385, DOI 10.1093/intimm/13.3.385; Huang JH, 2010, J VIROL, V84, P10784, DOI 10.1128/JVI.01292-10; Kren L, 2010, J NEUROIMMUNOL, V220, P131, DOI 10.1016/j.jneuroim.2010.01.014; LeMaoult J, 2004, P NATL ACAD SCI USA, V101, P7064, DOI 10.1073/pnas.0401922101; Liang S, 2008, P NATL ACAD SCI USA, V105, P8357, DOI 10.1073/pnas.0803341105; Liang SY, 2002, EUR J IMMUNOL, V32, P2418, DOI 10.1002/1521-4141(200209)32:9<2418::AID-IMMU2418>3.0.CO;2-L; Lila N, 2000, LANCET, V355, P2138, DOI 10.1016/S0140-6736(00)02386-2; Lila N, 2002, CIRCULATION, V105, P1949, DOI 10.1161/01.CIR.0000015075.89984.46; Lozano JM, 2002, AIDS, V16, P347, DOI 10.1097/00002030-200202150-00005; Mitsdoerffer M, 2005, J NEUROIMMUNOL, V159, P155, DOI 10.1016/j.jneuroim.2004.09.016; Morandi F, 2007, CANCER RES, V67, P6433, DOI 10.1158/0008-5472.CAN-06-4588; Nuckel H, 2005, BLOOD, V105, P1694, DOI 10.1182/blood-2004-08-3335; Pangault C, 2002, HUM IMMUNOL, V63, P83, DOI 10.1016/S0198-8859(01)00373-1; Paul P, 1998, P NATL ACAD SCI USA, V95, P4510, DOI 10.1073/pnas.95.8.4510; Rajagopalan S, 1999, J EXP MED, V189, P1093, DOI 10.1084/jem.189.7.1093; Rebmann V, 2005, HUM IMMUNOL, V66, P853, DOI 10.1016/j.humimm.2005.05.003; Ristich V, 2005, EUR J IMMUNOL, V35, P1133, DOI 10.1002/eji.200425741; Riteau B, 2001, J IMMUNOL, V166, P5018, DOI 10.4049/jimmunol.166.8.5018; Rouas-Freiss N, 2003, AM J TRANSPLANT, V3, P11, DOI 10.1034/j.1600-6143.2003.30103.x; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P5249, DOI 10.1073/pnas.94.10.5249; Shiroishi M, 2006, J BIOL CHEM, V281, P10439, DOI 10.1074/jbc.M512305200; Shiroishi M, 2003, P NATL ACAD SCI USA, V100, P8856, DOI 10.1073/pnas.1431057100; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; Wiendl H, 2000, ANN NEUROL, V48, P679, DOI 10.1002/1531-8249(200010)48:4<679::AID-ANA19>3.3.CO;2-M	36	18	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21011	10.1371/journal.pone.0021011	http://dx.doi.org/10.1371/journal.pone.0021011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779321	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811300006
J	Chen, YY; Enoksson, SL; Johansson, C; Karlsson, MA; Lundeberg, L; Nilsson, G; Scheynius, A; Karlsson, MCI				Chen, Yunying; Enoksson, Sara Lind; Johansson, Catharina; Karlsson, Maria A.; Lundeberg, Lena; Nilsson, Gunnar; Scheynius, Annika; Karlsson, Mikael C. I.			The Expression of BAFF, APRIL and TWEAK Is Altered in Eczema Skin but Not in the Circulation of Atopic and Seborrheic Eczema Patients	PLOS ONE			English	Article							IL-18; CYTOKINE; INDUCTION; CELLS; IGE; DERMATITIS; INTERLEUKIN-18; PATHOGENESIS; DIAGNOSIS; THERAPY	The TNF family cytokines BAFF (B-cell activating factor of the TNF family) and APRIL (a proliferation-inducing ligand) are crucial survival factors for B-cell development and activation. B-cell directed treatments have been shown to improve atopic eczema (AE), suggesting the involvement of these cytokines in the pathogenesis of AE. We therefore analyzed the expression of these TNF cytokines in AE, seborrheic eczema (SE) and healthy controls (HC). The serum/plasma concentration of BAFF, APRIL and a close TNF member TWEAK (TNF-like weak inducer of apoptosis) was measured by ELISA. The expression of these cytokines and their receptors in skin was analyzed by quantitative RT-PCR and immunofluorescence. Unlike other inflammatory diseases including autoimmune diseases and asthma, the circulating levels of BAFF, APRIL and TWEAK were not elevated in AE or SE patients compared with HCs and did not correlate with the disease severity or systemic IgE levels in AE patients. Interestingly, we found that the expression of these cytokines and their receptors was altered in positive atopy patch test reactions in AE patients (APT-AE) and in lesional skin of AE and SE patients. The expression of APRIL was decreased and the expression of BAFF was increased in eczema skin of AE and SE, which could contribute to a reduced negative regulatory input on B-cells. This was found to be more pronounced in APT-AE, the initiating acute stage of AE, which may result in dysregulation of over-activated B-cells. Furthermore, the expression levels of TWEAK and its receptor positively correlated to each other in SE lesions, but inversely correlated in AE lesions. These results shed light on potential pathogenic roles of these TNF factors in AE and SE, and pinpoint a potential of tailored treatments towards these factors in AE and SE.	[Chen, Yunying; Enoksson, Sara Lind; Johansson, Catharina; Scheynius, Annika; Karlsson, Mikael C. I.] Karolinska Inst, Dept Med Solna, Clin Allergy Res Unit, Stockholm, Sweden; [Chen, Yunying; Enoksson, Sara Lind; Johansson, Catharina; Karlsson, Maria A.; Lundeberg, Lena; Nilsson, Gunnar; Scheynius, Annika; Karlsson, Mikael C. I.] Karolinska Univ Hosp Solna, Stockholm, Sweden; [Karlsson, Maria A.; Lundeberg, Lena] Karolinska Inst, Dept Med Solna, Dermatol Unit, Stockholm, Sweden; [Nilsson, Gunnar] Karolinska Inst, Dept Med Solna, Clin Immunol & Allergy Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Chen, YY (corresponding author), Karolinska Inst, Dept Med Solna, Clin Allergy Res Unit, Stockholm, Sweden.	yunying.chen@ki.se		Nilsson, Gunnar/0000-0001-6795-5512	The Centre for Allergy Research, Karolinska Institutet; The Swedish Research Council; The Swedish Medical Society; The Hesselman Foundation; The Swedish International Development Agency; The Swedish Foundation for Strategic Research; Magnus Bergvall's Foundation; Stockholm County Council; The Karolinska Institutet	The Centre for Allergy Research, Karolinska Institutet; The Swedish Research Council(Swedish Research Council); The Swedish Medical Society; The Hesselman Foundation; The Swedish International Development Agency; The Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Magnus Bergvall's Foundation; Stockholm County Council(Stockholm County Council); The Karolinska Institutet(Karolinska Institutet)	This study was supported by grants from The Centre for Allergy Research, Karolinska Institutet, The Swedish Research Council, The Swedish Medical Society, The Hesselman Foundation, The Swedish International Development Agency, The Swedish Foundation for Strategic Research, Magnus Bergvall's Foundation, and through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and The Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2006, ALLERGY, V61, P969, DOI 10.1111/j.1398-9995.2006.01153.x; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Daridon C, 2008, AUTOIMMUN REV, V7, P267, DOI 10.1016/j.autrev.2007.05.002; Daridon C, 2009, CURR OPIN RHEUMATOL, V21, P205, DOI 10.1097/BOR.0b013e32832a0760; Darsow U, 2000, CLIN EXP DERMATOL, V25, P544, DOI 10.1046/j.1365-2230.2000.00695.x; Gaitanis G, 2010, MALASSEZIA AND THE SKIN: SCIENCE AND CLINICAL PRACTICE, P201, DOI 10.1007/978-3-642-03616-3; Harvima IT, 1999, ACTA DERM-VENEREOL, V79, P217; Hoshino T, 2000, EUR J IMMUNOL, V30, P1998, DOI 10.1002/1521-4141(200007)30:7<1998::AID-IMMU1998>3.0.CO;2-U; Jee HM, 2009, CLIN EXP DERMATOL, V53, P795; Jin L, 2004, J INVEST DERMATOL, V122, P1175, DOI 10.1111/j.0022-202X.2004.22419.x; Johansson C, 2002, J INVEST DERMATOL, V118, P1044, DOI 10.1046/j.1523-1747.2002.01758.x; Johansson C, 2009, INT ARCH ALLERGY IMM, V150, P51, DOI 10.1159/000210380; Kanda N, 2007, EUR J IMMUNOL, V37, P338, DOI 10.1002/eji.200636420; Kang JS, 2006, INT ARCH ALLERGY IMM, V141, P181, DOI 10.1159/000094897; Kunz B, 1997, DERMATOLOGY, V195, P10, DOI 10.1159/000245677; Lind SM, 2009, EUR J IMMUNOL, V39, P2293, DOI 10.1002/eji.200839195; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Matsushita T, 2008, EXP DERMATOL, V17, P197, DOI 10.1111/j.1600-0625.2007.00642.x; MITCHELL EB, 1982, LANCET, V1, P127; Nagel A, 2009, J INVEST DERMATOL, V129, P289, DOI 10.1038/jid.2008.192; Naldi L, 2009, NEW ENGL J MED, V360, P387, DOI 10.1056/NEJMcp0806464; Ohta Y, 2001, ARCH DERMATOL RES, V293, P334, DOI 10.1007/s004030100240; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Park MC, 2008, SCAND J RHEUMATOL, V37, P173, DOI 10.1080/03009740801898608; Pastore S, 2006, EUR J DERMATOL, V16, P125; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Seshasayee D, 2003, IMMUNITY, V18, P279, DOI 10.1016/S1074-7613(03)00025-6; Shaker OG, 2009, J DERMATOL SCI, V53, P153, DOI 10.1016/j.jdermsci.2008.08.018; Shibata S, 2010, J INVEST DERMATOL, V130, P1034, DOI 10.1038/jid.2009.349; Simon D, 2008, J ALLERGY CLIN IMMUN, V121, P122, DOI 10.1016/j.jaci.2007.11.016; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Tanaka T, 2001, INT ARCH ALLERGY IMM, V125, P236, DOI 10.1159/000053821; Vilhelmsson M, 2008, MOL IMMUNOL, V46, P294, DOI 10.1016/j.molimm.2008.07.036; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Wittmann M, 2009, AUTOIMMUN REV, V9, P45, DOI 10.1016/j.autrev.2009.03.003; Wittmann M, 2009, J ALLERGY CLIN IMMUN, V124, P81, DOI 10.1016/j.jaci.2009.04.026; Yanaba K, 2009, J RHEUMATOL, V36, P1657, DOI 10.3899/jrheum.081310; Yoshimoto T, 2000, NAT IMMUNOL, V1, P132, DOI 10.1038/77811; Zargari A, 2003, ALLERGY, V58, P306, DOI 10.1034/j.1398-9995.2003.00082.x; Zimmermann M, 2011, J ALLERGY CLIN IMMUN, V127, P200, DOI 10.1016/j.jaci.2010.11.005	41	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22202	10.1371/journal.pone.0022202	http://dx.doi.org/10.1371/journal.pone.0022202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765951	gold, Green Published, Green Submitted			2022-12-25	WOS:000292781500040
J	Halder, N; Kelso, JK; Milne, GJ				Halder, Nilimesh; Kelso, Joel K.; Milne, George J.			Cost-Effective Strategies for Mitigating a Future Influenza Pandemic with H1N1 2009 Characteristics	PLOS ONE			English	Article							UNITED-STATES; SCHOOL CLOSURE; TRANSMISSION; STRAIN	Background: We performed an analysis of the cost-effectiveness of pandemic intervention strategies using a detailed, individual-based simulation model of a community in Australia together with health outcome data of infected individuals gathered during 2009-2010. The aim was to examine the cost-effectiveness of a range of interventions to determine the most cost-effective strategies suitable for a future pandemic with H1N1 2009 characteristics. Methodology/Principal Findings: Using transmissibility, age-stratified attack rates and health outcomes determined from H1N1 2009 data, we determined that the most cost-effective strategies involved treatment and household prophylaxis using antiviral drugs combined with limited duration school closure, with costs ranging from $632 to $777 per case prevented. When school closure was used as a sole intervention we found the use of limited duration school closure to be significantly more cost-effective compared to continuous school closure, a result with applicability to countries with limited access to antiviral drugs. Other social distancing strategies, such as reduced workplace attendance, were found to be costly due to productivity losses. Conclusion: The mild severity (low hospitalisation and case fatality rates) and low transmissibility of H1N1 2009 meant that health treatment costs were dominated by the higher productivity losses arising from workplace absence due to illness and childcare requirements following school closure. Further analysis for higher transmissibility but with the same, mild severity had no effect on the overall findings.	[Halder, Nilimesh; Kelso, Joel K.; Milne, George J.] Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia	University of Western Australia	Halder, N (corresponding author), Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia.	joel@csse.uwa.edu.au	Kelso, Joel/C-2433-2013; Milne, George/C-6839-2013	Kelso, Joel/0000-0001-9814-6435; Milne, George/0000-0002-9796-0600	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge the funding of the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2004, 2004 AUSTR CENS; Australian Commonwealth Department of Health and Ageing, 2009, AUSTR HLTH MAN PLAN; Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Cruz-Pacheco G, 2009, EUROSURVEILLANCE, V14; *ECDC, 2009, ECDC RISK ASS 2009 I; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garber AA, 2008, J ECON PERSPECT, V22, P27, DOI 10.1257/jep.22.4.27; Gold MR, 1996, COST EFFECTIVENESS H; Halder N, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-221; Halder N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-168; Kelly HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011341; Kelso JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013797; Kelso JK, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-117; McBryde E, 2009, EURO SURVEILL, V14; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Milne G, 2010, J R SOC INTERFACE, V7, P573, DOI 10.1098/rsif.2009.0312; Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005; Munayco CV, 2009, EUROSURVEILLANCE, V14, P6; Newall AT, 2010, EMERG INFECT DIS, V16, P224, DOI 10.3201/eid1602.090571; Newall AT, 2008, VACCINE, V26, P6818, DOI 10.1016/j.vaccine.2008.09.086; Nishiura H, 2009, EUROSURVEILLANCE, V14; Perlroth DJ, 2010, CLIN INFECT DIS, V50, P165, DOI 10.1086/649867; *RAT, 2010, US HIST CONS PRIC IN; Sander B, 2009, VALUE HEALTH, V12, P226, DOI 10.1111/j.1524-4733.2008.00437.x; Sypsa V, 2009, EUROSURVEILLANCE, V14; *THOMS, 2006, PHYS DESK REF 2006 R; Tsuchiya A, 2001, EC EVALUATION HLTH C, P22; *UK DEP HLTH, 2007, PAND FLU FRAM RESP I; *US DEP HHS, 2009, PAND INFL PLAN; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; World Health Organization, 2009, PAND INFL PREP RESP	32	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2011	6	7							e22087	10.1371/journal.pone.0022087	http://dx.doi.org/10.1371/journal.pone.0022087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791IA	21760957	Green Published, Green Submitted, gold			2022-12-25	WOS:000292657200046
J	Junker, H; Venz, S; Zimmermann, U; Thiele, A; Scharf, C; Walther, R				Junker, Heike; Venz, Simone; Zimmermann, Uwe; Thiele, Andrea; Scharf, Christian; Walther, Reinhard			Stage-Related Alterations in Renal Cell Carcinoma - Comprehensive Quantitative Analysis by 2D-DIGE and Protein Network Analysis	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CANDIDATE BIOMARKERS; PROTEOMIC ANALYSIS; PEROXIREDOXIN-III; PROHIBITIN GENE; CANCER-CELLS; EXPRESSION; OVEREXPRESSION; PHOSPHORYLATION; IDENTIFICATION	Renal cell carcinoma accounts for about 3% of adult malignancies and 85% of neoplasms arising from the kidney. To identify potential progression markers for kidney cancer we examined non-neoplastic and neoplastic kidney tissue from three groups of patients, which represent different tumor stages (pT1, pT2, pT3) by a fluorescence two-dimensional difference gel electrophoresis (2D-DIGE) approach combined with MALDI-ToF-MS/MS. Delta2D software package was used for gel image based quantification and statistical analysis. Thereby, a comprehensive Principal Component Analysis (PCA) could be performed and allowed a robust quality control of the experiment as well as a classification of the analyzed samples, which correlated with the predicted stages from the pathological examination. Additionally for selected candidate proteins we detected a correlation to the tumor grading as revealed by immunohistochemistry. On the 2D protein map 176 spots out of 989 were detected as at least 2-fold differentially expressed. These spots were analyzed by MALDI-ToF-MS/MS and 187 different proteins were identified. The functional clustering of the identified proteins revealed ten groups. Within these groups we found 86 enzymes, 63 proteins of unknown function, 14 transporter, 8 peptidases and 7 kinases. From the systems biology approach we could map many of these proteins in major pathways involved in remodelling of cytoskeleton, mitochondrial dysfunctions and changes in lipid metabolism. Due to complexity of the highly interconnected pathway network, further expression and functional validation of these proteins might provide new insights in kidney cancer progression to design novel diagnostic and therapeutic strategies.	[Junker, Heike; Venz, Simone; Walther, Reinhard] Ernst Moritz Arndt Univ Greifswald, Dept Med Biochem & Mol Biol, Greifswald, Germany; [Venz, Simone; Scharf, Christian] Ernst Moritz Arndt Univ Greifswald, Interfacultary Inst Genet & Funct Genom, Greifswald, Germany; [Zimmermann, Uwe] Ernst Moritz Arndt Univ Greifswald, Dept Urol, Greifswald, Germany; [Thiele, Andrea] Ernst Moritz Arndt Univ Greifswald, Dept Pathol, Greifswald, Germany; [Scharf, Christian] Ernst Moritz Arndt Univ Greifswald, Dept Otorhinolaryngol Head & Neck Surg, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Junker, H (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Med Biochem & Mol Biol, Greifswald, Germany.	rwalther@uni-greifswald.de	Scharf, Christian/A-7931-2011	Scharf, Christian/0000-0001-6806-6450				Alessandro Riccardo, 2005, Clin Colorectal Cancer, V4, P396, DOI 10.3816/CCC.2005.n.012; Ande SR, 2009, BBA-MOL CELL RES, V1793, P1372, DOI 10.1016/j.bbamcr.2009.05.008; Ande SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004586; Arai K, 2008, CURR CANCER DRUG TAR, V8, P243, DOI 10.2174/156800908784533445; ASAMOTO M, 1994, CANCER LETT, V83, P201, DOI 10.1016/0304-3835(94)90320-4; Baak JPA, 2003, EUR J CANCER, V39, P1199, DOI 10.1016/S0959-8049(03)00265-X; Balabanov S, 2001, EUR J BIOCHEM, V268, P5977, DOI 10.1046/j.0014-2956.2001.02546.x; BJELLQVIST B, 1982, J BIOCHEM BIOPH METH, V6, P317, DOI 10.1016/0165-022X(82)90013-6; Boer JM, 2001, GENOME RES, V11, P1861, DOI 10.1101/gr.184501; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choi D, 2008, ONCOGENE, V27, P1716, DOI 10.1038/sj.onc.1210806; Choi JH, 2002, ANTICANCER RES, V22, P3331; Chowdhury I, 2007, ENDOCRINOLOGY, V148, P206, DOI 10.1210/en.2006-0187; Craven RA, 2006, PROTEOMICS, V6, P2853, DOI 10.1002/pmic.200500549; Dallmann K, 2004, INT J CANCER, V108, P342, DOI 10.1002/ijc.11459; Eymann C, 2004, PROTEOMICS, V4, P2849, DOI 10.1002/pmic.200400907; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Fusaro G, 2002, ONCOGENE, V21, P4539, DOI 10.1038/sj.onc.1205551; Ghavami S, 2009, EUR J PHARMACOL, V625, P73, DOI 10.1016/j.ejphar.2009.08.044; Gregory-Bass RC, 2008, INT J CANCER, V122, P1923, DOI 10.1002/ijc.23351; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Horsch S, 2004, INT J CLIN PHARM TH, V42, P63; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Immenschuh S, 2005, ANTIOXID REDOX SIGN, V7, P768, DOI 10.1089/ars.2005.7.768; Johann DJ, 2010, ANAL CHEM, V82, P1584, DOI 10.1021/ac902204k; Karihtala P, 2003, CLIN CANCER RES, V9, P3418; Kim DS, 2010, J PROTEOME RES, V9, P3710, DOI 10.1021/pr100236r; Kim HK, 2010, J PROTEOME RES, V9, P4123, DOI 10.1021/pr100302b; Kinnula VL, 2002, J PATHOL, V196, P316, DOI 10.1002/path.1042; Koskimaa HM, 2010, CANCER EPIDEM BIOMAR, V19, P2003, DOI 10.1158/1055-9965.EPI-09-0781; Lichtenfels R, 2009, MOL CELL PROTEOMICS, V8, P2827, DOI 10.1074/mcp.M900168-MCP200; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Manjeshwar S, 2003, CANCER RES, V63, P5251; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; MCCLUNG JK, 1989, BIOCHEM BIOPH RES CO, V164, P1316, DOI 10.1016/0006-291X(89)91813-5; Moch H, 1996, CANCER RES, V56, P27; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Okamura N, 2008, PROTEOMICS, V8, P3194, DOI 10.1002/pmic.200700619; Park JH, 2006, RESPIROLOGY, V11, P269, DOI 10.1111/j.1440-1843.2006.00849.x; Peng XJ, 2006, CANCER RES, V66, P7361, DOI 10.1158/0008-5472.CAN-06-1004; Perroud B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-64; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Sanchez-Quiles V, 2010, PROTEOMICS, V10, P1609, DOI 10.1002/pmic.200900757; Sarto C, 1999, ELECTROPHORESIS, V20, P3458, DOI 10.1002/(SICI)1522-2683(19991101)20:17<3458::AID-ELPS3458>3.3.CO;2-X; Sarto C, 1997, ELECTROPHORESIS, V18, P599, DOI 10.1002/elps.1150180343; Seliger B, 2007, PROTEOMICS, V7, P4601, DOI 10.1002/pmic.200700415; Seliger B, 2009, PROTEOMICS, V9, P1567, DOI 10.1002/pmic.200700288; Seyfried TN, 2008, EPILEPSIA, V49, P114, DOI 10.1111/j.1528-1167.2008.01853.x; Sievers C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012735; Sinz A, 2002, ELECTROPHORESIS, V23, P3445, DOI 10.1002/1522-2683(200210)23:19<3445::AID-ELPS3445>3.0.CO;2-J; Siu KWM, 2009, J PROTEOME RES, V8, P3797, DOI 10.1021/pr800389e; Smallbone K, 2005, J THEOR BIOL, V235, P476, DOI 10.1016/j.jtbi.2005.02.001; Sobin, 2009, UICC TNM CLASSIFICAT; Sonini Y, 2006, APMIS, V114, P329; Stern R, 2002, EXP CELL RES, V276, P24, DOI 10.1006/excr.2002.5508; Sun RC, 2010, BREAST CANCER RES TR, V120, P253, DOI 10.1007/s10549-009-0435-9; Thompson WE, 2003, BIOL REPROD, V69, P254, DOI 10.1095/biolreprod.102.010975; Unwin RD, 2003, PROTEOMICS, V3, P1620, DOI 10.1002/pmic.200300464; Wang S, 1999, ONCOGENE, V18, P3501, DOI 10.1038/sj.onc.1202684; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wilhelm M, 2002, CANCER RES, V62, P957; Wilkins MR, 1996, BIOTECHNOL GENET ENG, V13, P19, DOI 10.1080/02648725.1996.10647923; Wolf G, 2010, J ENDOCRINOL, V207, P163, DOI 10.1677/JOE-09-0455; Xu RH, 2005, CANCER RES, V65, P613; Zhang B, 2009, CANCER LETT, V286, P154, DOI 10.1016/j.canlet.2009.04.043; Zhao LA, 2010, FEBS J, V277, P4195, DOI 10.1111/j.1742-4658.2010.07808.x; Zimmermann U, 2004, CANCER LETT, V209, P111, DOI 10.1016/j.canlet.2003.12.002	68	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21867	10.1371/journal.pone.0021867	http://dx.doi.org/10.1371/journal.pone.0021867			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21760917	Green Published, gold, Green Submitted			2022-12-25	WOS:000292655400023
J	Li, JY; Wang, NA				Li, Jinyun; Wang, Nian			Genome-Wide Mutagenesis of Xanthomonas axonopodis pv. citri Reveals Novel Genetic Determinants and Regulation Mechanisms of Biofilm Formation	PLOS ONE			English	Article							CELL-CELL COMMUNICATION; C-DI-GMP; ESCHERICHIA-COLI; POLYSACCHARIDE PRODUCTION; STAPHYLOCOCCUS-AUREUS; SUBSP CITRI; HD-GYP; CAMPESTRIS; VIRULENCE; PROTEIN	Xanthomonas axonopodis pv. citri (Xac) causes citrus canker disease, a major threat to citrus production worldwide. Accumulating evidence suggests that the formation of biofilms on citrus leaves plays an important role in the epiphytic survival of this pathogen prior to the development of canker disease. However, the process of Xac biofilm formation is poorly understood. Here, we report a genome-scale study of Xac biofilm formation in which we identified 92 genes, including 33 novel genes involved in biofilm formation and 7 previously characterized genes, colR, fhaB, fliC, galU, gumD, wxacO, and rbfC, known to be important for Xac biofilm formation. In addition, 52 other genes with defined or putative functions in biofilm formation were identified, even though they had not previously reported been to be associated with biofilm formation. The 92 genes were isolated from 292 biofilm-defective mutants following a screen of a transposon insertion library containing 22,000 Xac strain 306 mutants. Further analyses indicated that 16 of the novel genes are involved in the production of extracellular polysaccharide (EPS) and/or lipopolysaccharide (LPS), 7 genes are involved in signaling and regulatory pathways, and 5 genes have unknown roles in biofilm formation. Furthermore, two novel genes, XAC0482, encoding a haloacid dehalogenase-like phosphatase, and XAC0494 (designated as rbfS), encoding a two-component sensor protein, were confirmed to be biofilm-related genes through complementation assays. Our data demonstrate that the formation of mature biofilm requires EPS, LPS, both flagellum-dependent and flagellum-independent cell motility, secreted proteins and extracellular DNA. Additionally, multiple signaling pathways are involved in Xac biofilm formation. This work is the first report on a genome-wide scale of the genetic processes of biofilm formation in plant pathogenic bacteria. The report provides significant new information about the genetic determinants and regulatory mechanism of biofilm formation.	[Li, Jinyun; Wang, Nian] Univ Florida, Ctr Citrus Res & Educ, Dept Microbiol & Cell Sci, Lake Alfred, FL USA	State University System of Florida; University of Florida	Li, JY (corresponding author), Univ Florida, Ctr Citrus Res & Educ, Dept Microbiol & Cell Sci, Lake Alfred, FL USA.	nianwang@crec.ifas.ufl.edu	Wang, Nian/HDM-2087-2022	Wang, Nian/0000-0001-7743-0728	United States Department of Agriculture, Cooperative State Research, Education, and Extension Service [88811]	United States Department of Agriculture, Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by the United States Department of Agriculture, Cooperative State Research, Education, and Extension Service, Special Citrus Canker Grant Project 88811 (www.csrees.usda.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria MC, 2005, J BACTERIOL, V187, P2315, DOI 10.1128/JB.187.7.2315-2325.2005; Andrade MO, 2006, MOL MICROBIOL, V62, P537, DOI 10.1111/j.1365-2958.2006.05386.x; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Brown BL, 2011, J BIOL CHEM, V286, P2285, DOI 10.1074/jbc.M110.172643; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Cheng DW, 2010, J PLANT PATHOL, V92, P415; Cubero J, 2002, APPL ENVIRON MICROB, V68, P1257, DOI 10.1128/AEM.68.3.1257-1264.2002; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; DUCEY TF, 2002, EPICENTRE FORUM, V9, P6; Dunger G, 2007, ARCH MICROBIOL, V188, P127, DOI 10.1007/s00203-007-0227-8; El Yacoubi B, 2007, APPL ENVIRON MICROB, V73, P1612, DOI 10.1128/AEM.00261-06; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; GABRIEL D, 2003, J BIOL CHEM, V278, P43728; Gerstmeir R, 2004, J BACTERIOL, V186, P2798, DOI 10.1128/JB.186.9.2798-2809.2004; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; Gottwald T. R., 2002, Plant Health Progress, P1; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Guo YP, 2010, APPL ENVIRON MICROB, V76, P2234, DOI 10.1128/AEM.02897-09; He YW, 2007, MOL MICROBIOL, V64, P281, DOI 10.1111/j.1365-2958.2007.05670.x; He YW, 2009, MOL MICROBIOL, V71, P1464, DOI 10.1111/j.1365-2958.2009.06617.x; He YW, 2006, MOL MICROBIOL, V59, P610, DOI 10.1111/j.1365-2958.2005.04961.x; Hennig S, 2010, J BACTERIOL, V192, P4153, DOI 10.1128/JB.00226-10; Kane SR, 2007, J BACTERIOL, V189, P1931, DOI 10.1128/JB.01259-06; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kube M, 2008, ENVIRON MICROBIOL, V10, P2211, DOI 10.1111/j.1462-2920.2008.01639.x; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Laia ML, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-12; Lau PCY, 2009, J BACTERIOL, V191, P6618, DOI 10.1128/JB.00698-09; Leduc JL, 2009, J BACTERIOL, V191, P7121, DOI 10.1128/JB.00845-09; Li JY, 2011, MOL PLANT PATHOL, V12, P381, DOI 10.1111/j.1364-3703.2010.00681.x; Lu GT, 2009, J BACTERIOL, V191, P3639, DOI 10.1128/JB.00009-09; Mack M, 1997, FEBS LETT, V405, P209, DOI 10.1016/S0014-5793(97)00187-7; Malamud F, 2011, MICROBIOL-SGM, V157, P819, DOI 10.1099/mic.0.044255-0; Marin M, 2010, J BACTERIOL, V192, P1543, DOI 10.1128/JB.01208-09; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Moreira LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-238; Puttamreddy S, 2010, INFECT IMMUN, V78, P2377, DOI 10.1128/IAI.00156-10; Qian W, 2008, MOL PLANT MICROBE IN, V21, P1128, DOI 10.1094/MPMI-21-8-1128; Quoc PHT, 2007, INFECT IMMUN, V75, P1079, DOI 10.1128/IAI.01143-06; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Rigano LA, 2007, MOL PLANT MICROBE IN, V20, P1222, DOI 10.1094/mpmi-20-10-1222; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Rosenshine I, 1996, EMBO J, V15, P2613, DOI 10.1002/j.1460-2075.1996.tb00621.x; Ryan RP, 2010, P NATL ACAD SCI USA, V107, P5989, DOI 10.1073/pnas.0912839107; Rybak M, 2009, MOL PLANT PATHOL, V10, P249, DOI 10.1111/j.1364-3703.2008.00528.x; Salzberg SL, 2008, BMC GENOMICS, DOI 10.1186/1471-2164-9-534; Sambrook J, 2001, MOL CLONING LAB MANU, P633; Schaad Norman W, 2006, Syst Appl Microbiol, V29, P690, DOI 10.1016/j.syapm.2006.08.001; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Spychala J, 1996, P NATL ACAD SCI USA, V93, P1232, DOI 10.1073/pnas.93.3.1232; Stojnev T, 2007, CURR MICROBIOL, V55, P99, DOI 10.1007/s00284-006-0516-5; Sukumaran SK, 2002, J BIOL CHEM, V277, P12253, DOI 10.1074/jbc.M110740200; Tao F, 2010, ENVIRON MICROBIOL, V12, P3159, DOI 10.1111/j.1462-2920.2010.02288.x; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Torres PS, 2007, ENVIRON MICROBIOL, V9, P2101, DOI 10.1111/j.1462-2920.2007.01332.x; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Wang L, 2007, APPL ENVIRON MICROB, V73, P8023, DOI 10.1128/AEM.01414-07; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wu LQ, 2005, APPL ENVIRON MICROB, V71, P1581, DOI 10.1128/AEM.71.3.1581-1590.2005; Yamashita Y, 1998, J BACTERIOL, V180, P5803, DOI 10.1128/JB.180.21.5803-5807.1998; Yan Q, 2011, J BACTERIOL, V193, P1590, DOI 10.1128/JB.01415-10	68	58	60	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21804	10.1371/journal.pone.0021804	http://dx.doi.org/10.1371/journal.pone.0021804			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750733	gold, Green Published, Green Submitted			2022-12-25	WOS:000292512000025
J	Kim, HK; Kim, HY; Schneewind, O; Missiakas, D				Kim, Hwan Keun; Kim, Hye-Young; Schneewind, Olaf; Missiakas, Dominique			Identifying protective antigens of Staphylococcus aureus, a pathogen that suppresses host immune responses	FASEB JOURNAL			English	Article						genetic vaccinology; protein A; sortase A; clumping factor; fibrinogen-binding protein; SdrD	SURFACE-PROTEINS; VACCINE; SORTASE; MUTANT; TUBERCULOSIS; INFECTIONS; RESISTANCE; DELETION; ANCHORS; MICE	Staphylococcus aureus infections result in abscesses as well as septicemia. Even with therapy, abscesses can persist or even reoccur, as staphylococcal infections fail to induce protective immune responses. Here, we show that prior infection with certain attenuated strains may elicit protective immunity. A closer examination reveals that protection correlates with antibody responses elicited on exposure to particular attenuated variants. Linear regression analysis was used to compare reduction in staphylococcal disease and antibody responses to infection with wild-type and attenuated variants. This analysis identified protective antigens that, when tested as vaccines in mice, elicited disease protection. Protection afforded by attenuated strains correlates in part with the ability of Staphylococcus aureus to modulate B cell responses via protein A (spa encoded). We designate this approach "genetic vaccinology," since it exploits genetic variants to draw a correlation between disease protection and humoral immune responses for the deduction of vaccine antigens. Genetic vaccinology is particularly useful for microbes that do not elicit natural protective immunity during infection.-Kim, H. K., Kim, H.-Y., Schneewind, O., Missiakas, D. Identifying protective antigens of Staphylococcus aureus, a pathogen that suppresses host immune responses. FASEB J. 25, 3605-3612 (2011). www.fasebj.org	[Kim, Hwan Keun; Kim, Hye-Young; Schneewind, Olaf; Missiakas, Dominique] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University of Chicago	Missiakas, D (corresponding author), Univ Chicago, Dept Microbiol, 920 E 58th St, Chicago, IL 60637 USA.	dmissiak@bsd.uchicago.edu		Kim, Hwan Keun/0000-0003-2095-9705	U.S. National Institute of Allergy and Infectious Diseases (NIAID), Infectious Diseases Branch [AI52747, AI92711, AI75258]; Region V Great Lakes Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (National Institutes of Health) [1-U54-AI-057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI075258, RC4AI092711, R41AI052747] Funding Source: NIH RePORTER	U.S. National Institute of Allergy and Infectious Diseases (NIAID), Infectious Diseases Branch(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Region V Great Lakes Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank members of their laboratory for experimental assistance and critical discussion. This work was supported by grants from the U.S. National Institute of Allergy and Infectious Diseases (NIAID), Infectious Diseases Branch (AI52747 and AI92711 to O.S. and AI75258 to D. M.). D.M. and O.S. acknowledge membership within and support from the Region V Great Lakes Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (National Institutes of Health award 1-U54-AI-057153).	Adhikari RP, 2008, MICROBIOL-SGM, V154, P949, DOI 10.1099/mic.0.2007/012245-0; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Behring EV., 1890, DEUT MED WOCHENSCHR, V49, P1113; Bordet J, 1923, BMJ-BRIT MED J, V1923, P175; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Fattom A, 2004, VACCINE, V23, P656, DOI 10.1016/j.vaccine.2004.06.043; Fitzgerald JR, 2006, MOL MICROBIOL, V59, P212, DOI 10.1111/j.1365-2958.2005.04922.x; FORSGREN A, 1968, J IMMUNOL, V100, P927; FORSGREN A, 1976, EUR J IMMUNOL, V6, P207, DOI 10.1002/eji.1830060312; Goodyear CS, 2004, P NATL ACAD SCI USA, V101, P11392, DOI 10.1073/pnas.0404382101; Goodyear CS, 2003, J EXP MED, V197, P1125, DOI 10.1084/jem.20020552; JENSEN KLAUS, 1958, ACTA PATHOL ET MICROBIOL SCAND, V44, P421; Kernodle DS, 2010, CLIN INFECT DIS, V51, P177, DOI 10.1086/653533; Kim HK, 2010, J EXP MED, V207, P1863, DOI 10.1084/jem.20092514; Kim HK, 2010, VACCINE, V28, P6382, DOI 10.1016/j.vaccine.2010.02.097; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; LANCEFIELD RC, 1962, J IMMUNOL, V89, P307; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523; Menzies BE, 1996, INFECT IMMUN, V64, P1839, DOI 10.1128/IAI.64.5.1839-1841.1996; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Projan SJ, 2006, CURR OPIN PHARMACOL, V6, P473, DOI 10.1016/j.coph.2006.04.005; Rampone H, 1996, CAN J VET RES, V60, P237; Rogers D. E., 1965, ANN NY ACAD SCI, V128, P45; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Silverman GJ, 2006, NAT REV IMMUNOL, V6, P465, DOI 10.1038/nri1853; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Smith T, 1907, J MED RES, V16, P359; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Thammavongsa V, 2009, J EXP MED, V206, P2417, DOI 10.1084/jem.20090097; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208	42	55	58	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3605	3612		10.1096/fj.11-187963	http://dx.doi.org/10.1096/fj.11-187963			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21753082	Green Published			2022-12-25	WOS:000295356400030
J	Cho, SH; Sun, BG; Zhou, YG; Kauppinen, TM; Halabisky, B; Wes, P; Ransohoff, RM; Gan, L				Cho, Seo-Hyun; Sun, Binggui; Zhou, Yungui; Kauppinen, Tiina M.; Halabisky, Brian; Wes, Paul; Ransohoff, Richard M.; Gan, Li			CX3CR1 Protein Signaling Modulates Microglial Activation and Protects against Plaque-independent Cognitive Deficits in a Mouse Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRACTALKINE RECEPTOR CX(3)CR1; AMYLOID-BETA-PEPTIDE; CHEMOKINE RECEPTORS; RECOGNITION MEMORY; TRANSGENIC MICE; DENTATE GYRUS; SYNAPSE LOSS; INTERLEUKIN-6; INFLAMMATION; DEPOSITION	Aberrant microglial activation has been proposed to contribute to the cognitive decline in Alzheimer disease (AD), but the underlying molecular mechanisms remain enigmatic. Fractalkine signaling, a pathway mediating the communication between microglia and neurons, is deficient in AD brains and down-regulated by amyloid-beta. Although fractalkine receptor (CX3CR1) on microglia was found to regulate plaque load, no functional effects have been reported. Our study demonstrates that CX3CR1 deficiency worsens the AD-related neuronal and behavioral deficits. The effects were associated with cytokine production but not with plaque deposition. Ablation of CX3CR1 in mice overexpressing human amyloid precursor protein enhanced Tau pathology and exacerbated the depletion of calbindin in the dentate gyrus. The levels of calbindin in the dentate gyrus correlated negatively with those of tumor necrosis factor alpha and interleukin 6, suggesting neurotoxic effects of inflammatory factors. Functionally, removing CX3CR1 in human amyloid precursor protein mice worsened the memory retention in passive avoidance and novel object recognition tests, and their memory loss in the novel object recognition test is associated with high levels of interleukin 6. Our findings identify CX3CR1 as a key microglial pathway in protecting against AD-related cognitive deficits that are associated with aberrant microglial activation and elevated inflammatory cytokines.	[Cho, Seo-Hyun; Sun, Binggui; Zhou, Yungui; Halabisky, Brian; Gan, Li] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Cho, Seo-Hyun; Sun, Binggui; Kauppinen, Tiina M.; Halabisky, Brian; Gan, Li] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Wes, Paul] Bristol Myers Squibb Co, Wallingford, CT 06492 USA; [Ransohoff, Richard M.] Cleveland Clin Fdn, Lerner Res Inst, Neuroinflammat Res Ctr, Cleveland, OH 44195 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Bristol-Myers Squibb; Cleveland Clinic Foundation	Gan, L (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	lgan@gladstone.ucsf.edu	Kauppinen, Tiina/I-1009-2019; Sun, Binggui/J-9028-2016	Sun, Binggui/0000-0002-0386-6569; Kauppinen, Tiina/0000-0001-7219-9862; Wes, Paul/0000-0002-8903-3102	National Institute on Aging [1R01AG030207]; Consortium for Frontotemporal Dementia Research; S. D. Bechtel Jr. Foundation; National Institutes of Health [NCRR CO6 RRO18928]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030207] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Consortium for Frontotemporal Dementia Research; S. D. Bechtel Jr. Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by grants from National Institute on Aging 1R01AG030207, Consortium for Frontotemporal Dementia Research, and S. D. Bechtel Jr. Foundation (to L. G.).; We thank Drs. Lennart Mucke and Israel Charo for insightful discussions, Dr. Nino Devidze and the Gladstone/University of California, San Francisco (UCSF) Behavioral Core to help with behavioral analyses, Dr. Dan Littman from New York University for CX3CR1 null mice, Kaitlyn Ho for advice on measuring A beta dimers, Dr. Katerina Mancevska from New York Brain Bank at Columbia University, Dr. Yong Shen from Sun Health Institute (now Banner Health), Dr. Eliezer Masliah from UCSD for human brain samples, Gary Howard for editorial review, and Kelley Nelson for administrative assistance. The J. David Gladstone Institutes were supported by National Institutes of Health Grant NCRR CO6 RRO18928.	Balschun D, 2004, FASEB J, V18, P1788, DOI 10.1096/fj.04-1625fje; BELLINGER FP, 1995, NEUROSCI LETT, V198, P95, DOI 10.1016/0304-3940(95)11976-4; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Clark AK, 2009, J NEUROSCI, V29, P6945, DOI 10.1523/JNEUROSCI.0828-09.2009; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799; Dong S, 1997, GLYCOCONJUGATE J, V14, P267, DOI 10.1023/A:1018554124545; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kim HC, 2003, NEUROSCIENCE, V119, P399, DOI 10.1016/S0306-4522(02)00993-4; Kitazawa M, 2004, ANN NY ACAD SCI, V1035, P85, DOI 10.1196/annals.1332.006; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Limatola C, 2005, J NEUROIMMUNOL, V166, P19, DOI 10.1016/j.jneuroim.2005.03.023; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McGeer PL, 2006, J ALZHEIMERS DIS, V9, P271; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Pittenger C, 2006, J NEUROSCI, V26, P2808, DOI 10.1523/JNEUROSCI.5406-05.2006; Potter MC, 2010, NEUROPSYCHOPHARMACOL, V35, P1734, DOI 10.1038/npp.2010.39; Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rogers J, 1996, NEUROBIOL AGING, V17, P681, DOI 10.1016/0197-4580(96)00115-7; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Sparkman NL, 2006, J NEUROSCI, V26, P10709, DOI 10.1523/JNEUROSCI.3376-06.2006; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tsou CL, 2001, J BIOL CHEM, V276, P44622, DOI 10.1074/jbc.M107327200; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V	49	180	185	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32713	32722		10.1074/jbc.M111.254268	http://dx.doi.org/10.1074/jbc.M111.254268			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21771791	hybrid, Green Published			2022-12-25	WOS:000294726800080
J	Hammel, M; Rey, M; Yu, YP; Mani, RS; Classen, S; Liu, M; Pique, ME; Fang, SJ; Mahaney, BL; Weinfeld, M; Schriemer, DC; Lees-Miller, SP; Tainer, JA				Hammel, Michal; Rey, Martial; Yu, Yaping; Mani, Rajam S.; Classen, Scott; Liu, Mona; Pique, Michael E.; Fang, Shujuan; Mahaney, Brandi L.; Weinfeld, Michael; Schriemer, David C.; Lees-Miller, Susan P.; Tainer, John A.			XRCC4 Protein Interactions with XRCC4-like Factor (XLF) Create an Extended Grooved Scaffold for DNA Ligation and Double Strand Break Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END-JOINING FACTOR; CRYSTAL-STRUCTURE; LIGASE-IV; STRUCTURAL-ANALYSES; PROMOTES; REVEALS; BASE; KU; XLF/CERNUNNOS; COMPUTATION	The XRCC4-like factor (XLF)-XRCC4 complex is essential for nonhomologous end joining, the major repair pathway for DNA double strand breaks in human cells. Yet, how XLF binds XRCC4 and impacts nonhomologous end joining functions has been enigmatic. Here, we report the XLF-XRCC4 complex crystal structure in combination with biophysical and mutational analyses to define the XLF-XRCC4 interactions. Crystal and solution structures plus mutations characterize alternating XRCC4 and XLF head domain interfaces forming parallel superhelical filaments. XLF Leu-115 ("Leu-lock") inserts into a hydrophobic pocket formed by XRCC4 Met-59, Met-61, Lys-65, Lys-99, Phe-106, and Leu-108 in synergy with pseudo-symmetric beta-zipper hydrogen bonds to drive specificity. XLF C terminus and DNA enhance parallel filament formation. Super-helical XLF-XRCC4 filaments form a positively charged channel to bind DNA and align ends for efficient ligation. Collective results reveal how human XLF and XRCC4 interact to bind DNA, suggest consequences of patient mutations, and support a unified molecular mechanism for XLF-XRCC4 stimulation of DNA ligation.	[Hammel, Michal; Classen, Scott; Liu, Mona] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Rey, Martial; Yu, Yaping; Fang, Shujuan; Mahaney, Brandi L.; Schriemer, David C.; Lees-Miller, Susan P.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Rey, Martial; Yu, Yaping; Fang, Shujuan; Mahaney, Brandi L.; Schriemer, David C.; Lees-Miller, Susan P.] Univ Calgary, So Alberta Canc Res Inst, Calgary, AB T2N 4N1, Canada; [Mani, Rajam S.; Weinfeld, Michael] Univ Alberta, Dept Oncol, Edmonton, AB T6G IZ2, Canada; [Mani, Rajam S.; Weinfeld, Michael] Cross Canc Inst, Edmonton, AB T6G IZ2, Canada; [Pique, Michael E.; Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Mol Biol, La Jolla, CA 92037 USA; [Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Calgary; University of Calgary; University of Alberta; University of Alberta; Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hammel, M (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	mhammel@lbl.gov; leesmill@ucalgary.ca; JATainer@LBL.gov	Tainer, John/GWQ-4878-2022; Classen, Scott/AAY-8176-2020	Tainer, John/0000-0003-1659-2429; Lees-Miller, Susan/0000-0001-5809-2516; Hammel, Michal/0000-0002-5610-9289	National Institutes of Health [P01 CA92584]; Canadian Institutes of Health Research [69139]; Alberta Cancer Foundation [23817]; United States Department of Energy [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation; United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 CA92584 (Structural Cell Biology of DNA Repair Machines) (to J. A. T. and S. P. L.-M.). This work was also supported by Grant 69139 from the Canadian Institutes of Health Research and Grant 23817 from Alberta Cancer Foundation (to S. P. L.-M. and M. W.).; We thank the Berkeley Laboratory Advanced Light Source, SIBYLS beamline (BL 12.3.1) staff; Dr. Robert Rambo for helpful advice; Dr. Aaron Goodarzi for comments on the manuscript; James Holton and George Meigs at beamline 8.3.1 for aiding SAXS and PX data collection; and Wayne Moffat (Department of Chemistry, University of Alberta) for CD analysis. SIBYLS beamline efforts to combine SAXS and crystallography at the Advanced Light Source of Lawrence Berkeley National Laboratory are supported in part by United States Department of Energy Program Integrated Diffraction Analysis Technologies under Contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Andres SN, 2007, MOL CELL, V28, P1093, DOI 10.1016/j.molcel.2007.10.024; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Classen S, 2010, J SYNCHROTRON RADIAT, V17, P774, DOI 10.1107/S0909049510028566; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; Dobbs TA, 2010, DNA REPAIR, V9, P1307, DOI 10.1016/j.dnarep.2010.09.019; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Guinier A., 1955, SMALL ANGLE SCATTERI; Hammel M, 2010, STRUCTURE, V18, P1431, DOI 10.1016/j.str.2010.09.009; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; Hentges P, 2006, J BIOL CHEM, V281, P37517, DOI 10.1074/jbc.M608727200; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Li Y, 2008, EMBO J, V27, P290, DOI 10.1038/sj.emboj.7601942; Lieber MR, 2010, NAT STRUCT MOL BIOL, V17, P393, DOI 10.1038/nsmb0410-393; Lu HH, 2007, J BIOL CHEM, V282, P11155, DOI 10.1074/jbc.M609904200; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Malivert L, 2010, J BIOL CHEM, V285, P26475, DOI 10.1074/jbc.M110.138156; Malivert L, 2009, MOL CELL BIOL, V29, P1116, DOI 10.1128/MCB.01521-08; Mani RS, 2010, J BIOL CHEM, V285, P37619, DOI 10.1074/jbc.M109.058719; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park EJ, 2003, NUCLEIC ACIDS RES, V31, P6819, DOI 10.1093/nar/gkg921; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Prudden J, 2009, NAT STRUCT MOL BIOL, V16, P509, DOI 10.1038/nsmb.1582; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2010, CURR OPIN STRUC BIOL, V20, P128, DOI 10.1016/j.sbi.2009.12.015; Rambo RP, 2010, RNA, V16, P638, DOI 10.1261/rna.1946310; Riballo E, 2009, NUCLEIC ACIDS RES, V37, P482, DOI 10.1093/nar/gkn957; Roberts SA, 2007, J BIOL CHEM, V282, P10605, DOI 10.1074/jbc.M611125200; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tsai AG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S1; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Tubbs JL, 2009, NATURE, V459, P808, DOI 10.1038/nature08076; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wu PY, 2009, MOL CELL BIOL, V29, P3163, DOI 10.1128/MCB.01895-08; Yano K, 2008, CELL CYCLE, V7, P1321, DOI 10.4161/cc.7.10.5898; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137; Yano K, 2011, FEBS LETT, V585, P841, DOI 10.1016/j.febslet.2011.02.020; Yu YP, 2008, DNA REPAIR, V7, P1680, DOI 10.1016/j.dnarep.2008.06.015	51	123	127	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32638	32650		10.1074/jbc.M111.272641	http://dx.doi.org/10.1074/jbc.M111.272641			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21775435	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000294726800073
J	Rauen, T; Benedyk, K; Juang, YT; Kerkhoff, C; Kyttaris, VC; Roth, J; Tsokos, GC; Tenbrock, K				Rauen, Thomas; Benedyk, Konrad; Juang, Yuang-Taung; Kerkhoff, Claus; Kyttaris, Vasileios C.; Roth, Johannes; Tsokos, George C.; Tenbrock, Klaus			A Novel Intronic cAMP Response Element Modulator (CREM) Promoter Is Regulated by Activator Protein-1 (AP-1) and Accounts for Altered Activation-induced CREM Expression in T Cells from Patients with Systemic Lupus Erythematosus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; CYCLIC-AMP; MESSENGER-RNA; IL-2 PROMOTER; BINDING; GENE; ISOFORMS; SITE; FOS	The transcriptional repressor cAMP response element modulator (CREM) alpha has important roles in normal T cell physiology and contributes to aberrant T cell function in patients with systemic lupus erythematosus (SLE). Recently, we characterized a specificity protein-1-dependent promoter located upstream of the CREM gene that accounts for increased basal CREM expression in SLE T cells and reflects disease activity. Here, we identify a novel intronic CREM promoter (denoted P2) in front of the second exon of the CREM gene that harbors putative binding sites for TATA-binding proteins and the transcriptional activator AP-1. DNA binding studies, chromatin immunoprecipitation, and reporter assays confirmed the functional relevance of these sites, and T cell activation through CD3/CD28 stimulation or phorbol 12-myristate 13-acetate/ionomycin treatment enhances P2 promoter activity. Although the basal CREM levels are increased in T cells from SLE patients compared with healthy controls, there are remarkable differences in the regulation of CREM expression in response to T cell activation. Whereas T cells from healthy individuals display increased CREM expression after T cell activation, most likely through AP-1-dependent up-regulation of the P2 promoter, SLE T cells fail to further increase their basal CREM levels upon T cell activation due to a decreased content of the AP-1 family member c-Fos. Because CREM trans-represses c-fos transcription in SLE T cells, we propose an autoregulatory feedback mechanism between CREM and AP-1. Our findings extend the understanding of CREM gene regulation in the context of T cell activation and disclose another difference in the transcriptional machinery in SLE T cells.	[Tenbrock, Klaus] Rhein Westfal TH Aachen, Dept Pediat, Div Allergol & Immunol, D-52074 Aachen, Germany; [Rauen, Thomas; Juang, Yuang-Taung; Kyttaris, Vasileios C.; Tsokos, George C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol,Dept Med, Boston, MA 02115 USA; [Rauen, Thomas] Rhein Westfal TH Aachen, Dept Nephrol & Clin Immunol, D-52074 Aachen, Germany; [Benedyk, Konrad; Kerkhoff, Claus; Roth, Johannes; Tenbrock, Klaus] Univ Munster, Inst Immunol, D-48149 Munster, Germany; [Benedyk, Konrad; Tenbrock, Klaus] Univ Munster, Interdisciplinary Ctr Clin Res IZKF Res Grp 5, D-48149 Munster, Germany	RWTH Aachen University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; RWTH Aachen University; University of Munster; University of Munster	Tenbrock, K (corresponding author), Rhein Westfal TH Aachen, Dept Pediat, Div Allergol & Immunol, D-52074 Aachen, Germany.	ktenbrock@ukaachen.de	tsokos, george C/O-3360-2013	tsokos, george C/0000-0001-9589-2360	Interdisciplinary Center for Clinical Research (IZKF) Munster Research Group 5; Deutsche Forschungsgemeinschaft [RA1927-1/1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR055672] Funding Source: NIH RePORTER	Interdisciplinary Center for Clinical Research (IZKF) Munster Research Group 5; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a grant from the Interdisciplinary Center for Clinical Research (IZKF) Munster Research Group 5 (to K.T.) and Deutsche Forschungsgemeinschaft Grant RA1927-1/1 (to T.R.).	Ahlmann M, 2009, J IMMUNOL, V182, P4167, DOI 10.4049/jimmunol.0802976; Bodor J, 2001, J LEUKOCYTE BIOL, V69, P1053; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Crispin JC, 2009, AUTOIMMUN REV, V8, P190, DOI 10.1016/j.autrev.2008.07.042; Daniel PB, 2000, ENDOCRINOLOGY, V141, P3923, DOI 10.1210/en.141.11.3923; DELMAS V, 1992, P NATL ACAD SCI USA, V89, P4226, DOI 10.1073/pnas.89.10.4226; Fimia GM, 2001, MOL CELL ENDOCRINOL, V179, P17, DOI 10.1016/S0303-7207(01)00463-4; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; Foulkes NS, 1996, NATURE, V381, P83, DOI 10.1038/381083a0; FUJIMOTO T, 1994, J BIOCHEM-TOKYO, V115, P298, DOI 10.1093/oxfordjournals.jbchem.a124332; Grassl C, 1999, J AM SOC NEPHROL, V10, P1466; Halder SK, 2002, MOL ENDOCRINOL, V16, P1853, DOI 10.1210/me.2001-0262; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; JAIN J, 1992, J IMMUNOL, V148, P1240; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Juang YT, 2005, J CLIN INVEST, V115, P996, DOI 10.1172/JCI22854; Juang YT, 2011, J BIOL CHEM, V286, P1795, DOI 10.1074/jbc.M110.166785; Jung SH, 2006, INT J CANCER, V118, P490, DOI 10.1002/ijc.21356; Kyttaris VC, 2006, LUPUS, V15, P840, DOI 10.1177/0961203306069985; Kyttaris VC, 2004, J IMMUNOL, V173, P3557, DOI 10.4049/jimmunol.173.5.3557; Lacroix I, 2002, J BIOL CHEM, V277, P9598, DOI 10.1074/jbc.M111444200; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Powell JD, 1999, J IMMUNOL, V163, P6631; Ragheb JA, 1999, J IMMUNOL, V163, P120; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Solomou EE, 2001, J IMMUNOL, V166, P4216, DOI 10.4049/jimmunol.166.6.4216; Tenbrock K, 2005, J IMMUNOL, V175, P5975, DOI 10.4049/jimmunol.175.9.5975; Tenbrock K, 2004, INT REV IMMUNOL, V23, P333, DOI 10.1080/08830180490452558; Tenbrock K, 2002, J IMMUNOL, V169, P4147, DOI 10.4049/jimmunol.169.8.4147; Tsokos GC, 2000, CURR OPIN RHEUMATOL, V12, P355, DOI 10.1097/00002281-200009000-00001	32	20	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32366	32372		10.1074/jbc.M111.245811	http://dx.doi.org/10.1074/jbc.M111.245811			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21757709	Green Published, hybrid			2022-12-25	WOS:000294726800046
J	Holla, VR; Wu, H; Shi, Q; Menter, DG; DuBois, RN				Holla, Vijaykumar R.; Wu, Hong; Shi, Qiong; Menter, David G.; DuBois, Raymond N.			Nuclear Orphan Receptor NR4A2 Modulates Fatty Acid Oxidation Pathways in Colorectal Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; NGFI-B; METABOLISM; GROWTH; CELLS; ACTIVATION; NURR1	Although cancer cells have traditionally been thought to rely on the glycolytic pathway to generate ATP, recent studies suggest that cancer cells can shift to the fatty acid oxidation pathway as an alternative energy source. All of the factors that induce and regulate this adaptive shift in metabolism are not known. Cyclooxygenase-2-derived prostaglandin E-2 (PGE(2)) is produced at high levels in colon cancer, and multiple lines of evidence from human-, animal-, and cell line-based studies indicate that PGE(2) plays a pro-oncogenic role in colorectal cancer progression. We have shown previously that exposure of colon cancer cells to PGE(2) promotes cell survival, in part by inducing the expression of the nuclear orphan receptor NR4A2. Here, we report that PGE(2)-induced NR4A2 increased fatty acid oxidation by inducing the expression of multiple proteins in the fatty acid oxidation pathway. NR4A2 was found to bind directly to Nur77-binding response elements located within the regulatory region of these genes. Nur77-binding response element binding also resulted in the recruitment of transcriptional coactivators and induction of gene expression. Collectively, our findings suggest that NR4A2 plays a key role as a transcriptional integration point between the eicosanoid and fatty acid metabolic pathways. Thus, PGE(2) is a potential regulator of the adaptive shift to energy utilization via fatty acid oxidation that has been observed in several types of cancer.	[DuBois, Raymond N.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Unit 1492, Houston, TX 77030 USA; [DuBois, Raymond N.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Shi, Qiong] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University	DuBois, RN (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Unit 1492, 1515 Holcombe Blvd, Houston, TX 77030 USA.	rdubois@mdanderson.org	DuBois, Raymond N./AAX-8869-2020		NCI [5R01 DK062112]; National Colorectal Cancer Research Alliance; Ellen F. Knisley Distinguished Chair in Colon Cancer; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062112] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Colorectal Cancer Research Alliance; Ellen F. Knisley Distinguished Chair in Colon Cancer; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01 DK062112 from NCI. This work was also supported the National Colorectal Cancer Research Alliance and the Ellen F. Knisley Distinguished Chair in Colon Cancer (to R. N. D.).	Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Gupta RA, 2004, NAT MED, V10, P245, DOI 10.1038/nm993; Holla VR, 2006, J BIOL CHEM, V281, P2676, DOI 10.1074/jbc.M507752200; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; Khasawneh J, 2009, P NATL ACAD SCI USA, V106, P3354, DOI 10.1073/pnas.0802864106; Luo B, 2007, J BIOL CHEM, V282, P7172, DOI 10.1074/jbc.M607362200; Luo J, 2002, CANCER RES, V62, P2220; Maxwell MA, 2005, J BIOL CHEM, V280, P12573, DOI 10.1074/jbc.M409580200; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Sacchetti P, 2006, NUCLEIC ACIDS RES, V34, P5515, DOI 10.1093/nar/gkl712; Wang F, 2009, METABOLISM, V58, P1131, DOI 10.1016/j.metabol.2009.03.027; WARBURG O, 1956, SCIENCE, V124, P269; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Zagani R, 2009, GASTROENTEROLOGY, V137, P1358, DOI 10.1053/j.gastro.2009.06.039; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656; Zha S, 2005, PROSTATE, V63, P316, DOI 10.1002/pros.20177	21	34	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30003	30009		10.1074/jbc.M110.184697	http://dx.doi.org/10.1074/jbc.M110.184697			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21757690	Green Published, hybrid			2022-12-25	WOS:000294046600059
J	Dong, SM; Yu, D; Cui, LK; Qutob, D; Tedman-Jones, J; Kale, SD; Tyler, BM; Wang, YC; Gijzen, M				Dong, Suomeng; Yu, Dan; Cui, Linkai; Qutob, Dinah; Tedman-Jones, Jennifer; Kale, Shiv D.; Tyler, Brett M.; Wang, Yuanchao; Gijzen, Mark			Sequence Variants of the Phytophthora sojae RXLR Effector Avr3a/5 Are Differentially Recognized by Rps3a and Rps5 in Soybean	PLOS ONE			English	Article							AVIRULENCE GENES; DISEASE RESISTANCE; PATHOGEN; EXPRESSION; PROTEIN; AVR4; ARABIDOPSIS; INHERITANCE; ENCODES; LINKAGE	The perception of Phytophthora sojae avirulence (Avr) gene products by corresponding soybean resistance (Rps) gene products causes effector triggered immunity. Past studies have shown that the Avr3a and Avr5 genes of P. sojae are genetically linked, and the Avr3a gene encoding a secreted RXLR effector protein was recently identified. We now provide evidence that Avr3a and Avr5 are allelic. Genetic mapping data from F-2 progeny indicates that Avr3a and Avr5 co-segregate, and haplotype analysis of P. sojae strain collections reveal sequence and transcriptional polymorphisms that are consistent with a single genetic locus encoding Avr3a/5. Transformation of P. sojae and transient expression in soybean were performed to test how Avr3a/5 alleles interact with soybean Rps3a and Rps5. Over-expression of Avr3a/5 in a P. sojae strain that is normally virulent on Rps3a and Rps5 results in avirulence to Rps3a and Rps5; whereas silencing of Avr3a/5 causes gain of virulence in a P. sojae strain that is normally avirulent on Rps3a and Rps5 soybean lines. Transient expression and co-bombardment with a reporter gene confirms that Avr3a/5 triggers cell death in Rps5 soybean leaves in an appropriate allele-specific manner. Sequence analysis of the Avr3a/5 gene identifies crucial residues in the effector domain that distinguish recognition by Rps3a and Rps5.	[Dong, Suomeng; Yu, Dan; Qutob, Dinah; Tedman-Jones, Jennifer; Gijzen, Mark] Agr & Agri Food Canada, London, ON, Canada; [Dong, Suomeng; Yu, Dan; Cui, Linkai; Wang, Yuanchao] Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Peoples R China; [Kale, Shiv D.; Tyler, Brett M.] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA	Agriculture & Agri Food Canada; Nanjing Agricultural University; Virginia Polytechnic Institute & State University	Dong, SM (corresponding author), Agr & Agri Food Canada, London, ON, Canada.	mark.gijzen@agr.gc.ca	Gijzen, Mark/C-6284-2011; wang, yuanchao/G-9667-2011	Gijzen, Mark/0000-0002-3715-6389; wang, yuanchao/0000-0001-5803-5343	Agriculture and Agri-Food Canada (AAFC) Crop Genomics Initiative; National Natural Science Foundation of China [30900932]; Agriculture and Food Research Initiative of the USDA National Institute for Food and Agriculture [2007-35600-18530, 2007-35319-18100]; US National Science Foundation (NSF) [MCB-0731969, IOS-0924861]; China Scholarship Council; NSF	Agriculture and Agri-Food Canada (AAFC) Crop Genomics Initiative(Agriculture & Agri Food Canada); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture and Food Research Initiative of the USDA National Institute for Food and Agriculture; US National Science Foundation (NSF)(National Science Foundation (NSF)); China Scholarship Council(China Scholarship Council); NSF(National Science Foundation (NSF))	This work was supported by grants to MG from the Agriculture and Agri-Food Canada (AAFC) Crop Genomics Initiative; to SD from the National Natural Science Foundation of China (30900932); and to BMT from the Agriculture and Food Research Initiative of the USDA National Institute for Food and Agriculture, grant numbers 2007-35600-18530 and 2007-35319-18100, and from the US National Science Foundation (NSF), grant numbers MCB-0731969 and IOS-0924861. SD and DY were supported at AAFC by the China Scholarship Council. SDK was supported by an NSF pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bailey K, 2011, MOL PLANT M IN PRESS; Cui LK, 2010, PLANT DIS, V94, P881, DOI 10.1094/PDIS-94-7-0881; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dong SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005556; Dorrance AE, 2003, PLANT DIS, V87, P139, DOI 10.1094/PDIS.2003.87.2.139; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Dou DL, 2010, MOL PLANT MICROBE IN, V23, P425, DOI 10.1094/MPMI-23-4-0425; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Gijzen M, 1996, CAN J BOT, V74, P800, DOI 10.1139/b96-100; Gijzen M., 2008, OOMYCETE GENETICS GE, P303, DOI [10.1002/9780470475898.ch15, DOI 10.1002/9780470475898.CH15]; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hua CL, 2008, EUKARYOT CELL, V7, P2133, DOI 10.1128/EC.00286-08; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; JUDELSON HS, 1991, MOL PLANT MICROBE IN, V4, P602, DOI 10.1094/MPMI-4-602; Kaitany RC, 2001, PLANT DIS, V85, P1103, DOI 10.1094/PDIS.2001.85.10.1103; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; May KJ, 2002, FUNGAL GENET BIOL, V37, P1, DOI 10.1016/S1087-1845(02)00027-0; Moy P, 2004, MOL PLANT MICROBE IN, V17, P1051, DOI 10.1094/MPMI.2004.17.10.1051; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Qutob D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005066; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; TYLER BM, 1995, MOL PLANT MICROBE IN, V8, P515, DOI 10.1094/MPMI-8-0515; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; WHISSON SC, 1994, CURR GENET, V27, P77, DOI 10.1007/BF00326582; Whisson SC, 1995, MOL PLANT MICROBE IN, V8, P988, DOI 10.1094/MPMI-8-0988; Whisson SC, 2004, FUNGAL GENET BIOL, V41, P62, DOI 10.1016/j.fgb.2003.08.007; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203	36	46	51	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e20172	10.1371/journal.pone.0020172	http://dx.doi.org/10.1371/journal.pone.0020172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779316	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811300002
J	Randazzo, J; Zhang, ZF; Hoff, M; Kawada, H; Sachs, A; Yuan, Y; Haider, N; Kador, P				Randazzo, James; Zhang, Zifeng; Hoff, Michael; Kawada, Hiroyoshi; Sachs, Andrew; Yuan, Yang; Haider, Neena; Kador, Peter			Orally Active Multi-Functional Antioxidants Are Neuroprotective in a Rat Model of Light-Induced Retinal Damage	PLOS ONE			English	Article							TERT-BUTYLNITRONE PROTECTS; PIGMENT EPITHELIAL-CELLS; ROD OUTER SEGMENTS; LIPID-PEROXIDATION; MACULAR DEGENERATION; OXIDATIVE STRESS; VISUAL IMPAIRMENT; PHOTIC INJURY; INDUCTION; IRON	Background: Progression of age-related macular degeneration has been linked to iron dysregulation and oxidative stress that induce apoptosis of neural retinal cells. Since both antioxidants and chelating agents have been reported to reduce the progression of retinal lesions associated with AMD in experimental animals, the present study evaluates the ability of multi-functional antioxidants containing functional groups that can independently chelate redox metals and quench free radicals to protect the retina against light-induced retinal degeneration, a rat model of dry atrophic AMD. Methods/Results: Proof of concept studies were conducted to evaluate the ability of 4-(5-hydroxypyrimidin-2-yl)-N,N-dimethyl-3,5-dioxopiperazine-1-sulfonamide (compound 4) and 4-(5-hydroxy-4,6-dimethoxypyrimidin-2-yl)-N,N-dimethyl-3,5-dioxopiperazine-1-sulfonamide (compound 8) to reduce retinal damage in 2-week dark adapted Wistar rats exposed to 1000 lx of light for 3 hours. Assessment of the oxidative stress markers 4- hydroxynonenal and nitrotyrosine modified proteins and Thioredoxin by ELISA and Western blots indicated that these compounds reduced the oxidative insult caused by light exposure. The beneficial antioxidant effects of these compounds in providing significant functional and structural protection were confirmed by electroretinography and quantitative histology of the retina. Conclusions/Significance: The present study suggests that multi-functional compounds may be effective candidates for preventive therapy of AMD.	[Randazzo, James; Zhang, Zifeng; Hoff, Michael; Kawada, Hiroyoshi; Kador, Peter] Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE USA; [Sachs, Andrew; Yuan, Yang; Haider, Neena] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Haider, Neena; Kador, Peter] Univ Nebraska Med Ctr, Dept Ophthalmol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Randazzo, J (corresponding author), Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE USA.	pkador@unmc.edu			National Institutes of Health [EY016730]; Therapeutic Vision, Inc. (Omaha, NE); NATIONAL EYE INSTITUTE [R01EY016730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Therapeutic Vision, Inc. (Omaha, NE); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grant EY016730 and an unrestricted grant from Therapeutic Vision, Inc. (Omaha, NE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RE, 1984, CURR EYE RES, V3, P223, DOI 10.3109/02713688408997203; AUST S D, 1985, Journal of Free Radicals in Biology and Medicine, V1, P3, DOI 10.1016/0748-5514(85)90025-X; BIRCH DG, 1980, EXP NEUROL, V68, P269, DOI 10.1016/0014-4886(80)90085-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brewer GJ, 2007, EXP BIOL MED, V232, P323; BUCKSER STANLEY, 1968, CURR MOD BIOL, V2, P14; Busch EM, 1999, PHOTOCHEM PHOTOBIOL, V70, P353, DOI 10.1111/j.1751-1097.1999.tb08148.x; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; DELAPAZ MA, 1992, INVEST OPHTH VIS SCI, V33, P2091; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Dunaief JL, 2006, INVEST OPHTH VIS SCI, V47, P4660, DOI 10.1167/iovs.06-0568; GAUNTT CD, 1994, INVEST OPHTH VIS SCI, V35, P2916; GREEN DG, 1973, J PHYSIOL-LONDON, V228, P781, DOI 10.1113/jphysiol.1973.sp010112; Gunnlaugsdottir E, 2008, ACTA OPHTHALMOL, V86, P778, DOI 10.1111/j.1755-3768.2008.01191.x; Hadziahmetovic M, 2011, INVEST OPHTH VIS SCI, V52, P959, DOI 10.1167/iovs.10-6207; Hardten D R, 1989, Prog Clin Biol Res, V314, P377; Jin HX, 2010, J MED CHEM, V53, P1117, DOI 10.1021/jm901381j; Kuhn F J, 1990, Lens Eye Toxic Res, V7, P667; LI ZL, 1991, CURR EYE RES, V10, P133, DOI 10.3109/02713689109001741; Mandal MNA, 2009, FREE RADICAL BIO MED, V46, P672, DOI 10.1016/j.freeradbiomed.2008.12.006; Marc RE, 2008, MOL VIS, V14, P782; MCKECHNIE NM, 1977, A GRAEF ARCH KLIN EX, V203, P283, DOI 10.1007/BF00409834; Mittag TW, 1999, EXP EYE RES, V69, P677, DOI 10.1006/exer.1999.0748; Moon S, 2005, INVEST OPHTH VIS SCI, V46, P3783, DOI 10.1167/iovs.05-0237; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Noell W K, 1966, Invest Ophthalmol, V5, P450; Nystuen AM, 2008, MAMM GENOME, V19, P623, DOI 10.1007/s00335-008-9138-5; OHIRA A, 1994, LAB INVEST, V70, P279; Ohishi K, 2005, FREE RADICAL RES, V39, P875, DOI 10.1080/10715760500177807; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; ORGANISCIAK DT, 1992, INVEST OPHTH VIS SCI, V33, P1599; Pratt DA, 2001, J AM CHEM SOC, V123, P4625, DOI 10.1021/ja005679l; Ramkumar HL, 2010, PROG RETIN EYE RES, V29, P169, DOI 10.1016/j.preteyeres.2010.02.002; Ranchon I, 1999, INVEST OPHTH VIS SCI, V40, P1191; Ranchon I, 2003, J NEUROSCI, V23, P6050, DOI 10.1523/JNEUROSCI.23-14-06050.2003; Ranchon I, 2001, INVEST OPHTH VIS SCI, V42, P1375; REME CE, 1991, PHOTOCHEM PHOTOBIOL, V54, P137, DOI 10.1111/j.1751-1097.1991.tb01997.x; ROSNER M, 1992, ARCH OPHTHALMOL-CHIC, V110, P857, DOI 10.1001/archopht.1992.01080180129040; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; SOMOGYI M, 1945, J BIOL CHEM, V160, P69; STONE WL, 1979, EXP EYE RES, V28, P387, DOI 10.1016/0014-4835(79)90114-3; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P3859, DOI 10.1167/iovs.05-0672; Tanito M, 2005, J NEUROSCI, V25, P2396, DOI 10.1523/JNEUROSCI.4866-04.2005; Tanito M, 2006, NEUROSCI LETT, V398, P63, DOI 10.1016/j.neulet.2005.12.070; Tanito M, 2006, FREE RADICAL BIO MED, V41, P1847, DOI 10.1016/j.freeradbiomed.2006.09.012; Tanito M, 2007, INVEST OPHTH VIS SCI, V48, P1900, DOI 10.1167/iovs.06-1057; Tanito M, 2007, INVEST OPHTH VIS SCI, V48, P1864, DOI 10.1167/iovs.06-1065; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; WANG M, 1995, RES COMMUN MOL PATH, V89, P291; WIEGAND RD, 1983, INVEST OPHTH VIS SCI, V24, P1433; Yamamoto M, 1997, EXP EYE RES, V65, P645, DOI 10.1006/exer.1997.0370; Zeiss CJ, 2010, VET PATHOL, V47, P396, DOI 10.1177/0300985809359598	53	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21926	10.1371/journal.pone.0021926	http://dx.doi.org/10.1371/journal.pone.0021926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779355	gold, Green Published			2022-12-25	WOS:000292811300027
J	Wu, CL; Guo, XZ; Wang, F; Li, XS; Tian, XC; Li, L; Wu, ZF; Zhang, SQ				Wu, Changli; Guo, Xinzheng; Wang, Fang; Li, Xiaoshuang; Tian, X. Cindy; Li, Li; Wu, Zhenfang; Zhang, Shouquan			Simulated Microgravity Compromises Mouse Oocyte Maturation by Disrupting Meiotic Spindle Organization and Inducing Cytoplasmic Blebbing	PLOS ONE			English	Article							SHEAR MODELED MICROGRAVITY; ACTIVATED PROTEIN-KINASE; GAMMA-TUBULIN COMPLEXES; GENE-EXPRESSION; IN-VITRO; SPACE; CELLS; CYTOSKELETON; SPACEFLIGHT; RATS	In the present study, we discovered that mouse oocyte maturation was inhibited by simulated microgravity via disturbing spindle organization. We cultured mouse oocytes under microgravity condition simulated by NASA's rotary cell culture system, examined the maturation rate and observed the spindle morphology (organization of cytoskeleton) during the mouse oocytes meiotic maturation. While the rate of germinal vesicle breakdown did not differ between 1 g gravity and simulated microgravity, rate of oocyte maturation decreased significantly in simulated microgravity. The rate of maturation was 8.94% in simulated microgravity and was 73.0% in 1 g gravity. The results show that the maturation of mouse oocytes in vitro was inhibited by the simulated microgravity. The spindle morphology observation shows that the microtubules and chromosomes can not form a complete spindle during oocyte meiotic maturation under simulated microgravity. And the disorder of gamma-tubulin may partially result in disorganization of microtubules under simulated microgravity. These observations suggest that the meiotic spindle organization is gravity dependent. Although the spindle organization was disrupted by simulated microgravity, the function and organization of microfilaments were not pronouncedly affected by simulated microgravity. And we found that simulated microgravity induced oocytes cytoplasmic blebbing via an unknown mechanism. Transmission electron microscope detection showed that the components of the blebs were identified with the cytoplasm. Collectively, these results indicated that the simulated microgravity inhibits mouse oocyte maturation via disturbing spindle organization and inducing cytoplasmic blebbing.	[Wu, Changli; Guo, Xinzheng; Wang, Fang; Li, Xiaoshuang; Li, Li; Wu, Zhenfang; Zhang, Shouquan] S China Agr Univ, Coll Anim Sci, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China; [Tian, X. Cindy] Univ Connecticut, Dept Anim Sci, Ctr Regenerat Biol, Storrs, CT 06269 USA	South China Agricultural University; University of Connecticut	Wu, CL (corresponding author), Guangdong Med Coll, 2 Wenming Donglu, Zhanjiang, Guangdong, Peoples R China.	sqzhang@scau.edu.cn	Guo, Xinzheng/AAF-4285-2019	Wu, Zhenfang/0000-0002-5586-6771	National Basic Research Program of China (973 Program) [2010CB945001, 2011CB944202, 2011CB944203]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	The work was supported by National Basic Research Program of China (973 Program, 2010CB945001; 2011CB944202; 2011CB944203) to Shouquan Zhang. The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Barrett SL, 2007, BIOL REPROD, V76, P949, DOI 10.1095/biolreprod.106.057141; Bezanilla M, 2009, CURR BIOL, V19, pR168, DOI 10.1016/j.cub.2008.12.026; Burden HW, 1999, J REPROD FERTIL, V116, P229; Calarco PG, 2005, MICROSC MICROANAL, V11, P146, DOI 10.1017/S1431927605050154; Carabatsos MJ, 2000, MICROSC RES TECHNIQ, V49, P435, DOI 10.1002/(SICI)1097-0029(20000601)49:5<435::AID-JEMT5>3.0.CO;2-H; Chang CC, 2006, REPROD BIOMED ONLINE, V13, P213, DOI 10.1016/S1472-6483(10)60618-9; DEAVER DR, 1992, J ANDROL, V13, P224; Gabrion J, 1996, BRAIN RES, V734, P301, DOI 10.1016/S0006-8993(96)00659-2; Gharbi N, 1996, J Gravit Physiol, V3, P63; Graebe A, 2004, J CLIN PHARMACOL, V44, P837, DOI 10.1177/0091270004267193; Higashibata Akira, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-19; Hughes-Fulford M, 2003, ADV SPACE RES-SERIES, V32, P1585, DOI 10.1016/S0273-1177(03)90399-1; HughesFulford M, 1996, EXP CELL RES, V224, P103, DOI 10.1006/excr.1996.0116; Infanger M, 2006, CELL TISSUE RES, V324, P267, DOI 10.1007/s00441-005-0142-8; Ingber D, 1999, FASEB J, V13, pS3; Jennings RT, 2000, OBSTET GYNECOL SURV, V55, P109, DOI 10.1097/00006254-200002000-00025; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Lewis ML, 1998, FASEB J, V12, P1007, DOI 10.1096/fasebj.12.11.1007; Maiato H, 2004, INT REV CYTOL, V241, P53, DOI 10.1016/S0074-7696(04)41002-X; Meloni MA, 2006, PROTOPLASMA, V229, P243, DOI 10.1007/s00709-006-0210-2; Meng XQ, 2004, J REPROD DEVELOP, V50, P97, DOI 10.1262/jrd.50.97; Nichiporuk I A, 1998, J Gravit Physiol, V5, pP101; Nickerson CA, 2003, J MICROBIOL METH, V54, P1, DOI 10.1016/S0167-7012(03)00018-6; Pellegrini M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009064; Purevdorj-Gage B, 2006, APPL ENVIRON MICROB, V72, P4569, DOI 10.1128/AEM.03050-05; Raynaud-Messina B, 2007, CURR OPIN CELL BIOL, V19, P24, DOI 10.1016/j.ceb.2006.12.008; Rosner H, 2006, PROTOPLASMA, V229, P225, DOI 10.1007/s00709-006-0202-2; Ronca A E, 2001, J Gravit Physiol, V8, pP133; Ronca AE, 2003, ADV SPACE B, V9, P217, DOI 10.1016/S1569-2574(03)09009-9; SAPP WJ, 1990, FASEB J, V4, P101, DOI 10.1096/fasebj.4.1.2295370; Schwarz R P, 1992, J Tissue Cult Methods, V14, P51, DOI 10.1007/BF01404744; Strollo F, 2004, J Gravit Physiol, V11, pP187; Sun QY, 2001, BIOL REPROD, V64, P879, DOI 10.1095/biolreprod64.3.879; Tou J, 2002, BIOL REPROD, V67, P1681, DOI 10.1095/biolreprod.102.007252; Vassy J, 2003, ADV SPACE RES-SERIES, V32, P1595, DOI 10.1016/S0273-1177(03)90400-5; Vassy J., 2001, FASEB Journal, V15, P1104; Verlhac MH, 2000, CURR BIOL, V10, P1303, DOI 10.1016/S0960-9822(00)00753-3; Wakayama S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006753; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; Xie YF, 2006, BIOL REPROD, V75, P45, DOI 10.1095/biolreprod.105.049791; Zayzafoon M, 2005, IMMUNOL REV, V208, P267, DOI 10.1111/j.0105-2896.2005.00330.x; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	42	15	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22214	10.1371/journal.pone.0022214	http://dx.doi.org/10.1371/journal.pone.0022214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765954	Green Published, gold, Green Submitted			2022-12-25	WOS:000292781500041
J	Losdat, S; Richner, H; Blount, JD; Helfenstein, F				Losdat, Sylvain; Richner, Heinz; Blount, Jonathan D.; Helfenstein, Fabrice			Immune Activation Reduces Sperm Quality in the Great Tit	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; BROOD SIZE MANIPULATION; VITAMIN-E; PARUS-MAJOR; GALLUS-DOMESTICUS; CAROTENOID AVAILABILITY; FERTILIZING EFFICIENCY; SEXUAL SIGNALS; ZEBRA FINCHES; FREE-RADICALS	Mounting an immune response against pathogens incurs costs to organisms by its effects on important life-history traits, such as reproductive investment and survival. As shown recently, immune activation produces large amounts of reactive species and is suggested to induce oxidative stress. Sperm are highly susceptible to oxidative stress, which can negatively impact sperm function and ultimately male fertilizing efficiency. Here we address the question as to whether mounting an immune response affects sperm quality through the damaging effects of oxidative stress. It has been demonstrated recently in birds that carotenoid-based ornaments can be reliable signals of a male's ability to protect sperm from oxidative damage. In a full-factorial design, we immune-challenged great tit males while simultaneously increasing their vitamin E availability, and assessed the effect on sperm quality and oxidative damage. We conducted this experiment in a natural population and tested the males' response to the experimental treatment in relation to their carotenoid-based breast coloration, a condition-dependent trait. Immune activation induced a steeper decline in sperm swimming velocity, thus highlighting the potential costs of an induced immune response on sperm competitive ability and fertilizing efficiency. We found sperm oxidative damage to be negatively correlated with sperm swimming velocity. However, blood resistance to a free-radical attack (a measure of somatic antioxidant capacity) as well as plasma and sperm levels of oxidative damage (lipid peroxidation) remained unaffected, thus suggesting that the observed effect did not arise through oxidative stress. Towards the end of their breeding cycle, swimming velocity of sperm of more intensely colored males was higher, which has important implications for the evolution of mate choice and multiple mating in females because females may accrue both direct and indirect benefits by mating with males having better quality sperm.	[Losdat, Sylvain; Richner, Heinz; Helfenstein, Fabrice] Univ Bern, Inst Ecol & Evolut, Evolutionary Ecol Lab, Bern, Switzerland; [Blount, Jonathan D.] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, England	University of Bern; University of Exeter	Losdat, S (corresponding author), Univ Bern, Inst Ecol & Evolut, Evolutionary Ecol Lab, Bern, Switzerland.	sylvain_losdat@yahoo.fr	Richner, Heinz/B-1659-2008; Blount, Jonathan/K-7695-2012; Helfenstein, Fabrice/I-5634-2013	Richner, Heinz/0000-0001-7390-0526; Blount, Jonathan/0000-0002-0016-0130; Helfenstein, Fabrice/0000-0001-8412-0461	Swiss National Science Foundation [3100A0-122566]; Royal Society	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Royal Society(Royal Society of London)	The study was financially supported by a Swiss National Science Foundation grant (3100A0-122566) to HR. JDB was supported by a Royal Society Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 1999, J REPROD FERTIL, V115, P1; Aitken RJ, 2006, MOL CELL ENDOCRINOL, V250, P66, DOI 10.1016/j.mce.2005.12.026; Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; AMIR D, 1973, ANN BIOL ANIM BIOCH, V13, P321, DOI 10.1051/rnd:19730302; Andersson S., 2006, BIRD COLORATION, P76; Armitage SAO, 2003, J EVOLUTION BIOL, V16, P1038, DOI 10.1046/j.1420-9101.2003.00551.x; Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; Bertrand S, 2006, OECOLOGIA, V147, P576, DOI 10.1007/s00442-005-0317-8; Bertrand S, 2006, J EXP BIOL, V209, P4414, DOI 10.1242/jeb.02540; BHAT G, 1988, ZOOL ANZ, V221, P430; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Birkhead TR, 1998, SPERM COMPETITION SE; Biswas A, 2007, THERIOGENOLOGY, V67, P259, DOI 10.1016/j.theriogenology.2006.07.010; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Blount JD, 2001, ECOL LETT, V4, P393, DOI 10.1046/j.1461-0248.2001.00255.x; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Brecchia G, 2010, ANIM REPROD SCI, V118, P310, DOI 10.1016/j.anireprosci.2009.06.016; Breque C, 2003, MOL REPROD DEV, V66, P314, DOI 10.1002/mrd.10347; Brzezinska-Slebodzinska E, 2001, ACTA VET HUNG, V49, P413, DOI 10.1556/AVet.49.2001.4.5; Catoni C, 2008, ANIM BEHAV, V76, P1107, DOI 10.1016/j.anbehav.2008.05.027; Charge R, 2010, J ANIM ECOL, V79, P843, DOI 10.1111/j.1365-2656.2010.01696.x; Costantini D, 2009, COMP BIOCHEM PHYS A, V153, P339, DOI 10.1016/j.cbpa.2009.03.010; CROCKER AH, 2002, METHODS ESTIMATING D; de Ayala RM, 2006, BEHAV ECOL SOCIOBIOL, V60, P619, DOI 10.1007/s00265-006-0206-0; de Reviers M., 1968, 6 INT C AN REPR, V1, P183; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; DIPLOCK AT, 1967, BRIT J NUTR, V21, P103, DOI 10.1079/BJN19670011; Eid Y, 2006, BRIT POULTRY SCI, V47, P350, DOI 10.1080/00071660600753912; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Esterbauer H, 1996, REV PHYSIOL BIOCH P, V127, P31, DOI 10.1007/BFb0048264; Evans SR, 2010, BIOL J LINN SOC, V101, P777, DOI 10.1111/j.1095-8312.2010.01548.x; Fair JM, 2002, ECOTOXICOLOGY, V11, P199, DOI 10.1023/A:1015474832239; Froman D, 2003, BIOL REPROD, V69, P248, DOI 10.1095/biolreprod.102.013482; Froman DP, 2006, BIOL REPROD, V74, P487, DOI 10.1095/biolreprod.105.046755; Froman DP, 2002, P ROY SOC B-BIOL SCI, V269, P607, DOI 10.1098/rspb.2001.1925; GARRATT M, 2010, P R SOC LOND B; Hadfield JD, 2006, J EVOLUTION BIOL, V19, P1104, DOI 10.1111/j.1420-9101.2006.01095.x; Halliwell B., 2007, FREE RADICALS BIOL M; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; Hartley RC, 2004, TRENDS ECOL EVOL, V19, P353, DOI 10.1016/j.tree.2004.04.002; Helfenstein F, 2010, ECOL LETT, V13, P213, DOI 10.1111/j.1461-0248.2009.01419.x; Ilmonen P, 2003, OECOLOGIA, V136, P148, DOI 10.1007/s00442-003-1243-2; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Keskes-Ammar L, 2003, ARCH ANDROLOGY, V49, P83, DOI 10.1080/713828100; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Locatello L, 2006, J EVOLUTION BIOL, V19, P1595, DOI 10.1111/j.1420-9101.2006.01117.x; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lopes S, 1998, FERTIL STERIL, V69, P528, DOI 10.1016/S0015-0282(97)00536-0; LOSDAT S, BEHAV ECOL IN PRESS; Lubjuhn T, 1999, BEHAVIOUR, V136, P1157, DOI 10.1163/156853999501810; Lubjuhn T, 2007, ZOOLOGY, V110, P387, DOI 10.1016/j.zool.2007.07.005; MARCHAND CR, 1977, CR SOC BIOL, V171, P927; Metukuri MR, 2010, INFLAMMATION, V33, P235, DOI 10.1007/s10753-009-9177-4; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Mougeot F, 2009, P ROY SOC B-BIOL SCI, V276, P1093, DOI 10.1098/rspb.2008.1570; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; O'Bryan MK, 2000, ENDOCRINOLOGY, V141, P238, DOI 10.1210/en.141.1.238; Parejo D, 2006, BEHAV ECOL SOCIOBIOL, V60, P184, DOI 10.1007/s00265-005-0155-z; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; PERRINS CM, 1965, J ANIM ECOL, V34, P601, DOI 10.2307/2453; Peters A, 2004, J EVOLUTION BIOL, V17, P1111, DOI 10.1111/j.1420-9101.2004.00743.x; Peters A, 2008, FUNCT ECOL, V22, P831, DOI 10.1111/j.1365-2435.2008.01437.x; Pike TW, 2010, BIOL LETTERS, V6, P191, DOI 10.1098/rsbl.2009.0815; Pitcher TE, 2007, J FISH BIOL, V70, P165, DOI 10.1111/j.1095-8649.2006.01292.x; Pizzari T, 2000, NATURE, V405, P787, DOI 10.1038/35015558; Pizzari T, 2007, P ROY SOC B-BIOL SCI, V274, P853, DOI 10.1098/rspb.2006.0080; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; Pizzari T, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-332; Pizzari Tommaso, 2007, P137; Prendergast BJ, 2004, BIOL REPROD, V70, P813, DOI 10.1095/biolreprod.103.023408; R Core Team, 2022, R LANG ENV STAT COMP; Raberg L, 2000, ECOL LETT, V3, P382, DOI 10.1046/j.1461-0248.2000.00154.x; Reddy MM, 2006, REPROD TOXICOL, V22, P493, DOI 10.1016/j.reprotox.2006.03.003; Saks L, 2003, FUNCT ECOL, V17, P555, DOI 10.1046/j.1365-2435.2003.00765.x; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; Sies H., 1991, OXIDATIVE STRESS OXI; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Surai P. F., 2002, NATURAL ANTIOXIDANTS; Swindle EJ, 2007, IMMUNOL REV, V217, P186, DOI 10.1111/j.1600-065X.2007.00513.x; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; Velando A, 2008, BIOESSAYS, V30, P1212, DOI 10.1002/bies.20838; Vernon GG, 1999, CELL MOTIL CYTOSKEL, V42, P149, DOI 10.1002/(SICI)1097-0169(1999)42:2<149::AID-CM6>3.0.CO;2-0; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286; Wahl RUR, 1998, J CHEM SOC PERK T 2, P2009, DOI 10.1039/a801624k; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wiersma P, 2004, P ROY SOC B-BIOL SCI, V271, pS360, DOI 10.1098/rsbl.2004.0171; Wilson-Leedy JG, 2007, THERIOGENOLOGY, V67, P661, DOI 10.1016/j.theriogenology.2006.10.003; Wolfson A., 1952, Bird-Banding, V23, P159; Yasui Y, 1997, AM NAT, V149, P573, DOI 10.1086/286006; Zou CG, 2001, LIFE SCI, V69, P75, DOI 10.1016/S0024-3205(01)01112-2	95	38	38	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22221	10.1371/journal.pone.0022221	http://dx.doi.org/10.1371/journal.pone.0022221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	21765955	Green Published, gold, Green Submitted			2022-12-25	WOS:000292699000031
J	Yaniv, Y; Juhaszova, M; Wang, S; Fishbein, KW; Zorov, DB; Sollott, SJ				Yaniv, Yael; Juhaszova, Magdalena; Wang, Su; Fishbein, Kenneth W.; Zorov, Dmitry B.; Sollott, Steven J.			Analysis of Mitochondrial 3D-Deformation in Cardiomyocytes during Active Contraction Reveals Passive Structural Anisotropy of Orthogonal Short Axes	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; RAT VENTRICULAR MYOCYTES; CARDIAC MYOCYTES; MATRIX VOLUME; HEART-MITOCHONDRIA; OSMOTIC STRENGTH; PAPILLARY-MUSCLE; LEFT ATRIUM; LENGTH; MEMBRANE	The cardiomyocyte cytoskeleton, composed of rigid and elastic elements, maintains the isolated cell in an elongated cylindrical shape with an elliptical cross-section, even during contraction-relaxation cycles. Cardiomyocyte mitochondria are micron-sized, fluid-filled passive spheres distributed throughout the cell in a crystal-like lattice, arranged in pairs sandwiched between the sarcomere contractile machinery, both longitudinally and radially. Their shape represents the extant 3-dimensional (3D) force-balance. We developed a novel method to examine mitochondrial 3D-deformation in response to contraction and relaxation to understand how dynamic forces are balanced inside cardiomyocytes. The variation in transmitted light intensity induced by the periodic lattice of myofilaments alternating with mitochondrial rows can be analyzed by Fourier transformation along a given cardiomyocyte axis to measure mitochondrial deformation along that axis. This technique enables precise detection of changes in dimension of similar to 1% in similar to 1 mu m (long-axis) structures with 8 ms time-resolution. During active contraction (1 Hz stimulation), mitochondria deform along the length-and width-axes of the cell with similar deformation kinetics in both sarcomere and mitochondrial structures. However, significant deformation anisotropy (without hysteresis) was observed between the orthogonal short-axes (i.e., width and depth) of mitochondria during electrical stimulation. The same degree of deformation anisotropy was also found between the myocyte orthogonal short-axes during electrical stimulation. Therefore, the deformation of the mitochondria reflects the overall deformation of the cell, and the apparent stiffness and stress/strain characteristics of the cytoskeleton differ appreciably between the two cardiomyocyte orthogonal short-axes. This method may be applied to obtaining a better understanding of the dynamic force-balance inside cardiomyocytes and of changes in the spatial stiffness characteristics of the cytoskeleton that may accompany aging or pathological conditions.	[Yaniv, Yael; Juhaszova, Magdalena; Wang, Su; Zorov, Dmitry B.; Sollott, Steven J.] NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Intramural Res Program,NIH, Baltimore, MD USA; [Fishbein, Kenneth W.] NIA, Lab Clin Invest, Gerontol Res Ctr, Intramural Res Program,NIH, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Yaniv, Y (corresponding author), NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Intramural Res Program,NIH, Baltimore, MD USA.	sollotts@mail.nih.gov	Fishbein, Kenneth/AAN-2595-2021; Yaniv, Yael/B-3311-2015; Zorov, Dmitry B./AAB-1738-2019	Fishbein, Kenneth/0000-0002-6353-4603; Yaniv, Yael/0000-0002-5183-6284; Zorov, Dmitry B./0000-0003-0863-8490	National Institutes of Health, National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000250, ZIAAG000823] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported entirely by the Intramural Research Program of the National Institutes of Health, National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013; Aon MA, 2009, INT J BIOCHEM CELL B, V41, P1940, DOI 10.1016/j.biocel.2009.02.016; APPLETON CP, 1988, J AM COLL CARDIOL, V12, P426, DOI 10.1016/0735-1097(88)90416-0; Baxi J, 2000, AM J PHYSIOL-HEART C, V278, pH1545, DOI 10.1152/ajpheart.2000.278.5.H1545; Beraud N, 2009, J BIOENERG BIOMEMBR, V41, P195, DOI 10.1007/s10863-009-9214-x; Bers D.M., 2001, EXCITATION CONTRACTI, V2nd ed.; BOYETT MR, 1991, EXP PHYSIOL, V76, P259, DOI 10.1113/expphysiol.1991.sp003492; BRAUNWALD E, 1961, CIRCULATION, V24, P633, DOI 10.1161/01.CIR.24.3.633; Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; CHIU YL, 1982, BIOPHYS J, V40, P109, DOI 10.1016/S0006-3495(82)84465-2; Chung CS, 2011, J MOL CELL CARDIOL, V50, P731, DOI 10.1016/j.yjmcc.2011.01.005; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; DETOMBE PP, 1992, J PHYSIOL-LONDON, V454, P619, DOI 10.1113/jphysiol.1992.sp019283; Farman GP, 2007, BIOPHYS J, V92, pL73, DOI 10.1529/biophysj.107.104257; FRATICELLI A, 1989, AM J PHYSIOL, V257, pH259, DOI 10.1152/ajpheart.1989.257.1.H259; Frohman MA, 2010, J MOL MED, V88, P967, DOI 10.1007/s00109-010-0662-x; Gottlieb RA, 2010, BIOCHIM BIOPHYS ACTA, V1813, P1295; Grutzner A, 2009, BIOPHYS J, V97, P825, DOI 10.1016/j.bpj.2009.05.037; HALESTRAP AP, 1994, BIOCHEM SOC T, V22, P522, DOI 10.1042/bst0220522; HALESTRAP AP, 1987, BIOCHEM J, V244, P159, DOI 10.1042/bj2440159; Hayashi T, 2009, J CELL SCI, V122, P1005, DOI 10.1242/jcs.028175; Hom J, 2010, BBA-BIOENERGETICS, V1797, P913, DOI 10.1016/j.bbabio.2010.03.018; Iribe G, 2007, AM J PHYSIOL-HEART C, V292, pH1487, DOI 10.1152/ajpheart.00909.2006; Jaburek M, 1998, J BIOL CHEM, V273, P13578; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Juhaszova M, 2008, ANN NY ACAD SCI, V1123, P197, DOI 10.1196/annals.1420.023; Kaasik A, 2004, FASEB J, V18, P1219, DOI 10.1096/fj.04-1508com; Kaasik A, 2010, CARDIOVASC RES, V87, P83, DOI 10.1093/cvr/cvq039; Katsnelson LB, 2011, J THEOR BIOL, V272, P83, DOI 10.1016/j.jtbi.2010.11.035; Konhilas JP, 2002, PFLUG ARCH EUR J PHY, V445, P305, DOI 10.1007/s00424-002-0902-1; Konhilas JP, 2002, CIRC RES, V90, P59, DOI 10.1161/hh0102.102269; Korge P, 2005, AM J PHYSIOL-HEART C, V289, pH66, DOI 10.1152/ajpheart.01296.2004; Korge P, 2002, P NATL ACAD SCI USA, V99, P3312, DOI 10.1073/pnas.052713199; Korzeniewski B, 2007, BIOPHYS CHEM, V129, P93, DOI 10.1016/j.bpc.2007.05.013; Kowaltowski AJ, 2001, AM J PHYSIOL-HEART C, V280, pH649, DOI 10.1152/ajpheart.2001.280.2.H649; Kulke M, 2001, CIRC RES, V89, P874, DOI 10.1161/hh2201.099453; LAKATTA EG, 1993, PHYSIOL REV, V73, P413, DOI 10.1152/physrev.1993.73.2.413; LAYLAND J, 1995, J EXP BIOL, V198, P2491; Lopes KD, 2011, J CELL BIOL, V193, P785, DOI 10.1083/jcb.201010099; MITCHELL JH, 1969, AM J CARDIOL, V23, P556, DOI 10.1016/0002-9149(69)90009-5; MITCHELL JH, 1965, CIRC RES, V17, P11, DOI 10.1161/01.RES.17.1.11; Natali AJ, 2002, J PHYSIOL-LONDON, V541, P863, DOI 10.1113/jphysiol.2001.013415; Nowikovsky K, 2009, BBA-BIOENERGETICS, V1787, P345, DOI 10.1016/j.bbabio.2008.10.006; O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804; Pagel PS, 2003, ANESTHESIOLOGY, V98, P975, DOI 10.1097/00000542-200304000-00027; Pedersen SF, 2007, METHOD ENZYMOL, V428, P183, DOI 10.1016/S0076-6879(07)28010-3; RAHIMTOOLA SH, 1975, AM J MED, V59, P686, DOI 10.1016/0002-9343(75)90229-6; Saks VA, 1998, MOL CELL BIOCHEM, V184, P81, DOI 10.1023/A:1006834912257; Satoh H, 1996, BIOPHYS J, V70, P1494, DOI 10.1016/S0006-3495(96)79711-4; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Syroeshkin AV, 1998, BBA-BIOENERGETICS, V1409, P59, DOI 10.1016/S0005-2728(98)00150-9; van Dalen BM, 2010, CIRC J, V74, P101, DOI 10.1253/circj.CJ-09-0436; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	53	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21985	10.1371/journal.pone.0021985	http://dx.doi.org/10.1371/journal.pone.0021985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779362	Green Submitted, Green Published, gold			2022-12-25	WOS:000292680900021
J	Fodrie, FJ; Heck, KL				Fodrie, F. Joel; Heck, Kenneth L., Jr.			Response of Coastal Fishes to the Gulf of Mexico Oil Disaster	PLOS ONE			English	Article							PRINCE-WILLIAM-SOUND; HERRING CLUPEA-PALLASI; DEEP-WATER-HORIZON; PINK SALMON; CRUDE-OIL; EXPOSURE; SPILL; CONSEQUENCES; SENSITIVITY; ECOLOGY	The ecosystem-level impacts of the Deepwater Horizon disaster have been largely unpredictable due to the unique setting and magnitude of this spill. We used a five-year (2006-2010) data set within the oil-affected region to explore acute consequences for early-stage survival of fish species inhabiting seagrass nursery habitat. Although many of these species spawned during spring-summer, and produced larvae vulnerable to oil-polluted water, overall and species-by-species catch rates were high in 2010 after the spill (1,989 +/- 220 fishes km-towed(-1) [mu +/- 1SE]) relative to the previous four years (1,080 +/- 43 fishes km-towed(-1)). Also, several exploited species were characterized by notably higher juvenile catch rates during 2010 following large-scale fisheries closures in the northern Gulf, although overall statistical results for the effects of fishery closures on assemblage-wide CPUE data were ambiguous. We conclude that immediate, catastrophic losses of 2010 cohorts were largely avoided, and that no shifts in species composition occurred following the spill. The potential long-term impacts facing fishes as a result of chronic exposure and delayed, indirect effects now require attention.	[Fodrie, F. Joel] Univ N Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC USA; [Fodrie, F. Joel] Univ N Carolina Chapel Hill, Dept Marine Sci, Morehead City, NC USA; [Heck, Kenneth L., Jr.] Univ S Alabama, Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Heck, Kenneth L., Jr.] Univ S Alabama, Dept Marine Sci, Dauphin Isl, AL USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Dauphin Island Sea Lab; University of South Alabama; University of South Alabama	Fodrie, FJ (corresponding author), Univ N Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC USA.	jfodrie@unc.edu			National Marine Fisheries Service; National Oceanic and Atmospheric Administration Marine Fisheries Initiative; Northern Gulf Institute	National Marine Fisheries Service; National Oceanic and Atmospheric Administration Marine Fisheries Initiative; Northern Gulf Institute	The authors acknowledge support from the National Marine Fisheries Service, National Oceanic and Atmospheric Administration Marine Fisheries Initiative and Northern Gulf Institute. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	ABLE KW, ECOLOGY ESTUARINE FI; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Brown ED, 1996, AM FISH S S, V18, P448; Bue BG, 1998, T AM FISH SOC, V127, P35, DOI 10.1577/1548-8659(1998)127<0035:EODTPS>2.0.CO;2; Byron D, 2006, ESTUARIES COASTS, V29, P939, DOI 10.1007/BF02798654; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Carls MG, 1999, ENVIRON TOXICOL CHEM, V18, P481, DOI 10.1002/etc.5620180317; CLARK KR, 2001, PRIMER V5 USER MANUA; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; D'Alessandro EK, 2010, MAR ECOL PROG SER, V410, P159, DOI 10.3354/meps08632; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Edgar GJ, 2003, MAR POLLUT BULL, V47, P296, DOI 10.1016/S0025-326X(03)00158-9; Fodrie FJ, 2010, GLOBAL CHANGE BIOL, V16, P48, DOI 10.1111/j.1365-2486.2009.01889.x; Graham WM, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/045301; HANZEN TC, 2010, SCIENCE, V330, P204; Heintz RA, 2000, MAR ECOL PROG SER, V208, P205, DOI 10.3354/meps208205; Hilborn R, 1996, AM FISH S S, V18, P639; Holt GJ, 2000, MAR ECOL PROG SER, V193, P181, DOI 10.3354/meps193181; Kerr R, 2010, SCIENCE, V328, P674, DOI 10.1126/science.328.5979.674; Kocan RM, 1996, CAN J FISH AQUAT SCI, V53, P2366, DOI 10.1139/cjfas-53-10-2366; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; MILLER BS, EARLY LIFE HIST MARI; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; *NOAA FISH SERV, DEEPW HOR OIL SPILL; Pearson WH, 1999, CAN J FISH AQUAT SCI, V56, P711, DOI 10.1139/cjfas-56-4-711; Peterson CH, 1996, CAN J FISH AQUAT SCI, V53, P2637, DOI 10.1139/cjfas-53-11-2637; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Sagarin R, 2010, FRONT ECOL ENVIRON, V8, P379, DOI 10.1890/090001; TUVIKENE A, 1995, ANN ZOOL FENN, V32, P295; UNDERWOOD AJ, DETECTING ECOLOGICAL, P151; *US DEP INT, 2002069 OCS MMS; Wertheimer AC, 2000, T AM FISH SOC, V129, P989, DOI 10.1577/1548-8659(2000)129&lt;0989:SOAPSF&gt;2.3.CO;2; [No title captured]	34	70	72	1	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21609	10.1371/journal.pone.0021609	http://dx.doi.org/10.1371/journal.pone.0021609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754992	Green Published, gold, Green Submitted			2022-12-25	WOS:000292632000016
J	Hoggard, SJ; Wilson, PD; Beattie, AJ; Stow, AJ				Hoggard, Stephen J.; Wilson, Peter D.; Beattie, Andrew J.; Stow, Adam J.			Social Complexity and Nesting Habits Are Factors in the Evolution of Antimicrobial Defences in Wasps	PLOS ONE			English	Article							BEES HYMENOPTERA; PHYLOGENY; VESPOIDEA	Microbial diseases are important selective agents in social insects and one major defense mechanism is the secretion of cuticular antimicrobial compounds. We hypothesized that given differences in group size, social complexity, and nest type the secretions of these antimicrobials will be under different selective pressures. To test this we extracted secretions from nine wasp species of varying social complexity and nesting habits and assayed their antimicrobial compounds against cultures of Staphylococcus aureus. These data were then combined with phylogenetic data to provide an evolutionary context. Social species showed significantly higher (18x) antimicrobial activity than solitary species and species with paper nests showed significantly higher (11x) antimicrobial activity than those which excavated burrows. Mud-nest species showed no antimicrobial activity. Solitary, burrow-provisioning wasps diverged at more basal nodes of the phylogenetic trees, while social wasps diverged from the most recent nodes. These data suggest that antimicrobial defences may have evolved in response to ground-dwelling pathogens but the most important variable leading to increased antimicrobial strength was increase in group size and social complexity.	[Hoggard, Stephen J.; Wilson, Peter D.; Beattie, Andrew J.; Stow, Adam J.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Macquarie University	Hoggard, SJ (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	stephen.hoggard@mq.edu.au		Wilson, Peter/0000-0001-7375-0791; Stow, Adam/0000-0002-6796-4854	Australian Research Council (ARC) [DP0879229]	Australian Research Council (ARC)(Australian Research Council)	The work was funded by Australian Research Council (ARC) Discovery Grant (#DP0879229). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROCKMANN HJ, 1980, FLA ENTOMOL, V63, P53, DOI 10.2307/3494656; Brothers DJ, 1999, ZOOL SCR, V28, P233, DOI 10.1046/j.1463-6409.1999.00003.x; COOPER KW, 1957, J EXP ZOOL, V134, P469, DOI 10.1002/jez.1401340305; Dowton M, 1998, MOL PHYLOGENET EVOL, V10, P354, DOI 10.1006/mpev.1998.0533; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EVANS HE, 1973, T ROY ENT SOC LONDON, V125, P45, DOI 10.1111/j.1365-2311.1973.tb00537.x; Evans HE., 2007, SAND WASPS NATURAL H; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hines HM, 2007, P NATL ACAD SCI USA, V104, P3295, DOI 10.1073/pnas.0610140104; Hunt J.H., 2007, EVOLUTION SOCIAL WAS, DOI DOI 10.1093/ACPROF:OSO/9780195307979.001.0001; Inoue M, 2008, J ETHOL, V26, P43, DOI 10.1007/s10164-006-0028-6; KLOOS WE, 1980, ANNU REV MICROBIOL, V34, P559, DOI 10.1146/annurev.mi.34.100180.003015; Pilgrim EM, 2008, ZOOL SCR, V37, P539, DOI 10.1111/j.1463-6409.2008.00340.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2021, R LANG ENV STAT COMP; Rambaut A., 2007, TRACER V1 4; Rambaut A, 2009, FIGTREE V1 3 1; Smith SM, 2008, J MICROBIOL METH, V72, P103, DOI 10.1016/j.mimet.2007.10.003; Stow A, 2008, BRAIN BEHAV IMMUN, V22, P1009, DOI 10.1016/j.bbi.2008.03.008; Stow A, 2007, BIOL LETTERS, V3, P422, DOI 10.1098/rsbl.2007.0178; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turillazzi S, 2006, J AM SOC MASS SPECTR, V17, P376, DOI 10.1016/j.jasms.2005.11.017; Turnbull C, 2011, BIOL LETTERS, V7, P249, DOI 10.1098/rsbl.2010.0719; Wcislo WT, 1996, ANNU REV ENTOMOL, V41, P257, DOI 10.1146/annurev.en.41.010196.001353	27	21	21	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2011	6	7							e21763	10.1371/journal.pone.0021763	http://dx.doi.org/10.1371/journal.pone.0021763			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791AK	21754998	Green Published, Green Submitted, gold			2022-12-25	WOS:000292632000025
J	Cyr, DD; Lucas, JE; Thompson, JW; Patel, K; Clark, PJ; Thompson, A; Tillmann, HL; McHutchison, JG; Moseley, MA; McCarthy, JJ				Cyr, Derek D.; Lucas, Joseph E.; Thompson, J. Will; Patel, Keyur; Clark, Paul J.; Thompson, Alexander; Tillmann, Hans L.; McHutchison, John G.; Moseley, M. Arthur; McCarthy, Jeanette J.			Characterization of Serum Proteins Associated with IL28B Genotype among Patients with Chronic Hepatitis C	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PITUITARY-ADRENAL AXIS; GENETIC-VARIATION; BINDING GLOBULIN; INSULIN; EXPRESSION; CLEARANCE; RIBAVIRIN; CORTISOL; THERAPY	Introduction: Polymorphisms near the IL28B gene (e.g. rs12979860) encoding interferon lambda 3 have recently been associated with both spontaneous clearance and treatment response to pegIFN/RBV in chronic hepatitis C (CHC) patients. The molecular consequences of this genetic variation are unknown. To gain further insight into IL28B function we assessed the association of rs12979860 with expression of protein quantitative traits (pQTL analysis) generated using open-platform proteomics in serum from patients. Methods: 41 patients with genotype 1 chronic hepatitis C infection from the Duke Liver Clinic were genotyped for rs12979860. Proteomic profiles were generated by LC-MS/MS analysis following immunodepletion of serum with MARS14 columns and trypsin-digestion. Next, a latent factor model was used to classify peptides into metaproteins based on co-expression and using only those peptides with protein identifications. Metaproteins were then analyzed for association with IL28B genotype using one-way analysis of variance. Results: There were a total of 4,186 peptides in the data set with positive identifications. These were matched with 253 proteins of which 110 had two or more associated, identified peptides. The IL28B treatment response genotype (rs12979860_CC) was significantly associated with lower serum levels of corticosteroid binding globulin (CBG; p = 9.2x10(-6)), a major transport protein for glucocorticoids and progestins. Moreover, the CBG metaprotein was associated with treatment response (p = 0.0148), but this association was attenuated when both IL28B genotype and CBG were included in the model, suggesting that the CBG association may be independent of treatment response. Conclusions: In this cohort of chronic hepatitis C patients, IL28B polymorphism was associated with serum levels of corticosteroid binding globulin, a major transporter of cortisol, however, CBG does not appear to mediate the association of IL28B with treatment response. Further investigation of this pathway is warranted to determine if it plays a role in other comorbidities of HCV-infection.	[Cyr, Derek D.; Lucas, Joseph E.; Thompson, J. Will; Moseley, M. Arthur; McCarthy, Jeanette J.] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Patel, Keyur; Clark, Paul J.; Thompson, Alexander; Tillmann, Hans L.; McHutchison, John G.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Patel, Keyur; Clark, Paul J.; Thompson, Alexander; Tillmann, Hans L.; McHutchison, John G.] Duke Univ, Med Ctr, Div Gastroenterol, Durham, NC 27710 USA; [McCarthy, Jeanette J.] Duke Univ, Med Ctr, Div Community & Family Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Cyr, DD (corresponding author), Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27708 USA.	jeanette.mccarthy@duke.edu	Clark, Paul J/A-1480-2012	Clark, Paul J/0000-0002-1821-4969	David H Murdock Institute for Business and Culture; NIH [1 UL1 RR024128-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER	David H Murdock Institute for Business and Culture; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded by a generous grant from the David H Murdock Institute for Business and Culture via the M.U.R.D.O.C.K. Study and NIH CTSA award 1 UL1 RR024128-01 to Duke University (Dr. Robert Califf, Principal Investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Brown RS, 2005, NATURE, V436, P973, DOI 10.1038/nature04083; Charlton MR, 2011, HEPATOLOGY, V53, P317, DOI 10.1002/hep.24074; CRAVE JC, 1995, J CLIN ENDOCR METAB, V80, P1283, DOI 10.1210/jc.80.4.1283; Dhillo WS, 2002, EUR J ENDOCRINOL, V146, P231, DOI 10.1530/eje.0.1460231; Fernandez-Real JM, 2002, J CLIN ENDOCR METAB, V87, P4686, DOI 10.1210/jc.2001-011843; Fernandez-Real JM, 1999, J CLIN ENDOCR METAB, V84, P3192, DOI 10.1210/jc.84.9.3192; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Gagliardi L, 2010, MOL CELL ENDOCRINOL, V316, P24, DOI 10.1016/j.mce.2009.07.015; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Hutin Y, 2004, J CLIN PHARMACOL, V44, P20, DOI 10.1177/0091270003258669; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Metz TO, 2008, J PROTEOME RES, V7, P698, DOI 10.1021/pr700606w; Ohno Y, 1998, J CLIN ENDOCR METAB, V83, P3681, DOI 10.1210/jc.83.10.3681; PATEL K, 2011, HEPATOLOGY IN PRESS; Raison CL, 2010, MOL PSYCHIATR, V15, P535, DOI 10.1038/mp.2008.58; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Vincent RP, 2009, ANN CLIN BIOCHEM, V46, P505, DOI 10.1258/acb.2009.009030	26	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21854	10.1371/journal.pone.0021854	http://dx.doi.org/10.1371/journal.pone.0021854			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750736	Green Published, Green Submitted, gold			2022-12-25	WOS:000292512000028
J	Yu, QJ; Wang, T; Zhou, XX; Wu, JX; Chen, XM; Liu, Y; Wu, DM; Zhai, QW				Yu, Qiujing; Wang, Ting; Zhou, Xuexia; Wu, Jingxia; Chen, Xingmiao; Liu, Yang; Wu, Dongmei; Zhai, Qiwei			Wld(S) Reduces Paraquat-Induced Cytotoxicity via SIRT1 in Non-Neuronal Cells by Attenuating the Depletion of NAD	PLOS ONE			English	Article							WALLERIAN DEGENERATION; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; AXONAL DEGENERATION; DEATH; GENE; MITOCHONDRIAL; DEACETYLASE; STRESS; APOPTOSIS; SURVIVAL	Wld(S) is a fusion protein with NAD synthesis activity, and has been reported to protect axonal and synaptic compartments of neurons from various mechanical, genetic and chemical insults. However, whether Wld(S) can protect non-neuronal cells against toxic chemicals is largely unknown. Here we found that Wld(S) significantly reduced the cytotoxicity of bipyridylium herbicides paraquat and diquat in mouse embryonic fibroblasts, but had no effect on the cytotoxicity induced by chromium (VI), hydrogen peroxide, etoposide, tunicamycin or brefeldin A. Wld(S) also slowed down the death of mice induced by intraperitoneal injection of paraquat. Further studies demonstrated that Wld(S) markedly attenuated mitochondrial injury including disruption of mitochondrial membrane potential, structural damage and decline of ATP induced by paraquat. Disruption of the NAD synthesis activity of Wld(S) by an H112A or F116S point mutation resulted in loss of its protective function against paraquat-induced cell death. Furthermore, WldS delayed the decrease of intracellular NAD levels induced by paraquat. Similarly, treatment with NAD or its precursor nicotinamide mononucleotide attenuated paraquat-induced cytotoxicity and decline of ATP and NAD levels. In addition, we showed that SIRT1 was required for both exogenous NAD and Wld(S)-mediated cellular protection against paraquat. These findings suggest that NAD and SIRT1 mediate the protective function of Wld(S) against the cytotoxicity induced by paraquat, which provides new clues for the mechanisms underlying the protective function of Wld(S) in both neuronal and non-neuronal cells, and implies that attenuation of NAD depletion may be effective to alleviate paraquat poisoning.	[Yu, Qiujing; Wang, Ting; Zhou, Xuexia; Wu, Jingxia; Chen, Xingmiao; Liu, Yang; Wu, Dongmei; Zhai, Qiwei] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Nutr Sci,Key Lab Nutr & Metab, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yu, QJ (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Inst Nutr Sci,Key Lab Nutr & Metab, Shanghai, Peoples R China.	qwzhai@sibs.ac.cn	wu, Jingxia/AFR-6587-2022	Zhai, Qiwei/0000-0002-9617-7403	National Natural Science Foundation of China [30825009, 30970619, 31030022, 81021002]; National Basic Research Program of China (973 Program) [2009CB918403, 2007CB914501]; Director Foundation of Institute for Nutritional Sciences [20090101]; Sanofi-Aventis-Shanghai Institutes for Biological Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Director Foundation of Institute for Nutritional Sciences; Sanofi-Aventis-Shanghai Institutes for Biological Sciences	This study was supported by grants from National Natural Science Foundation of China (30825009, 30970619, 31030022 and 81021002), National Basic Research Program of China (973 Program, 2009CB918403, 2007CB914501), Director Foundation of Institute for Nutritional Sciences (20090101) and Sanofi-Aventis-Shanghai Institutes for Biological Sciences Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalbert R, 2006, EUR J NEUROSCI, V24, P2163, DOI 10.1111/j.1460-9568.2006.05103.x; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Avery MA, 2009, J CELL BIOL, V184, P501, DOI 10.1083/jcb.200808042; Barrientos SA, 2011, J NEUROSCI, V31, P966, DOI 10.1523/JNEUROSCI.4065-10.2011; BROWN OR, 1981, SCIENCE, V212, P1510, DOI 10.1126/science.7233236; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Chen LH, 2007, MOL CANCER THER, V6, P2581, DOI 10.1158/1535-7163.MCT-07-0220; Cocheme HM, 2009, METHOD ENZYMOL, V456, P395, DOI 10.1016/S0076-6879(08)04422-4; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Conforti L, 2009, J CELL BIOL, V184, P491, DOI 10.1083/jcb.200807175; DECKWERTH TL, 1994, DEV BIOL, V165, P63, DOI 10.1006/dbio.1994.1234; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Ghazi-Khansari M, 2005, ARCH TOXICOL, V79, P341, DOI 10.1007/s00204-004-0632-6; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Hasmann M, 2003, CANCER RES, V63, P7436; HEITKAMP M, 1981, BIOCHIM BIOPHYS ACTA, V676, P345, DOI 10.1016/0304-4165(81)90169-0; Hilliard MA, 2009, J NEUROCHEM, V108, P23, DOI 10.1111/j.1471-4159.2008.05754.x; Ho YS, 2007, FREE RADICAL BIO MED, V43, P1299, DOI 10.1016/j.freeradbiomed.2007.07.025; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Hsu CP, 2009, CIRC RES, V105, P481, DOI 10.1161/CIRCRESAHA.109.203703; Jia HQ, 2007, NEUROSCI LETT, V413, P46, DOI 10.1016/j.neulet.2006.11.067; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Mi WQ, 2002, J NEUROSCI METH, V113, P215, DOI 10.1016/S0165-0270(01)00501-5; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Press C, 2008, J NEUROSCI, V28, P4861, DOI 10.1523/JNEUROSCI.0525-08.2008; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; RIBCHESTER RR, 1995, EUR J NEUROSCI, V7, P1641, DOI 10.1111/j.1460-9568.1995.tb01159.x; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; UEDA T, 1985, J ELECTRON MICROSC, V34, P85; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wishart TM, 2007, MOL CELL PROTEOMICS, V6, P1318, DOI 10.1074/mcp.M600457-MCP200; Wishart TM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-148; Wright AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015108; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang W, 2008, J TOXICOL ENV HEAL A, V71, P289, DOI 10.1080/15287390701738467; Ying WH, 2006, FRONT BIOSCI-LANDMRK, V11, P3129, DOI 10.2741/2038; Ying WH, 2001, P NATL ACAD SCI USA, V98, P12227, DOI 10.1073/pnas.211202598; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469	50	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21770	10.1371/journal.pone.0021770	http://dx.doi.org/10.1371/journal.pone.0021770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750730	Green Published, Green Submitted, gold			2022-12-25	WOS:000292512000022
J	Cooper, DM; Petchkovsky, DV; Hackett, TL; Knight, DA; Granville, DJ				Cooper, Dawn M.; Petchkovsky, Dmitri V.; Hackett, Tillie L.; Knight, Darryl A.; Granville, David J.			Granzyme K Activates Protease-Activated Receptor-1	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; FIBROBLAST PROLIFERATION; EXTRACELLULAR ACTIVITIES; SIGNALING PATHWAYS; TARGET-CELLS; THROMBIN; INFLAMMATION; RESPONSES; DISEASE; INTERLEUKIN-8	Granzyme K (GrK) is a trypsin-like serine protease that is elevated in patients with sepsis and acute lung inflammation. While GrK was originally believed to function exclusively as a pro-apoptotic protease, recent studies now suggest that GrK may possess other non-cytotoxic functions. In the context of acute lung inflammation, we hypothesized that GrK induces pro-inflammatory cytokine release through the activation of protease-activated receptors. The direct effect of extracellular GrK on PAR activation, intracellular signaling and cytokine was assessed using cultured human lung fibroblasts. Extracellular GrK induced secretion of IL-6, IL-8 and MCP-1 in a dose-and time-dependent manner in lung fibroblasts. Heat-inactivated GrK did not induce cytokine release indicating that protease activity is required. Furthermore, GrK induced activation of both the ERK1/2 and p38 MAP kinase signaling pathways, and significantly increased fibroblast proliferation. Inhibition of ERK1/2 abrogated the GrK-mediated cytokine release. Through the use of PAR-1 and PAR-2 neutralizing antibodies, it was determined that PAR-1 is essential for GrK-induced IL-6, IL-8 and MCP-1 release. In summary, extracellular GrK is capable of activating PAR-1 and inducing fibroblast cytokine secretion and proliferation.	[Cooper, Dawn M.; Petchkovsky, Dmitri V.; Hackett, Tillie L.; Knight, Darryl A.; Granville, David J.] St Pauls Hosp, Inst Heart & Lung Hlth, Vancouver, BC V6Z 1Y6, Canada; [Cooper, Dawn M.; Granville, David J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Petchkovsky, Dmitri V.; Hackett, Tillie L.; Knight, Darryl A.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada	St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of British Columbia	Cooper, DM (corresponding author), St Pauls Hosp, Inst Heart & Lung Hlth, Vancouver, BC V6Z 1Y6, Canada.	david.granville@hli.ubc.ca		Pechkovsky, Dmitri/0000-0001-8908-3444	British Columbia Lung Association [DJG:20R64011]; Natural Sciences Engineering Research Council (NSERC); Canadian Institutes for Health Research (CIHR) IMPACT; Heart & Stroke Foundation of Canada; CIHR/Candian Lung Association/GSK; IMPACT; Michael Smith Foundation for Health Research (MSFHR)	British Columbia Lung Association; Natural Sciences Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research (CIHR) IMPACT(Canadian Institutes of Health Research (CIHR)); Heart & Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); CIHR/Candian Lung Association/GSK(Canadian Institutes of Health Research (CIHR)GlaxoSmithKline); IMPACT(European Commission); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	This research was funded by a grants from the British Columbia Lung Association (DJG:20R64011). DMC is the recipient of Natural Sciences Engineering Research Council (NSERC), Canadian Institutes for Health Research (CIHR) IMPACT, and Heart & Stroke Foundation of Canada postdoctoral fellowships. TLH is supported by CIHR/Candian Lung Association/GSK, IMPACT, and Michael Smith Foundation for Health Research (MSFHR) postdoctoral fellowships. DAK is a Canada Research Chair in Airway Disease and a MSFHR Career Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers IA, 2000, AM J PHYSIOL-LUNG C, V278, pL193, DOI 10.1152/ajplung.2000.278.1.L193; Akira S, 1996, Curr Opin Hematol, V3, P87; AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; Anthony DA, 2010, IMMUNOL REV, V235, P73, DOI 10.1111/j.0105-2896.2010.00907.x; Bade B, 2005, EUR J IMMUNOL, V35, P2940, DOI 10.1002/eji.200526249; Boivin WA, 2009, LAB INVEST, V89, P1195, DOI 10.1038/labinvest.2009.91; Borensztajn K, 2008, AM J PATHOL, V172, P309, DOI 10.2353/ajpath.2008.070347; Bovenschen N, 2009, J BIOL CHEM, V284, P3504, DOI 10.1074/jbc.M806716200; Bratke K, 2008, THORAX, V63, P1006, DOI 10.1136/thx.2007.091215; Brousseau C, 2009, CAN J PHYSIOL PHARM, V87, P694, DOI [10.1139/y09-063, 10.1139/Y09-063]; Chambers RC, 1998, BIOCHEM J, V333, P121, DOI 10.1042/bj3330121; Darrah E, 2010, CELL DEATH DIFFER, V17, P624, DOI 10.1038/cdd.2009.197; Deng XL, 2008, MOL BIOL CELL, V19, P2520, DOI 10.1091/mbc.E07-07-0720; Froelich CJ, 2009, TRENDS IMMUNOL, V30, P117, DOI 10.1016/j.it.2009.01.002; Ge SJ, 2004, J BIOL CHEM, V279, P6688, DOI 10.1074/jbc.M311769200; Georganas C, 2000, J IMMUNOL, V165, P7199, DOI 10.4049/jimmunol.165.12.7199; GharaeeKermani M, 1996, J BIOL CHEM, V271, P17779, DOI 10.1074/jbc.271.30.17779; Granville DJ, 2010, CELL DEATH DIFFER, V17, P565, DOI 10.1038/cdd.2009.218; Guo YM, 2008, MOL IMMUNOL, V45, P2225, DOI 10.1016/j.molimm.2007.11.020; Hendel A, 2010, CELL DEATH DIFFER, V17, P596, DOI 10.1038/cdd.2010.5; HIEBERT PR, 2010, EXP GERONTOL; IRMLER M, 1995, J EXP MED, V181, P1917, DOI 10.1084/jem.181.5.1917; JOECKEL LT, 2011, CELL DEATH DIFFER; Lim YP, 2003, J INFECT DIS, V188, P919, DOI 10.1086/377642; Ludwicka-Bradley A, 2000, AM J RESP CELL MOL, V22, P235, DOI 10.1165/ajrcmb.22.2.3642; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Moore BB, 2005, AM J PATHOL, V166, P675, DOI 10.1016/S0002-9440(10)62289-4; Moore BB, 2003, AM J PHYSIOL-LUNG C, V284, pL342, DOI 10.1152/ajplung.00168.2002; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Ostrowska E, 2008, BIOCHEM BIOPH RES CO, V366, P1030, DOI 10.1016/j.bbrc.2007.12.064; Pao LI, 2005, J IMMUNOL, V175, P3235, DOI 10.4049/jimmunol.175.5.3235; Pardo J, 2009, BLOOD, V114, P3968, DOI 10.1182/blood-2009-07-231027; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Rucevic M, 2007, SHOCK, V27, P488, DOI 10.1097/01.shk.0000246905.24895.e5; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; Shi XL, 2004, MOL CANCER RES, V2, P395; Shinoda H, 2009, RESPIRATION, V78, P285, DOI 10.1159/000207617; Shpacovitch V, 2008, J LEUKOCYTE BIOL, V83, P1309, DOI 10.1189/jlb.0108001; Singh K, 2010, PEDIATR RES, V68, P242, DOI 10.1203/00006450-201011001-00474; Sower LE, 1996, CELL IMMUNOL, V171, P159, DOI 10.1006/cimm.1996.0187; Sower LE, 1996, J IMMUNOL, V156, P2585; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Suga M, 1999, EUR RESPIR J, V14, P376, DOI 10.1034/j.1399-3003.1999.14b23.x; Tak PP, 1999, CLIN EXP IMMUNOL, V116, P366; TAK PP, 1994, ARTHRITIS RHEUM, V37, P1735, DOI 10.1002/art.1780371205; Vernooy JHJ, 2007, AM J RESP CRIT CARE, V175, P464, DOI 10.1164/rccm.200602-169OC; Wang L, 2006, INT J BIOCHEM CELL B, V38, P1571, DOI 10.1016/j.biocel.2006.03.016; Zhao T, 2007, CELL DEATH DIFFER, V14, P489, DOI 10.1038/sj.cdd.4402040; Zhao TB, 2007, J BIOL CHEM, V282, P12104, DOI 10.1074/jbc.M611006200	51	48	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21484	10.1371/journal.pone.0021484	http://dx.doi.org/10.1371/journal.pone.0021484			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21760880	Green Published, gold, Green Submitted			2022-12-25	WOS:000292291800016
J	Li, YH; Romeis, J; Wang, P; Peng, YF; Shelton, AM				Li, Yunhe; Romeis, Joerg; Wang, Ping; Peng, Yufa; Shelton, Anthony M.			A Comprehensive Assessment of the Effects of Bt Cotton on Coleomegilla maculata Demonstrates No Detrimental Effects by Cry1Ac and Cry2Ab	PLOS ONE			English	Article							RESISTANT TRANSGENIC PLANTS; BACILLUS-THURINGIENSIS; CORN POLLEN; LEPIDOPTERA; NONTARGET; SURVIVAL; TOXIN; COLEOPTERA; PREDATORS; PROTEINS	The ladybird beetle, Coleomegilla maculata (DeGeer), is a common and abundant predator in many cropping systems. Its larvae and adults are predaceous, feeding on aphids, thrips, lepidopteran larvae and plant tissues, such as pollen. Therefore, this species is exposed to insecticidal proteins expressed in insect-resistant, genetically engineered cotton expressing Cry proteins derived from Bacillus thuringiensis (Bt). A tritrophic bioassay was conduced to evaluate the potential impact of Cry2Ab- and Cry1Ac-expressing cotton on fitness parameters of C. maculata using Bt-susceptible and -resistant larvae of Trichoplusia ni as prey. Coleomegilla maculata survival, development time, adult weight and fecundity were not different when they were fed with resistant T. ni larvae reared on either Bt or control cotton. To ensure that C. maculata were not sensitive to the tested Cry toxins independent from the plant background and to add certainty to the hazard assessment, C. maculata larvae were fed artificial diet incorporated with Cry2Ab, Cry1Ac or both at > 10 times higher concentrations than in cotton tissue. Artificial diet containing E-64 was included as a positive control. No differences were detected in any life-table parameters between Cry protein-containing diet treatments and the control diet. In contrast, larvae of C. maculata fed the E-64 could not develop to the pupal stage and the 7-d larval weight was significantly negatively affected. In both feeding assays, the stability and bioactivity of Cry proteins in the food sources were confirmed by ELISA and sensitive-insect bioassays. Our results show that C. maculata is not affected by Bt cotton and is not sensitive to Cry2Ab and Cry1Ac at concentrations exceeding the levels in Bt cotton, thus demonstrating that Bt cotton will pose a negligible risk to C. maculata. More importantly, this study demonstrates a comprehensive system for assessing the risk of genetically modified plants on non-target organisms.	[Li, Yunhe; Wang, Ping; Shelton, Anthony M.] Cornell Univ, Dept Entomol, NYSAES, Geneva, NY USA; [Li, Yunhe; Peng, Yufa] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Romeis, Joerg] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland	Cornell University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture	Shelton, AM (corresponding author), Cornell Univ, Dept Entomol, NYSAES, Geneva, NY USA.	ams5@cornell.edu	peng, yu/GXW-2071-2022; li, Yu/HCI-9086-2022; Chen, Yong/B-9051-2008; Romeis, Joerg/J-5360-2013; li, yu/HGL-9518-2022	Chen, Yong/0000-0003-2580-5895; Romeis, Joerg/0000-0003-3652-8360; 	National Key Basic Research and Development (973) Program in China [2007CB109204]; Swiss National Science Foundation [PBBEP3-125563]	National Key Basic Research and Development (973) Program in China(National Basic Research Program of China); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by the National Key Basic Research and Development (973) Program (2007CB109204) in China and funded by a postdoctoral grant from the Swiss National Science Foundation (PBBEP3-125563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Alfageme F, 2011, TRANSGENIC RES, V20, P467, DOI 10.1007/s11248-010-9430-5; BOODLEY JW, 1977, CORNELL U COOPERATIO, V43; BROOKES G, 2010, GM CROPS GLOBAL SOCI; CAB International, 2007, CROP PROT COMP; Chen M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002284; Duan JJ, 2002, ENTOMOL EXP APPL, V104, P271, DOI 10.1023/A:1021258803866; Dutton A, 2003, BIOCONTROL, V48, P611, DOI 10.1023/A:1026313719424; Ferry N, 2007, TRANSGENIC RES, V16, P795, DOI 10.1007/s11248-007-9088-9; Garcia-Alonso Monica, 2006, Environmental Biosafety Research, V5, P57, DOI 10.1051/ebr:2006018; Greenplate JT, 2003, J APPL ENTOMOL, V127, P340, DOI 10.1046/j.1439-0418.2003.00766.x; Groot AT, 2002, PLANT J, V31, P387, DOI 10.1046/j.1365-313X.2002.01366.x; Hogervorst PAM, 2006, J INSECT PHYSIOL, V52, P614, DOI 10.1016/j.jinsphys.2006.02.011; Kain WC, 2004, J ECON ENTOMOL, V97, P2073, DOI 10.1603/0022-0493-97.6.2073; Kennedy George G., 2008, V5, P1; Knox O. G. G., 2008, The Open Agriculture Journal, V2, P105, DOI 10.2174/1874331500802010105; Lawo NC, 2010, J INSECT PHYSIOL, V56, P1702, DOI 10.1016/j.jinsphys.2010.06.012; Li YX, 2006, CROP PROT, V25, P940, DOI 10.1016/j.cropro.2005.12.007; Li YH, 2011, ENVIRON ENTOMOL, V40, P496, DOI 10.1603/EN10248; Li YH, 2010, BIOL CONTROL, V53, P337, DOI 10.1016/j.biocontrol.2009.12.003; LIU CX, 2010, SCIENCE CHINA C, V8, P934; Lundgren JG, 2004, J INSECT PHYSIOL, V50, P567, DOI 10.1016/j.jinsphys.2004.04.003; Lundgren JG, 2002, ENVIRON ENTOMOL, V31, P1213, DOI 10.1603/0046-225X-31.6.1213; Naranjo S., 2009, CAB REV PERSPECTIVES, V4; Naranjo SE, 2011, J AGR FOOD CHEM, V59, P5842, DOI 10.1021/jf102939c; Naranjon Steven E., 2008, V5, P159, DOI 10.1007/978-1-4020-8373-0_6; NAS (National Academy of Sciences), 2002, ENV EFF TRANSG PLANT; Organisation for Economic Co-operation and Development (OECD), 2007, SER HARM REG OV BIOT; Pilcher CD, 1997, ENVIRON ENTOMOL, V26, P446, DOI 10.1093/ee/26.2.446; Raybould A, 2010, TRANSGENIC RES, V20, P599, DOI DOI 10.1007/S11248-010-9442-1; ROGER C, 1999, THESIS MCGILI U MONT; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Romeis J, 2011, TRANSGENIC RES, V20, P1, DOI 10.1007/s11248-010-9446-x; SHELTON AM, 1991, J ENTOMOL SCI, V26, P17, DOI 10.18474/0749-8004-26.1.17; Stewart SD, 2001, J ECON ENTOMOL, V94, P752, DOI 10.1603/0022-0493-94.3.752; USEPA, 2002, 006487 EPA AMENDED	36	76	84	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22185	10.1371/journal.pone.0022185	http://dx.doi.org/10.1371/journal.pone.0022185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	22022595	Green Submitted, gold, Green Published			2022-12-25	WOS:000292699000028
J	Vandevenne, P; Lebrun, M; El Mjiyad, N; Ote, I; Di Valentin, E; Habraken, Y; Dortu, E; Piette, J; Sadzot-Delvaux, C				Vandevenne, Patricia; Lebrun, Marielle; El Mjiyad, Nadia; Ote, Isabelle; Di Valentin, Emmanuel; Habraken, Yvette; Dortu, Estelle; Piette, Jacques; Sadzot-Delvaux, Catherine			The Varicella-Zoster Virus ORF47 Kinase Interferes with Host Innate Immune Response by Inhibiting the Activation of IRF3	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; NF-KAPPA-B; DOUBLE-STRANDED-RNA; TRANSCRIPTIONAL REGULATORY PROTEIN; ANTIVIRAL RESPONSE; GENE-EXPRESSION; I INTERFERON; VIRAL REPLICATION; STIMULATED GENES; SERINE KINASE	The innate immune response constitutes the first line of host defence that limits viral spread and plays an important role in the activation of adaptive immune response. Viral components are recognized by specific host pathogen recognition receptors triggering the activation of IRF3. IRF3, along with NF-kappa B, is a key regulator of IFN-beta expression. Until now, the role of IRF3 in the activation of the innate immune response during Varicella-Zoster Virus (VZV) infection has been poorly studied. In this work, we demonstrated for the first time that VZV rapidly induces an atypical phosphorylation of IRF3 that is inhibitory since it prevents subsequent IRF3 homodimerization and induction of target genes. Using a mutant virus unable to express the viral kinase ORF47p, we demonstrated that (i) IRF3 slower-migrating form disappears; (ii) IRF3 is phosphorylated on serine 396 again and recovers the ability to form homodimers; (iii) amounts of IRF3 target genes such as IFN-beta and ISG15 mRNA are greater than in cells infected with the wild-type virus; and (iv) IRF3 physically interacts with ORF47p. These data led us to hypothesize that the viral kinase ORF47p is involved in the atypical phosphorylation of IRF3 during VZV infection, which prevents its homodimerization and subsequent induction of target genes such as IFN-beta and ISG15.	[Vandevenne, Patricia; Lebrun, Marielle; Ote, Isabelle; Di Valentin, Emmanuel; Habraken, Yvette; Piette, Jacques; Sadzot-Delvaux, Catherine] Univ Liege, GIGA Res, Lab Virol & Immunol, Liege, Belgium; [El Mjiyad, Nadia] Inst Invest Biomed Bellvitge IDIBELL, Lab Mol Oncol LOM, Barcelona, Spain; [Dortu, Estelle] Univ Liege, Dept Pathol, Liege, Belgium	University of Liege; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Liege	Vandevenne, P (corresponding author), Univ Liege, GIGA Res, Lab Virol & Immunol, Liege, Belgium.	csadzot@ulg.ac.be	Lebrun, Marielle/GVT-8895-2022	Di Valentin, Emmanuel/0000-0002-5287-7950; Lobsiger, Christian/0000-0002-4313-010X; Cleveland, Don/0000-0002-1934-3682	Fonds pour la Recherche dans l'Agriculture et l'Industrie" (FRIA, Brussels, Belgium); "Fonds National pour la Recherche Scientifique" (FNRS); Interuniversity Attraction Poles (IAP) Programme [IAP6/18]	Fonds pour la Recherche dans l'Agriculture et l'Industrie" (FRIA, Brussels, Belgium); "Fonds National pour la Recherche Scientifique" (FNRS)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles (IAP) Programme(Belgian Federal Science Policy Office)	The work was supported by the "Fonds pour la Recherche dans l'Agriculture et l'Industrie" (FRIA, Brussels, Belgium), and The "Fonds National pour la Recherche Scientifique" (FNRS). This paper also presents research results of the IAP6/18, funded by the Interuniversity Attraction Poles (IAP) Programme, initiated by the Belgian State, Science Policy Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate DA, 2004, J VIROL, V78, P10995, DOI 10.1128/JVI.78.20.10995-11006.2004; Abendroth A, 2001, J VIROL, V75, P4878, DOI 10.1128/JVI.75.10.4878-4888.2001; Arvin AM, 1996, CLIN MICROBIOL REV, V9, P361, DOI 10.1128/CMR.9.3.361; Boehme KW, 2004, J VIROL, V78, P1202, DOI 10.1128/JVI.78.3.1202-1211.2004; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; DeFilippis VR, 2006, J VIROL, V80, P1032, DOI 10.1128/JVI.80.2.1032-1037.2006; Eidson KM, 2002, J VIROL, V76, P2180, DOI 10.1128/JVI.76.5.2180-2191.2002; Eisfeld AJ, 2006, J VIROL, V80, P1710, DOI 10.1128/JVI.80.4.1710-1723.2006; El Mjiyad N, 2007, J VIROL, V81, P13092, DOI 10.1128/JVI.01378-07; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gershburg E, 2008, BBA-PROTEINS PROTEOM, V1784, P203, DOI 10.1016/j.bbapap.2007.08.009; HEINEMAN TC, 1995, J VIROL, V69, P7367, DOI 10.1128/JVI.69.11.7367-7370.1995; Heineman TC, 1996, J VIROL, V70, P7312, DOI 10.1128/JVI.70.10.7312-7317.1996; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hu HL, 2005, VIROLOGY, V337, P304, DOI 10.1016/j.virol.2005.04.024; Hwang SM, 2009, CELL HOST MICROBE, V5, P166, DOI 10.1016/j.chom.2008.12.013; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Jones JO, 2006, J VIROL, V80, P5113, DOI 10.1128/JVI.01956-05; Kennedy PGE, 2001, VIROLOGY, V289, P218, DOI 10.1006/viro.2001.1173; Kenyon T. K., 2003, Journal of Medical Virology, V70, pS95, DOI 10.1002/jmv.10329; Kenyon TK, 2002, J VIROL, V76, P10980, DOI 10.1128/JVI.76.21.10980-10993.2002; Kenyon TK, 2001, J VIROL, V75, P8854, DOI 10.1128/JVI.75.18.8854-8858.2001; Kinchington PR, 2000, J VIROL, V74, P2265, DOI 10.1128/JVI.74.5.2265-2277.2000; KINCHINGTON PR, 1999, FRONTIERS BIOSCIENCE, V4; Lin RT, 2004, J VIROL, V78, P1675, DOI 10.1128/JVI.78.4.1675-1684.2004; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Melroe GT, 2007, VIROLOGY, V360, P305, DOI 10.1016/j.virol.2006.10.028; Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004; Moffat JF, 1998, P NATL ACAD SCI USA, V95, P11969, DOI 10.1073/pnas.95.20.11969; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; NG TI, 1994, J VIROL, V68, P1350, DOI 10.1128/JVI.68.3.1350-1359.1994; NIKKELS AF, 1993, VIRCHOWS ARCH A, V422, P121, DOI 10.1007/BF01607163; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Reddy SM, 1998, J VIROL, V72, P8083, DOI 10.1128/JVI.72.10.8083-8088.1998; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Schaap A, 2005, J VIROL, V79, P12921, DOI 10.1128/JVI.79.20.12921-12933.2005; Sen N, 2010, J VIROL, V84, P9240, DOI 10.1128/JVI.01147-10; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Servant MJ, 2002, BIOCHEM PHARMACOL, V64, P985, DOI 10.1016/S0006-2952(02)01165-6; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shibaki T, 2001, J INTERF CYTOK RES, V21, P279, DOI 10.1089/107999001300177466; SMITH RF, 1989, J VIROL, V63, P450, DOI 10.1128/JVI.63.1.450-455.1989; Spengler M, 2001, ARCH VIR S, V17, P71; STEVENSON D, 1994, J GEN VIROL, V75, P317, DOI 10.1099/0022-1317-75-2-317; Suhara W, 2000, J BIOCHEM-TOKYO, V128, P301, DOI 10.1093/oxfordjournals.jbchem.a022753; Takaoka A, 2008, ADV DRUG DELIVER REV, V60, P847, DOI 10.1016/j.addr.2007.12.002; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeshita F, 2008, CURR OPIN IMMUNOL, V20, P383, DOI 10.1016/j.coi.2008.05.009; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Taylor RT, 2006, J VIROL, V80, P920, DOI 10.1128/JVI.80.2.920-928.2006; Taylor RT, 2005, J VIROL, V79, P3873, DOI 10.1128/JVI.79.6.3873-3877.2005; VANDEVENNE P, 2010, BIOCH PHARM; Verpooten D, 2009, J BIOL CHEM, V284, P1097, DOI 10.1074/jbc.M805905200; Wang JT, 2009, J VIROL, V83, P1856, DOI 10.1128/JVI.01099-08; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zerboni L, 2000, VIROLOGY, V270, P278, DOI 10.1006/viro.2000.0304	65	95	97	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16870	10.1371/journal.pone.0016870	http://dx.doi.org/10.1371/journal.pone.0016870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347389	gold, Green Published, Green Submitted			2022-12-25	WOS:000287361700047
J	Zhao, CJ; Wang, XF; Zhao, YW; Li, ZM; Lin, S; Wei, YQ; Yang, HS				Zhao, Chengjian; Wang, Xiaofei; Zhao, Yuwei; Li, Zhimian; Lin, Shuo; Wei, Yuquan; Yang, Hanshuo			A Novel Xenograft Model in Zebrafish for High-Resolution Investigating Dynamics of Neovascularization in Tumors	PLOS ONE			English	Article							ANTIANGIOGENIC THERAPY; ANGIOGENESIS; GROWTH; RECRUITMENT; CELLS; METASTASIS; EXPRESSION; DISCOVERY; INVASION; CORNEA	Tumor neovascularization is a highly complex process including multiple steps. Understanding this process, especially the initial stage, has been limited by the difficulties of real-time visualizing the neovascularization embedded in tumor tissues in living animal models. In the present study, we have established a xenograft model in zebrafish by implanting mammalian tumor cells into the perivitelline space of 48 hours old Tg(Flk1:EGFP) transgenic zebrafish embryos. With this model, we dynamically visualized the process of tumor neovascularization, with unprecedented high-resolution, including new sprouts from the host vessels and the origination from VEGFR2(+) individual endothelial cells. Moreover, we quantified their contributions during the formation of vascular network in tumor. Real-time observations revealed that angiogenic sprouts in tumors preferred to connect each other to form endothelial loops, and more and more endothelial loops accumulated into the irregular and chaotic vascular network. The over-expression of VEGF165 in tumor cells significantly affected the vascularization in xenografts, not only the number and size of neo-vessels but the abnormalities of tumor vascular architecture. The specific inhibitor of VEGFR2, SU5416, significantly inhibited the vascularization and the growth of melanoma xenografts, but had little affects to normal vessels in zebrafish. Thus, this zebrafish/tumor xenograft model not only provides a unique window to investigate the earliest events of tumoral neoangiogenesis, but is sensitive to be used as an experimental platform to rapidly and visually evaluate functions of angiogenic-related genes. Finally, it also offers an efficient and cost-effective means for the rapid evaluation of anti-angiogenic chemicals.	[Zhao, Chengjian; Wang, Xiaofei; Zhao, Yuwei; Li, Zhimian; Lin, Shuo; Wei, Yuquan; Yang, Hanshuo] Sichuan Univ, W China Med Sch, State Key Lab Biotherapy, W China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Zhao, Chengjian; Wang, Xiaofei; Zhao, Yuwei; Li, Zhimian; Lin, Shuo; Wei, Yuquan; Yang, Hanshuo] Sichuan Univ, W China Med Sch, Ctr Canc, W China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	Sichuan University; Sichuan University; University of California System; University of California Los Angeles	Zhao, CJ (corresponding author), Sichuan Univ, W China Med Sch, State Key Lab Biotherapy, W China Hosp, Chengdu 610064, Sichuan, Peoples R China.	yhansh@scu.edu.cn		Dong, Jing/0000-0001-9856-5963; Wei, Yu-quan/0000-0002-6211-3217; chen, daozhen/0000-0003-4791-8065	National Key Basic Research Program of China [2010CB529900]	National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Key Basic Research Program of China (2010CB529900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Blagosklonny MV, 2004, CANCER CELL, V5, P13, DOI 10.1016/S1535-6108(03)00336-2; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Dvorak HF, 2003, AM J PATHOL, V162, P1747, DOI 10.1016/S0002-9440(10)64309-X; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Hasan Jurjees, 2004, Angiogenesis, V7, P1, DOI 10.1023/B:AGEN.0000037338.51851.d1; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; JAIN RK, 1994, SCI AM, V271, P58, DOI 10.1038/scientificamerican0794-58; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; KNIGHTON D, 1977, BRIT J CANCER, V35, P347, DOI 10.1038/bjc.1977.49; Lee SLC, 2009, P NATL ACAD SCI USA, V106, P19485, DOI 10.1073/pnas.0909228106; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Nicoli S, 2007, NAT PROTOC, V2, P2918, DOI 10.1038/nprot.2007.412; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Parng C, 2005, CURR OPIN DRUG DISC, V8, P100; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; Phillips G D, 1994, In Vivo, V8, P961; Pichler FB, 2003, NAT BIOTECHNOL, V21, P879, DOI 10.1038/nbt852; Rafii S, 2002, GENE THER, V9, P631, DOI 10.1038/sj.gt.3301723; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Vajkoczy P, 2002, J CLIN INVEST, V109, P777, DOI 10.1172/JCI200214105; Witek ME, 2005, CLIN CANCER RES, V11, P8549, DOI 10.1158/1078-0432.CCR-05-1624; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	31	214	220	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21768	10.1371/journal.pone.0021768	http://dx.doi.org/10.1371/journal.pone.0021768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765912	Green Published, gold, Green Submitted			2022-12-25	WOS:000292781500014
J	Li, YC; Li, YM; Zhang, H; Chen, Y				Li, Yichen; Li, Yumin; Zhang, Hui; Chen, Yong			MicroRNA-Mediated Positive Feedback Loop and Optimized Bistable Switch in a Cancer Network Involving miR-17-92	PLOS ONE			English	Article							CELL-CYCLE OSCILLATOR; GENE-REGULATION; NOISE; HETEROGENEITY; BIOGENESIS; MOTIFS; MEMORY	MicroRNAs (miRNAs) are small, noncoding RNAs that play an important role in many key biological processes, including development, cell differentiation, the cell cycle and apoptosis, as central post-transcriptional regulators of gene expression. Recent studies have shown that miRNAs can act as oncogenes and tumor suppressors depending on the context. The present work focuses on the physiological significance of miRNAs and their role in regulating the switching behavior. We illustrate an abstract model of the Myc/E2F/miR-17-92 network presented by Aguda et al. (2008), which is composed of coupling between the E2F/Myc positive feedback loops and the E2F/Myc/miR-17-92 negative feedback loop. By systematically analyzing the network in close association with plausible experimental parameters, we show that, in the presence of miRNAs, the system bistability emerges from the system, with a bistable switch and a one-way switch presented by Aguda et al. instead of a single one-way switch. Moreover, the miRNAs can optimize the switching process. The model produces a diverse array of response-signal behaviors in response to various potential regulating scenarios. The model predicts that this transition exists, one from cell death or the cancerous phenotype directly to cell quiescence, due to the existence of miRNAs. It was also found that the network involving miR-17-92 exhibits high noise sensitivity due to a positive feedback loop and also maintains resistance to noise from a negative feedback loop.	[Li, Yichen; Li, Yumin] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China; [Li, Yichen; Li, Yumin; Chen, Yong] Key Lab Digest Syst Tumors, Lanzhou, Peoples R China; [Zhang, Hui; Chen, Yong] Lanzhou Univ, Inst Theoret Phys, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University	Li, YC (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China.	liym@lzu.edu.cn; ychen@lzu.edu.cn	peng, yu/GXW-2071-2022; li, Yu/HCI-9086-2022; Chen, Yong/B-9051-2008; Romeis, Joerg/J-5360-2013; li, yu/HGL-9518-2022	Chen, Yong/0000-0003-2580-5895; Romeis, Joerg/0000-0003-3652-8360; 	National Natural Science Foundation of China [10975063, 30870364]; High Technology Research and Development Program of China (863 program) [2007AA021807]; Key Technology R&D Program of Gansu Province [0708NKCA129]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); Key Technology R&D Program of Gansu Province	This work was supported by the National Natural Science Foundation of China (Grant No. 10975063, 30870364), the High Technology Research and Development Program of China (863 program, Grant No. 2007AA021807), and The Key Technology R&D Program of Gansu Province (Grant No. 0708NKCA129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Barrio M, 2006, PLOS COMPUT BIOL, V2, P1017, DOI 10.1371/journal.pcbi.0020117; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 2001, CHAOS, V11, P221, DOI 10.1063/1.1350440; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Coller HA, 2007, PLOS GENET, V3, P1319, DOI 10.1371/journal.pgen.0030146; Cui QH, 2007, TRENDS GENET, V23, P372, DOI 10.1016/j.tig.2007.04.003; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; KASDIN NJ, 1995, P IEEE, V83, P802, DOI 10.1109/5.381848; KASDIN NJ, 1995, J GUID CONTROL DYNAM, V18, P114, DOI 10.2514/3.56665; Khanin R, 2008, J COMPUT BIOL, V15, P305, DOI 10.1089/cmb.2007.0184; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li MF, 2010, AAPS J, V12, P309, DOI 10.1208/s12248-010-9194-0; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Ramsey SA, 2006, NAT GENET, V38, P1082, DOI 10.1038/ng1869; Schlicht R, 2008, J MATH BIOL, V57, P613, DOI 10.1007/s00285-008-0178-y; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Smolen P, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031902; Tian XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011926; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; van der Pol B, 1926, PHILOS MAG, V2, P978; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wee KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004407; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wolf DM, 2003, CURR OPIN MICROBIOL, V6, P125, DOI 10.1016/S1369-5274(03)00033-X; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zhang XP, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031924; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106	53	76	84	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26302	10.1371/journal.pone.0026302	http://dx.doi.org/10.1371/journal.pone.0026302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022595	Green Submitted, Green Published, gold			2022-12-25	WOS:000295981600052
J	Dai, JN; Zong, Y; Zhong, LM; Li, YM; Zhang, W; Bian, LG; Ai, QL; Liu, YD; Sun, J; Lu, D				Dai, Ji-Nan; Zong, Yi; Zhong, Lian-Mei; Li, Yue-Min; Zhang, Wei; Bian, Li-Gong; Ai, Qing-Long; Liu, Yi-Dan; Sun, Jun; Lu, Di			Gastrodin Inhibits Expression of Inducible NO Synthase, Cyclooxygenase-2 and Proinflammatory Cytokines in Cultured LPS-Stimulated Microglia via MAPK Pathways	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; ADAPTIVE IMMUNE-RESPONSES; P-HYDROXYBENZYL ALCOHOL; CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE; NEURODEGENERATIVE DISEASES; SIGNALING PATHWAYS; CELLS; INFLAMMATION	Background: Microglial activation plays an important role in neurodegenerative diseases by producing several proinflammatory enzymes and proinflammatory cytokines. The phenolic glucoside gastrodin, a main constituent of a Chinese herbal medicine, has been known to display anti-inflammatory properties. The current study investigates the potential mechanisms whereby gastrodin affects the expression of potentially pro-inflammatory proteins by cultured murine microglial BV-2 cells stimulated with lipopolysaccharide (LPS). Methodology/Principal Findings: BV-2 cells were pretreated with gastrodin (30, 40, and 60 mu M) for 1 h and then stimulated with LPS (1 mu g/ml) for another 4 h. The effects on proinflammatory enzymes, inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), and proinflammatory cytokines, tumor necrosis factor-alpha (TNF-alpha), and interleukin-1 beta (IL-1 beta), are analysed by double-immunofluorescence labeling and RT-PCR assay. To reveal the mechanisms of action of gastrodin we investigated the involvement of mitogen-activated protein kinases (MAPKs) cascades and their downstream transcription factors, nuclear factor-kappa B (NF-kappa B) and cyclic AMP-responsive element (CRE)-binding protein (CREB). Gastrodin significantly reduced the LPS-induced protein and mRNA expression levels of iNOS, COX-2, TNF-alpha, IL-1 beta and NF-kappa B. LPS (1 mu g/ml, 30 min)-induced phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal protein kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) and this was inhibited by pretreatment of BV-2 cells with different concentrations of gastrodin (30, 40, and 60 mu M). In addition, gastrodin blocked LPS-induced phosphorylation of inhibitor kappa B-alpha (I kappa B-alpha) (and hence the activation of NF-kappa B) and of CREB, respectively. Conclusion and Implications: This study indicates that gastrodin significantly attenuate levels of neurotoxic proinflammatory mediators and proinflammatory cytokines by inhibition of the NF-kappa B signaling pathway and phosphorylation of MAPKs in LPS-stimulated microglial cells. Arising from the above, we suggest that gastrodin has a potential as an anti-inflammatory drug candidate in neurodegenerative diseases.	[Dai, Ji-Nan; Zong, Yi; Li, Yue-Min; Bian, Li-Gong; Sun, Jun; Lu, Di] Kunming Med Univ, Dept Anat, Kunming, Yunnan, Peoples R China; [Zhong, Lian-Mei; Zhang, Wei; Ai, Qing-Long] Kunming Med Univ, Affiliated Hosp 1, Dept Neurol, Kunming, Yunnan, Peoples R China; [Liu, Yi-Dan] Kunming Pharmaceut Corp, Kunming, Yunnan, Peoples R China; [Lu, Di] Kunming Med Univ, Rehabil Engn Res Lab, Biomed Engn Res Ctr, Kunming, Yunnan, Peoples R China	Kunming Medical University; Kunming Medical University; Kunming Medical University	Dai, JN (corresponding author), Kunming Med Univ, Dept Anat, Kunming, Yunnan, Peoples R China.	sunjun91@hotmail.com; ludi20040609@126.com		FRANCK, Gregory/0000-0002-4288-9034; Michineau, Stephanie/0000-0001-7752-2956; GERVAIS, Marianne/0000-0002-4431-789X	National Natural Sciences Foundation of China [30860336, 30560170]; Department of Science and Technology of Yunnan Province [2008CC007, 2009CI033]; Department of Science and Technology of Yunnan Province-Kunming Medical University [2008CD016, 2010CD156]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Yunnan Province; Department of Science and Technology of Yunnan Province-Kunming Medical University	This work was supported in part by grants (30860336 and 30560170) from the National Natural Sciences Foundation of China, the grants (2008CC007 and 2009CI033) from the Department of Science and Technology of Yunnan Province, and the grants (2008CD016 and 2010CD156) from the Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ajmone-Cat MA, 2003, J NEUROCHEM, V84, P413, DOI 10.1046/j.1471-4159.2003.01562.x; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001; Asanuma M, 2004, CURR PHARM DESIGN, V10, P695, DOI 10.2174/1381612043453072; Bal-Price A, 2002, J NEUROCHEM, V80, P73, DOI 10.1046/j.0022-3042.2001.00675.x; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Cao Q, 2010, J NEUROSCI RES, V88, P2701, DOI 10.1002/jnr.22429; Chen SR, 2010, BIOL PHARM BULL, V33, P1307, DOI 10.1248/bpb.33.1307; Choi Y, 2009, BRIT J PHARMACOL, V156, P933, DOI 10.1111/j.1476-5381.2009.00022.x; Fontana A, 2010, BRAIN, V133, P1300, DOI 10.1093/brain/awq086; Giovannini MG, 2003, INT J IMMUNOPATH PH, V16, P31; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hatziieremia S, 2006, BRIT J PHARMACOL, V149, P188, DOI 10.1038/sj.bjp.0706856; Hsieh MT, 1997, J ETHNOPHARMACOL, V56, P45, DOI 10.1016/S0378-8741(96)01501-2; Klegeris A, 2007, CURR OPIN NEUROL, V20, P351, DOI 10.1097/WCO.0b013e3280adc943; Lee MJ, 2009, J PHARMACOL SCI, V111, P216, DOI 10.1254/jphs.09153SC; Liang X, 2007, J MOL NEUROSCI, V33, P94, DOI 10.1007/s12031-007-0058-8; Lim JY, 2010, EUR J PHARMACOL, V642, P10, DOI 10.1016/j.ejphar.2010.05.047; Lin LC, 2008, J PHARMACEUT BIOMED, V48, P909, DOI 10.1016/j.jpba.2008.07.013; Long-Smith CM, 2009, PROG NEUROBIOL, V89, P277, DOI 10.1016/j.pneurobio.2009.08.001; Lue LF, 2010, MOL NEUROBIOL, V41, P115, DOI 10.1007/s12035-010-8106-8; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Matsuda T, 2005, AM J TRANSPLANT, V5, P484, DOI 10.1046/j.1600-6143.2004.00716.x; Miller RL, 2009, NEUROCHEM RES, V34, P55, DOI 10.1007/s11064-008-9656-2; Murphy S, 2000, GLIA, V29, P1, DOI 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N; Nakajima K, 1998, Hum Cell, V11, P141; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Nam KN, 2008, EUR J PHARMACOL, V589, P53, DOI 10.1016/j.ejphar.2008.03.034; Nam KN, 2010, EUR J PHARMACOL, V648, P110, DOI 10.1016/j.ejphar.2010.09.003; Ojemann LM, 2006, EPILEPSY BEHAV, V8, P376, DOI 10.1016/j.yebeh.2005.12.009; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Roy A, 2006, J BIOL CHEM, V281, P14971, DOI 10.1074/jbc.M600236200; SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; Son HY, 2009, J PHARMACOL SCI, V109, P368, DOI 10.1254/jphs.08197FP; Spooren A, 2010, CELL SIGNAL, V22, P871, DOI 10.1016/j.cellsig.2010.01.018; Suzumura A, 2006, ANN NY ACAD SCI, V1088, P219, DOI 10.1196/annals.1366.012; Szczepanik AM, 2003, J ALZHEIMERS DIS, V5, P105, DOI 10.3233/JAD-2003-5205; Tai YF, 2007, BRAIN RES BULL, V72, P148, DOI 10.1016/j.brainresbull.2006.10.029; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Vaillancourt F, 2007, J CELL BIOCHEM, V100, P1217, DOI 10.1002/jcb.21110; Vitor CE, 2009, BRIT J PHARMACOL, V157, P1034, DOI 10.1111/j.1476-5381.2009.00271.x; Wang JY, 2003, J NEUROSCI RES, V72, P508, DOI 10.1002/jnr.10597; Wang MJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-99; Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640; Wu CR, 1996, PLANTA MED, V62, P317, DOI 10.1055/s-2006-957892; Xu X, 2007, PLANTA MED, V73, P650, DOI 10.1055/s-2007-981523; Yabe T, 2005, GLIA, V50, P223, DOI 10.1002/glia.20171; Zeng XH, 2006, PLANTA MED, V72, P1359, DOI 10.1055/s-2006-951709	49	185	205	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21891	10.1371/journal.pone.0021891	http://dx.doi.org/10.1371/journal.pone.0021891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	22194945	Green Published, Green Submitted, gold			2022-12-25	WOS:000292699000014
J	Schmeier, S; Schaefer, U; MacPherson, CR; Bajic, VB				Schmeier, Sebastian; Schaefer, Ulf; MacPherson, Cameron R.; Bajic, Vladimir B.			dPORE-miRNA: Polymorphic Regulation of MicroRNA Genes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; DATABASE; CANCER; IDENTIFICATION; DISEASES; UPDATE; ROLES; SITES; SNP	Background: MicroRNAs (miRNAs) are short non-coding RNA molecules that act as post-transcriptional regulators and affect the regulation of protein-coding genes. Mostly transcribed by PolII, miRNA genes are regulated at the transcriptional level similarly to protein-coding genes. In this study we focus on human miRNAs. These miRNAs are involved in a variety of pathways and can affect many diseases. Our interest is on possible deregulation of the transcription initiation of the miRNA encoding genes, which is facilitated by variations in the genomic sequence of transcriptional control regions (promoters). Methodology: Our aim is to provide an online resource to facilitate the investigation of the potential effects of single nucleotide polymorphisms (SNPs) on miRNA gene regulation. We analyzed SNPs overlapped with predicted transcription factor binding sites (TFBSs) in promoters of miRNA genes. We also accounted for the creation of novel TFBSs due to polymorphisms not present in the reference genome. The resulting changes in the original TFBSs and potential creation of new TFBSs were incorporated into the Dragon Database of Polymorphic Regulation of miRNA genes (dPORE-miRNA). Conclusions: The dPORE-miRNA database enables researchers to explore potential effects of SNPs on the regulation of miRNAs. dPORE-miRNA can be interrogated with regards to: a/miRNAs (their targets, or involvement in diseases, or biological pathways), b/SNPs, or c/transcription factors. dPORE-miRNA can be accessed at http://cbrc.kaust.edu.sa/dpore and http://apps.sanbi.ac.za/dpore/. Its use is free for academic and non-profit users.	[Schmeier, Sebastian; Schaefer, Ulf; MacPherson, Cameron R.; Bajic, Vladimir B.] King Abdullah Univ Sci & Technol KAUST, Computat Biosci Res Ctr CBRC, Jeddah, Saudi Arabia	King Abdullah University of Science & Technology	Schmeier, S (corresponding author), King Abdullah Univ Sci & Technol KAUST, Computat Biosci Res Ctr CBRC, Jeddah, Saudi Arabia.	vladimir.bajic@kaust.edu.sa	Schmeier, Sebastian/D-4731-2011; Bajic, Vladimir/D-2810-2009	Schmeier, Sebastian/0000-0002-3947-8226; MacPherson, Cameron/0000-0002-8945-9736; Bajic, Vladimir/0000-0001-5435-4750; Jankovic, Boris/0000-0003-1868-6007				Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Bandiera S, 2010, CLIN GENET, V77, P306, DOI 10.1111/j.1399-0004.2010.01370.x; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Bracht J, 2004, RNA, V10, P1586, DOI 10.1261/rna.7122604; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Canella D, 2010, GENOME RES, V20, P710, DOI 10.1101/gr.101337.109; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Du LQ, 2010, CANCER METAST REV, V29, P109, DOI 10.1007/s10555-010-9204-9; Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hariharan M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-108; Heckmann JM, 2010, GENES IMMUN, V11, P1, DOI 10.1038/gene.2009.61; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim BC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S2; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li GQ, 2010, BLOOD, V115, P1416, DOI 10.1182/blood-2009-07-234963; Loeffler-Ragg J, 2008, EXPERT OPIN INV DRUG, V17, P1517, DOI 10.1517/13543784.17.10.1517 ; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Milanezi F, 2008, EXPERT REV MOL DIAGN, V8, P417, DOI 10.1586/14737159.8.4.417; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schmeier S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-595; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Yu ZR, 2010, AM J PATHOL, V176, P1058, DOI 10.2353/ajpath.2010.090664; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	50	27	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16657	10.1371/journal.pone.0016657	http://dx.doi.org/10.1371/journal.pone.0016657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21750739	gold, Green Submitted, Green Published			2022-12-25	WOS:000287037000016
